OMIM:606864	Carney-Stratakis syndrome	GO:0000104	succinate dehydrogenase activity	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:606864	Carney-Stratakis syndrome	GO:0045257	succinate dehydrogenase complex (ubiquinone)	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:606864	Carney-Stratakis syndrome	GO:0045283	fumarate reductase complex	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:606864	Carney-Stratakis syndrome	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:606864	Carney-Stratakis syndrome	GO:0006099	tricarboxylic acid cycle	3.368854750718242e-9	7.430009152709083e-5	3	29	3
OMIM:268150	Rh deficiency syndrome	GO:0019740	nitrogen utilization	5.162592575658209e-11	1.138609792561418e-6	3	8	3
OMIM:268150	Rh deficiency syndrome	GO:0015695	organic cation transport	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
OMIM:268150	Rh deficiency syndrome	GO:0072488	ammonium transmembrane transport	1.8660706313511355e-9	4.115618777444929e-5	3	24	3
OMIM:268150	Rh deficiency syndrome	GO:0008519	ammonium transmembrane transporter activity	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
DOID:0050594	glycogen storage disease IX	GO:0004689	phosphorylase kinase activity	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
DOID:0050594	glycogen storage disease IX	GO:0005964	phosphorylase kinase complex	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
DOID:0050594	glycogen storage disease IX	GO:0005980	glycogen catabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
OMIM:220290	Deafness, Autosomal Recessive 1A	GO:0005922	connexon complex	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
DOID:0060241	3-M syndrome	GO:1990393	3M complex	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:604571	MHC class I deficiency	GO:0042825	TAP complex	9.275913370743183e-13	2.045802693917409e-8	3	3	3
OMIM:604571	MHC class I deficiency	GO:0015440	peptide-transporting ATPase activity	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:604571	MHC class I deficiency	GO:0046977	TAP binding	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:604571	MHC class I deficiency	GO:0046978	TAP1 binding	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:604571	MHC class I deficiency	GO:0019885	antigen processing and presentation of endogenous peptide antigen via MHC class I	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
OMIM:604571	MHC class I deficiency	GO:0042287	MHC protein binding	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
DOID:0050798	cerebral creatine deficiency syndrome	GO:0006600	creatine metabolic process	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
DOID:0050731	vitamin B12 deficiency	GO:0009235	cobalamin metabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
DOID:0050721	serine deficiency	GO:0006564	L-serine biosynthetic process	3.687494753989995e-12	8.132769679924934e-8	3	4	3
Orphanet:51083	Familial short QT syndrome	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	3.226485745244645e-11	7.116014311137064e-7	3	7	3
Orphanet:51083	Familial short QT syndrome	GO:0086013	membrane repolarization during cardiac muscle cell action potential	1.1062939453410081e-10	2.4399312964495934e-6	3	10	3
Orphanet:51083	Familial short QT syndrome	GO:1901381	positive regulation of potassium ion transmembrane transport	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
Orphanet:51083	Familial short QT syndrome	GO:0060306	regulation of membrane repolarization	3.368854750718242e-9	7.430009152709083e-5	3	29	3
Orphanet:51083	Familial short QT syndrome	GO:0086091	regulation of heart rate by cardiac conduction	3.743259924249287e-9	8.255759762931802e-5	3	30	3
OMIM:230400	galactosemia	GO:0019388	galactose catabolic process	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0031720	haptoglobin binding	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0031838	haptoglobin-hemoglobin complex	3.687494753989995e-12	8.132769679924934e-8	3	4	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0005833	hemoglobin complex	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0005344	oxygen transporter activity	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0015671	oxygen transport	4.194929958956095e-10	9.251918024477668e-6	3	15	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0071682	endocytic vesicle lumen	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
Orphanet:330041	Autosomal dominant methemoglobinemia	GO:0042744	hydrogen peroxide catabolic process	1.2262154625020116e-9	2.7044182025481867e-5	3	21	3
OMIM:158320	Muir-Torre syndrome	GO:0032137	guanine/thymine mispair binding	9.275913370743183e-13	2.045802693917409e-8	3	3	3
OMIM:158320	Muir-Torre syndrome	GO:0032404	mismatch repair complex binding	5.162592575658209e-11	1.138609792561418e-6	3	8	3
OMIM:158320	Muir-Torre syndrome	GO:0032300	mismatch repair complex	5.162592575658209e-11	1.138609792561418e-6	3	8	3
OMIM:158320	Muir-Torre syndrome	GO:0016446	somatic hypermutation of immunoglobulin genes	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
OMIM:158320	Muir-Torre syndrome	GO:0045910	negative regulation of DNA recombination	5.162886784759735e-10	1.1386746803787595e-5	3	16	3
OMIM:158320	Muir-Torre syndrome	GO:0006298	mismatch repair	3.743259924249287e-9	8.255759762931802e-5	3	30	3
OMIM:608930	Myasthenic Syndrome, Congenital, 1B, Fast-Channel	GO:0004889	acetylcholine-activated cation-selective channel activity	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
OMIM:608930	Myasthenic Syndrome, Congenital, 1B, Fast-Channel	GO:0005892	acetylcholine-gated channel complex	7.523148770616217e-10	1.6592304613594067e-5	3	18	3
OMIM:608930	Myasthenic Syndrome, Congenital, 1B, Fast-Channel	GO:0042166	acetylcholine binding	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
OMIM:608930	Myasthenic Syndrome, Congenital, 1B, Fast-Channel	GO:0015464	acetylcholine receptor activity	1.8660706313511355e-9	4.115618777444929e-5	3	24	3
OMIM:608930	Myasthenic Syndrome, Congenital, 1B, Fast-Channel	GO:0007274	neuromuscular synaptic transmission	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
Orphanet:268145	Classic maple syrup urine disease	GO:0005947	mitochondrial alpha-ketoglutarate dehydrogenase complex	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
Orphanet:268145	Classic maple syrup urine disease	GO:0009083	branched-chain amino acid catabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:268145	Classic maple syrup urine disease	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:268173	Intermittent maple syrup urine disease	GO:0005947	mitochondrial alpha-ketoglutarate dehydrogenase complex	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
Orphanet:268173	Intermittent maple syrup urine disease	GO:0009083	branched-chain amino acid catabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:268173	Intermittent maple syrup urine disease	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:268184	Thiamine-responsive maple syrup urine disease	GO:0005947	mitochondrial alpha-ketoglutarate dehydrogenase complex	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
Orphanet:268184	Thiamine-responsive maple syrup urine disease	GO:0009083	branched-chain amino acid catabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:268184	Thiamine-responsive maple syrup urine disease	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
OMIM:616004	Familial dysfibrinogenemia	GO:0005577	fibrinogen complex	7.744938024245585e-11	1.7081460812473637e-6	3	9	3
OMIM:616004	Familial dysfibrinogenemia	GO:0034116	positive regulation of heterotypic cell-cell adhesion	1.1062939453410081e-10	2.4399312964495934e-6	3	10	3
OMIM:616004	Familial dysfibrinogenemia	GO:0031639	plasminogen activation	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
OMIM:616004	Familial dysfibrinogenemia	GO:2000352	negative regulation of endothelial cell apoptotic process	2.12057427173562e-9	4.67692655631291e-5	3	25	3
OMIM:616004	Familial dysfibrinogenemia	GO:0072378	blood coagulation, fibrin clot formation	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
OMIM:616004	Familial dysfibrinogenemia	GO:0042730	fibrinolysis	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
OMIM:616004	Familial dysfibrinogenemia	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
DOID:11446	sciatic neuropathy	GO:0003708	retinoic acid receptor activity	3.226485745244645e-11	7.116014311137064e-7	3	7	3
DOID:11446	sciatic neuropathy	GO:0055012	ventricular cardiac muscle cell differentiation	7.523148770616217e-10	1.6592304613594067e-5	3	18	3
OMIM:112600	Brachydactyly type A2	GO:0061036	positive regulation of cartilage development	3.368854750718242e-9	7.430009152709083e-5	3	29	3
Orphanet:79178	Glucose transport disorder	GO:0035428	hexose transmembrane transport	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
Orphanet:79178	Glucose transport disorder	GO:1904659	glucose transmembrane transport	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
Orphanet:79178	Glucose transport disorder	GO:0005355	glucose transmembrane transporter activity	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
Orphanet:31153	Hypoalphalipoproteinemia	GO:0034380	high-density lipoprotein particle assembly	7.744938024245585e-11	1.7081460812473637e-6	3	9	3
Orphanet:31153	Hypoalphalipoproteinemia	GO:0043691	reverse cholesterol transport	5.162886784759735e-10	1.1386746803787595e-5	3	16	3
Orphanet:31153	Hypoalphalipoproteinemia	GO:0034364	high-density lipoprotein particle	2.12057427173562e-9	4.67692655631291e-5	3	25	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0018636	phenanthrene 9,10-monooxygenase activity	9.275913370743183e-13	2.045802693917409e-8	3	3	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0047086	ketosteroid monooxygenase activity	9.275913370743183e-13	2.045802693917409e-8	3	3	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0009753	response to jasmonic acid	3.687494753989995e-12	8.132769679924934e-8	3	4	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0071395	cellular response to jasmonic acid stimulus	3.687494753989995e-12	8.132769679924934e-8	3	4	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0047115	trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity	3.687494753989995e-12	8.132769679924934e-8	3	4	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0004032	alditol:NADP+ 1-oxidoreductase activity	3.226485745244645e-11	7.116014311137064e-7	3	7	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0044597	daunorubicin metabolic process	5.162592575658209e-11	1.138609792561418e-6	3	8	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0044598	doxorubicin metabolic process	5.162592575658209e-11	1.138609792561418e-6	3	8	3
MESH:D009376	Neoplasms, Hormone-Dependent	GO:0042448	progesterone metabolic process	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
OMIM:264350	Generalized pseudohypoaldosteronism type 1	GO:0015280	ligand-gated sodium channel activity	7.744938024245585e-11	1.7081460812473637e-6	3	9	3
OMIM:264350	Generalized pseudohypoaldosteronism type 1	GO:0034706	sodium channel complex	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
OMIM:264350	Generalized pseudohypoaldosteronism type 1	GO:0050699	WW domain binding	3.368854750718242e-9	7.430009152709083e-5	3	29	3
OMIM:130000	Ehlers-Danlos syndrome, classic type	GO:0098643	banded collagen fibril	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
OMIM:130000	Ehlers-Danlos syndrome, classic type	GO:0005583	fibrillar collagen trimer	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
DOID:9275	tyrosinemia	GO:0006572	tyrosine catabolic process	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
DOID:9275	tyrosinemia	GO:0006559	L-phenylalanine catabolic process	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
OMIM:252150	Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A	GO:0051189	prosthetic group metabolic process	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
OMIM:252150	Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A	GO:0006777	Mo-molybdopterin cofactor biosynthetic process	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
OMIM:120435	Lynch Syndrome 1	GO:0032300	mismatch repair complex	5.162592575658209e-11	1.138609792561418e-6	3	8	3
OMIM:120435	Lynch Syndrome 1	GO:0030983	mismatched DNA binding	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
OMIM:120435	Lynch Syndrome 1	GO:0006298	mismatch repair	3.743259924249287e-9	8.255759762931802e-5	3	30	3
Orphanet:399994	Rare male infertility due to adrenal disorder of genetic origin	GO:0008211	glucocorticoid metabolic process	1.8660706313511355e-9	4.115618777444929e-5	3	24	3
OMIM:602522	Bartter Syndrome, Type 4A	GO:0005247	voltage-gated chloride channel activity	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
OMIM:602522	Bartter Syndrome, Type 4A	GO:1903959	regulation of anion transmembrane transport	4.1442890230669605e-9	9.140229440374181e-5	3	31	3
Orphanet:289857	Neonatal glycine encephalopathy	GO:0006546	glycine catabolic process	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289857	Neonatal glycine encephalopathy	GO:0019464	glycine decarboxylation via glycine cleavage system	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289857	Neonatal glycine encephalopathy	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:289863	Atypical glycine encephalopathy	GO:0006546	glycine catabolic process	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289863	Atypical glycine encephalopathy	GO:0019464	glycine decarboxylation via glycine cleavage system	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289863	Atypical glycine encephalopathy	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:289860	Infantile glycine encephalopathy	GO:0006546	glycine catabolic process	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289860	Infantile glycine encephalopathy	GO:0019464	glycine decarboxylation via glycine cleavage system	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:289860	Infantile glycine encephalopathy	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
DOID:2580	rhizomelic chondrodysplasia punctata	GO:0046504	glycerol ether biosynthetic process	3.687494753989995e-12	8.132769679924934e-8	3	4	3
DOID:2580	rhizomelic chondrodysplasia punctata	GO:0097384	cellular lipid biosynthetic process	3.687494753989995e-12	8.132769679924934e-8	3	4	3
DOID:2580	rhizomelic chondrodysplasia punctata	GO:0008611	ether lipid biosynthetic process	3.687494753989995e-12	8.132769679924934e-8	3	4	3
DC:0000699	Atrial Standstill	GO:0060306	regulation of membrane repolarization	3.368854750718242e-9	7.430009152709083e-5	3	29	3
MESH:D004915	Leukemia, Erythroblastic, Acute	GO:0044205	'de novo' UMP biosynthetic process	9.275913370743183e-13	2.045802693917409e-8	3	3	3
MESH:D004915	Leukemia, Erythroblastic, Acute	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
Orphanet:88637	Hypomyelination-hypogonadotropic-hypogonadism-hypodontia syndrome	GO:0001056	RNA polymerase III activity	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:88637	Hypomyelination-hypogonadotropic-hypogonadism-hypodontia syndrome	GO:0005666	DNA-directed RNA polymerase III complex	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
MESH:D006960	Hyperoxaluria, Primary	GO:0046487	glyoxylate metabolic process	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:98408	Constitutional megaloblastic anemia due to folate metabolism disorder	GO:0005542	folic acid binding	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
Orphanet:98408	Constitutional megaloblastic anemia due to folate metabolism disorder	GO:0006760	folic acid-containing compound metabolic process	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
MESH:C580205	Isodicentric Chromosome 15 Syndrome	GO:1902711	GABA-A receptor complex	7.523148770616217e-10	1.6592304613594067e-5	3	18	3
MESH:C580205	Isodicentric Chromosome 15 Syndrome	GO:0004890	GABA-A receptor activity	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:231512	Hermansky-Pudlak syndrome without pulmonary fibrosis	GO:0031084	BLOC-2 complex	9.275913370743183e-13	2.045802693917409e-8	3	3	3
OMIM:140700	Heinz body anemia	GO:0031720	haptoglobin binding	9.275913370743183e-13	2.045802693917409e-8	3	3	3
OMIM:140700	Heinz body anemia	GO:0031838	haptoglobin-hemoglobin complex	3.687494753989995e-12	8.132769679924934e-8	3	4	3
OMIM:140700	Heinz body anemia	GO:0005833	hemoglobin complex	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
OMIM:140700	Heinz body anemia	GO:0005344	oxygen transporter activity	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
OMIM:140700	Heinz body anemia	GO:0015671	oxygen transport	4.194929958956095e-10	9.251918024477668e-6	3	15	3
OMIM:140700	Heinz body anemia	GO:0071682	endocytic vesicle lumen	6.269079699805502e-10	1.3826455277921035e-5	3	17	3
OMIM:140700	Heinz body anemia	GO:0042744	hydrogen peroxide catabolic process	1.2262154625020116e-9	2.7044182025481867e-5	3	21	3
Orphanet:289103	Hypocalcemic rickets	GO:0042368	vitamin D biosynthetic process	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
OMIM:133200	Transgrediens et progrediens palmoplantar keratoderma	GO:0005922	connexon complex	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:98985	Early-onset sutural cataract	GO:0005212	structural constituent of eye lens	1.2262154625020116e-9	2.7044182025481867e-5	3	21	3
Orphanet:306577	Sodium channelopathy-related small fiber neuropathy	GO:0001518	voltage-gated sodium channel complex	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
Orphanet:306577	Sodium channelopathy-related small fiber neuropathy	GO:0005248	voltage-gated sodium channel activity	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:306577	Sodium channelopathy-related small fiber neuropathy	GO:0019228	neuronal action potential	4.1442890230669605e-9	9.140229440374181e-5	3	31	3
OMIM:231200	Bernard-Soulier syndrome	GO:0007597	blood coagulation, intrinsic pathway	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
OMIM:143465	Attention Deficit-Hyperactivity Disorder	GO:0035240	dopamine binding	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
OMIM:143465	Attention Deficit-Hyperactivity Disorder	GO:0001963	synaptic transmission, dopaminergic	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:93422	Type 11 collagen-related bone disorder	GO:0098643	banded collagen fibril	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
Orphanet:93422	Type 11 collagen-related bone disorder	GO:0005583	fibrillar collagen trimer	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
Orphanet:298644	Disorder of thiamine metabolism and transport	GO:0042723	thiamine-containing compound metabolic process	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
Orphanet:308459	Disorder of glycolysis	GO:0061718	glucose catabolic process to pyruvate	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
Orphanet:308459	Disorder of glycolysis	GO:0061621	canonical glycolysis	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
Orphanet:308459	Disorder of glycolysis	GO:0051156	glucose 6-phosphate metabolic process	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
Orphanet:308463	Disorder of fructose metabolism	GO:0006000	fructose metabolic process	4.194929958956095e-10	9.251918024477668e-6	3	15	3
OMIM:277580	Waardenburg Syndrome, Type 4A	GO:0030318	melanocyte differentiation	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
MESH:D013981	Tic Disorders	GO:0001504	neurotransmitter uptake	2.12057427173562e-9	4.67692655631291e-5	3	25	3
OMIM:216360	Joubert syndrome with hepatic defect	GO:0035869	ciliary transition zone	2.12057427173562e-9	4.67692655631291e-5	3	25	3
Orphanet:101041	Familial hypofibrinogenemia	GO:0005577	fibrinogen complex	7.744938024245585e-11	1.7081460812473637e-6	3	9	3
Orphanet:101041	Familial hypofibrinogenemia	GO:0034116	positive regulation of heterotypic cell-cell adhesion	1.1062939453410081e-10	2.4399312964495934e-6	3	10	3
Orphanet:101041	Familial hypofibrinogenemia	GO:0031639	plasminogen activation	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:101041	Familial hypofibrinogenemia	GO:2000352	negative regulation of endothelial cell apoptotic process	2.12057427173562e-9	4.67692655631291e-5	3	25	3
Orphanet:101041	Familial hypofibrinogenemia	GO:0072378	blood coagulation, fibrin clot formation	2.397144815979857e-9	5.2869028916435745e-5	3	26	3
Orphanet:101041	Familial hypofibrinogenemia	GO:0042730	fibrinolysis	2.6968018929096615e-9	5.9477965748122585e-5	3	27	3
Orphanet:101041	Familial hypofibrinogenemia	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	3.0203937129158476e-9	6.661478333835902e-5	3	28	3
Orphanet:394529	Multiple acyl-CoA dehydrogenation deficiency, severe neonatal type	GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:394532	Multiple acyl-CoA dehydrogenation deficiency, mild type	GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:622	Homocystinuria without methylmalonic aciduria	GO:0009235	cobalamin metabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
Orphanet:254749	Tricarboxylic acid cycle disorder	GO:0006099	tricarboxylic acid cycle	3.368854750718242e-9	7.430009152709083e-5	3	29	3
MESH:C562716	Delta-Beta Thalassemia	GO:0005833	hemoglobin complex	2.0283319468461514e-10	4.473486108769187e-6	3	12	3
MESH:C562716	Delta-Beta Thalassemia	GO:0005344	oxygen transporter activity	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
MESH:C562716	Delta-Beta Thalassemia	GO:0015671	oxygen transport	4.194929958956095e-10	9.251918024477668e-6	3	15	3
MESH:C535306	2-Hydroxyglutaricaciduria	GO:0006103	2-oxoglutarate metabolic process	1.0510335934910131e-9	2.3180545904444294e-5	3	20	3
DOID:3321	gangliosidosis GM2	GO:0004563	beta-N-acetylhexosaminidase activity	9.218514840370062e-12	2.0331434480436172e-7	3	5	3
OMIM:224230	Dyskeratosis Congenita, Autosomal Recessive 1	GO:0070034	telomerase RNA binding	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
OMIM:224230	Dyskeratosis Congenita, Autosomal Recessive 1	GO:0005697	telomerase holoenzyme complex	8.933879191985739e-10	1.9703670557924546e-5	3	19	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0034372	very-low-density lipoprotein particle remodeling	1.1062939453410081e-10	2.4399312964495934e-6	3	10	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0034375	high-density lipoprotein particle remodeling	3.3558544831890913e-10	7.401337062673541e-6	3	14	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0043691	reverse cholesterol transport	5.162886784759735e-10	1.1386746803787595e-5	3	16	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0034364	high-density lipoprotein particle	2.12057427173562e-9	4.67692655631291e-5	3	25	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0055090	acylglycerol homeostasis	3.368854750718242e-9	7.430009152709083e-5	3	29	3
Orphanet:181428	Hyperalphalipoproteinemia	GO:0070328	triglyceride homeostasis	3.368854750718242e-9	7.430009152709083e-5	3	29	3
OMIM:601539	Peroxisome Biogenesis Disorder 1B	GO:0016558	protein import into peroxisome matrix	2.637010609873869e-10	5.815926900076818e-6	3	13	3
OMIM:131800	Localized epidermolysis bullosa simplex	GO:0031581	hemidesmosome assembly	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
Orphanet:166002	Multiple epiphyseal dysplasia due to collagen 9 anomaly	GO:0005594	collagen type IX trimer	9.275913370743183e-13	2.045802693917409e-8	3	3	3
Orphanet:166002	Multiple epiphyseal dysplasia due to collagen 9 anomaly	GO:0030020	extracellular matrix structural constituent conferring tensile strength	1.8436696613832737e-11	4.06621343818081e-7	3	6	3
OMIM:601675	Trichothiodystrophy 1, Photosensitive	GO:0000439	core TFIIH complex	7.744938024245585e-11	1.7081460812473637e-6	3	9	3
OMIM:601675	Trichothiodystrophy 1, Photosensitive	GO:0006293	nucleotide-excision repair, preincision complex stabilization	1.4198685560629087e-9	3.131520100396745e-5	3	22	3
OMIM:601675	Trichothiodystrophy 1, Photosensitive	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	1.4198685560629087e-9	3.131520100396745e-5	3	22	3
OMIM:601675	Trichothiodystrophy 1, Photosensitive	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	1.6328420837652402e-9	3.601233215744237e-5	3	23	3
OMIM:601675	Trichothiodystrophy 1, Photosensitive	GO:0006294	nucleotide-excision repair, preincision complex assembly	3.743259924249287e-9	8.255759762931802e-5	3	30	3
OMIM:226730	Junctional epidermolysis bullosa - pyloric atresia	GO:0030056	hemidesmosome	3.226485745244645e-11	7.116014311137064e-7	3	7	3
OMIM:226730	Junctional epidermolysis bullosa - pyloric atresia	GO:0031581	hemidesmosome assembly	1.5213075243991625e-10	3.355243745062353e-6	3	11	3
MESH:D015318	Fructose Metabolism, Inborn Errors	GO:0006000	fructose metabolic process	4.194929958956095e-10	9.251918024477668e-6	3	15	3
DOID:0050577	Sensenbrenner syndrome	GO:0035721	intraciliary retrograde transport	1.021405182655144e-14	2.2527091303459201e-10	4	9	4
DOID:0050577	Sensenbrenner syndrome	GO:0030991	intraciliary transport particle A	1.176836406102666e-14	2.5955126936594297e-10	4	8	4
DOID:0050577	Sensenbrenner syndrome	GO:0097542	ciliary tip	2.4488411298762003e-11	5.40091911194196e-7	4	43	4
DOID:0050573	2-hydroxyglutaric aciduria	GO:0006103	2-oxoglutarate metabolic process	4.201340386700281e-9	9.266056222867469e-5	3	20	4
DOID:0050642	hypochromic microcytic anemia	GO:0097286	iron ion import	6.08308403649005e-10	1.3416241842478804e-5	3	11	4
DOID:11758	iron deficiency anemia	GO:0006879	cellular iron ion homeostasis	2.949074318081557e-11	6.504183408528874e-7	4	45	4
Orphanet:220489	Rare hereditary hemochromatosis	GO:0006879	cellular iron ion homeostasis	2.949074318081557e-11	6.504183408528874e-7	4	45	4
DOID:0050459	hyperphosphatemia	GO:0071774	response to fibroblast growth factor	2.5365273215172124e-9	5.594311007606212e-5	4	134	4
DOID:0050449	pachyonychia congenita	GO:0005200	structural constituent of cytoskeleton	8.064626744186398e-10	1.77865342843031e-5	4	101	4
DOID:0050558	Ullrich congenital muscular dystrophy	GO:0030574	collagen catabolic process	1.5149681509285529e-10	3.3412622568729233e-6	4	67	4
DOID:0050558	Ullrich congenital muscular dystrophy	GO:0005581	collagen trimer	4.605857917283629e-10	1.0158219636569044e-5	4	88	4
DOID:0060237	Warburg micro syndrome	GO:0071786	endoplasmic reticulum tubular network organization	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
DOID:0060237	Warburg micro syndrome	GO:0034389	lipid particle organization	1.341791233677725e-9	2.9593205658762223e-5	3	14	4
DOID:0050793	short QT syndrome	GO:0086011	membrane repolarization during action potential	2.808864252301646e-13	6.19495010845128e-9	4	15	4
DOID:0050793	short QT syndrome	GO:0086002	cardiac muscle cell action potential involved in contraction	1.1570744362643381e-11	2.551927669180998e-7	4	36	4
DOID:0050793	short QT syndrome	GO:1904064	positive regulation of cation transmembrane transport	1.7065171498131804e-10	3.7637235739129693e-6	4	69	4
DOID:0050793	short QT syndrome	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	2.506345797570475e-9	5.527745656541683e-5	3	17	4
DOID:0050713	fatal infantile encephalocardiomyopathy	GO:0008535	respiratory chain complex IV assembly	3.0074905899013515e-9	6.633020496027431e-5	3	18	4
DOID:653	purine-pyrimidine metabolic disorder	GO:0006144	purine nucleobase metabolic process	3.571294704407535e-9	7.876490470570818e-5	3	19	4
OMIM:102370	Acromicric dysplasia	GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus	1.253547265989141e-10	2.7646984951390507e-6	4	64	4
OMIM:102370	Acromicric dysplasia	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	1.253547265989141e-10	2.7646984951390507e-6	4	64	4
Orphanet:217454	Rare hereditary thrombophilia	GO:1900046	regulation of hemostasis	3.9993952594130633e-10	8.820666244635511e-6	4	85	4
Orphanet:217454	Rare hereditary thrombophilia	GO:0030193	regulation of blood coagulation	3.9993952594130633e-10	8.820666244635511e-6	4	85	4
OMIM:242300	Bathing suit ichthyosis	GO:0061436	establishment of skin barrier	2.506345797570475e-9	5.527745656541683e-5	3	17	4
OMIM:109400	nevoid basal cell carcinoma syndrome	GO:0008589	regulation of smoothened signaling pathway	1.1016687562204197e-10	2.4297304418441357e-6	4	62	4
OMIM:109400	nevoid basal cell carcinoma syndrome	GO:0001708	cell fate specification	3.287273786511946e-10	7.250082336152097e-6	4	81	4
OMIM:109400	nevoid basal cell carcinoma syndrome	GO:0060831	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	1.0543306228072424e-9	2.3253261886013732e-5	3	13	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0032404	mismatch repair complex binding	1.176836406102666e-14	2.5955126936594297e-10	4	8	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0032300	mismatch repair complex	1.176836406102666e-14	2.5955126936594297e-10	4	8	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0016446	somatic hypermutation of immunoglobulin genes	9.592326932761353e-14	2.1155877050205163e-9	4	12	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0030983	mismatched DNA binding	9.592326932761353e-14	2.1155877050205163e-9	4	12	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0032137	guanine/thymine mispair binding	3.687494753989995e-12	8.132769679924934e-8	3	3	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0006298	mismatch repair	5.375144773722695e-12	1.1854881798445405e-7	4	30	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0032138	single base insertion or deletion binding	1.4754197863453555e-11	3.2540383387846816e-7	3	4	4
Orphanet:99817	Non-polyposis Turcot syndrome	GO:0045910	negative regulation of DNA recombination	2.0641363063234053e-9	4.5524526235962703e-5	3	16	4
MESH:D007010	Hyponatremia	GO:0042538	hyperosmotic salinity response	7.373879284955365e-11	1.6263090762969057e-6	3	6	4
MESH:D019247	HIV Wasting Syndrome	GO:0006953	acute-phase response	5.777256451011681e-11	1.2741739102706262e-6	4	53	4
MESH:D019247	HIV Wasting Syndrome	GO:0042035	regulation of cytokine biosynthetic process	6.287712572827786e-10	1.3867550079371682e-5	4	95	4
MESH:D019247	HIV Wasting Syndrome	GO:0045073	regulation of chemokine biosynthetic process	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
MESH:D019247	HIV Wasting Syndrome	GO:0001660	fever generation	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
MESH:D019247	HIV Wasting Syndrome	GO:0050707	regulation of cytokine secretion	3.207012766459627e-9	7.073066656426708e-5	4	142	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0009650	UV protection	9.592326932761353e-14	2.1155877050205163e-9	4	12	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0006293	nucleotide-excision repair, preincision complex stabilization	1.5005774400833616e-12	3.309523544103854e-8	4	22	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	1.5005774400833616e-12	3.309523544103854e-8	4	22	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	1.4499512701604544e-11	3.1978675263388823e-7	4	38	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0006283	transcription-coupled nucleotide-excision repair	2.399885845605354e-10	5.292948232482608e-6	4	75	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0016591	DNA-directed RNA polymerase II, holoenzyme	7.746496777372158e-10	1.7084898642494295e-5	4	100	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0090575	RNA polymerase II transcription factor complex	8.394772654796157e-10	1.8514671090152923e-5	4	102	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0047485	protein N-terminus binding	8.732573553160705e-10	1.9259690971495935e-5	4	103	4
Orphanet:220295	Xeroderma pigmentosum-Cockayne syndrome complex	GO:0005675	holo TFIIH complex	1.0543306228072424e-9	2.3253261886013732e-5	3	13	4
OMIM:249000	Meckel Syndrome, Type 1	GO:0036038	TCTN-B9D complex	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
OMIM:609192	Loeys-Dietz Syndrome 1	GO:0005160	transforming growth factor beta receptor binding	4.551048427003934e-11	1.0037337305757177e-6	4	50	4
OMIM:609192	Loeys-Dietz Syndrome 1	GO:0010717	regulation of epithelial to mesenchymal transition	1.5149681509285529e-10	3.3412622568729233e-6	4	67	4
Orphanet:79196	Disorder of the gamma-glutamyl cycle	GO:0006750	glutathione biosynthetic process	2.808864252301646e-13	6.19495010845128e-9	4	15	4
MESH:C538118	Hidradenitis suppurativa, familial	GO:0007220	Notch receptor processing	2.0641363063234053e-9	4.5524526235962703e-5	3	16	4
MESH:C538118	Hidradenitis suppurativa, familial	GO:0042987	amyloid precursor protein catabolic process	3.571294704407535e-9	7.876490470570818e-5	3	19	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0008137	NADH dehydrogenase (ubiquinone) activity	2.949074318081557e-11	6.504183408528874e-7	4	45	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	5.777256451011681e-11	1.2741739102706262e-6	4	53	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0010257	NADH dehydrogenase complex assembly	1.0300515995709247e-10	2.2717788028536745e-6	4	61	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0097031	mitochondrial respiratory chain complex I biogenesis	1.0300515995709247e-10	2.2717788028536745e-6	4	61	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0032981	mitochondrial respiratory chain complex I assembly	1.0300515995709247e-10	2.2717788028536745e-6	4	61	4
OMIM:500001	Leber Optic Atrophy and Dystonia	GO:0070469	respiratory chain	5.046947304521154e-10	1.1131042280121406e-5	4	90	4
Orphanet:28	Vitamin B12-responsive methylmalonic acidemia	GO:0009235	cobalamin metabolic process	9.711120796396244e-13	2.1417876916451917e-8	4	20	4
DOID:14452	hypokalemic periodic paralysis	GO:0022843	voltage-gated cation channel activity	3.895782030305384e-9	8.592147267838524e-5	4	149	4
Orphanet:2524	Pontocerebellar hypoplasia type 2	GO:0000379	tRNA-type intron splice site recognition and cleavage	3.687494753989995e-12	8.132769679924934e-8	3	3	4
Orphanet:2524	Pontocerebellar hypoplasia type 2	GO:0000213	tRNA-intron endonuclease activity	1.4754197863453555e-11	3.2540383387846816e-7	3	4	4
Orphanet:2524	Pontocerebellar hypoplasia type 2	GO:0000214	tRNA-intron endonuclease complex	1.4754197863453555e-11	3.2540383387846816e-7	3	4	4
OMIM:242600	Iminoglycinuria	GO:0003333	amino acid transmembrane transport	1.4250178814734227e-10	3.1428769375896337e-6	4	66	4
OMIM:242600	Iminoglycinuria	GO:0015171	amino acid transmembrane transporter activity	2.671520782371317e-10	5.89203908551994e-6	4	77	4
OMIM:242600	Iminoglycinuria	GO:0015294	solute:cation symporter activity	7.136328195045394e-10	1.5739171834172616e-5	4	98	4
OMIM:242600	Iminoglycinuria	GO:0005328	neurotransmitter:sodium symporter activity	3.571294704407535e-9	7.876490470570818e-5	3	19	4
Orphanet:319543	Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency	GO:0060333	interferon-gamma-mediated signaling pathway	3.123760139445153e-10	6.889452987546285e-6	4	80	4
Orphanet:319543	Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	4.201340386700281e-9	9.266056222867469e-5	3	20	4
OMIM:158810	Bethlem myopathy	GO:0030574	collagen catabolic process	1.5149681509285529e-10	3.3412622568729233e-6	4	67	4
OMIM:158810	Bethlem myopathy	GO:0005581	collagen trimer	4.605857917283629e-10	1.0158219636569044e-5	4	88	4
DC:0000488	Cardioencephalomyopathy, Fatal Infantile	GO:0008535	respiratory chain complex IV assembly	3.0074905899013515e-9	6.633020496027431e-5	3	18	4
DC:0000274	Methylmalonic Aciduria and Homocystinuria	GO:0009235	cobalamin metabolic process	9.711120796396244e-13	2.1417876916451917e-8	4	20	4
DC:0000202	Hyperphenylalaninemia, BH4-Deficient	GO:0006729	tetrahydrobiopterin biosynthetic process	5.995204332975845e-15	1.3222423156378227e-10	4	7	4
DC:0000203	Hyperphosphatasia with Mental Retardation Syndrome	GO:0006506	GPI anchor biosynthetic process	8.030576204021145e-12	1.7711435817968635e-7	4	33	4
Orphanet:309130	Disorder of carnitine cycle and carnitine transport	GO:1902603	carnitine transmembrane transport	9.592326932761353e-14	2.1155877050205163e-9	4	12	4
Orphanet:309130	Disorder of carnitine cycle and carnitine transport	GO:0006853	carnitine shuttle	3.0969360409471847e-10	6.830292438309016e-6	3	9	4
Orphanet:238583	Hyperphenylalaninemia	GO:0006729	tetrahydrobiopterin biosynthetic process	5.995204332975845e-15	1.3222423156378227e-10	4	7	4
DC:0000600	Thiamine-Responsive Dysfunction Syndrome	GO:0042723	thiamine-containing compound metabolic process	7.373879284955365e-11	1.6263090762969057e-6	3	6	4
DC:0000564	Mosaic Variegated Aneuploidy Syndrome	GO:0000070	mitotic sister chromatid segregation	1.6228324239975223e-9	3.579156911126535e-5	4	120	4
DOID:12932	endomyocardial fibrosis	GO:0044236	multicellular organismal metabolic process	2.0414820944836265e-9	4.502488759383638e-5	4	127	4
DOID:10327	anthracosis	GO:0001660	fever generation	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
DOID:10327	anthracosis	GO:0005149	interleukin-1 receptor binding	2.0641363063234053e-9	4.5524526235962703e-5	3	16	4
DOID:10327	anthracosis	GO:0034114	regulation of heterotypic cell-cell adhesion	2.506345797570475e-9	5.527745656541683e-5	3	17	4
OMIM:149400	Hyperekplexia, Hereditary 1	GO:0060012	synaptic transmission, glycinergic	2.0647850096366938e-10	4.553883338753728e-6	3	8	4
OMIM:269160	Schizencephaly	GO:0021978	telencephalon regionalization	1.0543306228072424e-9	2.3253261886013732e-5	3	13	4
DOID:5759	sebaceous gland neoplasm	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	5.348854692499572e-11	1.1796899024307805e-6	4	52	4
DOID:5759	sebaceous gland neoplasm	GO:0002285	lymphocyte activation involved in immune response	3.5885693305814925e-9	7.914589658597482e-5	4	146	4
DOID:3012	Li-Fraumeni syndrome	GO:0090399	replicative senescence	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
Orphanet:280763	Severe intellectual disability and progressive spastic paraplegia	GO:0031904	endosome lumen	2.1155299734232358e-12	4.6658013563849465e-8	4	24	4
Orphanet:280763	Severe intellectual disability and progressive spastic paraplegia	GO:0032588	trans-Golgi network membrane	3.123760139445153e-10	6.889452987546285e-6	4	80	4
Orphanet:370980	Congenital muscular dystrophy without intellectual disability	GO:0035269	protein O-linked mannosylation	3.544942117628125e-13	7.81836984042883e-9	4	16	4
Orphanet:308998	Disorder of glyoxylate metabolism	GO:0006081	cellular aldehyde metabolic process	4.1940750872271337e-10	9.250032604879443e-6	4	86	4
OMIM:267430	Renal tubular dysgenesis of genetic origin	GO:0002016	regulation of blood volume by renin-angiotensin	6.683542608243442e-14	1.4740553222480912e-9	4	11	4
OMIM:267430	Renal tubular dysgenesis of genetic origin	GO:0002018	renin-angiotensin regulation of aldosterone production	1.4754197863453555e-11	3.2540383387846816e-7	3	4	4
OMIM:267430	Renal tubular dysgenesis of genetic origin	GO:0002003	angiotensin maturation	6.08308403649005e-10	1.3416241842478804e-5	3	11	4
DOID:9410	panhypopituitarism	GO:0021983	pituitary gland development	2.2136736888000996e-11	4.88225732064862e-7	4	42	4
Orphanet:98609	EEC syndrome and related syndrome	GO:0060601	lateral sprouting from an epithelium	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
Orphanet:98609	EEC syndrome and related syndrome	GO:0060572	morphogenesis of an epithelial bud	2.0641363063234053e-9	4.5524526235962703e-5	3	16	4
Orphanet:60033	Idiopathic bronchiectasis	GO:0015280	ligand-gated sodium channel activity	3.0969360409471847e-10	6.830292438309016e-6	3	9	4
Orphanet:60033	Idiopathic bronchiectasis	GO:0034706	sodium channel complex	2.506345797570475e-9	5.527745656541683e-5	3	17	4
Orphanet:60033	Idiopathic bronchiectasis	GO:0055067	monovalent inorganic cation homeostasis	3.207012766459627e-9	7.073066656426708e-5	4	142	4
MESH:D057130	Leber Congenital Amaurosis	GO:0031513	nonmotile primary cilium	2.5365273215172124e-9	5.594311007606212e-5	4	134	4
Orphanet:98853	Autosomal dominant Emery-Dreifuss muscular dystrophy	GO:0006997	nucleus organization	2.3867507970010138e-9	5.263978882785736e-5	4	132	4
Orphanet:353327	Congenital myasthenic syndromes with glycosylation defect	GO:0006488	dolichol-linked oligosaccharide biosynthetic process	4.201340386700281e-9	9.266056222867469e-5	3	20	4
Orphanet:3276	Disorder of plasmalogens biosynthesis	GO:0046485	ether lipid metabolic process	7.105427357601002e-15	1.567102003718901e-10	4	6	4
Orphanet:3276	Disorder of plasmalogens biosynthesis	GO:0031907	microbody lumen	2.2136736888000996e-11	4.88225732064862e-7	4	42	4
Orphanet:3276	Disorder of plasmalogens biosynthesis	GO:0005782	peroxisomal matrix	2.2136736888000996e-11	4.88225732064862e-7	4	42	4
Orphanet:93216	Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes	GO:0061318	renal filtration cell differentiation	2.506345797570475e-9	5.527745656541683e-5	3	17	4
Orphanet:93216	Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes	GO:0072112	glomerular visceral epithelial cell differentiation	2.506345797570475e-9	5.527745656541683e-5	3	17	4
OMIM:214150	COFS syndrome	GO:0006283	transcription-coupled nucleotide-excision repair	2.399885845605354e-10	5.292948232482608e-6	4	75	4
OMIM:214150	COFS syndrome	GO:0009650	UV protection	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
OMIM:608099	Muscular Dystrophy, Limb-Girdle, Type 2D	GO:0016012	sarcoglycan complex	7.105427357601002e-15	1.567102003718901e-10	4	6	4
OMIM:608099	Muscular Dystrophy, Limb-Girdle, Type 2D	GO:0042383	sarcolemma	1.9145474094983683e-9	4.2225343116486513e-5	4	125	4
DOID:13100	intracranial vasospasm	GO:0048306	calcium-dependent protein binding	9.632039610352194e-11	2.1243463360631765e-6	4	60	4
DOID:13100	intracranial vasospasm	GO:0044548	S100 protein binding	1.0543306228072424e-9	2.3253261886013732e-5	3	13	4
Orphanet:370	Glycogen storage disease due to phosphorylase kinase deficiency	GO:0004689	phosphorylase kinase activity	5.995204332975845e-15	1.3222423156378227e-10	4	5	4
Orphanet:370	Glycogen storage disease due to phosphorylase kinase deficiency	GO:0005964	phosphorylase kinase complex	5.995204332975845e-15	1.3222423156378227e-10	4	5	4
Orphanet:370	Glycogen storage disease due to phosphorylase kinase deficiency	GO:0005980	glycogen catabolic process	4.0135672563224034e-12	8.851922583819061e-8	4	28	4
OMIM:608106	Hyper-IgM syndrome type 5	GO:0002208	somatic diversification of immunoglobulins involved in immune response	1.4499512701604544e-11	3.1978675263388823e-7	4	38	4
OMIM:608106	Hyper-IgM syndrome type 5	GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	1.4499512701604544e-11	3.1978675263388823e-7	4	38	4
OMIM:608106	Hyper-IgM syndrome type 5	GO:0045190	isotype switching	1.4499512701604544e-11	3.1978675263388823e-7	4	38	4
DOID:13025	retinopathy of prematurity	GO:0035426	extracellular matrix-cell signaling	3.6869063357869436e-11	8.131471923578104e-7	3	5	4
DOID:13025	retinopathy of prematurity	GO:0061299	retina vasculature morphogenesis in camera-type eye	3.0969360409471847e-10	6.830292438309016e-6	3	9	4
Orphanet:46532	Hereditary persistence of fetal hemoglobin - beta-thalassemia	GO:0005833	hemoglobin complex	8.11041234172194e-10	1.7887514419667738e-5	3	12	4
Orphanet:46532	Hereditary persistence of fetal hemoglobin - beta-thalassemia	GO:0005344	oxygen transporter activity	1.341791233677725e-9	2.9593205658762223e-5	3	14	4
Orphanet:46532	Hereditary persistence of fetal hemoglobin - beta-thalassemia	GO:0015671	oxygen transport	1.6771934951975709e-9	3.6990502536582426e-5	3	15	4
Orphanet:250984	Autosomal recessive Stickler syndrome	GO:0005594	collagen type IX trimer	3.687494753989995e-12	8.132769679924934e-8	3	3	4
Orphanet:250984	Autosomal recessive Stickler syndrome	GO:0030020	extracellular matrix structural constituent conferring tensile strength	7.373879284955365e-11	1.6263090762969057e-6	3	6	4
OMIM:253290	Multiple Pterygium Syndrome, Lethal Type	GO:0007274	neuromuscular synaptic transmission	3.4398039971961225e-12	7.586487715816048e-8	4	27	4
OMIM:253290	Multiple Pterygium Syndrome, Lethal Type	GO:0007271	synaptic transmission, cholinergic	1.621824896602675e-11	3.5769348094571995e-7	4	39	4
OMIM:253290	Multiple Pterygium Syndrome, Lethal Type	GO:0004889	acetylcholine-activated cation-selective channel activity	2.506345797570475e-9	5.527745656541683e-5	3	17	4
OMIM:253290	Multiple Pterygium Syndrome, Lethal Type	GO:0005892	acetylcholine-gated channel complex	3.0074905899013515e-9	6.633020496027431e-5	3	18	4
OMIM:253290	Multiple Pterygium Syndrome, Lethal Type	GO:0042166	acetylcholine binding	3.571294704407535e-9	7.876490470570818e-5	3	19	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0004889	acetylcholine-activated cation-selective channel activity	4.594102875898898e-13	1.0132293892795019e-8	4	17	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0005892	acetylcholine-gated channel complex	5.880851361439454e-13	1.2970217677654716e-8	4	18	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0042166	acetylcholine binding	7.893685705084863e-13	1.7409523822564665e-8	4	19	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0015464	acetylcholine receptor activity	2.1155299734232358e-12	4.6658013563849465e-8	4	24	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0007274	neuromuscular synaptic transmission	3.4398039971961225e-12	7.586487715816048e-8	4	27	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0007271	synaptic transmission, cholinergic	1.621824896602675e-11	3.5769348094571995e-7	4	39	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0003009	skeletal muscle contraction	1.802191729183278e-11	3.9747338587137193e-7	4	40	4
OMIM:601462	Myasthenic Syndrome, Congenital, 1A, Slow-Channel	GO:0035094	response to nicotine	6.243516814663508e-11	1.3770076334740367e-6	4	54	4
OMIM:177200	Liddle syndrome	GO:0015280	ligand-gated sodium channel activity	3.0969360409471847e-10	6.830292438309016e-6	3	9	4
OMIM:177200	Liddle syndrome	GO:0034706	sodium channel complex	2.506345797570475e-9	5.527745656541683e-5	3	17	4
OMIM:601680	Sheldon-Hall syndrome	GO:0033275	actin-myosin filament sliding	1.621824896602675e-11	3.5769348094571995e-7	4	39	4
OMIM:601680	Sheldon-Hall syndrome	GO:0030049	muscle filament sliding	1.621824896602675e-11	3.5769348094571995e-7	4	39	4
OMIM:601680	Sheldon-Hall syndrome	GO:0005865	striated muscle thin filament	4.201340386700281e-9	9.266056222867469e-5	3	20	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0006555	methionine metabolic process	2.808864252301646e-13	6.19495010845128e-9	4	15	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0042558	pteridine-containing compound metabolic process	9.18531917193377e-12	2.025822143369993e-7	4	34	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0006767	water-soluble vitamin metabolic process	4.1940750872271337e-10	9.250032604879443e-6	4	86	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0009086	methionine biosynthetic process	6.08308403649005e-10	1.3416241842478804e-5	3	11	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0050667	homocysteine metabolic process	1.341791233677725e-9	2.9593205658762223e-5	3	14	4
OMIM:601634	Neural Tube Defects, Folate-Sensitive	GO:0046655	folic acid metabolic process	2.506345797570475e-9	5.527745656541683e-5	3	17	4
MESH:D003384	Coxsackievirus Infections	GO:0015651	quaternary ammonium group transmembrane transporter activity	2.0647850096366938e-10	4.553883338753728e-6	3	8	4
MESH:D003384	Coxsackievirus Infections	GO:0015697	quaternary ammonium group transport	3.0074905899013515e-9	6.633020496027431e-5	3	18	4
MESH:D003384	Coxsackievirus Infections	GO:0015695	organic cation transport	4.201340386700281e-9	9.266056222867469e-5	3	20	4
OMIM:226700	Junctional epidermolysis bullosa, Herlitz type	GO:0031581	hemidesmosome assembly	6.683542608243442e-14	1.4740553222480912e-9	4	11	4
OMIM:226700	Junctional epidermolysis bullosa, Herlitz type	GO:0043256	laminin complex	2.0647850096366938e-10	4.553883338753728e-6	3	8	4
DOID:1270	hereditary hemorrhagic telangiectasia	GO:0030513	positive regulation of BMP signaling pathway	7.175815497362237e-12	1.5826261079432413e-7	4	32	4
DOID:1270	hereditary hemorrhagic telangiectasia	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	3.850086915946349e-11	8.491366693119673e-7	4	48	4
DOID:1270	hereditary hemorrhagic telangiectasia	GO:0045446	endothelial cell differentiation	4.605857917283629e-10	1.0158219636569044e-5	4	88	4
OMIM:613776	chromosome 17p13.1 deletion syndrome	GO:0021987	cerebral cortex development	9.44338163222369e-10	2.082737818986935e-5	4	105	4
OMIM:613776	chromosome 17p13.1 deletion syndrome	GO:0001764	neuron migration	2.7742124153462555e-9	6.118525482046167e-5	4	137	4
OMIM:100300	Adams-Oliver syndrome	GO:0061314	Notch signaling involved in heart development	1.1057530446834107e-9	2.4387383400492624e-5	3	10	5
OMIM:100300	Adams-Oliver syndrome	GO:0003222	ventricular trabecula myocardium morphogenesis	1.5202816783244089e-9	3.352981241544484e-5	3	11	5
DOID:0050580	hereditary lymphedema	GO:0001946	lymphangiogenesis	3.352998878547453e-9	7.395039026636407e-5	3	14	5
DOID:11725	Cornelia de Lange syndrome	GO:0007062	sister chromatid cohesion	1.1620926443356439e-11	2.5629953270822625e-7	5	123	5
DOID:11725	Cornelia de Lange syndrome	GO:0036033	mediator complex binding	3.687616878522704e-11	8.133039025581823e-7	3	4	5
DOID:11725	Cornelia de Lange syndrome	GO:0030893	meiotic cohesin complex	3.2259128701639384e-10	7.114750835146566e-6	3	7	5
DOID:820	myocarditis	GO:0015651	quaternary ammonium group transmembrane transporter activity	5.160798455250415e-10	1.138214099305479e-5	3	8	5
Orphanet:99097	Single ventricular septal defect	GO:0035050	embryonic heart tube development	1.1330415494725798e-9	2.498923137361775e-5	4	74	5
Orphanet:171430	Severe congenital nemaline myopathy	GO:0030017	sarcomere	7.887701602982133e-11	1.7396325885377095e-6	5	180	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0086065	cell communication involved in cardiac conduction	1.5221157667610896e-13	3.357026323591583e-9	5	48	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	1.0510370351823894e-11	2.31806218109476e-7	4	24	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0010644	cell communication by electrical coupling	1.4727774555467477e-11	3.248210678208352e-7	4	26	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0034704	calcium channel complex	5.141398418118115e-10	1.1339354211159502e-5	4	61	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:1903779	regulation of cardiac conduction	7.551220759793864e-10	1.6654217385725367e-5	4	67	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0014701	junctional sarcoplasmic reticulum membrane	7.74087793864453e-10	1.707250629368051e-5	3	9	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:1901019	regulation of calcium ion transmembrane transporter activity	9.02979246930613e-10	1.991520729105467e-5	4	70	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0006936	muscle contraction	1.5030602318333308e-9	3.314999341308411e-5	5	323	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity	1.5202816783244089e-9	3.352981241544484e-5	3	11	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0055117	regulation of cardiac muscle contraction	1.899415402739635e-9	4.1891606707422646e-5	4	84	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0010649	regulation of cell communication by electrical coupling	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0002027	regulation of heart rate	2.1907582414826265e-9	4.831717301589933e-5	4	87	5
OMIM:604772	Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy	GO:0005513	detection of calcium ion	2.6347352077848996e-9	5.810908500769596e-5	3	13	5
DOID:0060306	Meier-Gorlin syndrome	GO:0006270	DNA replication initiation	4.569755684968868e-11	1.0078596163198839e-6	4	34	5
DOID:0060306	Meier-Gorlin syndrome	GO:0000082	G1/S transition of mitotic cell cycle	2.3766899559518606e-10	5.241789697851829e-6	5	224	5
DOID:0060306	Meier-Gorlin syndrome	GO:0000808	origin recognition complex	7.74087793864453e-10	1.707250629368051e-5	3	9	5
DOID:0060306	Meier-Gorlin syndrome	GO:0005664	nuclear origin of replication recognition complex	7.74087793864453e-10	1.707250629368051e-5	3	9	5
Orphanet:217572	Glycogen storage disease with hypertrophic cardiomyopathy	GO:0005977	glycogen metabolic process	1.2633143420259785e-9	2.7862397813382955e-5	4	76	5
Orphanet:90776	46,XX disorder of sex development induced by fetal androgens excess	GO:0042446	hormone biosynthetic process	5.868981967083187e-10	1.2944039728401968e-5	4	63	5
Orphanet:90776	46,XX disorder of sex development induced by fetal androgens excess	GO:0006705	mineralocorticoid biosynthetic process	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:90786	46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect	GO:0042446	hormone biosynthetic process	3.850253449400043e-13	8.491733982651795e-9	5	63	5
Orphanet:90786	46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect	GO:0008211	glucocorticoid metabolic process	1.0510370351823894e-11	2.31806218109476e-7	4	24	5
Orphanet:90786	46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect	GO:0006694	steroid biosynthetic process	3.044853258415969e-11	6.71542386143642e-7	5	149	5
Orphanet:90786	46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect	GO:0006702	androgen biosynthetic process	3.352998878547453e-9	7.395039026636407e-5	3	14	5
Orphanet:90786	46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect	GO:0071371	cellular response to gonadotropin stimulus	4.190931046643698e-9	9.243098423372675e-5	3	15	5
OMIM:606176	Permanent neonatal diabetes mellitus	GO:0090276	regulation of peptide hormone secretion	1.3060663661690342e-10	2.880529370585805e-6	5	199	5
OMIM:606176	Permanent neonatal diabetes mellitus	GO:0050708	regulation of protein secretion	3.403189396955497e-9	7.505734214985349e-5	5	380	5
Orphanet:95157	Acute hepatic porphyria	GO:0006782	protoporphyrinogen IX biosynthetic process	5.140332604014475e-14	1.1337003558153924e-9	4	8	5
Orphanet:95157	Acute hepatic porphyria	GO:0051597	response to methylmercury	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
DOID:11247	disseminated intravascular coagulation	GO:0018214	protein carboxylation	1.5202816783244089e-9	3.352981241544484e-5	3	11	5
DOID:11247	disseminated intravascular coagulation	GO:0017187	peptidyl-glutamic acid carboxylation	1.5202816783244089e-9	3.352981241544484e-5	3	11	5
DOID:11247	disseminated intravascular coagulation	GO:1900046	regulation of hemostasis	1.9930525008149402e-9	4.395677290547351e-5	4	85	5
DOID:11247	disseminated intravascular coagulation	GO:0030193	regulation of blood coagulation	1.9930525008149402e-9	4.395677290547351e-5	4	85	5
DOID:13809	familial combined hyperlipidemia	GO:0034372	very-low-density lipoprotein particle remodeling	1.1057530446834107e-9	2.4387383400492624e-5	3	10	5
DOID:13809	familial combined hyperlipidemia	GO:0042627	chylomicron	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:293355	Methylmalonic acidemia without homocystinuria	GO:0019626	short-chain fatty acid catabolic process	1.8434598292316196e-10	4.065750653370337e-6	3	6	5
OMIM:246900	Pyruvate dehydrogenase E3 deficiency	GO:0009083	branched-chain amino acid catabolic process	1.7763568394002505e-15	3.9177550092972524e-11	5	20	5
OMIM:246900	Pyruvate dehydrogenase E3 deficiency	GO:0045240	dihydrolipoyl dehydrogenase complex	2.148281552649678e-13	4.738034964368865e-9	4	10	5
OMIM:246900	Pyruvate dehydrogenase E3 deficiency	GO:0046487	glyoxylate metabolic process	2.0245471965552042e-11	4.465138842002503e-7	4	28	5
OMIM:246900	Pyruvate dehydrogenase E3 deficiency	GO:0005947	mitochondrial alpha-ketoglutarate dehydrogenase complex	9.217082652668296e-11	2.0328275790459926e-6	3	5	5
OMIM:209950	Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency	GO:0071346	cellular response to interferon-gamma	1.6886270159943706e-11	3.7242668837755843e-7	5	133	5
OMIM:209950	Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency	GO:0004896	cytokine receptor activity	2.402921417399284e-9	5.299643186074121e-5	4	89	5
Orphanet:309568	Defect in conserved oligomeric Golgi complex	GO:0017119	Golgi transport complex	1.4432899320127035e-15	3.1831759450540176e-11	5	12	5
Orphanet:309568	Defect in conserved oligomeric Golgi complex	GO:0032588	trans-Golgi network membrane	1.3352652317166758e-12	2.9449274685511284e-8	5	80	5
Orphanet:309568	Defect in conserved oligomeric Golgi complex	GO:0006888	ER to Golgi vesicle-mediated transport	5.5503046603178063e-11	1.2241196928330922e-6	5	168	5
Orphanet:309568	Defect in conserved oligomeric Golgi complex	GO:0006891	intra-Golgi vesicle-mediated transport	1.75889858233802e-10	3.879250823346503e-6	4	47	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0036109	alpha-linolenic acid metabolic process	1.0325074129013956e-14	2.277195099154028e-10	5	13	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0033540	fatty acid beta-oxidation using acyl-CoA oxidase	1.0325074129013956e-14	2.277195099154028e-10	5	13	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0044438	microbody part	2.292166456641098e-12	5.055373120121942e-8	5	90	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0044439	peroxisomal part	2.292166456641098e-12	5.055373120121942e-8	5	90	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0000038	very long-chain fatty acid metabolic process	2.0245471965552042e-11	4.465138842002503e-7	4	28	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0031907	microbody lumen	1.1046508152645629e-10	2.4363073730659934e-6	4	42	5
Orphanet:79188	Peroxisomal beta-oxidation disorder	GO:0005782	peroxisomal matrix	1.1046508152645629e-10	2.4363073730659934e-6	4	42	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0032404	mismatch repair complex binding	5.140332604014475e-14	1.1337003558153924e-9	4	8	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0032300	mismatch repair complex	5.140332604014475e-14	1.1337003558153924e-9	4	8	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0016446	somatic hypermutation of immunoglobulin genes	4.901634653720066e-13	1.0810555228779606e-8	4	12	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0030983	mismatched DNA binding	4.901634653720066e-13	1.0810555228779606e-8	4	12	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0032137	guanine/thymine mispair binding	9.222067554048863e-12	2.0339269990454767e-7	3	3	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0006298	mismatch repair	2.7027491356079736e-11	5.960913218583386e-7	4	30	5
OMIM:276300	Constitutional mismatch repair deficiency syndrome	GO:0032138	single base insertion or deletion binding	3.687616878522704e-11	8.133039025581823e-7	3	4	5
Orphanet:285657	Disorder of folate metabolism and transport	GO:0006760	folic acid-containing compound metabolic process	6.061817714453355e-14	1.3369338969226874e-9	5	27	5
Orphanet:285657	Disorder of folate metabolism and transport	GO:0005542	folic acid binding	3.2951419370874646e-13	7.267435542246403e-9	4	11	5
Orphanet:285657	Disorder of folate metabolism and transport	GO:0046655	folic acid metabolic process	2.311928426479426e-12	5.098958144600374e-8	4	17	5
DOID:2373	hereditary elliptocytosis	GO:0030863	cortical cytoskeleton	1.0651479698253752e-12	2.349183847449865e-8	5	78	5
DOID:2373	hereditary elliptocytosis	GO:0014731	spectrin-associated cytoskeleton	5.160798455250415e-10	1.138214099305479e-5	3	8	5
DOID:2373	hereditary elliptocytosis	GO:0008091	spectrin	7.74087793864453e-10	1.707250629368051e-5	3	9	5
Orphanet:169826	Congenital vitamin K-dependent coagulation factors deficiency	GO:0018200	peptidyl-glutamic acid modification	4.218847493575595e-15	9.304668147080974e-11	5	30	5
Orphanet:169826	Congenital vitamin K-dependent coagulation factors deficiency	GO:0018214	protein carboxylation	3.6637359812630166e-15	8.080369706675583e-11	5	11	5
Orphanet:169826	Congenital vitamin K-dependent coagulation factors deficiency	GO:0017187	peptidyl-glutamic acid carboxylation	3.6637359812630166e-15	8.080369706675583e-11	5	11	5
Orphanet:169826	Congenital vitamin K-dependent coagulation factors deficiency	GO:0007596	blood coagulation	2.3152819661476087e-9	5.106354376338551e-5	5	352	5
MESH:D014806	Vitamin B 12 Deficiency	GO:0009235	cobalamin metabolic process	1.7763568394002505e-15	3.9177550092972524e-11	5	20	5
MESH:D014806	Vitamin B 12 Deficiency	GO:0015889	cobalamin transport	5.140332604014475e-14	1.1337003558153924e-9	4	8	5
MESH:D014806	Vitamin B 12 Deficiency	GO:0031419	cobalamin binding	1.2811973704174306e-13	2.8256808004556433e-9	4	9	5
DC:0000184	Herpes Simplex Encephalitis, Susceptibility	GO:0002224	toll-like receptor signaling pathway	8.542944129885655e-12	1.884146327846281e-7	5	115	5
DC:0000184	Herpes Simplex Encephalitis, Susceptibility	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	2.0245471965552042e-11	4.465138842002503e-7	4	28	5
DC:0000184	Herpes Simplex Encephalitis, Susceptibility	GO:0032648	regulation of interferon-beta production	1.2177614472363985e-10	2.685772871879877e-6	4	43	5
DC:0000184	Herpes Simplex Encephalitis, Susceptibility	GO:0051607	defense response to virus	1.7260536333552068e-9	3.8068112883649086e-5	5	332	5
DC:0000184	Herpes Simplex Encephalitis, Susceptibility	GO:0045351	type I interferon biosynthetic process	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0014003	oligodendrocyte development	3.708144902248023e-14	8.178313581908014e-10	5	34	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0005851	eukaryotic translation initiation factor 2B complex	4.218847493575595e-15	9.304668147080974e-11	5	6	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0003743	translation initiation factor activity	1.1679546219056647e-13	2.5759239186129435e-9	5	50	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0006446	regulation of translational initiation	1.510125358095138e-12	3.330581477278827e-8	5	81	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0009408	response to heat	4.210465309739675e-11	9.286181240630853e-7	5	159	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0009749	response to glucose	7.053480022278791e-11	1.5556450189135873e-6	5	176	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0032057	negative regulation of translational initiation in response to stress	3.2259128701639384e-10	7.114750835146566e-6	3	7	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0005085	guanyl-nucleotide exchange factor activity	1.0892545754259686e-9	2.4023509661019737e-5	5	303	5
Orphanet:157713	Congenital or early infantile CACH syndrome	GO:0043434	response to peptide hormone	3.826934324990816e-9	8.440303653767245e-5	5	389	5
Orphanet:157716	Late infantile CACH syndrome	GO:0014003	oligodendrocyte development	3.708144902248023e-14	8.178313581908014e-10	5	34	5
Orphanet:157716	Late infantile CACH syndrome	GO:0005851	eukaryotic translation initiation factor 2B complex	4.218847493575595e-15	9.304668147080974e-11	5	6	5
Orphanet:157716	Late infantile CACH syndrome	GO:0003743	translation initiation factor activity	1.1679546219056647e-13	2.5759239186129435e-9	5	50	5
Orphanet:157716	Late infantile CACH syndrome	GO:0006446	regulation of translational initiation	1.510125358095138e-12	3.330581477278827e-8	5	81	5
Orphanet:157716	Late infantile CACH syndrome	GO:0009408	response to heat	4.210465309739675e-11	9.286181240630853e-7	5	159	5
Orphanet:157716	Late infantile CACH syndrome	GO:0009749	response to glucose	7.053480022278791e-11	1.5556450189135873e-6	5	176	5
Orphanet:157716	Late infantile CACH syndrome	GO:0032057	negative regulation of translational initiation in response to stress	3.2259128701639384e-10	7.114750835146566e-6	3	7	5
Orphanet:157716	Late infantile CACH syndrome	GO:0005085	guanyl-nucleotide exchange factor activity	1.0892545754259686e-9	2.4023509661019737e-5	5	303	5
Orphanet:157716	Late infantile CACH syndrome	GO:0043434	response to peptide hormone	3.826934324990816e-9	8.440303653767245e-5	5	389	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0014003	oligodendrocyte development	3.708144902248023e-14	8.178313581908014e-10	5	34	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0005851	eukaryotic translation initiation factor 2B complex	4.218847493575595e-15	9.304668147080974e-11	5	6	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0003743	translation initiation factor activity	1.1679546219056647e-13	2.5759239186129435e-9	5	50	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0006446	regulation of translational initiation	1.510125358095138e-12	3.330581477278827e-8	5	81	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0009408	response to heat	4.210465309739675e-11	9.286181240630853e-7	5	159	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0009749	response to glucose	7.053480022278791e-11	1.5556450189135873e-6	5	176	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0032057	negative regulation of translational initiation in response to stress	3.2259128701639384e-10	7.114750835146566e-6	3	7	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0005085	guanyl-nucleotide exchange factor activity	1.0892545754259686e-9	2.4023509661019737e-5	5	303	5
Orphanet:157719	Juvenile or adult CACH syndrome	GO:0043434	response to peptide hormone	3.826934324990816e-9	8.440303653767245e-5	5	389	5
Orphanet:289866	Disorder of proline metabolism	GO:0006560	proline metabolic process	2.148281552649678e-13	4.738034964368865e-9	4	10	5
Orphanet:289866	Disorder of proline metabolism	GO:0006561	proline biosynthetic process	3.2259128701639384e-10	7.114750835146566e-6	3	7	5
DOID:2602	chondroma	GO:0006099	tricarboxylic acid cycle	2.3386070857611685e-11	5.157797927646257e-7	4	29	5
Orphanet:79402	Generalized junctional epidermolysis bullosa, non-Herlitz type	GO:0031581	hemidesmosome assembly	3.6637359812630166e-15	8.080369706675583e-11	5	11	5
Orphanet:79402	Generalized junctional epidermolysis bullosa, non-Herlitz type	GO:0043256	laminin complex	5.160798455250415e-10	1.138214099305479e-5	3	8	5
Orphanet:216804	Osteogenesis imperfecta type 2	GO:0005788	endoplasmic reticulum lumen	1.3060663661690342e-10	2.880529370585805e-6	5	199	5
OMIM:252900	mucopolysaccharidosis III	GO:0006027	glycosaminoglycan catabolic process	4.80432804650377e-10	1.0595945506564064e-5	4	60	5
Orphanet:251380	Hereditary persistence of fetal hemoglobin - sickle cell disease	GO:0005833	hemoglobin complex	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:251380	Hereditary persistence of fetal hemoglobin - sickle cell disease	GO:0005344	oxygen transporter activity	3.352998878547453e-9	7.395039026636407e-5	3	14	5
Orphanet:251380	Hereditary persistence of fetal hemoglobin - sickle cell disease	GO:0015671	oxygen transport	4.190931046643698e-9	9.243098423372675e-5	3	15	5
Orphanet:251393	Localized junctional epidermolysis bullosa, non-Herlitz type	GO:0031581	hemidesmosome assembly	3.6637359812630166e-15	8.080369706675583e-11	5	11	5
Orphanet:251393	Localized junctional epidermolysis bullosa, non-Herlitz type	GO:0043256	laminin complex	5.160798455250415e-10	1.138214099305479e-5	3	8	5
Orphanet:231230	Beta-thalassemia associated with another hemoglobin anomaly	GO:0019825	oxygen binding	2.0893564656176977e-10	4.608075684919832e-6	4	49	5
Orphanet:231178	Usher syndrome type 2	GO:0032421	stereocilium bundle	1.304512053934559e-13	2.8771013349526697e-9	5	42	5
Orphanet:231178	Usher syndrome type 2	GO:0002139	stereocilia coupling link	9.222067554048863e-12	2.0339269990454767e-7	3	3	5
Orphanet:231178	Usher syndrome type 2	GO:0007605	sensory perception of sound	2.044531210998457e-11	4.509213585857097e-7	5	138	5
Orphanet:231178	Usher syndrome type 2	GO:0032420	stereocilium	5.8019145043886056e-11	1.279612243942907e-6	4	36	5
Orphanet:231178	Usher syndrome type 2	GO:0060113	inner ear receptor cell differentiation	2.4634683182256367e-10	5.433179375846642e-6	4	51	5
Orphanet:98360	Constitutional anemia due to iron metabolism disorder	GO:0055072	iron ion homeostasis	6.405986852087153e-13	1.4128404002278216e-8	5	68	5
Orphanet:98360	Constitutional anemia due to iron metabolism disorder	GO:0006879	cellular iron ion homeostasis	1.4701118100646227e-10	3.2423315970975253e-6	4	45	5
Orphanet:98360	Constitutional anemia due to iron metabolism disorder	GO:0000041	transition metal ion transport	4.522412777596685e-9	9.974181380989489e-5	4	104	5
Orphanet:169160	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	GO:0042105	alpha-beta T cell receptor complex	9.217082652668296e-11	2.0328275790459926e-6	3	5	5
Orphanet:169160	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	GO:0050870	positive regulation of T cell activation	1.4076895205050732e-10	3.104659237473939e-6	5	202	5
DOID:10783	methemoglobinemia	GO:0005833	hemoglobin complex	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:172976	Congenital myopathy with cores	GO:0003012	muscle system process	4.029314770725989e-9	8.886653726836169e-5	5	393	5
DOID:10983	Alport syndrome	GO:0005587	collagen type IV trimer	1.0658141036401503e-14	2.3506530055783514e-10	4	6	5
DOID:10983	Alport syndrome	GO:0030574	collagen catabolic process	7.551220759793864e-10	1.6654217385725367e-5	4	67	5
DOID:10983	Alport syndrome	GO:0005201	extracellular matrix structural constituent	1.1330415494725798e-9	2.498923137361775e-5	4	74	5
OMIM:172800	piebaldism	GO:0043473	pigmentation	2.630025752736742e-9	5.800521797660885e-5	4	91	5
DOID:9719	proliferative vitreoretinopathy	GO:0035426	extracellular matrix-cell signaling	9.217082652668296e-11	2.0328275790459926e-6	3	5	5
DOID:9719	proliferative vitreoretinopathy	GO:0061299	retina vasculature morphogenesis in camera-type eye	7.74087793864453e-10	1.707250629368051e-5	3	9	5
Orphanet:370968	Congenital muscular dystrophy with intellectual disability	GO:0035269	protein O-linked mannosylation	1.7891244041834398e-12	3.9459138734265764e-8	4	16	5
Orphanet:370959	Congenital muscular dystrophy with cerebellar involvement	GO:0006493	protein O-linked glycosylation	3.7031803179488065e-9	8.167364191236093e-5	4	99	5
Orphanet:284818	Disorder of tyrosine metabolism	GO:0006572	tyrosine catabolic process	6.661338147750939e-15	1.4691581284864696e-10	4	5	5
Orphanet:284818	Disorder of tyrosine metabolism	GO:0006559	L-phenylalanine catabolic process	3.2951419370874646e-13	7.267435542246403e-9	4	11	5
DOID:9409	diabetes insipidus	GO:0003091	renal water homeostasis	4.569755684968868e-11	1.0078596163198839e-6	4	34	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0042446	hormone biosynthetic process	3.850253449400043e-13	8.491733982651795e-9	5	63	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0034754	cellular hormone metabolic process	5.867195618236565e-12	1.2940099936020744e-7	5	108	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0008211	glucocorticoid metabolic process	1.0510370351823894e-11	2.31806218109476e-7	4	24	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0006694	steroid biosynthetic process	3.044853258415969e-11	6.71542386143642e-7	5	149	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0006702	androgen biosynthetic process	3.352998878547453e-9	7.395039026636407e-5	3	14	5
Orphanet:400018	Rare female infertility due to adrenal disorder of genetic origin	GO:0006066	alcohol metabolic process	3.493580313929101e-9	7.705091382370632e-5	5	382	5
OMIM:162900	Woolly hair nevus	GO:0038128	ERBB2 signaling pathway	8.109402038769531e-11	1.78852861965062e-6	4	39	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0007031	peroxisome organization	4.884981308350689e-14	1.0773826275567444e-9	5	33	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0006625	protein targeting to peroxisome	3.730349362740526e-14	8.22728551952423e-10	5	17	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0044743	intracellular protein transmembrane import	2.220446049250313e-15	4.8971937616215655e-11	5	40	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0031903	microbody membrane	5.329070518200751e-15	1.1753265027891757e-10	5	57	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0005778	peroxisomal membrane	5.329070518200751e-15	1.1753265027891757e-10	5	57	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0016558	protein import into peroxisome matrix	1.0325074129013956e-14	2.277195099154028e-10	5	13	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0031231	intrinsic component of peroxisomal membrane	3.352998878547453e-9	7.395039026636407e-5	3	14	5
OMIM:202370	Peroxisome Biogenesis Disorder 2B	GO:0005779	integral component of peroxisomal membrane	3.352998878547453e-9	7.395039026636407e-5	3	14	5
Orphanet:93271	Short rib-polydactyly syndrome, Verma-Naumoff type	GO:0097542	ciliary tip	1.2177614472363985e-10	2.685772871879877e-6	4	43	5
OMIM:236670	Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain and Eye Anomalies), Type A, 1	GO:0097502	mannosylation	4.884981308350689e-14	1.0773826275567444e-9	5	33	5
OMIM:236670	Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain and Eye Anomalies), Type A, 1	GO:0035269	protein O-linked mannosylation	7.549516567451064e-15	1.6650458789513323e-10	5	16	5
OMIM:248600	Maple Syrup Urine Disease	GO:0045240	dihydrolipoyl dehydrogenase complex	2.148281552649678e-13	4.738034964368865e-9	4	10	5
Orphanet:181437	Rare syndromic dyslipidemia	GO:0017127	cholesterol transporter activity	2.0268758893493555e-9	4.4702747739600035e-5	3	12	5
Orphanet:254892	Autosomal dominant progressive external ophthalmoplegia	GO:0000002	mitochondrial genome maintenance	6.061817714453355e-14	1.3369338969226874e-9	5	27	5
Orphanet:254892	Autosomal dominant progressive external ophthalmoplegia	GO:0032042	mitochondrial DNA metabolic process	2.311928426479426e-12	5.098958144600374e-8	4	17	5
Orphanet:254892	Autosomal dominant progressive external ophthalmoplegia	GO:0006264	mitochondrial DNA replication	1.5202816783244089e-9	3.352981241544484e-5	3	11	5
OMIM:214950	congenital bile acid synthesis defect	GO:0006699	bile acid biosynthetic process	1.4727774555467477e-11	3.248210678208352e-7	4	26	5
OMIM:179800	renal tubular acidosis	GO:0051453	regulation of intracellular pH	7.636113963371827e-13	1.6841449346216564e-8	5	74	5
MESH:C535781	Spondylocostal dysostosis, autosomal recessive	GO:0007219	Notch signaling pathway	4.6329717839910245e-11	1.0218019269592205e-6	5	162	5
MESH:C535781	Spondylocostal dysostosis, autosomal recessive	GO:0001756	somitogenesis	7.102153309901382e-10	1.56637991249875e-5	4	66	5
OMIM:601764	BFIS1	GO:0033268	node of Ranvier	4.190931046643698e-9	9.243098423372675e-5	3	15	5
OMIM:209880	Haddad syndrome	GO:0048483	autonomic nervous system development	3.30658833647135e-10	7.292680576087562e-6	4	42	6
OMIM:209880	Haddad syndrome	GO:0001755	neural crest cell migration	7.375218213923063e-10	1.6266043770807315e-5	4	51	6
OMIM:209880	Haddad syndrome	GO:0048484	enteric nervous system development	3.0395868044763574e-9	6.703808697272606e-5	3	11	6
DOID:11726	Emery-Dreifuss muscular dystrophy	GO:0031965	nuclear membrane	4.261830999219285e-9	9.399468268778133e-5	5	279	6
Orphanet:220493	Joubert syndrome with ocular defect	GO:0072372	primary cilium	1.0984546605641299e-12	2.4226417538741885e-8	6	199	6
Orphanet:220493	Joubert syndrome with ocular defect	GO:0044441	ciliary part	1.7114976103016488e-11	3.7747079795202865e-7	6	303	6
Orphanet:220493	Joubert syndrome with ocular defect	GO:0035869	ciliary transition zone	3.7422509535645077e-11	8.253534478086522e-7	4	25	6
Orphanet:220493	Joubert syndrome with ocular defect	GO:0042384	cilium assembly	5.239411127178073e-10	1.155552124099124e-5	5	184	6
Orphanet:220493	Joubert syndrome with ocular defect	GO:0036038	TCTN-B9D complex	4.052278845811941e-9	8.937300994438235e-5	3	12	6
DOID:0050535	exudative vitreoretinopathy	GO:0035426	extracellular matrix-cell signaling	1.8434598292316196e-10	4.065750653370337e-6	3	5	6
DOID:0050535	exudative vitreoretinopathy	GO:0061299	retina vasculature morphogenesis in camera-type eye	1.5477993331458606e-9	3.4136714292531956e-5	3	9	6
DOID:0060170	generalized epilepsy with febrile seizures plus	GO:0007268	synaptic transmission	1.1304202018891374e-9	2.4931417552664925e-5	6	605	6
DOID:0060170	generalized epilepsy with febrile seizures plus	GO:0034702	ion channel complex	3.89195098371431e-9	8.58369789458191e-5	5	274	6
MESH:D003294	Seizures, Febrile	GO:0034702	ion channel complex	3.89195098371431e-9	8.58369789458191e-5	5	274	6
DOID:614	lymphopenia	GO:0045582	positive regulation of T cell differentiation	2.259041620433777e-9	4.9823162938666954e-5	4	67	6
Orphanet:171436	Typical nemaline myopathy	GO:0030017	sarcomere	1.0079714840571796e-12	2.2230811080881097e-8	6	180	6
Orphanet:171436	Typical nemaline myopathy	GO:0030239	myofibril assembly	8.639260418163985e-10	1.905388885226067e-5	4	53	6
Orphanet:171439	Childhood-onset nemaline myopathy	GO:0033275	actin-myosin filament sliding	2.4296975542625887e-10	5.358697955926139e-6	4	39	6
Orphanet:171439	Childhood-onset nemaline myopathy	GO:0030049	muscle filament sliding	2.4296975542625887e-10	5.358697955926139e-6	4	39	6
Orphanet:171439	Childhood-onset nemaline myopathy	GO:0030017	sarcomere	4.692675137363267e-10	1.0349695015454685e-5	5	180	6
Orphanet:158665	Basal epidermolysis bullosa simplex	GO:0030056	hemidesmosome	6.450601164331715e-10	1.4226800867933598e-5	3	7	6
DOID:4193	intracranial thrombosis	GO:0072376	protein activation cascade	4.423867938641024e-9	9.756840738672778e-5	4	79	6
Orphanet:100033	Hypomaturation amelogenesis imperfecta	GO:0097186	amelogenesis	1.0103029524088925e-14	2.2282231615378123e-10	5	21	6
Orphanet:281103	Keratinopathic ichthyosis	GO:0043588	skin development	2.0413083445802727e-9	4.5021055539717914e-5	5	241	6
MESH:D019080	Cafe-au-Lait Spots	GO:0032404	mismatch repair complex binding	1.0319900489719203e-9	2.27605405300757e-5	3	8	6
MESH:D019080	Cafe-au-Lait Spots	GO:0032300	mismatch repair complex	1.0319900489719203e-9	2.27605405300757e-5	3	8	6
MESH:D019080	Cafe-au-Lait Spots	GO:0016446	somatic hypermutation of immunoglobulin genes	4.052278845811941e-9	8.937300994438235e-5	3	12	6
MESH:D019080	Cafe-au-Lait Spots	GO:0030983	mismatched DNA binding	4.052278845811941e-9	8.937300994438235e-5	3	12	6
Orphanet:268162	Intermediate maple syrup urine disease	GO:0005759	mitochondrial matrix	1.103995783680034e-10	2.434862700906315e-6	6	412	6
DOID:0080046	Stickler syndrome	GO:0005581	collagen trimer	5.1514348342607263e-14	1.1361489526962032e-9	6	88	6
DOID:0080046	Stickler syndrome	GO:0005201	extracellular matrix structural constituent	3.1530333899354446e-14	6.954015141502623e-10	6	74	6
DOID:0080046	Stickler syndrome	GO:0005788	endoplasmic reticulum lumen	1.0984546605641299e-12	2.4226417538741885e-8	6	199	6
DOID:0080046	Stickler syndrome	GO:0030198	extracellular matrix organization	2.4502289086569817e-11	5.403979858042973e-7	6	320	6
DOID:0080046	Stickler syndrome	GO:0005578	proteinaceous extracellular matrix	4.358624572375902e-11	9.612946494375052e-7	6	354	6
DOID:0080046	Stickler syndrome	GO:0098643	banded collagen fibril	4.052278845811941e-9	8.937300994438235e-5	3	12	6
DOID:0080046	Stickler syndrome	GO:0005583	fibrillar collagen trimer	4.052278845811941e-9	8.937300994438235e-5	3	12	6
OMIM:252650	gangliosidosis	GO:0006687	glycosphingolipid metabolic process	4.279465670720128e-12	9.438361536773243e-8	5	72	6
OMIM:252650	gangliosidosis	GO:0043202	lysosomal lumen	1.1657230736261681e-11	2.571002238882514e-7	5	87	6
OMIM:252650	gangliosidosis	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	1.7240098237891743e-11	3.802303666367024e-7	5	94	6
OMIM:252650	gangliosidosis	GO:1901136	carbohydrate derivative catabolic process	4.3103576263803234e-10	9.506493744981803e-6	5	177	6
OMIM:252650	gangliosidosis	GO:0042340	keratan sulfate catabolic process	3.0395868044763574e-9	6.703808697272606e-5	3	11	6
OMIM:252650	gangliosidosis	GO:0046479	glycosphingolipid catabolic process	4.052278845811941e-9	8.937300994438235e-5	3	12	6
MESH:D000784	Aneurysm, Dissecting	GO:0030335	positive regulation of cell migration	7.572464877370066e-11	1.6701071287039682e-6	6	387	6
MESH:D000784	Aneurysm, Dissecting	GO:0010718	positive regulation of epithelial to mesenchymal transition	1.3702450285535406e-10	3.0220754104748337e-6	4	34	6
MESH:D000784	Aneurysm, Dissecting	GO:0051216	cartilage development	4.692675137363267e-10	1.0349695015454685e-5	5	180	6
MESH:D000784	Aneurysm, Dissecting	GO:0048705	skeletal system morphogenesis	8.816923857679626e-10	1.9445725568112415e-5	5	204	6
MESH:D000784	Aneurysm, Dissecting	GO:0071560	cellular response to transforming growth factor beta stimulus	9.723968297237207e-10	2.144621207955666e-5	5	208	6
MESH:D046449	Hernia, Abdominal	GO:0001568	blood vessel development	7.818627967282055e-10	1.724398398184057e-5	6	569	6
Orphanet:79185	Disorder of ornithine or proline metabolism	GO:0006536	glutamate metabolic process	9.30086008210651e-11	2.051304691108591e-6	4	31	6
Orphanet:79185	Disorder of ornithine or proline metabolism	GO:0055129	L-proline biosynthetic process	1.8434598292316196e-10	4.065750653370337e-6	3	5	6
DOID:14203	childhood type dermatomyositis	GO:0002526	acute inflammatory response	1.365143553755388e-10	3.010824107807508e-6	5	141	6
DOID:14203	childhood type dermatomyositis	GO:0002673	regulation of acute inflammatory response	3.3891591755264017e-9	7.474790561623479e-5	4	74	6
DOID:14203	childhood type dermatomyositis	GO:0001660	fever generation	4.052278845811941e-9	8.937300994438235e-5	3	12	6
DOID:2962	Cockayne syndrome	GO:0009411	response to UV	1.2867484855405564e-13	2.8379237848596972e-9	6	125	6
DOID:2962	Cockayne syndrome	GO:0006293	nucleotide-excision repair, preincision complex stabilization	2.169597834722481e-11	4.785048024480432e-7	4	22	6
DOID:2962	Cockayne syndrome	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	2.169597834722481e-11	4.785048024480432e-7	4	22	6
DOID:2962	Cockayne syndrome	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	2.179946223535012e-10	4.807871396006469e-6	4	38	6
MESH:D010283	Paratuberculosis	GO:0072562	blood microparticle	4.662026320545465e-11	1.0282099049963023e-6	5	114	6
DOID:9258	Waardenburg's syndrome	GO:0043473	pigmentation	1.451605502467146e-11	3.2015159356912903e-7	5	91	6
DOID:9258	Waardenburg's syndrome	GO:0014031	mesenchymal cell development	3.622988575813224e-10	7.990501303956066e-6	5	171	6
DOID:9258	Waardenburg's syndrome	GO:0014032	neural crest cell development	2.259041620433777e-9	4.9823162938666954e-5	4	67	6
Orphanet:309819	Disorder of pterin metabolism	GO:0042559	pteridine-containing compound biosynthetic process	3.1530333899354446e-14	6.954015141502623e-10	5	16	6
MESH:D000608	Renal Aminoacidurias	GO:0000101	sulfur amino acid transport	3.6865133168362263e-10	8.130605120282297e-6	3	6	6
MESH:D000608	Renal Aminoacidurias	GO:0000099	sulfur amino acid transmembrane transporter activity	6.450601164331715e-10	1.4226800867933598e-5	3	7	6
MESH:D000608	Renal Aminoacidurias	GO:0003333	amino acid transmembrane transport	2.1245023518190465e-9	4.685589936936907e-5	4	66	6
DOID:9181	amebiasis	GO:0002637	regulation of immunoglobulin production	5.293543381412746e-13	1.1674909927705812e-8	5	46	6
DOID:9181	amebiasis	GO:0032944	regulation of mononuclear cell proliferation	9.131584377541913e-13	2.0139709344668688e-8	6	191	6
DOID:9181	amebiasis	GO:0050670	regulation of lymphocyte proliferation	1.038835684141759e-12	2.2911521013746494e-8	6	189	6
DOID:9181	amebiasis	GO:0050714	positive regulation of protein secretion	1.3001821841385208e-12	2.8675518071175077e-8	6	205	6
DOID:9181	amebiasis	GO:0005125	cytokine activity	2.2964963264371363e-12	5.064922647957104e-8	6	222	6
DOID:9181	amebiasis	GO:0046427	positive regulation of JAK-STAT cascade	5.792366586376829e-12	1.2775064506254097e-7	5	76	6
DOID:9181	amebiasis	GO:0005126	cytokine receptor binding	8.569922549384046e-12	1.8900964182666513e-7	6	270	6
DOID:9181	amebiasis	GO:0050864	regulation of B cell activation	2.3831714379696223e-11	5.256084606442002e-7	5	100	6
DOID:9181	amebiasis	GO:0070851	growth factor receptor binding	7.745948327197993e-11	1.7083689035635174e-6	5	126	6
DOID:9181	amebiasis	GO:0050671	positive regulation of lymphocyte proliferation	8.040845766998928e-11	1.7734085339116135e-6	5	127	6
DOID:9181	amebiasis	GO:1902107	positive regulation of leukocyte differentiation	8.040845766998928e-11	1.7734085339116135e-6	5	127	6
DOID:9181	amebiasis	GO:0002639	positive regulation of immunoglobulin production	8.100775605868193e-11	1.78662605987423e-6	4	30	6
DOID:9181	amebiasis	GO:0042129	regulation of T cell proliferation	1.415005890237353e-10	3.120795490918482e-6	5	142	6
DOID:9181	amebiasis	GO:0045428	regulation of nitric oxide biosynthetic process	7.375218213923063e-10	1.6266043770807315e-5	4	51	6
DOID:9181	amebiasis	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	9.963158076331524e-10	2.1973745137349177e-5	5	209	6
DOID:9181	amebiasis	GO:0050871	positive regulation of B cell activation	2.1245023518190465e-9	4.685589936936907e-5	4	66	6
DOID:9181	amebiasis	GO:0032642	regulation of chemokine production	2.1245023518190465e-9	4.685589936936907e-5	4	66	6
DOID:9181	amebiasis	GO:0051024	positive regulation of immunoglobulin secretion	2.210880145625538e-9	4.8760961611771236e-5	3	10	6
DOID:9181	amebiasis	GO:0045582	positive regulation of T cell differentiation	2.259041620433777e-9	4.9823162938666954e-5	4	67	6
DOID:9181	amebiasis	GO:0045073	regulation of chemokine biosynthetic process	4.052278845811941e-9	8.937300994438235e-5	3	12	6
DOID:9181	amebiasis	GO:0002443	leukocyte mediated immunity	4.261830999219285e-9	9.399468268778133e-5	5	279	6
Orphanet:319535	Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency	GO:0009615	response to virus	1.103995783680034e-10	2.434862700906315e-6	6	412	6
Orphanet:319535	Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency	GO:0019221	cytokine-mediated signaling pathway	5.328910646085205e-10	1.175291242994092e-5	6	534	6
DC:0000498	Cortical Dysplasia, Complex, with Other Brain Malformations	GO:0005874	microtubule	8.04424304945428e-11	1.7741578045571416e-6	6	391	6
DC:0000498	Cortical Dysplasia, Complex, with Other Brain Malformations	GO:0007017	microtubule-based process	9.818890145396608e-10	2.165556221567222e-5	6	591	6
DC:0000498	Cortical Dysplasia, Complex, with Other Brain Malformations	GO:0017111	nucleoside-triphosphatase activity	4.324918312370585e-9	9.538607337933325e-5	6	756	6
DC:0000436	Thyroid Dyshormonogenesis	GO:0006590	thyroid hormone generation	3.419486915845482e-14	7.541678392897211e-10	6	17	6
DC:0000305	Myopathy, Myofibrillar	GO:0030018	Z disc	1.2922996006636822e-13	2.850166769263751e-9	6	109	6
DC:0000166	Frontonasal Dysplasia	GO:0048704	embryonic skeletal system morphogenesis	1.627697976402942e-11	3.5898878869566886e-7	5	93	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0007409	axonogenesis	1.0176826048535759e-10	2.2444989850045616e-6	6	406	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0045860	positive regulation of protein kinase activity	1.885542832980036e-10	4.15856471813747e-6	6	450	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0043410	positive regulation of MAPK cascade	2.3086543787798064e-10	5.091737232398863e-6	6	464	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0060324	face development	6.797420404325294e-10	1.4991710701739436e-5	4	50	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0043406	positive regulation of MAP kinase activity	9.034840653399101e-10	1.9926341061071717e-5	5	205	6
OMIM:115150	Cardiofaciocutaneous Syndrome 1	GO:0070371	ERK1 and ERK2 cascade	2.3100406032483534e-9	5.0947945504642433e-5	5	247	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0019395	fatty acid oxidation	1.8052226380405045e-13	3.981418528198333e-9	6	91	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0072329	monocarboxylic acid catabolic process	1.2922996006636822e-13	2.850166769263751e-9	6	109	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0009062	fatty acid catabolic process	9.703349235223868e-14	2.140073673828624e-9	6	86	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0009055	electron carrier activity	4.617417559416026e-13	1.0183714427292045e-8	6	115	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0050660	flavin adenine dinucleotide binding	5.063949259920264e-12	1.1168540092754142e-7	5	74	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0052890	oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor	5.35460564776713e-12	1.1809582756150405e-7	4	16	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0003995	acyl-CoA dehydrogenase activity	7.0106143112980135e-12	1.546190986356777e-7	4	17	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0000062	fatty-acyl-CoA binding	9.30086008210651e-11	2.051304691108591e-6	4	31	6
Orphanet:309120	Acyl-CoA dehydrogenase deficiency	GO:0005759	mitochondrial matrix	1.103995783680034e-10	2.434862700906315e-6	6	412	6
OMIM:276900	Usher syndrome type 1	GO:0032420	stereocilium	2.1760371282653068e-14	4.799249886389134e-10	5	36	6
OMIM:276900	Usher syndrome type 1	GO:0050957	equilibrioception	9.992007221626409e-15	2.2037371927297045e-10	5	7	6
OMIM:276900	Usher syndrome type 1	GO:0045494	photoreceptor cell maintenance	4.107825191113079e-14	9.059808458999896e-10	5	34	6
OMIM:276900	Usher syndrome type 1	GO:0031513	nonmotile primary cilium	1.0547185347320465e-10	2.3261817283515285e-6	5	134	6
OMIM:276900	Usher syndrome type 1	GO:0007605	sensory perception of sound	1.224432777391371e-10	2.7004864905366688e-6	5	138	6
OMIM:276900	Usher syndrome type 1	GO:0001917	photoreceptor inner segment	1.7393197992987552e-10	3.836069817353405e-6	4	36	6
OMIM:276900	Usher syndrome type 1	GO:0050953	sensory perception of light stimulus	1.0456708832151662e-9	2.306227132931049e-5	5	211	6
OMIM:276900	Usher syndrome type 1	GO:0001750	photoreceptor outer segment	2.547340116620944e-9	5.6181586272074924e-5	4	69	6
Orphanet:324924	Hereditary periodic fever syndrome	GO:0050728	negative regulation of inflammatory response	2.3831714379696223e-11	5.256084606442002e-7	5	100	6
Orphanet:324924	Hereditary periodic fever syndrome	GO:0032611	interleukin-1 beta production	1.1649874398500515e-9	2.5693797985892886e-5	4	57	6
DC:0000692	Ventricular Fibrillation	GO:0034703	cation channel complex	3.115493418803794e-10	6.871220735171768e-6	5	166	6
DC:0000631	Adrenal Hyperplasia	GO:0006704	glucocorticoid biosynthetic process	3.219646771412954e-14	7.10093095435127e-10	5	17	6
DC:0000631	Adrenal Hyperplasia	GO:0042446	hormone biosynthetic process	1.730837695390619e-13	3.81736253718401e-9	6	63	6
DC:0000631	Adrenal Hyperplasia	GO:0034754	cellular hormone metabolic process	2.3026025530725747e-13	5.0783899308015634e-9	6	108	6
DC:0000631	Adrenal Hyperplasia	GO:0008395	steroid hydroxylase activity	9.30086008210651e-11	2.051304691108591e-6	4	31	6
DC:0000631	Adrenal Hyperplasia	GO:0008207	C21-steroid hormone metabolic process	9.30086008210651e-11	2.051304691108591e-6	4	31	6
DC:0000631	Adrenal Hyperplasia	GO:0016125	sterol metabolic process	9.748202245418724e-11	2.1499660052270997e-6	5	132	6
DC:0000631	Adrenal Hyperplasia	GO:0006705	mineralocorticoid biosynthetic process	4.052278845811941e-9	8.937300994438235e-5	3	12	6
MESH:D016870	Neisseriaceae Infections	GO:0006957	complement activation, alternative pathway	2.932876164152276e-12	6.468458380037845e-8	4	14	6
MESH:D016891	Polycystic Kidney, Autosomal Dominant	GO:0072218	metanephric ascending thin limb development	7.374589827691125e-11	1.6264657864972776e-6	3	4	6
MESH:D016891	Polycystic Kidney, Autosomal Dominant	GO:0072235	metanephric distal tubule development	6.450601164331715e-10	1.4226800867933598e-5	3	7	6
Orphanet:98078	46,XX disorder of sex development induced by androgens excess	GO:0006694	steroid biosynthetic process	1.808615479603759e-10	3.9889014402660905e-6	5	149	6
DOID:10320	asbestosis	GO:0036500	ATF6-mediated unfolded protein response	2.210880145625538e-9	4.8760961611771236e-5	3	10	6
DOID:10320	asbestosis	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	3.0395868044763574e-9	6.703808697272606e-5	3	11	6
MESH:D006314	Hearing Loss, Conductive	GO:0007605	sensory perception of sound	1.224432777391371e-10	2.7004864905366688e-6	5	138	6
OMIM:607426	Coenzyme Q10 Deficiency, Primary, 1	GO:0006744	ubiquinone biosynthetic process	3.9968028886505635e-15	8.814948770918818e-11	5	12	6
OMIM:255310	Myopathy, Congenital, With Fiber-Type Disproportion	GO:0003012	muscle system process	8.358091996285566e-11	1.8433771897807816e-6	6	393	6
OMIM:255310	Myopathy, Congenital, With Fiber-Type Disproportion	GO:0033275	actin-myosin filament sliding	2.4296975542625887e-10	5.358697955926139e-6	4	39	6
OMIM:255310	Myopathy, Congenital, With Fiber-Type Disproportion	GO:0030049	muscle filament sliding	2.4296975542625887e-10	5.358697955926139e-6	4	39	6
OMIM:255310	Myopathy, Congenital, With Fiber-Type Disproportion	GO:0030017	sarcomere	4.692675137363267e-10	1.0349695015454685e-5	5	180	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0005775	vacuolar lumen	1.8052226380405045e-13	3.981418528198333e-9	6	91	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0006687	glycosphingolipid metabolic process	1.467714838554457e-13	3.237045076431855e-9	6	72	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0043202	lysosomal lumen	2.2426505097428162e-14	4.946165699237781e-10	6	87	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0016798	hydrolase activity, acting on glycosyl bonds	3.8324898810060404e-13	8.452556432558822e-9	6	120	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	1.7240098237891743e-11	3.802303666367024e-7	5	94	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0016997	alpha-sialidase activity	3.6865133168362263e-10	8.130605120282297e-6	3	6	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0004308	exo-alpha-sialidase activity	3.6865133168362263e-10	8.130605120282297e-6	3	6	6
Orphanet:98714	Metabolic disease with macular cherry-red spot	GO:0042340	keratan sulfate catabolic process	3.0395868044763574e-9	6.703808697272606e-5	3	11	6
DOID:10247	pleurisy	GO:0045428	regulation of nitric oxide biosynthetic process	7.240874566605271e-13	1.5969748856647925e-8	5	51	6
DOID:10247	pleurisy	GO:0032496	response to lipopolysaccharide	2.4412583066180105e-11	5.384195195246022e-7	6	319	6
DOID:10247	pleurisy	GO:0002687	positive regulation of leukocyte migration	3.675570958705521e-11	8.106471749425026e-7	5	109	6
DOID:10247	pleurisy	GO:0002439	chronic inflammatory response to antigenic stimulus	1.8434598292316196e-10	4.065750653370337e-6	3	5	6
DOID:10247	pleurisy	GO:0071222	cellular response to lipopolysaccharide	1.9999890632504957e-10	4.410975878998968e-6	5	152	6
DOID:10247	pleurisy	GO:0007159	leukocyte cell-cell adhesion	2.2166246615995533e-10	4.888765691157815e-6	6	461	6
DOID:10247	pleurisy	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.6992785784329953e-10	5.953258904733971e-6	4	40	6
DOID:10247	pleurisy	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	9.963158076331524e-10	2.1973745137349177e-5	5	209	6
DOID:10247	pleurisy	GO:0030155	regulation of cell adhesion	1.3225192052601642e-9	2.916816107201292e-5	6	621	6
DOID:10247	pleurisy	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.4438479301048801e-9	3.184406609846313e-5	5	225	6
DOID:10247	pleurisy	GO:0032642	regulation of chemokine production	2.1245023518190465e-9	4.685589936936907e-5	4	66	6
DOID:10247	pleurisy	GO:0045073	regulation of chemokine biosynthetic process	4.052278845811941e-9	8.937300994438235e-5	3	12	6
DOID:10247	pleurisy	GO:0002443	leukocyte mediated immunity	4.261830999219285e-9	9.399468268778133e-5	5	279	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0044438	microbody part	8.126832540256146e-14	1.792372916753493e-9	6	90	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0044439	peroxisomal part	8.126832540256146e-14	1.792372916753493e-9	6	90	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0031907	microbody lumen	3.2862601528904634e-13	7.247846767199917e-9	5	42	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0005782	peroxisomal matrix	3.2862601528904634e-13	7.247846767199917e-9	5	42	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0031903	microbody membrane	1.1022294188478554e-12	2.430966983268945e-8	5	57	6
Orphanet:225686	Peroxisomal disease with epilepsy	GO:0005778	peroxisomal membrane	1.1022294188478554e-12	2.430966983268945e-8	5	57	6
Orphanet:1930	Herpes simplex encephalitis	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	9.769962616701378e-15	2.1547652551134888e-10	5	28	6
Orphanet:1930	Herpes simplex encephalitis	GO:0032648	regulation of interferon-beta production	3.6060043839825084e-13	7.953042668873422e-9	5	43	6
Orphanet:1930	Herpes simplex encephalitis	GO:0045351	type I interferon biosynthetic process	1.461497589616556e-12	3.2233329338993144e-8	4	12	6
Orphanet:1930	Herpes simplex encephalitis	GO:0051607	defense response to virus	3.0141444895548375e-11	6.647695671713194e-7	6	332	6
Orphanet:1930	Herpes simplex encephalitis	GO:0032728	positive regulation of interferon-beta production	7.020883874275796e-11	1.5484559384715268e-6	4	29	6
Orphanet:1930	Herpes simplex encephalitis	GO:0045359	positive regulation of interferon-beta biosynthetic process	6.450601164331715e-10	1.4226800867933598e-5	3	7	6
Orphanet:247262	Hyperphosphatasia-intellectual disability syndrome	GO:0006506	GPI anchor biosynthetic process	1.354472090042691e-13	2.987288194589155e-9	6	33	6
Orphanet:437	Hypophosphatemic rickets	GO:0072502	cellular trivalent inorganic anion homeostasis	1.5477993331458606e-9	3.4136714292531956e-5	3	9	6
Orphanet:437	Hypophosphatemic rickets	GO:0030643	cellular phosphate ion homeostasis	1.5477993331458606e-9	3.4136714292531956e-5	3	9	6
Orphanet:593	Myofibrillar myopathy	GO:0030018	Z disc	1.2922996006636822e-13	2.850166769263751e-9	6	109	6
Orphanet:95716	Familial thyroid dyshormonogenesis	GO:0006590	thyroid hormone generation	3.419486915845482e-14	7.541678392897211e-10	6	17	6
Orphanet:276234	Non-syndromic male infertility due to sperm motility disorder	GO:0030317	sperm motility	1.2514268510344095e-9	2.7600219199563902e-5	4	58	6
MESH:D003680	Deglutition Disorders	GO:0000379	tRNA-type intron splice site recognition and cleavage	1.8443802041190338e-11	4.067780540184529e-7	3	3	6
MESH:D003680	Deglutition Disorders	GO:0000213	tRNA-intron endonuclease activity	7.374589827691125e-11	1.6264657864972776e-6	3	4	6
MESH:D003680	Deglutition Disorders	GO:0000214	tRNA-intron endonuclease complex	7.374589827691125e-11	1.6264657864972776e-6	3	4	6
MESH:D003117	Color Vision Defects	GO:0007601	visual perception	3.29178606595093e-9	7.260034168454776e-5	5	207	7
DOID:0050756	Batten disease	GO:0007040	lysosome organization	1.7174144328890861e-9	3.7877575317368795e-5	4	51	7
Orphanet:217581	Lysosomal disease with hypertrophic cardiomyopathy	GO:0005775	vacuolar lumen	1.8318679906315083e-13	4.0401848533377915e-9	7	91	7
Orphanet:217581	Lysosomal disease with hypertrophic cardiomyopathy	GO:0043202	lysosomal lumen	7.505107646466058e-14	1.6552514914280891e-9	7	87	7
Orphanet:217581	Lysosomal disease with hypertrophic cardiomyopathy	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	1.2667644710973036e-13	2.793849041005103e-9	6	94	7
Orphanet:217581	Lysosomal disease with hypertrophic cardiomyopathy	GO:0009311	oligosaccharide metabolic process	8.506195747770562e-12	1.8760414721707974e-7	5	64	7
Orphanet:2318	Joubert syndrome with oculorenal defect	GO:0035869	ciliary transition zone	5.0182080713057076e-14	1.1067657901264738e-9	5	25	7
Orphanet:2318	Joubert syndrome with oculorenal defect	GO:0036038	TCTN-B9D complex	3.415601135259294e-12	7.533108303814373e-8	4	12	7
Orphanet:2318	Joubert syndrome with oculorenal defect	GO:0042384	cilium assembly	5.715095063862918e-12	1.2604642163349666e-7	6	184	7
DOID:13938	amenorrhea	GO:0042446	hormone biosynthetic process	4.087616023440432e-9	9.015237139697874e-5	4	63	7
Orphanet:317419	T-B- severe combined immunodeficiency	GO:0033151	V(D)J recombination	6.903477789421686e-12	1.5225620264569528e-7	4	14	7
Orphanet:317419	T-B- severe combined immunodeficiency	GO:0030098	lymphocyte differentiation	1.1051815018703337e-10	2.437477802375021e-6	6	299	7
Orphanet:317419	T-B- severe combined immunodeficiency	GO:0030183	B cell differentiation	1.2841172569721948e-10	2.8321206102521757e-6	5	109	7
Orphanet:317419	T-B- severe combined immunodeficiency	GO:0030217	T cell differentiation	2.6994999569041056e-9	5.953747154952005e-5	5	199	7
DOID:8545	malignant hyperthermia	GO:0006936	muscle contraction	1.77124870326395e-10	3.906489015048642e-6	6	323	7
MESH:D012891	Sleep Apnea Syndromes	GO:0014032	neural crest cell development	1.0631051594600649e-11	2.344678429189173e-7	5	67	7
Orphanet:275736	Rare hemorrhagic disorder due to a platelet receptor defect	GO:0007596	blood coagulation	2.9585278671362403e-10	6.525033210968978e-6	6	352	7
Orphanet:248361	Rare thrombotic disorder due to a constitutional coagulation factors defect	GO:1903035	negative regulation of response to wounding	8.711308341347035e-10	1.9212790546840885e-5	5	159	7
Orphanet:248361	Rare thrombotic disorder due to a constitutional coagulation factors defect	GO:1900047	negative regulation of hemostasis	1.4565714190339918e-9	3.212468264679469e-5	4	49	7
Orphanet:248361	Rare thrombotic disorder due to a constitutional coagulation factors defect	GO:0030195	negative regulation of blood coagulation	1.4565714190339918e-9	3.212468264679469e-5	4	49	7
OMIM:203300	Hermansky-Pudlak Syndrome 1	GO:0043473	pigmentation	1.0413891970983968e-13	2.2967838742005142e-9	6	91	7
OMIM:203300	Hermansky-Pudlak Syndrome 1	GO:0031082	BLOC complex	2.5646151868841116e-14	5.656258794672908e-10	7	20	7
OMIM:203300	Hermansky-Pudlak Syndrome 1	GO:0031084	BLOC-2 complex	3.226485745244645e-11	7.116014311137064e-7	3	3	7
Orphanet:79215	Oligosaccharidosis	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	1.2667644710973036e-13	2.793849041005103e-9	6	94	7
Orphanet:79215	Oligosaccharidosis	GO:0000323	lytic vacuole	1.308309016678777e-11	2.8854755362850426e-7	7	515	7
Orphanet:79215	Oligosaccharidosis	GO:0005764	lysosome	1.308309016678777e-11	2.8854755362850426e-7	7	515	7
Orphanet:79215	Oligosaccharidosis	GO:0043202	lysosomal lumen	4.0683900692783936e-11	8.972834297793497e-7	5	87	7
DOID:9263	homocystinuria	GO:0006767	water-soluble vitamin metabolic process	8.548717289613705e-15	1.8854195982243027e-10	6	86	7
Orphanet:2828	Young-onset Parkinson disease	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	4.131373021465379e-11	9.111743198841893e-7	4	21	7
Orphanet:2828	Young-onset Parkinson disease	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	3.225771871839811e-10	7.114439863342703e-6	3	5	7
Orphanet:2828	Young-onset Parkinson disease	GO:0016241	regulation of macroautophagy	5.663860491722517e-10	1.249164431449401e-5	5	146	7
Orphanet:2828	Young-onset Parkinson disease	GO:1903146	regulation of mitophagy	6.96911528486055e-10	1.5370383760759943e-5	4	41	7
Orphanet:2828	Young-onset Parkinson disease	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	2.0118129384627537e-9	4.437053435779603e-5	4	53	7
DOID:9111	cutaneous leishmaniasis	GO:0005125	cytokine activity	1.836053531434345e-11	4.049416063578448e-7	6	222	7
DOID:9111	cutaneous leishmaniasis	GO:0005126	cytokine receptor binding	6.03387340092354e-11	1.3307707785736866e-6	6	270	7
DOID:9111	cutaneous leishmaniasis	GO:0002544	chronic inflammatory response	6.114841966109452e-11	1.3486283956254397e-6	4	23	7
DOID:9111	cutaneous leishmaniasis	GO:0002687	positive regulation of leukocyte migration	1.2841172569721948e-10	2.8321206102521757e-6	5	109	7
DOID:9111	cutaneous leishmaniasis	GO:0002439	chronic inflammatory response to antigenic stimulus	3.225771871839811e-10	7.114439863342703e-6	3	5	7
DOID:9111	cutaneous leishmaniasis	GO:0071622	regulation of granulocyte chemotaxis	5.661313640104026e-10	1.248602723324943e-5	4	39	7
DOID:9111	cutaneous leishmaniasis	GO:0002703	regulation of leukocyte mediated immunity	6.713277711511978e-10	1.4806133992739667e-5	5	151	7
DOID:9111	cutaneous leishmaniasis	GO:0071222	cellular response to lipopolysaccharide	6.940965580071179e-10	1.5308299586846985e-5	5	152	7
DOID:9111	cutaneous leishmaniasis	GO:0045428	regulation of nitric oxide biosynthetic process	1.7174144328890861e-9	3.7877575317368795e-5	4	51	7
DOID:9111	cutaneous leishmaniasis	GO:0045080	positive regulation of chemokine biosynthetic process	2.707990942596439e-9	5.972474023896446e-5	3	9	7
MESH:C563426	Cataract, Pulverulent	GO:0005212	structural constituent of eye lens	4.131373021465379e-11	9.111743198841893e-7	4	21	7
Orphanet:209038	Qualitative or quantitative defects of myofibrillar proteins	GO:0030018	Z disc	3.3861802251067274e-14	7.468220486472887e-10	6	109	7
Orphanet:209038	Qualitative or quantitative defects of myofibrillar proteins	GO:0061061	muscle structure development	4.391471963849369e-9	9.685391416269784e-5	6	551	7
DOID:2058	chronic mucocutaneous candidiasis	GO:0031347	regulation of defense response	1.6410606207273304e-10	3.619359199014127e-6	7	749	7
DOID:2058	chronic mucocutaneous candidiasis	GO:0009620	response to fungus	1.1223492135670199e-9	2.4753411905220624e-5	4	46	7
DOID:2058	chronic mucocutaneous candidiasis	GO:1900017	positive regulation of cytokine production involved in inflammatory response	2.707990942596439e-9	5.972474023896446e-5	3	9	7
DOID:2058	chronic mucocutaneous candidiasis	GO:0098542	defense response to other organism	4.3432794027964405e-9	9.57910272286755e-5	6	550	7
DC:0000046	Atypical Mycobacteriosis, Familial	GO:0045087	innate immune response	2.2361890117394978e-10	4.931914865391462e-6	7	783	7
DC:0000046	Atypical Mycobacteriosis, Familial	GO:0009615	response to virus	7.642380062122811e-10	1.685526922701186e-5	6	412	7
DC:0000046	Atypical Mycobacteriosis, Familial	GO:0019221	cytokine-mediated signaling pathway	3.638547019235716e-9	8.024815450924372e-5	6	534	7
DOID:2560	morphine dependence	GO:0051931	regulation of sensory perception	4.054735436298529e-10	8.942719004756405e-6	4	36	7
DOID:2560	morphine dependence	GO:0051930	regulation of sensory perception of pain	4.054735436298529e-10	8.942719004756405e-6	4	36	7
DOID:2560	morphine dependence	GO:0044708	single-organism behavior	6.792312268188994e-10	1.4980444707490825e-5	6	404	7
DC:0000660	Muscular Dystrophy-Dystroglycanopathy, Type B	GO:0035269	protein O-linked mannosylation	1.3322676295501878e-15	2.938316256972939e-11	5	16	7
OMIM:101200	acrocephalosyndactylia	GO:0048705	skeletal system morphogenesis	5.901945598907332e-13	1.3016741018390121e-8	7	204	7
OMIM:101200	acrocephalosyndactylia	GO:0060349	bone morphogenesis	1.3222756223285614e-13	2.9162788850456423e-9	6	80	7
OMIM:101200	acrocephalosyndactylia	GO:0097094	craniofacial suture morphogenesis	6.903477789421686e-12	1.5225620264569528e-7	4	14	7
OMIM:101200	acrocephalosyndactylia	GO:0005007	fibroblast growth factor-activated receptor activity	3.225771871839811e-10	7.114439863342703e-6	3	5	7
OMIM:101200	acrocephalosyndactylia	GO:0035107	appendage morphogenesis	5.663860491722517e-10	1.249164431449401e-5	5	146	7
OMIM:101200	acrocephalosyndactylia	GO:0035108	limb morphogenesis	5.663860491722517e-10	1.249164431449401e-5	5	146	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0016485	protein processing	4.942712905631197e-13	1.0901153313369605e-8	7	308	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0002250	adaptive immune response	4.1744385725905886e-13	9.206724271848543e-9	7	334	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0006956	complement activation	1.6497914145929826e-13	3.638614964884823e-9	7	56	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:2000257	regulation of protein activation cascade	1.0769163338864018e-13	2.3751389743864593e-9	7	33	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0006958	complement activation, classical pathway	1.0769163338864018e-13	2.3751389743864593e-9	7	33	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0002673	regulation of acute inflammatory response	5.3290705182007514e-14	1.1753265027891757e-9	7	74	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0002920	regulation of humoral immune response	5.062616992290714e-14	1.116560177649717e-9	7	51	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0019835	cytolysis	4.618527782440651e-14	1.0186163024172856e-9	7	30	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0030449	regulation of complement activation	3.6637359812630166e-14	8.080369706675583e-10	7	32	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0006957	complement activation, alternative pathway	8.881784197001252e-15	1.9588775046486262e-10	6	14	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0046930	pore complex	5.10702591327572e-15	1.1263545651729601e-10	7	17	7
Orphanet:169150	Immunodeficiency due to a late component of complements deficiency	GO:0005579	membrane attack complex	4.551914400963142e-15	1.0039247211324209e-10	7	7	7
Orphanet:98994	Total early-onset cataract	GO:0002088	lens development in camera-type eye	1.0631051594600649e-11	2.344678429189173e-7	5	67	7
Orphanet:98994	Total early-onset cataract	GO:0005212	structural constituent of eye lens	4.131373021465379e-11	9.111743198841893e-7	4	21	7
OMIM:135900	Coffin-Siris syndrome	GO:0070603	SWI/SNF superfamily-type complex	1.765254609153999e-13	3.8932690404891446e-9	6	71	7
OMIM:135900	Coffin-Siris syndrome	GO:0071565	nBAF complex	8.881784197001252e-15	1.9588775046486262e-10	6	14	7
OMIM:135900	Coffin-Siris syndrome	GO:0016514	SWI/SNF complex	6.217248937900877e-15	1.3712142532540383e-10	6	15	7
OMIM:135900	Coffin-Siris syndrome	GO:0071564	npBAF complex	2.6645352591003757e-15	5.876632513945879e-11	5	12	7
OMIM:135900	Coffin-Siris syndrome	GO:0003713	transcription coactivator activity	1.478484001893321e-12	3.2607964661757194e-8	7	292	7
OMIM:135900	Coffin-Siris syndrome	GO:0006338	chromatin remodeling	2.0500268149703516e-12	4.5213341404171103e-8	6	148	7
OMIM:135900	Coffin-Siris syndrome	GO:0006337	nucleosome disassembly	1.6423418180977478e-11	3.622184879814583e-7	4	17	7
OMIM:135900	Coffin-Siris syndrome	GO:0031491	nucleosome binding	1.0248814019675478e-9	2.2603759320394268e-5	4	45	7
OMIM:218040	Costello syndrome	GO:0007409	axonogenesis	6.999171242583202e-10	1.5436672175517252e-5	6	406	7
OMIM:218040	Costello syndrome	GO:0045860	positive regulation of protein kinase activity	1.299888419126205e-9	2.866903908382845e-5	6	450	7
OMIM:218040	Costello syndrome	GO:0043410	positive regulation of MAPK cascade	1.5663706998125804e-9	3.454630578436646e-5	6	464	7
OMIM:218040	Costello syndrome	GO:0060324	face development	1.5829543231760113e-9	3.491205759764693e-5	4	50	7
OMIM:218040	Costello syndrome	GO:0043406	positive regulation of MAP kinase activity	3.134795756309927e-9	6.913792040541544e-5	5	205	7
DOID:12721	multiple epiphyseal dysplasia	GO:0005201	extracellular matrix structural constituent	3.1308289294429414e-14	6.905043203886407e-10	6	74	7
DOID:12721	multiple epiphyseal dysplasia	GO:0030198	extracellular matrix organization	1.6744616804231782e-10	3.6930252361733196e-6	6	320	7
DOID:12721	multiple epiphyseal dysplasia	GO:0005578	proteinaceous extracellular matrix	3.06040082165282e-10	6.7497140121552945e-6	6	354	7
Orphanet:93430	Multiple metaphyseal dysplasia	GO:0001503	ossification	3.568603190728936e-10	7.870554337152669e-6	6	363	7
Orphanet:93430	Multiple metaphyseal dysplasia	GO:0001501	skeletal system development	1.966002582953763e-9	4.3360186967045244e-5	6	482	7
DOID:1557	hypersensitivity reaction type III disease	GO:0019724	B cell mediated immunity	9.71445146547012e-14	2.142522270709435e-9	6	100	7
DOID:1557	hypersensitivity reaction type III disease	GO:0006958	complement activation, classical pathway	1.5543122344752192e-13	3.428035633135096e-9	5	33	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:0007530	sex determination	1.1368683772161603e-13	2.5073632059502415e-9	5	22	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:0030238	male sex determination	4.950262422198648e-12	1.0917803772159118e-7	4	13	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:0045137	development of primary sexual characteristics	1.9361068304135642e-11	4.270083614477116e-7	6	225	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:0046546	development of primary male sexual characteristics	3.024518413496935e-10	6.67057536096749e-6	5	129	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:0008584	male gonad development	3.024518413496935e-10	6.67057536096749e-6	5	129	7
Orphanet:242	46,XY complete gonadal dysgenesis	GO:2000020	positive regulation of male gonad development	1.8056133255228701e-9	3.98228018944069e-5	3	8	7
DOID:1926	Gaucher's disease	GO:0000323	lytic vacuole	2.927706410638109e-9	6.45705648866235e-5	6	515	7
DOID:1926	Gaucher's disease	GO:0005764	lysosome	2.927706410638109e-9	6.45705648866235e-5	6	515	7
OMIM:601144	Brugada Syndrome 1	GO:0002027	regulation of heart rate	1.509903313490213e-14	3.3300917579026645e-10	6	87	7
OMIM:601144	Brugada Syndrome 1	GO:0086019	cell-cell signaling involved in cardiac conduction	1.0902390101819037e-13	2.4045221369561887e-9	5	23	7
OMIM:601144	Brugada Syndrome 1	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	4.812816811750054e-13	1.0614667478314743e-8	4	8	7
OMIM:601144	Brugada Syndrome 1	GO:0086010	membrane depolarization during action potential	1.3058443215641091e-12	2.8800396512096427e-8	5	44	7
OMIM:601144	Brugada Syndrome 1	GO:0022843	voltage-gated cation channel activity	1.864952636765338e-12	4.113153040385953e-8	6	149	7
OMIM:601144	Brugada Syndrome 1	GO:0086001	cardiac muscle cell action potential	2.3333557308546915e-12	5.146216064400022e-8	5	50	7
OMIM:601144	Brugada Syndrome 1	GO:0034703	cation channel complex	3.0148106233696126e-12	6.64916482984168e-8	6	166	7
OMIM:601144	Brugada Syndrome 1	GO:0001518	voltage-gated sodium channel complex	6.903477789421686e-12	1.5225620264569528e-7	4	14	7
OMIM:601144	Brugada Syndrome 1	GO:0086012	membrane depolarization during cardiac muscle cell action potential	2.1119328508234503e-11	4.6578679024911196e-7	4	18	7
OMIM:601144	Brugada Syndrome 1	GO:0005248	voltage-gated sodium channel activity	3.345657084707909e-11	7.378846700323294e-7	4	20	7
OMIM:601144	Brugada Syndrome 1	GO:0055117	regulation of cardiac muscle contraction	3.41516814827969e-11	7.532153351030857e-7	5	84	7
OMIM:601144	Brugada Syndrome 1	GO:0086091	regulation of heart rate by cardiac conduction	1.8880763619222307e-10	4.16415241621948e-6	4	30	7
OMIM:601144	Brugada Syndrome 1	GO:0086006	voltage-gated sodium channel activity involved in cardiac muscle cell action potential	3.225771871839811e-10	7.114439863342703e-6	3	5	7
OMIM:601144	Brugada Syndrome 1	GO:0086002	cardiac muscle cell action potential involved in contraction	4.054735436298529e-10	8.942719004756405e-6	4	36	7
OMIM:601144	Brugada Syndrome 1	GO:0086016	AV node cell action potential	1.8056133255228701e-9	3.98228018944069e-5	3	8	7
Orphanet:156246	Nose and cavum anomaly	GO:0032808	lacrimal gland development	1.8056133255228701e-9	3.98228018944069e-5	3	8	7
OMIM:603932	Intervertebral Disc Disease	GO:0005578	proteinaceous extracellular matrix	7.549516567451064e-15	1.6650458789513323e-10	7	354	7
Orphanet:181431	Rare hypolipidemia	GO:0034377	plasma lipoprotein particle assembly	5.029310301551959e-14	1.1092143870072846e-9	5	19	7
Orphanet:181431	Rare hypolipidemia	GO:0055092	sterol homeostasis	7.937761559162482e-12	1.7506733118732853e-7	5	63	7
Orphanet:181431	Rare hypolipidemia	GO:0042632	cholesterol homeostasis	7.937761559162482e-12	1.7506733118732853e-7	5	63	7
Orphanet:181431	Rare hypolipidemia	GO:0042158	lipoprotein biosynthetic process	4.317168844636399e-11	9.521515886845577e-7	5	88	7
Orphanet:181431	Rare hypolipidemia	GO:0008203	cholesterol metabolic process	1.9277379692539398e-10	4.251626091189564e-6	5	118	7
Orphanet:181431	Rare hypolipidemia	GO:0010876	lipid localization	2.1176582709614422e-10	4.670495316605461e-6	6	333	7
Orphanet:181431	Rare hypolipidemia	GO:0034358	plasma lipoprotein particle	4.054735436298529e-10	8.942719004756405e-6	4	36	7
Orphanet:181431	Rare hypolipidemia	GO:0055091	phospholipid homeostasis	2.707990942596439e-9	5.972474023896446e-5	3	9	7
Orphanet:181431	Rare hypolipidemia	GO:0019915	lipid storage	3.5818340515803015e-9	7.899735000760355e-5	4	61	7
DOID:0050629	Aicardi-Goutieres syndrome	GO:0032299	ribonuclease H2 complex	5.162947847026089e-11	1.138688147661604e-6	3	3	8
DOID:0050629	Aicardi-Goutieres syndrome	GO:0004523	RNA-DNA hybrid ribonuclease activity	1.8056133255228701e-9	3.98228018944069e-5	3	7	8
DOID:6688	autoimmune lymphoproliferative syndrome	GO:0031265	CD95 death-inducing signaling complex	1.0319829435445627e-9	2.276038381987533e-5	3	6	8
DOID:0050847	sleep apnea	GO:0048863	stem cell differentiation	7.146505609512133e-13	1.576161812177901e-8	7	266	8
DOID:0050847	sleep apnea	GO:0014032	neural crest cell development	2.8297475473948452e-11	6.241008215779331e-7	5	67	8
DOID:0050730	coenzyme Q10 deficiency disease	GO:0042180	cellular ketone metabolic process	2.1516122217235534e-13	4.745380755011297e-9	7	253	8
DOID:0050730	coenzyme Q10 deficiency disease	GO:0006733	oxidoreduction coenzyme metabolic process	1.4588330543574557e-13	3.2174563013853685e-9	7	133	8
DOID:0050730	coenzyme Q10 deficiency disease	GO:0009108	coenzyme biosynthetic process	5.972999872483342e-14	1.3173451218762011e-9	7	132	8
DOID:0050730	coenzyme Q10 deficiency disease	GO:1901661	quinone metabolic process	2.020605904817785e-14	4.4564463230756246e-10	7	29	8
DOID:0060480	left ventricular noncompaction	GO:0033275	actin-myosin filament sliding	1.7723600365116e-12	3.9089400605263336e-8	5	39	8
DOID:0060480	left ventricular noncompaction	GO:0030049	muscle filament sliding	1.7723600365116e-12	3.9089400605263336e-8	5	39	8
DOID:0060480	left ventricular noncompaction	GO:0006941	striated muscle contraction	6.9468875096845295e-12	1.532136040260923e-7	6	150	8
DOID:0060480	left ventricular noncompaction	GO:0055008	cardiac muscle tissue morphogenesis	9.164669023675742e-12	2.021267753171685e-7	5	54	8
DOID:0060480	left ventricular noncompaction	GO:0060048	cardiac muscle contraction	4.4852299652120564e-10	9.89217468827519e-6	5	115	8
DOID:0060480	left ventricular noncompaction	GO:0055010	ventricular cardiac muscle tissue morphogenesis	1.130682214522949e-9	2.493719624130364e-5	4	39	8
DOID:0060480	left ventricular noncompaction	GO:0030017	sarcomere	4.309394174839554e-9	9.504368852608636e-5	5	180	8
MESH:D017193	Skin Diseases, Viral	GO:0009615	response to virus	3.002925574868698e-9	6.622952355372913e-5	6	412	8
OMIM:305000	Dyskeratosis Congenita, X-Linked	GO:0010833	telomere maintenance via telomere lengthening	1.6964207816272392e-13	3.741456033878876e-9	6	62	8
OMIM:305000	Dyskeratosis Congenita, X-Linked	GO:0007004	telomere maintenance via telomerase	8.244516180866412e-12	1.8183280436900873e-7	5	53	8
OMIM:305000	Dyskeratosis Congenita, X-Linked	GO:0070198	protein localization to chromosome, telomeric region	2.059180603808386e-10	4.541522821699395e-6	4	26	8
OMIM:305000	Dyskeratosis Congenita, X-Linked	GO:0032206	positive regulation of telomere maintenance	2.448463987114735e-9	5.400087323581548e-5	4	47	8
OMIM:305000	Dyskeratosis Congenita, X-Linked	GO:1904356	regulation of telomere maintenance via telomere lengthening	2.670598520104761e-9	5.8900050360910505e-5	4	48	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0072329	monocarboxylic acid catabolic process	2.4424906541753444e-13	5.386913137783722e-9	7	109	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0019395	fatty acid oxidation	1.6298074001497298e-13	3.594540221030229e-9	7	91	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0009062	fatty acid catabolic process	1.3500311979441904e-13	2.977493807065912e-9	7	86	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0006635	fatty acid beta-oxidation	4.574118861455645e-14	1.0088219148940425e-9	7	65	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0044429	mitochondrial part	4.732214620162267e-11	1.043689934476788e-6	8	956	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0000062	fatty-acyl-CoA binding	4.330689140630284e-10	9.551334899660091e-6	4	31	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0009055	electron carrier activity	4.4852299652120564e-10	9.89217468827519e-6	5	115	8
Orphanet:217591	Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy	GO:0005759	mitochondrial matrix	3.002925574868698e-9	6.622952355372913e-5	6	412	8
Orphanet:435603	Genetic otorhinolaryngological malformation	GO:0032808	lacrimal gland development	2.8883980762728356e-9	6.370361957219739e-5	3	8	8
DOID:13620	patent foramen ovale	GO:0003007	heart morphogenesis	4.778399897986674e-13	1.0538760975009609e-8	7	216	8
DOID:13620	patent foramen ovale	GO:0003206	cardiac chamber morphogenesis	6.820100040272337e-13	1.504173063882064e-8	6	104	8
DOID:13620	patent foramen ovale	GO:0060411	cardiac septum morphogenesis	5.683786774568489e-12	1.2535591731310802e-7	5	49	8
DOID:13620	patent foramen ovale	GO:0048738	cardiac muscle tissue development	1.3410494936749728e-11	2.9576846583001526e-7	6	168	8
DOID:13620	patent foramen ovale	GO:0060419	heart growth	2.2407964372916922e-11	4.942076542446827e-7	5	64	8
DOID:13620	patent foramen ovale	GO:0055007	cardiac muscle cell differentiation	1.0819500850800523e-10	2.3862409126440554e-6	5	87	8
DOID:13620	patent foramen ovale	GO:0003209	cardiac atrium morphogenesis	2.4174895418838105e-10	5.331773184624744e-6	4	27	8
DOID:13620	patent foramen ovale	GO:0003231	cardiac ventricle development	2.822186928597148e-10	6.22433327102101e-6	5	105	8
DOID:13620	patent foramen ovale	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	5.117924972708465e-10	1.128758352730852e-5	6	307	8
DOID:13620	patent foramen ovale	GO:0051891	positive regulation of cardioblast differentiation	5.160869509523991e-10	1.1382297703255162e-5	3	5	8
DOID:13620	patent foramen ovale	GO:0060420	regulation of heart growth	1.391596948785434e-9	3.069167070546275e-5	4	41	8
DOID:13620	patent foramen ovale	GO:0003012	muscle system process	2.2623566353630054e-9	4.989627559293108e-5	6	393	8
DOID:13620	patent foramen ovale	GO:0055013	cardiac muscle cell development	4.015253463052204e-9	8.855641512761636e-5	4	53	8
DOID:13620	patent foramen ovale	GO:0055008	cardiac muscle tissue morphogenesis	4.335804604238547e-9	9.562617054648115e-5	4	54	8
OMIM:606764	gastrointestinal stromal tumor	GO:0000104	succinate dehydrogenase activity	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
OMIM:606764	gastrointestinal stromal tumor	GO:0045257	succinate dehydrogenase complex (ubiquinone)	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
OMIM:606764	gastrointestinal stromal tumor	GO:0045283	fumarate reductase complex	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
OMIM:606764	gastrointestinal stromal tumor	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
OMIM:604131	alpha thalassemia	GO:0031720	haptoglobin binding	5.162947847026089e-11	1.138688147661604e-6	3	3	8
OMIM:604131	alpha thalassemia	GO:0031838	haptoglobin-hemoglobin complex	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
MESH:C538287	Cataract microcornea syndrome	GO:0005212	structural constituent of eye lens	3.68594044175552e-14	8.129341644291799e-10	6	21	8
MESH:C538287	Cataract microcornea syndrome	GO:0007601	visual perception	5.873079800267078e-14	1.295307749948904e-9	7	207	8
MESH:D009165	Mycobacterium Infections, Nontuberculous	GO:0034341	response to interferon-gamma	8.093303804912466e-12	1.7849781541734444e-7	6	155	8
MESH:D009165	Mycobacterium Infections, Nontuberculous	GO:0050776	regulation of immune response	2.28897678589135e-9	5.048338301283373e-5	7	816	8
MESH:D009165	Mycobacterium Infections, Nontuberculous	GO:0009615	response to virus	3.002925574868698e-9	6.622952355372913e-5	6	412	8
Orphanet:263676	Hereditary epidermolysis bullosa associated with ocular features	GO:0030198	extracellular matrix organization	6.587089762533083e-10	1.4527826471266714e-5	6	320	8
Orphanet:79194	Disorder of serine or glycine metabolism	GO:0006544	glycine metabolic process	1.8984813721090177e-14	4.1871006661864385e-10	5	16	8
Orphanet:79195	Sterol biosynthesis disorder	GO:0016126	sterol biosynthetic process	2.0450308113595383e-13	4.510315454453462e-9	7	53	8
Orphanet:79195	Sterol biosynthesis disorder	GO:0033490	cholesterol biosynthetic process via lathosterol	1.176836406102666e-14	2.5955126936594297e-10	4	4	8
Orphanet:79195	Sterol biosynthesis disorder	GO:0033489	cholesterol biosynthetic process via desmosterol	1.176836406102666e-14	2.5955126936594297e-10	4	4	8
Orphanet:33110	Autosomal agammaglobulinemia	GO:0042113	B cell activation	3.8613556796462944e-13	8.516219951459902e-9	7	212	8
Orphanet:33110	Autosomal agammaglobulinemia	GO:0030183	B cell differentiation	7.096545573404001e-13	1.5651431262142523e-8	6	109	8
Orphanet:33110	Autosomal agammaglobulinemia	GO:0019814	immunoglobulin complex	1.0319829435445627e-9	2.276038381987533e-5	3	6	8
DOID:9279	hyperhomocysteinemia	GO:0050667	homocysteine metabolic process	1.3790635300381382e-11	3.041524615499114e-7	4	14	8
DOID:9279	hyperhomocysteinemia	GO:0000098	sulfur amino acid catabolic process	4.331736080942505e-9	9.553643926518696e-5	3	9	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0006875	cellular metal ion homeostasis	5.551115123125783e-13	1.2242984404053914e-8	8	450	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0055076	transition metal ion homeostasis	2.4580337765200966e-13	5.421193494115073e-9	8	109	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0055072	iron ion homeostasis	9.547918011776346e-15	2.1057933174972732e-10	8	68	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0046916	cellular transition metal ion homeostasis	5.029310301551959e-14	1.1092143870072846e-9	8	81	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0000041	transition metal ion transport	6.820100040272337e-13	1.504173063882064e-8	6	104	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0006826	iron ion transport	9.97923965684322e-12	2.200921306316772e-7	5	55	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0010039	response to iron ion	7.201124141431592e-10	1.5882079293927376e-5	4	35	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0015684	ferrous iron transport	1.8056133255228701e-9	3.98228018944069e-5	3	7	8
Orphanet:309842	Disorder of iron metabolism and transport	GO:0060586	multicellular organismal iron ion homeostasis	4.331736080942505e-9	9.553643926518696e-5	3	9	8
DOID:4948	gallbladder carcinoma	GO:0038128	ERBB2 signaling pathway	1.7723600365116e-12	3.9089400605263336e-8	5	39	8
DOID:4948	gallbladder carcinoma	GO:0004716	receptor signaling protein tyrosine kinase activity	4.331736080942505e-9	9.553643926518696e-5	3	9	8
MESH:D002542	Intracranial Embolism and Thrombosis	GO:0007596	blood coagulation	5.507483358258014e-12	1.214675454663805e-7	7	352	8
MESH:D002542	Intracranial Embolism and Thrombosis	GO:0031091	platelet alpha granule	4.7207571185481356e-11	1.0411629824957913e-6	5	74	8
MESH:D002542	Intracranial Embolism and Thrombosis	GO:0002576	platelet degranulation	2.962583511845196e-10	6.53397793537458e-6	5	106	8
MESH:D002542	Intracranial Embolism and Thrombosis	GO:0030168	platelet activation	2.534724319325221e-9	5.590334486271775e-5	5	162	8
MESH:D002534	Hypoxia, Brain	GO:0001666	response to hypoxia	3.8030190108173656e-10	8.3875584283577e-6	6	292	8
DC:0000289	Mucolipidosis	GO:0005975	carbohydrate metabolic process	1.3929073450213991e-9	3.072057149444696e-5	7	760	8
DC:0000373	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions	GO:0032042	mitochondrial DNA metabolic process	4.3298697960381105e-15	9.549527835162053e-11	5	17	8
DC:0000373	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions	GO:0006261	DNA-dependent DNA replication	2.2508661601250424e-12	4.964285316155781e-8	6	125	8
DC:0000373	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions	GO:0006264	mitochondrial DNA replication	4.5535797355000796e-12	1.0042920106645425e-7	4	11	8
DC:0000373	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions	GO:0009295	nucleoid	1.5379134632453884e-9	3.391868143187704e-5	4	42	8
DC:0000373	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions	GO:0042645	mitochondrial nucleoid	1.5379134632453884e-9	3.391868143187704e-5	4	42	8
OMIM:115080	Cardiac Conduction Defect	GO:0048738	cardiac muscle tissue development	3.0446233312275695e-9	6.714916757022404e-5	5	168	8
MESH:D002375	Catalepsy	GO:0007631	feeding behavior	7.66053886991358e-15	1.68953184775944e-10	7	106	8
MESH:D002375	Catalepsy	GO:0045471	response to ethanol	1.0875075284744185e-9	2.39849785405033e-5	5	137	8
MESH:D002375	Catalepsy	GO:0007188	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	1.50031542744955e-9	3.3089456752399826e-5	5	146	8
MESH:D002375	Catalepsy	GO:0010243	response to organonitrogen compound	1.6703308736154554e-9	3.683914741758887e-5	7	780	8
MESH:D002375	Catalepsy	GO:0035094	response to nicotine	4.335804604238547e-9	9.562617054648115e-5	4	54	8
Orphanet:371183	Congenital disorder of glycosylation with cardiac malformation as a major feature	GO:0009101	glycoprotein biosynthetic process	3.3637537200092993e-12	7.41875882948051e-8	7	336	8
Orphanet:371183	Congenital disorder of glycosylation with cardiac malformation as a major feature	GO:0000139	Golgi membrane	7.168543536550942e-10	1.5810222769863103e-5	7	691	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0097542	ciliary tip	1.4521717162097048e-13	3.202764720100504e-9	6	43	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0072372	primary cilium	3.696443151568474e-11	8.152505370784269e-7	6	199	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0044782	cilium organization	3.92602617083071e-11	8.65885071976713e-7	6	201	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0060271	cilium morphogenesis	6.417455455931531e-11	1.4153698008056992e-6	6	218	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0030990	intraciliary transport particle	3.772683276892508e-10	8.320652967186426e-6	4	30	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0007224	smoothened signaling pathway	4.896372196583343e-10	1.0798948879564563e-5	5	117	8
OMIM:208500	asphyxiating thoracic dystrophy	GO:0035721	intraciliary retrograde transport	4.331736080942505e-9	9.553643926518696e-5	3	9	8
DOID:12971	hereditary spherocytosis	GO:0044205	'de novo' UMP biosynthetic process	5.162947847026089e-11	1.138688147661604e-6	3	3	8
DOID:12971	hereditary spherocytosis	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	1.0319829435445627e-9	2.276038381987533e-5	3	6	8
DOID:12971	hereditary spherocytosis	GO:0014731	spectrin-associated cytoskeleton	2.8883980762728356e-9	6.370361957219739e-5	3	8	8
DOID:5200	urinary tract obstruction	GO:0009746	response to hexose	4.430823485890301e-9	9.772181198131058e-5	5	181	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0046034	ATP metabolic process	1.113109604489182e-12	2.4549632327008908e-8	8	230	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0005996	monosaccharide metabolic process	6.161737786669619e-13	1.3589712688499844e-8	8	282	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0051186	cofactor metabolic process	5.750955267558311e-13	1.2683731842599855e-8	8	350	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0006006	glucose metabolic process	4.332090242087361e-13	9.554425028923674e-9	8	199	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0019674	NAD metabolic process	2.1960211427085596e-13	4.843324630243728e-9	7	57	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0009135	purine nucleoside diphosphate metabolic process	1.9584334154387761e-13	4.319324897750221e-9	8	89	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0009179	purine ribonucleoside diphosphate metabolic process	1.9584334154387761e-13	4.319324897750221e-9	8	89	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0046939	nucleotide phosphorylation	1.9584334154387761e-13	4.319324897750221e-9	8	89	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0046365	monosaccharide catabolic process	1.2212453270876722e-13	2.693456568891861e-9	7	60	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0006090	pyruvate metabolic process	9.681144774731365e-14	2.1351764800670026e-9	8	99	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0046031	ADP metabolic process	8.637535131583718e-14	1.905008373270789e-9	8	74	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0006734	NADH metabolic process	5.46229728115577e-14	1.2047096653589051e-9	7	37	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0061718	glucose catabolic process to pyruvate	4.085620730620576e-14	9.010836521383681e-10	7	26	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0061621	canonical glycolysis	4.085620730620576e-14	9.010836521383681e-10	7	26	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0006094	gluconeogenesis	7.520262190752192e-11	1.6585938261703959e-6	5	81	8
Orphanet:98372	Hemolytic anemia due to a disorder of glycolytic enzymes	GO:0051156	glucose 6-phosphate metabolic process	2.4174895418838105e-10	5.331773184624744e-6	4	27	8
DOID:3209	junctional epidermolysis bullosa	GO:0034329	cell junction assembly	9.43689570931383e-14	2.0813073486891653e-9	7	187	8
DOID:3209	junctional epidermolysis bullosa	GO:0005604	basement membrane	1.521311965291261e-10	3.355253539449876e-6	5	93	8
DOID:3209	junctional epidermolysis bullosa	GO:0030198	extracellular matrix organization	6.587089762533083e-10	1.4527826471266714e-5	6	320	8
DOID:14793	hypohidrotic ectodermal dysplasia	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	9.625222840980996e-11	2.1228428975783586e-6	6	233	8
DOID:14793	hypohidrotic ectodermal dysplasia	GO:0071345	cellular response to cytokine stimulus	6.209239789001231e-10	1.3694478354642214e-5	7	677	8
DOID:14793	hypohidrotic ectodermal dysplasia	GO:0051092	positive regulation of NF-kappaB transcription factor activity	8.338658652462527e-10	1.8390911658006104e-5	5	130	8
DOID:14793	hypohidrotic ectodermal dysplasia	GO:0033209	tumor necrosis factor-mediated signaling pathway	1.963356810463779e-9	4.330183445477864e-5	5	154	8
DOID:14793	hypohidrotic ectodermal dysplasia	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	4.309394174839554e-9	9.504368852608636e-5	5	180	8
MESH:D006327	Heart Block	GO:0060048	cardiac muscle contraction	4.4852299652120564e-10	9.89217468827519e-6	5	115	8
MESH:D006327	Heart Block	GO:0086070	SA node cell to atrial cardiac muscle cell communication	4.331736080942505e-9	9.553643926518696e-5	3	9	8
MESH:D006327	Heart Block	GO:0086015	SA node cell action potential	4.331736080942505e-9	9.553643926518696e-5	3	9	8
Orphanet:35656	Coenzyme Q10 deficiency	GO:1901661	quinone metabolic process	1.9984014443252818e-14	4.407474385459409e-10	6	29	8
MESH:D047928	Premature Birth	GO:0045428	regulation of nitric oxide biosynthetic process	3.4279731275788095e-9	7.560394732875064e-5	4	51	8
DOID:1825	childhood absence epilepsy	GO:0071420	cellular response to histamine	2.8883980762728356e-9	6.370361957219739e-5	3	8	8
DOID:1825	childhood absence epilepsy	GO:0034707	chloride channel complex	2.907481588820815e-9	6.412450644144307e-5	4	49	8
OMIM:155255	medulloblastoma	GO:0001708	cell fate specification	7.520262190752192e-11	1.6585938261703959e-6	5	81	8
Orphanet:93550	Basement membrane disease	GO:0098651	basement membrane collagen trimer	6.661338147750939e-15	1.4691581284864696e-10	5	8	8
Orphanet:93550	Basement membrane disease	GO:0030198	extracellular matrix organization	6.587089762533083e-10	1.4527826471266714e-5	6	320	8
Orphanet:250	Frontonasal dysplasia	GO:0048704	embryonic skeletal system morphogenesis	1.521311965291261e-10	3.355253539449876e-6	5	93	8
OMIM:608089	Endometrial Cancer	GO:0006298	mismatch repair	3.772683276892508e-10	8.320652967186426e-6	4	30	8
OMIM:608089	Endometrial Cancer	GO:0032300	mismatch repair complex	2.8883980762728356e-9	6.370361957219739e-5	3	8	8
Orphanet:95494	Combined pituitary hormone deficiencies, genetic forms	GO:0030900	forebrain development	1.270286431598322e-9	2.801616724890099e-5	6	357	8
Orphanet:95494	Combined pituitary hormone deficiencies, genetic forms	GO:0021983	pituitary gland development	1.5379134632453884e-9	3.391868143187704e-5	4	42	8
DOID:13382	megaloblastic anemia	GO:0006767	water-soluble vitamin metabolic process	1.3500311979441904e-13	2.977493807065912e-9	7	86	8
DOID:13382	megaloblastic anemia	GO:0051180	vitamin transport	8.970602038971265e-14	1.9784662796951125e-9	6	33	8
DOID:13382	megaloblastic anemia	GO:0015889	cobalamin transport	6.661338147750939e-15	1.4691581284864696e-10	5	8	8
DOID:13382	megaloblastic anemia	GO:0009235	cobalamin metabolic process	7.327471962526033e-14	1.6160739413351166e-9	5	20	8
DOID:13382	megaloblastic anemia	GO:0031419	cobalamin binding	1.7400525464950078e-12	3.83768589129474e-8	4	9	8
DOID:13382	megaloblastic anemia	GO:0006824	cobalt ion transport	5.160869509523991e-10	1.1382297703255162e-5	3	5	8
Orphanet:588	Muscle-eye-brain disease	GO:0006493	protein O-linked glycosylation	9.614531393253856e-14	2.120484898782138e-9	7	99	8
Orphanet:181393	Growth hormone insensitivity syndrome	GO:0048009	insulin-like growth factor receptor signaling pathway	8.445466548323566e-13	1.8626476472327624e-8	5	35	8
Orphanet:181393	Growth hormone insensitivity syndrome	GO:0040014	regulation of multicellular organism growth	2.432543055874703e-11	5.364973709731657e-7	5	65	8
Orphanet:181393	Growth hormone insensitivity syndrome	GO:0071375	cellular response to peptide hormone stimulus	3.265410164488003e-10	7.2018621177782904e-6	6	285	8
Orphanet:181393	Growth hormone insensitivity syndrome	GO:0040018	positive regulation of multicellular organism growth	4.948971232821009e-10	1.0914956053986735e-5	4	32	8
MESH:D013119	Spinal Cord Injuries	GO:0001666	response to hypoxia	3.8030190108173656e-10	8.3875584283577e-6	6	292	8
MESH:D013119	Spinal Cord Injuries	GO:0051384	response to glucocorticoid	2.9542840396246106e-9	6.515673449392079e-5	5	167	8
DOID:3265	chronic granulomatous disease	GO:0043020	NADPH oxidase complex	2.4424906541753444e-15	5.386913137783722e-11	5	10	8
DOID:3265	chronic granulomatous disease	GO:0016175	superoxide-generating NADPH oxidase activity	1.7400525464950078e-12	3.83768589129474e-8	4	9	8
DOID:3265	chronic granulomatous disease	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	1.468336563448247e-11	3.238416290685109e-7	5	59	8
DOID:3265	chronic granulomatous disease	GO:0045454	cell redox homeostasis	2.8297475473948452e-11	6.241008215779331e-7	5	67	8
DOID:3265	chronic granulomatous disease	GO:0045335	phagocytic vesicle	8.008393947989134e-11	1.7662512852290035e-6	5	82	8
DOID:3265	chronic granulomatous disease	GO:0042554	superoxide anion generation	1.2207879152015266e-10	2.692447746976967e-6	4	23	8
DOID:3265	chronic granulomatous disease	GO:0048010	vascular endothelial growth factor receptor signaling pathway	1.3605860882393017e-10	3.00077261761178e-6	5	91	8
DOID:3265	chronic granulomatous disease	GO:0045730	respiratory burst	2.4174895418838105e-10	5.331773184624744e-6	4	27	8
DOID:3265	chronic granulomatous disease	GO:0032010	phagolysosome	5.160869509523991e-10	1.1382297703255162e-5	3	5	8
DOID:1387	hypolipoproteinemia	GO:0034377	plasma lipoprotein particle assembly	8.204548151979907e-14	1.8095130949191685e-9	5	19	8
DOID:1387	hypolipoproteinemia	GO:0055092	sterol homeostasis	2.08429939974053e-11	4.596922326127739e-7	5	63	8
DOID:1387	hypolipoproteinemia	GO:0042632	cholesterol homeostasis	2.08429939974053e-11	4.596922326127739e-7	5	63	8
DOID:1387	hypolipoproteinemia	GO:0042158	lipoprotein biosynthetic process	1.1468237470779741e-10	2.529319774180472e-6	5	88	8
DOID:1387	hypolipoproteinemia	GO:0008203	cholesterol metabolic process	5.109080936094301e-10	1.1268078004555981e-5	5	118	8
DOID:1387	hypolipoproteinemia	GO:0034358	plasma lipoprotein particle	8.10013389695996e-10	1.7864845309745192e-5	4	36	8
DOID:1387	hypolipoproteinemia	GO:0010876	lipid localization	8.357291525484811e-10	1.843200645945675e-5	6	333	8
DOID:1387	hypolipoproteinemia	GO:0055091	phospholipid homeostasis	4.331736080942505e-9	9.553643926518696e-5	3	9	8
Orphanet:166311	Benign partial infantile seizures	GO:1902495	transmembrane transporter complex	5.222645649283209e-10	1.1518544979494116e-5	6	308	8
Orphanet:166311	Benign partial infantile seizures	GO:0034765	regulation of ion transmembrane transport	1.5004413267405425e-9	3.3092233461262666e-5	6	367	8
Orphanet:166311	Benign partial infantile seizures	GO:0022843	voltage-gated cation channel activity	1.6623037391028106e-9	3.666210896591249e-5	5	149	8
Orphanet:166311	Benign partial infantile seizures	GO:0086010	membrane depolarization during action potential	1.8645441857145784e-9	4.1122522015935026e-5	4	44	8
Orphanet:166311	Benign partial infantile seizures	GO:0034703	cation channel complex	2.8661506501492795e-9	6.321295258904236e-5	5	166	8
Orphanet:166311	Benign partial infantile seizures	GO:0046873	metal ion transmembrane transporter activity	3.1372581199562433e-9	6.919222783563495e-5	6	415	8
DOID:3883	Lynch syndrome	GO:1990391	DNA repair complex	5.3512749786932545e-14	1.1802236965507973e-9	6	37	8
DOID:3883	Lynch syndrome	GO:0005712	chiasma	5.162947847026089e-11	1.138688147661604e-6	3	3	8
DOID:3883	Lynch syndrome	GO:0003697	single-stranded DNA binding	9.614098406274252e-11	2.1203894035037862e-6	5	85	8
DOID:3883	Lynch syndrome	GO:0032389	MutLalpha complex	2.0647850096366938e-10	4.553883338753728e-6	3	4	8
DOID:3883	Lynch syndrome	GO:0007131	reciprocal meiotic recombination	1.5379134632453884e-9	3.391868143187704e-5	4	42	8
DOID:3883	Lynch syndrome	GO:0016887	ATPase activity	3.1372581199562433e-9	6.919222783563495e-5	6	415	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:1903522	regulation of blood circulation	4.1993597488243495e-10	9.261687926032103e-6	6	297	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:0060048	cardiac muscle contraction	4.4852299652120564e-10	9.89217468827519e-6	5	115	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:0086068	Purkinje myocyte to ventricular cardiac muscle cell communication	5.160869509523991e-10	1.1382297703255162e-5	3	5	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	5.160869509523991e-10	1.1382297703255162e-5	3	5	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:0006937	regulation of muscle contraction	2.780281005421159e-9	6.131909757456366e-5	5	165	8
OMIM:192605	Ventricular Tachycardia, Familial	GO:1903115	regulation of actin filament-based movement	3.7129391783352617e-9	8.18888735781842e-5	4	52	8
DOID:0050576	Senior-Loken syndrome	GO:0032391	photoreceptor connecting cilium	8.555378627761456e-13	1.8868887563527892e-8	5	30	9
DOID:0060326	myelomeningocele	GO:0016331	morphogenesis of embryonic epithelium	2.813054122974279e-9	6.204190868219772e-5	5	141	9
DOID:0060326	myelomeningocele	GO:0021915	neural tube development	3.974204410006621e-9	8.765107826269602e-5	5	151	9
OMIM:217095	double outlet right ventricle	GO:0003151	outflow tract morphogenesis	3.2984504017008476e-11	7.274732360951219e-7	5	59	9
OMIM:217095	double outlet right ventricle	GO:0035295	tube development	8.446110477677848e-10	1.8627896658518495e-5	7	573	9
OMIM:217095	double outlet right ventricle	GO:0003205	cardiac chamber development	2.9151341340849513e-9	6.42932833272436e-5	5	142	9
DOID:13911	achromatopsia	GO:0007601	visual perception	4.076738946423575e-13	8.991247746337194e-9	7	207	9
DOID:13911	achromatopsia	GO:0030553	cGMP binding	3.390787650658922e-11	7.478382163528252e-7	4	15	9
Orphanet:207012	Spinal muscular atrophy associated with central nervous system anomaly	GO:0006399	tRNA metabolic process	2.731148640577885e-14	6.023548326794526e-10	7	165	9
Orphanet:207012	Spinal muscular atrophy associated with central nervous system anomaly	GO:0090501	RNA phosphodiester bond hydrolysis	9.599141481686502e-10	2.117090653785958e-5	5	114	9
Orphanet:85410	Oligoarticular juvenile arthritis	GO:0038110	interleukin-2-mediated signaling pathway	7.740807994593979e-10	1.707235203207702e-5	3	5	9
Orphanet:85408	Juvenile rheumatoid factor-negative polyarthritis	GO:0038110	interleukin-2-mediated signaling pathway	7.740807994593979e-10	1.707235203207702e-5	3	5	9
Orphanet:2020	Congenital fiber-type disproportion myopathy	GO:0007517	muscle organ development	2.7987006046004126e-9	6.17253418344621e-5	6	340	9
MESH:D020149	Manganese Poisoning	GO:0046136	positive regulation of vitamin metabolic process	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
MESH:D020149	Manganese Poisoning	GO:0060557	positive regulation of vitamin D biosynthetic process	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
MESH:D020149	Manganese Poisoning	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
MESH:D020149	Manganese Poisoning	GO:1903409	reactive oxygen species biosynthetic process	1.9099788417520358e-10	4.212458335484115e-6	5	83	9
MESH:D020149	Manganese Poisoning	GO:2000377	regulation of reactive oxygen species metabolic process	3.471364307117142e-9	7.656093979346856e-5	5	147	9
MESH:D020149	Manganese Poisoning	GO:0009894	regulation of catabolic process	4.437599843143403e-9	9.787126454052775e-5	7	727	9
Orphanet:79197	Disorder of branched-chain amino acid metabolism	GO:0046395	carboxylic acid catabolic process	4.583000645652646e-13	1.0107807923986911e-8	8	219	9
Orphanet:79197	Disorder of branched-chain amino acid metabolism	GO:1901565	organonitrogen compound catabolic process	2.999822612537173e-13	6.616108771950735e-9	8	349	9
Orphanet:79197	Disorder of branched-chain amino acid metabolism	GO:0009081	branched-chain amino acid metabolic process	1.0436096431476471e-14	2.3016810679621358e-10	8	23	9
Orphanet:79197	Disorder of branched-chain amino acid metabolism	GO:0045239	tricarboxylic acid cycle enzyme complex	1.4432899320127035e-15	3.1831759450540176e-11	5	11	9
Orphanet:79197	Disorder of branched-chain amino acid metabolism	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	3.6763557753616283e-9	8.108202662560071e-5	4	45	9
DOID:2998	testicular cancer	GO:0046546	development of primary male sexual characteristics	1.7945563923760233e-9	3.957894123385319e-5	5	129	9
DOID:2998	testicular cancer	GO:0008584	male gonad development	1.7945563923760233e-9	3.957894123385319e-5	5	129	9
Orphanet:79212	Mucolipidosis	GO:0046514	ceramide catabolic process	1.7770784843662568e-11	3.9193465972697794e-7	4	13	9
Orphanet:79212	Mucolipidosis	GO:0009311	oligosaccharide metabolic process	5.028255589678565e-11	1.1089817703036076e-6	5	64	9
Orphanet:79212	Mucolipidosis	GO:0006689	ganglioside catabolic process	1.547792227718503e-9	3.4136557582331584e-5	3	6	9
DOID:14450	46 XX gonadal dysgenesis	GO:0008406	gonad development	2.0405821476998653e-10	4.500503926752053e-6	6	220	9
DOID:14450	46 XX gonadal dysgenesis	GO:0046546	development of primary male sexual characteristics	1.7945563923760233e-9	3.957894123385319e-5	5	129	9
DOID:14450	46 XX gonadal dysgenesis	GO:0008584	male gonad development	1.7945563923760233e-9	3.957894123385319e-5	5	129	9
Orphanet:138055	Pierre Robin syndrome associated with bone disease	GO:0001503	ossification	4.145142229461385e-9	9.142111187077084e-5	6	363	9
Orphanet:209182	Qualitative or quantitative defects of nebulin	GO:0030016	myofibril	5.577760475716786e-13	1.2301750729193373e-8	8	201	9
Orphanet:209182	Qualitative or quantitative defects of nebulin	GO:0044449	contractile fiber part	4.922728891187944e-13	1.085707856951501e-8	8	196	9
Orphanet:209182	Qualitative or quantitative defects of nebulin	GO:0005865	striated muscle thin filament	1.2022394191291141e-10	2.6515390388892612e-6	4	20	9
Orphanet:209182	Qualitative or quantitative defects of nebulin	GO:0030029	actin filament-based process	1.463744125906885e-9	3.228287669687635e-5	7	620	9
Orphanet:209182	Qualitative or quantitative defects of nebulin	GO:0055002	striated muscle cell development	1.6582969442069384e-9	3.6573739104484027e-5	5	127	9
OMIM:120200	Coloboma of choroid and retina	GO:0048859	formation of anatomical boundary	1.547792227718503e-9	3.4136557582331584e-5	3	6	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0016758	transferase activity, transferring hexosyl groups	8.320011346540923e-13	1.8349785024796006e-8	9	202	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0005996	monosaccharide metabolic process	4.505285033928885e-13	9.936406142330156e-9	9	282	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0009410	response to xenobiotic stimulus	3.348432642269472e-13	7.384968192525321e-9	9	106	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0032787	monocarboxylic acid metabolic process	2.5202062658991053e-13	5.558314919440477e-9	9	572	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0006805	xenobiotic metabolic process	1.1812772982011666e-13	2.605307081182673e-9	9	93	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0015020	glucuronosyltransferase activity	1.0835776720341528e-13	2.389830555671324e-9	9	35	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0009812	flavonoid metabolic process	3.1530333899354446e-14	6.954015141502623e-10	9	31	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0052695	cellular glucuronidation	2.6645352591003757e-14	5.876632513945879e-10	9	24	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0052697	xenobiotic glucuronidation	4.884981308350689e-15	1.0773826275567444e-10	9	9	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0051552	flavone metabolic process	2.886579864025407e-15	6.366351890108035e-11	5	6	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0001972	retinoic acid binding	2.1538326677728037e-14	4.750277948772919e-10	5	16	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0052696	flavonoid glucuronidation	3.019806626980426e-14	6.660183515805329e-10	9	22	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0009813	flavonoid biosynthetic process	3.7636560534792807e-14	8.300743425948554e-10	7	20	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0042573	retinoic acid metabolic process	2.0528023725319144e-13	4.527455632619137e-9	5	22	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0046982	protein heterodimerization activity	4.169331546677313e-12	9.195460726196814e-8	8	459	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0042803	protein homodimerization activity	3.538425108473575e-11	7.80399657673847e-7	8	703	9
OMIM:237900	Transient familial neonatal hyperbilirubinemia	GO:0005789	endoplasmic reticulum membrane	4.641749207223711e-10	1.0237377876531895e-5	8	977	9
OMIM:154700	Marfan syndrome	GO:0007566	embryo implantation	4.0256141753403085e-9	8.87849206371305e-5	4	46	9
Orphanet:290839	Autoinflammatory syndrome with immune deficiency	GO:0050728	negative regulation of inflammatory response	4.936043795922274e-10	1.0886444591906574e-5	5	100	9
Orphanet:290839	Autoinflammatory syndrome with immune deficiency	GO:0032651	regulation of interleukin-1 beta production	4.399056341419794e-9	9.702118761001355e-5	4	47	9
DC:0000661	Muscular Dystrophy-Dystroglycanopathy, Type C	GO:0009101	glycoprotein biosynthetic process	1.2214673716925972e-12	2.6939462882680232e-8	8	336	9
DC:0000661	Muscular Dystrophy-Dystroglycanopathy, Type C	GO:0006493	protein O-linked glycosylation	6.8833827526759706e-15	1.5181300661026853e-10	8	99	9
DC:0000661	Muscular Dystrophy-Dystroglycanopathy, Type C	GO:0035269	protein O-linked mannosylation	2.1538326677728037e-14	4.750277948772919e-10	5	16	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0014072	response to isoquinoline alkaloid	8.555378627761456e-13	1.8868887563527892e-8	5	30	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0043278	response to morphine	8.555378627761456e-13	1.8868887563527892e-8	5	30	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0048148	behavioral response to cocaine	1.2304823826525535e-11	2.713828894940207e-7	4	12	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0001964	startle response	3.134535964122165e-10	6.9132190688714346e-6	4	25	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0007268	synaptic transmission	1.2351626388351633e-9	2.7241511999509527e-5	7	605	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0004952	dopamine neurotransmitter receptor activity	2.7079908315741363e-9	5.972473779036758e-5	3	7	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0051940	regulation of catecholamine uptake involved in synaptic transmission	4.331736080942505e-9	9.553643926518696e-5	3	8	9
MESH:D004409	Dyskinesia, Drug-Induced	GO:0051584	regulation of dopamine uptake involved in synaptic transmission	4.331736080942505e-9	9.553643926518696e-5	3	8	9
Orphanet:289098	Disorders of vitamin D metabolism	GO:0010979	regulation of vitamin D 24-hydroxylase activity	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
Orphanet:289098	Disorders of vitamin D metabolism	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
Orphanet:289098	Disorders of vitamin D metabolism	GO:0042359	vitamin D metabolic process	9.621425878236778e-11	2.1220054774451214e-6	4	19	9
Orphanet:289098	Disorders of vitamin D metabolism	GO:0031214	biomineral tissue development	1.9399510886586313e-9	4.2785621260366113e-5	5	131	9
DOID:10808	gastric ulcer	GO:0006809	nitric oxide biosynthetic process	4.293709832126069e-11	9.469777034754046e-7	5	62	9
DOID:10808	gastric ulcer	GO:0051051	negative regulation of transport	1.6111734169044212e-10	3.553442970982701e-6	7	452	9
DOID:3133	acute porphyria	GO:0051186	cofactor metabolic process	5.597744490160039e-13	1.2345825473047967e-8	8	350	9
DOID:3133	acute porphyria	GO:0033013	tetrapyrrole metabolic process	1.2456702336294256e-13	2.7473257002696982e-9	8	56	9
DOID:3133	acute porphyria	GO:0006778	porphyrin-containing compound metabolic process	1.0347278589506459e-13	2.2820922929156495e-9	8	36	9
DOID:3133	acute porphyria	GO:0046148	pigment biosynthetic process	5.218048215738236e-14	1.1508405339810679e-9	7	50	9
DOID:3133	acute porphyria	GO:0006779	porphyrin-containing compound biosynthetic process	2.6645352591003757e-14	5.876632513945879e-10	7	24	9
DOID:3133	acute porphyria	GO:0042168	heme metabolic process	2.5757174171303632e-14	5.680744763481016e-10	7	29	9
DOID:3133	acute porphyria	GO:0006782	protoporphyrinogen IX biosynthetic process	8.881784197001252e-16	1.9588775046486262e-11	6	8	9
DOID:3133	acute porphyria	GO:0051597	response to methylmercury	9.880984919163893e-15	2.1792512239215966e-10	5	12	9
DOID:3133	acute porphyria	GO:0046685	response to arsenic-containing substance	7.6261219561502e-13	1.6819411974289267e-8	5	29	9
DOID:3133	acute porphyria	GO:0010038	response to metal ion	1.8949730673512022e-11	4.1793631000430764e-7	7	335	9
DOID:3133	acute porphyria	GO:0010288	response to lead ion	1.2022394191291141e-10	2.6515390388892612e-6	4	20	9
DOID:3133	acute porphyria	GO:0010039	response to iron ion	1.294576112975676e-9	2.8551876171678536e-5	4	35	9
Orphanet:206662	Inclusion myopathy	GO:0033275	actin-myosin filament sliding	2.0320921612082543e-9	4.481779261544805e-5	4	39	9
Orphanet:206662	Inclusion myopathy	GO:0030049	muscle filament sliding	2.0320921612082543e-9	4.481779261544805e-5	4	39	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0002250	adaptive immune response	1.3422596367718143e-12	2.9603536289002363e-8	9	334	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0004175	endopeptidase activity	5.17808018685173e-13	1.142025585210149e-8	8	404	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0008236	serine-type peptidase activity	2.6201263381153694e-13	5.778688638713447e-9	8	206	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0006958	complement activation, classical pathway	1.4410694859634532e-13	3.178278751292396e-9	9	33	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0004252	serine-type endopeptidase activity	8.548717289613705e-14	1.8854195982243027e-9	8	182	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0072562	blood microparticle	6.050715484207103e-14	1.3344853000418766e-9	7	114	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0045087	innate immune response	2.0763391006539678e-12	4.579365886492326e-8	9	783	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:0030449	regulation of complement activation	8.897279579755946e-10	1.9622950113151738e-5	4	32	9
Orphanet:169147	Immunodeficiency due to an early component of complement deficiency	GO:2000427	positive regulation of apoptotic cell clearance	4.331736080942505e-9	9.553643926518696e-5	3	8	9
OMIM:603554	Omenn syndrome	GO:0030098	lymphocyte differentiation	8.545941732052142e-12	1.8848074490041e-7	7	299	9
OMIM:603554	Omenn syndrome	GO:0033151	V(D)J recombination	2.484046301987064e-11	5.47856411903247e-7	4	14	9
OMIM:603554	Omenn syndrome	GO:0071594	thymocyte aggregation	7.956058034608304e-11	1.7547085995328615e-6	5	70	9
OMIM:603554	Omenn syndrome	GO:0033077	T cell differentiation in thymus	7.956058034608304e-11	1.7547085995328615e-6	5	70	9
OMIM:603554	Omenn syndrome	GO:0042113	B cell activation	1.6266421543065235e-10	3.5875592713230375e-6	6	212	9
MESH:D053098	Familial Hypophosphatemic Rickets	GO:0010979	regulation of vitamin D 24-hydroxylase activity	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
MESH:D053098	Familial Hypophosphatemic Rickets	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	7.744938024245585e-11	1.7081460812473637e-6	3	3	9
MESH:D053098	Familial Hypophosphatemic Rickets	GO:0042359	vitamin D metabolic process	9.621425878236778e-11	2.1220054774451214e-6	4	19	9
MESH:D053098	Familial Hypophosphatemic Rickets	GO:0031214	biomineral tissue development	1.9399510886586313e-9	4.2785621260366113e-5	5	131	9
Orphanet:98938	Colobomatous microphthalmia	GO:0001654	eye development	2.216809180666246e-9	4.8891726479594055e-5	6	327	9
DOID:14784	olivopontocerebellar atrophy	GO:0006399	tRNA metabolic process	2.731148640577885e-14	6.023548326794526e-10	7	165	9
DOID:14784	olivopontocerebellar atrophy	GO:0090501	RNA phosphodiester bond hydrolysis	9.599141481686502e-10	2.117090653785958e-5	5	114	9
Orphanet:98709	Ectodermal malformation syndrome associated with ocular features	GO:0009378	four-way junction helicase activity	7.740807994593979e-10	1.707235203207702e-5	3	5	9
Orphanet:98709	Ectodermal malformation syndrome associated with ocular features	GO:0043140	ATP-dependent 3'-5' DNA helicase activity	1.547792227718503e-9	3.4136557582331584e-5	3	6	9
Orphanet:98709	Ectodermal malformation syndrome associated with ocular features	GO:0000405	bubble DNA binding	2.7079908315741363e-9	5.972473779036758e-5	3	7	9
Orphanet:93429	Multiple epiphyseal dysplasia and pseudoachondroplasia	GO:0001501	skeletal system development	2.5108293222331213e-10	5.537634070185149e-6	7	482	9
DOID:1532	pleural disease	GO:1902533	positive regulation of intracellular signal transduction	1.7085732828547862e-10	3.768258375336231e-6	8	860	9
DOID:1532	pleural disease	GO:0014070	response to organic cyclic compound	1.9145329765990482e-10	4.222502479889201e-6	8	873	9
DOID:1532	pleural disease	GO:0070372	regulation of ERK1 and ERK2 cascade	2.876517912753229e-10	6.344160256577247e-6	6	233	9
DOID:1532	pleural disease	GO:0001101	response to acid chemical	1.7706428545594122e-9	3.9051528157307835e-5	6	315	9
DOID:1532	pleural disease	GO:0045123	cellular extravasation	3.0464168965238514e-9	6.718872465283354e-5	4	43	9
DOID:1532	pleural disease	GO:0043491	protein kinase B signaling	3.1283373669310777e-9	6.899548062766492e-5	5	144	9
DOID:1532	pleural disease	GO:0002703	regulation of leukocyte mediated immunity	3.974204410006621e-9	8.765107826269602e-5	5	151	9
DOID:1532	pleural disease	GO:0045785	positive regulation of cell adhesion	4.498696415389247e-9	9.921874944140985e-5	6	368	9
MESH:D011008	Pneumococcal Infections	GO:0002684	positive regulation of immune system process	1.895533729978638e-10	4.180599641467886e-6	8	872	9
MESH:D011008	Pneumococcal Infections	GO:0050778	positive regulation of immune response	1.20635368361377e-9	2.66061304921017e-5	7	603	9
Orphanet:71529	Obesity due to melanocortin 4 receptor deficiency	GO:0007631	feeding behavior	2.0691226509939042e-12	4.563450006767056e-8	6	106	9
Orphanet:71529	Obesity due to melanocortin 4 receptor deficiency	GO:0031667	response to nutrient levels	6.055856927034142e-10	1.33561924525738e-5	7	546	9
Orphanet:71529	Obesity due to melanocortin 4 receptor deficiency	GO:0048871	multicellular organismal homeostasis	1.983740283151292e-9	4.375139194490174e-5	6	321	9
Orphanet:71529	Obesity due to melanocortin 4 receptor deficiency	GO:0002024	diet induced thermogenesis	4.331736080942505e-9	9.553643926518696e-5	3	8	9
DOID:1923	sex differentiation disease	GO:0048608	reproductive structure development	9.167111514329918e-13	2.0218064444854633e-8	8	418	9
DOID:1923	sex differentiation disease	GO:0008209	androgen metabolic process	6.782691075457592e-10	1.4959225166921719e-5	4	30	9
DOID:1923	sex differentiation disease	GO:0007548	sex differentiation	7.666030032993376e-10	1.690742923776689e-5	6	274	9
DOID:1923	sex differentiation disease	GO:0046661	male sex differentiation	3.974204410006621e-9	8.765107826269602e-5	5	151	9
DOID:1029	familial periodic paralysis	GO:0015075	ion transmembrane transporter activity	2.2171153801764376e-13	4.889847970979133e-9	9	852	9
DOID:1029	familial periodic paralysis	GO:0098660	inorganic ion transmembrane transport	1.5081269566508126e-12	3.326174002893367e-8	9	660	9
DOID:1029	familial periodic paralysis	GO:0022890	inorganic cation transmembrane transporter activity	5.3292925628056764e-12	1.175375474726792e-7	8	527	9
DOID:1029	familial periodic paralysis	GO:0098662	inorganic cation transmembrane transport	6.29640783955665e-12	1.3886727490142192e-7	8	575	9
DOID:1029	familial periodic paralysis	GO:0022836	gated channel activity	1.8949730673512022e-11	4.1793631000430764e-7	7	335	9
DOID:1029	familial periodic paralysis	GO:0015077	monovalent inorganic cation transmembrane transporter activity	3.8026692905646087e-11	8.386787120340244e-7	7	368	9
DOID:1029	familial periodic paralysis	GO:0034702	ion channel complex	7.666030032993376e-10	1.690742923776689e-5	6	274	9
DOID:1029	familial periodic paralysis	GO:0015672	monovalent inorganic cation transport	8.33545232836741e-10	1.8383840110214322e-5	7	572	9
DOID:1029	familial periodic paralysis	GO:0034765	regulation of ion transmembrane transport	4.426439770277568e-9	9.762512913347177e-5	6	367	9
Orphanet:254807	Multiple mitochondrial DNA deletion syndrome	GO:0044429	mitochondrial part	3.958751104704561e-10	8.731025561425909e-6	8	956	9
Orphanet:254807	Multiple mitochondrial DNA deletion syndrome	GO:0009295	nucleoid	2.763616224754628e-9	6.095155583696332e-5	4	42	9
Orphanet:254807	Multiple mitochondrial DNA deletion syndrome	GO:0042645	mitochondrial nucleoid	2.763616224754628e-9	6.095155583696332e-5	4	42	9
Orphanet:748	Mendelian susceptibility to mycobacterial diseases	GO:0045087	innate immune response	2.0763391006539678e-12	4.579365886492326e-8	9	783	9
Orphanet:229717	Isolated agammaglobulinemia	GO:0050853	B cell receptor signaling pathway	4.0256141753403085e-9	8.87849206371305e-5	4	46	9
DOID:0050591	tooth agenesis	GO:0042476	odontogenesis	1.9105969029098446e-9	4.213821469367662e-5	5	114	10
DOID:6457	Cowden disease	GO:0000104	succinate dehydrogenase activity	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
DOID:6457	Cowden disease	GO:0045257	succinate dehydrogenase complex (ubiquinone)	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
DOID:6457	Cowden disease	GO:0045283	fumarate reductase complex	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
DOID:6457	Cowden disease	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
Orphanet:401854	Lipoic acid biosynthesis defect	GO:0005759	mitochondrial matrix	1.0103029524088925e-13	2.2282231615378123e-9	9	412	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0042445	hormone metabolic process	1.942890293094024e-13	4.28504454141887e-9	8	187	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0034754	cellular hormone metabolic process	1.6653345369377348e-13	3.672895321216174e-9	7	108	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0008209	androgen metabolic process	1.8072210394848298e-12	3.985826002583792e-8	5	30	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0016491	oxidoreductase activity	2.497335671591827e-12	5.507873823695775e-8	9	710	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0055114	oxidation-reduction process	2.3852586572559176e-11	5.260687968577926e-7	9	949	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0042180	cellular ketone metabolic process	1.1699547997068294e-9	2.580335310753412e-5	6	253	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0008207	C21-steroid hormone metabolic process	1.2962697581997418e-9	2.8589229517095305e-5	4	31	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	1.6689667425850985e-9	3.680906150771435e-5	5	111	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:1901615	organic hydroxy compound metabolic process	1.6791058543574877e-9	3.703267961785439e-5	7	534	10
Orphanet:90783	46,XY disorder of sex development due to a testosterone synthesis defect	GO:0016125	sterol metabolic process	4.0089241926111185e-9	8.841682306803822e-5	5	132	10
Orphanet:217638	Lysosomal disease with restrictive cardiomyopathy	GO:0005773	vacuole	1.2069234500700077e-12	2.661869669129402e-8	9	603	10
Orphanet:217638	Lysosomal disease with restrictive cardiomyopathy	GO:0043202	lysosomal lumen	1.5701884237273589e-12	3.46305056853069e-8	6	87	10
Orphanet:217638	Lysosomal disease with restrictive cardiomyopathy	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	7.174679739208045e-10	1.5823756164823344e-5	5	94	10
DOID:13543	hyperparathyroidism	GO:0001503	ossification	1.1420508982951105e-10	2.5187932561898663e-6	7	363	10
Orphanet:2134	Atypical hemolytic-uremic syndrome	GO:0006956	complement activation	1.5765166949677223e-13	3.4770075707513115e-9	7	56	10
Orphanet:2134	Atypical hemolytic-uremic syndrome	GO:0030449	regulation of complement activation	2.603917081955842e-12	5.74293912425361e-8	5	32	10
Orphanet:2134	Atypical hemolytic-uremic syndrome	GO:0006957	complement activation, alternative pathway	4.14069889487223e-11	9.132311412640703e-7	4	14	10
Orphanet:2134	Atypical hemolytic-uremic syndrome	GO:0072562	blood microparticle	1.9105969029098446e-9	4.213821469367662e-5	5	114	10
MESH:D020300	Intracranial Hemorrhages	GO:0001666	response to hypoxia	2.771119889111162e-9	6.111704915434668e-5	6	292	10
MESH:D019048	Prostatic Intraepithelial Neoplasia	GO:0097305	response to alcohol	1.2651624192727695e-10	2.790315715706093e-6	7	369	10
Orphanet:79190	Disorder of phenylalanin or tyrosine metabolism	GO:0009072	aromatic amino acid family metabolic process	1.4876988529977098e-14	3.281119820286449e-10	7	28	10
Orphanet:79190	Disorder of phenylalanin or tyrosine metabolism	GO:0006570	tyrosine metabolic process	5.995204332975845e-15	1.3222423156378227e-10	5	9	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0009064	glutamine family amino acid metabolic process	1.4432899320127035e-13	3.1831759450540176e-9	7	70	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0019627	urea metabolic process	1.354472090042691e-14	2.987288194589155e-10	7	14	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0000050	urea cycle	3.3306690738754696e-15	7.345790642432348e-11	7	12	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0006526	arginine biosynthetic process	3.3306690738754696e-15	7.345790642432348e-11	5	6	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0044429	mitochondrial part	2.3899326961895895e-11	5.27099656144614e-7	9	956	10
Orphanet:79167	Disorder of urea cycle metabolism and ammonia detoxification	GO:0016597	amino acid binding	1.1419137857515693e-9	2.518490854475086e-5	5	103	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0046146	tetrahydrobiopterin metabolic process	2.4424906541753444e-15	5.386913137783722e-11	5	8	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0042417	dopamine metabolic process	2.603917081955842e-12	5.74293912425361e-8	5	32	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0015842	synaptic vesicle amine transport	1.1063649996145841e-10	2.4400880066499653e-6	3	3	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0009713	catechol-containing compound biosynthetic process	1.6023582460888974e-10	3.5340011117490633e-6	4	19	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0042423	catecholamine biosynthetic process	1.6023582460888974e-10	3.5340011117490633e-6	4	19	10
Orphanet:79169	Disorder of neurotransmitter metabolism and transport	GO:0048037	cofactor binding	1.4118622937431269e-9	3.1138622888504663e-5	6	261	10
Orphanet:79168	Disorder of bile acid synthesis	GO:0072330	monocarboxylic acid biosynthetic process	3.2573943542502093e-13	7.184183248298837e-9	8	200	10
DOID:14448	46 XY gonadal dysgenesis	GO:0007530	sex determination	3.469446951953614e-13	7.651865252533696e-9	5	22	10
DOID:14448	46 XY gonadal dysgenesis	GO:2000020	positive regulation of male gonad development	2.8979041388765836e-12	6.391327578292305e-8	4	8	10
DOID:14448	46 XY gonadal dysgenesis	GO:2000195	negative regulation of female gonad development	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
DOID:9267	urea cycle disorder	GO:0019627	urea metabolic process	1.354472090042691e-14	2.987288194589155e-10	6	14	10
DOID:9267	urea cycle disorder	GO:0000050	urea cycle	3.3306690738754696e-15	7.345790642432348e-11	6	12	10
DOID:9267	urea cycle disorder	GO:0006525	arginine metabolic process	2.106093077713922e-13	4.644988282898055e-9	5	19	10
DOID:9267	urea cycle disorder	GO:0006526	arginine biosynthetic process	6.186162693211372e-13	1.3643581819877681e-8	4	6	10
DOID:9267	urea cycle disorder	GO:0010043	response to zinc ion	4.567868305827005e-11	1.007443354850146e-6	5	55	10
DOID:9267	urea cycle disorder	GO:1901606	alpha-amino acid catabolic process	7.986141747906572e-10	1.7613435625007945e-5	5	96	10
DOID:9267	urea cycle disorder	GO:0044429	mitochondrial part	1.8866350703916623e-9	4.160973647748811e-5	8	956	10
Orphanet:102006	Neurovascular malformation	GO:0072358	cardiovascular system development	1.3582468483264165e-12	2.9956134239839116e-8	10	910	10
Orphanet:102006	Neurovascular malformation	GO:0048514	blood vessel morphogenesis	8.866907208471275e-12	1.9555963848283398e-7	8	484	10
Orphanet:102006	Neurovascular malformation	GO:0045765	regulation of angiogenesis	3.598649156444367e-10	7.936820714538051e-6	6	208	10
Orphanet:102006	Neurovascular malformation	GO:0001937	negative regulation of endothelial cell proliferation	1.1292569102039351e-9	2.490576115454779e-5	4	30	10
Orphanet:102006	Neurovascular malformation	GO:0002009	morphogenesis of an epithelium	1.1539685873529493e-9	2.5450777194069296e-5	7	506	10
Orphanet:102006	Neurovascular malformation	GO:0010596	negative regulation of endothelial cell migration	3.3816857092361374e-9	7.458307831720301e-5	4	39	10
Orphanet:309816	Disorder of bilirubin metabolism and excretion	GO:0015721	bile acid and bile salt transport	2.2071233729548112e-12	4.867810599051836e-8	5	31	10
Orphanet:309816	Disorder of bilirubin metabolism and excretion	GO:0005319	lipid transporter activity	1.2588952102987605e-9	2.7764933863139163e-5	5	105	10
Orphanet:309816	Disorder of bilirubin metabolism and excretion	GO:0008206	bile acid metabolic process	4.161527455970315e-9	9.17824880414253e-5	4	41	10
Orphanet:209193	Qualitative or quantitative defects of selenoprotein N1	GO:0048747	muscle fiber development	2.7855828754752565e-11	6.143603031860678e-7	5	50	10
DOID:4644	epidermolysis bullosa simplex	GO:0045111	intermediate filament cytoskeleton	6.072031766279906e-12	1.3391866060530333e-7	7	236	10
DOID:4644	epidermolysis bullosa simplex	GO:0005882	intermediate filament	2.2866297744172925e-10	5.043161967477339e-6	6	193	10
Orphanet:226295	Primary congenital hypothyroidism	GO:0042403	thyroid hormone metabolic process	2.042810365310288e-14	4.5054182606918403e-10	7	21	10
Orphanet:226295	Primary congenital hypothyroidism	GO:0030878	thyroid gland development	6.166972488230726e-10	1.3601257822792867e-5	4	26	10
Orphanet:226295	Primary congenital hypothyroidism	GO:0015705	iodide transport	1.105738944850998e-9	2.438707242868876e-5	3	5	10
Orphanet:309136	Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes	GO:0044429	mitochondrial part	2.3899326961895895e-11	5.27099656144614e-7	9	956	10
OMIM:225500	Ellis-Van Creveld syndrome	GO:0044441	ciliary part	6.195044477408373e-14	1.3663170594924168e-9	8	303	10
OMIM:225500	Ellis-Van Creveld syndrome	GO:0008589	regulation of smoothened signaling pathway	8.536671369796522e-11	1.882762870608623e-6	5	62	10
OMIM:225500	Ellis-Van Creveld syndrome	GO:0045880	positive regulation of smoothened signaling pathway	4.3851644537795664e-10	9.671480202810834e-6	4	24	10
MESH:D004617	Embolism	GO:0042730	fibrinolysis	7.237414001437514e-10	1.5962116580170438e-5	4	27	10
Orphanet:216820	Osteogenesis imperfecta type 4	GO:0005788	endoplasmic reticulum lumen	2.7511581901507043e-10	6.067679388377378e-6	6	199	10
Orphanet:251510	46,XY partial gonadal dysgenesis	GO:2000020	positive regulation of male gonad development	2.4424906541753444e-15	5.386913137783722e-11	5	8	10
Orphanet:251510	46,XY partial gonadal dysgenesis	GO:0007530	sex determination	3.469446951953614e-13	7.651865252533696e-9	5	22	10
Orphanet:251510	46,XY partial gonadal dysgenesis	GO:2000195	negative regulation of female gonad development	4.4242398633542734e-10	9.75766101862785e-6	3	4	10
Orphanet:251510	46,XY partial gonadal dysgenesis	GO:0044798	nuclear transcription factor complex	3.4320716268965157e-9	7.569433973120265e-5	5	128	10
DC:0000638	Breast-Ovarian Cancer, Familial, Susceptibility to	GO:0000732	strand displacement	8.574252419180084e-13	1.8910513710501675e-8	5	26	10
DC:0000638	Breast-Ovarian Cancer, Familial, Susceptibility to	GO:0000731	DNA synthesis involved in DNA repair	5.769273947464626e-12	1.2724133691133233e-7	5	37	10
DC:0000638	Breast-Ovarian Cancer, Familial, Susceptibility to	GO:0000724	double-strand break repair via homologous recombination	6.43040065639866e-10	1.4182248647687246e-5	5	92	10
DC:0000638	Breast-Ovarian Cancer, Familial, Susceptibility to	GO:0097193	intrinsic apoptotic signaling pathway	1.8098287313250694e-9	3.9915772669374405e-5	6	272	10
MESH:D006940	Hyperemia	GO:0050880	regulation of blood vessel size	1.9051427102567686e-13	4.201792247471303e-9	7	139	10
MESH:D006940	Hyperemia	GO:0042311	vasodilation	4.0190073491430667e-13	8.863920708535034e-9	6	68	10
MESH:D006940	Hyperemia	GO:0044057	regulation of system process	1.3491430195244902e-12	2.9755349295612632e-8	9	508	10
MESH:D006940	Hyperemia	GO:0006954	inflammatory response	7.418399228242833e-11	1.636127949788957e-6	8	637	10
MESH:D006940	Hyperemia	GO:0008217	regulation of blood pressure	9.905798403764265e-11	2.1847238379502087e-6	6	168	10
MESH:D006940	Hyperemia	GO:1903034	regulation of response to wounding	2.513208530174893e-10	5.5428814133007265e-6	7	407	10
MESH:D006940	Hyperemia	GO:1903524	positive regulation of blood circulation	5.430719207666357e-10	1.197745121250815e-5	5	89	10
MESH:D006940	Hyperemia	GO:0050727	regulation of inflammatory response	2.60460453205269e-9	5.744455295442208e-5	6	289	10
MESH:D006940	Hyperemia	GO:0001666	response to hypoxia	2.771119889111162e-9	6.111704915434668e-5	6	292	10
MESH:D006940	Hyperemia	GO:0006869	lipid transport	3.2568134855637254e-9	7.182902142410796e-5	6	300	10
Orphanet:98396	Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder	GO:0033013	tetrapyrrole metabolic process	1.5787371410169726e-13	3.481904764512933e-9	8	56	10
Orphanet:98396	Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder	GO:0006767	water-soluble vitamin metabolic process	1.361133428190442e-13	3.0019797758740197e-9	8	86	10
Orphanet:98396	Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder	GO:0015889	cobalamin transport	2.8979041388765836e-12	6.391327578292305e-8	4	8	10
Orphanet:98396	Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder	GO:0031419	cobalamin binding	5.224820576188449e-12	1.1523341780783625e-7	4	9	10
Orphanet:98362	Constitutional sideroblastic anemia	GO:0044429	mitochondrial part	1.8866350703916623e-9	4.160973647748811e-5	8	956	10
DOID:3191	nemaline myopathy	GO:0030016	myofibril	8.257838857161914e-13	1.8212663599470602e-8	9	201	10
DOID:3191	nemaline myopathy	GO:0044449	contractile fiber part	3.412825577697731e-13	7.526986811612346e-9	9	196	10
DOID:3191	nemaline myopathy	GO:0005865	striated muscle thin filament	2.3780977187470853e-13	5.244894518696697e-9	5	20	10
DOID:3191	nemaline myopathy	GO:0055002	striated muscle cell development	3.298767148329773e-9	7.275430945641315e-5	5	127	10
DOID:14766	renal agenesis	GO:0001656	metanephros development	5.125971869190948e-10	1.1305330957500637e-5	5	88	10
Orphanet:35698	Mitochondrial DNA depletion syndrome	GO:0044429	mitochondrial part	2.3899326961895895e-11	5.27099656144614e-7	9	956	10
Orphanet:35698	Mitochondrial DNA depletion syndrome	GO:0000002	mitochondrial genome maintenance	7.237414001437514e-10	1.5962116580170438e-5	4	27	10
MESH:D008548	Melanosis	GO:0000165	MAPK cascade	6.931094587159237e-10	1.5286529111979696e-5	8	843	10
MESH:D008548	Melanosis	GO:0007167	enzyme linked receptor protein signaling pathway	1.5809126230337256e-9	3.486702790100882e-5	8	935	10
MESH:D008548	Melanosis	GO:0051347	positive regulation of transferase activity	4.378730711351864e-9	9.657290583886535e-5	7	613	10
Orphanet:166490	Infectious disease with epilepsy	GO:0051707	response to other organism	1.151016282285866e-9	2.5385664105814776e-5	8	898	10
OMIM:143500	Gilbert syndrome	GO:0005996	monosaccharide metabolic process	6.210587599753126e-13	1.3697450951255519e-8	9	282	10
OMIM:143500	Gilbert syndrome	GO:0016758	transferase activity, transferring hexosyl groups	6.141753772226366e-13	1.354563794464525e-8	9	202	10
OMIM:143500	Gilbert syndrome	GO:0009410	response to xenobiotic stimulus	1.7896795156957523e-13	3.947138171866982e-9	9	106	10
OMIM:143500	Gilbert syndrome	GO:0032787	monocarboxylic acid metabolic process	1.2945200467129325e-13	2.8550639630253727e-9	9	572	10
OMIM:143500	Gilbert syndrome	GO:0015020	glucuronosyltransferase activity	1.0857981180834031e-13	2.3947277494329455e-9	9	35	10
OMIM:143500	Gilbert syndrome	GO:0006063	uronic acid metabolic process	9.636735853746359e-14	2.1253820925437594e-9	9	29	10
OMIM:143500	Gilbert syndrome	GO:0019585	glucuronate metabolic process	9.636735853746359e-14	2.1253820925437594e-9	9	29	10
OMIM:143500	Gilbert syndrome	GO:0006805	xenobiotic metabolic process	8.326672684688674e-14	1.836447660608087e-9	9	93	10
OMIM:143500	Gilbert syndrome	GO:0052695	cellular glucuronidation	4.973799150320701e-14	1.0969714026032307e-9	9	24	10
OMIM:143500	Gilbert syndrome	GO:0009812	flavonoid metabolic process	4.551914400963142e-14	1.003924721132421e-9	9	31	10
OMIM:143500	Gilbert syndrome	GO:0051552	flavone metabolic process	3.3306690738754696e-15	7.345790642432348e-11	5	6	10
OMIM:143500	Gilbert syndrome	GO:0052696	flavonoid glucuronidation	2.886579864025407e-15	6.366351890108035e-11	9	22	10
OMIM:143500	Gilbert syndrome	GO:0052697	xenobiotic glucuronidation	4.3298697960381105e-15	9.549527835162053e-11	9	9	10
OMIM:143500	Gilbert syndrome	GO:0009813	flavonoid biosynthetic process	3.175237850427948e-14	7.002987079118839e-10	7	20	10
OMIM:143500	Gilbert syndrome	GO:0001972	retinoic acid binding	5.517808432387028e-14	1.216952649762959e-9	5	16	10
OMIM:143500	Gilbert syndrome	GO:0042573	retinoic acid metabolic process	3.469446951953614e-13	7.651865252533696e-9	5	22	10
OMIM:143500	Gilbert syndrome	GO:0046982	protein heterodimerization activity	7.598810469744421e-12	1.6759176491021321e-7	8	459	10
OMIM:143500	Gilbert syndrome	GO:0042803	protein homodimerization activity	1.651120351553459e-10	3.6415459353511537e-6	8	703	10
OMIM:143500	Gilbert syndrome	GO:0005789	endoplasmic reticulum membrane	2.233258689088302e-9	4.9254520387842504e-5	8	977	10
MESH:D059327	Brachydactyly	GO:0001501	skeletal system development	2.893241202173158e-13	6.3810434713929e-9	9	482	10
MESH:D059327	Brachydactyly	GO:0051216	cartilage development	8.806289031326742e-13	1.942227045859113e-8	7	180	10
MESH:D059327	Brachydactyly	GO:0061035	regulation of cartilage development	9.262379752073002e-11	2.0428178543197006e-6	5	63	10
MESH:D059327	Brachydactyly	GO:0007389	pattern specification process	3.841699180995306e-10	8.472867543685147e-6	7	432	10
MESH:D059327	Brachydactyly	GO:0002062	chondrocyte differentiation	7.571542282036603e-10	1.6699036503031728e-5	5	95	10
DOID:1699	congenital ichthyosiform erythroderma	GO:0043588	skin development	8.742646606663129e-10	1.928190709099553e-5	6	241	10
Orphanet:145	Hereditary breast and ovarian cancer syndrome	GO:0000732	strand displacement	8.574252419180084e-13	1.8910513710501675e-8	5	26	10
Orphanet:145	Hereditary breast and ovarian cancer syndrome	GO:0000731	DNA synthesis involved in DNA repair	5.769273947464626e-12	1.2724133691133233e-7	5	37	10
Orphanet:145	Hereditary breast and ovarian cancer syndrome	GO:0000724	double-strand break repair via homologous recombination	6.43040065639866e-10	1.4182248647687246e-5	5	92	10
Orphanet:145	Hereditary breast and ovarian cancer syndrome	GO:0097193	intrinsic apoptotic signaling pathway	1.8098287313250694e-9	3.9915772669374405e-5	6	272	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0005743	mitochondrial inner membrane	7.684963776455334e-13	1.6949187608972238e-8	9	478	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0070469	respiratory chain	1.3988810110276972e-13	3.0852320698215863e-9	7	90	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0034551	mitochondrial respiratory chain complex III assembly	2.4424906541753444e-15	5.386913137783722e-11	5	8	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0006122	mitochondrial electron transport, ubiquinol to cytochrome c	1.1102230246251565e-15	2.4485968808107827e-11	6	15	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0045275	respiratory chain complex III	5.995204332975845e-15	1.3222423156378227e-10	5	9	10
Orphanet:1460	Isolated CoQ-cytochrome C reductase deficiency	GO:0005750	mitochondrial respiratory chain complex III	5.995204332975845e-15	1.3222423156378227e-10	5	9	10
DOID:0050427	xeroderma pigmentosum	GO:0070911	global genome nucleotide-excision repair	1.5920598173124745e-13	3.5112879270826625e-9	6	33	10
DOID:0050427	xeroderma pigmentosum	GO:0006294	nucleotide-excision repair, preincision complex assembly	8.038014698286133e-14	1.7727841417070067e-9	6	30	10
DOID:0050427	xeroderma pigmentosum	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	1.0880185641326534e-14	2.399624943194567e-10	6	38	10
DOID:0050427	xeroderma pigmentosum	GO:0006293	nucleotide-excision repair, preincision complex stabilization	2.6645352591003757e-15	5.876632513945879e-11	6	22	10
DOID:0050427	xeroderma pigmentosum	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	2.6645352591003757e-15	5.876632513945879e-11	6	22	10
DOID:0050427	xeroderma pigmentosum	GO:0006283	transcription-coupled nucleotide-excision repair	5.67323965583455e-14	1.25123300609431e-9	7	75	10
DOID:0050427	xeroderma pigmentosum	GO:0009411	response to UV	7.993605777301127e-14	1.7629897541837636e-9	10	125	10
DOID:0050427	xeroderma pigmentosum	GO:0003684	damaged DNA binding	2.4558133304708463e-13	5.4162963003534514e-9	6	59	10
DOID:0050427	xeroderma pigmentosum	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	4.578559753554146e-13	1.0098013536463668e-8	5	23	10
DOID:0050427	xeroderma pigmentosum	GO:0009650	UV protection	2.048983205327204e-11	4.519032459349148e-7	4	12	10
DOID:0050427	xeroderma pigmentosum	GO:0034644	cellular response to UV	1.0869749544895058e-10	2.397323262126605e-6	5	65	10
DOID:0050427	xeroderma pigmentosum	GO:0047485	protein N-terminus binding	1.1419137857515693e-9	2.518490854475086e-5	5	103	10
DOID:0050427	xeroderma pigmentosum	GO:0006290	pyrimidine dimer repair	2.2108659347708226e-9	4.876064819137049e-5	3	6	10
OMIM:163950	Noonan Syndrome 1	GO:0000165	MAPK cascade	8.321121569565548e-13	1.8352233621676817e-8	10	843	11
OMIM:163950	Noonan Syndrome 1	GO:0007409	axonogenesis	6.7087446709024334e-12	1.4796136371675317e-7	8	406	11
OMIM:163950	Noonan Syndrome 1	GO:1902533	positive regulation of intracellular signal transduction	4.5924597458224525e-11	1.012866996941142e-6	9	860	11
OMIM:163950	Noonan Syndrome 1	GO:0060324	face development	5.102462896644511e-11	1.1253481918549468e-6	5	50	11
OMIM:163950	Noonan Syndrome 1	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	3.010588445206963e-10	6.639852815903957e-6	8	647	11
OMIM:163950	Noonan Syndrome 1	GO:0043408	regulation of MAPK cascade	3.1564661995275856e-10	6.96158620305809e-6	8	651	11
OMIM:163950	Noonan Syndrome 1	GO:0030878	thyroid gland development	9.68148672342295e-10	2.1352518968509315e-5	4	26	11
OMIM:163950	Noonan Syndrome 1	GO:0045860	positive regulation of protein kinase activity	1.3688699063152399e-9	3.0190425783782615e-5	7	450	11
OMIM:163950	Noonan Syndrome 1	GO:0043410	positive regulation of MAPK cascade	1.6968468852240903e-9	3.742395805361731e-5	7	464	11
OMIM:163950	Noonan Syndrome 1	GO:0070371	ERK1 and ERK2 cascade	2.2043182834607933e-9	4.8616239741727796e-5	6	247	11
DOID:0050581	brachydactyly	GO:0061448	connective tissue development	3.574918139293004e-13	7.88448195621072e-9	8	233	11
DOID:0050581	brachydactyly	GO:0051216	cartilage development	2.419175970658216e-13	5.335492603286696e-9	8	180	11
DOID:0050581	brachydactyly	GO:0061035	regulation of cartilage development	5.724309914967307e-13	1.2624965517460396e-8	6	63	11
DOID:0050581	brachydactyly	GO:0035107	appendage morphogenesis	1.0621503676588873e-12	2.342572635871676e-8	7	146	11
DOID:0050581	brachydactyly	GO:0035108	limb morphogenesis	1.0621503676588873e-12	2.342572635871676e-8	7	146	11
DOID:0050581	brachydactyly	GO:0008285	negative regulation of cell proliferation	3.443800800084773e-12	7.595302664586967e-8	9	634	11
DOID:0050581	brachydactyly	GO:0035113	embryonic appendage morphogenesis	3.601385856200068e-11	7.94285650584925e-7	6	125	11
DOID:0050581	brachydactyly	GO:0030326	embryonic limb morphogenesis	3.601385856200068e-11	7.94285650584925e-7	6	125	11
DOID:0050581	brachydactyly	GO:0030509	BMP signaling pathway	5.993505691748169e-11	1.3218676803150586e-6	6	136	11
DOID:0050581	brachydactyly	GO:0001649	osteoblast differentiation	7.399513224370935e-10	1.6319626416350097e-5	6	206	11
DOID:0050581	brachydactyly	GO:0007389	pattern specification process	1.0325270638489314e-9	2.2772384393188183e-5	7	432	11
DOID:0050581	brachydactyly	GO:0002062	chondrocyte differentiation	1.3825685041268798e-9	3.0492548358518334e-5	5	95	11
DOID:0050581	brachydactyly	GO:0045667	regulation of osteoblast differentiation	3.0455619137725876e-9	6.716986800825442e-5	5	111	11
DOID:0050569	Seckel syndrome	GO:0044450	microtubule organizing center part	7.499134646593575e-11	1.653934146306213e-6	6	141	11
DOID:0050569	Seckel syndrome	GO:0031570	DNA integrity checkpoint	1.1819800693757543e-10	2.606857043008226e-6	6	152	11
DOID:0050569	Seckel syndrome	GO:0000226	microtubule cytoskeleton organization	7.407062740938386e-10	1.633627687513961e-5	7	412	11
DOID:0050569	Seckel syndrome	GO:0007099	centriole replication	1.1362087937172305e-9	2.505908494543352e-5	4	27	11
DOID:0050569	Seckel syndrome	GO:0098535	de novo centriole assembly	1.5202744618747488e-9	3.3529653256647585e-5	3	5	11
DOID:0050569	Seckel syndrome	GO:0005814	centriole	1.7049641698463347e-9	3.760298476596091e-5	5	99	11
DOID:0050569	Seckel syndrome	GO:0044772	mitotic cell cycle phase transition	2.5147931514979405e-9	5.546376295628708e-5	7	491	11
MESH:D017674	Hypophosphatemia	GO:0072502	cellular trivalent inorganic anion homeostasis	1.4432899320127035e-15	3.1831759450540176e-11	5	9	11
MESH:D017674	Hypophosphatemia	GO:0030643	cellular phosphate ion homeostasis	1.4432899320127035e-15	3.1831759450540176e-11	5	9	11
OMIM:604302	juvenile rheumatoid arthritis	GO:0046649	lymphocyte activation	1.5228596161875885e-10	3.3586668835017264e-6	8	594	11
OMIM:604302	juvenile rheumatoid arthritis	GO:0051249	regulation of lymphocyte activation	3.6319880436508356e-10	8.010349630271918e-6	7	372	11
DOID:0050832	pyrimidine metabolic disorder	GO:0006213	pyrimidine nucleoside metabolic process	1.1834977442504169e-13	2.6102042749442944e-9	7	52	11
DOID:0050832	pyrimidine metabolic disorder	GO:0046135	pyrimidine nucleoside catabolic process	6.624700787938309e-13	1.461077758779794e-8	5	22	11
DOID:0050832	pyrimidine metabolic disorder	GO:0006206	pyrimidine nucleobase metabolic process	2.5160329375495394e-10	5.549110643765509e-6	4	19	11
DOID:0050832	pyrimidine metabolic disorder	GO:0019482	beta-alanine metabolic process	6.08308403649005e-10	1.3416241842478804e-5	3	4	11
Orphanet:325055	46,XX disorder of gonadal development	GO:0007530	sex determination	6.624700787938309e-13	1.461077758779794e-8	5	22	11
Orphanet:325055	46,XX disorder of gonadal development	GO:2000018	regulation of male gonad development	8.200218282183869e-12	1.8085581421356522e-7	4	9	11
DOID:422	congenital structural myopathy	GO:0006936	muscle contraction	2.644995333866973e-12	5.833537208843609e-8	8	323	11
DOID:422	congenital structural myopathy	GO:0048741	skeletal muscle fiber development	1.5367155326018178e-9	3.389226107153309e-5	4	29	11
DOID:57	aortic valve insufficiency	GO:0030198	extracellular matrix organization	2.1859181131844707e-12	4.82104239862835e-8	8	320	11
DOID:57	aortic valve insufficiency	GO:0031012	extracellular matrix	1.0765499602882755e-11	2.3743309374157917e-7	8	423	11
DOID:57	aortic valve insufficiency	GO:0072358	cardiovascular system development	7.637324106468668e-11	1.6844118316816648e-6	9	910	11
DOID:57	aortic valve insufficiency	GO:0005578	proteinaceous extracellular matrix	2.5615587428973186e-10	5.649517807460036e-6	7	354	11
DOID:57	aortic valve insufficiency	GO:0009725	response to hormone	2.9955343761045583e-9	6.606651066498603e-5	8	865	11
DOID:57	aortic valve insufficiency	GO:0009611	response to wounding	3.2798869176176026e-9	7.233790596805623e-5	8	875	11
DOID:57	aortic valve insufficiency	GO:0042060	wound healing	4.499653871725684e-9	9.923986614090996e-5	7	534	11
DOID:11335	sarcoidosis	GO:0050870	positive regulation of T cell activation	6.570725075150108e-10	1.4491734153243563e-5	6	202	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:0005789	endoplasmic reticulum membrane	4.792388708096951e-12	1.0569613295707825e-7	10	977	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:1901137	carbohydrate derivative biosynthetic process	8.406608742461685e-13	1.8540775581499247e-8	11	741	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:0008654	phospholipid biosynthetic process	8.30002733209767e-13	1.8305710280941412e-8	10	247	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:0046486	glycerolipid metabolic process	6.392664175791651e-13	1.4099020839708487e-8	10	383	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:0006650	glycerophospholipid metabolic process	3.7059244561987725e-13	8.173416388146393e-9	10	304	11
Orphanet:309515	Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation	GO:0016254	preassembly of GPI anchor in ER membrane	7.327471962526033e-15	1.6160739413351166e-10	6	15	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	6.750155989720952e-14	1.488746903532956e-9	6	53	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0008137	NADH dehydrogenase (ubiquinone) activity	1.6153745008296028e-13	3.562708461579689e-9	6	45	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0010257	NADH dehydrogenase complex assembly	5.241362899255364e-13	1.1559825874307705e-8	6	61	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0097031	mitochondrial respiratory chain complex I biogenesis	5.241362899255364e-13	1.1559825874307705e-8	6	61	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0032981	mitochondrial respiratory chain complex I assembly	5.241362899255364e-13	1.1559825874307705e-8	6	61	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0070469	respiratory chain	4.782840790085174e-12	1.0548555362532852e-7	6	90	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0098800	inner mitochondrial membrane protein complex	2.092281903287585e-11	4.614527737700769e-7	6	114	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0045271	respiratory chain complex I	4.1355918689589544e-11	9.121047866988974e-7	5	48	11
MESH:C536035	Maternally Inherited Leigh Syndrome	GO:0005747	mitochondrial respiratory chain complex I	4.1355918689589544e-11	9.121047866988974e-7	5	48	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0031903	microbody membrane	1.9895196601282805e-13	4.387885610412923e-9	11	57	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0005778	peroxisomal membrane	1.9895196601282805e-13	4.387885610412923e-9	11	57	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0007031	peroxisome organization	1.5276668818842154e-13	3.369269307995637e-9	11	33	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0071806	protein transmembrane transport	1.1080025785759062e-13	2.443699687049161e-9	11	53	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0065002	intracellular protein transmembrane transport	2.7755575615628914e-14	6.121492202026957e-10	11	47	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0031231	intrinsic component of peroxisomal membrane	2.1760371282653068e-14	4.799249886389134e-10	7	14	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0005779	integral component of peroxisomal membrane	2.1760371282653068e-14	4.799249886389134e-10	7	14	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0006625	protein targeting to peroxisome	1.9984014443252818e-15	4.407474385459409e-11	11	17	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0016558	protein import into peroxisome matrix	2.7200464103316335e-14	5.999062357986418e-10	9	13	11
OMIM:266510	Peroxisome Biogenesis Disorder 3B	GO:0045046	protein import into peroxisome membrane	9.782175069972254e-13	2.1574587116823807e-8	4	6	11
MESH:D051556	Hyperbilirubinemia, Neonatal	GO:0006063	uronic acid metabolic process	8.482103908136196e-14	1.870728016939438e-9	9	29	11
MESH:D051556	Hyperbilirubinemia, Neonatal	GO:0019585	glucuronate metabolic process	8.482103908136196e-14	1.870728016939438e-9	9	29	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0019953	sexual reproduction	1.5527468200104977e-11	3.4245831115331526e-7	9	754	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0048609	multicellular organismal reproductive process	1.8225532194549032e-11	4.019641125507789e-7	9	767	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0007276	gamete generation	1.7612011848910925e-10	3.884329213277304e-6	8	605	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0003006	developmental process involved in reproduction	2.1124180182852115e-10	4.658937939328034e-6	8	619	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0007281	germ cell development	1.0119213245118885e-9	2.2317924812109702e-5	6	217	11
Orphanet:399786	Male infertility with spermatogenesis disorder due to single gene mutation	GO:0007283	spermatogenesis	2.144318500540976e-9	4.7292944529431225e-5	7	480	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0006631	fatty acid metabolic process	7.969180870759374e-13	1.75760284104598e-8	9	348	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0016042	lipid catabolic process	6.832312493543213e-13	1.5068665204509557e-8	9	281	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0044282	small molecule catabolic process	6.390443729742401e-13	1.4094123645946866e-8	10	345	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0046395	carboxylic acid catabolic process	2.9110047705671604e-13	6.420221021485872e-9	10	219	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0034440	lipid oxidation	1.1590728377086634e-13	2.556335143566457e-9	9	93	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0006635	fatty acid beta-oxidation	1.3877787807814457e-14	3.0607461010134784e-10	9	65	11
Orphanet:309115	Disorder of fatty acid oxidation and ketogenesis	GO:0005743	mitochondrial inner membrane	2.083958228205063e-9	4.596169872306266e-5	7	478	11
Orphanet:216812	Osteogenesis imperfecta type 3	GO:0005788	endoplasmic reticulum lumen	2.9976021664879227e-13	6.6112115781891134e-9	8	199	11
Orphanet:216812	Osteogenesis imperfecta type 3	GO:0005578	proteinaceous extracellular matrix	2.5615587428973186e-10	5.649517807460036e-6	7	354	11
Orphanet:216812	Osteogenesis imperfecta type 3	GO:0001501	skeletal system development	2.2085864248566622e-9	4.8710373600213686e-5	7	482	11
DOID:10322	berylliosis	GO:0022409	positive regulation of cell-cell adhesion	1.6437518013390218e-11	3.6252945978532125e-7	7	239	11
DOID:10322	berylliosis	GO:0098552	side of membrane	6.233596971938482e-10	1.3748198121610322e-5	7	402	11
DOID:10322	berylliosis	GO:0050870	positive regulation of T cell activation	6.570725075150108e-10	1.4491734153243563e-5	6	202	11
DOID:10322	berylliosis	GO:0009986	cell surface	6.644285122092697e-10	1.4653970836775443e-5	8	715	11
DOID:10322	berylliosis	GO:0032943	mononuclear cell proliferation	2.486829075998287e-9	5.484701527114222e-5	6	252	11
DOID:10603	glucose intolerance	GO:0045821	positive regulation of glycolytic process	6.503986238470816e-11	1.4344541648947384e-6	4	14	11
Orphanet:206650	Autosomal dominant distal myopathy	GO:0030018	Z disc	3.3018032752352156e-13	7.282127123531268e-9	7	109	11
Orphanet:206650	Autosomal dominant distal myopathy	GO:0008092	cytoskeletal protein binding	1.8194921125314067e-9	4.0128898541880176e-5	8	812	11
Orphanet:314749	Rare disease with Cushing syndrome as a major feature	GO:0010948	negative regulation of cell cycle process	9.570036985095953e-10	2.1106716570629125e-5	6	215	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0000729	DNA double-strand break processing	4.4519943287468777e-13	9.818873492051239e-9	5	21	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0000732	strand displacement	1.5413226250871048e-12	3.39938704962961e-8	5	26	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0000731	DNA synthesis involved in DNA repair	1.0544010109470037e-11	2.3254814296436166e-7	5	37	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0007095	mitotic G2 DNA damage checkpoint	6.503986238470816e-11	1.4344541648947384e-6	4	14	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0051052	regulation of DNA metabolic process	1.7365031634852812e-10	3.829857727066788e-6	7	335	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0006303	double-strand break repair via nonhomologous end joining	1.9871626566470013e-10	4.382687239234961e-6	5	65	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0051054	positive regulation of DNA metabolic process	3.6230252131730367e-10	7.990582107653132e-6	6	183	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0031860	telomeric 3' overhang formation	6.08308403649005e-10	1.3416241842478804e-5	3	4	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0000724	double-strand break repair via homologous recombination	1.1744321071205377e-9	2.590210012254346e-5	5	92	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:1904354	negative regulation of telomere capping	1.5202744618747488e-9	3.3529653256647585e-5	3	5	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0035861	site of double-strand break	2.03461536507632e-9	4.4873441876758235e-5	4	31	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0004003	ATP-dependent DNA helicase activity	2.6443833789357996e-9	5.832187542242906e-5	4	33	11
Orphanet:169346	DNA repair defect other than combined T-cell and B-cell immunodeficiencies	GO:0030870	Mre11 complex	3.039579699049e-9	6.703793026252569e-5	3	6	11
Orphanet:98708	Pigmentation disorder with eye involvement, excluding albinism	GO:0050931	pigment cell differentiation	1.1524114995609125e-13	2.5416435622815925e-9	7	35	11
Orphanet:98708	Pigmentation disorder with eye involvement, excluding albinism	GO:0048863	stem cell differentiation	3.440718709946111e-9	7.588505114786148e-5	6	266	11
OMIM:131440	chronic myeloproliferative disease	GO:1903725	regulation of phospholipid metabolic process	1.2069556465377218e-10	2.6619406784389454e-6	5	59	11
OMIM:131440	chronic myeloproliferative disease	GO:2000591	positive regulation of metanephric mesenchymal cell migration	1.5212719972623745e-10	3.355165389962167e-6	3	3	11
OMIM:131440	chronic myeloproliferative disease	GO:0035793	positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway	1.5212719972623745e-10	3.355165389962167e-6	3	3	11
OMIM:131440	chronic myeloproliferative disease	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	1.5367155326018178e-9	3.389226107153309e-5	4	29	11
OMIM:131440	chronic myeloproliferative disease	GO:0043410	positive regulation of MAPK cascade	1.6968468852240903e-9	3.742395805361731e-5	7	464	11
OMIM:131440	chronic myeloproliferative disease	GO:0008284	positive regulation of cell proliferation	1.8718923078253624e-9	4.128458484908837e-5	8	815	11
OMIM:131440	chronic myeloproliferative disease	GO:0050921	positive regulation of chemotaxis	4.330627301207812e-9	9.55119851281383e-5	5	119	11
OMIM:131440	chronic myeloproliferative disease	GO:0042060	wound healing	4.499653871725684e-9	9.923986614090996e-5	7	534	11
Orphanet:93438	Mesomelic and rhizo-mesomelic dysplasia	GO:0042471	ear morphogenesis	1.8801515899724563e-11	4.1466743316842525e-7	6	112	11
Orphanet:93438	Mesomelic and rhizo-mesomelic dysplasia	GO:0042472	inner ear morphogenesis	1.1744321071205377e-9	2.590210012254346e-5	5	92	11
Orphanet:93438	Mesomelic and rhizo-mesomelic dysplasia	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	2.6511894901659616e-9	5.8471984205610283e-5	5	108	11
Orphanet:93441	Primary bone dysplasia with multiple joint dislocations	GO:0006029	proteoglycan metabolic process	6.838973831690964e-14	1.5083356785794422e-9	7	85	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048562	embryonic organ morphogenesis	4.285460875053104e-14	9.451583959929621e-10	8	280	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048736	appendage development	1.2279066652354231e-13	2.7081481501767257e-9	9	168	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0060173	limb development	1.2279066652354231e-13	2.7081481501767257e-9	9	168	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0035113	embryonic appendage morphogenesis	1.509903313490213e-13	3.3300917579026645e-9	8	125	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0030326	embryonic limb morphogenesis	1.509903313490213e-13	3.3300917579026645e-9	8	125	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048706	embryonic skeletal system development	5.149214388211476e-13	1.135659233320041e-8	7	122	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0051216	cartilage development	2.4310553570217053e-12	5.361692589911371e-8	7	180	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048589	developmental growth	4.438449607846451e-12	9.789000610105347e-8	9	558	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048704	embryonic skeletal system morphogenesis	5.755063092749424e-12	1.2692791651058855e-7	6	93	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0002062	chondrocyte differentiation	6.6133765130871325e-12	1.458580189961367e-7	6	95	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048638	regulation of developmental growth	5.2963300412045555e-11	1.1681055905876647e-6	7	283	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0035295	tube development	1.1305412161988215e-10	2.493408652326501e-6	8	573	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0048645	organ formation	1.2069556465377218e-10	2.6619406784389454e-6	5	59	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0071363	cellular response to growth factor stimulus	1.5228596161875885e-10	3.3586668835017264e-6	8	594	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0001503	ossification	3.0677571594139863e-10	6.765938415087547e-6	7	363	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0043583	ear development	5.478969500316566e-10	1.2083867232948187e-5	6	196	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0001649	osteoblast differentiation	7.399513224370935e-10	1.6319626416350097e-5	6	206	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0060043	regulation of cardiac muscle cell proliferation	1.3251441055572855e-9	2.922605324806593e-5	4	28	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0010092	specification of organ identity	1.5367155326018178e-9	3.389226107153309e-5	4	29	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0001657	ureteric bud development	1.5370940076309125e-9	3.3900608338299776e-5	5	97	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0090596	sensory organ morphogenesis	1.8096170117942734e-9	3.99111031951227e-5	6	239	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0008543	fibroblast growth factor receptor signaling pathway	2.298017887092385e-9	5.068278449982255e-5	5	105	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0045667	regulation of osteoblast differentiation	3.0455619137725876e-9	6.716986800825442e-5	5	111	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0002009	morphogenesis of an epithelium	3.096947143177431e-9	6.830316924277824e-5	7	506	11
Orphanet:93459	Syndrome with synostosis or other joint formation defect	GO:0042471	ear morphogenesis	3.187190511511062e-9	7.029348673137648e-5	5	112	11
Orphanet:211247	Capillary malformation	GO:0072358	cardiovascular system development	1.9262369477246466e-12	4.248315588206708e-8	10	910	11
Orphanet:211247	Capillary malformation	GO:0048514	blood vessel morphogenesis	3.06534797545055e-11	6.760624959856187e-7	8	484	11
Orphanet:211247	Capillary malformation	GO:0001937	negative regulation of endothelial cell proliferation	1.772605839889252e-9	3.909482179875745e-5	4	30	11
OMIM:145400	Hypertelorism	GO:0048704	embryonic skeletal system morphogenesis	1.2407520566526387e-9	2.7364786609473946e-5	5	93	11
OMIM:535000	leber hereditary optic neuropathy	GO:0046128	purine ribonucleoside metabolic process	7.498446308318307e-13	1.6537823332996027e-8	10	342	11
OMIM:535000	leber hereditary optic neuropathy	GO:0046034	ATP metabolic process	7.083222897108499e-13	1.5622048099572794e-8	10	230	11
OMIM:535000	leber hereditary optic neuropathy	GO:0042775	mitochondrial ATP synthesis coupled electron transport	1.3811174426336947e-13	3.0460545197286137e-9	9	88	11
OMIM:535000	leber hereditary optic neuropathy	GO:0098803	respiratory chain complex	1.0325074129013956e-13	2.277195099154028e-9	8	73	11
OMIM:535000	leber hereditary optic neuropathy	GO:0005743	mitochondrial inner membrane	1.021405182655144e-14	2.2527091303459201e-10	10	478	11
OMIM:535000	leber hereditary optic neuropathy	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	6.750155989720952e-14	1.488746903532956e-9	6	53	11
OMIM:535000	leber hereditary optic neuropathy	GO:0005746	mitochondrial respiratory chain	1.3855583347321954e-13	3.055848907251857e-9	7	79	11
OMIM:535000	leber hereditary optic neuropathy	GO:0008137	NADH dehydrogenase (ubiquinone) activity	1.6153745008296028e-13	3.562708461579689e-9	6	45	11
OMIM:535000	leber hereditary optic neuropathy	GO:0098800	inner mitochondrial membrane protein complex	4.806155473602303e-13	1.0599975897029879e-8	8	114	11
OMIM:535000	leber hereditary optic neuropathy	GO:1990204	oxidoreductase complex	9.307887793852387e-12	2.052854652934144e-7	6	100	11
OMIM:535000	leber hereditary optic neuropathy	GO:0045271	respiratory chain complex I	4.1355918689589544e-11	9.121047866988974e-7	5	48	11
OMIM:535000	leber hereditary optic neuropathy	GO:0005747	mitochondrial respiratory chain complex I	4.1355918689589544e-11	9.121047866988974e-7	5	48	11
OMIM:535000	leber hereditary optic neuropathy	GO:0010257	NADH dehydrogenase complex assembly	1.4336165587991445e-10	3.1618413204315132e-6	5	61	11
OMIM:535000	leber hereditary optic neuropathy	GO:0097031	mitochondrial respiratory chain complex I biogenesis	1.4336165587991445e-10	3.1618413204315132e-6	5	61	11
OMIM:535000	leber hereditary optic neuropathy	GO:0032981	mitochondrial respiratory chain complex I assembly	1.4336165587991445e-10	3.1618413204315132e-6	5	61	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0008209	androgen metabolic process	8.815170815523743e-14	1.9441859233637615e-9	6	30	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0016491	oxidoreductase activity	8.99469387860563e-12	1.9837797349264719e-7	9	710	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0055114	oxidation-reduction process	1.1178857839411194e-10	2.4654970964821388e-6	9	949	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0018963	phthalate metabolic process	6.08308403649005e-10	1.3416241842478804e-5	3	4	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0016229	steroid dehydrogenase activity	1.1362087937172305e-9	2.505908494543352e-5	4	27	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0034698	response to gonadotropin	1.3251441055572855e-9	2.922605324806593e-5	4	28	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0018879	biphenyl metabolic process	1.5202744618747488e-9	3.3529653256647585e-5	3	5	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0008207	C21-steroid hormone metabolic process	2.03461536507632e-9	4.4873441876758235e-5	4	31	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0042180	cellular ketone metabolic process	2.546000854586339e-9	5.61520488479017e-5	6	253	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0018894	dibenzo-p-dioxin metabolic process	3.039579699049e-9	6.703793026252569e-5	3	6	11
Orphanet:325632	46,XY disorder of sex development of gynecological interest	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	3.0455619137725876e-9	6.716986800825442e-5	5	111	11
Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus	1.8337298346438047e-10	4.044291150306911e-6	5	64	11
Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	1.8337298346438047e-10	4.044291150306911e-6	5	64	11
Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	GO:0010718	positive regulation of epithelial to mesenchymal transition	2.996167980384712e-9	6.608048480738482e-5	4	34	11
Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	GO:0072358	cardiovascular system development	4.473615478062243e-9	9.866558936866276e-5	8	910	11
Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	GO:0042060	wound healing	4.499653871725684e-9	9.923986614090996e-5	7	534	11
Orphanet:220452	Inherited giant platelet disorder	GO:0030168	platelet activation	2.699729328980993e-12	5.9542530350675804e-8	7	162	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086001	cardiac muscle cell action potential	1.4588330543574557e-13	3.2174563013853685e-9	7	50	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0070252	actin-mediated cell contraction	1.3722356584366935e-13	3.0264657446821275e-9	8	95	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0002027	regulation of heart rate	1.1057821325266559e-13	2.4388024932875396e-9	7	87	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086091	regulation of heart rate by cardiac conduction	1.0369483049998962e-13	2.286989486677271e-9	6	30	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:1903115	regulation of actin filament-based movement	6.994405055138486e-14	1.5426160349107931e-9	7	52	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086003	cardiac muscle cell contraction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086065	cell communication involved in cardiac conduction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086002	cardiac muscle cell action potential involved in contraction	3.597122599785507e-14	7.933453893826936e-10	7	36	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086005	ventricular cardiac muscle cell action potential	1.532107773982716e-14	3.37906369551888e-10	7	24	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086083	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0086073	bundle of His cell-Purkinje myocyte adhesion involved in cell communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0098911	regulation of ventricular cardiac muscle cell action potential	4.6629367034256575e-15	1.0284106899405288e-10	7	9	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0014704	intercalated disc	1.4621637234313312e-13	3.224802092027801e-9	6	49	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0030057	desmosome	1.755373624234835e-12	3.8714765282499286e-8	5	24	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0002934	desmosome organization	1.2304823826525535e-11	2.713828894940207e-7	4	9	12
Orphanet:293910	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form	GO:0048738	cardiac muscle tissue development	4.2897552177123544e-10	9.461055132664598e-6	6	168	12
MESH:D007805	Language Development Disorders	GO:0098596	imitative learning	3.415601135259294e-12	7.533108303814373e-8	4	7	12
MESH:D007805	Language Development Disorders	GO:0098598	learned vocalization behavior or vocal learning	3.415601135259294e-12	7.533108303814373e-8	4	7	12
MESH:D007805	Language Development Disorders	GO:0042297	vocal learning	3.415601135259294e-12	7.533108303814373e-8	4	7	12
MESH:D007805	Language Development Disorders	GO:0097106	postsynaptic density organization	2.026868783921998e-9	4.470259102939966e-5	3	5	12
MESH:D007805	Language Development Disorders	GO:0097107	postsynaptic density assembly	2.026868783921998e-9	4.470259102939966e-5	3	5	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086001	cardiac muscle cell action potential	1.4588330543574557e-13	3.2174563013853685e-9	7	50	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0070252	actin-mediated cell contraction	1.3722356584366935e-13	3.0264657446821275e-9	8	95	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0002027	regulation of heart rate	1.1057821325266559e-13	2.4388024932875396e-9	7	87	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086091	regulation of heart rate by cardiac conduction	1.0369483049998962e-13	2.286989486677271e-9	6	30	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:1903115	regulation of actin filament-based movement	6.994405055138486e-14	1.5426160349107931e-9	7	52	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086003	cardiac muscle cell contraction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086065	cell communication involved in cardiac conduction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086002	cardiac muscle cell action potential involved in contraction	3.597122599785507e-14	7.933453893826936e-10	7	36	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086005	ventricular cardiac muscle cell action potential	1.532107773982716e-14	3.37906369551888e-10	7	24	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086083	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0086073	bundle of His cell-Purkinje myocyte adhesion involved in cell communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0098911	regulation of ventricular cardiac muscle cell action potential	4.6629367034256575e-15	1.0284106899405288e-10	7	9	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0014704	intercalated disc	1.4621637234313312e-13	3.224802092027801e-9	6	49	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0030057	desmosome	1.755373624234835e-12	3.8714765282499286e-8	5	24	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0002934	desmosome organization	1.2304823826525535e-11	2.713828894940207e-7	4	9	12
Orphanet:293899	Familial isolated arrhythmogenic ventricular dysplasia, biventricular form	GO:0048738	cardiac muscle tissue development	4.2897552177123544e-10	9.461055132664598e-6	6	168	12
MESH:D007744	Obstetric Labor Complications	GO:0032963	collagen metabolic process	3.111644275577419e-11	6.862731449785997e-7	6	109	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086001	cardiac muscle cell action potential	1.4588330543574557e-13	3.2174563013853685e-9	7	50	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0070252	actin-mediated cell contraction	1.3722356584366935e-13	3.0264657446821275e-9	8	95	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0002027	regulation of heart rate	1.1057821325266559e-13	2.4388024932875396e-9	7	87	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086091	regulation of heart rate by cardiac conduction	1.0369483049998962e-13	2.286989486677271e-9	6	30	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:1903115	regulation of actin filament-based movement	6.994405055138486e-14	1.5426160349107931e-9	7	52	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086003	cardiac muscle cell contraction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086065	cell communication involved in cardiac conduction	5.240252676230739e-14	1.1557377277426895e-9	7	48	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086002	cardiac muscle cell action potential involved in contraction	3.597122599785507e-14	7.933453893826936e-10	7	36	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086005	ventricular cardiac muscle cell action potential	1.532107773982716e-14	3.37906369551888e-10	7	24	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086083	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0086073	bundle of His cell-Purkinje myocyte adhesion involved in cell communication	1.1324274851176597e-14	2.4975688184269984e-10	6	6	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0098911	regulation of ventricular cardiac muscle cell action potential	4.6629367034256575e-15	1.0284106899405288e-10	7	9	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0014704	intercalated disc	1.4621637234313312e-13	3.224802092027801e-9	6	49	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0030057	desmosome	1.755373624234835e-12	3.8714765282499286e-8	5	24	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0002934	desmosome organization	1.2304823826525535e-11	2.713828894940207e-7	4	9	12
Orphanet:293888	Familial isolated arrhythmogenic ventricular dysplasia, left dominant form	GO:0048738	cardiac muscle tissue development	4.2897552177123544e-10	9.461055132664598e-6	6	168	12
DOID:446	hyperaldosteronism	GO:0022832	voltage-gated channel activity	8.731114720106348e-10	1.925647351519455e-5	6	189	12
DOID:446	hyperaldosteronism	GO:0005244	voltage-gated ion channel activity	8.731114720106348e-10	1.925647351519455e-5	6	189	12
Orphanet:307837	Focal palmoplantar keratoderma	GO:0005882	intermediate filament	8.395728556820359e-12	1.85167793320673e-7	7	193	12
MESH:D048629	Micronuclei, Chromosome-Defective	GO:0003684	damaged DNA binding	2.0642831888295632e-10	4.552776572963602e-6	5	59	12
Orphanet:179490	Obesity due to congenital leptin resistance	GO:0006112	energy reserve metabolic process	8.94961882380585e-12	1.97383843159038e-7	6	89	12
Orphanet:179490	Obesity due to congenital leptin resistance	GO:0032098	regulation of appetite	8.603147083618978e-10	1.8974240892921657e-5	4	23	12
DOID:2615	papilloma	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.1875515015802307e-9	2.6191448367351988e-5	5	83	12
Orphanet:98010	Infectious disease of the nervous system	GO:0009607	response to biotic stimulus	3.6400560343707866e-10	8.02814358380477e-6	9	934	12
Orphanet:98010	Infectious disease of the nervous system	GO:0002252	immune effector process	3.0183582300225e-9	6.656989076314623e-5	8	757	12
DOID:10609	rickets	GO:0030282	bone mineralization	1.5643042416968456e-13	3.450073005062393e-9	7	100	12
DOID:10609	rickets	GO:0030500	regulation of bone mineralization	4.614740811703655e-10	1.017781086021241e-5	5	69	12
DOID:3159	photosensitivity disease	GO:0006259	DNA metabolic process	4.4075854077618715e-13	9.720929616818808e-9	11	937	12
DOID:3159	photosensitivity disease	GO:0071478	cellular response to radiation	2.847587721177547e-10	6.28035471905708e-6	6	157	12
DOID:3159	photosensitivity disease	GO:0006362	transcription elongation from RNA polymerase I promoter	3.482800825516108e-9	7.681317220675776e-5	4	32	12
Orphanet:98991	Early-onset nuclear cataract	GO:0005212	structural constituent of eye lens	2.5091040356528538e-14	5.533828950632369e-10	7	21	12
Orphanet:98991	Early-onset nuclear cataract	GO:0007601	visual perception	1.687538997430238e-14	3.72186725883239e-10	8	207	12
Orphanet:98991	Early-onset nuclear cataract	GO:0002088	lens development in camera-type eye	3.968536610443607e-10	8.752607494333375e-6	5	67	12
DOID:9588	encephalitis	GO:0002252	immune effector process	3.0183582300225e-9	6.656989076314623e-5	8	757	12
OMIM:607948	Mycobacterium Tuberculosis, Susceptibility to	GO:0045087	innate immune response	3.9378120764155256e-9	8.684844534534442e-5	8	783	12
DOID:12798	mucopolysaccharidosis	GO:0044437	vacuolar part	6.73683331342545e-13	1.485808587275983e-8	11	396	12
DOID:12798	mucopolysaccharidosis	GO:1901565	organonitrogen compound catabolic process	4.434230760352875e-13	9.779695941958266e-9	11	349	12
DOID:12798	mucopolysaccharidosis	GO:0043202	lysosomal lumen	1.3944401189291966e-13	3.075437682298343e-9	10	87	12
DOID:12798	mucopolysaccharidosis	GO:0030203	glycosaminoglycan metabolic process	7.993605777301127e-14	1.7629897541837636e-9	11	161	12
DOID:12798	mucopolysaccharidosis	GO:0044273	sulfur compound catabolic process	9.9253938401489e-14	2.1890456114448398e-9	7	39	12
DOID:12798	mucopolysaccharidosis	GO:0008484	sulfuric ester hydrolase activity	2.724487302430134e-13	6.008856745509661e-9	5	17	12
DOID:12798	mucopolysaccharidosis	GO:1903510	mucopolysaccharide metabolic process	6.326050794314142e-13	1.395210502685984e-8	8	113	12
DOID:12798	mucopolysaccharidosis	GO:0030207	chondroitin sulfate catabolic process	9.753764462772097e-11	2.151192752264386e-6	4	14	12
DOID:12798	mucopolysaccharidosis	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	2.237146357053632e-9	4.9340262904817855e-5	5	94	12
OMIM:613985	beta thalassemia	GO:0044205	'de novo' UMP biosynthetic process	2.0283663637599147e-10	4.473562015272492e-6	3	3	12
OMIM:613985	beta thalassemia	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	4.052271740384583e-9	8.937285323418198e-5	3	6	12
Orphanet:93436	Acromelic dysplasia	GO:0001501	skeletal system development	1.8597345885495997e-12	4.101644635046142e-8	9	482	12
Orphanet:93436	Acromelic dysplasia	GO:0007507	heart development	9.409151235928448e-11	2.075188305084019e-6	8	487	12
Orphanet:1333	Familial pancreatic carcinoma	GO:0031049	programmed DNA elimination	8.110413451944964e-10	1.788751686826462e-5	3	4	12
Orphanet:1333	Familial pancreatic carcinoma	GO:0031052	chromosome breakage	8.110413451944964e-10	1.788751686826462e-5	3	4	12
Orphanet:1333	Familial pancreatic carcinoma	GO:0000732	strand displacement	1.450882303188905e-9	3.19992091968313e-5	4	26	12
DOID:13364	chronobiology disease	GO:0007623	circadian rhythm	1.0865137678450765e-9	2.396306114982316e-5	6	196	12
Orphanet:284385	Familial intrahepatic cholestasis	GO:0072330	monocarboxylic acid biosynthetic process	3.752553823233029e-13	8.276257457140446e-9	8	200	12
DOID:13268	porphyria	GO:0033014	tetrapyrrole biosynthetic process	7.838174553853605e-14	1.7287093978524126e-9	9	27	12
DOID:13268	porphyria	GO:0006783	heme biosynthetic process	4.39648317751562e-14	9.6964436480107e-10	9	20	12
OMIM:145500	essential hypertension	GO:0042312	regulation of vasodilation	5.6784799085107807e-11	1.2523887438220527e-6	5	46	12
OMIM:145500	essential hypertension	GO:0008217	regulation of blood pressure	4.2897552177123544e-10	9.461055132664598e-6	6	168	12
OMIM:145500	essential hypertension	GO:0019932	second-messenger-mediated signaling	2.118409114792996e-9	4.672151302675953e-5	6	219	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0032787	monocarboxylic acid metabolic process	1.5285550603039155e-12	3.371228185500286e-8	10	572	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0006081	cellular aldehyde metabolic process	2.1871393585115584e-13	4.823735855197242e-9	9	86	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0006084	acetyl-CoA metabolic process	1.0325074129013956e-13	2.277195099154028e-9	6	33	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0042762	regulation of sulfur metabolic process	4.3298697960381105e-14	9.549527835162053e-10	6	20	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0034603	pyruvate dehydrogenase [NAD(P)+] activity	1.1102230246251565e-14	2.448596880810783e-10	5	6	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0034604	pyruvate dehydrogenase (NAD+) activity	1.1102230246251565e-14	2.448596880810783e-10	5	6	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0045254	pyruvate dehydrogenase complex	7.549516567451064e-15	1.6650458789513323e-10	5	8	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate	6.106226635438361e-15	1.3467282844459305e-10	6	12	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0005759	mitochondrial matrix	4.806155473602303e-13	1.0599975897029879e-8	12	412	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0061732	mitochondrial acetyl-CoA biosynthetic process from pyruvate	1.454392162258955e-12	3.2076619138621254e-8	4	6	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0016624	oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	1.2304823826525535e-11	2.713828894940207e-7	4	9	12
DOID:3649	pyruvate decarboxylase deficiency	GO:0006099	tricarboxylic acid cycle	2.3026643924950463e-9	5.0785263176478246e-5	4	29	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0060047	heart contraction	4.907185768843192e-13	1.082279821318366e-8	9	253	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0090257	regulation of muscle system process	1.035838081975271e-13	2.2845408897964603e-9	8	213	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:1903115	regulation of actin filament-based movement	2.452482661396971e-13	5.408950509711019e-9	6	52	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0060048	cardiac muscle contraction	1.0521583604372609e-12	2.3205352639443788e-8	7	115	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:1903522	regulation of blood circulation	1.9755308500180035e-12	4.357033289714707e-8	8	297	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0006937	regulation of muscle contraction	3.098188372518962e-12	6.83305445559057e-8	7	165	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0070252	actin-mediated cell contraction	1.3190226688664097e-11	2.9091044961848667e-7	6	95	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0006942	regulation of striated muscle contraction	1.529232296348937e-11	3.3727218295975803e-7	6	97	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0008016	regulation of heart contraction	2.3542390259478907e-11	5.192274171728073e-7	7	224	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0061337	cardiac conduction	9.495859654151673e-11	2.0943118467231514e-6	6	131	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0055117	regulation of cardiac muscle contraction	1.2622290990194074e-9	2.783846277887303e-5	5	84	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0002027	regulation of heart rate	1.5091281557744196e-9	3.3283821475604825e-5	5	87	12
Orphanet:871	Familial progressive cardiac conduction defect	GO:0003231	cardiac ventricle development	3.921923674710115e-9	8.649802664573158e-5	5	105	12
Orphanet:227786	Familial flecked retinopathy	GO:0007601	visual perception	1.687538997430238e-14	3.72186725883239e-10	8	207	12
Orphanet:227786	Familial flecked retinopathy	GO:0001750	photoreceptor outer segment	4.614740811703655e-10	1.017781086021241e-5	5	69	12
Orphanet:227786	Familial flecked retinopathy	GO:0001523	retinoid metabolic process	1.5995550439740214e-9	3.527818649484704e-5	5	88	12
DOID:0050646	distal arthrogryposis	GO:0030016	myofibril	2.3274555616126236e-9	5.133203241136641e-5	6	201	13
DOID:0050444	infantile refsum disease	GO:0071806	protein transmembrane transport	1.7208456881689926e-13	3.795325165256713e-9	12	53	13
DOID:0050444	infantile refsum disease	GO:0007031	peroxisome organization	1.3367085216486885e-13	2.9481106444961824e-9	13	33	13
DOID:0050444	infantile refsum disease	GO:0065002	intracellular protein transmembrane transport	7.971401316808624e-14	1.758092560422142e-9	12	47	13
DOID:0050444	infantile refsum disease	GO:0043574	peroxisomal transport	2.8199664825478976e-14	6.219436077259388e-10	12	18	13
DOID:0050444	infantile refsum disease	GO:0031231	intrinsic component of peroxisomal membrane	9.325873406851315e-15	2.0568213798810575e-10	8	14	13
DOID:0050444	infantile refsum disease	GO:0005779	integral component of peroxisomal membrane	9.325873406851315e-15	2.0568213798810575e-10	8	14	13
DOID:0050444	infantile refsum disease	GO:0045046	protein import into peroxisome membrane	4.884981308350689e-15	1.0773826275567444e-10	5	6	13
DOID:0050444	infantile refsum disease	GO:0016558	protein import into peroxisome matrix	2.098321516541546e-14	4.6278481047323794e-10	10	13	13
DOID:0050811	congenital adrenal hyperplasia	GO:0008211	glucocorticoid metabolic process	6.017408793468348e-14	1.3271395093994443e-9	6	24	13
DOID:0050811	congenital adrenal hyperplasia	GO:0042446	hormone biosynthetic process	1.0791367799356522e-13	2.380036168148081e-9	7	63	13
DOID:0050811	congenital adrenal hyperplasia	GO:0006694	steroid biosynthetic process	2.604583215770617e-13	5.744408282382096e-9	8	149	13
DOID:0050811	congenital adrenal hyperplasia	GO:0006704	glucocorticoid biosynthetic process	4.2443826231419735e-13	9.360985875339622e-9	5	17	13
DOID:0050811	congenital adrenal hyperplasia	GO:0032870	cellular response to hormone stimulus	7.430944748421098e-12	1.638894864264273e-7	9	519	13
DOID:0050811	congenital adrenal hyperplasia	GO:0034754	cellular hormone metabolic process	5.4240056890364485e-11	1.1962644547169887e-6	6	108	13
DOID:0050811	congenital adrenal hyperplasia	GO:0016125	sterol metabolic process	1.835515073267402e-10	4.048228494091255e-6	6	132	13
DOID:0050811	congenital adrenal hyperplasia	GO:0008395	steroid hydroxylase activity	4.398264308314026e-9	9.700371931986584e-5	4	31	13
DOID:0050811	congenital adrenal hyperplasia	GO:0008207	C21-steroid hormone metabolic process	4.398264308314026e-9	9.700371931986584e-5	4	31	13
DOID:0050811	congenital adrenal hyperplasia	GO:1901652	response to peptide	4.450102730757521e-9	9.814701572685713e-5	7	423	13
DOID:0060043	sexual disorder	GO:0004970	ionotropic glutamate receptor activity	5.442947204059578e-10	1.20044200585534e-5	4	19	13
DOID:0060043	sexual disorder	GO:0005234	extracellular-glutamate-gated ion channel activity	6.801152974134084e-10	1.4999942884452722e-5	4	20	13
DOID:0060043	sexual disorder	GO:0035235	ionotropic glutamate receptor signaling pathway	1.4893126731863049e-9	3.2846791007123954e-5	4	24	13
DOID:0050778	Meckel syndrome	GO:0072372	primary cilium	6.223910276048628e-13	1.3726834113825248e-8	11	199	13
DOID:0050778	Meckel syndrome	GO:0044782	cilium organization	5.984102102729594e-13	1.3197937187570119e-8	10	201	13
DOID:0050778	Meckel syndrome	GO:0060271	cilium morphogenesis	3.368416656712725e-13	7.429042936379915e-9	11	218	13
DOID:0050778	Meckel syndrome	GO:0042384	cilium assembly	3.0309088572266774e-13	6.684669484613437e-9	10	184	13
DOID:0050778	Meckel syndrome	GO:0031513	nonmotile primary cilium	1.0258460747536446e-13	2.2625035178691633e-9	10	134	13
DOID:0050778	Meckel syndrome	GO:0035869	ciliary transition zone	2.7977620220553945e-14	6.170464139643173e-10	10	25	13
DOID:0050778	Meckel syndrome	GO:0007224	smoothened signaling pathway	8.887979241478661e-11	1.9602438217081186e-6	6	117	13
MESH:D017180	Tachycardia, Ventricular	GO:0008016	regulation of heart contraction	8.835154829966996e-13	1.948593397749221e-8	9	224	13
MESH:D017180	Tachycardia, Ventricular	GO:0035637	multicellular organismal signaling	2.0894397323445446e-13	4.608259329685893e-9	8	184	13
MESH:D017180	Tachycardia, Ventricular	GO:0003012	muscle system process	1.2811973704174306e-13	2.8256808004556433e-9	9	393	13
MESH:D017180	Tachycardia, Ventricular	GO:0061337	cardiac conduction	7.138734048339757e-14	1.5744477943613333e-9	8	131	13
MESH:D017180	Tachycardia, Ventricular	GO:1904062	regulation of cation transmembrane transport	6.3117289172964774e-12	1.392051812709738e-7	7	165	13
MESH:D017180	Tachycardia, Ventricular	GO:0034703	cation channel complex	6.357914195120884e-12	1.402237975733911e-7	7	166	13
MESH:D017180	Tachycardia, Ventricular	GO:0010959	regulation of metal ion transport	1.0427547714186858e-11	2.2997956483639115e-7	8	321	13
MESH:D017180	Tachycardia, Ventricular	GO:0070252	actin-mediated cell contraction	2.4599766668131906e-11	5.425478538656492e-7	6	95	13
MESH:D017180	Tachycardia, Ventricular	GO:0086002	cardiac muscle cell action potential involved in contraction	2.5330071373730334e-11	5.586547241476225e-7	5	36	13
MESH:D017180	Tachycardia, Ventricular	GO:1904064	positive regulation of cation transmembrane transport	7.479066255200451e-10	1.6495080625844594e-5	5	69	13
MESH:D017180	Tachycardia, Ventricular	GO:0086005	ventricular cardiac muscle cell action potential	1.4893126731863049e-9	3.2846791007123954e-5	4	24	13
MESH:D017180	Tachycardia, Ventricular	GO:0060306	regulation of membrane repolarization	3.322481179068859e-9	7.327732240436369e-5	4	29	13
MESH:D017180	Tachycardia, Ventricular	GO:0086091	regulation of heart rate by cardiac conduction	3.83215759125477e-9	8.451823567512395e-5	4	30	13
DOID:0060264	pontocerebellar hypoplasia	GO:0006399	tRNA metabolic process	2.715605518233133e-13	5.989267970463175e-9	8	165	13
DOID:0060264	pontocerebellar hypoplasia	GO:0090501	RNA phosphodiester bond hydrolysis	7.56602558382724e-11	1.668686942513098e-6	6	114	13
DOID:0060264	pontocerebellar hypoplasia	GO:0006388	tRNA splicing, via endonucleolytic cleavage and ligation	1.9200252499018688e-10	4.234615688658572e-6	4	15	13
MESH:D054079	Vascular Malformations	GO:0072358	cardiovascular system development	5.377920331284258e-13	1.1861003290647432e-8	11	910	13
MESH:D054079	Vascular Malformations	GO:0001944	vasculature development	3.3728575488112256e-13	7.438837323903158e-9	10	588	13
MESH:D054079	Vascular Malformations	GO:0001568	blood vessel development	5.164757510556228e-13	1.1390872689531761e-8	10	569	13
MESH:D054079	Vascular Malformations	GO:0048514	blood vessel morphogenesis	9.421352586969078e-13	2.0778793130560302e-8	10	484	13
MESH:D054079	Vascular Malformations	GO:0001525	angiogenesis	6.331635216128007e-11	1.3964421469170318e-6	8	413	13
MESH:D054079	Vascular Malformations	GO:0043542	endothelial cell migration	4.149984800250195e-10	9.152791476951805e-6	6	151	13
MESH:D054079	Vascular Malformations	GO:0022603	regulation of anatomical structure morphogenesis	1.8181501859615423e-9	4.0099302351381816e-5	9	986	13
MESH:D054079	Vascular Malformations	GO:0045765	regulation of angiogenesis	2.8597386680928594e-9	6.307153632478801e-5	6	208	13
Orphanet:199647	Isolated encephalocele	GO:0035869	ciliary transition zone	2.7977620220553945e-14	6.170464139643173e-10	7	25	13
Orphanet:199647	Isolated encephalocele	GO:0042384	cilium assembly	1.2839618257487473e-11	2.831777806688862e-7	7	184	13
DOID:11328	schizophreniform disorder	GO:0043279	response to alkaloid	2.624952477603415e-10	5.789332689354332e-6	6	140	13
DOID:11328	schizophreniform disorder	GO:0050804	modulation of synaptic transmission	2.854393388318499e-10	6.29536461793645e-6	7	285	13
DOID:11252	microcytic anemia	GO:0055072	iron ion homeostasis	3.1790126087116732e-12	7.011312308513595e-8	6	68	13
DOID:11252	microcytic anemia	GO:0072510	trivalent inorganic cation transmembrane transporter activity	2.636832974189929e-10	5.815535124575888e-6	3	3	13
DOID:11252	microcytic anemia	GO:0015091	ferric iron transmembrane transporter activity	2.636832974189929e-10	5.815535124575888e-6	3	3	13
Orphanet:248368	Rare thrombotic disorder due to a platelet anomaly	GO:0042060	wound healing	1.2861933740282439e-12	2.8366994864192918e-8	10	534	13
Orphanet:248368	Rare thrombotic disorder due to a platelet anomaly	GO:0007596	blood coagulation	1.723510223428093e-11	3.801201797770659e-7	8	352	13
Orphanet:248368	Rare thrombotic disorder due to a platelet anomaly	GO:0009986	cell surface	1.0651279858109319e-10	2.3491397727060104e-6	9	715	13
Orphanet:248368	Rare thrombotic disorder due to a platelet anomaly	GO:0030335	positive regulation of cell migration	2.400478260611294e-9	5.294254803778209e-5	7	387	13
Orphanet:79173	Disorder of methionine cycle and sulfur amino acid metabolism	GO:0000096	sulfur amino acid metabolic process	9.64783808399261e-14	2.1278306894245702e-9	7	39	13
Orphanet:79173	Disorder of methionine cycle and sulfur amino acid metabolism	GO:0000097	sulfur amino acid biosynthetic process	4.2443826231419735e-13	9.360985875339622e-9	5	17	13
Orphanet:79173	Disorder of methionine cycle and sulfur amino acid metabolism	GO:0050667	homocysteine metabolic process	1.4083678667731192e-10	3.1061553301681144e-6	4	14	13
Orphanet:79173	Disorder of methionine cycle and sulfur amino acid metabolism	GO:0046500	S-adenosylmethionine metabolic process	3.3449631953175185e-10	7.377316327272787e-6	4	17	13
Orphanet:79173	Disorder of methionine cycle and sulfur amino acid metabolism	GO:1901607	alpha-amino acid biosynthetic process	9.984358895209766e-10	2.202050354338514e-5	5	73	13
Orphanet:2512	Autosomal recessive primary microcephaly	GO:0098534	centriole assembly	1.1790568521519162e-13	2.6004098874210513e-9	6	30	13
Orphanet:2512	Autosomal recessive primary microcephaly	GO:0007099	centriole replication	6.372680161348399e-14	1.4054946095853893e-9	6	27	13
Orphanet:2512	Autosomal recessive primary microcephaly	GO:0044450	microtubule organizing center part	2.4795721031978246e-12	5.468696273602802e-8	7	141	13
Orphanet:2512	Autosomal recessive primary microcephaly	GO:0005814	centriole	3.184119634624949e-11	7.022575854165325e-7	6	99	13
Orphanet:2512	Autosomal recessive primary microcephaly	GO:1903047	mitotic cell cycle process	5.255097468293002e-10	1.1590117466320216e-5	9	857	13
MESH:D000309	Adrenal Insufficiency	GO:0043574	peroxisomal transport	2.7755575615628914e-14	6.121492202026957e-10	6	18	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0032787	monocarboxylic acid metabolic process	1.8127721546079556e-12	3.998068986987846e-8	11	572	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0072330	monocarboxylic acid biosynthetic process	2.902122986370159e-13	6.400632246439386e-9	8	200	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0044282	small molecule catabolic process	1.2745360322696797e-13	2.8109892191707786e-9	9	345	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0046395	carboxylic acid catabolic process	7.571721027943568e-14	1.6699430727129538e-9	9	219	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0009062	fatty acid catabolic process	6.616929226765933e-14	1.4593637409632265e-9	7	86	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0031903	microbody membrane	2.7991808870808654e-10	6.173593446456849e-6	5	57	13
Orphanet:309810	Disorder of peroxisomal alpha-, beta- and omega-oxidation	GO:0005778	peroxisomal membrane	2.7991808870808654e-10	6.173593446456849e-6	5	57	13
MESH:D010014	Osteolysis	GO:0001503	ossification	1.3211653993039363e-12	2.9138302881648315e-8	9	363	13
DOID:9065	leishmaniasis	GO:0002237	response to molecule of bacterial origin	5.362377208939506e-13	1.182672293431608e-8	10	333	13
DOID:9065	leishmaniasis	GO:0006954	inflammatory response	2.220446049250313e-13	4.8971937616215655e-9	10	637	13
DOID:9065	leishmaniasis	GO:0071219	cellular response to molecule of bacterial origin	8.260059303211165e-14	1.8217560793232224e-9	9	158	13
DOID:9065	leishmaniasis	GO:0050755	chemokine metabolic process	9.325873406851315e-15	2.0568213798810575e-10	6	14	13
DOID:9065	leishmaniasis	GO:0032602	chemokine production	9.103828801926284e-15	2.0078494422648419e-10	7	72	13
DOID:9065	leishmaniasis	GO:0042033	chemokine biosynthetic process	2.098321516541546e-14	4.6278481047323794e-10	6	13	13
DOID:9065	leishmaniasis	GO:0045073	regulation of chemokine biosynthetic process	5.895284260759581e-14	1.3002049437105256e-9	5	12	13
DOID:9065	leishmaniasis	GO:0050900	leukocyte migration	6.394884621840902e-14	1.4103918033470109e-9	9	354	13
DOID:9065	leishmaniasis	GO:0030155	regulation of cell adhesion	5.000444502911705e-13	1.1028480351171766e-8	10	621	13
DOID:9065	leishmaniasis	GO:0046427	positive regulation of JAK-STAT cascade	6.346811964874632e-12	1.3997893788531002e-7	6	76	13
DOID:9065	leishmaniasis	GO:0030595	leukocyte chemotaxis	1.0129008742865153e-11	2.2339528782389095e-7	7	177	13
DOID:9065	leishmaniasis	GO:0045785	positive regulation of cell adhesion	2.495259554535778e-11	5.503294947528659e-7	8	368	13
DOID:9065	leishmaniasis	GO:0022407	regulation of cell-cell adhesion	2.933153719908432e-11	6.469070529258047e-7	8	376	13
DOID:9065	leishmaniasis	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.2388314252784767e-11	7.14324270845168e-7	7	209	13
DOID:9065	leishmaniasis	GO:0022409	positive regulation of cell-cell adhesion	8.30627788772631e-11	1.8319495881380377e-6	7	239	13
DOID:9065	leishmaniasis	GO:0002637	regulation of immunoglobulin production	9.203870998675256e-11	2.029913748757828e-6	5	46	13
DOID:9065	leishmaniasis	GO:0007159	leukocyte cell-cell adhesion	1.5158507782331299e-10	3.343208891393168e-6	8	461	13
DOID:9065	leishmaniasis	GO:0031347	regulation of defense response	1.608297939270642e-10	3.547101105061401e-6	9	749	13
DOID:9065	leishmaniasis	GO:0034097	response to cytokine	2.382618546903359e-10	5.254865205195358e-6	9	784	13
DOID:9065	leishmaniasis	GO:0002443	leukocyte mediated immunity	2.453621750220236e-10	5.411462770110731e-6	7	279	13
DOID:9065	leishmaniasis	GO:0046136	positive regulation of vitamin metabolic process	2.636832974189929e-10	5.815535124575888e-6	3	3	13
DOID:9065	leishmaniasis	GO:0060557	positive regulation of vitamin D biosynthetic process	2.636832974189929e-10	5.815535124575888e-6	3	3	13
DOID:9065	leishmaniasis	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	2.636832974189929e-10	5.815535124575888e-6	3	3	13
DOID:9065	leishmaniasis	GO:0050863	regulation of T cell activation	2.7865276752692125e-10	6.145686787806248e-6	7	284	13
DOID:9065	leishmaniasis	GO:0032103	positive regulation of response to external stimulus	2.854393388318499e-10	6.29536461793645e-6	7	285	13
DOID:9065	leishmaniasis	GO:0050707	regulation of cytokine secretion	2.8637925364449757e-10	6.316094439129394e-6	6	142	13
DOID:9065	leishmaniasis	GO:0042129	regulation of T cell proliferation	2.8637925364449757e-10	6.316094439129394e-6	6	142	13
DOID:9065	leishmaniasis	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	3.063597153740716e-10	6.756763522575149e-6	5	58	13
DOID:9065	leishmaniasis	GO:0050727	regulation of inflammatory response	3.150867344814401e-10	6.949237928988161e-6	7	289	13
DOID:9065	leishmaniasis	GO:0002699	positive regulation of immune effector process	3.986311281067856e-10	8.791809530395156e-6	6	150	13
DOID:9065	leishmaniasis	GO:0042832	defense response to protozoan	4.2986636472619466e-10	9.480702674036223e-6	4	18	13
DOID:9065	leishmaniasis	GO:0097529	myeloid leukocyte migration	4.4938008869621626e-10	9.91107785619505e-6	6	153	13
DOID:9065	leishmaniasis	GO:0051384	response to glucocorticoid	7.62578333812769e-10	1.681866515224062e-5	6	167	13
DOID:9065	leishmaniasis	GO:0051043	regulation of membrane protein ectodomain proteolysis	8.397987860675471e-10	1.852176222671975e-5	4	21	13
DOID:9065	leishmaniasis	GO:0002690	positive regulation of leukocyte chemotaxis	1.5939616293536574e-9	3.515482373539491e-5	5	80	13
DOID:9065	leishmaniasis	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.922981884838748e-9	4.241136547011859e-5	5	83	13
DOID:9065	leishmaniasis	GO:0002705	positive regulation of leukocyte mediated immunity	1.922981884838748e-9	4.241136547011859e-5	5	83	13
DOID:9065	leishmaniasis	GO:0050870	positive regulation of T cell activation	2.398228837741101e-9	5.289293701637998e-5	6	202	13
DOID:9065	leishmaniasis	GO:0071345	cellular response to cytokine stimulus	3.1432976221879017e-9	6.932542905735417e-5	8	677	13
DOID:9065	leishmaniasis	GO:0042102	positive regulation of T cell proliferation	3.820731508952235e-9	8.426623342994155e-5	5	95	13
DOID:9065	leishmaniasis	GO:0071407	cellular response to organic cyclic compound	3.963356975944521e-9	8.741183810445641e-5	7	416	13
DC:0000284	Mitochondrial DNA Depletion Syndrome	GO:0000002	mitochondrial genome maintenance	7.238654120556021e-14	1.5964851662886304e-9	7	27	13
DC:0000284	Mitochondrial DNA Depletion Syndrome	GO:0006264	mitochondrial DNA replication	4.6499581962677894e-11	1.025548280186861e-6	4	11	13
DC:0000284	Mitochondrial DNA Depletion Syndrome	GO:0044429	mitochondrial part	1.3853632685467687e-9	3.0554186887798984e-5	9	956	13
OMIM:235200	Hemochromatosis, Type 1	GO:0060586	multicellular organismal iron ion homeostasis	1.9984014443252818e-15	4.407474385459409e-11	5	9	13
OMIM:235200	Hemochromatosis, Type 1	GO:0010039	response to iron ion	3.219646771412954e-15	7.10093095435127e-11	6	35	13
OMIM:235200	Hemochromatosis, Type 1	GO:0006879	cellular iron ion homeostasis	5.739853037312059e-14	1.2659245873791747e-9	8	45	13
OMIM:235200	Hemochromatosis, Type 1	GO:0015684	ferrous iron transport	4.9359405451809835e-12	1.0886216872396659e-7	4	7	13
OMIM:235200	Hemochromatosis, Type 1	GO:0071281	cellular response to iron ion	2.9594215966710635e-11	6.527004331458031e-7	4	10	13
OMIM:235200	Hemochromatosis, Type 1	GO:0070627	ferrous iron import	2.6347138915028268e-9	5.8108614877094844e-5	3	5	13
DC:0000094	Complement Component Deficiency	GO:0002250	adaptive immune response	9.9342756243459e-13	2.1910044889494884e-8	13	334	13
DC:0000094	Complement Component Deficiency	GO:0002253	activation of immune response	9.137135492665038e-13	2.0151952329072742e-8	13	475	13
DC:0000094	Complement Component Deficiency	GO:0009611	response to wounding	7.980283101005625e-13	1.7600514379267906e-8	11	875	13
DC:0000094	Complement Component Deficiency	GO:0006954	inflammatory response	7.369660437461789e-13	1.6253786094821976e-8	11	637	13
DC:0000094	Complement Component Deficiency	GO:0016485	protein processing	7.145395386487507e-13	1.5759169524898198e-8	11	308	13
DC:0000094	Complement Component Deficiency	GO:0002697	regulation of immune effector process	1.474376176702208e-13	3.2517366577167195e-9	11	418	13
DC:0000094	Complement Component Deficiency	GO:2000257	regulation of protein activation cascade	1.3367085216486885e-13	2.9481106444961824e-9	11	33	13
DC:0000094	Complement Component Deficiency	GO:0006958	complement activation, classical pathway	1.3367085216486885e-13	2.9481106444961824e-9	13	33	13
DC:0000094	Complement Component Deficiency	GO:0019835	cytolysis	1.1790568521519162e-13	2.6004098874210513e-9	6	30	13
DC:0000094	Complement Component Deficiency	GO:1903034	regulation of response to wounding	9.547918011776346e-14	2.105793317497273e-9	11	407	13
DC:0000094	Complement Component Deficiency	GO:0002920	regulation of humoral immune response	7.283063041541027e-14	1.6062795538118735e-9	11	51	13
DC:0000094	Complement Component Deficiency	GO:0030449	regulation of complement activation	4.440892098500626e-14	9.79438752324313e-10	11	32	13
DC:0000094	Complement Component Deficiency	GO:0006957	complement activation, alternative pathway	9.325873406851315e-15	2.0568213798810575e-10	6	14	13
DC:0000094	Complement Component Deficiency	GO:0005579	membrane attack complex	1.9984014443252818e-15	4.407474385459409e-11	6	7	13
DC:0000094	Complement Component Deficiency	GO:0072562	blood microparticle	4.840572387365683e-13	1.0675882400335013e-8	8	114	13
DC:0000094	Complement Component Deficiency	GO:2000427	positive regulation of apoptotic cell clearance	9.875433804040767e-12	2.1780269254811913e-7	4	8	13
DC:0000094	Complement Component Deficiency	GO:0004252	serine-type endopeptidase activity	1.280688555205245e-9	2.8245586085051677e-5	6	182	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0044463	cell projection part	5.364597654988756e-13	1.1831620128077702e-8	11	939	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0030991	intraciliary transport particle A	9.875433804040767e-12	2.1780269254811913e-7	4	8	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0042384	cilium assembly	1.2839618257487473e-11	2.831777806688862e-7	7	184	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0036064	ciliary basal body	1.4949098625649526e-9	3.297023701887003e-5	5	79	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0097014	ciliary cytoplasm	2.90335022690158e-9	6.403338925431434e-5	5	90	13
DC:0000131	Short-Rib Thoracic Dysplasia	GO:0005930	axoneme	2.90335022690158e-9	6.403338925431434e-5	5	90	13
DOID:2729	dyskeratosis congenita	GO:0006260	DNA replication	1.0402789740737717e-12	2.2943352773197034e-8	10	337	13
DOID:2729	dyskeratosis congenita	GO:0034513	box H/ACA snoRNA binding	1.4421797089880783e-13	3.1807273481732068e-9	4	4	13
DOID:2729	dyskeratosis congenita	GO:0090661	box H/ACA telomerase RNP complex	1.4421797089880783e-13	3.1807273481732068e-9	4	4	13
DOID:2729	dyskeratosis congenita	GO:0031429	box H/ACA snoRNP complex	1.4421797089880783e-13	3.1807273481732068e-9	4	4	13
DOID:2729	dyskeratosis congenita	GO:0031118	rRNA pseudouridine synthesis	1.4421797089880783e-13	3.1807273481732068e-9	4	4	13
DOID:2729	dyskeratosis congenita	GO:0072589	box H/ACA scaRNP complex	1.4421797089880783e-13	3.1807273481732068e-9	4	4	13
DOID:2729	dyskeratosis congenita	GO:0051972	regulation of telomerase activity	3.883238175461656e-11	8.564481795980683e-7	5	39	13
DOID:2729	dyskeratosis congenita	GO:0000783	nuclear telomere cap complex	1.0066414368736787e-10	2.2201476890248983e-6	4	13	13
DOID:2729	dyskeratosis congenita	GO:0070200	establishment of protein localization to telomere	1.9200252499018688e-10	4.234615688658572e-6	4	15	13
DOID:2729	dyskeratosis congenita	GO:0090672	telomerase RNA localization	2.559051859307715e-10	5.643988875703165e-6	4	16	13
DOID:2729	dyskeratosis congenita	GO:0090671	telomerase RNA localization to Cajal body	2.559051859307715e-10	5.643988875703165e-6	4	16	13
DOID:2729	dyskeratosis congenita	GO:0032202	telomere assembly	1.0543165229748297e-9	2.325295091420987e-5	3	4	13
DOID:2729	dyskeratosis congenita	GO:0042162	telomeric DNA binding	3.83215759125477e-9	8.451823567512395e-5	4	30	13
OMIM:213300	Joubert Syndrome 1	GO:0044463	cell projection part	8.832934383917745e-13	1.9481036783730588e-8	12	939	13
OMIM:213300	Joubert Syndrome 1	GO:0072372	primary cilium	6.223910276048628e-13	1.3726834113825248e-8	10	199	13
OMIM:213300	Joubert Syndrome 1	GO:0044782	cilium organization	5.972999872483342e-13	1.3173451218762011e-8	9	201	13
OMIM:213300	Joubert Syndrome 1	GO:0060271	cilium morphogenesis	3.368416656712725e-13	7.429042936379915e-9	11	218	13
OMIM:213300	Joubert Syndrome 1	GO:0042384	cilium assembly	2.0894397323445446e-13	4.608259329685893e-9	8	184	13
OMIM:213300	Joubert Syndrome 1	GO:0035869	ciliary transition zone	2.7977620220553945e-14	6.170464139643173e-10	7	25	13
OMIM:213300	Joubert Syndrome 1	GO:0007224	smoothened signaling pathway	1.3274936705442997e-12	2.927787290385453e-8	7	117	13
OMIM:213300	Joubert Syndrome 1	GO:0036038	TCTN-B9D complex	6.970812815865202e-11	1.5374127665390702e-6	4	12	13
DOID:5426	premature ovarian failure	GO:0007292	female gamete generation	6.413869435561992e-11	1.4145789040131973e-6	6	111	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0006259	DNA metabolic process	1.0254019855437946e-12	2.261524079116839e-8	12	937	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0006281	DNA repair	7.247535904753022e-13	1.598444043793279e-8	12	503	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0090305	nucleic acid phosphodiester bond hydrolysis	1.5037970868547745e-12	3.316624475058205e-8	8	252	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0003684	damaged DNA binding	3.345486110362117e-10	7.378469616403649e-6	5	59	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0032508	DNA duplex unwinding	1.2267183935321668e-9	2.705527416935194e-5	5	76	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0006302	double-strand break repair	1.7669743446191433e-9	3.8970619170575205e-5	6	192	13
Orphanet:98097	Autosomal recessive cerebellar ataxia due to a DNA repair defect	GO:0006294	nucleotide-excision repair, preincision complex assembly	3.83215759125477e-9	8.451823567512395e-5	4	30	13
OMIM:208550	Asthma, Nasal Polyps, and Aspirin Intolerance	GO:0004953	icosanoid receptor activity	2.1749269052406817e-13	4.796801289508323e-9	5	15	13
DOID:12177	common variable immunodeficiency	GO:0042100	B cell proliferation	5.995204332975845e-14	1.3222423156378227e-9	7	85	13
DOID:12678	hypercalcemia	GO:0001503	ossification	1.0829115382193777e-12	2.3883613975428375e-8	10	363	13
Orphanet:98611	Conjunctival vascular anomaly	GO:0072358	cardiovascular system development	7.835954107804355e-13	1.7282196784762505e-8	12	910	13
Orphanet:98611	Conjunctival vascular anomaly	GO:0045766	positive regulation of angiogenesis	9.804013156866631e-11	2.1622751017469355e-6	6	119	13
Orphanet:98611	Conjunctival vascular anomaly	GO:0009790	embryo development	1.1048896242371598e-9	2.436834066255056e-5	9	932	13
Orphanet:424033	Rare epithelial tumor of pancreas	GO:0071897	DNA biosynthetic process	7.62578333812769e-10	1.681866515224062e-5	6	167	13
Orphanet:95618	Pituitary hormone deficiency secondary to storage disease	GO:0019825	oxygen binding	1.2773027080470456e-10	2.817091122597759e-6	5	49	13
Orphanet:95618	Pituitary hormone deficiency secondary to storage disease	GO:0031720	haptoglobin binding	2.636832974189929e-10	5.815535124575888e-6	3	3	13
Orphanet:95618	Pituitary hormone deficiency secondary to storage disease	GO:0005506	iron ion binding	6.110257855240775e-10	1.3476173699733529e-5	6	161	13
Orphanet:95618	Pituitary hormone deficiency secondary to storage disease	GO:0031838	haptoglobin-hemoglobin complex	1.0543165229748297e-9	2.325295091420987e-5	3	4	13
Orphanet:254746	Pyruvate metabolism disorder	GO:0006085	acetyl-CoA biosynthetic process	2.731148640577885e-14	6.023548326794526e-10	6	19	13
DOID:0050439	Usher syndrome	GO:0001894	tissue homeostasis	2.2382096176443156e-13	4.936371311714538e-9	9	197	13
DOID:0050439	Usher syndrome	GO:0050954	sensory perception of mechanical stimulus	2.97761815204467e-13	6.567136834334519e-9	10	153	13
DOID:0050439	Usher syndrome	GO:0060122	inner ear receptor stereocilium organization	1.326494469822137e-12	2.9255835531927232e-8	5	21	13
DOID:0050534	congenital stationary night blindness	GO:0009581	detection of external stimulus	1.9961809982760315e-13	4.402577191697787e-9	8	130	14
DOID:0050534	congenital stationary night blindness	GO:0009582	detection of abiotic stimulus	1.3522516439934407e-13	2.9823910008275334e-9	8	133	14
DOID:0050534	congenital stationary night blindness	GO:0007601	visual perception	1.2967404927621828e-13	2.8599611567869943e-9	14	207	14
DOID:0050534	congenital stationary night blindness	GO:0009416	response to light stimulus	9.914291609902648e-14	2.186597014564029e-9	10	297	14
DOID:0050534	congenital stationary night blindness	GO:0009583	detection of light stimulus	1.3589129821411916e-13	2.997082582112398e-9	8	75	14
DOID:0050534	congenital stationary night blindness	GO:0009584	detection of visible light	1.4832579608992091e-13	3.2713254327632058e-9	7	62	14
DOID:0050534	congenital stationary night blindness	GO:0007602	phototransduction	2.5479618415147343e-12	5.6195298414607464e-8	6	60	14
DOID:0050534	congenital stationary night blindness	GO:0022400	regulation of rhodopsin mediated signaling pathway	1.2351897282769642e-11	2.7242109457148445e-7	5	29	14
DOID:0050534	congenital stationary night blindness	GO:0097381	photoreceptor disc membrane	6.014346798366432e-10	1.3264641863797166e-5	4	18	14
DOID:0050534	congenital stationary night blindness	GO:0001654	eye development	1.4650541890759428e-9	3.231177014006992e-5	7	327	14
DOID:0050524	maturity-onset diabetes of the young	GO:0015833	peptide transport	7.140954494389007e-13	1.5749375137374955e-8	9	307	14
DOID:0050524	maturity-onset diabetes of the young	GO:0009914	hormone transport	7.140954494389007e-13	1.5749375137374955e-8	9	307	14
DOID:0050524	maturity-onset diabetes of the young	GO:0090276	regulation of peptide hormone secretion	2.69562150378988e-13	5.9451932266085805e-9	8	199	14
DOID:0050524	maturity-onset diabetes of the young	GO:0030073	insulin secretion	2.69562150378988e-13	5.9451932266085805e-9	8	199	14
DOID:0050524	maturity-onset diabetes of the young	GO:0050796	regulation of insulin secretion	1.4614420784653248e-11	3.223210504055274e-7	7	169	14
DOID:0050524	maturity-onset diabetes of the young	GO:0033500	carbohydrate homeostasis	7.05919767085561e-11	1.5569060463072049e-6	7	212	14
DOID:0050524	maturity-onset diabetes of the young	GO:0042593	glucose homeostasis	7.05919767085561e-11	1.5569060463072049e-6	7	212	14
DOID:0050524	maturity-onset diabetes of the young	GO:0009749	response to glucose	1.8170646098880638e-9	4.007535997108125e-5	6	176	14
DOID:0050560	Walker-Warburg syndrome	GO:0009101	glycoprotein biosynthetic process	1.2108092306561957e-12	2.6704397582122397e-8	13	336	14
DOID:0050560	Walker-Warburg syndrome	GO:0035268	protein mannosylation	1.509903313490213e-14	3.3300917579026645e-10	9	21	14
DOID:0050560	Walker-Warburg syndrome	GO:0016758	transferase activity, transferring hexosyl groups	4.9834247839442014e-11	1.0990943360988936e-6	7	202	14
DOID:0050560	Walker-Warburg syndrome	GO:0008375	acetylglucosaminyltransferase activity	1.7819279385378195e-10	3.930042068445161e-6	5	48	14
DOID:626	complement deficiency	GO:0002684	positive regulation of immune system process	2.2883916983573727e-12	5.0470478907271854e-8	14	872	14
DOID:626	complement deficiency	GO:0032101	regulation of response to external stimulus	8.282263763703668e-13	1.826653273084844e-8	12	920	14
DOID:626	complement deficiency	GO:0050778	positive regulation of immune response	7.496225862269057e-13	1.6532926139234405e-8	14	603	14
DOID:626	complement deficiency	GO:0046930	pore complex	3.907985046680551e-14	8.619061020453955e-10	6	17	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0034698	response to gonadotropin	1.0237810599278419e-11	2.2579491276708552e-7	5	28	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0042448	progesterone metabolic process	1.970944518703277e-10	4.3469181360000775e-6	4	14	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0046661	male sex differentiation	7.210971819660017e-10	1.5903798348260167e-5	6	151	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0018963	phthalate metabolic process	1.341798450127385e-9	2.9593364817559475e-5	3	4	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0018879	biphenyl metabolic process	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0016229	steroid dehydrogenase activity	3.436385731525604e-9	7.57894873087972e-5	4	27	14
Orphanet:325357	46,XY disorder of sex development due to impaired androgen production	GO:0006066	alcohol metabolic process	4.3091147317042555e-9	9.503752540773736e-5	7	382	14
DOID:8893	psoriasis	GO:0098542	defense response to other organism	2.961064726747509e-11	6.530628254841631e-7	9	550	14
DOID:8893	psoriasis	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	9.978808890309665e-10	2.2008263007577966e-5	5	67	14
DOID:8893	psoriasis	GO:0002708	positive regulation of lymphocyte mediated immunity	9.978808890309665e-10	2.2008263007577966e-5	5	67	14
DOID:8893	psoriasis	GO:0032660	regulation of interleukin-17 production	1.435445540209912e-9	3.165875138932961e-5	4	22	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0009952	anterior/posterior pattern specification	6.779021788361206e-13	1.495113255423064e-8	9	199	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0009790	embryo development	2.3514523661560816e-13	5.186128193557238e-9	11	932	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0009880	embryonic pattern specification	1.911915070706982e-12	4.216728688444249e-8	6	57	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0045165	cell fate commitment	1.9675372442407024e-12	4.339403392172869e-8	8	243	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0001708	cell fate specification	1.6282530879152546e-11	3.591112185397094e-7	6	81	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0009798	axis specification	3.082478716720516e-11	6.798406809727098e-7	6	90	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0048598	embryonic morphogenesis	3.683475746640852e-11	8.123905759216399e-7	9	560	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0009953	dorsal/ventral pattern formation	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0048729	tissue morphogenesis	1.0026990349132348e-10	2.2114527215011393e-6	9	635	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0007368	determination of left/right symmetry	1.1803835686663433e-10	2.60333596069362e-6	6	112	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0048568	embryonic organ development	1.3024481493317808e-10	2.8725493933512425e-6	8	408	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0007224	smoothened signaling pathway	1.5388346152889198e-10	3.3938997440197127e-6	6	117	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0007420	brain development	1.5826850940925397e-10	3.4906119750210962e-6	9	669	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0001947	heart looping	4.753153426406698e-10	1.0483079881939972e-5	5	58	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0008589	regulation of smoothened signaling pathway	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
Orphanet:220386	Semilobar holoprosencephaly	GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:220386	Semilobar holoprosencephaly	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
DOID:14018	alcoholic liver cirrhosis	GO:1901698	response to nitrogen compound	1.3284928712664623e-12	2.9299910275781826e-8	11	870	14
DOID:14018	alcoholic liver cirrhosis	GO:0007568	aging	9.654721466745286e-12	2.129348819490673e-7	8	290	14
DOID:14018	alcoholic liver cirrhosis	GO:0000302	response to reactive oxygen species	8.021983077810546e-11	1.769248367811116e-6	7	216	14
DOID:14018	alcoholic liver cirrhosis	GO:0010243	response to organonitrogen compound	6.160449927961054e-10	1.3586872316118104e-5	9	780	14
DOID:14018	alcoholic liver cirrhosis	GO:0001101	response to acid chemical	1.1293995738625995e-9	2.490890760153963e-5	7	315	14
DOID:14018	alcoholic liver cirrhosis	GO:0001503	ossification	3.026117356697e-9	6.674101830195234e-5	7	363	14
Orphanet:79171	Disorder of cobalamin metabolism and transport	GO:0006767	water-soluble vitamin metabolic process	1.2079226507921703e-13	2.6640734063221316e-9	12	86	14
Orphanet:79171	Disorder of cobalamin metabolism and transport	GO:0031419	cobalamin binding	8.43769498715119e-15	1.860933629416195e-10	6	9	14
Orphanet:79171	Disorder of cobalamin metabolism and transport	GO:0015889	cobalamin transport	7.771561172376096e-15	1.714017816567548e-10	5	8	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:1903825	organic acid transmembrane transport	3.9745984281580604e-14	8.765976833302602e-10	8	102	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:0015179	L-amino acid transmembrane transporter activity	1.3020695632803836e-12	2.871714421814886e-8	6	54	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:0015807	L-amino acid transport	3.623101818561736e-12	7.990751060837908e-8	6	63	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:0015175	neutral amino acid transmembrane transporter activity	2.1080914791582472e-11	4.6493957572835143e-7	5	32	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:0015804	neutral amino acid transport	3.3945291022519086e-11	7.486633935016584e-7	5	35	14
Orphanet:79166	Disorder of amino acid absorption and transport	GO:0015291	secondary active transmembrane transporter activity	1.1726841719905678e-10	2.5863549413251974e-6	7	228	14
DC:0000280	Microphthalmia, Syndromic	GO:0001654	eye development	1.4650541890759428e-9	3.231177014006992e-5	7	327	14
DC:0000659	Muscular Dystrophy-Dystroglycanopathy, Type A	GO:0009101	glycoprotein biosynthetic process	1.2108092306561957e-12	2.6704397582122397e-8	13	336	14
DC:0000659	Muscular Dystrophy-Dystroglycanopathy, Type A	GO:0035268	protein mannosylation	1.509903313490213e-14	3.3300917579026645e-10	9	21	14
DC:0000659	Muscular Dystrophy-Dystroglycanopathy, Type A	GO:0016758	transferase activity, transferring hexosyl groups	4.9834247839442014e-11	1.0990943360988936e-6	7	202	14
DC:0000659	Muscular Dystrophy-Dystroglycanopathy, Type A	GO:0008375	acetylglucosaminyltransferase activity	1.7819279385378195e-10	3.930042068445161e-6	5	48	14
Orphanet:280200	Microform holoprosencephaly	GO:0009952	anterior/posterior pattern specification	6.779021788361206e-13	1.495113255423064e-8	9	199	14
Orphanet:280200	Microform holoprosencephaly	GO:0009790	embryo development	2.3514523661560816e-13	5.186128193557238e-9	11	932	14
Orphanet:280200	Microform holoprosencephaly	GO:0009880	embryonic pattern specification	1.911915070706982e-12	4.216728688444249e-8	6	57	14
Orphanet:280200	Microform holoprosencephaly	GO:0045165	cell fate commitment	1.9675372442407024e-12	4.339403392172869e-8	8	243	14
Orphanet:280200	Microform holoprosencephaly	GO:0001708	cell fate specification	1.6282530879152546e-11	3.591112185397094e-7	6	81	14
Orphanet:280200	Microform holoprosencephaly	GO:0009798	axis specification	3.082478716720516e-11	6.798406809727098e-7	6	90	14
Orphanet:280200	Microform holoprosencephaly	GO:0048598	embryonic morphogenesis	3.683475746640852e-11	8.123905759216399e-7	9	560	14
Orphanet:280200	Microform holoprosencephaly	GO:0009953	dorsal/ventral pattern formation	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
Orphanet:280200	Microform holoprosencephaly	GO:0048729	tissue morphogenesis	1.0026990349132348e-10	2.2114527215011393e-6	9	635	14
Orphanet:280200	Microform holoprosencephaly	GO:0007368	determination of left/right symmetry	1.1803835686663433e-10	2.60333596069362e-6	6	112	14
Orphanet:280200	Microform holoprosencephaly	GO:0048568	embryonic organ development	1.3024481493317808e-10	2.8725493933512425e-6	8	408	14
Orphanet:280200	Microform holoprosencephaly	GO:0007224	smoothened signaling pathway	1.5388346152889198e-10	3.3938997440197127e-6	6	117	14
Orphanet:280200	Microform holoprosencephaly	GO:0007420	brain development	1.5826850940925397e-10	3.4906119750210962e-6	9	669	14
Orphanet:280200	Microform holoprosencephaly	GO:0001947	heart looping	4.753153426406698e-10	1.0483079881939972e-5	5	58	14
Orphanet:280200	Microform holoprosencephaly	GO:0008589	regulation of smoothened signaling pathway	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
Orphanet:280200	Microform holoprosencephaly	GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:280200	Microform holoprosencephaly	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0009952	anterior/posterior pattern specification	6.779021788361206e-13	1.495113255423064e-8	9	199	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0009790	embryo development	2.3514523661560816e-13	5.186128193557238e-9	11	932	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0009880	embryonic pattern specification	1.911915070706982e-12	4.216728688444249e-8	6	57	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0045165	cell fate commitment	1.9675372442407024e-12	4.339403392172869e-8	8	243	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0001708	cell fate specification	1.6282530879152546e-11	3.591112185397094e-7	6	81	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0009798	axis specification	3.082478716720516e-11	6.798406809727098e-7	6	90	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0048598	embryonic morphogenesis	3.683475746640852e-11	8.123905759216399e-7	9	560	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0009953	dorsal/ventral pattern formation	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0048729	tissue morphogenesis	1.0026990349132348e-10	2.2114527215011393e-6	9	635	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0007368	determination of left/right symmetry	1.1803835686663433e-10	2.60333596069362e-6	6	112	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0048568	embryonic organ development	1.3024481493317808e-10	2.8725493933512425e-6	8	408	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0007224	smoothened signaling pathway	1.5388346152889198e-10	3.3938997440197127e-6	6	117	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0007420	brain development	1.5826850940925397e-10	3.4906119750210962e-6	9	669	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0001947	heart looping	4.753153426406698e-10	1.0483079881939972e-5	5	58	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0008589	regulation of smoothened signaling pathway	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:280195	Septopreoptic holoprosencephaly	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0042092	type 2 immune response	2.4824364786013575e-11	5.475013653555294e-7	5	33	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0002700	regulation of production of molecular mediator of immune response	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0006954	inflammatory response	1.0153666796242078e-10	2.2393912119111903e-6	9	637	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0002637	regulation of immunoglobulin production	1.4285639338140754e-10	3.1506977560269434e-6	5	46	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0050865	regulation of cell activation	3.2782720982282854e-10	7.230229112642483e-6	8	458	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0032602	chemokine production	1.4428545025424455e-9	3.1822156053573636e-5	5	72	14
OMIM:147050	Ige Responsiveness, Atopic	GO:0043030	regulation of macrophage activation	2.9285313063454055e-9	6.458875796144792e-5	4	26	14
DOID:10591	pre-eclampsia	GO:0050886	endocrine process	3.3647038488737735e-9	7.420854338691107e-5	5	85	14
MESH:D006525	Hepatitis, Viral, Human	GO:0019221	cytokine-mediated signaling pathway	1.0987200038670153e-9	2.4232269685287022e-5	8	534	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0030016	myofibril	5.218048215738236e-13	1.1508405339810679e-8	10	201	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0044449	contractile fiber part	4.745093207247919e-13	1.0465303068585285e-8	10	196	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0055002	striated muscle cell development	1.7488233083895466e-12	3.857029806653145e-8	7	127	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0048747	muscle fiber development	2.20376494830532e-10	4.8604035934873835e-6	5	50	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0015629	actin cytoskeleton	2.415678768130647e-10	5.327779523112142e-6	8	441	14
Orphanet:284790	Qualitative or quantitative defects of tropomyosin	GO:0005865	striated muscle thin filament	9.515004339988309e-10	2.0985342071844215e-5	4	20	14
Orphanet:98605	Excretory apparatus of the lacrimal system anomaly	GO:0000723	telomere maintenance	1.5076828674409626e-13	3.325194564141043e-9	10	133	14
Orphanet:98605	Excretory apparatus of the lacrimal system anomaly	GO:0051054	positive regulation of DNA metabolic process	2.4836244172377064e-11	5.477633652217762e-7	7	183	14
Orphanet:98605	Excretory apparatus of the lacrimal system anomaly	GO:0045740	positive regulation of DNA replication	3.570885476200658e-9	7.875587917760551e-5	5	86	14
Orphanet:98631	Secondary dysgenetic glaucoma	GO:0043010	camera-type eye development	7.331357743112221e-12	1.6169309502434004e-7	8	283	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0044431	Golgi apparatus part	3.4661162828797387e-13	7.644519461891264e-9	12	875	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0031984	organelle subcompartment	5.551115123125783e-14	1.2242984404053914e-9	9	304	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0017119	Golgi transport complex	1.2212453270876722e-15	2.693456568891861e-11	6	12	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0032588	trans-Golgi network membrane	1.8640644583456378e-13	4.111194162881304e-9	7	80	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0070085	glycosylation	6.113554107400887e-12	1.3483443583872656e-7	8	268	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0006891	intra-Golgi vesicle-mediated transport	1.596921483937308e-10	3.522010332823733e-6	5	47	14
OMIM:607906	congenital disorder of glycosylation type II	GO:0006888	ER to Golgi vesicle-mediated transport	1.3730223624719429e-9	3.02820082043187e-5	6	168	14
DOID:1882	atrial heart septal defect	GO:0060413	atrial septum morphogenesis	1.970944518703277e-10	4.3469181360000775e-6	4	14	14
DOID:1882	atrial heart septal defect	GO:0055017	cardiac muscle tissue growth	4.3447323516687675e-10	9.582307201605467e-6	5	57	14
DOID:1882	atrial heart septal defect	GO:0003208	cardiac ventricle morphogenesis	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
DOID:1882	atrial heart septal defect	GO:0060043	regulation of cardiac muscle cell proliferation	4.007382425896822e-9	8.83828194031544e-5	4	28	14
Orphanet:166466	Neurocutaneous syndrome with epilepsy	GO:0042552	myelination	9.438860804067417e-11	2.081740750337069e-6	6	108	14
Orphanet:166466	Neurocutaneous syndrome with epilepsy	GO:0045859	regulation of protein kinase activity	2.638884666339436e-10	5.820060131611626e-6	9	709	14
Orphanet:166466	Neurocutaneous syndrome with epilepsy	GO:0051345	positive regulation of hydrolase activity	2.175375657387235e-9	4.797791012367547e-5	9	900	14
OMIM:192500	Romano-Ward syndrome	GO:0015672	monovalent inorganic cation transport	1.4668266601347568e-12	3.235086198927206e-8	11	572	14
OMIM:192500	Romano-Ward syndrome	GO:1902495	transmembrane transporter complex	1.0298428776422952e-12	2.271318466640082e-8	10	308	14
OMIM:192500	Romano-Ward syndrome	GO:0060047	heart contraction	9.707790127322369e-13	2.1410531125809484e-8	12	253	14
OMIM:192500	Romano-Ward syndrome	GO:0008016	regulation of heart contraction	8.542055951465954e-13	1.8839504400958162e-8	12	224	14
OMIM:192500	Romano-Ward syndrome	GO:0003012	muscle system process	7.960299086562372e-13	1.7556439635413312e-8	11	393	14
OMIM:192500	Romano-Ward syndrome	GO:0042391	regulation of membrane potential	6.696865284538944e-13	1.4769936385050642e-8	10	340	14
OMIM:192500	Romano-Ward syndrome	GO:0022836	gated channel activity	6.212808045802376e-13	1.370234814501714e-8	9	335	14
OMIM:192500	Romano-Ward syndrome	GO:0034762	regulation of transmembrane transport	4.340972026284362e-13	9.57401380397016e-9	13	383	14
OMIM:192500	Romano-Ward syndrome	GO:0035637	multicellular organismal signaling	3.863576125695545e-13	8.521117145221524e-9	10	184	14
OMIM:192500	Romano-Ward syndrome	GO:1904064	positive regulation of cation transmembrane transport	1.2678746941219288e-13	2.796297637885914e-9	8	69	14
OMIM:192500	Romano-Ward syndrome	GO:0060306	regulation of membrane repolarization	1.0746958878371515e-13	2.3702417806248377e-9	10	29	14
OMIM:192500	Romano-Ward syndrome	GO:0086091	regulation of heart rate by cardiac conduction	9.50350909079134e-14	2.09599892997403e-9	8	30	14
OMIM:192500	Romano-Ward syndrome	GO:0086003	cardiac muscle cell contraction	9.037215420448774e-14	1.993157860979977e-9	9	48	14
OMIM:192500	Romano-Ward syndrome	GO:0086004	regulation of cardiac muscle cell contraction	8.415490526658687e-14	1.8560364356545733e-9	9	47	14
OMIM:192500	Romano-Ward syndrome	GO:0086005	ventricular cardiac muscle cell action potential	6.350475700855895e-14	1.4005974158237677e-9	8	24	14
OMIM:192500	Romano-Ward syndrome	GO:0032409	regulation of transporter activity	5.573319583618286e-14	1.229195634167013e-9	8	193	14
OMIM:192500	Romano-Ward syndrome	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	3.9745984281580604e-14	8.765976833302602e-10	10	17	14
OMIM:192500	Romano-Ward syndrome	GO:0034703	cation channel complex	2.1094237467877974e-14	4.652334073540487e-10	10	166	14
OMIM:192500	Romano-Ward syndrome	GO:0034705	potassium channel complex	8.215650382226158e-15	1.8119616917999792e-10	8	90	14
OMIM:192500	Romano-Ward syndrome	GO:0008076	voltage-gated potassium channel complex	3.452793606584237e-14	7.615136299321534e-10	8	89	14
OMIM:192500	Romano-Ward syndrome	GO:1901379	regulation of potassium ion transmembrane transport	4.9404924595819466e-14	1.0896256119607983e-9	7	60	14
OMIM:192500	Romano-Ward syndrome	GO:0044325	ion channel binding	1.432187701766452e-13	3.1586899762459097e-9	10	109	14
OMIM:192500	Romano-Ward syndrome	GO:0098915	membrane repolarization during ventricular cardiac muscle cell action potential	1.965094753586527e-13	4.3340164790350855e-9	4	4	14
OMIM:192500	Romano-Ward syndrome	GO:1902282	voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	1.965094753586527e-13	4.3340164790350855e-9	4	4	14
OMIM:192500	Romano-Ward syndrome	GO:0022898	regulation of transmembrane transporter activity	2.433608869978343e-13	5.367324362737236e-9	8	178	14
OMIM:192500	Romano-Ward syndrome	GO:0032412	regulation of ion transmembrane transporter activity	4.658495811327157e-13	1.0274312511882044e-8	8	174	14
OMIM:192500	Romano-Ward syndrome	GO:0086065	cell communication involved in cardiac conduction	5.268008251846368e-13	1.1618592199447164e-8	6	48	14
OMIM:192500	Romano-Ward syndrome	GO:0050998	nitric-oxide synthase binding	1.2225775947172224e-12	2.696394885148834e-8	5	19	14
OMIM:192500	Romano-Ward syndrome	GO:1904063	negative regulation of cation transmembrane transport	1.5060175329040248e-12	3.321521668819827e-8	6	55	14
OMIM:192500	Romano-Ward syndrome	GO:1901381	positive regulation of potassium ion transmembrane transport	6.8480776604928906e-12	1.510343528021707e-7	5	26	14
OMIM:192500	Romano-Ward syndrome	GO:1901016	regulation of potassium ion transmembrane transporter activity	6.03002092702809e-11	1.3299211154560453e-6	5	39	14
OMIM:192500	Romano-Ward syndrome	GO:0071435	potassium ion export	9.755185548243617e-11	2.1515061726651297e-6	4	12	14
OMIM:192500	Romano-Ward syndrome	GO:0086010	membrane depolarization during action potential	1.1334677640917334e-10	2.499863153704318e-6	5	44	14
OMIM:192500	Romano-Ward syndrome	GO:0016247	channel regulator activity	2.5239943468591264e-10	5.566669531997803e-6	6	127	14
OMIM:192500	Romano-Ward syndrome	GO:0032413	negative regulation of ion transmembrane transporter activity	2.700906165387096e-10	5.95684854776124e-6	5	52	14
OMIM:192500	Romano-Ward syndrome	GO:0086012	membrane depolarization during cardiac muscle cell action potential	6.014346798366432e-10	1.3264641863797166e-5	4	18	14
OMIM:192500	Romano-Ward syndrome	GO:0032414	positive regulation of ion transmembrane transporter activity	8.541770624148626e-10	1.8838875111559794e-5	5	65	14
OMIM:192500	Romano-Ward syndrome	GO:1901380	negative regulation of potassium ion transmembrane transport	9.515004339988309e-10	2.0985342071844215e-5	4	20	14
OMIM:192500	Romano-Ward syndrome	GO:1901019	regulation of calcium ion transmembrane transporter activity	1.2489613787636245e-9	2.7545843208631737e-5	5	70	14
OMIM:192500	Romano-Ward syndrome	GO:0086019	cell-cell signaling involved in cardiac conduction	1.7368397831063476e-9	3.8306001416410496e-5	4	23	14
OMIM:192500	Romano-Ward syndrome	GO:0030017	sarcomere	2.0802197742142425e-9	4.587924712029512e-5	6	180	14
OMIM:192500	Romano-Ward syndrome	GO:2001257	regulation of cation channel activity	3.3647038488737735e-9	7.420854338691107e-5	5	85	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0005777	peroxisome	1.3167245072054357e-13	2.9040359006415883e-9	14	127	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0065002	intracellular protein transmembrane transport	8.415490526658687e-14	1.8560364356545733e-9	12	47	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0043574	peroxisomal transport	5.639932965095795e-14	1.2438872154518776e-9	12	18	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0006625	protein targeting to peroxisome	3.9745984281580604e-14	8.765976833302602e-10	12	17	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0044438	microbody part	8.881784197001252e-15	1.9588775046486262e-10	14	90	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0044439	peroxisomal part	8.881784197001252e-15	1.9588775046486262e-10	14	90	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0031231	intrinsic component of peroxisomal membrane	5.551115123125783e-15	1.2242984404053914e-10	7	14	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0005779	integral component of peroxisomal membrane	5.551115123125783e-15	1.2242984404053914e-10	7	14	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0045046	protein import into peroxisome membrane	1.7763568394002505e-15	3.9177550092972524e-11	5	6	14
OMIM:214100	Peroxisome Biogenesis Disorder 1A (Zellweger)	GO:0016558	protein import into peroxisome matrix	1.9095836023552692e-14	4.2115866349945463e-10	10	13	14
MESH:D011618	Psychotic Disorders	GO:0043005	neuron projection	3.216430455310615e-9	7.093837369187561e-5	9	941	14
MESH:D013923	Thromboembolism	GO:0006465	signal peptide processing	4.405031894805234e-12	9.715297843992943e-8	5	24	14
MESH:D013923	Thromboembolism	GO:0072378	blood coagulation, fibrin clot formation	6.8480776604928906e-12	1.510343528021707e-7	5	26	14
MESH:D013923	Thromboembolism	GO:1900046	regulation of hemostasis	2.1657342585967854e-11	4.77652690733521e-7	6	85	14
MESH:D013923	Thromboembolism	GO:0030193	regulation of blood coagulation	2.1657342585967854e-11	4.77652690733521e-7	6	85	14
MESH:D013923	Thromboembolism	GO:0018214	protein carboxylation	6.506806204953364e-11	1.4350761085024644e-6	4	11	14
MESH:D013923	Thromboembolism	GO:0017187	peptidyl-glutamic acid carboxylation	6.506806204953364e-11	1.4350761085024644e-6	4	11	14
MESH:D013923	Thromboembolism	GO:0007597	blood coagulation, intrinsic pathway	7.615599262322803e-10	1.6796204173052942e-5	4	19	14
MESH:D013923	Thromboembolism	GO:0006888	ER to Golgi vesicle-mediated transport	1.3730223624719429e-9	3.02820082043187e-5	6	168	14
MESH:D013923	Thromboembolism	GO:0050900	leukocyte migration	2.541689747559417e-9	5.605696738242294e-5	7	354	14
MESH:D001919	Bradycardia	GO:0008015	blood circulation	1.4437340212225536e-12	3.184155383806342e-8	10	489	14
MESH:D001919	Bradycardia	GO:0035813	regulation of renal sodium excretion	4.405031894805234e-12	9.715297843992943e-8	5	24	14
MESH:D001919	Bradycardia	GO:0008217	regulation of blood pressure	1.3909318141713811e-11	3.067700116154981e-7	7	168	14
MESH:D001919	Bradycardia	GO:0007268	synaptic transmission	6.429912158267825e-11	1.4181171265059689e-6	9	605	14
MESH:D001919	Bradycardia	GO:0046883	regulation of hormone secretion	2.37781794254488e-10	5.244277472282732e-6	7	252	14
MESH:D001919	Bradycardia	GO:0050804	modulation of synaptic transmission	5.626691335081091e-10	1.2409667739521346e-5	7	285	14
MESH:D001919	Bradycardia	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	1.0767192692995309e-9	2.3747043484401154e-5	5	68	14
MESH:D001919	Bradycardia	GO:0045187	regulation of circadian sleep/wake cycle, sleep	1.7368397831063476e-9	3.8306001416410496e-5	4	23	14
MESH:D001919	Bradycardia	GO:2000852	regulation of corticosterone secretion	3.353013089402168e-9	7.395070368676482e-5	3	5	14
DOID:3650	lactic acidosis	GO:0005759	mitochondrial matrix	2.0614621121239907e-12	4.5465546882894614e-8	9	412	14
DOID:3650	lactic acidosis	GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate	9.755185548243617e-11	2.1515061726651297e-6	4	12	14
Orphanet:168491	Late infantile neuronal ceroid lipofuscinosis	GO:0007040	lysosome organization	8.61866134016509e-13	1.9008457585734106e-8	6	51	14
Orphanet:168491	Late infantile neuronal ceroid lipofuscinosis	GO:0007042	lysosomal lumen acidification	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:264719	Secondary interstitial lung disease specific to childhood associated with a metabolic disease	GO:0000323	lytic vacuole	8.270811813204659e-10	1.8241275454022876e-5	8	515	14
Orphanet:264719	Secondary interstitial lung disease specific to childhood associated with a metabolic disease	GO:0005764	lysosome	8.270811813204659e-10	1.8241275454022876e-5	8	515	14
Orphanet:93925	Alobar holoprosencephaly	GO:0009952	anterior/posterior pattern specification	6.779021788361206e-13	1.495113255423064e-8	9	199	14
Orphanet:93925	Alobar holoprosencephaly	GO:0009790	embryo development	2.3514523661560816e-13	5.186128193557238e-9	11	932	14
Orphanet:93925	Alobar holoprosencephaly	GO:0009880	embryonic pattern specification	1.911915070706982e-12	4.216728688444249e-8	6	57	14
Orphanet:93925	Alobar holoprosencephaly	GO:0045165	cell fate commitment	1.9675372442407024e-12	4.339403392172869e-8	8	243	14
Orphanet:93925	Alobar holoprosencephaly	GO:0001708	cell fate specification	1.6282530879152546e-11	3.591112185397094e-7	6	81	14
Orphanet:93925	Alobar holoprosencephaly	GO:0009798	axis specification	3.082478716720516e-11	6.798406809727098e-7	6	90	14
Orphanet:93925	Alobar holoprosencephaly	GO:0048598	embryonic morphogenesis	3.683475746640852e-11	8.123905759216399e-7	9	560	14
Orphanet:93925	Alobar holoprosencephaly	GO:0009953	dorsal/ventral pattern formation	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
Orphanet:93925	Alobar holoprosencephaly	GO:0048729	tissue morphogenesis	1.0026990349132348e-10	2.2114527215011393e-6	9	635	14
Orphanet:93925	Alobar holoprosencephaly	GO:0007368	determination of left/right symmetry	1.1803835686663433e-10	2.60333596069362e-6	6	112	14
Orphanet:93925	Alobar holoprosencephaly	GO:0048568	embryonic organ development	1.3024481493317808e-10	2.8725493933512425e-6	8	408	14
Orphanet:93925	Alobar holoprosencephaly	GO:0007224	smoothened signaling pathway	1.5388346152889198e-10	3.3938997440197127e-6	6	117	14
Orphanet:93925	Alobar holoprosencephaly	GO:0007420	brain development	1.5826850940925397e-10	3.4906119750210962e-6	9	669	14
Orphanet:93925	Alobar holoprosencephaly	GO:0001947	heart looping	4.753153426406698e-10	1.0483079881939972e-5	5	58	14
Orphanet:93925	Alobar holoprosencephaly	GO:0008589	regulation of smoothened signaling pathway	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
Orphanet:93925	Alobar holoprosencephaly	GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:93925	Alobar holoprosencephaly	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0009952	anterior/posterior pattern specification	6.779021788361206e-13	1.495113255423064e-8	9	199	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0009790	embryo development	2.3514523661560816e-13	5.186128193557238e-9	11	932	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0009880	embryonic pattern specification	1.911915070706982e-12	4.216728688444249e-8	6	57	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0045165	cell fate commitment	1.9675372442407024e-12	4.339403392172869e-8	8	243	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0001708	cell fate specification	1.6282530879152546e-11	3.591112185397094e-7	6	81	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0009798	axis specification	3.082478716720516e-11	6.798406809727098e-7	6	90	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0048598	embryonic morphogenesis	3.683475746640852e-11	8.123905759216399e-7	9	560	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0009953	dorsal/ventral pattern formation	5.536426872509992e-11	1.2210589467320787e-6	6	99	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0048729	tissue morphogenesis	1.0026990349132348e-10	2.2114527215011393e-6	9	635	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0007368	determination of left/right symmetry	1.1803835686663433e-10	2.60333596069362e-6	6	112	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0048568	embryonic organ development	1.3024481493317808e-10	2.8725493933512425e-6	8	408	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0007224	smoothened signaling pathway	1.5388346152889198e-10	3.3938997440197127e-6	6	117	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0007420	brain development	1.5826850940925397e-10	3.4906119750210962e-6	9	669	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0001947	heart looping	4.753153426406698e-10	1.0483079881939972e-5	5	58	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0008589	regulation of smoothened signaling pathway	6.701049715118756e-10	1.4779165146694417e-5	5	62	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
Orphanet:93926	Midline interhemispheric variant of holoprosencephaly	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	3.353013089402168e-9	7.395070368676482e-5	3	5	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0043255	regulation of carbohydrate biosynthetic process	2.507394292194931e-11	5.53005811143592e-7	6	87	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0006112	energy reserve metabolic process	2.882249994229369e-11	6.356802362272873e-7	6	89	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0006006	glucose metabolic process	4.4610759530883115e-11	9.83890301453627e-7	7	199	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0033500	carbohydrate homeostasis	7.05919767085561e-11	1.5569060463072049e-6	7	212	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0042593	glucose homeostasis	7.05919767085561e-11	1.5569060463072049e-6	7	212	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0010906	regulation of glucose metabolic process	7.95535859410279e-11	1.7545543379293704e-6	6	105	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0030072	peptide hormone secretion	1.7442292055136477e-10	3.84689751276035e-6	7	241	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0071417	cellular response to organonitrogen compound	3.5031066936141997e-10	7.726101812766117e-6	8	462	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0009725	response to hormone	1.5298032840505016e-9	3.373981142973381e-5	9	865	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0090276	regulation of peptide hormone secretion	3.8017414771829294e-9	8.384740827926951e-5	6	199	14
OMIM:601820	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	GO:0030073	insulin secretion	3.8017414771829294e-9	8.384740827926951e-5	6	199	14
DOID:0050451	Brugada syndrome	GO:0060047	heart contraction	1.0154099783221682e-12	2.239486707189542e-8	12	253	15
DOID:0050451	Brugada syndrome	GO:0022836	gated channel activity	8.688605390716475e-13	1.9162719189225186e-8	12	335	15
DOID:0050451	Brugada syndrome	GO:0042391	regulation of membrane potential	7.778222510523847e-13	1.7154869746960344e-8	12	340	15
DOID:0050451	Brugada syndrome	GO:0003012	muscle system process	7.103206911551752e-13	1.5666122843427388e-8	12	393	15
DOID:0050451	Brugada syndrome	GO:0008016	regulation of heart contraction	6.02629057766535e-13	1.3290983869040929e-8	12	224	15
DOID:0050451	Brugada syndrome	GO:1902495	transmembrane transporter complex	5.262457136723242e-13	1.160634921504311e-8	10	308	15
DOID:0050451	Brugada syndrome	GO:0034762	regulation of transmembrane transport	3.701483564100272e-13	8.16362200062315e-9	11	383	15
DOID:0050451	Brugada syndrome	GO:0035637	multicellular organismal signaling	2.5646151868841116e-13	5.656258794672908e-9	10	184	15
DOID:0050451	Brugada syndrome	GO:0022832	voltage-gated channel activity	2.1160850849355484e-13	4.667025654825352e-9	11	189	15
DOID:0050451	Brugada syndrome	GO:0005244	voltage-gated ion channel activity	2.1160850849355484e-13	4.667025654825352e-9	11	189	15
DOID:0050451	Brugada syndrome	GO:0046873	metal ion transmembrane transporter activity	2.0938806244430452e-13	4.618053717209136e-9	12	415	15
DOID:0050451	Brugada syndrome	GO:0090257	regulation of muscle system process	1.2723155862204294e-13	2.806092025409157e-9	10	213	15
DOID:0050451	Brugada syndrome	GO:0086004	regulation of cardiac muscle cell contraction	1.170175067954915e-13	2.580821112374565e-9	8	47	15
DOID:0050451	Brugada syndrome	GO:0005261	cation channel activity	1.1390888232654106e-13	2.512260399711863e-9	12	298	15
DOID:0050451	Brugada syndrome	GO:0043269	regulation of ion transport	9.08162434143378e-14	2.0029522485032203e-9	12	583	15
DOID:0050451	Brugada syndrome	GO:0086065	cell communication involved in cardiac conduction	4.3076653355456074e-14	9.500555897545837e-10	8	48	15
DOID:0050451	Brugada syndrome	GO:0098662	inorganic cation transmembrane transport	1.2434497875801753e-14	2.7424285065080767e-10	13	575	15
DOID:0050451	Brugada syndrome	GO:0003254	regulation of membrane depolarization	9.348077867343818e-14	2.061718573642679e-9	7	41	15
DOID:0050451	Brugada syndrome	GO:0042383	sarcolemma	1.0935696792557792e-13	2.411867927598621e-9	8	125	15
DOID:0050451	Brugada syndrome	GO:0005272	sodium channel activity	2.4868995751603507e-13	5.484857013016153e-9	6	37	15
DOID:0050451	Brugada syndrome	GO:0034765	regulation of ion transmembrane transport	2.8121949213755215e-13	6.202295899093713e-9	11	367	15
DOID:0050451	Brugada syndrome	GO:0015672	monovalent inorganic cation transport	2.942091015256665e-13	6.488781734148574e-9	10	572	15
DOID:0050451	Brugada syndrome	GO:0098797	plasma membrane protein complex	1.0200729150255938e-12	2.2497708140889472e-8	10	499	15
DOID:0050451	Brugada syndrome	GO:0035725	sodium ion transmembrane transport	3.3114622155494544e-12	7.303429916394322e-8	7	126	15
DOID:0050451	Brugada syndrome	GO:1904062	regulation of cation transmembrane transport	2.2576718272659946e-11	4.979295215035151e-7	7	165	15
DOID:0050451	Brugada syndrome	GO:0010959	regulation of metal ion transport	4.2718384385409536e-11	9.421539676202073e-7	8	321	15
DOID:0050451	Brugada syndrome	GO:0086009	membrane repolarization	5.908562528134098e-11	1.3031334655799753e-6	5	36	15
DOID:0050451	Brugada syndrome	GO:0044325	ion channel binding	1.6543144631953055e-10	3.6485905485772463e-6	6	109	15
DOID:0050451	Brugada syndrome	GO:0030315	T-tubule	1.907084490326838e-10	4.206074843415841e-6	5	45	15
DOID:0050451	Brugada syndrome	GO:0043270	positive regulation of ion transport	2.5485391574875393e-10	5.620803111838768e-6	7	233	15
DOID:0050451	Brugada syndrome	GO:0086014	atrial cardiac muscle cell action potential	2.686599831491776e-10	5.925295928355112e-6	4	14	15
DOID:0050451	Brugada syndrome	GO:0086045	membrane depolarization during AV node cell action potential	1.6771865007925157e-9	3.6990348274978935e-5	3	4	15
DOID:0050451	Brugada syndrome	GO:0032412	regulation of ion transmembrane transporter activity	2.8052741241069157e-9	6.187032080717803e-5	6	174	15
DOID:0050451	Brugada syndrome	GO:0086005	ventricular cardiac muscle cell action potential	2.8384019579164033e-9	6.260095518184627e-5	4	24	15
DOID:0050451	Brugada syndrome	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	4.190931046643698e-9	9.243098423372675e-5	3	5	15
MESH:D029242	Optic Atrophy, Hereditary, Leber	GO:0070469	respiratory chain	4.696243394164412e-14	1.035756480582961e-9	9	90	15
MESH:D029242	Optic Atrophy, Hereditary, Leber	GO:0042773	ATP synthesis coupled electron transport	5.384581669432009e-14	1.1875694871932296e-9	9	89	15
MESH:D029242	Optic Atrophy, Hereditary, Leber	GO:0098798	mitochondrial protein complex	4.1533443351227106e-13	9.160200931113138e-9	8	144	15
DOID:750	peptic ulcer disease	GO:0031622	positive regulation of fever generation	5.6481042065570364e-11	1.2456893827561544e-6	4	10	15
DOID:750	peptic ulcer disease	GO:0030728	ovulation	1.9558550334863867e-9	4.313638276354226e-5	4	22	15
DOID:750	peptic ulcer disease	GO:0032496	response to lipopolysaccharide	2.2793948950550202e-9	5.027205441043847e-5	7	319	15
OMIM:187500	tetralogy of Fallot	GO:0072358	cardiovascular system development	1.8991475059237928e-12	4.188569824314925e-8	14	910	15
OMIM:187500	tetralogy of Fallot	GO:0009790	embryo development	1.8967050152696174e-12	4.183182911177141e-8	12	932	15
OMIM:187500	tetralogy of Fallot	GO:0060537	muscle tissue development	1.4364065492600275e-12	3.167994644392991e-8	10	336	15
OMIM:187500	tetralogy of Fallot	GO:0001568	blood vessel development	7.87148124459236e-13	1.736055188494845e-8	11	569	15
OMIM:187500	tetralogy of Fallot	GO:0003007	heart morphogenesis	4.496403249731884e-13	9.91681736728367e-9	12	216	15
OMIM:187500	tetralogy of Fallot	GO:0035295	tube development	2.8377300509419e-13	6.258613627352361e-9	14	573	15
OMIM:187500	tetralogy of Fallot	GO:0048844	artery morphogenesis	7.216449660063518e-14	1.5915879725270088e-9	7	51	15
OMIM:187500	tetralogy of Fallot	GO:0003215	cardiac right ventricle morphogenesis	3.4638958368304884e-14	7.639622268129642e-10	6	16	15
OMIM:187500	tetralogy of Fallot	GO:0060411	cardiac septum morphogenesis	7.105427357601002e-15	1.567102003718901e-10	8	49	15
OMIM:187500	tetralogy of Fallot	GO:0003151	outflow tract morphogenesis	8.704148513061227e-14	1.9196999545556537e-9	11	59	15
OMIM:187500	tetralogy of Fallot	GO:0035050	embryonic heart tube development	1.7053025658242404e-13	3.761044808925362e-9	9	74	15
OMIM:187500	tetralogy of Fallot	GO:0048738	cardiac muscle tissue development	2.405853294362714e-13	5.306109440716966e-9	9	168	15
OMIM:187500	tetralogy of Fallot	GO:0060485	mesenchyme development	5.340172748447003e-13	1.1777750996699865e-8	10	237	15
OMIM:187500	tetralogy of Fallot	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.950795411990839e-13	1.3124479281145796e-8	12	996	15
OMIM:187500	tetralogy of Fallot	GO:0003278	apoptotic process involved in heart morphogenesis	1.344591105123527e-12	2.965495682349939e-8	4	5	15
OMIM:187500	tetralogy of Fallot	GO:0061061	muscle structure development	3.192335285007175e-12	7.040695471083325e-8	10	551	15
OMIM:187500	tetralogy of Fallot	GO:0060415	muscle tissue morphogenesis	6.196487767340386e-12	1.3666353770869222e-7	6	64	15
OMIM:187500	tetralogy of Fallot	GO:0048863	stem cell differentiation	1.018141126962746e-11	2.2455102555163364e-7	8	266	15
OMIM:187500	tetralogy of Fallot	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	3.832867356834413e-11	8.453388955498298e-7	8	317	15
OMIM:187500	tetralogy of Fallot	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	5.1238124854080525e-11	1.130056843656746e-6	6	90	15
OMIM:187500	tetralogy of Fallot	GO:0048598	embryonic morphogenesis	8.250367056206187e-11	1.8196184542462746e-6	9	560	15
OMIM:187500	tetralogy of Fallot	GO:0055010	ventricular cardiac muscle tissue morphogenesis	9.021616786952791e-11	1.989717582362438e-6	5	39	15
OMIM:187500	tetralogy of Fallot	GO:0071363	cellular response to growth factor stimulus	1.3213430349878763e-10	2.914222063665761e-6	9	594	15
OMIM:187500	tetralogy of Fallot	GO:0035051	cardiocyte differentiation	1.4779222290428606e-10	3.259557476154029e-6	6	107	15
OMIM:187500	tetralogy of Fallot	GO:0007368	determination of left/right symmetry	1.9554169394808696e-10	4.312672060025058e-6	6	112	15
OMIM:187500	tetralogy of Fallot	GO:0003148	outflow tract septum morphogenesis	2.686599831491776e-10	5.925295928355112e-6	4	14	15
OMIM:187500	tetralogy of Fallot	GO:0001525	angiogenesis	3.0136526607549285e-10	6.646610943294995e-6	8	413	15
OMIM:187500	tetralogy of Fallot	GO:0045165	cell fate commitment	3.4135894111386733e-10	7.528671446266344e-6	7	243	15
OMIM:187500	tetralogy of Fallot	GO:0007498	mesoderm development	3.4486424826951634e-10	7.605980995584183e-6	6	123	15
OMIM:187500	tetralogy of Fallot	GO:0003281	ventricular septum development	4.918624396665905e-10	1.0848026106846653e-5	5	54	15
OMIM:187500	tetralogy of Fallot	GO:0055017	cardiac muscle tissue growth	6.50145492997467e-10	1.4338958848059136e-5	5	57	15
OMIM:187500	tetralogy of Fallot	GO:0014032	neural crest cell development	1.492724388540978e-9	3.292203638927127e-5	5	67	15
OMIM:187500	tetralogy of Fallot	GO:0008134	transcription factor binding	1.8058323725256287e-9	3.982763297605274e-5	8	518	15
OMIM:187500	tetralogy of Fallot	GO:0003002	regionalization	2.7053830287115943e-9	5.966722269823421e-5	7	327	15
OMIM:187500	tetralogy of Fallot	GO:0043009	chordate embryonic development	2.976592528014521e-9	6.564874820536026e-5	8	552	15
OMIM:187500	tetralogy of Fallot	GO:0035239	tube morphogenesis	3.4017941796804507e-9	7.502657063285234e-5	7	338	15
OMIM:187500	tetralogy of Fallot	GO:0060548	negative regulation of cell death	3.747948951193791e-9	8.266101411857907e-5	9	867	15
OMIM:187500	tetralogy of Fallot	GO:0051891	positive regulation of cardioblast differentiation	4.190931046643698e-9	9.243098423372675e-5	3	5	15
OMIM:109650	Behcet's disease	GO:0050900	leukocyte migration	8.850242760871652e-11	1.9519210409102428e-6	8	354	15
DOID:13714	anodontia	GO:0048732	gland development	8.232636794502923e-12	1.8157080450276197e-7	9	421	15
DOID:13714	anodontia	GO:0048863	stem cell differentiation	1.018141126962746e-11	2.2455102555163364e-7	8	266	15
DOID:13714	anodontia	GO:0042475	odontogenesis of dentin-containing tooth	2.694244827239345e-11	5.942156966476375e-7	6	81	15
DOID:13714	anodontia	GO:0008544	epidermis development	1.3537266863039576e-9	2.9856442066433786e-5	7	296	15
DOID:13714	anodontia	GO:0003002	regionalization	2.7053830287115943e-9	5.966722269823421e-5	7	327	15
DOID:13714	anodontia	GO:0048762	mesenchymal cell differentiation	3.924626845730472e-9	8.655764508258557e-5	6	184	15
DOID:8677	perinatal necrotizing enterocolitis	GO:0044282	small molecule catabolic process	5.844214001626824e-13	1.288941398058796e-8	10	345	15
DOID:8677	perinatal necrotizing enterocolitis	GO:0046395	carboxylic acid catabolic process	1.6425405480191557e-10	3.622623178656248e-6	7	219	15
DOID:8677	perinatal necrotizing enterocolitis	GO:0051167	xylulose 5-phosphate metabolic process	4.190931046643698e-9	9.243098423372675e-5	3	5	15
DOID:8677	perinatal necrotizing enterocolitis	GO:1901159	xylulose 5-phosphate biosynthetic process	4.190931046643698e-9	9.243098423372675e-5	3	5	15
DOID:8677	perinatal necrotizing enterocolitis	GO:0006064	glucuronate catabolic process	4.190931046643698e-9	9.243098423372675e-5	3	5	15
DOID:8677	perinatal necrotizing enterocolitis	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	4.190931046643698e-9	9.243098423372675e-5	3	5	15
MESH:D019190	Iron Overload	GO:0006875	cellular metal ion homeostasis	1.0376144388146713e-12	2.2884586448057576e-8	10	450	15
MESH:D019190	Iron Overload	GO:1990712	HFE-transferrin receptor complex	1.8829826586852505e-11	4.15291825373032e-7	4	8	15
MESH:D019190	Iron Overload	GO:0097460	ferrous iron import into cell	1.6771865007925157e-9	3.6990348274978935e-5	3	4	15
OMIM:227650	Fanconi Anemia, Complementation Group a	GO:0006259	DNA metabolic process	1.2565504192707522e-12	2.771321949701644e-8	13	937	15
OMIM:227650	Fanconi Anemia, Complementation Group a	GO:0043240	Fanconi anaemia nuclear complex	2.3314683517128287e-15	5.142053449702644e-11	8	14	15
OMIM:227650	Fanconi Anemia, Complementation Group a	GO:0036297	interstrand cross-link repair	6.661338147750939e-15	1.4691581284864696e-10	10	45	15
Orphanet:275749	Beta-thalassemia and related diseases	GO:0050878	regulation of body fluid levels	1.454957931912304e-9	3.2089097188325866e-5	8	504	15
Orphanet:275749	Beta-thalassemia and related diseases	GO:0005506	iron ion binding	1.75727687956595e-9	3.8756741578827025e-5	6	161	15
Orphanet:79298	Diazoxide-resistant focal hyperinsulinism	GO:0010243	response to organonitrogen compound	3.9125480633117604e-11	8.629124753634088e-7	10	780	15
Orphanet:79298	Diazoxide-resistant focal hyperinsulinism	GO:0043434	response to peptide hormone	1.8679491287088013e-10	4.119761803367261e-6	8	389	15
Orphanet:79298	Diazoxide-resistant focal hyperinsulinism	GO:0050796	regulation of insulin secretion	2.3541422145001434e-9	5.192060654080066e-5	6	169	15
Orphanet:165988	Diazoxide-resistant diffuse hyperinsulinism	GO:0010243	response to organonitrogen compound	3.9125480633117604e-11	8.629124753634088e-7	10	780	15
Orphanet:165988	Diazoxide-resistant diffuse hyperinsulinism	GO:0043434	response to peptide hormone	1.8679491287088013e-10	4.119761803367261e-6	8	389	15
Orphanet:165988	Diazoxide-resistant diffuse hyperinsulinism	GO:0050796	regulation of insulin secretion	2.3541422145001434e-9	5.192060654080066e-5	6	169	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0044449	contractile fiber part	7.776002064474596e-13	1.7149972553198722e-8	11	196	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0030016	myofibril	5.442313266712517e-13	1.2003021909734457e-8	11	201	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0055002	striated muscle cell development	9.769962616701378e-15	2.1547652551134888e-10	8	127	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0048747	muscle fiber development	1.2702061624736416e-12	2.8014396913356165e-8	6	50	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0048741	skeletal muscle fiber development	1.8565038395479405e-11	4.094519218122983e-7	5	29	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0015629	actin cytoskeleton	5.060444285831522e-10	1.1160809872401423e-5	8	441	15
Orphanet:209059	Qualitative or quantitative defects of alpha-actin	GO:0005865	striated muscle thin filament	1.2966546725223793e-9	2.8597718802481076e-5	4	20	15
DOID:2559	opiate dependence	GO:0007268	synaptic transmission	3.215538946221841e-12	7.09187114589227e-8	10	605	15
DOID:2559	opiate dependence	GO:0044057	regulation of system process	3.397848669095538e-11	7.493955239690209e-7	9	508	15
DOID:2559	opiate dependence	GO:1900273	positive regulation of long-term synaptic potentiation	2.686599831491776e-10	5.925295928355112e-6	4	14	15
DOID:2559	opiate dependence	GO:0023061	signal release	3.192566211396297e-10	7.041204779234533e-6	8	416	15
DOID:2559	opiate dependence	GO:0051046	regulation of secretion	4.1259984318031684e-10	9.099889541341888e-6	9	675	15
DOID:2559	opiate dependence	GO:0046883	regulation of hormone secretion	4.4033499069229265e-10	9.711588219718514e-6	7	252	15
DOID:2559	opiate dependence	GO:0045471	response to ethanol	6.627730586572511e-10	1.4617459808685673e-5	6	137	15
DOID:2559	opiate dependence	GO:0008217	regulation of blood pressure	2.271268728648579e-9	5.009283181034441e-5	6	168	15
DOID:2559	opiate dependence	GO:0048511	rhythmic process	2.822441169669787e-9	6.224893999706715e-5	7	329	15
Orphanet:309279	Glycoproteinosis	GO:0005773	vacuole	1.6300294447546548e-12	3.595029940406391e-8	13	603	15
Orphanet:309279	Glycoproteinosis	GO:0044437	vacuolar part	5.975220318532593e-13	1.3178348412523633e-8	11	396	15
Orphanet:309279	Glycoproteinosis	GO:0009313	oligosaccharide catabolic process	1.2956302697375577e-13	2.8575125599061835e-9	5	12	15
Orphanet:309279	Glycoproteinosis	GO:0019377	glycolipid catabolic process	3.191891195797325e-13	7.039716032331e-9	5	14	15
Orphanet:309279	Glycoproteinosis	GO:0015929	hexosaminidase activity	3.6619973720064536e-10	8.076535203960233e-6	4	15	15
DOID:7998	hyperthyroidism	GO:0016209	antioxidant activity	1.6105222711004785e-9	3.5520068689121054e-5	5	68	15
DOID:7998	hyperthyroidism	GO:0098869	cellular oxidant detoxification	3.4649609848003138e-9	7.641971451977092e-5	5	79	15
Orphanet:98369	Rare constitutional hemolytic anemia due to an enzyme disorder	GO:0046128	purine ribonucleoside metabolic process	9.072742557236779e-13	2.0009933709985717e-8	10	342	15
Orphanet:98369	Rare constitutional hemolytic anemia due to an enzyme disorder	GO:0061615	glycolytic process through fructose-6-phosphate	1.092459456231154e-13	2.4094193307178102e-9	7	27	15
Orphanet:98369	Rare constitutional hemolytic anemia due to an enzyme disorder	GO:0061620	glycolytic process through glucose-6-phosphate	1.092459456231154e-13	2.4094193307178102e-9	7	27	15
DOID:5773	oral submucous fibrosis	GO:0032963	collagen metabolic process	1.4191980923783376e-12	3.1300413927404236e-8	7	109	15
DOID:5773	oral submucous fibrosis	GO:0030198	extracellular matrix organization	1.8923751454735793e-12	4.173633383341979e-8	11	320	15
DOID:5773	oral submucous fibrosis	GO:0031012	extracellular matrix	6.389222484415313e-12	1.4091430189377974e-7	9	423	15
DOID:5773	oral submucous fibrosis	GO:0030574	collagen catabolic process	8.328004952318224e-12	1.8367414922337844e-7	6	67	15
DOID:5773	oral submucous fibrosis	GO:0022617	extracellular matrix disassembly	3.6022629323895217e-11	7.94479089738509e-7	6	85	15
DOID:5773	oral submucous fibrosis	GO:0005578	proteinaceous extracellular matrix	8.850242760871652e-11	1.9519210409102428e-6	8	354	15
Orphanet:98913	Postsynaptic congenital myasthenic syndromes	GO:0007528	neuromuscular junction development	1.0302891872981945e-10	2.272302802586168e-6	5	40	15
Orphanet:98913	Postsynaptic congenital myasthenic syndromes	GO:0097060	synaptic membrane	4.9225645781803e-10	1.085671617717665e-5	7	256	15
DOID:12558	chronic progressive external ophthalmoplegia	GO:0000002	mitochondrial genome maintenance	8.43769498715119e-14	1.8609336294161949e-9	6	27	15
DOID:12554	hemolytic-uremic syndrome	GO:0002673	regulation of acute inflammatory response	1.7075230118734908e-13	3.765942002686984e-9	8	74	15
DOID:12554	hemolytic-uremic syndrome	GO:0006959	humoral immune response	6.694644838489694e-13	1.476503919128902e-8	8	173	15
DOID:12554	hemolytic-uremic syndrome	GO:0002920	regulation of humoral immune response	1.4279688542728763e-12	3.149385308098829e-8	6	51	15
DOID:12554	hemolytic-uremic syndrome	GO:0006956	complement activation	2.8942404028953206e-12	6.38324720858563e-8	6	56	15
DOID:12554	hemolytic-uremic syndrome	GO:0030449	regulation of complement activation	3.165490092271739e-11	6.98148839850532e-7	5	32	15
DOID:12554	hemolytic-uremic syndrome	GO:0072562	blood microparticle	2.1754376078320092e-10	4.797927644073496e-6	6	114	15
Orphanet:98648	Musculoskeletal disease with cataract	GO:0001501	skeletal system development	2.1807444738897175e-11	4.809631937163772e-7	9	482	15
DOID:1657	ventricular septal defect	GO:0003279	cardiac septum development	2.7189361873070084e-13	5.996613761105607e-9	7	84	15
DOID:1657	ventricular septal defect	GO:0003007	heart morphogenesis	1.241673430740775e-12	2.7385107514987794e-8	8	216	15
DOID:1657	ventricular septal defect	GO:0007368	determination of left/right symmetry	2.05568895239594e-12	4.5338219845092453e-8	7	112	15
DOID:1657	ventricular septal defect	GO:0003206	cardiac chamber morphogenesis	1.2426160100886818e-10	2.7405896102505878e-6	6	104	15
DOID:1657	ventricular septal defect	GO:0009790	embryo development	2.169535662233102e-10	4.784910903055106e-6	10	932	15
DOID:1657	ventricular septal defect	GO:0060411	cardiac septum morphogenesis	2.971024537501421e-10	6.552594617459384e-6	5	49	15
DOID:1657	ventricular septal defect	GO:0048565	digestive tract development	6.928506657288835e-10	1.5280821432650527e-5	6	138	15
DOID:1657	ventricular septal defect	GO:0003002	regionalization	2.7053830287115943e-9	5.966722269823421e-5	7	327	15
DOID:1657	ventricular septal defect	GO:0051891	positive regulation of cardioblast differentiation	4.190931046643698e-9	9.243098423372675e-5	3	5	15
Orphanet:1505	Short rib-polydactyly syndrome	GO:0044463	cell projection part	1.6373569167171809e-12	3.6111906798197424e-8	12	939	15
Orphanet:1505	Short rib-polydactyly syndrome	GO:0042073	intraciliary transport	8.43769498715119e-14	1.8609336294161949e-9	6	27	15
Orphanet:1505	Short rib-polydactyly syndrome	GO:0005815	microtubule organizing center	4.6838088962886104e-12	1.033014052076453e-7	10	617	15
Orphanet:1505	Short rib-polydactyly syndrome	GO:0042384	cilium assembly	4.8214987558026223e-11	1.0633815505922684e-6	7	184	15
Orphanet:1505	Short rib-polydactyly syndrome	GO:0036064	ciliary basal body	3.4649609848003138e-9	7.641971451977092e-5	5	79	15
Orphanet:666	Osteogenesis imperfecta	GO:0060348	bone development	3.038913565234225e-11	6.702323868124083e-7	7	172	15
Orphanet:768	Familial long QT syndrome	GO:0090257	regulation of muscle system process	1.2723155862204294e-13	2.806092025409157e-9	12	213	15
Orphanet:768	Familial long QT syndrome	GO:0098662	inorganic cation transmembrane transport	1.2434497875801753e-14	2.7424285065080767e-10	14	575	15
Orphanet:768	Familial long QT syndrome	GO:0030315	T-tubule	1.907084490326838e-10	4.206074843415841e-6	5	45	15
Orphanet:768	Familial long QT syndrome	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	8.196839873519934e-10	1.8078130341048215e-5	4	18	15
DOID:3388	periodontal disease	GO:0042056	chemoattractant activity	3.989691355066327e-9	8.799264283598784e-5	4	26	15
DOID:3262	phagocyte bactericidal dysfunction	GO:0072593	reactive oxygen species metabolic process	1.8647416943906592e-10	4.112687806978599e-6	7	223	15
DOID:3262	phagocyte bactericidal dysfunction	GO:1903409	reactive oxygen species biosynthetic process	4.455593338725805e-9	9.826811108559763e-5	5	83	15
DOID:1426	ureteral disease	GO:0035295	tube development	3.9893006675839615e-9	8.798402622356427e-5	8	573	15
DOID:1426	ureteral disease	GO:0034284	response to monosaccharide	4.465370295747562e-9	9.848374187271247e-5	6	188	15
DOID:1339	Diamond-Blackfan anemia	GO:0044265	cellular macromolecule catabolic process	1.8145485114473558e-12	4.001986741997143e-8	13	946	15
DOID:1339	Diamond-Blackfan anemia	GO:0044802	single-organism membrane organization	1.8118839761882555e-12	3.9961101094831974e-8	13	934	15
DOID:1339	Diamond-Blackfan anemia	GO:0043604	amide biosynthetic process	1.1284306822290091e-12	2.4887538696560796e-8	13	734	15
DOID:1339	Diamond-Blackfan anemia	GO:0072657	protein localization to membrane	1.0336176359260207e-12	2.2796436960348387e-8	13	475	15
DOID:1339	Diamond-Blackfan anemia	GO:0019439	aromatic compound catabolic process	9.330314298949816e-13	2.0578008186333818e-8	13	447	15
DOID:1339	Diamond-Blackfan anemia	GO:0042254	ribosome biogenesis	8.133493878403897e-13	1.7938420748819794e-8	14	306	15
DOID:1339	Diamond-Blackfan anemia	GO:0044764	multi-organism cellular process	7.533973445106312e-13	1.6616178433181972e-8	13	740	15
DOID:1339	Diamond-Blackfan anemia	GO:1901361	organic cyclic compound catabolic process	7.196465645620265e-13	1.5871804981415494e-8	13	477	15
DOID:1339	Diamond-Blackfan anemia	GO:0034655	nucleobase-containing compound catabolic process	7.103206911551752e-13	1.5666122843427388e-8	13	393	15
DOID:1339	Diamond-Blackfan anemia	GO:0005840	ribosome	6.45705711121991e-13	1.4241039458795512e-8	13	219	15
DOID:1339	Diamond-Blackfan anemia	GO:0044033	multi-organism metabolic process	5.442313266712517e-13	1.2003021909734457e-8	13	201	15
DOID:1339	Diamond-Blackfan anemia	GO:0006364	rRNA processing	5.122569035620472e-13	1.1297826008060952e-8	14	248	15
DOID:1339	Diamond-Blackfan anemia	GO:0000956	nuclear-transcribed mRNA catabolic process	3.290701044988964e-13	7.25764115472316e-9	13	195	15
DOID:1339	Diamond-Blackfan anemia	GO:0006612	protein targeting to membrane	2.5646151868841116e-13	5.656258794672908e-9	13	184	15
DOID:1339	Diamond-Blackfan anemia	GO:0006413	translational initiation	2.1160850849355484e-13	4.667025654825352e-9	13	189	15
DOID:1339	Diamond-Blackfan anemia	GO:0072594	establishment of protein localization to organelle	1.9673151996357774e-13	4.338913672796707e-9	13	641	15
DOID:1339	Diamond-Blackfan anemia	GO:0003735	structural constituent of ribosome	1.8607337892717624e-13	4.103848372238872e-9	13	206	15
DOID:1339	Diamond-Blackfan anemia	GO:0019080	viral gene expression	1.4033219031261979e-13	3.0950264573448294e-9	13	186	15
DOID:1339	Diamond-Blackfan anemia	GO:0006613	cotranslational protein targeting to membrane	1.0325074129013956e-13	2.277195099154028e-9	13	101	15
DOID:1339	Diamond-Blackfan anemia	GO:0044391	ribosomal subunit	6.88338275267597e-14	1.5181300661026853e-9	13	158	15
DOID:1339	Diamond-Blackfan anemia	GO:0045047	protein targeting to ER	7.960299086562372e-14	1.7556439635413312e-9	13	100	15
DOID:1339	Diamond-Blackfan anemia	GO:0006614	SRP-dependent cotranslational protein targeting to membrane	1.2234657731369225e-13	2.6983537626534826e-9	13	94	15
DOID:1339	Diamond-Blackfan anemia	GO:0015935	small ribosomal subunit	1.2667644710973036e-13	2.793849041005103e-9	8	66	15
DOID:1339	Diamond-Blackfan anemia	GO:0022627	cytosolic small ribosomal subunit	1.2712053631958042e-13	2.8036434285283462e-9	8	42	15
DOID:1339	Diamond-Blackfan anemia	GO:0042274	ribosomal small subunit biogenesis	1.4510614931850796e-13	3.200316123219693e-9	7	58	15
DOID:1339	Diamond-Blackfan anemia	GO:0019083	viral transcription	3.4450220454118607e-13	7.597996121155859e-9	13	175	15
DOID:1339	Diamond-Blackfan anemia	GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	4.0401015866109447e-13	8.910444049270438e-9	13	121	15
DOID:1339	Diamond-Blackfan anemia	GO:0042255	ribosome assembly	4.918624396665905e-10	1.0848026106846653e-5	5	54	15
DOID:1339	Diamond-Blackfan anemia	GO:0022625	cytosolic large ribosomal subunit	6.50145492997467e-10	1.4338958848059136e-5	5	57	15
DOID:11720	distal muscular dystrophy	GO:0044449	contractile fiber part	7.265299473147024e-13	1.6023617988025762e-8	9	196	16
DOID:11720	distal muscular dystrophy	GO:0030016	myofibril	5.25135490647699e-13	1.1581863246235002e-8	9	201	16
DOID:11720	distal muscular dystrophy	GO:0030017	sarcomere	1.4432899320127035e-14	3.1831759450540176e-10	9	180	16
DOID:11720	distal muscular dystrophy	GO:0031674	I band	1.170175067954915e-13	2.580821112374565e-9	9	122	16
DOID:11720	distal muscular dystrophy	GO:0006936	muscle contraction	2.6442181777497353e-12	5.831823191027041e-8	9	323	16
DOID:11720	distal muscular dystrophy	GO:0030048	actin filament-based movement	3.461272379823299e-10	7.633836233700286e-6	6	114	16
MESH:D003286	Contracture	GO:0043062	extracellular structure organization	3.2681635175890733e-12	7.207934638042701e-8	9	321	16
MESH:D003286	Contracture	GO:0030198	extracellular matrix organization	3.2751579226442118e-12	7.223360798391809e-8	9	320	16
MESH:D003286	Contracture	GO:0031012	extracellular matrix	7.14030723436565e-10	1.5747947605393442e-5	8	423	16
OMIM:171300	phaeochromocytoma	GO:0042417	dopamine metabolic process	1.6076029396572267e-13	3.5455682834140134e-9	6	32	16
OMIM:171300	phaeochromocytoma	GO:0042420	dopamine catabolic process	1.7961188092385783e-12	3.9613400337756843e-8	4	5	16
DOID:8719	in situ carcinoma	GO:0032355	response to estradiol	1.6346479725370955e-11	3.605216103430564e-7	7	145	16
DOID:8719	in situ carcinoma	GO:0042493	response to drug	8.598080025734589e-10	1.8963065496757636e-5	8	433	16
DOID:8719	in situ carcinoma	GO:0010035	response to inorganic substance	2.7521582790512866e-9	6.0698850844476127e-5	8	502	16
Orphanet:155896	Otomandibular dysplasia	GO:0048754	branching morphogenesis of an epithelial tube	1.6136737501781795e-9	3.558957456017975e-5	6	147	16
Orphanet:155896	Otomandibular dysplasia	GO:0033002	muscle cell proliferation	1.8970826021202924e-9	4.184015678976305e-5	6	151	16
Orphanet:155896	Otomandibular dysplasia	GO:0042481	regulation of odontogenesis	3.78134867862201e-9	8.339764510700842e-5	4	24	16
DOID:14227	azoospermia	GO:0032504	multicellular organism reproduction	1.1379786002407855e-12	2.5098118028310523e-8	12	780	16
DOID:14227	azoospermia	GO:0007276	gamete generation	1.2383427616668996e-12	2.731164960856347e-8	11	605	16
DOID:14227	azoospermia	GO:0022412	cellular process involved in reproduction in multicellular organism	1.2986278719040456e-12	2.8641237714843726e-8	9	266	16
DOID:14227	azoospermia	GO:0007283	spermatogenesis	2.4339419368857307e-12	5.368058941801479e-8	10	480	16
DOID:14227	azoospermia	GO:0007281	germ cell development	2.9598545836506673e-12	6.527959284241547e-8	8	217	16
DC:0000277	Microcephaly, Primary, Autosomal Recessive	GO:0000226	microtubule cytoskeleton organization	3.390621117205228e-13	7.47801487399613e-9	11	412	16
DC:0000277	Microcephaly, Primary, Autosomal Recessive	GO:0007099	centriole replication	1.0724754417879012e-13	2.365344586863216e-9	7	27	16
DC:0000277	Microcephaly, Primary, Autosomal Recessive	GO:0044450	microtubule organizing center part	5.182521078950231e-13	1.1430050239624734e-8	8	141	16
DC:0000277	Microcephaly, Primary, Autosomal Recessive	GO:0005814	centriole	1.0590417431899368e-12	2.3357165646054057e-8	7	99	16
DC:0000277	Microcephaly, Primary, Autosomal Recessive	GO:1903047	mitotic cell cycle process	6.557754339553412e-12	1.446312719588505e-7	11	857	16
DOID:4607	biliary tract cancer	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	1.4544441206965075e-9	3.2077765081961473e-5	5	62	16
DOID:2485	phosphorus metabolism disease	GO:0030282	bone mineralization	1.5548407006349407e-10	3.4292011652503618e-6	6	100	16
DOID:2485	phosphorus metabolism disease	GO:0030500	regulation of bone mineralization	2.5170878714675382e-9	5.5514373005216555e-5	5	69	16
Orphanet:98267	Genetic non-syndromic obesity	GO:0002021	response to dietary excess	2.1330832655763743e-9	4.7045151422286935e-5	4	21	16
Orphanet:98267	Genetic non-syndromic obesity	GO:0046849	bone remodeling	3.5991670754853544e-9	7.937962984982949e-5	5	74	16
Orphanet:294929	Terminal limb defects	GO:0045669	positive regulation of osteoblast differentiation	6.680211939169567e-12	1.473320743183848e-7	6	60	16
Orphanet:294929	Terminal limb defects	GO:0009887	organ morphogenesis	2.101996354753055e-11	4.635952960407863e-7	11	950	16
Orphanet:294929	Terminal limb defects	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.065440069503154e-9	2.3498280732892063e-5	10	996	16
Orphanet:294929	Terminal limb defects	GO:0042733	embryonic digit morphogenesis	1.228678603304445e-9	2.7098506595879535e-5	5	60	16
Orphanet:294929	Terminal limb defects	GO:0050678	regulation of epithelial cell proliferation	1.4962945327212651e-9	3.30007759191675e-5	7	277	16
MESH:D018754	Ventricular Dysfunction	GO:1903522	regulation of blood circulation	5.699885008425554e-13	1.2571096386082559e-8	9	297	16
MESH:D018754	Ventricular Dysfunction	GO:0008016	regulation of heart contraction	3.717470775654874e-12	8.198881795706825e-8	8	224	16
MESH:D018754	Ventricular Dysfunction	GO:0006941	striated muscle contraction	2.0433987835133394e-11	4.50671601703867e-7	7	150	16
MESH:D018754	Ventricular Dysfunction	GO:0060048	cardiac muscle contraction	3.6509617551416795e-10	8.052196150964974e-6	6	115	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0002521	leukocyte differentiation	2.27803331753762e-11	5.024202481829221e-7	9	448	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0034109	homotypic cell-cell adhesion	5.906120037479923e-11	1.302594774266197e-6	9	495	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0031347	regulation of defense response	6.830846999150708e-11	1.5065433056626887e-6	10	749	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0050776	regulation of immune response	1.535430671495419e-10	3.386392345983147e-6	10	816	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	2.5590529695307396e-10	5.643991324300046e-6	4	13	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0046649	lymphocyte activation	2.9427560388484153e-10	6.49024844368018e-6	9	594	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0051707	response to other organism	3.91309762370895e-10	8.630336809090089e-6	10	898	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0002757	immune response-activating signal transduction	6.637653759966611e-10	1.463934536760636e-5	8	419	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0070489	T cell aggregation	7.271881985460027e-10	1.603813571893209e-5	8	424	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0042110	T cell activation	7.271881985460027e-10	1.603813571893209e-5	8	424	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0050866	negative regulation of cell activation	2.053619607700341e-9	4.529258044783102e-5	6	153	16
Orphanet:169355	Immunodeficiency syndrome with autoimmunity	GO:0035877	death effector domain binding	2.064143411750763e-9	4.5524682946163075e-5	3	4	16
DOID:5467	conjunctival cancer	GO:0051054	positive regulation of DNA metabolic process	8.208977941848161e-11	1.810490085074612e-6	7	183	16
DOID:12347	osteogenesis imperfecta	GO:0005788	endoplasmic reticulum lumen	4.876099524153688e-13	1.0754237500520958e-8	9	199	16
DOID:12347	osteogenesis imperfecta	GO:0001501	skeletal system development	4.779643347774254e-11	1.0541503403516117e-6	9	482	16
DOID:12347	osteogenesis imperfecta	GO:0060348	bone development	5.347322584725589e-11	1.1793519960612286e-6	7	172	16
DOID:12347	osteogenesis imperfecta	GO:0005578	proteinaceous extracellular matrix	1.7386536654839801e-10	3.834600659224918e-6	8	354	16
DOID:12347	osteogenesis imperfecta	GO:0018208	peptidyl-proline modification	1.0318670362607918e-9	2.2757827484731763e-5	5	58	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0072006	nephron development	9.2148511043888e-15	2.0323354110729497e-10	8	131	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0032835	glomerulus development	3.552713678800501e-14	7.835510018594505e-10	8	58	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0035850	epithelial cell differentiation involved in kidney development	3.913536161803677e-13	8.63130400485801e-9	6	37	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0061318	renal filtration cell differentiation	1.3596901382584292e-12	2.9987965999289656e-8	5	17	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0072112	glomerular visceral epithelial cell differentiation	1.3596901382584292e-12	2.9987965999289656e-8	5	17	16
Orphanet:93213	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	GO:0032836	glomerular basement membrane development	7.528278000989985e-11	1.6603617131183412e-6	4	10	16
MESH:D008108	Liver Diseases, Alcoholic	GO:0045926	negative regulation of growth	4.087945537634141e-10	9.015963883252098e-6	7	230	16
MESH:D008108	Liver Diseases, Alcoholic	GO:0051093	negative regulation of developmental process	3.5625771221958757e-9	7.857263843003004e-5	9	788	16
MESH:D008108	Liver Diseases, Alcoholic	GO:0030198	extracellular matrix organization	4.079279358748522e-9	8.996850625719865e-5	7	320	16
Orphanet:93447	Primary bone dysplasia with defective bone mineralization	GO:0001503	ossification	3.821387650759789e-12	8.428070463750714e-8	9	363	16
Orphanet:211240	Genetic vascular anomaly	GO:0072358	cardiovascular system development	1.6482371023585074e-12	3.635186929251688e-8	15	910	16
Orphanet:211240	Genetic vascular anomaly	GO:0001568	blood vessel development	4.2166270475263445e-13	9.299770953319353e-9	13	569	16
Orphanet:211240	Genetic vascular anomaly	GO:0043542	endothelial cell migration	3.396172232328354e-13	7.490257858400184e-9	8	151	16
Orphanet:211240	Genetic vascular anomaly	GO:0048514	blood vessel morphogenesis	1.3020695632803836e-12	2.871714421814886e-8	12	484	16
Orphanet:211240	Genetic vascular anomaly	GO:0042327	positive regulation of phosphorylation	1.048017228555409e-11	2.3114019975789546e-7	11	910	16
Orphanet:211240	Genetic vascular anomaly	GO:0001525	angiogenesis	1.1532330645991351e-11	2.5434555239733925e-7	9	413	16
Orphanet:211240	Genetic vascular anomaly	GO:0050678	regulation of epithelial cell proliferation	2.4167667866947795e-11	5.330179148055336e-7	8	277	16
Orphanet:211240	Genetic vascular anomaly	GO:0001936	regulation of endothelial cell proliferation	9.976464099281657e-11	2.2003091570965694e-6	6	93	16
Orphanet:211240	Genetic vascular anomaly	GO:0045765	regulation of angiogenesis	2.022430001247244e-10	4.460469367750797e-6	7	208	16
Orphanet:211240	Genetic vascular anomaly	GO:0060548	negative regulation of cell death	2.752296168750945e-10	6.070189200180209e-6	10	867	16
Orphanet:211240	Genetic vascular anomaly	GO:0001934	positive regulation of protein phosphorylation	2.83648660115432e-10	6.255871198845853e-6	10	870	16
Orphanet:211240	Genetic vascular anomaly	GO:0010594	regulation of endothelial cell migration	3.1085289897703205e-10	6.855860686938442e-6	6	112	16
Orphanet:211240	Genetic vascular anomaly	GO:0097285	cell-type specific apoptotic process	8.007050578129338e-10	1.7659550050064254e-5	8	429	16
Orphanet:211240	Genetic vascular anomaly	GO:0001570	vasculogenesis	2.1651407333678208e-9	4.775217887442729e-5	5	67	16
Orphanet:211240	Genetic vascular anomaly	GO:0002009	morphogenesis of an epithelium	2.9301912007895226e-9	6.462536693341292e-5	8	506	16
Orphanet:211240	Genetic vascular anomaly	GO:0043066	negative regulation of apoptotic process	3.8504811561423935e-9	8.492236189872049e-5	9	795	16
Orphanet:181376	Rare diabetes mellitus type 2	GO:0002790	peptide secretion	2.3003821070233244e-13	5.073492737039942e-9	9	247	16
Orphanet:181376	Rare diabetes mellitus type 2	GO:0030072	peptide hormone secretion	9.225953334635051e-14	2.0347840079537605e-9	9	241	16
DOID:0050588	muscular dystrophy-dystroglycanopathy	GO:0031501	mannosyltransferase complex	3.283917582308504e-11	7.242680227781406e-7	4	8	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0017004	cytochrome complex assembly	1.0857981180834031e-13	2.3947277494329455e-9	8	26	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0016676	oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor	1.8207657603852567e-14	4.0156988845296837e-10	6	27	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0004129	cytochrome-c oxidase activity	1.8207657603852567e-14	4.0156988845296837e-10	6	27	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0008535	respiratory chain complex IV assembly	1.1213252548714081e-14	2.4730828496188906e-10	8	18	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0045333	cellular respiration	1.709743457922741e-13	3.7708391964486054e-9	9	173	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	3.8187231155006884e-12	8.422193831236768e-8	5	19	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0031966	mitochondrial membrane	4.335365400010005e-11	9.561648389722066e-7	10	656	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:1902600	hydrogen ion transmembrane transport	4.049199864297748e-10	8.930510300708683e-6	6	109	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0009060	aerobic respiration	2.0550583457179528e-9	4.532431181480945e-5	5	62	17
OMIM:220110	cytochrome-c oxidase deficiency disease	GO:0005743	mitochondrial inner membrane	3.4570047935389425e-9	7.624424072150138e-5	8	478	17
DOID:0001816	angiosarcoma	GO:0001934	positive regulation of protein phosphorylation	7.689404668553834e-13	1.695898199649548e-8	12	870	17
DOID:0001816	angiosarcoma	GO:0050679	positive regulation of epithelial cell proliferation	1.9628743075372768e-13	4.329119285273464e-9	9	155	17
DOID:0001816	angiosarcoma	GO:0072358	cardiovascular system development	1.0302869668521453e-13	2.2722979053924064e-9	12	910	17
DOID:0001816	angiosarcoma	GO:0001568	blood vessel development	9.725553695716371e-14	2.1449708675902457e-9	12	569	17
DOID:0001816	angiosarcoma	GO:0001525	angiogenesis	1.2945200467129325e-13	2.8550639630253727e-9	11	413	17
DOID:0001816	angiosarcoma	GO:0045765	regulation of angiogenesis	4.685474230825548e-12	1.0333813416085746e-7	8	208	17
DOID:0001816	angiosarcoma	GO:0045766	positive regulation of angiogenesis	6.682210340613892e-12	1.473761490622394e-7	7	119	17
DOID:0001816	angiosarcoma	GO:0030335	positive regulation of cell migration	1.296085461177654e-11	2.858516484627316e-7	9	387	17
DOID:0001816	angiosarcoma	GO:0097285	cell-type specific apoptotic process	3.7512437600639714e-11	8.273368112821089e-7	9	429	17
DOID:0001816	angiosarcoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	3.802802517327564e-11	8.387080951965942e-7	10	647	17
DOID:0001816	angiosarcoma	GO:0043408	regulation of MAPK cascade	3.9757086511826856e-11	8.768425430183413e-7	10	651	17
DOID:0001816	angiosarcoma	GO:0010632	regulation of epithelial cell migration	6.429123899920342e-11	1.4179432761274313e-6	7	164	17
DOID:0001816	angiosarcoma	GO:0043410	positive regulation of MAPK cascade	6.973777111340951e-11	1.5380665419062467e-6	9	464	17
DOID:0001816	angiosarcoma	GO:0010634	positive regulation of epithelial cell migration	2.542118737736132e-10	5.606642876077039e-6	6	101	17
DOID:0001816	angiosarcoma	GO:0050900	leukocyte migration	3.234070788948884e-10	7.132743125026764e-6	8	354	17
DOID:0001816	angiosarcoma	GO:0010594	regulation of endothelial cell migration	4.778434314900437e-10	1.0538836881512914e-5	6	112	17
DOID:0001816	angiosarcoma	GO:0070848	response to growth factor	9.02118935108831e-10	1.9896233113825268e-5	9	621	17
DOID:0001816	angiosarcoma	GO:0010595	positive regulation of endothelial cell migration	2.618953387489853e-9	5.776101696108871e-5	5	65	17
DOID:0001816	angiosarcoma	GO:0050926	regulation of positive chemotaxis	3.4049851826978283e-9	7.50969482044006e-5	4	22	17
DOID:0001816	angiosarcoma	GO:0043534	blood vessel endothelial cell migration	4.114821816614267e-9	9.075239516542766e-5	5	71	17
Orphanet:352456	Mitochondrial DNA maintenance syndrome	GO:0005759	mitochondrial matrix	1.072539501656422e-9	2.365485870903239e-5	8	412	17
Orphanet:325351	46,XY disorder of sex development of endocrine origin	GO:0048608	reproductive structure development	2.7736257735000436e-11	6.117231643454346e-7	9	418	17
Orphanet:325351	46,XY disorder of sex development of endocrine origin	GO:0008406	gonad development	5.034659356084603e-10	1.1103941209844592e-5	7	220	17
Orphanet:325351	46,XY disorder of sex development of endocrine origin	GO:0046546	development of primary male sexual characteristics	1.1248684206321968e-9	2.48089730170431e-5	6	129	17
Orphanet:325351	46,XY disorder of sex development of endocrine origin	GO:0008584	male gonad development	1.1248684206321968e-9	2.48089730170431e-5	6	129	17
Orphanet:183681	Functional neutrophil defect	GO:0072593	reactive oxygen species metabolic process	5.536719971388493e-10	1.2211235896897321e-5	7	223	17
Orphanet:183681	Functional neutrophil defect	GO:0006801	superoxide metabolic process	8.29873836316608e-10	1.830286745996279e-5	5	52	17
MESH:D054062	Deaf-Blind Disorders	GO:0001895	retina homeostasis	1.454392162258955e-14	3.2076619138621254e-10	9	66	17
MESH:D010610	Pharyngeal Neoplasms	GO:0006069	ethanol oxidation	2.317002145701963e-10	5.110148232345679e-6	4	12	17
Orphanet:222628	Hereditary poikiloderma	GO:0000784	nuclear chromosome, telomeric region	1.3758549854969715e-11	3.0344481705135706e-7	7	132	17
Orphanet:222628	Hereditary poikiloderma	GO:0071897	DNA biosynthetic process	7.315592576162544e-11	1.613453942672649e-6	7	167	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0009101	glycoprotein biosynthetic process	1.3911094498553211e-12	3.068091891655911e-8	10	336	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0030203	glycosaminoglycan metabolic process	7.793765632868599e-14	1.7189150103291695e-9	10	161	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0015012	heparan sulfate proteoglycan biosynthetic process	6.061817714453355e-14	1.3369338969226874e-9	6	26	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0050650	chondroitin sulfate proteoglycan biosynthetic process	1.2068124277675452e-13	2.661624809441321e-9	6	30	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0030204	chondroitin sulfate metabolic process	9.942047185518277e-13	2.192718506766056e-8	6	41	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0000139	Golgi membrane	3.77819997510187e-12	8.332820045087175e-8	11	691	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0030206	chondroitin sulfate biosynthetic process	1.7154944131902994e-11	3.7835229282912053e-7	5	25	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0008194	UDP-glycosyltransferase activity	2.114042274570238e-11	4.66252023656466e-7	7	140	17
Orphanet:309450	Disorder of O-xylosylglycan synthesis	GO:0016758	transferase activity, transferring hexosyl groups	2.7680691072617947e-10	6.104976416065888e-6	7	202	17
Orphanet:102005	Brain inflammatory disease	GO:0050776	regulation of immune response	1.2529199899802279e-11	2.7633150379013927e-7	11	816	17
Orphanet:102005	Brain inflammatory disease	GO:0002275	myeloid cell activation involved in immune response	3.5557105038108716e-9	7.842119516154877e-5	5	69	17
DOID:2187	amelogenesis imperfecta	GO:0031214	biomineral tissue development	1.056932319443149e-13	2.331064230531865e-9	8	131	17
DOID:2187	amelogenesis imperfecta	GO:0070166	enamel mineralization	3.34510752431072e-10	7.3776346448672925e-6	4	13	17
DOID:2048	autoimmune hepatitis	GO:0001775	cell activation	2.367439577710684e-12	5.221387988640913e-8	12	854	17
DOID:2048	autoimmune hepatitis	GO:0033993	response to lipid	2.2928325904558733e-12	5.0568422782504285e-8	12	850	17
DOID:2048	autoimmune hepatitis	GO:0002684	positive regulation of immune system process	1.1572964808692632e-12	2.55241738855716e-8	13	872	17
DOID:2048	autoimmune hepatitis	GO:0034110	regulation of homotypic cell-cell adhesion	6.816769371198461e-13	1.5034384848178206e-8	10	304	17
DOID:2048	autoimmune hepatitis	GO:0032944	regulation of mononuclear cell proliferation	6.572520305780927e-13	1.4495693534399834e-8	11	191	17
DOID:2048	autoimmune hepatitis	GO:0046651	lymphocyte proliferation	5.895284260759581e-13	1.3002049437105256e-8	11	249	17
DOID:2048	autoimmune hepatitis	GO:0050870	positive regulation of T cell activation	5.768718835952313e-13	1.2722909392692827e-8	9	202	17
DOID:2048	autoimmune hepatitis	GO:0005125	cytokine activity	5.271338920920243e-13	1.1625937990089596e-8	14	222	17
DOID:2048	autoimmune hepatitis	GO:0050670	regulation of lymphocyte proliferation	3.9124259387790516e-13	8.628855407977198e-9	11	189	17
DOID:2048	autoimmune hepatitis	GO:0032946	positive regulation of mononuclear cell proliferation	1.98507876802978e-13	4.3780912228896796e-9	9	129	17
DOID:2048	autoimmune hepatitis	GO:0050671	positive regulation of lymphocyte proliferation	1.680877659282487e-13	3.707175677547525e-9	9	127	17
DOID:2048	autoimmune hepatitis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	7.793765632868599e-14	1.7189150103291695e-9	10	161	17
DOID:2048	autoimmune hepatitis	GO:0007260	tyrosine phosphorylation of STAT protein	7.349676423018536e-14	1.6209711350967382e-9	8	71	17
DOID:2048	autoimmune hepatitis	GO:0002700	regulation of production of molecular mediator of immune response	5.795364188543317e-14	1.2781675717832286e-9	8	99	17
DOID:2048	autoimmune hepatitis	GO:0050864	regulation of B cell activation	4.951594689828198e-14	1.0920742088416091e-9	8	100	17
DOID:2048	autoimmune hepatitis	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	3.708144902248023e-14	8.178313581908014e-10	8	67	17
DOID:2048	autoimmune hepatitis	GO:0002377	immunoglobulin production	2.886579864025407e-14	6.366351890108035e-10	8	81	17
DOID:2048	autoimmune hepatitis	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	1.8207657603852567e-14	4.0156988845296837e-10	8	58	17
DOID:2048	autoimmune hepatitis	GO:0002639	positive regulation of immunoglobulin production	2.4424906541753444e-15	5.386913137783722e-11	7	30	17
DOID:2048	autoimmune hepatitis	GO:0008083	growth factor activity	4.0190073491430667e-14	8.863920708535034e-10	9	159	17
DOID:2048	autoimmune hepatitis	GO:0050871	positive regulation of B cell activation	1.084687895058778e-13	2.3922791525521347e-9	7	66	17
DOID:2048	autoimmune hepatitis	GO:0001819	positive regulation of cytokine production	1.829647544582258e-13	4.03528765957617e-9	11	381	17
DOID:2048	autoimmune hepatitis	GO:1903708	positive regulation of hemopoiesis	2.795541576006144e-13	6.165566945881551e-9	8	158	17
DOID:2048	autoimmune hepatitis	GO:0042129	regulation of T cell proliferation	3.503863865716994e-13	7.72777175583883e-9	9	142	17
DOID:2048	autoimmune hepatitis	GO:0051222	positive regulation of protein transport	4.816147480823929e-13	1.0622013268957176e-8	10	447	17
DOID:2048	autoimmune hepatitis	GO:0002703	regulation of leukocyte mediated immunity	5.146993942162226e-13	1.1351695139438789e-8	8	151	17
DOID:2048	autoimmune hepatitis	GO:0006954	inflammatory response	6.320499679191016e-13	1.3939862042455786e-8	14	637	17
DOID:2048	autoimmune hepatitis	GO:0005126	cytokine receptor binding	9.151568391985165e-13	2.0183784088523282e-8	13	270	17
DOID:2048	autoimmune hepatitis	GO:0042102	positive regulation of T cell proliferation	1.2994050280212832e-12	2.86583778930094e-8	7	95	17
DOID:2048	autoimmune hepatitis	GO:1903532	positive regulation of secretion by cell	2.539302101922658e-12	5.600430785790422e-8	9	335	17
DOID:2048	autoimmune hepatitis	GO:0002237	response to molecule of bacterial origin	2.6418867093980225e-12	5.8266811375773386e-8	9	333	17
DOID:2048	autoimmune hepatitis	GO:0032496	response to lipopolysaccharide	4.354960836394639e-12	9.604866124668376e-8	9	319	17
DOID:2048	autoimmune hepatitis	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.7947201764486636e-12	1.0574755349157527e-7	8	209	17
DOID:2048	autoimmune hepatitis	GO:0097305	response to alcohol	8.978817689353491e-12	1.9802782413869124e-7	9	369	17
DOID:2048	autoimmune hepatitis	GO:1902107	positive regulation of leukocyte differentiation	1.0308642828249504e-11	2.273571175770428e-7	7	127	17
DOID:2048	autoimmune hepatitis	GO:0050708	regulation of protein secretion	1.1897482998790565e-11	2.623989875383259e-7	9	380	17
DOID:2048	autoimmune hepatitis	GO:0045191	regulation of isotype switching	1.3731793480076249e-11	3.0285470520308166e-7	5	24	17
DOID:2048	autoimmune hepatitis	GO:0014070	response to organic cyclic compound	2.10926831556435e-11	4.6519912699771737e-7	11	873	17
DOID:2048	autoimmune hepatitis	GO:0097285	cell-type specific apoptotic process	3.7512437600639714e-11	8.273368112821089e-7	9	429	17
DOID:2048	autoimmune hepatitis	GO:0071222	cellular response to lipopolysaccharide	3.7598035795838314e-11	8.29224679477214e-7	7	152	17
DOID:2048	autoimmune hepatitis	GO:0032103	positive regulation of response to external stimulus	5.8193005969542355e-11	1.2834467466582566e-6	8	285	17
DOID:2048	autoimmune hepatitis	GO:0050727	regulation of inflammatory response	6.571754251893935e-11	1.4494004002552074e-6	8	289	17
DOID:2048	autoimmune hepatitis	GO:0051384	response to glucocorticoid	7.315592576162544e-11	1.613453942672649e-6	7	167	17
DOID:2048	autoimmune hepatitis	GO:0002705	positive regulation of leukocyte mediated immunity	7.644174182530605e-11	1.685922615957125e-6	6	83	17
DOID:2048	autoimmune hepatitis	GO:0030595	leukocyte chemotaxis	1.0965839347676365e-10	2.4185158681300223e-6	7	177	17
DOID:2048	autoimmune hepatitis	GO:0034097	response to cytokine	2.412408051100101e-10	5.320565956701273e-6	10	784	17
DOID:2048	autoimmune hepatitis	GO:0050714	positive regulation of protein secretion	3.0736779788043123e-10	6.778996782252911e-6	7	205	17
DOID:2048	autoimmune hepatitis	GO:0042089	cytokine biosynthetic process	3.224159828008055e-10	7.110884500671766e-6	6	105	17
DOID:2048	autoimmune hepatitis	GO:0042033	chemokine biosynthetic process	3.34510752431072e-10	7.3776346448672925e-6	4	13	17
DOID:2048	autoimmune hepatitis	GO:0050921	positive regulation of chemotaxis	6.899353310885203e-10	1.5216523727157316e-5	6	119	17
DOID:2048	autoimmune hepatitis	GO:0045830	positive regulation of isotype switching	8.499769776904031e-10	1.874624224296184e-5	4	16	17
DOID:2048	autoimmune hepatitis	GO:0030888	regulation of B cell proliferation	9.157364866396733e-10	2.0196568212837995e-5	5	53	17
DOID:2048	autoimmune hepatitis	GO:0070851	growth factor receptor binding	9.754871355127648e-10	2.1514368773734027e-5	6	126	17
DOID:2048	autoimmune hepatitis	GO:0042832	defense response to protozoan	1.4275569615307404e-9	3.148476878656048e-5	4	18	17
DOID:2048	autoimmune hepatitis	GO:0031341	regulation of cell killing	1.4582852703171056e-9	3.2162481636843765e-5	5	58	17
DOID:2048	autoimmune hepatitis	GO:0042493	response to drug	1.5901778782634324e-9	3.50713731051e-5	8	433	17
DOID:2048	autoimmune hepatitis	GO:0045471	response to ethanol	1.6191478158233963e-9	3.5710305077985005e-5	6	137	17
DOID:2048	autoimmune hepatitis	GO:2000377	regulation of reactive oxygen species metabolic process	2.4774527984661177e-9	5.4640221470170225e-5	6	147	17
DOID:2048	autoimmune hepatitis	GO:0045582	positive regulation of T cell differentiation	3.0587903321332988e-9	6.74616207751999e-5	5	67	17
DOID:2048	autoimmune hepatitis	GO:0097529	myeloid leukocyte migration	3.1523038623859634e-9	6.952406168492242e-5	6	153	17
DOID:2048	autoimmune hepatitis	GO:0032660	regulation of interleukin-17 production	3.4049851826978283e-9	7.50969482044006e-5	4	22	17
DOID:4621	holoprosencephaly	GO:0060322	head development	2.674083177112152e-12	5.8976904471208513e-8	11	708	17
DOID:4621	holoprosencephaly	GO:0048562	embryonic organ morphogenesis	5.060118990485307e-11	1.1160092433515345e-6	8	280	17
DOID:4621	holoprosencephaly	GO:0071363	cellular response to growth factor stimulus	6.087812476351928e-10	1.3426670416594177e-5	9	594	17
DOID:4621	holoprosencephaly	GO:0048732	gland development	1.274481631341473e-9	2.810869237923619e-5	8	421	17
DOID:4621	holoprosencephaly	GO:0007423	sensory organ development	4.47543135884132e-9	9.87056386192453e-5	8	494	17
MESH:D002280	Carcinoma, Basal Cell	GO:0042438	melanin biosynthetic process	1.4275569615307404e-9	3.148476878656048e-5	4	18	17
MESH:D002280	Carcinoma, Basal Cell	GO:0021904	dorsal/ventral neural tube patterning	4.119526941792628e-9	9.085616670123642e-5	4	23	17
Orphanet:206959	Muscular glycogenosis	GO:0044247	cellular polysaccharide catabolic process	7.216449660063518e-14	1.5915879725270088e-9	7	29	17
Orphanet:206959	Muscular glycogenosis	GO:0009251	glucan catabolic process	7.216449660063518e-14	1.5915879725270088e-9	7	29	17
Orphanet:206959	Muscular glycogenosis	GO:0005980	glycogen catabolic process	5.1736392947532295e-14	1.1410461464578248e-9	7	28	17
Orphanet:206959	Muscular glycogenosis	GO:0019674	NAD metabolic process	1.3331894477275341e-9	2.9403493269630765e-5	5	57	17
Orphanet:206959	Muscular glycogenosis	GO:0006096	glycolytic process	2.618953387489853e-9	5.776101696108871e-5	5	65	17
Orphanet:294057	Rare nevus	GO:0038128	ERBB2 signaling pathway	1.852471509522502e-10	4.085625914251878e-6	5	39	17
DOID:14749	methylmalonic acidemia	GO:0006767	water-soluble vitamin metabolic process	7.860379014346108e-14	1.7336065916140342e-9	8	86	17
DOID:14749	methylmalonic acidemia	GO:0031419	cobalamin binding	5.908029621082278e-11	1.3030159329296964e-6	4	9	17
DOID:14749	methylmalonic acidemia	GO:0009236	cobalamin biosynthetic process	6.269436081396407e-10	1.3827241277519775e-5	3	3	17
MESH:D006222	Hamartoma	GO:0048732	gland development	1.274481631341473e-9	2.810869237923619e-5	8	421	17
MESH:D008844	Micrognathism	GO:0044454	nuclear chromosome part	3.9381807814820036e-9	8.685657713558559e-5	8	486	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0001819	positive regulation of cytokine production	1.193567467083767e-11	2.632413048653248e-7	9	381	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0022409	positive regulation of cell-cell adhesion	1.4018231020429539e-11	3.091720851555735e-7	8	239	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0002684	positive regulation of immune system process	1.9566348541388834e-11	4.3153581708033073e-7	11	872	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0007159	leukocyte cell-cell adhesion	6.649270023473264e-11	1.4664965036770283e-6	9	461	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.5220804051050436e-10	7.767948333459174e-6	7	209	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0050778	positive regulation of immune response	6.952584064023881e-10	1.533392415320467e-5	9	603	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0006954	inflammatory response	1.127742454976044e-9	2.487235984449665e-5	9	637	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0032729	positive regulation of interferon-gamma production	2.618953387489853e-9	5.776101696108871e-5	5	65	17
Orphanet:98482	Idiopathic inflammatory myopathy	GO:0050764	regulation of phagocytosis	3.2999412091783142e-9	7.278020336842772e-5	5	68	17
DOID:10241	thalassemia	GO:0019825	oxygen binding	6.098225258099887e-10	1.3449635806739302e-5	5	49	17
DOID:10241	thalassemia	GO:0005506	iron ion binding	4.283827514939276e-9	9.447981584198573e-5	6	161	17
DOID:12712	nephronophthisis	GO:0072372	primary cilium	5.906386491005833e-13	1.3026535405913364e-8	9	199	17
DOID:12712	nephronophthisis	GO:0044441	ciliary part	8.026912468039882e-13	1.770335544826196e-8	9	303	17
DOID:12712	nephronophthisis	GO:0044782	cilium organization	2.6735758051898983e-10	5.896571438346321e-6	7	201	17
DOID:12712	nephronophthisis	GO:0060271	cilium morphogenesis	4.722129354206572e-10	1.0414656290702595e-5	7	218	17
Orphanet:93454	Dysostosis with predominant vertebral and costal involvement	GO:0001501	skeletal system development	3.6911069756229153e-9	8.14073643473634e-5	8	482	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0009790	embryo development	1.0931255900459291e-12	2.4108884888462967e-8	12	932	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0003002	regionalization	1.7257384410385157e-10	3.8061161317104464e-6	8	327	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0008284	positive regulation of cell proliferation	3.5189939850965857e-10	7.76114123413052e-6	10	815	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0045596	negative regulation of cell differentiation	6.385523221297262e-10	1.4083271464571112e-5	9	597	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0050679	positive regulation of epithelial cell proliferation	3.4085497757629923e-9	7.51755653044528e-5	6	155	17
Orphanet:93457	Non-syndromic limb reduction defect	GO:0060571	morphogenesis of an epithelial fold	4.119526941792628e-9	9.085616670123642e-5	4	23	17
Orphanet:325638	Syndrome with disorder of sex development of gynecological interest	GO:0002064	epithelial cell development	2.7680691072617947e-10	6.104976416065888e-6	7	202	17
Orphanet:325638	Syndrome with disorder of sex development of gynecological interest	GO:0008406	gonad development	5.034659356084603e-10	1.1103941209844592e-5	7	220	17
Orphanet:325638	Syndrome with disorder of sex development of gynecological interest	GO:0046546	development of primary male sexual characteristics	1.1248684206321968e-9	2.48089730170431e-5	6	129	17
Orphanet:325638	Syndrome with disorder of sex development of gynecological interest	GO:0008584	male gonad development	1.1248684206321968e-9	2.48089730170431e-5	6	129	17
Orphanet:325638	Syndrome with disorder of sex development of gynecological interest	GO:0007530	sex determination	3.4049851826978283e-9	7.50969482044006e-5	4	22	17
DOID:255	hemangioma	GO:0097285	cell-type specific apoptotic process	1.4797655323306458e-9	3.263622881555239e-5	8	429	17
DOID:255	hemangioma	GO:0050678	regulation of epithelial cell proliferation	2.5121724700483128e-9	5.540596382691554e-5	7	277	17
DOID:255	hemangioma	GO:0048514	blood vessel morphogenesis	3.812334337105483e-9	8.408103380486143e-5	8	484	17
DOID:3948	adrenocortical carcinoma	GO:0006260	DNA replication	2.1755430790193486e-10	4.798160260777173e-6	8	337	17
DOID:3948	adrenocortical carcinoma	GO:0000278	mitotic cell cycle	1.2291373474582201e-9	2.7108624198191045e-5	10	927	17
DOID:3948	adrenocortical carcinoma	GO:0051338	regulation of transferase activity	1.2406163873990295e-9	2.7361794424085595e-5	10	928	17
MESH:D017114	Liver Failure, Acute	GO:0097190	apoptotic signaling pathway	2.2527202325761664e-11	4.968374472946735e-7	10	564	18
MESH:D030401	Cytochrome-c Oxidase Deficiency	GO:0044429	mitochondrial part	8.382627925129782e-12	1.8487885888873734e-7	12	956	18
MESH:D030401	Cytochrome-c Oxidase Deficiency	GO:0019866	organelle inner membrane	4.4175785252065225e-10	9.742969437342985e-6	9	531	18
Orphanet:167762	Rare disease with dentinogenesis imperfecta	GO:0030199	collagen fibril organization	9.32032229172819e-13	2.055597081440652e-8	6	38	18
Orphanet:167762	Rare disease with dentinogenesis imperfecta	GO:0032963	collagen metabolic process	5.985434370359144e-12	1.3200875503827092e-7	7	109	18
Orphanet:167762	Rare disease with dentinogenesis imperfecta	GO:0005518	collagen binding	3.616510868553746e-9	7.976214720595287e-5	5	65	18
MESH:D009378	Neoplasms, Multiple Primary	GO:0007167	enzyme linked receptor protein signaling pathway	2.8655361417051495e-9	6.319939960530707e-5	10	935	18
MESH:D009378	Neoplasms, Multiple Primary	GO:0050678	regulation of epithelial cell proliferation	4.059317992854972e-9	8.95282583324164e-5	7	277	18
Orphanet:79226	Sterol metabolism disorder	GO:1901617	organic hydroxy compound biosynthetic process	9.35695965154082e-13	2.0636774511473277e-8	14	224	18
Orphanet:79226	Sterol metabolism disorder	GO:0006066	alcohol metabolic process	2.0294876890147862e-13	4.476035098122111e-9	11	382	18
Orphanet:79226	Sterol metabolism disorder	GO:0016125	sterol metabolic process	7.37188088351104e-14	1.6258683288583597e-9	11	132	18
Orphanet:79226	Sterol metabolism disorder	GO:0006695	cholesterol biosynthetic process	9.547918011776346e-15	2.1057933174972732e-10	7	48	18
Orphanet:79226	Sterol metabolism disorder	GO:0055114	oxidation-reduction process	6.5785155101139026e-12	1.4508915957556212e-7	12	949	18
Orphanet:79226	Sterol metabolism disorder	GO:0016491	oxidoreductase activity	1.9910528781252879e-10	4.391267122705322e-6	10	710	18
MESH:D014804	Vitamin B Deficiency	GO:0006766	vitamin metabolic process	2.19824158875781e-13	4.84822182400535e-9	13	128	18
MESH:D014804	Vitamin B Deficiency	GO:0033013	tetrapyrrole metabolic process	5.46229728115577e-14	1.2047096653589051e-9	9	56	18
MESH:D014804	Vitamin B Deficiency	GO:0051180	vitamin transport	1.0325074129013956e-14	2.277195099154028e-10	8	33	18
MESH:D014804	Vitamin B Deficiency	GO:0046655	folic acid metabolic process	1.4275565174415306e-9	3.1484758992172956e-5	4	17	18
Orphanet:108973	Syndromic visceral malformation	GO:0044441	ciliary part	8.564260411958458e-13	1.8888476338574378e-8	11	303	18
Orphanet:108973	Syndromic visceral malformation	GO:0007368	determination of left/right symmetry	7.129827839236214e-10	1.572483529943547e-5	6	112	18
Orphanet:79361	Inherited epidermolysis bullosa	GO:0008544	epidermis development	2.0032864256336325e-12	4.4182482117349764e-8	9	296	18
Orphanet:371200	Congenital disorder of glycosylation with skin involvement	GO:0009101	glycoprotein biosynthetic process	1.4153123117921496e-12	3.121471303657586e-8	11	336	18
Orphanet:371200	Congenital disorder of glycosylation with skin involvement	GO:0006486	protein glycosylation	2.152167333235866e-12	4.7466050534517024e-8	9	259	18
DOID:10487	Hirschsprung's disease	GO:0048762	mesenchymal cell differentiation	4.953815135877448e-13	1.0925639282177713e-8	11	184	18
DOID:10487	Hirschsprung's disease	GO:0014032	neural crest cell development	5.573319583618286e-14	1.229195634167013e-9	11	67	18
DOID:10487	Hirschsprung's disease	GO:0001755	neural crest cell migration	8.026912468039882e-14	1.770335544826196e-9	10	51	18
DOID:10487	Hirschsprung's disease	GO:0048484	enteric nervous system development	2.070565940925917e-13	4.56663318271211e-9	5	11	18
DOID:10487	Hirschsprung's disease	GO:0060284	regulation of cell development	8.863555445159932e-10	1.954857153430023e-5	10	828	18
DOID:10487	Hirschsprung's disease	GO:0048666	neuron development	2.61320176608848e-9	5.7634164951081424e-5	10	926	18
DOID:10487	Hirschsprung's disease	GO:0050767	regulation of neurogenesis	2.906793916679362e-9	6.410933983236333e-5	9	658	18
OMIM:127750	Lewy body dementia	GO:2000377	regulation of reactive oxygen species metabolic process	4.837552580738702e-11	1.0669222216819207e-6	7	147	18
OMIM:127750	Lewy body dementia	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.14374065773859e-10	2.5225200206424603e-6	6	83	18
OMIM:127750	Lewy body dementia	GO:0071417	cellular response to organonitrogen compound	1.3059975323415074e-10	2.8803775575791946e-6	9	462	18
OMIM:127750	Lewy body dementia	GO:0048015	phosphatidylinositol-mediated signaling	3.259535974464711e-10	7.188906591681921e-6	7	193	18
OMIM:127750	Lewy body dementia	GO:0043066	negative regulation of apoptotic process	5.985983930756333e-10	1.3202087559283093e-5	10	795	18
OMIM:127750	Lewy body dementia	GO:0045840	positive regulation of mitotic nuclear division	8.428057141074419e-10	1.858808002463963e-5	5	49	18
OMIM:127750	Lewy body dementia	GO:0001934	positive regulation of protein phosphorylation	1.4264613934500403e-9	3.146060603254064e-5	10	870	18
OMIM:127750	Lewy body dementia	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.507594243361666e-9	5.5304991037341544e-5	9	647	18
OMIM:127750	Lewy body dementia	GO:0043408	regulation of MAPK cascade	2.6463451430203122e-9	5.8365142129312986e-5	9	651	18
OMIM:127750	Lewy body dementia	GO:0004714	transmembrane receptor protein tyrosine kinase activity	3.081133348459275e-9	6.795439600026931e-5	5	63	18
OMIM:127750	Lewy body dementia	GO:1903426	regulation of reactive oxygen species biosynthetic process	3.081133348459275e-9	6.795439600026931e-5	5	63	18
Orphanet:98995	Early-onset zonular cataract	GO:0001654	eye development	1.709743457922741e-14	3.7708391964486054e-10	11	327	18
Orphanet:98586	Pigmented palpebral tumor	GO:0051338	regulation of transferase activity	2.8653746042550665e-12	6.319583689684549e-8	12	928	18
Orphanet:98586	Pigmented palpebral tumor	GO:0045859	regulation of protein kinase activity	1.9541179785420582e-10	4.309807201674509e-6	10	709	18
Orphanet:98586	Pigmented palpebral tumor	GO:0051347	positive regulation of transferase activity	1.5605083891756522e-9	3.441701252326901e-5	9	613	18
Orphanet:98697	Genetic keratinization disorder associated with ocular features	GO:0006665	sphingolipid metabolic process	3.260295367013555e-9	7.190581431948395e-5	6	144	18
Orphanet:71864	Muscular channelopathy	GO:0022836	gated channel activity	1.2829737272568309e-12	2.8295985554649405e-8	14	335	18
Orphanet:71864	Muscular channelopathy	GO:0042391	regulation of membrane potential	1.0433875985427221e-12	2.3011913485859736e-8	10	340	18
Orphanet:71864	Muscular channelopathy	GO:0003012	muscle system process	9.070522111187529e-13	2.0005036516224095e-8	11	393	18
Orphanet:71864	Muscular channelopathy	GO:0022832	voltage-gated channel activity	5.688782778179302e-13	1.254661041727445e-8	11	189	18
Orphanet:71864	Muscular channelopathy	GO:0005244	voltage-gated ion channel activity	5.688782778179302e-13	1.254661041727445e-8	11	189	18
Orphanet:71864	Muscular channelopathy	GO:0035637	multicellular organismal signaling	4.951594689828198e-13	1.0920742088416091e-8	10	184	18
Orphanet:71864	Muscular channelopathy	GO:0005261	cation channel activity	3.6548541970660153e-13	8.060780931629097e-9	13	298	18
Orphanet:71864	Muscular channelopathy	GO:1902495	transmembrane transporter complex	2.5934809855243657e-13	5.7199223135739885e-9	13	308	18
Orphanet:71864	Muscular channelopathy	GO:0034762	regulation of transmembrane transport	1.1390888232654106e-13	2.512260399711863e-9	10	383	18
Orphanet:71864	Muscular channelopathy	GO:0001508	action potential	7.693845560652335e-14	1.6968776384018724e-9	8	119	18
Orphanet:71864	Muscular channelopathy	GO:0034703	cation channel complex	9.381384558082573e-14	2.0690643642851114e-9	9	166	18
Orphanet:71864	Muscular channelopathy	GO:0046873	metal ion transmembrane transporter activity	2.873257187729905e-13	6.336968727538306e-9	12	415	18
Orphanet:71864	Muscular channelopathy	GO:0034765	regulation of ion transmembrane transport	5.268008251846368e-13	1.1618592199447164e-8	10	367	18
Orphanet:71864	Muscular channelopathy	GO:0098797	plasma membrane protein complex	1.3359313655314509e-12	2.946396626679615e-8	11	499	18
Orphanet:71864	Muscular channelopathy	GO:0098655	cation transmembrane transport	1.372790769949006e-12	3.027690043122533e-8	13	642	18
Orphanet:71864	Muscular channelopathy	GO:0098660	inorganic ion transmembrane transport	3.6279867998700865e-12	8.001524887113476e-8	11	660	18
Orphanet:71864	Muscular channelopathy	GO:0050879	multicellular organismal movement	4.8648862716049734e-12	1.0729506672024769e-7	6	50	18
Orphanet:71864	Muscular channelopathy	GO:0050881	musculoskeletal movement	4.8648862716049734e-12	1.0729506672024769e-7	6	50	18
Orphanet:71864	Muscular channelopathy	GO:0030001	metal ion transport	2.2755908268834446e-11	5.018815568691437e-7	11	792	18
Orphanet:71864	Muscular channelopathy	GO:0098662	inorganic cation transmembrane transport	2.5728197350360915e-11	5.6743539256221e-7	10	575	18
Orphanet:71864	Muscular channelopathy	GO:0019226	transmission of nerve impulse	3.0523583660624354e-11	6.731976376350701e-7	6	67	18
Orphanet:71864	Muscular channelopathy	GO:0022834	ligand-gated channel activity	6.365119542550701e-11	1.4038271151095572e-6	7	153	18
Orphanet:71864	Muscular channelopathy	GO:0015276	ligand-gated ion channel activity	6.365119542550701e-11	1.4038271151095572e-6	7	153	18
Orphanet:71864	Muscular channelopathy	GO:0003009	skeletal muscle contraction	2.923872255422566e-10	6.448600259334469e-6	5	40	18
DOID:1852	intrahepatic cholestasis	GO:1901617	organic hydroxy compound biosynthetic process	7.416289804496046e-13	1.635662716381603e-8	9	224	18
Orphanet:68373	Peroxisomal disease	GO:0005777	peroxisome	1.389999226830696e-13	3.0656432947751e-9	13	127	18
Orphanet:68373	Peroxisomal disease	GO:0019395	fatty acid oxidation	2.55351295663786e-15	5.6317728258648003e-11	8	91	18
Orphanet:68373	Peroxisomal disease	GO:0006635	fatty acid beta-oxidation	8.548717289613705e-15	1.8854195982243027e-10	8	65	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0072001	renal system development	4.2676973066591017e-13	9.412406409836649e-9	12	276	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0001822	kidney development	9.71445146547012e-13	2.142522270709435e-8	11	262	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0048729	tissue morphogenesis	6.777622907350178e-11	1.4948047322160818e-6	10	635	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0001823	mesonephros development	4.033824385629714e-10	8.896599682506334e-6	6	102	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0090183	regulation of kidney development	1.5319591151197187e-9	3.3787358283965396e-5	5	55	18
Orphanet:93546	Non-syndromic renal or urinary tract malformation	GO:0048863	stem cell differentiation	3.0654077054492745e-9	6.760756694368375e-5	7	266	18
DOID:1555	urticaria	GO:0007159	leukocyte cell-cell adhesion	2.241984375928041e-12	4.944696541109295e-8	11	461	18
DOID:1555	urticaria	GO:0002237	response to molecule of bacterial origin	5.657141421977485e-12	1.2476825406171344e-7	9	333	18
DOID:1555	urticaria	GO:0032496	response to lipopolysaccharide	6.519007555993994e-12	1.4377671164744754e-7	9	319	18
DOID:1555	urticaria	GO:0045321	leukocyte activation	6.621592163469359e-12	1.460392151653167e-7	11	694	18
DOID:1555	urticaria	GO:0022409	positive regulation of cell-cell adhesion	2.462374748546381e-11	5.430767507919043e-7	8	239	18
DOID:1555	urticaria	GO:0050776	regulation of immune response	2.814604105338958e-11	6.207609354325072e-7	11	816	18
DOID:1555	urticaria	GO:0046649	lymphocyte activation	3.490085997981396e-11	7.697384668547969e-7	10	594	18
DOID:1555	urticaria	GO:0002684	positive regulation of immune system process	5.0561554942873954e-11	1.115135094265085e-6	11	872	18
DOID:1555	urticaria	GO:0070489	T cell aggregation	6.109412975519035e-11	1.3474310317507232e-6	9	424	18
DOID:1555	urticaria	GO:0042110	T cell activation	6.109412975519035e-11	1.3474310317507232e-6	9	424	18
DOID:1555	urticaria	GO:0006954	inflammatory response	6.782729933263454e-11	1.4959310867812547e-6	10	637	18
DOID:1555	urticaria	GO:0002696	positive regulation of leukocyte activation	8.95041818438358e-11	1.9740147305657985e-6	8	280	18
DOID:1555	urticaria	GO:0050870	positive regulation of T cell activation	4.48966197552636e-10	9.901949487023387e-6	7	202	18
DOID:1555	urticaria	GO:0034097	response to cytokine	5.214559894994863e-10	1.1500711848411171e-5	10	784	18
DOID:1555	urticaria	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	5.710272255043947e-10	1.2594005458499424e-5	7	209	18
DOID:1555	urticaria	GO:0098552	side of membrane	1.5607943826267956e-9	3.442332010883398e-5	8	402	18
DOID:1555	urticaria	GO:0002526	acute inflammatory response	2.8718957212348073e-9	6.333966013183367e-5	6	141	18
DOID:1555	urticaria	GO:0002443	leukocyte mediated immunity	4.2676698841503935e-9	9.412345929493693e-5	7	279	18
Orphanet:93573	Thrombotic microangiopathy	GO:0009611	response to wounding	5.42512701429132e-11	1.1965117630019506e-6	11	875	18
DOID:3627	aortic aneurysm	GO:0007179	transforming growth factor beta receptor signaling pathway	1.4178658247487874e-12	3.1271030764834506e-8	8	166	18
DOID:3627	aortic aneurysm	GO:0030198	extracellular matrix organization	1.564415263999308e-12	3.450317864750474e-8	11	320	18
DOID:3627	aortic aneurysm	GO:0001501	skeletal system development	1.935118731921648e-12	4.2679043632531943e-8	12	482	18
DOID:3627	aortic aneurysm	GO:0009887	organ morphogenesis	6.213585201919614e-12	1.3704062162833708e-7	12	950	18
DOID:3627	aortic aneurysm	GO:0090288	negative regulation of cellular response to growth factor stimulus	1.141664540682541e-11	2.517941144475344e-7	7	120	18
DOID:3627	aortic aneurysm	GO:0060537	muscle tissue development	3.77273656759769e-10	8.320770499836705e-6	8	336	18
DOID:3627	aortic aneurysm	GO:0048705	skeletal system morphogenesis	4.813894838306965e-10	1.061704506588601e-5	7	204	18
DOID:3627	aortic aneurysm	GO:0001568	blood vessel development	8.105126569901699e-10	1.7875856649918198e-5	9	569	18
DOID:3627	aortic aneurysm	GO:0048729	tissue morphogenesis	2.12833517476696e-9	4.69404322794853e-5	9	635	18
DOID:3627	aortic aneurysm	GO:0009790	embryo development	2.77752409960641e-9	6.125829401681937e-5	10	932	18
Orphanet:181412	Adrenogenital syndrome	GO:0006705	mineralocorticoid biosynthetic process	2.9779456678369343e-10	6.5678591704143585e-6	4	12	18
Orphanet:181412	Adrenogenital syndrome	GO:0006702	androgen biosynthetic process	6.014632125683761e-10	1.3265271153195535e-5	4	14	18
Orphanet:181412	Adrenogenital syndrome	GO:0090031	positive regulation of steroid hormone biosynthetic process	3.0075046897337643e-9	6.633051593207817e-5	3	4	18
Orphanet:181412	Adrenogenital syndrome	GO:0006700	C21-steroid hormone biosynthetic process	3.5812187659800543e-9	7.89837798836901e-5	4	21	18
MESH:D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	9.055423078052627e-12	1.9971735598645068e-7	4	6	18
MESH:D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	GO:0032922	circadian regulation of gene expression	1.2405299010254112e-11	2.7359886967115443e-7	6	58	18
MESH:D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	GO:0042752	regulation of circadian rhythm	4.539636444533812e-10	1.0012168178419323e-5	6	104	18
MESH:D003318	Corneal Opacity	GO:0001654	eye development	7.327471962526033e-14	1.6160739413351166e-9	10	327	18
MESH:D003318	Corneal Opacity	GO:0043010	camera-type eye development	1.8572920978954244e-12	4.0962577219083585e-8	9	283	18
MESH:D003318	Corneal Opacity	GO:0048593	camera-type eye morphogenesis	3.5745262305653114e-10	7.883617601511794e-6	6	100	18
MESH:D003318	Corneal Opacity	GO:0048568	embryonic organ development	1.754603573544955e-9	3.869778181453398e-5	8	408	18
MESH:D003560	Cysts	GO:0021915	neural tube development	4.339026804522916e-9	9.569723617375292e-5	6	151	18
DOID:0050773	paraganglioma	GO:0000104	succinate dehydrogenase activity	7.681633107381458e-13	1.6941841818329806e-8	4	4	19
DOID:0050773	paraganglioma	GO:0045257	succinate dehydrogenase complex (ubiquinone)	7.681633107381458e-13	1.6941841818329806e-8	4	4	19
DOID:0050773	paraganglioma	GO:0045283	fumarate reductase complex	7.681633107381458e-13	1.6941841818329806e-8	4	4	19
DOID:0050773	paraganglioma	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	7.681633107381458e-13	1.6941841818329806e-8	4	4	19
DOID:0050773	paraganglioma	GO:0048037	cofactor binding	4.203244530209815e-9	9.270255811377748e-5	7	261	19
DOID:906	peroxisomal disease	GO:0006605	protein targeting	9.769962616701378e-14	2.154765255113489e-9	13	675	19
DOID:906	peroxisomal disease	GO:0009062	fatty acid catabolic process	2.067058746391126e-10	4.5588980651656286e-6	6	86	19
DOID:906	peroxisomal disease	GO:0019395	fatty acid oxidation	2.9229085818371914e-10	6.446474877241926e-6	6	91	19
DOID:906	peroxisomal disease	GO:0031907	microbody lumen	5.114823009577663e-10	1.1280742147623535e-5	5	42	19
DOID:906	peroxisomal disease	GO:0005782	peroxisomal matrix	5.114823009577663e-10	1.1280742147623535e-5	5	42	19
DOID:0050703	infancy electroclinical syndrome	GO:0034702	ion channel complex	1.2783063496613067e-10	2.819304654178012e-6	8	274	19
DOID:0050703	infancy electroclinical syndrome	GO:0022836	gated channel activity	6.278141340132493e-10	1.3846440725662212e-5	8	335	19
DOID:0050703	infancy electroclinical syndrome	GO:0007268	synaptic transmission	2.56696719436178e-9	5.661446147164906e-5	9	605	19
DOID:0050703	infancy electroclinical syndrome	GO:0005216	ion channel activity	3.5303485690363345e-9	7.786183769009636e-5	8	417	19
DOID:13636	Fanconi's anemia	GO:0006310	DNA recombination	3.204933318734504e-9	7.068480434468949e-5	7	251	19
DOID:11372	megacolon	GO:0014033	neural crest cell differentiation	4.6407322429331543e-14	1.0235134961789072e-9	11	75	19
DOID:11372	megacolon	GO:0090066	regulation of anatomical structure size	2.5520063839934437e-10	5.62845007989754e-6	9	465	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0005975	carbohydrate metabolic process	2.549627176051672e-12	5.6232027367819626e-8	12	760	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0070085	glycosylation	3.2678304506816858e-12	7.207200058978458e-8	9	268	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0000139	Golgi membrane	1.114786041256366e-11	2.458660613990915e-7	11	691	19
Orphanet:309526	Disorder of multiple glycosylation	GO:1901137	carbohydrate derivative biosynthetic process	2.114342034786887e-11	4.663181357722479e-7	11	741	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0006487	protein N-linked glycosylation	8.217104774388417e-11	1.8122824579913654e-6	6	74	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0033185	dolichol-phosphate-mannose synthase complex	8.933950246259315e-10	1.9703827268124918e-5	3	3	19
Orphanet:309526	Disorder of multiple glycosylation	GO:0004582	dolichyl-phosphate beta-D-mannosyltransferase activity	3.5712734991477646e-9	7.876443702370395e-5	3	4	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0044437	vacuolar part	8.733014311701481e-13	1.9260663064457617e-8	13	396	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0006643	membrane lipid metabolic process	6.559197629485425e-13	1.4466310371830104e-8	12	191	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:1901565	organonitrogen compound catabolic process	1.361133428190442e-13	3.0019797758740197e-9	10	349	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0046466	membrane lipid catabolic process	3.3306690738754696e-14	7.345790642432348e-10	6	24	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0030149	sphingolipid catabolic process	9.43689570931383e-15	2.0813073486891653e-10	6	21	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0046514	ceramide catabolic process	8.019140906867506e-13	1.7686215270096284e-8	5	13	19
Orphanet:371442	Sphingolipidosis with epilepsy	GO:0005975	carbohydrate metabolic process	7.815155189661027e-10	1.7236324770797395e-5	10	760	19
DOID:2843	long QT syndrome	GO:0006813	potassium ion transport	4.987121826616203e-13	1.0999097188602036e-8	10	213	19
DOID:2843	long QT syndrome	GO:0022832	voltage-gated channel activity	4.853895063661184e-13	1.0705265562904742e-8	9	189	19
DOID:2843	long QT syndrome	GO:0005244	voltage-gated ion channel activity	4.853895063661184e-13	1.0705265562904742e-8	9	189	19
DOID:2843	long QT syndrome	GO:0043270	positive regulation of ion transport	3.672617765460018e-13	8.09995848172207e-9	12	233	19
DOID:2843	long QT syndrome	GO:0002027	regulation of heart rate	1.1612932837579137e-13	2.5612323373280788e-9	15	87	19
DOID:2843	long QT syndrome	GO:0070252	actin-mediated cell contraction	9.903189379656396e-14	2.1841484176832182e-9	12	95	19
DOID:2843	long QT syndrome	GO:0086011	membrane repolarization during action potential	1.4432899320127035e-15	3.1831759450540176e-11	6	15	19
DOID:2843	long QT syndrome	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	7.882583474838611e-15	1.7385037853756558e-10	5	7	19
DOID:2843	long QT syndrome	GO:0042383	sarcolemma	7.382983113757291e-14	1.6283169257391705e-9	8	125	19
DOID:2843	long QT syndrome	GO:0086013	membrane repolarization during cardiac muscle cell action potential	1.5409895581797173e-13	3.3986524705653665e-9	5	10	19
DOID:2843	long QT syndrome	GO:0098900	regulation of action potential	1.339817146117639e-12	2.9549667157624526e-8	6	38	19
DOID:2843	long QT syndrome	GO:2001259	positive regulation of cation channel activity	1.9610124635249804e-10	4.325012988304344e-6	5	35	19
DOID:2843	long QT syndrome	GO:0030018	Z disc	8.78936812220843e-10	1.938495139353069e-5	6	109	19
DOID:2843	long QT syndrome	GO:0014704	intercalated disc	1.1414815759280827e-9	2.5175376157093865e-5	5	49	19
DOID:2843	long QT syndrome	GO:0098901	regulation of cardiac muscle cell action potential	2.939409049496078e-9	6.4828666586636e-5	4	19	19
Orphanet:79214	Disorder of biogenic amine metabolism and transport	GO:0006520	cellular amino acid metabolic process	8.840317367031503e-11	1.949731995298798e-6	9	413	19
Orphanet:79214	Disorder of biogenic amine metabolism and transport	GO:0050662	coenzyme binding	3.8092240473019956e-10	8.401243636324551e-6	7	185	19
Orphanet:309833	Disorder of other vitamins and cofactors metabolism and transport	GO:0051186	cofactor metabolic process	8.888179081623093e-10	1.9602878964519732e-5	8	350	19
Orphanet:309833	Disorder of other vitamins and cofactors metabolism and transport	GO:0006766	vitamin metabolic process	2.3265671611483185e-9	5.1312438739126165e-5	6	128	19
Orphanet:309833	Disorder of other vitamins and cofactors metabolism and transport	GO:0009108	coenzyme biosynthetic process	2.8020483711088673e-9	6.179917682480607e-5	6	132	19
Orphanet:108967	Non-syndromic intestinal malformation	GO:0014033	neural crest cell differentiation	4.6407322429331543e-14	1.0235134961789072e-9	11	75	19
DOID:4676	uremia	GO:0022603	regulation of anatomical structure morphogenesis	5.546674231027282e-13	1.223319001653067e-8	13	986	19
DOID:4676	uremia	GO:0033993	response to lipid	8.413125751616235e-11	1.8555148845189606e-6	11	850	19
DOID:4676	uremia	GO:0014070	response to organic cyclic compound	1.1679202049919013e-10	2.5758480121096383e-6	11	873	19
DOID:4676	uremia	GO:0001501	skeletal system development	3.4870073495341103e-10	7.69059470939748e-6	9	482	19
DOID:4676	uremia	GO:0030198	extracellular matrix organization	4.393526653601043e-10	9.6899230345171e-6	8	320	19
DOID:4676	uremia	GO:0007584	response to nutrient	5.917031309365939e-10	1.3050012552806578e-5	7	197	19
DOID:4676	uremia	GO:0097305	response to alcohol	1.3485600414142596e-9	2.9742491713391495e-5	8	369	19
DOID:4676	uremia	GO:0070848	response to growth factor	3.2255489390564662e-9	7.113948185089036e-5	9	621	19
DOID:4676	uremia	GO:0048771	tissue remodeling	3.8271891211749676e-9	8.440865606751391e-5	6	139	19
Orphanet:79389	Premature aging	GO:0006259	DNA metabolic process	1.2159162565694714e-12	2.6817033038639693e-8	14	937	19
Orphanet:79389	Premature aging	GO:0009416	response to light stimulus	1.694200335577989e-13	3.7365588401172545e-9	11	297	19
Orphanet:79389	Premature aging	GO:0033683	nucleotide-excision repair, DNA incision	8.715250743307479e-14	1.9221485514364645e-9	7	40	19
Orphanet:79389	Premature aging	GO:1990391	DNA repair complex	2.6299540323293513e-10	5.800363618302384e-6	5	37	19
Orphanet:79389	Premature aging	GO:0000109	nucleotide-excision repair complex	7.615325037235721e-10	1.6795599369623382e-5	4	14	19
Orphanet:79389	Premature aging	GO:0006979	response to oxidative stress	1.9222003988517145e-9	4.239412979667456e-5	8	386	19
Orphanet:79389	Premature aging	GO:0003684	damaged DNA binding	2.978000290809746e-9	6.567979641380894e-5	5	59	19
Orphanet:324761	Microcephalic primordial dwarfism	GO:1903047	mitotic cell cycle process	4.594102875898898e-13	1.0132293892795019e-8	13	857	19
Orphanet:324761	Microcephalic primordial dwarfism	GO:0044770	cell cycle phase transition	2.9168889525976738e-12	6.43319858495417e-8	12	517	19
Orphanet:324761	Microcephalic primordial dwarfism	GO:0006260	DNA replication	1.2692291662119715e-11	2.799284926080503e-7	9	337	19
DOID:2730	epidermolysis bullosa	GO:0008544	epidermis development	4.094502514817577e-12	9.030425296430167e-8	9	296	19
DOID:2730	epidermolysis bullosa	GO:0070161	anchoring junction	3.678976012722046e-10	8.113981596058473e-6	9	485	19
Orphanet:98074	Gonadal dysgenesis of gynecological interest	GO:2000018	regulation of male gonad development	1.9984014443252818e-15	4.407474385459409e-11	6	9	19
Orphanet:98074	Gonadal dysgenesis of gynecological interest	GO:0008585	female gonad development	8.312158739087749e-10	1.833246609905803e-5	6	108	19
OMIM:188890	nicotine dependence	GO:0035094	response to nicotine	8.404388296412435e-14	1.8535878387737625e-9	7	54	19
OMIM:188890	nicotine dependence	GO:0070405	ammonium ion binding	2.2293278334473143e-13	4.916782536668052e-9	7	65	19
OMIM:188890	nicotine dependence	GO:0004889	acetylcholine-activated cation-selective channel activity	3.790412428372747e-12	8.359754610776093e-8	5	17	19
OMIM:188890	nicotine dependence	GO:0005892	acetylcholine-gated channel complex	5.211497899892947e-12	1.1493958618213895e-7	5	18	19
OMIM:188890	nicotine dependence	GO:0042166	acetylcholine binding	7.1032069115517515e-12	1.5666122843427388e-7	5	19	19
OMIM:188890	nicotine dependence	GO:0015464	acetylcholine receptor activity	2.5748625454014018e-11	5.678859343882792e-7	5	24	19
OMIM:188890	nicotine dependence	GO:0007271	synaptic transmission, cholinergic	3.469137199729744e-10	7.65118209400395e-6	5	39	19
MESH:D016113	Ichthyosiform Erythroderma, Congenital	GO:0008544	epidermis development	2.354683115157741e-10	5.193253610480397e-6	8	296	19
MESH:D016113	Ichthyosiform Erythroderma, Congenital	GO:0009913	epidermal cell differentiation	2.686549871455668e-10	5.925185741495476e-6	7	176	19
OMIM:605027	Lymphoma, Non-Hodgkin, Familial	GO:0042493	response to drug	1.3612944105290126e-10	3.0023348224217372e-6	9	433	19
Orphanet:98645	Cerebral disease with cataract	GO:0044441	ciliary part	8.93285445613401e-13	1.9701410503003558e-8	10	303	19
DOID:3525	middle cerebral artery infarction	GO:0006954	inflammatory response	1.389285353425862e-10	3.0640688469807387e-6	10	637	19
DOID:3525	middle cerebral artery infarction	GO:0097305	response to alcohol	1.3485600414142596e-9	2.9742491713391495e-5	8	369	19
DOID:3525	middle cerebral artery infarction	GO:0002526	acute inflammatory response	4.171346379422403e-9	9.199904439816109e-5	6	141	19
DOID:3490	Noonan syndrome	GO:0007265	Ras protein signal transduction	4.2033043712308427e-13	9.270387790749623e-9	10	304	19
DOID:3490	Noonan syndrome	GO:0046578	regulation of Ras protein signal transduction	4.785838392251662e-12	1.0555166574111041e-7	8	183	19
DOID:3490	Noonan syndrome	GO:0051057	positive regulation of small GTPase mediated signal transduction	3.0262103933864637e-10	6.674307022613846e-6	5	38	19
DOID:3490	Noonan syndrome	GO:0007173	epidermal growth factor receptor signaling pathway	1.8286074876527891e-9	4.0329938140182264e-5	6	123	19
DOID:3947	adrenal gland hyperfunction	GO:0034765	regulation of ion transmembrane transport	1.2925658321449873e-9	2.8507539427957695e-5	8	367	19
OMIM:611162	Malaria, Susceptibility to	GO:0072593	reactive oxygen species metabolic process	1.4067675913054245e-9	3.102625922624114e-5	7	223	19
OMIM:611162	Malaria, Susceptibility to	GO:0006954	inflammatory response	4.027598143885314e-9	8.882867706339059e-5	9	637	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0006954	inflammatory response	3.4453551123192483e-12	7.598730700220102e-8	11	637	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0050776	regulation of immune response	5.216382881201298e-12	1.1504732444489463e-7	12	816	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0031347	regulation of defense response	2.5511814882861472e-11	5.626630772415098e-7	11	749	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0019221	cytokine-mediated signaling pathway	2.7794988533003107e-11	6.130184720953835e-7	10	534	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0000165	MAPK cascade	7.687761538477389e-11	1.6955358073111881e-6	11	843	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0050778	positive regulation of immune response	8.243017379783169e-11	1.8179974831111778e-6	10	603	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0031663	lipopolysaccharide-mediated signaling pathway	1.1414815759280827e-9	2.5175376157093865e-5	5	49	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:1903034	regulation of response to wounding	2.9163941261955983e-9	6.432107245324392e-5	8	407	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0002697	regulation of immune effector process	3.596587028198428e-9	7.932272690691633e-5	8	418	19
Orphanet:264704	Secondary interstitial lung disease specific to childhood associated with a connective tissue disease	GO:0050707	regulation of cytokine secretion	4.352835536458599e-9	9.60017877565944e-5	6	142	19
Orphanet:156140	Predominantly large-vessel vasculitis	GO:0071222	cellular response to lipopolysaccharide	1.4638501522057368e-10	3.2285215106897525e-6	7	152	20
Orphanet:156140	Predominantly large-vessel vasculitis	GO:0006954	inflammatory response	2.7027813320756877e-10	5.960984227892929e-6	10	637	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0060271	cilium morphogenesis	1.3444800828210646e-12	2.965250822661858e-8	16	218	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0044782	cilium organization	7.400746682151293e-13	1.6322346807484678e-8	17	201	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0042384	cilium assembly	6.814548925149211e-13	1.5029487654416585e-8	16	184	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0044441	ciliary part	6.52145004664817e-13	1.4383058077882538e-8	13	303	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0070491	repressing transcription factor binding	2.5979218776228663e-14	5.729716701097232e-10	8	57	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0034464	BBSome	4.884981308350689e-15	1.0773826275567444e-10	9	9	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0001103	RNA polymerase II repressing transcription factor binding	5.329070518200751e-15	1.1753265027891757e-10	8	27	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0035058	nonmotile primary cilium assembly	5.773159728050814e-15	1.273270378021607e-10	7	27	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0051905	establishment of pigment granule localization	9.658940314238862e-15	2.130279286305381e-10	6	24	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0061512	protein localization to cilium	1.1879386363489175e-14	2.6199986624675375e-10	7	28	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0051904	pigment granule transport	1.8540724511240114e-14	4.089156790954007e-10	6	23	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0032401	establishment of melanosome localization	1.8540724511240114e-14	4.089156790954007e-10	6	23	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0032402	melanosome transport	2.7977620220553945e-14	6.170464139643173e-10	6	22	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0060170	ciliary membrane	5.895284260759581e-14	1.3002049437105256e-9	9	79	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0036064	ciliary basal body	6.750155989720952e-14	1.488746903532956e-9	8	79	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0007601	visual perception	8.026912468039882e-14	1.770335544826196e-9	9	207	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0045494	photoreceptor cell maintenance	9.554579349924097e-13	2.1072624756257596e-8	6	34	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0005813	centrosome	2.3665513992909837e-12	5.2194291111362645e-8	11	482	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0045444	fat cell differentiation	1.3700707235386744e-11	3.0216909807645465e-7	8	196	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0072372	primary cilium	1.5511147921642987e-11	3.420983674118361e-7	8	199	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0035869	ciliary transition zone	4.296918376667236e-11	9.476853479739589e-7	5	25	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0007368	determination of left/right symmetry	1.4736977194118595e-9	3.250240320162856e-5	6	112	20
OMIM:209900	Bardet-Biedl Syndrome 1	GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway	4.201326286867868e-9	9.266025125687083e-5	3	4	20
Orphanet:79174	Disorder of fatty acid oxidation and ketone body metabolism	GO:0019752	carboxylic acid metabolic process	2.2006840794119853e-12	4.8536087371431336e-8	17	967	20
Orphanet:79174	Disorder of fatty acid oxidation and ketone body metabolism	GO:0050662	coenzyme binding	4.849454171562684e-13	1.0695471175381499e-8	9	185	20
Orphanet:79174	Disorder of fatty acid oxidation and ketone body metabolism	GO:0044242	cellular lipid catabolic process	2.779998453661392e-13	6.1312865895502e-9	11	177	20
Orphanet:79174	Disorder of fatty acid oxidation and ketone body metabolism	GO:0046950	cellular ketone body metabolic process	2.0017643098668714e-10	4.414891185411385e-6	4	10	20
Orphanet:79174	Disorder of fatty acid oxidation and ketone body metabolism	GO:1902224	ketone body metabolic process	3.143412197204043e-10	6.932795600933517e-6	4	11	20
DOID:14503	neuronal ceroid lipofuscinosis	GO:0044437	vacuolar part	1.0714495957131476e-10	2.363082083345347e-6	9	396	20
DOID:14503	neuronal ceroid lipofuscinosis	GO:0000323	lytic vacuole	1.1082107453930234e-9	2.4441587989643132e-5	9	515	20
DOID:14503	neuronal ceroid lipofuscinosis	GO:0005764	lysosome	1.1082107453930234e-9	2.4441587989643132e-5	9	515	20
DC:0000057	Bleeding Disorder, Platelet-Type	GO:0007596	blood coagulation	1.6775469902086115e-13	3.6998298869050927e-9	14	352	20
DC:0000057	Bleeding Disorder, Platelet-Type	GO:0030168	platelet activation	2.1804780203638074e-13	4.809044273912377e-9	9	162	20
DC:0000057	Bleeding Disorder, Platelet-Type	GO:0009986	cell surface	8.348354230136579e-10	1.8412295254566224e-5	10	715	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:1903034	regulation of response to wounding	4.589661983800397e-13	1.0122499505271776e-8	11	407	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0050818	regulation of coagulation	1.0902390101819037e-13	2.4045221369561887e-9	9	88	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0061041	regulation of wound healing	1.0036416142611415e-13	2.2135315802529476e-9	10	125	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0061045	negative regulation of wound healing	1.2656542480726785e-14	2.7914004441242923e-10	8	61	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0050819	negative regulation of coagulation	1.0813572259849025e-13	2.3849333619097024e-9	7	51	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	9.393531508194997e-10	2.0717433741324065e-5	6	104	20
Orphanet:182054	Rare thrombotic disease of hematologic origin	GO:0031093	platelet alpha granule lumen	2.7597421015101986e-9	6.086611204880743e-5	5	55	20
Orphanet:98992	Early-onset partial cataract	GO:0070306	lens fiber cell differentiation	6.526612583712676e-11	1.4394444053378308e-6	5	27	20
DOID:14791	Leber congenital amaurosis	GO:0007601	visual perception	2.4091839634365897e-13	5.3134552313593986e-9	11	207	20
DOID:14791	Leber congenital amaurosis	GO:0046530	photoreceptor cell differentiation	1.1013412404281553e-13	2.4290081057642965e-9	7	50	20
DOID:14791	Leber congenital amaurosis	GO:0042461	photoreceptor cell development	1.5698553568199713e-12	3.462315989466447e-8	6	37	20
DOID:14791	Leber congenital amaurosis	GO:0001895	retina homeostasis	5.782374579155203e-11	1.27530271343268e-6	6	66	20
DOID:14791	Leber congenital amaurosis	GO:0042462	eye photoreceptor cell development	1.1499856622521065e-10	2.536293378097021e-6	5	30	20
DOID:14791	Leber congenital amaurosis	GO:0031513	nonmotile primary cilium	4.357529004295202e-9	9.610530218973068e-5	6	134	20
Orphanet:98670	Vitreoretinal degeneration	GO:0031012	extracellular matrix	6.64679422612835e-12	1.4659504665726075e-7	10	423	20
Orphanet:98670	Vitreoretinal degeneration	GO:0007423	sensory organ development	7.678278013401041e-10	1.6934442158555996e-5	9	494	20
Orphanet:98670	Vitreoretinal degeneration	GO:0007601	visual perception	1.2757294109988493e-9	2.813621215957962e-5	7	207	20
Orphanet:98670	Vitreoretinal degeneration	GO:0060041	retina development in camera-type eye	3.801386316837352e-9	8.38395752178478e-5	6	131	20
Orphanet:98669	Congenital vitreoretinal dysplasia	GO:0061299	retina vasculature morphogenesis in camera-type eye	1.2018142037106827e-10	2.6506012262839107e-6	4	9	20
Orphanet:98669	Congenital vitreoretinal dysplasia	GO:0061304	retinal blood vessel morphogenesis	4.201326286867868e-9	9.266025125687083e-5	3	4	20
MESH:D001766	Blindness	GO:0098858	actin-based cell projection	1.9984014443252818e-14	4.407474385459409e-10	9	179	20
MESH:D001766	Blindness	GO:0007601	visual perception	1.2757294109988493e-9	2.813621215957962e-5	7	207	20
DOID:13359	Ehlers-Danlos syndrome	GO:0030199	collagen fibril organization	2.0650148258027912e-14	4.554390198308056e-10	8	38	20
DOID:13359	Ehlers-Danlos syndrome	GO:0032963	collagen metabolic process	1.409461436452375e-11	3.108567198095713e-7	7	109	20
DOID:13359	Ehlers-Danlos syndrome	GO:0030574	collagen catabolic process	6.335043600813606e-11	1.3971938661594407e-6	6	67	20
DOID:13359	Ehlers-Danlos syndrome	GO:0005201	extracellular matrix structural constituent	1.1696166257735285e-10	2.579589468143517e-6	6	74	20
DOID:13359	Ehlers-Danlos syndrome	GO:0048407	platelet-derived growth factor binding	3.143412197204043e-10	6.932795600933517e-6	4	11	20
DOID:13359	Ehlers-Danlos syndrome	GO:0043206	extracellular fibril organization	6.801439411674437e-10	1.500057462244797e-5	4	13	20
DOID:13359	Ehlers-Danlos syndrome	GO:0043588	skin development	3.6767670019699494e-9	8.109109622844723e-5	7	241	20
DOID:3614	Kallmann syndrome	GO:0008543	fibroblast growth factor receptor signaling pathway	9.95704074746584e-10	2.196025336853591e-5	6	105	20
DOID:3587	pancreatic ductal carcinoma	GO:0048844	artery morphogenesis	1.0813572259849025e-13	2.3849333619097024e-9	7	51	20
DOID:3587	pancreatic ductal carcinoma	GO:0007219	Notch signaling pathway	1.8385293287792592e-13	4.054876434622656e-9	10	162	20
DOID:3587	pancreatic ductal carcinoma	GO:0008593	regulation of Notch signaling pathway	5.647704526268171e-13	1.2456012332684452e-8	7	66	20
DOID:3587	pancreatic ductal carcinoma	GO:0097084	vascular smooth muscle cell development	3.342826015995115e-11	7.372602778277226e-7	4	7	20
DOID:3587	pancreatic ductal carcinoma	GO:0003184	pulmonary valve morphogenesis	1.2018142037106827e-10	2.6506012262839107e-6	4	9	20
DOID:3587	pancreatic ductal carcinoma	GO:0042491	auditory receptor cell differentiation	1.6234946720317112e-10	3.580617499165939e-6	5	32	20
DOID:3587	pancreatic ductal carcinoma	GO:0061314	Notch signaling involved in heart development	2.0017643098668714e-10	4.414891185411385e-6	4	10	20
DOID:3587	pancreatic ductal carcinoma	GO:0060948	cardiac vascular smooth muscle cell development	1.0510513570594071e-9	2.3180937679945224e-5	3	3	20
DOID:3587	pancreatic ductal carcinoma	GO:0060411	cardiac septum morphogenesis	1.519051995302334e-9	3.350269175639298e-5	5	49	20
DOID:3587	pancreatic ductal carcinoma	GO:0007220	Notch receptor processing	1.727738285772773e-9	3.810526789271851e-5	4	16	20
DOID:3587	pancreatic ductal carcinoma	GO:0005112	Notch binding	2.9008342394831743e-9	6.397789915180141e-5	4	18	20
DOID:3587	pancreatic ductal carcinoma	GO:0045165	cell fate commitment	3.893352751305201e-9	8.586789493003621e-5	7	243	20
DOID:3587	pancreatic ductal carcinoma	GO:0045596	negative regulation of cell differentiation	4.0348326901806786e-9	8.898823498193487e-5	9	597	20
Orphanet:29072	Hereditary pheochromocytoma-paraganglioma	GO:0000104	succinate dehydrogenase activity	9.57012247226885e-13	2.1106905112588947e-8	4	4	20
Orphanet:29072	Hereditary pheochromocytoma-paraganglioma	GO:0045257	succinate dehydrogenase complex (ubiquinone)	9.57012247226885e-13	2.1106905112588947e-8	4	4	20
Orphanet:29072	Hereditary pheochromocytoma-paraganglioma	GO:0045283	fumarate reductase complex	9.57012247226885e-13	2.1106905112588947e-8	4	4	20
Orphanet:29072	Hereditary pheochromocytoma-paraganglioma	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	9.57012247226885e-13	2.1106905112588947e-8	4	4	20
Orphanet:29072	Hereditary pheochromocytoma-paraganglioma	GO:0006099	tricarboxylic acid cycle	9.585032767489565e-11	2.1139789768698236e-6	5	29	20
DOID:898	polycystic kidney disease	GO:0072372	primary cilium	9.938716516444401e-13	2.1919839277018127e-8	13	199	21
DOID:898	polycystic kidney disease	GO:0060271	cilium morphogenesis	9.485745522397337e-13	2.0920811749647328e-8	10	218	21
DOID:898	polycystic kidney disease	GO:0042384	cilium assembly	6.463718449367661e-13	1.4255731040080377e-8	9	184	21
DOID:898	polycystic kidney disease	GO:0035869	ciliary transition zone	5.0182080713057076e-14	1.1067657901264738e-9	7	25	21
DOID:898	polycystic kidney disease	GO:0072001	renal system development	3.563905837111747e-10	7.860194323749958e-6	8	276	21
DOID:898	polycystic kidney disease	GO:0002009	morphogenesis of an epithelium	1.619748557502021e-9	3.572355443570707e-5	9	506	21
OMIM:268000	Retinitis Pigmentosa	GO:0072372	primary cilium	9.938716516444401e-13	2.1919839277018127e-8	12	199	21
OMIM:268000	Retinitis Pigmentosa	GO:0007600	sensory perception	4.18332035678759e-13	9.22631304689503e-9	19	902	21
OMIM:268000	Retinitis Pigmentosa	GO:0001894	tissue homeostasis	2.313704783318826e-13	5.102875899609671e-9	9	197	21
OMIM:268000	Retinitis Pigmentosa	GO:0007601	visual perception	1.9917401061775308e-13	4.392782804174544e-9	19	207	21
OMIM:268000	Retinitis Pigmentosa	GO:0001750	photoreceptor outer segment	1.5543122344752192e-15	3.428035633135096e-11	9	69	21
OMIM:268000	Retinitis Pigmentosa	GO:0045494	photoreceptor cell maintenance	8.01581023779363e-14	1.7678869479453851e-9	7	34	21
OMIM:268000	Retinitis Pigmentosa	GO:0009584	detection of visible light	8.115730310009894e-14	1.7899243198726822e-9	8	62	21
OMIM:268000	Retinitis Pigmentosa	GO:0060170	ciliary membrane	2.141398169897002e-12	4.722853663707838e-8	7	79	21
OMIM:268000	Retinitis Pigmentosa	GO:0007603	phototransduction, visible light	2.9510838217561286e-12	6.508615368883142e-8	6	39	21
OMIM:268000	Retinitis Pigmentosa	GO:0060041	retina development in camera-type eye	7.625633458019365e-11	1.681833459166171e-6	7	131	21
OMIM:268000	Retinitis Pigmentosa	GO:0022400	regulation of rhodopsin mediated signaling pathway	1.2571799157257146e-10	2.7727103041330636e-6	5	29	21
OMIM:268000	Retinitis Pigmentosa	GO:0001917	photoreceptor inner segment	3.9704983745281197e-10	8.756934165021768e-6	5	36	21
OMIM:268000	Retinitis Pigmentosa	GO:0001523	retinoid metabolic process	4.726982139047209e-10	1.042535910766862e-5	6	88	21
OMIM:268000	Retinitis Pigmentosa	GO:0046530	photoreceptor cell differentiation	2.209204708059076e-9	4.872400983624292e-5	5	50	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0002250	adaptive immune response	5.666578317686799e-13	1.2497638479658235e-8	10	334	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	2.569056078982612e-13	5.666053182196151e-9	10	212	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0002443	leukocyte mediated immunity	1.2463363674442007e-12	2.7487948583981847e-8	11	279	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0050776	regulation of immune response	4.2842396297260166e-12	9.44889050336073e-8	13	816	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	5.567546423890235e-12	1.2279223637889913e-7	6	43	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0050778	positive regulation of immune response	1.0557887897277851e-11	2.32854217574463e-7	11	603	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0002521	leukocyte differentiation	1.693056805862625e-11	3.7340367853300194e-7	10	448	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0045589	regulation of regulatory T cell differentiation	5.818484583031136e-10	1.283266774787517e-5	4	12	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0071345	cellular response to cytokine stimulus	9.04193608874948e-10	1.994199004373698e-5	10	677	21
DOID:0060031	autoimmune disease of gastrointestinal tract	GO:0019221	cytokine-mediated signaling pathway	2.595111681102935e-9	5.7235188126725234e-5	9	534	21
Orphanet:217610	Neuromuscular disease with dilated cardiomyopathy	GO:0007517	muscle organ development	1.2423395645555502e-12	2.739979909627266e-8	11	340	21
Orphanet:217610	Neuromuscular disease with dilated cardiomyopathy	GO:0042692	muscle cell differentiation	3.9565573040079016e-11	8.726187133989427e-7	9	334	21
Orphanet:217610	Neuromuscular disease with dilated cardiomyopathy	GO:0055001	muscle cell development	1.2230727541862052e-10	2.6974869593576756e-6	7	140	21
Orphanet:217610	Neuromuscular disease with dilated cardiomyopathy	GO:0014706	striated muscle tissue development	1.231809432233888e-9	2.71675570279184e-5	8	323	21
DOID:4123	nail disease	GO:0008544	epidermis development	7.454037387333301e-13	1.6439879457763595e-8	12	296	21
DOID:4123	nail disease	GO:0042633	hair cycle	1.4999113062685865e-13	3.3080543859753675e-9	8	101	21
DOID:4123	nail disease	GO:0035878	nail development	1.4843493101324157e-10	3.2737324034970428e-6	4	9	21
DOID:4123	nail disease	GO:0022405	hair cycle process	2.636950657830539e-10	5.815794675845254e-6	6	80	21
DOID:4123	nail disease	GO:0001942	hair follicle development	2.636950657830539e-10	5.815794675845254e-6	6	80	21
DOID:4123	nail disease	GO:0005882	intermediate filament	1.1625151952188162e-9	2.563927263055099e-5	7	193	21
OMIM:189960	Tracheoesophageal Fistula With or Without Esophageal Atresia	GO:0006259	DNA metabolic process	2.5157653738006047e-13	5.548520531917234e-9	16	937	21
OMIM:189960	Tracheoesophageal Fistula With or Without Esophageal Atresia	GO:0043240	Fanconi anaemia nuclear complex	1.3766765505351941e-14	3.0362601322053706e-10	8	14	21
OMIM:189960	Tracheoesophageal Fistula With or Without Esophageal Atresia	GO:0036297	interstrand cross-link repair	4.0967229608668276e-14	9.035322490191788e-10	12	45	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:0006954	inflammatory response	1.1590728377086634e-13	2.556335143566457e-9	14	637	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:1903035	negative regulation of response to wounding	4.161782030109862e-12	9.1788102674073e-8	8	159	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:0032692	negative regulation of interleukin-1 production	6.575184841040027e-12	1.450157016691378e-7	5	17	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:0050728	negative regulation of inflammatory response	1.1399658994548645e-11	2.5141947912477036e-7	7	100	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:0009617	response to bacterium	1.955261730302027e-9	4.3123297461811205e-5	9	517	21
MESH:D056660	Hereditary Autoinflammatory Diseases	GO:0032611	interleukin-1 beta production	4.343869375311726e-9	9.580403907250012e-5	5	57	21
OMIM:244400	Kartagener syndrome	GO:0060271	cilium morphogenesis	9.607870055106105e-13	2.1190157406536514e-8	16	218	21
OMIM:244400	Kartagener syndrome	GO:0007018	microtubule-based movement	8.857359290459499e-13	1.9534905915108425e-8	11	213	21
OMIM:244400	Kartagener syndrome	GO:0042384	cilium assembly	8.375522497772181e-13	1.8472214868836545e-8	16	184	21
OMIM:244400	Kartagener syndrome	GO:0070286	axonemal dynein complex assembly	4.263256414560601e-14	9.402612022313406e-10	12	22	21
OMIM:244400	Kartagener syndrome	GO:0036158	outer dynein arm assembly	1.021405182655144e-14	2.2527091303459201e-10	8	12	21
OMIM:244400	Kartagener syndrome	GO:0044441	ciliary part	6.8833827526759706e-15	1.5181300661026853e-10	12	303	21
OMIM:244400	Kartagener syndrome	GO:0044447	axoneme part	1.9317880628477724e-14	4.260558572610762e-10	7	30	21
OMIM:244400	Kartagener syndrome	GO:0003341	cilium movement	8.237854842718662e-14	1.8168588855616008e-9	10	43	21
OMIM:244400	Kartagener syndrome	GO:0009799	specification of symmetry	3.226308109560705e-13	7.115622535636135e-9	8	122	21
OMIM:244400	Kartagener syndrome	GO:0009855	determination of bilateral symmetry	5.424549698318515e-13	1.1963844359641485e-8	8	121	21
OMIM:244400	Kartagener syndrome	GO:0007368	determination of left/right symmetry	6.589173651150304e-13	1.4532422487611996e-8	8	112	21
OMIM:244400	Kartagener syndrome	GO:0005858	axonemal dynein complex	1.396882609583372e-12	3.080824595436127e-8	5	13	21
OMIM:244400	Kartagener syndrome	GO:0036157	outer dynein arm	5.900391286672857e-12	1.3013312982756986e-7	4	5	21
OMIM:244400	Kartagener syndrome	GO:0044458	motile cilium assembly	1.1749472506039638e-9	2.591346161207042e-5	4	14	21
DOID:14221	metabolic syndrome X	GO:0045598	regulation of fat cell differentiation	1.601663246475482e-11	3.5324682901016757e-7	7	105	21
DOID:14221	metabolic syndrome X	GO:0032868	response to insulin	1.0903689062757849e-10	2.4048086227912435e-6	8	238	21
DOID:14221	metabolic syndrome X	GO:0010876	lipid localization	1.5644670003922556e-9	3.45043196936512e-5	8	333	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0090665	glycoprotein complex	2.4202861936828413e-14	5.337941200167506e-10	6	21	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0016010	dystrophin-associated glycoprotein complex	2.4202861936828413e-14	5.337941200167506e-10	6	21	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0016011	dystroglycan complex	3.0531133177191805e-14	6.733641422229653e-10	5	7	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0035269	protein O-linked mannosylation	4.64805971489568e-12	1.0251295701202423e-7	5	16	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0008307	structural constituent of muscle	7.863637518923383e-10	1.734325254798552e-5	5	41	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0044449	contractile fiber part	1.294866769363523e-9	2.85582865983125e-5	7	196	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0030016	myofibril	1.5437401357232261e-9	3.404718869337575e-5	7	201	21
Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy	GO:0007517	muscle organ development	1.8426897785417395e-9	4.0640523065738066e-5	8	340	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0043434	response to peptide hormone	5.782041512247815e-13	1.2752292555262557e-8	11	389	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0050796	regulation of insulin secretion	5.5289106626332796e-14	1.2194012466437698e-9	11	169	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0046888	negative regulation of hormone secretion	1.3959944311636718e-12	3.078865717931478e-8	7	74	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0032868	response to insulin	1.687983086640088e-12	3.722846697584714e-8	9	238	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0010907	positive regulation of glucose metabolic process	1.7772450178199506e-12	3.919713886801901e-8	6	36	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0006111	regulation of gluconeogenesis	2.9510838217561286e-12	6.508615368883142e-8	6	39	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0090278	negative regulation of peptide hormone secretion	9.617640017722806e-12	2.121170505908765e-7	6	47	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0032870	cellular response to hormone stimulus	6.949985031923234e-11	1.5328191987906692e-6	10	519	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0071375	cellular response to peptide hormone stimulus	4.584953527952962e-10	1.0112115005900257e-5	8	285	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0046676	negative regulation of insulin secretion	8.921037242259899e-10	1.9675347637804208e-5	5	42	21
Orphanet:165985	Diazoxide-sensitive diffuse hyperinsulinism	GO:0045725	positive regulation of glycogen biosynthetic process	1.6010484049644447e-9	3.531112257149083e-5	4	15	21
MESH:D006948	Hyperkinesis	GO:0007611	learning or memory	9.605649609056854e-13	2.1185260212774892e-8	11	218	21
MESH:D006948	Hyperkinesis	GO:0007613	memory	2.994271497414047e-13	6.603865787546681e-9	8	99	21
MESH:D006948	Hyperkinesis	GO:0015872	dopamine transport	1.0060841049153169e-12	2.2189184933907313e-8	6	33	21
MESH:D006948	Hyperkinesis	GO:0007268	synaptic transmission	2.2836177393514845e-12	5.036518924139699e-8	12	605	21
MESH:D006948	Hyperkinesis	GO:0030424	axon	8.433587161960077e-12	1.860027648570295e-7	10	414	21
MESH:D006948	Hyperkinesis	GO:0043025	neuronal cell body	1.3403167464787202e-11	2.9560685843588175e-7	10	434	21
MESH:D006948	Hyperkinesis	GO:0007270	neuron-neuron synaptic transmission	7.212308528181666e-11	1.5906746458904664e-6	7	130	21
MESH:D006948	Hyperkinesis	GO:0007612	learning	7.212308528181666e-11	1.5906746458904664e-6	7	130	21
MESH:D006948	Hyperkinesis	GO:0007616	long-term memory	1.0408540696005275e-10	2.2956036505039634e-6	5	28	21
MESH:D006948	Hyperkinesis	GO:0045761	regulation of adenylate cyclase activity	1.0593681487591766e-10	2.336436452088364e-6	6	69	21
MESH:D006948	Hyperkinesis	GO:0010243	response to organonitrogen compound	1.5562418020920177e-10	3.432291294513945e-6	11	780	21
MESH:D006948	Hyperkinesis	GO:0015837	amine transport	2.4404167575653446e-10	5.3823391588103675e-6	6	79	21
MESH:D006948	Hyperkinesis	GO:0035240	dopamine binding	3.8819492065300665e-10	8.561638975002062e-6	4	11	21
MESH:D006948	Hyperkinesis	GO:0050804	modulation of synaptic transmission	4.584953527952962e-10	1.0112115005900257e-5	8	285	21
MESH:D006948	Hyperkinesis	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	5.410406567207815e-10	1.1932651683976836e-5	7	173	21
MESH:D006948	Hyperkinesis	GO:0007631	feeding behavior	1.46966805392168e-9	3.241352892924265e-5	6	106	21
MESH:D006948	Hyperkinesis	GO:0051966	regulation of synaptic transmission, glutamatergic	2.209204708059076e-9	4.872400983624292e-5	5	50	21
MESH:D006948	Hyperkinesis	GO:0033267	axon part	2.6319065815627596e-9	5.804669965636666e-5	7	217	21
MESH:D006948	Hyperkinesis	GO:0035094	response to nicotine	3.2880697053983e-9	7.25183773525595e-5	5	54	21
DOID:12365	malaria	GO:0009617	response to bacterium	1.955261730302027e-9	4.3123297461811205e-5	9	517	21
Orphanet:98733	Noonan syndrome and Noonan-related syndrome	GO:0048679	regulation of axon regeneration	3.5812187659800543e-9	7.89837798836901e-5	4	18	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0044437	vacuolar part	1.2467804566540508e-12	2.749774297150509e-8	17	396	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:1901565	organonitrogen compound catabolic process	4.547473508864641e-13	1.0029452823800966e-8	13	349	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:1901136	carbohydrate derivative catabolic process	3.3506530883187224e-13	7.389865386286942e-9	13	177	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0030203	glycosaminoglycan metabolic process	1.8474111129762605e-13	4.0744652096691425e-9	12	161	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0043202	lysosomal lumen	8.948397578478762e-14	1.973569085933491e-9	15	87	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	6.639133687258436e-14	1.464260934724848e-9	10	94	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0044273	sulfur compound catabolic process	1.865174681370263e-14	4.113642759762115e-10	7	39	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:1903510	mucopolysaccharide metabolic process	6.022959908591474e-13	1.3283638078398496e-8	8	113	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0008484	sulfuric ester hydrolase activity	6.575184841040027e-12	1.450157016691378e-7	5	17	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0009311	oligosaccharide metabolic process	6.654043982479152e-11	1.467549400335777e-6	6	64	21
Orphanet:93448	Lysosomal storage disease with skeletal involvement	GO:0030207	chondroitin sulfate catabolic process	1.1749472506039638e-9	2.591346161207042e-5	4	14	21
DOID:3451	skin carcinoma	GO:0045165	cell fate commitment	1.2904588508888537e-10	2.846106995635367e-6	8	243	21
DOID:3390	palmoplantar keratosis	GO:0045104	intermediate filament cytoskeleton organization	8.921037242259899e-10	1.9675347637804208e-5	5	42	21
DOID:3390	palmoplantar keratosis	GO:0005882	intermediate filament	1.1625151952188162e-9	2.563927263055099e-5	7	193	21
DOID:0060061	cutaneous T cell lymphoma	GO:0001775	cell activation	1.0345058143457209e-12	2.2816025735394874e-8	14	854	22
DOID:0060061	cutaneous T cell lymphoma	GO:0030098	lymphocyte differentiation	1.5498713423767185e-13	3.4182412456118527e-9	10	299	22
DOID:0060061	cutaneous T cell lymphoma	GO:0045086	positive regulation of interleukin-2 biosynthetic process	1.0996759058912176e-12	2.4253352104430803e-8	5	12	22
DOID:0060061	cutaneous T cell lymphoma	GO:0051249	regulation of lymphocyte activation	4.392042285417119e-12	9.686649260487457e-8	10	372	22
DOID:0060061	cutaneous T cell lymphoma	GO:0050864	regulation of B cell activation	1.64790403545112e-11	3.634452350187445e-7	7	100	22
DOID:0060061	cutaneous T cell lymphoma	GO:0070489	T cell aggregation	1.954936212911207e-11	4.311611817575667e-7	10	424	22
DOID:0060061	cutaneous T cell lymphoma	GO:0042110	T cell activation	1.954936212911207e-11	4.311611817575667e-7	10	424	22
DOID:0060061	cutaneous T cell lymphoma	GO:0007568	aging	2.044486802077472e-11	4.5091156419818645e-7	9	290	22
DOID:0060061	cutaneous T cell lymphoma	GO:0097285	cell-type specific apoptotic process	2.195066350907382e-11	4.841218836926231e-7	10	429	22
DOID:0060061	cutaneous T cell lymphoma	GO:1902533	positive regulation of intracellular signal transduction	3.8367753418810935e-11	8.462008016518752e-7	12	860	22
DOID:0060061	cutaneous T cell lymphoma	GO:0030217	T cell differentiation	3.9884096025843974e-11	8.796437378499888e-7	8	199	22
DOID:0060061	cutaneous T cell lymphoma	GO:0045619	regulation of lymphocyte differentiation	1.0515188719750768e-10	2.319124872141032e-6	7	130	22
DOID:0060061	cutaneous T cell lymphoma	GO:0070661	leukocyte proliferation	4.1225067803907223e-10	9.092188704151738e-6	8	266	22
DOID:0060061	cutaneous T cell lymphoma	GO:0045058	T cell selection	1.469160126887914e-9	3.240232659851294e-5	5	44	22
DOID:0060061	cutaneous T cell lymphoma	GO:0045580	regulation of T cell differentiation	1.899069346222859e-9	4.188397443094516e-5	6	105	22
DOID:0060061	cutaneous T cell lymphoma	GO:0070663	regulation of leukocyte proliferation	2.1674166905683023e-9	4.780237511048391e-5	7	200	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0019221	cytokine-mediated signaling pathway	1.6300716332295906e-10	3.595122987087862e-6	10	534	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0006959	humoral immune response	7.872910101625052e-10	1.7363703229134053e-5	7	173	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0002684	positive regulation of immune system process	9.529311784106653e-10	2.1016897139847224e-5	11	872	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0032101	regulation of response to external stimulus	1.678429728535491e-9	3.7017767662850254e-5	11	920	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0031347	regulation of defense response	4.248348450808237e-9	9.369732508257567e-5	10	749	22
MESH:D017444	Skin Diseases, Papulosquamous	GO:0042742	defense response to bacterium	4.478776349792213e-9	9.877941239466725e-5	7	222	22
Orphanet:202948	Syndromic microphthalmia	GO:0001654	eye development	5.664724245235675e-11	1.2493549322867281e-6	9	327	22
Orphanet:248296	Constitutional deficiency anemia	GO:0051180	vitamin transport	1.3692380562702056e-12	3.0198545331039384e-8	6	33	22
Orphanet:248296	Constitutional deficiency anemia	GO:0019842	vitamin binding	3.1969982217106008e-12	7.05097957798273e-8	7	79	22
Orphanet:248296	Constitutional deficiency anemia	GO:0042558	pteridine-containing compound metabolic process	3.7934788643667616e-10	8.366517635360893e-6	5	34	22
DOID:14447	gonadal dysgenesis	GO:2000018	regulation of male gonad development	1.7630341631047486e-13	3.888371846727523e-9	5	9	22
DOID:14447	gonadal dysgenesis	GO:0008202	steroid metabolic process	1.5905055050779993e-12	3.5078598914495274e-8	11	275	22
DOID:14447	gonadal dysgenesis	GO:0006694	steroid biosynthetic process	3.8792302703427595e-12	8.555642361240956e-8	8	149	22
DOID:14447	gonadal dysgenesis	GO:0008585	female gonad development	2.8582136657462343e-11	6.30379023980332e-7	7	108	22
Orphanet:319328	Inherited renal cancer-predisposing syndrome	GO:0008285	negative regulation of cell proliferation	2.0965451597021456e-12	4.623930349723082e-8	12	634	22
Orphanet:319328	Inherited renal cancer-predisposing syndrome	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	3.4046672148235757e-9	7.508993542293396e-5	10	732	22
Orphanet:309813	Disorder of porphyrin and haem metabolism	GO:0042493	response to drug	6.807928665253371e-10	1.501488667121631e-5	9	433	22
DOID:2212	coagulation protein disease	GO:0061041	regulation of wound healing	3.3795188869589765e-13	7.453528905188023e-9	9	125	22
DOID:2212	coagulation protein disease	GO:0034774	secretory granule lumen	1.0547118733938987e-13	2.3261670367702436e-9	9	85	22
DOID:2212	coagulation protein disease	GO:1900046	regulation of hemostasis	1.0547118733938987e-13	2.3261670367702436e-9	9	85	22
DOID:2212	coagulation protein disease	GO:0030193	regulation of blood coagulation	1.0547118733938987e-13	2.3261670367702436e-9	9	85	22
DOID:2212	coagulation protein disease	GO:0031093	platelet alpha granule lumen	5.329070518200751e-15	1.1753265027891757e-10	9	55	22
DOID:2212	coagulation protein disease	GO:0007597	blood coagulation, intrinsic pathway	2.7200464103316335e-14	5.999062357986418e-10	6	19	22
DOID:2212	coagulation protein disease	GO:0002576	platelet degranulation	8.593126210598712e-14	1.895213985747546e-9	9	106	22
DOID:2212	coagulation protein disease	GO:0018214	protein carboxylation	6.346034808757395e-13	1.3996179770714434e-8	5	11	22
DOID:2212	coagulation protein disease	GO:0017187	peptidyl-glutamic acid carboxylation	6.346034808757395e-13	1.3996179770714434e-8	5	11	22
DOID:2212	coagulation protein disease	GO:0072562	blood microparticle	4.16717771400954e-11	9.190710448248041e-7	7	114	22
DOID:2212	coagulation protein disease	GO:0030168	platelet activation	4.970329703368748e-10	1.0962062160779773e-5	7	162	22
DOID:2212	coagulation protein disease	GO:0006888	ER to Golgi vesicle-mediated transport	6.411147168705611e-10	1.4139785080580225e-5	7	168	22
DOID:2212	coagulation protein disease	GO:0051917	regulation of fibrinolysis	1.4354173405450865e-9	3.165812944572188e-5	4	14	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0001525	angiogenesis	1.7634782523145986e-12	3.889351285479847e-8	11	413	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0001666	response to hypoxia	2.202749094237788e-11	4.858163127341442e-7	9	292	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0030334	regulation of cell migration	1.2554861594793465e-9	2.7689747247316987e-5	10	660	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0007160	cell-matrix adhesion	1.6301128225038042e-9	3.59521383003214e-5	7	192	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0030198	extracellular matrix organization	1.7720869216475421e-9	3.908337705693654e-5	8	320	22
OMIM:614519	Hemorrhage, Intracerebral, Susceptibility to	GO:0097191	extrinsic apoptotic signaling pathway	4.206060055800265e-9	9.276465453067484e-5	7	220	22
MESH:D000138	Acidosis	GO:0006885	regulation of pH	7.427679582505675e-10	1.6381747319216267e-5	6	90	22
Orphanet:79391	Immune deficiency with skin involvement	GO:0019882	antigen processing and presentation	4.0747537566332426e-9	8.986869410254616e-5	7	219	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:1900046	regulation of hemostasis	6.572520305780927e-14	1.4495693534399834e-9	8	85	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:0030193	regulation of blood coagulation	6.572520305780927e-14	1.4495693534399834e-9	8	85	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:0072378	blood coagulation, fibrin clot formation	2.4091839634365897e-13	5.3134552313593986e-9	6	26	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:0016485	protein processing	1.3105273533042805e-9	2.8903680777125906e-5	8	308	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:1900047	negative regulation of hemostasis	2.569887969094964e-9	5.667887915838943e-5	5	49	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:0030195	negative regulation of blood coagulation	2.569887969094964e-9	5.667887915838943e-5	5	49	22
OMIM:188050	Thrombophilia Due to Thrombin Defect	GO:0006953	acute-phase response	3.855476937708602e-9	8.503254386116321e-5	5	53	22
OMIM:115000	Cardiac Arrhythmia	GO:0042391	regulation of membrane potential	1.233901869568399e-12	2.721370573333104e-8	12	340	22
OMIM:115000	Cardiac Arrhythmia	GO:0035637	multicellular organismal signaling	8.404388296412435e-13	1.8535878387737625e-8	11	184	22
OMIM:115000	Cardiac Arrhythmia	GO:0090257	regulation of muscle system process	7.256417688950023e-13	1.6004029212979276e-8	12	213	22
OMIM:115000	Cardiac Arrhythmia	GO:1903522	regulation of blood circulation	3.590461261637756e-13	7.918762312542071e-9	15	297	22
OMIM:115000	Cardiac Arrhythmia	GO:0008016	regulation of heart contraction	2.1049828546892968e-13	4.642539686017244e-9	11	224	22
OMIM:115000	Cardiac Arrhythmia	GO:0001508	action potential	2.071676163950542e-13	4.569081779592921e-9	10	119	22
OMIM:115000	Cardiac Arrhythmia	GO:0070252	actin-mediated cell contraction	1.545430450278218e-13	3.4084468580886096e-9	10	95	22
OMIM:115000	Cardiac Arrhythmia	GO:0006941	striated muscle contraction	1.2945200467129325e-13	2.8550639630253727e-9	10	150	22
OMIM:115000	Cardiac Arrhythmia	GO:0086005	ventricular cardiac muscle cell action potential	9.658940314238862e-14	2.130279286305381e-9	8	24	22
OMIM:115000	Cardiac Arrhythmia	GO:0086009	membrane repolarization	3.952393967665557e-14	8.717004895686387e-10	8	36	22
OMIM:115000	Cardiac Arrhythmia	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	3.6193270602780103e-14	7.982425831443152e-10	6	17	22
OMIM:115000	Cardiac Arrhythmia	GO:0051899	membrane depolarization	3.1530333899354446e-14	6.954015141502623e-10	8	94	22
OMIM:115000	Cardiac Arrhythmia	GO:0002027	regulation of heart rate	1.554312234475219e-14	3.428035633135096e-10	11	87	22
OMIM:115000	Cardiac Arrhythmia	GO:0086091	regulation of heart rate by cardiac conduction	1.2656542480726785e-14	2.7914004441242923e-10	9	30	22
OMIM:115000	Cardiac Arrhythmia	GO:0086019	cell-cell signaling involved in cardiac conduction	7.815970093361102e-14	1.723812204090791e-9	6	23	22
OMIM:115000	Cardiac Arrhythmia	GO:0043270	positive regulation of ion transport	1.425526363618701e-13	3.143998394961045e-9	11	233	22
OMIM:115000	Cardiac Arrhythmia	GO:0010959	regulation of metal ion transport	1.2043699371133698e-12	2.656237896303537e-8	11	321	22
OMIM:115000	Cardiac Arrhythmia	GO:0086014	atrial cardiac muscle cell action potential	2.7738922270259536e-12	6.117819306705741e-8	5	14	22
OMIM:115000	Cardiac Arrhythmia	GO:0022843	voltage-gated cation channel activity	3.8792302703427595e-12	8.555642361240956e-8	8	149	22
OMIM:115000	Cardiac Arrhythmia	GO:1903524	positive regulation of blood circulation	7.158384995875622e-12	1.5787818108403684e-7	7	89	22
OMIM:115000	Cardiac Arrhythmia	GO:0086010	membrane depolarization during action potential	8.741674051293558e-12	1.927976212012794e-7	6	44	22
OMIM:115000	Cardiac Arrhythmia	GO:1904062	regulation of cation transmembrane transport	8.991363209531755e-12	1.9830451558622286e-7	8	165	22
OMIM:115000	Cardiac Arrhythmia	GO:0034703	cation channel complex	9.450329407911795e-12	2.0842701509149464e-7	8	166	22
OMIM:115000	Cardiac Arrhythmia	GO:0086012	membrane depolarization during cardiac muscle cell action potential	1.17957865697349e-11	2.6015607279550323e-7	5	18	22
OMIM:115000	Cardiac Arrhythmia	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	5.0460524647633065e-11	1.1129068711035472e-6	4	7	22
OMIM:115000	Cardiac Arrhythmia	GO:1901379	regulation of potassium ion transmembrane transport	6.103495486797783e-11	1.346125929613251e-6	6	60	22
OMIM:115000	Cardiac Arrhythmia	GO:0098797	plasma membrane protein complex	8.433376219585398e-11	1.8599811252295595e-6	10	499	22
OMIM:115000	Cardiac Arrhythmia	GO:1904064	positive regulation of cation transmembrane transport	1.452266085166798e-10	3.2029728508353728e-6	6	69	22
OMIM:115000	Cardiac Arrhythmia	GO:0086013	membrane repolarization during cardiac muscle cell action potential	3.020776961903948e-10	6.662323589479158e-6	4	10	22
OMIM:115000	Cardiac Arrhythmia	GO:0098900	regulation of action potential	6.820496389892128e-10	1.5042604787907088e-5	5	38	22
OMIM:115000	Cardiac Arrhythmia	GO:0050801	ion homeostasis	1.4102072842803182e-9	3.110212165480242e-5	10	668	22
OMIM:115000	Cardiac Arrhythmia	GO:2000021	regulation of ion homeostasis	1.4604156772790589e-9	3.220946776238964e-5	7	189	22
OMIM:115000	Cardiac Arrhythmia	GO:0044325	ion channel binding	2.3823500949760046e-9	5.254273134469578e-5	6	109	22
OMIM:115000	Cardiac Arrhythmia	GO:0014704	intercalated disc	2.569887969094964e-9	5.667887915838943e-5	5	49	22
DOID:9565	dextrocardia	GO:0097014	ciliary cytoplasm	1.2212453270876722e-14	2.693456568891861e-10	12	90	22
DOID:9565	dextrocardia	GO:0005930	axoneme	1.2212453270876722e-14	2.693456568891861e-10	12	90	22
Orphanet:98558	Rare eye disease due to a differentiation anomaly	GO:0001654	eye development	1.0547118733938987e-13	2.3261670367702436e-9	11	327	22
Orphanet:98558	Rare eye disease due to a differentiation anomaly	GO:0043010	camera-type eye development	6.720672907079006e-10	1.4822444096562748e-5	8	283	22
Orphanet:98558	Rare eye disease due to a differentiation anomaly	GO:0007420	brain development	1.4304694095912396e-9	3.154900282853479e-5	10	669	22
Orphanet:98558	Rare eye disease due to a differentiation anomaly	GO:0009887	organ morphogenesis	2.3546645744332295e-9	5.193212718912488e-5	11	950	22
OMIM:182940	Neural Tube Defects, Susceptibility to	GO:0021915	neural tube development	4.773959005888173e-14	1.0528966587486366e-9	9	151	22
OMIM:182940	Neural Tube Defects, Susceptibility to	GO:0001843	neural tube closure	4.002131959168764e-12	8.82670203594671e-8	7	82	22
OMIM:182940	Neural Tube Defects, Susceptibility to	GO:0009887	organ morphogenesis	2.3546645744332295e-9	5.193212718912488e-5	11	950	22
DOID:1921	Klinefelter's syndrome	GO:0008543	fibroblast growth factor receptor signaling pathway	1.899069346222859e-9	4.188397443094516e-5	6	105	22
MESH:D020751	Alcohol-Induced Disorders	GO:0007565	female pregnancy	4.1634473646467995e-11	9.182483162728516e-7	8	190	23
MESH:D020751	Alcohol-Induced Disorders	GO:0072593	reactive oxygen species metabolic process	1.532798332704033e-10	3.3805867227787445e-6	8	223	23
MESH:D020751	Alcohol-Induced Disorders	GO:0051241	negative regulation of multicellular organismal process	2.716784575085285e-10	5.991868380350596e-6	12	966	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0003073	regulation of systemic arterial blood pressure	6.272427022224747e-12	1.383383779751668e-7	7	83	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	2.328126580408707e-11	5.134683173091403e-7	6	49	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0061061	muscle structure development	3.794353720110166e-10	8.368447129702972e-6	10	551	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0043500	muscle adaptation	6.566549526354493e-10	1.4482524980374833e-5	6	84	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0014888	striated muscle adaptation	8.701972475932962e-10	1.9192200295670148e-5	5	38	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0001990	regulation of systemic arterial blood pressure by hormone	9.97422033854889e-10	2.1998142956669575e-5	5	39	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0072358	cardiovascular system development	2.7397879520663082e-9	6.042602328282243e-5	11	910	23
MESH:D017379	Hypertrophy, Left Ventricular	GO:0044057	regulation of system process	4.435388722967559e-9	9.782249828504952e-5	9	508	23
Orphanet:2445	Conotruncal heart malformations	GO:0048568	embryonic organ development	2.786659791809143e-13	6.145978170835065e-9	12	408	23
Orphanet:2445	Conotruncal heart malformations	GO:0003279	cardiac septum development	2.1649348980190553e-14	4.774763917581026e-10	9	84	23
Orphanet:2445	Conotruncal heart malformations	GO:0060840	artery development	2.786659791809143e-14	6.145978170835065e-10	8	75	23
Orphanet:2445	Conotruncal heart malformations	GO:0048729	tissue morphogenesis	3.874900400546721e-12	8.546092833405794e-8	12	635	23
Orphanet:2445	Conotruncal heart malformations	GO:0048732	gland development	8.588726396752122e-10	1.8942436068036805e-5	9	421	23
Orphanet:2445	Conotruncal heart malformations	GO:0009952	anterior/posterior pattern specification	2.981786040301415e-9	6.576329111884771e-5	7	199	23
Orphanet:2445	Conotruncal heart malformations	GO:0002009	morphogenesis of an epithelium	4.285892640787381e-9	9.452536219256569e-5	9	506	23
Orphanet:99893	ACTH-independent Cushing syndrome	GO:0045859	regulation of protein kinase activity	4.280663379319094e-9	9.441003083088262e-5	10	709	23
DOID:2893	cervix carcinoma	GO:0003007	heart morphogenesis	1.2484457911909885e-12	2.7534471924717252e-8	9	216	23
DOID:2893	cervix carcinoma	GO:0003206	cardiac chamber morphogenesis	3.103661772030364e-11	6.845126038212968e-7	7	104	23
DOID:2893	cervix carcinoma	GO:0043066	negative regulation of apoptotic process	3.46537243345324e-11	7.64287890198112e-7	12	795	23
DOID:2893	cervix carcinoma	GO:0008284	positive regulation of cell proliferation	4.208389192683626e-11	9.281602364463737e-7	12	815	23
DOID:2893	cervix carcinoma	GO:0003156	regulation of organ formation	2.9630764508681295e-10	6.53506511238966e-6	5	31	23
DOID:2893	cervix carcinoma	GO:0048568	embryonic organ development	6.483251713262916e-10	1.4298811653601362e-5	9	408	23
DOID:2893	cervix carcinoma	GO:1902533	positive regulation of intracellular signal transduction	1.5141480291802623e-9	3.3394534783570684e-5	11	860	23
DOID:2893	cervix carcinoma	GO:0060411	cardiac septum morphogenesis	3.2772627944765986e-9	7.228003093218138e-5	5	49	23
DOID:2893	cervix carcinoma	GO:0040007	growth	3.6815848147853103e-9	8.119735309009002e-5	11	936	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0042417	dopamine metabolic process	1.5875079029115113e-12	3.501248679871338e-8	6	32	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0007626	locomotory behavior	3.083366895140216e-11	6.800365687231746e-7	8	183	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0030534	adult behavior	1.9669565975988235e-10	4.338122776004205e-6	7	135	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0008344	adult locomotory behavior	4.870720493599379e-10	1.074237404863343e-5	6	80	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0046928	regulation of neurotransmitter secretion	3.6384114610044094e-9	8.024516477245225e-5	5	50	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0042069	regulation of catecholamine metabolic process	4.119498520083198e-9	9.085553986043493e-5	4	17	23
OMIM:168600	Parkinson Disease, Late-Onset	GO:0042053	regulation of dopamine metabolic process	4.119498520083198e-9	9.085553986043493e-5	4	17	23
MESH:D000419	Albuminuria	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.1390473009242896e-9	2.5121688221885208e-5	5	40	23
MESH:D000419	Albuminuria	GO:0090066	regulation of anatomical structure size	2.0471461192883567e-9	4.5149807660904706e-5	9	465	23
DOID:2351	iron metabolism disease	GO:1990267	response to transition metal nanoparticle	1.9340085088970227e-13	4.2654557663723836e-9	10	150	23
DOID:2351	iron metabolism disease	GO:0006826	iron ion transport	6.572520305780927e-14	1.4495693534399834e-9	8	55	23
DOID:2351	iron metabolism disease	GO:0097286	iron ion import	8.236744619694036e-13	1.8166140258735197e-8	5	11	23
DOID:2351	iron metabolism disease	GO:0005381	iron ion transmembrane transporter activity	1.2205014776611733e-10	2.691816008981718e-6	4	8	23
DOID:2351	iron metabolism disease	GO:0072510	trivalent inorganic cation transmembrane transporter activity	1.6328172147694886e-9	3.601178367174107e-5	3	3	23
DOID:2351	iron metabolism disease	GO:0015091	ferric iron transmembrane transporter activity	1.6328172147694886e-9	3.601178367174107e-5	3	3	23
DOID:2174	ocular cancer	GO:0034502	protein localization to chromosome	7.424216796891869e-11	1.6374110145545018e-6	6	59	23
Orphanet:371157	Congenital disorder of glycosylation with hepatic involvement	GO:0009101	glycoprotein biosynthetic process	1.5123458041443882e-12	3.335478671040448e-8	11	336	23
Orphanet:371157	Congenital disorder of glycosylation with hepatic involvement	GO:0006486	protein glycosylation	1.9501067427540875e-12	4.30096042114414e-8	11	259	23
Orphanet:371157	Congenital disorder of glycosylation with hepatic involvement	GO:0006487	protein N-linked glycosylation	2.6791902030254278e-12	5.908953992772581e-8	7	74	23
Orphanet:371157	Congenital disorder of glycosylation with hepatic involvement	GO:0016758	transferase activity, transferring hexosyl groups	6.910616523470026e-11	1.5241364742513142e-6	8	202	23
Orphanet:101992	Immunodeficiency due to a complement cascade protein anomaly	GO:0051604	protein maturation	5.591083152012288e-13	1.2331133891763102e-8	15	332	23
Orphanet:101992	Immunodeficiency due to a complement cascade protein anomaly	GO:1903034	regulation of response to wounding	2.753353101070388e-13	6.072520264410741e-9	15	407	23
Orphanet:101992	Immunodeficiency due to a complement cascade protein anomaly	GO:0006959	humoral immune response	1.7008616737257398e-13	3.751250421402119e-9	23	173	23
Orphanet:101992	Immunodeficiency due to a complement cascade protein anomaly	GO:0001848	complement binding	2.7226887411302414e-11	6.004890018562747e-7	5	20	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0022832	voltage-gated channel activity	3.668176873361517e-13	8.090164094198826e-9	9	189	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0005244	voltage-gated ion channel activity	3.668176873361517e-13	8.090164094198826e-9	9	189	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0022843	voltage-gated cation channel activity	2.042810365310288e-14	4.5054182606918403e-10	9	149	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0044304	main axon	4.650724250154781e-13	1.0257172333716369e-8	7	58	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0015077	monovalent inorganic cation transmembrane transporter activity	7.646328015198378e-12	1.6863976437520023e-7	10	368	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0034703	cation channel complex	1.4164114325865285e-11	3.1238954145695885e-7	8	166	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0046873	metal ion transmembrane transporter activity	2.389688447124172e-11	5.270457870132361e-7	10	415	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0034220	ion transmembrane transport	2.6254365348421516e-10	5.790400277594365e-6	12	962	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0015672	monovalent inorganic cation transport	5.378485434803792e-10	1.1862249626459764e-5	10	572	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0043194	axon initial segment	8.603009415963925e-10	1.8973937266908436e-5	4	12	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0005249	voltage-gated potassium channel activity	1.0010285933503837e-9	2.2077685626342713e-5	6	90	23
Orphanet:98257	Neonatal epilepsy syndrome	GO:0042391	regulation of membrane potential	4.3027704732523375e-9	9.48976027875803e-5	8	340	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0048705	skeletal system morphogenesis	7.245315458703772e-13	1.5979543244171168e-8	9	204	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0030198	extracellular matrix organization	1.1565193247520256e-12	2.5507033707405924e-8	11	320	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0048598	embryonic morphogenesis	1.9910961768232482e-11	4.391362617983674e-7	11	560	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0031012	extracellular matrix	3.1527669364095345e-11	6.953427478251228e-7	10	423	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0048568	embryonic organ development	6.483251713262916e-10	1.4298811653601362e-5	9	408	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0022617	extracellular matrix disassembly	7.059270945575236e-10	1.5569222070466182e-5	6	85	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0048562	embryonic organ morphogenesis	9.347380647284353e-10	2.061564801758564e-5	8	280	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0048701	embryonic cranial skeleton morphogenesis	2.3616245625746046e-9	5.2085629727582905e-5	5	46	23
Orphanet:284993	Marfan and Marfan-related disorder	GO:0007423	sensory organ development	3.4744696009170184e-9	7.662942704822484e-5	9	494	23
DOID:1659	supratentorial cancer	GO:0040007	growth	3.6815848147853103e-9	8.119735309009002e-5	11	936	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0046395	carboxylic acid catabolic process	7.87370169064161e-13	1.736544907871007e-8	12	219	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:1901565	organonitrogen compound catabolic process	4.75175454539567e-14	1.047999464987015e-9	12	349	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:1901606	alpha-amino acid catabolic process	1.9062529332813938e-13	4.204240844352114e-9	10	96	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0009108	coenzyme biosynthetic process	2.322919634423215e-12	5.123199253720401e-8	8	132	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0016491	oxidoreductase activity	1.1121104037670193e-11	2.452759495508161e-7	12	710	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0048037	cofactor binding	1.3292478229232074e-11	2.931656073457134e-7	9	261	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0005759	mitochondrial matrix	2.2568391599975257e-11	4.977458767374543e-7	10	412	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0043648	dicarboxylic acid metabolic process	2.8992697131968725e-11	6.394339352455702e-7	7	103	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0050662	coenzyme binding	3.361100286980445e-11	7.412906682935372e-7	8	185	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0055114	oxidation-reduction process	2.2714141678648048e-10	5.009603947225827e-6	12	949	23
Orphanet:225689	Amino acid or protein metabolism disease with epilepsy	GO:0009071	serine family amino acid catabolic process	5.739978492513842e-10	1.2659522565239278e-5	4	11	23
DOID:1935	Bardet-Biedl syndrome	GO:0031513	nonmotile primary cilium	2.4734658765623863e-12	5.455228990758343e-8	8	134	23
DOID:1935	Bardet-Biedl syndrome	GO:0031514	motile cilium	1.6821583015413921e-9	3.71000013404954e-5	6	98	23
Orphanet:717	Catecholamine-producing tumor	GO:0009712	catechol-containing compound metabolic process	1.603162047558726e-13	3.5357738958907703e-9	7	50	23
Orphanet:717	Catecholamine-producing tumor	GO:0006584	catecholamine metabolic process	1.603162047558726e-13	3.5357738958907703e-9	7	50	23
DOID:3328	temporal lobe epilepsy	GO:0007216	G-protein coupled glutamate receptor signaling pathway	2.3099300250351007e-12	5.0945506702149146e-8	5	13	23
DOID:3328	temporal lobe epilepsy	GO:0051966	regulation of synaptic transmission, glutamatergic	2.6371127503921343e-11	5.816152170989852e-7	6	50	23
DOID:3328	temporal lobe epilepsy	GO:0008066	glutamate receptor activity	1.4121370739417216e-10	3.114468316578467e-6	5	27	23
MESH:D015418	Optic Atrophies, Hereditary	GO:0044455	mitochondrial membrane part	1.2279066652354231e-13	2.7081481501767257e-9	9	179	23
DOID:3953	adrenal gland cancer	GO:0009725	response to hormone	1.6053182116948506e-9	3.540529315892993e-5	11	865	23
DOID:3953	adrenal gland cancer	GO:1901698	response to nitrogen compound	1.7089628601141271e-9	3.7691175879817074e-5	11	870	23
DOID:3953	adrenal gland cancer	GO:0042633	hair cycle	2.0203876349711436e-9	4.455964928928857e-5	6	101	23
DOID:3953	adrenal gland cancer	GO:0051726	regulation of cell cycle	3.4394067593979116e-9	7.585611607852094e-5	11	930	23
DOID:3953	adrenal gland cancer	GO:0045859	regulation of protein kinase activity	4.280663379319094e-9	9.441003083088262e-5	10	709	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0060537	muscle tissue development	1.5731860258938468e-12	3.469661780108879e-8	14	336	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0007517	muscle organ development	1.1617373729677638e-12	2.562211776080403e-8	12	340	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0090257	regulation of muscle system process	1.1444178937836114e-12	2.524013664739755e-8	14	213	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0003007	heart morphogenesis	9.814371537686384e-13	2.164559642636732e-8	11	216	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0044449	contractile fiber part	9.809930645587883e-13	2.1635802038844076e-8	15	196	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0030016	myofibril	8.140155216551648e-13	1.795311233010466e-8	15	201	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0030017	sarcomere	6.792344464656708e-13	1.498051571680037e-8	15	180	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:1903522	regulation of blood circulation	4.904965322793942e-13	1.0817901019422038e-8	12	297	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0008016	regulation of heart contraction	2.7622348852673895e-13	6.0921090394572275e-9	12	224	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0006941	striated muscle contraction	1.942890293094024e-13	4.28504454141887e-9	16	150	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0048738	cardiac muscle tissue development	9.259260025373806e-14	2.042129798596193e-9	14	168	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0055010	ventricular cardiac muscle tissue morphogenesis	7.593925488436071e-14	1.6748402664745754e-9	8	39	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0033275	actin-myosin filament sliding	7.593925488436071e-14	1.6748402664745754e-9	11	39	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0030049	muscle filament sliding	7.593925488436071e-14	1.6748402664745754e-9	11	39	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0002027	regulation of heart rate	1.021405182655144e-14	2.2527091303459201e-10	9	87	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:1903115	regulation of actin filament-based movement	2.220446049250313e-15	4.8971937616215655e-11	10	52	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0006937	regulation of muscle contraction	3.219646771412954e-15	7.10093095435127e-11	14	165	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0086005	ventricular cardiac muscle cell action potential	2.1604940059205546e-13	4.764969530057783e-9	6	24	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0031674	I band	1.1299849944634843e-12	2.4921819052892147e-8	8	122	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0032971	regulation of muscle filament sliding	1.748046152272309e-12	3.8553157888365774e-8	4	4	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0015629	actin cytoskeleton	2.4668045384146353e-12	5.440537409473478e-8	11	441	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0008092	cytoskeletal protein binding	4.973244038808389e-12	1.0968489727591901e-7	14	812	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0003779	actin binding	1.0176304243714185e-11	2.2443839009511635e-7	10	385	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0055013	cardiac muscle cell development	3.791922331686237e-11	8.363084702533996e-7	6	53	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0030239	myofibril assembly	3.791922331686237e-11	8.363084702533996e-7	6	53	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0030018	Z disc	4.3405501415350045e-11	9.573083337155452e-7	7	109	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0036379	myofilament	5.901379385164773e-11	1.3015492233980908e-6	5	23	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0043462	regulation of ATPase activity	8.24010859545865e-11	1.8173559507284054e-6	6	60	23
OMIM:192600	Cardiomyopathy, Familial Hypertrophic, 1	GO:0008307	structural constituent of muscle	1.2962380058212375e-9	2.8588529218387393e-5	5	41	23
OMIM:114480	Breast Cancer	GO:0006302	double-strand break repair	9.277023593767808e-13	2.04604755360549e-8	10	192	24
OMIM:114480	Breast Cancer	GO:0000731	DNA synthesis involved in DNA repair	1.0014211682118912e-13	2.208634386491326e-9	8	37	24
OMIM:114480	Breast Cancer	GO:0000732	strand displacement	3.7969627442180354e-14	8.374201332372877e-10	8	26	24
OMIM:114480	Breast Cancer	GO:0009314	response to radiation	3.3465452631276094e-12	7.380805577827942e-8	11	431	24
OMIM:114480	Breast Cancer	GO:0010212	response to ionizing radiation	7.157163750548534e-12	1.5785124651834792e-7	8	145	24
OMIM:114480	Breast Cancer	GO:0000724	double-strand break repair via homologous recombination	1.7932988427560304e-11	3.955120597698425e-7	7	92	24
OMIM:114480	Breast Cancer	GO:0072331	signal transduction by p53 class mediator	6.020101084303064e-10	1.3277332941430409e-5	8	252	24
OMIM:114480	Breast Cancer	GO:1901796	regulation of signal transduction by p53 class mediator	9.512952647838802e-10	2.0980817064808477e-5	7	161	24
DOID:4254	osteosclerosis	GO:0001503	ossification	3.6424141480750905e-10	8.033344403579612e-6	9	363	24
DOID:4254	osteosclerosis	GO:0046849	bone remodeling	4.008359200113887e-10	8.840436215851177e-6	6	74	24
DOID:4254	osteosclerosis	GO:0030316	osteoclast differentiation	9.378731125053719e-10	2.0684791496305976e-5	6	85	24
MESH:D020914	Myopathies, Structural, Congenital	GO:0031674	I band	1.3011813848606835e-13	2.8697555443102374e-9	9	122	24
MESH:D020914	Myopathies, Structural, Congenital	GO:0048747	muscle fiber development	2.368105711525459e-13	5.2228571467694e-9	7	50	24
MESH:D020914	Myopathies, Structural, Congenital	GO:0015629	actin cytoskeleton	2.8848035071860068e-12	6.362434135098738e-8	11	441	24
MESH:D020914	Myopathies, Structural, Congenital	GO:0008092	cytoskeletal protein binding	7.527767298398658e-11	1.660249077661824e-6	12	812	24
MESH:D020914	Myopathies, Structural, Congenital	GO:0003779	actin binding	6.100115967910824e-10	1.3453805767227323e-5	9	385	24
Orphanet:2982	46,XX disorder of sex development	GO:0006704	glucocorticoid biosynthetic process	1.3760326211809115e-11	3.0348399460145004e-7	5	17	24
Orphanet:2982	46,XX disorder of sex development	GO:0042445	hormone metabolic process	5.482758691499612e-11	1.2092224294102394e-6	8	187	24
OMIM:252010	mitochondrial complex I deficiency	GO:0046128	purine ribonucleoside metabolic process	9.456879723757083e-13	2.0857148230746247e-8	17	342	24
OMIM:252010	mitochondrial complex I deficiency	GO:0044455	mitochondrial membrane part	4.976019596369952e-13	1.0974611219793928e-8	19	179	24
OMIM:252010	mitochondrial complex I deficiency	GO:0045333	cellular respiration	2.0894397323445446e-13	4.608259329685893e-9	18	173	24
OMIM:252010	mitochondrial complex I deficiency	GO:0098803	respiratory chain complex	1.0480505352461478e-13	2.311475455485379e-9	18	73	24
OMIM:252010	mitochondrial complex I deficiency	GO:0042773	ATP synthesis coupled electron transport	6.661338147750939e-14	1.4691581284864696e-9	17	89	24
OMIM:252010	mitochondrial complex I deficiency	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	5.040412531798211e-14	1.1116629838880954e-9	16	59	24
OMIM:252010	mitochondrial complex I deficiency	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	2.531308496145357e-14	5.582800888248585e-10	17	53	24
OMIM:252010	mitochondrial complex I deficiency	GO:0034622	cellular macromolecular complex assembly	4.118927421359331e-14	9.084294427808004e-10	23	926	24
OMIM:252010	mitochondrial complex I deficiency	GO:0033108	mitochondrial respiratory chain complex assembly	4.7628567756419216e-14	1.0504480618678258e-9	23	80	24
OMIM:252010	mitochondrial complex I deficiency	GO:0045271	respiratory chain complex I	6.306066779870889e-14	1.3908030283005246e-9	18	48	24
OMIM:252010	mitochondrial complex I deficiency	GO:0005747	mitochondrial respiratory chain complex I	6.306066779870889e-14	1.3908030283005246e-9	18	48	24
OMIM:252010	mitochondrial complex I deficiency	GO:0010257	NADH dehydrogenase complex assembly	1.0413891970983968e-13	2.2967838742005142e-9	23	61	24
OMIM:252010	mitochondrial complex I deficiency	GO:0097031	mitochondrial respiratory chain complex I biogenesis	1.0413891970983968e-13	2.2967838742005142e-9	23	61	24
OMIM:252010	mitochondrial complex I deficiency	GO:0032981	mitochondrial respiratory chain complex I assembly	1.0413891970983968e-13	2.2967838742005142e-9	23	61	24
OMIM:252010	mitochondrial complex I deficiency	GO:0008137	NADH dehydrogenase (ubiquinone) activity	1.4344081478157023e-13	3.1635871700075313e-9	16	45	24
OMIM:252010	mitochondrial complex I deficiency	GO:0051536	iron-sulfur cluster binding	1.2156353701442413e-10	2.681083808853124e-6	6	61	24
OMIM:252010	mitochondrial complex I deficiency	GO:0051539	4 iron, 4 sulfur cluster binding	1.4365920675274424e-9	3.168403804931774e-5	5	40	24
Orphanet:363294	Genetic syndromic Pierre Robin syndrome	GO:0048704	embryonic skeletal system morphogenesis	1.9324875033532862e-11	4.262101188645673e-7	7	93	24
Orphanet:363294	Genetic syndromic Pierre Robin syndrome	GO:0002062	chondrocyte differentiation	1.8484125341444724e-9	4.076673844055634e-5	6	95	24
Orphanet:363294	Genetic syndromic Pierre Robin syndrome	GO:0043583	ear development	3.753901300918017e-9	8.279229319174686e-5	7	196	24
Orphanet:182064	Rare neuroinflammatory or neuroimmunological disease	GO:0045087	innate immune response	6.976530464442021e-12	1.5386737939326878e-7	13	783	24
DOID:12270	coloboma	GO:0001654	eye development	8.171241461241152e-14	1.8021673042767361e-9	11	327	24
DOID:12270	coloboma	GO:0048598	embryonic morphogenesis	3.123257208414998e-11	6.888343773159278e-7	11	560	24
DOID:12270	coloboma	GO:0043010	camera-type eye development	4.0603742590406e-11	8.955155428314043e-7	9	283	24
DOID:12270	coloboma	GO:0035295	tube development	9.119814903257861e-10	2.0113751769135213e-5	10	573	24
DOID:12270	coloboma	GO:0048568	embryonic organ development	1.017771200650941e-9	2.2446943830356503e-5	9	408	24
MESH:D018326	Nevi and Melanomas	GO:0043473	pigmentation	1.4221570587835686e-9	3.1365673931471605e-5	6	91	24
Orphanet:306768	Rare paroxysmal movement disorder	GO:0050905	neuromuscular process	2.0982928727875105e-9	4.6277849309328545e-5	6	97	24
OMIM:277900	Wilson disease	GO:0005507	copper ion binding	5.052702700680811e-11	1.114373580635153e-6	6	53	24
OMIM:277900	Wilson disease	GO:0010038	response to metal ion	1.7739909541347743e-10	3.912537049344245e-6	9	335	24
OMIM:277900	Wilson disease	GO:0046688	response to copper ion	3.137825554944129e-10	6.920474261429277e-6	5	30	24
DOID:1927	sphingolipidosis	GO:0006643	membrane lipid metabolic process	8.557599073810707e-13	1.8873784757289513e-8	13	191	24
DOID:1927	sphingolipidosis	GO:0044437	vacuolar part	7.687184222504584e-13	1.695408480273386e-8	14	396	24
DOID:1927	sphingolipidosis	GO:0005775	vacuolar lumen	1.234568003383174e-13	2.7228397314615904e-9	12	91	24
DOID:1927	sphingolipidosis	GO:0016798	hydrolase activity, acting on glycosyl bonds	7.349676423018536e-14	1.6209711350967382e-9	10	120	24
DOID:1927	sphingolipidosis	GO:0030149	sphingolipid catabolic process	5.129230373768223e-14	1.1312517589345816e-9	7	21	24
DOID:1927	sphingolipidosis	GO:0019377	glycolipid catabolic process	6.661338147750939e-16	1.4691581284864696e-11	6	14	24
DOID:1927	sphingolipidosis	GO:0046514	ceramide catabolic process	2.4424906541753444e-14	5.386913137783722e-10	6	13	24
DOID:1927	sphingolipidosis	GO:0046477	glycosylceramide catabolic process	3.142675009115692e-11	6.931169732604658e-7	4	6	24
OMIM:540000	MELAS syndrome	GO:0042773	ATP synthesis coupled electron transport	6.705747068735946e-14	1.4789525160097128e-9	8	89	24
OMIM:540000	MELAS syndrome	GO:0070469	respiratory chain	7.405187574249794e-14	1.633214119500792e-9	8	90	24
OMIM:540000	MELAS syndrome	GO:0042775	mitochondrial ATP synthesis coupled electron transport	9.781064846947629e-14	2.1572138519942996e-9	8	88	24
OMIM:540000	MELAS syndrome	GO:0098803	respiratory chain complex	3.307909501870654e-12	7.295594406375727e-8	7	73	24
OMIM:540000	MELAS syndrome	GO:0044429	mitochondrial part	4.682079168816244e-10	1.0326325606824227e-5	12	956	24
OMIM:540000	MELAS syndrome	GO:0005743	mitochondrial inner membrane	4.0740463225219514e-9	8.985309164322164e-5	9	478	24
DOID:999	eosinophilia	GO:0001775	cell activation	1.5207834991315394e-12	3.35408800733461e-8	14	854	25
DOID:999	eosinophilia	GO:0030097	hemopoiesis	2.2661428289438845e-11	4.997978009235737e-7	12	695	25
DOID:999	eosinophilia	GO:0098602	single organism cell adhesion	5.1071369355781826e-11	1.1263790511417682e-6	12	746	25
DOID:999	eosinophilia	GO:0050865	regulation of cell activation	1.7029200272133949e-10	3.7557901200191424e-6	10	458	25
DOID:999	eosinophilia	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	1.76581416155841e-10	3.894503133317073e-6	6	62	25
DOID:999	eosinophilia	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	1.76581416155841e-10	3.894503133317073e-6	6	62	25
DOID:999	eosinophilia	GO:0034109	homotypic cell-cell adhesion	3.600265641168221e-10	7.940385871596511e-6	10	495	25
DOID:999	eosinophilia	GO:0005088	Ras guanyl-nucleotide exchange factor activity	3.95758426030568e-10	8.728452086104177e-6	8	228	25
DOID:999	eosinophilia	GO:0050795	regulation of behavior	6.555468390345709e-10	1.4458085534907461e-5	8	243	25
DOID:999	eosinophilia	GO:0048407	platelet-derived growth factor binding	8.195186751436268e-10	1.8074484380292688e-5	4	11	25
DOID:999	eosinophilia	GO:0030335	positive regulation of cell migration	9.79968994840874e-10	2.1613216181215478e-5	9	387	25
DOID:999	eosinophilia	GO:0046854	phosphatidylinositol phosphorylation	1.8639887411353584e-9	4.111027168574033e-5	6	91	25
DOID:999	eosinophilia	GO:0046649	lymphocyte activation	2.091958051231302e-9	4.613813481990636e-5	10	594	25
DOID:999	eosinophilia	GO:0070489	T cell aggregation	2.186854364261137e-9	4.823107300377938e-5	9	424	25
DOID:999	eosinophilia	GO:0042110	T cell activation	2.186854364261137e-9	4.823107300377938e-5	9	424	25
DOID:999	eosinophilia	GO:0050920	regulation of chemotaxis	2.7496447341235353e-9	6.064341461109457e-5	7	179	25
DOID:999	eosinophilia	GO:0005161	platelet-derived growth factor receptor binding	3.3775774399558145e-9	7.449247043822549e-5	4	15	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	6.67021993194794e-13	1.4711170059911183e-8	11	233	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	5.677680547933051e-13	1.2522124448466343e-8	10	180	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0001819	positive regulation of cytokine production	3.539391002504999e-13	7.806126856024775e-9	12	381	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0031349	positive regulation of defense response	3.0464519795714295e-13	6.718949840944788e-9	15	398	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0002221	pattern recognition receptor signaling pathway	2.355893258254582e-13	5.195922581080481e-9	10	155	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0071345	cellular response to cytokine stimulus	4.213296378452469e-13	9.29242516267692e-9	14	677	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0002224	toll-like receptor signaling pathway	5.165867733580853e-13	1.1393321286412572e-8	9	115	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0042089	cytokine biosynthetic process	6.460432189214771e-11	1.4248483193313177e-6	7	105	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0032479	regulation of type I interferon production	1.0205214451275424e-10	2.2507600472287947e-6	7	112	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0006954	inflammatory response	1.9248014293538063e-10	4.24514955243982e-6	11	637	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0032755	positive regulation of interleukin-6 production	3.1252334053988307e-10	6.892702275607121e-6	6	68	25
Orphanet:183710	Genetic susceptibility to infections due to particular pathogens	GO:0042035	regulation of cytokine biosynthetic process	2.422189671058561e-9	5.3421393195196565e-5	6	95	25
Orphanet:281082	Inherited non-syndromic ichthyosis	GO:0008544	epidermis development	5.235811784132238e-13	1.1547582889903651e-8	12	296	25
Orphanet:281082	Inherited non-syndromic ichthyosis	GO:0009913	epidermal cell differentiation	1.5365486660812167e-13	3.3888580830421233e-9	10	176	25
Orphanet:281082	Inherited non-syndromic ichthyosis	GO:0030216	keratinocyte differentiation	7.760458942129844e-14	1.7115692196867371e-9	9	126	25
MESH:D000783	Aneurysm	GO:0071559	response to transforming growth factor beta	1.7896795156957523e-13	3.947138171866982e-9	10	211	25
MESH:D000783	Aneurysm	GO:0043062	extracellular structure organization	1.095679103002567e-12	2.4165202616721615e-8	13	321	25
MESH:D000783	Aneurysm	GO:1903844	regulation of cellular response to transforming growth factor beta stimulus	3.673494841649472e-11	8.10189287325791e-7	7	97	25
MESH:D000783	Aneurysm	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	3.673494841649472e-11	8.10189287325791e-7	7	97	25
MESH:D000783	Aneurysm	GO:0005114	type II transforming growth factor beta receptor binding	8.723521904840936e-11	1.9239727561126685e-6	4	7	25
MESH:D000783	Aneurysm	GO:0007507	heart development	3.079021482221833e-10	6.790781879040253e-6	10	487	25
MESH:D000783	Aneurysm	GO:0060325	face morphogenesis	4.667315423034779e-10	1.0293764165503205e-5	5	31	25
MESH:D000783	Aneurysm	GO:0048598	embryonic morphogenesis	1.1878173999946284e-9	2.619731275688153e-5	10	560	25
MESH:D000783	Aneurysm	GO:0030199	collagen fibril organization	1.3700419687623366e-9	3.0216275621053335e-5	5	38	25
MESH:D000783	Aneurysm	GO:0035295	tube development	1.478048572423063e-9	3.2598361264790654e-5	10	573	25
MESH:D000783	Aneurysm	GO:0051270	regulation of cellular component movement	1.8100974052970287e-9	3.992169827382597e-5	11	787	25
MESH:D000783	Aneurysm	GO:0031012	extracellular matrix	2.142834132357052e-9	4.7260206789134784e-5	9	423	25
MESH:D000783	Aneurysm	GO:0050431	transforming growth factor beta binding	4.4993546666205475e-9	9.923326717231618e-5	4	16	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0006979	response to oxidative stress	3.068789666826888e-11	6.768215610186701e-7	10	386	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0044708	single-organism behavior	4.851008483797159e-11	1.0698899211014634e-6	10	404	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0007626	locomotory behavior	6.773748228994236e-11	1.4939501719046788e-6	8	183	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:1900407	regulation of cellular response to oxidative stress	1.1648659814511575e-10	2.569111922090528e-6	6	58	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0001963	synaptic transmission, dopaminergic	2.7069702035475984e-10	5.970222783924228e-6	5	28	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:1902803	regulation of synaptic vesicle transport	2.7069702035475984e-10	5.970222783924228e-6	5	28	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0010035	response to inorganic substance	4.12249900882955e-10	9.092171563973572e-6	10	502	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:1903202	negative regulation of oxidative stress-induced cell death	6.506535310535355e-10	1.4350163627385726e-5	5	33	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0015872	dopamine transport	6.506535310535355e-10	1.4350163627385726e-5	5	33	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0007005	mitochondrion organization	7.40075556393549e-10	1.6322366396259724e-5	11	723	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:1990267	response to transition metal nanoparticle	7.988850692086658e-10	1.7619410201397123e-5	7	150	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0051934	catecholamine uptake involved in synaptic transmission	8.195186751436268e-10	1.8074484380292688e-5	4	11	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0051583	dopamine uptake involved in synaptic transmission	8.195186751436268e-10	1.8074484380292688e-5	4	11	25
Orphanet:307055	Rare parkinsonian syndrome due to genetic neurodegenerative disease	GO:0008344	adult locomotory behavior	8.485981917161212e-10	1.8715833118299052e-5	6	80	25
Orphanet:307061	Rare genetic tremor disorder	GO:1903531	negative regulation of secretion by cell	2.256976272541067e-9	4.977761169089323e-5	7	174	25
Orphanet:399877	Female infertility due to gonadal dysgenesis	GO:2000018	regulation of male gonad development	4.6629367034256575e-15	1.0284106899405288e-10	6	9	25
Orphanet:399877	Female infertility due to gonadal dysgenesis	GO:0008585	female gonad development	7.881939545484329e-11	1.7383617667565687e-6	7	108	25
Orphanet:399877	Female infertility due to gonadal dysgenesis	GO:0008202	steroid metabolic process	1.7435097809936906e-9	3.8453108219815846e-5	8	275	25
OMIM:612376	acute promyelocytic leukemia	GO:0001775	cell activation	8.982370403032292e-12	1.981061792388772e-7	13	854	25
OMIM:612376	acute promyelocytic leukemia	GO:0048732	gland development	2.0568917680208187e-9	4.536474794369916e-5	9	421	25
OMIM:612376	acute promyelocytic leukemia	GO:0046649	lymphocyte activation	2.091958051231302e-9	4.613813481990636e-5	10	594	25
OMIM:612376	acute promyelocytic leukemia	GO:0008284	positive regulation of cell proliferation	2.610994642715525e-9	5.7585486845090905e-5	11	815	25
MESH:D016905	Gram-Negative Bacterial Infections	GO:0002526	acute inflammatory response	5.177042128323706e-10	1.1417966414017933e-5	7	141	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0043583	ear development	7.86926079854311e-13	1.7355654691186828e-8	10	196	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0042471	ear morphogenesis	4.1822101337629647e-13	9.223864450014219e-9	9	112	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0042474	middle ear morphogenesis	4.2969960922789596e-11	9.477024881521245e-7	5	20	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0001501	skeletal system development	2.7838586991180136e-10	6.139800360904779e-6	10	482	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:2000027	regulation of organ morphogenesis	5.20738674403276e-10	1.1484891463964253e-5	8	236	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0001822	kidney development	1.1901812868586603e-9	2.6249448281667753e-5	8	262	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0007389	pattern specification process	2.5741923037614356e-9	5.677381125945846e-5	9	432	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0001823	mesonephros development	3.7298665267471165e-9	8.226220624740765e-5	6	102	25
Orphanet:96333	Rare otorhinolaryngological malformation	GO:0071599	otic vesicle development	4.4993546666205475e-9	9.923326717231618e-5	4	16	25
Orphanet:306712	Rare tremor disorder	GO:1903531	negative regulation of secretion by cell	2.256976272541067e-9	4.977761169089323e-5	7	174	25
OMIM:160750	myositis	GO:0006954	inflammatory response	1.9248014293538063e-10	4.24514955243982e-6	11	637	25
OMIM:160750	myositis	GO:0022409	positive regulation of cell-cell adhesion	5.747198272842979e-10	1.2675445790755191e-5	8	239	25
OMIM:160750	myositis	GO:0001819	positive regulation of cytokine production	8.545207874632865e-10	1.8846455967502784e-5	9	381	25
OMIM:123500	Crouzon syndrome	GO:0035107	appendage morphogenesis	1.1341150241150899e-11	2.501290685685831e-7	8	146	25
OMIM:123500	Crouzon syndrome	GO:0035108	limb morphogenesis	1.1341150241150899e-11	2.501290685685831e-7	8	146	25
OMIM:123500	Crouzon syndrome	GO:0009790	embryo development	3.140343540763979e-11	6.926027679154956e-7	13	932	25
OMIM:123500	Crouzon syndrome	GO:0048598	embryonic morphogenesis	5.1302184722601396e-11	1.1314696840569738e-6	11	560	25
OMIM:123500	Crouzon syndrome	GO:0007389	pattern specification process	9.599576689112155e-11	2.1171866387836857e-6	10	432	25
OMIM:123500	Crouzon syndrome	GO:0048706	embryonic skeletal system development	1.8623558251107397e-10	4.1074257722817364e-6	7	122	25
OMIM:123500	Crouzon syndrome	GO:0035113	embryonic appendage morphogenesis	2.2125035137321447e-10	4.879676499536245e-6	7	125	25
OMIM:123500	Crouzon syndrome	GO:0030326	embryonic limb morphogenesis	2.2125035137321447e-10	4.879676499536245e-6	7	125	25
OMIM:123500	Crouzon syndrome	GO:0048562	embryonic organ morphogenesis	2.008310850953876e-9	4.429329581778774e-5	8	280	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0006694	steroid biosynthetic process	1.8973711490843925e-13	4.184652069305628e-9	9	149	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0034754	cellular hormone metabolic process	7.881939545484329e-11	1.7383617667565687e-6	7	108	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0008585	female gonad development	7.881939545484329e-11	1.7383617667565687e-6	7	108	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0007292	female gamete generation	9.555323199350596e-11	2.107426531616774e-6	7	111	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0042446	hormone biosynthetic process	1.949352901320367e-10	4.299297823862069e-6	6	63	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0008209	androgen metabolic process	3.9176684119013316e-10	8.640417682448387e-6	5	30	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0008207	C21-steroid hormone metabolic process	4.667315423034779e-10	1.0293764165503205e-5	5	31	25
Orphanet:95710	Non-acquired premature ovarian failure	GO:0022602	ovulation cycle process	2.271225096883711e-9	5.009186951177025e-5	6	94	25
DOID:3635	congenital myasthenic syndrome	GO:0045202	synapse	2.5622837185323988e-12	5.6511167412232055e-8	14	755	25
DOID:3635	congenital myasthenic syndrome	GO:1904396	regulation of neuromuscular junction development	8.723521904840936e-11	1.9239727561126685e-6	4	7	25
DOID:3635	congenital myasthenic syndrome	GO:0051124	synaptic growth at neuromuscular junction	8.723521904840936e-11	1.9239727561126685e-6	4	7	25
DOID:3635	congenital myasthenic syndrome	GO:0044456	synapse part	1.29466104503706e-10	2.8553749348292357e-6	11	613	25
DOID:3635	congenital myasthenic syndrome	GO:0001941	postsynaptic membrane organization	2.7069702035475984e-10	5.970222783924228e-6	5	28	25
DOID:3635	congenital myasthenic syndrome	GO:0071340	skeletal muscle acetylcholine-gated channel clustering	5.219903398412384e-10	1.1512496945198514e-5	4	10	25
DOID:3635	congenital myasthenic syndrome	GO:0050997	quaternary ammonium group binding	2.6158870625181407e-9	5.7693389163837594e-5	5	43	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0034358	plasma lipoprotein particle	1.4077627952246985e-13	3.1048208448680725e-9	7	36	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0008203	cholesterol metabolic process	2.1760371282653068e-14	4.799249886389134e-10	10	118	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0055092	sterol homeostasis	2.1782575743145571e-13	4.804147080150756e-9	8	63	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0042632	cholesterol homeostasis	2.1782575743145571e-13	4.804147080150756e-9	8	63	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0097006	regulation of plasma lipoprotein particle levels	5.114797474448096e-13	1.1280685829895276e-8	7	55	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0030301	cholesterol transport	3.0272451212454143e-12	6.676589114906761e-8	7	68	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0042157	lipoprotein metabolic process	5.644817946404146e-12	1.2449645980794344e-7	8	134	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0034381	plasma lipoprotein particle clearance	5.526780144649024e-10	1.2189313609023422e-5	5	32	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0071827	plasma lipoprotein particle organization	6.506535310535355e-10	1.4350163627385726e-5	5	33	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0032371	regulation of sterol transport	1.1907720365300634e-9	2.6262477265670547e-5	5	37	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0032374	regulation of cholesterol transport	1.1907720365300634e-9	2.6262477265670547e-5	5	37	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0042627	chylomicron	1.2281473615871619e-9	2.7086790059804855e-5	4	12	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0017127	cholesterol transporter activity	1.2281473615871619e-9	2.7086790059804855e-5	4	12	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0033344	cholesterol efflux	2.040090985033771e-9	4.499420667491982e-5	5	41	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0006641	triglyceride metabolic process	3.1121197840988657e-9	6.863780183830048e-5	6	99	25
OMIM:143890	Hypercholesterolemia, Familial	GO:0006954	inflammatory response	4.097173600392523e-9	9.03631637566571e-5	10	637	25
DOID:0050777	Joubert syndrome	GO:0031513	nonmotile primary cilium	2.0872192862952943e-14	4.6033621359242716e-10	14	134	26
DOID:0050777	Joubert syndrome	GO:0036064	ciliary basal body	1.157818285690837e-11	2.553568229091141e-7	7	79	26
DOID:0050777	Joubert syndrome	GO:0005813	centrosome	4.405845688282284e-10	9.717092665506577e-6	10	482	26
MESH:D020821	Dystonic Disorders	GO:0001963	synaptic transmission, dopaminergic	1.461497589616556e-12	3.2233329338993144e-8	6	28	26
MESH:D020821	Dystonic Disorders	GO:0042417	dopamine metabolic process	6.834092181051687e-10	1.5072590305309497e-5	5	32	26
MESH:D020821	Dystonic Disorders	GO:0035240	dopamine binding	9.682192825266611e-10	2.135407627612551e-5	4	11	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0043604	amide biosynthetic process	4.74953409934642e-13	1.0475097456108529e-8	17	734	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0006399	tRNA metabolic process	8.881784197001252e-14	1.958877504648626e-9	12	165	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0006412	translation	8.848477506262498e-14	1.951531714006194e-9	17	634	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0004812	aminoacyl-tRNA ligase activity	1.4832579608992091e-13	3.2713254327632058e-9	7	42	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0006414	translational elongation	1.7075230118734908e-13	3.765942002686984e-9	9	129	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0032543	mitochondrial translation	2.488009798184976e-13	5.487305609896964e-9	12	116	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0006418	tRNA aminoacylation for protein translation	3.516076318987871e-13	7.754706321527749e-9	7	48	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0005759	mitochondrial matrix	7.590594819362195e-13	1.6741056874103322e-8	16	412	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0000959	mitochondrial RNA metabolic process	2.842615032250251e-12	6.269387453627928e-8	6	31	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0070125	mitochondrial translational elongation	1.646061065230242e-11	3.630387679365299e-7	7	83	26
DOID:0060286	combined oxidative phosphorylation deficiency	GO:0008033	tRNA processing	1.219717660205788e-10	2.6900872995838654e-6	7	110	26
DOID:4195	hyperglycemia	GO:0010827	regulation of glucose transport	9.36806188178707e-13	2.0661260480281385e-8	8	99	26
DOID:4195	hyperglycemia	GO:1901701	cellular response to oxygen-containing compound	1.7889023595785147e-12	3.945424154050414e-8	15	873	26
DOID:4195	hyperglycemia	GO:0046324	regulation of glucose import	1.8671686419224898e-10	4.118040439760051e-6	6	60	26
DOID:4195	hyperglycemia	GO:0071417	cellular response to organonitrogen compound	2.912060592663579e-10	6.4225496371195234e-6	10	462	26
DOID:4195	hyperglycemia	GO:0033500	carbohydrate homeostasis	3.166488182770877e-10	6.983689687101169e-6	8	212	26
DOID:4195	hyperglycemia	GO:0042593	glucose homeostasis	3.166488182770877e-10	6.983689687101169e-6	8	212	26
DOID:4195	hyperglycemia	GO:0072593	reactive oxygen species metabolic process	4.745837056674418e-10	1.0466943628495429e-5	8	223	26
DOID:4195	hyperglycemia	GO:0009725	response to hormone	4.809566078733951e-10	1.060749798664773e-5	12	865	26
DOID:4195	hyperglycemia	GO:0032870	cellular response to hormone stimulus	9.011797974523006e-10	1.987552043281049e-5	10	519	26
DOID:4195	hyperglycemia	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.377181590989096e-9	3.0373739989264514e-5	6	83	26
DOID:4195	hyperglycemia	GO:0006979	response to oxidative stress	1.4391665636992457e-9	3.174081856238686e-5	9	386	26
DOID:4195	hyperglycemia	GO:0046326	positive regulation of glucose import	1.693801654489846e-9	3.735679548977355e-5	5	38	26
DOID:4195	hyperglycemia	GO:0071375	cellular response to peptide hormone stimulus	3.289883254709025e-9	7.255837518260755e-5	8	285	26
DOID:4195	hyperglycemia	GO:0045725	positive regulation of glycogen biosynthetic process	3.989776731216921e-9	8.799452580698919e-5	4	15	26
OMIM:144010	familial hypercholesterolemia	GO:1902652	secondary alcohol metabolic process	8.482103908136196e-14	1.870728016939438e-9	11	121	26
OMIM:144010	familial hypercholesterolemia	GO:0015918	sterol transport	2.3869795029440866e-14	5.264483293743183e-10	8	69	26
OMIM:144010	familial hypercholesterolemia	GO:0055088	lipid homeostasis	1.0691447727140257e-13	2.3579987962207838e-9	9	111	26
OMIM:144010	familial hypercholesterolemia	GO:0070325	lipoprotein particle receptor binding	9.024947456026666e-11	1.9904521614266812e-6	5	22	26
OMIM:144010	familial hypercholesterolemia	GO:0019218	regulation of steroid metabolic process	5.281152182234905e-10	1.1647581137919083e-5	6	71	26
OMIM:144010	familial hypercholesterolemia	GO:0005769	early endosome	3.980551999127613e-9	8.77910743407595e-5	8	292	26
DOID:11193	syndactyly	GO:0009790	embryo development	1.205480160137995e-12	2.658686493184348e-8	15	932	26
DOID:11193	syndactyly	GO:0048736	appendage development	1.6431300764452317e-13	3.6239233835999585e-9	14	168	26
DOID:11193	syndactyly	GO:0060173	limb development	1.6431300764452317e-13	3.6239233835999585e-9	14	168	26
DOID:11193	syndactyly	GO:0035113	embryonic appendage morphogenesis	1.1235457009206584e-13	2.477980043380512e-9	12	125	26
DOID:11193	syndactyly	GO:0030326	embryonic limb morphogenesis	1.1235457009206584e-13	2.477980043380512e-9	12	125	26
DOID:11193	syndactyly	GO:0042733	embryonic digit morphogenesis	1.765254609153999e-13	3.8932690404891446e-9	8	60	26
DOID:11193	syndactyly	GO:0001501	skeletal system development	1.7745804825608502e-12	3.913837254287955e-8	12	482	26
DOID:11193	syndactyly	GO:0007423	sensory organ development	1.960986928395414e-12	4.3249566705760856e-8	12	494	26
DOID:11193	syndactyly	GO:0042476	odontogenesis	2.261080211951594e-12	4.98681240745924e-8	8	114	26
DOID:11193	syndactyly	GO:0002009	morphogenesis of an epithelium	4.07740508023835e-12	8.992716904465681e-8	12	506	26
DOID:11193	syndactyly	GO:0048589	developmental growth	5.016209669861382e-12	1.1063250426879279e-7	12	558	26
DOID:11193	syndactyly	GO:0007389	pattern specification process	5.750511178348461e-12	1.268275240384753e-7	11	432	26
DOID:11193	syndactyly	GO:0003002	regionalization	9.837908265808437e-12	2.1697506680240508e-7	10	327	26
DOID:11193	syndactyly	GO:0001503	ossification	2.822098110755178e-11	6.224137383270545e-7	10	363	26
DOID:11193	syndactyly	GO:0030278	regulation of ossification	7.452261030493901e-11	1.6435961702754298e-6	8	177	26
DOID:11193	syndactyly	GO:0048562	embryonic organ morphogenesis	8.546030549894112e-11	1.8848270377791465e-6	9	280	26
DOID:11193	syndactyly	GO:0060688	regulation of morphogenesis of a branching structure	8.59440296707703e-11	1.895495574388839e-6	6	53	26
DOID:11193	syndactyly	GO:0060571	morphogenesis of an epithelial fold	1.1517098386093494e-10	2.54009604905292e-6	5	23	26
DOID:11193	syndactyly	GO:0071363	cellular response to growth factor stimulus	1.5335988035047876e-10	3.382352161129809e-6	11	594	26
DOID:11193	syndactyly	GO:0051093	negative regulation of developmental process	1.6730905549877662e-10	3.6900012190255183e-6	12	788	26
DOID:11193	syndactyly	GO:0048645	organ formation	1.6815726588959024e-10	3.7087084991949126e-6	6	59	26
DOID:11193	syndactyly	GO:0043583	ear development	1.6891110732331072e-10	3.725334472015618e-6	8	196	26
DOID:11193	syndactyly	GO:0060740	prostate gland epithelium morphogenesis	1.8148371694337584e-10	4.002623377186154e-6	5	25	26
DOID:11193	syndactyly	GO:0035265	organ growth	4.423184041257855e-10	9.755332402994199e-6	7	132	26
DOID:11193	syndactyly	GO:0035239	tube morphogenesis	4.465134928466341e-10	9.847855084732515e-6	9	338	26
DOID:11193	syndactyly	GO:2000027	regulation of organ morphogenesis	7.437654936381932e-10	1.640374796219035e-5	8	236	26
DOID:11193	syndactyly	GO:0042475	odontogenesis of dentin-containing tooth	1.186204467984453e-9	2.616173954139711e-5	6	81	26
DOID:11193	syndactyly	GO:0060601	lateral sprouting from an epithelium	1.4509534684847836e-9	3.20007787474319e-5	4	12	26
DOID:11193	syndactyly	GO:0060594	mammary gland specification	2.3971306051251418e-9	5.2868715496035e-5	3	3	26
DOID:11193	syndactyly	GO:0043010	camera-type eye development	3.11281067588709e-9	6.865303945668977e-5	8	283	26
DOID:11193	syndactyly	GO:0060070	canonical Wnt signaling pathway	3.4756275635317024e-9	7.66549659136917e-5	8	287	26
DOID:11193	syndactyly	GO:0016202	regulation of striated muscle tissue development	4.28152702180995e-9	9.442907846601845e-5	6	100	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:1902652	secondary alcohol metabolic process	8.482103908136196e-14	1.870728016939438e-9	11	121	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:0015918	sterol transport	2.3869795029440866e-14	5.264483293743183e-10	8	69	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:0055088	lipid homeostasis	1.0691447727140257e-13	2.3579987962207838e-9	9	111	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:0070325	lipoprotein particle receptor binding	9.024947456026666e-11	1.9904521614266812e-6	5	22	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:0019218	regulation of steroid metabolic process	5.281152182234905e-10	1.1647581137919083e-5	6	71	26
Orphanet:391665	Homozygous familial hypercholesterolemia	GO:0005769	early endosome	3.980551999127613e-9	8.77910743407595e-5	8	292	26
MESH:D007247	Infertility, Female	GO:0003006	developmental process involved in reproduction	5.865308239094702e-13	1.2935937321323365e-8	13	619	26
MESH:D007247	Infertility, Female	GO:0048608	reproductive structure development	1.4068746168049984e-12	3.102861967363424e-8	13	418	26
MESH:D007247	Infertility, Female	GO:0032870	cellular response to hormone stimulus	1.433297924791077e-12	3.1611385731267205e-8	13	519	26
MESH:D007247	Infertility, Female	GO:0008202	steroid metabolic process	3.628986000592249e-12	8.003728624306206e-8	10	275	26
MESH:D007247	Infertility, Female	GO:0044706	multi-multicellular organism process	1.963762485956977e-11	4.3310781627781125e-7	9	237	26
MESH:D007247	Infertility, Female	GO:0014070	response to organic cyclic compound	2.936018095311965e-11	6.475387909210539e-7	13	873	26
MESH:D007247	Infertility, Female	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	4.0528913558546265e-11	8.938651885337379e-7	6	47	26
MESH:D007247	Infertility, Female	GO:0071396	cellular response to lipid	1.0614686907217674e-10	2.341069197386858e-6	10	416	26
MESH:D007247	Infertility, Female	GO:0048732	gland development	1.207405286862695e-10	2.662932360175674e-6	10	421	26
MESH:D007247	Infertility, Female	GO:0007565	female pregnancy	1.3158596434692527e-10	2.9021284436714367e-6	8	190	26
MESH:D007247	Infertility, Female	GO:0003707	steroid hormone receptor activity	1.511176739299458e-10	3.3329002985249545e-6	6	58	26
MESH:D007247	Infertility, Female	GO:0001890	placenta development	6.049929446305669e-10	1.3343119393827152e-5	7	138	26
MESH:D007247	Infertility, Female	GO:0040007	growth	1.1832518298504624e-9	2.6096619107351948e-5	12	936	26
MESH:D007247	Infertility, Female	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.3993026454505184e-9	5.2916619845411184e-5	12	996	26
MESH:D007247	Infertility, Female	GO:0007548	sex differentiation	2.415716293668879e-9	5.327862285686713e-5	8	274	26
MESH:D007247	Infertility, Female	GO:0030522	intracellular receptor signaling pathway	2.9445126337179772e-9	6.494122613664999e-5	8	281	26
Orphanet:104009	Rare disease involving intestinal motility	GO:0000904	cell morphogenesis involved in differentiation	1.1852643311272004e-9	2.6141004823010405e-5	11	720	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0015672	monovalent inorganic cation transport	1.6995294060961896e-12	3.748312105145146e-8	13	572	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0022836	gated channel activity	1.1537437671904627e-12	2.5445818785385654e-8	13	335	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0042391	regulation of membrane potential	1.042055330913172e-12	2.2982530323290007e-8	12	340	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0034762	regulation of transmembrane transport	8.137934770502397e-13	1.7948215136343038e-8	12	383	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0022832	voltage-gated channel activity	8.053557820630886e-13	1.7762121773401418e-8	11	189	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0005244	voltage-gated ion channel activity	8.053557820630886e-13	1.7762121773401418e-8	11	189	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0034220	ion transmembrane transport	2.26929586233382e-13	5.00493202437724e-9	15	962	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0001508	action potential	1.0946799022804043e-13	2.4143165244794318e-9	9	119	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0005248	voltage-gated sodium channel activity	9.725553695716371e-14	2.1449708675902457e-9	6	20	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0098660	inorganic ion transmembrane transport	5.767608612927688e-13	1.2720460795812016e-8	14	660	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0098797	plasma membrane protein complex	1.7701395904623496e-12	3.904042866764712e-8	12	499	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0098662	inorganic cation transmembrane transport	3.3629765638920617e-12	7.417044811663942e-8	12	575	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0019226	transmission of nerve impulse	3.602673714908633e-12	7.94569687823099e-8	7	67	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0001518	voltage-gated sodium channel complex	6.905476190866011e-12	1.5230027738954988e-7	5	14	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0030001	metal ion transport	1.2699730156384703e-11	2.8009254859906463e-7	13	792	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0060078	regulation of postsynaptic membrane potential	1.9428125774823002e-11	4.284873139637213e-7	7	85	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0006814	sodium ion transport	2.067882531875398e-10	4.56071492405119e-6	8	201	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0035725	sodium ion transmembrane transport	3.184272845402347e-10	7.022913760534877e-6	7	126	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0019228	neuronal action potential	5.771866318227126e-10	1.2729851164849926e-5	5	31	26
Orphanet:98258	Infantile epilepsy syndrome	GO:0043194	axon initial segment	1.4509534684847836e-9	3.20007787474319e-5	4	12	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0006979	response to oxidative stress	4.9669268697982716e-11	1.0954557211340088e-6	10	386	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0044708	single-organism behavior	7.810807556296595e-11	1.722673606541214e-6	10	404	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0007626	locomotory behavior	9.729428374072313e-11	2.1458254279016487e-6	8	183	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:1900407	regulation of cellular response to oxidative stress	1.511176739299458e-10	3.3329002985249545e-6	6	58	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0001963	synaptic transmission, dopaminergic	3.3479907735056713e-10	7.383993650966758e-6	5	28	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:1902803	regulation of synaptic vesicle transport	3.3479907735056713e-10	7.383993650966758e-6	5	28	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0010035	response to inorganic substance	6.532475671505722e-10	1.440737509350587e-5	10	502	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:1903202	negative regulation of oxidative stress-induced cell death	8.045900612430046e-10	1.7745233800714466e-5	5	33	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0015872	dopamine transport	8.045900612430046e-10	1.7745233800714466e-5	5	33	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0051934	catecholamine uptake involved in synaptic transmission	9.682192825266611e-10	2.135407627612551e-5	4	11	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0051583	dopamine uptake involved in synaptic transmission	9.682192825266611e-10	2.135407627612551e-5	4	11	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:1990267	response to transition metal nanoparticle	1.0860001786738849e-9	2.395173394065253e-5	7	150	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0008344	adult locomotory behavior	1.0993999044472957e-9	2.4247264892585108e-5	6	80	26
Orphanet:306666	Rare parkinsonian syndrome due to neurodegenerative disease	GO:0007005	mitochondrion organization	1.2366266899377365e-9	2.727380164657678e-5	11	723	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0051604	protein maturation	2.1271873151818e-13	4.69151162363346e-9	11	332	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0061041	regulation of wound healing	1.1235457009206584e-13	2.477980043380512e-9	12	125	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0031093	platelet alpha granule lumen	1.0014211682118912e-13	2.208634386491326e-9	11	55	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:1903035	negative regulation of response to wounding	7.194245199571014e-14	1.5866907787653872e-9	11	159	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0050818	regulation of coagulation	3.863576125695545e-14	8.521117145221524e-10	12	88	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0007597	blood coagulation, intrinsic pathway	2.3314683517128287e-14	5.142053449702644e-10	8	19	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0051917	regulation of fibrinolysis	7.327471962526033e-15	1.6160739413351166e-10	6	14	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0002576	platelet degranulation	2.2470914018413168e-13	4.955960086761024e-9	11	106	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0006888	ER to Golgi vesicle-mediated transport	6.896705428971472e-13	1.5210683823596582e-8	9	168	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0030168	platelet activation	3.704081485977895e-11	8.169351717324247e-7	8	162	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:1900048	positive regulation of hemostasis	1.4529299985355237e-10	3.2044371117700976e-6	5	24	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0030194	positive regulation of blood coagulation	1.4529299985355237e-10	3.2044371117700976e-6	5	24	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0072562	blood microparticle	1.570398255879013e-10	3.4635133533411633e-6	7	114	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0051918	negative regulation of fibrinolysis	6.167396593426133e-10	1.3602193186801337e-5	4	10	26
Orphanet:68334	Rare hemorrhagic disorder due to a constitutional coagulation factors defect	GO:0004252	serine-type endopeptidase activity	4.1896299762811395e-9	9.240228912688053e-5	7	182	26
Orphanet:253	Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia	GO:0001501	skeletal system development	1.2571055307830648e-12	2.7725462481420493e-8	13	482	26
Orphanet:253	Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia	GO:0061448	connective tissue development	6.709121036507781e-10	1.4796966446017912e-5	8	233	26
Orphanet:253	Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia	GO:0051216	cartilage development	3.879773835535616e-9	8.556841194273801e-5	7	180	26
MESH:D003398	Craniosynostoses	GO:0035295	tube development	1.616928813064078e-12	3.566136497212824e-8	13	573	26
MESH:D003398	Craniosynostoses	GO:0060348	bone development	2.6556534749033744e-13	5.857043738899392e-9	10	172	26
MESH:D003398	Craniosynostoses	GO:0007389	pattern specification process	8.271161533457416e-13	1.824204676204033e-8	12	432	26
MESH:D003398	Craniosynostoses	GO:0009790	embryo development	1.6574519534628962e-12	3.6555102833624176e-8	14	932	26
MESH:D003398	Craniosynostoses	GO:0045667	regulation of osteoblast differentiation	1.8139933999350433e-12	4.000762443556738e-8	8	111	26
MESH:D003398	Craniosynostoses	GO:0035113	embryonic appendage morphogenesis	4.431011113581462e-12	9.772595011003915e-8	8	125	26
MESH:D003398	Craniosynostoses	GO:0030326	embryonic limb morphogenesis	4.431011113581462e-12	9.772595011003915e-8	8	125	26
MESH:D003398	Craniosynostoses	GO:0060562	epithelial tube morphogenesis	4.472311410097518e-12	9.863682814970076e-8	10	301	26
MESH:D003398	Craniosynostoses	GO:0009792	embryo development ending in birth or egg hatching	5.016209669861382e-12	1.1063250426879279e-7	12	558	26
MESH:D003398	Craniosynostoses	GO:0043009	chordate embryonic development	6.511569061729006e-12	1.4361265565643322e-7	12	552	26
MESH:D003398	Craniosynostoses	GO:0003002	regionalization	9.837908265808437e-12	2.1697506680240508e-7	10	327	26
MESH:D003398	Craniosynostoses	GO:0007507	heart development	2.0252688415212106e-11	4.46673042997503e-7	11	487	26
MESH:D003398	Craniosynostoses	GO:0048704	embryonic skeletal system morphogenesis	3.690636685149684e-11	8.139699209097628e-7	7	93	26
MESH:D003398	Craniosynostoses	GO:0048645	organ formation	1.6815726588959024e-10	3.7087084991949126e-6	6	59	26
MESH:D003398	Craniosynostoses	GO:0003007	heart morphogenesis	3.67240460263929e-10	8.099488351120954e-6	8	216	26
MESH:D003398	Craniosynostoses	GO:0010092	specification of organ identity	4.041503798291046e-10	8.913536627130902e-6	5	29	26
MESH:D003398	Craniosynostoses	GO:0007423	sensory organ development	5.590160556678825e-10	1.2329099107755148e-5	10	494	26
MESH:D003398	Craniosynostoses	GO:0090596	sensory organ morphogenesis	8.215250701937293e-10	1.81187354231227e-5	8	239	26
MESH:D003398	Craniosynostoses	GO:0001657	ureteric bud development	3.5591538605217465e-9	7.849713839380712e-5	6	97	26
MESH:D003398	Craniosynostoses	GO:0061138	morphogenesis of a branching epithelium	3.732300468684002e-9	8.231588683682567e-5	7	179	26
DOID:0050572	cone-rod dystrophy	GO:0072372	primary cilium	5.841993555577574e-13	1.2884516786826339e-8	10	199	27
DOID:0050572	cone-rod dystrophy	GO:0007601	visual perception	3.610445276081009e-13	7.962837056396666e-9	17	207	27
DOID:0050572	cone-rod dystrophy	GO:0001750	photoreceptor outer segment	6.661338147750939e-14	1.4691581284864696e-9	9	69	27
DOID:0050572	cone-rod dystrophy	GO:0009583	detection of light stimulus	1.6542323066914832e-13	3.6484093524080663e-9	8	75	27
DOID:0050572	cone-rod dystrophy	GO:0044441	ciliary part	1.0663692151524629e-12	2.3518773040187568e-8	11	303	27
DOID:0050572	cone-rod dystrophy	GO:0009584	detection of visible light	2.841171742318238e-12	6.266204277682874e-8	7	62	27
DOID:0050572	cone-rod dystrophy	GO:0060170	ciliary membrane	1.5491163907199734e-11	3.4165761997329014e-7	7	79	27
DOID:0050572	cone-rod dystrophy	GO:0007602	phototransduction	2.3938873106033043e-10	5.279718463535588e-6	6	60	27
DOID:0050572	cone-rod dystrophy	GO:0001895	retina homeostasis	4.319125057605788e-10	9.525830314549566e-6	6	66	27
DOID:11724	limb-girdle muscular dystrophy	GO:0055001	muscle cell development	1.6053824936079764e-11	3.540671089652392e-7	8	140	27
DOID:11724	limb-girdle muscular dystrophy	GO:0030017	sarcomere	1.2044742980776846e-10	2.6564680644103333e-6	8	180	27
DOID:11724	limb-girdle muscular dystrophy	GO:0030018	Z disc	1.5344425730035027e-10	3.3842130947592253e-6	7	109	27
DOID:11724	limb-girdle muscular dystrophy	GO:0048738	cardiac muscle tissue development	3.214473687229713e-9	7.089521717185132e-5	7	168	27
DOID:0050749	peripheral T-cell lymphoma	GO:0046649	lymphocyte activation	2.107203300738547e-13	4.647436879778866e-9	14	594	27
DOID:0050749	peripheral T-cell lymphoma	GO:0007159	leukocyte cell-cell adhesion	7.259748358023899e-13	1.601137500362171e-8	12	461	27
DOID:0050749	peripheral T-cell lymphoma	GO:0070486	leukocyte aggregation	1.315947351088198e-12	2.9023218828250208e-8	12	432	27
DOID:0050749	peripheral T-cell lymphoma	GO:0050778	positive regulation of immune response	2.9571112225568186e-10	6.521908801349063e-6	11	603	27
DOID:0050749	peripheral T-cell lymphoma	GO:0002250	adaptive immune response	5.934585045608287e-10	1.3088727318089077e-5	9	334	27
DOID:0050749	peripheral T-cell lymphoma	GO:0071594	thymocyte aggregation	6.204348146354732e-10	1.3683689836785362e-5	6	70	27
DOID:0050749	peripheral T-cell lymphoma	GO:0033077	T cell differentiation in thymus	6.204348146354732e-10	1.3683689836785362e-5	6	70	27
DOID:0050749	peripheral T-cell lymphoma	GO:0046651	lymphocyte proliferation	1.5953608434315925e-9	3.518568340188377e-5	8	249	27
DOID:0050749	peripheral T-cell lymphoma	GO:0002757	immune response-activating signal transduction	4.345093507218678e-9	9.583103730170794e-5	9	419	27
DOID:0050749	peripheral T-cell lymphoma	GO:0050863	regulation of T cell activation	4.488361682319919e-9	9.899081690356581e-5	8	284	27
DOID:0060388	chromosomal deletion syndrome	GO:0048667	cell morphogenesis involved in neuron differentiation	8.830478570587275e-10	1.9475620487430234e-5	10	495	27
DOID:0060388	chromosomal deletion syndrome	GO:0048812	neuron projection morphogenesis	2.009770239119746e-9	4.4325482623785994e-5	10	539	27
DOID:520	aortic disease	GO:0009611	response to wounding	5.560707450058544e-11	1.2264140281104119e-6	13	875	27
DOID:520	aortic disease	GO:0051241	negative regulation of multicellular organismal process	2.902325491049851e-9	6.401078870510446e-5	12	966	27
DOID:47	prostate disease	GO:0014070	response to organic cyclic compound	5.2269522043957295e-11	1.1528043086794781e-6	13	873	27
DOID:47	prostate disease	GO:0097305	response to alcohol	1.4293438654888746e-9	3.152417895335713e-5	9	369	27
Orphanet:307141	Diffuse palmoplantar keratoderma	GO:0005882	intermediate filament	2.1047641407534456e-10	4.642057312431724e-6	8	193	27
Orphanet:307141	Diffuse palmoplantar keratoderma	GO:0043588	skin development	1.2330755305711705e-9	2.7195480826747165e-5	8	241	27
Orphanet:307141	Diffuse palmoplantar keratoderma	GO:0045104	intermediate filament cytoskeleton organization	3.504226353534534e-9	7.728571222720415e-5	5	42	27
DOID:2671	transitional cell carcinoma	GO:0009416	response to light stimulus	2.1122692483999117e-10	4.658609827346005e-6	9	297	27
DOID:2671	transitional cell carcinoma	GO:0009411	response to UV	4.0408543178216405e-10	8.912104197955628e-6	7	125	27
MESH:D018901	Peroxisomal Disorders	GO:0044438	microbody part	1.5831780331154732e-13	3.491699152036176e-9	22	90	27
MESH:D018901	Peroxisomal Disorders	GO:0044439	peroxisomal part	1.5831780331154732e-13	3.491699152036176e-9	22	90	27
MESH:D018901	Peroxisomal Disorders	GO:0071806	protein transmembrane transport	1.0480505352461478e-13	2.311475455485379e-9	13	53	27
MESH:D018901	Peroxisomal Disorders	GO:0043574	peroxisomal transport	3.4861002973229915e-14	7.688594205745858e-10	13	18	27
MESH:D018901	Peroxisomal Disorders	GO:0045046	protein import into peroxisome membrane	2.098321516541546e-14	4.6278481047323794e-10	5	6	27
MESH:D018901	Peroxisomal Disorders	GO:0031907	microbody lumen	1.326716514427062e-13	2.9260732725688854e-9	9	42	27
MESH:D018901	Peroxisomal Disorders	GO:0005782	peroxisomal matrix	1.326716514427062e-13	2.9260732725688854e-9	9	42	27
MESH:D018901	Peroxisomal Disorders	GO:0046395	carboxylic acid catabolic process	3.099742684753437e-13	6.8364824912237054e-9	10	219	27
MESH:D018901	Peroxisomal Disorders	GO:0072329	monocarboxylic acid catabolic process	2.1859181131844707e-12	4.82104239862835e-8	8	109	27
MESH:D018901	Peroxisomal Disorders	GO:0009062	fatty acid catabolic process	2.8141267094383693e-11	6.206556457666323e-7	7	86	27
MESH:D018901	Peroxisomal Disorders	GO:0019395	fatty acid oxidation	4.236855311035015e-11	9.344384388487725e-7	7	91	27
MESH:D018901	Peroxisomal Disorders	GO:0006635	fatty acid beta-oxidation	3.929938596769489e-10	8.667479575175108e-6	6	65	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:0005773	vacuole	1.092015367021304e-12	2.408439891965486e-8	16	603	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:0043202	lysosomal lumen	8.149037000748649e-14	1.7972701105151145e-9	9	87	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:0006665	sphingolipid metabolic process	2.0066948103192317e-11	4.4257654041590655e-7	8	144	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:0006687	glycosphingolipid metabolic process	7.379700184273474e-10	1.6275928756415148e-5	6	72	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:1901565	organonitrogen compound catabolic process	8.764892145407543e-10	1.9330969626696337e-5	9	349	27
Orphanet:98544	Cerebral lipidosis with dementia	GO:0006672	ceramide metabolic process	1.5198783342995625e-9	3.352091666297685e-5	6	81	27
Orphanet:93440	Slender bone dysplasia	GO:0000278	mitotic cell cycle	4.5086157030027607e-13	9.943751932972589e-9	17	927	27
Orphanet:139042	Malformation syndrome with odontal and/or periodontal component	GO:0042476	odontogenesis	2.4868995751603507e-14	5.484857013016153e-10	12	114	27
Orphanet:139042	Malformation syndrome with odontal and/or periodontal component	GO:0042475	odontogenesis of dentin-containing tooth	5.6621374255882984e-14	1.2487844092134992e-9	9	81	27
Orphanet:139042	Malformation syndrome with odontal and/or periodontal component	GO:0031214	biomineral tissue development	5.62799695735805e-10	1.241254728945318e-5	7	131	27
DOID:205	hyperostosis	GO:0001503	ossification	9.985345883478658e-13	2.202268034601218e-8	12	363	27
Orphanet:183490	Genetic photodermatosis	GO:0006289	nucleotide-excision repair	1.0913492332065289e-13	2.4069707338369994e-9	10	115	28
Orphanet:183490	Genetic photodermatosis	GO:0032508	DNA duplex unwinding	1.552458162024095e-11	3.423946476344142e-7	7	76	28
Orphanet:183490	Genetic photodermatosis	GO:0000405	bubble DNA binding	1.4114476254434294e-10	3.1129477379154835e-6	4	7	28
Orphanet:183490	Genetic photodermatosis	GO:0009636	response to toxic substance	2.208273341963718e-9	4.87034685570098e-5	8	249	28
Orphanet:183490	Genetic photodermatosis	GO:0000109	nucleotide-excision repair complex	4.007439824427195e-9	8.838408532774178e-5	4	14	28
OMIM:608579	Stevens-Johnson syndrome	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	3.747224752714828e-12	8.264504192112554e-8	11	384	28
OMIM:608579	Stevens-Johnson syndrome	GO:0034976	response to endoplasmic reticulum stress	9.022904645661356e-11	1.990001619600612e-6	9	258	28
OMIM:608579	Stevens-Johnson syndrome	GO:0044419	interspecies interaction between organisms	3.2419245066250824e-10	7.150064499361619e-6	12	761	28
OMIM:608579	Stevens-Johnson syndrome	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.2419245066250824e-10	7.150064499361619e-6	12	761	28
OMIM:608579	Stevens-Johnson syndrome	GO:0032446	protein modification by small protein conjugation	1.804609905953214e-9	3.980067147579813e-5	12	885	28
OMIM:608579	Stevens-Johnson syndrome	GO:0016032	viral process	3.3424096823608807e-9	7.371684554446922e-5	11	726	28
OMIM:608579	Stevens-Johnson syndrome	GO:0042176	regulation of protein catabolic process	3.589218033894781e-9	7.91602037375494e-5	9	393	28
DOID:8927	learning disability	GO:0044708	single-organism behavior	7.327471962526033e-14	1.6160739413351166e-9	13	404	28
DOID:8927	learning disability	GO:0007611	learning or memory	4.0889513996944515e-13	9.018182312026113e-9	10	218	28
DOID:8927	learning disability	GO:0044456	synapse part	1.48947520983711e-12	3.285037575295746e-8	13	613	28
DOID:8927	learning disability	GO:0098793	presynapse	1.0848544285124717e-11	2.3926464420842564e-7	9	205	28
DOID:8927	learning disability	GO:0007268	synaptic transmission	2.2079227335325413e-11	4.86957358880602e-7	12	605	28
DOID:8927	learning disability	GO:0001505	regulation of neurotransmitter levels	1.602492583074877e-10	3.5342973919716414e-6	8	179	28
DOID:8927	learning disability	GO:0043005	neuron projection	2.3013646544001176e-10	5.075659745279459e-6	13	941	28
DOID:8927	learning disability	GO:0030424	axon	2.382982700055436e-10	5.255668344972264e-6	10	414	28
DOID:8927	learning disability	GO:1901615	organic hydroxy compound metabolic process	2.78236667039522e-9	6.136509691556657e-5	10	534	28
MESH:D061085	Agenesis of Corpus Callosum	GO:0007507	heart development	1.1465171034785726e-9	2.528643471721992e-5	10	487	28
Orphanet:79390	Rare photodermatosis	GO:0006289	nucleotide-excision repair	1.0913492332065289e-13	2.4069707338369994e-9	10	115	28
Orphanet:79390	Rare photodermatosis	GO:0032508	DNA duplex unwinding	1.552458162024095e-11	3.423946476344142e-7	7	76	28
Orphanet:79390	Rare photodermatosis	GO:0000405	bubble DNA binding	1.4114476254434294e-10	3.1129477379154835e-6	4	7	28
Orphanet:79390	Rare photodermatosis	GO:0009636	response to toxic substance	2.208273341963718e-9	4.87034685570098e-5	8	249	28
Orphanet:79390	Rare photodermatosis	GO:0000109	nucleotide-excision repair complex	4.007439824427195e-9	8.838408532774178e-5	4	14	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0006954	inflammatory response	1.4912515666765103e-12	3.2889553303050434e-8	15	637	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0031347	regulation of defense response	1.6637025090915358e-11	3.6692958838013823e-7	13	749	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0032652	regulation of interleukin-1 production	1.9776869031318256e-10	4.361788464857241e-6	6	56	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0050727	regulation of inflammatory response	2.414786148818848e-10	5.32581085121997e-6	9	289	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0050706	regulation of interleukin-1 beta secretion	6.025252519137325e-10	1.328869443095737e-5	5	29	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0071345	cellular response to cytokine stimulus	1.6076304731882374e-9	3.5456290086166575e-5	11	677	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:0009617	response to bacterium	2.0398347455596877e-9	4.498855531331891e-5	10	517	28
Orphanet:290842	Autoinflammatory syndrome with skin involvement	GO:1903035	negative regulation of response to wounding	2.8979936228523684e-9	6.391524935200898e-5	7	159	28
OMIM:178600	Pulmonary Hypertension, Primary, 1	GO:0003018	vascular process in circulatory system	1.8385293287792592e-13	4.054876434622656e-9	11	159	28
OMIM:178600	Pulmonary Hypertension, Primary, 1	GO:0050880	regulation of blood vessel size	1.1457501614131615e-13	2.526951980996728e-9	11	139	28
OMIM:178600	Pulmonary Hypertension, Primary, 1	GO:0042310	vasoconstriction	2.794431352981519e-13	6.16311834900074e-9	8	80	28
DOID:2452	thrombophilia	GO:0061041	regulation of wound healing	1.978417429882029e-13	4.363399641604815e-9	10	125	28
DOID:2452	thrombophilia	GO:0050818	regulation of coagulation	1.2523315717771766e-13	2.762017281554563e-9	10	88	28
DOID:2452	thrombophilia	GO:0051604	protein maturation	3.8902214782865485e-13	8.579883470360983e-9	11	332	28
DOID:2452	thrombophilia	GO:0042730	fibrinolysis	1.860844811574225e-12	4.104093231926953e-8	6	27	28
DOID:2452	thrombophilia	GO:0007598	blood coagulation, extrinsic pathway	2.0196622152468535e-11	4.4543650157269354e-7	4	5	28
DOID:2452	thrombophilia	GO:0031093	platelet alpha granule lumen	1.7666801355176176e-10	3.896413038884106e-6	6	55	28
DOID:2452	thrombophilia	GO:0006465	signal peptide processing	2.1673962624646492e-10	4.780192456865784e-6	5	24	28
DOID:2452	thrombophilia	GO:1900048	positive regulation of hemostasis	2.1673962624646492e-10	4.780192456865784e-6	5	24	28
DOID:2452	thrombophilia	GO:0030194	positive regulation of blood coagulation	2.1673962624646492e-10	4.780192456865784e-6	5	24	28
DOID:2452	thrombophilia	GO:0002526	acute inflammatory response	1.2504559609993748e-9	2.7578806219841212e-5	7	141	28
DOID:2452	thrombophilia	GO:0052548	regulation of endopeptidase activity	1.7510356498107171e-9	3.8619091256575366e-5	9	362	28
DOID:2452	thrombophilia	GO:0030168	platelet activation	3.301685258527698e-9	7.281866837682838e-5	7	162	28
DOID:2452	thrombophilia	GO:0006888	ER to Golgi vesicle-mediated transport	4.253709828816454e-9	9.38155702745469e-5	7	168	28
MESH:D013610	Tachycardia	GO:0043269	regulation of ion transport	5.382361223382759e-13	1.1870797678170675e-8	14	583	28
MESH:D013610	Tachycardia	GO:0005179	hormone activity	2.3714363805993344e-13	5.230202937411832e-9	10	117	28
MESH:D013610	Tachycardia	GO:0051050	positive regulation of transport	4.618527782440651e-13	1.0186163024172856e-8	15	920	28
MESH:D013610	Tachycardia	GO:0043270	positive regulation of ion transport	5.043743200872086e-13	1.1123975629523386e-8	11	233	28
MESH:D013610	Tachycardia	GO:0010817	regulation of hormone levels	2.5163204853129173e-12	5.549744830357639e-8	12	473	28
MESH:D013610	Tachycardia	GO:0043271	negative regulation of ion transport	6.881717418139033e-12	1.5177627765705637e-7	8	121	28
MESH:D013610	Tachycardia	GO:0046879	hormone secretion	1.0046741216740429e-11	2.2158087753521016e-7	10	297	28
MESH:D013610	Tachycardia	GO:0030072	peptide hormone secretion	4.881328674599672e-11	1.0765770391829577e-6	9	241	28
MESH:D013610	Tachycardia	GO:0046883	regulation of hormone secretion	7.276457214544507e-11	1.604822638667791e-6	9	252	28
MESH:D013610	Tachycardia	GO:0034767	positive regulation of ion transmembrane transport	8.910361337655104e-11	1.965180193019833e-6	7	97	28
MESH:D013610	Tachycardia	GO:0046887	positive regulation of hormone secretion	2.9757918351691615e-10	6.563108892465586e-6	7	115	28
MESH:D013610	Tachycardia	GO:0052652	cyclic purine nucleotide metabolic process	1.6744856612405101e-9	3.693078125865945e-5	7	147	28
MESH:D013610	Tachycardia	GO:0043266	regulation of potassium ion transport	2.077869210026506e-9	4.582740542713459e-5	6	82	28
DOID:3454	brain infarction	GO:0072593	reactive oxygen species metabolic process	9.243323884078336e-10	2.038615082633477e-5	8	223	28
DOID:3454	brain infarction	GO:1903409	reactive oxygen species biosynthetic process	2.2376152042369313e-9	4.935060332944552e-5	6	83	28
DOID:0050650	familial atrial fibrillation	GO:0015672	monovalent inorganic cation transport	1.9095836023552692e-12	4.211586634994546e-8	16	572	29
DOID:0050650	familial atrial fibrillation	GO:0035637	multicellular organismal signaling	1.375344282905644e-12	3.033321815948398e-8	15	184	29
DOID:0050650	familial atrial fibrillation	GO:0001508	action potential	3.526068326209497e-13	7.776743693455046e-9	12	119	29
DOID:0050650	familial atrial fibrillation	GO:0006937	regulation of muscle contraction	2.7822188997106423e-13	6.1361837833118216e-9	15	165	29
DOID:0050650	familial atrial fibrillation	GO:0006941	striated muscle contraction	2.4802382370125997e-13	5.470165431731289e-9	14	150	29
DOID:0050650	familial atrial fibrillation	GO:0030048	actin filament-based movement	1.9029222642075183e-13	4.196895053709682e-9	12	114	29
DOID:0050650	familial atrial fibrillation	GO:0002027	regulation of heart rate	1.7363888105137448e-13	3.829605521588064e-9	13	87	29
DOID:0050650	familial atrial fibrillation	GO:0086009	membrane repolarization	9.903189379656396e-14	2.1841484176832182e-9	9	36	29
DOID:0050650	familial atrial fibrillation	GO:0086002	cardiac muscle cell action potential involved in contraction	9.903189379656396e-14	2.1841484176832182e-9	10	36	29
DOID:0050650	familial atrial fibrillation	GO:0086091	regulation of heart rate by cardiac conduction	8.570921750106208e-14	1.8903167919859243e-9	10	30	29
DOID:0050650	familial atrial fibrillation	GO:0034762	regulation of transmembrane transport	8.526512829121202e-14	1.880522404462681e-9	12	383	29
DOID:0050650	familial atrial fibrillation	GO:0060306	regulation of membrane repolarization	7.105427357601002e-14	1.567102003718901e-9	9	29	29
DOID:0050650	familial atrial fibrillation	GO:0086019	cell-cell signaling involved in cardiac conduction	2.7977620220553945e-14	6.170464139643173e-10	8	23	29
DOID:0050650	familial atrial fibrillation	GO:0051899	membrane depolarization	1.6209256159527285e-13	3.574951445983743e-9	9	94	29
DOID:0050650	familial atrial fibrillation	GO:0006813	potassium ion transport	2.566835632933362e-13	5.66115598843453e-9	10	213	29
DOID:0050650	familial atrial fibrillation	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	3.4428015993626104e-13	7.593098927394237e-9	5	8	29
DOID:0050650	familial atrial fibrillation	GO:0098662	inorganic cation transmembrane transport	5.234701561107613e-13	1.154513429302284e-8	13	575	29
DOID:0050650	familial atrial fibrillation	GO:0022843	voltage-gated cation channel activity	8.805178808302117e-13	1.9419821861710318e-8	9	149	29
DOID:0050650	familial atrial fibrillation	GO:0034703	cation channel complex	1.9380053117856733e-12	4.2742707151433024e-8	9	166	29
DOID:0050650	familial atrial fibrillation	GO:0071805	potassium ion transmembrane transport	3.5438318946034997e-12	7.815921243548019e-8	9	177	29
DOID:0050650	familial atrial fibrillation	GO:0086043	bundle of His cell action potential	4.692357613578224e-12	1.0348994716746773e-7	4	4	29
DOID:0050650	familial atrial fibrillation	GO:0015077	monovalent inorganic cation transmembrane transporter activity	4.82369699739138e-12	1.0638663727746689e-7	11	368	29
DOID:0050650	familial atrial fibrillation	GO:0046873	metal ion transmembrane transporter activity	1.5162537891910688e-11	3.344097732060902e-7	11	415	29
DOID:0050650	familial atrial fibrillation	GO:0086011	membrane repolarization during action potential	1.8678392166293634e-11	4.119519392276061e-7	5	15	29
DOID:0050650	familial atrial fibrillation	GO:0010959	regulation of metal ion transport	3.105660173474689e-11	6.849533512598427e-7	10	321	29
DOID:0050650	familial atrial fibrillation	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	3.8342995445361794e-11	8.456547645474544e-7	5	17	29
DOID:0050650	familial atrial fibrillation	GO:0043270	positive regulation of ion transport	5.1283977064997543e-11	1.1310681141685208e-6	9	233	29
DOID:0050650	familial atrial fibrillation	GO:0086012	membrane depolarization during cardiac muscle cell action potential	5.313161022257873e-11	1.1718176634589739e-6	5	18	29
DOID:0050650	familial atrial fibrillation	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	7.023037706943569e-11	1.5489309662664041e-6	4	6	29
DOID:0050650	familial atrial fibrillation	GO:0005248	voltage-gated sodium channel activity	9.587874938432606e-11	2.114605817671311e-6	5	20	29
DOID:0050650	familial atrial fibrillation	GO:0014704	intercalated disc	1.0799217076140621e-10	2.381767326142814e-6	6	49	29
DOID:0050650	familial atrial fibrillation	GO:1904062	regulation of cation transmembrane transport	1.146942540941609e-10	2.5295817740467186e-6	8	165	29
DOID:0050650	familial atrial fibrillation	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	1.637024960032818e-10	3.61045854935238e-6	4	7	29
DOID:0050650	familial atrial fibrillation	GO:0086005	ventricular cardiac muscle cell action potential	2.616994398962902e-10	5.77178114691268e-6	5	24	29
DOID:0050650	familial atrial fibrillation	GO:0086070	SA node cell to atrial cardiac muscle cell communication	5.880399500668432e-10	1.2969221098724226e-5	4	9	29
DOID:0050650	familial atrial fibrillation	GO:0086015	SA node cell action potential	5.880399500668432e-10	1.2969221098724226e-5	4	9	29
DOID:0050650	familial atrial fibrillation	GO:0086013	membrane repolarization during cardiac muscle cell action potential	9.790147581512088e-10	2.159217049102491e-5	4	10	29
DOID:0050650	familial atrial fibrillation	GO:0050880	regulation of blood vessel size	1.4818163363017334e-9	3.268145929713473e-5	7	139	29
DOID:0050650	familial atrial fibrillation	GO:0098797	plasma membrane protein complex	2.159306400351113e-9	4.76235026597438e-5	10	499	29
DOID:0050650	familial atrial fibrillation	GO:0071435	potassium ion export	2.302735113701715e-9	5.078682293269132e-5	4	12	29
DOID:0050650	familial atrial fibrillation	GO:0043266	regulation of potassium ion transport	2.6108140094294185e-9	5.7581502977965826e-5	6	82	29
DOID:0050650	familial atrial fibrillation	GO:0086017	Purkinje myocyte action potential	3.3688901668327276e-9	7.43008726294958e-5	3	3	29
DOID:0050650	familial atrial fibrillation	GO:1903524	positive regulation of blood circulation	4.300449218952451e-9	9.484640752399631e-5	6	89	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0008610	lipid biosynthetic process	2.0450308113595383e-13	4.510315454453462e-9	14	627	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0030148	sphingolipid biosynthetic process	5.355715870791755e-13	1.1812031353031216e-8	8	88	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0046513	ceramide biosynthetic process	1.5661294483493293e-10	3.454098498334446e-6	6	52	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0044242	cellular lipid catabolic process	2.0081813989492048e-10	4.429044075382471e-6	8	177	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0005789	endoplasmic reticulum membrane	6.255870266258512e-10	1.3797321872233148e-5	13	977	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0046486	glycerolipid metabolic process	4.080682902696253e-9	8.999946141896586e-5	9	383	29
Orphanet:352301	Disorder of phospholipids, sphingolipids and fatty acids biosynthesis	GO:0042439	ethanolamine-containing compound metabolic process	4.300449218952451e-9	9.484640752399631e-5	6	89	29
DOID:0050523	adult T-cell leukemia	GO:0001775	cell activation	2.112754415861673e-12	4.6596798641829196e-8	16	854	29
DOID:0050523	adult T-cell leukemia	GO:0050778	positive regulation of immune response	1.3151701949709604e-12	2.9006078650084532e-8	14	603	29
DOID:0050523	adult T-cell leukemia	GO:0002521	leukocyte differentiation	1.085798118083403e-12	2.3947277494329455e-8	13	448	29
DOID:0050523	adult T-cell leukemia	GO:0002250	adaptive immune response	9.674483436583614e-13	2.133707321938516e-8	12	334	29
DOID:0050523	adult T-cell leukemia	GO:0030217	T cell differentiation	8.686384944667225e-13	1.9157821995463564e-8	11	199	29
DOID:0050523	adult T-cell leukemia	GO:0050870	positive regulation of T cell activation	6.554756737386924e-13	1.4456515984306861e-8	12	202	29
DOID:0050523	adult T-cell leukemia	GO:0050851	antigen receptor-mediated signaling pathway	9.43689570931383e-14	2.0813073486891653e-9	10	203	29
DOID:0050523	adult T-cell leukemia	GO:0045619	regulation of lymphocyte differentiation	9.836575998178887e-14	2.1694568363983535e-9	9	130	29
DOID:0050523	adult T-cell leukemia	GO:0045580	regulation of T cell differentiation	1.268984917146554e-13	2.7987462347667247e-9	9	105	29
DOID:0050523	adult T-cell leukemia	GO:0031294	lymphocyte costimulation	2.453592884421596e-13	5.41139910659183e-9	8	78	29
DOID:0050523	adult T-cell leukemia	GO:0050864	regulation of B cell activation	3.211875210240578e-13	7.0837907761855945e-9	9	100	29
DOID:0050523	adult T-cell leukemia	GO:0045058	T cell selection	4.691802502065912e-13	1.0347770418306368e-8	7	44	29
DOID:0050523	adult T-cell leukemia	GO:0002285	lymphocyte activation involved in immune response	7.16315895488151e-13	1.579834707499117e-8	9	146	29
DOID:0050523	adult T-cell leukemia	GO:0048302	regulation of isotype switching to IgG isotypes	7.907008381380365e-13	1.7438906985134395e-8	5	9	29
DOID:0050523	adult T-cell leukemia	GO:0042035	regulation of cytokine biosynthetic process	1.4962475702873235e-12	3.299974016268692e-8	8	95	29
DOID:0050523	adult T-cell leukemia	GO:0046651	lymphocyte proliferation	3.6376457401843254e-12	8.02282767997653e-8	10	249	29
DOID:0050523	adult T-cell leukemia	GO:0045589	regulation of regulatory T cell differentiation	4.944045173260747e-12	1.0904091629626578e-7	5	12	29
DOID:0050523	adult T-cell leukemia	GO:0050670	regulation of lymphocyte proliferation	6.81010803305071e-12	1.5019693266893341e-7	9	189	29
DOID:0050523	adult T-cell leukemia	GO:1902533	positive regulation of intracellular signal transduction	7.665534873524393e-12	1.690633716355805e-7	14	860	29
DOID:0050523	adult T-cell leukemia	GO:0002708	positive regulation of lymphocyte mediated immunity	8.184231070629266e-12	1.8050321626272847e-7	7	67	29
DOID:0050523	adult T-cell leukemia	GO:0031295	T cell costimulation	2.2238322294754198e-11	4.904661982108038e-7	7	77	29
DOID:0050523	adult T-cell leukemia	GO:0048304	positive regulation of isotype switching to IgG isotypes	7.023037706943569e-11	1.5489309662664041e-6	4	6	29
DOID:0050523	adult T-cell leukemia	GO:0050852	T cell receptor signaling pathway	1.146942540941609e-10	2.5295817740467186e-6	8	165	29
DOID:0050523	adult T-cell leukemia	GO:0042098	T cell proliferation	1.2635670287863832e-10	2.786797081988368e-6	8	167	29
DOID:0050523	adult T-cell leukemia	GO:0001819	positive regulation of cytokine production	1.5844192624570042e-10	3.4944366833489227e-6	10	381	29
DOID:0050523	adult T-cell leukemia	GO:0030888	regulation of B cell proliferation	1.7635948257321843e-10	3.8896083881523325e-6	6	53	29
DOID:0050523	adult T-cell leukemia	GO:0031347	regulation of defense response	4.439595358007864e-10	9.791527562086344e-6	12	749	29
DOID:0050523	adult T-cell leukemia	GO:0046634	regulation of alpha-beta T cell activation	7.559783909982798e-10	1.667310341346706e-5	6	67	29
DOID:0050523	adult T-cell leukemia	GO:0050671	positive regulation of lymphocyte proliferation	7.857371420172399e-10	1.7329432667190225e-5	7	127	29
DOID:0050523	adult T-cell leukemia	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	8.009408691833642e-10	1.7664750869839096e-5	13	996	29
DOID:0050523	adult T-cell leukemia	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	1.4470687981216201e-9	3.191510234257233e-5	5	33	29
DOID:0050523	adult T-cell leukemia	GO:0046427	positive regulation of JAK-STAT cascade	1.6403781666340933e-9	3.617854046511493e-5	6	76	29
DOID:0050523	adult T-cell leukemia	GO:0042129	regulation of T cell proliferation	1.7210206593176736e-9	3.795711064125129e-5	7	142	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0009725	response to hormone	7.538414337204813e-13	1.6625972820705215e-8	16	865	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0048878	chemical homeostasis	2.4136248555350903e-13	5.323249618882642e-9	17	988	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0050801	ion homeostasis	1.3455903058456897e-13	2.9676994195426687e-9	14	668	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0005179	hormone activity	1.6209256159527285e-13	3.574951445983743e-9	9	117	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0098771	inorganic ion homeostasis	2.896460848944571e-12	6.388144402347251e-8	13	609	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0055065	metal ion homeostasis	8.697709219518401e-12	1.9182797683647834e-7	12	516	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0051241	negative regulation of multicellular organismal process	2.94400059885902e-11	6.492993320783569e-7	14	966	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0035811	negative regulation of urine volume	7.023037706943569e-11	1.5489309662664041e-6	4	6	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0033993	response to lipid	1.0803513639245921e-10	2.382714933135688e-6	13	850	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0051046	regulation of secretion	1.3348921967804017e-10	2.944104739999176e-6	12	675	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0072507	divalent inorganic cation homeostasis	2.1372859038137904e-10	4.713784060861315e-6	10	393	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0035813	regulation of renal sodium excretion	2.616994398962902e-10	5.77178114691268e-6	5	24	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0051050	positive regulation of transport	3.008343574251171e-10	6.634901753010958e-6	13	920	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0010243	response to organonitrogen compound	7.051013106718074e-10	1.555100940686671e-5	12	780	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0048545	response to steroid hormone	7.294151949110983e-10	1.6087252123764273e-5	10	446	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0008015	blood circulation	1.7769116178456557e-9	3.9189785731585935e-5	10	489	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0045777	positive regulation of blood pressure	2.2914213859692723e-9	5.05372986675523e-5	5	36	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0051047	positive regulation of secretion	2.5562411076762714e-9	5.637789762980017e-5	9	363	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0055074	calcium ion homeostasis	2.618335770421254e-9	5.7747395416640757e-5	9	364	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0097305	response to alcohol	2.9492894793037294e-9	6.504657946604375e-5	9	369	29
MESH:D014883	Water-Electrolyte Imbalance	GO:0003018	vascular process in circulatory system	3.793034553112307e-9	8.365537706889192e-5	7	159	29
Orphanet:138044	Rare disease with Pierre Robin syndrome	GO:0048704	embryonic skeletal system morphogenesis	8.633249670708665e-11	1.904063214874796e-6	7	93	29
Orphanet:138044	Rare disease with Pierre Robin syndrome	GO:0043583	ear development	4.5331971509909863e-10	9.99796631651062e-6	8	196	29
DOID:2340	craniosynostosis	GO:0048736	appendage development	3.6926017799032707e-13	8.144033225576663e-9	10	168	29
DOID:2340	craniosynostosis	GO:0060173	limb development	3.6926017799032707e-13	8.144033225576663e-9	10	168	29
DOID:2340	craniosynostosis	GO:0048705	skeletal system morphogenesis	1.482947098452314e-11	3.2706398256365787e-7	9	204	29
DOID:2340	craniosynostosis	GO:0048762	mesenchymal cell differentiation	2.7328439511364877e-10	6.027287334231524e-6	8	184	29
DOID:2340	craniosynostosis	GO:0042733	embryonic digit morphogenesis	3.821297722694794e-10	8.427872127403369e-6	6	60	29
DOID:2340	craniosynostosis	GO:0035116	embryonic hindlimb morphogenesis	7.272127344748469e-10	1.603867685884275e-5	5	29	29
DOID:2340	craniosynostosis	GO:0035115	embryonic forelimb morphogenesis	1.2292104001332405e-9	2.7110235374938618e-5	5	32	29
DOID:2747	glycogen storage disease	GO:0016051	carbohydrate biosynthetic process	6.87672141452822e-13	1.516660907974199e-8	12	197	29
DOID:2747	glycogen storage disease	GO:0006006	glucose metabolic process	6.199485369506874e-13	1.3672964982447411e-8	10	199	29
DOID:2747	glycogen storage disease	GO:0000272	polysaccharide catabolic process	9.481304630298837e-14	2.0911017362124085e-9	12	31	29
DOID:2747	glycogen storage disease	GO:0044247	cellular polysaccharide catabolic process	7.105427357601002e-14	1.567102003718901e-9	12	29	29
DOID:2747	glycogen storage disease	GO:0009251	glucan catabolic process	7.105427357601002e-14	1.567102003718901e-9	12	29	29
DOID:2747	glycogen storage disease	GO:0006073	cellular glucan metabolic process	3.375077994860476e-14	7.44373451766478e-10	16	77	29
DOID:2747	glycogen storage disease	GO:0046496	nicotinamide nucleotide metabolic process	4.474198789239381e-14	9.867845429667454e-10	9	120	29
DOID:2747	glycogen storage disease	GO:0006096	glycolytic process	2.0439205883349132e-13	4.507866857572651e-9	8	65	29
DOID:2747	glycogen storage disease	GO:0009250	glucan biosynthetic process	8.497647030480948e-13	1.874156052572573e-8	7	49	29
DOID:2747	glycogen storage disease	GO:0005978	glycogen biosynthetic process	8.497647030480948e-13	1.874156052572573e-8	7	49	29
DOID:2747	glycogen storage disease	GO:0019674	NAD metabolic process	2.542299704089146e-12	5.6070419973686114e-8	7	57	29
DOID:2747	glycogen storage disease	GO:0019320	hexose catabolic process	1.225208823285584e-10	2.7021980597563555e-6	6	50	29
DOID:2747	glycogen storage disease	GO:0061718	glucose catabolic process to pyruvate	4.041219581196742e-10	8.912909786329415e-6	5	26	29
DOID:2747	glycogen storage disease	GO:0061621	canonical glycolysis	4.041219581196742e-10	8.912909786329415e-6	5	26	29
DOID:2747	glycogen storage disease	GO:0006094	gluconeogenesis	2.4222778227667163e-9	5.342333738111993e-5	6	81	29
Orphanet:226292	Permanent congenital hypothyroidism	GO:0035270	endocrine system development	4.618527782440651e-14	1.0186163024172856e-9	10	129	29
DOID:2590	familial nephrotic syndrome	GO:0072006	nephron development	1.795485982114542e-11	3.959944333553622e-7	8	131	29
DOID:2590	familial nephrotic syndrome	GO:0030198	extracellular matrix organization	3.0219937663389373e-11	6.665007251660526e-7	10	320	29
DOID:2590	familial nephrotic syndrome	GO:0061318	renal filtration cell differentiation	3.8342995445361794e-11	8.456547645474544e-7	5	17	29
DOID:2590	familial nephrotic syndrome	GO:0072112	glomerular visceral epithelial cell differentiation	3.8342995445361794e-11	8.456547645474544e-7	5	17	29
DOID:2590	familial nephrotic syndrome	GO:0030155	regulation of cell adhesion	1.011712824627864e-9	2.231332634716754e-5	11	621	29
DOID:2590	familial nephrotic syndrome	GO:0050878	regulation of body fluid levels	2.377041452561457e-9	5.242564923624293e-5	10	504	29
MESH:D006937	Hypercholesterolemia	GO:0010876	lipid localization	6.850076061937216e-13	1.510784275460253e-8	12	333	29
MESH:D006937	Hypercholesterolemia	GO:0015918	sterol transport	1.7141843500212417e-13	3.7806335839718486e-9	10	69	29
MESH:D006937	Hypercholesterolemia	GO:0048878	chemical homeostasis	1.2745360322696797e-13	2.8109892191707786e-9	16	988	29
MESH:D006937	Hypercholesterolemia	GO:0055088	lipid homeostasis	2.0650148258027912e-14	4.554390198308056e-10	11	111	29
MESH:D006937	Hypercholesterolemia	GO:0098856	intestinal lipid absorption	4.944045173260747e-12	1.0904091629626578e-7	5	12	29
MESH:D006937	Hypercholesterolemia	GO:0030299	intestinal cholesterol absorption	4.944045173260747e-12	1.0904091629626578e-7	5	12	29
MESH:D006937	Hypercholesterolemia	GO:1904729	regulation of intestinal lipid absorption	7.023037706943569e-11	1.5489309662664041e-6	4	6	29
MESH:D006937	Hypercholesterolemia	GO:0030300	regulation of intestinal cholesterol absorption	7.023037706943569e-11	1.5489309662664041e-6	4	6	29
MESH:D006937	Hypercholesterolemia	GO:0070325	lipoprotein particle receptor binding	1.6252532653027174e-10	3.5844960766251432e-6	5	22	29
MESH:D006937	Hypercholesterolemia	GO:0019218	regulation of steroid metabolic process	1.0801034511231933e-9	2.3821681614522028e-5	6	71	29
DOID:3007	breast ductal carcinoma	GO:0003190	atrioventricular valve formation	1.637024960032818e-10	3.61045854935238e-6	4	7	29
DOID:3007	breast ductal carcinoma	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	4.954526788836233e-10	1.0927208832778312e-5	5	27	29
DOID:3007	breast ductal carcinoma	GO:0001655	urogenital system development	6.972910027158719e-10	1.5378753064898554e-5	9	313	29
DOID:3007	breast ductal carcinoma	GO:0048729	tissue morphogenesis	1.280497041733497e-9	2.824136225543228e-5	11	635	29
DOID:3007	breast ductal carcinoma	GO:0003279	cardiac septum development	3.024138717222513e-9	6.669737940834253e-5	6	84	29
DOID:3007	breast ductal carcinoma	GO:0045446	endothelial cell differentiation	4.0146064250734526e-9	8.8542144704995e-5	6	88	29
DOID:3007	breast ductal carcinoma	GO:0001822	kidney development	4.495827155004406e-9	9.915546790362217e-5	8	262	29
Orphanet:98620	Syndromic myopia	GO:0043062	extracellular structure organization	1.6312506900817425e-12	3.597723396975283e-8	13	321	29
Orphanet:98620	Syndromic myopia	GO:0001501	skeletal system development	3.4102720647410933e-12	7.521355038786481e-8	12	482	29
Orphanet:269528	Syndrome with microcephaly as major feature	GO:0000278	mitotic cell cycle	4.198863479132342e-13	9.26059340322638e-9	16	927	29
DOID:1681	heart septal defect	GO:0060537	muscle tissue development	8.346656699131927e-13	1.8408551349935465e-8	13	336	29
DOID:1681	heart septal defect	GO:0072358	cardiovascular system development	7.076561558960748e-13	1.560735651828793e-8	20	910	29
DOID:1681	heart septal defect	GO:0009799	specification of symmetry	1.0447198661722723e-13	2.3041296648429466e-9	9	122	29
DOID:1681	heart septal defect	GO:0060485	mesenchyme development	6.03467276150127e-11	1.330947077549105e-6	9	237	29
DOID:1681	heart septal defect	GO:0001568	blood vessel development	4.016844634691097e-10	8.859150841811214e-6	11	569	29
DOID:1681	heart septal defect	GO:0048729	tissue morphogenesis	1.280497041733497e-9	2.824136225543228e-5	11	635	29
DOID:1681	heart septal defect	GO:0060976	coronary vasculature development	3.488448196975469e-9	7.693772498429396e-5	5	39	29
Orphanet:217720	Non-familial restrictive cardiomyopathy	GO:0001775	cell activation	4.3300918406430355e-12	9.550017554538215e-8	14	854	29
Orphanet:217720	Non-familial restrictive cardiomyopathy	GO:0050867	positive regulation of cell activation	1.0942580175310468e-11	2.4133860576647237e-7	10	288	29
MESH:D003327	Coronary Disease	GO:0030301	cholesterol transport	9.083511720575643e-12	2.003368509972958e-7	7	68	29
MESH:D003327	Coronary Disease	GO:0097006	regulation of plasma lipoprotein particle levels	2.222910744364981e-10	4.9026296466969654e-6	6	55	29
MESH:D003327	Coronary Disease	GO:0034381	plasma lipoprotein particle clearance	1.2292104001332405e-9	2.7110235374938618e-5	5	32	29
MESH:D003327	Coronary Disease	GO:0050880	regulation of blood vessel size	1.4818163363017334e-9	3.268145929713473e-5	7	139	29
MESH:D003327	Coronary Disease	GO:0034358	plasma lipoprotein particle	2.2914213859692723e-9	5.05372986675523e-5	5	36	29
MESH:D003327	Coronary Disease	GO:0034362	low-density lipoprotein particle	3.322621844326079e-9	7.328042477661167e-5	4	13	29
DOID:0050557	congenital muscular dystrophy	GO:0042383	sarcolemma	9.116037924528086e-10	2.0105421642546695e-5	7	125	30
DOID:0050557	congenital muscular dystrophy	GO:0030198	extracellular matrix organization	1.190702314524117e-9	2.6260939546829398e-5	9	320	30
MESH:D005532	Foot Deformities, Congenital	GO:0048736	appendage development	3.68816088780477e-13	8.13423883805342e-9	11	168	30
MESH:D005532	Foot Deformities, Congenital	GO:0060173	limb development	3.68816088780477e-13	8.13423883805342e-9	11	168	30
MESH:D005532	Foot Deformities, Congenital	GO:0035113	embryonic appendage morphogenesis	6.994405055138486e-14	1.5426160349107931e-9	10	125	30
MESH:D005532	Foot Deformities, Congenital	GO:0030326	embryonic limb morphogenesis	6.994405055138486e-14	1.5426160349107931e-9	10	125	30
MESH:D005532	Foot Deformities, Congenital	GO:0001501	skeletal system development	6.677991493120317e-13	1.4728310238076858e-8	15	482	30
MESH:D005532	Foot Deformities, Congenital	GO:0045667	regulation of osteoblast differentiation	6.2484462048928435e-12	1.3780948104891166e-7	8	111	30
MESH:D005532	Foot Deformities, Congenital	GO:0009887	organ morphogenesis	5.2353787971526344e-11	1.1546627937120135e-6	14	950	30
MESH:D005532	Foot Deformities, Congenital	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.3438806734100694e-9	2.963928825205908e-5	13	996	30
MESH:D005532	Foot Deformities, Congenital	GO:0060537	muscle tissue development	1.8236752108435894e-9	4.0221156775155364e-5	9	336	30
OMIM:114500	Colorectal Cancer	GO:0010564	regulation of cell cycle process	5.342601916424883e-10	1.1783108526675079e-5	11	561	30
OMIM:114500	Colorectal Cancer	GO:0045930	negative regulation of mitotic cell cycle	7.198347473647004e-10	1.5875955353128468e-5	8	200	30
OMIM:114500	Colorectal Cancer	GO:0000075	cell cycle checkpoint	1.1015650613899197e-9	2.429501742895468e-5	8	211	30
OMIM:114500	Colorectal Cancer	GO:1901991	negative regulation of mitotic cell cycle phase transition	1.9208084012234394e-9	4.236342928898296e-5	7	139	30
OMIM:114500	Colorectal Cancer	GO:0007093	mitotic cell cycle checkpoint	2.4599859926865975e-9	5.425499106870291e-5	7	144	30
OMIM:114500	Colorectal Cancer	GO:0033365	protein localization to organelle	3.35126704165134e-9	7.391219460362031e-5	12	859	30
OMIM:114500	Colorectal Cancer	GO:0001934	positive regulation of protein phosphorylation	3.866854392242658e-9	8.528347362091182e-5	12	870	30
Orphanet:180779	Syndromic diaphragmatic or thoracic malformation	GO:0005578	proteinaceous extracellular matrix	1.0648149029179876e-12	2.3484492683856217e-8	12	354	30
Orphanet:180779	Syndromic diaphragmatic or thoracic malformation	GO:0044420	extracellular matrix component	1.671207616738002e-11	3.685848398715663e-7	8	125	30
Orphanet:180779	Syndromic diaphragmatic or thoracic malformation	GO:0030199	collagen fibril organization	2.684230615557226e-11	5.920070622611462e-7	6	38	30
Orphanet:180779	Syndromic diaphragmatic or thoracic malformation	GO:0048251	elastic fiber assembly	1.8884982466715883e-10	4.165082883034188e-6	4	7	30
Orphanet:79163	Classic organic aciduria	GO:0019752	carboxylic acid metabolic process	1.7552626019323725e-12	3.8712316685618475e-8	17	967	30
Orphanet:79163	Classic organic aciduria	GO:0044429	mitochondrial part	9.325873406851315e-13	2.0568213798810575e-8	19	956	30
Orphanet:79163	Classic organic aciduria	GO:0006767	water-soluble vitamin metabolic process	1.5432100042289676e-13	3.403549664326988e-9	13	86	30
Orphanet:79163	Classic organic aciduria	GO:0032787	monocarboxylic acid metabolic process	9.903189379656396e-14	2.1841484176832182e-9	13	572	30
Orphanet:79163	Classic organic aciduria	GO:0006551	leucine metabolic process	2.7755575615628914e-15	6.121492202026957e-11	5	5	30
Orphanet:79163	Classic organic aciduria	GO:0006552	leucine catabolic process	2.7755575615628914e-15	6.121492202026957e-11	5	5	30
Orphanet:79163	Classic organic aciduria	GO:0006768	biotin metabolic process	2.0539125955565396e-14	4.529904229499948e-10	6	14	30
Orphanet:79163	Classic organic aciduria	GO:0005759	mitochondrial matrix	1.1195488980320079e-12	2.4691650946095933e-8	17	412	30
Orphanet:79163	Classic organic aciduria	GO:0016421	CoA carboxylase activity	8.102885029614981e-11	1.7870912932815841e-6	4	6	30
Orphanet:108979	Syndromic diaphragmatic or abdominal wall malformation	GO:0005578	proteinaceous extracellular matrix	1.0648149029179876e-12	2.3484492683856217e-8	12	354	30
Orphanet:108979	Syndromic diaphragmatic or abdominal wall malformation	GO:0044420	extracellular matrix component	1.671207616738002e-11	3.685848398715663e-7	8	125	30
Orphanet:108979	Syndromic diaphragmatic or abdominal wall malformation	GO:0030199	collagen fibril organization	2.684230615557226e-11	5.920070622611462e-7	6	38	30
Orphanet:108979	Syndromic diaphragmatic or abdominal wall malformation	GO:0048251	elastic fiber assembly	1.8884982466715883e-10	4.165082883034188e-6	4	7	30
MESH:D002780	Cholestasis, Intrahepatic	GO:0006694	steroid biosynthetic process	6.972200594645983e-14	1.5377188411491716e-9	10	149	30
DOID:2583	agammaglobulinemia	GO:0001775	cell activation	1.603384092163651e-12	3.5362636152669324e-8	20	854	30
DOID:2583	agammaglobulinemia	GO:0046649	lymphocyte activation	1.5298873279334657e-13	3.3741665017572586e-9	19	594	30
DOID:2583	agammaglobulinemia	GO:0009897	external side of plasma membrane	5.669908986760674e-13	1.2504984270300668e-8	10	212	30
DOID:2583	agammaglobulinemia	GO:0002250	adaptive immune response	9.776623954849128e-13	2.1562344132419753e-8	11	334	30
DOID:2583	agammaglobulinemia	GO:0002684	positive regulation of immune system process	1.5948353748740374e-11	3.5174094192846894e-7	14	872	30
DOID:2583	agammaglobulinemia	GO:0002429	immune response-activating cell surface receptor signaling pathway	1.847211272831828e-11	4.0740244622305966e-7	10	292	30
DOID:2583	agammaglobulinemia	GO:0050864	regulation of B cell activation	1.8834467319095438e-10	4.153941767226499e-6	7	100	30
DOID:2583	agammaglobulinemia	GO:0050851	antigen receptor-mediated signaling pathway	8.104656945562283e-10	1.7874820893437615e-5	8	203	30
DOID:2583	agammaglobulinemia	GO:0050871	positive regulation of B cell activation	8.590095301741485e-10	1.8945455187990845e-5	6	66	30
DOID:10629	microphthalmia	GO:0043010	camera-type eye development	8.202327705930657e-13	1.8090233755430063e-8	13	283	30
DOID:10629	microphthalmia	GO:0048592	eye morphogenesis	3.298261663786661e-11	7.274316099481482e-7	8	136	30
DOID:10629	microphthalmia	GO:0048598	embryonic morphogenesis	5.252560608681733e-10	1.1584522422447563e-5	11	560	30
Orphanet:98602	Rare lacrimal system disease	GO:0042633	hair cycle	2.019142630871329e-10	4.453219072386716e-6	7	101	30
Orphanet:98602	Rare lacrimal system disease	GO:0042476	odontogenesis	4.758995419962275e-10	1.0495964398726798e-5	7	114	30
Orphanet:98602	Rare lacrimal system disease	GO:0022405	hair cycle process	2.7970029625734583e-9	6.168790033955762e-5	6	80	30
Orphanet:98602	Rare lacrimal system disease	GO:0001942	hair follicle development	2.7970029625734583e-9	6.168790033955762e-5	6	80	30
Orphanet:98602	Rare lacrimal system disease	GO:0042475	odontogenesis of dentin-containing tooth	3.0175278942223827e-9	6.655157770707465e-5	6	81	30
Orphanet:98543	Metabolic disease with dementia	GO:0006643	membrane lipid metabolic process	8.22675261247241e-13	1.81441028868079e-8	10	191	30
DOID:9835	refractive error	GO:0007423	sensory organ development	6.751932346560352e-12	1.4891386790338856e-7	12	494	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0006954	inflammatory response	7.953637748414621e-13	1.7541748054128448e-8	14	637	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0002237	response to molecule of bacterial origin	1.2344569810807116e-12	2.7225948717735093e-8	11	333	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0007159	leukocyte cell-cell adhesion	2.109312724485335e-12	4.652089213852406e-8	12	461	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0002684	positive regulation of immune system process	1.5948353748740374e-11	3.5174094192846894e-7	14	872	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0045321	leukocyte activation	1.6723955553743508e-11	3.6884683973781307e-7	13	694	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0070489	T cell aggregation	2.796152198669688e-11	6.166913674165997e-7	11	424	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0042110	T cell activation	2.796152198669688e-11	6.166913674165997e-7	11	424	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0032496	response to lipopolysaccharide	4.2253200938091595e-11	9.318943466896101e-7	10	319	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0071222	cellular response to lipopolysaccharide	8.074951818315412e-11	1.7809306235294642e-6	8	152	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0030155	regulation of cell adhesion	8.202827306291738e-11	1.8091335624026428e-6	12	621	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0050776	regulation of immune response	1.2014955697026153e-10	2.649898478979118e-6	13	816	30
Orphanet:166484	Inflammatory and autoimmune disease with epilepsy	GO:0001819	positive regulation of cytokine production	2.3268287296929202e-10	5.1318207633377355e-6	10	381	30
MESH:D003928	Diabetic Nephropathies	GO:0033993	response to lipid	1.8723644856777355e-10	4.129499873162246e-6	13	850	30
MESH:D003928	Diabetic Nephropathies	GO:0071216	cellular response to biotic stimulus	2.485367467386368e-10	5.4814779493206345e-6	8	175	30
MESH:D003928	Diabetic Nephropathies	GO:0006897	endocytosis	9.55498791199716e-10	2.1073525839909735e-5	11	593	30
MESH:D003928	Diabetic Nephropathies	GO:0071222	cellular response to lipopolysaccharide	3.5893098493389175e-9	7.916222872716983e-5	7	152	30
MESH:D003928	Diabetic Nephropathies	GO:0009611	response to wounding	4.128086206200976e-9	9.104494127776253e-5	12	875	30
Orphanet:91492	Early-onset non-syndromic cataract	GO:0070307	lens fiber cell development	5.9254823270293855e-12	1.306865127226331e-7	5	12	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0045786	negative regulation of cell cycle	4.1011638529653283e-13	9.045116877715031e-9	13	449	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0007093	mitotic cell cycle checkpoint	8.053557820630886e-13	1.7762121773401418e-8	9	144	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0007050	cell cycle arrest	1.3871126469666706e-12	3.059276942884992e-8	12	242	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0044773	mitotic DNA damage checkpoint	1.493138945818373e-12	3.293117945002422e-8	8	92	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0051053	negative regulation of DNA metabolic process	5.0780490923330035e-12	1.1199637273140439e-7	8	108	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0010948	negative regulation of cell cycle process	3.450095764634398e-11	7.609186208901164e-7	9	215	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:1901991	negative regulation of mitotic cell cycle phase transition	3.9083181135879386e-11	8.619795599518199e-7	8	139	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0008285	negative regulation of cell proliferation	1.0499845437550448e-10	2.3157409112517513e-6	12	634	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0007507	heart development	1.2092871148894346e-10	2.667082731888648e-6	11	487	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	2.019142630871329e-10	4.453219072386716e-6	7	101	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0002200	somatic diversification of immune receptors	4.2934833466290456e-10	9.46927752099036e-6	6	59	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0009314	response to radiation	7.711813410082868e-10	1.7008404475937766e-5	10	431	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0009411	response to UV	9.116037924528086e-10	2.0105421642546695e-5	7	125	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0044427	chromosomal part	1.0629205293710697e-9	2.3442712275278943e-5	12	776	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0031571	mitotic G1 DNA damage checkpoint	1.1293138646450984e-9	2.4907017284747646e-5	6	69	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0006281	DNA repair	3.4134763904347665e-9	7.528422179103877e-5	10	503	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0008340	determination of adult lifespan	3.832313022478218e-9	8.452166371075709e-5	4	13	30
Orphanet:252190	Inherited nervous system cancer-predisposing syndrome	GO:0072331	signal transduction by p53 class mediator	4.464248637425783e-9	9.845900369842564e-5	8	252	30
DOID:0050564	autosomal dominant nonsyndromic deafness	GO:0007600	sensory perception	2.795541576006144e-13	6.165566945881551e-9	23	902	31
DOID:0050564	autosomal dominant nonsyndromic deafness	GO:0007605	sensory perception of sound	2.220446049250313e-15	4.8971937616215655e-11	23	138	31
DOID:0050564	autosomal dominant nonsyndromic deafness	GO:0048839	inner ear development	2.640442309242985e-10	5.823495513035404e-6	8	170	31
DOID:0050545	visceral heterotaxy	GO:0007507	heart development	1.822678674656686e-10	4.019917816955321e-6	11	487	31
MESH:D020140	Lysosomal Storage Diseases, Nervous System	GO:0005773	vacuole	4.760636329592671e-13	1.0499583424916636e-8	23	603	31
MESH:D020140	Lysosomal Storage Diseases, Nervous System	GO:0006665	sphingolipid metabolic process	1.8340884366807586e-13	4.045082047099413e-9	14	144	31
MESH:D020140	Lysosomal Storage Diseases, Nervous System	GO:0046466	membrane lipid catabolic process	3.6637359812630166e-14	8.080369706675583e-10	8	24	31
MESH:D020140	Lysosomal Storage Diseases, Nervous System	GO:0005975	carbohydrate metabolic process	2.741029625497049e-12	6.045340839033742e-8	16	760	31
DOID:0080100	congenital myopathy	GO:0042692	muscle cell differentiation	1.0031975250512914e-12	2.2125521415006233e-8	13	334	31
DOID:0080100	congenital myopathy	GO:0060537	muscle tissue development	6.143974218275616e-13	1.3550535138406872e-8	12	336	31
DOID:0080100	congenital myopathy	GO:0055001	muscle cell development	1.674216321134736e-13	3.6924840962626604e-9	12	140	31
DOID:0080100	congenital myopathy	GO:0048741	skeletal muscle fiber development	1.2745360322696797e-13	2.8109892191707786e-9	7	29	31
DOID:0080100	congenital myopathy	GO:0031674	I band	1.8343881968974074e-11	4.045743168257232e-7	8	122	31
DOID:0080100	congenital myopathy	GO:0015629	actin cytoskeleton	6.388123363620934e-11	1.408900607846597e-6	11	441	31
DOID:0080100	congenital myopathy	GO:0008092	cytoskeletal protein binding	1.8616597152742997e-10	4.105890502037468e-6	13	812	31
DOID:0080100	congenital myopathy	GO:0006941	striated muscle contraction	4.1983602150352795e-9	9.259483454260309e-5	7	150	31
DOID:9296	cleft lip	GO:0035295	tube development	8.573142196155459e-13	1.8908065113620864e-8	15	573	31
DOID:9296	cleft lip	GO:0001763	morphogenesis of a branching structure	8.359979375427429e-13	1.8437934512505194e-8	11	193	31
DOID:9296	cleft lip	GO:0061138	morphogenesis of a branching epithelium	7.30526750203353e-13	1.611176747573495e-8	11	179	31
DOID:9296	cleft lip	GO:0043583	ear development	4.68070027181966e-13	1.032328444949826e-8	10	196	31
DOID:9296	cleft lip	GO:0071774	response to fibroblast growth factor	6.195044477408373e-14	1.3663170594924168e-9	10	134	31
DOID:9296	cleft lip	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	4.1300296516055823e-14	9.108780396616112e-10	9	49	31
DOID:9296	cleft lip	GO:0052742	phosphatidylinositol kinase activity	4.1300296516055823e-14	9.108780396616112e-10	9	49	31
DOID:9296	cleft lip	GO:0044344	cellular response to fibroblast growth factor stimulus	3.8968828164342995e-14	8.594575051645847e-10	10	128	31
DOID:9296	cleft lip	GO:0035004	phosphatidylinositol 3-kinase activity	4.030109579389318e-14	8.888406677343141e-10	9	70	31
DOID:9296	cleft lip	GO:0010463	mesenchymal cell proliferation	9.392486788328824e-14	2.071512961165922e-9	8	42	31
DOID:9296	cleft lip	GO:0008543	fibroblast growth factor receptor signaling pathway	1.0269562977782698e-13	2.264952114749974e-9	10	105	31
DOID:9296	cleft lip	GO:0016303	1-phosphatidylinositol-3-kinase activity	1.042499420123022e-13	2.299232471081325e-9	9	43	31
DOID:9296	cleft lip	GO:0046854	phosphatidylinositol phosphorylation	1.1879386363489175e-13	2.6199986624675375e-9	9	91	31
DOID:9296	cleft lip	GO:0052813	phosphatidylinositol bisphosphate kinase activity	1.4865886299730846e-13	3.278671223405638e-9	9	65	31
DOID:9296	cleft lip	GO:0042471	ear morphogenesis	1.872946242542639e-13	4.1307829379277905e-9	9	112	31
DOID:9296	cleft lip	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	2.589040093425865e-13	5.710127926050745e-9	9	62	31
DOID:9296	cleft lip	GO:0035265	organ growth	5.142553050063725e-13	1.1341900751915546e-8	9	132	31
DOID:9296	cleft lip	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	8.858469513484124e-13	1.9537354511989236e-8	9	138	31
DOID:9296	cleft lip	GO:0055024	regulation of cardiac muscle tissue development	1.1679546219056647e-12	2.5759239186129435e-8	7	48	31
DOID:9296	cleft lip	GO:0035107	appendage morphogenesis	1.726951914804431e-12	3.8087924481011726e-8	9	146	31
DOID:9296	cleft lip	GO:0035108	limb morphogenesis	1.726951914804431e-12	3.8087924481011726e-8	9	146	31
DOID:9296	cleft lip	GO:0042472	inner ear morphogenesis	2.0088375407567582e-12	4.43049119613903e-8	8	92	31
DOID:9296	cleft lip	GO:0051302	regulation of cell division	2.079003635913068e-12	4.585242519006272e-8	12	293	31
DOID:9296	cleft lip	GO:0005104	fibroblast growth factor receptor binding	2.7562396809344136e-12	6.078886616300849e-8	6	26	31
DOID:9296	cleft lip	GO:0001823	mesonephros development	4.411582210650522e-12	9.729744565589726e-8	8	102	31
DOID:9296	cleft lip	GO:0004713	protein tyrosine kinase activity	6.6530114750662506e-12	1.4673216808258616e-7	9	174	31
DOID:9296	cleft lip	GO:0030324	lung development	7.211342634150242e-12	1.5904616179618358e-7	9	175	31
DOID:9296	cleft lip	GO:0022612	gland morphogenesis	1.4867107545057934e-11	3.2789405690625273e-7	8	119	31
DOID:9296	cleft lip	GO:0010464	regulation of mesenchymal cell proliferation	1.6237011735142914e-11	3.58107293818577e-7	6	34	31
DOID:9296	cleft lip	GO:0005088	Ras guanyl-nucleotide exchange factor activity	8.21229750869179e-11	1.8112222155419744e-6	9	228	31
DOID:9296	cleft lip	GO:0048754	branching morphogenesis of an epithelial tube	8.267897477765018e-11	1.8234847887210748e-6	8	147	31
DOID:9296	cleft lip	GO:0050673	epithelial cell proliferation	9.52963263856077e-11	2.101760478434578e-6	10	335	31
DOID:9296	cleft lip	GO:2000027	regulation of organ morphogenesis	1.1288592283165144e-10	2.4896990280520725e-6	9	236	31
DOID:9296	cleft lip	GO:0008201	heparin binding	1.1380152376005981e-10	2.509892606528119e-6	8	153	31
DOID:9296	cleft lip	GO:0050679	positive regulation of epithelial cell proliferation	1.259649051732481e-10	2.778155983595987e-6	8	155	31
DOID:9296	cleft lip	GO:0001657	ureteric bud development	1.9497337078178134e-10	4.3001376925921875e-6	7	97	31
DOID:9296	cleft lip	GO:0060449	bud elongation involved in lung branching	2.168045742934055e-10	4.781624886041058e-6	4	7	31
DOID:9296	cleft lip	GO:0060445	branching involved in salivary gland morphogenesis	2.3217450184631616e-10	5.120608638220503e-6	5	22	31
DOID:9296	cleft lip	GO:0048645	organ formation	5.310576423056546e-10	1.1712476301051211e-5	6	59	31
DOID:9296	cleft lip	GO:0042056	chemoattractant activity	5.771002564713967e-10	1.2727946156476655e-5	5	26	31
DOID:9296	cleft lip	GO:0042476	odontogenesis	6.117902850988344e-10	1.3493034737854792e-5	7	114	31
DOID:9296	cleft lip	GO:2000648	positive regulation of stem cell proliferation	6.529168317115364e-10	1.4400080723397934e-5	6	61	31
DOID:9296	cleft lip	GO:0002053	positive regulation of mesenchymal cell proliferation	7.074236751947183e-10	1.560222915641951e-5	5	27	31
DOID:9296	cleft lip	GO:0008544	epidermis development	8.32855118204634e-10	1.8368619632003202e-5	9	296	31
DOID:9296	cleft lip	GO:0010092	specification of organ identity	1.0381925319435936e-9	2.2897336292015957e-5	5	29	31
DOID:9296	cleft lip	GO:0055025	positive regulation of cardiac muscle tissue development	1.0381925319435936e-9	2.2897336292015957e-5	5	29	31
DOID:9296	cleft lip	GO:0035113	embryonic appendage morphogenesis	1.1708807257093667e-9	2.5823774405520084e-5	7	125	31
DOID:9296	cleft lip	GO:0030326	embryonic limb morphogenesis	1.1708807257093667e-9	2.5823774405520084e-5	7	125	31
DOID:9296	cleft lip	GO:0051781	positive regulation of cell division	1.5424757027204805e-9	3.40193016235002e-5	7	130	31
DOID:9296	cleft lip	GO:0042558	pteridine-containing compound metabolic process	2.418793276781628e-9	5.33464857194188e-5	5	34	31
DOID:9296	cleft lip	GO:0090287	regulation of cellular response to growth factor stimulus	2.5272385295593836e-9	5.5738245769432204e-5	8	226	31
DOID:9296	cleft lip	GO:0016331	morphogenesis of embryonic epithelium	2.7252134993105415e-9	6.010458372729399e-5	7	141	31
DOID:9296	cleft lip	GO:0060601	lateral sprouting from an epithelium	3.0485362012555584e-9	6.723546591869134e-5	4	12	31
DOID:9296	cleft lip	GO:0001501	skeletal system development	3.2678236783212355e-9	7.207185122537485e-5	10	482	31
DOID:9296	cleft lip	GO:0060485	mesenchyme development	3.6737847208812013e-9	8.10253220190349e-5	8	237	31
DOID:9296	cleft lip	GO:0042475	odontogenesis of dentin-containing tooth	3.72871566955979e-9	8.223682409214117e-5	6	81	31
DOID:9296	cleft lip	GO:0046622	positive regulation of organ growth	3.775963208774158e-9	8.327886856951405e-5	5	37	31
DOID:9296	cleft lip	GO:0043616	keratinocyte proliferation	3.775963208774158e-9	8.327886856951405e-5	5	37	31
DOID:9296	cleft lip	GO:0018108	peptidyl-tyrosine phosphorylation	3.9934502371608005e-9	8.807554498058145e-5	9	354	31
DOID:9296	cleft lip	GO:0000165	MAPK cascade	4.236125783485534e-9	9.342775415477345e-5	12	843	31
DOID:9296	cleft lip	GO:0045165	cell fate commitment	4.471194081645535e-9	9.861218547069228e-5	8	243	31
DOID:14557	primary pulmonary hypertension	GO:0044057	regulation of system process	2.8383417838284686e-10	6.2599628042336875e-6	11	508	31
DOID:14557	primary pulmonary hypertension	GO:0055065	metal ion homeostasis	3.3480640482252966e-10	7.384155258360892e-6	11	516	31
DOID:14557	primary pulmonary hypertension	GO:1903522	regulation of blood circulation	8.580746113651117e-10	1.8924835553657537e-5	9	297	31
DOID:14557	primary pulmonary hypertension	GO:0001568	blood vessel development	9.310195947520583e-10	2.0533637162256646e-5	11	569	31
DOID:14557	primary pulmonary hypertension	GO:0019229	regulation of vasoconstriction	9.667330269635954e-10	2.1321296909682097e-5	6	65	31
DOID:14557	primary pulmonary hypertension	GO:0035295	tube development	1.0017284779451074e-9	2.2093121581079345e-5	11	573	31
DOID:14557	primary pulmonary hypertension	GO:0042493	response to drug	1.1646388298203192e-9	2.568610939168714e-5	10	433	31
DOID:14557	primary pulmonary hypertension	GO:0051241	negative regulation of multicellular organismal process	1.5138230669009545e-9	3.338736774050055e-5	13	966	31
DOID:14557	primary pulmonary hypertension	GO:0006875	cellular metal ion homeostasis	1.687152528795366e-9	3.7210149022581795e-5	10	450	31
DOID:14557	primary pulmonary hypertension	GO:0048771	tissue remodeling	2.4657330621735696e-9	5.438174268623808e-5	7	139	31
DOID:4905	pancreatic carcinoma	GO:0001701	in utero embryonic development	2.986499936241671e-12	6.586725609381006e-8	11	312	31
DOID:4905	pancreatic carcinoma	GO:0003190	atrioventricular valve formation	2.168045742934055e-10	4.781624886041058e-6	4	7	31
DOID:4905	pancreatic carcinoma	GO:0001655	urogenital system development	1.3610078619663568e-9	3.0017028395668e-5	9	313	31
DOID:4905	pancreatic carcinoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.2010857581022947e-9	4.854494639494611e-5	13	996	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0006029	proteoglycan metabolic process	8.260059303211165e-14	1.8217560793232224e-9	9	85	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:1901137	carbohydrate derivative biosynthetic process	1.4270806758531762e-12	3.14742643059418e-8	16	741	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0030166	proteoglycan biosynthetic process	6.24122975523278e-12	1.3765032225165896e-7	7	60	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0006024	glycosaminoglycan biosynthetic process	8.448131083582666e-12	1.863235310484157e-7	8	111	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0000139	Golgi membrane	2.4934387887753928e-11	5.499279248644129e-7	13	691	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0001501	skeletal system development	1.6207502007148378e-10	3.5745645676765747e-6	11	482	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0016758	transferase activity, transferring hexosyl groups	1.0404855865786544e-9	2.2947909611992223e-5	8	202	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0050650	chondroitin sulfate proteoglycan biosynthetic process	1.244381042653231e-9	2.7444823895717008e-5	5	30	31
Orphanet:371195	Congenital disorder of glycosylation-related bone disorder	GO:0008194	UDP-glycosyltransferase activity	2.5926192304126516e-9	5.718021712675103e-5	7	140	31
Orphanet:399584	Rare male infertility due to adrenal disorder	GO:1901698	response to nitrogen compound	4.229450123460765e-10	9.328052247292717e-6	13	870	31
DOID:10871	age related macular degeneration	GO:0006956	complement activation	3.7948533204712476e-12	8.369548998299337e-8	7	56	31
DOID:10871	age related macular degeneration	GO:0030449	regulation of complement activation	1.0932033056576529e-11	2.4110598906279535e-7	6	32	31
DOID:10871	age related macular degeneration	GO:0072562	blood microparticle	6.117902850988344e-10	1.3493034737854792e-5	7	114	31
DOID:9637	stomatitis	GO:0030163	protein catabolic process	1.2955636563560802e-11	2.857365644093335e-7	14	808	31
DOID:9637	stomatitis	GO:0031334	positive regulation of protein complex assembly	1.583455477849327e-9	3.492311056396691e-5	8	213	31
DOID:9637	stomatitis	GO:0030099	myeloid cell differentiation	1.995752674233131e-9	4.4016325230211706e-5	9	327	31
DOID:9637	stomatitis	GO:0007050	cell cycle arrest	4.329115732559785e-9	9.547864748160606e-5	8	242	31
MESH:D018299	Neoplasms, Ductal, Lobular, and Medullary	GO:0042490	mechanoreceptor differentiation	3.432409911852119e-10	7.570180060589848e-6	6	55	31
MESH:D018299	Neoplasms, Ductal, Lobular, and Medullary	GO:0072006	nephron development	1.6276464620545994e-9	3.589774272061419e-5	7	131	31
MESH:D018299	Neoplasms, Ductal, Lobular, and Medullary	GO:0072073	kidney epithelium development	2.2278655587015805e-9	4.913557489716336e-5	7	137	31
Orphanet:98580	Palpebral tumor	GO:0097190	apoptotic signaling pathway	8.497151871011965e-10	1.874046845151689e-5	11	564	31
Orphanet:98580	Palpebral tumor	GO:0051726	regulation of cell cycle	9.53654821778116e-10	2.103285709431635e-5	13	930	31
Orphanet:98580	Palpebral tumor	GO:0045786	negative regulation of cell cycle	1.6525280033263812e-9	3.644650511336334e-5	10	449	31
Orphanet:227535	Hereditary breast cancer	GO:0071897	DNA biosynthetic process	3.1175062531474396e-13	6.875660041316678e-9	13	167	31
Orphanet:227535	Hereditary breast cancer	GO:0000400	four-way junction DNA binding	2.6685986753705038e-11	5.885594378529646e-7	5	15	31
Orphanet:227535	Hereditary breast cancer	GO:0051321	meiotic cell cycle	3.4566682849401786e-11	7.623681902435564e-7	9	207	31
Orphanet:227535	Hereditary breast cancer	GO:0007131	reciprocal meiotic recombination	6.31237284665076e-11	1.3921938313288251e-6	6	42	31
Orphanet:227535	Hereditary breast cancer	GO:0051052	regulation of DNA metabolic process	9.52963263856077e-11	2.101760478434578e-6	10	335	31
Orphanet:227535	Hereditary breast cancer	GO:0010332	response to gamma radiation	1.8911505694774178e-10	4.170932580982445e-6	6	50	31
Orphanet:227535	Hereditary breast cancer	GO:0042148	strand invasion	2.168045742934055e-10	4.781624886041058e-6	4	7	31
Orphanet:227535	Hereditary breast cancer	GO:0097193	intrinsic apoptotic signaling pathway	3.964718553461921e-10	8.744186769660267e-6	9	272	31
Orphanet:227535	Hereditary breast cancer	GO:0000150	recombinase activity	4.330961145271317e-10	9.55193480589589e-6	4	8	31
Orphanet:227535	Hereditary breast cancer	GO:0000730	DNA recombinase assembly	7.787005484871656e-10	1.7174240596884438e-5	4	9	31
Orphanet:227535	Hereditary breast cancer	GO:0000075	cell cycle checkpoint	1.4704433226597757e-9	3.2430627481261354e-5	8	211	31
Orphanet:227535	Hereditary breast cancer	GO:0006260	DNA replication	2.596931447662598e-9	5.72753230781986e-5	9	337	31
Orphanet:227535	Hereditary breast cancer	GO:0008094	DNA-dependent ATPase activity	2.7364277510599777e-9	6.035191404962781e-5	6	77	31
Orphanet:227535	Hereditary breast cancer	GO:0060249	anatomical structure homeostasis	3.7078545789270834e-9	8.177673273823682e-5	9	351	31
Orphanet:227535	Hereditary breast cancer	GO:0007050	cell cycle arrest	4.329115732559785e-9	9.547864748160606e-5	8	242	31
Orphanet:227535	Hereditary breast cancer	GO:0008340	determination of adult lifespan	4.398362896118613e-9	9.7005893673896e-5	4	13	31
Orphanet:109007	Arthrogryposis syndrome	GO:0003009	skeletal muscle contraction	5.687283977096058e-11	1.2543304811485356e-6	6	40	32
Orphanet:183734	Genetic gynecological tumor	GO:0000725	recombinational repair	1.1324274851176597e-13	2.4975688184269984e-9	11	93	32
Orphanet:183734	Genetic gynecological tumor	GO:0033063	Rad51B-Rad51C-Rad51D-XRCC2 complex	3.546929416842204e-11	7.822752828845481e-7	4	5	32
Orphanet:183734	Genetic gynecological tumor	GO:0006312	mitotic recombination	1.0407363859599172e-10	2.2953440992345975e-6	6	44	32
Orphanet:183734	Genetic gynecological tumor	GO:0000228	nuclear chromosome	5.381051160213701e-10	1.1867908333851318e-5	11	520	32
Orphanet:183734	Genetic gynecological tumor	GO:0005657	replication fork	8.015347274792362e-10	1.7677848414554553e-5	6	61	32
Orphanet:183734	Genetic gynecological tumor	GO:0051726	regulation of cell cycle	1.534244842282817e-9	3.383776999654753e-5	13	930	32
Orphanet:183734	Genetic gynecological tumor	GO:0000723	telomere maintenance	2.3034798513066335e-9	5.08032481205678e-5	7	133	32
DOID:438	autoimmune disease of the nervous system	GO:0034097	response to cytokine	2.8789289840958077e-9	6.349477874423304e-5	12	784	32
MESH:D012874	Skin Diseases, Infectious	GO:0009607	response to biotic stimulus	1.3011813848606835e-12	2.8697555443102374e-8	24	934	32
MESH:D012874	Skin Diseases, Infectious	GO:0071216	cellular response to biotic stimulus	4.312106227644108e-13	9.51035028506908e-9	12	175	32
MESH:D012874	Skin Diseases, Infectious	GO:0031349	positive regulation of defense response	3.0464519795714295e-13	6.718949840944788e-9	16	398	32
MESH:D012874	Skin Diseases, Infectious	GO:0001819	positive regulation of cytokine production	2.731148640577885e-14	6.023548326794526e-10	15	381	32
MESH:D012874	Skin Diseases, Infectious	GO:0032635	interleukin-6 production	1.2989609388114332e-14	2.864858350548616e-10	10	109	32
MESH:D012874	Skin Diseases, Infectious	GO:0032675	regulation of interleukin-6 production	4.118927421359331e-14	9.084294427808004e-10	10	103	32
MESH:D012874	Skin Diseases, Infectious	GO:0032755	positive regulation of interleukin-6 production	5.0959236830294685e-14	1.1239059682921493e-9	9	68	32
MESH:D012874	Skin Diseases, Infectious	GO:0050663	cytokine secretion	5.262457136723242e-14	1.160634921504311e-9	10	162	32
MESH:D012874	Skin Diseases, Infectious	GO:0050729	positive regulation of inflammatory response	1.936228954946273e-13	4.270352960134005e-9	9	114	32
MESH:D012874	Skin Diseases, Infectious	GO:0050778	positive regulation of immune response	3.2229774404868294e-13	7.108276744993702e-9	14	603	32
MESH:D012874	Skin Diseases, Infectious	GO:0006509	membrane protein ectodomain proteolysis	3.986810881428937e-13	8.792911398991521e-9	7	39	32
MESH:D012874	Skin Diseases, Infectious	GO:1902533	positive regulation of intracellular signal transduction	2.1144197503986106e-12	4.663352759504136e-8	16	860	32
MESH:D012874	Skin Diseases, Infectious	GO:0050715	positive regulation of cytokine secretion	3.2484015477507455e-12	7.164349613564269e-8	8	95	32
MESH:D012874	Skin Diseases, Infectious	GO:0002252	immune effector process	3.286815264402776e-12	7.249071065640322e-8	18	757	32
MESH:D012874	Skin Diseases, Infectious	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	4.3791636983314675e-12	9.658245536670051e-8	10	233	32
MESH:D012874	Skin Diseases, Infectious	GO:0019221	cytokine-mediated signaling pathway	5.581091144790662e-12	1.2309096519835805e-7	13	534	32
MESH:D012874	Skin Diseases, Infectious	GO:0001775	cell activation	3.2030711416553004e-11	7.064373402920765e-7	14	854	32
MESH:D012874	Skin Diseases, Infectious	GO:0045321	leukocyte activation	4.400202424648114e-11	9.704646447561416e-7	13	694	32
MESH:D012874	Skin Diseases, Infectious	GO:0014070	response to organic cyclic compound	4.930655883583768e-11	1.0874561551244e-6	14	873	32
MESH:D012874	Skin Diseases, Infectious	GO:0051241	negative regulation of multicellular organismal process	1.7220935788486713e-10	3.7980773881507446e-6	14	966	32
MESH:D012874	Skin Diseases, Infectious	GO:0031663	lipopolysaccharide-mediated signaling pathway	2.0474122397473593e-10	4.515567694762801e-6	6	49	32
MESH:D012874	Skin Diseases, Infectious	GO:0045088	regulation of innate immune response	2.1815083073306596e-10	4.81131657181777e-6	10	351	32
MESH:D012874	Skin Diseases, Infectious	GO:0071621	granulocyte chemotaxis	2.871125559522625e-10	6.332267421527149e-6	7	99	32
MESH:D012874	Skin Diseases, Infectious	GO:0007259	JAK-STAT cascade	3.494403655324163e-10	7.706907261817442e-6	8	170	32
MESH:D012874	Skin Diseases, Infectious	GO:0071706	tumor necrosis factor superfamily cytokine production	4.657935148699721e-10	1.0273075970457235e-5	7	106	32
MESH:D012874	Skin Diseases, Infectious	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	5.500634392419101e-10	1.2131649152480328e-5	8	180	32
MESH:D012874	Skin Diseases, Infectious	GO:0032677	regulation of interleukin-8 production	5.863628471658444e-10	1.2932232594242699e-5	6	58	32
MESH:D012874	Skin Diseases, Infectious	GO:0002697	regulation of immune effector process	1.182173692271249e-9	2.6072840783042395e-5	10	418	32
MESH:D012874	Skin Diseases, Infectious	GO:0070489	T cell aggregation	1.3550323085809168e-9	2.988523756575212e-5	10	424	32
MESH:D012874	Skin Diseases, Infectious	GO:0042110	T cell activation	1.3550323085809168e-9	2.988523756575212e-5	10	424	32
MESH:D012874	Skin Diseases, Infectious	GO:0002366	leukocyte activation involved in immune response	1.7335295421361252e-9	3.823299405181224e-5	8	208	32
MESH:D012874	Skin Diseases, Infectious	GO:0051093	negative regulation of developmental process	3.049662633536343e-9	6.726030938264405e-5	12	788	32
Orphanet:180257	Rare malignant breast tumor	GO:0000725	recombinational repair	1.1324274851176597e-13	2.4975688184269984e-9	11	93	32
Orphanet:180257	Rare malignant breast tumor	GO:0033063	Rad51B-Rad51C-Rad51D-XRCC2 complex	3.546929416842204e-11	7.822752828845481e-7	4	5	32
Orphanet:180257	Rare malignant breast tumor	GO:0006312	mitotic recombination	1.0407363859599172e-10	2.2953440992345975e-6	6	44	32
Orphanet:180257	Rare malignant breast tumor	GO:0000228	nuclear chromosome	5.381051160213701e-10	1.1867908333851318e-5	11	520	32
Orphanet:180257	Rare malignant breast tumor	GO:0005657	replication fork	8.015347274792362e-10	1.7677848414554553e-5	6	61	32
Orphanet:180257	Rare malignant breast tumor	GO:0051726	regulation of cell cycle	1.534244842282817e-9	3.383776999654753e-5	13	930	32
Orphanet:180257	Rare malignant breast tumor	GO:0000723	telomere maintenance	2.3034798513066335e-9	5.08032481205678e-5	7	133	32
Orphanet:300846	Aggressive B-cell non-Hodgkin lymphoma	GO:0008134	transcription factor binding	5.166761463115677e-10	1.1395292406901625e-5	11	518	32
Orphanet:300846	Aggressive B-cell non-Hodgkin lymphoma	GO:0014041	regulation of neuron maturation	1.4811264437142313e-9	3.266624371611737e-5	4	10	32
MESH:D006951	Hyperlipoproteinemias	GO:0048878	chemical homeostasis	1.0516032489249483e-12	2.3193109655039734e-8	18	988	32
MESH:D006951	Hyperlipoproteinemias	GO:0010876	lipid localization	7.123190925995004e-13	1.5710197587281982e-8	14	333	32
MESH:D006951	Hyperlipoproteinemias	GO:0006066	alcohol metabolic process	6.348255254806645e-13	1.4001076964476056e-8	13	382	32
MESH:D006951	Hyperlipoproteinemias	GO:0034364	high-density lipoprotein particle	2.4646951146678475e-14	5.435885075399938e-10	8	25	32
MESH:D006951	Hyperlipoproteinemias	GO:0034372	very-low-density lipoprotein particle remodeling	7.882583474838611e-15	1.7385037853756558e-10	6	10	32
MESH:D006951	Hyperlipoproteinemias	GO:0016125	sterol metabolic process	2.531308496145357e-14	5.582800888248585e-10	13	132	32
MESH:D006951	Hyperlipoproteinemias	GO:0006638	neutral lipid metabolic process	9.481304630298837e-14	2.0911017362124085e-9	9	111	32
MESH:D006951	Hyperlipoproteinemias	GO:0043691	reverse cholesterol transport	1.325606291402437e-13	2.9236246756880746e-9	6	16	32
MESH:D006951	Hyperlipoproteinemias	GO:0034361	very-low-density lipoprotein particle	4.4797499043625066e-13	9.880088414071508e-9	6	19	32
MESH:D006951	Hyperlipoproteinemias	GO:0034377	plasma lipoprotein particle assembly	4.4797499043625066e-13	9.880088414071508e-9	6	19	32
MESH:D006951	Hyperlipoproteinemias	GO:0046503	glycerolipid catabolic process	1.4781509349859334e-12	3.260061887111476e-8	7	48	32
MESH:D006951	Hyperlipoproteinemias	GO:0015914	phospholipid transport	5.332512209577089e-12	1.176085567822227e-7	7	57	32
MESH:D006951	Hyperlipoproteinemias	GO:0033700	phospholipid efflux	1.3608225657435469e-11	3.0012941687473926e-7	5	13	32
MESH:D006951	Hyperlipoproteinemias	GO:0046464	acylglycerol catabolic process	1.64103175492869e-11	3.619295535495226e-7	6	33	32
MESH:D006951	Hyperlipoproteinemias	GO:0019216	regulation of lipid metabolic process	1.9678592089178437e-11	4.3401134852683043e-7	10	272	32
MESH:D006951	Hyperlipoproteinemias	GO:0015485	cholesterol binding	2.8865465573346683e-11	6.366278432201611e-7	6	36	32
MESH:D006951	Hyperlipoproteinemias	GO:0050750	low-density lipoprotein particle receptor binding	6.499789595437733e-11	1.433528595273792e-6	5	17	32
MESH:D006951	Hyperlipoproteinemias	GO:0034383	low-density lipoprotein particle clearance	1.2186640585554187e-10	2.687763581143976e-6	5	19	32
MESH:D006951	Hyperlipoproteinemias	GO:0005543	phospholipid binding	2.114667330133102e-10	4.6638987966085566e-6	10	350	32
MESH:D006951	Hyperlipoproteinemias	GO:0006898	receptor-mediated endocytosis	2.9711322291348097e-10	6.552832131356823e-6	9	254	32
MESH:D006951	Hyperlipoproteinemias	GO:0071814	protein-lipid complex binding	4.4260406451002154e-10	9.761632642768525e-6	5	24	32
MESH:D006951	Hyperlipoproteinemias	GO:0071813	lipoprotein particle binding	4.4260406451002154e-10	9.761632642768525e-6	5	24	32
MESH:D006951	Hyperlipoproteinemias	GO:0034380	high-density lipoprotein particle assembly	8.897419467857048e-10	1.962325863635872e-5	4	9	32
MESH:D006951	Hyperlipoproteinemias	GO:0019433	triglyceride catabolic process	1.018478856806837e-9	2.246255118687479e-5	5	28	32
MESH:D006951	Hyperlipoproteinemias	GO:0055090	acylglycerol homeostasis	1.22915222444675e-9	2.7108952310173073e-5	5	29	32
MESH:D006951	Hyperlipoproteinemias	GO:0070328	triglyceride homeostasis	1.22915222444675e-9	2.7108952310173073e-5	5	29	32
MESH:D006951	Hyperlipoproteinemias	GO:0045834	positive regulation of lipid metabolic process	1.4088871180817364e-9	3.1073005389292696e-5	7	124	32
MESH:D006951	Hyperlipoproteinemias	GO:0034374	low-density lipoprotein particle remodeling	2.324688219701443e-9	5.127099868551532e-5	4	11	32
MESH:D006951	Hyperlipoproteinemias	GO:0098856	intestinal lipid absorption	3.4828434580802536e-9	7.681411246796e-5	4	12	32
MESH:D006951	Hyperlipoproteinemias	GO:0030299	intestinal cholesterol absorption	3.4828434580802536e-9	7.681411246796e-5	4	12	32
Orphanet:98514	Malformation of the cerebellar vermis	GO:0007368	determination of left/right symmetry	6.877721725473407e-10	1.5168815265531599e-5	7	112	32
Orphanet:98514	Malformation of the cerebellar vermis	GO:0048598	embryonic morphogenesis	1.1716159153962735e-9	2.5839989014064813e-5	11	560	32
Orphanet:98594	Rare eyebrow/eyelashes anomaly	GO:0030217	T cell differentiation	1.2211921474047926e-9	2.6933392811012702e-5	8	199	32
MESH:D008569	Memory Disorders	GO:0044456	synapse part	5.793143742494067e-13	1.2776778524070664e-8	15	613	32
MESH:D008569	Memory Disorders	GO:0044708	single-organism behavior	1.050270981295398e-12	2.3163726492470005e-8	14	404	32
MESH:D008569	Memory Disorders	GO:0007268	synaptic transmission	1.3559153799747037e-12	2.990471370534209e-8	16	605	32
MESH:D008569	Memory Disorders	GO:0007611	learning or memory	2.104205698572059e-12	4.6408256682006765e-8	10	218	32
MESH:D008569	Memory Disorders	GO:0007417	central nervous system development	8.513079130523238e-12	1.8775596022369e-7	15	889	32
MESH:D008569	Memory Disorders	GO:0007420	brain development	2.7487345732879476e-11	6.062334101386568e-7	13	669	32
MESH:D008569	Memory Disorders	GO:0098793	presynapse	4.361222494253525e-11	9.61867621107615e-7	9	205	32
MESH:D008569	Memory Disorders	GO:0043005	neuron projection	1.2475775967857317e-10	2.751532389710931e-6	14	941	32
MESH:D008569	Memory Disorders	GO:0015696	ammonium transport	1.7043211286704718e-10	3.7588802492827256e-6	7	92	32
MESH:D008569	Memory Disorders	GO:0007613	memory	2.871125559522625e-10	6.332267421527149e-6	7	99	32
MESH:D008569	Memory Disorders	GO:0001505	regulation of neurotransmitter levels	5.262660307536748e-10	1.1606797308272299e-5	8	179	32
MESH:D008569	Memory Disorders	GO:0006836	neurotransmitter transport	6.275744368622327e-10	1.3841154204996542e-5	8	183	32
MESH:D008569	Memory Disorders	GO:0015844	monoamine transport	1.87199633572277e-9	4.128687918436569e-5	6	70	32
Orphanet:93446	Primary bone dysplasia with decreased bone density	GO:0031012	extracellular matrix	1.3248908636853685e-9	2.92204679985808e-5	10	423	32
MESH:D054506	Chloracne	GO:0005833	hemoglobin complex	9.866885086751154e-12	2.176141505882967e-7	5	12	33
MESH:D054506	Chloracne	GO:0005344	oxygen transporter activity	2.488242945020147e-11	5.487819815241934e-7	5	14	33
MESH:D054506	Chloracne	GO:0015671	oxygen transport	3.7267966490617255e-11	8.219450009505636e-7	5	15	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0072358	cardiovascular system development	5.921929613350585e-13	1.3060815762244715e-8	18	910	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0001944	vasculature development	2.3936408410918375e-13	5.279174875028048e-9	17	588	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0001568	blood vessel development	3.7125857943465235e-13	8.188107969431258e-9	16	569	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0048514	blood vessel morphogenesis	1.102784530360168e-12	2.4321912817093505e-8	15	484	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0048729	tissue morphogenesis	2.6474378245211483e-12	5.8389241219813925e-8	14	635	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0001525	angiogenesis	4.518607710224387e-12	9.965789304899886e-8	12	413	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0002009	morphogenesis of an epithelium	3.2807423444580763e-11	7.235677240702287e-7	12	506	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0061298	retina vasculature development in camera-type eye	5.412892356559951e-11	1.1938134092392971e-6	5	16	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0060562	epithelial tube morphogenesis	1.7942809460436138e-9	3.95728662649919e-5	9	301	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0045765	regulation of angiogenesis	2.2664767840296918e-9	4.998714547177485e-5	8	208	33
Orphanet:183503	Genetic central nervous system and retinal vascular disease	GO:0051241	negative regulation of multicellular organismal process	3.825771699439429e-9	8.43773948311366e-5	13	966	33
DOID:627	severe combined immunodeficiency	GO:0001775	cell activation	3.254729818991109e-12	7.178306615784891e-8	20	854	33
DOID:627	severe combined immunodeficiency	GO:0002250	adaptive immune response	5.917599743554547e-12	1.3051266234409553e-7	11	334	33
DOID:627	severe combined immunodeficiency	GO:0050852	T cell receptor signaling pathway	8.161360476321988e-12	1.7999880530528145e-7	9	165	33
DOID:627	severe combined immunodeficiency	GO:0046651	lymphocyte proliferation	1.1697087742845724e-11	2.5797927016846245e-7	10	249	33
DOID:627	severe combined immunodeficiency	GO:0042101	T cell receptor complex	1.4353995769766925e-10	3.1657737670220953e-6	5	19	33
DOID:627	severe combined immunodeficiency	GO:0045061	thymic T cell selection	3.237778933851132e-10	7.140921438608672e-6	5	22	33
DOID:627	severe combined immunodeficiency	GO:0045580	regulation of T cell differentiation	5.503625333247442e-10	1.2138245672477233e-5	7	105	33
DOID:627	severe combined immunodeficiency	GO:0070419	nonhomologous end joining complex	1.0122434002113323e-9	2.2325028191660934e-5	4	9	33
DOID:627	severe combined immunodeficiency	GO:0098552	side of membrane	1.140577410296828e-9	2.5155434784096542e-5	10	402	33
DOID:627	severe combined immunodeficiency	GO:0050671	positive regulation of lymphocyte proliferation	2.1029836760888543e-9	4.638130497613968e-5	7	127	33
DOID:627	severe combined immunodeficiency	GO:0001772	immunological synapse	2.8778873728541043e-9	6.347180600829727e-5	5	33	33
DOID:4448	macular degeneration	GO:0007601	visual perception	6.516676087642281e-11	1.4372529111295052e-6	9	207	33
Orphanet:217613	Mitochondrial disease with dilated cardiomyopathy	GO:0045333	cellular respiration	5.32018873400375e-13	1.1733676252845271e-8	12	173	33
Orphanet:217613	Mitochondrial disease with dilated cardiomyopathy	GO:0009116	nucleoside metabolic process	3.019806626980426e-14	6.660183515805329e-10	13	394	33
Orphanet:217613	Mitochondrial disease with dilated cardiomyopathy	GO:0009119	ribonucleoside metabolic process	2.6867397195928788e-14	5.925604451562094e-10	13	372	33
Orphanet:217613	Mitochondrial disease with dilated cardiomyopathy	GO:0006119	oxidative phosphorylation	1.199040866595169e-14	2.6444846312756454e-10	12	110	33
Orphanet:102373	Primary glomerular disease	GO:0072015	glomerular visceral epithelial cell development	1.6849872608304395e-9	3.716239403761534e-5	4	10	33
Orphanet:180250	Rare breast tumor	GO:0060548	negative regulation of cell death	1.0324834320840637e-9	2.2771422094614024e-5	13	867	33
Orphanet:399849	Rare female infertility due to an adrenal disorder	GO:1901698	response to nitrogen compound	7.567713122824671e-11	1.6690591292389811e-6	14	870	33
Orphanet:399849	Rare female infertility due to an adrenal disorder	GO:0032870	cellular response to hormone stimulus	7.692934067549118e-10	1.696676608597958e-5	11	519	33
Orphanet:399849	Rare female infertility due to an adrenal disorder	GO:0043434	response to peptide hormone	8.290301778401954e-10	1.828426057226551e-5	10	389	33
Orphanet:98027	Rare disease with odontological manifestation	GO:0044420	extracellular matrix component	8.548717289613705e-14	1.8854195982243027e-9	12	125	33
Orphanet:98027	Rare disease with odontological manifestation	GO:0060348	bone development	1.1795564525129976e-11	2.601511756017416e-7	9	172	33
Orphanet:98027	Rare disease with odontological manifestation	GO:0043588	skin development	2.5364987887854795e-10	5.594248078666375e-6	9	241	33
Orphanet:98027	Rare disease with odontological manifestation	GO:0042476	odontogenesis	9.838402315054395e-10	2.169859630585247e-5	7	114	33
Orphanet:424936	Carcinoma of liver and intrahepatic biliary tract	GO:1903827	regulation of cellular protein localization	7.148337477502764e-11	1.5765658306632346e-6	12	543	33
Orphanet:424936	Carcinoma of liver and intrahepatic biliary tract	GO:0002009	morphogenesis of an epithelium	5.903725286415806e-10	1.302066611919006e-5	11	506	33
Orphanet:424936	Carcinoma of liver and intrahepatic biliary tract	GO:0060562	epithelial tube morphogenesis	1.7942809460436138e-9	3.95728662649919e-5	9	301	33
Orphanet:98610	Rare conjunctival disease	GO:0071897	DNA biosynthetic process	5.1736392947532295e-14	1.1410461464578248e-9	10	167	33
Orphanet:98610	Rare conjunctival disease	GO:0006275	regulation of DNA replication	5.440092820663267e-15	1.1998124715972835e-10	10	157	33
Orphanet:98610	Rare conjunctival disease	GO:0032204	regulation of telomere maintenance	2.381428387820961e-13	5.252240309339129e-9	8	66	33
Orphanet:98610	Rare conjunctival disease	GO:0051053	negative regulation of DNA metabolic process	1.1893819262809302e-11	2.6231818384125916e-7	8	108	33
Orphanet:98610	Rare conjunctival disease	GO:2000278	regulation of DNA biosynthetic process	3.700739714673773e-11	8.161981440713006e-7	7	72	33
Orphanet:98610	Rare conjunctival disease	GO:0000784	nuclear chromosome, telomeric region	6.02620175982338e-11	1.3290787981290464e-6	8	132	33
Orphanet:98610	Rare conjunctival disease	GO:1904358	positive regulation of telomere maintenance via telomere lengthening	2.8778873728541043e-9	6.347180600829727e-5	5	33	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0048736	appendage development	2.2670754162845697e-13	5.000034830615618e-9	12	168	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0060173	limb development	2.2670754162845697e-13	5.000034830615618e-9	12	168	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0048729	tissue morphogenesis	3.999547359967437e-10	8.821001702408182e-6	12	635	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0048762	mesenchymal cell differentiation	8.579726928914511e-10	1.8922587741720953e-5	8	184	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0042733	embryonic digit morphogenesis	8.820634223027923e-10	1.9453908778888085e-5	6	60	33
Orphanet:98684	Craniostenosis associated with a strabismus	GO:0060562	epithelial tube morphogenesis	1.7942809460436138e-9	3.95728662649919e-5	9	301	33
DOID:1827	idiopathic generalized epilepsy	GO:0022836	gated channel activity	6.71740441049451e-12	1.481523542734564e-7	11	335	33
DOID:1827	idiopathic generalized epilepsy	GO:0005216	ion channel activity	7.771183696547723e-11	1.7139345642736004e-6	11	417	33
Orphanet:139033	Progeroid syndrome	GO:0000109	nucleotide-excision repair complex	7.771561172376096e-14	1.714017816567548e-9	6	14	33
Orphanet:139033	Progeroid syndrome	GO:0032508	DNA duplex unwinding	5.4847237862531983e-11	1.2096558310581429e-6	7	76	33
Orphanet:139033	Progeroid syndrome	GO:0000405	bubble DNA binding	2.8188584799693217e-10	6.216992377572339e-6	4	7	33
Orphanet:139033	Progeroid syndrome	GO:0006979	response to oxidative stress	7.686443703747159e-10	1.695245158861436e-5	10	386	33
DOID:1793	pancreatic cancer	GO:0048608	reproductive structure development	1.6621031218022608e-9	3.665768435134886e-5	10	418	33
DOID:1793	pancreatic cancer	GO:0030855	epithelial cell differentiation	1.9785121319060295e-9	4.363608506918748e-5	11	568	33
Orphanet:309	Familial partial epilepsy	GO:0034220	ion transmembrane transport	1.3939960297193466e-12	3.074458243546019e-8	20	962	33
Orphanet:309	Familial partial epilepsy	GO:0022832	voltage-gated channel activity	9.028333636251773e-13	1.9911989834753285e-8	11	189	33
Orphanet:309	Familial partial epilepsy	GO:0005244	voltage-gated ion channel activity	9.028333636251773e-13	1.9911989834753285e-8	11	189	33
Orphanet:309	Familial partial epilepsy	GO:0034703	cation channel complex	1.900701818158268e-13	4.19199785994806e-9	10	166	33
Orphanet:309	Familial partial epilepsy	GO:0098660	inorganic ion transmembrane transport	1.7430501486614958e-14	3.844297102872929e-10	17	660	33
Orphanet:309	Familial partial epilepsy	GO:0022843	voltage-gated cation channel activity	2.0949908474676704e-13	4.620502314089947e-9	10	149	33
Orphanet:309	Familial partial epilepsy	GO:0034762	regulation of transmembrane transport	2.4003021792395884e-13	5.293866456312912e-9	12	383	33
Orphanet:309	Familial partial epilepsy	GO:0042391	regulation of membrane potential	4.57522908448027e-13	1.0090667745821236e-8	13	340	33
Orphanet:309	Familial partial epilepsy	GO:0060078	regulation of postsynaptic membrane potential	1.6373569167171809e-12	3.6111906798197424e-8	8	85	33
Orphanet:309	Familial partial epilepsy	GO:0034765	regulation of ion transmembrane transport	1.6699974736411605e-12	3.6831794281155794e-8	12	367	33
Orphanet:309	Familial partial epilepsy	GO:0098655	cation transmembrane transport	3.0122571104129747e-12	6.643533057015816e-8	14	642	33
Orphanet:309	Familial partial epilepsy	GO:0098797	plasma membrane protein complex	3.862798969578307e-12	8.519403127404956e-8	13	499	33
Orphanet:309	Familial partial epilepsy	GO:0046873	metal ion transmembrane transporter activity	7.27861104721228e-11	1.6052976664626684e-6	11	415	33
Orphanet:309	Familial partial epilepsy	GO:0098662	inorganic cation transmembrane transport	1.2771095292407608e-10	2.816665066740498e-6	12	575	33
Orphanet:309	Familial partial epilepsy	GO:0051899	membrane depolarization	2.508860896810461e-10	5.5332927079154715e-6	7	94	33
Orphanet:309	Familial partial epilepsy	GO:0030001	metal ion transport	3.4609037857791236e-10	7.633023299535857e-6	13	792	33
Orphanet:309	Familial partial epilepsy	GO:0001508	action potential	1.331229237955256e-9	2.936026084310317e-5	7	119	33
Orphanet:309	Familial partial epilepsy	GO:0005230	extracellular ligand-gated ion channel activity	3.2072653421977293e-9	7.073623712217092e-5	6	74	33
OMIM:603903	sickle cell anemia	GO:0006063	uronic acid metabolic process	1.5432100042289676e-13	3.403549664326988e-9	9	29	33
OMIM:603903	sickle cell anemia	GO:0019585	glucuronate metabolic process	1.5432100042289676e-13	3.403549664326988e-9	9	29	33
OMIM:603903	sickle cell anemia	GO:0015020	glucuronosyltransferase activity	6.816769371198461e-14	1.5034384848178206e-9	9	35	33
OMIM:603903	sickle cell anemia	GO:0052695	cellular glucuronidation	5.773159728050814e-14	1.273270378021607e-9	9	24	33
OMIM:603903	sickle cell anemia	GO:0009812	flavonoid metabolic process	3.086420008457935e-14	6.807099328653976e-10	9	31	33
OMIM:603903	sickle cell anemia	GO:0052697	xenobiotic glucuronidation	2.886579864025407e-15	6.366351890108035e-11	9	9	33
OMIM:603903	sickle cell anemia	GO:0009813	flavonoid biosynthetic process	5.218048215738236e-15	1.1508405339810679e-10	7	20	33
OMIM:603903	sickle cell anemia	GO:0052696	flavonoid glucuronidation	1.965094753586527e-14	4.3340164790350855e-10	9	22	33
OMIM:603903	sickle cell anemia	GO:0051552	flavone metabolic process	6.705747068735946e-14	1.4789525160097128e-9	5	6	33
OMIM:603903	sickle cell anemia	GO:0001972	retinoic acid binding	5.412892356559951e-11	1.1938134092392971e-6	5	16	33
OMIM:603903	sickle cell anemia	GO:0042573	retinoic acid metabolic process	3.237778933851132e-10	7.140921438608672e-6	5	22	33
DOID:0050453	lissencephaly	GO:0021795	cerebral cortex cell migration	1.3317502656207125e-10	2.9371752108264815e-6	6	43	34
DOID:0050453	lissencephaly	GO:0022030	telencephalon glial cell migration	2.2385659992352203e-10	4.937157311313278e-6	5	20	34
DOID:0050453	lissencephaly	GO:0021801	cerebral cortex radial glia guided migration	2.2385659992352203e-10	4.937157311313278e-6	5	20	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0044429	mitochondrial part	1.4905854328617352e-12	3.287486172176557e-8	28	956	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0044455	mitochondrial membrane part	9.701128789174618e-13	2.139583954452462e-8	20	179	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0045333	cellular respiration	6.261657858885883e-13	1.3810086407772815e-8	22	173	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0009119	ribonucleoside metabolic process	3.4305891460917337e-13	7.566164361705319e-9	21	372	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0098803	respiratory chain complex	1.5232259897857148e-13	3.359474920472394e-9	18	73	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0046034	ATP metabolic process	1.3322676295501878e-13	2.9383162569729393e-9	21	230	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	7.016609515630989e-14	1.5475132286724147e-9	16	53	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0033108	mitochondrial respiratory chain complex assembly	4.107825191113079e-14	9.059808458999896e-10	19	80	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0098800	inner mitochondrial membrane protein complex	3.5083047578154947e-14	7.737566143362073e-10	18	114	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0005746	mitochondrial respiratory chain	2.7200464103316335e-14	5.999062357986418e-10	19	79	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0045271	respiratory chain complex I	3.552713678800501e-14	7.835510018594505e-10	15	48	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0005747	mitochondrial respiratory chain complex I	3.552713678800501e-14	7.835510018594505e-10	15	48	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	4.496403249731884e-14	9.91681736728367e-10	16	59	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0010257	NADH dehydrogenase complex assembly	4.929390229335695e-14	1.0871770150799875e-9	19	61	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0097031	mitochondrial respiratory chain complex I biogenesis	4.929390229335695e-14	1.0871770150799875e-9	19	61	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0032981	mitochondrial respiratory chain complex I assembly	4.929390229335695e-14	1.0871770150799875e-9	19	61	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0008137	NADH dehydrogenase (ubiquinone) activity	1.1446399383885364e-13	2.524503384115917e-9	16	45	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0008535	respiratory chain complex IV assembly	1.2405310112484358e-10	2.735991145308425e-6	5	18	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0009060	aerobic respiration	1.30850708046637e-9	2.8859123659685793e-5	6	62	34
OMIM:256000	Leigh syndrome with cardiomyopathy	GO:0009055	electron carrier activity	1.3113958807764448e-9	2.892283615052449e-5	7	115	34
Orphanet:183601	Rare genetic refraction anomaly	GO:0044420	extracellular matrix component	2.3559307837928145e-9	5.1960053436550524e-5	7	125	34
Orphanet:79191	Disorder of purine metabolism	GO:0034470	ncRNA processing	6.472600233564663e-13	1.4275319815126863e-8	14	384	34
Orphanet:79191	Disorder of purine metabolism	GO:0022626	cytosolic ribosome	5.0182080713057076e-14	1.1067657901264738e-9	13	107	34
Orphanet:79191	Disorder of purine metabolism	GO:0043094	cellular metabolic compound salvage	1.2434497875801753e-14	2.7424285065080767e-10	8	34	34
Orphanet:79191	Disorder of purine metabolism	GO:0072599	establishment of protein localization to endoplasmic reticulum	2.6645352591003757e-15	5.876632513945879e-11	13	104	34
Orphanet:79191	Disorder of purine metabolism	GO:0043101	purine-containing compound salvage	2.4980018054066022e-14	5.509342981824261e-10	7	15	34
Orphanet:79191	Disorder of purine metabolism	GO:0009124	nucleoside monophosphate biosynthetic process	4.973799150320701e-14	1.0969714026032307e-9	10	89	34
Orphanet:79191	Disorder of purine metabolism	GO:0032261	purine nucleotide salvage	3.100852907778062e-13	6.838931088104516e-9	5	7	34
Orphanet:79191	Disorder of purine metabolism	GO:0009127	purine nucleoside monophosphate biosynthetic process	3.5993430458347575e-13	7.938351087588558e-9	8	68	34
Orphanet:79191	Disorder of purine metabolism	GO:0009168	purine ribonucleoside monophosphate biosynthetic process	3.5993430458347575e-13	7.938351087588558e-9	8	68	34
Orphanet:79191	Disorder of purine metabolism	GO:0016072	rRNA metabolic process	1.113997782908882e-12	2.4569221102055394e-8	14	254	34
Orphanet:79191	Disorder of purine metabolism	GO:0006188	IMP biosynthetic process	3.695932448977146e-12	8.151379016219096e-8	5	10	34
Orphanet:79191	Disorder of purine metabolism	GO:0006144	purine nucleobase metabolic process	1.6814782899388092e-10	3.7085003684600437e-6	5	19	34
Orphanet:79191	Disorder of purine metabolism	GO:0009116	nucleoside metabolic process	1.3043153224145954e-9	2.87666744358539e-5	10	394	34
Orphanet:79191	Disorder of purine metabolism	GO:0009113	purine nucleobase biosynthetic process	1.909162716806634e-9	4.210658371917031e-5	4	10	34
OMIM:254500	multiple myeloma	GO:0097285	cell-type specific apoptotic process	2.1150858842133857e-12	4.664821917632622e-8	13	429	34
OMIM:254500	multiple myeloma	GO:0070997	neuron death	2.344457961100943e-12	5.17070203320813e-8	11	281	34
OMIM:254500	multiple myeloma	GO:0051402	neuron apoptotic process	3.1766811403599604e-12	7.006170255063893e-8	10	211	34
OMIM:254500	multiple myeloma	GO:1901214	regulation of neuron death	4.710756229542312e-10	1.038957286425557e-5	9	250	34
OMIM:254500	multiple myeloma	GO:0006979	response to oxidative stress	1.0693487206836494e-9	2.3584486034677887e-5	10	386	34
OMIM:254500	multiple myeloma	GO:0043523	regulation of neuron apoptotic process	1.4354644140013306e-9	3.165916765079935e-5	8	190	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0019882	antigen processing and presentation	4.758415883543421e-13	1.0494686231155015e-8	11	219	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0006954	inflammatory response	1.9070300893986314e-12	4.2059548621686815e-8	14	637	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0030139	endocytic vesicle	2.4662494269023227e-12	5.439313111033073e-8	11	251	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0007159	leukocyte cell-cell adhesion	3.0645486148728196e-12	6.758861970102004e-8	13	461	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0070489	T cell aggregation	6.287081966149799e-12	1.3866159276343382e-7	12	424	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0042110	T cell activation	6.287081966149799e-12	1.3866159276343382e-7	12	424	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0048002	antigen processing and presentation of peptide antigen	1.9736212664156483e-11	4.3528217030797123e-7	9	176	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0002684	positive regulation of immune system process	1.2582768160740443e-10	2.7751295178513047e-6	14	872	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0072593	reactive oxygen species metabolic process	1.7014645248281113e-10	3.7525800095083994e-6	9	223	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0030155	regulation of cell adhesion	4.6360548733304086e-10	1.0224819023130216e-5	12	621	34
Orphanet:280930	Systemic diseases with posterior uveitis	GO:0009617	response to bacterium	1.0654360727002654e-9	2.3498192583404354e-5	11	517	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0019882	antigen processing and presentation	4.758415883543421e-13	1.0494686231155015e-8	11	219	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0006954	inflammatory response	1.9070300893986314e-12	4.2059548621686815e-8	14	637	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0030139	endocytic vesicle	2.4662494269023227e-12	5.439313111033073e-8	11	251	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0007159	leukocyte cell-cell adhesion	3.0645486148728196e-12	6.758861970102004e-8	13	461	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0070489	T cell aggregation	6.287081966149799e-12	1.3866159276343382e-7	12	424	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0042110	T cell activation	6.287081966149799e-12	1.3866159276343382e-7	12	424	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0048002	antigen processing and presentation of peptide antigen	1.9736212664156483e-11	4.3528217030797123e-7	9	176	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0002684	positive regulation of immune system process	1.2582768160740443e-10	2.7751295178513047e-6	14	872	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0072593	reactive oxygen species metabolic process	1.7014645248281113e-10	3.7525800095083994e-6	9	223	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0030155	regulation of cell adhesion	4.6360548733304086e-10	1.0224819023130216e-5	12	621	34
Orphanet:280933	Systemic diseases with panuveitis	GO:0009617	response to bacterium	1.0654360727002654e-9	2.3498192583404354e-5	11	517	34
MESH:D038061	Lower Extremity Deformities, Congenital	GO:0009790	embryo development	3.481659405224491e-13	7.678799818222615e-9	16	932	34
MESH:D038061	Lower Extremity Deformities, Congenital	GO:0007389	pattern specification process	1.6131151969744906e-10	3.557725566927239e-6	11	432	34
MESH:D038061	Lower Extremity Deformities, Congenital	GO:0035295	tube development	1.84168125194617e-10	4.061828001167278e-6	12	573	34
MESH:D038061	Lower Extremity Deformities, Congenital	GO:0060043	regulation of cardiac muscle cell proliferation	1.4044491125630998e-9	3.0975125177579166e-5	5	28	34
Orphanet:98203	Combined dystonia	GO:0042417	dopamine metabolic process	2.0037416170737288e-11	4.419252136456109e-7	6	32	34
Orphanet:98203	Combined dystonia	GO:0050905	neuromuscular process	3.9346315094945794e-10	8.677829794190295e-6	7	97	34
Orphanet:98203	Combined dystonia	GO:0007610	behavior	2.2587087755709945e-9	4.981582204521828e-5	12	714	34
Orphanet:182058	Primary orthostatic hypotension	GO:0007626	locomotory behavior	1.0036416142611415e-12	2.2135315802529476e-8	11	183	34
Orphanet:182058	Primary orthostatic hypotension	GO:0030534	adult behavior	1.7215118219837677e-12	3.7967943233852e-8	9	135	34
Orphanet:182058	Primary orthostatic hypotension	GO:0032104	regulation of response to extracellular stimulus	1.456901266294608e-11	3.213195742812758e-7	9	170	34
Orphanet:182058	Primary orthostatic hypotension	GO:0032107	regulation of response to nutrient levels	1.456901266294608e-11	3.213195742812758e-7	9	170	34
Orphanet:182058	Primary orthostatic hypotension	GO:0008344	adult locomotory behavior	9.933487365998417e-11	2.190830638570951e-6	7	80	34
Orphanet:182058	Primary orthostatic hypotension	GO:1900407	regulation of cellular response to oxidative stress	8.659380990039267e-10	1.9098264773531604e-5	6	58	34
Orphanet:182058	Primary orthostatic hypotension	GO:1903202	negative regulation of oxidative stress-induced cell death	3.369974965750089e-9	7.432479786961821e-5	5	33	34
Orphanet:98618	Rare refraction anomaly	GO:0044420	extracellular matrix component	2.3559307837928145e-9	5.1960053436550524e-5	7	125	34
DOID:9993	hypoglycemia	GO:0032880	regulation of protein localization	2.190470027585434e-12	4.8310816458396744e-8	17	933	34
DOID:9993	hypoglycemia	GO:0032940	secretion by cell	1.4905854328617352e-12	3.287486172176557e-8	20	956	34
DOID:9993	hypoglycemia	GO:1903531	negative regulation of secretion by cell	7.314149286230531e-13	1.6131356250781437e-8	11	174	34
DOID:9993	hypoglycemia	GO:0006109	regulation of carbohydrate metabolic process	1.7719159473017498e-13	3.907960621774009e-9	10	163	34
DOID:9993	hypoglycemia	GO:0010676	positive regulation of cellular carbohydrate metabolic process	3.186340080674199e-14	7.027473047926946e-10	8	64	34
DOID:9993	hypoglycemia	GO:0050709	negative regulation of protein secretion	1.2387646464162572e-11	2.732095427671055e-7	8	105	34
DOID:9993	hypoglycemia	GO:0032869	cellular response to insulin stimulus	3.2346236800151473e-11	7.133962526273407e-7	9	186	34
DOID:9993	hypoglycemia	GO:0034284	response to monosaccharide	3.585809427164577e-11	7.908502691611474e-7	9	188	34
DOID:9993	hypoglycemia	GO:0015758	glucose transport	1.5781309592455273e-10	3.4805678306160104e-6	8	144	34
DOID:9993	hypoglycemia	GO:0032787	monocarboxylic acid metabolic process	1.8059209683229938e-10	3.982958695636363e-6	12	572	34
DOID:9993	hypoglycemia	GO:0050994	regulation of lipid catabolic process	3.8882097541659277e-10	8.575446612812954e-6	6	51	34
DOID:9993	hypoglycemia	GO:0010827	regulation of glucose transport	4.546487630818774e-10	1.0027278469770806e-5	7	99	34
DOID:9993	hypoglycemia	GO:0033993	response to lipid	1.2540311011832728e-9	2.765765593659708e-5	13	850	34
DOID:9993	hypoglycemia	GO:0006635	fatty acid beta-oxidation	1.751259803839389e-9	3.862403497367772e-5	6	65	34
DOID:9993	hypoglycemia	GO:0031667	response to nutrient levels	1.887216605211961e-9	4.16225622279498e-5	11	546	34
DOID:9993	hypoglycemia	GO:0045834	positive regulation of lipid metabolic process	2.227045214908685e-9	4.911748221481105e-5	7	124	34
DOID:9993	hypoglycemia	GO:0032844	regulation of homeostatic process	2.830841117074101e-9	6.24342008370693e-5	10	427	34
DOID:9993	hypoglycemia	GO:0046323	glucose import	3.282733418430439e-9	7.240068554348333e-5	6	72	34
DOID:9993	hypoglycemia	GO:0048545	response to steroid hormone	4.294583244579542e-9	9.47170334592018e-5	10	446	34
DOID:9993	hypoglycemia	GO:0046628	positive regulation of insulin receptor signaling pathway	4.488590166218387e-9	9.899585611594652e-5	4	12	34
DOID:1701	steroid inherited metabolic disorder	GO:0042445	hormone metabolic process	1.0058620603103918e-12	2.2184287740145692e-8	11	187	34
DOID:1701	steroid inherited metabolic disorder	GO:1901617	organic hydroxy compound biosynthetic process	5.555556015224283e-13	1.2252778791577157e-8	12	224	34
DOID:1701	steroid inherited metabolic disorder	GO:0016229	steroid dehydrogenase activity	8.903988657493755e-14	1.9637746984102478e-9	7	27	34
DOID:1701	steroid inherited metabolic disorder	GO:0008209	androgen metabolic process	8.104628079763643e-15	1.7874757229918714e-10	7	30	34
DOID:1701	steroid inherited metabolic disorder	GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	2.9226621123257246e-12	6.445931288734386e-8	6	24	34
DOID:1701	steroid inherited metabolic disorder	GO:0055114	oxidation-reduction process	3.97326616052851e-12	8.763038517045629e-8	20	949	34
DOID:1701	steroid inherited metabolic disorder	GO:0006702	androgen biosynthetic process	2.9129476608602545e-11	6.424506066027291e-7	5	14	34
DOID:1701	steroid inherited metabolic disorder	GO:0008203	cholesterol metabolic process	3.175415486111888e-11	7.003378854619768e-7	8	118	34
DOID:1701	steroid inherited metabolic disorder	GO:0005789	endoplasmic reticulum membrane	5.414068082743029e-10	1.194072715648975e-5	14	977	34
MESH:D001169	Arthritis, Experimental	GO:0033993	response to lipid	2.3934187964869125e-12	5.2786851556518855e-8	16	850	34
MESH:D001169	Arthritis, Experimental	GO:0050663	cytokine secretion	1.6209256159527285e-13	3.574951445983743e-9	11	162	34
MESH:D001169	Arthritis, Experimental	GO:0072593	reactive oxygen species metabolic process	4.529709940470639e-14	9.990275273707994e-10	11	223	34
MESH:D001169	Arthritis, Experimental	GO:0050707	regulation of cytokine secretion	1.1834977442504169e-13	2.6102042749442944e-9	10	142	34
MESH:D001169	Arthritis, Experimental	GO:0009725	response to hormone	6.941114349956479e-13	1.5308627698829014e-8	16	865	34
MESH:D001169	Arthritis, Experimental	GO:0006954	inflammatory response	1.9070300893986314e-12	4.2059548621686815e-8	14	637	34
MESH:D001169	Arthritis, Experimental	GO:0032722	positive regulation of chemokine production	3.251510172219696e-12	7.17120568483054e-8	7	50	34
MESH:D001169	Arthritis, Experimental	GO:0050727	regulation of inflammatory response	3.3024694090499906e-12	7.283596281659754e-8	11	289	34
MESH:D001169	Arthritis, Experimental	GO:2000377	regulation of reactive oxygen species metabolic process	4.32365254710021e-12	9.535815692629512e-8	9	147	34
MESH:D001169	Arthritis, Experimental	GO:0050715	positive regulation of cytokine secretion	5.5209170568559784e-12	1.217638256889586e-7	8	95	34
MESH:D001169	Arthritis, Experimental	GO:0071345	cellular response to cytokine stimulus	5.6492588385026465e-12	1.2459440368317587e-7	14	677	34
MESH:D001169	Arthritis, Experimental	GO:0001101	response to acid chemical	6.512457240148706e-12	1.436322444314797e-7	11	315	34
MESH:D001169	Arthritis, Experimental	GO:0042493	response to drug	9.344747198269943e-12	2.0609839945784358e-7	12	433	34
MESH:D001169	Arthritis, Experimental	GO:0048545	response to steroid hormone	1.0723533172551925e-11	2.365075241206327e-7	12	446	34
MESH:D001169	Arthritis, Experimental	GO:1901698	response to nitrogen compound	1.1179390746463014e-11	2.4656146291324177e-7	15	870	34
MESH:D001169	Arthritis, Experimental	GO:0050729	positive regulation of inflammatory response	2.391720155259236e-11	5.274938802424245e-7	8	114	34
MESH:D001169	Arthritis, Experimental	GO:0051241	negative regulation of multicellular organismal process	2.941136223455487e-11	6.486675940831077e-7	15	966	34
MESH:D001169	Arthritis, Experimental	GO:0010243	response to organonitrogen compound	3.2949531991732783e-11	7.267019280776665e-7	14	780	34
MESH:D001169	Arthritis, Experimental	GO:0007584	response to nutrient	5.575717665351476e-11	1.229724531093268e-6	9	197	34
MESH:D001169	Arthritis, Experimental	GO:0010876	lipid localization	2.5462409958265653e-10	5.61573451629549e-6	10	333	34
MESH:D001169	Arthritis, Experimental	GO:0050900	leukocyte migration	4.632676464666474e-10	1.0217367942821909e-5	10	354	34
MESH:D001169	Arthritis, Experimental	GO:0006953	acute-phase response	4.942591891321513e-10	1.0900886416309596e-5	6	53	34
MESH:D001169	Arthritis, Experimental	GO:0032635	interleukin-6 production	8.982916632760407e-10	1.9811822633553078e-5	7	109	34
MESH:D001169	Arthritis, Experimental	GO:0032637	interleukin-8 production	1.5914930484584033e-9	3.5100379183750086e-5	6	64	34
MESH:D001169	Arthritis, Experimental	GO:0001934	positive regulation of protein phosphorylation	1.6709463812603076e-9	3.6852722438696084e-5	13	870	34
MESH:D001169	Arthritis, Experimental	GO:0007568	aging	1.7363152027272122e-9	3.8294431796148665e-5	9	290	34
MESH:D001169	Arthritis, Experimental	GO:1901701	cellular response to oxygen-containing compound	1.7415788811092625e-9	3.8410522222864785e-5	13	873	34
MESH:D001169	Arthritis, Experimental	GO:0030856	regulation of epithelial cell differentiation	1.9867752998337096e-9	4.3818329237832465e-5	7	122	34
MESH:D001169	Arthritis, Experimental	GO:0032755	positive regulation of interleukin-6 production	2.3117137093464635e-9	5.098484585963625e-5	6	68	34
MESH:D001169	Arthritis, Experimental	GO:0009607	response to biotic stimulus	3.937197123882186e-9	8.68348825672216e-5	13	934	34
MESH:D001169	Arthritis, Experimental	GO:0045073	regulation of chemokine biosynthetic process	4.488590166218387e-9	9.899585611594652e-5	4	12	34
DOID:6536	plasma cell neoplasm	GO:0043066	negative regulation of apoptotic process	8.551226393649358e-10	1.885972981119366e-5	13	795	35
DOID:865	vasculitis	GO:0033993	response to lipid	6.466049917719374e-12	1.426087309353008e-7	15	850	35
DOID:865	vasculitis	GO:0050776	regulation of immune response	8.757872205222839e-11	1.931548714861897e-6	14	816	35
DOID:865	vasculitis	GO:0002684	positive regulation of immune system process	1.9892354430339765e-10	4.387258769611435e-6	14	872	35
DOID:865	vasculitis	GO:0032496	response to lipopolysaccharide	2.328506276683129e-10	5.135520593224641e-6	10	319	35
DOID:865	vasculitis	GO:0031347	regulation of defense response	4.149238730377647e-10	9.1511460198479e-6	13	749	35
DOID:865	vasculitis	GO:0002697	regulation of immune effector process	3.1651999909954043e-9	6.980848580140364e-5	10	418	35
MESH:D054219	Neoplasms, Plasma Cell	GO:0043066	negative regulation of apoptotic process	8.551226393649358e-10	1.885972981119366e-5	13	795	35
DOID:715	T-cell leukemia	GO:0032944	regulation of mononuclear cell proliferation	9.692247004977617e-13	2.1376250769478133e-8	11	191	35
DOID:715	T-cell leukemia	GO:0042107	cytokine metabolic process	1.7674750552032492e-13	3.898166234250766e-9	9	107	35
DOID:715	T-cell leukemia	GO:0007259	JAK-STAT cascade	1.9412249585570862e-11	4.2813716460976536e-7	9	170	35
DOID:715	T-cell leukemia	GO:0050871	positive regulation of B cell activation	3.1030733538273125e-11	6.843828281866138e-7	7	66	35
DOID:715	T-cell leukemia	GO:0071594	thymocyte aggregation	4.721489865744388e-11	1.0413245898899248e-6	7	70	35
DOID:715	T-cell leukemia	GO:0033077	T cell differentiation in thymus	4.721489865744388e-11	1.0413245898899248e-6	7	70	35
DOID:715	T-cell leukemia	GO:0006954	inflammatory response	5.5729532100201595e-11	1.2291148304699462e-6	13	637	35
DOID:715	T-cell leukemia	GO:0048872	homeostasis of number of cells	1.2204859345388286e-10	2.6917817286253864e-6	9	208	35
DOID:715	T-cell leukemia	GO:0045076	regulation of interleukin-2 biosynthetic process	1.446173181207655e-10	3.189534951153483e-6	5	18	35
DOID:715	T-cell leukemia	GO:0042102	positive regulation of T cell proliferation	4.22308299441454e-10	9.314009544181268e-6	7	95	35
DOID:715	T-cell leukemia	GO:0045061	thymic T cell selection	4.421477628469006e-10	9.751568909588393e-6	5	22	35
DOID:715	T-cell leukemia	GO:0008285	negative regulation of cell proliferation	8.661834582923689e-10	1.9103676172638195e-5	12	634	35
DOID:715	T-cell leukemia	GO:0042108	positive regulation of cytokine biosynthetic process	1.1590943760353412e-9	2.556382646345945e-5	6	59	35
DOID:715	T-cell leukemia	GO:0050727	regulation of inflammatory response	2.236795415555548e-9	4.933252289007761e-5	9	289	35
DOID:715	T-cell leukemia	GO:0045582	positive regulation of T cell differentiation	2.539912502541597e-9	5.601777024355492e-5	6	67	35
DOID:715	T-cell leukemia	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	2.539912502541597e-9	5.601777024355492e-5	6	67	35
DOID:715	T-cell leukemia	GO:0032633	interleukin-4 production	2.8187161493775648e-9	6.216678467452219e-5	5	31	35
Orphanet:163637	Rare disorder related with pregnancy, childbirth and puerperium	GO:0010876	lipid localization	3.514452062702844e-10	7.751124024291123e-6	10	333	35
Orphanet:163637	Rare disorder related with pregnancy, childbirth and puerperium	GO:0006869	lipid transport	3.1008596801385124e-9	6.838946024545489e-5	9	300	35
Orphanet:209016	Hematological disease associated with an acquired peripheral neuropathy	GO:0043066	negative regulation of apoptotic process	8.551226393649358e-10	1.885972981119366e-5	13	795	35
Orphanet:420755	Rare genetic odontal or periodontal disorder	GO:0042481	regulation of odontogenesis	7.116848221855321e-10	1.569620875330191e-5	5	24	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0005789	endoplasmic reticulum membrane	7.775113886054896e-12	1.7148013675694074e-7	18	977	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0016758	transferase activity, transferring hexosyl groups	7.247535904753022e-13	1.598444043793279e-8	15	202	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0009101	glycoprotein biosynthetic process	3.914646384828302e-13	8.63375260173882e-9	18	336	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0000030	mannosyltransferase activity	6.683542608243442e-14	1.4740553222480912e-9	7	24	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0006487	protein N-linked glycosylation	4.8183679268731794e-14	1.0626910462718797e-9	12	74	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0097502	mannosylation	1.1080025785759062e-13	2.443699687049161e-9	7	33	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0015780	nucleotide-sugar transport	1.294690576969515e-9	2.8554400675062652e-5	4	9	35
Orphanet:309347	Disorder of protein N-glycosylation	GO:0005338	nucleotide-sugar transmembrane transporter activity	1.294690576969515e-9	2.8554400675062652e-5	4	9	35
DOID:2468	psychotic disorder	GO:0007268	synaptic transmission	3.0999869338188546e-11	6.837021182537484e-7	13	605	35
DOID:2468	psychotic disorder	GO:0043005	neuron projection	4.0789704947030714e-11	8.996169426067624e-7	15	941	35
DOID:2468	psychotic disorder	GO:0030424	axon	1.4582390850392812e-10	3.2161463020541348e-6	11	414	35
DOID:2468	psychotic disorder	GO:0044463	cell projection part	5.216043152955763e-10	1.1503983173843935e-5	14	939	35
DOID:2468	psychotic disorder	GO:0044456	synapse part	5.905069766498627e-10	1.3023631370012723e-5	12	613	35
DOID:2468	psychotic disorder	GO:0036477	somatodendritic compartment	1.1286817036548769e-9	2.489307497410831e-5	12	649	35
DOID:2468	psychotic disorder	GO:0007270	neuron-neuron synaptic transmission	3.854111474410615e-9	8.500242856812612e-5	7	130	35
DOID:2468	psychotic disorder	GO:0051952	regulation of amine transport	3.949876759001825e-9	8.711453191978524e-5	6	72	35
DOID:3213	demyelinating disease	GO:0043209	myelin sheath	6.949752995311087e-10	1.5327680231158602e-5	8	168	35
DOID:5723	optic atrophy	GO:0044429	mitochondrial part	1.156408302449563e-12	2.5504585110525113e-8	19	956	35
DOID:5723	optic atrophy	GO:0045333	cellular respiration	7.86926079854311e-13	1.7355654691186828e-8	11	173	35
DOID:5723	optic atrophy	GO:0009119	ribonucleoside metabolic process	2.69562150378988e-13	5.9451932266085805e-9	13	372	35
DOID:5723	optic atrophy	GO:0022900	electron transport chain	1.1435297153639112e-13	2.5220547872351062e-9	10	107	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0043603	cellular amide metabolic process	1.9841905896100798e-12	4.376132345385031e-8	22	955	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0044429	mitochondrial part	1.1568523916594131e-12	2.5514379498048356e-8	27	956	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0006399	tRNA metabolic process	4.3298697960381105e-13	9.549527835162053e-9	17	165	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0006414	translational elongation	1.2967404927621828e-13	2.8599611567869943e-9	11	129	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0000959	mitochondrial RNA metabolic process	1.687538997430238e-14	3.72186725883239e-10	10	31	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0070127	tRNA aminoacylation for mitochondrial protein translation	1.9872992140790302e-14	4.382988416651301e-10	5	5	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0016876	ligase activity, forming aminoacyl-tRNA and related compounds	1.63202784619898e-13	3.5994374147918506e-9	12	43	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0004812	aminoacyl-tRNA ligase activity	2.0805579481475434e-13	4.588670554639407e-9	12	42	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0005759	mitochondrial matrix	1.1826095658307167e-12	2.6082453974396458e-8	21	412	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0070125	mitochondrial translational elongation	1.6122481127922583e-10	3.5558132127633257e-6	7	83	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0000049	tRNA binding	2.135642773737345e-10	4.710160137477715e-6	6	45	35
Orphanet:35696	Mitochondrial disorder due to a defect in mitochondrial protein synthesis	GO:0008033	tRNA processing	1.192084986278985e-9	2.6291434372383016e-5	7	110	35
Orphanet:98689	Myopathy with eye involvement	GO:0043113	receptor clustering	1.8539469959222288e-10	4.0888800995064756e-6	6	44	35
Orphanet:98689	Myopathy with eye involvement	GO:0048589	developmental growth	2.0523738264444091e-10	4.526510474223144e-6	12	558	35
Orphanet:98689	Myopathy with eye involvement	GO:0031594	neuromuscular junction	5.952349724225314e-10	1.312790731677893e-5	6	53	35
Orphanet:164001	Rare odontal or periodontal disorder	GO:0042481	regulation of odontogenesis	7.116848221855321e-10	1.569620875330191e-5	5	24	35
DOID:0060224	atrial fibrillation	GO:0022832	voltage-gated channel activity	7.251976796851523e-13	1.5994234825456033e-8	11	189	36
DOID:0060224	atrial fibrillation	GO:0005244	voltage-gated ion channel activity	7.251976796851523e-13	1.5994234825456033e-8	11	189	36
DOID:0060224	atrial fibrillation	GO:0003012	muscle system process	6.803446694902959e-13	1.5005001685608477e-8	20	393	36
DOID:0060224	atrial fibrillation	GO:0008016	regulation of heart contraction	3.2085445411667024e-13	7.076444985543162e-9	20	224	36
DOID:0060224	atrial fibrillation	GO:0032970	regulation of actin filament-based process	6.905587213168474e-14	1.5230272598643069e-9	14	326	36
DOID:0060224	atrial fibrillation	GO:0086006	voltage-gated sodium channel activity involved in cardiac muscle cell action potential	1.3433698597964394e-14	2.962802225781047e-10	5	5	36
DOID:0060224	atrial fibrillation	GO:1903115	regulation of actin filament-based movement	3.9968028886505635e-14	8.814948770918818e-10	13	52	36
DOID:0060224	atrial fibrillation	GO:0070252	actin-mediated cell contraction	4.007905118896815e-14	8.839434739726926e-10	14	95	36
DOID:0060224	atrial fibrillation	GO:0001518	voltage-gated sodium channel complex	9.114931032172535e-14	2.0102980391456526e-9	6	14	36
DOID:0060224	atrial fibrillation	GO:0044325	ion channel binding	2.7530200341630007e-11	6.071785685346498e-7	8	109	36
DOID:0060224	atrial fibrillation	GO:0072358	cardiovascular system development	3.913358526119737e-11	8.630912229357079e-7	15	910	36
DOID:0060224	atrial fibrillation	GO:0086014	atrial cardiac muscle cell action potential	3.943478876777817e-11	8.697342662733476e-7	5	14	36
DOID:0060224	atrial fibrillation	GO:0016247	channel regulator activity	9.4560914654096e-11	2.085540972696087e-6	8	127	36
DOID:0060224	atrial fibrillation	GO:0060078	regulation of postsynaptic membrane potential	2.3638568880102184e-10	5.213486366506537e-6	7	85	36
DOID:0060224	atrial fibrillation	GO:0055007	cardiac muscle cell differentiation	2.79044454210009e-10	6.154325437601749e-6	7	87	36
DOID:0060224	atrial fibrillation	GO:0086016	AV node cell action potential	8.101137538574221e-10	1.7867058841325445e-5	4	8	36
DOID:0060224	atrial fibrillation	GO:0006814	sodium ion transport	3.666141279445867e-9	8.08567459181786e-5	8	201	36
DOID:0060224	atrial fibrillation	GO:0035725	sodium ion transmembrane transport	3.8229288623625735e-9	8.431469605940656e-5	7	126	36
DOID:0060224	atrial fibrillation	GO:0055002	striated muscle cell development	4.040391465842674e-9	8.911083377916018e-5	7	127	36
DOID:6432	pulmonary hypertension	GO:0014070	response to organic cyclic compound	3.153366456842832e-10	6.954749720566866e-6	14	873	36
DOID:6432	pulmonary hypertension	GO:0033993	response to lipid	2.871515469848873e-9	6.33312736875169e-5	13	850	36
DOID:6432	pulmonary hypertension	GO:0042311	vasodilation	3.328982423056459e-9	7.34207073405102e-5	6	68	36
DOID:0050709	Ohtahara syndrome	GO:0022836	gated channel activity	4.3220982348657344e-13	9.532387656996377e-9	12	335	36
DOID:0050709	Ohtahara syndrome	GO:0034702	ion channel complex	4.3933745530466695e-12	9.68958757674443e-8	11	274	36
DOID:0050709	Ohtahara syndrome	GO:0034220	ion transmembrane transport	4.792166663492026e-12	1.0569123576331663e-7	16	962	36
DOID:0050709	Ohtahara syndrome	GO:0022843	voltage-gated cation channel activity	8.180678356950466e-12	1.8042486116254253e-7	9	149	36
DOID:0050709	Ohtahara syndrome	GO:0030424	axon	1.0797585048294422e-11	2.381407382401335e-7	12	414	36
DOID:0050709	Ohtahara syndrome	GO:0007268	synaptic transmission	4.6566306366457866e-11	1.0270198869122282e-6	13	605	36
DOID:0050709	Ohtahara syndrome	GO:0005248	voltage-gated sodium channel activity	3.028757245004954e-10	6.679924103858426e-6	5	20	36
DOID:0050709	Ohtahara syndrome	GO:0034703	cation channel complex	8.065832446391141e-10	1.7789193460515662e-5	8	166	36
DOID:0050709	Ohtahara syndrome	GO:0030001	metal ion transport	1.2266129223448274e-9	2.705294800231517e-5	13	792	36
DOID:0050709	Ohtahara syndrome	GO:0044304	main axon	1.2481399247477043e-9	2.752772604031062e-5	6	58	36
DOID:0050709	Ohtahara syndrome	GO:0019228	neuronal action potential	3.2696308993607204e-9	7.211170948540069e-5	5	31	36
DOID:535	sleep disorder	GO:0001101	response to acid chemical	2.801904264160271e-10	6.1795998546054776e-6	10	315	36
DOID:535	sleep disorder	GO:1901698	response to nitrogen compound	3.810347259936009e-9	8.403720881788868e-5	13	870	36
Orphanet:163588	Rare parasitic disease	GO:0033993	response to lipid	3.5447200730232e-12	7.817880121052667e-8	17	850	36
Orphanet:163588	Rare parasitic disease	GO:0009607	response to biotic stimulus	1.0169642905566434e-12	2.242914742822677e-8	20	934	36
Orphanet:163588	Rare parasitic disease	GO:0071216	cellular response to biotic stimulus	8.377742943821431e-13	1.8477112062598167e-8	13	175	36
Orphanet:163588	Rare parasitic disease	GO:0006809	nitric oxide biosynthetic process	2.19824158875781e-14	4.84822182400535e-10	9	62	36
Orphanet:163588	Rare parasitic disease	GO:0032642	regulation of chemokine production	4.74953409934642e-13	1.0475097456108529e-8	8	66	36
Orphanet:163588	Rare parasitic disease	GO:0032635	interleukin-6 production	2.7530200341630007e-11	6.071785685346498e-7	8	109	36
Orphanet:163588	Rare parasitic disease	GO:0009636	response to toxic substance	2.9066082873896448e-11	6.410524577837862e-7	10	249	36
Orphanet:163588	Rare parasitic disease	GO:0043200	response to amino acid	3.441757989719463e-11	7.590797246326275e-7	8	112	36
Orphanet:163588	Rare parasitic disease	GO:0044130	negative regulation of growth of symbiont in host	3.943478876777817e-11	8.697342662733476e-7	5	14	36
Orphanet:163588	Rare parasitic disease	GO:0010035	response to inorganic substance	9.041312143409641e-11	1.9940613932289963e-6	12	502	36
Orphanet:163588	Rare parasitic disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.2145384697959116e-10	2.678664595134883e-6	6	40	36
Orphanet:163588	Rare parasitic disease	GO:0050776	regulation of immune response	1.3460355052785644e-10	2.968681306891874e-6	14	816	36
Orphanet:163588	Rare parasitic disease	GO:0002449	lymphocyte mediated immunity	1.6825907334094836e-10	3.710953862534616e-6	9	209	36
Orphanet:163588	Rare parasitic disease	GO:0019221	cytokine-mediated signaling pathway	1.8365786669249928e-10	4.050574249903072e-6	12	534	36
Orphanet:163588	Rare parasitic disease	GO:0009897	external side of plasma membrane	1.914287617310606e-10	4.221961339978542e-6	9	212	36
Orphanet:163588	Rare parasitic disease	GO:0002526	acute inflammatory response	2.1947099693164773e-10	4.840432837327491e-6	8	141	36
Orphanet:163588	Rare parasitic disease	GO:1902533	positive regulation of intracellular signal transduction	2.5887725296769304e-10	5.70953781420247e-6	14	860	36
Orphanet:163588	Rare parasitic disease	GO:0097191	extrinsic apoptotic signaling pathway	2.657710718168005e-10	5.861580988919535e-6	9	220	36
Orphanet:163588	Rare parasitic disease	GO:0042742	defense response to bacterium	2.8740321234010935e-10	6.338677848161112e-6	9	222	36
Orphanet:163588	Rare parasitic disease	GO:0032722	positive regulation of chemokine production	4.955079679902497e-10	1.0928428234024956e-5	6	50	36
Orphanet:163588	Rare parasitic disease	GO:0050663	cytokine secretion	6.643916528048521e-10	1.4653157902611014e-5	8	162	36
Orphanet:163588	Rare parasitic disease	GO:0032675	regulation of interleukin-6 production	9.257827837672039e-10	2.0418139295985682e-5	7	103	36
Orphanet:163588	Rare parasitic disease	GO:0007259	JAK-STAT cascade	9.746025098067435e-10	2.1494858353787727e-5	8	170	36
Orphanet:163588	Rare parasitic disease	GO:0001906	cell killing	1.2115886072194826e-9	2.672158673222569e-5	7	107	36
Orphanet:163588	Rare parasitic disease	GO:0031341	regulation of cell killing	1.2481399247477043e-9	2.752772604031062e-5	6	58	36
Orphanet:163588	Rare parasitic disease	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.569518737198905e-9	3.461573574892185e-5	7	111	36
Orphanet:163588	Rare parasitic disease	GO:0002706	regulation of lymphocyte mediated immunity	1.6721648510298337e-9	3.687959578946298e-5	7	112	36
Orphanet:163588	Rare parasitic disease	GO:0032637	interleukin-8 production	2.2927856280219316e-9	5.05673870260237e-5	6	64	36
Orphanet:163588	Rare parasitic disease	GO:0001775	cell activation	3.040636631368443e-9	6.706124090483101e-5	13	854	36
Orphanet:163588	Rare parasitic disease	GO:0032755	positive regulation of interleukin-6 production	3.328982423056459e-9	7.34207073405102e-5	6	68	36
Orphanet:163588	Rare parasitic disease	GO:0045321	leukocyte activation	3.4932210457583324e-9	7.704299016420002e-5	12	694	36
Orphanet:163588	Rare parasitic disease	GO:0001934	positive regulation of protein phosphorylation	3.810347259936009e-9	8.403720881788868e-5	13	870	36
Orphanet:163588	Rare parasitic disease	GO:0014070	response to organic cyclic compound	3.970847761713969e-9	8.757704738460159e-5	13	873	36
DOID:2789	parasitic protozoa infectious disease	GO:0033993	response to lipid	2.674971355531852e-12	5.8996493246255e-8	16	850	36
DOID:2789	parasitic protozoa infectious disease	GO:0009607	response to biotic stimulus	1.0169642905566434e-12	2.242914742822677e-8	20	934	36
DOID:2789	parasitic protozoa infectious disease	GO:0071216	cellular response to biotic stimulus	8.377742943821431e-13	1.8477112062598167e-8	13	175	36
DOID:2789	parasitic protozoa infectious disease	GO:0002250	adaptive immune response	1.716404796070492e-13	3.78553077773347e-9	12	334	36
DOID:2789	parasitic protozoa infectious disease	GO:0006809	nitric oxide biosynthetic process	2.19824158875781e-14	4.84822182400535e-10	9	62	36
DOID:2789	parasitic protozoa infectious disease	GO:0007259	JAK-STAT cascade	1.3644640972643174e-13	3.009325566516452e-9	10	170	36
DOID:2789	parasitic protozoa infectious disease	GO:0042327	positive regulation of phosphorylation	2.215228001034575e-12	4.885685356281755e-8	16	910	36
DOID:2789	parasitic protozoa infectious disease	GO:0002377	immunoglobulin production	2.3092638912203256e-12	5.093081512086428e-8	8	81	36
DOID:2789	parasitic protozoa infectious disease	GO:0002449	lymphocyte mediated immunity	4.8937520702452275e-12	1.0793170190925849e-7	10	209	36
DOID:2789	parasitic protozoa infectious disease	GO:0001934	positive regulation of protein phosphorylation	4.903522032861929e-12	1.0814717843476984e-7	16	870	36
DOID:2789	parasitic protozoa infectious disease	GO:0050776	regulation of immune response	1.4364065492600275e-11	3.1679946443929907e-7	15	816	36
DOID:2789	parasitic protozoa infectious disease	GO:0019221	cytokine-mediated signaling pathway	1.5579870726867284e-11	3.4361404888105795e-7	13	534	36
DOID:2789	parasitic protozoa infectious disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.5697332322872626e-11	3.4620466438095576e-7	9	161	36
DOID:2789	parasitic protozoa infectious disease	GO:0032635	interleukin-6 production	2.7530200341630007e-11	6.071785685346498e-7	8	109	36
DOID:2789	parasitic protozoa infectious disease	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.1727953597737724e-11	6.997600165981055e-7	8	111	36
DOID:2789	parasitic protozoa infectious disease	GO:0002706	regulation of lymphocyte mediated immunity	3.441757989719463e-11	7.590797246326275e-7	8	112	36
DOID:2789	parasitic protozoa infectious disease	GO:0043200	response to amino acid	3.441757989719463e-11	7.590797246326275e-7	8	112	36
DOID:2789	parasitic protozoa infectious disease	GO:0044130	negative regulation of growth of symbiont in host	3.943478876777817e-11	8.697342662733476e-7	5	14	36
DOID:2789	parasitic protozoa infectious disease	GO:0001819	positive regulation of cytokine production	8.362954773133424e-11	1.8444496752145767e-6	11	381	36
DOID:2789	parasitic protozoa infectious disease	GO:0002889	regulation of immunoglobulin mediated immune response	1.034147212308767e-10	2.2808116767469855e-6	6	39	36
DOID:2789	parasitic protozoa infectious disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.2145384697959116e-10	2.678664595134883e-6	6	40	36
DOID:2789	parasitic protozoa infectious disease	GO:0002526	acute inflammatory response	2.1947099693164773e-10	4.840432837327491e-6	8	141	36
DOID:2789	parasitic protozoa infectious disease	GO:0097191	extrinsic apoptotic signaling pathway	2.657710718168005e-10	5.861580988919535e-6	9	220	36
DOID:2789	parasitic protozoa infectious disease	GO:0042742	defense response to bacterium	2.8740321234010935e-10	6.338677848161112e-6	9	222	36
DOID:2789	parasitic protozoa infectious disease	GO:0097285	cell-type specific apoptotic process	2.991676906205498e-10	6.598143416636226e-6	11	429	36
DOID:2789	parasitic protozoa infectious disease	GO:0042493	response to drug	3.3087876882831324e-10	7.2975312465084485e-6	11	433	36
DOID:2789	parasitic protozoa infectious disease	GO:0051223	regulation of protein transport	4.531169883748021e-10	9.99349517860626e-6	13	730	36
DOID:2789	parasitic protozoa infectious disease	GO:0032722	positive regulation of chemokine production	4.955079679902497e-10	1.0928428234024956e-5	6	50	36
DOID:2789	parasitic protozoa infectious disease	GO:0009306	protein secretion	6.542018038402375e-10	1.4428420783696438e-5	11	462	36
DOID:2789	parasitic protozoa infectious disease	GO:0050663	cytokine secretion	6.643916528048521e-10	1.4653157902611014e-5	8	162	36
DOID:2789	parasitic protozoa infectious disease	GO:0050778	positive regulation of immune response	7.12835790395161e-10	1.5721593357165276e-5	12	603	36
DOID:2789	parasitic protozoa infectious disease	GO:0009636	response to toxic substance	7.955653913427341e-10	1.7546194706064e-5	9	249	36
DOID:2789	parasitic protozoa infectious disease	GO:0032675	regulation of interleukin-6 production	9.257827837672039e-10	2.0418139295985682e-5	7	103	36
DOID:2789	parasitic protozoa infectious disease	GO:0031341	regulation of cell killing	1.2481399247477043e-9	2.752772604031062e-5	6	58	36
DOID:2789	parasitic protozoa infectious disease	GO:0097305	response to alcohol	1.2955445605200566e-9	2.857323528226985e-5	10	369	36
DOID:2789	parasitic protozoa infectious disease	GO:0034109	homotypic cell-cell adhesion	1.3475514037963876e-9	2.972024621072933e-5	11	495	36
DOID:2789	parasitic protozoa infectious disease	GO:0050708	regulation of protein secretion	1.7194150547794607e-9	3.7921699033161005e-5	10	380	36
DOID:2789	parasitic protozoa infectious disease	GO:0002702	positive regulation of production of molecular mediator of immune response	1.8852229777266416e-9	4.157859277376108e-5	6	62	36
DOID:2789	parasitic protozoa infectious disease	GO:0032637	interleukin-8 production	2.2927856280219316e-9	5.05673870260237e-5	6	64	36
DOID:2789	parasitic protozoa infectious disease	GO:0031349	positive regulation of defense response	2.6838279376661944e-9	5.919182516522792e-5	10	398	36
DOID:2789	parasitic protozoa infectious disease	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.0393996208744056e-9	6.703395863838502e-5	6	67	36
DOID:2789	parasitic protozoa infectious disease	GO:0002708	positive regulation of lymphocyte mediated immunity	3.0393996208744056e-9	6.703395863838502e-5	6	67	36
DOID:2789	parasitic protozoa infectious disease	GO:0032755	positive regulation of interleukin-6 production	3.328982423056459e-9	7.34207073405102e-5	6	68	36
DOID:2789	parasitic protozoa infectious disease	GO:0030097	hemopoiesis	3.5497570438636217e-9	7.828989160241218e-5	12	695	36
DOID:2789	parasitic protozoa infectious disease	GO:0014070	response to organic cyclic compound	3.970847761713969e-9	8.757704738460159e-5	13	873	36
Orphanet:79387	Metabolic disease with skin involvement	GO:0009100	glycoprotein metabolic process	1.0380585280245214e-13	2.289438083558082e-9	13	380	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0071396	cellular response to lipid	2.4115154317883025e-12	5.318597284809101e-8	13	416	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0006954	inflammatory response	8.49894599141976e-11	1.874442538407628e-6	13	637	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:1903706	regulation of hemopoiesis	2.0485024787575412e-10	4.517972216899757e-6	10	305	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:1901701	cellular response to oxygen-containing compound	3.153366456842832e-10	6.954749720566866e-6	14	873	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0071222	cellular response to lipopolysaccharide	4.0012693158786306e-10	8.82479947617032e-6	8	152	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	6.321325685121337e-10	1.394168379853511e-5	8	161	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0034097	response to cytokine	1.0836724850804558e-9	2.3900396658449452e-5	13	784	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0019216	regulation of lipid metabolic process	1.7302757004955538e-9	3.816123057442944e-5	9	272	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0045834	positive regulation of lipid metabolic process	3.41784256452371e-9	7.538051776057042e-5	7	124	36
MESH:D065626	Non-alcoholic Fatty Liver Disease	GO:0031667	response to nutrient levels	3.752083532759798e-9	8.275220231501734e-5	11	546	36
MESH:D002386	Cataract	GO:0001654	eye development	7.37188088351104e-14	1.6258683288583597e-9	13	327	36
MESH:D002386	Cataract	GO:0002088	lens development in camera-type eye	4.957145804951324e-13	1.0932985072820145e-8	8	67	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.0869083411080283e-13	2.3971763463137563e-9	11	209	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0050778	positive regulation of immune response	3.597899755902745e-12	7.935167911643504e-8	14	603	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0019724	B cell mediated immunity	1.3642309504291461e-11	3.0088113611714817e-7	8	100	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0002768	immune response-regulating cell surface receptor signaling pathway	1.4819589999603977e-11	3.268460574412657e-7	11	323	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0016064	immunoglobulin mediated immune response	6.052347512053302e-10	1.3348452437833558e-5	7	97	36
Orphanet:101977	Immunodeficiency predominantly affecting antibody production	GO:0030888	regulation of B cell proliferation	7.127384238359014e-10	1.5719445937700804e-5	6	53	36
OMIM:137800	Glioma Susceptibility 1	GO:0010001	glial cell differentiation	1.3988810110276972e-13	3.0852320698215863e-9	10	176	36
OMIM:137800	Glioma Susceptibility 1	GO:0043523	regulation of neuron apoptotic process	1.0833556274292278e-12	2.3893408362951618e-8	10	190	36
OMIM:137800	Glioma Susceptibility 1	GO:0030855	epithelial cell differentiation	2.708278046270607e-12	5.973107231049823e-8	15	568	36
OMIM:137800	Glioma Susceptibility 1	GO:0048608	reproductive structure development	1.1944001343522359e-11	2.6342494963138563e-7	12	418	36
OMIM:137800	Glioma Susceptibility 1	GO:0060548	negative regulation of cell death	2.2728818827033592e-11	5.012840992302259e-7	15	867	36
OMIM:137800	Glioma Susceptibility 1	GO:0000904	cell morphogenesis involved in differentiation	2.746503025008451e-11	6.057412421656139e-7	14	720	36
OMIM:137800	Glioma Susceptibility 1	GO:0042327	positive regulation of phosphorylation	3.913358526119737e-11	8.630912229357079e-7	15	910	36
OMIM:137800	Glioma Susceptibility 1	GO:0040007	growth	5.819356108105467e-11	1.2834589896426607e-6	15	936	36
OMIM:137800	Glioma Susceptibility 1	GO:0007507	heart development	6.526945650620064e-11	1.4395178632442551e-6	12	487	36
OMIM:137800	Glioma Susceptibility 1	GO:0001701	in utero embryonic development	2.5570190409496263e-10	5.639505494814401e-6	10	312	36
OMIM:137800	Glioma Susceptibility 1	GO:0009725	response to hormone	2.773621332607945e-10	6.117221849066823e-6	14	865	36
OMIM:137800	Glioma Susceptibility 1	GO:0060411	cardiac septum morphogenesis	4.3670345117874376e-10	9.631494615747194e-6	6	49	36
OMIM:137800	Glioma Susceptibility 1	GO:0060485	mesenchyme development	5.150642135021144e-10	1.1359741228789133e-5	9	237	36
OMIM:137800	Glioma Susceptibility 1	GO:0045165	cell fate commitment	6.420635134674058e-10	1.4160710789523634e-5	9	243	36
OMIM:137800	Glioma Susceptibility 1	GO:0040008	regulation of growth	9.265976874672788e-10	2.0436111997090833e-5	12	617	36
OMIM:137800	Glioma Susceptibility 1	GO:1901215	negative regulation of neuron death	9.746025098067435e-10	2.1494858353787727e-5	8	170	36
OMIM:137800	Glioma Susceptibility 1	GO:0043066	negative regulation of apoptotic process	1.2842162888659914e-9	2.832339025093944e-5	13	795	36
OMIM:137800	Glioma Susceptibility 1	GO:0003184	pulmonary valve morphogenesis	1.456218146067556e-9	3.211689121151995e-5	4	9	36
OMIM:137800	Glioma Susceptibility 1	GO:0048762	mesenchymal cell differentiation	1.824338125011593e-9	4.0235777347130686e-5	8	184	36
OMIM:137800	Glioma Susceptibility 1	GO:0032870	cellular response to hormone stimulus	2.2108417319088858e-9	4.8760114397250476e-5	11	519	36
OMIM:137800	Glioma Susceptibility 1	GO:0061314	Notch signaling involved in heart development	2.423698797215934e-9	5.3454676972597426e-5	4	10	36
OMIM:137800	Glioma Susceptibility 1	GO:0030097	hemopoiesis	3.5497570438636217e-9	7.828989160241218e-5	12	695	36
OMIM:137800	Glioma Susceptibility 1	GO:0001934	positive regulation of protein phosphorylation	3.810347259936009e-9	8.403720881788868e-5	13	870	36
Orphanet:95503	Pituitary hormone deficiency from tumoral origin	GO:0050678	regulation of epithelial cell proliferation	2.0290209512552337e-9	4.475005707993418e-5	9	277	36
Orphanet:95503	Pituitary hormone deficiency from tumoral origin	GO:0009725	response to hormone	3.5515349550152564e-9	7.832910343286148e-5	13	865	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0071897	DNA biosynthetic process	4.89386309254769e-13	1.079341505061393e-8	11	167	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0000781	chromosome, telomeric region	2.4491519923230953e-13	5.401604719068587e-9	11	162	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0000784	nuclear chromosome, telomeric region	9.658940314238862e-15	2.130279286305381e-10	10	132	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0032204	regulation of telomere maintenance	3.519406988061746e-14	7.762052112170181e-10	10	66	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0051053	negative regulation of DNA metabolic process	4.154454558147336e-13	9.162649527993949e-9	9	108	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0016233	telomere capping	3.767097744855619e-12	8.308334076279067e-8	7	48	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0032205	negative regulation of telomere maintenance	4.2404968425557854e-12	9.352415786256785e-8	6	24	36
Orphanet:331217	Syndrome with combined immunodeficiency	GO:0006275	regulation of DNA replication	1.2780443370274952e-11	2.8187267853141407e-7	9	157	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0045333	cellular respiration	6.388223283693151e-13	1.4089226452185244e-8	11	173	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0009119	ribonucleoside metabolic process	3.532729664357248e-13	7.79143527473991e-9	13	372	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0022900	electron transport chain	1.0058620603103918e-13	2.218428774014569e-9	11	107	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0006119	oxidative phosphorylation	9.547918011776346e-15	2.1057933174972732e-10	11	110	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0022904	respiratory electron transport chain	3.2529534621517087e-14	7.174388860775593e-10	11	105	36
Orphanet:254776	Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA	GO:0098798	mitochondrial protein complex	1.2856382625159313e-13	2.8354751879788864e-9	10	144	36
DOID:1342	congenital hypoplastic anemia	GO:0034470	ncRNA processing	5.200284647344233e-13	1.1469227789717706e-8	14	384	36
DOID:1342	congenital hypoplastic anemia	GO:0022626	cytosolic ribosome	1.0058620603103918e-13	2.218428774014569e-9	13	107	36
DOID:1342	congenital hypoplastic anemia	GO:0016072	rRNA metabolic process	8.125722317231521e-13	1.792128057065412e-8	14	254	36
OMIM:614286	myelodysplastic syndrome	GO:0055072	iron ion homeostasis	3.961975414412677e-9	8.73813677648716e-5	6	68	37
Orphanet:217587	Mitochondrial disease with hypertrophic cardiomyopathy	GO:0045333	cellular respiration	6.834532939592464e-13	1.507356239827118e-8	13	173	37
Orphanet:217587	Mitochondrial disease with hypertrophic cardiomyopathy	GO:0009119	ribonucleoside metabolic process	4.3520742565306136e-13	9.598499772778268e-9	14	372	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0001944	vasculature development	1.173394714726328e-12	2.5879220433289163e-8	17	588	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0001568	blood vessel development	2.068456517179129e-12	4.5619808486385693e-8	16	569	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0001525	angiogenesis	1.4849010909756544e-11	3.2749493561468057e-7	12	413	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0061298	retina vasculature development in camera-type eye	9.917211496457412e-11	2.1872409955436822e-6	5	16	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0048729	tissue morphogenesis	1.2406298210976274e-10	2.7362090704308173e-6	13	635	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0051241	negative regulation of multicellular organismal process	1.7896099047121083e-9	3.946984644842555e-5	14	966	37
Orphanet:71281	Rare central nervous system and retinal vascular disease	GO:0022603	regulation of anatomical structure morphogenesis	2.3370559931734647e-9	5.1543769929440764e-5	14	986	37
MESH:D017093	Liver Failure	GO:0033993	response to lipid	3.3552827183314093e-10	7.400076035279923e-6	14	850	37
MESH:D017093	Liver Failure	GO:0032496	response to lipopolysaccharide	4.271214493201114e-10	9.420163564755057e-6	10	319	37
MESH:D004890	Erythema	GO:0030163	protein catabolic process	1.7561063714310876e-11	3.8730926021912637e-7	15	808	37
MESH:D004890	Erythema	GO:0031347	regulation of defense response	9.241426512929252e-10	2.0381966174265465e-5	13	749	37
MESH:D006949	Hyperlipidemias	GO:0015850	organic hydroxy compound transport	2.5002222514558525e-13	5.514240175585883e-9	13	230	37
MESH:D006949	Hyperlipidemias	GO:0015248	sterol transporter activity	4.0190073491430667e-14	8.863920708535034e-10	8	17	37
MESH:D006949	Hyperlipidemias	GO:0034368	protein-lipid complex remodeling	3.8191672047105385e-14	8.423173269989093e-10	7	23	37
MESH:D006949	Hyperlipidemias	GO:0034369	plasma lipoprotein particle remodeling	3.8191672047105385e-14	8.423173269989093e-10	7	23	37
MESH:D006949	Hyperlipidemias	GO:0032368	regulation of lipid transport	1.2212453270876722e-14	2.693456568891861e-10	11	91	37
MESH:D006949	Hyperlipidemias	GO:0031667	response to nutrient levels	3.3605962457272653e-10	7.411795019951484e-6	12	546	37
MESH:D006949	Hyperlipidemias	GO:0007584	response to nutrient	3.956661331905309e-9	8.726416567517159e-5	8	197	37
MESH:D006949	Hyperlipidemias	GO:0032372	negative regulation of sterol transport	4.263171704543822e-9	9.4024251943714e-5	4	11	37
MESH:D006949	Hyperlipidemias	GO:0032375	negative regulation of cholesterol transport	4.263171704543822e-9	9.4024251943714e-5	4	11	37
Orphanet:182083	Channelopathy with epilepsy	GO:0022834	ligand-gated channel activity	5.338322006664953e-10	1.1773669185699553e-5	8	153	37
Orphanet:182083	Channelopathy with epilepsy	GO:0015276	ligand-gated ion channel activity	5.338322006664953e-10	1.1773669185699553e-5	8	153	37
Orphanet:182083	Channelopathy with epilepsy	GO:0045202	synapse	1.0165790431670985e-9	2.2420650797050357e-5	13	755	37
Orphanet:182083	Channelopathy with epilepsy	GO:0044708	single-organism behavior	4.164642852799716e-9	9.185119811849773e-5	10	404	37
Orphanet:206638	Acquired skeletal muscle disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.2843338332023677e-10	5.038098269127822e-6	15	996	37
Orphanet:206638	Acquired skeletal muscle disease	GO:0009611	response to wounding	5.000987401970747e-10	1.1029677715046482e-5	14	875	37
OMIM:603596	polydactyly	GO:0048736	appendage development	1.5332179970073412e-13	3.381512292399691e-9	10	168	37
OMIM:603596	polydactyly	GO:0060173	limb development	1.5332179970073412e-13	3.381512292399691e-9	10	168	37
OMIM:603596	polydactyly	GO:0035107	appendage morphogenesis	9.13502606891825e-12	2.0147299994999202e-7	9	146	37
OMIM:603596	polydactyly	GO:0035108	limb morphogenesis	9.13502606891825e-12	2.0147299994999202e-7	9	146	37
OMIM:603596	polydactyly	GO:0009953	dorsal/ventral pattern formation	1.5917378526353332e-11	3.5105778339872273e-7	8	99	37
OMIM:603596	polydactyly	GO:0005813	centrosome	8.225387038152121e-11	1.8141091112644503e-6	12	482	37
OMIM:603596	polydactyly	GO:0035113	embryonic appendage morphogenesis	1.0551504114886257e-10	2.327134232538164e-6	8	125	37
OMIM:603596	polydactyly	GO:0030326	embryonic limb morphogenesis	1.0551504114886257e-10	2.327134232538164e-6	8	125	37
OMIM:603596	polydactyly	GO:0021904	dorsal/ventral neural tube patterning	7.563530912690908e-10	1.6681367427939797e-5	5	23	37
OMIM:603596	polydactyly	GO:0061525	hindgut development	9.081568830282549e-10	2.0029400055188162e-5	4	8	37
OMIM:603596	polydactyly	GO:0042733	embryonic digit morphogenesis	1.8328407680456849e-9	4.042330313924758e-5	6	60	37
Orphanet:306636	Rare tumor of liver and intrahepatic biliary tract	GO:0001934	positive regulation of protein phosphorylation	4.6379444729183206e-10	1.0228986535021356e-5	14	870	37
Orphanet:306636	Rare tumor of liver and intrahepatic biliary tract	GO:0008285	negative regulation of cell proliferation	1.8056894868223594e-9	3.982448163186714e-5	12	634	37
Orphanet:306636	Rare tumor of liver and intrahepatic biliary tract	GO:0030163	protein catabolic process	2.310648783421243e-9	5.0961358918355515e-5	13	808	37
Orphanet:98668	Vitreoretinopathy	GO:0009100	glycoprotein metabolic process	2.41140440948584e-13	5.31835242512102e-9	16	380	37
Orphanet:98668	Vitreoretinopathy	GO:0006493	protein O-linked glycosylation	1.6209256159527285e-14	3.574951445983743e-10	13	99	37
Orphanet:93444	Primary bone dysplasia with increased bone density	GO:0046849	bone remodeling	1.5331069747048787e-12	3.38126743271161e-8	8	74	37
Orphanet:93444	Primary bone dysplasia with increased bone density	GO:0001503	ossification	4.0112357879706906e-12	8.846780530369358e-8	12	363	37
Orphanet:93444	Primary bone dysplasia with increased bone density	GO:0042476	odontogenesis	5.034983541207794e-11	1.110465620013379e-6	8	114	37
Orphanet:93444	Primary bone dysplasia with increased bone density	GO:0001501	skeletal system development	8.225387038152121e-11	1.8141091112644503e-6	12	482	37
Orphanet:93444	Primary bone dysplasia with increased bone density	GO:0034103	regulation of tissue remodeling	2.029944212722512e-9	4.4770419611595e-5	6	61	37
Orphanet:181422	Rare hyperlipidemia	GO:0006066	alcohol metabolic process	9.381384558082573e-13	2.0690643642851114e-8	15	382	37
Orphanet:181422	Rare hyperlipidemia	GO:0010876	lipid localization	5.526690216584029e-13	1.2189115272676077e-8	15	333	37
Orphanet:181422	Rare hyperlipidemia	GO:0015850	organic hydroxy compound transport	2.3736568266485847e-13	5.2351001311734535e-9	12	230	37
Orphanet:181422	Rare hyperlipidemia	GO:0016125	sterol metabolic process	1.7852386235972517e-13	3.937343784343739e-9	15	132	37
Orphanet:181422	Rare hyperlipidemia	GO:0034368	protein-lipid complex remodeling	5.395683899678261e-14	1.1900180840740404e-9	8	23	37
Orphanet:181422	Rare hyperlipidemia	GO:0034369	plasma lipoprotein particle remodeling	5.395683899678261e-14	1.1900180840740404e-9	8	23	37
Orphanet:181422	Rare hyperlipidemia	GO:0006638	neutral lipid metabolic process	4.241051954068098e-14	9.35364008469719e-10	10	111	37
Orphanet:181422	Rare hyperlipidemia	GO:0006639	acylglycerol metabolic process	1.7763568394002505e-14	3.9177550092972524e-10	10	110	37
Orphanet:181422	Rare hyperlipidemia	GO:0046503	glycerolipid catabolic process	1.071365218763276e-13	2.3628959899824054e-9	8	48	37
Orphanet:181422	Rare hyperlipidemia	GO:0046464	acylglycerol catabolic process	2.772226892489016e-13	6.1141464113845245e-9	7	33	37
Orphanet:181422	Rare hyperlipidemia	GO:0034361	very-low-density lipoprotein particle	1.0439427100550347e-12	2.302415647026379e-8	6	19	37
Orphanet:181422	Rare hyperlipidemia	GO:0034383	low-density lipoprotein particle clearance	1.0439427100550347e-12	2.302415647026379e-8	6	19	37
Orphanet:181422	Rare hyperlipidemia	GO:0034377	plasma lipoprotein particle assembly	1.0439427100550347e-12	2.302415647026379e-8	6	19	37
Orphanet:181422	Rare hyperlipidemia	GO:0071814	protein-lipid complex binding	5.0847104304807544e-12	1.1214328854425304e-7	6	24	37
Orphanet:181422	Rare hyperlipidemia	GO:0071813	lipoprotein particle binding	5.0847104304807544e-12	1.1214328854425304e-7	6	24	37
Orphanet:181422	Rare hyperlipidemia	GO:0034374	low-density lipoprotein particle remodeling	1.057243181890044e-11	2.3317498376584922e-7	5	11	37
Orphanet:181422	Rare hyperlipidemia	GO:0019433	triglyceride catabolic process	1.4395373781894705e-11	3.174899687596877e-7	6	28	37
Orphanet:181422	Rare hyperlipidemia	GO:0015914	phospholipid transport	1.606248467567184e-11	3.5425809952194243e-7	7	57	37
Orphanet:181422	Rare hyperlipidemia	GO:0033700	phospholipid efflux	2.9381053145982605e-11	6.479991271346464e-7	5	13	37
Orphanet:181422	Rare hyperlipidemia	GO:0015485	cholesterol binding	7.381717459509218e-11	1.628037785694758e-6	6	36	37
Orphanet:181422	Rare hyperlipidemia	GO:0050750	low-density lipoprotein particle receptor binding	1.40260469905229e-10	3.0934446637598256e-6	5	17	37
Orphanet:181422	Rare hyperlipidemia	GO:0009743	response to carbohydrate	2.405661225779454e-10	5.305685833456586e-6	9	211	37
Orphanet:181422	Rare hyperlipidemia	GO:0033993	response to lipid	3.3552827183314093e-10	7.400076035279923e-6	14	850	37
Orphanet:181422	Rare hyperlipidemia	GO:0071830	triglyceride-rich lipoprotein particle clearance	4.547195953108485e-10	1.0028840674580763e-5	4	7	37
Orphanet:181422	Rare hyperlipidemia	GO:0034382	chylomicron remnant clearance	4.547195953108485e-10	1.0028840674580763e-5	4	7	37
Orphanet:181422	Rare hyperlipidemia	GO:0044241	lipid digestion	9.53993772867534e-10	2.1040332660593464e-5	5	24	37
Orphanet:181422	Rare hyperlipidemia	GO:0005543	phospholipid binding	1.0480833978476767e-9	2.311547933953051e-5	10	350	37
Orphanet:181422	Rare hyperlipidemia	GO:0006898	receptor-mediated endocytosis	1.2367922241907081e-9	2.7277452504526067e-5	9	254	37
Orphanet:181422	Rare hyperlipidemia	GO:0008610	lipid biosynthetic process	1.5926110430442009e-9	3.512503655433985e-5	12	627	37
Orphanet:181422	Rare hyperlipidemia	GO:0034380	high-density lipoprotein particle assembly	1.6323713492027991e-9	3.6001950106667735e-5	4	9	37
Orphanet:181422	Rare hyperlipidemia	GO:0044283	small molecule biosynthetic process	3.8144031266895695e-9	8.412666095913846e-5	11	530	37
Orphanet:181422	Rare hyperlipidemia	GO:0046470	phosphatidylcholine metabolic process	3.961975414412677e-9	8.73813677648716e-5	6	68	37
Orphanet:181422	Rare hyperlipidemia	GO:0045834	positive regulation of lipid metabolic process	4.192339808639645e-9	9.246205447954736e-5	7	124	37
DOID:3856	male reproductive organ cancer	GO:0051052	regulation of DNA metabolic process	2.9459656936126066e-11	6.497327337262604e-7	11	335	37
DOID:3856	male reproductive organ cancer	GO:0048608	reproductive structure development	3.1581759429855083e-10	6.9653570422545386e-6	11	418	37
DOID:3856	male reproductive organ cancer	GO:0007548	sex differentiation	2.4064520376398946e-9	5.3074299690147875e-5	9	274	37
OMIM:222100	IDDM	GO:0009607	response to biotic stimulus	9.962253244566455e-12	2.1971749530891316e-7	16	934	38
OMIM:222100	IDDM	GO:0007159	leukocyte cell-cell adhesion	7.081890629478949e-11	1.561910978331582e-6	12	461	38
OMIM:222100	IDDM	GO:0051707	response to other organism	8.644140958580238e-11	1.9064652884148714e-6	15	898	38
OMIM:222100	IDDM	GO:0022407	regulation of cell-cell adhesion	1.399459437223527e-10	3.0865077887964887e-6	11	376	38
OMIM:222100	IDDM	GO:0050708	regulation of protein secretion	1.5767620542561644e-10	3.4775487106619707e-6	11	380	38
OMIM:222100	IDDM	GO:0050863	regulation of T cell activation	1.842223040782187e-10	4.063022916445114e-6	10	284	38
OMIM:222100	IDDM	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.8591573553171656e-10	6.305871547152009e-6	9	209	38
OMIM:222100	IDDM	GO:0072593	reactive oxygen species metabolic process	5.077979148282452e-10	1.1199483011536948e-5	9	223	38
OMIM:222100	IDDM	GO:0050709	negative regulation of protein secretion	1.5886457704894497e-9	3.503758246814481e-5	7	105	38
OMIM:222100	IDDM	GO:0042089	cytokine biosynthetic process	1.5886457704894497e-9	3.503758246814481e-5	7	105	38
OMIM:222100	IDDM	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.350059258304782e-9	5.1830556941911965e-5	7	111	38
OMIM:222100	IDDM	GO:0006954	inflammatory response	2.695691558862734e-9	5.94534773307176e-5	12	637	38
OMIM:222100	IDDM	GO:0009617	response to bacterium	4.042951862182065e-9	8.916730332042544e-5	11	517	38
DOID:93	language disorder	GO:0044708	single-organism behavior	4.072298054325074e-13	8.981453358813951e-9	14	404	38
DOID:93	language disorder	GO:0050890	cognition	3.244848834071945e-12	7.156514103545675e-8	11	251	38
DOID:93	language disorder	GO:0031223	auditory behavior	6.651013073621925e-12	1.4668809333873156e-7	5	10	38
DOID:93	language disorder	GO:0007611	learning or memory	1.3186562952682834e-11	2.908296459214199e-7	10	218	38
DOID:93	language disorder	GO:0021537	telencephalon development	1.9299006837059096e-11	4.2563959579133837e-7	10	226	38
DOID:93	language disorder	GO:0031175	neuron projection development	2.2579493830221509e-10	4.979907364255354e-6	14	796	38
DOID:93	language disorder	GO:0030534	adult behavior	2.4685309352179274e-10	5.444344977623139e-6	8	135	38
DOID:93	language disorder	GO:0021543	pallium development	6.71638189508883e-10	1.4812980269618414e-5	8	153	38
DOID:93	language disorder	GO:0060998	regulation of dendritic spine development	1.416457395819748e-9	3.123996786480454e-5	6	56	38
DOID:93	language disorder	GO:0048667	cell morphogenesis involved in neuron differentiation	2.5693592808906374e-9	5.666721894004301e-5	11	495	38
Orphanet:271835	Genetic digestive tract tumor	GO:0046649	lymphocyte activation	1.2237442170714985e-9	2.69896787075119e-5	12	594	38
Orphanet:271835	Genetic digestive tract tumor	GO:0002520	immune system development	2.2737999261224218e-9	5.014865737063001e-5	13	782	38
DOID:2115	B cell deficiency	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.7347902548390266e-13	8.237079907047473e-9	11	209	38
DOID:2115	B cell deficiency	GO:0050778	positive regulation of immune response	1.6621148901663219e-12	3.665794390261823e-8	15	603	38
DOID:2115	B cell deficiency	GO:0019724	B cell mediated immunity	2.1912804903934102e-11	4.832869121562666e-7	8	100	38
DOID:2115	B cell deficiency	GO:0002768	immune response-regulating cell surface receptor signaling pathway	2.8027802301267002e-11	6.181531797544437e-7	11	323	38
DOID:2115	B cell deficiency	GO:0016064	immunoglobulin mediated immune response	9.07269481764672e-10	2.0009828420319842e-5	7	97	38
DOID:2115	B cell deficiency	GO:0030888	regulation of B cell proliferation	1.0059211241753019e-9	2.2185590393686283e-5	6	53	38
Orphanet:108969	Syndromic intestinal malformation	GO:0035295	tube development	2.4392710074039314e-12	5.379812206829371e-8	14	573	38
Orphanet:108969	Syndromic intestinal malformation	GO:0035239	tube morphogenesis	4.527167529744247e-11	9.984667986850937e-7	11	338	38
Orphanet:108969	Syndromic intestinal malformation	GO:0060563	neuroepithelial cell differentiation	1.3146850275091992e-10	2.899537828171539e-6	7	74	38
Orphanet:108969	Syndromic intestinal malformation	GO:0048729	tissue morphogenesis	1.8135104529193313e-10	3.999697303913585e-6	13	635	38
Orphanet:108969	Syndromic intestinal malformation	GO:0002009	morphogenesis of an epithelium	2.0186108340425335e-10	4.452046194480808e-6	12	506	38
Orphanet:108969	Syndromic intestinal malformation	GO:0055123	digestive system development	5.7362525840432e-10	1.2651305074107277e-5	8	150	38
Orphanet:108969	Syndromic intestinal malformation	GO:0007389	pattern specification process	6.189417867119573e-10	1.3650761105932219e-5	11	432	38
Orphanet:108969	Syndromic intestinal malformation	GO:0007423	sensory organ development	2.5158953809167883e-9	5.5488072626119767e-5	11	494	38
DOID:10316	pneumoconiosis	GO:0045073	regulation of chemokine biosynthetic process	2.08314476779492e-11	4.594375785371696e-7	5	12	38
DOID:10316	pneumoconiosis	GO:0071216	cellular response to biotic stimulus	5.784284162757558e-11	1.2757238720961794e-6	9	175	38
DOID:10316	pneumoconiosis	GO:0050670	regulation of lymphocyte proliferation	1.1583256576130907e-10	2.5546872378656715e-6	9	189	38
DOID:10316	pneumoconiosis	GO:0001819	positive regulation of cytokine production	1.6185186524353412e-10	3.569642887946145e-6	11	381	38
DOID:10316	pneumoconiosis	GO:0002637	regulation of immunoglobulin production	4.147910903640195e-10	9.14821749797845e-6	6	46	38
DOID:10316	pneumoconiosis	GO:0050864	regulation of B cell activation	1.1255658627362664e-9	2.4824355102648354e-5	7	100	38
DOID:10316	pneumoconiosis	GO:0051251	positive regulation of lymphocyte activation	1.7764791859775642e-9	3.918024844673518e-5	9	257	38
DOID:10316	pneumoconiosis	GO:0045080	positive regulation of chemokine biosynthetic process	1.8240355892373827e-9	4.0229104920630476e-5	4	9	38
DOID:10316	pneumoconiosis	GO:0034097	response to cytokine	2.343580551844582e-9	5.168766907093225e-5	13	784	38
DOID:10316	pneumoconiosis	GO:0006809	nitric oxide biosynthetic process	2.6583558687676145e-9	5.863003868566974e-5	6	62	38
DOID:10316	pneumoconiosis	GO:0002443	leukocyte mediated immunity	3.6442115991519586e-9	8.037308681929645e-5	9	279	38
DOID:10316	pneumoconiosis	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.283785104419735e-9	9.447888047797726e-5	6	67	38
DOID:5074	malignant ependymoma	GO:0009887	organ morphogenesis	1.8263723866596138e-10	4.028064298777778e-6	15	950	38
DOID:5074	malignant ependymoma	GO:0048545	response to steroid hormone	8.614107205318078e-10	1.899841344132902e-5	11	446	38
DOID:5074	malignant ependymoma	GO:0008284	positive regulation of cell proliferation	3.73964603728183e-9	8.247789335225075e-5	13	815	38
DOID:5074	malignant ependymoma	GO:0050767	regulation of neurogenesis	3.882439036928531e-9	8.562719295945875e-5	12	658	38
DOID:5074	malignant ependymoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	4.013508525524401e-9	8.851793053044066e-5	14	996	38
MESH:D018241	Neuroectodermal Tumors, Primitive, Peripheral	GO:0043069	negative regulation of programmed cell death	3.271865334220081e-9	7.216098994622389e-5	13	806	38
Orphanet:98555	Anophthalmia - microphthalmia	GO:0060322	head development	6.799428797776841e-10	1.4996140213496822e-5	13	708	38
Orphanet:98555	Anophthalmia - microphthalmia	GO:0007417	central nervous system development	9.271461376414436e-10	2.044820806568204e-5	14	889	38
Orphanet:98555	Anophthalmia - microphthalmia	GO:0048593	camera-type eye morphogenesis	1.1255658627362664e-9	2.4824355102648354e-5	7	100	38
Orphanet:98555	Anophthalmia - microphthalmia	GO:0009790	embryo development	1.7022476761496819e-9	3.7543072497481234e-5	14	932	38
DOID:9973	substance dependence	GO:0005230	extracellular ligand-gated ion channel activity	1.8911539001464917e-12	4.1709399267730873e-8	8	74	38
DOID:9973	substance dependence	GO:0030594	neurotransmitter receptor activity	5.334621633323877e-12	1.1765508012295811e-7	8	84	38
DOID:9973	substance dependence	GO:0098794	postsynapse	6.71829258891421e-12	1.481719430485029e-7	12	381	38
DOID:9973	substance dependence	GO:0005231	excitatory extracellular ligand-gated ion channel activity	1.7372658867031987e-11	3.831539913123905e-7	7	56	38
DOID:9973	substance dependence	GO:0098590	plasma membrane region	1.277470351723764e-10	2.8174608607267615e-6	15	926	38
DOID:9973	substance dependence	GO:0043005	neuron projection	1.6165069283147204e-10	3.565206030398116e-6	15	941	38
DOID:9973	substance dependence	GO:0045211	postsynaptic membrane	2.5130530989514455e-10	5.542538609737413e-6	9	206	38
DOID:9973	substance dependence	GO:0034220	ion transmembrane transport	2.56337573389942e-9	5.653525181115171e-5	14	962	38
DOID:9973	substance dependence	GO:0098655	cation transmembrane transport	2.945171218016185e-9	6.495575121334696e-5	12	642	38
DOID:9973	substance dependence	GO:0050804	modulation of synaptic transmission	4.387605168076902e-9	9.676863198193608e-5	9	285	38
DOID:12849	autistic disorder	GO:0051703	intraspecies interaction between organisms	4.147910903640195e-10	9.14821749797845e-6	6	46	38
DOID:12849	autistic disorder	GO:0035176	social behavior	4.147910903640195e-10	9.14821749797845e-6	6	46	38
DOID:12849	autistic disorder	GO:0097105	presynaptic membrane assembly	1.0148175633162282e-9	2.2381801358939413e-5	4	8	38
DOID:1089	tethered spinal cord syndrome	GO:0048562	embryonic organ morphogenesis	1.6055512475077194e-10	3.541043276378275e-6	10	280	38
DOID:0050570	congenital disorder of glycosylation type I	GO:0005789	endoplasmic reticulum membrane	8.770317805328887e-12	1.934293591965286e-7	22	977	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0016758	transferase activity, transferring hexosyl groups	3.6504133049675147e-13	8.050986544105854e-9	17	202	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0009100	glycoprotein metabolic process	1.745270594710746e-13	3.8491942966345505e-9	22	380	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0009101	glycoprotein biosynthetic process	1.4366285938649526e-13	3.168484363769153e-9	21	336	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0000030	mannosyltransferase activity	8.79296635503124e-14	1.93928872960214e-9	10	24	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0006487	protein N-linked glycosylation	6.417089082333405e-14	1.4152889971086324e-9	14	74	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0006488	dolichol-linked oligosaccharide biosynthetic process	4.3520742565306136e-14	9.598499772778268e-10	12	20	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0097502	mannosylation	1.5543122344752192e-15	3.428035633135096e-11	10	33	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0018279	protein N-linked glycosylation via asparagine	1.2729817200352045e-12	2.8075611835376435e-8	7	38	39
DOID:0050570	congenital disorder of glycosylation type I	GO:0019348	dolichol metabolic process	2.430055046076518e-10	5.3594864041217605e-6	4	6	39
DOID:890	mitochondrial encephalomyopathy	GO:0045333	cellular respiration	9.585665594613602e-13	2.1141185468920298e-8	12	173	39
DOID:890	mitochondrial encephalomyopathy	GO:0022900	electron transport chain	7.993605777301127e-14	1.7629897541837636e-9	11	107	39
DOID:890	mitochondrial encephalomyopathy	GO:0098798	mitochondrial protein complex	4.143352327901084e-13	9.138163559185841e-9	10	144	39
DOID:890	mitochondrial encephalomyopathy	GO:0031966	mitochondrial membrane	1.2841949725839186e-12	2.8322920120338324e-8	16	656	39
DOID:890	mitochondrial encephalomyopathy	GO:0044455	mitochondrial membrane part	1.7352785874891197e-12	3.8271569247072534e-8	10	179	39
DOID:890	mitochondrial encephalomyopathy	GO:0098800	inner mitochondrial membrane protein complex	1.7535972673954348e-12	3.8675587732406314e-8	9	114	39
DOID:890	mitochondrial encephalomyopathy	GO:0005746	mitochondrial respiratory chain	4.012901122507628e-12	8.850453425690574e-8	8	79	39
DOID:890	mitochondrial encephalomyopathy	GO:0007005	mitochondrion organization	8.411382701467573e-12	1.8551304548086733e-7	15	723	39
DOID:890	mitochondrial encephalomyopathy	GO:1990204	oxidoreductase complex	2.7444824191036332e-11	6.052955975333063e-7	8	100	39
DOID:890	mitochondrial encephalomyopathy	GO:0010257	NADH dehydrogenase complex assembly	3.939726322954584e-11	8.689066405276336e-7	7	61	39
DOID:890	mitochondrial encephalomyopathy	GO:0097031	mitochondrial respiratory chain complex I biogenesis	3.939726322954584e-11	8.689066405276336e-7	7	61	39
DOID:890	mitochondrial encephalomyopathy	GO:0032981	mitochondrial respiratory chain complex I assembly	3.939726322954584e-11	8.689066405276336e-7	7	61	39
DOID:890	mitochondrial encephalomyopathy	GO:0016491	oxidoreductase activity	7.506295585102407e-11	1.6555134912943359e-6	14	710	39
DOID:890	mitochondrial encephalomyopathy	GO:0008137	NADH dehydrogenase (ubiquinone) activity	4.261310193598433e-10	9.398319631981344e-6	6	45	39
DOID:890	mitochondrial encephalomyopathy	GO:0045271	respiratory chain complex I	6.389991868971379e-10	1.4093127067016376e-5	6	48	39
DOID:890	mitochondrial encephalomyopathy	GO:0005747	mitochondrial respiratory chain complex I	6.389991868971379e-10	1.4093127067016376e-5	6	48	39
DOID:890	mitochondrial encephalomyopathy	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	1.1861800430779113e-9	2.6161200850083333e-5	6	53	39
DOID:890	mitochondrial encephalomyopathy	GO:0009055	electron carrier activity	3.655093450127822e-9	8.061308604256912e-5	7	115	39
Orphanet:183634	Rare genetic parathyroid disease and phosphocalcic metabolism disorder	GO:0001503	ossification	1.3357248640488706e-10	2.945941187659784e-6	11	363	39
Orphanet:183634	Rare genetic parathyroid disease and phosphocalcic metabolism disorder	GO:0033280	response to vitamin D	1.4603207532104534e-10	3.220737421205655e-6	6	38	39
DOID:53	pituitary gland disease	GO:0040014	regulation of multicellular organism growth	6.262301788240165e-11	1.3811506593963685e-6	7	65	39
DOID:53	pituitary gland disease	GO:0021536	diencephalon development	2.1213919509932566e-10	4.6787299479156275e-6	7	77	39
DOID:53	pituitary gland disease	GO:0005179	hormone activity	4.124870556232452e-9	9.097402011770672e-5	7	117	39
DOID:2975	cystic kidney disease	GO:0031513	nonmotile primary cilium	1.4099832412739488e-13	3.109718038629694e-9	15	134	39
DOID:2975	cystic kidney disease	GO:0060170	ciliary membrane	2.55305443452869e-10	5.6307615553530255e-6	7	79	39
DOID:2975	cystic kidney disease	GO:0048729	tissue morphogenesis	2.621102224154015e-10	5.78084095537168e-6	13	635	39
DOID:2975	cystic kidney disease	GO:0001822	kidney development	2.7008952852014545e-9	5.956824551511808e-5	9	262	39
Orphanet:165707	Syndromic urogenital tract malformation	GO:0021772	olfactory bulb development	5.89949200602291e-11	1.301132961928353e-6	6	33	39
Orphanet:165707	Syndromic urogenital tract malformation	GO:0048589	developmental growth	8.490019798301773e-10	1.872473866515456e-5	12	558	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0009790	embryo development	1.7834622667578515e-12	3.9334260293344414e-8	19	932	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048736	appendage development	6.317169010117141e-13	1.3932516251813354e-8	16	168	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060173	limb development	6.317169010117141e-13	1.3932516251813354e-8	16	168	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0042733	embryonic digit morphogenesis	1.0902390101819037e-13	2.4045221369561887e-9	12	60	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0008589	regulation of smoothened signaling pathway	6.368239269249898e-13	1.404515170833065e-8	8	62	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0001655	urogenital system development	1.776689906307638e-12	3.9184895883614956e-8	12	313	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048729	tissue morphogenesis	3.54516416223305e-12	7.818859559804991e-8	15	635	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0035295	tube development	3.959499395023158e-12	8.732675915723576e-8	14	573	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0007389	pattern specification process	3.983813279262449e-12	8.786300187413332e-8	14	432	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0002009	morphogenesis of an epithelium	5.018541138213095e-12	1.1068392480328981e-7	15	506	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0043583	ear development	5.373701483790683e-12	1.1851698622500351e-7	10	196	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0001822	kidney development	6.460387780293786e-12	1.4248385249437945e-7	11	262	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048568	embryonic organ development	2.41158204516978e-11	5.31874420062195e-7	12	408	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048839	inner ear development	5.766376265370354e-11	1.2717742853274316e-6	9	170	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048566	embryonic digestive tract development	5.89949200602291e-11	1.301132961928353e-6	6	33	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0035239	tube morphogenesis	6.19665430079408e-11	1.3666721060401343e-6	11	338	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0007368	determination of left/right symmetry	6.896971882497382e-11	1.5211271486847977e-6	8	112	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060322	head development	7.200484652969408e-11	1.5880668902124029e-6	14	708	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0048562	embryonic organ morphogenesis	2.128854870164787e-10	4.6951894161484375e-6	10	280	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060541	respiratory system development	2.715255797980376e-10	5.988496662445719e-6	9	202	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060562	epithelial tube morphogenesis	4.3052483800209984e-10	9.495225302136312e-6	10	301	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0030111	regulation of Wnt signaling pathway	5.047698925508826e-10	1.1132699980209715e-5	10	306	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0007442	hindgut morphogenesis	5.661457969097228e-10	1.2486345550843936e-5	4	7	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0021915	neural tube development	7.556012482368146e-10	1.6664785529862947e-5	8	151	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0003002	regionalization	9.591892835558724e-10	2.1154919648824766e-5	10	327	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060571	morphogenesis of an epithelial fold	9.974504555643193e-10	2.1998769797471063e-5	5	23	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060828	regulation of canonical Wnt signaling pathway	1.03858099897991e-9	2.2905903932501914e-5	9	235	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0060740	prostate gland epithelium morphogenesis	1.5701845379467727e-9	3.463041998441607e-5	5	25	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0072358	cardiovascular system development	1.8624376485476546e-9	4.107606233871852e-5	14	910	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0001501	skeletal system development	2.6462667612747737e-9	5.836341341991513e-5	11	482	39
Orphanet:294959	Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy	GO:0061138	morphogenesis of a branching epithelium	2.9117052102733965e-9	6.421765841257976e-5	8	179	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0072358	cardiovascular system development	1.1903811270030928e-12	2.6253855756053213e-8	22	910	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0030017	sarcomere	1.0516032489249483e-12	2.3193109655039734e-8	23	180	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0048738	cardiac muscle tissue development	6.317169010117141e-13	1.3932516251813354e-8	18	168	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0003012	muscle system process	5.979661210631093e-13	1.3188142800046876e-8	20	393	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0007517	muscle organ development	4.554134847012392e-13	1.0044144405085831e-8	16	340	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0003007	heart morphogenesis	3.510525203864745e-13	7.742463337123695e-9	12	216	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0008016	regulation of heart contraction	2.0516921495072893e-13	4.5250070357383265e-9	12	224	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0042692	muscle cell differentiation	2.013944566670034e-13	4.44175474179076e-9	13	334	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0030239	myofibril assembly	1.3344880755994382e-13	2.943213450734561e-9	9	53	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0048644	muscle organ morphogenesis	1.1590728377086634e-13	2.556335143566457e-9	10	70	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0006941	striated muscle contraction	9.08162434143378e-14	2.0029522485032203e-9	16	150	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0070252	actin-mediated cell contraction	8.615330671091215e-14	1.9001111795091674e-9	16	95	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0060415	muscle tissue morphogenesis	7.149836278586008e-14	1.576896391242144e-9	10	64	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0030018	Z disc	3.6193270602780103e-14	7.982425831443152e-10	16	109	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0055013	cardiac muscle cell development	4.884981308350689e-15	1.0773826275567444e-10	8	53	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0055008	cardiac muscle tissue morphogenesis	4.785061236134425e-14	1.0553452556294474e-9	10	54	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0008307	structural constituent of muscle	4.785061236134425e-14	1.0553452556294474e-9	8	41	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0033275	actin-myosin filament sliding	9.725553695716371e-14	2.1449708675902457e-9	13	39	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0030049	muscle filament sliding	9.725553695716371e-14	2.1449708675902457e-9	13	39	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0003229	ventricular cardiac muscle tissue development	1.3311574065255627e-13	2.9358676600921285e-9	8	45	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0045214	sarcomere organization	4.014566457044566e-13	8.85412632101179e-9	7	33	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0003779	actin binding	4.106714968088454e-13	9.057359862119085e-9	13	385	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0060048	cardiac muscle contraction	5.559996907322784e-13	1.22625731791004e-8	16	115	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0006937	regulation of muscle contraction	6.138423103152491e-13	1.3538292154002818e-8	10	165	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0055010	ventricular cardiac muscle tissue morphogenesis	1.5356604876615165e-12	3.386899205537475e-8	7	39	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0015629	actin cytoskeleton	5.036970840421873e-12	1.110903918855044e-7	13	441	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0043462	regulation of ATPase activity	3.4882985389117493e-11	7.693442427569863e-7	7	60	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0035994	response to muscle stretch	3.467706122251002e-10	7.648025852624585e-6	5	19	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0002027	regulation of heart rate	5.083461429578051e-10	1.1211574182934392e-5	7	87	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0036379	myofilament	9.974504555643193e-10	2.1998769797471063e-5	5	23	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:1903115	regulation of actin filament-based movement	1.0536319594578458e-9	2.323785286584279e-5	6	52	39
Orphanet:154	Familial isolated dilated cardiomyopathy	GO:0048739	cardiac muscle fiber development	1.1306124925170025e-9	2.493565852246249e-5	4	8	39
Orphanet:68415	Rare parathyroid disease and phosphocalcic metabolism anomaly	GO:0001503	ossification	1.3357248640488706e-10	2.945941187659784e-6	11	363	39
Orphanet:68415	Rare parathyroid disease and phosphocalcic metabolism anomaly	GO:0033280	response to vitamin D	1.4603207532104534e-10	3.220737421205655e-6	6	38	39
Orphanet:217595	Syndrome associated with hypertrophic cardiomyopathy	GO:0035270	endocrine system development	6.00997029920336e-12	1.325498949489301e-7	9	129	40
Orphanet:217595	Syndrome associated with hypertrophic cardiomyopathy	GO:0048732	gland development	8.665838047150487e-10	1.91125058129904e-5	11	421	40
DOID:12574	posterior uveitis	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	6.65874355654239e-10	1.4685858913954242e-5	7	88	40
DOID:12574	posterior uveitis	GO:0002478	antigen processing and presentation of exogenous peptide antigen	1.278579353503062e-9	2.8199067641510034e-5	8	157	40
DOID:12574	posterior uveitis	GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I	3.67708397064348e-9	8.109808697254195e-5	6	62	40
MESH:D001361	Avitaminosis	GO:0006775	fat-soluble vitamin metabolic process	3.497202527569243e-14	7.713080174553966e-10	9	41	40
MESH:D001361	Avitaminosis	GO:0019842	vitamin binding	1.4632739464559563e-13	3.2272506889086117e-9	11	79	40
MESH:D001361	Avitaminosis	GO:0044283	small molecule biosynthetic process	7.523759393279761e-12	1.6593651341878513e-7	14	530	40
MESH:D001361	Avitaminosis	GO:0009110	vitamin biosynthetic process	1.1390499654595487e-9	2.5121746988210347e-5	5	23	40
MESH:D001361	Avitaminosis	GO:0051183	vitamin transporter activity	1.1390499654595487e-9	2.5121746988210347e-5	5	23	40
DOID:3952	adrenal cortex disease	GO:0032870	cellular response to hormone stimulus	5.195988084238934e-10	1.1459751719788969e-5	12	519	40
DOID:3952	adrenal cortex disease	GO:1901698	response to nitrogen compound	1.5377712436759339e-9	3.391554477927272e-5	14	870	40
DOID:3952	adrenal cortex disease	GO:0001503	ossification	3.4418365935096062e-9	7.590970606985437e-5	10	363	40
MESH:D056784	Leukoencephalopathies	GO:0044438	microbody part	9.384718557825522e-10	2.069799677928419e-5	7	90	41
MESH:D056784	Leukoencephalopathies	GO:0044439	peroxisomal part	9.384718557825522e-10	2.069799677928419e-5	7	90	41
OMIM:119540	CPI	GO:0061138	morphogenesis of a branching epithelium	1.0593748100973244e-12	2.336451143669649e-8	13	179	41
OMIM:119540	CPI	GO:0042327	positive regulation of phosphorylation	9.237055564881302e-13	2.0372326048345712e-8	18	910	41
OMIM:119540	CPI	GO:0051216	cartilage development	8.990586053414518e-13	1.982873754080572e-8	11	180	41
OMIM:119540	CPI	GO:0004713	protein tyrosine kinase activity	8.173461907290402e-13	1.8026570236528983e-8	12	174	41
OMIM:119540	CPI	GO:0048015	phosphatidylinositol-mediated signaling	8.004708007547379e-13	1.7654383510645744e-8	12	193	41
OMIM:119540	CPI	GO:0046488	phosphatidylinositol metabolic process	4.982680934517703e-13	1.0989302801078793e-8	11	195	41
OMIM:119540	CPI	GO:0048705	skeletal system morphogenesis	2.404743071338089e-13	5.3036608438361554e-9	12	204	41
OMIM:119540	CPI	GO:0035239	tube morphogenesis	2.333688797762079e-13	5.146950643464265e-9	13	338	41
OMIM:119540	CPI	GO:0014065	phosphatidylinositol 3-kinase signaling	2.2248869413488137e-13	4.906988149144809e-9	12	154	41
OMIM:119540	CPI	GO:0071774	response to fibroblast growth factor	2.0028423364237824e-13	4.417268772982652e-9	11	134	41
OMIM:119540	CPI	GO:0051781	positive regulation of cell division	2.000621890374532e-13	4.4123715792210305e-9	11	130	41
OMIM:119540	CPI	GO:0009790	embryo development	1.5543122344752192e-13	3.428035633135096e-9	19	932	41
OMIM:119540	CPI	GO:0035265	organ growth	1.247890679678676e-13	2.75222289403132e-9	12	132	41
OMIM:119540	CPI	GO:0046834	lipid phosphorylation	1.241229341530925e-13	2.737531312746455e-9	11	95	41
OMIM:119540	CPI	GO:0035004	phosphatidylinositol 3-kinase activity	8.08242361927114e-14	1.7825785292302498e-9	11	70	41
OMIM:119540	CPI	GO:0044344	cellular response to fibroblast growth factor stimulus	5.46229728115577e-14	1.2047096653589051e-9	11	128	41
OMIM:119540	CPI	GO:0008543	fibroblast growth factor receptor signaling pathway	2.4646951146678475e-14	5.435885075399938e-10	11	105	41
OMIM:119540	CPI	GO:0052813	phosphatidylinositol bisphosphate kinase activity	3.552713678800501e-15	7.835510018594505e-11	11	65	41
OMIM:119540	CPI	GO:0090287	regulation of cellular response to growth factor stimulus	9.325873406851315e-15	2.0568213798810575e-10	12	226	41
OMIM:119540	CPI	GO:0035272	exocrine system development	1.887379141862766e-14	4.1626146973783307e-10	9	50	41
OMIM:119540	CPI	GO:0046854	phosphatidylinositol phosphorylation	2.5757174171303632e-14	5.680744763481016e-10	11	91	41
OMIM:119540	CPI	GO:0007431	salivary gland development	4.0745185003743245e-14	8.986350552575573e-10	8	37	41
OMIM:119540	CPI	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	5.129230373768223e-14	1.1312517589345816e-9	11	62	41
OMIM:119540	CPI	GO:0007435	salivary gland morphogenesis	5.6288307348495437e-14	1.2414386185710669e-9	8	34	41
OMIM:119540	CPI	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	6.794564910705958e-14	1.498541291056199e-9	9	49	41
OMIM:119540	CPI	GO:0052742	phosphatidylinositol kinase activity	6.794564910705958e-14	1.498541291056199e-9	9	49	41
OMIM:119540	CPI	GO:0060541	respiratory system development	9.892087149410145e-14	2.1816998208024074e-9	11	202	41
OMIM:119540	CPI	GO:0016303	1-phosphatidylinositol-3-kinase activity	1.1035616864774056e-13	2.433905299525918e-9	9	43	41
OMIM:119540	CPI	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.376676550535194e-13	3.0362601322053706e-9	12	138	41
OMIM:119540	CPI	GO:0050673	epithelial cell proliferation	2.1393997684526767e-13	4.718446189322378e-9	13	335	41
OMIM:119540	CPI	GO:0000165	MAPK cascade	2.460254222569347e-13	5.4260906878766946e-9	21	843	41
OMIM:119540	CPI	GO:0048562	embryonic organ morphogenesis	4.2799097599299785e-13	9.439340975525568e-9	13	280	41
OMIM:119540	CPI	GO:0018108	peptidyl-tyrosine phosphorylation	7.706058013923212e-13	1.6995710949707643e-8	13	354	41
OMIM:119540	CPI	GO:0043408	regulation of MAPK cascade	8.19455614475828e-13	1.8073093577264387e-8	18	651	41
OMIM:119540	CPI	GO:0035107	appendage morphogenesis	9.009459844833145e-13	1.9870363687779502e-8	10	146	41
OMIM:119540	CPI	GO:0035108	limb morphogenesis	9.009459844833145e-13	1.9870363687779502e-8	10	146	41
OMIM:119540	CPI	GO:0048754	branching morphogenesis of an epithelial tube	9.328093852900565e-13	2.0573110992572197e-8	10	147	41
OMIM:119540	CPI	GO:0001823	mesonephros development	9.479084184249587e-13	2.0906120168362463e-8	9	102	41
OMIM:119540	CPI	GO:0008083	growth factor activity	1.0185186027911186e-12	2.246342778455812e-8	10	159	41
OMIM:119540	CPI	GO:0050678	regulation of epithelial cell proliferation	1.3055112546567216e-12	2.8793050721453994e-8	12	277	41
OMIM:119540	CPI	GO:0005088	Ras guanyl-nucleotide exchange factor activity	1.6929790902509012e-12	3.7338653835483626e-8	11	228	41
OMIM:119540	CPI	GO:0030324	lung development	2.8500535265152394e-12	6.28579305272936e-8	10	175	41
OMIM:119540	CPI	GO:0043410	positive regulation of MAPK cascade	3.092637257395836e-12	6.820811471186516e-8	16	464	41
OMIM:119540	CPI	GO:0007423	sensory organ development	3.1310509740478665e-12	6.90553292326257e-8	16	494	41
OMIM:119540	CPI	GO:0010463	mesenchymal cell proliferation	3.778977131219108e-12	8.334534062903742e-8	7	42	41
OMIM:119540	CPI	GO:0008285	negative regulation of cell proliferation	4.09816625079884e-12	9.038505666136842e-8	15	634	41
OMIM:119540	CPI	GO:0060485	mesenchyme development	4.408362563879109e-12	9.722643634635375e-8	11	237	41
OMIM:119540	CPI	GO:0008284	positive regulation of cell proliferation	5.652811552181447e-12	1.2467275878336181e-7	17	815	41
OMIM:119540	CPI	GO:0055024	regulation of cardiac muscle tissue development	9.93294335671635e-12	2.190710657323791e-7	7	48	41
OMIM:119540	CPI	GO:0043583	ear development	1.0136447237130142e-11	2.2355934381490528e-7	10	196	41
OMIM:119540	CPI	GO:0060322	head development	1.182531850218993e-11	2.608073995657989e-7	15	708	41
OMIM:119540	CPI	GO:0001503	ossification	1.2404521854136874e-11	2.7358172949298876e-7	12	363	41
OMIM:119540	CPI	GO:0048565	digestive tract development	1.4636403200540826e-11	3.228058725879279e-7	9	138	41
OMIM:119540	CPI	GO:0005104	fibroblast growth factor receptor binding	1.7005064023578598e-11	3.7504668704002597e-7	6	26	41
OMIM:119540	CPI	GO:0033674	positive regulation of kinase activity	1.924926884555589e-11	4.2454262438873513e-7	13	480	41
OMIM:119540	CPI	GO:0001657	ureteric bud development	3.289635230885324e-11	7.255290501717582e-7	8	97	41
OMIM:119540	CPI	GO:2000027	regulation of organ morphogenesis	7.010847458133185e-11	1.546242406891274e-6	10	236	41
OMIM:119540	CPI	GO:0048839	inner ear development	9.39546218603482e-11	2.0721691851299795e-6	9	170	41
OMIM:119540	CPI	GO:0043009	chordate embryonic development	9.861478300621229e-11	2.174949039202012e-6	13	552	41
OMIM:119540	CPI	GO:0042471	ear morphogenesis	1.0585365917137324e-10	2.3346024530246368e-6	8	112	41
OMIM:119540	CPI	GO:0042476	odontogenesis	1.2209977473531808e-10	2.6929105317874402e-6	8	114	41
OMIM:119540	CPI	GO:0043616	keratinocyte proliferation	1.6917700573770844e-10	3.7311988615451597e-6	6	37	41
OMIM:119540	CPI	GO:0048863	stem cell differentiation	2.2355906015292248e-10	4.930595071672705e-6	10	266	41
OMIM:119540	CPI	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.3855839526021327e-10	5.261405407464004e-6	14	732	41
OMIM:119540	CPI	GO:0030879	mammary gland development	3.0910418669094497e-10	6.817292837468791e-6	8	128	41
OMIM:119540	CPI	GO:0060349	bone morphogenesis	4.055312752271334e-10	8.943992275134427e-6	7	80	41
OMIM:119540	CPI	GO:0060070	canonical Wnt signaling pathway	4.651395935084679e-10	1.025865373482926e-5	10	287	41
OMIM:119540	CPI	GO:0051726	regulation of cell cycle	4.837050759931572e-10	1.0668115451029081e-5	15	930	41
OMIM:119540	CPI	GO:0060021	palate development	6.249774031630295e-10	1.3783876626760616e-5	7	85	41
OMIM:119540	CPI	GO:0060445	branching involved in salivary gland morphogenesis	1.016075334980826e-9	2.2409541513002118e-5	5	22	41
OMIM:119540	CPI	GO:0048608	reproductive structure development	1.0735486943858064e-9	2.367711645467896e-5	11	418	41
OMIM:119540	CPI	GO:0060993	kidney morphogenesis	1.0968347341488993e-9	2.4190690061653974e-5	7	92	41
OMIM:119540	CPI	GO:0042472	inner ear morphogenesis	1.0968347341488993e-9	2.4190690061653974e-5	7	92	41
OMIM:119540	CPI	GO:0050679	positive regulation of epithelial cell proliferation	1.4245843393823066e-9	3.141920760507677e-5	8	155	41
OMIM:119540	CPI	GO:0007389	pattern specification process	1.5192085367488062e-9	3.350614427799492e-5	11	432	41
OMIM:119540	CPI	GO:0060548	negative regulation of cell death	2.1377237757747025e-9	4.7147497874711064e-5	14	867	41
OMIM:119540	CPI	GO:0045165	cell fate commitment	2.2542375743839216e-9	4.971720970303739e-5	9	243	41
OMIM:119540	CPI	GO:0045860	positive regulation of protein kinase activity	2.323174097540459e-9	5.1237604721254826e-5	11	450	41
OMIM:119540	CPI	GO:0031069	hair follicle morphogenesis	2.5217665733379135e-9	5.561756177496768e-5	5	26	41
OMIM:119540	CPI	GO:0070371	ERK1 and ERK2 cascade	2.60036880916914e-9	5.7351134086225386e-5	9	247	41
OMIM:119540	CPI	GO:0002053	positive regulation of mesenchymal cell proliferation	3.0898992253725055e-9	6.814772741559061e-5	5	27	41
OMIM:119540	CPI	GO:0001658	branching involved in ureteric bud morphogenesis	3.1640979836211613e-9	6.978418102876471e-5	6	59	41
OMIM:119540	CPI	GO:0055025	positive regulation of cardiac muscle tissue development	4.530821162695986e-9	9.992726074325997e-5	5	29	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0033013	tetrapyrrole metabolic process	2.113864638886298e-13	4.66212846106373e-9	12	56	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0051180	vitamin transport	1.1546319456101628e-14	2.546540756043214e-10	12	33	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0051183	vitamin transporter activity	3.019806626980426e-14	6.660183515805329e-10	7	23	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0042558	pteridine-containing compound metabolic process	7.907008381380365e-13	1.7438906985134395e-8	7	34	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0006732	coenzyme metabolic process	2.0445867221496883e-12	4.5093360157011375e-8	13	295	41
Orphanet:309827	Disorder of vitamin and non-protein cofactor absorption and transportB	GO:0072341	modified amino acid binding	4.2963983482025014e-9	9.475706556960617e-5	6	62	41
Orphanet:98277	Acute myeloid leukemia with recurrent genetic anomaly	GO:0030097	hemopoiesis	1.154198958630559e-11	2.545585803259698e-7	15	695	41
Orphanet:98277	Acute myeloid leukemia with recurrent genetic anomaly	GO:0030099	myeloid cell differentiation	7.970490933928431e-11	1.7578917754779155e-6	11	327	41
Orphanet:98277	Acute myeloid leukemia with recurrent genetic anomaly	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.2514614899927778e-9	2.7600983161790715e-5	15	996	41
MESH:D006228	Hand Deformities, Congenital	GO:0035107	appendage morphogenesis	9.009459844833145e-13	1.9870363687779502e-8	10	146	41
MESH:D006228	Hand Deformities, Congenital	GO:0035108	limb morphogenesis	9.009459844833145e-13	1.9870363687779502e-8	10	146	41
MESH:D006228	Hand Deformities, Congenital	GO:0001501	skeletal system development	2.7218227671710338e-12	6.002980112995715e-8	15	482	41
MESH:D006228	Hand Deformities, Congenital	GO:0009887	organ morphogenesis	5.1523230126804265e-12	1.136344840446668e-7	17	950	41
MESH:D006228	Hand Deformities, Congenital	GO:0003682	chromatin binding	6.653122497368713e-12	1.4673461667946697e-7	13	433	41
MESH:D006228	Hand Deformities, Congenital	GO:0001503	ossification	1.2404521854136874e-11	2.7358172949298876e-7	12	363	41
MESH:D006228	Hand Deformities, Congenital	GO:0044212	transcription regulatory region DNA binding	7.151867986721072e-11	1.5773444844713325e-6	15	807	41
MESH:D006228	Hand Deformities, Congenital	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.1706569047476023e-10	2.581883803420837e-6	16	996	41
MESH:D006228	Hand Deformities, Congenital	GO:0035295	tube development	1.5003498443633134e-10	3.3090215817432878e-6	13	573	41
MESH:D006228	Hand Deformities, Congenital	GO:0001047	core promoter binding	1.2200629395664464e-9	2.6908488132137975e-5	8	152	41
MESH:D006228	Hand Deformities, Congenital	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.9708057125432674e-9	6.552111999014176e-5	13	732	41
MESH:D006228	Hand Deformities, Congenital	GO:0030278	regulation of ossification	4.072035375557448e-9	8.980874020791951e-5	8	177	41
Orphanet:98671	Hereditary optic neuropathy	GO:0044429	mitochondrial part	3.6992631180510216e-13	8.158724806861528e-9	18	956	41
Orphanet:98671	Hereditary optic neuropathy	GO:0022904	respiratory electron transport chain	5.10702591327572e-15	1.1263545651729601e-10	10	105	41
Orphanet:98671	Hereditary optic neuropathy	GO:0031966	mitochondrial membrane	1.201816424156732e-12	2.6506061234776723e-8	17	656	41
Orphanet:269523	Syndrome with a cerebellar malformation as major feature	GO:0031513	nonmotile primary cilium	2.0028423364237824e-13	4.417268772982652e-9	11	134	41
DOID:783	end stage renal failure	GO:0033993	response to lipid	1.581845765485923e-12	3.488760835779203e-8	18	850	42
DOID:783	end stage renal failure	GO:0019915	lipid storage	1.5765166949677223e-14	3.4770075707513115e-10	10	61	42
DOID:783	end stage renal failure	GO:0010742	macrophage derived foam cell differentiation	3.8968828164342995e-14	8.594575051645847e-10	8	31	42
DOID:783	end stage renal failure	GO:0009991	response to extracellular stimulus	5.773159728050814e-14	1.273270378021607e-9	16	573	42
DOID:783	end stage renal failure	GO:0010883	regulation of lipid storage	6.317169010117141e-14	1.3932516251813354e-9	10	41	42
DOID:783	end stage renal failure	GO:0010885	regulation of cholesterol storage	1.6697754290362354e-13	3.6826897087394173e-9	6	13	42
DOID:783	end stage renal failure	GO:0010743	regulation of macrophage derived foam cell differentiation	2.2093438190040615e-13	4.872707792813458e-9	7	28	42
DOID:783	end stage renal failure	GO:0045834	positive regulation of lipid metabolic process	3.2307490016592055e-13	7.125416923159378e-9	11	124	42
DOID:783	end stage renal failure	GO:0006979	response to oxidative stress	7.429612480791548e-13	1.6386010326385758e-8	13	386	42
DOID:783	end stage renal failure	GO:0001101	response to acid chemical	7.767120280277595e-13	1.7130383778152236e-8	13	315	42
DOID:783	end stage renal failure	GO:0006869	lipid transport	1.01019193010643e-12	2.2279783018497312e-8	13	300	42
DOID:783	end stage renal failure	GO:0010888	negative regulation of lipid storage	1.0389467064442215e-12	2.2913969610627305e-8	6	17	42
DOID:783	end stage renal failure	GO:0009743	response to carbohydrate	1.850297692840286e-12	4.0808315615592505e-8	11	211	42
DOID:783	end stage renal failure	GO:0072593	reactive oxygen species metabolic process	1.884381539696278e-12	4.1560034858001416e-8	11	223	42
DOID:783	end stage renal failure	GO:0007568	aging	3.2371882952020314e-12	7.13961878506808e-8	12	290	42
DOID:783	end stage renal failure	GO:1901701	cellular response to oxygen-containing compound	3.719358154796737e-12	8.203044410404203e-8	20	873	42
DOID:783	end stage renal failure	GO:0014070	response to organic cyclic compound	3.836486683894691e-12	8.461371381329741e-8	18	873	42
DOID:783	end stage renal failure	GO:0006954	inflammatory response	3.9787062533491735e-12	8.775036641761602e-8	15	637	42
DOID:783	end stage renal failure	GO:0071407	cellular response to organic cyclic compound	5.07305308872219e-12	1.1188618587176791e-7	13	416	42
DOID:783	end stage renal failure	GO:0071396	cellular response to lipid	5.07305308872219e-12	1.1188618587176791e-7	13	416	42
DOID:783	end stage renal failure	GO:0031667	response to nutrient levels	5.284550574913283e-12	1.1655076292971245e-7	16	546	42
DOID:783	end stage renal failure	GO:0016175	superoxide-generating NADPH oxidase activity	5.628386645639694e-12	1.2413406746958344e-7	5	9	42
DOID:783	end stage renal failure	GO:0055114	oxidation-reduction process	8.258616013279152e-12	1.821437761728717e-7	17	949	42
DOID:783	end stage renal failure	GO:0034284	response to monosaccharide	8.413492125214361e-12	1.8555956882160274e-7	10	188	42
DOID:783	end stage renal failure	GO:0042554	superoxide anion generation	8.743672452737883e-12	1.92841695945134e-7	6	23	42
DOID:783	end stage renal failure	GO:0042493	response to drug	8.758216374360472e-12	1.9316246213652022e-7	13	433	42
DOID:783	end stage renal failure	GO:0006631	fatty acid metabolic process	1.0188405674682599e-11	2.2470528715512472e-7	12	348	42
DOID:783	end stage renal failure	GO:0008202	steroid metabolic process	1.7953860620423256e-11	3.959723959834349e-7	11	275	42
DOID:783	end stage renal failure	GO:0009725	response to hormone	2.4778068485886706e-11	5.464803004562313e-7	16	865	42
DOID:783	end stage renal failure	GO:1901698	response to nitrogen compound	2.713751445782009e-11	5.985178813672221e-7	16	870	42
DOID:783	end stage renal failure	GO:0071222	cellular response to lipopolysaccharide	4.4034442758800196e-11	9.711796350453383e-7	9	152	42
DOID:783	end stage renal failure	GO:0048660	regulation of smooth muscle cell proliferation	5.178857342968968e-11	1.1421969869918058e-6	8	100	42
DOID:783	end stage renal failure	GO:0010745	negative regulation of macrophage derived foam cell differentiation	5.7185922663904876e-11	1.261235524352422e-6	5	13	42
DOID:783	end stage renal failure	GO:0048661	positive regulation of smooth muscle cell proliferation	6.081979364580548e-11	1.3413805488582398e-6	7	60	42
DOID:783	end stage renal failure	GO:0010243	response to organonitrogen compound	6.806777363976835e-11	1.501234747625091e-6	15	780	42
DOID:783	end stage renal failure	GO:0015850	organic hydroxy compound transport	6.937128649298074e-11	1.5299837236026903e-6	10	230	42
DOID:783	end stage renal failure	GO:0045923	positive regulation of fatty acid metabolic process	7.751332908867425e-11	1.7095564730507107e-6	6	32	42
DOID:783	end stage renal failure	GO:0044283	small molecule biosynthetic process	8.651324101549562e-11	1.908049530596756e-6	13	530	42
DOID:783	end stage renal failure	GO:0030301	cholesterol transport	1.5092205263300684e-10	3.328585870820966e-6	7	68	42
DOID:783	end stage renal failure	GO:0009746	response to hexose	2.0872592543241808e-10	4.603450285411981e-6	9	181	42
DOID:783	end stage renal failure	GO:0020037	heme binding	3.1399871591730744e-10	6.9252416795562155e-6	8	125	42
DOID:783	end stage renal failure	GO:0007584	response to nutrient	4.451078394751562e-10	9.81685339962457e-6	9	197	42
DOID:783	end stage renal failure	GO:0008015	blood circulation	4.975893030945144e-10	1.0974332079749516e-5	12	489	42
DOID:783	end stage renal failure	GO:0006909	phagocytosis	6.068522351299066e-10	1.338412604579009e-5	9	204	42
DOID:783	end stage renal failure	GO:0032101	regulation of response to external stimulus	6.189757595365109e-10	1.3651510376577747e-5	15	920	42
DOID:783	end stage renal failure	GO:2000379	positive regulation of reactive oxygen species metabolic process	6.307611100098143e-10	1.3911436281266454e-5	7	83	42
DOID:783	end stage renal failure	GO:0044057	regulation of system process	7.6566308848669e-10	1.6886699416573947e-5	12	508	42
DOID:783	end stage renal failure	GO:0000302	response to reactive oxygen species	1.0049413523560702e-9	2.2163981526213128e-5	9	216	42
DOID:783	end stage renal failure	GO:1903034	regulation of response to wounding	1.0778833381408504e-9	2.3772717022696455e-5	11	407	42
DOID:783	end stage renal failure	GO:0032368	regulation of lipid transport	1.213176559211604e-9	2.6756609013411925e-5	7	91	42
DOID:783	end stage renal failure	GO:0048878	chemical homeostasis	1.6516760181772838e-9	3.6427714580899995e-5	15	988	42
DOID:783	end stage renal failure	GO:0032868	response to insulin	2.363812812156141e-9	5.2133891572103686e-5	9	238	42
DOID:783	end stage renal failure	GO:0048545	response to steroid hormone	2.8069415680676e-9	6.190709628373092e-5	11	446	42
DOID:783	end stage renal failure	GO:0051051	negative regulation of transport	3.227980771569605e-9	7.119311591696764e-5	11	452	42
Orphanet:89832	Syndromic lymphedema	GO:0051056	regulation of small GTPase mediated signal transduction	2.0090595853616833e-12	4.4309809155151925e-8	12	275	42
Orphanet:89832	Syndromic lymphedema	GO:0035270	endocrine system development	9.882206164490981e-12	2.1795205695784858e-7	9	129	42
Orphanet:89832	Syndromic lymphedema	GO:0007507	heart development	3.305411500065247e-11	7.290085063393903e-7	13	487	42
Orphanet:89832	Syndromic lymphedema	GO:0009887	organ morphogenesis	9.641142328931096e-10	2.1263539406457532e-5	15	950	42
Orphanet:89832	Syndromic lymphedema	GO:0010631	epithelial cell migration	1.090771251099909e-9	2.4056959943008493e-5	9	218	42
Orphanet:89832	Syndromic lymphedema	GO:0048732	gland development	1.5383089246867598e-9	3.392740333396649e-5	11	421	42
Orphanet:89832	Syndromic lymphedema	GO:0060322	head development	2.776767260570523e-9	6.124160193188288e-5	13	708	42
Orphanet:89832	Syndromic lymphedema	GO:0045859	regulation of protein kinase activity	2.824273814816536e-9	6.22893589857787e-5	13	709	42
Orphanet:89832	Syndromic lymphedema	GO:0035295	tube development	2.969477219672001e-9	6.549182007986598e-5	12	573	42
Orphanet:100091	Adrenal/paraganglial tumor	GO:0042493	response to drug	1.2482304079242112e-10	2.752972164676848e-6	12	433	42
Orphanet:100091	Adrenal/paraganglial tumor	GO:1901698	response to nitrogen compound	2.8938473839446033e-10	6.3823804052898225e-6	15	870	42
Orphanet:100091	Adrenal/paraganglial tumor	GO:0070997	neuron death	4.89506324363731e-10	1.0796061983842087e-5	10	281	42
Orphanet:100091	Adrenal/paraganglial tumor	GO:0010243	response to organonitrogen compound	7.876549412699774e-10	1.737172972970935e-5	14	780	42
Orphanet:100091	Adrenal/paraganglial tumor	GO:0009314	response to radiation	1.966541263165311e-9	4.337206755911094e-5	11	431	42
MESH:D007022	Hypotension	GO:0051241	negative regulation of multicellular organismal process	1.6260326418660043e-12	3.5862149916354724e-8	21	966	42
MESH:D007022	Hypotension	GO:0032940	secretion by cell	6.845635169838715e-13	1.5098048367079286e-8	22	956	42
MESH:D007022	Hypotension	GO:1903531	negative regulation of secretion by cell	6.368239269249898e-13	1.404515170833065e-8	11	174	42
MESH:D007022	Hypotension	GO:0008217	regulation of blood pressure	5.728750807065808e-13	1.2634759904983639e-8	14	168	42
MESH:D007022	Hypotension	GO:0007611	learning or memory	4.858335955759685e-13	1.0715059950427985e-8	12	218	42
MESH:D007022	Hypotension	GO:0007565	female pregnancy	4.4653170050423796e-13	9.848256654620968e-9	11	190	42
MESH:D007022	Hypotension	GO:0003018	vascular process in circulatory system	1.6719958750854857e-13	3.687586902501039e-9	14	159	42
MESH:D007022	Hypotension	GO:0051952	regulation of amine transport	1.580957587066223e-13	3.4868019582745546e-9	9	72	42
MESH:D007022	Hypotension	GO:0015844	monoamine transport	1.2656542480726785e-13	2.7914004441242923e-9	9	70	42
MESH:D007022	Hypotension	GO:0060359	response to ammonium ion	9.214851104388799e-14	2.0323354110729497e-9	10	92	42
MESH:D007022	Hypotension	GO:0005184	neuropeptide hormone activity	2.5091040356528538e-14	5.533828950632369e-10	8	28	42
MESH:D007022	Hypotension	GO:0042311	vasodilation	2.708944180085382e-14	5.97457638917831e-10	9	68	42
MESH:D007022	Hypotension	GO:0006939	smooth muscle contraction	1.4444001550373287e-13	3.1856245419348284e-9	10	97	42
MESH:D007022	Hypotension	GO:0045776	negative regulation of blood pressure	1.724176357242868e-13	3.802670955899146e-9	8	43	42
MESH:D007022	Hypotension	GO:0043279	response to alkaloid	2.6900703886667543e-13	5.932950242204527e-9	11	140	42
MESH:D007022	Hypotension	GO:0045471	response to ethanol	3.771427614651657e-13	8.317883604114229e-9	10	137	42
MESH:D007022	Hypotension	GO:0051937	catecholamine transport	4.268807529683727e-13	9.41485500671746e-9	8	58	42
MESH:D007022	Hypotension	GO:0051047	positive regulation of secretion	5.810907310888069e-13	1.2815956074163637e-8	14	363	42
MESH:D007022	Hypotension	GO:0009914	hormone transport	6.610267888618182e-13	1.45789458283474e-8	13	307	42
MESH:D007022	Hypotension	GO:0052652	cyclic purine nucleotide metabolic process	1.0840217612440028e-12	2.3908099944236483e-8	10	147	42
MESH:D007022	Hypotension	GO:0007268	synaptic transmission	1.116773340470445e-12	2.4630436024075664e-8	17	605	42
MESH:D007022	Hypotension	GO:0007188	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	1.2609913113692528e-12	2.781116337224887e-8	10	146	42
MESH:D007022	Hypotension	GO:0050804	modulation of synaptic transmission	1.2998491172311333e-12	2.8668172280532644e-8	13	285	42
MESH:D007022	Hypotension	GO:0048878	chemical homeostasis	1.518341008477364e-12	3.3487010941968265e-8	20	988	42
MESH:D007022	Hypotension	GO:0046883	regulation of hormone secretion	1.5516476992161188e-12	3.42215900062115e-8	12	252	42
MESH:D007022	Hypotension	GO:1903522	regulation of blood circulation	1.6430190541427692e-12	3.6236785239118774e-8	15	297	42
MESH:D007022	Hypotension	GO:0030431	sleep	1.698086116164177e-12	3.745128929200092e-8	7	37	42
MESH:D007022	Hypotension	GO:0001659	temperature homeostasis	2.027933376780311e-12	4.472607062488976e-8	7	38	42
MESH:D007022	Hypotension	GO:0050795	regulation of behavior	2.192024339819909e-12	4.8345096814728095e-8	12	243	42
MESH:D007022	Hypotension	GO:0001664	G-protein coupled receptor binding	2.240430063693566e-12	4.9412685054761596e-8	13	255	42
MESH:D007022	Hypotension	GO:0050878	regulation of body fluid levels	3.945177518005494e-12	8.701089015961117e-8	15	504	42
MESH:D007022	Hypotension	GO:0006954	inflammatory response	3.9787062533491735e-12	8.775036641761602e-8	15	637	42
MESH:D007022	Hypotension	GO:0002790	peptide secretion	6.437517185986508e-12	1.4197944153693243e-7	11	247	42
MESH:D007022	Hypotension	GO:0055065	metal ion homeostasis	8.1512574467979e-12	1.7977598298912767e-7	14	516	42
MESH:D007022	Hypotension	GO:0045187	regulation of circadian sleep/wake cycle, sleep	8.743672452737883e-12	1.92841695945134e-7	6	23	42
MESH:D007022	Hypotension	GO:0050432	catecholamine secretion	8.748890500953621e-12	1.929567799985321e-7	7	46	42
MESH:D007022	Hypotension	GO:0032844	regulation of homeostatic process	9.113487742240522e-12	2.0099797215511472e-7	13	427	42
MESH:D007022	Hypotension	GO:0032846	positive regulation of homeostatic process	1.0599410238398832e-11	2.3376999280788624e-7	10	192	42
MESH:D007022	Hypotension	GO:0007270	neuron-neuron synaptic transmission	1.0616840739885447e-11	2.3415442251817353e-7	9	130	42
MESH:D007022	Hypotension	GO:0035813	regulation of renal sodium excretion	1.157640650006897e-11	2.5531764535902113e-7	6	24	42
MESH:D007022	Hypotension	GO:0044070	regulation of anion transport	1.5195400493439593e-11	3.351345578828102e-7	9	135	42
MESH:D007022	Hypotension	GO:0051953	negative regulation of amine transport	1.5295542610260782e-11	3.3734319226930154e-7	6	25	42
MESH:D007022	Hypotension	GO:0002526	acute inflammatory response	2.2710389124824815e-11	5.008776321480113e-7	9	141	42
MESH:D007022	Hypotension	GO:0001934	positive regulation of protein phosphorylation	2.713751445782009e-11	5.985178813672221e-7	16	870	42
MESH:D007022	Hypotension	GO:0033267	axon part	3.7900460547746206e-11	8.358946573805426e-7	10	217	42
MESH:D007022	Hypotension	GO:0032228	regulation of synaptic transmission, GABAergic	4.079558912906123e-11	8.997467182414454e-7	6	29	42
MESH:D007022	Hypotension	GO:0007613	memory	4.7749026954591045e-11	1.0531047894835055e-6	8	99	42
MESH:D007022	Hypotension	GO:0019725	cellular homeostasis	5.865297136864456e-11	1.2935912835354557e-6	15	771	42
MESH:D007022	Hypotension	GO:1903792	negative regulation of anion transport	6.306877242678866e-11	1.3909817758728238e-6	6	31	42
MESH:D007022	Hypotension	GO:0035815	positive regulation of renal sodium excretion	8.876444024252805e-11	1.9576997295489562e-6	5	14	42
MESH:D007022	Hypotension	GO:0055082	cellular chemical homeostasis	9.047207427670401e-11	1.995361598172707e-6	14	661	42
MESH:D007022	Hypotension	GO:0009152	purine ribonucleotide biosynthetic process	1.0660472504753216e-10	2.3511672109233217e-6	10	240	42
MESH:D007022	Hypotension	GO:0030072	peptide hormone secretion	1.1137468725053168e-10	2.456368727310476e-6	10	241	42
MESH:D007022	Hypotension	GO:1903532	positive regulation of secretion by cell	1.3715462099384013e-10	3.024945166019144e-6	11	335	42
MESH:D007022	Hypotension	GO:0030817	regulation of cAMP biosynthetic process	1.399216298381134e-10	3.085971546079591e-6	8	113	42
MESH:D007022	Hypotension	GO:0060047	heart contraction	1.76730963197258e-10	3.897801393315525e-6	10	253	42
MESH:D007022	Hypotension	GO:1902533	positive regulation of intracellular signal transduction	2.4817115029662773e-10	5.4734147197921246e-6	15	860	42
MESH:D007022	Hypotension	GO:0046888	negative regulation of hormone secretion	2.77231904100006e-10	6.114349644925632e-6	7	74	42
MESH:D007022	Hypotension	GO:0014070	response to organic cyclic compound	3.0289803998329035e-10	6.680416271831469e-6	15	873	42
MESH:D007022	Hypotension	GO:0009611	response to wounding	3.146122251607153e-10	6.938772625919576e-6	15	875	42
MESH:D007022	Hypotension	GO:0042310	vasoconstriction	4.849071144619188e-10	1.069462640945762e-5	7	80	42
MESH:D007022	Hypotension	GO:0050433	regulation of catecholamine secretion	5.117756218808722e-10	1.1287211340582637e-5	6	43	42
MESH:D007022	Hypotension	GO:0002791	regulation of peptide secretion	6.068522351299066e-10	1.338412604579009e-5	9	204	42
MESH:D007022	Hypotension	GO:0032101	regulation of response to external stimulus	6.189757595365109e-10	1.3651510376577747e-5	15	920	42
MESH:D007022	Hypotension	GO:1902930	regulation of alcohol biosynthetic process	6.814024899881588e-10	1.5028331916688842e-5	6	45	42
MESH:D007022	Hypotension	GO:0042321	negative regulation of circadian sleep/wake cycle, sleep	7.701429494133549e-10	1.6985502749311543e-5	4	7	42
MESH:D007022	Hypotension	GO:0050995	negative regulation of lipid catabolic process	8.919901484105708e-10	1.967284272319514e-5	5	21	42
MESH:D007022	Hypotension	GO:0042220	response to cocaine	8.95229779196427e-10	1.9744292780177197e-5	6	47	42
MESH:D007022	Hypotension	GO:1903034	regulation of response to wounding	1.0778833381408504e-9	2.3772717022696455e-5	11	407	42
MESH:D007022	Hypotension	GO:0051966	regulation of synaptic transmission, glutamatergic	1.3182477331952214e-9	2.9073953755620607e-5	6	50	42
MESH:D007022	Hypotension	GO:0008284	positive regulation of cell proliferation	1.3858313385739507e-9	3.056451017224848e-5	14	815	42
MESH:D007022	Hypotension	GO:0008016	regulation of heart contraction	1.38633671209476e-9	3.057565618524993e-5	9	224	42
MESH:D007022	Hypotension	GO:1902932	positive regulation of alcohol biosynthetic process	1.4702147277390054e-9	3.2425585820283764e-5	5	23	42
MESH:D007022	Hypotension	GO:0043270	positive regulation of ion transport	1.9609874835069263e-9	4.324957894874526e-5	9	233	42
MESH:D007022	Hypotension	GO:0007204	positive regulation of cytosolic calcium ion concentration	2.036508073288701e-9	4.49151855563823e-5	9	234	42
MESH:D007022	Hypotension	GO:0043025	neuronal cell body	2.114147634735275e-9	4.662752608408649e-5	11	434	42
MESH:D007022	Hypotension	GO:0001817	regulation of cytokine production	2.1197147370699554e-9	4.6750308526077866e-5	12	556	42
MESH:D007022	Hypotension	GO:0033993	response to lipid	2.373105489894556e-9	5.233884157962443e-5	14	850	42
MESH:D007022	Hypotension	GO:0010876	lipid localization	2.5246443824400444e-9	5.568103185471518e-5	10	333	42
MESH:D007022	Hypotension	GO:0009306	protein secretion	4.056374902638993e-9	8.946334847770299e-5	11	462	42
MESH:D007022	Hypotension	GO:0071855	neuropeptide receptor binding	4.258830954562143e-9	9.392851670286806e-5	5	28	42
MESH:D007022	Hypotension	GO:0002675	positive regulation of acute inflammatory response	4.258830954562143e-9	9.392851670286806e-5	5	28	42
Orphanet:289644	Epstein-Barr virus-associated malignant lymphoproliferative disorder	GO:0002521	leukocyte differentiation	1.4788170688007085e-13	3.2615310452399626e-9	14	448	42
Orphanet:289644	Epstein-Barr virus-associated malignant lymphoproliferative disorder	GO:0042113	B cell activation	3.1444735704155846e-11	6.935136459551572e-7	10	212	42
Orphanet:289644	Epstein-Barr virus-associated malignant lymphoproliferative disorder	GO:1902105	regulation of leukocyte differentiation	1.4415321158978145e-9	3.17929908161263e-5	9	225	42
MESH:D004266	DNA Virus Infections	GO:0009615	response to virus	7.050404704500579e-11	1.5549667575776027e-6	12	412	42
MESH:D004266	DNA Virus Infections	GO:0050776	regulation of immune response	1.2214151912104398e-10	2.693831204214625e-6	15	816	42
DOID:9562	primary ciliary dyskinesia	GO:0001578	microtubule bundle formation	5.1736392947532295e-14	1.1410461464578248e-9	20	66	42
DOID:9562	primary ciliary dyskinesia	GO:0036159	inner dynein arm assembly	5.873079800267078e-14	1.295307749948904e-9	6	11	42
DOID:9562	primary ciliary dyskinesia	GO:0035869	ciliary transition zone	1.5295542610260782e-11	3.3734319226930154e-7	6	25	42
DOID:9562	primary ciliary dyskinesia	GO:0003356	regulation of cilium beat frequency	1.1037315506001733e-10	2.434279934848682e-6	4	5	42
DOID:9562	primary ciliary dyskinesia	GO:0036064	ciliary basal body	4.43326930721355e-10	9.777575457059484e-6	7	79	42
DOID:9562	primary ciliary dyskinesia	GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry	1.5377721318543536e-9	3.391556436804777e-5	4	8	42
DOID:9562	primary ciliary dyskinesia	GO:0021591	ventricular system development	2.8598332590945574e-9	6.307362252933046e-5	5	26	42
DOID:9562	primary ciliary dyskinesia	GO:0030317	sperm motility	3.3134546217894467e-9	7.307824168356625e-5	6	58	42
Orphanet:98554	Major induction processes eye anomaly	GO:0009798	axis specification	1.1218017625935772e-9	2.4741337874001346e-5	7	90	42
Orphanet:98554	Major induction processes eye anomaly	GO:0007420	brain development	1.4008395554654385e-9	3.0895516395790246e-5	13	669	42
DOID:1891	optic nerve disease	GO:0031966	mitochondrial membrane	1.0980105713542798e-12	2.421662315121864e-8	17	656	42
Orphanet:117573	Syndromic anorectal malformation	GO:0009952	anterior/posterior pattern specification	7.915890165577366e-14	1.745849576018088e-9	11	199	42
Orphanet:117573	Syndromic anorectal malformation	GO:0009887	organ morphogenesis	1.2919665337562947e-12	2.849432190199508e-8	19	950	42
Orphanet:117573	Syndromic anorectal malformation	GO:0048598	embryonic morphogenesis	4.659383989746857e-12	1.0276271389386693e-7	15	560	42
Orphanet:117573	Syndromic anorectal malformation	GO:0048729	tissue morphogenesis	5.970779426434092e-12	1.316855402500039e-7	15	635	42
Orphanet:117573	Syndromic anorectal malformation	GO:0035107	appendage morphogenesis	3.103362011813715e-11	6.844464917055149e-7	9	146	42
Orphanet:117573	Syndromic anorectal malformation	GO:0035108	limb morphogenesis	3.103362011813715e-11	6.844464917055149e-7	9	146	42
Orphanet:117573	Syndromic anorectal malformation	GO:0007507	heart development	3.305411500065247e-11	7.290085063393903e-7	13	487	42
Orphanet:117573	Syndromic anorectal malformation	GO:0002009	morphogenesis of an epithelium	5.026923322049015e-11	1.1086879386779103e-6	13	506	42
Orphanet:117573	Syndromic anorectal malformation	GO:0048568	embryonic organ development	6.290978848966233e-11	1.3874753851395027e-6	12	408	42
Orphanet:117573	Syndromic anorectal malformation	GO:0035295	tube development	2.1110990733319568e-10	4.656029006233631e-6	13	573	42
Orphanet:117573	Syndromic anorectal malformation	GO:0035113	embryonic appendage morphogenesis	3.1399871591730744e-10	6.9252416795562155e-6	8	125	42
Orphanet:117573	Syndromic anorectal malformation	GO:0030326	embryonic limb morphogenesis	3.1399871591730744e-10	6.9252416795562155e-6	8	125	42
Orphanet:117573	Syndromic anorectal malformation	GO:0048562	embryonic organ morphogenesis	4.726781188679752e-10	1.0424915911633192e-5	10	280	42
Orphanet:117573	Syndromic anorectal malformation	GO:0035239	tube morphogenesis	2.9125746259239804e-9	6.423683337475339e-5	10	338	42
MESH:D013927	Thrombosis	GO:0030335	positive regulation of cell migration	1.1020073742429304e-12	2.430477263892783e-8	16	387	42
MESH:D013927	Thrombosis	GO:0032940	secretion by cell	6.843414723789465e-13	1.5093151173317665e-8	21	956	42
MESH:D013927	Thrombosis	GO:0001775	cell activation	5.653255641391297e-13	1.2468255317088506e-8	19	854	42
MESH:D013927	Thrombosis	GO:0030168	platelet activation	3.270717030545711e-13	7.213566410868566e-9	15	162	42
MESH:D013927	Thrombosis	GO:1903036	positive regulation of response to wounding	2.76445533131664e-13	6.097006233218849e-9	11	162	42
MESH:D013927	Thrombosis	GO:0031093	platelet alpha granule lumen	2.728928194528635e-13	6.018651133032904e-9	9	55	42
MESH:D013927	Thrombosis	GO:1900046	regulation of hemostasis	4.39648317751562e-14	9.6964436480107e-10	10	85	42
MESH:D013927	Thrombosis	GO:0030193	regulation of blood coagulation	4.39648317751562e-14	9.6964436480107e-10	10	85	42
MESH:D013927	Thrombosis	GO:0002576	platelet degranulation	5.662137425588298e-15	1.2487844092134992e-10	11	106	42
MESH:D013927	Thrombosis	GO:0072378	blood coagulation, fibrin clot formation	3.1530333899354446e-14	6.954015141502623e-10	7	26	42
MESH:D013927	Thrombosis	GO:0050819	negative regulation of coagulation	1.609823385706477e-13	3.550465477175635e-9	8	51	42
MESH:D013927	Thrombosis	GO:1900047	negative regulation of hemostasis	1.9817480989559044e-13	4.370745432247247e-9	8	49	42
MESH:D013927	Thrombosis	GO:0030195	negative regulation of blood coagulation	1.9817480989559044e-13	4.370745432247247e-9	8	49	42
MESH:D013927	Thrombosis	GO:0006954	inflammatory response	4.5419223937415154e-13	1.0017209839396912e-8	19	637	42
MESH:D013927	Thrombosis	GO:0050900	leukocyte migration	4.739542092124793e-13	1.0453060084181232e-8	17	354	42
MESH:D013927	Thrombosis	GO:0002526	acute inflammatory response	9.5679020262196e-13	2.1102007918827326e-8	10	141	42
MESH:D013927	Thrombosis	GO:0016485	protein processing	2.672750909482602e-12	5.8947521308638784e-8	12	308	42
MESH:D013927	Thrombosis	GO:0009986	cell surface	3.562594663719665e-12	7.857302530833721e-8	16	715	42
MESH:D013927	Thrombosis	GO:0006465	signal peptide processing	1.157640650006897e-11	2.5531764535902113e-7	6	24	42
MESH:D013927	Thrombosis	GO:0018214	protein carboxylation	2.0608514894604468e-11	4.5452079600050155e-7	5	11	42
MESH:D013927	Thrombosis	GO:0017187	peptidyl-glutamic acid carboxylation	2.0608514894604468e-11	4.5452079600050155e-7	5	11	42
MESH:D013927	Thrombosis	GO:0006953	acute-phase response	2.4437896151141558e-11	5.389777996134271e-7	7	53	42
MESH:D013927	Thrombosis	GO:1902533	positive regulation of intracellular signal transduction	2.4622082150926872e-11	5.430400218386922e-7	16	860	42
MESH:D013927	Thrombosis	GO:0042730	fibrinolysis	2.5530133562767787e-11	5.630670957268435e-7	6	27	42
MESH:D013927	Thrombosis	GO:0032103	positive regulation of response to external stimulus	2.5593083208264034e-11	5.644554501582633e-7	11	285	42
MESH:D013927	Thrombosis	GO:0050727	regulation of inflammatory response	3.038136409116987e-11	6.700609850307515e-7	11	289	42
MESH:D013927	Thrombosis	GO:0008015	blood circulation	3.396793957222144e-11	7.491629072653438e-7	13	489	42
MESH:D013927	Thrombosis	GO:0002685	regulation of leukocyte migration	3.684219596067351e-11	8.125546319126542e-7	9	149	42
MESH:D013927	Thrombosis	GO:0009617	response to bacterium	6.41944275514561e-11	1.4158080996473643e-6	13	517	42
MESH:D013927	Thrombosis	GO:0003018	vascular process in circulatory system	6.559763843227984e-11	1.4467559156239318e-6	9	159	42
MESH:D013927	Thrombosis	GO:0032496	response to lipopolysaccharide	8.212308610922037e-11	1.8112246641388552e-6	11	319	42
MESH:D013927	Thrombosis	GO:0002687	positive regulation of leukocyte migration	1.0435841080180808e-10	2.301624750233877e-6	8	109	42
MESH:D013927	Thrombosis	GO:0007597	blood coagulation, intrinsic pathway	5.113933720934938e-10	1.1278780821522005e-5	5	19	42
MESH:D013927	Thrombosis	GO:0051050	positive regulation of transport	6.189757595365109e-10	1.3651510376577747e-5	15	920	42
MESH:D013927	Thrombosis	GO:0050880	regulation of blood vessel size	7.346899755233949e-10	1.6203587410168474e-5	8	139	42
MESH:D013927	Thrombosis	GO:0044057	regulation of system process	7.6566308848669e-10	1.6886699416573947e-5	12	508	42
MESH:D013927	Thrombosis	GO:0009897	external side of plasma membrane	8.535772089146576e-10	1.8825645342612773e-5	9	212	42
MESH:D013927	Thrombosis	GO:0031589	cell-substrate adhesion	9.234593090212684e-10	2.0366895060464074e-5	10	300	42
MESH:D013927	Thrombosis	GO:0043066	negative regulation of apoptotic process	1.0087328750074676e-9	2.2247603558289697e-5	14	795	42
MESH:D013927	Thrombosis	GO:1900048	positive regulation of hemostasis	1.8539823010144119e-9	4.0889579648872854e-5	5	24	42
MESH:D013927	Thrombosis	GO:0030194	positive regulation of blood coagulation	1.8539823010144119e-9	4.0889579648872854e-5	5	24	42
MESH:D013927	Thrombosis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.361257189775756e-9	5.20775273205043e-5	8	161	42
MESH:D013927	Thrombosis	GO:0070527	platelet aggregation	2.3848397701087265e-9	5.259764112974796e-5	6	55	42
MESH:D013927	Thrombosis	GO:0014070	response to organic cyclic compound	3.3507377983355013e-9	7.390052214228948e-5	14	873	42
MESH:D050197	Atherosclerosis	GO:0033993	response to lipid	1.6562307081358085e-12	3.652816826793526e-8	20	850	42
MESH:D050197	Atherosclerosis	GO:0042327	positive regulation of phosphorylation	7.23421322845752e-13	1.595505727536306e-8	18	910	42
MESH:D050197	Atherosclerosis	GO:1903036	positive regulation of response to wounding	2.76445533131664e-13	6.097006233218849e-9	11	162	42
MESH:D050197	Atherosclerosis	GO:1903426	regulation of reactive oxygen species biosynthetic process	2.2537527399890678e-14	4.970651668045889e-10	9	63	42
MESH:D050197	Atherosclerosis	GO:0009991	response to extracellular stimulus	5.773159728050814e-14	1.273270378021607e-9	16	573	42
MESH:D050197	Atherosclerosis	GO:0097305	response to alcohol	7.249756350802272e-14	1.5989337631694411e-9	14	369	42
MESH:D050197	Atherosclerosis	GO:0002237	response to molecule of bacterial origin	9.814371537686384e-14	2.164559642636732e-9	14	333	42
MESH:D050197	Atherosclerosis	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.4765966227514582e-13	3.256633851478341e-9	11	83	42
MESH:D050197	Atherosclerosis	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	1.8851586958135158e-13	4.157717503616709e-9	8	46	42
MESH:D050197	Atherosclerosis	GO:0006954	inflammatory response	4.5419223937415154e-13	1.0017209839396912e-8	23	637	42
MESH:D050197	Atherosclerosis	GO:0050729	positive regulation of inflammatory response	4.659606034351782e-13	1.0276761108762855e-8	11	114	42
MESH:D050197	Atherosclerosis	GO:0032496	response to lipopolysaccharide	6.855627177060342e-13	1.5120085739006583e-8	14	319	42
MESH:D050197	Atherosclerosis	GO:0009636	response to toxic substance	9.546807788751721e-13	2.105548457809192e-8	12	249	42
MESH:D050197	Atherosclerosis	GO:0006809	nitric oxide biosynthetic process	1.0201839373280563e-12	2.2500156737770283e-8	8	62	42
MESH:D050197	Atherosclerosis	GO:0071407	cellular response to organic cyclic compound	1.149524919696887e-12	2.5352772103914845e-8	15	416	42
MESH:D050197	Atherosclerosis	GO:0071222	cellular response to lipopolysaccharide	1.2798651027878805e-12	2.8227424841986704e-8	10	152	42
MESH:D050197	Atherosclerosis	GO:0001819	positive regulation of cytokine production	1.5057954882990998e-12	3.3210319494436646e-8	13	381	42
MESH:D050197	Atherosclerosis	GO:0048878	chemical homeostasis	2.476241434123949e-12	5.46135048296037e-8	18	988	42
MESH:D050197	Atherosclerosis	GO:0042493	response to drug	2.5656143876062742e-12	5.658462531865638e-8	14	433	42
MESH:D050197	Atherosclerosis	GO:0045429	positive regulation of nitric oxide biosynthetic process	3.0686564400639327e-12	6.767921778561004e-8	7	40	42
MESH:D050197	Atherosclerosis	GO:1901698	response to nitrogen compound	4.286571098077729e-12	9.454032556810432e-8	18	870	42
MESH:D050197	Atherosclerosis	GO:0001934	positive regulation of protein phosphorylation	4.286571098077729e-12	9.454032556810432e-8	18	870	42
MESH:D050197	Atherosclerosis	GO:0051050	positive regulation of transport	4.497402450454047e-12	9.9190211044764e-8	17	920	42
MESH:D050197	Atherosclerosis	GO:0002684	positive regulation of immune system process	4.6663783948019955e-12	1.0291697549735801e-7	17	872	42
MESH:D050197	Atherosclerosis	GO:0031667	response to nutrient levels	5.284550574913283e-12	1.1655076292971245e-7	16	546	42
MESH:D050197	Atherosclerosis	GO:1902533	positive regulation of intracellular signal transduction	5.307310146918098e-12	1.1705272529027866e-7	20	860	42
MESH:D050197	Atherosclerosis	GO:0044057	regulation of system process	7.08988423525625e-12	1.5636739680857659e-7	14	508	42
MESH:D050197	Atherosclerosis	GO:0051241	negative regulation of multicellular organismal process	7.255973599740173e-12	1.6003049774226952e-7	17	966	42
MESH:D050197	Atherosclerosis	GO:1901699	cellular response to nitrogen compound	7.776557175986909e-12	1.7151196851639128e-7	14	518	42
MESH:D050197	Atherosclerosis	GO:0097285	cell-type specific apoptotic process	9.190426197847046e-12	2.026948497935166e-7	13	429	42
MESH:D050197	Atherosclerosis	GO:0010243	response to organonitrogen compound	1.0470735389844776e-11	2.3093206902302654e-7	16	780	42
MESH:D050197	Atherosclerosis	GO:0050900	leukocyte migration	1.2365553025972531e-11	2.7272227198782417e-7	12	354	42
MESH:D050197	Atherosclerosis	GO:0034612	response to tumor necrosis factor	1.3488987704590727e-11	2.974996238247485e-7	11	265	42
MESH:D050197	Atherosclerosis	GO:0008284	positive regulation of cell proliferation	1.396882609583372e-11	3.080824595436127e-7	16	815	42
MESH:D050197	Atherosclerosis	GO:0071417	cellular response to organonitrogen compound	1.7887580305853135e-11	3.945105836455909e-7	13	462	42
MESH:D050197	Atherosclerosis	GO:0050880	regulation of blood vessel size	1.9836021714070284e-11	4.374834589038201e-7	9	139	42
MESH:D050197	Atherosclerosis	GO:0002526	acute inflammatory response	2.2710389124824815e-11	5.008776321480113e-7	9	141	42
MESH:D050197	Atherosclerosis	GO:0030335	positive regulation of cell migration	3.240863133413541e-11	7.147723640743564e-7	12	387	42
MESH:D050197	Atherosclerosis	GO:0033002	muscle cell proliferation	4.1368797276675195e-11	9.123888239370714e-7	9	151	42
MESH:D050197	Atherosclerosis	GO:0042742	defense response to bacterium	4.8707593514052405e-11	1.0742459749524258e-6	10	222	42
MESH:D050197	Atherosclerosis	GO:0019725	cellular homeostasis	5.865297136864456e-11	1.2935912835354557e-6	15	771	42
MESH:D050197	Atherosclerosis	GO:0048659	smooth muscle cell proliferation	7.11348757675978e-11	1.5688796850543696e-6	8	104	42
MESH:D050197	Atherosclerosis	GO:0050663	cytokine secretion	7.745115659929525e-11	1.7081852587974566e-6	9	162	42
MESH:D050197	Atherosclerosis	GO:0002687	positive regulation of leukocyte migration	1.0435841080180808e-10	2.301624750233877e-6	8	109	42
MESH:D050197	Atherosclerosis	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.0717360332535009e-10	2.363713821340596e-6	9	168	42
MESH:D050197	Atherosclerosis	GO:0071356	cellular response to tumor necrosis factor	1.2039713670475294e-10	2.655358850023326e-6	10	243	42
MESH:D050197	Atherosclerosis	GO:1901214	regulation of neuron death	1.574838037754489e-10	3.4733052922675256e-6	10	250	42
MESH:D050197	Atherosclerosis	GO:0060548	negative regulation of cell death	2.7692692583514145e-10	6.107623349294045e-6	15	867	42
MESH:D050197	Atherosclerosis	GO:0002443	leukocyte mediated immunity	4.572259237889398e-10	1.0084117749165067e-5	10	279	42
MESH:D050197	Atherosclerosis	GO:0071346	cellular response to interferon-gamma	5.161622240734687e-10	1.1383957851940352e-5	8	133	42
MESH:D050197	Atherosclerosis	GO:0006979	response to oxidative stress	6.15727580033365e-10	1.3579871777635866e-5	11	386	42
MESH:D050197	Atherosclerosis	GO:0007568	aging	6.662737028761967e-10	1.4694666516934518e-5	10	290	42
MESH:D050197	Atherosclerosis	GO:0051093	negative regulation of developmental process	8.97228846774567e-10	1.9788382215613076e-5	14	788	42
MESH:D050197	Atherosclerosis	GO:0090322	regulation of superoxide metabolic process	1.1525163046144371e-9	2.541874709827141e-5	5	22	42
MESH:D050197	Atherosclerosis	GO:0055082	cellular chemical homeostasis	1.2099351520689083e-9	2.6685119778879773e-5	13	661	42
MESH:D050197	Atherosclerosis	GO:0044283	small molecule biosynthetic process	1.2371417223988601e-9	2.728516068750686e-5	12	530	42
MESH:D050197	Atherosclerosis	GO:0019221	cytokine-mediated signaling pathway	1.347425948594605e-9	2.9717479296254012e-5	12	534	42
MESH:D050197	Atherosclerosis	GO:0050801	ion homeostasis	1.375589864238691e-9	3.033863445578433e-5	13	668	42
MESH:D050197	Atherosclerosis	GO:0002703	regulation of leukocyte mediated immunity	1.4203034304216544e-9	3.132479215794959e-5	8	151	42
MESH:D050197	Atherosclerosis	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.4415321158978145e-9	3.17929908161263e-5	9	225	42
MESH:D050197	Atherosclerosis	GO:0017038	protein import	1.4789539592996448e-9	3.2618329572353666e-5	10	315	42
MESH:D050197	Atherosclerosis	GO:0032930	positive regulation of superoxide anion generation	1.5377721318543536e-9	3.391556436804777e-5	4	8	42
MESH:D050197	Atherosclerosis	GO:0022603	regulation of anatomical structure morphogenesis	1.604299804114362e-9	3.538283217974225e-5	15	986	42
MESH:D050197	Atherosclerosis	GO:0060326	cell chemotaxis	1.6202583719149288e-9	3.5734798392583755e-5	9	228	42
MESH:D050197	Atherosclerosis	GO:0070482	response to oxygen levels	1.7741321745035066e-9	3.912848510867484e-5	10	321	42
MESH:D050197	Atherosclerosis	GO:0006953	acute-phase response	1.8949255498057482e-9	4.179258300096578e-5	6	53	42
MESH:D050197	Atherosclerosis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.361257189775756e-9	5.20775273205043e-5	8	161	42
MESH:D050197	Atherosclerosis	GO:0048660	regulation of smooth muscle cell proliferation	2.364314077851759e-9	5.2144946987020546e-5	7	100	42
MESH:D050197	Atherosclerosis	GO:0050673	epithelial cell proliferation	2.67397848308093e-9	5.897459544434991e-5	10	335	42
MESH:D050197	Atherosclerosis	GO:0048545	response to steroid hormone	2.8069415680676e-9	6.190709628373092e-5	11	446	42
MESH:D050197	Atherosclerosis	GO:0002521	leukocyte differentiation	2.9408758761562126e-9	6.486101744862527e-5	11	448	42
MESH:D050197	Atherosclerosis	GO:0007610	behavior	3.074444587802816e-9	6.78068753839911e-5	13	714	42
MESH:D050197	Atherosclerosis	GO:0031341	regulation of cell killing	3.3134546217894467e-9	7.307824168356625e-5	6	58	42
Orphanet:93665	Autoinflammatory syndrome	GO:0006954	inflammatory response	4.5419223937415154e-13	1.0017209839396912e-8	20	637	42
Orphanet:93665	Autoinflammatory syndrome	GO:0001819	positive regulation of cytokine production	1.5057954882990998e-12	3.3210319494436646e-8	13	381	42
Orphanet:93665	Autoinflammatory syndrome	GO:0032612	interleukin-1 production	1.6355805598777806e-12	3.607272924810445e-8	8	66	42
Orphanet:93665	Autoinflammatory syndrome	GO:0002684	positive regulation of immune system process	3.0440094889172542e-12	6.713562927807004e-8	18	872	42
Orphanet:93665	Autoinflammatory syndrome	GO:0009617	response to bacterium	5.040523554100673e-12	1.1116874698569035e-7	15	517	42
Orphanet:93665	Autoinflammatory syndrome	GO:0031347	regulation of defense response	5.395572877375798e-12	1.1899935981052323e-7	18	749	42
Orphanet:93665	Autoinflammatory syndrome	GO:0002237	response to molecule of bacterial origin	5.9112714723141835e-12	1.3037309232188932e-7	12	333	42
Orphanet:93665	Autoinflammatory syndrome	GO:0050776	regulation of immune response	5.984324147334519e-12	1.319842690694628e-7	17	816	42
Orphanet:93665	Autoinflammatory syndrome	GO:0045087	innate immune response	6.758371640103178e-12	1.490558865224756e-7	17	783	42
Orphanet:93665	Autoinflammatory syndrome	GO:0034097	response to cytokine	9.670042544485113e-12	2.1327278831861918e-7	16	784	42
Orphanet:93665	Autoinflammatory syndrome	GO:0050727	regulation of inflammatory response	3.038136409116987e-11	6.700609850307515e-7	11	289	42
Orphanet:93665	Autoinflammatory syndrome	GO:0032652	regulation of interleukin-1 production	3.659350600315747e-11	8.07069774899638e-7	7	56	42
Orphanet:93665	Autoinflammatory syndrome	GO:0032496	response to lipopolysaccharide	8.212308610922037e-11	1.8112246641388552e-6	11	319	42
Orphanet:93665	Autoinflammatory syndrome	GO:0071345	cellular response to cytokine stimulus	1.2418344130793457e-10	2.738865798046497e-6	14	677	42
Orphanet:93665	Autoinflammatory syndrome	GO:0050702	interleukin-1 beta secretion	1.653519543509674e-10	3.6468373532105858e-6	6	36	42
Orphanet:93665	Autoinflammatory syndrome	GO:0045321	leukocyte activation	1.7397661089546546e-10	3.837054153299491e-6	14	694	42
Orphanet:93665	Autoinflammatory syndrome	GO:0016337	single organismal cell-cell adhesion	1.8269741275389606e-10	4.029391438287178e-6	14	697	42
Orphanet:93665	Autoinflammatory syndrome	GO:0007159	leukocyte cell-cell adhesion	2.54396170795701e-10	5.610707546899185e-6	12	461	42
Orphanet:93665	Autoinflammatory syndrome	GO:0032692	negative regulation of interleukin-1 production	2.730224935021397e-10	6.021511094189691e-6	5	17	42
Orphanet:93665	Autoinflammatory syndrome	GO:0046649	lymphocyte activation	3.28974958385686e-10	7.255542707196305e-6	13	594	42
Orphanet:93665	Autoinflammatory syndrome	GO:0051092	positive regulation of NF-kappaB transcription factor activity	4.2992143178821607e-10	9.481917178089105e-6	8	130	42
Orphanet:93665	Autoinflammatory syndrome	GO:0030155	regulation of cell adhesion	5.661978663695777e-10	1.2487493942781036e-5	13	621	42
Orphanet:93665	Autoinflammatory syndrome	GO:0031349	positive regulation of defense response	8.516056748675283e-10	1.8782163159203336e-5	11	398	42
Orphanet:93665	Autoinflammatory syndrome	GO:0032651	regulation of interleukin-1 beta production	8.95229779196427e-10	1.9744292780177197e-5	6	47	42
Orphanet:93665	Autoinflammatory syndrome	GO:0070489	T cell aggregation	1.6558135973454569e-9	3.651896888945405e-5	11	424	42
Orphanet:93665	Autoinflammatory syndrome	GO:0042110	T cell activation	1.6558135973454569e-9	3.651896888945405e-5	11	424	42
Orphanet:93665	Autoinflammatory syndrome	GO:1903035	negative regulation of response to wounding	2.1391128868231135e-9	4.717813471888377e-5	8	159	42
MESH:D003424	Crohn Disease	GO:0051241	negative regulation of multicellular organismal process	1.6262546864709293e-12	3.5867047110116346e-8	22	966	42
MESH:D003424	Crohn Disease	GO:0033993	response to lipid	1.581845765485923e-12	3.488760835779203e-8	18	850	42
MESH:D003424	Crohn Disease	GO:0022407	regulation of cell-cell adhesion	1.198374732780394e-12	2.643015473147159e-8	16	376	42
MESH:D003424	Crohn Disease	GO:0051249	regulation of lymphocyte activation	6.803446694902959e-13	1.5005001685608477e-8	14	372	42
MESH:D003424	Crohn Disease	GO:0050663	cytokine secretion	3.2596148002994596e-13	7.189080442060458e-9	12	162	42
MESH:D003424	Crohn Disease	GO:0002521	leukocyte differentiation	1.4788170688007085e-13	3.2615310452399626e-9	14	448	42
MESH:D003424	Crohn Disease	GO:0010888	negative regulation of lipid storage	4.218847493575595e-14	9.304668147080974e-10	7	17	42
MESH:D003424	Crohn Disease	GO:0001818	negative regulation of cytokine production	2.1094237467877974e-15	4.652334073540487e-11	13	203	42
MESH:D003424	Crohn Disease	GO:0002237	response to molecule of bacterial origin	8.992806499463768e-14	1.983363473456734e-9	15	333	42
MESH:D003424	Crohn Disease	GO:0001819	positive regulation of cytokine production	2.107203300738547e-13	4.647436879778866e-9	15	381	42
MESH:D003424	Crohn Disease	GO:0050870	positive regulation of T cell activation	3.5349501104064984e-13	7.796332468501532e-9	11	202	42
MESH:D003424	Crohn Disease	GO:0032101	regulation of response to external stimulus	4.2654768606098514e-13	9.407509216075027e-9	19	920	42
MESH:D003424	Crohn Disease	GO:0050707	regulation of cytokine secretion	4.496403249731884e-13	9.91681736728367e-9	11	142	42
MESH:D003424	Crohn Disease	GO:0006954	inflammatory response	4.5419223937415154e-13	1.0017209839396912e-8	24	637	42
MESH:D003424	Crohn Disease	GO:0032496	response to lipopolysaccharide	8.164580123093401e-13	1.8006981461482496e-8	13	319	42
MESH:D003424	Crohn Disease	GO:0032640	tumor necrosis factor production	9.651168753066486e-13	2.1285652684888134e-8	9	101	42
MESH:D003424	Crohn Disease	GO:1903034	regulation of response to wounding	1.0093037516867298e-12	2.2260194243450826e-8	17	407	42
MESH:D003424	Crohn Disease	GO:0050728	negative regulation of inflammatory response	1.0301759445496828e-12	2.2720530457043253e-8	9	100	42
MESH:D003424	Crohn Disease	GO:0032680	regulation of tumor necrosis factor production	1.0301759445496828e-12	2.2720530457043253e-8	9	100	42
MESH:D003424	Crohn Disease	GO:0032637	interleukin-8 production	1.1814993428060916e-12	2.605796800558835e-8	8	64	42
MESH:D003424	Crohn Disease	GO:0071396	cellular response to lipid	1.3213874439088613e-12	2.9143200075409936e-8	14	416	42
MESH:D003424	Crohn Disease	GO:0042742	defense response to bacterium	1.6738832542273485e-12	3.691749517198417e-8	11	222	42
MESH:D003424	Crohn Disease	GO:0050778	positive regulation of immune response	1.7034151866823777e-12	3.756882194227984e-8	15	603	42
MESH:D003424	Crohn Disease	GO:0002443	leukocyte mediated immunity	1.7486012637846216e-12	3.856540087276983e-8	12	279	42
MESH:D003424	Crohn Disease	GO:0051170	nuclear import	2.3592239273284576e-12	5.2032683717229133e-8	12	287	42
MESH:D003424	Crohn Disease	GO:0006606	protein import into nucleus	3.2341906930355435e-12	7.133007573489891e-8	12	268	42
MESH:D003424	Crohn Disease	GO:0042306	regulation of protein import into nucleus	4.041544876542957e-12	8.913627225215492e-8	10	175	42
MESH:D003424	Crohn Disease	GO:0051050	positive regulation of transport	4.497402450454047e-12	9.9190211044764e-8	17	920	42
MESH:D003424	Crohn Disease	GO:1901701	cellular response to oxygen-containing compound	5.488720589141849e-12	1.2105373259352348e-7	17	873	42
MESH:D003424	Crohn Disease	GO:0051222	positive regulation of protein transport	9.65838520272655e-12	2.1301568564613405e-7	13	447	42
MESH:D003424	Crohn Disease	GO:0045087	innate immune response	1.1167400337797062e-11	2.462970144501142e-7	16	783	42
MESH:D003424	Crohn Disease	GO:0032620	interleukin-17 production	1.5295542610260782e-11	3.3734319226930154e-7	6	25	42
MESH:D003424	Crohn Disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.6924684703999446e-11	5.938239211467078e-7	10	209	42
MESH:D003424	Crohn Disease	GO:0032649	regulation of interferon-gamma production	2.8482438629851003e-11	6.281801839813639e-7	8	93	42
MESH:D003424	Crohn Disease	GO:0002285	lymphocyte activation involved in immune response	3.103362011813715e-11	6.844464917055149e-7	9	146	42
MESH:D003424	Crohn Disease	GO:0002440	production of molecular mediator of immune response	3.47464279570886e-11	7.663324685935891e-7	9	148	42
MESH:D003424	Crohn Disease	GO:0002703	regulation of leukocyte mediated immunity	4.1368797276675195e-11	9.123888239370714e-7	9	151	42
MESH:D003424	Crohn Disease	GO:0042307	positive regulation of protein import into nucleus	4.4033443558078034e-11	9.71157597673411e-7	8	98	42
MESH:D003424	Crohn Disease	GO:0071222	cellular response to lipopolysaccharide	4.4034442758800196e-11	9.711796350453383e-7	9	152	42
MESH:D003424	Crohn Disease	GO:0032677	regulation of interleukin-8 production	4.74408290429551e-11	1.0463074845423748e-6	7	58	42
MESH:D003424	Crohn Disease	GO:1903706	regulation of hemopoiesis	5.079003884134181e-11	1.1201743066457936e-6	11	305	42
MESH:D003424	Crohn Disease	GO:1902105	regulation of leukocyte differentiation	5.53157519789238e-11	1.2199889098951644e-6	10	225	42
MESH:D003424	Crohn Disease	GO:0034097	response to cytokine	7.152867187443235e-11	1.5775648581906054e-6	15	784	42
MESH:D003424	Crohn Disease	GO:0019221	cytokine-mediated signaling pathway	9.527878486181862e-11	2.1013736001274097e-6	13	534	42
MESH:D003424	Crohn Disease	GO:0042098	T cell proliferation	1.0161016472665096e-10	2.241012183046287e-6	9	167	42
MESH:D003424	Crohn Disease	GO:0032635	interleukin-6 production	1.0435841080180808e-10	2.301624750233877e-6	8	109	42
MESH:D003424	Crohn Disease	GO:0097285	cell-type specific apoptotic process	1.1355771878385212e-10	2.5045154877778586e-6	12	429	42
MESH:D003424	Crohn Disease	GO:0007259	JAK-STAT cascade	1.1899115026636764e-10	2.6243498191247383e-6	9	170	42
MESH:D003424	Crohn Disease	GO:0032642	regulation of chemokine production	1.2158840601017573e-10	2.6816322945544258e-6	7	66	42
MESH:D003424	Crohn Disease	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	1.3557377442907637e-10	2.9900795950332792e-6	7	67	42
MESH:D003424	Crohn Disease	GO:0048545	response to steroid hormone	1.7174628386129598e-10	3.787864290560883e-6	12	446	42
MESH:D003424	Crohn Disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.7708357002987896e-10	3.90557813700898e-6	16	996	42
MESH:D003424	Crohn Disease	GO:0050829	defense response to Gram-negative bacterium	1.9706736242852685e-10	4.34632067836116e-6	6	37	42
MESH:D003424	Crohn Disease	GO:0002367	cytokine production involved in immune response	2.0573986958538626e-10	4.537592823705694e-6	7	71	42
MESH:D003424	Crohn Disease	GO:0002573	myeloid leukocyte differentiation	2.3048740693809577e-10	5.083399760019702e-6	9	183	42
MESH:D003424	Crohn Disease	GO:0006111	regulation of gluconeogenesis	2.756778139101357e-10	6.0800741857880425e-6	6	39	42
MESH:D003424	Crohn Disease	GO:0001934	positive regulation of protein phosphorylation	2.8938473839446033e-10	6.3823804052898225e-6	15	870	42
MESH:D003424	Crohn Disease	GO:0050670	regulation of lymphocyte proliferation	3.0755309410324116e-10	6.783083490446984e-6	9	189	42
MESH:D003424	Crohn Disease	GO:0005126	cytokine receptor binding	3.3391200915389163e-10	7.36442936188908e-6	10	270	42
MESH:D003424	Crohn Disease	GO:0046427	positive regulation of JAK-STAT cascade	3.3586255998585557e-10	7.4074487604880446e-6	7	76	42
MESH:D003424	Crohn Disease	GO:0050671	positive regulation of lymphocyte proliferation	3.5653080487918487e-10	7.863286901610422e-6	8	127	42
MESH:D003424	Crohn Disease	GO:0042832	defense response to protozoan	3.774075496565388e-10	8.323723507674963e-6	5	18	42
MESH:D003424	Crohn Disease	GO:0030217	T cell differentiation	4.867796166152516e-10	1.0735924444449374e-5	9	199	42
MESH:D003424	Crohn Disease	GO:0050710	negative regulation of cytokine secretion	5.117756218808722e-10	1.1287211340582637e-5	6	43	42
MESH:D003424	Crohn Disease	GO:0002449	lymphocyte mediated immunity	7.521596678827791e-10	1.6588881475154693e-5	9	209	42
MESH:D003424	Crohn Disease	GO:0042129	regulation of T cell proliferation	8.7127449699409e-10	1.9215959031204655e-5	8	142	42
MESH:D003424	Crohn Disease	GO:0042348	NF-kappaB import into nucleus	8.95229779196427e-10	1.9744292780177197e-5	6	47	42
MESH:D003424	Crohn Disease	GO:0042345	regulation of NF-kappaB import into nucleus	8.95229779196427e-10	1.9744292780177197e-5	6	47	42
MESH:D003424	Crohn Disease	GO:0051093	negative regulation of developmental process	8.97228846774567e-10	1.9788382215613076e-5	14	788	42
MESH:D003424	Crohn Disease	GO:0032660	regulation of interleukin-17 production	1.1525163046144371e-9	2.541874709827141e-5	5	22	42
MESH:D003424	Crohn Disease	GO:0032722	positive regulation of chemokine production	1.3182477331952214e-9	2.9073953755620607e-5	6	50	42
MESH:D003424	Crohn Disease	GO:0032655	regulation of interleukin-12 production	1.3182477331952214e-9	2.9073953755620607e-5	6	50	42
MESH:D003424	Crohn Disease	GO:0002699	positive regulation of immune effector process	1.3473260285223887e-9	2.9715275559061283e-5	8	150	42
MESH:D003424	Crohn Disease	GO:0045597	positive regulation of cell differentiation	1.3858313385739507e-9	3.056451017224848e-5	14	815	42
MESH:D003424	Crohn Disease	GO:0042102	positive regulation of T cell proliferation	1.6455893314670789e-9	3.6293472705506424e-5	7	95	42
MESH:D003424	Crohn Disease	GO:0042035	regulation of cytokine biosynthetic process	1.6455893314670789e-9	3.6293472705506424e-5	7	95	42
MESH:D003424	Crohn Disease	GO:0034341	response to interferon-gamma	1.7475747515760531e-9	3.854276114600985e-5	8	155	42
MESH:D003424	Crohn Disease	GO:0043372	positive regulation of CD4-positive, alpha-beta T cell differentiation	1.8539823010144119e-9	4.0889579648872854e-5	5	24	42
MESH:D003424	Crohn Disease	GO:0032800	receptor biosynthetic process	1.8539823010144119e-9	4.0889579648872854e-5	5	24	42
MESH:D003424	Crohn Disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.361257189775756e-9	5.20775273205043e-5	8	161	42
MESH:D003424	Crohn Disease	GO:0032868	response to insulin	2.363812812156141e-9	5.2133891572103686e-5	9	238	42
MESH:D003424	Crohn Disease	GO:0048660	regulation of smooth muscle cell proliferation	2.364314077851759e-9	5.2144946987020546e-5	7	100	42
MESH:D003424	Crohn Disease	GO:1903036	positive regulation of response to wounding	2.4802482290198213e-9	5.470187469103216e-5	8	162	42
MESH:D003424	Crohn Disease	GO:0032760	positive regulation of tumor necrosis factor production	2.6666806540731613e-9	5.8813641825583574e-5	6	56	42
MESH:D003424	Crohn Disease	GO:0032652	regulation of interleukin-1 production	2.6666806540731613e-9	5.8813641825583574e-5	6	56	42
MESH:D003424	Crohn Disease	GO:0045859	regulation of protein kinase activity	2.824273814816536e-9	6.22893589857787e-5	13	709	42
MESH:D003424	Crohn Disease	GO:0032675	regulation of interleukin-6 production	2.9119142652689334e-9	6.422226912050633e-5	7	103	42
MESH:D003424	Crohn Disease	GO:0070371	ERK1 and ERK2 cascade	3.2711569009080677e-9	7.214536544952743e-5	9	247	42
MESH:D003424	Crohn Disease	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	3.3134546217894467e-9	7.307824168356625e-5	6	58	42
MESH:D003424	Crohn Disease	GO:0045598	regulation of fat cell differentiation	3.3341961414024013e-9	7.353569589862996e-5	7	105	42
MESH:D003424	Crohn Disease	GO:0002761	regulation of myeloid leukocyte differentiation	3.564002537537192e-9	7.860407596538277e-5	7	106	42
MESH:D003424	Crohn Disease	GO:0045088	regulation of innate immune response	4.18466794549488e-9	9.229285153788958e-5	10	351	42
DOID:1398	parasitic infectious disease	GO:0046209	nitric oxide metabolic process	7.260858581048524e-14	1.601382360050252e-9	9	65	42
DOID:1398	parasitic infectious disease	GO:0010035	response to inorganic substance	4.443712064983174e-11	9.80060695932039e-7	13	502	42
DOID:1398	parasitic infectious disease	GO:0009897	external side of plasma membrane	8.535772089146576e-10	1.8825645342612773e-5	9	212	42
DOID:1398	parasitic infectious disease	GO:0000302	response to reactive oxygen species	1.0049413523560702e-9	2.2163981526213128e-5	9	216	42
DOID:1398	parasitic infectious disease	GO:0032940	secretion by cell	1.0493114155352146e-9	2.3142563269629157e-5	15	956	42
DOID:0050338	primary bacterial infectious disease	GO:0042742	defense response to bacterium	1.2810582594724451e-9	2.8253739912664777e-5	9	222	42
DOID:0050338	primary bacterial infectious disease	GO:0030139	endocytic vesicle	3.764645817305734e-9	8.302926350067796e-5	9	251	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0009611	response to wounding	3.0788038785090066e-11	6.790301954051614e-7	16	875	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0002694	regulation of leukocyte activation	1.0221412605204705e-10	2.2543325500778977e-6	12	425	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0002684	positive regulation of immune system process	2.973826740415575e-10	6.5587748759865505e-6	15	872	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0043408	regulation of MAPK cascade	1.0052210175359733e-9	2.217014954175589e-5	13	651	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0045859	regulation of protein kinase activity	2.824273814816536e-9	6.22893589857787e-5	13	709	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0032675	regulation of interleukin-6 production	2.9119142652689334e-9	6.422226912050633e-5	7	103	42
Orphanet:264699	Secondary interstitial lung disease specific to childhood associated with a systemic disease	GO:0007159	leukocyte cell-cell adhesion	3.965602290989523e-9	8.746135852777392e-5	11	461	42
Orphanet:163582	Rare bacterial infectious disease	GO:0042742	defense response to bacterium	1.603932542337816e-9	3.537473222126053e-5	9	222	43
Orphanet:309836	Disorder of mineral absorption and transport	GO:1990267	response to transition metal nanoparticle	1.283417816466681e-13	2.830577994217265e-9	12	150	43
Orphanet:309836	Disorder of mineral absorption and transport	GO:0070838	divalent metal ion transport	5.665024005452324e-12	1.24942104440251e-7	13	410	43
Orphanet:309836	Disorder of mineral absorption and transport	GO:0046915	transition metal ion transmembrane transporter activity	2.710924817961313e-10	5.978944686013676e-6	6	38	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0022407	regulation of cell-cell adhesion	9.57456336436735e-13	2.111669950011219e-8	14	376	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0001775	cell activation	7.065459328714496e-13	1.558287054947982e-8	21	854	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0051249	regulation of lymphocyte activation	4.0389913635863195e-13	8.907995452389628e-9	14	372	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0006954	inflammatory response	0.0	0.0	18	637	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0034110	regulation of homotypic cell-cell adhesion	1.1046719095020308e-12	2.436353896406729e-8	13	304	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0050863	regulation of T cell activation	1.7998935675223038e-12	3.969665263170441e-8	13	284	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0019882	antigen processing and presentation	1.9744206269933784e-12	4.354584692833896e-8	11	219	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0002684	positive regulation of immune system process	2.7077229347582943e-12	5.971882932609418e-8	19	872	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0050776	regulation of immune response	4.835687406057332e-12	1.0665108574059445e-7	18	816	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0002237	response to molecule of bacterial origin	8.209433133288258e-12	1.8105904775467252e-7	12	333	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0030139	endocytic vesicle	9.935496869672988e-12	2.1912738346063776e-7	11	251	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0045087	innate immune response	1.3173462320992257e-11	2.9054071148948424e-7	16	783	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0031347	regulation of defense response	5.687883497529356e-11	1.2544627053800994e-6	15	749	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0032496	response to lipopolysaccharide	1.0850886855706676e-10	2.3931630960261074e-6	11	319	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0048002	antigen processing and presentation of peptide antigen	2.0394996802508558e-10	4.4981165447932625e-6	9	176	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0001819	positive regulation of cytokine production	7.094513865268937e-10	1.564695032985064e-5	11	381	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0034097	response to cytokine	1.1954581768947037e-9	2.636583009141269e-5	14	784	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0071222	cellular response to lipopolysaccharide	1.8262493739484853e-9	4.027792994243384e-5	8	152	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0071345	cellular response to cytokine stimulus	2.2405773902889337e-9	4.941593434282243e-5	13	677	43
Orphanet:280926	Systemic diseases with anterior uveitis	GO:0046651	lymphocyte proliferation	4.3873409349970416e-9	9.676280432135975e-5	9	249	43
Orphanet:79378	Dermis elastic tissue disorder	GO:0048251	elastic fiber assembly	8.490178560194295e-10	1.8725088814508517e-5	4	7	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0048736	appendage development	8.602007994795713e-13	1.8971728632521945e-8	11	168	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0060173	limb development	8.602007994795713e-13	1.8971728632521945e-8	11	168	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0001067	regulatory region nucleic acid binding	1.5520362772747376e-11	3.423016009529434e-7	16	811	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0035113	embryonic appendage morphogenesis	3.8352798714669234e-10	8.4587097565203e-6	8	125	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0030326	embryonic limb morphogenesis	3.8352798714669234e-10	8.4587097565203e-6	8	125	43
MESH:D038062	Upper Extremity Deformities, Congenital	GO:0002009	morphogenesis of an epithelium	9.894730590431777e-10	2.1822828317197285e-5	12	506	43
Orphanet:255241	Leigh syndrome with leukodystrophy	GO:1990204	oxidoreductase complex	4.884981308350689e-14	1.0773826275567444e-9	23	100	43
Orphanet:255241	Leigh syndrome with leukodystrophy	GO:0005759	mitochondrial matrix	9.536826883760341e-11	2.103347169213343e-6	12	412	43
Orphanet:255241	Leigh syndrome with leukodystrophy	GO:0070069	cytochrome complex	2.6158255561625765e-9	5.7692032641165625e-5	5	25	43
Orphanet:255241	Leigh syndrome with leukodystrophy	GO:0016676	oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor	3.96127808333091e-9	8.736598812786323e-5	5	27	43
Orphanet:255241	Leigh syndrome with leukodystrophy	GO:0004129	cytochrome-c oxidase activity	3.96127808333091e-9	8.736598812786323e-5	5	27	43
DOID:10747	lymphoid leukemia	GO:0022407	regulation of cell-cell adhesion	1.0229594948896192e-12	2.2561371659790552e-8	17	376	43
DOID:10747	lymphoid leukemia	GO:0051249	regulation of lymphocyte activation	4.602984660095899e-13	1.0151882667841505e-8	18	372	43
DOID:10747	lymphoid leukemia	GO:0002312	B cell activation involved in immune response	6.854516954035716e-13	1.5117637142125773e-8	8	58	43
DOID:10747	lymphoid leukemia	GO:0002208	somatic diversification of immunoglobulins involved in immune response	2.4528157283043583e-12	5.409685088775262e-8	7	38	43
DOID:10747	lymphoid leukemia	GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	2.4528157283043583e-12	5.409685088775262e-8	7	38	43
DOID:10747	lymphoid leukemia	GO:0045190	isotype switching	2.4528157283043583e-12	5.409685088775262e-8	7	38	43
DOID:10747	lymphoid leukemia	GO:0030183	B cell differentiation	1.2736212084973886e-10	2.8089715753409905e-6	8	109	43
DOID:10747	lymphoid leukemia	GO:0043069	negative regulation of programmed cell death	1.7076959846207274e-9	3.766323494081014e-5	14	806	43
Orphanet:98572	Canthal anomaly	GO:0048667	cell morphogenesis involved in neuron differentiation	7.706526528039603e-10	1.6996744257591345e-5	12	495	43
Orphanet:95617	Pituitary hormone deficiency secondary to a granulomatous disease	GO:0030139	endocytic vesicle	2.1107060543812395e-10	4.655162202937824e-6	10	251	43
Orphanet:95617	Pituitary hormone deficiency secondary to a granulomatous disease	GO:0051251	positive regulation of lymphocyte activation	2.667427390079524e-10	5.883011108820391e-6	10	257	43
Orphanet:95617	Pituitary hormone deficiency secondary to a granulomatous disease	GO:0042098	T cell proliferation	3.84574572187546e-9	8.481792189596327e-5	8	167	43
MESH:D050171	Dyslipidemias	GO:1904478	regulation of intestinal absorption	1.1102230246251565e-14	2.448596880810783e-10	6	8	43
MESH:D050171	Dyslipidemias	GO:0034375	high-density lipoprotein particle remodeling	2.8466118351389014e-13	6.278202402398847e-9	6	14	43
MESH:D050171	Dyslipidemias	GO:0032489	regulation of Cdc42 protein signal transduction	2.4382496022212763e-11	5.377559497699025e-7	4	4	43
MESH:D050171	Dyslipidemias	GO:0034434	sterol esterification	3.985878294088252e-11	8.79085457761164e-7	5	12	43
MESH:D050171	Dyslipidemias	GO:0034435	cholesterol esterification	3.985878294088252e-11	8.79085457761164e-7	5	12	43
MESH:D050171	Dyslipidemias	GO:0046165	alcohol biosynthetic process	4.6181392043820324e-11	1.0185306015264572e-6	9	149	43
MESH:D050171	Dyslipidemias	GO:0051004	regulation of lipoprotein lipase activity	1.004040184326982e-10	2.2144106265331587e-6	5	14	43
MESH:D050171	Dyslipidemias	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	1.2169054652844125e-10	2.6838850036847717e-6	4	5	43
MESH:D050171	Dyslipidemias	GO:0010901	regulation of very-low-density lipoprotein particle remodeling	1.2169054652844125e-10	2.6838850036847717e-6	4	5	43
MESH:D050171	Dyslipidemias	GO:0046470	phosphatidylcholine metabolic process	1.7984114197844292e-10	3.966396386334559e-6	7	68	43
MESH:D050171	Dyslipidemias	GO:0046890	regulation of lipid biosynthetic process	4.087872262914516e-10	9.015802275857965e-6	8	126	43
MESH:D050171	Dyslipidemias	GO:0055081	anion homeostasis	4.3935466376154864e-10	9.689967109260955e-6	6	41	43
MESH:D050171	Dyslipidemias	GO:0010873	positive regulation of cholesterol esterification	8.490178560194295e-10	1.8725088814508517e-5	4	7	43
MESH:D050171	Dyslipidemias	GO:0070508	cholesterol import	8.490178560194295e-10	1.8725088814508517e-5	4	7	43
MESH:D050171	Dyslipidemias	GO:0006695	cholesterol biosynthetic process	1.1848043657280982e-9	2.6130860286133206e-5	6	48	43
MESH:D050171	Dyslipidemias	GO:0090181	regulation of cholesterol metabolic process	1.3031868917323663e-9	2.874178689715734e-5	5	22	43
MESH:D050171	Dyslipidemias	GO:0034366	spherical high-density lipoprotein particle	1.6951942072296333e-9	3.738750824044956e-5	4	8	43
MESH:D050171	Dyslipidemias	GO:0050994	regulation of lipid catabolic process	1.72983505297708e-9	3.81515120934095e-5	6	51	43
MESH:D050171	Dyslipidemias	GO:0034384	high-density lipoprotein particle clearance	3.046274454909792e-9	6.718558310303546e-5	4	9	43
MESH:D050171	Dyslipidemias	GO:0033993	response to lipid	3.372819690206086e-9	7.438753826749522e-5	14	850	43
Orphanet:364803	Rare bone disease related to a common gene or pathway defect	GO:0044272	sulfur compound biosynthetic process	1.1733904958788344e-9	2.5879127386607692e-5	9	209	44
Orphanet:364803	Rare bone disease related to a common gene or pathway defect	GO:0061448	connective tissue development	3.0510696191754505e-9	6.729134045091456e-5	9	233	44
DOID:784	chronic kidney failure	GO:0010876	lipid localization	3.3306690738754696e-14	7.345790642432348e-10	16	333	44
DOID:784	chronic kidney failure	GO:1901699	cellular response to nitrogen compound	1.7265426865975542e-9	3.807889895290906e-5	12	518	44
DOID:784	chronic kidney failure	GO:0014074	response to purine-containing compound	2.5876412124148374e-9	5.707042693980924e-5	8	155	44
DOID:0060307	autosomal dominant non-syndromic intellectual disability	GO:0005694	chromosome	6.474309977022585e-11	1.4279090654323312e-6	16	876	44
DOID:0060307	autosomal dominant non-syndromic intellectual disability	GO:0016568	chromatin modification	8.385583338821334e-10	1.8494404053770452e-5	13	608	44
DOID:0060307	autosomal dominant non-syndromic intellectual disability	GO:0044427	chromosomal part	1.4770995537816134e-9	3.2577430658653483e-5	14	776	44
DOID:0060307	autosomal dominant non-syndromic intellectual disability	GO:0003682	chromatin binding	3.5436656942167133e-9	7.815554688594961e-5	11	433	44
DOID:2527	nephrosis	GO:0043062	extracellular structure organization	1.2493339696106887e-12	2.7554060699763738e-8	13	321	44
DOID:2527	nephrosis	GO:0072009	nephron epithelium development	1.2352396883130723e-10	2.724321132574481e-6	8	106	44
DOID:2527	nephrosis	GO:0001568	blood vessel development	3.7410641251511834e-10	8.250916928020935e-6	13	569	44
DOID:2527	nephrosis	GO:0009611	response to wounding	6.645258787685293e-10	1.4656118256239914e-5	15	875	44
DOID:2527	nephrosis	GO:0008015	blood circulation	9.014448076882786e-10	1.9881365233564985e-5	12	489	44
DOID:2527	nephrosis	GO:1903034	regulation of response to wounding	1.856641729247599e-9	4.0948233338555795e-5	11	407	44
DOID:2527	nephrosis	GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	2.362932183253008e-9	5.2114469301645094e-5	5	24	44
DOID:2527	nephrosis	GO:0022603	regulation of anatomical structure morphogenesis	3.3853944092498978e-9	7.46648736960065e-5	15	986	44
Orphanet:182228	Systemic autoimmune disease	GO:0002684	positive regulation of immune system process	6.30944185786575e-10	1.391547401752291e-5	15	872	44
Orphanet:182228	Systemic autoimmune disease	GO:0050778	positive regulation of immune response	7.56946283431148e-10	1.669445028107397e-5	13	603	44
Orphanet:93587	Familial cystic renal disease	GO:0005813	centrosome	5.720979245893432e-12	1.2617619726817964e-7	14	482	44
MESH:D003866	Depressive Disorder	GO:0033993	response to lipid	1.999955756559757e-12	4.410902421092544e-8	20	850	44
MESH:D003866	Depressive Disorder	GO:0051241	negative regulation of multicellular organismal process	9.71001057337162e-13	2.1415428319571106e-8	18	966	44
MESH:D003866	Depressive Disorder	GO:0009991	response to extracellular stimulus	8.221201497349284e-13	1.8131859902403846e-8	15	573	44
MESH:D003866	Depressive Disorder	GO:0007610	behavior	1.9380053117856733e-12	4.2742707151433024e-8	17	714	44
MESH:D003866	Depressive Disorder	GO:0014070	response to organic cyclic compound	3.3771874186072637e-12	7.44838685173832e-8	20	873	44
MESH:D003866	Depressive Disorder	GO:1901698	response to nitrogen compound	3.672173676250168e-12	8.098979042969745e-8	19	870	44
MESH:D003866	Depressive Disorder	GO:0044057	regulation of system process	5.270783809407931e-12	1.1624713691649191e-7	15	508	44
MESH:D003866	Depressive Disorder	GO:0044708	single-organism behavior	6.0276228452949e-12	1.3293922185297902e-7	13	404	44
MESH:D003866	Depressive Disorder	GO:0010243	response to organonitrogen compound	6.284417430890699e-12	1.3860282643829436e-7	18	780	44
MESH:D003866	Depressive Disorder	GO:0031667	response to nutrient levels	6.398215290914777e-12	1.411126382411254e-7	15	546	44
MESH:D003866	Depressive Disorder	GO:0008015	blood circulation	7.595035711460696e-12	1.6750851261626565e-7	14	489	44
MESH:D003866	Depressive Disorder	GO:0043005	neuron projection	1.3607115434410844e-11	3.0010493090593116e-7	17	941	44
MESH:D003866	Depressive Disorder	GO:2000849	regulation of glucocorticoid secretion	1.4354961663798349e-11	3.165986794950726e-7	5	10	44
MESH:D003866	Depressive Disorder	GO:0050804	modulation of synaptic transmission	4.36840563722285e-11	9.634518632894995e-7	11	285	44
MESH:D003866	Depressive Disorder	GO:0009725	response to hormone	5.14295273035259e-11	1.1342782246792638e-6	16	865	44
MESH:D003866	Depressive Disorder	GO:0015850	organic hydroxy compound transport	1.1421930068422625e-10	2.51910667659061e-6	10	230	44
MESH:D003866	Depressive Disorder	GO:2000852	regulation of corticosterone secretion	1.3385359487472215e-10	2.952141034961997e-6	4	5	44
MESH:D003866	Depressive Disorder	GO:0044706	multi-multicellular organism process	1.5486034676825966e-10	3.415444947973967e-6	10	237	44
MESH:D003866	Depressive Disorder	GO:0008217	regulation of blood pressure	1.6767087718250195e-10	3.6979811962600806e-6	9	168	44
MESH:D003866	Depressive Disorder	GO:0006875	cellular metal ion homeostasis	3.484292854238902e-10	7.684607890023898e-6	12	450	44
MESH:D003866	Depressive Disorder	GO:1902533	positive regulation of intracellular signal transduction	5.24986165650887e-10	1.1578569883430312e-5	15	860	44
MESH:D003866	Depressive Disorder	GO:0007270	neuron-neuron synaptic transmission	6.379451411575587e-10	1.4069880088229958e-5	8	130	44
MESH:D003866	Depressive Disorder	GO:1901701	cellular response to oxygen-containing compound	6.4188065973525e-10	1.4156677950460939e-5	15	873	44
MESH:D003866	Depressive Disorder	GO:0042310	vasoconstriction	6.842070243706644e-10	1.5090185922495003e-5	7	80	44
MESH:D003866	Depressive Disorder	GO:0043627	response to estrogen	1.6326232588070866e-9	3.6007505972990295e-5	9	217	44
MESH:D003866	Depressive Disorder	GO:0007611	learning or memory	1.7002057539627913e-9	3.749803790364936e-5	9	218	44
MESH:D003866	Depressive Disorder	GO:0060359	response to ammonium ion	1.8473453877732027e-9	4.0743202527337985e-5	7	92	44
MESH:D003866	Depressive Disorder	GO:0032496	response to lipopolysaccharide	2.7322396567441842e-9	6.025954562949298e-5	10	319	44
MESH:D003866	Depressive Disorder	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3.4943413718124816e-9	7.706769895532428e-5	8	161	44
MESH:D003866	Depressive Disorder	GO:0042493	response to drug	3.5436656942167133e-9	7.815554688594961e-5	11	433	44
MESH:D003866	Depressive Disorder	GO:0019233	sensory perception of pain	3.570681861297942e-9	7.875138845092611e-5	7	101	44
Orphanet:156532	Rare syndrome with cardiac malformations	GO:0009887	organ morphogenesis	2.0387713739467017e-9	4.4965102652394506e-5	15	950	44
Orphanet:183435	Inherited ichthyosis	GO:0033561	regulation of water loss via skin	3.681055460447169e-12	8.118567818016231e-8	6	19	45
Orphanet:183435	Inherited ichthyosis	GO:0006665	sphingolipid metabolic process	1.7436647681279283e-9	3.845652646106146e-5	8	144	45
Orphanet:207085	Qualitative or quantitative defects of dystrophin	GO:0060537	muscle tissue development	1.0171863351615684e-12	2.243404462198839e-8	20	336	45
Orphanet:207085	Qualitative or quantitative defects of dystrophin	GO:0031674	I band	1.4521717162097048e-13	3.202764720100504e-9	17	122	45
Orphanet:207085	Qualitative or quantitative defects of dystrophin	GO:0048747	muscle fiber development	2.034384660731803e-9	4.486835369243991e-5	6	50	45
Orphanet:207085	Qualitative or quantitative defects of dystrophin	GO:0051270	regulation of cellular component movement	2.467602122635526e-9	5.4422964814726527e-5	14	787	45
Orphanet:251870	Central nervous system primitive neuroectodermal tumor	GO:0019900	kinase binding	6.912259653546471e-11	1.5244988665896742e-6	14	598	45
Orphanet:251870	Central nervous system primitive neuroectodermal tumor	GO:0008285	negative regulation of cell proliferation	1.4991896613025801e-10	3.3064627980028405e-6	14	634	45
Orphanet:251870	Central nervous system primitive neuroectodermal tumor	GO:0007417	central nervous system development	1.1814179634583866e-9	2.6056173184074716e-5	15	889	45
Orphanet:251870	Central nervous system primitive neuroectodermal tumor	GO:0019901	protein kinase binding	3.097351597425302e-9	6.831208948121503e-5	12	532	45
Orphanet:251870	Central nervous system primitive neuroectodermal tumor	GO:0007420	brain development	3.6261085245570257e-9	7.99738235091052e-5	13	669	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009164	nucleoside catabolic process	8.548717289613705e-14	1.8854195982243027e-9	9	35	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009112	nucleobase metabolic process	2.3092638912203256e-14	5.093081512086428e-10	10	37	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009156	ribonucleoside monophosphate biosynthetic process	4.555245070037017e-13	1.0046593001966642e-8	9	81	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0072527	pyrimidine-containing compound metabolic process	5.184741524999481e-13	1.1434947433386355e-8	9	79	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009165	nucleotide biosynthetic process	8.583134203377085e-13	1.893010248554816e-8	13	304	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0072529	pyrimidine-containing compound catabolic process	1.4612822063497788e-10	3.222857906104437e-6	6	33	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0046112	nucleobase biosynthetic process	2.768482110226955e-10	6.10588729410555e-6	5	16	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0046113	nucleobase catabolic process	4.399541841948462e-10	9.703189532417333e-6	4	6	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009163	nucleoside biosynthetic process	5.28652788212014e-10	1.1659437244015969e-5	8	124	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0009120	deoxyribonucleoside metabolic process	1.0247672710406164e-9	2.2601242162800794e-5	4	7	45
Orphanet:79224	Disorder of purine or pyrimidine metabolism	GO:0072523	purine-containing compound catabolic process	4.112443496850915e-9	9.069994132304693e-5	6	56	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0035107	appendage morphogenesis	1.8721690864254015e-12	4.129068920111223e-8	10	146	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0035108	limb morphogenesis	1.8721690864254015e-12	4.129068920111223e-8	10	146	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0035113	embryonic appendage morphogenesis	1.4431122963287635e-11	3.182784169553088e-7	9	125	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0030326	embryonic limb morphogenesis	1.4431122963287635e-11	3.182784169553088e-7	9	125	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0005694	chromosome	9.278000590029478e-11	2.0462630301310014e-6	16	876	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0007059	chromosome segregation	1.2695011708530046e-10	2.7998848323163017e-6	11	308	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0007126	meiotic nuclear division	1.422120199379151e-10	3.1364860997307176e-6	9	161	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0098813	nuclear chromosome segregation	5.190748941785728e-10	1.1448196791108423e-5	10	262	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0006302	double-strand break repair	6.851741396474154e-10	1.5111515649923746e-5	9	192	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0019827	stem cell population maintenance	1.8422015024555094e-9	4.062975413665626e-5	8	145	45
Orphanet:294955	Syndrome with limb reduction defects	GO:0048608	reproductive structure development	3.1811355771793615e-9	7.015994515469082e-5	11	418	45
Orphanet:139393	Syndromic craniosynostosis	GO:0035295	tube development	1.460387366591931e-12	3.2208843370185036e-8	16	573	45
Orphanet:139393	Syndromic craniosynostosis	GO:0048736	appendage development	9.461320615855584e-13	2.086694261826949e-8	18	168	45
Orphanet:139393	Syndromic craniosynostosis	GO:0060173	limb development	9.461320615855584e-13	2.086694261826949e-8	18	168	45
Orphanet:139393	Syndromic craniosynostosis	GO:0060348	bone development	5.81312775693732e-13	1.2820853267925258e-8	11	172	45
Orphanet:139393	Syndromic craniosynostosis	GO:0042733	embryonic digit morphogenesis	2.8310687127941492e-14	6.243922046067496e-10	9	60	45
Orphanet:139393	Syndromic craniosynostosis	GO:0060562	epithelial tube morphogenesis	3.808064974464287e-13	8.398687301180985e-9	13	301	45
Orphanet:139393	Syndromic craniosynostosis	GO:0003002	regionalization	4.4220183070819985e-13	9.752761376269348e-9	14	327	45
Orphanet:139393	Syndromic craniosynostosis	GO:0090596	sensory organ morphogenesis	1.7806867091962886e-12	3.9273045371324145e-8	12	239	45
Orphanet:139393	Syndromic craniosynostosis	GO:0045667	regulation of osteoblast differentiation	5.270561764803006e-12	1.1624223972273029e-7	9	111	45
Orphanet:139393	Syndromic craniosynostosis	GO:0035115	embryonic forelimb morphogenesis	1.1990486381563414e-10	2.644501771453811e-6	6	32	45
Orphanet:139393	Syndromic craniosynostosis	GO:0048762	mesenchymal cell differentiation	4.693492261509391e-10	1.0351497182758962e-5	9	184	45
Orphanet:139393	Syndromic craniosynostosis	GO:0035265	organ growth	8.717597754781536e-10	1.922666184817068e-5	8	132	45
Orphanet:139393	Syndromic craniosynostosis	GO:0043010	camera-type eye development	1.092102519528737e-9	2.4086321068206296e-5	10	283	45
Orphanet:139393	Syndromic craniosynostosis	GO:0007507	heart development	1.1454215353978725e-9	2.5262271963200078e-5	12	487	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0042445	hormone metabolic process	8.530953721219703e-13	1.8815018432150055e-8	15	187	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0006704	glucocorticoid biosynthetic process	1.6301404670571173e-12	3.595274800094472e-8	6	17	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0050810	regulation of steroid biosynthetic process	1.9804158313263542e-11	4.3678071159902743e-7	7	48	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:1901615	organic hydroxy compound metabolic process	2.2056356741018135e-11	4.86452947923155e-7	14	534	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0016125	sterol metabolic process	2.3920865288573623e-11	5.275746839394913e-7	9	132	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0020037	heme binding	5.635989452912327e-10	1.2430174738398136e-5	8	125	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0046660	female sex differentiation	6.400444618748224e-10	1.4116180606649209e-5	8	127	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0009725	response to hormone	8.1045314903605e-10	1.7874544201990084e-5	15	865	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0030325	adrenal gland development	2.106493202091997e-9	4.645870757213899e-5	5	23	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0032870	cellular response to hormone stimulus	2.3438181395718516e-9	5.169290906825719e-5	12	519	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0004497	monooxygenase activity	2.352144035100423e-9	5.187653669413983e-5	7	93	45
Orphanet:325620	Disorder of sex development of gynecological interest	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	2.410621147141967e-9	5.316624940021608e-5	8	150	45
MESH:D003875	Drug Eruptions	GO:0002684	positive regulation of immune system process	9.047873561485176e-12	1.9955085139855555e-7	17	872	45
MESH:D003875	Drug Eruptions	GO:0031347	regulation of defense response	1.3551604283179586e-11	2.9888063246552576e-7	16	749	45
MESH:D003875	Drug Eruptions	GO:0034097	response to cytokine	2.1180668330345043e-10	4.671396400257599e-6	15	784	45
MESH:D003875	Drug Eruptions	GO:0042493	response to drug	3.013023164299966e-10	6.645222588863575e-6	12	433	45
MESH:D003875	Drug Eruptions	GO:0045321	leukocyte activation	4.870854830585358e-10	1.0742670328856008e-5	14	694	45
MESH:D003875	Drug Eruptions	GO:0050865	regulation of cell activation	5.709249739638267e-10	1.2591750300772198e-5	12	458	45
MESH:D003875	Drug Eruptions	GO:0046649	lymphocyte activation	8.612942581365246e-10	1.899584486320105e-5	13	594	45
MESH:D003875	Drug Eruptions	GO:1903409	reactive oxygen species biosynthetic process	1.0496220559375047e-9	2.3149414443701666e-5	7	83	45
MESH:D003875	Drug Eruptions	GO:0006954	inflammatory response	2.007998101127839e-9	4.428639812037449e-5	13	637	45
MESH:D003875	Drug Eruptions	GO:0002694	regulation of leukocyte activation	3.784943802820351e-9	8.347693557120284e-5	11	425	45
MESH:D003875	Drug Eruptions	GO:0050776	regulation of immune response	3.922665636757472e-9	8.651439061868604e-5	14	816	45
DOID:0070004	myeloma	GO:0097305	response to alcohol	6.287059761689306e-11	1.3866110304405765e-6	12	369	46
DOID:0070004	myeloma	GO:1902533	positive regulation of intracellular signal transduction	1.0249734394562893e-10	2.260578920720846e-6	16	860	46
DOID:0070004	myeloma	GO:0030335	positive regulation of cell migration	1.0882861278815881e-10	2.4002150550428425e-6	12	387	46
DOID:0070004	myeloma	GO:0010035	response to inorganic substance	1.5191670144076852e-10	3.3505228502761497e-6	13	502	46
DOID:0070004	myeloma	GO:0043549	regulation of kinase activity	2.0203527739681704e-10	4.4558880429868e-6	15	761	46
DOID:0070004	myeloma	GO:0043408	regulation of MAPK cascade	2.9250202260300284e-10	6.451132108509228e-6	14	651	46
DOID:0070004	myeloma	GO:0051093	negative regulation of developmental process	3.2255398352276643e-10	7.113928106594614e-6	15	788	46
DOID:0070004	myeloma	GO:0051241	negative regulation of multicellular organismal process	5.289167992472699e-10	1.1665260007398537e-5	16	966	46
DOID:0070004	myeloma	GO:0048545	response to steroid hormone	5.544008585545157e-10	1.2227310935419844e-5	12	446	46
DOID:0070004	myeloma	GO:0045859	regulation of protein kinase activity	8.877907298199261e-10	1.958022454617847e-5	14	709	46
DOID:0070004	myeloma	GO:0060548	negative regulation of cell death	1.187423381843189e-9	2.6188622686551533e-5	15	867	46
DOID:0070004	myeloma	GO:0009611	response to wounding	1.3478521632137586e-9	2.9726879459679445e-5	15	875	46
DOID:0070004	myeloma	GO:0032355	response to estradiol	2.2154459378143088e-9	4.886166015849458e-5	8	145	46
DOID:0070004	myeloma	GO:0034599	cellular response to oxidative stress	2.6956505916331253e-9	5.945257379846858e-5	9	219	46
DOID:0070004	myeloma	GO:0043066	negative regulation of apoptotic process	3.883357635459106e-9	8.564745265005058e-5	14	795	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0042327	positive regulation of phosphorylation	2.4567015088905464e-12	5.4182551778581e-8	19	910	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0050673	epithelial cell proliferation	7.605027718682322e-13	1.6772888633553862e-8	17	335	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0001944	vasculature development	3.801403636316536e-13	8.38399571989612e-9	23	588	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:1901342	regulation of vasculature development	7.168710070004636e-13	1.5810590059395224e-8	12	228	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0036293	response to decreased oxygen levels	9.325873406851315e-13	2.0568213798810575e-8	13	302	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043542	endothelial cell migration	2.490008199629301e-12	5.4917130842824236e-8	10	151	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0060548	negative regulation of cell death	3.1827873669953988e-12	7.019637537908352e-8	19	867	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0001666	response to hypoxia	3.4178215813085444e-12	7.538005497575995e-8	13	292	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0000165	MAPK cascade	3.4201530496602572e-12	7.543147551025697e-8	17	843	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043069	negative regulation of programmed cell death	5.0565107656552755e-12	1.115213449365271e-7	19	806	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0007610	behavior	7.893463660479938e-12	1.7409034103188503e-7	16	714	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:1901215	negative regulation of neuron death	8.357980973983103e-12	1.8433527038119735e-7	10	170	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043066	negative regulation of apoptotic process	8.415157459751299e-12	1.855962977748149e-7	19	795	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0008285	negative regulation of cell proliferation	1.6652679235562573e-11	3.6727484054033255e-7	15	634	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0042493	response to drug	2.593236736458948e-11	5.71938362226021e-7	13	433	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:1904018	positive regulation of vasculature development	2.7643887179351623e-11	6.096859317406e-7	9	131	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0051093	negative regulation of developmental process	3.184918995202679e-11	7.024338843919509e-7	16	788	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0009887	organ morphogenesis	3.803213299846675e-11	8.387986932811842e-7	17	950	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0001952	regulation of cell-matrix adhesion	4.7604697961389775e-11	1.0499216135384515e-6	8	90	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0030855	epithelial cell differentiation	5.1126103350895846e-11	1.1275862094040079e-6	14	568	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0001936	regulation of endothelial cell proliferation	6.231815063983959e-11	1.374426812361662e-6	8	93	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0014070	response to organic cyclic compound	1.2344059108215788e-10	2.722482236316992e-6	16	873	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0001938	positive regulation of endothelial cell proliferation	2.9605851104008707e-10	6.52957046098912e-6	7	68	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0009790	embryo development	3.156340744325803e-10	6.961309511610558e-6	16	932	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0009314	response to radiation	3.785987079396591e-10	8.349994503609182e-6	12	431	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0048545	response to steroid hormone	5.544008585545157e-10	1.2227310935419844e-5	12	446	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043523	regulation of neuron apoptotic process	7.695907244809064e-10	1.697332342842639e-5	9	190	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0072006	nephron development	9.87321668866059e-10	2.1775379406840933e-5	8	131	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0071363	cellular response to growth factor stimulus	1.1656412501892532e-9	2.570821777292398e-5	13	594	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0071456	cellular response to hypoxia	1.1826171153472842e-9	2.6082620478984353e-5	8	134	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0002052	positive regulation of neuroblast proliferation	1.4333243480990632e-9	3.161196849732484e-5	5	21	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0007507	heart development	1.511754277316868e-9	3.334174058622352e-5	12	487	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0045216	cell-cell junction organization	2.0258977828646607e-9	4.468117560108009e-5	9	212	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043535	regulation of blood vessel endothelial cell migration	2.058471060273348e-9	4.539957923432869e-5	6	49	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0002009	morphogenesis of an epithelium	2.326018821996456e-9	5.130034511913184e-5	12	506	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0043536	positive regulation of blood vessel endothelial cell migration	2.3615424060707824e-9	5.2083817765891105e-5	5	23	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0060562	epithelial tube morphogenesis	2.4934317943703377e-9	5.49926382248378e-5	10	301	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0032403	protein complex binding	2.827812761729831e-9	6.236741045995142e-5	15	924	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0051338	regulation of transferase activity	2.99943836434835e-9	6.615261312570286e-5	15	928	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0046777	protein autophosphorylation	3.986600161098863e-9	8.792446655303543e-5	9	229	46
MESH:D009383	Neoplasms, Vascular Tissue	GO:0048732	gland development	4.416468746271107e-9	9.740521819900927e-5	11	421	46
DOID:4977	lymphedema	GO:0072358	cardiovascular system development	9.9253938401489e-13	2.1890456114448398e-8	18	910	46
DOID:4977	lymphedema	GO:0043542	endothelial cell migration	3.054964170523533e-9	6.737723478089652e-5	8	151	46
Orphanet:101953	Rare dyslipidemia	GO:0044242	cellular lipid catabolic process	5.946354519892338e-13	1.3114684893622552e-8	11	177	46
Orphanet:101953	Rare dyslipidemia	GO:0015248	sterol transporter activity	4.3076653355456074e-14	9.500555897545837e-10	9	17	46
Orphanet:101953	Rare dyslipidemia	GO:0098856	intestinal lipid absorption	1.4654943925052066e-14	3.232147882670233e-10	7	12	46
Orphanet:101953	Rare dyslipidemia	GO:0030299	intestinal cholesterol absorption	1.4654943925052066e-14	3.232147882670233e-10	7	12	46
Orphanet:101953	Rare dyslipidemia	GO:1904729	regulation of intestinal lipid absorption	1.1102230246251565e-14	2.448596880810783e-10	6	6	46
Orphanet:101953	Rare dyslipidemia	GO:0030300	regulation of intestinal cholesterol absorption	1.1102230246251565e-14	2.448596880810783e-10	6	6	46
Orphanet:101953	Rare dyslipidemia	GO:0065005	protein-lipid complex assembly	9.2148511043888e-15	2.0323354110729497e-10	9	22	46
Orphanet:101953	Rare dyslipidemia	GO:0032489	regulation of Cdc42 protein signal transduction	3.223799005525052e-11	7.110088706685502e-7	4	4	46
Orphanet:101953	Rare dyslipidemia	GO:0006631	fatty acid metabolic process	3.2457481147218914e-11	7.158497467019131e-7	12	348	46
Orphanet:101953	Rare dyslipidemia	GO:0031667	response to nutrient levels	3.419964311746071e-11	7.54273128955596e-7	14	546	46
Orphanet:101953	Rare dyslipidemia	GO:0034434	sterol esterification	5.6699089867606745e-11	1.2504984270300668e-6	5	12	46
Orphanet:101953	Rare dyslipidemia	GO:0034435	cholesterol esterification	5.6699089867606745e-11	1.2504984270300668e-6	5	12	46
Orphanet:101953	Rare dyslipidemia	GO:1901617	organic hydroxy compound biosynthetic process	1.4126821934468126e-10	3.115670577646945e-6	10	224	46
Orphanet:101953	Rare dyslipidemia	GO:0034185	apolipoprotein binding	1.4279810667261472e-10	3.1494122426645177e-6	5	14	46
Orphanet:101953	Rare dyslipidemia	GO:0051004	regulation of lipoprotein lipase activity	1.4279810667261472e-10	3.1494122426645177e-6	5	14	46
Orphanet:101953	Rare dyslipidemia	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	1.6088796961355456e-10	3.548384169826946e-6	4	5	46
Orphanet:101953	Rare dyslipidemia	GO:0010901	regulation of very-low-density lipoprotein particle remodeling	1.6088796961355456e-10	3.548384169826946e-6	4	5	46
Orphanet:101953	Rare dyslipidemia	GO:0055081	anion homeostasis	6.717436606962224e-10	1.4815306436655185e-5	6	41	46
Orphanet:101953	Rare dyslipidemia	GO:0046890	regulation of lipid biosynthetic process	7.232092702480486e-10	1.5950380455320712e-5	8	126	46
Orphanet:101953	Rare dyslipidemia	GO:0007584	response to nutrient	1.0608179890070346e-9	2.339634074755015e-5	9	197	46
Orphanet:101953	Rare dyslipidemia	GO:0010873	positive regulation of cholesterol esterification	1.1222351936623909e-9	2.475089719622403e-5	4	7	46
Orphanet:101953	Rare dyslipidemia	GO:0070508	cholesterol import	1.1222351936623909e-9	2.475089719622403e-5	4	7	46
Orphanet:101953	Rare dyslipidemia	GO:0034366	spherical high-density lipoprotein particle	2.240416185905758e-9	4.9412378980151495e-5	4	8	46
Orphanet:101953	Rare dyslipidemia	GO:0050994	regulation of lipid catabolic process	2.6412508846718197e-9	5.825278826143698e-5	6	51	46
Orphanet:101953	Rare dyslipidemia	GO:0046165	alcohol biosynthetic process	2.7488951115373084e-9	6.0626881684955336e-5	8	149	46
Orphanet:101953	Rare dyslipidemia	GO:0006694	steroid biosynthetic process	2.7488951115373084e-9	6.0626881684955336e-5	8	149	46
Orphanet:101953	Rare dyslipidemia	GO:0034384	high-density lipoprotein particle clearance	4.025500932591797e-9	8.878242306831208e-5	4	9	46
DOID:3068	glioblastoma multiforme	GO:0043069	negative regulation of programmed cell death	7.910005983546853e-12	1.7445518196712584e-7	17	806	46
DOID:3068	glioblastoma multiforme	GO:0048732	gland development	2.002831234193536e-11	4.417244287013844e-7	13	421	46
DOID:3068	glioblastoma multiforme	GO:0009887	organ morphogenesis	3.803213299846675e-11	8.387986932811842e-7	17	950	46
DOID:3068	glioblastoma multiforme	GO:0008284	positive regulation of cell proliferation	5.0993109734776e-10	1.1246530352004847e-5	15	815	46
DOID:3068	glioblastoma multiforme	GO:0048545	response to steroid hormone	5.544008585545157e-10	1.2227310935419844e-5	12	446	46
DOID:3068	glioblastoma multiforme	GO:0030900	forebrain development	7.865281759222853e-10	1.7346878919966002e-5	11	357	46
DOID:3068	glioblastoma multiforme	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	8.39416869347076e-10	1.8513339053449762e-5	16	996	46
DOID:3068	glioblastoma multiforme	GO:0051145	smooth muscle cell differentiation	9.074981877077448e-10	2.0014872529894312e-5	6	43	46
DOID:3068	glioblastoma multiforme	GO:0035265	organ growth	1.0490074364710722e-9	2.3135859011369497e-5	8	132	46
DOID:3068	glioblastoma multiforme	GO:1902533	positive regulation of intracellular signal transduction	1.0653908866231632e-9	2.3497196004473864e-5	15	860	46
DOID:3068	glioblastoma multiforme	GO:0050678	regulation of epithelial cell proliferation	1.1190744997335855e-9	2.468118809162423e-5	10	277	46
DOID:3068	glioblastoma multiforme	GO:0097084	vascular smooth muscle cell development	1.1222351936623909e-9	2.475089719622403e-5	4	7	46
DOID:3068	glioblastoma multiforme	GO:0048844	artery morphogenesis	2.6412508846718197e-9	5.825278826143698e-5	6	51	46
DOID:3068	glioblastoma multiforme	GO:0007167	enzyme linked receptor protein signaling pathway	3.3202884885952244e-9	7.322896261596767e-5	15	935	46
DOID:3068	glioblastoma multiforme	GO:0051093	negative regulation of developmental process	3.4655175396025584e-9	7.643198933593442e-5	14	788	46
DOID:3068	glioblastoma multiforme	GO:0001667	ameboidal-type cell migration	3.858498076603212e-9	8.509917507948384e-5	10	315	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0001775	cell activation	1.2958523143424827e-12	2.8580022792823456e-8	19	854	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0051249	regulation of lymphocyte activation	9.00834962180852e-13	1.986791509089869e-8	15	372	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050778	positive regulation of immune response	1.5654144647214707e-13	3.4525216019432037e-9	20	603	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050864	regulation of B cell activation	2.5159874184055298e-12	5.549010251293396e-8	9	100	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002253	activation of immune response	2.635780482762584e-12	5.813213854732879e-8	15	475	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050863	regulation of T cell activation	4.763189842549309e-12	1.0505215197742501e-7	12	284	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050727	regulation of inflammatory response	6.434852650727407e-12	1.4192067521179297e-7	12	289	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0001817	regulation of cytokine production	6.612155267760045e-12	1.458310844304478e-7	15	556	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002252	immune effector process	1.9756529745507123e-11	4.357302635371596e-7	16	757	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0051251	positive regulation of lymphocyte activation	2.649236385821041e-11	5.842890848928306e-7	11	257	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0070661	leukocyte proliferation	3.636124734640589e-11	8.019473102249819e-7	11	266	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0070663	regulation of leukocyte proliferation	4.582056956081715e-11	1.0105726616638222e-6	10	200	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050870	positive regulation of T cell activation	5.0879411794824136e-11	1.1221454271348463e-6	10	202	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0098552	side of membrane	1.7014079034538554e-10	3.752455131067478e-6	12	402	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0045087	innate immune response	2.9648838939522193e-10	6.53905142811162e-6	15	783	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0051250	negative regulation of lymphocyte activation	3.730111775013256e-10	8.226761519791737e-6	8	116	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002250	adaptive immune response	3.876482468356812e-10	8.54958208396095e-6	11	334	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0050670	regulation of lymphocyte proliferation	7.344523877961251e-10	1.619834741284354e-5	9	189	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0031294	lymphocyte costimulation	7.922679179372949e-10	1.747346893010704e-5	7	78	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002443	leukocyte mediated immunity	1.2008719574296833e-9	2.6485231021111666e-5	10	279	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0001818	negative regulation of cytokine production	1.3831594758428878e-9	3.050558223971489e-5	9	203	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.7879250302499372e-9	3.9432686542162365e-5	9	209	46
OMIM:152700	Systemic Lupus Erythematosus	GO:0002757	immune response-activating signal transduction	4.2020621426885896e-9	9.267648055699684e-5	11	419	46
DOID:9540	vascular skin disease	GO:0006954	inflammatory response	1.6451062734290645e-11	3.6282818860478017e-7	15	637	46
DOID:9540	vascular skin disease	GO:0071222	cellular response to lipopolysaccharide	1.0523926174954568e-10	2.32105191788623e-6	9	152	46
DOID:9540	vascular skin disease	GO:0050776	regulation of immune response	5.18800336024583e-10	1.1442141411022178e-5	15	816	46
DOID:9540	vascular skin disease	GO:0072358	cardiovascular system development	2.293780720918903e-9	5.058933379986641e-5	15	910	46
MESH:D013964	Thyroid Neoplasms	GO:0009725	response to hormone	1.0723155696723552e-10	2.3649919889123794e-6	16	865	46
MESH:D013964	Thyroid Neoplasms	GO:0097305	response to alcohol	1.111985725721354e-9	2.452484518078446e-5	11	369	46
Orphanet:553	Cushing syndrome	GO:1901698	response to nitrogen compound	1.253275261348108e-11	2.764098588903252e-7	17	870	46
Orphanet:553	Cushing syndrome	GO:0032870	cellular response to hormone stimulus	1.8550383451554353e-11	4.0912870702403126e-7	14	519	46
Orphanet:553	Cushing syndrome	GO:0042493	response to drug	3.986458940730131e-10	8.792135193780304e-6	12	433	46
Orphanet:553	Cushing syndrome	GO:0045786	negative regulation of cell cycle	6.007842001665153e-10	1.3250295534672496e-5	12	449	46
Orphanet:553	Cushing syndrome	GO:0010243	response to organonitrogen compound	3.0416811291900103e-9	6.708427730428568e-5	14	780	46
Orphanet:171915	B-cell non-Hodgkin lymphoma	GO:0048534	hematopoietic or lymphoid organ development	4.1171510645199305e-12	9.080376672798707e-8	17	739	46
Orphanet:171915	B-cell non-Hodgkin lymphoma	GO:0002521	leukocyte differentiation	3.628719547066339e-11	8.003140961054811e-7	13	448	46
Orphanet:171915	B-cell non-Hodgkin lymphoma	GO:0030098	lymphocyte differentiation	1.2063339216439317e-10	2.6605694641856914e-6	11	299	46
Orphanet:171915	B-cell non-Hodgkin lymphoma	GO:0051726	regulation of cell cycle	3.088775679671585e-9	6.81229476151568e-5	15	930	46
Orphanet:171915	B-cell non-Hodgkin lymphoma	GO:0043066	negative regulation of apoptotic process	3.883357635459106e-9	8.564745265005058e-5	14	795	46
Orphanet:289638	Epstein-Barr Virus-related tumor	GO:0051726	regulation of cell cycle	4.3284360540241096e-9	9.546365717150174e-5	15	930	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0005773	vacuole	1.8607337892717624e-13	4.103848372238872e-9	20	603	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0006665	sphingolipid metabolic process	3.1086244689504383e-15	6.856071266270192e-11	11	144	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:1901565	organonitrogen compound catabolic process	5.775380174100064e-13	1.2737600973977692e-8	14	349	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0044273	sulfur compound catabolic process	5.867972774353802e-12	1.294181395383731e-7	7	39	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0051235	maintenance of location	6.217193426749645e-11	1.3712020102696343e-6	11	274	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0006026	aminoglycan catabolic process	2.5056334784778755e-10	5.5261746367829545e-6	7	65	47
Orphanet:98711	Metabolic disease with corneal opacity	GO:0034380	high-density lipoprotein particle assembly	4.399013153744136e-9	9.702023510582691e-5	4	9	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0005773	vacuole	1.8607337892717624e-13	4.103848372238872e-9	33	603	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0006665	sphingolipid metabolic process	5.6621374255882984e-14	1.2487844092134992e-9	16	144	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0016798	hydrolase activity, acting on glycosyl bonds	8.826273045769994e-14	1.9466345202445723e-9	11	120	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0006672	ceramide metabolic process	1.4621637234313312e-13	3.224802092027801e-9	10	81	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0019377	glycolipid catabolic process	5.103695244201845e-13	1.1256199861087168e-8	6	14	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0006026	aminoglycan catabolic process	3.9929171080643755e-12	8.80637868183598e-8	8	65	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0098852	lytic vacuole membrane	5.749978271296641e-11	1.2681577077344741e-6	11	272	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0005765	lysosomal membrane	5.749978271296641e-11	1.2681577077344741e-6	11	272	47
Orphanet:225681	Lysosomal disease with epilepsy	GO:0015929	hexosaminidase activity	2.3920954106415593e-10	5.275766428169959e-6	5	15	47
DOID:3324	mood disorder	GO:0032940	secretion by cell	2.5662805214210493e-12	5.659931689994124e-8	18	956	47
DOID:3324	mood disorder	GO:1903530	regulation of secretion by cell	1.824529416438736e-11	4.023999627955632e-7	15	624	47
DOID:3324	mood disorder	GO:0071417	cellular response to organonitrogen compound	7.543321522973656e-11	1.6636795618918399e-6	13	462	47
DOID:3324	mood disorder	GO:0048878	chemical homeostasis	1.0869560806980871e-10	2.397281635979631e-6	17	988	47
DOID:3324	mood disorder	GO:0019725	cellular homeostasis	3.372178092320155e-10	7.437338782612102e-6	15	771	47
DOID:3324	mood disorder	GO:0055082	cellular chemical homeostasis	4.92306639898743e-10	1.0857822942966777e-5	14	661	47
DOID:3324	mood disorder	GO:0050801	ion homeostasis	5.646496603617379e-10	1.245334825927813e-5	14	668	47
DOID:3324	mood disorder	GO:0060548	negative regulation of cell death	1.6683324721711301e-9	3.6795072673734275e-5	15	867	47
DOID:3324	mood disorder	GO:0001934	positive regulation of protein phosphorylation	1.7487227221835155e-9	3.8568079637757435e-5	15	870	47
DOID:3324	mood disorder	GO:0051223	regulation of protein transport	1.778535096974565e-9	3.922559156377403e-5	14	730	47
DOID:3324	mood disorder	GO:0043434	response to peptide hormone	2.479698446578027e-9	5.4689749239278385e-5	11	389	47
DOID:3324	mood disorder	GO:0051050	positive regulation of transport	3.736090437023165e-9	8.239947458854591e-5	15	920	47
DOID:3827	congenital diaphragmatic hernia	GO:0051241	negative regulation of multicellular organismal process	5.323741447682551e-12	1.1741511762863865e-7	22	966	47
DOID:3827	congenital diaphragmatic hernia	GO:0033993	response to lipid	3.1861180360692742e-12	7.026983328550784e-8	19	850	47
DOID:3827	congenital diaphragmatic hernia	GO:0072358	cardiovascular system development	2.7327029528123603e-12	6.02697636242766e-8	20	910	47
DOID:3827	congenital diaphragmatic hernia	GO:0035295	tube development	1.560307438808195e-12	3.441258056291474e-8	20	573	47
DOID:3827	congenital diaphragmatic hernia	GO:0009887	organ morphogenesis	6.461498003318411e-13	1.4250833846318756e-8	26	950	47
DOID:3827	congenital diaphragmatic hernia	GO:0009952	anterior/posterior pattern specification	5.313527395855999e-13	1.1718984671560406e-8	12	199	47
DOID:3827	congenital diaphragmatic hernia	GO:0009790	embryo development	4.318767565791859e-13	9.525041866353945e-9	23	932	47
DOID:3827	congenital diaphragmatic hernia	GO:0030324	lung development	4.1810999107383395e-13	9.221415853133408e-9	11	175	47
DOID:3827	congenital diaphragmatic hernia	GO:0001944	vasculature development	3.7703173916270316e-13	8.315435007233418e-9	18	588	47
DOID:3827	congenital diaphragmatic hernia	GO:0061138	morphogenesis of a branching epithelium	2.6423307986078726e-13	5.827660576329663e-9	11	179	47
DOID:3827	congenital diaphragmatic hernia	GO:0035239	tube morphogenesis	2.2937207688755734e-13	5.058801155755077e-9	14	338	47
DOID:3827	congenital diaphragmatic hernia	GO:0042692	muscle cell differentiation	3.079758670310184e-13	6.792407747369111e-9	13	334	47
DOID:3827	congenital diaphragmatic hernia	GO:0035270	endocrine system development	5.229150445984487e-13	1.1532891308618787e-8	10	129	47
DOID:3827	congenital diaphragmatic hernia	GO:0001568	blood vessel development	8.166800569142652e-13	1.8011878655244118e-8	18	569	47
DOID:3827	congenital diaphragmatic hernia	GO:0022603	regulation of anatomical structure morphogenesis	1.3644640972643174e-12	3.009325566516452e-8	19	986	47
DOID:3827	congenital diaphragmatic hernia	GO:0048754	branching morphogenesis of an epithelial tube	2.6965096822095802e-12	5.947152104113229e-8	10	147	47
DOID:3827	congenital diaphragmatic hernia	GO:0060485	mesenchyme development	2.8602675783417908e-12	6.30832014403282e-8	12	237	47
DOID:3827	congenital diaphragmatic hernia	GO:0043009	chordate embryonic development	2.9118929489868606e-12	6.422179898990521e-8	16	552	47
DOID:3827	congenital diaphragmatic hernia	GO:0048514	blood vessel morphogenesis	3.099076550938662e-12	6.835013333095219e-8	17	484	47
DOID:3827	congenital diaphragmatic hernia	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	3.163913575576771e-12	6.978011390934569e-8	17	732	47
DOID:3827	congenital diaphragmatic hernia	GO:0033002	muscle cell proliferation	3.1773472741747355e-12	7.007639413192379e-8	10	151	47
DOID:3827	congenital diaphragmatic hernia	GO:0009612	response to mechanical stimulus	3.478883847662928e-12	7.672678326020588e-8	11	210	47
DOID:3827	congenital diaphragmatic hernia	GO:0060428	lung epithelium development	8.507639037702575e-12	1.8763597897653028e-7	7	41	47
DOID:3827	congenital diaphragmatic hernia	GO:0048738	cardiac muscle tissue development	9.397371769637175e-12	2.072590343793479e-7	10	168	47
DOID:3827	congenital diaphragmatic hernia	GO:0051146	striated muscle cell differentiation	1.0151435247962581e-11	2.2388990439381473e-7	11	230	47
DOID:3827	congenital diaphragmatic hernia	GO:0007610	behavior	1.0644707337803538e-11	2.3476902033525704e-7	16	714	47
DOID:3827	congenital diaphragmatic hernia	GO:0001501	skeletal system development	1.1126655152793319e-11	2.4539837939485665e-7	14	482	47
DOID:3827	congenital diaphragmatic hernia	GO:0008015	blood circulation	1.2776890656596152e-11	2.817943234312281e-7	14	489	47
DOID:3827	congenital diaphragmatic hernia	GO:0009725	response to hormone	1.4890533250877525e-11	3.284107108481038e-7	17	865	47
DOID:3827	congenital diaphragmatic hernia	GO:0014070	response to organic cyclic compound	1.7957857423311907e-11	3.960605454711441e-7	17	873	47
DOID:3827	congenital diaphragmatic hernia	GO:0009611	response to wounding	2.0027535185818124e-11	4.417072885232187e-7	17	875	47
DOID:3827	congenital diaphragmatic hernia	GO:0046660	female sex differentiation	2.5360491484605063e-11	5.593256396929647e-7	9	127	47
DOID:3827	congenital diaphragmatic hernia	GO:0019725	cellular homeostasis	3.39422934203526e-11	7.485972813858766e-7	16	771	47
DOID:3827	congenital diaphragmatic hernia	GO:0051093	negative regulation of developmental process	4.422096022693722e-11	9.752932778051004e-7	16	788	47
DOID:3827	congenital diaphragmatic hernia	GO:0040007	growth	4.5348280686141607e-11	1.0001563305328531e-6	17	936	47
DOID:3827	congenital diaphragmatic hernia	GO:0048565	digestive tract development	5.448030915289337e-11	1.2015632183670633e-6	9	138	47
DOID:3827	congenital diaphragmatic hernia	GO:0030855	epithelial cell differentiation	6.950451325593576e-11	1.5329220398596632e-6	14	568	47
DOID:3827	congenital diaphragmatic hernia	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.272275618191543e-10	2.806003875921448e-6	17	996	47
DOID:3827	congenital diaphragmatic hernia	GO:0008406	gonad development	1.4903478451344654e-10	3.2869621724440634e-6	10	220	47
DOID:3827	congenital diaphragmatic hernia	GO:0008083	growth factor activity	1.9307011545066644e-10	4.258161396264448e-6	9	159	47
DOID:3827	congenital diaphragmatic hernia	GO:0003018	vascular process in circulatory system	1.9307011545066644e-10	4.258161396264448e-6	9	159	47
DOID:3827	congenital diaphragmatic hernia	GO:0060419	heart growth	2.2396906551591655e-10	4.93963773995354e-6	7	64	47
DOID:3827	congenital diaphragmatic hernia	GO:0061448	connective tissue development	2.625346606777157e-10	5.79020194124702e-6	10	233	47
DOID:3827	congenital diaphragmatic hernia	GO:0001525	angiogenesis	3.0518687577085757e-10	6.730896545126264e-6	12	413	47
DOID:3827	congenital diaphragmatic hernia	GO:0032496	response to lipopolysaccharide	3.0794078398344027e-10	6.791633990754775e-6	11	319	47
DOID:3827	congenital diaphragmatic hernia	GO:0044706	multi-multicellular organism process	3.106388479778843e-10	6.851139792152239e-6	10	237	47
DOID:3827	congenital diaphragmatic hernia	GO:0071396	cellular response to lipid	3.3180724834380726e-10	7.318008862222669e-6	12	416	47
DOID:3827	congenital diaphragmatic hernia	GO:0046545	development of primary female sexual characteristics	3.621759558924964e-10	7.987790707209008e-6	8	113	47
DOID:3827	congenital diaphragmatic hernia	GO:0045165	cell fate commitment	3.9522363159960605e-10	8.716657194929311e-6	10	243	47
DOID:3827	congenital diaphragmatic hernia	GO:0042060	wound healing	4.340767745247831e-10	9.573563262144091e-6	13	534	47
DOID:3827	congenital diaphragmatic hernia	GO:0051270	regulation of cellular component movement	4.4506531793331305e-10	9.81591558701922e-6	15	787	47
DOID:3827	congenital diaphragmatic hernia	GO:0055082	cellular chemical homeostasis	4.92306639898743e-10	1.0857822942966777e-5	14	661	47
DOID:3827	congenital diaphragmatic hernia	GO:0050673	epithelial cell proliferation	5.15250397903344e-10	1.1363847525758253e-5	11	335	47
DOID:3827	congenital diaphragmatic hernia	GO:0051216	cartilage development	5.84156056859797e-10	1.2883561834042823e-5	9	180	47
DOID:3827	congenital diaphragmatic hernia	GO:0007517	muscle organ development	6.029625687631324e-10	1.3298339454070884e-5	11	340	47
DOID:3827	congenital diaphragmatic hernia	GO:0045597	positive regulation of cell differentiation	7.168784454947286e-10	1.581075411538624e-5	15	815	47
DOID:3827	congenital diaphragmatic hernia	GO:0048545	response to steroid hormone	7.291893755478895e-10	1.6082271677708704e-5	12	446	47
DOID:3827	congenital diaphragmatic hernia	GO:0043410	positive regulation of MAPK cascade	1.1464402760452685e-9	2.5284740288178398e-5	12	464	47
DOID:3827	congenital diaphragmatic hernia	GO:0043269	regulation of ion transport	1.246992953340964e-9	2.7502429585934962e-5	13	583	47
DOID:3827	congenital diaphragmatic hernia	GO:0050678	regulation of epithelial cell proliferation	1.4035580475635356e-9	3.095547273901378e-5	10	277	47
DOID:3827	congenital diaphragmatic hernia	GO:0097305	response to alcohol	1.4264811554198786e-9	3.146104188278542e-5	11	369	47
DOID:3827	congenital diaphragmatic hernia	GO:0050880	regulation of blood vessel size	1.8964579906466383e-9	4.182638098371161e-5	8	139	47
DOID:3827	congenital diaphragmatic hernia	GO:0043279	response to alkaloid	2.007614741117436e-9	4.427794311534505e-5	8	140	47
DOID:3827	congenital diaphragmatic hernia	GO:0051924	regulation of calcium ion transport	2.012538136142439e-9	4.438652859262149e-5	9	207	47
DOID:3827	congenital diaphragmatic hernia	GO:0055007	cardiac muscle cell differentiation	2.0170642933692307e-9	4.448635299025838e-5	7	87	47
DOID:3827	congenital diaphragmatic hernia	GO:0030335	positive regulation of cell migration	2.3490154266170293e-9	5.180753523403858e-5	11	387	47
DOID:3827	congenital diaphragmatic hernia	GO:0003012	muscle system process	2.758947181824567e-9	6.0848580095140825e-5	11	393	47
DOID:3827	congenital diaphragmatic hernia	GO:0044057	regulation of system process	3.183634800230095e-9	7.021506551907475e-5	12	508	47
DOID:3827	congenital diaphragmatic hernia	GO:0048609	multicellular organismal reproductive process	3.359700295746393e-9	7.40981900226867e-5	14	767	47
DOID:3827	congenital diaphragmatic hernia	GO:0035282	segmentation	3.487363731125015e-9	7.69138070899622e-5	7	94	47
DOID:3827	congenital diaphragmatic hernia	GO:0043542	endothelial cell migration	3.6566012440175655e-9	8.06463404368074e-5	8	151	47
DOID:3827	congenital diaphragmatic hernia	GO:0032870	cellular response to hormone stimulus	4.046004420388272e-9	8.923462749166333e-5	12	519	47
DOID:3827	congenital diaphragmatic hernia	GO:0048568	embryonic organ development	4.0770717912863574e-9	8.991981835682061e-5	11	408	47
Orphanet:183625	Rare genetic diabetes mellitus	GO:0030072	peptide hormone secretion	2.1526447291364548e-11	4.747657950110451e-7	11	241	48
Orphanet:183625	Rare genetic diabetes mellitus	GO:0042493	response to drug	6.821782028154644e-10	1.5045440263095067e-5	12	433	48
Orphanet:183625	Rare genetic diabetes mellitus	GO:0031016	pancreas development	1.08240127971726e-9	2.387236022416417e-5	7	78	48
MESH:D010900	Pituitary Diseases	GO:0040014	regulation of multicellular organism growth	4.6491699379203055e-12	1.0253744298083234e-7	8	65	48
MESH:D010900	Pituitary Diseases	GO:0040018	positive regulation of multicellular organism growth	1.7985801736841722e-10	3.966768573060442e-6	6	32	48
MESH:D010900	Pituitary Diseases	GO:0048009	insulin-like growth factor receptor signaling pathway	3.203111109684187e-10	7.064461552408474e-6	6	35	48
MESH:D010900	Pituitary Diseases	GO:0005179	hormone activity	5.717883944100777e-10	1.2610793038714263e-5	8	117	48
MESH:D010900	Pituitary Diseases	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	2.3093894574444107e-9	5.093358448393648e-5	5	22	48
MESH:D010900	Pituitary Diseases	GO:1901698	response to nitrogen compound	2.433781620680975e-9	5.36770536441189e-5	15	870	48
Orphanet:309447	Disorder of protein O-glycosylation	GO:0030166	proteoglycan biosynthetic process	1.0813572259849025e-13	2.3849333619097024e-9	10	60	48
Orphanet:309447	Disorder of protein O-glycosylation	GO:0006024	glycosaminoglycan biosynthetic process	1.8129941992128806e-13	3.998558706364008e-9	12	111	48
Orphanet:309447	Disorder of protein O-glycosylation	GO:0015020	glucuronosyltransferase activity	3.203111109684187e-10	7.064461552408474e-6	6	35	48
DOID:9120	amyloidosis	GO:0001775	cell activation	1.809569161181912e-10	3.991004784986707e-6	16	854	48
DOID:9120	amyloidosis	GO:0098602	single organism cell adhesion	2.977386115432523e-10	6.56662507758643e-6	15	746	48
DOID:9120	amyloidosis	GO:0030155	regulation of cell adhesion	2.979507751632582e-10	6.571304346225659e-6	14	621	48
DOID:9120	amyloidosis	GO:0051093	negative regulation of developmental process	6.32042862491744e-10	1.3939705332255414e-5	15	788	48
DOID:9120	amyloidosis	GO:0010038	response to metal ion	6.580990197235792e-10	1.451437388000354e-5	11	335	48
DOID:9120	amyloidosis	GO:0051241	negative regulation of multicellular organismal process	1.094497159570551e-9	2.4139134854328503e-5	16	966	48
DOID:9120	amyloidosis	GO:0016337	single organismal cell-cell adhesion	1.3359876538387994e-9	2.946520770541472e-5	14	697	48
DOID:9120	amyloidosis	GO:0034109	homotypic cell-cell adhesion	3.093193368108871e-9	6.822037973364115e-5	12	495	48
DOID:9120	amyloidosis	GO:0051707	response to other organism	3.742154697228273e-9	8.253322184736955e-5	15	898	48
MESH:D014786	Vision Disorders	GO:0007600	sensory perception	1.8973711490843925e-12	4.184652069305628e-8	33	902	48
MESH:D014786	Vision Disorders	GO:0072372	primary cilium	6.072919944699606e-13	1.3393824938034982e-8	14	199	48
MESH:D014786	Vision Disorders	GO:0042462	eye photoreceptor cell development	8.738565426824607e-13	1.927290604886167e-8	7	30	48
MESH:D014786	Vision Disorders	GO:0071482	cellular response to light stimulus	3.2335334410049654e-10	7.131558004136451e-6	8	109	48
MESH:D014786	Vision Disorders	GO:0042622	photoreceptor outer segment membrane	3.8748348973882685e-10	8.545948366189826e-6	5	16	48
MESH:D014786	Vision Disorders	GO:0060041	retina development in camera-type eye	1.411019523445134e-9	3.112003558958243e-5	8	131	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0044463	cell projection part	1.503464019947387e-12	3.315889895993962e-8	29	939	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0097014	ciliary cytoplasm	6.350475700855895e-14	1.4005974158237677e-9	19	90	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0005930	axoneme	6.350475700855895e-14	1.4005974158237677e-9	19	90	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0031514	motile cilium	1.871836019518014e-13	4.12833434104698e-9	10	98	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0072372	primary cilium	1.8394175071989594e-12	4.056835312127305e-8	11	199	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0001539	cilium or flagellum-dependent cell motility	7.850387007124482e-12	1.7314028544213045e-7	6	20	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0003352	regulation of cilium movement	7.078915231772953e-11	1.5612547543675248e-6	5	12	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0060285	cilium-dependent cell motility	2.668988363652147e-10	5.886453836034811e-6	5	15	48
Orphanet:399813	Male infertility due to sperm motility disorder	GO:0003351	epithelial cilium movement	7.571274718287668e-10	1.6698446391183452e-5	5	18	48
Orphanet:101952	Rare diabetes mellitus	GO:0042493	response to drug	6.821782028154644e-10	1.5045440263095067e-5	12	433	48
Orphanet:101952	Rare diabetes mellitus	GO:0031016	pancreas development	1.08240127971726e-9	2.387236022416417e-5	7	78	48
DOID:9744	type 1 diabetes mellitus	GO:0070489	T cell aggregation	3.5148772781212756e-11	7.752061836896473e-7	13	424	48
DOID:9744	type 1 diabetes mellitus	GO:0042110	T cell activation	3.5148772781212756e-11	7.752061836896473e-7	13	424	48
DOID:9744	type 1 diabetes mellitus	GO:0050776	regulation of immune response	9.746747853256466e-11	2.1496452390357135e-6	16	816	48
DOID:9744	type 1 diabetes mellitus	GO:0009306	protein secretion	9.970746450704837e-11	2.199048129702952e-6	13	462	48
DOID:9744	type 1 diabetes mellitus	GO:0001819	positive regulation of cytokine production	1.573928765097321e-10	3.4712998914221416e-6	12	381	48
DOID:9744	type 1 diabetes mellitus	GO:0071216	cellular response to biotic stimulus	5.555294002590472e-10	1.2252200922713286e-5	9	175	48
DOID:9744	type 1 diabetes mellitus	GO:1903409	reactive oxygen species biosynthetic process	1.6847567785305273e-9	3.715731075049078e-5	7	83	48
Orphanet:69028	Syndrome with brachydactyly	GO:0051216	cartilage development	1.0635936575909e-12	2.34575581181673e-8	13	180	48
Orphanet:69028	Syndrome with brachydactyly	GO:0035107	appendage morphogenesis	3.248512570053208e-12	7.16459447325235e-8	10	146	48
Orphanet:69028	Syndrome with brachydactyly	GO:0035108	limb morphogenesis	3.248512570053208e-12	7.16459447325235e-8	10	146	48
Orphanet:69028	Syndrome with brachydactyly	GO:0009790	embryo development	6.274358810287595e-11	1.383809835608929e-6	17	932	48
Orphanet:69028	Syndrome with brachydactyly	GO:0035113	embryonic appendage morphogenesis	9.702990633186914e-10	2.139994584149374e-5	8	125	48
Orphanet:69028	Syndrome with brachydactyly	GO:0030326	embryonic limb morphogenesis	9.702990633186914e-10	2.139994584149374e-5	8	125	48
Orphanet:98712	Metabolic disease with cataract	GO:0055114	oxidation-reduction process	7.302713989076892e-12	1.6106135702909086e-7	18	949	48
Orphanet:98712	Metabolic disease with cataract	GO:0044283	small molecule biosynthetic process	4.2188363913453486e-11	9.304643661112166e-7	14	530	48
Orphanet:98712	Metabolic disease with cataract	GO:0010035	response to inorganic substance	2.7154911652615965e-10	5.989015764984451e-6	13	502	48
Orphanet:98712	Metabolic disease with cataract	GO:1901607	alpha-amino acid biosynthetic process	6.739834246261012e-10	1.4864704430128661e-5	7	73	48
Orphanet:98712	Metabolic disease with cataract	GO:0044282	small molecule catabolic process	8.982985466587934e-10	1.9811974446559688e-5	11	345	48
Orphanet:98712	Metabolic disease with cataract	GO:0016491	oxidoreductase activity	1.6938719316073048e-9	3.7358345451599106e-5	14	710	48
DOID:1588	thrombocytopenia	GO:0072376	protein activation cascade	1.3300471835009375e-13	2.9334190632113177e-9	11	79	48
DOID:1588	thrombocytopenia	GO:0007599	hemostasis	7.608358387756198e-13	1.6780234424196294e-8	15	357	48
DOID:1588	thrombocytopenia	GO:0007596	blood coagulation	9.390266342279574e-13	2.07102324178976e-8	15	352	48
DOID:1588	thrombocytopenia	GO:0030168	platelet activation	8.215206293016308e-12	1.8118637479247468e-7	10	162	48
DOID:1588	thrombocytopenia	GO:0016485	protein processing	2.705508039824167e-10	5.9669979818322005e-6	11	308	48
Orphanet:1531	Craniosynostosis	GO:0009887	organ morphogenesis	7.422951142643797e-13	1.6371318745100893e-8	24	950	48
DOID:1192	peripheral nervous system neoplasm	GO:0019900	kinase binding	2.258587428194403e-9	4.981314572882756e-5	13	598	48
Orphanet:97945	Intestinal malformation	GO:0009790	embryo development	9.258043220938816e-10	2.041861432378056e-5	16	932	49
Orphanet:97945	Intestinal malformation	GO:0090066	regulation of anatomical structure size	1.980464015005623e-9	4.3679133850949015e-5	12	465	49
MESH:D009164	Mycobacterium Infections	GO:0006954	inflammatory response	5.625880872273115e-10	1.2407880263798354e-5	14	637	49
MESH:D009164	Mycobacterium Infections	GO:0030139	endocytic vesicle	8.388627570354856e-10	1.8501118106417636e-5	10	251	49
Orphanet:307058	Miscellaneous movement disorder due to genetic neurodegenerative disease	GO:0019725	cellular homeostasis	6.337708136072706e-11	1.3977815294108353e-6	16	771	49
Orphanet:307058	Miscellaneous movement disorder due to genetic neurodegenerative disease	GO:0006873	cellular ion homeostasis	7.29688531819761e-10	1.609328056928483e-5	13	532	49
Orphanet:307058	Miscellaneous movement disorder due to genetic neurodegenerative disease	GO:0098771	inorganic ion homeostasis	3.717328667107722e-9	8.198568375306081e-5	13	609	49
Orphanet:289635	Rare virus associated tumor	GO:0010942	positive regulation of cell death	2.3659685322030555e-10	5.218143597773839e-6	14	596	49
Orphanet:289635	Rare virus associated tumor	GO:0030155	regulation of cell adhesion	4.0432801551304465e-10	8.9174543821402e-6	14	621	49
Orphanet:289635	Rare virus associated tumor	GO:0032844	regulation of homeostatic process	7.558501602389356e-10	1.6670275284069724e-5	12	427	49
Orphanet:289635	Rare virus associated tumor	GO:0042493	response to drug	8.843350496334779e-10	1.9504009519666354e-5	12	433	49
Orphanet:289635	Rare virus associated tumor	GO:0043065	positive regulation of apoptotic process	1.2429884899134436e-9	2.7414111145040998e-5	13	556	49
Orphanet:289635	Rare virus associated tumor	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	1.7936097052029254e-9	3.955806204825052e-5	6	45	49
Orphanet:289635	Rare virus associated tumor	GO:0050851	antigen receptor-mediated signaling pathway	2.5073348952631136e-9	5.529927111502797e-5	9	203	49
Orphanet:289635	Rare virus associated tumor	GO:1901701	cellular response to oxygen-containing compound	3.516020474769732e-9	7.754583157104644e-5	15	873	49
Orphanet:289635	Rare virus associated tumor	GO:0009611	response to wounding	3.6275914494510175e-9	8.000652941764219e-5	15	875	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0060541	respiratory system development	4.5274894944213884e-13	9.985378079946372e-9	12	202	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0048608	reproductive structure development	3.8321013029474216e-11	8.451699423650538e-7	13	418	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0048732	gland development	4.43436398711583e-11	9.779989773583964e-7	13	421	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0048863	stem cell differentiation	7.420397629687159e-11	1.6365686972275029e-6	11	266	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0008284	positive regulation of cell proliferation	1.3433054668610112e-10	2.96266020716196e-6	16	815	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0045596	negative regulation of cell differentiation	2.4213009375273487e-10	5.3401792177165675e-6	14	597	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:1901342	regulation of vasculature development	3.2912594871703504e-10	7.258872798954208e-6	10	228	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0035051	cardiocyte differentiation	3.3121971831917563e-10	7.3050508875294184e-6	8	107	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0071383	cellular response to steroid hormone stimulus	3.3911651264872944e-10	7.479214686467728e-6	9	162	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0060284	regulation of cell development	1.711193742259809e-9	3.7740377985540086e-5	15	828	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0001503	ossification	1.941217186995914e-9	4.281354505919488e-5	11	363	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0003279	cardiac septum development	2.132232501672604e-9	4.702638782438928e-5	7	84	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0060548	negative regulation of cell death	3.20287951716125e-9	7.063950775099137e-5	15	867	49
Orphanet:108977	Non-syndromic diaphragmatic or abdominal wall malformation	GO:0007568	aging	3.3730214177296602e-9	7.439198736802766e-5	10	290	49
Orphanet:371064	Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature	GO:0005789	endoplasmic reticulum membrane	9.519496302345942e-12	2.0995249094823976e-7	21	977	49
Orphanet:371064	Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature	GO:0000030	mannosyltransferase activity	3.730349362740526e-14	8.22728551952423e-10	8	24	49
Orphanet:371064	Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature	GO:0006488	dolichol-linked oligosaccharide biosynthetic process	6.272760089132134e-14	1.3834572376580923e-9	7	20	49
Orphanet:371064	Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature	GO:0006487	protein N-linked glycosylation	1.142419492339286e-13	2.5196061903542954e-9	11	74	49
Orphanet:371064	Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature	GO:0000139	Golgi membrane	2.1765922397776194e-12	4.8004741848295396e-8	23	691	49
OMIM:105400	amyotrophic lateral sclerosis type 1	GO:0010035	response to inorganic substance	3.598841225027627e-10	7.937244321798431e-6	13	502	49
OMIM:105400	amyotrophic lateral sclerosis type 1	GO:0045104	intermediate filament cytoskeleton organization	1.162117624353698e-9	2.5630504205120808e-5	6	42	49
OMIM:105400	amyotrophic lateral sclerosis type 1	GO:0014070	response to organic cyclic compound	3.516020474769732e-9	7.754583157104644e-5	15	873	49
DOID:5113	nutritional deficiency disease	GO:0006066	alcohol metabolic process	1.7985612998927536e-14	3.966726946913468e-10	14	382	49
DOID:5113	nutritional deficiency disease	GO:0050801	ion homeostasis	8.898393133449645e-11	1.962540605582319e-6	15	668	49
DOID:5113	nutritional deficiency disease	GO:0031526	brush border membrane	1.0100209557606377e-10	2.2276012179300864e-6	7	55	49
DOID:5113	nutritional deficiency disease	GO:0098771	inorganic ion homeostasis	3.141525928285205e-10	6.928635434833019e-6	14	609	49
DOID:5113	nutritional deficiency disease	GO:0006873	cellular ion homeostasis	7.29688531819761e-10	1.609328056928483e-5	13	532	49
DOID:5113	nutritional deficiency disease	GO:0007584	response to nutrient	1.9251829019850675e-9	4.245990890328066e-5	9	197	49
DOID:3069	astrocytoma	GO:0048534	hematopoietic or lymphoid organ development	3.3475222593892795e-11	7.382960343083056e-7	16	739	49
DOID:3069	astrocytoma	GO:0060322	head development	1.980120512001804e-10	4.367155789219979e-6	15	708	49
DOID:3069	astrocytoma	GO:0008285	negative regulation of cell proliferation	5.305086370199774e-10	1.1700367989475602e-5	14	634	49
DOID:3069	astrocytoma	GO:0043410	positive regulation of MAPK cascade	1.9329079448127118e-9	4.263028472284436e-5	12	464	49
MESH:D055370	Lung Injury	GO:0006954	inflammatory response	1.340039190722564e-13	2.9554564351386148e-9	17	637	49
MESH:D055370	Lung Injury	GO:1903409	reactive oxygen species biosynthetic process	9.547918011776346e-13	2.105793317497273e-8	9	83	49
MESH:D055370	Lung Injury	GO:0071345	cellular response to cytokine stimulus	1.245337166722038e-12	2.746591121205455e-8	17	677	49
MESH:D055370	Lung Injury	GO:0002237	response to molecule of bacterial origin	1.8599566331545248e-12	4.1021343544223043e-8	13	333	49
MESH:D055370	Lung Injury	GO:0042108	positive regulation of cytokine biosynthetic process	2.3778756741421603e-12	5.2444047993205345e-8	8	59	49
MESH:D055370	Lung Injury	GO:0032496	response to lipopolysaccharide	2.4520385721871207e-12	5.407971070958695e-8	13	319	49
MESH:D055370	Lung Injury	GO:0009611	response to wounding	3.0824232055692846e-12	6.798284379883057e-8	20	875	49
MESH:D055370	Lung Injury	GO:0002684	positive regulation of immune system process	4.664268971055208e-12	1.028704521566226e-7	18	872	49
MESH:D055370	Lung Injury	GO:0002699	positive regulation of immune effector process	4.712119583416552e-12	1.0392579741225205e-7	10	150	49
MESH:D055370	Lung Injury	GO:0002703	regulation of leukocyte mediated immunity	5.097922084473794e-12	1.1243467157306952e-7	10	151	49
MESH:D055370	Lung Injury	GO:0002694	regulation of leukocyte activation	5.287215110172383e-12	1.1660952925485191e-7	14	425	49
MESH:D055370	Lung Injury	GO:0071222	cellular response to lipopolysaccharide	5.67501601267395e-12	1.2516247815952397e-7	10	152	49
MESH:D055370	Lung Injury	GO:0051249	regulation of lymphocyte activation	8.329004153040387e-12	1.8369618659530573e-7	13	372	49
MESH:D055370	Lung Injury	GO:0032103	positive regulation of response to external stimulus	9.399037104174113e-12	2.0729576333256006e-7	12	285	49
MESH:D055370	Lung Injury	GO:0050727	regulation of inflammatory response	1.1384226894506355e-11	2.5107912415833766e-7	12	289	49
MESH:D055370	Lung Injury	GO:0050729	positive regulation of inflammatory response	1.4415801885547808e-11	3.179405105857569e-7	9	114	49
MESH:D055370	Lung Injury	GO:0008284	positive regulation of cell proliferation	1.5436096845178326e-11	3.40443115920408e-7	17	815	49
MESH:D055370	Lung Injury	GO:1902533	positive regulation of intracellular signal transduction	3.18133297483314e-11	7.01642987599449e-7	17	860	49
MESH:D055370	Lung Injury	GO:0009636	response to toxic substance	3.751621235892344e-11	8.274200635760565e-7	11	249	49
MESH:D055370	Lung Injury	GO:0031663	lipopolysaccharide-mediated signaling pathway	4.325828584228475e-11	9.540614942515901e-7	7	49	49
MESH:D055370	Lung Injury	GO:0002685	regulation of leukocyte migration	1.6068157915327674e-10	3.5438322282255186e-6	9	149	49
MESH:D055370	Lung Injury	GO:0002700	regulation of production of molecular mediator of immune response	1.7676249353115736e-10	3.898496794829676e-6	8	99	49
MESH:D055370	Lung Injury	GO:0030335	positive regulation of cell migration	2.4560731226586086e-10	5.416869272023561e-6	12	387	49
MESH:D055370	Lung Injury	GO:0005125	cytokine activity	2.534332743664436e-10	5.589470866151913e-6	10	222	49
MESH:D055370	Lung Injury	GO:0002687	positive regulation of leukocyte migration	3.845661566970193e-10	8.481606585952761e-6	8	109	49
MESH:D055370	Lung Injury	GO:0019221	cytokine-mediated signaling pathway	7.639501253819958e-10	1.6848920015299917e-5	13	534	49
MESH:D055370	Lung Injury	GO:0050921	positive regulation of chemotaxis	7.780278643565453e-10	1.7159404548383606e-5	8	119	49
MESH:D055370	Lung Injury	GO:0042493	response to drug	8.843350496334779e-10	1.9504009519666354e-5	12	433	49
MESH:D055370	Lung Injury	GO:0050671	positive regulation of lymphocyte proliferation	1.3090040162921923e-9	2.88700835793243e-5	8	127	49
MESH:D055370	Lung Injury	GO:0005126	cytokine receptor binding	1.6959815773986975e-9	3.740487368952827e-5	10	270	49
MESH:D055370	Lung Injury	GO:0007584	response to nutrient	1.9251829019850675e-9	4.245990890328066e-5	9	197	49
MESH:D055370	Lung Injury	GO:0002705	positive regulation of leukocyte mediated immunity	1.9585648658448918e-9	4.319614811620909e-5	7	83	49
MESH:D055370	Lung Injury	GO:0097305	response to alcohol	2.3033108753622855e-9	5.079952135611521e-5	11	369	49
MESH:D055370	Lung Injury	GO:0002366	leukocyte activation involved in immune response	3.1047749926571555e-9	6.847581246305356e-5	9	208	49
MESH:D055370	Lung Injury	GO:0001934	positive regulation of protein phosphorylation	3.3565953350134237e-9	7.402971011372106e-5	15	870	49
MESH:D055370	Lung Injury	GO:0014070	response to organic cyclic compound	3.516020474769732e-9	7.754583157104644e-5	15	873	49
MESH:D055370	Lung Injury	GO:0043491	protein kinase B signaling	3.5542803145105495e-9	7.838965233653017e-5	8	144	49
MESH:D055370	Lung Injury	GO:0045428	regulation of nitric oxide biosynthetic process	3.918850244311045e-9	8.64302421382801e-5	6	51	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0043005	neuron projection	3.220756994437579e-12	7.103379551232081e-8	19	941	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	1.1184386750073827e-12	2.4667164977287825e-8	16	173	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0032940	secretion by cell	1.0980105713542798e-12	2.421662315121864e-8	19	956	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007623	circadian rhythm	7.915890165577366e-13	1.745849576018088e-8	14	196	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007612	learning	3.1041835768519377e-13	6.8462768787469486e-9	11	130	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0043279	response to alkaloid	1.971756091734278e-13	4.34870806031995e-9	13	140	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	1.1302070390684094e-13	2.492671624665377e-9	10	68	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0031644	regulation of neurological system process	1.1302070390684094e-13	2.492671624665377e-9	10	68	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0019233	sensory perception of pain	4.418687638008123e-14	9.745415585626915e-10	11	101	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0051952	regulation of amine transport	1.4432899320127035e-14	3.1831759450540176e-10	10	72	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0008306	associative learning	5.329070518200751e-15	1.1753265027891757e-10	11	73	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0035094	response to nicotine	3.1086244689504383e-15	6.856071266270192e-11	10	54	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0042752	regulation of circadian rhythm	2.220446049250313e-15	4.8971937616215655e-11	12	104	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0030431	sleep	2.8754776337791554e-14	6.341865921299927e-10	10	37	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0030594	neurotransmitter receptor activity	4.163336342344337e-14	9.182238303040435e-10	10	84	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0070405	ammonium ion binding	7.049916206369744e-14	1.554859019314847e-9	9	65	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007631	feeding behavior	7.593925488436071e-14	1.6748402664745754e-9	15	106	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007613	memory	9.325873406851315e-14	2.0568213798810575e-9	13	99	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007626	locomotory behavior	1.0169642905566434e-13	2.242914742822677e-9	11	183	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0015844	monoamine transport	1.142419492339286e-13	2.5196061903542954e-9	9	70	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0051046	regulation of secretion	1.284528039491306e-13	2.8330265910980756e-9	19	675	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0045187	regulation of circadian sleep/wake cycle, sleep	1.3955503419538218e-13	3.077886279179154e-9	7	23	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0003014	renal system process	3.331779296900095e-13	7.348239239313159e-9	10	109	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0098794	postsynapse	4.3509640335059885e-13	9.596051175897458e-9	14	381	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0043269	regulation of ion transport	5.183631301974856e-13	1.1432498836505545e-8	16	583	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007268	synaptic transmission	9.167111514329918e-13	2.0218064444854633e-8	31	605	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	9.335865414072941e-13	2.0590251170737872e-8	9	86	49
MESH:D013375	Substance Withdrawal Syndrome	GO:1903530	regulation of secretion by cell	1.1648459974367142e-12	2.5690678473466733e-8	18	624	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0005231	excitatory extracellular ligand-gated ion channel activity	1.5053513990892498e-12	3.32005251069134e-8	8	56	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0044070	regulation of anion transport	1.7877921365538896e-12	3.9429755571696035e-8	10	135	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0051937	catecholamine transport	2.013722522065109e-12	4.441265022414598e-8	8	58	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0015696	ammonium transport	2.046030012081701e-12	4.5125191916461915e-8	9	92	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0015872	dopamine transport	2.14572803969304e-12	4.732403191543e-8	7	33	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0050804	modulation of synaptic transmission	2.313482738713901e-12	5.102386180233509e-8	18	285	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0023061	signal release	3.360645095540349e-12	7.41190275821424e-8	14	416	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0003013	circulatory system process	3.42204042880212e-12	7.547310165723076e-8	17	493	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0008015	blood circulation	3.74333897212864e-12	8.255934103029716e-8	17	489	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0052652	cyclic purine nucleotide metabolic process	4.072520098929999e-12	8.981943078190113e-8	10	147	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0045211	postsynaptic membrane	4.587552560053609e-12	1.0117847171198235e-7	11	206	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0050878	regulation of body fluid levels	5.875411268618791e-12	1.2958219552938743e-7	15	504	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007271	synaptic transmission, cholinergic	7.995715201047915e-12	1.7634549875911176e-7	7	39	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0046879	hormone secretion	1.2560064099886858e-11	2.7701221372300466e-7	12	297	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0008217	regulation of blood pressure	1.5102696870883392e-11	3.330899794873332e-7	10	168	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0050433	regulation of catecholamine secretion	1.6544210446056695e-11	3.648825613877804e-7	7	43	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0014046	dopamine secretion	1.721744968818939e-11	3.79730852873017e-7	6	22	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0014059	regulation of dopamine secretion	1.721744968818939e-11	3.79730852873017e-7	6	22	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0050803	regulation of synapse structure or activity	1.9029888775889958e-11	4.1970419695225303e-7	11	233	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0015464	acetylcholine receptor activity	3.085631750110451e-11	6.8053608248686e-7	6	24	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0046883	regulation of hormone secretion	4.2971626257326534e-11	9.477392171053367e-7	11	252	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0030802	regulation of cyclic nucleotide biosynthetic process	5.795630642069227e-11	1.278226338108368e-6	9	133	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0050880	regulation of blood vessel size	8.623113334493837e-11	1.9018276459226158e-6	9	139	49
MESH:D013375	Substance Withdrawal Syndrome	GO:1900371	regulation of purine nucleotide biosynthetic process	8.623113334493837e-11	1.9018276459226158e-6	9	139	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0048167	regulation of synaptic plasticity	9.187106631003417e-11	2.0262163674678035e-6	9	140	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0060359	response to ammonium ion	9.742151529934517e-11	2.148631519927058e-6	8	92	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0004930	G-protein coupled receptor activity	1.2155665363167145e-10	2.680931995846514e-6	16	809	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0046717	acid secretion	3.070497189838761e-10	6.771981552189388e-6	8	106	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0009725	response to hormone	3.139316584466201e-10	6.923762727040206e-6	16	865	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0051931	regulation of sensory perception	4.365898753633246e-10	9.628989701138124e-6	6	36	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0051930	regulation of sensory perception of pain	4.365898753633246e-10	9.628989701138124e-6	6	36	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0030817	regulation of cAMP biosynthetic process	5.13928011258713e-10	1.1334682288310916e-5	8	113	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0004889	acetylcholine-activated cation-selective channel activity	6.097929938775337e-10	1.3448984479969006e-5	5	17	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0005892	acetylcholine-gated channel complex	8.427243347597368e-10	1.8586285203125996e-5	5	18	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0042493	response to drug	8.843350496334779e-10	1.9504009519666354e-5	12	433	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0042391	regulation of membrane potential	9.76157377152731e-10	2.1529150953103482e-5	11	340	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0042166	acetylcholine binding	1.1414504896833932e-9	2.5174690549967238e-5	5	19	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0045776	negative regulation of blood pressure	1.3478606009087457e-9	2.9727065553042387e-5	6	43	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0007270	neuron-neuron synaptic transmission	1.5769362482487281e-9	3.47793289551257e-5	8	130	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0008542	visual learning	1.7936097052029254e-9	3.955806204825052e-5	6	45	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0006816	calcium ion transport	2.115323805007563e-9	4.66534665194418e-5	11	366	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0097305	response to alcohol	2.3033108753622855e-9	5.079952135611521e-5	11	369	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0045471	response to ethanol	2.3938535598233557e-9	5.279644026190411e-5	8	137	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0033993	response to lipid	2.4415152122259087e-9	5.384761800564242e-5	15	850	49
MESH:D013375	Substance Withdrawal Syndrome	GO:0022600	digestive system process	2.7343847186500625e-9	6.030685496982713e-5	7	87	49
MESH:D013375	Substance Withdrawal Syndrome	GO:1903522	regulation of blood circulation	4.237752704305819e-9	9.346363589346485e-5	10	297	49
DOID:706	mature B-cell neoplasm	GO:0051093	negative regulation of developmental process	1.1774947683562687e-10	2.5969647116097505e-6	16	788	50
DOID:2349	arteriosclerosis	GO:2000377	regulation of reactive oxygen species metabolic process	3.97015753605956e-13	8.756182445779359e-9	13	147	50
DOID:2349	arteriosclerosis	GO:1903409	reactive oxygen species biosynthetic process	5.417888360170764e-14	1.194915277835662e-9	11	83	50
DOID:2349	arteriosclerosis	GO:0001816	cytokine production	7.188694084447889e-13	1.5854664803249818e-8	17	613	50
DOID:2349	arteriosclerosis	GO:0071396	cellular response to lipid	1.5937251518494122e-12	3.5149608224038786e-8	15	416	50
DOID:2349	arteriosclerosis	GO:1901701	cellular response to oxygen-containing compound	2.5275337378616314e-12	5.574475658853828e-8	24	873	50
DOID:2349	arteriosclerosis	GO:0001817	regulation of cytokine production	1.3397394305059152e-11	2.954795313980796e-7	15	556	50
DOID:2349	arteriosclerosis	GO:0043410	positive regulation of MAPK cascade	1.81492154638363e-10	4.002809470549096e-6	13	464	50
DOID:2349	arteriosclerosis	GO:0009725	response to hormone	4.419629107133005e-10	9.747491995781843e-6	16	865	50
DOID:2349	arteriosclerosis	GO:0001568	blood vessel development	2.152659939191892e-9	4.747691495887718e-5	13	569	50
DOID:2349	arteriosclerosis	GO:0055080	cation homeostasis	3.6886105281297432e-9	8.135230519790149e-5	13	595	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0005789	endoplasmic reticulum membrane	9.289236047038685e-12	2.048741010174382e-7	23	977	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0000030	mannosyltransferase activity	3.4861002973229915e-14	7.688594205745858e-10	9	24	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0006488	dolichol-linked oligosaccharide biosynthetic process	4.107825191113079e-15	9.059808458999896e-11	8	20	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0006487	protein N-linked glycosylation	1.7963408538435033e-13	3.9618297531518465e-9	11	74	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0000139	Golgi membrane	2.1440627051561023e-12	4.7287302962217836e-8	21	691	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0009247	glycolipid biosynthetic process	3.945150872652903e-10	8.701030249635977e-6	7	65	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0018279	protein N-linked glycosylation via asparagine	6.994256285253186e-10	1.5425832237125903e-5	6	38	50
Orphanet:371071	Congenital disorder of glycosylation with epilepsy as a major feature	GO:0031501	mannosyltransferase complex	3.159673522823425e-9	6.968659954587064e-5	4	8	50
DOID:10273	heart conduction disease	GO:2000021	regulation of ion homeostasis	9.612310947204605e-13	2.1199951794059757e-8	13	189	50
DOID:10273	heart conduction disease	GO:0061337	cardiac conduction	1.2456702336294256e-13	2.7473257002696982e-9	22	131	50
DOID:10273	heart conduction disease	GO:0051050	positive regulation of transport	4.5152770411505116e-13	9.958443514257453e-9	19	920	50
DOID:10273	heart conduction disease	GO:0005267	potassium channel activity	5.226929999935237e-13	1.1527994114857165e-8	10	121	50
DOID:10273	heart conduction disease	GO:0045823	positive regulation of heart contraction	2.5344171206143074e-12	5.589656959514855e-8	7	33	50
DOID:10273	heart conduction disease	GO:0098900	regulation of action potential	7.581713035165194e-12	1.6721468099056835e-7	7	38	50
DOID:10273	heart conduction disease	GO:0010460	positive regulation of heart rate	1.9549695196019456e-11	4.311685275482091e-7	6	22	50
DOID:10273	heart conduction disease	GO:0003209	cardiac atrium morphogenesis	7.670752921740132e-11	1.691784556889786e-6	6	27	50
DOID:10273	heart conduction disease	GO:0008076	voltage-gated potassium channel complex	8.814771135234878e-11	1.9440977738760523e-6	8	89	50
DOID:10273	heart conduction disease	GO:0055013	cardiac muscle cell development	8.935385764630155e-11	1.9706993303891807e-6	7	53	50
DOID:10273	heart conduction disease	GO:0005249	voltage-gated potassium channel activity	9.656075938835329e-11	2.129647548310132e-6	8	90	50
DOID:10273	heart conduction disease	GO:0010765	positive regulation of sodium ion transport	3.434901252319378e-10	7.575674711990388e-6	6	34	50
DOID:10273	heart conduction disease	GO:1904064	positive regulation of cation transmembrane transport	6.064938551375576e-10	1.3376221975058833e-5	7	69	50
DOID:10273	heart conduction disease	GO:1901387	positive regulation of voltage-gated calcium channel activity	6.797488127929796e-10	1.4991860066149165e-5	4	6	50
DOID:10273	heart conduction disease	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	1.5829674238077018e-9	3.4912346532078864e-5	4	7	50
DOID:10273	heart conduction disease	GO:1902305	regulation of sodium ion transmembrane transport	2.671118881636403e-9	5.8911526934490865e-5	6	47	50
DOID:10273	heart conduction disease	GO:0030016	myofibril	2.7762406817899432e-9	6.12299882368772e-5	9	201	50
DOID:10273	heart conduction disease	GO:0060411	cardiac septum morphogenesis	3.464710629508261e-9	7.641419293380469e-5	6	49	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0032944	regulation of mononuclear cell proliferation	9.563461134121098e-13	2.1092213531304083e-8	12	191	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.6764367671839864e-13	3.697381290024282e-9	13	209	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0051052	regulation of DNA metabolic process	2.8110846983508964e-13	6.199847302212902e-9	14	335	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.055644708955697e-13	8.94472440560179e-9	10	111	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0032663	regulation of interleukin-2 production	4.348743587456738e-13	9.591153982135836e-9	8	48	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0071887	leukocyte apoptotic process	2.919331443251849e-12	6.438585498091953e-8	9	94	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0006954	inflammatory response	4.5822234895354086e-12	1.0106093906170344e-7	16	637	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0045076	regulation of interleukin-2 biosynthetic process	4.8894222004491894e-12	1.0783620663090687e-7	6	18	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0008285	negative regulation of cell proliferation	5.208389275423997e-12	1.1487102546947625e-7	16	634	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0043069	negative regulation of programmed cell death	5.25002263884744e-12	1.157892492997803e-7	18	806	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0048872	homeostasis of number of cells	6.173839217638033e-12	1.3616402394500682e-7	11	208	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0042327	positive regulation of phosphorylation	7.319034267538882e-12	1.6142130077057004e-7	18	910	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0001934	positive regulation of protein phosphorylation	8.137490681292547e-12	1.7947235697590713e-7	18	870	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	8.325451439361586e-12	1.836178314951198e-7	8	67	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0043066	negative regulation of apoptotic process	9.25148846420143e-12	2.0404157807796253e-7	18	795	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:2000106	regulation of leukocyte apoptotic process	2.4275914611848748e-11	5.354052967643241e-7	8	76	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0009611	response to wounding	5.3209547878907415e-11	1.173536578469303e-6	17	875	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0042100	B cell proliferation	6.045652867214812e-11	1.3333687398642269e-6	8	85	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0042493	response to drug	7.777289923183162e-11	1.7152812925580463e-6	13	433	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0034097	response to cytokine	1.08509645713184e-10	2.393180236204273e-6	16	784	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0050869	negative regulation of B cell activation	1.225187729048116e-10	2.70215153641562e-6	6	29	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0009607	response to biotic stimulus	1.3709888779800394e-10	3.023715970384977e-6	17	934	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0042102	positive regulation of T cell proliferation	1.4983181362282494e-10	3.304540649451404e-6	8	95	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0035710	CD4-positive, alpha-beta T cell activation	3.148338256764305e-10	6.943660025293674e-6	7	63	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0050871	positive regulation of B cell activation	4.403478692793783e-10	9.711872256956688e-6	7	66	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:1903034	regulation of response to wounding	5.637567079830319e-10	1.2433654194565769e-5	12	407	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0002677	negative regulation of chronic inflammatory response	6.797488127929796e-10	1.4991860066149165e-5	4	6	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	6.994256285253186e-10	1.5425832237125903e-5	6	38	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0051707	response to other organism	7.615371666602755e-10	1.6795702210692376e-5	16	898	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0001776	leukocyte homeostasis	9.086815744296928e-10	2.0040972124046874e-5	7	73	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0003682	chromatin binding	1.1389881260370771e-9	2.5120383119747736e-5	12	433	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0051726	regulation of cell cycle	1.2607797028607592e-9	2.7806496346594045e-5	16	930	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0097190	apoptotic signaling pathway	1.936932281232373e-9	4.271904146257999e-5	13	564	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0045061	thymic T cell selection	2.8532014528792615e-9	6.292735804325211e-5	5	22	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0032753	positive regulation of interleukin-4 production	2.8532014528792615e-9	6.292735804325211e-5	5	22	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0070997	neuron death	3.0720366250847064e-9	6.77537677662432e-5	10	281	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0051402	neuron apoptotic process	4.2520996723638405e-9	9.37800582739845e-5	9	211	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0009897	external side of plasma membrane	4.431234379431714e-9	9.773087423836646e-5	9	212	50
Orphanet:178551	Aggressive primary cutaneous T-cell lymphoma	GO:0070228	regulation of lymphocyte apoptotic process	4.444073997689202e-9	9.801405201903535e-5	6	51	50
Orphanet:93460	Overgrowth syndrome	GO:0032869	cellular response to insulin stimulus	1.439293129124053e-12	3.174360996283099e-8	12	186	50
Orphanet:93460	Overgrowth syndrome	GO:0006109	regulation of carbohydrate metabolic process	1.3720136138317685e-12	3.025976025305965e-8	12	163	50
Orphanet:93460	Overgrowth syndrome	GO:0010675	regulation of cellular carbohydrate metabolic process	8.58424442640171e-13	1.8932551082428972e-8	12	153	50
Orphanet:93460	Overgrowth syndrome	GO:0016051	carbohydrate biosynthetic process	5.693223670277803e-13	1.2556404804797694e-8	12	197	50
Orphanet:93460	Overgrowth syndrome	GO:0010676	positive regulation of cellular carbohydrate metabolic process	1.1235457009206584e-13	2.477980043380512e-9	10	64	50
Orphanet:93460	Overgrowth syndrome	GO:0046323	glucose import	1.9384494009955233e-13	4.275250153895627e-9	9	72	50
Orphanet:93460	Overgrowth syndrome	GO:0051051	negative regulation of transport	1.2404521854136874e-12	2.7358172949298876e-8	15	452	50
Orphanet:93460	Overgrowth syndrome	GO:0046324	regulation of glucose import	3.346656285430072e-12	7.381050437516024e-8	8	60	50
Orphanet:93460	Overgrowth syndrome	GO:0046326	positive regulation of glucose import	7.581713035165194e-12	1.6721468099056835e-7	7	38	50
Orphanet:93460	Overgrowth syndrome	GO:1900078	positive regulation of cellular response to insulin stimulus	2.6369462169384406e-11	5.815784881457731e-7	6	23	50
Orphanet:93460	Overgrowth syndrome	GO:0043491	protein kinase B signaling	1.4330925335315214e-10	3.1606855827037705e-6	9	144	50
Orphanet:93460	Overgrowth syndrome	GO:0032787	monocarboxylic acid metabolic process	1.8521539857374592e-10	4.084925615543966e-6	14	572	50
Orphanet:93460	Overgrowth syndrome	GO:0008286	insulin receptor signaling pathway	6.086556814111077e-10	1.342390105352198e-5	8	113	50
DOID:3652	Leigh disease	GO:0098798	mitochondrial protein complex	3.8391512191537913e-13	8.467248013843687e-9	22	144	50
DOID:1168	familial hyperlipidemia	GO:0044242	cellular lipid catabolic process	1.212363542890671e-12	2.6738677938453748e-8	12	177	50
DOID:1168	familial hyperlipidemia	GO:0009991	response to extracellular stimulus	6.88338275267597e-14	1.5181300661026853e-9	16	573	50
DOID:1168	familial hyperlipidemia	GO:0050994	regulation of lipid catabolic process	6.74379441178985e-11	1.4873438575202513e-6	7	51	50
DOID:1168	familial hyperlipidemia	GO:0010243	response to organonitrogen compound	1.0128109462215207e-10	2.233754541891564e-6	16	780	50
DOID:1168	familial hyperlipidemia	GO:0050880	regulation of blood vessel size	1.0426048913103614e-10	2.299465087785002e-6	9	139	50
DOID:1168	familial hyperlipidemia	GO:0009725	response to hormone	4.419629107133005e-10	9.747491995781843e-6	16	865	50
DOID:1168	familial hyperlipidemia	GO:1901701	cellular response to oxygen-containing compound	5.050850848675736e-10	1.1139651546754337e-5	16	873	50
DOID:1168	familial hyperlipidemia	GO:1903034	regulation of response to wounding	5.637567079830319e-10	1.2433654194565769e-5	12	407	50
DOID:1168	familial hyperlipidemia	GO:0042180	cellular ketone metabolic process	1.1171241709462265e-9	2.4638173590219026e-5	10	253	50
DOID:1168	familial hyperlipidemia	GO:0010565	regulation of cellular ketone metabolic process	1.5402311648315958e-9	3.3969798340360846e-5	9	188	50
DOID:1168	familial hyperlipidemia	GO:0006631	fatty acid metabolic process	1.572705743413394e-9	3.4686025170982404e-5	11	348	50
DOID:1168	familial hyperlipidemia	GO:0051241	negative regulation of multicellular organismal process	2.1737588395964735e-9	4.7942251207300224e-5	16	966	50
DOID:628	combined T cell and B cell immunodeficiency	GO:0042098	T cell proliferation	1.0944578576754793e-12	2.4138268051032696e-8	13	167	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0032944	regulation of mononuclear cell proliferation	8.586464872450961e-13	1.8937448276190594e-8	12	191	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0050670	regulation of lymphocyte proliferation	7.809308755213351e-13	1.7223430459623046e-8	12	189	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0022407	regulation of cell-cell adhesion	7.494005416219807e-13	1.6528028945472784e-8	19	376	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0032946	positive regulation of mononuclear cell proliferation	4.0123460109953157e-13	8.849229127250169e-9	12	129	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0042100	B cell proliferation	1.3082868122182845e-12	2.8854265643474264e-8	9	85	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002443	leukocyte mediated immunity	2.5247581803000685e-12	5.568354166651801e-8	13	279	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0042102	positive regulation of T cell proliferation	3.9475089863572066e-12	8.706231069410819e-8	9	95	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0031295	T cell costimulation	3.1784463949691144e-11	7.010063524104382e-7	8	77	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002697	regulation of immune effector process	6.603961821838311e-11	1.4565037798064395e-6	13	418	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	8.990663769026241e-11	1.9828908942587375e-6	7	52	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002449	lymphocyte mediated immunity	2.132983789593368e-10	4.704295747948173e-6	10	209	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002440	production of molecular mediator of immune response	2.2121005027742058e-10	4.878787658868511e-6	9	148	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0050871	positive regulation of B cell activation	5.089979548955625e-10	1.1225949895221632e-5	7	66	51
DOID:628	combined T cell and B cell immunodeficiency	GO:0002377	immunoglobulin production	2.2040788083543816e-9	4.861095811825589e-5	7	81	51
MESH:D044342	Malnutrition	GO:0046906	tetrapyrrole binding	2.1338486533295509e-13	4.7062032049183244e-9	11	134	51
MESH:D044342	Malnutrition	GO:0048037	cofactor binding	1.8541127522198053e-9	4.0892456750207806e-5	10	261	51
MESH:D044342	Malnutrition	GO:0055114	oxidation-reduction process	2.3428351481058485e-9	5.167122919147449e-5	16	949	51
MESH:D020521	Stroke	GO:0033993	response to lipid	1.3455903058456897e-12	2.9676994195426687e-8	19	850	51
MESH:D020521	Stroke	GO:2000377	regulation of reactive oxygen species metabolic process	3.892441924335799e-13	8.584780664122604e-9	12	147	51
MESH:D020521	Stroke	GO:2000379	positive regulation of reactive oxygen species metabolic process	4.7628567756419216e-14	1.0504480618678258e-9	11	83	51
MESH:D020521	Stroke	GO:0030335	positive regulation of cell migration	7.893685705084863e-14	1.7409523822564665e-9	17	387	51
MESH:D020521	Stroke	GO:0002237	response to molecule of bacterial origin	1.8274270985330077e-13	4.030390465814548e-9	14	333	51
MESH:D020521	Stroke	GO:1903034	regulation of response to wounding	5.240252676230739e-13	1.1557377277426895e-8	15	407	51
MESH:D020521	Stroke	GO:0032101	regulation of response to external stimulus	5.456746166032644e-13	1.2034853669184997e-8	19	920	51
MESH:D020521	Stroke	GO:0050900	leukocyte migration	7.424061365668422e-13	1.6373767341981704e-8	14	354	51
MESH:D020521	Stroke	GO:0032496	response to lipopolysaccharide	1.279532035880493e-12	2.822007905134427e-8	14	319	51
MESH:D020521	Stroke	GO:0019915	lipid storage	4.626077299008102e-12	1.020281348296237e-7	8	61	51
MESH:D020521	Stroke	GO:0034097	response to cytokine	5.051292717439537e-12	1.11406260883129e-7	19	784	51
MESH:D020521	Stroke	GO:0006809	nitric oxide biosynthetic process	5.2873261324748455e-12	1.1661197785173272e-7	8	62	51
MESH:D020521	Stroke	GO:0002684	positive regulation of immune system process	7.680744928961758e-12	1.6939882940825157e-7	18	872	51
MESH:D020521	Stroke	GO:0014070	response to organic cyclic compound	7.881473251813986e-12	1.7382589256875747e-7	18	873	51
MESH:D020521	Stroke	GO:0051384	response to glucocorticoid	2.2186696924109128e-11	4.893276006612268e-7	10	167	51
MESH:D020521	Stroke	GO:0008284	positive regulation of cell proliferation	2.715205837944268e-11	5.988386475586083e-7	17	815	51
MESH:D020521	Stroke	GO:0048514	blood vessel morphogenesis	2.97047941799633e-11	6.551392356390906e-7	14	484	51
MESH:D020521	Stroke	GO:0001934	positive regulation of protein phosphorylation	6.92538248969754e-11	1.5273931081027925e-6	17	870	51
MESH:D020521	Stroke	GO:1901701	cellular response to oxygen-containing compound	7.063349904967708e-11	1.557821821540628e-6	17	873	51
MESH:D020521	Stroke	GO:0006801	superoxide metabolic process	8.990663769026241e-11	1.9828908942587375e-6	7	52	51
MESH:D020521	Stroke	GO:0042493	response to drug	1.0176226528102461e-10	2.244366760772998e-6	13	433	51
MESH:D020521	Stroke	GO:0019221	cytokine-mediated signaling pathway	1.0534806360595894e-10	2.3234515428294245e-6	14	534	51
MESH:D020521	Stroke	GO:0042060	wound healing	1.0534806360595894e-10	2.3234515428294245e-6	14	534	51
MESH:D020521	Stroke	GO:0002675	positive regulation of acute inflammatory response	1.1025458324098736e-10	2.431664833379976e-6	6	28	51
MESH:D020521	Stroke	GO:0007596	blood coagulation	1.380313641163866e-10	3.0442817355869067e-6	12	352	51
MESH:D020521	Stroke	GO:0010574	regulation of vascular endothelial growth factor production	2.1416091122716807e-10	4.723318897115192e-6	6	31	51
MESH:D020521	Stroke	GO:0002685	regulation of leukocyte migration	2.348456984435643e-10	5.17952187917281e-6	9	149	51
MESH:D020521	Stroke	GO:0071222	cellular response to lipopolysaccharide	2.8061264423229204e-10	6.188911868543201e-6	9	152	51
MESH:D020521	Stroke	GO:1903426	regulation of reactive oxygen species biosynthetic process	3.639669676758217e-10	8.027291472090248e-6	7	63	51
MESH:D020521	Stroke	GO:0003018	vascular process in circulatory system	4.1926873084463523e-10	9.24697185877843e-6	9	159	51
MESH:D020521	Stroke	GO:0022603	regulation of anatomical structure morphogenesis	4.572454637141732e-10	1.008454870221609e-5	17	986	51
MESH:D020521	Stroke	GO:0001775	cell activation	5.100702082927455e-10	1.1249598443896502e-5	16	854	51
MESH:D020521	Stroke	GO:0002687	positive regulation of leukocyte migration	5.375674350105442e-10	1.1856049779157551e-5	8	109	51
MESH:D020521	Stroke	GO:1902533	positive regulation of intracellular signal transduction	5.693401305961743e-10	1.2556796580298624e-5	16	860	51
MESH:D020521	Stroke	GO:0010035	response to inorganic substance	6.192117929515462e-10	1.365671609354635e-5	13	502	51
MESH:D020521	Stroke	GO:1901698	response to nitrogen compound	6.70434152638677e-10	1.4786425236446021e-5	16	870	51
MESH:D020521	Stroke	GO:0044057	regulation of system process	7.1603001305931e-10	1.5792041938023083e-5	13	508	51
MESH:D020521	Stroke	GO:0044706	multi-multicellular organism process	7.298155413337781e-10	1.6096081764116477e-5	10	237	51
MESH:D020521	Stroke	GO:0001525	angiogenesis	8.537592854906961e-10	1.8829661041497303e-5	12	413	51
MESH:D020521	Stroke	GO:0002821	positive regulation of adaptive immune response	8.603855405908689e-10	1.8975803097731614e-5	7	71	51
MESH:D020521	Stroke	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.0959889662487399e-9	2.4172036650615958e-5	6	40	51
MESH:D020521	Stroke	GO:0006935	chemotaxis	1.1958052326122015e-9	2.6373484405262104e-5	13	530	51
MESH:D020521	Stroke	GO:0019725	cellular homeostasis	1.2092212786640744e-9	2.666937530093616e-5	15	771	51
MESH:D020521	Stroke	GO:0010883	regulation of lipid storage	1.281178718670617e-9	2.8256396640280457e-5	6	41	51
MESH:D020521	Stroke	GO:0010243	response to organonitrogen compound	1.4155577821028942e-9	3.122012688427933e-5	15	780	51
MESH:D020521	Stroke	GO:0002520	immune system development	1.4664136571695963e-9	3.2341753208875446e-5	15	782	51
MESH:D020521	Stroke	GO:0034113	heterotypic cell-cell adhesion	1.729949072881709e-9	3.8154026802406094e-5	6	43	51
MESH:D020521	Stroke	GO:0007565	female pregnancy	2.036106061531484e-9	4.490631918707688e-5	9	190	51
MESH:D020521	Stroke	GO:0002521	leukocyte differentiation	2.1397466021255696e-9	4.7192111309879436e-5	12	448	51
MESH:D020521	Stroke	GO:0051051	negative regulation of transport	2.365392326453275e-9	5.216872775992698e-5	12	452	51
MESH:D020521	Stroke	GO:0005126	cytokine receptor binding	2.5694613103866004e-9	5.666946920057647e-5	10	270	51
MESH:D020521	Stroke	GO:0030728	ovulation	3.160928185863554e-9	6.971427113922068e-5	5	22	51
MESH:D020521	Stroke	GO:0050880	regulation of blood vessel size	3.745099341756486e-9	8.25981659824393e-5	8	139	51
MESH:D020521	Stroke	GO:1903524	positive regulation of blood circulation	4.295582889390914e-9	9.473908062551661e-5	7	89	51
Orphanet:268357	Neural tube closure defect	GO:0035295	tube development	1.226574397605873e-12	2.7052098339197528e-8	19	573	51
Orphanet:268357	Neural tube closure defect	GO:0035239	tube morphogenesis	3.9745984281580604e-14	8.765976833302602e-10	14	338	51
Orphanet:268357	Neural tube closure defect	GO:0048568	embryonic organ development	6.423750420481156e-13	1.4167581552371189e-8	15	408	51
Orphanet:268357	Neural tube closure defect	GO:0007389	pattern specification process	8.022249531336456e-12	1.7693071341362554e-7	14	432	51
Orphanet:268357	Neural tube closure defect	GO:0007423	sensory organ development	3.8957836956399206e-11	8.592150940733845e-7	14	494	51
Orphanet:268357	Neural tube closure defect	GO:0003002	regionalization	1.0264777916546564e-9	2.2638967694943446e-5	11	327	51
Orphanet:268357	Neural tube closure defect	GO:0048706	embryonic skeletal system development	1.3263942166830134e-9	2.925362444894386e-5	8	122	51
Orphanet:268357	Neural tube closure defect	GO:0048705	skeletal system morphogenesis	3.804392134654222e-9	8.390586852979887e-5	9	204	51
MESH:D010146	Pain	GO:0051241	negative regulation of multicellular organismal process	4.57389681685072e-12	1.0087729429564263e-7	20	966	51
MESH:D010146	Pain	GO:0033993	response to lipid	1.66733293838206e-12	3.6773027956016335e-8	22	850	51
MESH:D010146	Pain	GO:0051050	positive regulation of transport	6.543654507140673e-13	1.4432030015498754e-8	20	920	51
MESH:D010146	Pain	GO:0043269	regulation of ion transport	5.015987625256457e-13	1.1062760707503116e-8	17	583	51
MESH:D010146	Pain	GO:0008217	regulation of blood pressure	4.5341508325691393e-13	1.0000069661231237e-8	11	168	51
MESH:D010146	Pain	GO:0051046	regulation of secretion	2.2604140781368187e-13	4.985343249330754e-9	19	675	51
MESH:D010146	Pain	GO:0043279	response to alkaloid	1.7386092565629951e-13	3.834502715349686e-9	11	140	51
MESH:D010146	Pain	GO:0009607	response to biotic stimulus	1.3322676295501878e-15	2.938316256972939e-11	19	934	51
MESH:D010146	Pain	GO:0019233	sensory perception of pain	2.4424906541753444e-15	5.386913137783722e-11	13	101	51
MESH:D010146	Pain	GO:0002237	response to molecule of bacterial origin	3.774758283725532e-15	8.325229394756661e-11	17	333	51
MESH:D010146	Pain	GO:0006954	inflammatory response	1.59539048638635e-13	3.518633717725095e-9	17	637	51
MESH:D010146	Pain	GO:0035813	regulation of renal sodium excretion	2.0972112935169207e-13	4.625399507851569e-9	7	24	51
MESH:D010146	Pain	GO:0031644	regulation of neurological system process	3.114175584073564e-13	6.868314250674246e-9	9	68	51
MESH:D010146	Pain	GO:0048265	response to pain	1.028510610012745e-12	2.268380150383109e-8	7	29	51
MESH:D010146	Pain	GO:0032496	response to lipopolysaccharide	1.1801670751765414e-12	2.602858484301862e-8	17	319	51
MESH:D010146	Pain	GO:0014070	response to organic cyclic compound	1.653122083666858e-12	3.6459607555272555e-8	23	873	51
MESH:D010146	Pain	GO:0007610	behavior	1.7098544802252036e-12	3.7710840561366865e-8	18	714	51
MESH:D010146	Pain	GO:0007268	synaptic transmission	3.141042981269493e-12	6.927570295189867e-8	16	605	51
MESH:D010146	Pain	GO:0007204	positive regulation of cytosolic calcium ion concentration	3.1553648582871574e-12	6.959157194952326e-8	12	234	51
MESH:D010146	Pain	GO:0044708	single-organism behavior	3.254951863596034e-12	7.178796335161053e-8	14	404	51
MESH:D010146	Pain	GO:0051048	negative regulation of secretion	3.2985836284638026e-12	7.275026192576917e-8	11	195	51
MESH:D010146	Pain	GO:0044706	multi-multicellular organism process	3.5601521730654895e-12	7.851915617695937e-8	12	237	51
MESH:D010146	Pain	GO:0001934	positive regulation of protein phosphorylation	9.760636743294526e-12	2.1527084337336078e-7	18	870	51
MESH:D010146	Pain	GO:0051047	positive regulation of secretion	1.1305623104362894e-11	2.4934551756672363e-7	13	363	51
MESH:D010146	Pain	GO:1903522	regulation of blood circulation	2.021760536763395e-11	4.458992863831668e-7	12	297	51
MESH:D010146	Pain	GO:0005179	hormone activity	2.6799784613729116e-11	5.910692496557957e-7	9	117	51
MESH:D010146	Pain	GO:0032940	secretion by cell	2.7080004905144506e-11	5.972495081829621e-7	18	956	51
MESH:D010146	Pain	GO:0043270	positive regulation of ion transport	2.941091814534502e-11	6.486577996955845e-7	11	233	51
MESH:D010146	Pain	GO:1903530	regulation of secretion by cell	6.493916515637466e-11	1.432233287523843e-6	15	624	51
MESH:D010146	Pain	GO:0001664	G-protein coupled receptor binding	7.573142113415088e-11	1.6702564931136976e-6	11	255	51
MESH:D010146	Pain	GO:0040012	regulation of locomotion	1.0900957914117271e-10	2.404206267958564e-6	16	766	51
MESH:D010146	Pain	GO:0005184	neuropeptide hormone activity	1.1025458324098736e-10	2.431664833379976e-6	6	28	51
MESH:D010146	Pain	GO:0050880	regulation of blood vessel size	1.2589373987736963e-10	2.776586432995387e-6	9	139	51
MESH:D010146	Pain	GO:0043005	neuron projection	2.1793278293102958e-10	4.806507527543857e-6	17	941	51
MESH:D010146	Pain	GO:0034765	regulation of ion transmembrane transport	2.2102530916612295e-10	4.874713193658842e-6	12	367	51
MESH:D010146	Pain	GO:0009612	response to mechanical stimulus	2.2382473652271528e-10	4.936454564008486e-6	10	210	51
MESH:D010146	Pain	GO:0097305	response to alcohol	2.355191597303019e-10	5.194375067851809e-6	12	369	51
MESH:D010146	Pain	GO:0035815	positive regulation of renal sodium excretion	2.4427093681111955e-10	5.387395511369242e-6	5	14	51
MESH:D010146	Pain	GO:0007611	learning or memory	3.221459765612167e-10	7.104929513057634e-6	10	218	51
MESH:D010146	Pain	GO:0051931	regulation of sensory perception	5.607123654272073e-10	1.2366511219497056e-5	6	36	51
MESH:D010146	Pain	GO:0051930	regulation of sensory perception of pain	5.607123654272073e-10	1.2366511219497056e-5	6	36	51
MESH:D010146	Pain	GO:0050878	regulation of body fluid levels	6.507984151582491e-10	1.4353359046315184e-5	13	504	51
MESH:D010146	Pain	GO:0009611	response to wounding	7.273416313680059e-10	1.604151967982137e-5	16	875	51
MESH:D010146	Pain	GO:0030424	axon	8.769460713153876e-10	1.9341045602860873e-5	12	414	51
MESH:D010146	Pain	GO:0031960	response to corticosteroid	1.2022517426046875e-9	2.6515662183146382e-5	9	179	51
MESH:D010146	Pain	GO:0010876	lipid localization	1.2417881167792189e-9	2.7387636915565672e-5	11	333	51
MESH:D010146	Pain	GO:1903532	positive regulation of secretion by cell	1.3223084849300903e-9	2.9163513635133143e-5	11	335	51
MESH:D010146	Pain	GO:0042493	response to drug	1.4581298390936581e-9	3.215905360121063e-5	12	433	51
MESH:D010146	Pain	GO:0030334	regulation of cell migration	1.598762344734439e-9	3.526070351311805e-5	14	660	51
MESH:D010146	Pain	GO:0045776	negative regulation of blood pressure	1.729949072881709e-9	3.8154026802406094e-5	6	43	51
MESH:D010146	Pain	GO:0030001	metal ion transport	1.7455470402438777e-9	3.8498039972578724e-5	15	792	51
MESH:D010146	Pain	GO:0009651	response to salt stress	1.8686243663523783e-9	4.12125103999017e-5	5	20	51
MESH:D010146	Pain	GO:0042310	vasoconstriction	2.017724209935068e-9	4.450090745011792e-5	7	80	51
MESH:D010146	Pain	GO:0045471	response to ethanol	3.3386668985002643e-9	7.363429844642333e-5	8	137	51
MESH:D010146	Pain	GO:0002027	regulation of heart rate	3.6578707840462243e-9	8.067434014213948e-5	7	87	51
MESH:D010146	Pain	GO:0000165	MAPK cascade	4.060682234907631e-9	8.95583466908878e-5	15	843	51
DOID:12030	panuveitis	GO:0046649	lymphocyte activation	1.034949903555571e-12	2.2825820122918117e-8	22	594	51
DOID:12030	panuveitis	GO:1903037	regulation of leukocyte cell-cell adhesion	1.6553425297161084e-12	3.650857949288877e-8	15	294	51
DOID:12030	panuveitis	GO:0030217	T cell differentiation	1.3107870344697403e-10	2.8909408045230123e-6	10	199	51
DOID:12030	panuveitis	GO:0001817	regulation of cytokine production	1.759813406110311e-10	3.881268467176291e-6	14	556	51
DOID:12030	panuveitis	GO:0002367	cytokine production involved in immune response	8.603855405908689e-10	1.8975803097731614e-5	7	71	51
DOID:12030	panuveitis	GO:0002250	adaptive immune response	1.2810800198437278e-9	2.8254219837653416e-5	11	334	51
DOID:12030	panuveitis	GO:0019221	cytokine-mediated signaling pathway	1.3096151940672485e-9	2.8883563105153165e-5	13	534	51
DOID:12030	panuveitis	GO:0045619	regulation of lymphocyte differentiation	2.2010084865797808e-9	4.8543242171517065e-5	8	130	51
MESH:D014071	Tooth Abnormalities	GO:0009887	organ morphogenesis	6.585842982076429e-13	1.4525076696969563e-8	30	950	51
MESH:D014071	Tooth Abnormalities	GO:0001501	skeletal system development	3.2380764736217316e-12	7.141577662572729e-8	17	482	51
MESH:D014071	Tooth Abnormalities	GO:0035107	appendage morphogenesis	5.81312775693732e-12	1.2820853267925258e-7	10	146	51
MESH:D014071	Tooth Abnormalities	GO:0035108	limb morphogenesis	5.81312775693732e-12	1.2820853267925258e-7	10	146	51
MESH:D014071	Tooth Abnormalities	GO:0001503	ossification	1.1305623104362894e-11	2.4934551756672363e-7	13	363	51
MESH:D014071	Tooth Abnormalities	GO:0042481	regulation of odontogenesis	3.968547712673853e-11	8.752631980302183e-7	6	24	51
MESH:D014071	Tooth Abnormalities	GO:0048598	embryonic morphogenesis	1.9184709376673936e-10	4.231187653025437e-6	14	560	51
MESH:D014071	Tooth Abnormalities	GO:0030278	regulation of ossification	1.0883364209846036e-9	2.4003259764815432e-5	9	177	51
MESH:D014071	Tooth Abnormalities	GO:0035113	embryonic appendage morphogenesis	1.610164002130432e-9	3.551216706698668e-5	8	125	51
MESH:D014071	Tooth Abnormalities	GO:0030326	embryonic limb morphogenesis	1.610164002130432e-9	3.551216706698668e-5	8	125	51
MESH:D014071	Tooth Abnormalities	GO:0032808	lacrimal gland development	3.42800154928824e-9	7.560457416955213e-5	4	8	51
MESH:D014071	Tooth Abnormalities	GO:0048562	embryonic organ morphogenesis	3.6437489692175973e-9	8.036288351609411e-5	10	280	51
MESH:D014071	Tooth Abnormalities	GO:0048705	skeletal system morphogenesis	3.804392134654222e-9	8.390586852979887e-5	9	204	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0044420	extracellular matrix component	3.888001032237298e-13	8.574986276599361e-9	12	125	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0006029	proteoglycan metabolic process	1.3082868122182845e-12	2.8854265643474264e-8	9	85	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0030166	proteoglycan biosynthetic process	4.0467629247586956e-12	8.925135630555303e-8	8	60	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0050650	chondroitin sulfate proteoglycan biosynthetic process	1.730185994475164e-10	3.815925210814974e-6	6	30	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0030204	chondroitin sulfate metabolic process	1.281178718670617e-9	2.8256396640280457e-5	6	41	51
Orphanet:139030	Rare developmental defect with connective tissue involvement	GO:0048251	elastic fiber assembly	1.7174559552302071e-9	3.787849109260222e-5	4	7	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0032200	telomere organization	2.702282841937631e-13	5.959884807893445e-9	14	146	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0022613	ribonucleoprotein complex biogenesis	1.5987211554602254e-13	3.525979508367527e-9	19	443	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0070972	protein localization to endoplasmic reticulum	1.432187701766452e-13	3.1586899762459097e-9	14	123	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0000723	telomere maintenance	7.30526750203353e-14	1.611176747573495e-9	14	133	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0022626	cytosolic ribosome	1.7763568394002505e-14	3.9177550092972524e-10	13	107	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0034470	ncRNA processing	6.047384815133228e-13	1.3337507209776334e-8	20	384	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0016072	rRNA metabolic process	2.0941026690479703e-12	4.6185434365852984e-8	19	254	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0032204	regulation of telomere maintenance	8.722689237572467e-12	1.9237891113466077e-7	8	66	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0071897	DNA biosynthetic process	2.2186696924109128e-11	4.893276006612268e-7	10	167	51
Orphanet:68383	Rare constitutional medullar aplasia	GO:0000784	nuclear chromosome, telomeric region	7.9005357811468e-11	1.7424631665319268e-6	9	132	51
Orphanet:183637	Rare genetic adrenal disease	GO:0055114	oxidation-reduction process	1.7985612998927536e-13	3.966726946913468e-9	23	949	52
Orphanet:183637	Rare genetic adrenal disease	GO:0016491	oxidoreductase activity	1.6344703368531555e-12	3.6048243279296344e-8	19	710	52
Orphanet:183637	Rare genetic adrenal disease	GO:0048037	cofactor binding	1.1950596068288633e-10	2.635703962861058e-6	11	261	52
Orphanet:183637	Rare genetic adrenal disease	GO:1901615	organic hydroxy compound metabolic process	1.3879453142351394e-10	3.0611133905456e-6	14	534	52
Orphanet:183637	Rare genetic adrenal disease	GO:0018958	phenol-containing compound metabolic process	2.268329968302396e-10	5.0028017450909346e-6	8	96	52
Orphanet:183637	Rare genetic adrenal disease	GO:0009725	response to hormone	8.500904424835198e-10	1.874874470897403e-5	16	865	52
Orphanet:183637	Rare genetic adrenal disease	GO:0030325	adrenal gland development	4.455838920058852e-9	9.827352738189798e-5	5	23	52
DOID:8469	influenza	GO:0009607	response to biotic stimulus	2.489564110419451e-12	5.490733645530099e-8	28	934	52
DOID:8469	influenza	GO:0050792	regulation of viral process	1.0345058143457209e-12	2.2816025735394874e-8	12	180	52
DOID:8469	influenza	GO:0034341	response to interferon-gamma	6.590283874174929e-13	1.4534871084492806e-8	11	155	52
DOID:8469	influenza	GO:1903900	regulation of viral life cycle	2.6778579353958776e-13	5.906015676515608e-9	11	168	52
DOID:8469	influenza	GO:0043901	negative regulation of multi-organism process	2.240430063693566e-13	4.94126850547616e-9	11	150	52
DOID:8469	influenza	GO:1903901	negative regulation of viral life cycle	9.547918011776346e-14	2.105793317497273e-9	10	86	52
DOID:8469	influenza	GO:0045071	negative regulation of viral genome replication	5.395683899678261e-14	1.1900180840740404e-9	10	48	52
DOID:8469	influenza	GO:0071357	cellular response to type I interferon	7.649436639667329e-14	1.6870832508786293e-9	18	76	52
DOID:8469	influenza	GO:0060337	type I interferon signaling pathway	7.649436639667329e-14	1.6870832508786293e-9	18	76	52
DOID:8469	influenza	GO:0051607	defense response to virus	2.94320123828129e-13	6.491230331029385e-9	25	332	52
DOID:8469	influenza	GO:0071346	cellular response to interferon-gamma	2.8875790647475696e-12	6.368555627300765e-8	10	133	52
DOID:8469	influenza	GO:0003725	double-stranded RNA binding	6.219136317042739e-12	1.3716305147237762e-7	8	62	52
DOID:8469	influenza	GO:0035455	response to interferon-alpha	9.152900659614716e-12	2.0186722404780255e-7	6	19	52
DOID:8469	influenza	GO:0060333	interferon-gamma-mediated signaling pathway	5.138844905161477e-11	1.1333722438333638e-6	8	80	52
DOID:0080074	neural tube defect	GO:0009790	embryo development	1.2425616091604752e-12	2.740469629003428e-8	21	932	52
DOID:0080074	neural tube defect	GO:0072358	cardiovascular system development	1.763492019080104e-9	3.8893816480811694e-5	16	910	52
Orphanet:251852	Embryonal tumor of neuroepithelial tissue	GO:0006338	chromatin remodeling	2.658728792681586e-10	5.863826352259238e-6	9	148	52
Orphanet:251852	Embryonal tumor of neuroepithelial tissue	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	3.4029358220166728e-9	7.505174955457772e-5	11	359	52
DOID:10595	Charcot-Marie-Tooth disease	GO:0007272	ensheathment of neurons	1.9908297232973382e-11	4.3907749547322794e-7	9	111	52
DOID:10595	Charcot-Marie-Tooth disease	GO:0008366	axon ensheathment	1.9908297232973382e-11	4.3907749547322794e-7	9	111	52
DOID:10595	Charcot-Marie-Tooth disease	GO:0042552	myelination	5.872455854927239e-10	1.2951701388042025e-5	8	108	52
DOID:10595	Charcot-Marie-Tooth disease	GO:0004812	aminoacyl-tRNA ligase activity	1.6833977545260836e-9	3.7127337476072775e-5	6	42	52
DOID:10595	Charcot-Marie-Tooth disease	GO:0006418	tRNA aminoacylation for protein translation	3.888122601658495e-9	8.57525439795781e-5	6	48	52
DOID:0050702	neonatal period electroclinical syndrome	GO:0022832	voltage-gated channel activity	5.513367540288527e-13	1.2159732110106347e-8	12	189	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0005244	voltage-gated ion channel activity	5.513367540288527e-13	1.2159732110106347e-8	12	189	53
DOID:0050702	neonatal period electroclinical syndrome	GO:1902495	transmembrane transporter complex	4.283240429003854e-13	9.446686766168e-9	16	308	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0033268	node of Ranvier	1.9136914275463823e-12	4.220646443453546e-8	6	15	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0043269	regulation of ion transport	4.5623615996248645e-11	1.0062288507972639e-6	15	583	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0098660	inorganic ion transmembrane transport	2.5810775738932534e-10	5.6925665892215704e-6	15	660	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0034765	regulation of ion transmembrane transport	3.586541064137805e-10	7.910116316955929e-6	12	367	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0098797	plasma membrane protein complex	9.667755485054386e-10	2.1322234722287448e-5	13	499	53
DOID:0050702	neonatal period electroclinical syndrome	GO:0046873	metal ion transmembrane transporter activity	1.4545130655463367e-9	3.207928566062446e-5	12	415	53
MESH:D009436	Neural Tube Defects	GO:0009790	embryo development	2.752909011860538e-12	6.071540825658417e-8	21	932	53
MESH:D009436	Neural Tube Defects	GO:0035295	tube development	1.0982326159592048e-12	2.4221520344980263e-8	19	573	53
MESH:D009436	Neural Tube Defects	GO:0035239	tube morphogenesis	3.68594044175552e-14	8.129341644291799e-10	14	338	53
MESH:D009436	Neural Tube Defects	GO:0048568	embryonic organ development	4.731770530952417e-13	1.0435919906015556e-8	15	408	53
MESH:D009436	Neural Tube Defects	GO:0007389	pattern specification process	1.317712605697352e-11	2.90621515186551e-7	14	432	53
MESH:D009436	Neural Tube Defects	GO:0007423	sensory organ development	6.689515608115926e-11	1.4753726673699674e-6	14	494	53
MESH:D009436	Neural Tube Defects	GO:0003002	regionalization	1.5910817108277797e-9	3.509130713230668e-5	11	327	53
MESH:D009436	Neural Tube Defects	GO:0048706	embryonic skeletal system development	1.8264362244835297e-9	4.028205093098425e-5	8	122	53
MESH:D009436	Neural Tube Defects	GO:0072358	cardiovascular system development	2.4123292252653528e-9	5.3203921063227355e-5	16	910	53
DOID:2860	hemoglobinopathy	GO:0020037	heme binding	2.216739125593392e-9	4.8890181414962264e-5	8	125	53
DOID:3021	acute kidney failure	GO:0051241	negative regulation of multicellular organismal process	4.355182880999564e-12	9.605355844044539e-8	20	966	53
DOID:3021	acute kidney failure	GO:0033993	response to lipid	6.863398738232718e-13	1.513722591717226e-8	19	850	53
DOID:3021	acute kidney failure	GO:2001234	negative regulation of apoptotic signaling pathway	4.96269692007445e-13	1.0945228057224199e-8	13	199	53
DOID:3021	acute kidney failure	GO:0002367	cytokine production involved in immune response	3.97015753605956e-13	8.756182445779359e-9	9	71	53
DOID:3021	acute kidney failure	GO:0006954	inflammatory response	6.518119377574294e-13	1.4375712287240106e-8	17	637	53
DOID:3021	acute kidney failure	GO:0033135	regulation of peptidyl-serine phosphorylation	1.173394714726328e-12	2.5879220433289163e-8	10	117	53
DOID:3021	acute kidney failure	GO:0014070	response to organic cyclic compound	1.4128698211379742e-12	3.116084390519802e-8	19	873	53
DOID:3021	acute kidney failure	GO:0072593	reactive oxygen species metabolic process	1.4183099139586375e-12	3.128082515235775e-8	12	223	53
DOID:3021	acute kidney failure	GO:0042493	response to drug	1.4560574967958928e-12	3.2113348091833416e-8	17	433	53
DOID:3021	acute kidney failure	GO:0006801	superoxide metabolic process	1.5438761380437427e-12	3.4050188224554745e-8	8	52	53
DOID:3021	acute kidney failure	GO:0009611	response to wounding	2.3492319201068312e-12	5.181230999795616e-8	22	875	53
DOID:3021	acute kidney failure	GO:1903034	regulation of response to wounding	4.971356659666526e-12	1.0964327112894523e-7	14	407	53
DOID:3021	acute kidney failure	GO:0019725	cellular homeostasis	7.475020602498716e-12	1.648615793881092e-7	18	771	53
DOID:3021	acute kidney failure	GO:0097193	intrinsic apoptotic signaling pathway	1.2904122215218194e-11	2.846004154566373e-7	12	272	53
DOID:3021	acute kidney failure	GO:0031667	response to nutrient levels	2.201383519917499e-11	4.855151353178044e-7	15	546	53
DOID:3021	acute kidney failure	GO:0034599	cellular response to oxidative stress	2.2412405265015423e-11	4.943055981199151e-7	11	219	53
DOID:3021	acute kidney failure	GO:0001817	regulation of cytokine production	2.709954483037791e-11	5.976804612339848e-7	15	556	53
DOID:3021	acute kidney failure	GO:0071216	cellular response to biotic stimulus	5.481137765883659e-11	1.208864934265641e-6	10	175	53
DOID:3021	acute kidney failure	GO:0008015	blood circulation	5.907085931511347e-11	1.3028078021948275e-6	14	489	53
DOID:3021	acute kidney failure	GO:0032496	response to lipopolysaccharide	7.29010185551715e-11	1.6078319642343075e-6	12	319	53
DOID:3021	acute kidney failure	GO:2000379	positive regulation of reactive oxygen species metabolic process	8.140843554826915e-11	1.7954630460170762e-6	8	83	53
DOID:3021	acute kidney failure	GO:1903409	reactive oxygen species biosynthetic process	8.140843554826915e-11	1.7954630460170762e-6	8	83	53
DOID:3021	acute kidney failure	GO:0048878	chemical homeostasis	1.0523981686105799e-10	2.321064160870634e-6	18	988	53
DOID:3021	acute kidney failure	GO:0033138	positive regulation of peptidyl-serine phosphorylation	1.312013830911951e-10	2.893646504076308e-6	8	88	53
DOID:3021	acute kidney failure	GO:1901701	cellular response to oxygen-containing compound	1.3838064027993369e-10	3.0519850213739375e-6	17	873	53
DOID:3021	acute kidney failure	GO:0042060	wound healing	1.8274004531804167e-10	4.030331699489409e-6	14	534	53
DOID:3021	acute kidney failure	GO:0001818	negative regulation of cytokine production	2.401396859141869e-10	5.296280772837392e-6	10	203	53
DOID:3021	acute kidney failure	GO:0048545	response to steroid hormone	2.4474489102033203e-10	5.397848571453423e-6	13	446	53
DOID:3021	acute kidney failure	GO:2001242	regulation of intrinsic apoptotic signaling pathway	2.6478363945869887e-10	5.839803168261604e-6	9	145	53
DOID:3021	acute kidney failure	GO:0034097	response to cytokine	2.836951784601638e-10	6.256897160938912e-6	16	784	53
DOID:3021	acute kidney failure	GO:0050801	ion homeostasis	3.051832120348763e-10	6.730815741429197e-6	15	668	53
DOID:3021	acute kidney failure	GO:0097305	response to alcohol	3.821704064321807e-10	8.428768313861745e-6	12	369	53
DOID:3021	acute kidney failure	GO:0006809	nitric oxide biosynthetic process	4.294146149774747e-10	9.470739333328204e-6	7	62	53
DOID:3021	acute kidney failure	GO:0008217	regulation of blood pressure	9.829422831231227e-10	2.167879205428047e-5	9	168	53
DOID:3021	acute kidney failure	GO:0044057	regulation of system process	1.2011892591701212e-9	2.6492229110997023e-5	13	508	53
DOID:3021	acute kidney failure	GO:1901698	response to nitrogen compound	1.2658232240170264e-9	2.7917731205695517e-5	16	870	53
DOID:3021	acute kidney failure	GO:0071396	cellular response to lipid	1.495484847069406e-9	3.298291830211575e-5	12	416	53
DOID:3021	acute kidney failure	GO:0097285	cell-type specific apoptotic process	2.115742470110149e-9	4.666270017827934e-5	12	429	53
DOID:3021	acute kidney failure	GO:0020037	heme binding	2.216739125593392e-9	4.8890181414962264e-5	8	125	53
DOID:3021	acute kidney failure	GO:0032101	regulation of response to external stimulus	2.8234817817107682e-9	6.2271890695631e-5	16	920	53
DOID:3021	acute kidney failure	GO:0051050	positive regulation of transport	2.8234817817107682e-9	6.2271890695631e-5	16	920	53
DOID:3021	acute kidney failure	GO:0055082	cellular chemical homeostasis	2.8392728168569192e-9	6.262016197577935e-5	14	661	53
DOID:3021	acute kidney failure	GO:0030141	secretory granule	3.338068599312294e-9	7.362110295783264e-5	11	351	53
DOID:3021	acute kidney failure	GO:0051051	negative regulation of transport	3.804299208987061e-9	8.390381905420963e-5	12	452	53
DOID:3021	acute kidney failure	GO:0002719	negative regulation of cytokine production involved in immune response	3.8555904025017185e-9	8.50350463271754e-5	5	22	53
DOID:3021	acute kidney failure	GO:0071345	cellular response to cytokine stimulus	3.856798103107906e-9	8.506168216404486e-5	14	677	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0008285	negative regulation of cell proliferation	1.2975509555701592e-11	2.861748632509986e-7	16	634	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0007417	central nervous system development	1.8737245088829013e-10	4.132499404341239e-6	17	889	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0007420	brain development	3.114754010269394e-10	6.869589969649148e-6	15	669	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0009887	organ morphogenesis	5.073654829601537e-10	1.118994572668619e-5	17	950	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0060562	epithelial tube morphogenesis	6.651490469522514e-10	1.4669862230531905e-5	11	301	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0019900	kinase binding	7.803551138607645e-10	1.721073203619916e-5	14	598	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0048568	embryonic organ development	1.1994530924042124e-9	2.6453937952974904e-5	12	408	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0061138	morphogenesis of a branching epithelium	1.723393094898995e-9	3.8009434707997336e-5	9	179	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0051093	negative regulation of developmental process	2.9445671456684863e-9	6.494242839771847e-5	15	788	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0051726	regulation of cell cycle	3.2976776864757085e-9	7.273028137522175e-5	16	930	53
MESH:D018242	Neuroectodermal Tumors, Primitive	GO:0048863	stem cell differentiation	3.3110377772871402e-9	7.302493817806788e-5	10	266	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0022407	regulation of cell-cell adhesion	1.3458123504506148e-12	2.968189138918831e-8	17	376	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0002764	immune response-regulating signaling pathway	4.853895063661184e-13	1.0705265562904742e-8	16	451	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0045785	positive regulation of cell adhesion	2.886579864025407e-13	6.366351890108035e-9	15	368	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0042113	B cell activation	1.3500311979441904e-13	2.977493807065912e-9	15	212	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0051050	positive regulation of transport	2.8234817817107682e-9	6.2271890695631e-5	16	920	53
Orphanet:171918	T-cell non-Hodgkin lymphoma	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	4.220715776881434e-9	9.308788645912003e-5	11	359	53
DOID:182	calcinosis	GO:0033993	response to lipid	6.863398738232718e-13	1.513722591717226e-8	19	850	53
DOID:182	calcinosis	GO:0009725	response to hormone	2.139066701545289e-12	4.717711610258135e-8	20	865	53
DOID:182	calcinosis	GO:0009611	response to wounding	2.44715359087877e-12	5.3971972446831273e-8	20	875	53
DOID:182	calcinosis	GO:0031214	biomineral tissue development	3.1872282590938994e-12	7.029431925431595e-8	10	131	53
DOID:182	calcinosis	GO:0006954	inflammatory response	1.2533307724993392e-11	2.7642210187472926e-7	16	637	53
DOID:182	calcinosis	GO:0033273	response to vitamin	1.32062139002187e-11	2.912630475693234e-7	9	104	53
DOID:182	calcinosis	GO:0050900	leukocyte migration	1.3582801550171553e-11	2.995686881890336e-7	13	354	53
DOID:182	calcinosis	GO:0001503	ossification	1.8829937609154968e-11	4.152942739699128e-7	13	363	53
DOID:182	calcinosis	GO:0030334	regulation of cell migration	2.1986634735071675e-11	4.849152290820058e-7	16	660	53
DOID:182	calcinosis	GO:0007159	leukocyte cell-cell adhesion	2.7433055826975306e-11	6.050360462639404e-7	14	461	53
DOID:182	calcinosis	GO:0030335	positive regulation of cell migration	4.1900150016260795e-11	9.241078086086318e-7	13	387	53
DOID:182	calcinosis	GO:0030198	extracellular matrix organization	7.609368690708607e-11	1.6782462647357832e-6	12	320	53
DOID:182	calcinosis	GO:0001775	cell activation	9.902711983755808e-11	2.1840431280173433e-6	17	854	53
DOID:182	calcinosis	GO:0030155	regulation of cell adhesion	1.1050516057764526e-10	2.437191316539966e-6	15	621	53
DOID:182	calcinosis	GO:0014070	response to organic cyclic compound	1.3838064027993369e-10	3.0519850213739375e-6	17	873	53
DOID:182	calcinosis	GO:0050865	regulation of cell activation	3.409766913264889e-10	7.5202409272057125e-6	13	458	53
DOID:182	calcinosis	GO:0050863	regulation of T cell activation	3.6203806619283796e-10	7.984749549883041e-6	11	284	53
DOID:182	calcinosis	GO:0097305	response to alcohol	3.821704064321807e-10	8.428768313861745e-6	12	369	53
DOID:182	calcinosis	GO:0001568	blood vessel development	4.0974612591782034e-10	9.036950807117528e-6	14	569	53
DOID:182	calcinosis	GO:0008284	positive regulation of cell proliferation	4.933957686859003e-10	1.0881843678367531e-5	16	815	53
DOID:182	calcinosis	GO:0048878	chemical homeostasis	9.309045756467071e-10	2.0531100415888126e-5	17	988	53
DOID:182	calcinosis	GO:0098771	inorganic ion homeostasis	9.893348362766119e-10	2.1819779814080675e-5	14	609	53
DOID:182	calcinosis	GO:0033280	response to vitamin D	1.0059841848431006e-9	2.2186981196714584e-5	6	38	53
DOID:182	calcinosis	GO:0032496	response to lipopolysaccharide	1.227915769064225e-9	2.7081682286711484e-5	11	319	53
DOID:182	calcinosis	GO:0001934	positive regulation of protein phosphorylation	1.2658232240170264e-9	2.7917731205695517e-5	16	870	53
DOID:182	calcinosis	GO:1901701	cellular response to oxygen-containing compound	1.3280210264809966e-9	2.928950373903838e-5	16	873	53
DOID:182	calcinosis	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.1584550813358305e-9	4.760472681886174e-5	14	647	53
DOID:182	calcinosis	GO:0007565	female pregnancy	2.9150004632327864e-9	6.42903352165991e-5	9	190	53
DOID:182	calcinosis	GO:0048545	response to steroid hormone	3.2742015765307997e-9	7.221251577038679e-5	12	446	53
DOID:182	calcinosis	GO:0007566	embryo implantation	3.354728383975214e-9	7.398853450857334e-5	6	46	53
DOID:182	calcinosis	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.464434850108944e-9	7.640811061915276e-5	7	83	53
DOID:674	cleft palate	GO:0007167	enzyme linked receptor protein signaling pathway	5.673461700439475e-12	1.2512819780319262e-7	20	935	54
DOID:674	cleft palate	GO:0048736	appendage development	1.1088907569956064e-12	2.4456585645538098e-8	12	168	54
DOID:674	cleft palate	GO:0060173	limb development	1.1088907569956064e-12	2.4456585645538098e-8	12	168	54
DOID:674	cleft palate	GO:0035295	tube development	8.01581023779363e-13	1.767886947945385e-8	25	573	54
DOID:674	cleft palate	GO:0009887	organ morphogenesis	5.380140777333509e-13	1.1865900484409053e-8	30	950	54
DOID:674	cleft palate	GO:0071363	cellular response to growth factor stimulus	4.007905118896815e-13	8.839434739726926e-9	21	594	54
DOID:674	cleft palate	GO:0055123	digestive system development	3.326228181776969e-13	7.335996254909105e-9	11	150	54
DOID:674	cleft palate	GO:0022612	gland morphogenesis	2.9665159217984183e-13	6.5426508655264115e-9	12	119	54
DOID:674	cleft palate	GO:0060562	epithelial tube morphogenesis	2.8066438062523957e-13	6.190052914689659e-9	14	301	54
DOID:674	cleft palate	GO:0048568	embryonic organ development	1.0202949596305189e-13	2.2502605334651093e-9	20	408	54
DOID:674	cleft palate	GO:0090596	sensory organ morphogenesis	7.237543897531395e-13	1.5962403066005493e-8	13	239	54
DOID:674	cleft palate	GO:0048706	embryonic skeletal system development	1.6966428262321642e-12	3.741945753255038e-8	10	122	54
DOID:674	cleft palate	GO:0001934	positive regulation of protein phosphorylation	2.449929148440333e-12	5.403318736885154e-8	20	870	54
DOID:674	cleft palate	GO:0048704	embryonic skeletal system morphogenesis	5.551559212335633e-12	1.2243963842806238e-7	9	93	54
DOID:674	cleft palate	GO:0060348	bone development	5.6107340995481536e-11	1.2374474056553453e-6	10	172	54
DOID:674	cleft palate	GO:0030278	regulation of ossification	7.47589767868817e-11	1.648809233034676e-6	10	177	54
DOID:674	cleft palate	GO:0035113	embryonic appendage morphogenesis	8.298239873028024e-11	1.8301768039963306e-6	9	125	54
DOID:674	cleft palate	GO:0030326	embryonic limb morphogenesis	8.298239873028024e-11	1.8301768039963306e-6	9	125	54
DOID:674	cleft palate	GO:0048762	mesenchymal cell differentiation	1.0986278553559714e-10	2.423023734987595e-6	10	184	54
DOID:674	cleft palate	GO:0003002	regionalization	1.2060108467437658e-10	2.6598569224933755e-6	12	327	54
DOID:674	cleft palate	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.7148094055841057e-10	3.782012144015745e-6	18	996	54
DOID:674	cleft palate	GO:0016331	morphogenesis of embryonic epithelium	2.459433767754149e-10	5.424281174781775e-6	9	141	54
DOID:674	cleft palate	GO:0001649	osteoblast differentiation	3.3646452290980733e-10	7.420725052775801e-6	10	206	54
DOID:674	cleft palate	GO:0010464	regulation of mesenchymal cell proliferation	5.554365856141885e-10	1.2250153895720928e-5	6	34	54
DOID:674	cleft palate	GO:0001654	eye development	1.9669625928031564e-9	4.3381359984273615e-5	11	327	54
DOID:674	cleft palate	GO:0060449	bud elongation involved in lung branching	2.172633628561016e-9	4.7917434677913207e-5	4	7	54
DOID:674	cleft palate	GO:0007417	central nervous system development	2.3493436085431085e-9	5.181477328641826e-5	16	889	54
DOID:674	cleft palate	GO:0002065	columnar/cuboidal epithelial cell differentiation	3.1249897114449254e-9	6.892164808591783e-5	8	128	54
DOID:674	cleft palate	GO:0042475	odontogenesis of dentin-containing tooth	3.3364498941423903e-9	7.358540241531042e-5	7	81	54
Orphanet:77830	Rare genetic odontologic disease	GO:0009887	organ morphogenesis	5.380140777333509e-13	1.1865900484409053e-8	29	950	54
Orphanet:77830	Rare genetic odontologic disease	GO:0043062	extracellular structure organization	1.7437162824762709e-12	3.8457662610014154e-8	14	321	54
Orphanet:77830	Rare genetic odontologic disease	GO:0030198	extracellular matrix organization	1.784017378270164e-12	3.934650327774847e-8	14	320	54
Orphanet:77830	Rare genetic odontologic disease	GO:0001503	ossification	2.4102830842309686e-11	5.315879342271401e-7	13	363	54
Orphanet:77830	Rare genetic odontologic disease	GO:0044420	extracellular matrix component	8.298239873028024e-11	1.8301768039963306e-6	9	125	54
Orphanet:77830	Rare genetic odontologic disease	GO:0007423	sensory organ development	1.099124902204096e-9	2.424119971811134e-5	13	494	54
Orphanet:77830	Rare genetic odontologic disease	GO:0060348	bone development	1.4420458160913086e-9	3.180432047389381e-5	9	172	54
Orphanet:77830	Rare genetic odontologic disease	GO:0043588	skin development	1.5516239404433918e-9	3.4221066006479006e-5	10	241	54
Orphanet:77830	Rare genetic odontologic disease	GO:0005201	extracellular matrix structural constituent	1.7537111762777613e-9	3.8678099992806025e-5	7	74	54
Orphanet:77830	Rare genetic odontologic disease	GO:0034505	tooth mineralization	1.8871074702886403e-9	4.162015525721596e-5	5	19	54
Orphanet:83001	Urogenital tract malformation	GO:0048608	reproductive structure development	1.3352652317166758e-12	2.9449274685511284e-8	15	418	54
Orphanet:83001	Urogenital tract malformation	GO:0007548	sex differentiation	2.4225066397320916e-12	5.342838393929128e-8	13	274	54
Orphanet:83001	Urogenital tract malformation	GO:0008406	gonad development	6.401426055901993e-10	1.4118345166291846e-5	10	220	54
Orphanet:83001	Urogenital tract malformation	GO:0000904	cell morphogenesis involved in differentiation	1.1483382023058653e-9	2.5326599051855858e-5	15	720	54
Orphanet:83001	Urogenital tract malformation	GO:0007389	pattern specification process	2.8824433950802586e-9	6.35722890784951e-5	12	432	54
Orphanet:83001	Urogenital tract malformation	GO:0048863	stem cell differentiation	4.012416954246589e-9	8.849385592590853e-5	10	266	54
MESH:D007333	Insulin Resistance	GO:0040007	growth	3.96882526843001e-12	8.753244129522386e-8	20	936	54
MESH:D007333	Insulin Resistance	GO:0042327	positive regulation of phosphorylation	1.6224799281872038e-12	3.578379481616878e-8	21	910	54
MESH:D007333	Insulin Resistance	GO:0008643	carbohydrate transport	1.1266543253896089e-12	2.4848361146467823e-8	12	184	54
MESH:D007333	Insulin Resistance	GO:0010565	regulation of cellular ketone metabolic process	8.979483823168266e-13	1.980425157199761e-8	12	188	54
MESH:D007333	Insulin Resistance	GO:0009991	response to extracellular stimulus	7.860379014346108e-13	1.7336065916140342e-8	18	573	54
MESH:D007333	Insulin Resistance	GO:0045444	fat cell differentiation	7.636113963371827e-13	1.6841449346216564e-8	14	196	54
MESH:D007333	Insulin Resistance	GO:0015758	glucose transport	4.447553436648377e-13	9.809079104527996e-9	12	144	54
MESH:D007333	Insulin Resistance	GO:0043434	response to peptide hormone	4.0678571622265736e-13	8.971658971290708e-9	18	389	54
MESH:D007333	Insulin Resistance	GO:0010675	regulation of cellular carbohydrate metabolic process	3.248512570053208e-13	7.16459447325235e-9	11	153	54
MESH:D007333	Insulin Resistance	GO:0033993	response to lipid	3.2085445411667024e-13	7.076444985543162e-9	28	850	54
MESH:D007333	Insulin Resistance	GO:1901653	cellular response to peptide	2.8066438062523957e-13	6.190052914689659e-9	14	301	54
MESH:D007333	Insulin Resistance	GO:0097305	response to alcohol	2.1715962361668062e-13	4.789455498865891e-9	15	369	54
MESH:D007333	Insulin Resistance	GO:0006006	glucose metabolic process	1.0946799022804043e-13	2.4143165244794318e-9	12	199	54
MESH:D007333	Insulin Resistance	GO:0010883	regulation of lipid storage	1.1102230246251565e-14	2.448596880810783e-10	9	41	54
MESH:D007333	Insulin Resistance	GO:0010827	regulation of glucose transport	9.825473767932635e-14	2.1670082395175427e-9	11	99	54
MESH:D007333	Insulin Resistance	GO:0051050	positive regulation of transport	1.304512053934559e-13	2.8771013349526697e-9	23	920	54
MESH:D007333	Insulin Resistance	GO:0033500	carbohydrate homeostasis	4.71955807768154e-13	1.0408985340326637e-8	12	212	54
MESH:D007333	Insulin Resistance	GO:0042593	glucose homeostasis	4.71955807768154e-13	1.0408985340326637e-8	12	212	54
MESH:D007333	Insulin Resistance	GO:0048545	response to steroid hormone	5.405675906899887e-13	1.1922218212667701e-8	20	446	54
MESH:D007333	Insulin Resistance	GO:0006631	fatty acid metabolic process	7.104317134576377e-13	1.56685714403082e-8	14	348	54
MESH:D007333	Insulin Resistance	GO:0071396	cellular response to lipid	1.3731238368563936e-12	3.028424622186776e-8	17	416	54
MESH:D007333	Insulin Resistance	GO:0019217	regulation of fatty acid metabolic process	1.3793410857942945e-12	3.0421367647193165e-8	9	79	54
MESH:D007333	Insulin Resistance	GO:0071375	cellular response to peptide hormone stimulus	1.794120407794253e-12	3.956932559390225e-8	14	285	54
MESH:D007333	Insulin Resistance	GO:0046890	regulation of lipid biosynthetic process	2.30593322214645e-12	5.085735721443996e-8	10	126	54
MESH:D007333	Insulin Resistance	GO:0008202	steroid metabolic process	2.4213964167074664e-12	5.340389797048317e-8	13	275	54
MESH:D007333	Insulin Resistance	GO:0032869	cellular response to insulin stimulus	3.624212041586361e-12	7.993199657718719e-8	11	186	54
MESH:D007333	Insulin Resistance	GO:0031667	response to nutrient levels	4.0891734442993766e-12	9.018672031402275e-8	18	546	54
MESH:D007333	Insulin Resistance	GO:0008284	positive regulation of cell proliferation	4.424571820038636e-12	9.758393149095212e-8	19	815	54
MESH:D007333	Insulin Resistance	GO:0001101	response to acid chemical	4.8117065887254284e-12	1.0612218881433932e-7	13	315	54
MESH:D007333	Insulin Resistance	GO:0046324	regulation of glucose import	6.45350439754111e-12	1.4233203948776918e-7	8	60	54
MESH:D007333	Insulin Resistance	GO:1902533	positive regulation of intracellular signal transduction	7.225331444260519e-12	1.5935468500316574e-7	19	860	54
MESH:D007333	Insulin Resistance	GO:0048511	rhythmic process	7.661093981425893e-12	1.6896542776034806e-7	13	329	54
MESH:D007333	Insulin Resistance	GO:0070201	regulation of establishment of protein localization	9.520939592277955e-12	2.099843227076903e-7	18	803	54
MESH:D007333	Insulin Resistance	GO:0000165	MAPK cascade	1.0050849041931542e-11	2.2167147561980016e-7	18	843	54
MESH:D007333	Insulin Resistance	GO:0051223	regulation of protein transport	1.3498868689509891e-11	2.9771754894714064e-7	17	730	54
MESH:D007333	Insulin Resistance	GO:0009894	regulation of catabolic process	1.368460900152968e-11	3.018140515287371e-7	17	727	54
MESH:D007333	Insulin Resistance	GO:0031329	regulation of cellular catabolic process	1.4165335571192372e-11	3.1241647602264777e-7	16	624	54
MESH:D007333	Insulin Resistance	GO:0010906	regulation of glucose metabolic process	1.723288178823168e-11	3.800712078394497e-7	9	105	54
MESH:D007333	Insulin Resistance	GO:0030301	cholesterol transport	1.858246889696602e-11	4.098363515225856e-7	8	68	54
MESH:D007333	Insulin Resistance	GO:0001934	positive regulation of protein phosphorylation	2.0214385720862538e-11	4.4582827707362327e-7	18	870	54
MESH:D007333	Insulin Resistance	GO:0043408	regulation of MAPK cascade	2.491240547186635e-11	5.494431026820124e-7	16	651	54
MESH:D007333	Insulin Resistance	GO:0051051	negative regulation of transport	2.686662003981155e-11	5.925433049780437e-7	14	452	54
MESH:D007333	Insulin Resistance	GO:0010828	positive regulation of glucose transport	2.8250402017704346e-11	6.230626165004693e-7	7	42	54
MESH:D007333	Insulin Resistance	GO:0043410	positive regulation of MAPK cascade	3.958777750057152e-11	8.731084327751049e-7	14	464	54
MESH:D007333	Insulin Resistance	GO:0046879	hormone secretion	3.986544427903027e-11	8.792323735740126e-7	12	297	54
MESH:D007333	Insulin Resistance	GO:0051384	response to glucocorticoid	4.147582277624906e-11	9.14749271330173e-7	10	167	54
MESH:D007333	Insulin Resistance	GO:0001819	positive regulation of cytokine production	4.534839170844407e-11	1.000158779129734e-6	13	381	54
MESH:D007333	Insulin Resistance	GO:0008203	cholesterol metabolic process	4.936850928061176e-11	1.0888224721838924e-6	9	118	54
MESH:D007333	Insulin Resistance	GO:0045834	positive regulation of lipid metabolic process	7.742184671144514e-11	1.7075388292209226e-6	9	124	54
MESH:D007333	Insulin Resistance	GO:1901654	response to ketone	9.310985316091092e-11	2.0535378114638903e-6	10	181	54
MESH:D007333	Insulin Resistance	GO:2000379	positive regulation of reactive oxygen species metabolic process	9.543199563921689e-11	2.1047526638229286e-6	8	83	54
MESH:D007333	Insulin Resistance	GO:1903034	regulation of response to wounding	1.0222289681394159e-10	2.2545259892314817e-6	13	407	54
MESH:D007333	Insulin Resistance	GO:0044057	regulation of system process	1.2657308534613776e-10	2.7915693973090683e-6	14	508	54
MESH:D007333	Insulin Resistance	GO:0046883	regulation of hormone secretion	1.2697987106236042e-10	2.800541056280359e-6	11	252	54
MESH:D007333	Insulin Resistance	GO:0097009	energy homeostasis	1.5761636440458915e-10	3.4762289169432137e-6	6	28	54
MESH:D007333	Insulin Resistance	GO:0007623	circadian rhythm	2.0610468887127809e-10	4.545638913056038e-6	10	196	54
MESH:D007333	Insulin Resistance	GO:0044283	small molecule biosynthetic process	2.1659463111944888e-10	4.776994589339445e-6	14	530	54
MESH:D007333	Insulin Resistance	GO:1903827	regulation of cellular protein localization	2.963006506817578e-10	6.534910850786169e-6	14	543	54
MESH:D007333	Insulin Resistance	GO:0043491	protein kinase B signaling	2.9668645318281506e-10	6.543419724946986e-6	9	144	54
MESH:D007333	Insulin Resistance	GO:0032355	response to estradiol	3.1570612790687846e-10	6.9628986509862045e-6	9	145	54
MESH:D007333	Insulin Resistance	GO:0032101	regulation of response to external stimulus	4.327815883442554e-10	9.544997930932553e-6	17	920	54
MESH:D007333	Insulin Resistance	GO:0005159	insulin-like growth factor receptor binding	4.916648199682072e-10	1.084366760439881e-5	5	15	54
MESH:D007333	Insulin Resistance	GO:0033157	regulation of intracellular protein transport	5.791118695697151e-10	1.2772312283360066e-5	12	375	54
MESH:D007333	Insulin Resistance	GO:0006979	response to oxidative stress	8.061390444069616e-10	1.7779396624395538e-5	12	386	54
MESH:D007333	Insulin Resistance	GO:1903533	regulation of protein targeting	8.829446063174373e-10	1.947334329233108e-5	11	303	54
MESH:D007333	Insulin Resistance	GO:0032371	regulation of sterol transport	9.537610701215726e-10	2.1035200401531284e-5	6	37	54
MESH:D007333	Insulin Resistance	GO:0032374	regulation of cholesterol transport	9.537610701215726e-10	2.1035200401531284e-5	6	37	54
MESH:D007333	Insulin Resistance	GO:0050764	regulation of phagocytosis	9.574065984452318e-10	2.1115602528709587e-5	7	68	54
MESH:D007333	Insulin Resistance	GO:2000505	regulation of energy homeostasis	1.0086180779467213e-9	2.224507170911494e-5	5	17	54
MESH:D007333	Insulin Resistance	GO:0010035	response to inorganic substance	1.3354727323999782e-9	2.945385111308152e-5	13	502	54
MESH:D007333	Insulin Resistance	GO:0040008	regulation of growth	1.5348107229584684e-9	3.385025049484902e-5	14	617	54
MESH:D007333	Insulin Resistance	GO:0051896	regulation of protein kinase B signaling	1.7481800451690788e-9	3.855611089620403e-5	8	119	54
MESH:D007333	Insulin Resistance	GO:0071407	cellular response to organic cyclic compound	1.8838681725696915e-9	4.1548712546024547e-5	12	416	54
MESH:D007333	Insulin Resistance	GO:0043549	regulation of kinase activity	2.4425739209021913e-9	5.387096782549783e-5	15	761	54
MESH:D007333	Insulin Resistance	GO:0010874	regulation of cholesterol efflux	2.5106208223490967e-9	5.537174223690933e-5	5	20	54
MESH:D007333	Insulin Resistance	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.8221808223705125e-9	6.224319803738165e-5	14	647	54
MESH:D007333	Insulin Resistance	GO:0042493	response to drug	2.9567672754637897e-9	6.521150226035388e-5	12	433	54
MESH:D007333	Insulin Resistance	GO:0070542	response to fatty acid	3.6397588276670945e-9	8.027488094419777e-5	7	82	54
MESH:D007333	Insulin Resistance	GO:0060259	regulation of feeding behavior	4.245776175082483e-9	9.364059354144416e-5	5	22	54
MESH:D007333	Insulin Resistance	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	4.308855827694913e-9	9.50318152798113e-5	6	47	54
MESH:D007333	Insulin Resistance	GO:0018108	peptidyl-tyrosine phosphorylation	4.50231552040492e-9	9.929856880253052e-5	11	354	54
Orphanet:199633	Cerebral malformation	GO:0021543	pallium development	8.746336987996983e-13	1.9290046227027347e-8	13	153	54
Orphanet:199633	Cerebral malformation	GO:0061351	neural precursor cell proliferation	7.105427357601002e-14	1.567102003718901e-9	11	132	54
Orphanet:199633	Cerebral malformation	GO:0003002	regionalization	1.6209256159527285e-14	3.574951445983743e-10	14	327	54
Orphanet:199633	Cerebral malformation	GO:0021987	cerebral cortex development	1.411093464298574e-13	3.112166635510505e-9	11	105	54
Orphanet:199633	Cerebral malformation	GO:0051298	centrosome duplication	6.45350439754111e-12	1.4233203948776918e-7	8	60	54
Orphanet:199633	Cerebral malformation	GO:0072358	cardiovascular system development	3.58956198098781e-11	7.916778949068615e-7	18	910	54
Orphanet:199633	Cerebral malformation	GO:0060562	epithelial tube morphogenesis	4.603162295779839e-11	1.0152274443342435e-6	12	301	54
Orphanet:199633	Cerebral malformation	GO:0000278	mitotic cell cycle	4.883683457634902e-10	1.0770963865813776e-5	17	927	54
Orphanet:199633	Cerebral malformation	GO:0003007	heart morphogenesis	5.342191133905771e-10	1.1782202545829179e-5	10	216	54
Orphanet:199633	Cerebral malformation	GO:0005815	microtubule organizing center	1.5348107229584684e-9	3.385025049484902e-5	14	617	54
Orphanet:199633	Cerebral malformation	GO:0051093	negative regulation of developmental process	3.91811649791407e-9	8.641405936149482e-5	15	788	54
MESH:D048909	Diabetes Complications	GO:0009991	response to extracellular stimulus	8.01581023779363e-13	1.767886947945385e-8	20	573	54
MESH:D048909	Diabetes Complications	GO:0007584	response to nutrient	6.73683331342545e-13	1.485808587275983e-8	13	197	54
MESH:D048909	Diabetes Complications	GO:0007167	enzyme linked receptor protein signaling pathway	4.842792833414933e-13	1.0680779594096634e-8	19	935	54
MESH:D048909	Diabetes Complications	GO:0051384	response to glucocorticoid	3.091971123581061e-13	6.81934231305803e-9	11	167	54
MESH:D048909	Diabetes Complications	GO:0033273	response to vitamin	4.960476474025199e-13	1.0940330863462577e-8	10	104	54
MESH:D048909	Diabetes Complications	GO:0001101	response to acid chemical	8.361089598452054e-13	1.8440383109386005e-8	14	315	54
MESH:D048909	Diabetes Complications	GO:0072593	reactive oxygen species metabolic process	1.8595125439446747e-12	4.10115491566998e-8	12	223	54
MESH:D048909	Diabetes Complications	GO:1901654	response to ketone	2.1012080964055713e-12	4.6342144566224874e-8	11	181	54
MESH:D048909	Diabetes Complications	GO:1901701	cellular response to oxygen-containing compound	2.2745139105495582e-12	5.0164404297170506e-8	19	873	54
MESH:D048909	Diabetes Complications	GO:0030334	regulation of cell migration	2.910005569844998e-12	6.418017284293143e-8	17	660	54
MESH:D048909	Diabetes Complications	GO:0043069	negative regulation of programmed cell death	4.196976099990479e-12	9.256430788529002e-8	19	806	54
MESH:D048909	Diabetes Complications	GO:0070482	response to oxygen levels	6.7806871228981436e-12	1.4954805449551856e-7	13	321	54
MESH:D048909	Diabetes Complications	GO:0043066	negative regulation of apoptotic process	8.842149235022134e-12	1.9501360137841317e-7	19	795	54
MESH:D048909	Diabetes Complications	GO:0010035	response to inorganic substance	1.1271983346716752e-11	2.4860359271183796e-7	15	502	54
MESH:D048909	Diabetes Complications	GO:2000377	regulation of reactive oxygen species metabolic process	1.1702971924876238e-11	2.581090458031454e-7	10	147	54
MESH:D048909	Diabetes Complications	GO:0097285	cell-type specific apoptotic process	1.4827361560776353e-11	3.2701745922292247e-7	14	429	54
MESH:D048909	Diabetes Complications	GO:0042493	response to drug	1.5970336164627952e-11	3.522257641108695e-7	14	433	54
MESH:D048909	Diabetes Complications	GO:0006954	inflammatory response	1.750077860407373e-11	3.859796721128461e-7	16	637	54
MESH:D048909	Diabetes Complications	GO:1901698	response to nitrogen compound	2.0214385720862538e-11	4.4582827707362327e-7	18	870	54
MESH:D048909	Diabetes Complications	GO:0097305	response to alcohol	3.001310311390171e-11	6.619389891771021e-7	13	369	54
MESH:D048909	Diabetes Complications	GO:0001666	response to hypoxia	3.4710900820300594e-11	7.655489175917296e-7	12	292	54
MESH:D048909	Diabetes Complications	GO:0010243	response to organonitrogen compound	3.915490154327017e-11	8.635613535368236e-7	17	780	54
MESH:D048909	Diabetes Complications	GO:0032101	regulation of response to external stimulus	4.50550707853381e-11	9.936895861706319e-7	18	920	54
MESH:D048909	Diabetes Complications	GO:0051050	positive regulation of transport	4.50550707853381e-11	9.936895861706319e-7	18	920	54
MESH:D048909	Diabetes Complications	GO:0030335	positive regulation of cell migration	5.418920867583665e-11	1.1951429973455774e-6	13	387	54
MESH:D048909	Diabetes Complications	GO:0034284	response to monosaccharide	1.3626866302018925e-10	3.005405362910274e-6	10	188	54
MESH:D048909	Diabetes Complications	GO:0030155	regulation of cell adhesion	1.4880219278978757e-10	3.281832361978765e-6	15	621	54
MESH:D048909	Diabetes Complications	GO:0007565	female pregnancy	1.5154599797284618e-10	3.3423469852911225e-6	10	190	54
MESH:D048909	Diabetes Complications	GO:0030100	regulation of endocytosis	2.3964130679843265e-10	5.285289021439432e-6	10	199	54
MESH:D048909	Diabetes Complications	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.6407054320998213e-10	5.824075830496156e-6	15	647	54
MESH:D048909	Diabetes Complications	GO:0042327	positive regulation of phosphorylation	3.6412772796978743e-10	8.030837040373662e-6	17	910	54
MESH:D048909	Diabetes Complications	GO:0000302	response to reactive oxygen species	5.342191133905771e-10	1.1782202545829179e-5	10	216	54
MESH:D048909	Diabetes Complications	GO:0010631	epithelial cell migration	5.852254236771159e-10	1.2907146719198792e-5	10	218	54
MESH:D048909	Diabetes Complications	GO:0030097	hemopoiesis	7.069025365069592e-10	1.5590735442660986e-5	15	695	54
MESH:D048909	Diabetes Complications	GO:0071363	cellular response to growth factor stimulus	9.38043087650442e-10	2.0688540298130498e-5	14	594	54
MESH:D048909	Diabetes Complications	GO:0010632	regulation of epithelial cell migration	9.453497984424075e-10	2.0849689804647298e-5	9	164	54
MESH:D048909	Diabetes Complications	GO:0008015	blood circulation	9.720437788018899e-10	2.143842554147568e-5	13	489	54
MESH:D048909	Diabetes Complications	GO:0007610	behavior	1.0228534685907675e-9	2.2559033249769378e-5	15	714	54
MESH:D048909	Diabetes Complications	GO:0014823	response to activity	1.0629959135144418e-9	2.3444374872561013e-5	7	69	54
MESH:D048909	Diabetes Complications	GO:0044259	multicellular organismal macromolecule metabolic process	1.2405876326226917e-9	2.7361160237493465e-5	8	114	54
MESH:D048909	Diabetes Complications	GO:0045807	positive regulation of endocytosis	1.2405876326226917e-9	2.7361160237493465e-5	8	114	54
MESH:D048909	Diabetes Complications	GO:0001934	positive regulation of protein phosphorylation	1.7205904478956313e-9	3.794762232833815e-5	16	870	54
MESH:D048909	Diabetes Complications	GO:0009749	response to glucose	1.766909951683715e-9	3.8969198984384334e-5	9	176	54
MESH:D048909	Diabetes Complications	GO:0002684	positive regulation of immune system process	1.7760302117864057e-9	3.917034632094918e-5	16	872	54
MESH:D048909	Diabetes Complications	GO:0009636	response to toxic substance	2.126009923664185e-9	4.68891488664136e-5	10	249	54
MESH:D048909	Diabetes Complications	GO:0042542	response to hydrogen peroxide	2.42758313451219e-9	5.354034603166635e-5	8	124	54
MESH:D048909	Diabetes Complications	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.966446948666658e-9	8.747998745284313e-5	7	83	54
DOID:2871	endometrial carcinoma	GO:0048608	reproductive structure development	8.233413950620161e-13	1.8158794468092765e-8	16	418	54
DOID:2871	endometrial carcinoma	GO:0009725	response to hormone	1.700034557572394e-10	3.749426216725915e-6	17	865	54
DOID:2871	endometrial carcinoma	GO:1901701	cellular response to oxygen-containing compound	1.934493676358784e-10	4.266525803209298e-6	17	873	54
DOID:2871	endometrial carcinoma	GO:0048545	response to steroid hormone	3.157107908435819e-10	6.963001492055199e-6	13	446	54
DOID:2871	endometrial carcinoma	GO:0044597	daunorubicin metabolic process	4.335942493938205e-9	9.562921170380712e-5	4	8	54
DOID:2871	endometrial carcinoma	GO:0044598	doxorubicin metabolic process	4.335942493938205e-9	9.562921170380712e-5	4	8	54
DOID:9074	systemic lupus erythematosus	GO:0001816	cytokine production	1.3680168109431179e-12	3.0171610765350465e-8	17	613	54
DOID:9074	systemic lupus erythematosus	GO:0031349	positive regulation of defense response	7.78410669255436e-11	1.7167847310428641e-6	13	398	54
DOID:9074	systemic lupus erythematosus	GO:0051707	response to other organism	2.998776782447976e-10	6.613802193689011e-6	17	898	54
DOID:9074	systemic lupus erythematosus	GO:0016064	immunoglobulin mediated immune response	3.383583413452129e-10	7.462493218368671e-6	8	97	54
DOID:9074	systemic lupus erythematosus	GO:0001819	positive regulation of cytokine production	6.957563414289325e-10	1.5344906110215106e-5	12	381	54
DOID:9074	systemic lupus erythematosus	GO:0009617	response to bacterium	1.908551872098485e-9	4.209311153913209e-5	13	517	54
DOID:9074	systemic lupus erythematosus	GO:0046651	lymphocyte proliferation	2.126009923664185e-9	4.68891488664136e-5	10	249	54
DOID:9074	systemic lupus erythematosus	GO:0002237	response to molecule of bacterial origin	2.3789820113861992e-9	5.2468448261122624e-5	11	333	54
DOID:9074	systemic lupus erythematosus	GO:0002520	immune system development	3.533585091197722e-9	7.793321918636575e-5	15	782	54
MESH:D016769	Embolism and Thrombosis	GO:0051241	negative regulation of multicellular organismal process	4.773959005888173e-12	1.0528966587486366e-7	22	966	54
MESH:D016769	Embolism and Thrombosis	GO:1903035	negative regulation of response to wounding	1.2725376308253544e-12	2.8065817447853192e-8	14	159	54
MESH:D016769	Embolism and Thrombosis	GO:0061041	regulation of wound healing	3.157474282033945e-13	6.963809529025866e-9	15	125	54
MESH:D016769	Embolism and Thrombosis	GO:0002237	response to molecule of bacterial origin	1.8096635301390052e-13	3.991212915721576e-9	14	333	54
MESH:D016769	Embolism and Thrombosis	GO:0031638	zymogen activation	3.621158928268642e-11	7.98646601629649e-7	9	114	54
MESH:D016769	Embolism and Thrombosis	GO:0030162	regulation of proteolysis	7.449185712715689e-11	1.6429179089394452e-6	16	701	54
MESH:D016769	Embolism and Thrombosis	GO:2000379	positive regulation of reactive oxygen species metabolic process	9.543199563921689e-11	2.1047526638229286e-6	8	83	54
MESH:D016769	Embolism and Thrombosis	GO:0043491	protein kinase B signaling	2.9668645318281506e-10	6.543419724946986e-6	9	144	54
MESH:D016769	Embolism and Thrombosis	GO:0007598	blood coagulation, extrinsic pathway	3.117068825275737e-10	6.8746952941456385e-6	4	5	54
MESH:D016769	Embolism and Thrombosis	GO:0052548	regulation of endopeptidase activity	3.881456267507133e-10	8.560551797986982e-6	12	362	54
MESH:D016769	Embolism and Thrombosis	GO:1901342	regulation of vasculature development	9.064359263177835e-10	1.9991444354938714e-5	10	228	54
MESH:D016769	Embolism and Thrombosis	GO:0050729	positive regulation of inflammatory response	1.2405876326226917e-9	2.7361160237493465e-5	8	114	54
MESH:D016769	Embolism and Thrombosis	GO:0045861	negative regulation of proteolysis	1.9050154786981466e-9	4.201511638268762e-5	11	326	54
MESH:D016769	Embolism and Thrombosis	GO:0004252	serine-type endopeptidase activity	2.374694108020492e-9	5.237387855239195e-5	9	182	54
Orphanet:182073	Syndromic neurometabolic disease with non-X-linked intellectual disability	GO:0009311	oligosaccharide metabolic process	6.18821438536088e-10	1.364810682691342e-5	7	64	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0001819	positive regulation of cytokine production	2.1549428907974288e-13	4.752726545653729e-9	16	381	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0001775	cell activation	2.3598900611432327e-12	5.2047375298514e-8	19	854	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0034109	homotypic cell-cell adhesion	9.138467760294589e-12	2.0154890645329715e-7	15	495	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0070489	T cell aggregation	1.2324696818666325e-11	2.718211883356858e-7	14	424	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0042110	T cell activation	1.2324696818666325e-11	2.718211883356858e-7	14	424	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0051707	response to other organism	3.186140240529767e-11	7.027032300488401e-7	18	898	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0002684	positive regulation of immune system process	1.8947565738614003e-10	4.178885623651318e-6	17	872	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0051093	negative regulation of developmental process	4.159752542420847e-10	9.174334232309178e-6	16	788	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0050865	regulation of cell activation	4.3854164744061563e-10	9.672036034302778e-6	13	458	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0051249	regulation of lymphocyte activation	5.291070914736906e-10	1.1669456902452247e-5	12	372	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0008284	positive regulation of cell proliferation	6.718641198943942e-10	1.4817963164270864e-5	16	815	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0050778	positive regulation of immune response	1.1392393695075498e-9	2.512592429448901e-5	14	603	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0060548	negative regulation of cell death	1.6387958767793975e-9	3.614364306236961e-5	16	867	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0030155	regulation of cell adhesion	1.665907078951534e-9	3.674158062627608e-5	14	621	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0009617	response to bacterium	1.908551872098485e-9	4.209311153913209e-5	13	517	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0030139	endocytic vesicle	2.2973446478502524e-9	5.0667936208337316e-5	10	251	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0002237	response to molecule of bacterial origin	2.3789820113861992e-9	5.2468448261122624e-5	11	333	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0051251	positive regulation of lymphocyte activation	2.88385326729923e-9	6.360338381028452e-5	10	257	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0034097	response to cytokine	3.6568009731396955e-9	8.065074546259599e-5	15	784	54
Orphanet:182086	Acquired peripheral neuropathy	GO:0098542	defense response to other organism	4.007096099378771e-9	8.837650447179879e-5	13	550	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0051188	cofactor biosynthetic process	1.2445600106048005e-12	2.7448771033888875e-8	13	157	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0045333	cellular respiration	1.0678125050844756e-12	2.355060479963811e-8	15	173	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0098798	mitochondrial protein complex	4.447553436648377e-13	9.809079104527996e-9	12	144	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0009108	coenzyme biosynthetic process	1.7785772854495008e-13	3.922652203058874e-9	13	132	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0006733	oxidoreduction coenzyme metabolic process	1.9984014443252818e-15	4.407474385459409e-11	11	133	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:1990204	oxidoreductase complex	1.5010215292932116e-13	3.3105029828561783e-9	15	100	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0045239	tricarboxylic acid cycle enzyme complex	2.0028423364237824e-13	4.417268772982652e-9	6	11	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	5.919709167301335e-13	1.3055918568483094e-8	8	45	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0009060	aerobic respiration	8.523182160047327e-12	1.879787825398438e-7	8	62	54
Orphanet:225700	Mitochondrial disease with epilepsy	GO:0005740	mitochondrial envelope	6.937150853758567e-10	1.529988620796452e-5	15	694	54
MESH:D001849	Bone Diseases, Endocrine	GO:0009725	response to hormone	1.5840228018149105e-9	3.493562289402785e-5	16	865	54
MESH:D001849	Bone Diseases, Endocrine	GO:0021983	pituitary gland development	2.1284800588716735e-9	4.694362769841476e-5	6	42	54
DOID:397	restrictive cardiomyopathy	GO:0060047	heart contraction	1.3170708967891187e-10	2.9047998628684013e-6	11	253	54
DOID:397	restrictive cardiomyopathy	GO:0006941	striated muscle contraction	4.271372144870611e-10	9.420511265512133e-6	9	150	54
DOID:397	restrictive cardiomyopathy	GO:1903522	regulation of blood circulation	7.153485581667951e-10	1.5777012450368666e-5	11	297	54
DOID:397	restrictive cardiomyopathy	GO:0008016	regulation of heart contraction	7.630081011456014e-10	1.6828143670766238e-5	10	224	54
DOID:397	restrictive cardiomyopathy	GO:0060048	cardiac muscle contraction	1.3305759827275665e-9	2.934585329905648e-5	8	115	54
DOID:397	restrictive cardiomyopathy	GO:0009611	response to wounding	1.869183363645277e-9	4.1224839085196585e-5	16	875	54
DOID:8857	lupus erythematosus	GO:0002684	positive regulation of immune system process	5.397904345727511e-13	1.1905078034502026e-8	28	872	55
Orphanet:182231	Rare rheumatologic disease	GO:0009607	response to biotic stimulus	4.824807220416005e-12	1.06411123246275e-7	23	934	55
Orphanet:182231	Rare rheumatologic disease	GO:0022407	regulation of cell-cell adhesion	1.3040679647247089e-12	2.8761218962003454e-8	15	376	55
Orphanet:182231	Rare rheumatologic disease	GO:0050663	cytokine secretion	2.341460358934455e-13	5.164090821629941e-9	11	162	55
Orphanet:182231	Rare rheumatologic disease	GO:0050778	positive regulation of immune response	5.797584634592567e-13	1.2786572911593908e-8	17	603	55
Orphanet:182231	Rare rheumatologic disease	GO:0032101	regulation of response to external stimulus	1.0721423748805137e-12	2.364610007798973e-8	20	920	55
Orphanet:182231	Rare rheumatologic disease	GO:1903037	regulation of leukocyte cell-cell adhesion	3.2148728124070658e-12	7.090401987763784e-8	13	294	55
Orphanet:182231	Rare rheumatologic disease	GO:0034110	regulation of homotypic cell-cell adhesion	3.4163782913765317e-12	7.534822321630941e-8	13	304	55
Orphanet:182231	Rare rheumatologic disease	GO:0050863	regulation of T cell activation	3.485545185810679e-12	7.687369907305452e-8	13	284	55
Orphanet:182231	Rare rheumatologic disease	GO:0019221	cytokine-mediated signaling pathway	5.723643781152532e-12	1.262349635933191e-7	17	534	55
Orphanet:182231	Rare rheumatologic disease	GO:0050707	regulation of cytokine secretion	9.948042389851253e-12	2.1940407490816938e-7	10	142	55
Orphanet:182231	Rare rheumatologic disease	GO:0071222	cellular response to lipopolysaccharide	1.958300188675821e-11	4.3190310661245235e-7	10	152	55
Orphanet:182231	Rare rheumatologic disease	GO:0050710	negative regulation of cytokine secretion	3.845990192985482e-11	8.482331370629481e-7	7	43	55
Orphanet:182231	Rare rheumatologic disease	GO:0009986	cell surface	1.3708267854184442e-10	3.0233584752403786e-6	16	715	55
Orphanet:182231	Rare rheumatologic disease	GO:0051251	positive regulation of lymphocyte activation	1.9261536809977997e-10	4.248131943440647e-6	11	257	55
Orphanet:182231	Rare rheumatologic disease	GO:0002440	production of molecular mediator of immune response	4.50251613770547e-10	9.930299341709414e-6	9	148	55
Orphanet:182231	Rare rheumatologic disease	GO:0098542	defense response to other organism	4.5437431595019007e-10	1.0021225538281442e-5	14	550	55
Orphanet:182231	Rare rheumatologic disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	9.63587432067925e-10	2.1251920814258085e-5	10	225	55
Orphanet:182231	Rare rheumatologic disease	GO:0002367	cytokine production involved in immune response	1.490218615174399e-9	3.286677155767137e-5	7	71	55
Orphanet:182231	Rare rheumatologic disease	GO:1902533	positive regulation of intracellular signal transduction	1.969862384321175e-9	4.344531488620351e-5	16	860	55
Orphanet:182231	Rare rheumatologic disease	GO:0071356	cellular response to tumor necrosis factor	2.030871693037284e-9	4.4790875189937296e-5	10	243	55
Orphanet:182231	Rare rheumatologic disease	GO:0046651	lymphocyte proliferation	2.5680312321085808e-9	5.663792882415475e-5	10	249	55
Orphanet:182231	Rare rheumatologic disease	GO:0050670	regulation of lymphocyte proliferation	3.92412224936578e-9	8.654651620976228e-5	9	189	55
MESH:D004065	Digestive System Abnormalities	GO:0009790	embryo development	3.553823901825126e-12	7.837958615475316e-8	20	932	55
MESH:D004065	Digestive System Abnormalities	GO:0035295	tube development	4.38193925589303e-12	9.664367028872078e-8	16	573	55
MESH:D004065	Digestive System Abnormalities	GO:0048589	developmental growth	6.9182437556492005e-12	1.5258186603084312e-7	16	558	55
MESH:D004065	Digestive System Abnormalities	GO:0035239	tube morphogenesis	1.260425097626694e-11	2.7798675528156735e-7	13	338	55
MESH:D004065	Digestive System Abnormalities	GO:0035107	appendage morphogenesis	3.9911218774335566e-10	8.802419300679709e-6	9	146	55
MESH:D004065	Digestive System Abnormalities	GO:0035108	limb morphogenesis	3.9911218774335566e-10	8.802419300679709e-6	9	146	55
MESH:D004065	Digestive System Abnormalities	GO:0048598	embryonic morphogenesis	5.744628106540972e-10	1.2669777288976114e-5	14	560	55
MESH:D004065	Digestive System Abnormalities	GO:0002009	morphogenesis of an epithelium	1.878470268223964e-9	4.1429661765679526e-5	13	506	55
MESH:D004065	Digestive System Abnormalities	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.0073445128332423e-9	4.427198323053716e-5	17	996	55
Orphanet:98643	Systemic disease with cataract	GO:0098644	complex of collagen trimers	3.127498260369066e-13	6.897697413243975e-9	7	23	55
DOID:169	neuroendocrine tumor	GO:0008285	negative regulation of cell proliferation	2.4395485631600877e-11	5.380424356049573e-7	16	634	55
DOID:169	neuroendocrine tumor	GO:0009314	response to radiation	2.682666311315529e-10	5.9166205496063995e-6	13	431	55
DOID:169	neuroendocrine tumor	GO:0009416	response to light stimulus	8.816226637620161e-10	1.9444187849271266e-5	11	297	55
DOID:169	neuroendocrine tumor	GO:1901698	response to nitrogen compound	2.32073549266687e-9	5.118382129076782e-5	16	870	55
Orphanet:264656	Interstitial lung disease specific to childhood	GO:0034097	response to cytokine	5.214494391836411e-10	1.1500567381195204e-5	16	784	55
Orphanet:264656	Interstitial lung disease specific to childhood	GO:0071345	cellular response to cytokine stimulus	6.549804032474071e-10	1.4445592793621564e-5	15	677	55
Orphanet:264656	Interstitial lung disease specific to childhood	GO:0009617	response to bacterium	2.4357037498035083e-9	5.3719446201916377e-5	13	517	55
Orphanet:264656	Interstitial lung disease specific to childhood	GO:0002237	response to molecule of bacterial origin	2.9267535062160732e-9	6.45495485795955e-5	11	333	55
DOID:2234	focal epilepsy	GO:0043005	neuron projection	2.758016037773814e-12	6.082804371310147e-8	21	941	56
DOID:2234	focal epilepsy	GO:0015672	monovalent inorganic cation transport	4.5430326167661406e-13	1.0019658436277723e-8	19	572	56
DOID:2234	focal epilepsy	GO:0007270	neuron-neuron synaptic transmission	1.2234657731369225e-13	2.6983537626534826e-9	11	130	56
DOID:2234	focal epilepsy	GO:0007610	behavior	2.7505775435088253e-12	6.066398772208714e-8	19	714	56
DOID:2234	focal epilepsy	GO:0044456	synapse part	2.7592372831009015e-12	6.085497827879038e-8	17	613	56
DOID:2234	focal epilepsy	GO:0015077	monovalent inorganic cation transmembrane transporter activity	2.9323210526399635e-12	6.46723408159744e-8	14	368	56
DOID:2234	focal epilepsy	GO:0006820	anion transport	9.443668069764044e-12	2.08280099278646e-7	16	588	56
DOID:2234	focal epilepsy	GO:0044708	single-organism behavior	9.515055410247442e-12	2.0985454707300732e-7	14	404	56
DOID:2234	focal epilepsy	GO:0098590	plasma membrane region	1.2060907828015388e-11	2.660033221468794e-7	19	926	56
DOID:2234	focal epilepsy	GO:0097060	synaptic membrane	1.274325089895001e-11	2.8105239857634245e-7	12	256	56
DOID:2234	focal epilepsy	GO:0019226	transmission of nerve impulse	2.2199242444287393e-11	4.896042921087584e-7	8	67	56
DOID:2234	focal epilepsy	GO:0007215	glutamate receptor signaling pathway	2.5222823829551544e-11	5.562893795607593e-7	8	68	56
DOID:2234	focal epilepsy	GO:0050804	modulation of synaptic transmission	4.0412895252472936e-11	8.913064047932906e-7	12	285	56
DOID:2234	focal epilepsy	GO:0030424	axon	2.0752488616437859e-10	4.57696136435537e-6	13	414	56
DOID:2234	focal epilepsy	GO:0044304	main axon	3.9547476404777626e-10	8.722195921073705e-6	7	58	56
DOID:2234	focal epilepsy	GO:0001518	voltage-gated sodium channel complex	3.9642111815396675e-10	8.743067760885737e-6	5	14	56
DOID:2234	focal epilepsy	GO:0019233	sensory perception of pain	6.342883995813509e-10	1.3989230652766693e-5	8	101	56
DOID:2234	focal epilepsy	GO:0006821	chloride transport	6.342883995813509e-10	1.3989230652766693e-5	8	101	56
DOID:2234	focal epilepsy	GO:0098794	postsynapse	1.0919386506103024e-9	2.408270693921022e-5	12	381	56
DOID:2234	focal epilepsy	GO:0035249	synaptic transmission, glutamatergic	1.534118831969522e-9	3.383499083908781e-5	7	70	56
DOID:2234	focal epilepsy	GO:0005248	voltage-gated sodium channel activity	3.028368222857125e-9	6.67906611551139e-5	5	20	56
DOID:2234	focal epilepsy	GO:0086010	membrane depolarization during action potential	3.5723176639024246e-9	7.878746607736797e-5	6	44	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0009119	ribonucleoside metabolic process	1.020961093445294e-12	2.2517296915935958e-8	31	372	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0098798	mitochondrial protein complex	4.922728891187944e-13	1.085707856951501e-8	27	144	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0098800	inner mitochondrial membrane protein complex	1.6497914145929826e-13	3.638614964884823e-9	27	114	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0070069	cytochrome complex	2.864375403532904e-14	6.31737995249182e-10	8	25	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0009055	electron carrier activity	1.2023715356690445e-13	2.6518304219180777e-9	14	115	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0015078	hydrogen ion transmembrane transporter activity	8.250067295989538e-13	1.8195523421304927e-8	10	105	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0034551	mitochondrial respiratory chain complex III assembly	1.1235568031509047e-11	2.47800452934932e-7	5	8	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0006122	mitochondrial electron transport, ubiquinol to cytochrome c	5.932906388395054e-10	1.3085025039605291e-5	5	15	56
DC:0000283	Mitochondrial Complex Deficiency	GO:0005759	mitochondrial matrix	2.6412976250611564e-9	5.8253819120723804e-5	12	412	56
Orphanet:98085	46,XY disorder of sex development	GO:0048589	developmental growth	6.276834607632509e-11	1.3843558727133498e-6	15	558	56
Orphanet:98085	46,XY disorder of sex development	GO:0030900	forebrain development	5.207981823573959e-10	1.1486203911892368e-5	12	357	56
Orphanet:98085	46,XY disorder of sex development	GO:0048806	genitalia development	2.2911362806965485e-9	5.053101067076238e-5	6	41	56
Orphanet:98085	46,XY disorder of sex development	GO:0030539	male genitalia development	3.9657289674366325e-9	8.746415237681493e-5	5	21	56
Orphanet:206644	Progressive muscular dystrophy	GO:0042692	muscle cell differentiation	1.1790568521519162e-12	2.6004098874210513e-8	15	334	56
Orphanet:206644	Progressive muscular dystrophy	GO:0051146	striated muscle cell differentiation	4.016897925396279e-12	8.859268374461493e-8	12	230	56
Orphanet:206644	Progressive muscular dystrophy	GO:0014706	striated muscle tissue development	9.988787574854996e-12	2.2030270996342693e-7	13	323	56
Orphanet:206644	Progressive muscular dystrophy	GO:0055002	striated muscle cell development	1.3513246077678787e-10	2.9803464224320564e-6	9	127	56
Orphanet:206644	Progressive muscular dystrophy	GO:0030198	extracellular matrix organization	2.3673739635299285e-9	5.221243276565257e-5	11	320	56
Orphanet:206644	Progressive muscular dystrophy	GO:0006936	muscle contraction	2.6088632365528497e-9	5.75384786821731e-5	11	323	56
MESH:D003638	Deafness	GO:0007600	sensory perception	1.4075407506197735e-12	3.1043311254919104e-8	26	902	56
MESH:D003638	Deafness	GO:0098858	actin-based cell projection	1.070477040343576e-12	2.3609371124777567e-8	12	179	56
MESH:D003638	Deafness	GO:0048839	inner ear development	8.941736240331011e-13	1.9720999278050044e-8	12	170	56
MESH:D003638	Deafness	GO:0098862	cluster of actin-based cell projections	1.8030021919912542e-13	3.976521334436711e-9	13	138	56
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0007600	sensory perception	2.0183854587685346e-12	4.451549129314003e-8	37	902	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0098858	actin-based cell projection	1.1597389715234385e-12	2.5578043016949437e-8	23	179	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0048839	inner ear development	1.006750238730092e-12	2.2203876515192178e-8	17	170	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0050954	sensory perception of mechanical stimulus	9.277023593767808e-13	2.04604755360549e-8	36	153	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0042490	mechanoreceptor differentiation	1.8274270985330077e-13	4.030390465814548e-9	10	55	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0098862	cluster of actin-based cell projections	1.7119639039719914e-13	3.775736390210227e-9	22	138	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0007605	sensory perception of sound	1.7119639039719914e-13	3.775736390210227e-9	36	138	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0060113	inner ear receptor cell differentiation	6.705747068735946e-14	1.4789525160097128e-9	10	51	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0032420	stereocilium	4.3520742565306136e-14	9.598499772778268e-10	21	36	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0060119	inner ear receptor cell development	2.930988785010413e-14	6.464295765340466e-10	10	35	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0060122	inner ear receptor stereocilium organization	2.220446049250313e-15	4.8971937616215655e-11	8	21	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0060117	auditory receptor cell development	2.708944180085382e-14	5.97457638917831e-10	7	18	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0045177	apical part of cell	4.08623135328412e-11	9.012183249668126e-7	13	356	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0042471	ear morphogenesis	5.148104165186851e-11	1.13541437363196e-6	9	112	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0060088	auditory receptor cell stereocilium organization	5.520228718580711e-11	1.2174864438829758e-6	5	10	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0050957	equilibrioception	2.712647995117834e-9	5.982745153232383e-5	4	7	57
DOID:0050565	autosomal recessive nonsyndromic deafness	GO:0005902	microvillus	2.853592140361627e-9	6.293597465567569e-5	7	75	57
DOID:0060159	organic acidemia	GO:1901565	organonitrogen compound catabolic process	5.053735208093713e-13	1.1146013001450683e-8	18	349	57
DOID:0060159	organic acidemia	GO:0033013	tetrapyrrole metabolic process	1.9340085088970227e-13	4.2654557663723836e-9	10	56	57
DOID:0060159	organic acidemia	GO:0009081	branched-chain amino acid metabolic process	2.531308496145357e-14	5.582800888248585e-10	16	23	57
DOID:0060159	organic acidemia	GO:1901606	alpha-amino acid catabolic process	2.0738966099997924e-13	4.573978973354542e-9	10	96	57
DOID:0060159	organic acidemia	GO:0019842	vitamin binding	2.064348691988016e-12	4.5529210401795694e-8	9	79	57
DOID:0060159	organic acidemia	GO:0050662	coenzyme binding	2.0534751676848373e-10	4.528939482328909e-6	10	185	57
DOID:0060159	organic acidemia	GO:0055114	oxidation-reduction process	1.7845256383708374e-9	3.935771295426882e-5	17	949	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0007259	JAK-STAT cascade	1.0036416142611415e-12	2.2135315802529476e-8	13	170	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0046425	regulation of JAK-STAT cascade	2.1738166822160565e-13	4.794352692627513e-9	12	143	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0008206	bile acid metabolic process	4.085620730620576e-14	9.010836521383681e-10	10	41	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0002637	regulation of immunoglobulin production	6.5503158452884236e-15	1.4446721596783618e-10	9	46	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0071407	cellular response to organic cyclic compound	2.0966783864651006e-11	4.6242241813487794e-7	14	416	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0008284	positive regulation of cell proliferation	2.1046608900121555e-11	4.641829592921809e-7	18	815	57
Orphanet:101939	Rare parenchymatous liver disease	GO:1901701	cellular response to oxygen-containing compound	5.39177591463158e-11	1.189156177971995e-6	18	873	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0048545	response to steroid hormone	6.529704554836258e-10	1.4401263395691366e-5	13	446	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0002443	leukocyte mediated immunity	6.863744017593376e-10	1.5137987430802191e-5	11	279	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0009306	protein secretion	1.0050804633010557e-9	2.2167049618104784e-5	13	462	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0071345	cellular response to cytokine stimulus	1.1337422112234208e-9	2.5004684468532545e-5	15	677	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0002889	regulation of immunoglobulin mediated immune response	1.863840748406176e-9	4.110700770609821e-5	6	39	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0001101	response to acid chemical	2.4500459439025235e-9	5.4035763292770156e-5	11	315	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0022409	positive regulation of cell-cell adhesion	2.496476581015372e-9	5.505979099429403e-5	10	239	57
Orphanet:101939	Rare parenchymatous liver disease	GO:0022612	gland morphogenesis	2.7328427298911606e-9	6.027284640774955e-5	8	119	57
Orphanet:182040	Medullar aplasia	GO:0044445	cytosolic part	8.704148513061227e-14	1.9196999545556537e-9	13	211	57
Orphanet:182040	Medullar aplasia	GO:0000732	strand displacement	1.3556522571178675e-10	2.989891053073457e-6	6	26	57
DOID:12449	aplastic anemia	GO:0044445	cytosolic part	8.704148513061227e-14	1.9196999545556537e-9	13	211	57
DOID:12449	aplastic anemia	GO:0002262	myeloid cell homeostasis	2.229800677433502e-9	4.917825394079589e-5	8	116	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0044429	mitochondrial part	2.567723811353062e-12	5.6631148659391783e-8	50	956	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0009119	ribonucleoside metabolic process	1.1004530620084552e-12	2.427049228259648e-8	32	372	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0098798	mitochondrial protein complex	3.6770586575585185e-13	8.109752869245312e-9	28	144	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0006818	hydrogen transport	1.0746958878371515e-13	2.3702417806248377e-9	11	154	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0098800	inner mitochondrial membrane protein complex	7.971401316808624e-14	1.758092560422142e-9	28	114	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0070069	cytochrome complex	1.709743457922741e-14	3.7708391964486054e-10	9	25	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0015078	hydrogen ion transmembrane transporter activity	7.671641100159832e-14	1.6919804446402509e-9	11	105	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0009055	electron carrier activity	2.3736568266485847e-13	5.2351001311734535e-9	15	115	57
Orphanet:254846	Isolated oxidative phosphorylation complex disorder	GO:0005759	mitochondrial matrix	3.2795969273635706e-9	7.233151023300355e-5	12	412	57
DOID:0050567	orofacial cleft	GO:0051241	negative regulation of multicellular organismal process	3.1389569832285247e-9	6.922969626510511e-5	17	966	58
Orphanet:183592	Genetic renal tubular disease	GO:0015672	monovalent inorganic cation transport	8.852918398360998e-13	1.952511152758518e-8	18	572	58
Orphanet:183592	Genetic renal tubular disease	GO:0034220	ion transmembrane transport	8.575362642204709e-13	1.8912962307382486e-8	28	962	58
Orphanet:183592	Genetic renal tubular disease	GO:0006820	anion transport	3.1175062531474396e-13	6.875660041316678e-9	19	588	58
Orphanet:183592	Genetic renal tubular disease	GO:0007588	excretion	1.3566925360919413e-13	2.9921853883507765e-9	12	70	58
Orphanet:183592	Genetic renal tubular disease	GO:0015698	inorganic anion transport	1.3211653993039363e-13	2.9138302881648315e-9	13	133	58
Orphanet:183592	Genetic renal tubular disease	GO:0098590	plasma membrane region	1.5876189252139739e-13	3.5014935395594193e-9	26	926	58
Orphanet:183592	Genetic renal tubular disease	GO:0045177	apical part of cell	2.028377465990161e-13	4.4735865012413e-9	19	356	58
Orphanet:183592	Genetic renal tubular disease	GO:0006814	sodium ion transport	3.519406988061746e-13	7.762052112170181e-9	12	201	58
Orphanet:183592	Genetic renal tubular disease	GO:0098660	inorganic ion transmembrane transport	1.0051959264956167e-12	2.2169596158860827e-8	21	660	58
Orphanet:183592	Genetic renal tubular disease	GO:0050801	ion homeostasis	1.1155520951433573e-12	2.4603501458386745e-8	23	668	58
Orphanet:183592	Genetic renal tubular disease	GO:0016323	basolateral plasma membrane	1.141531313919586e-12	2.5176473128496468e-8	12	207	58
Orphanet:183592	Genetic renal tubular disease	GO:0016324	apical plasma membrane	1.1728396032140154e-12	2.586697744888511e-8	16	286	58
Orphanet:183592	Genetic renal tubular disease	GO:0098771	inorganic ion homeostasis	1.3203882431866987e-12	2.912116270348264e-8	20	609	58
Orphanet:183592	Genetic renal tubular disease	GO:0015103	inorganic anion transmembrane transporter activity	1.917244141225183e-12	4.228481953472141e-8	10	114	58
Orphanet:183592	Genetic renal tubular disease	GO:0043269	regulation of ion transport	2.3723245590190345e-12	5.2321618149164806e-8	17	583	58
Orphanet:183592	Genetic renal tubular disease	GO:0098656	anion transmembrane transport	3.506195334068707e-12	7.732913809288533e-8	13	259	58
Orphanet:183592	Genetic renal tubular disease	GO:0008324	cation transmembrane transporter activity	5.3794746435187335e-12	1.1864431326280567e-7	17	623	58
Orphanet:183592	Genetic renal tubular disease	GO:0031526	brush border membrane	5.438871575336179e-12	1.1995431259403944e-7	8	55	58
Orphanet:183592	Genetic renal tubular disease	GO:0034762	regulation of transmembrane transport	7.967404513919973e-12	1.7572110655450501e-7	14	383	58
Orphanet:183592	Genetic renal tubular disease	GO:0055067	monovalent inorganic cation homeostasis	1.7655543693706477e-11	3.8939301616469635e-7	10	142	58
Orphanet:183592	Genetic renal tubular disease	GO:0006821	chloride transport	2.353239825225728e-11	5.190070434535343e-7	9	101	58
Orphanet:183592	Genetic renal tubular disease	GO:0098661	inorganic anion transmembrane transport	4.724221014384966e-11	1.0419269447226043e-6	9	109	58
Orphanet:183592	Genetic renal tubular disease	GO:0034765	regulation of ion transmembrane transport	7.502221066602033e-11	1.6546148562390783e-6	13	367	58
Orphanet:183592	Genetic renal tubular disease	GO:0098662	inorganic cation transmembrane transport	1.548270400775209e-10	3.4147103689097236e-6	15	575	58
Orphanet:183592	Genetic renal tubular disease	GO:0035725	sodium ion transmembrane transport	1.7522383544132936e-10	3.864561690658519e-6	9	126	58
Orphanet:183592	Genetic renal tubular disease	GO:0022838	substrate-specific channel activity	5.146749693096808e-10	1.135115644812501e-5	13	429	58
Orphanet:183592	Genetic renal tubular disease	GO:0022890	inorganic cation transmembrane transporter activity	5.621167975533581e-10	1.2397485970039313e-5	14	527	58
Orphanet:183592	Genetic renal tubular disease	GO:0022804	active transmembrane transporter activity	5.633457034193157e-10	1.2424589488913007e-5	12	346	58
Orphanet:183592	Genetic renal tubular disease	GO:0015077	monovalent inorganic cation transmembrane transporter activity	1.1344444272864962e-9	2.5020171843803674e-5	12	368	58
Orphanet:183592	Genetic renal tubular disease	GO:0015291	secondary active transmembrane transporter activity	1.893390666474204e-9	4.175873114908857e-5	10	228	58
Orphanet:183592	Genetic renal tubular disease	GO:0046873	metal ion transmembrane transporter activity	4.396874309087195e-9	9.69730628869181e-5	12	415	58
DOID:657	adenoma	GO:0008285	negative regulation of cell proliferation	1.677658012511074e-12	3.700074746593174e-8	18	634	58
DOID:657	adenoma	GO:0050678	regulation of epithelial cell proliferation	4.578404322330698e-11	1.0097670732900355e-6	12	277	58
DOID:657	adenoma	GO:0045930	negative regulation of mitotic cell cycle	5.293361304836708e-10	1.167450835781736e-5	10	200	58
DOID:657	adenoma	GO:0001649	osteoblast differentiation	7.064813178914164e-10	1.558144546609519e-5	10	206	58
DOID:657	adenoma	GO:0045667	regulation of osteoblast differentiation	1.8096655285404495e-9	3.9912173231959613e-5	8	111	58
DOID:657	adenoma	GO:0050680	negative regulation of epithelial cell proliferation	1.9444003074298166e-9	4.2883748780364606e-5	8	112	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0048872	homeostasis of number of cells	1.2424505868580127e-12	2.740224769315347e-8	12	208	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0001067	regulatory region nucleic acid binding	2.8756996783840805e-12	6.34235564067609e-8	21	811	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0030097	hemopoiesis	3.6077807408219087e-12	7.95696042388272e-8	18	695	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0044212	transcription regulatory region DNA binding	3.8155034687292755e-12	8.415092900282417e-8	21	807	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	7.364775456153438e-12	1.6243012268546408e-7	21	996	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0002521	leukocyte differentiation	6.719247380715387e-11	1.4819300098167787e-6	14	448	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0003690	double-stranded DNA binding	7.952860592297384e-11	1.754003403631188e-6	17	756	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:1990837	sequence-specific double-stranded DNA binding	1.6754553300302177e-10	3.6952167303816452e-6	16	683	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	4.734094227742958e-10	1.0441044819287093e-5	15	623	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0000976	transcription regulatory region sequence-specific DNA binding	9.015985735771892e-10	1.9884756540244908e-5	15	653	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:1903706	regulation of hemopoiesis	2.124259323998956e-9	4.6850539390796975e-5	11	305	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	3.182578311999862e-9	7.019176467115695e-5	11	317	58
MESH:D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	4.265887865173568e-9	9.408415686640303e-5	15	732	58
Orphanet:183487	Genetic skin tumor	GO:0051726	regulation of cell cycle	1.3788969965844444e-12	3.041157325966992e-8	20	930	58
Orphanet:183487	Genetic skin tumor	GO:0097305	response to alcohol	3.113065361048939e-13	6.865865653793435e-9	16	369	58
Orphanet:183487	Genetic skin tumor	GO:0050679	positive regulation of epithelial cell proliferation	3.630429290524262e-14	8.00691180025126e-10	11	155	58
Orphanet:183487	Genetic skin tumor	GO:0009411	response to UV	4.831024469353906e-12	1.065482446716004e-7	10	125	58
Orphanet:183487	Genetic skin tumor	GO:0043069	negative regulation of programmed cell death	5.980882455958181e-12	1.3190836256615768e-7	19	806	58
Orphanet:183487	Genetic skin tumor	GO:0051093	negative regulation of developmental process	7.809752844423201e-12	1.722440989837537e-7	20	788	58
Orphanet:183487	Genetic skin tumor	GO:0014070	response to organic cyclic compound	8.61466453727644e-12	1.8999642636963188e-7	19	873	58
Orphanet:183487	Genetic skin tumor	GO:0043066	negative regulation of apoptotic process	1.051148057484852e-11	2.318307040782841e-7	19	795	58
Orphanet:183487	Genetic skin tumor	GO:0001655	urogenital system development	1.1299849944634843e-11	2.4921819052892147e-7	13	313	58
Orphanet:183487	Genetic skin tumor	GO:0006259	DNA metabolic process	2.2291168910726356e-11	4.916317303260698e-7	19	937	58
Orphanet:183487	Genetic skin tumor	GO:0032403	protein complex binding	2.2692403511825887e-11	5.004809594533199e-7	19	924	58
Orphanet:183487	Genetic skin tumor	GO:0045596	negative regulation of cell differentiation	2.3828161666017422e-11	5.255301055440142e-7	16	597	58
Orphanet:183487	Genetic skin tumor	GO:0051052	regulation of DNA metabolic process	2.382982700055436e-11	5.255668344972264e-7	13	335	58
Orphanet:183487	Genetic skin tumor	GO:0048732	gland development	3.2357339030397725e-11	7.136411123154218e-7	14	421	58
Orphanet:183487	Genetic skin tumor	GO:0051241	negative regulation of multicellular organismal process	3.797595571342072e-11	8.375597032594939e-7	19	966	58
Orphanet:183487	Genetic skin tumor	GO:0097285	cell-type specific apoptotic process	3.964117922805599e-11	8.742862078747748e-7	14	429	58
Orphanet:183487	Genetic skin tumor	GO:0070848	response to growth factor	4.124500740942949e-11	9.096586384149674e-7	16	621	58
Orphanet:183487	Genetic skin tumor	GO:0072001	renal system development	4.481837123648802e-11	9.884691776207433e-7	12	276	58
Orphanet:183487	Genetic skin tumor	GO:0033993	response to lipid	4.814237897221574e-11	1.061780168232218e-6	18	850	58
Orphanet:183487	Genetic skin tumor	GO:0045786	negative regulation of cell cycle	7.008071900571622e-11	1.5456302576710712e-6	14	449	58
Orphanet:183487	Genetic skin tumor	GO:0007346	regulation of mitotic cell cycle	7.815736946525931e-11	1.723760783556294e-6	14	453	58
Orphanet:183487	Genetic skin tumor	GO:0071363	cellular response to growth factor stimulus	2.439766166872914e-10	5.380904281038212e-6	15	594	58
Orphanet:183487	Genetic skin tumor	GO:0009887	organ morphogenesis	2.917640573585345e-10	6.434856285042478e-6	18	950	58
Orphanet:183487	Genetic skin tumor	GO:0001822	kidney development	4.2994807714080707e-10	9.4825048413405e-6	11	262	58
Orphanet:183487	Genetic skin tumor	GO:0009725	response to hormone	5.906576339143044e-10	1.3026954115979983e-5	17	865	58
Orphanet:183487	Genetic skin tumor	GO:0032355	response to estradiol	6.159038834496755e-10	1.3583760149482593e-5	9	145	58
Orphanet:183487	Genetic skin tumor	GO:0001649	osteoblast differentiation	7.064813178914164e-10	1.558144546609519e-5	10	206	58
Orphanet:183487	Genetic skin tumor	GO:0051302	regulation of cell division	1.3962239142628619e-9	3.079371842906742e-5	11	293	58
Orphanet:183487	Genetic skin tumor	GO:0001568	blood vessel development	1.502585722512606e-9	3.3139528110015526e-5	14	569	58
Orphanet:183487	Genetic skin tumor	GO:0072111	cell proliferation involved in kidney development	2.727404968538849e-9	6.0152916581124316e-5	5	19	58
Orphanet:183487	Genetic skin tumor	GO:0007050	cell cycle arrest	3.3641077701318522e-9	7.4195396870258e-5	10	242	58
Orphanet:183487	Genetic skin tumor	GO:0002009	morphogenesis of an epithelium	3.786887137202655e-9	8.351979581100455e-5	13	506	58
Orphanet:183487	Genetic skin tumor	GO:0061138	morphogenesis of a branching epithelium	3.975609175199679e-9	8.768206035902892e-5	9	179	58
Orphanet:183487	Genetic skin tumor	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	4.265887865173568e-9	9.408415686640303e-5	15	732	58
DOID:576	proteinuria	GO:0050870	positive regulation of T cell activation	4.869438186005937e-13	1.0739545919236093e-8	13	202	58
DOID:576	proteinuria	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.926636793494254e-12	8.660197448051576e-8	9	83	58
DOID:576	proteinuria	GO:0031347	regulation of defense response	7.204825624995692e-11	1.5890242915928e-6	17	749	58
DOID:576	proteinuria	GO:0045834	positive regulation of lipid metabolic process	1.5174239642590237e-10	3.3466785531732768e-6	9	124	58
DOID:576	proteinuria	GO:0045859	regulation of protein kinase activity	2.8731161894057777e-10	6.336657755734443e-6	16	709	58
DOID:576	proteinuria	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	9.346733387260997e-10	2.061422048560413e-5	10	212	58
DOID:576	proteinuria	GO:0003018	vascular process in circulatory system	1.3973985302229153e-9	3.0819624584066396e-5	9	159	58
DOID:576	proteinuria	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.560776730080704e-9	3.442293078192993e-5	9	161	58
DOID:576	proteinuria	GO:0050776	regulation of immune response	2.191916315119613e-9	4.8342714329963066e-5	16	816	58
DOID:576	proteinuria	GO:0008015	blood circulation	2.5113771062734713e-9	5.538842207886141e-5	13	489	58
DOID:576	proteinuria	GO:0033135	regulation of peptidyl-serine phosphorylation	2.755416228517049e-9	6.077070491994352e-5	8	117	58
DOID:576	proteinuria	GO:0050778	positive regulation of immune response	3.162023198832742e-9	6.973842165025612e-5	14	603	58
DOID:2256	osteochondrodysplasia	GO:0051216	cartilage development	1.021849271864994e-12	2.2536885690982444e-8	18	180	58
DOID:2256	osteochondrodysplasia	GO:0048705	skeletal system morphogenesis	3.6703973194107675e-13	8.095061287960448e-9	15	204	58
DOID:2256	osteochondrodysplasia	GO:0002062	chondrocyte differentiation	1.4410694859634532e-13	3.178278751292396e-9	12	95	58
DOID:2256	osteochondrodysplasia	GO:0001503	ossification	7.194245199571014e-14	1.5866907787653872e-9	18	363	58
DOID:2256	osteochondrodysplasia	GO:0060349	bone morphogenesis	4.907185768843192e-14	1.082279821318366e-9	12	80	58
DOID:2256	osteochondrodysplasia	GO:0044236	multicellular organismal metabolic process	2.708944180085382e-14	5.97457638917831e-10	11	127	58
DOID:2256	osteochondrodysplasia	GO:0060350	endochondral bone morphogenesis	1.5543122344752192e-15	3.428035633135096e-11	10	46	58
DOID:2256	osteochondrodysplasia	GO:0032963	collagen metabolic process	1.251554415659939e-12	2.7603032637379954e-8	10	109	58
DOID:2256	osteochondrodysplasia	GO:0043062	extracellular structure organization	1.273758876152442e-12	2.809275201354211e-8	17	321	58
DOID:2256	osteochondrodysplasia	GO:0005581	collagen trimer	6.5287775186106956e-12	1.439921881729589e-7	9	88	58
DOID:2256	osteochondrodysplasia	GO:0030574	collagen catabolic process	2.9724778194406554e-11	6.555799830776365e-7	8	67	58
DOID:2256	osteochondrodysplasia	GO:0060351	cartilage development involved in endochondral bone morphogenesis	3.601929865482134e-11	7.944056318320847e-7	6	21	58
DOID:2256	osteochondrodysplasia	GO:0002063	chondrocyte development	1.165110230516575e-10	2.5696506134043062e-6	6	25	58
DOID:2256	osteochondrodysplasia	GO:0036075	replacement ossification	1.5106538242548595e-10	3.3317470093940926e-6	6	26	58
DOID:2256	osteochondrodysplasia	GO:0001958	endochondral ossification	1.5106538242548595e-10	3.3317470093940926e-6	6	26	58
DOID:2256	osteochondrodysplasia	GO:0098643	banded collagen fibril	1.888819101125705e-10	4.165790527532742e-6	5	12	58
DOID:2256	osteochondrodysplasia	GO:0005583	fibrillar collagen trimer	1.888819101125705e-10	4.165790527532742e-6	5	12	58
DOID:2256	osteochondrodysplasia	GO:0061036	positive regulation of cartilage development	3.094871026121382e-10	6.825738048110708e-6	6	29	58
DOID:2256	osteochondrodysplasia	GO:0005518	collagen binding	1.1622132145561181e-9	2.5632612447035186e-5	7	65	58
DOID:2256	osteochondrodysplasia	GO:0030199	collagen fibril organization	1.760531387340336e-9	3.882851974779111e-5	6	38	58
DOID:2256	osteochondrodysplasia	GO:0048736	appendage development	2.2744516270378767e-9	5.016303063432037e-5	9	168	58
DOID:2256	osteochondrodysplasia	GO:0060173	limb development	2.2744516270378767e-9	5.016303063432037e-5	9	168	58
DOID:2256	osteochondrodysplasia	GO:0032332	positive regulation of chondrocyte differentiation	2.727404968538849e-9	6.0152916581124316e-5	5	19	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0030203	glycosaminoglycan metabolic process	1.419087070075875e-12	3.1297965330523425e-8	13	161	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0044272	sulfur compound biosynthetic process	1.2756462552943049e-12	2.8134378160515894e-8	12	209	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:1903510	mucopolysaccharide metabolic process	1.8233192733418946e-12	4.0213306573555485e-8	10	113	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0030204	chondroitin sulfate metabolic process	3.973954498803778e-11	8.764556647111732e-7	7	41	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0030206	chondroitin sulfate biosynthetic process	1.165110230516575e-10	2.5696506134043062e-6	6	25	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0015012	heparan sulfate proteoglycan biosynthetic process	1.5106538242548595e-10	3.3317470093940926e-6	6	26	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0005789	endoplasmic reticulum membrane	4.507131334818837e-10	9.940478158942945e-6	18	977	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0016254	preassembly of GPI anchor in ER membrane	7.110811939270434e-10	1.5682895732060942e-5	5	15	58
Orphanet:371235	Congenital disorder of glycosylation with developmental anomaly	GO:0015020	glucuronosyltransferase activity	1.0425486030030129e-9	2.299340943923145e-5	6	35	58
DOID:10579	leukodystrophy	GO:0019752	carboxylic acid metabolic process	3.1912117393062545e-9	7.038217491039944e-5	17	967	58
DOID:10579	leukodystrophy	GO:0006520	cellular amino acid metabolic process	4.165823130897195e-9	9.187722915193763e-5	12	413	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0009790	embryo development	2.8197444379429726e-12	6.218946357883226e-8	20	932	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0048598	embryonic morphogenesis	1.2055134668287337e-11	2.658759951090772e-7	16	560	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0072358	cardiovascular system development	1.4355472366389677e-10	3.166099430407243e-6	18	910	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0007507	heart development	2.040544400117028e-10	4.5004206744581055e-6	14	487	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0007423	sensory organ development	2.439056734360179e-10	5.379339627631374e-6	14	494	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0009887	organ morphogenesis	2.917640573585345e-10	6.434856285042478e-6	18	950	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0048568	embryonic organ development	3.6325787933222387e-9	8.011652528672197e-5	12	408	58
Orphanet:98638	Rare disease with glaucoma as a major feature	GO:0001654	eye development	4.396969122133498e-9	9.69751539886543e-5	11	327	58
Orphanet:166472	Monogenic disease with epilepsy	GO:1902495	transmembrane transporter complex	3.779199175824033e-13	8.335023782279904e-9	18	308	58
Orphanet:166472	Monogenic disease with epilepsy	GO:0022836	gated channel activity	3.4861002973229915e-13	7.688594205745858e-9	19	335	58
Orphanet:166472	Monogenic disease with epilepsy	GO:0044456	synapse part	3.903319445441866e-9	8.608771036922036e-5	14	613	58
MESH:D001930	Brain Injuries	GO:0032880	regulation of protein localization	5.795808277753167e-12	1.278265515658461e-7	21	933	58
MESH:D001930	Brain Injuries	GO:0009607	response to biotic stimulus	4.340972026284362e-12	9.57401380397016e-8	28	934	58
MESH:D001930	Brain Injuries	GO:0071219	cellular response to molecule of bacterial origin	1.2174705688039467e-12	2.6851313394971044e-8	14	158	58
MESH:D001930	Brain Injuries	GO:0050663	cytokine secretion	1.1961542867311437e-12	2.6381182793855373e-8	12	162	58
MESH:D001930	Brain Injuries	GO:1904589	regulation of protein import	8.009148899645879e-13	1.7664177898168987e-8	12	179	58
MESH:D001930	Brain Injuries	GO:0071222	cellular response to lipopolysaccharide	7.509548538564559e-13	1.6562309301804135e-8	13	152	58
MESH:D001930	Brain Injuries	GO:0042306	regulation of protein import into nucleus	6.579181643928678e-13	1.4510385115684699e-8	12	175	58
MESH:D001930	Brain Injuries	GO:0006954	inflammatory response	5.093703236980218e-13	1.1234162489159871e-8	24	637	58
MESH:D001930	Brain Injuries	GO:0050707	regulation of cytokine secretion	2.964295475749168e-13	6.53775367176479e-9	12	142	58
MESH:D001930	Brain Injuries	GO:0042035	regulation of cytokine biosynthetic process	1.3811174426336947e-13	3.0460545197286137e-9	11	95	58
MESH:D001930	Brain Injuries	GO:0032649	regulation of interferon-gamma production	1.3811174426336947e-13	3.0460545197286137e-9	12	93	58
MESH:D001930	Brain Injuries	GO:0032388	positive regulation of intracellular transport	5.972999872483342e-14	1.3173451218762011e-9	15	347	58
MESH:D001930	Brain Injuries	GO:1904591	positive regulation of protein import	3.6193270602780103e-14	7.982425831443152e-10	11	101	58
MESH:D001930	Brain Injuries	GO:1900182	positive regulation of protein localization to nucleus	2.731148640577885e-14	6.023548326794526e-10	11	125	58
MESH:D001930	Brain Injuries	GO:0042993	positive regulation of transcription factor import into nucleus	5.329070518200751e-15	1.1753265027891757e-10	9	49	58
MESH:D001930	Brain Injuries	GO:0050778	positive regulation of immune response	1.8984813721090177e-14	4.1871006661864385e-10	18	603	58
MESH:D001930	Brain Injuries	GO:0032729	positive regulation of interferon-gamma production	8.559819519859957e-14	1.8878681951051135e-9	10	65	58
MESH:D001930	Brain Injuries	GO:0002683	negative regulation of immune system process	1.0680345496894006e-13	2.355550199339973e-9	15	359	58
MESH:D001930	Brain Injuries	GO:0031349	positive regulation of defense response	1.907363156306019e-13	4.206689441232925e-9	17	398	58
MESH:D001930	Brain Injuries	GO:0032675	regulation of interleukin-6 production	7.825962100582728e-13	1.7260159412835208e-8	10	103	58
MESH:D001930	Brain Injuries	GO:0001775	cell activation	8.019140906867506e-13	1.7686215270096284e-8	22	854	58
MESH:D001930	Brain Injuries	GO:0002521	leukocyte differentiation	8.583134203377085e-13	1.893010248554816e-8	18	448	58
MESH:D001930	Brain Injuries	GO:0042346	positive regulation of NF-kappaB import into nucleus	1.1715073355844652e-12	2.583759428631538e-8	7	26	58
MESH:D001930	Brain Injuries	GO:0005125	cytokine activity	1.2254641745812478e-12	2.702761237038942e-8	13	222	58
MESH:D001930	Brain Injuries	GO:0009612	response to mechanical stimulus	1.336819543951151e-12	2.9483555041842635e-8	12	210	58
MESH:D001930	Brain Injuries	GO:0046649	lymphocyte activation	1.6765477894864489e-12	3.697626149712363e-8	17	594	58
MESH:D001930	Brain Injuries	GO:0050729	positive regulation of inflammatory response	1.917244141225183e-12	4.228481953472141e-8	10	114	58
MESH:D001930	Brain Injuries	GO:0005126	cytokine receptor binding	2.5724977703589502e-12	5.673643832526665e-8	14	270	58
MESH:D001930	Brain Injuries	GO:0071345	cellular response to cytokine stimulus	2.8289592890473614e-12	6.239269711993956e-8	23	677	58
MESH:D001930	Brain Injuries	GO:0002694	regulation of leukocyte activation	3.059219544354619e-12	6.747108705074112e-8	16	425	58
MESH:D001930	Brain Injuries	GO:0098542	defense response to other organism	3.9644953986339715e-12	8.743694601687224e-8	17	550	58
MESH:D001930	Brain Injuries	GO:0042742	defense response to bacterium	4.360400929215302e-12	9.616864249384349e-8	12	222	58
MESH:D001930	Brain Injuries	GO:0051249	regulation of lymphocyte activation	4.697353617189037e-12	1.0360013402710422e-7	14	372	58
MESH:D001930	Brain Injuries	GO:0019221	cytokine-mediated signaling pathway	5.870415265007978e-12	1.2947200866975095e-7	22	534	58
MESH:D001930	Brain Injuries	GO:0002252	immune effector process	6.2088112429137254e-12	1.3693533196246221e-7	19	757	58
MESH:D001930	Brain Injuries	GO:0042108	positive regulation of cytokine biosynthetic process	1.0025202890062701e-11	2.2110584974033287e-7	8	59	58
MESH:D001930	Brain Injuries	GO:0007159	leukocyte cell-cell adhesion	1.0078715639849634e-11	2.2228607343688367e-7	15	461	58
MESH:D001930	Brain Injuries	GO:0097190	apoptotic signaling pathway	1.1088463480746213e-11	2.4455606206785774e-7	16	564	58
MESH:D001930	Brain Injuries	GO:0050670	regulation of lymphocyte proliferation	1.21417320642081e-11	2.6778590067610963e-7	11	189	58
MESH:D001930	Brain Injuries	GO:0032642	regulation of chemokine production	2.630251572099951e-11	5.801019842266442e-7	8	66	58
MESH:D001930	Brain Injuries	GO:0070489	T cell aggregation	3.3447911107487016e-11	7.376936794756261e-7	14	424	58
MESH:D001930	Brain Injuries	GO:0042110	T cell activation	3.3447911107487016e-11	7.376936794756261e-7	14	424	58
MESH:D001930	Brain Injuries	GO:0032755	positive regulation of interleukin-6 production	3.364486467205552e-11	7.420374903421845e-7	8	68	58
MESH:D001930	Brain Injuries	GO:0009897	external side of plasma membrane	4.45210535104934e-11	9.81911835173932e-7	11	212	58
MESH:D001930	Brain Injuries	GO:0060548	negative regulation of cell death	6.793066109622714e-11	1.4982107304772896e-6	18	867	58
MESH:D001930	Brain Injuries	GO:1902105	regulation of leukocyte differentiation	8.556977348916917e-11	1.887241354303626e-6	11	225	58
MESH:D001930	Brain Injuries	GO:0031663	lipopolysaccharide-mediated signaling pathway	1.4896139877151882e-10	3.2853436499058475e-6	7	49	58
MESH:D001930	Brain Injuries	GO:0043066	negative regulation of apoptotic process	1.6978984884730153e-10	3.744715116327235e-6	17	795	58
MESH:D001930	Brain Injuries	GO:0032722	positive regulation of chemokine production	1.7274925934174234e-10	3.8099849147821274e-6	7	50	58
MESH:D001930	Brain Injuries	GO:0070851	growth factor receptor binding	1.7522383544132936e-10	3.864561690658519e-6	9	126	58
MESH:D001930	Brain Injuries	GO:0002695	negative regulation of leukocyte activation	3.253165514749412e-10	7.174856542779828e-6	9	135	58
MESH:D001930	Brain Injuries	GO:0002250	adaptive immune response	3.7552860820966316e-10	8.282283454064121e-6	12	334	58
MESH:D001930	Brain Injuries	GO:0034612	response to tumor necrosis factor	4.845750467552534e-10	1.0687302656187114e-5	11	265	58
MESH:D001930	Brain Injuries	GO:0032677	regulation of interleukin-8 production	5.10144260168488e-10	1.1251231658016003e-5	7	58	58
MESH:D001930	Brain Injuries	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.290112875007026e-10	1.3872843945827995e-5	18	996	58
MESH:D001930	Brain Injuries	GO:0002440	production of molecular mediator of immune response	7.393332612792847e-10	1.6305995077514623e-5	9	148	58
MESH:D001930	Brain Injuries	GO:0032680	regulation of tumor necrosis factor production	7.831110204747915e-10	1.7271513556571527e-5	8	100	58
MESH:D001930	Brain Injuries	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	8.133712592339748e-10	1.7938903122405314e-5	10	209	58
MESH:D001930	Brain Injuries	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	8.659356565132725e-10	1.9098210904400226e-5	6	34	58
MESH:D001930	Brain Injuries	GO:0050863	regulation of T cell activation	1.0061261823679502e-9	2.219011295212514e-5	11	284	58
MESH:D001930	Brain Injuries	GO:0008284	positive regulation of cell proliferation	2.153360378898128e-9	4.7492363156598216e-5	16	815	58
MESH:D001930	Brain Injuries	GO:0010035	response to inorganic substance	3.4412547256224e-9	7.589687297360204e-5	13	502	58
MESH:D001930	Brain Injuries	GO:0032757	positive regulation of interleukin-8 production	3.841801876625084e-9	8.473094038896622e-5	6	43	58
Orphanet:93603	Rare renal tubular disease	GO:0015672	monovalent inorganic cation transport	8.852918398360998e-13	1.952511152758518e-8	18	572	58
Orphanet:93603	Rare renal tubular disease	GO:0034220	ion transmembrane transport	8.575362642204709e-13	1.8912962307382486e-8	28	962	58
Orphanet:93603	Rare renal tubular disease	GO:0006820	anion transport	3.1175062531474396e-13	6.875660041316678e-9	19	588	58
Orphanet:93603	Rare renal tubular disease	GO:0007588	excretion	1.3566925360919413e-13	2.9921853883507765e-9	12	70	58
Orphanet:93603	Rare renal tubular disease	GO:0015698	inorganic anion transport	1.3211653993039363e-13	2.9138302881648315e-9	13	133	58
Orphanet:93603	Rare renal tubular disease	GO:0098590	plasma membrane region	1.5876189252139739e-13	3.5014935395594193e-9	26	926	58
Orphanet:93603	Rare renal tubular disease	GO:0045177	apical part of cell	2.028377465990161e-13	4.4735865012413e-9	19	356	58
Orphanet:93603	Rare renal tubular disease	GO:0006814	sodium ion transport	3.519406988061746e-13	7.762052112170181e-9	12	201	58
Orphanet:93603	Rare renal tubular disease	GO:0098660	inorganic ion transmembrane transport	1.0051959264956167e-12	2.2169596158860827e-8	21	660	58
Orphanet:93603	Rare renal tubular disease	GO:0050801	ion homeostasis	1.1155520951433573e-12	2.4603501458386745e-8	23	668	58
Orphanet:93603	Rare renal tubular disease	GO:0016323	basolateral plasma membrane	1.141531313919586e-12	2.5176473128496468e-8	12	207	58
Orphanet:93603	Rare renal tubular disease	GO:0016324	apical plasma membrane	1.1728396032140154e-12	2.586697744888511e-8	16	286	58
Orphanet:93603	Rare renal tubular disease	GO:0098771	inorganic ion homeostasis	1.3203882431866987e-12	2.912116270348264e-8	20	609	58
Orphanet:93603	Rare renal tubular disease	GO:0015103	inorganic anion transmembrane transporter activity	1.917244141225183e-12	4.228481953472141e-8	10	114	58
Orphanet:93603	Rare renal tubular disease	GO:0043269	regulation of ion transport	2.3723245590190345e-12	5.2321618149164806e-8	17	583	58
Orphanet:93603	Rare renal tubular disease	GO:0098656	anion transmembrane transport	3.506195334068707e-12	7.732913809288533e-8	13	259	58
Orphanet:93603	Rare renal tubular disease	GO:0008324	cation transmembrane transporter activity	5.3794746435187335e-12	1.1864431326280567e-7	17	623	58
Orphanet:93603	Rare renal tubular disease	GO:0031526	brush border membrane	5.438871575336179e-12	1.1995431259403944e-7	8	55	58
Orphanet:93603	Rare renal tubular disease	GO:0034762	regulation of transmembrane transport	7.967404513919973e-12	1.7572110655450501e-7	14	383	58
Orphanet:93603	Rare renal tubular disease	GO:0055067	monovalent inorganic cation homeostasis	1.7655543693706477e-11	3.8939301616469635e-7	10	142	58
Orphanet:93603	Rare renal tubular disease	GO:0006821	chloride transport	2.353239825225728e-11	5.190070434535343e-7	9	101	58
Orphanet:93603	Rare renal tubular disease	GO:0098661	inorganic anion transmembrane transport	4.724221014384966e-11	1.0419269447226043e-6	9	109	58
Orphanet:93603	Rare renal tubular disease	GO:0034765	regulation of ion transmembrane transport	7.502221066602033e-11	1.6546148562390783e-6	13	367	58
Orphanet:93603	Rare renal tubular disease	GO:0098662	inorganic cation transmembrane transport	1.548270400775209e-10	3.4147103689097236e-6	15	575	58
Orphanet:93603	Rare renal tubular disease	GO:0035725	sodium ion transmembrane transport	1.7522383544132936e-10	3.864561690658519e-6	9	126	58
Orphanet:93603	Rare renal tubular disease	GO:0022838	substrate-specific channel activity	5.146749693096808e-10	1.135115644812501e-5	13	429	58
Orphanet:93603	Rare renal tubular disease	GO:0022890	inorganic cation transmembrane transporter activity	5.621167975533581e-10	1.2397485970039313e-5	14	527	58
Orphanet:93603	Rare renal tubular disease	GO:0022804	active transmembrane transporter activity	5.633457034193157e-10	1.2424589488913007e-5	12	346	58
Orphanet:93603	Rare renal tubular disease	GO:0015077	monovalent inorganic cation transmembrane transporter activity	1.1344444272864962e-9	2.5020171843803674e-5	12	368	58
Orphanet:93603	Rare renal tubular disease	GO:0015291	secondary active transmembrane transporter activity	1.893390666474204e-9	4.175873114908857e-5	10	228	58
Orphanet:93603	Rare renal tubular disease	GO:0046873	metal ion transmembrane transporter activity	4.396874309087195e-9	9.69730628869181e-5	12	415	58
Orphanet:264740	Primary interstitial lung disease specific to adulthood	GO:0016337	single organismal cell-cell adhesion	2.195763681989149e-9	4.842756800627068e-5	15	697	58
DOID:11843	coronary artery anomaly	GO:1901701	cellular response to oxygen-containing compound	1.0352563251103675e-10	2.2832578250309155e-6	18	873	59
DOID:11843	coronary artery anomaly	GO:0048660	regulation of smooth muscle cell proliferation	9.020104663193251e-10	1.9893840834672716e-5	8	100	59
DOID:11843	coronary artery anomaly	GO:0042311	vasodilation	1.8177879201886071e-9	4.009131257975973e-5	7	68	59
DOID:11843	coronary artery anomaly	GO:0034383	low-density lipoprotein particle clearance	2.978080781979031e-9	6.568157164654753e-5	5	19	59
MESH:D020261	Arsenic Poisoning	GO:0034097	response to cytokine	1.6297629912287448e-9	3.5944422771549966e-5	16	784	59
MESH:D016399	Lymphoma, T-Cell	GO:0006259	DNA metabolic process	1.864508547555488e-12	4.1121736016336286e-8	21	937	59
MESH:D016399	Lymphoma, T-Cell	GO:0022407	regulation of cell-cell adhesion	5.075939668586216e-13	1.1194984939066899e-8	18	376	59
MESH:D016399	Lymphoma, T-Cell	GO:0042113	B cell activation	9.348077867343818e-14	2.061718573642679e-9	17	212	59
MESH:D016399	Lymphoma, T-Cell	GO:0002706	regulation of lymphocyte mediated immunity	1.936228954946273e-13	4.270352960134005e-9	11	112	59
MESH:D016399	Lymphoma, T-Cell	GO:0002764	immune response-regulating signaling pathway	3.1441516057384433e-13	6.934426366456137e-9	17	451	59
MESH:D016399	Lymphoma, T-Cell	GO:0002768	immune response-regulating cell surface receptor signaling pathway	4.670708264598034e-13	1.0301247077570963e-8	15	323	59
MESH:D016399	Lymphoma, T-Cell	GO:0045191	regulation of isotype switching	7.025491299827991e-13	1.5494721061770633e-8	7	24	59
MESH:D016399	Lymphoma, T-Cell	GO:0060548	negative regulation of cell death	2.5013324744804777e-12	5.5166887724666935e-8	22	867	59
MESH:D016399	Lymphoma, T-Cell	GO:0010942	positive regulation of cell death	3.01487723675109e-11	6.649311745654529e-7	16	596	59
MESH:D016399	Lymphoma, T-Cell	GO:0030183	B cell differentiation	5.5522919595318854e-11	1.2245579916747573e-6	9	109	59
MESH:D016399	Lymphoma, T-Cell	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	6.343181535584108e-11	1.398988687673075e-6	17	732	59
MESH:D016399	Lymphoma, T-Cell	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	7.174683069877119e-11	1.5823763510613986e-6	13	359	59
MESH:D016399	Lymphoma, T-Cell	GO:0050727	regulation of inflammatory response	8.98018326367378e-11	1.980579418803252e-6	12	289	59
MESH:D016399	Lymphoma, T-Cell	GO:0051050	positive regulation of transport	2.3926127745710346e-10	5.276907474316417e-6	18	920	59
MESH:D016399	Lymphoma, T-Cell	GO:0045597	positive regulation of cell differentiation	3.2199953814426863e-10	7.1016998137718446e-6	17	815	59
MESH:D016399	Lymphoma, T-Cell	GO:0043367	CD4-positive, alpha-beta T cell differentiation	4.4753878380987544e-10	9.870467876926803e-6	7	56	59
MESH:D016399	Lymphoma, T-Cell	GO:0033993	response to lipid	6.071327884882294e-10	1.3390313650107899e-5	17	850	59
MESH:D016399	Lymphoma, T-Cell	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	6.147441444781521e-10	1.3558182106465644e-5	15	623	59
MESH:D016399	Lymphoma, T-Cell	GO:0033044	regulation of chromosome organization	7.448510697116717e-10	1.642769034249092e-5	11	271	59
MESH:D016399	Lymphoma, T-Cell	GO:0009725	response to hormone	7.936948875908456e-10	1.75049407458161e-5	17	865	59
MESH:D016399	Lymphoma, T-Cell	GO:1901698	response to nitrogen compound	8.663353368021376e-10	1.9107025853171145e-5	17	870	59
MESH:D016399	Lymphoma, T-Cell	GO:0050728	negative regulation of inflammatory response	9.020104663193251e-10	1.9893840834672716e-5	8	100	59
MESH:D016399	Lymphoma, T-Cell	GO:0044427	chromosomal part	1.4056267261253197e-9	3.1001097444693926e-5	16	776	59
MESH:D016399	Lymphoma, T-Cell	GO:0043065	positive regulation of apoptotic process	1.4261944958349204e-9	3.145471960563917e-5	14	556	59
MESH:D016399	Lymphoma, T-Cell	GO:0097191	extrinsic apoptotic signaling pathway	1.5966158395386287e-9	3.521336234102446e-5	10	220	59
MESH:D016399	Lymphoma, T-Cell	GO:0051053	negative regulation of DNA metabolic process	1.6732910612660135e-9	3.690443435622193e-5	8	108	59
MESH:D016399	Lymphoma, T-Cell	GO:0010720	positive regulation of cell development	1.8997936557241246e-9	4.189994907699557e-5	13	469	59
MESH:D016399	Lymphoma, T-Cell	GO:0010638	positive regulation of organelle organization	2.0921878673973993e-9	4.614320341544964e-5	14	573	59
MESH:D016399	Lymphoma, T-Cell	GO:0000278	mitotic cell cycle	2.2617961947801746e-9	4.988391507587675e-5	17	927	59
MESH:D016399	Lymphoma, T-Cell	GO:0044212	transcription regulatory region DNA binding	2.461018500099499e-9	5.427776301969445e-5	16	807	59
MESH:D016399	Lymphoma, T-Cell	GO:0045596	negative regulation of cell differentiation	3.5427301092738617e-9	7.813491256003502e-5	14	597	59
MESH:D016399	Lymphoma, T-Cell	GO:0051241	negative regulation of multicellular organismal process	4.20106804899234e-9	9.265455582052606e-5	17	966	59
MESH:D016399	Lymphoma, T-Cell	GO:0016568	chromatin modification	4.472512804554185e-9	9.864126990444255e-5	14	608	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0048568	embryonic organ development	1.7474910407599964e-13	3.854091490396172e-9	16	408	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0035295	tube development	1.4516721158486234e-11	3.201662851504139e-7	16	573	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0007507	heart development	2.4732216274969687e-11	5.454690299444565e-7	15	487	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0030850	prostate gland development	1.2406442539969476e-10	2.736240902190268e-6	7	47	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0060562	epithelial tube morphogenesis	1.4023238126270599e-10	3.0928251687489805e-6	12	301	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0090596	sensory organ morphogenesis	1.9750689972397595e-10	4.3560146734122895e-6	11	239	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0050673	epithelial cell proliferation	4.802008790605328e-10	1.059083038768005e-5	12	335	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0016331	morphogenesis of embryonic epithelium	5.630519384069999e-10	1.2418110501566382e-5	9	141	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0050678	regulation of epithelial cell proliferation	9.384706345372251e-10	2.06979698447185e-5	11	277	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0030900	forebrain development	9.916132359677476e-10	2.1870029919268674e-5	12	357	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0060572	morphogenesis of an epithelial bud	1.1268261879138208e-9	2.485215157443932e-5	5	16	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0043009	chordate embryonic development	1.2975850394170152e-9	2.861823804434227e-5	14	552	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0042471	ear morphogenesis	2.23829232925965e-9	4.9365537321821584e-5	8	112	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0035136	forelimb morphogenesis	2.7077600162073168e-9	5.971964715745237e-5	6	40	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0061448	connective tissue development	2.779391383711527e-9	6.129947696775773e-5	10	233	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0007442	hindgut morphogenesis	3.124682068644802e-9	6.89148630239611e-5	4	7	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0016303	1-phosphatidylinositol-3-kinase activity	4.269411491009123e-9	9.416187043420621e-5	6	43	59
Orphanet:93458	Non-syndromic polydactyly, syndactyly and/or hyperphalangy	GO:0048706	embryonic skeletal system development	4.423327815139544e-9	9.755649496290264e-5	8	122	59
Orphanet:240371	Syndromic obesity	GO:0061371	determination of heart left/right asymmetry	8.321801026056619e-10	1.8353732162967873e-5	7	61	59
Orphanet:240371	Syndromic obesity	GO:0003143	embryonic heart tube morphogenesis	1.0501919334160448e-9	2.3161983091490868e-5	7	63	59
Orphanet:240371	Syndromic obesity	GO:0007224	smoothened signaling pathway	3.1712389381155504e-9	6.994167478013846e-5	8	117	59
DOID:3770	pulmonary fibrosis	GO:0051241	negative regulation of multicellular organismal process	3.815836535636663e-12	8.41582747934666e-8	23	966	59
DOID:3770	pulmonary fibrosis	GO:0009607	response to biotic stimulus	3.5842440126998554e-12	7.905050170009531e-8	24	934	59
DOID:3770	pulmonary fibrosis	GO:0032940	secretion by cell	2.192690473634684e-12	4.835978839601296e-8	22	956	59
DOID:3770	pulmonary fibrosis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.5241141682054149e-12	3.3614337979770426e-8	16	161	59
DOID:3770	pulmonary fibrosis	GO:0050679	positive regulation of epithelial cell proliferation	1.3378187446733136e-12	2.9505592413769932e-8	12	155	59
DOID:3770	pulmonary fibrosis	GO:0097529	myeloid leukocyte migration	1.198818821990244e-12	2.6439949118994832e-8	14	153	59
DOID:3770	pulmonary fibrosis	GO:0030595	leukocyte chemotaxis	1.1592948823135885e-12	2.5568248629426193e-8	14	177	59
DOID:3770	pulmonary fibrosis	GO:2000147	positive regulation of cell motility	1.1521894549559875e-12	2.5411538429054303e-8	22	399	59
DOID:3770	pulmonary fibrosis	GO:0071219	cellular response to molecule of bacterial origin	1.0973444375395047e-12	2.4201931569933777e-8	12	158	59
DOID:3770	pulmonary fibrosis	GO:0008083	growth factor activity	1.0893508317622036e-12	2.40256325945154e-8	18	159	59
DOID:3770	pulmonary fibrosis	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.020739048840369e-12	2.2512399722174337e-8	14	168	59
DOID:3770	pulmonary fibrosis	GO:0071222	cellular response to lipopolysaccharide	9.388045896230324e-13	2.070533522413598e-8	12	152	59
DOID:3770	pulmonary fibrosis	GO:0050920	regulation of chemotaxis	8.646416915780719e-13	1.9069672507754376e-8	15	179	59
DOID:3770	pulmonary fibrosis	GO:0002685	regulation of leukocyte migration	8.075762281123389e-13	1.7811093711017634e-8	13	149	59
DOID:3770	pulmonary fibrosis	GO:0006954	inflammatory response	6.772360450213455e-13	1.4936440972945775e-8	26	637	59
DOID:3770	pulmonary fibrosis	GO:0048520	positive regulation of behavior	6.163958232718869e-13	1.3594609882261466e-8	13	145	59
DOID:3770	pulmonary fibrosis	GO:0030335	positive regulation of cell migration	5.573319583618286e-13	1.229195634167013e-8	22	387	59
DOID:3770	pulmonary fibrosis	GO:0001944	vasculature development	5.52891066263328e-13	1.2194012466437698e-8	21	588	59
DOID:3770	pulmonary fibrosis	GO:0061138	morphogenesis of a branching epithelium	5.500044863993026e-13	1.2130348947536618e-8	12	179	59
DOID:3770	pulmonary fibrosis	GO:0045765	regulation of angiogenesis	3.779199175824033e-13	8.335023782279904e-9	15	208	59
DOID:3770	pulmonary fibrosis	GO:0097305	response to alcohol	3.093081346605686e-13	6.821790909938841e-9	15	369	59
DOID:3770	pulmonary fibrosis	GO:1903034	regulation of response to wounding	1.6631140908884845e-13	3.6679981274545526e-9	19	407	59
DOID:3770	pulmonary fibrosis	GO:1904018	positive regulation of vasculature development	1.176836406102666e-13	2.5955126936594297e-9	14	131	59
DOID:3770	pulmonary fibrosis	GO:0045766	positive regulation of angiogenesis	1.0058620603103918e-13	2.218428774014569e-9	13	119	59
DOID:3770	pulmonary fibrosis	GO:0050921	positive regulation of chemotaxis	1.0058620603103918e-13	2.218428774014569e-9	13	119	59
DOID:3770	pulmonary fibrosis	GO:0070851	growth factor receptor binding	6.061817714453355e-14	1.3369338969226874e-9	15	126	59
DOID:3770	pulmonary fibrosis	GO:0002548	monocyte chemotaxis	1.1546319456101628e-14	2.546540756043214e-10	10	60	59
DOID:3770	pulmonary fibrosis	GO:0051781	positive regulation of cell division	5.10702591327572e-15	1.1263545651729601e-10	11	130	59
DOID:3770	pulmonary fibrosis	GO:0002688	regulation of leukocyte chemotaxis	3.352873534367973e-14	7.394762580048564e-10	11	96	59
DOID:3770	pulmonary fibrosis	GO:0002690	positive regulation of leukocyte chemotaxis	8.248957072964913e-14	1.8193074824424116e-9	10	80	59
DOID:3770	pulmonary fibrosis	GO:0070098	chemokine-mediated signaling pathway	8.248957072964913e-14	1.8193074824424116e-9	10	80	59
DOID:3770	pulmonary fibrosis	GO:0002699	positive regulation of immune effector process	3.0586644328423063e-13	6.7458844066337065e-9	11	150	59
DOID:3770	pulmonary fibrosis	GO:0014065	phosphatidylinositol 3-kinase signaling	4.71511718558304e-13	1.0399190952803394e-8	11	154	59
DOID:3770	pulmonary fibrosis	GO:0070663	regulation of leukocyte proliferation	6.649125694480063e-13	1.4664646719175778e-8	12	200	59
DOID:3770	pulmonary fibrosis	GO:0005125	cytokine activity	9.916512055951898e-13	2.187086733940191e-8	22	222	59
DOID:3770	pulmonary fibrosis	GO:0001775	cell activation	1.5166756739404263e-12	3.34502819887561e-8	22	854	59
DOID:3770	pulmonary fibrosis	GO:1903036	positive regulation of response to wounding	1.7955636977262657e-12	3.960115735335279e-8	11	162	59
DOID:3770	pulmonary fibrosis	GO:0051050	positive regulation of transport	1.908029290120794e-12	4.208158599361411e-8	21	920	59
DOID:3770	pulmonary fibrosis	GO:0005126	cytokine receptor binding	2.1527224447481785e-12	4.747829351892108e-8	19	270	59
DOID:3770	pulmonary fibrosis	GO:0050729	positive regulation of inflammatory response	2.341460358934455e-12	5.164090821629941e-8	10	114	59
DOID:3770	pulmonary fibrosis	GO:0060548	negative regulation of cell death	2.5013324744804777e-12	5.5166887724666935e-8	22	867	59
DOID:3770	pulmonary fibrosis	GO:0050865	regulation of cell activation	2.9960478542534474e-12	6.607783542555978e-8	17	458	59
DOID:3770	pulmonary fibrosis	GO:0007259	JAK-STAT cascade	4.0607517348689726e-12	8.955987951253519e-8	11	170	59
DOID:3770	pulmonary fibrosis	GO:0045321	leukocyte activation	4.316991208952459e-12	9.521124111344648e-8	18	694	59
DOID:3770	pulmonary fibrosis	GO:1900182	positive regulation of protein localization to nucleus	5.9332538882017616e-12	1.3085791450428985e-7	10	125	59
DOID:3770	pulmonary fibrosis	GO:0031093	platelet alpha granule lumen	6.330602708715105e-12	1.3962144274071164e-7	8	55	59
DOID:3770	pulmonary fibrosis	GO:0043069	negative regulation of programmed cell death	6.523004358882645e-12	1.4386486113515673e-7	19	806	59
DOID:3770	pulmonary fibrosis	GO:0045597	positive regulation of cell differentiation	7.1559425052214465e-12	1.57824311952659e-7	19	815	59
DOID:3770	pulmonary fibrosis	GO:0045860	positive regulation of protein kinase activity	7.387535028158254e-12	1.629320850460303e-7	15	450	59
DOID:3770	pulmonary fibrosis	GO:0042379	chemokine receptor binding	8.536948925552679e-12	1.8828240855306433e-7	8	57	59
DOID:3770	pulmonary fibrosis	GO:0001819	positive regulation of cytokine production	9.969358671924056e-12	2.1987420550928505e-7	14	381	59
DOID:3770	pulmonary fibrosis	GO:0002573	myeloid leukocyte differentiation	1.0122569449322327e-11	2.2325326920480393e-7	11	183	59
DOID:3770	pulmonary fibrosis	GO:0051054	positive regulation of DNA metabolic process	1.0122569449322327e-11	2.2325326920480393e-7	11	183	59
DOID:3770	pulmonary fibrosis	GO:0043066	negative regulation of apoptotic process	1.0663914196129554e-11	2.351926275956373e-7	19	795	59
DOID:3770	pulmonary fibrosis	GO:0071347	cellular response to interleukin-1	1.1710854508351076e-11	2.58282896181683e-7	9	92	59
DOID:3770	pulmonary fibrosis	GO:0014070	response to organic cyclic compound	1.2527867632172729e-11	2.7630212062756954e-7	19	873	59
DOID:3770	pulmonary fibrosis	GO:0048661	positive regulation of smooth muscle cell proliferation	1.3654855024469725e-11	3.011578275646798e-7	8	60	59
DOID:3770	pulmonary fibrosis	GO:0010638	positive regulation of organelle organization	1.4516721158486234e-11	3.201662851504139e-7	16	573	59
DOID:3770	pulmonary fibrosis	GO:0050670	regulation of lymphocyte proliferation	1.5146883747263473e-11	3.340645210458959e-7	11	189	59
DOID:3770	pulmonary fibrosis	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.593047915804391e-11	3.513467178306584e-7	10	138	59
DOID:3770	pulmonary fibrosis	GO:0030198	extracellular matrix organization	1.8253398792467124e-11	4.025787103678624e-7	13	320	59
DOID:3770	pulmonary fibrosis	GO:0042307	positive regulation of protein import into nucleus	2.1118551352117265e-11	4.657696500709463e-7	9	98	59
DOID:3770	pulmonary fibrosis	GO:0006887	exocytosis	2.2467361304734368e-11	4.955176535759165e-7	14	405	59
DOID:3770	pulmonary fibrosis	GO:0071621	granulocyte chemotaxis	2.314537450587295e-11	5.104712347270279e-7	9	99	59
DOID:3770	pulmonary fibrosis	GO:0043491	protein kinase B signaling	2.4089952255224034e-11	5.313038969889661e-7	10	144	59
DOID:3770	pulmonary fibrosis	GO:0071363	cellular response to growth factor stimulus	2.7707391936360182e-11	6.110865291564238e-7	16	594	59
DOID:3770	pulmonary fibrosis	GO:0043406	positive regulation of MAP kinase activity	3.742961496300268e-11	8.255101580090241e-7	11	205	59
DOID:3770	pulmonary fibrosis	GO:0042089	cytokine biosynthetic process	3.9621972369729974e-11	8.738626006143946e-7	9	105	59
DOID:3770	pulmonary fibrosis	GO:0002274	myeloid leukocyte activation	4.4012793409820006e-11	9.707021586535802e-7	10	153	59
DOID:3770	pulmonary fibrosis	GO:0097285	cell-type specific apoptotic process	4.940325926128253e-11	1.0895888830075862e-6	14	429	59
DOID:3770	pulmonary fibrosis	GO:0002544	chronic inflammatory response	7.424594272720242e-11	1.6374942668484493e-6	6	23	59
DOID:3770	pulmonary fibrosis	GO:0048545	response to steroid hormone	8.073197665936505e-11	1.780543745222296e-6	14	446	59
DOID:3770	pulmonary fibrosis	GO:0001503	ossification	8.25642887392064e-11	1.8209553881431972e-6	13	363	59
DOID:3770	pulmonary fibrosis	GO:0050867	positive regulation of cell activation	8.579348342863113e-11	1.8921752770184597e-6	12	288	59
DOID:3770	pulmonary fibrosis	GO:0007568	aging	9.315814786248211e-11	2.054602951107043e-6	12	290	59
DOID:3770	pulmonary fibrosis	GO:0046427	positive regulation of JAK-STAT cascade	9.68323199401766e-11	2.135636816280595e-6	8	76	59
DOID:3770	pulmonary fibrosis	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.0097489511196045e-10	2.2270013116942877e-6	16	647	59
DOID:3770	pulmonary fibrosis	GO:0019725	cellular homeostasis	1.4135037584850352e-10	3.117482539338745e-6	17	771	59
DOID:3770	pulmonary fibrosis	GO:0036293	response to decreased oxygen levels	1.4600887165983067e-10	3.2202256644575655e-6	12	302	59
DOID:3770	pulmonary fibrosis	GO:1903706	regulation of hemopoiesis	1.6357049048565386e-10	3.607547167661096e-6	12	305	59
DOID:3770	pulmonary fibrosis	GO:0042056	chemoattractant activity	1.6802859104103618e-10	3.705870575410053e-6	6	26	59
DOID:3770	pulmonary fibrosis	GO:0045840	positive regulation of mitotic nuclear division	1.6869172725364479e-10	3.7204960445791357e-6	7	49	59
DOID:3770	pulmonary fibrosis	GO:0008009	chemokine activity	1.6869172725364479e-10	3.7204960445791357e-6	7	49	59
DOID:3770	pulmonary fibrosis	GO:0044706	multi-multicellular organism process	1.811055749811885e-10	3.994283456210113e-6	11	237	59
DOID:3770	pulmonary fibrosis	GO:0050918	positive chemotaxis	1.9560975061949648e-10	4.314173049912995e-6	7	50	59
DOID:3770	pulmonary fibrosis	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.9928136918423434e-10	4.395150597358288e-6	8	83	59
DOID:3770	pulmonary fibrosis	GO:0045073	regulation of chemokine biosynthetic process	2.0629042918329787e-10	4.549735415637635e-6	5	12	59
DOID:3770	pulmonary fibrosis	GO:0030593	neutrophil chemotaxis	2.1965584906524782e-10	4.844509751134041e-6	8	84	59
DOID:3770	pulmonary fibrosis	GO:0050671	positive regulation of lymphocyte proliferation	2.2060475668439494e-10	4.8654379086743305e-6	9	127	59
DOID:3770	pulmonary fibrosis	GO:0071356	cellular response to tumor necrosis factor	2.35986785668274e-10	5.204688557913784e-6	11	243	59
DOID:3770	pulmonary fibrosis	GO:0006953	acute-phase response	2.9958102665261777e-10	6.607259542823485e-6	7	53	59
DOID:3770	pulmonary fibrosis	GO:0060688	regulation of morphogenesis of a branching structure	2.9958102665261777e-10	6.607259542823485e-6	7	53	59
DOID:3770	pulmonary fibrosis	GO:0007565	female pregnancy	3.8242531363863463e-10	8.434390292300087e-6	10	190	59
DOID:3770	pulmonary fibrosis	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	5.774581923745359e-10	1.2735840432820389e-5	7	58	59
DOID:3770	pulmonary fibrosis	GO:0042129	regulation of T cell proliferation	5.996606544655947e-10	1.3225515734238691e-5	9	142	59
DOID:3770	pulmonary fibrosis	GO:2001234	negative regulation of apoptotic signaling pathway	6.012721431858381e-10	1.326105711796366e-5	10	199	59
DOID:3770	pulmonary fibrosis	GO:0032844	regulation of homeostatic process	6.106612993050931e-10	1.3468134956173827e-5	13	427	59
DOID:3770	pulmonary fibrosis	GO:0043547	positive regulation of GTPase activity	6.147441444781521e-10	1.3558182106465644e-5	15	623	59
DOID:3770	pulmonary fibrosis	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	7.057026074619444e-10	1.5564271007573183e-5	8	97	59
DOID:3770	pulmonary fibrosis	GO:0006874	cellular calcium ion homeostasis	8.448800548066515e-10	1.86338296087607e-5	12	352	59
DOID:3770	pulmonary fibrosis	GO:0042060	wound healing	8.495710801526002e-10	1.8737290172765597e-5	14	534	59
DOID:3770	pulmonary fibrosis	GO:0007435	salivary gland morphogenesis	9.627235675324641e-10	2.1232868281928496e-5	6	34	59
DOID:3770	pulmonary fibrosis	GO:0002443	leukocyte mediated immunity	1.012559702751048e-9	2.2332004244174364e-5	11	279	59
DOID:3770	pulmonary fibrosis	GO:0002703	regulation of leukocyte mediated immunity	1.0357766866420093e-9	2.2844054823889515e-5	9	151	59
DOID:3770	pulmonary fibrosis	GO:0070997	neuron death	1.0905438774244658e-9	2.4051945216596593e-5	11	281	59
DOID:3770	pulmonary fibrosis	GO:0048020	CCR chemokine receptor binding	1.1590374215941779e-9	2.5562570333259593e-5	6	35	59
DOID:3770	pulmonary fibrosis	GO:0032147	activation of protein kinase activity	1.411903149950433e-9	3.11395239721568e-5	11	288	59
DOID:3770	pulmonary fibrosis	GO:0002576	platelet degranulation	1.4404031301040732e-9	3.1768091034445334e-5	8	106	59
DOID:3770	pulmonary fibrosis	GO:0010631	epithelial cell migration	1.460948362286274e-9	3.222121613022377e-5	10	218	59
DOID:3770	pulmonary fibrosis	GO:1903708	positive regulation of hemopoiesis	1.5481931292526951e-9	3.414539946566819e-5	9	158	59
DOID:3770	pulmonary fibrosis	GO:0001666	response to hypoxia	1.632558532804751e-9	3.600607844100878e-5	11	292	59
DOID:3770	pulmonary fibrosis	GO:0030212	hyaluronan metabolic process	1.6519927648062094e-9	3.643470042780095e-5	6	37	59
DOID:3770	pulmonary fibrosis	GO:0051093	negative regulation of developmental process	1.7527944651263283e-9	3.865788192836117e-5	16	788	59
DOID:3770	pulmonary fibrosis	GO:0043900	regulation of multi-organism process	1.8040088312076819e-9	3.978741477228542e-5	13	467	59
DOID:3770	pulmonary fibrosis	GO:1902105	regulation of leukocyte differentiation	1.9842536502778785e-9	4.376271425687861e-5	10	225	59
DOID:3770	pulmonary fibrosis	GO:0010632	regulation of epithelial cell migration	2.153017542028124e-9	4.748480188943027e-5	9	164	59
DOID:3770	pulmonary fibrosis	GO:0043200	response to amino acid	2.23829232925965e-9	4.9365537321821584e-5	8	112	59
DOID:3770	pulmonary fibrosis	GO:0071622	regulation of granulocyte chemotaxis	2.3071781152239623e-9	5.088481333126449e-5	6	39	59
DOID:3770	pulmonary fibrosis	GO:1901215	negative regulation of neuron death	2.956373923446165e-9	6.520282688160517e-5	9	170	59
DOID:3770	pulmonary fibrosis	GO:0022409	positive regulation of cell-cell adhesion	3.551241745114453e-9	7.832263668849926e-5	10	239	59
DOID:3770	pulmonary fibrosis	GO:0030278	regulation of ossification	4.215805704532727e-9	9.297959481346929e-5	9	177	59
DOID:447	renal tubular transport disease	GO:0008514	organic anion transmembrane transporter activity	6.563638521583925e-13	1.4476104759353348e-8	12	175	60
DOID:447	renal tubular transport disease	GO:0022804	active transmembrane transporter activity	4.5430326167661406e-13	1.0019658436277723e-8	18	346	60
DOID:447	renal tubular transport disease	GO:0006820	anion transport	4.227729277772596e-13	9.32425692212746e-9	26	588	60
DOID:447	renal tubular transport disease	GO:0015293	symporter activity	3.7281289166912757e-13	8.222388325762608e-9	12	140	60
DOID:447	renal tubular transport disease	GO:0031526	brush border membrane	3.035349749325178e-13	6.69446387213668e-9	11	55	60
DOID:447	renal tubular transport disease	GO:0015698	inorganic anion transport	1.6719958750854857e-13	3.687586902501039e-9	13	133	60
DOID:447	renal tubular transport disease	GO:0045177	apical part of cell	1.6342482922482304e-13	3.6043346085534722e-9	19	356	60
DOID:447	renal tubular transport disease	GO:0015077	monovalent inorganic cation transmembrane transporter activity	1.3100631690576847e-13	2.8893443193567236e-9	15	368	60
DOID:447	renal tubular transport disease	GO:0015081	sodium ion transmembrane transporter activity	1.688649220454863e-13	3.7243158557132006e-9	11	135	60
DOID:447	renal tubular transport disease	GO:0015672	monovalent inorganic cation transport	1.928457393773897e-13	4.25321278196833e-9	17	572	60
DOID:447	renal tubular transport disease	GO:0005342	organic acid transmembrane transporter activity	3.157474282033945e-13	6.963809529025866e-9	11	140	60
DOID:447	renal tubular transport disease	GO:0034220	ion transmembrane transport	6.163958232718869e-13	1.3594609882261466e-8	30	962	60
DOID:447	renal tubular transport disease	GO:0098660	inorganic ion transmembrane transport	6.483702463810914e-13	1.4299805783934971e-8	19	660	60
DOID:447	renal tubular transport disease	GO:0016324	apical plasma membrane	6.675771047071066e-13	1.4723413044315237e-8	17	286	60
DOID:447	renal tubular transport disease	GO:0006814	sodium ion transport	8.949507801503387e-13	1.973813945621572e-8	12	201	60
DOID:447	renal tubular transport disease	GO:1903825	organic acid transmembrane transport	1.02784447619797e-12	2.2669109922546227e-8	10	102	60
DOID:447	renal tubular transport disease	GO:0007588	excretion	1.0451639553821224e-12	2.305109103595271e-8	9	70	60
DOID:447	renal tubular transport disease	GO:0050801	ion homeostasis	1.273758876152442e-12	2.809275201354211e-8	21	668	60
DOID:447	renal tubular transport disease	GO:0098656	anion transmembrane transport	2.2691848400313575e-12	5.004687164689159e-8	19	259	60
DOID:447	renal tubular transport disease	GO:0015103	inorganic anion transmembrane transporter activity	2.788658193253468e-12	6.150385645220524e-8	10	114	60
DOID:447	renal tubular transport disease	GO:0015711	organic anion transport	4.6354031724149536e-12	1.022338169676118e-7	15	423	60
DOID:447	renal tubular transport disease	GO:0098771	inorganic ion homeostasis	5.791589430259592e-12	1.277335048843753e-7	17	609	60
DOID:447	renal tubular transport disease	GO:0006821	chloride transport	3.2504776648067946e-11	7.168928489731385e-7	9	101	60
DOID:447	renal tubular transport disease	GO:0072502	cellular trivalent inorganic anion homeostasis	3.6057046237658597e-11	7.952381547715603e-7	5	9	60
DOID:447	renal tubular transport disease	GO:0030643	cellular phosphate ion homeostasis	3.6057046237658597e-11	7.952381547715603e-7	5	9	60
DOID:447	renal tubular transport disease	GO:0098661	inorganic anion transmembrane transport	6.489309090085271e-11	1.4312171198183066e-6	9	109	60
DOID:447	renal tubular transport disease	GO:0035725	sodium ion transmembrane transport	2.404810794942591e-10	5.303810208245885e-6	9	126	60
DOID:447	renal tubular transport disease	GO:0015296	anion:cation symporter activity	3.3838609692082855e-10	7.463105367588874e-6	7	53	60
DOID:447	renal tubular transport disease	GO:0016323	basolateral plasma membrane	1.0497659408414961e-9	2.3152587825259197e-5	10	207	60
DOID:447	renal tubular transport disease	GO:0034762	regulation of transmembrane transport	2.6950389697688593e-9	5.943908447825219e-5	12	383	60
DOID:447	renal tubular transport disease	GO:0043269	regulation of ion transport	3.3136794419519333e-9	7.308320009224989e-5	14	583	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0071219	cellular response to molecule of bacterial origin	1.5416556919944924e-12	3.400121628693853e-8	11	158	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0071345	cellular response to cytokine stimulus	2.225553075163589e-12	4.908457307273295e-8	20	677	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0044130	negative regulation of growth of symbiont in host	2.518429909059705e-12	5.5543971644311796e-8	6	14	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0019221	cytokine-mediated signaling pathway	5.92126347953581e-12	1.305934660411623e-7	18	534	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0002443	leukocyte mediated immunity	6.162181875879469e-12	1.3590692127252169e-7	13	279	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0031347	regulation of defense response	9.379608201243173e-12	2.0686725887841817e-7	19	749	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0031349	positive regulation of defense response	2.2058688209369848e-11	4.86504368457652e-7	14	398	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0002821	positive regulation of adaptive immune response	6.349376580061517e-11	1.4003550047325675e-6	8	71	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0045088	regulation of innate immune response	6.844624866886306e-11	1.5095820143917749e-6	13	351	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0032103	positive regulation of response to external stimulus	9.357614683125348e-11	2.0638219183632955e-6	12	285	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0042742	defense response to bacterium	1.086675194272857e-10	2.396662140968786e-6	11	222	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1.8120860367787373e-10	3.996555754115505e-6	11	233	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0002253	activation of immune response	2.3722412922921876e-10	5.23197817015042e-6	14	475	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0032496	response to lipopolysaccharide	3.3902736173985204e-10	7.477248463172437e-6	12	319	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0032760	positive regulation of tumor necrosis factor production	5.054713314578407e-10	1.1148170215302677e-5	7	56	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0060627	regulation of vesicle-mediated transport	1.097733126620426e-9	2.4210504107613495e-5	13	440	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0002449	lymphocyte mediated immunity	1.1527643284381384e-9	2.542421726370314e-5	10	209	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0071222	cellular response to lipopolysaccharide	1.2832979123800214e-9	2.8303135457541373e-5	9	152	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0071221	cellular response to bacterial lipopeptide	1.4380632240573732e-9	3.1716484406585366e-5	4	6	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.8452689376502462e-9	4.069740641987618e-5	7	67	60
MESH:D016908	Gram-Positive Bacterial Infections	GO:0006897	endocytosis	4.1177998788555215e-9	9.081807632815853e-5	14	593	60
Orphanet:182214	Rare inflammatory eye disease	GO:0070486	leukocyte aggregation	1.2352341371979492e-12	2.724308889590077e-8	20	432	60
Orphanet:182214	Rare inflammatory eye disease	GO:0007162	negative regulation of cell adhesion	1.7355392678553017e-9	3.827731855254868e-5	10	218	60
MESH:D006259	Craniocerebral Trauma	GO:0001819	positive regulation of cytokine production	4.984901380566953e-14	1.0994199994840415e-9	22	381	60
MESH:D006259	Craniocerebral Trauma	GO:1903034	regulation of response to wounding	9.825473767932635e-14	2.1670082395175427e-9	16	407	60
MESH:D006259	Craniocerebral Trauma	GO:0050727	regulation of inflammatory response	1.4497292255555294e-12	3.19737780696272e-8	15	289	60
MESH:D006259	Craniocerebral Trauma	GO:0045321	leukocyte activation	2.1793677973391823e-12	4.8065956770315665e-8	21	694	60
DOID:1924	hypogonadism	GO:0046661	male sex differentiation	1.1326495297225847e-12	2.4980585378031606e-8	14	151	60
DOID:1924	hypogonadism	GO:0046660	female sex differentiation	2.580418101416626e-10	5.691112122674369e-6	9	127	60
MESH:D012174	Retinitis Pigmentosa	GO:0072372	primary cilium	6.543654507140673e-13	1.4432030015498754e-8	22	199	61
MESH:D012174	Retinitis Pigmentosa	GO:0044441	ciliary part	5.275779813018744e-13	1.163573237761284e-8	17	303	61
MESH:D012174	Retinitis Pigmentosa	GO:0007601	visual perception	4.807265696626928e-13	1.060242449391069e-8	33	207	61
MESH:D012174	Retinitis Pigmentosa	GO:0009416	response to light stimulus	3.057554209817681e-13	6.743435809752896e-9	16	297	61
MESH:D012174	Retinitis Pigmentosa	GO:0009581	detection of external stimulus	1.9628743075372768e-13	4.329119285273464e-9	16	130	61
MESH:D012174	Retinitis Pigmentosa	GO:0009582	detection of abiotic stimulus	1.4055423491754482e-13	3.099923651106451e-9	16	133	61
MESH:D012174	Retinitis Pigmentosa	GO:0046530	photoreceptor cell differentiation	7.704947790898586e-14	1.6993262352826832e-9	9	50	61
MESH:D012174	Retinitis Pigmentosa	GO:0009583	detection of light stimulus	4.773959005888173e-14	1.0528966587486366e-9	15	75	61
MESH:D012174	Retinitis Pigmentosa	GO:0007603	phototransduction, visible light	2.7755575615628914e-14	6.121492202026957e-10	10	39	61
MESH:D012174	Retinitis Pigmentosa	GO:0022400	regulation of rhodopsin mediated signaling pathway	2.886579864025407e-15	6.366351890108035e-11	8	29	61
MESH:D012174	Retinitis Pigmentosa	GO:0097381	photoreceptor disc membrane	8.748557434046234e-14	1.929494342078897e-9	7	18	61
MESH:D012174	Retinitis Pigmentosa	GO:0042461	photoreceptor cell development	1.73749903353837e-13	3.832054118468875e-9	8	37	61
MESH:D012174	Retinitis Pigmentosa	GO:0001654	eye development	1.8320900352364333e-12	4.040674572713954e-8	14	327	61
MESH:D012174	Retinitis Pigmentosa	GO:0060041	retina development in camera-type eye	1.3599343873238467e-11	2.999335291242744e-7	10	131	61
MESH:D012174	Retinitis Pigmentosa	GO:0032391	photoreceptor connecting cilium	5.277193126929092e-10	1.1638849441442112e-5	6	30	61
DOID:2476	hereditary spastic paraplegia	GO:0005789	endoplasmic reticulum membrane	1.1701195568036837e-11	2.5806986825305245e-7	20	977	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0051338	regulation of transferase activity	2.2157831125468874e-12	4.88690965472216e-8	23	928	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0051052	regulation of DNA metabolic process	1.0373923942097463e-12	2.2879689254295954e-8	15	335	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0050673	epithelial cell proliferation	1.0373923942097463e-12	2.2879689254295954e-8	15	335	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0072358	cardiovascular system development	2.660094367001875e-13	5.8668381264226355e-9	23	910	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0008285	negative regulation of cell proliferation	7.164269177906135e-13	1.580079567187198e-8	19	634	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0007167	enzyme linked receptor protein signaling pathway	1.890376744029254e-12	4.16922590895652e-8	20	935	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0048732	gland development	2.7700064464397656e-12	6.109249217622903e-8	17	421	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0009790	embryo development	3.0127011996228248e-12	6.64451249576814e-8	20	932	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0050678	regulation of epithelial cell proliferation	6.2346794393874916e-12	1.3750585503569113e-7	13	277	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0045859	regulation of protein kinase activity	8.099965143060217e-12	1.786447312301931e-7	18	709	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0007507	heart development	3.840938678223438e-11	8.471190254821792e-7	15	487	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0001649	osteoblast differentiation	5.773814759635343e-11	1.2734148452375749e-6	11	206	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0006275	regulation of DNA replication	8.164224851725521e-11	1.8006197910480637e-6	10	157	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0010631	epithelial cell migration	1.0708567366179977e-10	2.361774532610994e-6	11	218	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:1903827	regulation of cellular protein localization	1.576061503527626e-10	3.476003646030179e-6	15	543	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0001934	positive regulation of protein phosphorylation	1.810425143133898e-10	3.992892653181812e-6	18	870	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0060562	epithelial tube morphogenesis	2.1208323985888455e-10	4.677495855087699e-6	12	301	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0023014	signal transduction by protein phosphorylation	2.1486090684419423e-10	4.738757300448704e-6	18	879	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0051054	positive regulation of DNA metabolic process	3.7321901125153545e-10	8.231345293152614e-6	10	183	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0034504	protein localization to nucleus	9.78631953252318e-10	2.1583727728979873e-5	12	344	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0043009	chordate embryonic development	2.079537431143308e-9	4.5864198043865656e-5	14	552	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0051053	negative regulation of DNA metabolic process	2.2009762901120666e-9	4.854253207842163e-5	8	108	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0048598	embryonic morphogenesis	2.501049811698408e-9	5.516065359700839e-5	14	560	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0050680	negative regulation of epithelial cell proliferation	2.943174370884094e-9	6.49117107498487e-5	8	112	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:0030855	epithelial cell differentiation	2.9966549242033125e-9	6.609122435330406e-5	14	568	61
Orphanet:98196	Malformation syndrome with hamartosis	GO:2000278	regulation of DNA biosynthetic process	3.4765404999248517e-9	7.66751007258426e-5	7	72	61
Orphanet:168778	Rare pervasive developmental disorder	GO:0007420	brain development	2.8636426563366513e-11	6.315763878550484e-7	17	669	61
Orphanet:168778	Rare pervasive developmental disorder	GO:0044708	single-organism behavior	4.812421572353287e-10	1.0613795777825175e-5	13	404	61
Orphanet:168778	Rare pervasive developmental disorder	GO:0071625	vocalization behavior	6.161926524583805e-10	1.3590128949969582e-5	5	14	61
Orphanet:168778	Rare pervasive developmental disorder	GO:0043005	neuron projection	6.270486352377702e-10	1.3829557650169022e-5	18	941	61
DOID:1319	brain cancer	GO:0097305	response to alcohol	1.021627227260069e-12	2.2531988497220823e-8	16	369	61
DOID:1319	brain cancer	GO:0000278	mitotic cell cycle	5.098144129078719e-13	1.1243956876683114e-8	21	927	61
DOID:1319	brain cancer	GO:0050673	epithelial cell proliferation	1.6824319715169622e-12	3.71060371318066e-8	14	335	61
DOID:1319	brain cancer	GO:0050678	regulation of epithelial cell proliferation	2.021938172447335e-12	4.4593846393325975e-8	14	277	61
DOID:1319	brain cancer	GO:0040008	regulation of growth	3.61710661422876e-12	7.97752863768153e-8	18	617	61
DOID:1319	brain cancer	GO:0008284	positive regulation of cell proliferation	1.0327405597365669e-11	2.2777093044989982e-7	19	815	61
DOID:1319	brain cancer	GO:0008285	negative regulation of cell proliferation	1.2096657009408318e-11	2.6679177034250046e-7	17	634	61
DOID:1319	brain cancer	GO:0007346	regulation of mitotic cell cycle	1.3083867322905007e-11	2.8856469380666994e-7	15	453	61
DOID:1319	brain cancer	GO:0072080	nephron tubule development	1.4554357719021027e-11	3.2099635949300875e-7	9	91	61
DOID:1319	brain cancer	GO:0002520	immune system development	4.014089061143977e-11	8.853073424353042e-7	18	782	61
DOID:1319	brain cancer	GO:0051093	negative regulation of developmental process	4.304423484313702e-11	9.49340599465387e-7	18	788	61
DOID:1319	brain cancer	GO:0051052	regulation of DNA metabolic process	4.67400562698117e-11	1.030851941030697e-6	13	335	61
DOID:1319	brain cancer	GO:0048732	gland development	6.354272663600113e-11	1.401434835957005e-6	14	421	61
DOID:1319	brain cancer	GO:0072078	nephron tubule morphogenesis	9.171718939882112e-11	2.022822612191e-6	8	73	61
DOID:1319	brain cancer	GO:0051241	negative regulation of multicellular organismal process	1.1109035913392518e-10	2.4500978706987198e-6	19	966	61
DOID:1319	brain cancer	GO:0033993	response to lipid	1.2357548317964984e-10	2.725457281527177e-6	18	850	61
DOID:1319	brain cancer	GO:0048545	response to steroid hormone	1.3078005345334986e-10	2.8843540789136313e-6	14	446	61
DOID:1319	brain cancer	GO:0051302	regulation of cell division	1.5772005923508914e-10	3.478515906429891e-6	12	293	61
DOID:1319	brain cancer	GO:0043009	chordate embryonic development	1.9521406713352008e-10	4.305446250629785e-6	15	552	61
DOID:1319	brain cancer	GO:0010564	regulation of cell cycle process	2.43665421173489e-10	5.3740408639813e-6	15	561	61
DOID:1319	brain cancer	GO:0030879	mammary gland development	3.230511413931936e-10	7.124892923426884e-6	9	128	61
DOID:1319	brain cancer	GO:0045596	negative regulation of cell differentiation	5.683166159897723e-10	1.2534222965654429e-5	15	597	61
DOID:1319	brain cancer	GO:0035264	multicellular organism growth	5.932387914242554e-10	1.3083881544861953e-5	9	137	61
DOID:1319	brain cancer	GO:0001658	branching involved in ureteric bud morphogenesis	8.321509037401142e-10	1.835308818198822e-5	7	59	61
DOID:1319	brain cancer	GO:0007389	pattern specification process	1.0916914039427184e-9	2.4077253913956653e-5	13	432	61
DOID:1319	brain cancer	GO:0042493	response to drug	1.1225169682660407e-9	2.475711173510753e-5	13	433	61
DOID:1319	brain cancer	GO:0001649	osteoblast differentiation	1.1864828008967265e-9	2.6167878173777304e-5	10	206	61
DOID:1319	brain cancer	GO:1903047	mitotic cell cycle process	1.2240788382911205e-9	2.6997058778510663e-5	17	857	61
DOID:1319	brain cancer	GO:0032135	DNA insertion or deletion binding	1.538848826143635e-9	3.393931086059787e-5	4	6	61
DOID:1319	brain cancer	GO:0045667	regulation of osteoblast differentiation	2.7396678259350438e-9	6.042337390099739e-5	8	111	61
DOID:1319	brain cancer	GO:0030855	epithelial cell differentiation	2.9966549242033125e-9	6.609122435330406e-5	14	568	61
DOID:1319	brain cancer	GO:0007224	smoothened signaling pathway	4.16794099233897e-9	9.192393858603598e-5	8	117	61
DOID:1319	brain cancer	GO:0030097	hemopoiesis	4.510565476678607e-9	9.948052158814669e-5	15	695	61
DOID:1319	brain cancer	GO:0001709	cell fate determination	4.52315329635411e-9	9.97581459510899e-5	6	42	61
DOID:0060340	ciliopathy	GO:0097014	ciliary cytoplasm	7.993605777301127e-14	1.7629897541837636e-9	19	90	62
DOID:0060340	ciliopathy	GO:0005930	axoneme	7.993605777301127e-14	1.7629897541837636e-9	19	90	62
DOID:0060340	ciliopathy	GO:0031514	motile cilium	1.1537869548661206e-9	2.544677128957229e-5	8	98	62
MESH:D009056	Mouth Abnormalities	GO:0030323	respiratory tube development	1.5831780331154732e-13	3.491699152036176e-9	12	179	62
MESH:D009056	Mouth Abnormalities	GO:0051241	negative regulation of multicellular organismal process	1.5381240725531597e-10	3.392332642015994e-6	19	966	62
MESH:D009056	Mouth Abnormalities	GO:0002062	chondrocyte differentiation	8.979387233765124e-10	1.980403854406898e-5	8	95	62
MESH:D009056	Mouth Abnormalities	GO:0048566	embryonic digestive tract development	1.0801936012327928e-9	2.3823669875189246e-5	6	33	62
MESH:D009056	Mouth Abnormalities	GO:0045667	regulation of osteoblast differentiation	3.1300977365589233e-9	6.903430557980705e-5	8	111	62
MESH:D009056	Mouth Abnormalities	GO:0007420	brain development	3.435647322191926e-9	7.577320169094293e-5	15	669	62
MESH:D009056	Mouth Abnormalities	GO:0001568	blood vessel development	3.847320018124378e-9	8.485264299973316e-5	14	569	62
MESH:D009056	Mouth Abnormalities	GO:0051093	negative regulation of developmental process	3.869704889858383e-9	8.534634134582664e-5	16	788	62
MESH:D006930	Hyperalgesia	GO:0043005	neuron projection	1.6993073614912646e-12	3.747822385768984e-8	21	941	62
MESH:D006930	Hyperalgesia	GO:2000147	positive regulation of cell motility	1.3766765505351941e-12	3.0362601322053706e-8	18	399	62
MESH:D006930	Hyperalgesia	GO:0002237	response to molecule of bacterial origin	1.3180567748349858e-12	2.9069742168985613e-8	18	333	62
MESH:D006930	Hyperalgesia	GO:0032940	secretion by cell	1.2516654379624015e-12	2.7605481234260765e-8	27	956	62
MESH:D006930	Hyperalgesia	GO:0003018	vascular process in circulatory system	1.199262911200094e-12	2.6449743506518075e-8	16	159	62
MESH:D006930	Hyperalgesia	GO:0030799	regulation of cyclic nucleotide metabolic process	9.763301278553627e-13	2.1532960969850024e-8	12	154	62
MESH:D006930	Hyperalgesia	GO:0006874	cellular calcium ion homeostasis	9.5767838104166e-13	2.1121596693873812e-8	22	352	62
MESH:D006930	Hyperalgesia	GO:0008217	regulation of blood pressure	9.443557047461582e-13	2.0827765068176518e-8	13	168	62
MESH:D006930	Hyperalgesia	GO:0030335	positive regulation of cell migration	9.408029910673577e-13	2.0749409967990573e-8	18	387	62
MESH:D006930	Hyperalgesia	GO:0044708	single-organism behavior	9.252598687226055e-13	2.0406606404677063e-8	20	404	62
MESH:D006930	Hyperalgesia	GO:2000021	regulation of ion homeostasis	7.707168236947837e-13	1.6998159546588454e-8	17	189	62
MESH:D006930	Hyperalgesia	GO:0006816	calcium ion transport	6.836753385641714e-13	1.50784595920328e-8	16	366	62
MESH:D006930	Hyperalgesia	GO:0006954	inflammatory response	5.591083152012288e-13	1.2331133891763102e-8	22	637	62
MESH:D006930	Hyperalgesia	GO:0032846	positive regulation of homeostatic process	5.138112157965224e-13	1.1332106364392303e-8	16	192	62
MESH:D006930	Hyperalgesia	GO:0046879	hormone secretion	4.5341508325691393e-13	1.0000069661231237e-8	17	297	62
MESH:D006930	Hyperalgesia	GO:1903522	regulation of blood circulation	4.5341508325691393e-13	1.0000069661231237e-8	18	297	62
MESH:D006930	Hyperalgesia	GO:1900542	regulation of purine nucleotide metabolic process	4.11448652926083e-13	9.074500040284761e-9	14	203	62
MESH:D006930	Hyperalgesia	GO:0003012	muscle system process	3.921307722976053e-13	8.648444183023685e-9	18	393	62
MESH:D006930	Hyperalgesia	GO:0043279	response to alkaloid	3.75921516138078e-13	8.29094903842531e-9	14	140	62
MESH:D006930	Hyperalgesia	GO:0035150	regulation of tube size	3.75921516138078e-13	8.29094903842531e-9	15	140	62
MESH:D006930	Hyperalgesia	GO:0050880	regulation of blood vessel size	3.5771385853422544e-13	7.889379149972342e-9	15	139	62
MESH:D006930	Hyperalgesia	GO:0097305	response to alcohol	3.235189893757706e-13	7.135211310682621e-9	15	369	62
MESH:D006930	Hyperalgesia	GO:0051047	positive regulation of secretion	1.7497114868092467e-13	3.858988684157794e-9	16	363	62
MESH:D006930	Hyperalgesia	GO:0007600	sensory perception	1.361133428190442e-13	3.0019797758740197e-9	26	902	62
MESH:D006930	Hyperalgesia	GO:0009612	response to mechanical stimulus	1.2079226507921703e-13	2.6640734063221316e-9	16	210	62
MESH:D006930	Hyperalgesia	GO:1903524	positive regulation of blood circulation	9.658940314238862e-14	2.130279286305381e-9	13	89	62
MESH:D006930	Hyperalgesia	GO:0019233	sensory perception of pain	6.661338147750939e-14	1.4691581284864696e-9	21	101	62
MESH:D006930	Hyperalgesia	GO:0042310	vasoconstriction	2.9753977059954195e-14	6.562239640572898e-10	11	80	62
MESH:D006930	Hyperalgesia	GO:0019229	regulation of vasoconstriction	2.4091839634365897e-14	5.313455231359399e-10	11	65	62
MESH:D006930	Hyperalgesia	GO:0006939	smooth muscle contraction	1.2012613126444194e-13	2.649381825037267e-9	13	97	62
MESH:D006930	Hyperalgesia	GO:0043269	regulation of ion transport	1.220135104063047e-13	2.6910079720110502e-9	22	583	62
MESH:D006930	Hyperalgesia	GO:0031644	regulation of neurological system process	1.362243651215067e-13	3.0044283727548304e-9	10	68	62
MESH:D006930	Hyperalgesia	GO:0032496	response to lipopolysaccharide	1.7741363933510002e-13	3.912857815535631e-9	18	319	62
MESH:D006930	Hyperalgesia	GO:0030802	regulation of cyclic nucleotide biosynthetic process	3.483879851273741e-13	7.683697011984236e-9	11	133	62
MESH:D006930	Hyperalgesia	GO:0009266	response to temperature stimulus	4.2166270475263445e-13	9.299770953319353e-9	15	219	62
MESH:D006930	Hyperalgesia	GO:1900371	regulation of purine nucleotide biosynthetic process	6.007416786246722e-13	1.3249357722067145e-8	11	139	62
MESH:D006930	Hyperalgesia	GO:0006809	nitric oxide biosynthetic process	6.284972542403011e-13	1.3861506942269841e-8	9	62	62
MESH:D006930	Hyperalgesia	GO:0007268	synaptic transmission	7.243095012654521e-13	1.5974646050409547e-8	25	605	62
MESH:D006930	Hyperalgesia	GO:0050804	modulation of synaptic transmission	1.0185186027911186e-12	2.246342778455812e-8	14	285	62
MESH:D006930	Hyperalgesia	GO:0035813	regulation of renal sodium excretion	1.0210721157477565e-12	2.251974551281677e-8	7	24	62
MESH:D006930	Hyperalgesia	GO:0052652	cyclic purine nucleotide metabolic process	1.1001199951010676e-12	2.4263146491954046e-8	11	147	62
MESH:D006930	Hyperalgesia	GO:0051480	cytosolic calcium ion homeostasis	1.1214362771738706e-12	2.4733277093069717e-8	20	255	62
MESH:D006930	Hyperalgesia	GO:0001664	G-protein coupled receptor binding	1.2105871860512707e-12	2.6699500388360775e-8	14	255	62
MESH:D006930	Hyperalgesia	GO:1903530	regulation of secretion by cell	1.4634959910608814e-12	3.227740408284774e-8	21	624	62
MESH:D006930	Hyperalgesia	GO:0007204	positive regulation of cytosolic calcium ion concentration	1.4727108421652702e-12	3.248063762395503e-8	20	234	62
MESH:D006930	Hyperalgesia	GO:0048545	response to steroid hormone	1.7621459846850485e-12	3.8864129692228744e-8	16	446	62
MESH:D006930	Hyperalgesia	GO:1903532	positive regulation of secretion by cell	2.4014124022642136e-12	5.296315053193723e-8	14	335	62
MESH:D006930	Hyperalgesia	GO:0043408	regulation of MAPK cascade	2.8677060726067793e-12	6.324725743134252e-8	18	651	62
MESH:D006930	Hyperalgesia	GO:0070482	response to oxygen levels	2.904232410116947e-12	6.405284580512927e-8	14	321	62
MESH:D006930	Hyperalgesia	GO:0010959	regulation of metal ion transport	2.904232410116947e-12	6.405284580512927e-8	14	321	62
MESH:D006930	Hyperalgesia	GO:0044706	multi-multicellular organism process	2.9813929103283954e-12	6.575462063729276e-8	13	237	62
MESH:D006930	Hyperalgesia	GO:0009408	response to heat	3.0143665341597625e-12	6.648185391089356e-8	11	159	62
MESH:D006930	Hyperalgesia	GO:0035815	positive regulation of renal sodium excretion	3.071543019927958e-12	6.774288130451112e-8	6	14	62
MESH:D006930	Hyperalgesia	GO:0045765	regulation of angiogenesis	3.081646049452047e-12	6.79657036206649e-8	12	208	62
MESH:D006930	Hyperalgesia	GO:1903034	regulation of response to wounding	3.4984237728963308e-12	7.715773631122858e-8	15	407	62
MESH:D006930	Hyperalgesia	GO:0043410	positive regulation of MAPK cascade	3.629985201314412e-12	8.005932361498935e-8	17	464	62
MESH:D006930	Hyperalgesia	GO:0008284	positive regulation of cell proliferation	4.1602277178753866e-12	9.175382231774165e-8	22	815	62
MESH:D006930	Hyperalgesia	GO:0050878	regulation of body fluid levels	5.661693336378448e-12	1.2486864653382668e-7	17	504	62
MESH:D006930	Hyperalgesia	GO:0014072	response to isoquinoline alkaloid	5.9713345379464045e-12	1.3169778323440795e-7	7	30	62
MESH:D006930	Hyperalgesia	GO:0043278	response to morphine	5.9713345379464045e-12	1.3169778323440795e-7	7	30	62
MESH:D006930	Hyperalgesia	GO:0042493	response to drug	1.0165979169585171e-11	2.2421067058520094e-7	15	433	62
MESH:D006930	Hyperalgesia	GO:0043069	negative regulation of programmed cell death	1.0993317367535838e-11	2.424576145410029e-7	19	806	62
MESH:D006930	Hyperalgesia	GO:0001666	response to hypoxia	1.224675916233764e-11	2.7010227332535663e-7	13	292	62
MESH:D006930	Hyperalgesia	GO:0030814	regulation of cAMP metabolic process	1.2604473020871865e-11	2.77991652475329e-7	10	128	62
MESH:D006930	Hyperalgesia	GO:0051241	negative regulation of multicellular organismal process	1.3709255952676358e-11	3.023576400362771e-7	20	966	62
MESH:D006930	Hyperalgesia	GO:0043270	positive regulation of ion transport	1.4238610290817633e-11	3.140325499639829e-7	12	233	62
MESH:D006930	Hyperalgesia	GO:0043066	negative regulation of apoptotic process	1.4386714042302629e-11	3.1729897820298447e-7	19	795	62
MESH:D006930	Hyperalgesia	GO:0051051	negative regulation of transport	1.603905896985225e-11	3.5374144558009135e-7	15	452	62
MESH:D006930	Hyperalgesia	GO:0045981	positive regulation of nucleotide metabolic process	1.7098877869159423e-11	3.771157514043111e-7	10	132	62
MESH:D006930	Hyperalgesia	GO:1900544	positive regulation of purine nucleotide metabolic process	1.7098877869159423e-11	3.771157514043111e-7	10	132	62
MESH:D006930	Hyperalgesia	GO:0042060	wound healing	1.8553047986813453e-11	4.091874733491707e-7	16	534	62
MESH:D006930	Hyperalgesia	GO:0045471	response to ethanol	2.4783841645614757e-11	5.466076274940335e-7	10	137	62
MESH:D006930	Hyperalgesia	GO:0070371	ERK1 and ERK2 cascade	2.809308341511496e-11	6.195929547203605e-7	12	247	62
MESH:D006930	Hyperalgesia	GO:0002526	acute inflammatory response	3.322864206012355e-11	7.328577006360248e-7	10	141	62
MESH:D006930	Hyperalgesia	GO:0046883	regulation of hormone secretion	3.48586715048782e-11	7.688080000400888e-7	12	252	62
MESH:D006930	Hyperalgesia	GO:0010634	positive regulation of epithelial cell migration	4.406364162434784e-11	9.718236160249916e-7	9	101	62
MESH:D006930	Hyperalgesia	GO:0071705	nitrogen compound transport	4.430689148904321e-11	9.77188491790848e-7	18	777	62
MESH:D006930	Hyperalgesia	GO:0045429	positive regulation of nitric oxide biosynthetic process	5.3662851939861866e-11	1.1835341995336535e-6	7	40	62
MESH:D006930	Hyperalgesia	GO:0048659	smooth muscle cell proliferation	5.7740145997797754e-11	1.2734589199814295e-6	9	104	62
MESH:D006930	Hyperalgesia	GO:0042311	vasodilation	5.866562791112528e-11	1.2938704235798681e-6	8	68	62
MESH:D006930	Hyperalgesia	GO:0032101	regulation of response to external stimulus	7.099254517584086e-11	1.5657405838531702e-6	19	920	62
MESH:D006930	Hyperalgesia	GO:0002687	positive regulation of leukocyte migration	8.818246133301955e-11	1.944864184699746e-6	9	109	62
MESH:D006930	Hyperalgesia	GO:0030817	regulation of cAMP biosynthetic process	1.2237677537996206e-10	2.699019781005063e-6	9	113	62
MESH:D006930	Hyperalgesia	GO:0070848	response to growth factor	1.2291345719006586e-10	2.7108562983269024e-6	16	621	62
MESH:D006930	Hyperalgesia	GO:0007611	learning or memory	1.2891054890218356e-10	2.8431221560376585e-6	11	218	62
MESH:D006930	Hyperalgesia	GO:1903036	positive regulation of response to wounding	1.3239220830740805e-10	2.9199101542198846e-6	10	162	62
MESH:D006930	Hyperalgesia	GO:0050729	positive regulation of inflammatory response	1.3252676733799262e-10	2.9228778536394273e-6	9	114	62
MESH:D006930	Hyperalgesia	GO:0005179	hormone activity	1.6778289868568663e-10	3.7004518305128187e-6	9	117	62
MESH:D006930	Hyperalgesia	GO:0051384	response to glucocorticoid	1.7917545225287768e-10	3.951714599437217e-6	10	167	62
MESH:D006930	Hyperalgesia	GO:0060402	calcium ion transport into cytosol	1.9515100646572137e-10	4.304055447601485e-6	9	119	62
MESH:D006930	Hyperalgesia	GO:0036477	somatodendritic compartment	2.3491397715957874e-10	5.181027766254509e-6	16	649	62
MESH:D006930	Hyperalgesia	GO:1901701	cellular response to oxygen-containing compound	2.559267242574492e-10	5.644463903498043e-6	18	873	62
MESH:D006930	Hyperalgesia	GO:0009306	protein secretion	2.6423185861546017e-10	5.827633641763974e-6	14	462	62
MESH:D006930	Hyperalgesia	GO:0015833	peptide transport	3.264492010046638e-10	7.19983712815786e-6	12	307	62
MESH:D006930	Hyperalgesia	GO:0043434	response to peptide hormone	3.7637515326593984e-10	8.300954005280303e-6	13	389	62
MESH:D006930	Hyperalgesia	GO:0018105	peptidyl-serine phosphorylation	3.776674528666035e-10	8.32945567297294e-6	11	241	62
MESH:D006930	Hyperalgesia	GO:0030072	peptide hormone secretion	3.776674528666035e-10	8.32945567297294e-6	11	241	62
MESH:D006930	Hyperalgesia	GO:0048265	response to pain	4.681148801921609e-10	1.0324273682638108e-5	6	29	62
MESH:D006930	Hyperalgesia	GO:0033198	response to ATP	4.681148801921609e-10	1.0324273682638108e-5	6	29	62
MESH:D006930	Hyperalgesia	GO:0045987	positive regulation of smooth muscle contraction	5.836079397525396e-10	1.287147311124226e-5	6	30	62
MESH:D006930	Hyperalgesia	GO:0071363	cellular response to growth factor stimulus	6.783008599242635e-10	1.4959925465629631e-5	15	594	62
MESH:D006930	Hyperalgesia	GO:0045909	positive regulation of vasodilation	7.218586839385921e-10	1.592059327426565e-5	6	31	62
MESH:D006930	Hyperalgesia	GO:0010035	response to inorganic substance	7.720613037776047e-10	1.7027812054815072e-5	14	502	62
MESH:D006930	Hyperalgesia	GO:0034220	ion transmembrane transport	1.2036931451575583e-9	2.654745231644995e-5	18	962	62
MESH:D006930	Hyperalgesia	GO:0030804	positive regulation of cyclic nucleotide biosynthetic process	1.2520043890518195e-9	2.761295680053788e-5	8	99	62
MESH:D006930	Hyperalgesia	GO:0045907	positive regulation of vasoconstriction	1.3083870653574081e-9	2.8856476726457636e-5	6	34	62
MESH:D006930	Hyperalgesia	GO:0048660	regulation of smooth muscle cell proliferation	1.357324030948348e-9	2.9935781502565817e-5	8	100	62
MESH:D006930	Hyperalgesia	GO:0051924	regulation of calcium ion transport	1.468703825224793e-9	3.239226286533281e-5	10	207	62
MESH:D006930	Hyperalgesia	GO:0007596	blood coagulation	1.54910451133361e-9	3.416549999746277e-5	12	352	62
MESH:D006930	Hyperalgesia	GO:1903649	regulation of cytoplasmic transport	1.5537664488363134e-9	3.426831902908489e-5	13	437	62
MESH:D006930	Hyperalgesia	GO:0008285	negative regulation of cell proliferation	1.655505399433821e-9	3.651217158451292e-5	15	634	62
MESH:D006930	Hyperalgesia	GO:0071222	cellular response to lipopolysaccharide	1.7372668859039209e-9	3.8315421168610975e-5	9	152	62
MESH:D006930	Hyperalgesia	GO:1900373	positive regulation of purine nucleotide biosynthetic process	1.8594148443185077e-9	4.100939439144469e-5	8	104	62
MESH:D006930	Hyperalgesia	GO:0051931	regulation of sensory perception	1.8851081806658954e-9	4.157606092458632e-5	6	36	62
MESH:D006930	Hyperalgesia	GO:0051930	regulation of sensory perception of pain	1.8851081806658954e-9	4.157606092458632e-5	6	36	62
MESH:D006930	Hyperalgesia	GO:0098655	cation transmembrane transport	1.964310047952722e-9	4.3322858107597284e-5	15	642	62
MESH:D006930	Hyperalgesia	GO:0030425	dendrite	2.2718977810143315e-9	5.010670556027108e-5	13	451	62
MESH:D006930	Hyperalgesia	GO:0031667	response to nutrient levels	2.273896515525564e-9	5.015078764991632e-5	14	546	62
MESH:D006930	Hyperalgesia	GO:0019226	transmission of nerve impulse	2.3366557577730873e-9	5.153494273768544e-5	7	67	62
MESH:D006930	Hyperalgesia	GO:0019932	second-messenger-mediated signaling	2.534713217094975e-9	5.590310000302967e-5	10	219	62
MESH:D006930	Hyperalgesia	GO:0014832	urinary bladder smooth muscle contraction	3.8284305725611034e-9	8.443603627783514e-5	4	7	62
MESH:D006930	Hyperalgesia	GO:0051952	regulation of amine transport	3.907024148652738e-9	8.616941759853614e-5	7	72	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0034622	cellular macromolecular complex assembly	1.7863488466218769e-12	3.9397923812245494e-8	28	926	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0051188	cofactor biosynthetic process	1.149080830487037e-12	2.53429777163916e-8	15	157	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0042278	purine nucleoside metabolic process	8.659739592076221e-13	1.9099055670324105e-8	27	345	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0046128	purine ribonucleoside metabolic process	7.556177905598815e-13	1.6665150370798187e-8	27	342	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0009108	coenzyme biosynthetic process	2.8843594179761567e-13	6.3614546963464136e-9	13	132	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0006733	oxidoreduction coenzyme metabolic process	3.483879851273741e-13	7.683697011984236e-9	11	133	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0051536	iron-sulfur cluster binding	1.1905411101409413e-9	2.625738418415846e-5	7	61	62
MESH:D015323	Pyruvate Metabolism, Inborn Errors	GO:0051539	4 iron, 4 sulfur cluster binding	3.677020132819564e-9	8.109667902933548e-5	6	40	62
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0050954	sensory perception of mechanical stimulus	9.245937349078304e-13	2.03919148233922e-8	38	153	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0048839	inner ear development	7.813749647311852e-13	1.723322484714629e-8	18	170	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0098858	actin-based cell projection	6.195044477408373e-13	1.3663170594924168e-8	23	179	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0042490	mechanoreceptor differentiation	2.2959412149248237e-13	5.063698349516699e-9	11	55	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060113	inner ear receptor cell differentiation	1.509903313490213e-13	3.3300917579026645e-9	11	51	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060119	inner ear receptor cell development	1.4233059175694507e-13	3.1391012011994235e-9	11	35	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0032420	stereocilium	9.880984919163893e-14	2.1792512239215966e-9	21	36	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0007605	sensory perception of sound	4.3520742565306136e-14	9.598499772778268e-10	38	138	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0035315	hair cell differentiation	2.6867397195928788e-14	5.925604451562094e-10	9	39	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0045177	apical part of cell	1.0658141036401503e-14	2.3506530055783514e-10	15	356	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060122	inner ear receptor stereocilium organization	8.43769498715119e-15	1.860933629416195e-10	8	21	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060117	auditory receptor cell development	7.549516567451064e-15	1.6650458789513323e-10	8	18	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0002093	auditory receptor cell morphogenesis	1.9679813334505525e-12	4.3403828309251935e-8	6	13	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060088	auditory receptor cell stereocilium organization	9.25379772809265e-11	2.040925088930834e-6	5	10	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0060091	kinocilium	1.7562034049234398e-9	3.8733066095586466e-5	4	6	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0016324	apical plasma membrane	2.732749471157092e-9	6.0270789586369666e-5	11	286	63
Orphanet:90636	Autosomal recessive non-syndromic sensorineural deafness type DFNB	GO:0050957	equilibrioception	4.087446603406875e-9	9.014863483813862e-5	4	7	63
DOID:2033	communication disorder	GO:0007612	learning	1.6364687382974807e-13	3.6092318023150938e-9	12	130	63
DOID:2033	communication disorder	GO:0050804	modulation of synaptic transmission	1.0967893260271921e-12	2.4189688585529723e-8	14	285	63
DOID:2033	communication disorder	GO:0007613	memory	1.233679824963474e-12	2.7208808539569418e-8	10	99	63
DOID:2033	communication disorder	GO:0050803	regulation of synapse structure or activity	1.8721690864254015e-12	4.129068920111223e-8	13	233	63
DOID:2033	communication disorder	GO:0007417	central nervous system development	4.09683398316929e-12	9.03556734987987e-8	21	889	63
DOID:2033	communication disorder	GO:0036477	somatodendritic compartment	4.108380302625392e-12	9.061032757440302e-8	18	649	63
DOID:2033	communication disorder	GO:0051705	multi-organism behavior	5.962785820656791e-12	1.3150924127458552e-7	9	80	63
DOID:2033	communication disorder	GO:0007420	brain development	6.792677531564095e-12	1.4981250295864612e-7	18	669	63
DOID:2033	communication disorder	GO:0033267	axon part	6.84408085760424e-12	1.5094620331446151e-7	12	217	63
DOID:2033	communication disorder	GO:0048666	neuron development	8.892775404945041e-12	1.961301615560629e-7	20	926	63
DOID:2033	communication disorder	GO:0007270	neuron-neuron synaptic transmission	1.745181776868776e-11	3.8489984088840856e-7	10	130	63
DOID:2033	communication disorder	GO:0030425	dendrite	1.8910095711532904e-11	4.170621609178582e-7	15	451	63
DOID:2033	communication disorder	GO:0098597	observational learning	2.0648149856583586e-11	4.55394945086951e-7	5	8	63
DOID:2033	communication disorder	GO:0051960	regulation of nervous system development	3.204192466910172e-11	7.066846485770384e-7	18	744	63
DOID:2033	communication disorder	GO:0048167	regulation of synaptic plasticity	3.650113544750866e-11	8.050325422948035e-7	10	140	63
DOID:2033	communication disorder	GO:0035249	synaptic transmission, glutamatergic	8.474310142503327e-11	1.8690091019291089e-6	8	70	63
DOID:2033	communication disorder	GO:0042391	regulation of membrane potential	8.76861916410121e-11	1.933918956642522e-6	13	340	63
DOID:2033	communication disorder	GO:0051962	positive regulation of nervous system development	1.5077994408585482e-10	3.325451666813528e-6	14	435	63
DOID:2033	communication disorder	GO:0019904	protein domain specific binding	1.531891280492914e-10	3.378586219127122e-6	16	619	63
DOID:2033	communication disorder	GO:0048638	regulation of developmental growth	1.5635404082559035e-10	3.448388370408395e-6	12	283	63
DOID:2033	communication disorder	GO:0051703	intraspecies interaction between organisms	1.7048695788446366e-10	3.760089856141846e-6	7	46	63
DOID:2033	communication disorder	GO:0035176	social behavior	1.7048695788446366e-10	3.760089856141846e-6	7	46	63
DOID:2033	communication disorder	GO:0001964	startle response	1.9473644918832633e-10	4.294912386848537e-6	6	25	63
DOID:2033	communication disorder	GO:0050767	regulation of neurogenesis	3.7141578701493927e-10	8.191575182614486e-6	16	658	63
DOID:2033	communication disorder	GO:0097164	ammonium ion metabolic process	3.9661773865162786e-10	8.747404225961652e-6	10	178	63
DOID:2033	communication disorder	GO:0007626	locomotory behavior	5.204640052269838e-10	1.1478833635281127e-5	10	183	63
DOID:2033	communication disorder	GO:0060079	excitatory postsynaptic potential	5.52134227227441e-10	1.2177320381501211e-5	7	54	63
DOID:2033	communication disorder	GO:0016358	dendrite development	6.104620142721728e-10	1.3463739724772772e-5	10	186	63
DOID:2033	communication disorder	GO:0007416	synapse assembly	9.701660586003413e-10	2.1397012422430528e-5	9	140	63
DOID:2033	communication disorder	GO:0042417	dopamine metabolic process	9.782429311044893e-10	2.1575147845509512e-5	6	32	63
DOID:2033	communication disorder	GO:0032940	secretion by cell	1.4507541834518634e-9	3.1996383516030846e-5	18	956	63
DOID:2033	communication disorder	GO:0050805	negative regulation of synaptic transmission	2.1095577507068697e-9	4.652629619184001e-5	7	65	63
DOID:2033	communication disorder	GO:0019725	cellular homeostasis	3.654246794049243e-9	8.059441304275605e-5	16	771	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0060249	anatomical structure homeostasis	7.081002451059248e-13	1.5617150905811172e-8	18	351	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0032200	telomere organization	4.4009240696141205e-13	9.706238035533943e-9	14	146	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0000723	telomere maintenance	1.028066520802895e-13	2.267400711630785e-9	14	133	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0071897	DNA biosynthetic process	7.85604914455007e-12	1.732651638830518e-7	11	167	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0000784	nuclear chromosome, telomeric region	2.0311308190912314e-11	4.479659021505711e-7	10	132	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0032204	regulation of telomere maintenance	5.230460509153545e-11	1.1535780652938143e-6	8	66	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0051053	negative regulation of DNA metabolic process	9.433898107147343e-11	2.0806462275313464e-6	9	108	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0051338	regulation of transferase activity	9.019319735514841e-10	1.9892109676677983e-5	18	928	63
Orphanet:79375	Hyperpigmentation of the skin	GO:0007126	meiotic nuclear division	3.3456704073842047e-9	7.378876083485864e-5	9	161	63
Orphanet:101955	Rare thyroid disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.7374777172562972e-9	3.8320071054087634e-5	16	732	63
Orphanet:101955	Rare thyroid disease	GO:0007417	central nervous system development	3.663447545321219e-9	8.079733561205948e-5	17	889	63
Orphanet:3394	Soft tissue sarcoma	GO:0001944	vasculature development	1.9806378759312793e-13	4.3682968353664364e-9	20	588	63
Orphanet:3394	Soft tissue sarcoma	GO:0070482	response to oxygen levels	1.0152989560197057e-12	2.2392418475014608e-8	15	321	63
Orphanet:3394	Soft tissue sarcoma	GO:0048545	response to steroid hormone	1.2887468869848817e-12	2.8423312592451566e-8	17	446	63
Orphanet:3394	Soft tissue sarcoma	GO:0010942	positive regulation of cell death	1.3746781490908688e-12	3.031852657819911e-8	18	596	63
Orphanet:3394	Soft tissue sarcoma	GO:0035497	cAMP response element binding	1.9679813334505525e-12	4.3403828309251935e-8	6	13	63
Orphanet:3394	Soft tissue sarcoma	GO:0042493	response to drug	2.649991337477786e-12	5.8445558948072573e-8	23	433	63
Orphanet:3394	Soft tissue sarcoma	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	2.755906614027026e-12	6.078152037236606e-8	14	317	63
Orphanet:3394	Soft tissue sarcoma	GO:0043065	positive regulation of apoptotic process	3.9716008259915725e-12	8.759365621724413e-8	18	556	63
Orphanet:3394	Soft tissue sarcoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.015743458931411e-12	1.3267722198673226e-7	25	996	63
Orphanet:3394	Soft tissue sarcoma	GO:0060548	negative regulation of cell death	6.157074849966193e-12	1.357942858160044e-7	20	867	63
Orphanet:3394	Soft tissue sarcoma	GO:0008134	transcription factor binding	7.310818617156656e-12	1.6124010460139004e-7	18	518	63
Orphanet:3394	Soft tissue sarcoma	GO:0010035	response to inorganic substance	1.1405321131974233e-11	2.515443575656917e-7	16	502	63
Orphanet:3394	Soft tissue sarcoma	GO:1901342	regulation of vasculature development	1.2872369836713915e-11	2.839001167487254e-7	12	228	63
Orphanet:3394	Soft tissue sarcoma	GO:0007610	behavior	1.6399548385948037e-11	3.6169203965208396e-7	18	714	63
Orphanet:3394	Soft tissue sarcoma	GO:1902533	positive regulation of intracellular signal transduction	3.684597071895723e-11	8.126378842066018e-7	19	860	63
Orphanet:3394	Soft tissue sarcoma	GO:1901214	regulation of neuron death	3.866496012250309e-11	8.527556955018056e-7	12	250	63
Orphanet:3394	Soft tissue sarcoma	GO:0043066	negative regulation of apoptotic process	8.350742319862547e-11	1.8417562186456848e-6	18	795	63
Orphanet:3394	Soft tissue sarcoma	GO:0051726	regulation of cell cycle	1.0989309462416941e-10	2.4236922019360563e-6	19	930	63
Orphanet:3394	Soft tissue sarcoma	GO:0007167	enzyme linked receptor protein signaling pathway	1.1812217870499353e-10	2.6051846513386323e-6	19	935	63
Orphanet:3394	Soft tissue sarcoma	GO:0032844	regulation of homeostatic process	1.1847733905057112e-10	2.613017712760346e-6	14	427	63
Orphanet:3394	Soft tissue sarcoma	GO:0009314	response to radiation	1.3397793985348017e-10	2.954883463468505e-6	14	431	63
Orphanet:3394	Soft tissue sarcoma	GO:0009887	organ morphogenesis	1.629107959644216e-10	3.5929976049953183e-6	19	950	63
Orphanet:3394	Soft tissue sarcoma	GO:0008285	negative regulation of cell proliferation	2.1625479185161112e-10	4.769499434287283e-6	16	634	63
Orphanet:3394	Soft tissue sarcoma	GO:0045786	negative regulation of cell cycle	2.2716528658150992e-10	5.010130395555201e-6	14	449	63
Orphanet:3394	Soft tissue sarcoma	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	2.379028085641721e-10	5.246946442882816e-6	11	227	63
Orphanet:3394	Soft tissue sarcoma	GO:0097305	response to alcohol	2.42733833033526e-10	5.3534946875544165e-6	13	369	63
Orphanet:3394	Soft tissue sarcoma	GO:0007346	regulation of mitotic cell cycle	2.5473811948728553e-10	5.618249225292082e-6	14	453	63
Orphanet:3394	Soft tissue sarcoma	GO:0043535	regulation of blood vessel endothelial cell migration	2.7136937141847284e-10	5.9850514866344184e-6	7	49	63
Orphanet:3394	Soft tissue sarcoma	GO:0048145	regulation of fibroblast proliferation	3.1076707873722853e-10	6.853967921549575e-6	8	82	63
Orphanet:3394	Soft tissue sarcoma	GO:0003690	double-stranded DNA binding	3.1894020757761155e-10	7.034226278124223e-6	17	756	63
Orphanet:3394	Soft tissue sarcoma	GO:0031099	regeneration	4.933088382230721e-10	1.0879926427009856e-5	10	182	63
Orphanet:3394	Soft tissue sarcoma	GO:0010243	response to organonitrogen compound	5.127983593311569e-10	1.1309767815048666e-5	17	780	63
Orphanet:3394	Soft tissue sarcoma	GO:1904018	positive regulation of vasculature development	5.364564348298018e-10	1.1831546670171278e-5	9	131	63
Orphanet:3394	Soft tissue sarcoma	GO:0000989	transcription factor activity, transcription factor binding	5.390157209461677e-10	1.1887991725467728e-5	15	574	63
Orphanet:3394	Soft tissue sarcoma	GO:0043523	regulation of neuron apoptotic process	7.516979261268375e-10	1.65786977607274e-5	10	190	63
Orphanet:3394	Soft tissue sarcoma	GO:0045930	negative regulation of mitotic cell cycle	1.2384623326866517e-9	2.7314286747404104e-5	10	200	63
Orphanet:3394	Soft tissue sarcoma	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	1.403857474713277e-9	3.0962076604801325e-5	12	343	63
Orphanet:3394	Soft tissue sarcoma	GO:0043627	response to estrogen	2.729058312667121e-9	6.018938108587335e-5	10	217	63
Orphanet:3394	Soft tissue sarcoma	GO:0031667	response to nutrient levels	2.8448055022778362e-9	6.274218535273768e-5	14	546	63
Orphanet:3394	Soft tissue sarcoma	GO:0001666	response to hypoxia	3.395967507202613e-9	7.489806337135363e-5	11	292	63
DOID:896	metal metabolism disorder	GO:1990267	response to transition metal nanoparticle	9.898748487557896e-13	2.183168978930894e-8	14	150	64
DOID:896	metal metabolism disorder	GO:0046916	cellular transition metal ion homeostasis	4.951594689828198e-14	1.0920742088416091e-9	14	81	64
DOID:896	metal metabolism disorder	GO:0000041	transition metal ion transport	2.3454571618231057e-12	5.1729057704008596e-8	10	104	64
DOID:896	metal metabolism disorder	GO:0070838	divalent metal ion transport	6.136868790918015e-12	1.3534864118369683e-7	15	410	64
DOID:896	metal metabolism disorder	GO:0046873	metal ion transmembrane transporter activity	1.014148764966194e-10	2.236705101132941e-6	14	415	64
DOID:896	metal metabolism disorder	GO:0051353	positive regulation of oxidoreductase activity	1.6240553346591469e-10	3.5818540405907484e-6	7	45	64
DOID:896	metal metabolism disorder	GO:1902930	regulation of alcohol biosynthetic process	1.6240553346591469e-10	3.5818540405907484e-6	7	45	64
DOID:896	metal metabolism disorder	GO:0032940	secretion by cell	1.923258885483392e-9	4.241747471933621e-5	18	956	64
DOID:896	metal metabolism disorder	GO:0046915	transition metal ion transmembrane transporter activity	3.2324307674969077e-9	7.12912605771443e-5	6	38	64
Orphanet:399771	Male infertility due to sperm disorder	GO:0034622	cellular macromolecular complex assembly	2.8204105717577477e-12	6.220415516011712e-8	22	926	64
Orphanet:371047	Congenital disorder of glycosylation with neurological involvement	GO:0008194	UDP-glycosyltransferase activity	3.4705571749782393e-13	7.654313849414507e-9	12	140	64
Orphanet:371047	Congenital disorder of glycosylation with neurological involvement	GO:0006506	GPI anchor biosynthetic process	1.3140954990831233e-9	2.8982376232278284e-5	6	33	64
Orphanet:371047	Congenital disorder of glycosylation with neurological involvement	GO:0009225	nucleotide-sugar metabolic process	1.5915408990707647e-9	3.5101434529005715e-5	6	34	64
Orphanet:371047	Congenital disorder of glycosylation with neurological involvement	GO:0019348	dolichol metabolic process	1.873116217687709e-9	4.1311578181102426e-5	4	6	64
DOID:3070	malignant glioma	GO:0009790	embryo development	4.3089976031751576e-12	9.50349421380281e-8	22	932	64
DOID:3070	malignant glioma	GO:0007417	central nervous system development	4.2627013030482885e-12	9.401387723873e-8	21	889	64
DOID:3070	malignant glioma	GO:0007420	brain development	8.403611140295197e-12	1.8534164369921058e-7	18	669	64
DOID:3070	malignant glioma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	3.9253045258647035e-11	8.657259131794603e-7	17	647	64
DOID:3070	malignant glioma	GO:0001655	urogenital system development	3.9905745374824164e-11	8.801212142417469e-7	13	313	64
DOID:3070	malignant glioma	GO:0048568	embryonic organ development	8.054801270418466e-11	1.7764864201907926e-6	14	408	64
DOID:3070	malignant glioma	GO:0045596	negative regulation of cell differentiation	1.1601686278339685e-10	2.5587519086878174e-6	16	597	64
DOID:3070	malignant glioma	GO:0051338	regulation of transferase activity	1.4530676661905773e-10	3.204740737783318e-6	19	928	64
DOID:3070	malignant glioma	GO:0003007	heart morphogenesis	1.667416205108907e-10	3.6774864403676943e-6	11	216	64
DOID:3070	malignant glioma	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2.1436630248672373e-10	4.727848801344692e-6	13	359	64
DOID:3070	malignant glioma	GO:0048709	oligodendrocyte differentiation	2.611629801307913e-10	5.759949526784602e-6	8	79	64
DOID:3070	malignant glioma	GO:0021537	telencephalon development	2.7150759418503867e-10	5.988099989751028e-6	11	226	64
DOID:3070	malignant glioma	GO:0051241	negative regulation of multicellular organismal process	2.8765612114511896e-10	6.344255751855599e-6	19	966	64
DOID:3070	malignant glioma	GO:0008544	epidermis development	3.1696911761969204e-10	6.990753889102308e-6	12	296	64
DOID:3070	malignant glioma	GO:0051960	regulation of nervous system development	3.273042947782301e-10	7.2186962213338646e-6	17	744	64
DOID:3070	malignant glioma	GO:0009913	epidermal cell differentiation	4.176833323654705e-10	9.212005895320452e-6	10	176	64
DOID:3070	malignant glioma	GO:0097190	apoptotic signaling pathway	5.397602365064813e-10	1.1904412016150445e-5	15	564	64
DOID:3070	malignant glioma	GO:0001568	blood vessel development	6.081174452887694e-10	1.341203025584381e-5	15	569	64
DOID:3070	malignant glioma	GO:0035295	tube development	6.686626807805851e-10	1.4747355424615805e-5	15	573	64
DOID:3070	malignant glioma	GO:0048514	blood vessel morphogenesis	7.539997515237928e-10	1.662946451985725e-5	14	484	64
DOID:3070	malignant glioma	GO:0071363	cellular response to growth factor stimulus	1.096182478121932e-9	2.417630455497921e-5	15	594	64
DOID:3070	malignant glioma	GO:0010942	positive regulation of cell death	1.1484510009651672e-9	2.5329086826286762e-5	15	596	64
DOID:3070	malignant glioma	GO:0045597	positive regulation of cell differentiation	1.2914660452167936e-9	2.8483283627256384e-5	17	815	64
DOID:3070	malignant glioma	GO:0071407	cellular response to organic cyclic compound	1.2989801456697592e-9	2.864900711274654e-5	13	416	64
DOID:3070	malignant glioma	GO:0035239	tube morphogenesis	1.4391690061898998e-9	3.174087243151824e-5	12	338	64
DOID:3070	malignant glioma	GO:0032355	response to estradiol	1.5323239344056105e-9	3.379540437331574e-5	9	145	64
DOID:3070	malignant glioma	GO:0008134	transcription factor binding	1.8091393938490796e-9	3.990056933134145e-5	14	518	64
DOID:3070	malignant glioma	GO:0007389	pattern specification process	2.0509536291513086e-9	4.523378229093211e-5	13	432	64
DOID:3070	malignant glioma	GO:0021543	pallium development	2.465442516808025e-9	5.4375334708200995e-5	9	153	64
DOID:3070	malignant glioma	GO:0019901	protein kinase binding	2.542655419546236e-9	5.607826527809223e-5	14	532	64
DOID:3070	malignant glioma	GO:0021987	cerebral cortex development	2.60394583673218e-9	5.743002542912823e-5	8	105	64
DOID:3070	malignant glioma	GO:0048729	tissue morphogenesis	2.7229413168683436e-9	6.005447074353132e-5	15	635	64
DOID:3070	malignant glioma	GO:2001233	regulation of apoptotic signaling pathway	2.8437880938980697e-9	6.271974641092193e-5	12	359	64
DOID:3070	malignant glioma	GO:0001503	ossification	3.2207059241784464e-9	7.103266915775563e-5	12	363	64
DOID:3070	malignant glioma	GO:0043065	positive regulation of apoptotic process	4.464379532720386e-9	9.846189059414812e-5	14	556	64
DOID:1824	status epilepticus	GO:0009607	response to biotic stimulus	4.007016940477115e-12	8.837475862222277e-8	25	934	64
DOID:1824	status epilepticus	GO:0043005	neuron projection	2.7762236953776664e-12	6.122961360155443e-8	27	941	64
DOID:1824	status epilepticus	GO:0002237	response to molecule of bacterial origin	1.4874768083927847e-12	3.280630100910287e-8	20	333	64
DOID:1824	status epilepticus	GO:0010038	response to metal ion	1.2749801214795298e-12	2.811968657923103e-8	16	335	64
DOID:1824	status epilepticus	GO:0072507	divalent inorganic cation homeostasis	1.1712852909795402e-12	2.5832697092553758e-8	17	393	64
DOID:1824	status epilepticus	GO:0006874	cellular calcium ion homeostasis	1.1526335441658375e-12	2.5421332816577547e-8	16	352	64
DOID:1824	status epilepticus	GO:0031960	response to corticosteroid	5.027089855502709e-13	1.1087246676311224e-8	13	179	64
DOID:1824	status epilepticus	GO:0009612	response to mechanical stimulus	2.864375403532904e-13	6.3173799524918195e-9	16	210	64
DOID:1824	status epilepticus	GO:0051384	response to glucocorticoid	2.8488322811881517e-13	6.2830995961604685e-9	12	167	64
DOID:1824	status epilepticus	GO:0036293	response to decreased oxygen levels	3.9335201762469296e-13	8.675378748712603e-9	14	302	64
DOID:1824	status epilepticus	GO:0004994	somatostatin receptor activity	3.999023334699814e-13	8.81984596468044e-9	5	5	64
DOID:1824	status epilepticus	GO:0038169	somatostatin receptor signaling pathway	3.999023334699814e-13	8.81984596468044e-9	5	5	64
DOID:1824	status epilepticus	GO:0038170	somatostatin signaling pathway	3.999023334699814e-13	8.81984596468044e-9	5	5	64
DOID:1824	status epilepticus	GO:0097305	response to alcohol	4.199973702156967e-13	9.263042000107191e-9	15	369	64
DOID:1824	status epilepticus	GO:0032496	response to lipopolysaccharide	4.225508831723346e-13	9.319359728365839e-9	20	319	64
DOID:1824	status epilepticus	GO:0070997	neuron death	4.96269692007445e-13	1.0945228057224199e-8	15	281	64
DOID:1824	status epilepticus	GO:0098857	membrane microdomain	5.38680211548126e-13	1.1880592065693918e-8	14	283	64
DOID:1824	status epilepticus	GO:0010942	positive regulation of cell death	6.350475700855895e-13	1.4005974158237677e-8	21	596	64
DOID:1824	status epilepticus	GO:0007268	synaptic transmission	9.86322135076989e-13	2.1753334689122994e-8	22	605	64
DOID:1824	status epilepticus	GO:0050804	modulation of synaptic transmission	1.0456080445919724e-12	2.3060885423475952e-8	14	285	64
DOID:1824	status epilepticus	GO:0016493	C-C chemokine receptor activity	1.1707301794672276e-12	2.5820454108149704e-8	6	12	64
DOID:1824	status epilepticus	GO:1901214	regulation of neuron death	1.4028778139163478e-12	3.094047018592505e-8	14	250	64
DOID:1824	status epilepticus	GO:0048520	positive regulation of behavior	1.6054935159104389e-12	3.540915949340473e-8	11	145	64
DOID:1824	status epilepticus	GO:0043523	regulation of neuron apoptotic process	1.6470158570314197e-12	3.632493472682796e-8	12	190	64
DOID:1824	status epilepticus	GO:0030335	positive regulation of cell migration	1.7988943668001411e-12	3.967461525977711e-8	15	387	64
DOID:1824	status epilepticus	GO:0001666	response to hypoxia	2.0476953466186387e-12	4.516192086967408e-8	14	292	64
DOID:1824	status epilepticus	GO:0071407	cellular response to organic cyclic compound	2.276179245086496e-12	5.020113325038267e-8	16	416	64
DOID:1824	status epilepticus	GO:0071396	cellular response to lipid	2.276179245086496e-12	5.020113325038267e-8	16	416	64
DOID:1824	status epilepticus	GO:0007204	positive regulation of cytosolic calcium ion concentration	2.5632829192545614e-12	5.653320478415935e-8	13	234	64
DOID:1824	status epilepticus	GO:0042493	response to drug	2.625233364028645e-12	5.789952184365177e-8	18	433	64
DOID:1824	status epilepticus	GO:0060548	negative regulation of cell death	2.85360624019404e-12	6.293628562747955e-8	22	867	64
DOID:1824	status epilepticus	GO:0043068	positive regulation of programmed cell death	3.6768366129535934e-12	8.10926314986915e-8	19	561	64
DOID:1824	status epilepticus	GO:0043065	positive regulation of apoptotic process	3.845368468091692e-12	8.480960156376227e-8	19	556	64
DOID:1824	status epilepticus	GO:0043410	positive regulation of MAPK cascade	4.316214052835221e-12	9.51941009352808e-8	17	464	64
DOID:1824	status epilepticus	GO:0009991	response to extracellular stimulus	4.8763215687586126e-12	1.075472721989712e-7	17	573	64
DOID:1824	status epilepticus	GO:0043069	negative regulation of programmed cell death	5.131339797515011e-12	1.1317169923419357e-7	20	806	64
DOID:1824	status epilepticus	GO:0042391	regulation of membrane potential	5.768718835952313e-12	1.2722909392692827e-7	14	340	64
DOID:1824	status epilepticus	GO:0045597	positive regulation of cell differentiation	5.8580917894346385e-12	1.2920021441598095e-7	20	815	64
DOID:1824	status epilepticus	GO:0070098	chemokine-mediated signaling pathway	6.863287715930255e-12	1.5136981057484178e-7	9	80	64
DOID:1824	status epilepticus	GO:0043066	negative regulation of apoptotic process	9.749645535350737e-12	2.150284322821605e-7	20	795	64
DOID:1824	status epilepticus	GO:0045121	membrane raft	1.1580070236050233e-11	2.553984490560879e-7	13	282	64
DOID:1824	status epilepticus	GO:0032103	positive regulation of response to external stimulus	1.2573941887694673e-11	2.77318288333106e-7	13	285	64
DOID:1824	status epilepticus	GO:1903530	regulation of secretion by cell	2.2783219755240225e-11	5.024839117018232e-7	17	624	64
DOID:1824	status epilepticus	GO:0006935	chemotaxis	2.4430235612271645e-11	5.388088464286511e-7	16	530	64
DOID:1824	status epilepticus	GO:0043524	negative regulation of neuron apoptotic process	2.7878033215245068e-11	6.1485002256223e-7	10	134	64
DOID:1824	status epilepticus	GO:0046683	response to organophosphorus	3.2518432391270835e-11	7.171940263894783e-7	10	136	64
DOID:1824	status epilepticus	GO:0071248	cellular response to metal ion	3.2518432391270835e-11	7.171940263894783e-7	10	136	64
DOID:1824	status epilepticus	GO:0031667	response to nutrient levels	3.548961124977268e-11	7.827233761137364e-7	16	546	64
DOID:1824	status epilepticus	GO:0006979	response to oxidative stress	3.7730041313466245e-11	8.32136061168498e-7	14	386	64
DOID:1824	status epilepticus	GO:0043269	regulation of ion transport	8.143508090086016e-11	1.7960507092684708e-6	16	583	64
DOID:1824	status epilepticus	GO:0071496	cellular response to external stimulus	1.1281264811202618e-10	2.4880829541107374e-6	12	270	64
DOID:1824	status epilepticus	GO:0014074	response to purine-containing compound	1.1855305626085055e-10	2.614687655833059e-6	10	155	64
DOID:1824	status epilepticus	GO:0032880	regulation of protein localization	1.566915486250764e-10	3.45583210492606e-6	19	933	64
DOID:1824	status epilepticus	GO:0007611	learning or memory	1.8469914486729522e-10	4.073539640048196e-6	11	218	64
DOID:1824	status epilepticus	GO:0050921	positive regulation of chemotaxis	2.623199435447532e-10	5.7854663548795315e-6	9	119	64
DOID:1824	status epilepticus	GO:0034220	ion transmembrane transport	2.720450531512597e-10	5.999953647251033e-6	19	962	64
DOID:1824	status epilepticus	GO:0051966	regulation of synaptic transmission, glutamatergic	3.5260738773246203e-10	7.77675593643945e-6	7	50	64
DOID:1824	status epilepticus	GO:0050803	regulation of synapse structure or activity	3.764881739698467e-10	8.303446676904969e-6	11	233	64
DOID:1824	status epilepticus	GO:0045202	synapse	4.082406634964286e-10	9.003747833413733e-6	17	755	64
DOID:1824	status epilepticus	GO:0022603	regulation of anatomical structure morphogenesis	4.1877634693321397e-10	9.236112331612034e-6	19	986	64
DOID:1824	status epilepticus	GO:0001819	positive regulation of cytokine production	4.4463166481989447e-10	9.806351367602772e-6	13	381	64
DOID:1824	status epilepticus	GO:0098794	postsynapse	4.4463166481989447e-10	9.806351367602772e-6	13	381	64
DOID:1824	status epilepticus	GO:0090066	regulation of anatomical structure size	4.5034953544131895e-10	9.93245900415829e-6	14	465	64
DOID:1824	status epilepticus	GO:0002573	myeloid leukocyte differentiation	6.119424966755105e-10	1.3496391764178384e-5	10	183	64
DOID:1824	status epilepticus	GO:0051345	positive regulation of hydrolase activity	7.381264488515171e-10	1.627937882942021e-5	18	900	64
DOID:1824	status epilepticus	GO:0030001	metal ion transport	8.41084424330063e-10	1.855011697859954e-5	17	792	64
DOID:1824	status epilepticus	GO:0031175	neuron projection development	9.084891727795252e-10	2.003672870565243e-5	17	796	64
DOID:1824	status epilepticus	GO:0007584	response to nutrient	1.2559890905095017e-9	2.770083939118706e-5	10	197	64
DOID:1824	status epilepticus	GO:0044057	regulation of system process	1.4106762424859198e-9	3.111246452802696e-5	14	508	64
DOID:1824	status epilepticus	GO:0032844	regulation of homeostatic process	1.7802832541491398e-9	3.926414717025928e-5	13	427	64
DOID:1824	status epilepticus	GO:0031344	regulation of cell projection organization	2.095078110997406e-9	4.620694773804779e-5	14	524	64
DOID:1824	status epilepticus	GO:0008285	negative regulation of cell proliferation	2.6645662343227627e-9	5.876700829798853e-5	15	634	64
DOID:1824	status epilepticus	GO:0030900	forebrain development	2.669944376698652e-9	5.888562322808877e-5	12	357	64
DOID:1824	status epilepticus	GO:0000302	response to reactive oxygen species	3.0621580826561967e-9	6.753589651298242e-5	10	216	64
DOID:1824	status epilepticus	GO:0043627	response to estrogen	3.2019670248573107e-9	7.061938273322799e-5	10	217	64
DOID:1824	status epilepticus	GO:0007215	glutamate receptor signaling pathway	3.263020298405195e-9	7.196591268132657e-5	7	68	64
DOID:1824	status epilepticus	GO:0034765	regulation of ion transmembrane transport	3.6419646187724197e-9	8.032352966702572e-5	12	367	64
Orphanet:211243	Vascular malformation	GO:0007167	enzyme linked receptor protein signaling pathway	5.9257043716343105e-12	1.3069140991639472e-7	25	935	64
Orphanet:211243	Vascular malformation	GO:0050673	epithelial cell proliferation	1.2920775560587572e-12	2.849677049887589e-8	17	335	64
Orphanet:211243	Vascular malformation	GO:0010632	regulation of epithelial cell migration	8.364420267525929e-13	1.8447728900028437e-8	14	164	64
Orphanet:211243	Vascular malformation	GO:0001944	vasculature development	3.044231533522179e-13	6.714052647183166e-9	24	588	64
Orphanet:211243	Vascular malformation	GO:0042327	positive regulation of phosphorylation	1.1146639167236572e-13	2.458391268334026e-9	25	910	64
Orphanet:211243	Vascular malformation	GO:0045765	regulation of angiogenesis	5.861977570020827e-14	1.2928591530680933e-9	13	208	64
Orphanet:211243	Vascular malformation	GO:0060562	epithelial tube morphogenesis	8.348877145181177e-14	1.8413448543697086e-9	14	301	64
Orphanet:211243	Vascular malformation	GO:0010594	regulation of endothelial cell migration	4.688471832992036e-13	1.0340424627663936e-8	12	112	64
Orphanet:211243	Vascular malformation	GO:0008285	negative regulation of cell proliferation	9.774403508799878e-13	2.155744693865813e-8	19	634	64
Orphanet:211243	Vascular malformation	GO:0050678	regulation of epithelial cell proliferation	1.5696333122150463e-12	3.4618262700902847e-8	14	277	64
Orphanet:211243	Vascular malformation	GO:0043534	blood vessel endothelial cell migration	1.9803048090238917e-12	4.367562256302193e-8	9	71	64
Orphanet:211243	Vascular malformation	GO:0030155	regulation of cell adhesion	2.194577852776547e-12	4.840141454298674e-8	18	621	64
Orphanet:211243	Vascular malformation	GO:0001934	positive regulation of protein phosphorylation	2.862043935181191e-12	6.312237899042117e-8	24	870	64
Orphanet:211243	Vascular malformation	GO:0014065	phosphatidylinositol 3-kinase signaling	3.4464653353438734e-12	7.601179297100913e-8	11	154	64
Orphanet:211243	Vascular malformation	GO:0043535	regulation of blood vessel endothelial cell migration	4.750977389278432e-12	1.0478280632053583e-7	8	49	64
Orphanet:211243	Vascular malformation	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	3.775280088547106e-11	8.326380235290642e-7	10	138	64
Orphanet:211243	Vascular malformation	GO:0060548	negative regulation of cell death	4.9246384747902994e-11	1.0861290156150005e-6	19	867	64
Orphanet:211243	Vascular malformation	GO:0050679	positive regulation of epithelial cell proliferation	1.1855305626085055e-10	2.614687655833059e-6	10	155	64
Orphanet:211243	Vascular malformation	GO:0009790	embryo development	1.547370009902238e-10	3.412724556839386e-6	19	932	64
Orphanet:211243	Vascular malformation	GO:0097285	cell-type specific apoptotic process	1.5683554455137028e-10	3.4590079350804714e-6	14	429	64
Orphanet:211243	Vascular malformation	GO:0070848	response to growth factor	2.0592560989740605e-10	4.54168932628729e-6	16	621	64
Orphanet:211243	Vascular malformation	GO:0030855	epithelial cell differentiation	5.94443938517486e-10	1.3110461064003154e-5	15	568	64
Orphanet:211243	Vascular malformation	GO:0033674	positive regulation of kinase activity	6.773889227318364e-10	1.4939812690850651e-5	14	480	64
Orphanet:211243	Vascular malformation	GO:2000147	positive regulation of cell motility	7.800834422866387e-10	1.7204740319631817e-5	13	399	64
Orphanet:211243	Vascular malformation	GO:1901214	regulation of neuron death	7.930935908007086e-10	1.749167914510963e-5	11	250	64
Orphanet:211243	Vascular malformation	GO:0043066	negative regulation of apoptotic process	8.913479954131276e-10	1.965868003883653e-5	17	795	64
Orphanet:211243	Vascular malformation	GO:0001936	regulation of endothelial cell proliferation	9.819055568627277e-10	2.165592705660746e-5	8	93	64
Orphanet:211243	Vascular malformation	GO:0071363	cellular response to growth factor stimulus	1.096182478121932e-9	2.417630455497921e-5	15	594	64
Orphanet:211243	Vascular malformation	GO:0010634	positive regulation of epithelial cell migration	1.9075245827337994e-9	4.2070454672193947e-5	8	101	64
Orphanet:211243	Vascular malformation	GO:0001570	vasculogenesis	2.934874232529694e-9	6.47286511984424e-5	7	67	64
Orphanet:211243	Vascular malformation	GO:0009611	response to wounding	3.760463052060459e-9	8.293701261319342e-5	17	875	64
Orphanet:211243	Vascular malformation	GO:0038128	ERBB2 signaling pathway	3.81004117144812e-9	8.403045803628828e-5	6	39	64
DOID:11971	synostosis	GO:0048754	branching morphogenesis of an epithelial tube	6.583622536027178e-13	1.4520179503207942e-8	12	147	65
DOID:11971	synostosis	GO:0001649	osteoblast differentiation	1.603162047558726e-13	3.5357738958907703e-9	13	206	65
DOID:11971	synostosis	GO:0014855	striated muscle cell proliferation	1.5987211554602254e-13	3.525979508367527e-9	9	51	65
DOID:11971	synostosis	GO:0035136	forelimb morphogenesis	4.6407322429331543e-14	1.0235134961789072e-9	9	40	65
DOID:11971	synostosis	GO:0001823	mesonephros development	2.1027624086400465e-13	4.6376424922556225e-9	11	102	65
DOID:11971	synostosis	GO:0051216	cartilage development	4.762856775641922e-13	1.0504480618678258e-8	12	180	65
DOID:11971	synostosis	GO:0002062	chondrocyte differentiation	9.728884364790247e-13	2.145705446654489e-8	10	95	65
DOID:11971	synostosis	GO:0042471	ear morphogenesis	5.99276184232167e-12	1.3217036243240443e-7	10	112	65
DOID:11971	synostosis	GO:0050673	epithelial cell proliferation	6.239342376090917e-12	1.3760869610468518e-7	14	335	65
DOID:11971	synostosis	GO:0003156	regulation of organ formation	1.0853873355642918e-11	2.3938217685870455e-7	7	31	65
DOID:11971	synostosis	GO:0050678	regulation of epithelial cell proliferation	1.1747602890466169e-11	2.5909338174923136e-7	13	277	65
DOID:11971	synostosis	GO:0048839	inner ear development	1.423983153614472e-11	3.140594845296718e-7	11	170	65
DOID:11971	synostosis	GO:0001658	branching involved in ureteric bud morphogenesis	2.6649238371589945e-11	5.877489522854162e-7	8	59	65
DOID:11971	synostosis	GO:0008589	regulation of smoothened signaling pathway	4.030231703922027e-11	8.888676023000031e-7	8	62	65
DOID:11971	synostosis	GO:0016331	morphogenesis of embryonic epithelium	5.4676929650554484e-11	1.2058996834429792e-6	10	141	65
DOID:11971	synostosis	GO:0009952	anterior/posterior pattern specification	8.22364398800346e-11	1.813724681554163e-6	11	199	65
DOID:11971	synostosis	GO:0001654	eye development	8.323375322305537e-11	1.8357204273344863e-6	13	327	65
DOID:11971	synostosis	GO:0060541	respiratory system development	9.66744462260749e-11	2.132154911516082e-6	11	202	65
DOID:11971	synostosis	GO:0008285	negative regulation of cell proliferation	3.579162521916146e-10	7.89384294208606e-6	16	634	65
DOID:11971	synostosis	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.618484649223433e-10	1.4597067893862281e-5	19	996	65
DOID:11971	synostosis	GO:0045165	cell fate commitment	6.998204238328753e-10	1.5434539447634066e-5	11	243	65
DOID:11971	synostosis	GO:0048565	digestive tract development	1.1388190390704267e-9	2.511665390669826e-5	9	138	65
DOID:11971	synostosis	GO:0072089	stem cell proliferation	1.214190969989204e-9	2.6778981843111893e-5	9	139	65
DOID:11971	synostosis	GO:0048566	embryonic digestive tract development	1.4459469177552364e-9	3.189035927109174e-5	6	33	65
DOID:11971	synostosis	GO:0045596	negative regulation of cell differentiation	1.4828874794758917e-9	3.270508335984079e-5	15	597	65
DOID:11971	synostosis	GO:0061035	regulation of cartilage development	2.1095233337931063e-9	4.652553712680696e-5	7	63	65
DOID:11971	synostosis	GO:0060284	regulation of cell development	2.1276067574405033e-9	4.69243670353503e-5	17	828	65
DOID:11971	synostosis	GO:0048557	embryonic digestive tract morphogenesis	2.6189215240890462e-9	5.7760314213783914e-5	5	17	65
DOID:11971	synostosis	GO:0035137	hindlimb morphogenesis	3.0025821828871813e-9	6.622195004357678e-5	6	37	65
DOID:11971	synostosis	GO:0060038	cardiac muscle cell proliferation	3.5559121203121435e-9	7.842564181348433e-5	6	38	65
DOID:11971	synostosis	GO:0001759	organ induction	3.616505539483228e-9	7.976202967330259e-5	5	18	65
DOID:11971	synostosis	GO:0001707	mesoderm formation	3.646253521338849e-9	8.041812141312832e-5	7	68	65
DOID:11971	synostosis	GO:0030279	negative regulation of ossification	3.646253521338849e-9	8.041812141312832e-5	7	68	65
OMIM:166710	osteoporosis	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	9.264811140496931e-13	2.0433540970365982e-8	13	225	65
OMIM:166710	osteoporosis	GO:0009725	response to hormone	2.2004620348070603e-12	4.8531190177669714e-8	21	865	65
OMIM:166710	osteoporosis	GO:0009611	response to wounding	3.718914065586887e-12	8.202064971651879e-8	22	875	65
OMIM:166710	osteoporosis	GO:0030198	extracellular matrix organization	4.9107384825219924e-12	1.0830633723202254e-7	14	320	65
OMIM:166710	osteoporosis	GO:0002009	morphogenesis of an epithelium	2.073530236401666e-11	4.5731709363838746e-7	16	506	65
OMIM:166710	osteoporosis	GO:0042060	wound healing	3.33466587676412e-11	7.354605591203267e-7	16	534	65
OMIM:166710	osteoporosis	GO:0033993	response to lipid	4.5674353188474015e-11	1.0073478595717944e-6	19	850	65
OMIM:166710	osteoporosis	GO:0010035	response to inorganic substance	1.405012772792702e-10	3.0987556703943042e-6	15	502	65
OMIM:166710	osteoporosis	GO:0030168	platelet activation	2.1642443392977384e-10	4.773240890321162e-6	10	162	65
OMIM:166710	osteoporosis	GO:0009887	organ morphogenesis	2.958948641662573e-10	6.525961229186805e-6	19	950	65
OMIM:166710	osteoporosis	GO:0043209	myelin sheath	3.0995250810406105e-10	6.8360025662350665e-6	10	168	65
OMIM:166710	osteoporosis	GO:0046879	hormone secretion	3.987293828444649e-10	8.793976538634674e-6	12	297	65
OMIM:166710	osteoporosis	GO:0031667	response to nutrient levels	4.3973735763813693e-10	9.69840742270911e-6	15	546	65
OMIM:166710	osteoporosis	GO:2000027	regulation of organ morphogenesis	5.139616510163592e-10	1.1335424213165801e-5	11	236	65
OMIM:166710	osteoporosis	GO:0070527	platelet aggregation	7.906115762068566e-10	1.7436938313242223e-5	7	55	65
OMIM:166710	osteoporosis	GO:1903034	regulation of response to wounding	1.2195763288147532e-9	2.6897755932009382e-5	13	407	65
OMIM:166710	osteoporosis	GO:0007584	response to nutrient	1.4708800843976633e-9	3.244026026139046e-5	10	197	65
OMIM:166710	osteoporosis	GO:0045597	positive regulation of cell differentiation	1.6769099442370816e-9	3.6984248820148835e-5	17	815	65
OMIM:166710	osteoporosis	GO:0044283	small molecule biosynthetic process	3.0070808065829624e-9	6.632116718918724e-5	14	530	65
OMIM:166710	osteoporosis	GO:0048545	response to steroid hormone	3.6783490697800403e-9	8.112598873399879e-5	13	446	65
OMIM:166710	osteoporosis	GO:0001503	ossification	3.881764576441071e-9	8.561231773340783e-5	12	363	65
DOID:9553	adrenal gland disease	GO:1901699	cellular response to nitrogen compound	2.4473534310232026e-11	5.397637992121673e-7	16	518	65
DOID:9553	adrenal gland disease	GO:0071417	cellular response to organonitrogen compound	4.617861648625876e-11	1.018469386604437e-6	15	462	65
DOID:9553	adrenal gland disease	GO:0043434	response to peptide hormone	5.317268847448986e-11	1.1727236443048739e-6	14	389	65
DOID:9553	adrenal gland disease	GO:0030325	adrenal gland development	1.3545531363234886e-10	2.987466942161454e-6	6	23	65
DOID:9553	adrenal gland disease	GO:0048608	reproductive structure development	1.3908507678905835e-10	3.067521368582682e-6	14	418	65
DOID:9553	adrenal gland disease	GO:0071375	cellular response to peptide hormone stimulus	2.4942448106912707e-10	5.5010569299795975e-6	12	285	65
DOID:9553	adrenal gland disease	GO:0006705	mineralocorticoid biosynthetic process	3.3973046598134715e-10	7.4927554272186114e-6	5	12	65
DOID:9553	adrenal gland disease	GO:0042493	response to drug	2.579634061916636e-9	5.68938292355714e-5	13	433	65
Orphanet:139039	Orofacial clefting syndrome	GO:0022626	cytosolic ribosome	1.624256285026604e-13	3.582297236626175e-9	13	107	65
Orphanet:139039	Orofacial clefting syndrome	GO:0016072	rRNA metabolic process	6.188383139260623e-13	1.3648479013639303e-8	15	254	65
Orphanet:139039	Orofacial clefting syndrome	GO:0048598	embryonic morphogenesis	6.212600434096771e-10	1.3701890257400429e-5	15	560	65
Orphanet:139039	Orofacial clefting syndrome	GO:0070925	organelle assembly	6.983195133258846e-10	1.5401436866402385e-5	15	565	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0046649	lymphocyte activation	5.456746166032644e-13	1.2034853669184997e-8	18	594	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0051249	regulation of lymphocyte activation	1.7854606682021767e-12	3.937833503719901e-8	15	372	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0042033	chemokine biosynthetic process	2.400857290751901e-12	5.295090754753318e-8	6	13	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0042098	T cell proliferation	1.1728396032140154e-11	2.586697744888511e-7	11	167	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0050671	positive regulation of lymphocyte proliferation	1.9365065107024293e-11	4.270965109354208e-7	10	127	65
Orphanet:264735	Interstitial lung disease specific to adulthood	GO:0042102	positive regulation of T cell proliferation	3.919586877287884e-11	8.644648857858428e-7	9	95	65
MESH:D020886	Somatosensory Disorders	GO:0051050	positive regulation of transport	1.77280412572145e-12	3.909919499278658e-8	28	920	66
MESH:D020886	Somatosensory Disorders	GO:0072507	divalent inorganic cation homeostasis	1.3729017922514686e-12	3.027934902810614e-8	22	393	66
MESH:D020886	Somatosensory Disorders	GO:2001057	reactive nitrogen species metabolic process	3.1308289294429414e-14	6.905043203886407e-10	10	68	66
MESH:D020886	Somatosensory Disorders	GO:0006936	muscle contraction	3.9745984281580604e-14	8.765976833302602e-10	17	323	66
MESH:D020886	Somatosensory Disorders	GO:0014070	response to organic cyclic compound	5.829781102306697e-13	1.285758222113742e-8	27	873	66
MESH:D020886	Somatosensory Disorders	GO:0009725	response to hormone	1.3078427230084344e-12	2.884447125595102e-8	23	865	66
MESH:D020886	Somatosensory Disorders	GO:0060548	negative regulation of cell death	2.5185409313621676e-12	5.5546420241192607e-8	22	867	66
MESH:D020886	Somatosensory Disorders	GO:0001934	positive regulation of protein phosphorylation	2.848721258885689e-12	6.282854736472387e-8	21	870	66
MESH:D020886	Somatosensory Disorders	GO:0010638	positive regulation of organelle organization	1.0636180824974417e-9	2.3458096809481077e-5	15	573	66
MESH:D020886	Somatosensory Disorders	GO:0043491	protein kinase B signaling	1.911716340785574e-9	4.216290389602584e-5	9	144	66
MESH:D020886	Somatosensory Disorders	GO:0019216	regulation of lipid metabolic process	2.7115074630046365e-9	5.980229709656726e-5	11	272	66
MESH:D020886	Somatosensory Disorders	GO:0051223	regulation of protein transport	3.4908662627231024e-9	7.699105542435802e-5	16	730	66
DOID:484	vascular hemostatic disease	GO:0001944	vasculature development	1.2247980407664727e-12	2.7012920789104555e-8	18	588	66
DOID:484	vascular hemostatic disease	GO:0001568	blood vessel development	1.4841461393189093e-12	3.2732843102678544e-8	18	569	66
DOID:484	vascular hemostatic disease	GO:0051093	negative regulation of developmental process	1.5920809115499424e-10	3.511334450423398e-6	18	788	66
DOID:484	vascular hemostatic disease	GO:0060548	negative regulation of cell death	7.076811359141288e-10	1.560790745258611e-5	18	867	66
DOID:484	vascular hemostatic disease	GO:0022603	regulation of anatomical structure morphogenesis	7.453262451662113e-10	1.643817033714079e-5	19	986	66
DOID:484	vascular hemostatic disease	GO:0043066	negative regulation of apoptotic process	1.4945052972947792e-9	3.2961314331836356e-5	17	795	66
DOID:484	vascular hemostatic disease	GO:0045765	regulation of angiogenesis	2.9058859762898237e-9	6.408931520707206e-5	10	208	66
DOID:3042	allergic contact dermatitis	GO:0005125	cytokine activity	1.3050671654468715e-12	2.878325633393075e-8	13	222	66
DOID:3042	allergic contact dermatitis	GO:0005126	cytokine receptor binding	1.2124190540419022e-11	2.6739902236894153e-7	13	270	66
DOID:3042	allergic contact dermatitis	GO:0006954	inflammatory response	4.9350190600705446e-11	1.0884184536985586e-6	17	637	66
DOID:3042	allergic contact dermatitis	GO:0009611	response to wounding	1.0209466605459738e-10	2.2516978598341453e-6	19	875	66
DOID:3042	allergic contact dermatitis	GO:1903034	regulation of response to wounding	1.212052680443776e-10	2.6731821867187477e-6	14	407	66
DOID:3042	allergic contact dermatitis	GO:0034097	response to cytokine	1.4757595145908908e-10	3.2547876094302097e-6	18	784	66
DOID:3042	allergic contact dermatitis	GO:0032101	regulation of response to external stimulus	2.2916024633445886e-10	5.05412923290649e-6	19	920	66
DOID:3042	allergic contact dermatitis	GO:0032946	positive regulation of mononuclear cell proliferation	7.182635597402509e-10	1.5841302810071234e-5	9	129	66
DOID:3042	allergic contact dermatitis	GO:0032496	response to lipopolysaccharide	1.086501666414108e-9	2.3962794252763153e-5	12	319	66
Orphanet:139021	Malformation syndrome with short stature	GO:0048667	cell morphogenesis involved in neuron differentiation	4.591771407547185e-12	1.0127151839345316e-7	18	495	66
Orphanet:139021	Malformation syndrome with short stature	GO:0009887	organ morphogenesis	4.64539517963658e-12	1.0245419068688477e-7	21	950	66
Orphanet:139021	Malformation syndrome with short stature	GO:0048812	neuron projection morphogenesis	5.017652959793395e-12	1.1066433602824333e-7	19	539	66
Orphanet:139021	Malformation syndrome with short stature	GO:0007507	heart development	1.5370815731330367e-11	3.3900334095449125e-7	16	487	66
Orphanet:139021	Malformation syndrome with short stature	GO:0048589	developmental growth	7.433975657278324e-10	1.6395633312127345e-5	15	558	66
Orphanet:139021	Malformation syndrome with short stature	GO:0051726	regulation of cell cycle	2.1463810728761246e-9	4.733843456228293e-5	18	930	66
DOID:552	pneumonia	GO:0009607	response to biotic stimulus	5.926370505449086e-12	1.3070610149767958e-7	31	934	67
DOID:552	pneumonia	GO:0032101	regulation of response to external stimulus	3.311795282456842e-12	7.304164495458565e-8	32	920	67
DOID:552	pneumonia	GO:2000147	positive regulation of cell motility	1.5303314171433158e-12	3.375145940509583e-8	25	399	67
DOID:552	pneumonia	GO:0097529	myeloid leukocyte migration	1.1881606809538425e-12	2.6204883818436997e-8	19	153	67
DOID:552	pneumonia	GO:0002237	response to molecule of bacterial origin	1.099120794378905e-12	2.424110912002675e-8	21	333	67
DOID:552	pneumonia	GO:0048520	positive regulation of behavior	1.0458300891968975e-12	2.3065782617237574e-8	17	145	67
DOID:552	pneumonia	GO:0071219	cellular response to molecule of bacterial origin	9.99422766767566e-13	2.2042269121058666e-8	13	158	67
DOID:552	pneumonia	GO:0070374	positive regulation of ERK1 and ERK2 cascade	9.967582315084655e-13	2.1983502795919208e-8	15	168	67
DOID:552	pneumonia	GO:0002684	positive regulation of immune system process	8.877343304902752e-13	1.957898065896302e-8	33	872	67
DOID:552	pneumonia	GO:0002685	regulation of leukocyte migration	8.839595722065496e-13	1.9495728365015452e-8	22	149	67
DOID:552	pneumonia	GO:0031349	positive regulation of defense response	8.826273045769994e-13	1.9466345202445723e-8	18	398	67
DOID:552	pneumonia	GO:0071222	cellular response to lipopolysaccharide	8.526512829121202e-13	1.880522404462681e-8	13	152	67
DOID:552	pneumonia	GO:1903036	positive regulation of response to wounding	8.377742943821431e-13	1.8477112062598167e-8	16	162	67
DOID:552	pneumonia	GO:0030335	positive regulation of cell migration	7.704947790898586e-13	1.6993262352826832e-8	25	387	67
DOID:552	pneumonia	GO:0050920	regulation of chemotaxis	6.936673457857978e-13	1.529883331130577e-8	17	179	67
DOID:552	pneumonia	GO:0030595	leukocyte chemotaxis	6.59916565837193e-13	1.4554459859539293e-8	24	177	67
DOID:552	pneumonia	GO:0070663	regulation of leukocyte proliferation	5.184741524999481e-13	1.1434947433386355e-8	13	200	67
DOID:552	pneumonia	GO:0008009	chemokine activity	1.8141044222375058e-13	4.001007303244819e-9	15	49	67
DOID:552	pneumonia	GO:0001819	positive regulation of cytokine production	1.780797731498751e-13	3.9275493968204955e-9	20	381	67
DOID:552	pneumonia	GO:0048247	lymphocyte chemotaxis	1.290079154614432e-13	2.8452695755021296e-9	12	52	67
DOID:552	pneumonia	GO:0048020	CCR chemokine receptor binding	1.0835776720341528e-13	2.389830555671324e-9	11	35	67
DOID:552	pneumonia	GO:0002690	positive regulation of leukocyte chemotaxis	8.237854842718662e-14	1.8168588855616008e-9	16	80	67
DOID:552	pneumonia	GO:0070098	chemokine-mediated signaling pathway	8.237854842718662e-14	1.8168588855616008e-9	20	80	67
DOID:552	pneumonia	GO:0002548	monocyte chemotaxis	5.861977570020827e-14	1.2928591530680933e-9	13	60	67
DOID:552	pneumonia	GO:1990266	neutrophil migration	3.574918139293004e-14	7.88448195621072e-10	15	91	67
DOID:552	pneumonia	GO:0007259	JAK-STAT cascade	1.84297022087776e-14	4.0646708221458994e-10	12	170	67
DOID:552	pneumonia	GO:0030593	neutrophil chemotaxis	5.10702591327572e-15	1.1263545651729601e-10	15	84	67
DOID:552	pneumonia	GO:0071347	cellular response to interleukin-1	0.0	0.0	15	92	67
DOID:552	pneumonia	GO:0050755	chemokine metabolic process	1.0658141036401503e-14	2.3506530055783514e-10	7	14	67
DOID:552	pneumonia	GO:0042033	chemokine biosynthetic process	2.398081733190338e-14	5.288969262551291e-10	7	13	67
DOID:552	pneumonia	GO:0006954	inflammatory response	8.748557434046234e-14	1.929494342078897e-9	36	637	67
DOID:552	pneumonia	GO:0050729	positive regulation of inflammatory response	2.8255175976710234e-13	6.231679061663442e-9	15	114	67
DOID:552	pneumonia	GO:0001775	cell activation	6.282752096353761e-13	1.385660974850822e-8	24	854	67
DOID:552	pneumonia	GO:0004896	cytokine receptor activity	6.908917882242349e-13	1.52376183892855e-8	10	89	67
DOID:552	pneumonia	GO:0009897	external side of plasma membrane	7.162048731856885e-13	1.579589847811036e-8	13	212	67
DOID:552	pneumonia	GO:0071346	cellular response to interferon-gamma	1.1980416658730064e-12	2.6422808940829157e-8	11	133	67
DOID:552	pneumonia	GO:0045073	regulation of chemokine biosynthetic process	1.5427659150191175e-12	3.402570225574664e-8	6	12	67
DOID:552	pneumonia	GO:0034612	response to tumor necrosis factor	1.922240144835996e-12	4.239500639435789e-8	17	265	67
DOID:552	pneumonia	GO:0071356	cellular response to tumor necrosis factor	2.0058399385902703e-12	4.423879984560841e-8	17	243	67
DOID:552	pneumonia	GO:0002443	leukocyte mediated immunity	2.2276624989103766e-12	4.9131096413468356e-8	14	279	67
DOID:552	pneumonia	GO:0032944	regulation of mononuclear cell proliferation	2.6216806503498447e-12	5.7821166743465824e-8	12	191	67
DOID:552	pneumonia	GO:0050670	regulation of lymphocyte proliferation	2.6364466165773592e-12	5.814683012861366e-8	12	189	67
DOID:552	pneumonia	GO:0002821	positive regulation of adaptive immune response	3.276490190273762e-12	7.226299114648782e-8	9	71	67
DOID:552	pneumonia	GO:0022409	positive regulation of cell-cell adhesion	4.022338018216942e-12	8.871266499177466e-8	13	239	67
DOID:552	pneumonia	GO:0002699	positive regulation of immune effector process	4.411804255255447e-12	9.730234284965888e-8	11	150	67
DOID:552	pneumonia	GO:0008284	positive regulation of cell proliferation	4.897526828528953e-12	1.0801495420320606e-7	22	815	67
DOID:552	pneumonia	GO:0045765	regulation of angiogenesis	9.007794510296208e-12	1.9866690792458286e-7	12	208	67
DOID:552	pneumonia	GO:0097191	extrinsic apoptotic signaling pathway	1.8791079803293087e-11	4.1443726506162903e-7	12	220	67
DOID:552	pneumonia	GO:0006874	cellular calcium ion homeostasis	2.080724481601237e-11	4.5890378441715285e-7	14	352	67
DOID:552	pneumonia	GO:0050671	positive regulation of lymphocyte proliferation	2.6214586057449196e-11	5.78162695497042e-7	10	127	67
DOID:552	pneumonia	GO:1902107	positive regulation of leukocyte differentiation	2.6214586057449196e-11	5.78162695497042e-7	10	127	67
DOID:552	pneumonia	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	2.971389800876523e-11	6.553400205833171e-7	8	58	67
DOID:552	pneumonia	GO:0002573	myeloid leukocyte differentiation	4.656919294632189e-11	1.0270835504311293e-6	11	183	67
DOID:552	pneumonia	GO:0042102	positive regulation of T cell proliferation	5.208133924128333e-11	1.1486539369665039e-6	9	95	67
DOID:552	pneumonia	GO:0045080	positive regulation of chemokine biosynthetic process	6.36799502018448e-11	1.4044613017016871e-6	5	9	67
DOID:552	pneumonia	GO:0071622	regulation of granulocyte chemotaxis	7.795719625391939e-11	1.7193459633801922e-6	7	39	67
DOID:552	pneumonia	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.9713219945316496e-10	4.347750658939553e-6	11	209	67
DOID:552	pneumonia	GO:0051345	positive regulation of hydrolase activity	2.123093922890007e-10	4.68248364693391e-6	19	900	67
DOID:552	pneumonia	GO:0002637	regulation of immunoglobulin production	2.6597823943319554e-10	5.866150070699128e-6	7	46	67
DOID:552	pneumonia	GO:0051050	positive regulation of transport	3.0429714303892297e-10	6.711273489723446e-6	19	920	67
DOID:552	pneumonia	GO:0045766	positive regulation of angiogenesis	4.005988873956312e-10	8.835208461510646e-6	9	119	67
DOID:552	pneumonia	GO:0031663	lipopolysaccharide-mediated signaling pathway	4.231716088654025e-10	9.333049833526452e-6	7	49	67
DOID:552	pneumonia	GO:0098542	defense response to other organism	7.635407861528165e-10	1.6839892038600368e-5	15	550	67
DOID:552	pneumonia	GO:0051054	positive regulation of DNA metabolic process	9.770794173746822e-10	2.1549486550198615e-5	10	183	67
DOID:552	pneumonia	GO:0010574	regulation of vascular endothelial growth factor production	1.1650588271905349e-9	2.5695372433687247e-5	6	31	67
DOID:552	pneumonia	GO:1901099	negative regulation of signal transduction in absence of ligand	1.1650588271905349e-9	2.5695372433687247e-5	6	31	67
DOID:552	pneumonia	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	1.1650588271905349e-9	2.5695372433687247e-5	6	31	67
DOID:552	pneumonia	GO:0032386	regulation of intracellular transport	1.3978285196003526e-9	3.0829107999785776e-5	15	575	67
DOID:552	pneumonia	GO:0032846	positive regulation of homeostatic process	1.5588316193415608e-9	3.438003136457812e-5	10	192	67
DOID:552	pneumonia	GO:0051093	negative regulation of developmental process	1.681676020659495e-9	3.708936463564516e-5	17	788	67
DOID:552	pneumonia	GO:0050707	regulation of cytokine secretion	1.9383394889160854e-9	4.2750077428044264e-5	9	142	67
DOID:552	pneumonia	GO:0045236	CXCR chemokine receptor binding	2.1651637149844305e-9	4.7752685733981615e-5	5	16	67
DOID:552	pneumonia	GO:0006606	protein import into nucleus	2.7440379968268758e-9	6.0519758020016745e-5	11	268	67
DOID:552	pneumonia	GO:0050714	positive regulation of protein secretion	2.9401986401111913e-9	6.484608100765232e-5	10	205	67
DOID:552	pneumonia	GO:0002703	regulation of leukocyte mediated immunity	3.3380810338101696e-9	7.362137720068329e-5	9	151	67
DOID:552	pneumonia	GO:0002274	myeloid leukocyte activation	3.748658605751132e-9	8.267666554984121e-5	9	153	67
DOID:552	pneumonia	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.073943071780661e-9	8.985081444812248e-5	7	67	67
DOID:552	pneumonia	GO:0043547	positive regulation of GTPase activity	4.1517439486327135e-9	9.15667127870945e-5	15	623	67
DOID:2394	ovarian cancer	GO:0014070	response to organic cyclic compound	1.5132339825640884e-12	3.337437548545097e-8	21	873	67
DOID:2394	ovarian cancer	GO:0033993	response to lipid	8.979705867773191e-12	1.9804741291373773e-7	20	850	67
DOID:2394	ovarian cancer	GO:0008406	gonad development	1.8791079803293087e-11	4.1443726506162903e-7	12	220	67
DOID:2394	ovarian cancer	GO:0046546	development of primary male sexual characteristics	3.0636604364531195e-11	6.756903092597355e-7	10	129	67
DOID:2394	ovarian cancer	GO:0008584	male gonad development	3.0636604364531195e-11	6.756903092597355e-7	10	129	67
DOID:2394	ovarian cancer	GO:0032870	cellular response to hormone stimulus	3.5379144058822476e-11	7.802870222173297e-7	16	519	67
DOID:2394	ovarian cancer	GO:0097305	response to alcohol	4.108513529388347e-11	9.061326589065999e-7	14	369	67
DOID:2394	ovarian cancer	GO:0040007	growth	4.430245059694471e-11	9.770905479156156e-7	20	936	67
DOID:2394	ovarian cancer	GO:0006259	DNA metabolic process	4.7241544010034886e-11	1.0419122531413194e-6	20	937	67
DOID:2394	ovarian cancer	GO:0031667	response to nutrient levels	7.035383386977401e-11	1.5516538059978657e-6	16	546	67
DOID:2394	ovarian cancer	GO:0071407	cellular response to organic cyclic compound	2.0163415381801997e-10	4.44704126245643e-6	14	416	67
DOID:2394	ovarian cancer	GO:0097285	cell-type specific apoptotic process	3.0159630348691735e-10	6.651706473403962e-6	14	429	67
DOID:2394	ovarian cancer	GO:1901699	cellular response to nitrogen compound	3.3916114361431937e-10	7.480199022413814e-6	15	518	67
DOID:2394	ovarian cancer	GO:0000228	nuclear chromosome	3.561932970796988e-10	7.855843167092758e-6	15	520	67
DOID:2394	ovarian cancer	GO:0097306	cellular response to alcohol	5.390911050895397e-10	1.1889654322749799e-5	9	123	67
DOID:2394	ovarian cancer	GO:0034698	response to gonadotropin	6.011475761624752e-10	1.325830979226339e-5	6	28	67
DOID:2394	ovarian cancer	GO:0048589	developmental growth	9.308124271356633e-10	2.0529068080477053e-5	15	558	67
DOID:2394	ovarian cancer	GO:0008207	C21-steroid hormone metabolic process	1.1650588271905349e-9	2.5695372433687247e-5	6	31	67
DOID:2394	ovarian cancer	GO:0001890	placenta development	1.5042214140947863e-9	3.317560328786051e-5	9	138	67
DOID:2394	ovarian cancer	GO:0051052	regulation of DNA metabolic process	2.264410770003167e-9	4.9941579532419844e-5	12	335	67
DOID:2394	ovarian cancer	GO:0009790	embryo development	2.8954612041331984e-9	6.385939685715769e-5	18	932	67
DOID:2394	ovarian cancer	GO:0009314	response to radiation	3.6145385573504996e-9	7.971864788236527e-5	13	431	67
DOID:2018	hyperinsulinism	GO:0032880	regulation of protein localization	7.169376203819411e-12	1.581205921752371e-7	26	933	67
DOID:2018	hyperinsulinism	GO:0032940	secretion by cell	3.3026914536549157e-12	7.284086001035917e-8	25	956	67
DOID:2018	hyperinsulinism	GO:0014070	response to organic cyclic compound	3.419486915845482e-14	7.541678392897211e-10	26	873	67
DOID:2018	hyperinsulinism	GO:0046323	glucose import	3.906652779051001e-12	8.616122704196982e-8	9	72	67
DOID:2018	hyperinsulinism	GO:0051224	negative regulation of protein transport	4.278910559207816e-12	9.437137238332838e-8	12	197	67
DOID:2018	hyperinsulinism	GO:0015850	organic hydroxy compound transport	3.1198821304201374e-11	6.880900038641613e-7	12	230	67
DOID:2018	hyperinsulinism	GO:0010676	positive regulation of cellular carbohydrate metabolic process	6.737022051339636e-11	1.4858502134229568e-6	8	64	67
DOID:2018	hyperinsulinism	GO:0050709	negative regulation of protein secretion	1.295922258393034e-10	2.8581565408858367e-6	9	105	67
DOID:2018	hyperinsulinism	GO:0046434	organophosphate catabolic process	1.9055657052291508e-10	4.202725162882892e-6	10	155	67
DOID:2018	hyperinsulinism	GO:0043066	negative regulation of apoptotic process	2.380785568689703e-10	5.2508225717451396e-6	18	795	67
DOID:2018	hyperinsulinism	GO:0072593	reactive oxygen species metabolic process	3.9424241649044234e-10	8.695016495696706e-6	11	223	67
DOID:2018	hyperinsulinism	GO:0045821	positive regulation of glycolytic process	9.97873339514399e-10	2.200809650299007e-5	5	14	67
DOID:2018	hyperinsulinism	GO:0045721	negative regulation of gluconeogenesis	9.97873339514399e-10	2.200809650299007e-5	5	14	67
DOID:2018	hyperinsulinism	GO:0072358	cardiovascular system development	1.9902335335331145e-9	4.389460058207284e-5	18	910	67
DOID:2018	hyperinsulinism	GO:0044320	cellular response to leptin stimulus	2.1651637149844305e-9	4.7752685733981615e-5	5	16	67
DOID:2018	hyperinsulinism	GO:0007167	enzyme linked receptor protein signaling pathway	3.0440775455886637e-9	6.713713026795798e-5	18	935	67
DOID:2018	hyperinsulinism	GO:0044282	small molecule catabolic process	3.154763450474718e-9	6.95783079002199e-5	12	345	67
DOID:2018	hyperinsulinism	GO:0007610	behavior	3.225379852089816e-9	7.113575263784089e-5	16	714	67
DOID:2018	hyperinsulinism	GO:0051347	positive regulation of transferase activity	3.3359733864202212e-9	7.357489303749798e-5	15	613	67
DOID:2018	hyperinsulinism	GO:0009743	response to carbohydrate	3.884529364839295e-9	8.567329514153066e-5	10	211	67
DOID:2018	hyperinsulinism	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	4.064786174318158e-9	8.964885907458697e-5	10	212	67
DOID:2018	hyperinsulinism	GO:0007631	feeding behavior	4.081216364859586e-9	9.001122692697816e-5	8	106	67
DOID:2018	hyperinsulinism	GO:0014074	response to purine-containing compound	4.203120074208755e-9	9.269981323667409e-5	9	155	67
DOID:2018	hyperinsulinism	GO:1900180	regulation of protein localization to nucleus	4.25298873896196e-9	9.379966663780603e-5	10	213	67
DOID:2018	hyperinsulinism	GO:0016042	lipid catabolic process	4.4956585121269654e-9	9.915174848496022e-5	11	281	67
Orphanet:68419	Vascular anomaly or angioma	GO:0043009	chordate embryonic development	8.014405805667479e-10	1.7675772004399626e-5	15	552	67
Orphanet:68419	Vascular anomaly or angioma	GO:0048598	embryonic morphogenesis	9.782347154541071e-10	2.1574966649340332e-5	15	560	67
Orphanet:68419	Vascular anomaly or angioma	GO:0030335	positive regulation of cell migration	9.82600556476143e-10	2.1671255273081336e-5	13	387	67
Orphanet:68419	Vascular anomaly or angioma	GO:0048608	reproductive structure development	2.4995709946296074e-9	5.512803828655599e-5	13	418	67
DOID:0080011	bone resorption disease	GO:0072521	purine-containing compound metabolic process	1.5059464786304488e-10	3.321364958619455e-6	16	568	68
DOID:0080011	bone resorption disease	GO:0055086	nucleobase-containing small molecule metabolic process	4.340879877773318e-10	9.573810570429053e-6	17	709	68
DOID:0080011	bone resorption disease	GO:0006163	purine nucleotide metabolic process	4.697120470353866e-10	1.0359499197365452e-5	15	522	68
DOID:0080011	bone resorption disease	GO:0048771	tissue remodeling	1.8368582210825934e-9	4.05119080659766e-5	9	139	68
DOID:0080011	bone resorption disease	GO:0006006	glucose metabolic process	2.562611900458478e-9	5.651840546461173e-5	10	199	68
DOID:0080011	bone resorption disease	GO:0033273	response to vitamin	3.954855110066546e-9	8.722432945251768e-5	8	104	68
MESH:D020260	Heavy Metal Poisoning, Nervous System	GO:0071345	cellular response to cytokine stimulus	2.1497992275243405e-10	4.741382196304933e-6	17	677	68
MESH:D020260	Heavy Metal Poisoning, Nervous System	GO:0030593	neutrophil chemotaxis	7.088042375258397e-10	1.5632677458632394e-5	8	84	68
MESH:D020260	Heavy Metal Poisoning, Nervous System	GO:0006979	response to oxidative stress	1.155650242168349e-9	2.5487866091022937e-5	13	386	68
MESH:D020260	Heavy Metal Poisoning, Nervous System	GO:0032496	response to lipopolysaccharide	1.5585859269862112e-9	3.437461261968089e-5	12	319	68
MESH:D020260	Heavy Metal Poisoning, Nervous System	GO:0005126	cytokine receptor binding	3.4922539304815814e-9	7.702166043677128e-5	11	270	68
MESH:D020196	Trauma, Nervous System	GO:0051050	positive regulation of transport	4.519273844039162e-12	9.967258463028372e-8	26	920	68
MESH:D020196	Trauma, Nervous System	GO:0002237	response to molecule of bacterial origin	1.2612133559741778e-12	2.7816060566010492e-8	25	333	68
MESH:D020196	Trauma, Nervous System	GO:0002684	positive regulation of immune system process	1.2463363674442007e-12	2.7487948583981847e-8	27	872	68
MESH:D020196	Trauma, Nervous System	GO:1903533	regulation of protein targeting	1.4144241333724494e-13	3.1195124261529372e-9	15	303	68
MESH:D020196	Trauma, Nervous System	GO:0032103	positive regulation of response to external stimulus	1.7368328997235949e-12	3.8305849603403885e-8	14	285	68
MESH:D020196	Trauma, Nervous System	GO:1902533	positive regulation of intracellular signal transduction	3.713140905858836e-12	8.189332267871663e-8	25	860	68
MESH:D020196	Trauma, Nervous System	GO:0043069	negative regulation of programmed cell death	4.144351528623247e-12	9.140367296378571e-8	22	806	68
MESH:D020196	Trauma, Nervous System	GO:0006979	response to oxidative stress	6.019962306424986e-12	1.3277026866820307e-7	15	386	68
MESH:D020196	Trauma, Nervous System	GO:0071260	cellular response to mechanical stimulus	1.2242096225634214e-11	2.699994322563626e-7	9	80	68
MESH:D020196	Trauma, Nervous System	GO:0000302	response to reactive oxygen species	1.7194801138487037e-11	3.792313391093316e-7	12	216	68
MESH:D020196	Trauma, Nervous System	GO:1901698	response to nitrogen compound	1.876565569602917e-11	4.1387653637592337e-7	20	870	68
MESH:D020196	Trauma, Nervous System	GO:0010243	response to organonitrogen compound	3.333389120285801e-11	7.351789704790335e-7	19	780	68
MESH:D020196	Trauma, Nervous System	GO:1903706	regulation of hemopoiesis	6.397160579041383e-11	1.410893765707577e-6	13	305	68
MESH:D020196	Trauma, Nervous System	GO:0045765	regulation of angiogenesis	2.2122592646667272e-10	4.879137808222467e-6	11	208	68
MESH:D020196	Trauma, Nervous System	GO:0014074	response to purine-containing compound	2.2219237560960892e-10	4.900452844069925e-6	10	155	68
MESH:D020196	Trauma, Nervous System	GO:0009408	response to heat	2.861372250251293e-10	6.310756497929226e-6	10	159	68
MESH:D020196	Trauma, Nervous System	GO:0007610	behavior	4.839173506354655e-10	1.0672797168265191e-5	17	714	68
MESH:D020196	Trauma, Nervous System	GO:1903409	reactive oxygen species biosynthetic process	6.431538634998901e-10	1.4184758459490077e-5	8	83	68
MESH:D020196	Trauma, Nervous System	GO:0097305	response to alcohol	6.685745290724299e-10	1.474541123869244e-5	13	369	68
MESH:D020196	Trauma, Nervous System	GO:0006953	acute-phase response	8.35382985009403e-10	1.8424371734382383e-5	7	53	68
MESH:D020196	Trauma, Nervous System	GO:0030888	regulation of B cell proliferation	8.35382985009403e-10	1.8424371734382383e-5	7	53	68
MESH:D020196	Trauma, Nervous System	GO:0002573	myeloid leukocyte differentiation	1.1360334895016422e-9	2.5055218610958718e-5	10	183	68
MESH:D020196	Trauma, Nervous System	GO:0010574	regulation of vascular endothelial growth factor production	1.2764147516719504e-9	2.8151327348124866e-5	6	31	68
MESH:D020196	Trauma, Nervous System	GO:0009636	response to toxic substance	1.4934282699385903e-9	3.293756049349561e-5	11	249	68
MESH:D020196	Trauma, Nervous System	GO:0044708	single-organism behavior	2.0073969153600046e-9	4.42731389682649e-5	13	404	68
MESH:D020196	Trauma, Nervous System	GO:0042129	regulation of T cell proliferation	2.2198808347084764e-9	4.895947180949545e-5	9	142	68
MESH:D020196	Trauma, Nervous System	GO:0042327	positive regulation of phosphorylation	2.584124580984337e-9	5.6992867633609556e-5	18	910	68
MESH:D020196	Trauma, Nervous System	GO:0006809	nitric oxide biosynthetic process	2.5981456985846307e-9	5.730210338228403e-5	7	62	68
MESH:D020196	Trauma, Nervous System	GO:0010038	response to metal ion	2.7060004237355884e-9	5.96808393454884e-5	12	335	68
MESH:D020196	Trauma, Nervous System	GO:0050714	positive regulation of protein secretion	3.414718285910112e-9	7.531161179574752e-5	10	205	68
DOID:1091	tooth disease	GO:0008543	fibroblast growth factor receptor signaling pathway	4.743538895013444e-12	1.046187503295215e-7	10	105	68
DOID:1091	tooth disease	GO:0061448	connective tissue development	4.367395334270441e-11	9.632290409733457e-7	12	233	68
DOID:1091	tooth disease	GO:0008284	positive regulation of cell proliferation	5.756117804622818e-11	1.2695117818095625e-6	19	815	68
DOID:1091	tooth disease	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	5.866684915645237e-11	1.293897358145557e-6	8	62	68
DOID:1091	tooth disease	GO:0016303	1-phosphatidylinositol-3-kinase activity	1.797997306596244e-10	3.965483059698016e-6	7	43	68
DOID:1091	tooth disease	GO:0050673	epithelial cell proliferation	2.0316515136897806e-10	4.480807413442811e-6	13	335	68
DOID:1091	tooth disease	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	4.708313738888137e-10	1.0384185951117786e-5	7	49	68
DOID:1091	tooth disease	GO:0022405	hair cycle process	4.766749217566257e-10	1.051306539934238e-5	8	80	68
DOID:1091	tooth disease	GO:0001942	hair follicle development	4.766749217566257e-10	1.051306539934238e-5	8	80	68
DOID:1091	tooth disease	GO:0035272	exocrine system development	5.459394047946375e-10	1.2040693572745731e-5	7	50	68
DOID:1091	tooth disease	GO:0060348	bone development	6.201941182837345e-10	1.3678381278747764e-5	10	172	68
DOID:1091	tooth disease	GO:0051216	cartilage development	9.672085354850424e-10	2.133178425012261e-5	10	180	68
DOID:1091	tooth disease	GO:0035265	organ growth	1.160387896881332e-9	2.5592355065717776e-5	9	132	68
DOID:1091	tooth disease	GO:0046854	phosphatidylinositol phosphorylation	1.354323986291206e-9	2.9869615517652548e-5	8	91	68
DOID:1091	tooth disease	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.7230538107426696e-9	3.800195179592958e-5	9	138	68
DOID:1091	tooth disease	GO:0007435	salivary gland morphogenesis	2.311647318009591e-9	5.098338159870153e-5	6	34	68
DOID:1091	tooth disease	GO:0031012	extracellular matrix	3.4925712322220193e-9	7.702865852665663e-5	13	423	68
DOID:10584	retinitis pigmentosa	GO:0044463	cell projection part	1.5152323840084136e-12	3.341845022930556e-8	25	939	69
DOID:10584	retinitis pigmentosa	GO:0060249	anatomical structure homeostasis	1.1153300505384323e-12	2.4598604264625124e-8	17	351	69
DOID:10584	retinitis pigmentosa	GO:0009416	response to light stimulus	9.796607969292381e-13	2.1606418876274347e-8	17	297	69
DOID:10584	retinitis pigmentosa	GO:0031253	cell projection membrane	9.796607969292381e-13	2.1606418876274347e-8	17	297	69
DOID:10584	retinitis pigmentosa	GO:0001654	eye development	7.907008381380365e-13	1.7438906985134395e-8	18	327	69
DOID:10584	retinitis pigmentosa	GO:0043010	camera-type eye development	4.738431869100168e-13	1.045061148730042e-8	15	283	69
DOID:10584	retinitis pigmentosa	GO:0031513	nonmotile primary cilium	4.525269048372138e-13	9.98048088618475e-9	23	134	69
DOID:10584	retinitis pigmentosa	GO:0044441	ciliary part	4.5230486023228877e-13	9.975583692423129e-9	23	303	69
DOID:10584	retinitis pigmentosa	GO:0009581	detection of external stimulus	2.0805579481475434e-13	4.588670554639407e-9	17	130	69
DOID:10584	retinitis pigmentosa	GO:0009582	detection of abiotic stimulus	7.793765632868599e-14	1.7189150103291695e-9	17	133	69
DOID:10584	retinitis pigmentosa	GO:0001895	retina homeostasis	7.549516567451064e-14	1.6650458789513323e-9	16	66	69
DOID:10584	retinitis pigmentosa	GO:0042461	photoreceptor cell development	3.708144902248023e-14	8.178313581908014e-10	9	37	69
DOID:10584	retinitis pigmentosa	GO:0009583	detection of light stimulus	3.042011087472929e-14	6.709155453421545e-10	17	75	69
DOID:10584	retinitis pigmentosa	GO:0001754	eye photoreceptor cell differentiation	9.2148511043888e-15	2.0323354110729497e-10	9	40	69
DOID:10584	retinitis pigmentosa	GO:0036064	ciliary basal body	3.467226505904364e-13	7.646968058772075e-9	10	79	69
DOID:10584	retinitis pigmentosa	GO:0042462	eye photoreceptor cell development	1.3039791468827389e-11	2.8759260084498806e-7	7	30	69
DOID:10584	retinitis pigmentosa	GO:0097381	photoreceptor disc membrane	3.6521674573464225e-11	8.054855327177535e-7	6	18	69
DOID:10584	retinitis pigmentosa	GO:0042622	photoreceptor outer segment membrane	2.5170977524524574e-9	5.551459093033895e-5	5	16	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0044463	cell projection part	1.5163426070330388e-12	3.344293619811367e-8	28	939	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0060249	anatomical structure homeostasis	1.1231016117108084e-12	2.4770006046281878e-8	20	351	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0030031	cell projection assembly	7.573941473992818e-13	1.670432792089116e-8	27	359	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0001895	retina homeostasis	7.549516567451064e-14	1.6650458789513323e-9	16	66	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0007423	sensory organ development	7.049472117159894e-12	1.5547610754396146e-7	17	494	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0032391	photoreceptor connecting cilium	1.3039791468827389e-11	2.8759260084498806e-7	7	30	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0048568	embryonic organ development	1.8494872300323095e-11	4.0790440858362587e-7	15	408	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0060119	inner ear receptor cell development	4.257261210227625e-11	9.389389599157028e-7	7	35	69
Orphanet:98661	Syndromic retinitis pigmentosa	GO:0007224	smoothened signaling pathway	4.5179937568917694e-10	9.964435230824797e-6	9	117	69
Orphanet:93618	Rare cause of hypertension	GO:0042493	response to drug	4.6345149939952535e-11	1.0221422819256532e-6	15	433	69
Orphanet:93618	Rare cause of hypertension	GO:1901698	response to nitrogen compound	1.643726155187153e-9	3.625238035265266e-5	18	870	69
Orphanet:93618	Rare cause of hypertension	GO:0010243	response to organonitrogen compound	2.3557390482764617e-9	5.1955824709737364e-5	17	780	69
Orphanet:93618	Rare cause of hypertension	GO:0019900	kinase binding	3.683234495177601e-9	8.123373679114199e-5	15	598	69
DOID:0080014	chromosomal disease	GO:0048666	neuron development	3.921085678371128e-12	8.647954463647523e-8	23	926	70
DOID:0080014	chromosomal disease	GO:0048589	developmental growth	6.161848808972081e-12	1.3589957548187925e-7	18	558	70
DOID:0080014	chromosomal disease	GO:0007409	axonogenesis	2.165412293919644e-11	4.775816814239775e-7	15	406	70
DOID:0080014	chromosomal disease	GO:0036477	somatodendritic compartment	1.8377266375324552e-10	4.05310609907783e-6	17	649	70
DOID:0080014	chromosomal disease	GO:0048638	regulation of developmental growth	5.662706969999931e-10	1.2489100222334848e-5	12	283	70
DOID:0080014	chromosomal disease	GO:0021537	telencephalon development	7.413806235589959e-10	1.6351149652593655e-5	11	226	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0051241	negative regulation of multicellular organismal process	1.6202594821379535e-12	3.5734822878552563e-8	23	966	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0005578	proteinaceous extracellular matrix	7.713829575095588e-13	1.701285112787332e-8	16	354	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0097435	fibril organization	1.687538997430238e-14	3.72186725883239e-10	8	22	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0044420	extracellular matrix component	9.804379530464757e-13	2.1623559054440022e-8	11	125	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0009611	response to wounding	2.8415048092256256e-12	6.266938856747117e-8	24	875	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0001501	skeletal system development	6.25755003369477e-12	1.3801026599313815e-7	18	482	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0009887	organ morphogenesis	1.929967297087387e-11	4.2565428737262323e-7	21	950	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0002576	platelet degranulation	2.1155222018620634e-10	4.665784216206781e-6	9	106	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0046332	SMAD binding	2.555328171283122e-10	5.635776281764926e-6	8	72	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:1903034	regulation of response to wounding	2.7896729370979756e-10	6.152623662769585e-6	14	407	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0071560	cellular response to transforming growth factor beta stimulus	3.0649160986939705e-10	6.759672455669552e-6	11	208	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:1903035	negative regulation of response to wounding	3.851517993425091e-10	8.494522934499038e-6	10	159	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0007179	transforming growth factor beta receptor signaling pathway	5.879592368529529e-10	1.2967440968791877e-5	10	166	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0061448	connective tissue development	1.0237753977904163e-9	2.257936639826763e-5	11	233	70
Orphanet:271870	Rare genetic systemic or rheumatologic disease	GO:0005788	endoplasmic reticulum lumen	3.4326529396722094e-9	7.570716058447058e-5	10	199	70
DOID:9500	leukocyte disease	GO:0018108	peptidyl-tyrosine phosphorylation	1.1504130981165872e-12	2.537236087896133e-8	17	354	71
DOID:9500	leukocyte disease	GO:0030217	T cell differentiation	9.618972285352356e-13	2.1214643375344622e-8	14	199	71
DOID:9500	leukocyte disease	GO:0002684	positive regulation of immune system process	5.185851748024106e-13	1.1437396030267166e-8	22	872	71
DOID:9500	leukocyte disease	GO:0071345	cellular response to cytokine stimulus	3.6555203308807904e-12	8.062250089757583e-8	20	677	71
DOID:9500	leukocyte disease	GO:0045580	regulation of T cell differentiation	7.300160476120254e-12	1.610050393008322e-7	10	105	71
DOID:9500	leukocyte disease	GO:0019221	cytokine-mediated signaling pathway	7.69451169446711e-12	1.697024554214721e-7	18	534	71
DOID:9500	leukocyte disease	GO:1902533	positive regulation of intracellular signal transduction	9.393708033655912e-12	2.0717823068228114e-7	21	860	71
DOID:9500	leukocyte disease	GO:0050776	regulation of immune response	2.0570323222557363e-11	4.5367847867350264e-7	20	816	71
DOID:9500	leukocyte disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	2.3979596086576294e-11	5.288699916894402e-7	12	212	71
DOID:9500	leukocyte disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	2.5852542329118933e-11	5.701778210687181e-7	9	83	71
DOID:9500	leukocyte disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.6412649845042324e-11	5.825309923324085e-7	18	647	71
DOID:9500	leukocyte disease	GO:0051272	positive regulation of cellular component movement	2.9012237057202128e-11	6.398648882965929e-7	15	408	71
DOID:9500	leukocyte disease	GO:0019882	antigen processing and presentation	3.456379626953776e-11	7.623045267246553e-7	12	219	71
DOID:9500	leukocyte disease	GO:0002443	leukocyte mediated immunity	3.812827831239929e-11	8.409191781799663e-7	13	279	71
DOID:9500	leukocyte disease	GO:0040012	regulation of locomotion	5.188882656881333e-11	1.144408069975178e-6	19	766	71
DOID:9500	leukocyte disease	GO:0050900	leukocyte migration	5.327649432729231e-11	1.175013082388432e-6	14	354	71
DOID:9500	leukocyte disease	GO:0060326	cell chemotaxis	5.67164093467909e-11	1.2508804081434732e-6	12	228	71
DOID:9500	leukocyte disease	GO:0030099	myeloid cell differentiation	2.6744484404872537e-10	5.898496035494638e-6	13	327	71
DOID:9500	leukocyte disease	GO:0070661	leukocyte proliferation	3.335862697184666e-10	7.357245178640781e-6	12	266	71
DOID:9500	leukocyte disease	GO:0001934	positive regulation of protein phosphorylation	3.611778653933584e-10	7.96577782125052e-6	19	870	71
DOID:9500	leukocyte disease	GO:0019216	regulation of lipid metabolic process	4.2877945638508663e-10	9.456730910573086e-6	12	272	71
DOID:9500	leukocyte disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	5.031230987384561e-10	1.1096379942676649e-5	10	161	71
DOID:9500	leukocyte disease	GO:0070851	growth factor receptor binding	1.1383476383741709e-9	2.5106257164342338e-5	9	126	71
DOID:9500	leukocyte disease	GO:0046651	lymphocyte proliferation	2.4072882576220422e-9	5.309274252185414e-5	11	249	71
DOID:9500	leukocyte disease	GO:0032496	response to lipopolysaccharide	2.6165966060531787e-9	5.7709038146502856e-5	12	319	71
DOID:9500	leukocyte disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	3.966556194612281e-9	8.748239687217385e-5	7	63	71
DOID:9500	leukocyte disease	GO:0002250	adaptive immune response	4.383936880181238e-9	9.668772789239721e-5	12	334	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0009607	response to biotic stimulus	5.560440996532634e-12	1.2263552617852724e-7	25	934	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0002237	response to molecule of bacterial origin	1.7559287357471476e-12	3.872700826690334e-8	16	333	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2001233	regulation of apoptotic signaling pathway	7.889244812986362e-13	1.7399729435041422e-8	16	359	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0071216	cellular response to biotic stimulus	5.146993942162226e-13	1.1351695139438789e-8	14	175	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0036293	response to decreased oxygen levels	4.760636329592671e-13	1.0499583424916636e-8	16	302	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0070997	neuron death	2.757793993168889e-13	6.082314651933984e-9	15	281	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0097191	extrinsic apoptotic signaling pathway	8.459899447643693e-14	1.8658308231778165e-9	15	220	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0032496	response to lipopolysaccharide	6.8833827526759706e-15	1.5181300661026853e-10	16	319	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0007568	aging	9.814371537686384e-14	2.164559642636732e-9	15	290	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0014070	response to organic cyclic compound	5.042632977847461e-13	1.1121527032642575e-8	31	873	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:1901214	regulation of neuron death	5.06816810741384e-13	1.1177844760901223e-8	15	250	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0001666	response to hypoxia	5.248024237403115e-13	1.157451745559257e-8	16	292	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0000302	response to reactive oxygen species	7.847056338050606e-13	1.7306682753570612e-8	13	216	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0009725	response to hormone	1.0913492332065289e-12	2.4069707338369994e-8	25	865	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:1901698	response to nitrogen compound	1.6227019727921288e-12	3.57886920099304e-8	28	870	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0048545	response to steroid hormone	1.7243984018477931e-12	3.803160675275308e-8	19	446	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0010942	positive regulation of cell death	1.787903158856352e-12	3.9432204168576845e-8	22	596	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0072593	reactive oxygen species metabolic process	1.925681836212334e-12	4.247091289766303e-8	13	223	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0060548	negative regulation of cell death	2.024491685403973e-12	4.4650164121584623e-8	22	867	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:1903034	regulation of response to wounding	2.1330714972123133e-12	4.704489187101757e-8	16	407	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0051051	negative regulation of transport	2.7211566333562587e-12	6.001510954867229e-8	18	452	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0006954	inflammatory response	3.2692737406136985e-12	7.210383234923512e-8	19	637	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0042493	response to drug	3.582911745070305e-12	7.902111853752558e-8	22	433	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043068	positive regulation of programmed cell death	3.649414104245352e-12	8.048782806913124e-8	21	561	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0097285	cell-type specific apoptotic process	3.9291903064508915e-12	8.665829220877441e-8	18	429	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0071396	cellular response to lipid	4.7062354013860386e-12	1.0379602177756908e-7	16	416	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043523	regulation of neuron apoptotic process	5.905054223376283e-12	1.302359708965639e-7	12	190	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0097305	response to alcohol	6.0813576396867575e-12	1.3412434274329144e-7	15	369	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043065	positive regulation of apoptotic process	6.129541318955489e-12	1.3518703378956332e-7	21	556	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0008015	blood circulation	6.27742302583556e-12	1.3844856483480328e-7	19	489	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0001934	positive regulation of protein phosphorylation	6.743494651573201e-12	1.4872777454044694e-7	21	870	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2000377	regulation of reactive oxygen species metabolic process	7.677858349097733e-12	1.693351658893505e-7	11	147	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0010035	response to inorganic substance	8.249956273687076e-12	1.8195278561616846e-7	19	502	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:1902533	positive regulation of intracellular signal transduction	9.393708033655912e-12	2.0717823068228114e-7	21	860	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0010243	response to organonitrogen compound	9.495848551921426e-12	2.0943093981262706e-7	24	780	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.0277556583559999e-11	2.2667151045041578e-7	11	151	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0071222	cellular response to lipopolysaccharide	1.1346146244761712e-11	2.5023925542821956e-7	11	152	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0034097	response to cytokine	1.5675238884682585e-11	3.457173936016744e-7	20	784	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043069	negative regulation of programmed cell death	1.601929700001392e-11	3.5330559533530703e-7	20	806	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0042060	wound healing	1.7808532426499823e-11	3.927671826664536e-7	17	534	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043066	negative regulation of apoptotic process	1.8135271062647007e-11	3.9997340328667974e-7	20	795	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0003018	vascular process in circulatory system	1.889310929925614e-11	4.1668752559509414e-7	11	159	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0048511	rhythmic process	2.0143331447286528e-11	4.4426117506990437e-7	14	329	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0051235	maintenance of location	3.0957458818647865e-11	6.827667542452787e-7	13	274	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0030334	regulation of cell migration	3.4104163937342946e-11	7.521673356380987e-7	18	660	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:1901215	negative regulation of neuron death	4.0495384823202585e-11	8.93125712275733e-7	11	170	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0050900	leukocyte migration	5.327649432729231e-11	1.175013082388432e-6	14	354	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0019725	cellular homeostasis	5.63722402091571e-11	1.2432897578129598e-6	19	771	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0032844	regulation of homeostatic process	5.864619900819434e-11	1.2934419191257263e-6	15	427	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	6.444689226725586e-11	1.421376208954328e-6	14	359	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0006809	nitric oxide biosynthetic process	8.360756531544666e-11	1.8439648530321762e-6	8	62	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043279	response to alkaloid	1.2602463517197293e-10	2.779473328717863e-6	10	140	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0044703	multi-organism reproductive process	1.3066614457102332e-10	2.8818418185139194e-6	20	926	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0007565	female pregnancy	1.3573941970435044e-10	2.993732901579449e-6	11	190	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0031667	response to nutrient levels	1.724561604632413e-10	3.803520619016787e-6	16	546	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0032943	mononuclear cell proliferation	1.7838897026223322e-10	3.9343687391335536e-6	12	252	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2001234	negative regulation of apoptotic signaling pathway	2.2304669222705797e-10	4.919294797067764e-6	11	199	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0001775	cell activation	2.6254098894895606e-10	5.790341511269226e-6	19	854	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0050866	negative regulation of cell activation	3.0456881461304874e-10	6.71726520629079e-6	10	153	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0014074	response to purine-containing compound	3.461122499714975e-10	7.633505673121377e-6	10	155	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0005126	cytokine receptor binding	3.951129423640509e-10	8.714215943839143e-6	12	270	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043200	response to amino acid	3.9670777773892496e-10	8.74939003803199e-6	9	112	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0071407	cellular response to organic cyclic compound	4.5501347134546677e-10	1.003532211052427e-5	14	416	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0043627	response to estrogen	5.631831667685105e-10	1.24210047430795e-5	11	217	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0051384	response to glucocorticoid	7.209197683266666e-10	1.5899885490444632e-5	10	167	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	8.278041585541018e-10	1.8257220716910716e-5	11	225	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0002439	chronic inflammatory response to antigenic stimulus	9.569715020418812e-10	2.110600647753369e-5	4	5	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0045597	positive regulation of cell differentiation	9.709920645306624e-10	2.141522998322376e-5	18	815	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0031329	regulation of cellular catabolic process	1.164347840365565e-9	2.5679691619262535e-5	16	624	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0060284	regulation of cell development	1.2466001564348517e-9	2.7493766450170654e-5	18	828	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0008285	negative regulation of cell proliferation	1.4638080747531035e-9	3.22842870886797e-5	16	634	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0048534	hematopoietic or lymphoid organ development	1.6804978519857627e-9	3.7063380125546e-5	17	739	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0030335	positive regulation of cell migration	2.0872489292500518e-9	4.603427513460989e-5	13	387	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0010720	positive regulation of cell development	2.1392254634378105e-9	4.718061759612091e-5	14	469	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2000021	regulation of ion homeostasis	2.405648236170066e-9	5.3056571848730805e-5	10	189	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0046651	lymphocyte proliferation	2.4072882576220422e-9	5.309274252185414e-5	11	249	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0050880	regulation of blood vessel size	2.7242145206329837e-9	6.0082551252560457e-5	9	139	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:0022603	regulation of anatomical structure morphogenesis	2.885931271734421e-9	6.364921419810265e-5	19	986	71
OMIM:608446	Myocardial Infarction, Susceptibility to	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	3.2173561592685473e-9	7.095879009266781e-5	8	97	71
DOID:0050950	autosomal recessive cerebellar ataxia	GO:0030031	cell projection assembly	8.273381979506667e-13	1.8246943955801953e-8	16	359	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0009607	response to biotic stimulus	5.943689984633238e-12	1.3108808261108607e-7	25	934	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0002237	response to molecule of bacterial origin	2.2073454175597362e-12	4.868300318427998e-8	22	333	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0001775	cell activation	1.879829625295315e-12	4.1459642385888174e-8	24	854	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0022407	regulation of cell-cell adhesion	1.5203394099216894e-12	3.353108568582286e-8	17	376	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0002684	positive regulation of immune system process	9.015010959956271e-13	1.9882606672183556e-8	24	872	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0051249	regulation of lymphocyte activation	6.428191312579656e-13	1.4177375939894432e-8	16	372	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:1901701	cellular response to oxygen-containing compound	3.4416913763379853e-13	7.590650330513427e-9	24	873	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0071222	cellular response to lipopolysaccharide	1.438849039914203e-13	3.1733815575307744e-9	12	152	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0001819	positive regulation of cytokine production	2.9409807922320397e-13	6.4863331372677635e-9	16	381	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:1901698	response to nitrogen compound	9.86322135076989e-13	2.1753334689122994e-8	23	870	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0006954	inflammatory response	1.6329160246186802e-12	3.601396292296499e-8	25	637	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042742	defense response to bacterium	2.2375434838295405e-12	4.9349021535860516e-8	13	222	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042306	regulation of protein import into nucleus	2.5942581416416033e-12	5.721636331390556e-8	12	175	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0071345	cellular response to cytokine stimulus	3.0886404545071855e-12	6.811996522415598e-8	27	677	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050863	regulation of T cell activation	3.272826454292499e-12	7.218218744942106e-8	14	284	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0034612	response to tumor necrosis factor	3.417932603611007e-12	7.538250357264076e-8	14	265	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0045859	regulation of protein kinase activity	5.008993220201319e-12	1.1047334547154009e-7	20	709	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:1902533	positive regulation of intracellular signal transduction	5.330846875040152e-12	1.1757182782901054e-7	22	860	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0030098	lymphocyte differentiation	6.0744742569340815e-12	1.3397252973668117e-7	14	299	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050776	regulation of immune response	6.781020189805531e-12	1.49555400286161e-7	22	816	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0019221	cytokine-mediated signaling pathway	6.9109162836866744e-12	1.524202586367096e-7	25	534	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0045785	positive regulation of cell adhesion	7.440492666432874e-12	1.6410006575817704e-7	15	368	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0001934	positive regulation of protein phosphorylation	7.823963699138403e-12	1.7255751938449748e-7	21	870	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0010243	response to organonitrogen compound	9.620526597586831e-12	2.1218071410977757e-7	23	780	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042107	cytokine metabolic process	1.0069500788745245e-11	2.2208283989577637e-7	10	107	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042493	response to drug	1.0398126804034291e-11	2.293306866629763e-7	16	433	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0046651	lymphocyte proliferation	1.067168575730193e-11	2.3536402937729406e-7	13	249	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0032495	response to muramyl dipeptide	1.2929657344784573e-11	2.8516359273922376e-7	6	15	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0040012	regulation of locomotion	1.6624590593039557e-11	3.666553455294874e-7	20	766	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0045087	innate immune response	1.9128254535871747e-11	4.218736537886514e-7	20	783	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0008285	negative regulation of cell proliferation	2.3634205703615407e-11	5.212524067932378e-7	18	634	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0008284	positive regulation of cell proliferation	2.451383540602592e-11	5.406526398799016e-7	20	815	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	2.8314350863922755e-11	6.244730083038164e-7	12	212	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:1903409	reactive oxygen species biosynthetic process	2.957689648752648e-11	6.523184520323966e-7	9	83	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0005126	cytokine receptor binding	3.1743052630872626e-11	7.000930257738958e-7	13	270	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0043065	positive regulation of apoptotic process	3.26467741729175e-11	7.200246043836955e-7	17	556	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0032494	response to peptidoglycan	4.107669759889632e-11	9.059465655436583e-7	5	8	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0030334	regulation of cell migration	4.3538395111397676e-11	9.602393041818758e-7	18	660	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050900	leukocyte migration	6.501887916954274e-11	1.4339913800842652e-6	14	354	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042035	regulation of cytokine biosynthetic process	1.0163114794181638e-10	2.2414749678567603e-6	9	95	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:1903426	regulation of reactive oxygen species biosynthetic process	1.0714584774973446e-10	2.3631016721203935e-6	8	63	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042307	positive regulation of protein import into nucleus	1.3492873485176915e-10	2.9758532471557686e-6	9	98	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0071356	cellular response to tumor necrosis factor	1.3973333601313698e-10	3.081818725769736e-6	12	243	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050670	regulation of lymphocyte proliferation	1.5028223110391536e-10	3.3144746069968534e-6	11	189	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0071417	cellular response to organonitrogen compound	2.0856105731326124e-10	4.599814119043977e-6	15	462	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0032675	regulation of interleukin-6 production	2.1166912667069937e-10	4.668362588722275e-6	9	103	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0002252	immune effector process	3.8727732132315396e-10	8.54140132178216e-6	18	757	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0034341	response to interferon-gamma	3.9926295603009976e-10	8.80574449524385e-6	10	155	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0002250	adaptive immune response	4.1499448322213084e-10	9.152703327464096e-6	13	334	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.4183068315106766e-10	9.744575716896797e-6	11	209	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042113	B cell activation	5.141747028147847e-10	1.1340123070580077e-5	11	212	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042098	T cell proliferation	8.310653276666358e-10	1.8329145801687652e-5	10	167	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050778	positive regulation of immune response	8.856100297549574e-10	1.9532129206245585e-5	16	603	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0045428	regulation of nitric oxide biosynthetic process	9.511530452144257e-10	2.0977680412204158e-5	7	51	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0050867	positive regulation of cell activation	9.721228266812432e-10	2.1440168942454818e-5	12	288	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1.3984532420963092e-9	3.08428862544341e-5	11	233	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0045619	regulation of lymphocyte differentiation	1.7088201964554628e-9	3.768802943282523e-5	9	130	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	1.7257352213917443e-9	3.806109030779492e-5	10	180	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0004896	cytokine receptor activity	1.8048589289776373e-9	3.980616367860179e-5	8	89	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0022409	positive regulation of cell-cell adhesion	1.8271425483717962e-9	4.0297628904339966e-5	11	239	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0030335	positive regulation of cell migration	2.500192164411885e-9	5.514173818610413e-5	13	387	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0032649	regulation of interferon-gamma production	2.570870960560967e-9	5.670055903517213e-5	8	93	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0014070	response to organic cyclic compound	3.653552904658852e-9	8.057910931225098e-5	18	873	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0042129	regulation of T cell proliferation	3.736803866338789e-9	8.2415209272102e-5	9	142	72
OMIM:266600	Inflammatory Bowel Disease 1	GO:0051251	positive regulation of lymphocyte activation	3.910762713665861e-9	8.625187164990056e-5	11	257	72
MESH:D002524	Cerebellar Ataxia	GO:0036477	somatodendritic compartment	2.948598032403993e-10	6.503132960467006e-6	17	649	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0051050	positive regulation of transport	5.015987625256457e-12	1.1062760707503116e-7	31	920	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0060537	muscle tissue development	2.5905944056603403e-12	5.7135559616838805e-8	17	336	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0022891	substrate-specific transmembrane transporter activity	2.0090595853616833e-12	4.4309809155151925e-8	29	923	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0044449	contractile fiber part	9.57900425646585e-13	2.1126493887635434e-8	18	196	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0032970	regulation of actin filament-based process	9.323652960802065e-13	2.0563316605048954e-8	28	326	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0070588	calcium ion transmembrane transport	8.280043317654417e-13	1.8261635537086818e-8	16	188	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0015079	potassium ion transmembrane transporter activity	8.164580123093401e-13	1.8006981461482496e-8	13	144	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0030016	myofibril	7.676081992258332e-13	1.6929598833925752e-8	19	201	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0003205	cardiac chamber development	5.546674231027282e-13	1.223319001653067e-8	12	142	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:2000021	regulation of ion homeostasis	5.486722187697524e-13	1.2100965784966888e-8	22	189	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0051924	regulation of calcium ion transport	1.3922196728799463e-13	3.0705404885367216e-9	17	207	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1901021	positive regulation of calcium ion transmembrane transporter activity	6.861178292183467e-14	1.5132328723410637e-9	9	30	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:2001259	positive regulation of cation channel activity	3.086420008457935e-14	6.807099328653976e-10	9	35	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0098900	regulation of action potential	2.19824158875781e-14	4.84822182400535e-10	12	38	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0098901	regulation of cardiac muscle cell action potential	1.4876988529977098e-14	3.281119820286449e-10	9	19	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0015459	potassium channel regulator activity	1.0436096431476471e-14	2.3016810679621358e-10	9	45	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0003229	ventricular cardiac muscle tissue development	1.0436096431476471e-14	2.3016810679621358e-10	9	45	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:2001258	negative regulation of cation channel activity	9.325873406851315e-15	2.0568213798810575e-10	9	32	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0086069	bundle of His cell to Purkinje myocyte communication	1.432187701766452e-14	3.15868997624591e-10	7	12	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	4.2521541843143495e-14	9.378126053505298e-10	7	13	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0031674	I band	5.795364188543317e-14	1.2781675717832286e-9	13	122	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0043267	negative regulation of potassium ion transport	2.0461410343841635e-13	4.512764051334273e-9	8	31	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0030018	Z disc	3.275157922644212e-13	7.223360798391809e-9	13	109	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0045823	positive regulation of heart contraction	3.5060843117662444e-13	7.732668949600452e-9	8	33	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0086068	Purkinje myocyte to ventricular cardiac muscle cell communication	7.260858581048524e-13	1.601382360050252e-8	5	5	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	7.260858581048524e-13	1.601382360050252e-8	5	5	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0043268	positive regulation of potassium ion transport	1.138533711753098e-12	2.5110361012714577e-8	8	37	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0010460	positive regulation of heart rate	1.5322187962851785e-12	3.379308555206961e-8	7	22	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	1.5322187962851785e-12	3.379308555206961e-8	7	22	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0061061	muscle structure development	4.676259379721159e-12	1.0313490061975017e-7	19	551	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0055001	muscle cell development	4.832578781588381e-12	1.0658252502793175e-7	11	140	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1901385	regulation of voltage-gated calcium channel activity	5.763944876946425e-12	1.271238042610534e-7	7	26	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0003206	cardiac chamber morphogenesis	7.56605889051798e-12	1.6686942883037403e-7	10	104	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1902305	regulation of sodium ion transmembrane transport	9.097167463778533e-12	2.0063802841363554e-7	8	47	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	1.5449419521473828e-11	3.407369475461053e-7	5	7	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0017080	sodium channel regulator activity	2.2928436926861195e-11	5.056866764219237e-7	7	31	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0055007	cardiac muscle cell differentiation	4.5362824607764196e-11	1.0004770967242393e-6	9	87	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0055002	striated muscle cell development	5.531530788971395e-11	1.2199791155076412e-6	10	127	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0098911	regulation of ventricular cardiac muscle cell action potential	9.217437924036176e-11	2.0329059341461786e-6	5	9	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0003208	cardiac ventricle morphogenesis	9.38512600967556e-11	2.0698895414339447e-6	8	62	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0055010	ventricular cardiac muscle tissue morphogenesis	1.3110978969166354e-10	2.8916264116496393e-6	7	39	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1901841	regulation of high voltage-gated calcium channel activity	1.8380430510944734e-10	4.053803949188861e-6	5	10	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0051592	response to calcium ion	5.720159901301258e-10	1.2615812662319925e-5	9	115	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0008092	cytoskeletal protein binding	1.170711083631204e-9	2.5820032949486205e-5	18	812	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0055013	cardiac muscle cell development	1.2586589548391203e-9	2.7759723248976798e-5	7	53	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0003230	cardiac atrium development	1.8136331325635524e-9	3.999967873868915e-5	6	31	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	2.1576788133970126e-9	4.758760622947111e-5	5	15	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1901387	positive regulation of voltage-gated calcium channel activity	3.0308411336221752e-9	6.684520120203707e-5	4	6	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:1990454	L-type voltage-gated calcium channel complex	3.0308411336221752e-9	6.684520120203707e-5	4	6	72
Orphanet:101934	Genetic cardiac rhythm disease	GO:0010765	positive regulation of sodium ion transport	3.2828444407329016e-9	7.240313414036414e-5	6	34	72
Orphanet:101949	Rare acquired eye disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	9.668189582257014e-10	2.1323192123667845e-5	11	225	72
Orphanet:101949	Rare acquired eye disease	GO:0009986	cell surface	1.2880250199742704e-9	2.8407391815532534e-5	17	715	72
DOID:1115	sarcoma	GO:0007167	enzyme linked receptor protein signaling pathway	4.239941731043473e-12	9.351191487816379e-8	22	935	72
DOID:1115	sarcoma	GO:0050673	epithelial cell proliferation	4.4586556668946287e-13	9.833565073336104e-9	15	335	72
DOID:1115	sarcoma	GO:0042327	positive regulation of phosphorylation	2.97761815204467e-13	6.567136834334519e-9	23	910	72
DOID:1115	sarcoma	GO:0001944	vasculature development	6.847855615887966e-13	1.5102945560840908e-8	20	588	72
DOID:1115	sarcoma	GO:0060548	negative regulation of cell death	6.961098364399732e-13	1.5352702442683608e-8	24	867	72
DOID:1115	sarcoma	GO:0046777	protein autophosphorylation	4.275912957041328e-12	9.430526026754649e-8	13	229	72
DOID:1115	sarcoma	GO:0008285	negative regulation of cell proliferation	4.4472203697409896e-12	9.808344525463752e-8	19	634	72
DOID:1115	sarcoma	GO:0048514	blood vessel morphogenesis	9.132472555961613e-12	2.0141668222173337e-7	17	484	72
DOID:1115	sarcoma	GO:0043066	negative regulation of apoptotic process	9.539369294486733e-12	2.1039078978990489e-7	22	795	72
DOID:1115	sarcoma	GO:0001667	ameboidal-type cell migration	1.4102385925696126e-11	3.1102812159122806e-7	14	315	72
DOID:1115	sarcoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.5516810059068575e-11	3.4222324585275743e-7	22	996	72
DOID:1115	sarcoma	GO:0010631	epithelial cell migration	3.8636982502282535e-11	8.521386490878413e-7	12	218	72
DOID:1115	sarcoma	GO:0010001	glial cell differentiation	6.968647880967183e-11	1.5369352901473121e-6	11	176	72
DOID:1115	sarcoma	GO:0019900	kinase binding	8.4099727182263e-11	1.8548194830048104e-6	17	598	72
DOID:1115	sarcoma	GO:0042493	response to drug	8.567857534558243e-11	1.8896409792468205e-6	15	433	72
DOID:1115	sarcoma	GO:0004714	transmembrane receptor protein tyrosine kinase activity	1.0714584774973446e-10	2.3631016721203935e-6	8	63	72
DOID:1115	sarcoma	GO:0043523	regulation of neuron apoptotic process	1.5903411920703547e-10	3.5074974991111674e-6	11	190	72
DOID:1115	sarcoma	GO:0051338	regulation of transferase activity	1.797846316264895e-10	3.965150050522226e-6	20	928	72
DOID:1115	sarcoma	GO:0009887	organ morphogenesis	2.775958352074781e-10	6.1223761455009296e-6	20	950	72
DOID:1115	sarcoma	GO:0043549	regulation of kinase activity	4.212615811738374e-10	9.290924172788984e-6	18	761	72
DOID:1115	sarcoma	GO:0051093	negative regulation of developmental process	7.305411831026731e-10	1.6112085793329456e-5	18	788	72
DOID:1115	sarcoma	GO:0018108	peptidyl-tyrosine phosphorylation	8.487283098546072e-10	1.8718702873843363e-5	13	354	72
DOID:1115	sarcoma	GO:0045859	regulation of protein kinase activity	1.1316189096888252e-9	2.495785505318704e-5	17	709	72
DOID:1115	sarcoma	GO:0007610	behavior	1.2603764698582154e-9	2.779760304272294e-5	17	714	72
DOID:1115	sarcoma	GO:0006935	chemotaxis	1.3445702329306641e-9	2.9654496487285797e-5	15	530	72
DOID:1115	sarcoma	GO:0019901	protein kinase binding	1.4160621564229814e-9	3.1231250859908855e-5	15	532	72
DOID:1115	sarcoma	GO:0050767	regulation of neurogenesis	3.1016456070176446e-9	6.840679386277415e-5	16	658	72
DOID:1115	sarcoma	GO:0048015	phosphatidylinositol-mediated signaling	3.390936531566524e-9	7.478710520369969e-5	10	193	72
DOID:1115	sarcoma	GO:0033674	positive regulation of kinase activity	3.4916262103834583e-9	7.700781607000717e-5	14	480	72
DOID:670	amphetamine abuse	GO:0007270	neuron-neuron synaptic transmission	3.816946758661288e-13	8.418276076227471e-9	12	130	73
DOID:670	amphetamine abuse	GO:0015844	monoamine transport	7.194245199571014e-14	1.5866907787653872e-9	10	70	73
DOID:670	amphetamine abuse	GO:0032225	regulation of synaptic transmission, dopaminergic	4.6629367034256575e-14	1.0284106899405288e-9	8	17	73
DOID:670	amphetamine abuse	GO:0001504	neurotransmitter uptake	2.5757174171303632e-14	5.680744763481016e-10	9	25	73
DOID:670	amphetamine abuse	GO:0051934	catecholamine uptake involved in synaptic transmission	1.7319479184152442e-14	3.819811134064821e-10	7	11	73
DOID:670	amphetamine abuse	GO:0051583	dopamine uptake involved in synaptic transmission	1.7319479184152442e-14	3.819811134064821e-10	7	11	73
DOID:670	amphetamine abuse	GO:0051940	regulation of catecholamine uptake involved in synaptic transmission	7.860379014346108e-14	1.7336065916140342e-9	6	8	73
DOID:670	amphetamine abuse	GO:0051584	regulation of dopamine uptake involved in synaptic transmission	7.860379014346108e-14	1.7336065916140342e-9	6	8	73
DOID:670	amphetamine abuse	GO:0060359	response to ammonium ion	8.271161533457416e-14	1.8242046762040331e-9	11	92	73
DOID:670	amphetamine abuse	GO:0042220	response to cocaine	1.1501910535116622e-13	2.536746368519971e-9	9	47	73
DOID:670	amphetamine abuse	GO:0043005	neuron projection	1.3233858453531866e-12	2.918727481926453e-8	22	941	73
DOID:670	amphetamine abuse	GO:0044456	synapse part	2.454259018236371e-12	5.4128682647203163e-8	21	613	73
DOID:670	amphetamine abuse	GO:0048148	behavioral response to cocaine	2.6386670626266095e-12	5.8195802066229874e-8	6	12	73
DOID:670	amphetamine abuse	GO:0070405	ammonium ion binding	3.4059421949450552e-12	7.511805510951319e-8	9	65	73
DOID:670	amphetamine abuse	GO:0098794	postsynapse	1.5829559885105482e-11	3.491209432660014e-7	15	381	73
DOID:670	amphetamine abuse	GO:0042417	dopamine metabolic process	3.239597479165468e-11	7.14493224029944e-7	7	32	73
DOID:670	amphetamine abuse	GO:0007626	locomotory behavior	1.2413425842794368e-10	2.737781069628298e-6	11	183	73
DOID:670	amphetamine abuse	GO:0008144	drug binding	3.391231739868772e-10	7.4793616022805764e-6	9	107	73
DOID:670	amphetamine abuse	GO:0035240	dopamine binding	3.6057234975572783e-10	7.952423173862577e-6	5	11	73
DOID:670	amphetamine abuse	GO:0031279	regulation of cyclase activity	1.2657765946499921e-9	2.7916702795005577e-5	8	84	73
DOID:670	amphetamine abuse	GO:0030594	neurotransmitter receptor activity	1.2657765946499921e-9	2.7916702795005577e-5	8	84	73
DOID:670	amphetamine abuse	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	1.3486215477698238e-9	2.9743848236063464e-5	10	173	73
DOID:670	amphetamine abuse	GO:0051339	regulation of lyase activity	1.3929000175494366e-9	3.0720409887052824e-5	8	85	73
DOID:670	amphetamine abuse	GO:0097305	response to alcohol	1.6808225922204656e-9	3.707054227142237e-5	13	369	73
DOID:670	amphetamine abuse	GO:0009187	cyclic nucleotide metabolic process	3.0221440905364716e-9	6.665338791678188e-5	10	188	73
DOID:670	amphetamine abuse	GO:0007212	dopamine receptor signaling pathway	4.298033484673169e-9	9.479312850446675e-5	6	35	73
DOID:707	B-cell lymphoma	GO:0060548	negative regulation of cell death	1.826427897810845e-12	4.028186728621819e-8	23	867	73
DOID:707	B-cell lymphoma	GO:0002521	leukocyte differentiation	3.6197711494878604e-12	7.983405270195476e-8	17	448	73
DOID:707	B-cell lymphoma	GO:0043069	negative regulation of programmed cell death	4.711897538811627e-12	1.0392090021849043e-7	23	806	73
DOID:707	B-cell lymphoma	GO:0010942	positive regulation of cell death	1.1703638058691013e-11	2.581237373844303e-7	18	596	73
DOID:707	B-cell lymphoma	GO:0043065	positive regulation of apoptotic process	3.9369507653930214e-11	8.682944913074309e-7	17	556	73
DOID:707	B-cell lymphoma	GO:0001775	cell activation	5.4410809191551834e-11	1.2000303967196757e-6	20	854	73
DOID:707	B-cell lymphoma	GO:0046649	lymphocyte activation	9.521805566237163e-11	2.100034217633606e-6	17	594	73
DOID:707	B-cell lymphoma	GO:0030098	lymphocyte differentiation	1.272604244206832e-10	2.806728660598168e-6	13	299	73
DOID:707	B-cell lymphoma	GO:0051241	negative regulation of multicellular organismal process	4.8953152642639e-10	1.0796617815334031e-5	20	966	73
DOID:707	B-cell lymphoma	GO:0042113	B cell activation	5.992492058126686e-10	1.3216441234198406e-5	11	212	73
DOID:707	B-cell lymphoma	GO:0034109	homotypic cell-cell adhesion	6.514250250333475e-10	1.436717892711048e-5	15	495	73
DOID:707	B-cell lymphoma	GO:0070489	T cell aggregation	8.586565902746202e-10	1.8937671098506748e-5	14	424	73
DOID:707	B-cell lymphoma	GO:0042110	T cell activation	8.586565902746202e-10	1.8937671098506748e-5	14	424	73
DOID:707	B-cell lymphoma	GO:0008134	transcription factor binding	1.2092685741649234e-9	2.6670418403207385e-5	15	518	73
DOID:707	B-cell lymphoma	GO:0008284	positive regulation of cell proliferation	1.578638109123176e-9	3.481686349671165e-5	18	815	73
DOID:707	B-cell lymphoma	GO:0002573	myeloid leukocyte differentiation	2.328327530776164e-9	5.13512636912683e-5	10	183	73
MESH:D007027	Hypothalamic Diseases	GO:0030031	cell projection assembly	1.354472090042691e-12	2.987288194589155e-8	17	359	73
MESH:D007027	Hypothalamic Diseases	GO:0035264	multicellular organism growth	5.17808018685173e-13	1.142025585210149e-8	12	137	73
MESH:D007027	Hypothalamic Diseases	GO:0007224	smoothened signaling pathway	1.4340750809083147e-12	3.162852590943288e-8	11	117	73
MESH:D007027	Hypothalamic Diseases	GO:0009887	organ morphogenesis	5.497713395641313e-12	1.2125206894086915e-7	22	950	73
MESH:D007027	Hypothalamic Diseases	GO:0007389	pattern specification process	1.2560952278306559e-11	2.7703180249805115e-7	16	432	73
MESH:D007027	Hypothalamic Diseases	GO:0048871	multicellular organismal homeostasis	2.1951440665191058e-11	4.841390238707888e-7	14	321	73
MESH:D007027	Hypothalamic Diseases	GO:0043473	pigmentation	7.78348496766057e-11	1.7166476096175387e-6	9	91	73
MESH:D007027	Hypothalamic Diseases	GO:0007423	sensory organ development	6.336737801149184e-10	1.3975675220434525e-5	15	494	73
MESH:D007027	Hypothalamic Diseases	GO:0048562	embryonic organ morphogenesis	8.328130407520007e-10	1.8367691613785375e-5	12	280	73
MESH:D007027	Hypothalamic Diseases	GO:0009799	specification of symmetry	1.1006192623952415e-9	2.4274157832127052e-5	9	122	73
MESH:D007027	Hypothalamic Diseases	GO:0009725	response to hormone	4.0182720484338574e-9	8.862299002820873e-5	18	865	73
MESH:D007027	Hypothalamic Diseases	GO:0008589	regulation of smoothened signaling pathway	4.3104519953374165e-9	9.506701875716672e-5	7	62	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0030031	cell projection assembly	1.354472090042691e-12	2.987288194589155e-8	17	359	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0007389	pattern specification process	4.5315973196125015e-12	9.994437888405372e-8	18	432	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048666	neuron development	2.6070257064247926e-11	5.74979519551988e-7	21	926	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0033210	leptin-mediated signaling pathway	9.89381909732856e-11	2.182081801915814e-6	5	9	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048589	developmental growth	3.607266707561507e-10	7.955826723526904e-6	16	558	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048598	embryonic morphogenesis	3.804946357988115e-10	8.391809192542787e-6	16	560	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048568	embryonic organ development	5.193593333174817e-10	1.145447009631706e-5	14	408	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0035295	tube development	5.249373158378035e-10	1.1577492500802755e-5	16	573	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048562	embryonic organ morphogenesis	8.328130407520007e-10	1.8367691613785375e-5	12	280	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0002009	morphogenesis of an epithelium	8.819763808176617e-10	1.945198907893353e-5	15	506	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0003006	developmental process involved in reproduction	1.6049370721304967e-9	3.5396887125838106e-5	16	619	73
Orphanet:399839	Rare female infertility due to a congenital hypogonadotropic hypogonadism	GO:0048854	brain morphogenesis	3.5722489410972003e-9	7.878595039589875e-5	6	34	73
DOID:10124	corneal disease	GO:0048592	eye morphogenesis	5.380140777333509e-13	1.1865900484409053e-8	14	136	73
DOID:10124	corneal disease	GO:0035295	tube development	4.938049968927771e-12	1.08908692064702e-7	18	573	73
DOID:10124	corneal disease	GO:0001501	skeletal system development	7.256084622042636e-12	1.6003294633915033e-7	18	482	73
DOID:10124	corneal disease	GO:0048598	embryonic morphogenesis	7.923883771354667e-12	1.7476125657722719e-7	18	560	73
DOID:10124	corneal disease	GO:0001568	blood vessel development	5.0679016538879296e-11	1.1177257097649829e-6	17	569	73
DOID:10124	corneal disease	GO:0031012	extracellular matrix	7.554334935377938e-11	1.6661085699976041e-6	15	423	73
DOID:10124	corneal disease	GO:0030198	extracellular matrix organization	2.96075053363154e-10	6.529935301924361e-6	13	320	73
DOID:10124	corneal disease	GO:0048514	blood vessel morphogenesis	4.790603469473353e-10	1.0565675951923481e-5	15	484	73
DOID:10124	corneal disease	GO:0001525	angiogenesis	6.098058724646194e-10	1.344926851720718e-5	14	413	73
DOID:10124	corneal disease	GO:0072001	renal system development	7.082054942486593e-10	1.561947217565418e-5	12	276	73
DOID:10124	corneal disease	GO:0048562	embryonic organ morphogenesis	8.328130407520007e-10	1.8367691613785375e-5	12	280	73
DOID:10124	corneal disease	GO:0005578	proteinaceous extracellular matrix	1.0150127405239573e-9	2.2386105992255878e-5	13	354	73
DOID:10124	corneal disease	GO:0061061	muscle structure development	2.7897072429894365e-9	6.152699324413202e-5	15	551	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0030900	forebrain development	1.5702994460298214e-12	3.463295428218771e-8	21	357	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0021543	pallium development	7.491784970170556e-13	1.6523131751711162e-8	15	153	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0003002	regionalization	8.160139230994901e-13	1.7997187073959253e-8	15	327	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0061351	neural precursor cell proliferation	3.018141292443488e-12	6.656510620484113e-8	11	132	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0042063	gliogenesis	7.900280429851136e-11	1.7424068488036681e-6	12	228	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0021885	forebrain cell migration	7.989731098945185e-11	1.7621351938723606e-6	8	60	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0031175	neuron projection development	1.4487655519701548e-10	3.1952524248701764e-6	19	796	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0000904	cell morphogenesis involved in differentiation	2.2333002114294231e-10	4.925543616307593e-6	18	720	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0007411	axon guidance	6.952197706411312e-10	1.5333072041490148e-5	11	215	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0021819	layer formation in cerebral cortex	1.5482106707764842e-9	3.414578634397536e-5	5	14	73
Orphanet:166478	Cerebral malformation with epilepsy	GO:0060562	epithelial tube morphogenesis	1.8926066269742137e-9	4.174143915791628e-5	12	301	73
Orphanet:109011	Non-syndromic limb malformation	GO:0040007	growth	2.5348612098241574e-12	5.590636398267179e-8	22	936	74
Orphanet:109011	Non-syndromic limb malformation	GO:0009792	embryo development ending in birth or egg hatching	3.748001908832066e-12	8.266218209929121e-8	19	558	74
Orphanet:109011	Non-syndromic limb malformation	GO:0072358	cardiovascular system development	3.819722316222851e-12	8.424397568429498e-8	22	910	74
Orphanet:109011	Non-syndromic limb malformation	GO:0008544	epidermis development	7.706502103133062e-12	1.6996690388459967e-7	14	296	74
Orphanet:109011	Non-syndromic limb malformation	GO:0055123	digestive system development	1.5989765067558892e-11	3.5265426856501136e-7	11	150	74
Orphanet:109011	Non-syndromic limb malformation	GO:0022405	hair cycle process	2.7049029682757464e-11	5.965663496532159e-7	9	80	74
Orphanet:109011	Non-syndromic limb malformation	GO:0001942	hair follicle development	2.7049029682757464e-11	5.965663496532159e-7	9	80	74
Orphanet:109011	Non-syndromic limb malformation	GO:0048839	inner ear development	6.51653175864908e-11	1.4372210793700546e-6	11	170	74
Orphanet:109011	Non-syndromic limb malformation	GO:0060513	prostatic bud formation	1.0608847134108146e-10	2.3397812354275516e-6	5	9	74
Orphanet:109011	Non-syndromic limb malformation	GO:0048704	embryonic skeletal system morphogenesis	1.0774947600822316e-10	2.3764146933613617e-6	9	93	74
Orphanet:109011	Non-syndromic limb malformation	GO:0045165	cell fate commitment	1.9406642959296505e-10	4.280135104672844e-6	12	243	74
Orphanet:109011	Non-syndromic limb malformation	GO:0035050	embryonic heart tube development	5.045314166451931e-10	1.1127440394109733e-5	8	74	74
Orphanet:109011	Non-syndromic limb malformation	GO:0072001	renal system development	8.338655321793453e-10	1.839090431221546e-5	12	276	74
Orphanet:109011	Non-syndromic limb malformation	GO:0048546	digestive tract morphogenesis	8.64026739044732e-10	1.9056109729631565e-5	7	49	74
Orphanet:109011	Non-syndromic limb malformation	GO:0060021	palate development	1.5560972510542115e-9	3.4319724872000634e-5	8	85	74
Orphanet:109011	Non-syndromic limb malformation	GO:0060828	regulation of canonical Wnt signaling pathway	2.0693744495758892e-9	4.564005348539624e-5	11	235	74
Orphanet:109011	Non-syndromic limb malformation	GO:0009954	proximal/distal pattern formation	2.632381979061904e-9	5.8057184548210294e-5	6	32	74
Orphanet:109011	Non-syndromic limb malformation	GO:0021522	spinal cord motor neuron differentiation	3.8824350401256424e-9	8.562710480997104e-5	6	34	74
Orphanet:77828	Genetic obesity	GO:0030031	cell projection assembly	1.2601031329495527e-12	2.7791574597202384e-8	21	359	74
Orphanet:77828	Genetic obesity	GO:0001894	tissue homeostasis	1.6146861625543352e-11	3.561190331513586e-7	12	197	74
Orphanet:77828	Genetic obesity	GO:0032095	regulation of response to food	8.207956536665506e-11	1.8102648141615774e-6	6	19	74
Orphanet:77828	Genetic obesity	GO:0033210	leptin-mediated signaling pathway	1.0608847134108146e-10	2.3397812354275516e-6	5	9	74
Orphanet:77828	Genetic obesity	GO:0045927	positive regulation of growth	1.322217890731281e-10	2.91615155800784e-6	12	235	74
Orphanet:77828	Genetic obesity	GO:0048639	positive regulation of developmental growth	4.6476511528226183e-10	1.0250394617550285e-5	10	153	74
Orphanet:77828	Genetic obesity	GO:0044450	microtubule organizing center part	4.501489070385389e-9	9.928034144734976e-5	9	141	74
Orphanet:71209	Rare soft tissue tumor	GO:0014070	response to organic cyclic compound	1.4910295220715852e-12	3.288465610928881e-8	23	873	74
Orphanet:71209	Rare soft tissue tumor	GO:0043068	positive regulation of programmed cell death	4.076405879516187e-12	8.990513167272951e-8	19	561	74
Orphanet:71209	Rare soft tissue tumor	GO:0051338	regulation of transferase activity	3.7771563654587226e-11	8.330518364019213e-7	21	928	74
Orphanet:71209	Rare soft tissue tumor	GO:0048661	positive regulation of smooth muscle cell proliferation	8.941902773784705e-11	1.9721366567582166e-6	8	60	74
Orphanet:71209	Rare soft tissue tumor	GO:0043549	regulation of kinase activity	6.796491147653683e-10	1.4989661226150197e-5	18	761	74
Orphanet:71209	Rare soft tissue tumor	GO:0071363	cellular response to growth factor stimulus	1.0966287877778313e-9	2.418614791444007e-5	16	594	74
Orphanet:71209	Rare soft tissue tumor	GO:0042542	response to hydrogen peroxide	1.4406579262882246e-9	3.1773710564286795e-5	9	124	74
Orphanet:71209	Rare soft tissue tumor	GO:0005667	transcription factor complex	2.2267018229271685e-9	4.91099087046587e-5	12	301	74
Orphanet:71209	Rare soft tissue tumor	GO:0072006	nephron development	2.347675165381702e-9	5.1777975772493434e-5	9	131	74
Orphanet:71209	Rare soft tissue tumor	GO:1901991	negative regulation of mitotic cell cycle phase transition	3.967719486297483e-9	8.750805327029099e-5	9	139	74
OMIM:259500	osteosarcoma	GO:0051338	regulation of transferase activity	3.7771563654587226e-11	8.330518364019213e-7	21	928	74
OMIM:259500	osteosarcoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.5977674738820724e-10	3.5238761636469107e-6	21	996	74
OMIM:259500	osteosarcoma	GO:0048666	neuron development	3.021470851294339e-10	6.6638539625296644e-6	20	926	74
OMIM:259500	osteosarcoma	GO:0043408	regulation of MAPK cascade	4.875071457632885e-10	1.0751970099809327e-5	17	651	74
OMIM:259500	osteosarcoma	GO:0043406	positive regulation of MAP kinase activity	4.879904258459078e-10	1.0762628842031496e-5	11	205	74
OMIM:259500	osteosarcoma	GO:0097285	cell-type specific apoptotic process	1.2061014409425752e-9	2.6600567279988496e-5	14	429	74
OMIM:259500	osteosarcoma	GO:0019900	kinase binding	1.208231736882226e-9	2.6647550956937494e-5	16	598	74
OMIM:259500	osteosarcoma	GO:0043066	negative regulation of apoptotic process	1.3549570354598472e-9	2.988357741706693e-5	18	795	74
OMIM:259500	osteosarcoma	GO:0031175	neuron projection development	1.3822604172375463e-9	3.0485753502174084e-5	18	796	74
OMIM:259500	osteosarcoma	GO:0046777	protein autophosphorylation	1.5759331617459793e-9	3.4757205882307574e-5	11	229	74
Orphanet:68366	Lysosomal disease	GO:0006665	sphingolipid metabolic process	6.841194277740215e-13	1.5088253979556043e-8	20	144	74
Orphanet:68366	Lysosomal disease	GO:0007033	vacuole organization	6.743494651573201e-13	1.4872777454044694e-8	13	148	74
Orphanet:68366	Lysosomal disease	GO:0005774	vacuolar membrane	5.626610288800293e-13	1.2409488991949047e-8	18	315	74
Orphanet:68366	Lysosomal disease	GO:0046466	membrane lipid catabolic process	6.217248937900877e-14	1.3712142532540383e-9	10	24	74
Orphanet:68366	Lysosomal disease	GO:0098852	lytic vacuole membrane	1.9118040484045196e-13	4.216483828756168e-9	18	272	74
Orphanet:68366	Lysosomal disease	GO:0005765	lysosomal membrane	1.9118040484045196e-13	4.216483828756168e-9	18	272	74
Orphanet:68366	Lysosomal disease	GO:0006677	glycosylceramide metabolic process	1.6597566654397156e-9	3.660593325627293e-5	5	14	74
MESH:D015428	Myocardial Reperfusion Injury	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	4.729061586772332e-11	1.0429945329626378e-6	5	8	74
MESH:D015428	Myocardial Reperfusion Injury	GO:0010038	response to metal ion	6.16528827990237e-10	1.3597543301324677e-5	13	335	74
DOID:1283	enterocele	GO:0060537	muscle tissue development	2.5777158185746885e-12	5.6851522378664754e-8	16	336	74
DOID:1283	enterocele	GO:0003002	regionalization	1.2669865157022286e-12	2.7943387603812653e-8	22	327	74
DOID:1283	enterocele	GO:0060562	epithelial tube morphogenesis	1.2660983372825285e-12	2.7923798828766166e-8	17	301	74
DOID:1283	enterocele	GO:0055123	digestive system development	8.375522497772181e-13	1.8472214868836545e-8	14	150	74
DOID:1283	enterocele	GO:0060541	respiratory system development	5.468958619303521e-13	1.2061788234873916e-8	15	202	74
DOID:1283	enterocele	GO:0030323	respiratory tube development	1.6964207816272392e-13	3.741456033878876e-9	14	179	74
DOID:1283	enterocele	GO:0009792	embryo development ending in birth or egg hatching	3.3769653740023386e-12	7.447897132362158e-8	27	558	74
DOID:1283	enterocele	GO:0048732	gland development	4.007461029686965e-12	8.838455300974601e-8	17	421	74
DOID:1283	enterocele	GO:0048598	embryonic morphogenesis	4.318989610396784e-12	9.525531585730107e-8	24	560	74
DOID:1283	enterocele	GO:1901342	regulation of vasculature development	5.464406704902558e-12	1.2051748987662592e-7	13	228	74
DOID:1283	enterocele	GO:0003205	cardiac chamber development	8.660072658983609e-12	1.909979024938835e-7	11	142	74
DOID:1283	enterocele	GO:0001503	ossification	9.743983397925149e-12	2.1490355384123916e-7	15	363	74
DOID:1283	enterocele	GO:0007423	sensory organ development	1.2944867400221938e-11	2.8549905051189484e-7	17	494	74
DOID:1283	enterocele	GO:0008585	female gonad development	1.494060430928812e-11	3.2951502804134947e-7	10	108	74
DOID:1283	enterocele	GO:0030198	extracellular matrix organization	2.5415336502021546e-11	5.605352465520852e-7	14	320	74
DOID:1283	enterocele	GO:0001822	kidney development	3.1634472819064285e-11	6.976982980244628e-7	13	262	74
DOID:1283	enterocele	GO:0001654	eye development	3.3001712473890166e-11	7.278527686116476e-7	14	327	74
DOID:1283	enterocele	GO:0048863	stem cell differentiation	3.7190694968103344e-11	8.202407775215192e-7	13	266	74
DOID:1283	enterocele	GO:0008284	positive regulation of cell proliferation	3.762923306283028e-11	8.299127352007218e-7	20	815	74
DOID:1283	enterocele	GO:0003279	cardiac septum development	4.24519308594995e-11	9.362773351062614e-7	9	84	74
DOID:1283	enterocele	GO:0055017	cardiac muscle tissue growth	5.825706583806323e-11	1.2848595870584845e-6	8	57	74
DOID:1283	enterocele	GO:0048562	embryonic organ morphogenesis	6.727662871242046e-11	1.4837860462524333e-6	13	280	74
DOID:1283	enterocele	GO:0030334	regulation of cell migration	6.989886447428262e-11	1.5416194559803031e-6	18	660	74
DOID:1283	enterocele	GO:0048762	mesenchymal cell differentiation	1.5297751954079786e-10	3.3739191934722967e-6	11	184	74
DOID:1283	enterocele	GO:0048659	smooth muscle cell proliferation	2.9733537854070846e-10	6.557731773715325e-6	9	104	74
DOID:1283	enterocele	GO:0048705	skeletal system morphogenesis	4.630725802812208e-10	1.0213065758102324e-5	11	204	74
DOID:1283	enterocele	GO:0045765	regulation of angiogenesis	5.693551186070067e-10	1.2557127140877533e-5	11	208	74
DOID:1283	enterocele	GO:0042476	odontogenesis	6.796185836321911e-10	1.4988987862007974e-5	9	114	74
DOID:1283	enterocele	GO:0071363	cellular response to growth factor stimulus	1.0966287877778313e-9	2.418614791444007e-5	16	594	74
DOID:1283	enterocele	GO:0043010	camera-type eye development	1.1065662830489487e-9	2.4405319372644563e-5	12	283	74
DOID:1283	enterocele	GO:0045596	negative regulation of cell differentiation	1.1802344657141361e-9	2.6030071141325273e-5	16	597	74
DOID:1283	enterocele	GO:0009799	specification of symmetry	1.2462664233936493e-9	2.7486405967946936e-5	9	122	74
DOID:1283	enterocele	GO:0090287	regulation of cellular response to growth factor stimulus	1.371886271250844e-9	3.0256951712437363e-5	11	226	74
DOID:1283	enterocele	GO:0014031	mesenchymal cell development	1.3815673050032728e-9	3.0470466911847183e-5	10	171	74
DOID:1283	enterocele	GO:0060322	head development	1.7437378208029486e-9	3.845813763780903e-5	17	708	74
DOID:1283	enterocele	GO:2000027	regulation of organ morphogenesis	2.1640863545613342e-9	4.772892454985023e-5	11	236	74
DOID:1283	enterocele	GO:0060284	regulation of cell development	2.5652846513679606e-9	5.657735298592037e-5	18	828	74
DOID:1283	enterocele	GO:0001701	in utero embryonic development	3.338510801143002e-9	7.363085571920891e-5	12	312	74
DOID:1283	enterocele	GO:0001667	ameboidal-type cell migration	3.7176458578258575e-9	8.199267939434929e-5	12	315	74
DOID:1283	enterocele	GO:0048661	positive regulation of smooth muscle cell proliferation	3.752478883178867e-9	8.276092176850991e-5	7	60	74
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0022836	gated channel activity	2.7136071167888076e-12	5.984860496077715e-8	19	335	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:1902495	transmembrane transporter complex	1.2576606422953773e-12	2.7737705465824547e-8	20	308	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0005216	ion channel activity	1.7010837183306649e-12	3.751740140778281e-8	19	417	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0005261	cation channel activity	1.138489302832113e-11	2.5109381573962253e-7	14	298	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0045202	synapse	9.923650790000238e-11	2.1886611817345525e-6	19	755	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0044708	single-organism behavior	6.656287743211919e-10	1.4680442617653888e-5	14	404	75
Orphanet:98260	Adolescent-onset epilepsy syndrome	GO:0044456	synapse part	2.128093701259104e-9	4.693510658126954e-5	16	613	75
DOID:5844	myocardial infarction	GO:0006979	response to oxidative stress	4.773959005888173e-14	1.0528966587486366e-9	16	386	75
DOID:5844	myocardial infarction	GO:0009611	response to wounding	2.830846668189224e-12	6.243432326691334e-8	28	875	75
DOID:5844	myocardial infarction	GO:1901701	cellular response to oxygen-containing compound	1.8441581595141088e-11	4.067290820808367e-7	21	873	75
DOID:5844	myocardial infarction	GO:0051270	regulation of cellular component movement	2.968358892019296e-11	6.546715536348557e-7	20	787	75
DOID:5844	myocardial infarction	GO:0072358	cardiovascular system development	2.9199676010449593e-10	6.439988544104658e-6	20	910	75
DOID:5844	myocardial infarction	GO:0055082	cellular chemical homeostasis	7.703041537965305e-10	1.698905811198248e-5	17	661	75
DOID:5844	myocardial infarction	GO:0050801	ion homeostasis	9.044081039633056e-10	1.9946720732910705e-5	17	668	75
DOID:5844	myocardial infarction	GO:0006874	cellular calcium ion homeostasis	1.3446975755115886e-9	2.9657305027908087e-5	13	352	75
DOID:5844	myocardial infarction	GO:0044057	regulation of system process	1.3807925913766894e-9	3.0453380602812885e-5	15	508	75
DOID:5844	myocardial infarction	GO:0043086	negative regulation of catalytic activity	2.8866983248221345e-9	6.366613155395218e-5	18	822	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:1990267	response to transition metal nanoparticle	8.65529869997772e-13	1.9089261282800862e-8	15	150	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0044283	small molecule biosynthetic process	6.834754984197389e-12	1.507405211764734e-7	18	530	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0044282	small molecule catabolic process	8.209610768972198e-11	1.8106296550968182e-6	14	345	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0042493	response to drug	1.5499546091035654e-10	3.4184248903779135e-6	15	433	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0010243	response to organonitrogen compound	1.6815904224642964e-10	3.7087476767450056e-6	19	780	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0019752	carboxylic acid metabolic process	8.488729719147159e-10	1.872189339557906e-5	20	967	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0009725	response to hormone	9.078965357289803e-10	2.002365809550266e-5	19	865	75
Orphanet:93593	Nephropathy secondary to a storage or other metabolic disease	GO:0048545	response to steroid hormone	2.3882066324532047e-9	5.267189727875543e-5	14	446	75
DOID:13580	cholestasis	GO:0008206	bile acid metabolic process	1.2567724638756772e-13	2.771811669077806e-9	11	41	76
DOID:13580	cholestasis	GO:0015721	bile acid and bile salt transport	3.393529901529746e-11	7.484430197823855e-7	7	31	76
DOID:13580	cholestasis	GO:0002237	response to molecule of bacterial origin	8.110653260118283e-10	1.7888045765190874e-5	13	333	76
Orphanet:391799	Rare genetic dystonia	GO:1990267	response to transition metal nanoparticle	2.1808888028829188e-11	4.809950254758277e-7	11	150	76
Orphanet:391799	Rare genetic dystonia	GO:0019725	cellular homeostasis	2.95442559306025e-11	6.515985645494382e-7	20	771	76
Orphanet:391799	Rare genetic dystonia	GO:0023061	signal release	1.0739820144323176e-10	2.3686673328304764e-6	15	416	76
Orphanet:391799	Rare genetic dystonia	GO:0055082	cellular chemical homeostasis	1.1317613513028846e-10	2.496099660298512e-6	18	661	76
Orphanet:391799	Rare genetic dystonia	GO:0001505	regulation of neurotransmitter levels	1.537616700630906e-10	3.3912136332414633e-6	11	179	76
Orphanet:391799	Rare genetic dystonia	GO:0007626	locomotory behavior	1.9454526878348588e-10	4.290695903019781e-6	11	183	76
Orphanet:391799	Rare genetic dystonia	GO:0071705	nitrogen compound transport	1.9963430908376267e-10	4.402934686842386e-6	19	777	76
Orphanet:391799	Rare genetic dystonia	GO:0006875	cellular metal ion homeostasis	3.17146975348237e-10	6.994676541305367e-6	15	450	76
Orphanet:391799	Rare genetic dystonia	GO:0001963	synaptic transmission, dopaminergic	1.3050793779001424e-9	2.878352567958764e-5	6	28	76
Orphanet:391799	Rare genetic dystonia	GO:1903409	reactive oxygen species biosynthetic process	1.5944005005152917e-9	3.516450303886476e-5	8	83	76
Orphanet:391799	Rare genetic dystonia	GO:0050804	modulation of synaptic transmission	1.6505307121050805e-9	3.640245485547755e-5	12	285	76
Orphanet:391799	Rare genetic dystonia	GO:0042493	response to drug	1.9617444335651157e-9	4.326627348227863e-5	14	433	76
Orphanet:391799	Rare genetic dystonia	GO:0007568	aging	2.010207111879936e-9	4.4335117852511985e-5	12	290	76
Orphanet:391799	Rare genetic dystonia	GO:1903531	negative regulation of secretion by cell	2.1395920590805417e-9	4.718870286302135e-5	10	174	76
Orphanet:391799	Rare genetic dystonia	GO:0030072	peptide hormone secretion	3.611158150285121e-9	7.964409300453834e-5	11	241	76
Orphanet:391799	Rare genetic dystonia	GO:0015696	ammonium transport	3.6541568659842483e-9	8.05924296792826e-5	8	92	76
Orphanet:391799	Rare genetic dystonia	GO:0015872	dopamine transport	3.775553092388861e-9	8.326982345263634e-5	6	33	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0003002	regionalization	1.2081446953970953e-12	2.6645631256982938e-8	18	327	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0001763	morphogenesis of a branching structure	9.992007221626409e-15	2.2037371927297045e-10	13	193	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0030198	extracellular matrix organization	2.3779866964446228e-12	5.2446496590086156e-8	15	320	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0060537	muscle tissue development	2.580158309228864e-12	5.690539151004259e-8	15	336	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0009792	embryo development ending in birth or egg hatching	2.8238522631340857e-12	6.228006166342226e-8	21	558	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0048598	embryonic morphogenesis	1.1434964086731725e-11	2.521981329328682e-7	18	560	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0060562	epithelial tube morphogenesis	1.5428436306308413e-11	3.4027416273563205e-7	14	301	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0048589	developmental growth	7.373812671573887e-11	1.6262943847156208e-6	17	558	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0007548	sex differentiation	7.421918635230895e-11	1.636904155000174e-6	13	274	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0085029	extracellular matrix assembly	8.026428410801145e-10	1.7702287860021926e-5	6	26	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0009948	anterior/posterior axis specification	8.991195565855037e-10	1.9830081820493284e-5	7	48	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0072001	renal system development	1.1480822958986892e-9	2.532095503604559e-5	12	276	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:1901701	cellular response to oxygen-containing compound	1.3474886761954963e-9	2.971886275349167e-5	19	873	76
Orphanet:98043	Diaphragmatic or abdominal wall malformation	GO:0006801	superoxide metabolic process	1.6124831470065715e-9	3.5563315807229934e-5	7	52	76
Orphanet:306695	Miscellaneous movement disorder due to neurodegenerative disease	GO:0019725	cellular homeostasis	1.3286624023223226e-9	2.9303649283218824e-5	18	771	76
Orphanet:306695	Miscellaneous movement disorder due to neurodegenerative disease	GO:0006873	cellular ion homeostasis	3.126757741611641e-9	6.896064199124474e-5	15	532	76
Orphanet:68363	Rare dystonia	GO:1990267	response to transition metal nanoparticle	2.1808888028829188e-11	4.809950254758277e-7	11	150	76
Orphanet:68363	Rare dystonia	GO:0019725	cellular homeostasis	2.95442559306025e-11	6.515985645494382e-7	20	771	76
Orphanet:68363	Rare dystonia	GO:0023061	signal release	1.0739820144323176e-10	2.3686673328304764e-6	15	416	76
Orphanet:68363	Rare dystonia	GO:0055082	cellular chemical homeostasis	1.1317613513028846e-10	2.496099660298512e-6	18	661	76
Orphanet:68363	Rare dystonia	GO:0001505	regulation of neurotransmitter levels	1.537616700630906e-10	3.3912136332414633e-6	11	179	76
Orphanet:68363	Rare dystonia	GO:0007626	locomotory behavior	1.9454526878348588e-10	4.290695903019781e-6	11	183	76
Orphanet:68363	Rare dystonia	GO:0071705	nitrogen compound transport	1.9963430908376267e-10	4.402934686842386e-6	19	777	76
Orphanet:68363	Rare dystonia	GO:0006875	cellular metal ion homeostasis	3.17146975348237e-10	6.994676541305367e-6	15	450	76
Orphanet:68363	Rare dystonia	GO:0001963	synaptic transmission, dopaminergic	1.3050793779001424e-9	2.878352567958764e-5	6	28	76
Orphanet:68363	Rare dystonia	GO:1903409	reactive oxygen species biosynthetic process	1.5944005005152917e-9	3.516450303886476e-5	8	83	76
Orphanet:68363	Rare dystonia	GO:0050804	modulation of synaptic transmission	1.6505307121050805e-9	3.640245485547755e-5	12	285	76
Orphanet:68363	Rare dystonia	GO:0042493	response to drug	1.9617444335651157e-9	4.326627348227863e-5	14	433	76
Orphanet:68363	Rare dystonia	GO:0007568	aging	2.010207111879936e-9	4.4335117852511985e-5	12	290	76
Orphanet:68363	Rare dystonia	GO:1903531	negative regulation of secretion by cell	2.1395920590805417e-9	4.718870286302135e-5	10	174	76
Orphanet:68363	Rare dystonia	GO:0030072	peptide hormone secretion	3.611158150285121e-9	7.964409300453834e-5	11	241	76
Orphanet:68363	Rare dystonia	GO:0015696	ammonium transport	3.6541568659842483e-9	8.05924296792826e-5	8	92	76
Orphanet:68363	Rare dystonia	GO:0015872	dopamine transport	3.775553092388861e-9	8.326982345263634e-5	6	33	76
DOID:332	amyotrophic lateral sclerosis	GO:0043005	neuron projection	6.766861515572486e-10	1.4924313072595119e-5	20	941	76
OMIM:600807	Asthma, Susceptibility to	GO:0009607	response to biotic stimulus	4.817035659243629e-12	1.0623972146461824e-7	27	934	77
OMIM:600807	Asthma, Susceptibility to	GO:0002237	response to molecule of bacterial origin	2.516653552220305e-12	5.5504794094218823e-8	18	333	77
OMIM:600807	Asthma, Susceptibility to	GO:0001775	cell activation	1.4372947276797277e-12	3.1699535218976393e-8	26	854	77
OMIM:600807	Asthma, Susceptibility to	GO:0022407	regulation of cell-cell adhesion	1.4215295607300504e-12	3.135183446190126e-8	19	376	77
OMIM:600807	Asthma, Susceptibility to	GO:0033993	response to lipid	1.4130918657428992e-12	3.116574109895964e-8	33	850	77
OMIM:600807	Asthma, Susceptibility to	GO:0071219	cellular response to molecule of bacterial origin	1.233679824963474e-12	2.7208808539569418e-8	14	158	77
OMIM:600807	Asthma, Susceptibility to	GO:0051249	regulation of lymphocyte activation	1.2165823903842465e-12	2.6831724619924557e-8	20	372	77
OMIM:600807	Asthma, Susceptibility to	GO:0045471	response to ethanol	1.1690648449302898e-12	2.5783725154937542e-8	15	137	77
OMIM:600807	Asthma, Susceptibility to	GO:0002699	positive regulation of immune effector process	1.070699084948501e-12	2.361426831853919e-8	13	150	77
OMIM:600807	Asthma, Susceptibility to	GO:0050900	leukocyte migration	9.92761428619815e-13	2.189535330821002e-8	16	354	77
OMIM:600807	Asthma, Susceptibility to	GO:0034110	regulation of homotypic cell-cell adhesion	9.401368572525826e-13	2.0734718386705708e-8	17	304	77
OMIM:600807	Asthma, Susceptibility to	GO:0009991	response to extracellular stimulus	9.385825450181073e-13	2.0700438030374357e-8	21	573	77
OMIM:600807	Asthma, Susceptibility to	GO:0007584	response to nutrient	8.855138844410249e-13	1.9530008721346803e-8	15	197	77
OMIM:600807	Asthma, Susceptibility to	GO:0043627	response to estrogen	8.455458555545192e-13	1.864851384425492e-8	14	217	77
OMIM:600807	Asthma, Susceptibility to	GO:0071222	cellular response to lipopolysaccharide	7.527312106958561e-13	1.6601486851897107e-8	14	152	77
OMIM:600807	Asthma, Susceptibility to	GO:0051384	response to glucocorticoid	6.512568262451168e-13	1.4363469302836052e-8	16	167	77
OMIM:600807	Asthma, Susceptibility to	GO:0002696	positive regulation of leukocyte activation	6.45039577307216e-13	1.4226347877510648e-8	18	280	77
OMIM:600807	Asthma, Susceptibility to	GO:0071346	cellular response to interferon-gamma	4.838351941316432e-13	1.0670985206573391e-8	12	133	77
OMIM:600807	Asthma, Susceptibility to	GO:0050863	regulation of T cell activation	4.602984660095899e-13	1.0151882667841505e-8	16	284	77
OMIM:600807	Asthma, Susceptibility to	GO:0032103	positive regulation of response to external stimulus	2.431388423929093e-13	5.362427168975614e-9	15	285	77
OMIM:600807	Asthma, Susceptibility to	GO:0007568	aging	1.887379141862766e-13	4.162614697378331e-9	16	290	77
OMIM:600807	Asthma, Susceptibility to	GO:0006954	inflammatory response	3.7114755713218983e-13	8.185659372550447e-9	21	637	77
OMIM:600807	Asthma, Susceptibility to	GO:0033273	response to vitamin	7.079892228034623e-13	1.561470230893036e-8	11	104	77
OMIM:600807	Asthma, Susceptibility to	GO:0005125	cytokine activity	8.180123245438153e-13	1.8041261817813847e-8	18	222	77
OMIM:600807	Asthma, Susceptibility to	GO:1901698	response to nitrogen compound	9.862111127745266e-13	2.1750886092242183e-8	27	870	77
OMIM:600807	Asthma, Susceptibility to	GO:0072593	reactive oxygen species metabolic process	1.0267342531733448e-12	2.264462395373812e-8	14	223	77
OMIM:600807	Asthma, Susceptibility to	GO:0001819	positive regulation of cytokine production	1.3389289676979388e-12	2.953007838257804e-8	16	381	77
OMIM:600807	Asthma, Susceptibility to	GO:0009611	response to wounding	1.5429879596240426e-12	3.403059944950826e-8	23	875	77
OMIM:600807	Asthma, Susceptibility to	GO:0051251	positive regulation of lymphocyte activation	2.3486768085945187e-12	5.180006701355211e-8	16	257	77
OMIM:600807	Asthma, Susceptibility to	GO:0000302	response to reactive oxygen species	2.97939450888407e-12	6.571054589343817e-8	13	216	77
OMIM:600807	Asthma, Susceptibility to	GO:0042493	response to drug	3.059885678169394e-12	6.748577863202598e-8	19	433	77
OMIM:600807	Asthma, Susceptibility to	GO:0050778	positive regulation of immune response	3.17268433747131e-12	6.997355306292974e-8	19	603	77
OMIM:600807	Asthma, Susceptibility to	GO:0051241	negative regulation of multicellular organismal process	3.799960346384523e-12	8.380812543951066e-8	23	966	77
OMIM:600807	Asthma, Susceptibility to	GO:0002521	leukocyte differentiation	4.260147790091651e-12	9.395755951047136e-8	17	448	77
OMIM:600807	Asthma, Susceptibility to	GO:0032649	regulation of interferon-gamma production	4.8513415507045465e-12	1.0699633790078877e-7	10	93	77
OMIM:600807	Asthma, Susceptibility to	GO:1903034	regulation of response to wounding	8.078204771777564e-12	1.7816480624155417e-7	16	407	77
OMIM:600807	Asthma, Susceptibility to	GO:0010243	response to organonitrogen compound	8.218425939787721e-12	1.812573841020182e-7	25	780	77
OMIM:600807	Asthma, Susceptibility to	GO:0010035	response to inorganic substance	8.734679646238419e-12	1.9264335959778833e-7	18	502	77
OMIM:600807	Asthma, Susceptibility to	GO:0050727	regulation of inflammatory response	1.1425083101812561e-11	2.5198020781047603e-7	14	289	77
OMIM:600807	Asthma, Susceptibility to	GO:0043279	response to alkaloid	1.1429301949306137e-11	2.5207325449194684e-7	11	140	77
OMIM:600807	Asthma, Susceptibility to	GO:0051270	regulation of cellular component movement	1.1563860979890705e-11	2.550409539114895e-7	21	787	77
OMIM:600807	Asthma, Susceptibility to	GO:0044706	multi-multicellular organism process	1.545563677041173e-11	3.408740689714307e-7	13	237	77
OMIM:600807	Asthma, Susceptibility to	GO:0022409	positive regulation of cell-cell adhesion	1.6344259279321705e-11	3.604726384054402e-7	13	239	77
OMIM:600807	Asthma, Susceptibility to	GO:0007565	female pregnancy	1.6867285346222616e-11	3.720079783109398e-7	12	190	77
OMIM:600807	Asthma, Susceptibility to	GO:0002685	regulation of leukocyte migration	2.3636870238874508e-11	5.213111731183773e-7	11	149	77
OMIM:600807	Asthma, Susceptibility to	GO:0002703	regulation of leukocyte mediated immunity	2.7324142948259578e-11	6.02633972723865e-7	11	151	77
OMIM:600807	Asthma, Susceptibility to	GO:0070663	regulation of leukocyte proliferation	3.198941112003695e-11	7.055264622524149e-7	12	200	77
OMIM:600807	Asthma, Susceptibility to	GO:1901699	cellular response to nitrogen compound	3.4492408929054363e-11	7.60730078930294e-7	17	518	77
OMIM:600807	Asthma, Susceptibility to	GO:0050870	positive regulation of T cell activation	3.610611809534703e-11	7.963204345928787e-7	12	202	77
OMIM:600807	Asthma, Susceptibility to	GO:0030335	positive regulation of cell migration	4.457212376962616e-11	9.83038189739105e-7	15	387	77
OMIM:600807	Asthma, Susceptibility to	GO:0070482	response to oxygen levels	4.7104320444191217e-11	1.0388857873966373e-6	14	321	77
OMIM:600807	Asthma, Susceptibility to	GO:0019221	cytokine-mediated signaling pathway	4.994515911960207e-11	1.1015404843828236e-6	17	534	77
OMIM:600807	Asthma, Susceptibility to	GO:0002705	positive regulation of leukocyte mediated immunity	5.499878330539332e-11	1.2129981658004496e-6	9	83	77
OMIM:600807	Asthma, Susceptibility to	GO:1903409	reactive oxygen species biosynthetic process	5.499878330539332e-11	1.2129981658004496e-6	9	83	77
OMIM:600807	Asthma, Susceptibility to	GO:0071417	cellular response to organonitrogen compound	5.746492170999318e-11	1.2673888483138995e-6	16	462	77
OMIM:600807	Asthma, Susceptibility to	GO:0042327	positive regulation of phosphorylation	6.298872534671318e-11	1.3892163375217592e-6	21	910	77
OMIM:600807	Asthma, Susceptibility to	GO:0005126	cytokine receptor binding	7.421552261632769e-11	1.6368233513031072e-6	13	270	77
OMIM:600807	Asthma, Susceptibility to	GO:0008284	positive regulation of cell proliferation	7.571254734273225e-11	1.6698402316439598e-6	20	815	77
OMIM:600807	Asthma, Susceptibility to	GO:0051050	positive regulation of transport	7.618705666345704e-11	1.680305534712545e-6	21	920	77
OMIM:600807	Asthma, Susceptibility to	GO:1902105	regulation of leukocyte differentiation	1.2947953820230396e-10	2.8556712150518138e-6	12	225	77
OMIM:600807	Asthma, Susceptibility to	GO:0071407	cellular response to organic cyclic compound	1.3058132353194196e-10	2.87997109049698e-6	15	416	77
OMIM:600807	Asthma, Susceptibility to	GO:0006809	nitric oxide biosynthetic process	1.6296564098183808e-10	3.594207211854439e-6	8	62	77
OMIM:600807	Asthma, Susceptibility to	GO:0001666	response to hypoxia	1.9342760726459574e-10	4.266045878220659e-6	13	292	77
OMIM:600807	Asthma, Susceptibility to	GO:0001934	positive regulation of protein phosphorylation	2.235045482024134e-10	4.929392810604227e-6	20	870	77
OMIM:600807	Asthma, Susceptibility to	GO:0002700	regulation of production of molecular mediator of immune response	2.74114508869161e-10	6.045595493109346e-6	9	99	77
OMIM:600807	Asthma, Susceptibility to	GO:0050670	regulation of lymphocyte proliferation	3.1820146517702597e-10	7.017933314479308e-6	11	189	77
OMIM:600807	Asthma, Susceptibility to	GO:0009636	response to toxic substance	4.1509040649145845e-10	9.154818915169116e-6	12	249	77
OMIM:600807	Asthma, Susceptibility to	GO:2000377	regulation of reactive oxygen species metabolic process	4.690718924393877e-10	1.0345380587750697e-5	10	147	77
OMIM:600807	Asthma, Susceptibility to	GO:0001101	response to acid chemical	4.891295146691732e-10	1.0787751446028615e-5	13	315	77
OMIM:600807	Asthma, Susceptibility to	GO:0002687	positive regulation of leukocyte migration	6.529546903166761e-10	1.4400915694934291e-5	9	109	77
OMIM:600807	Asthma, Susceptibility to	GO:0002637	regulation of immunoglobulin production	7.223446285564705e-10	1.5931310782812957e-5	7	46	77
OMIM:600807	Asthma, Susceptibility to	GO:0043200	response to amino acid	8.333693735096404e-10	1.8379961532755118e-5	9	112	77
OMIM:600807	Asthma, Susceptibility to	GO:0051924	regulation of calcium ion transport	8.398237660856012e-10	1.8522313161017934e-5	11	207	77
OMIM:600807	Asthma, Susceptibility to	GO:0050729	positive regulation of inflammatory response	9.763923003447417e-10	2.1534332184103278e-5	9	114	77
OMIM:600807	Asthma, Susceptibility to	GO:0050777	negative regulation of immune response	1.056123632992012e-9	2.3292806725638826e-5	9	115	77
OMIM:600807	Asthma, Susceptibility to	GO:0055082	cellular chemical homeostasis	1.1901416518966812e-9	2.6248574132581304e-5	17	661	77
OMIM:600807	Asthma, Susceptibility to	GO:0010638	positive regulation of organelle organization	1.2145681127506691e-9	2.6787299726716007e-5	16	573	77
OMIM:600807	Asthma, Susceptibility to	GO:0032388	positive regulation of intracellular transport	1.587077691489469e-9	3.500299848580024e-5	13	347	77
OMIM:600807	Asthma, Susceptibility to	GO:0006801	superoxide metabolic process	1.7700890753147291e-9	3.903931455606635e-5	7	52	77
OMIM:600807	Asthma, Susceptibility to	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.7729259171872513e-9	3.910188110356483e-5	8	83	77
OMIM:600807	Asthma, Susceptibility to	GO:0032844	regulation of homeostatic process	1.9626440472819695e-9	4.328611446280384e-5	14	427	77
OMIM:600807	Asthma, Susceptibility to	GO:0002639	positive regulation of immunoglobulin production	2.214022520874437e-9	4.8830266697885705e-5	6	30	77
OMIM:600807	Asthma, Susceptibility to	GO:1902107	positive regulation of leukocyte differentiation	2.5569012462867136e-9	5.639245698685347e-5	9	127	77
OMIM:600807	Asthma, Susceptibility to	GO:1901654	response to ketone	3.573621953911754e-9	7.881623219352374e-5	10	181	77
OMIM:600807	Asthma, Susceptibility to	GO:0006875	cellular metal ion homeostasis	3.838357631735789e-9	8.465497756793283e-5	14	450	77
OMIM:600807	Asthma, Susceptibility to	GO:0002573	myeloid leukocyte differentiation	3.973935069900847e-9	8.764513796666318e-5	10	183	77
OMIM:600807	Asthma, Susceptibility to	GO:0071548	response to dexamethasone	4.089551697283866e-9	9.019506268359567e-5	6	33	77
Orphanet:98641	Syndromic cataract	GO:0007423	sensory organ development	1.4728007702302648e-10	3.248262098742849e-6	16	494	77
Orphanet:98695	Mitochondrial disease with eye involvement	GO:0034622	cellular macromolecular complex assembly	4.969358258222201e-12	1.0959919638509064e-7	29	926	77
Orphanet:98695	Mitochondrial disease with eye involvement	GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	1.0487566370898094e-10	2.3130327631015746e-6	6	19	77
Orphanet:98695	Mitochondrial disease with eye involvement	GO:1902600	hydrogen ion transmembrane transport	6.529546903166761e-10	1.4400915694934291e-5	9	109	77
DOID:3620	central nervous system cancer	GO:0051726	regulation of cell cycle	2.8597124668294782e-12	6.307095845592414e-8	23	930	77
DOID:3620	central nervous system cancer	GO:0032403	protein complex binding	1.4426237981979284e-12	3.181706786925531e-8	23	924	77
DOID:3620	central nervous system cancer	GO:0001655	urogenital system development	2.0803359035426183e-12	4.588180835263245e-8	15	313	77
DOID:3620	central nervous system cancer	GO:0009790	embryo development	8.269607221222941e-12	1.8238618726407196e-7	22	932	77
DOID:3620	central nervous system cancer	GO:0001656	metanephros development	9.380840548800506e-11	2.0689443830379517e-6	9	88	77
DOID:3620	central nervous system cancer	GO:0021537	telencephalon development	1.3653789210366085e-10	3.01134321034624e-6	12	226	77
DOID:3620	central nervous system cancer	GO:0010001	glial cell differentiation	1.482479694558947e-10	3.2696089663497574e-6	11	176	77
DOID:3620	central nervous system cancer	GO:0071887	leukocyte apoptotic process	1.7124379692035063e-10	3.776781941078333e-6	9	94	77
DOID:3620	central nervous system cancer	GO:0060675	ureteric bud morphogenesis	2.1176549402923683e-10	4.670487970814818e-6	8	64	77
DOID:3620	central nervous system cancer	GO:0051054	positive regulation of DNA metabolic process	2.2508039876356634e-10	4.9641481947304555e-6	11	183	77
DOID:3620	central nervous system cancer	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	3.520725933015001e-10	7.764961045264585e-6	21	996	77
DOID:3620	central nervous system cancer	GO:0045787	positive regulation of cell cycle	3.704643258828355e-10	8.170590707345937e-6	13	308	77
DOID:3620	central nervous system cancer	GO:0032355	response to estradiol	4.0957959246412656e-10	9.033277911796311e-6	10	145	77
DOID:3620	central nervous system cancer	GO:0050679	positive regulation of epithelial cell proliferation	7.893974363071266e-10	1.7410160457753676e-5	10	155	77
DOID:3620	central nervous system cancer	GO:0051960	regulation of nervous system development	9.48246703380562e-10	2.0913581043058294e-5	18	744	77
DOID:3620	central nervous system cancer	GO:0031016	pancreas development	1.0713708809007016e-9	2.3629084778264975e-5	8	78	77
DOID:3620	central nervous system cancer	GO:0048568	embryonic organ development	1.0903365987857683e-9	2.404737368622012e-5	14	408	77
DOID:3620	central nervous system cancer	GO:0050767	regulation of neurogenesis	1.111729375224968e-9	2.4519191370586668e-5	17	658	77
DOID:3620	central nervous system cancer	GO:0030856	regulation of epithelial cell differentiation	1.7891120807078664e-9	3.9458866940011994e-5	9	122	77
DOID:3620	central nervous system cancer	GO:0009411	response to UV	2.2207417016417708e-9	4.8978458229709254e-5	9	125	77
DOID:3620	central nervous system cancer	GO:0007568	aging	2.348930161488738e-9	5.180565471163412e-5	12	290	77
DOID:3620	central nervous system cancer	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2.39590647321819e-9	5.284171726682718e-5	13	359	77
DOID:3620	central nervous system cancer	GO:0045926	negative regulation of growth	2.553958711182247e-9	5.632755937512446e-5	11	230	77
DOID:3620	central nervous system cancer	GO:0003006	developmental process involved in reproduction	3.675512449952123e-9	8.106342708369407e-5	16	619	77
DOID:620	blood protein disease	GO:0051249	regulation of lymphocyte activation	9.745537710159624e-13	2.149378341975705e-8	17	372	78
DOID:620	blood protein disease	GO:0050778	positive regulation of immune response	5.32018873400375e-13	1.1733676252845271e-8	22	603	78
DOID:620	blood protein disease	GO:0030098	lymphocyte differentiation	4.594102875898898e-13	1.0132293892795019e-8	16	299	78
DOID:620	blood protein disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	7.704947790898586e-14	1.6993262352826832e-9	14	209	78
DOID:620	blood protein disease	GO:0002696	positive regulation of leukocyte activation	6.483702463810914e-14	1.4299805783934971e-9	15	280	78
DOID:620	blood protein disease	GO:0002764	immune response-regulating signaling pathway	4.955480470414386e-12	1.0929312177498929e-7	17	451	78
DOID:620	blood protein disease	GO:0009611	response to wounding	6.4648286723922865e-12	1.4258179636961188e-7	22	875	78
DOID:620	blood protein disease	GO:0002252	immune effector process	9.155121105663966e-12	2.0191619598541877e-7	21	757	78
DOID:620	blood protein disease	GO:0043069	negative regulation of programmed cell death	1.2944645355617013e-11	2.854941533181332e-7	21	806	78
DOID:620	blood protein disease	GO:0002253	activation of immune response	1.3252177133438181e-11	2.922767666779791e-7	17	475	78
DOID:620	blood protein disease	GO:0050727	regulation of inflammatory response	1.3854140057389941e-11	3.0555305896573515e-7	14	289	78
DOID:620	blood protein disease	GO:0002757	immune response-activating signal transduction	1.7651435868515364e-11	3.8930241808010635e-7	16	419	78
DOID:620	blood protein disease	GO:0051707	response to other organism	7.141920388420431e-11	1.575150541666126e-6	21	898	78
DOID:620	blood protein disease	GO:0034109	homotypic cell-cell adhesion	1.8458501394036375e-10	4.0710224824547225e-6	16	495	78
DOID:620	blood protein disease	GO:0019724	B cell mediated immunity	3.3803748689109625e-10	7.455416773383128e-6	9	100	78
DOID:620	blood protein disease	GO:0034097	response to cytokine	3.688178651373164e-10	8.134278015603513e-6	19	784	78
DOID:620	blood protein disease	GO:0002285	lymphocyte activation involved in immune response	4.999636260549778e-10	1.1026697772642535e-5	10	146	78
DOID:620	blood protein disease	GO:0001819	positive regulation of cytokine production	5.348358422807564e-10	1.1795804501502083e-5	14	381	78
DOID:620	blood protein disease	GO:0002768	immune response-regulating cell surface receptor signaling pathway	7.848730554371741e-10	1.7310375237666875e-5	13	323	78
DOID:620	blood protein disease	GO:0070489	T cell aggregation	2.138409227470106e-9	4.716261551185319e-5	14	424	78
DOID:620	blood protein disease	GO:0042110	T cell activation	2.138409227470106e-9	4.716261551185319e-5	14	424	78
DOID:620	blood protein disease	GO:0030888	regulation of B cell proliferation	2.2282580225407855e-9	4.9144230687137025e-5	7	53	78
DOID:620	blood protein disease	GO:0050671	positive regulation of lymphocyte proliferation	2.873995486041281e-9	6.338597044464045e-5	9	127	78
DOID:620	blood protein disease	GO:0009617	response to bacterium	3.1023438262778313e-9	6.842219308855757e-5	15	517	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0022836	gated channel activity	2.687183808802729e-12	5.9265838903144186e-8	19	335	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:1902495	transmembrane transporter complex	9.299228054260311e-13	2.0509447473671116e-8	19	308	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0005216	ion channel activity	2.1884716261411086e-12	4.826674171454215e-8	19	417	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0005261	cation channel activity	2.0683010859556816e-11	4.561638045075256e-7	14	298	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0044708	single-organism behavior	1.0362644076167271e-10	2.2854811509986916e-6	15	404	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0045202	synapse	1.9839296871992929e-10	4.37555692511804e-6	19	755	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0044456	synapse part	4.688792687446153e-10	1.034113227216249e-5	17	613	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0030424	axon	1.5729871849501365e-9	3.469223236407526e-5	14	414	78
Orphanet:98259	Childhood-onset epilepsy syndrome	GO:0043269	regulation of ion transport	1.905223978582171e-9	4.2019714847629785e-5	16	583	78
OMIM:104300	Alzheimer Disease	GO:0010038	response to metal ion	2.1798118865490324e-12	4.807575115783891e-8	16	335	78
OMIM:104300	Alzheimer Disease	GO:0043279	response to alkaloid	9.490186414495838e-13	2.093060613717057e-8	14	140	78
OMIM:104300	Alzheimer Disease	GO:0070997	neuron death	8.233413950620161e-13	1.8158794468092765e-8	17	281	78
OMIM:104300	Alzheimer Disease	GO:0042987	amyloid precursor protein catabolic process	6.661338147750939e-16	1.4691581284864696e-11	9	19	78
OMIM:104300	Alzheimer Disease	GO:0050435	beta-amyloid metabolic process	1.7430501486614958e-14	3.844297102872929e-10	11	23	78
OMIM:104300	Alzheimer Disease	GO:1990267	response to transition metal nanoparticle	1.8751666885918894e-13	4.135680131689412e-9	12	150	78
OMIM:104300	Alzheimer Disease	GO:0007611	learning or memory	2.3359092438113294e-13	5.151847837225887e-9	14	218	78
OMIM:104300	Alzheimer Disease	GO:0034205	beta-amyloid formation	9.25592935629993e-13	2.0413952195319496e-8	6	10	78
OMIM:104300	Alzheimer Disease	GO:1901214	regulation of neuron death	1.2654322034677534e-12	2.7909107247481302e-8	15	250	78
OMIM:104300	Alzheimer Disease	GO:0001540	beta-amyloid binding	1.6830981053317373e-12	3.7120728713091466e-8	8	36	78
OMIM:104300	Alzheimer Disease	GO:0006979	response to oxidative stress	2.291278278221398e-12	5.0534142426172934e-8	16	386	78
OMIM:104300	Alzheimer Disease	GO:0060548	negative regulation of cell death	2.3776536295372352e-12	5.2439150799443723e-8	23	867	78
OMIM:104300	Alzheimer Disease	GO:0014070	response to organic cyclic compound	4.217848292853432e-12	9.302464409888245e-8	22	873	78
OMIM:104300	Alzheimer Disease	GO:0042327	positive regulation of phosphorylation	7.717604333379313e-12	1.7021176357268075e-7	22	910	78
OMIM:104300	Alzheimer Disease	GO:0030162	regulation of proteolysis	9.272582701669307e-12	2.0450681148531658e-7	20	701	78
OMIM:104300	Alzheimer Disease	GO:0051050	positive regulation of transport	9.494294239686951e-12	2.093966594562957e-7	22	920	78
OMIM:104300	Alzheimer Disease	GO:0045859	regulation of protein kinase activity	1.0334844091630657e-11	2.2793498644091414e-7	20	709	78
OMIM:104300	Alzheimer Disease	GO:0048878	chemical homeostasis	1.1112000208868267e-11	2.450751646065896e-7	23	988	78
OMIM:104300	Alzheimer Disease	GO:0043069	negative regulation of programmed cell death	1.2944645355617013e-11	2.854941533181332e-7	21	806	78
OMIM:104300	Alzheimer Disease	GO:0043066	negative regulation of apoptotic process	1.425037865487866e-11	3.1429210123334883e-7	21	795	78
OMIM:104300	Alzheimer Disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	1.7175816324765947e-11	3.7881262904271296e-7	10	104	78
OMIM:104300	Alzheimer Disease	GO:1902992	negative regulation of amyloid precursor protein catabolic process	2.331834725310955e-11	5.142861486673311e-7	5	7	78
OMIM:104300	Alzheimer Disease	GO:0006897	endocytosis	3.069555720713879e-11	6.76990514203446e-7	18	593	78
OMIM:104300	Alzheimer Disease	GO:0001934	positive regulation of protein phosphorylation	3.884248478414065e-11	8.566710019142221e-7	21	870	78
OMIM:104300	Alzheimer Disease	GO:0055065	metal ion homeostasis	3.940592296913792e-11	8.690976310843368e-7	17	516	78
OMIM:104300	Alzheimer Disease	GO:0006875	cellular metal ion homeostasis	4.4862336068263176e-11	9.894388219855443e-7	16	450	78
OMIM:104300	Alzheimer Disease	GO:0035094	response to nicotine	5.7288285226775315e-11	1.2634931306765296e-6	8	54	78
OMIM:104300	Alzheimer Disease	GO:0009986	cell surface	8.094525050239554e-11	1.7852474998303336e-6	19	715	78
OMIM:104300	Alzheimer Disease	GO:0031667	response to nutrient levels	8.345069080206713e-11	1.8405049856395905e-6	17	546	78
OMIM:104300	Alzheimer Disease	GO:0051604	protein maturation	8.646161564485055e-11	1.906910933047179e-6	14	332	78
OMIM:104300	Alzheimer Disease	GO:0043086	negative regulation of catalytic activity	1.1112377684696639e-10	2.450834898359844e-6	20	822	78
OMIM:104300	Alzheimer Disease	GO:0060284	regulation of cell development	1.2426726314629377e-10	2.740714488691509e-6	20	828	78
OMIM:104300	Alzheimer Disease	GO:0070838	divalent metal ion transport	1.2804068916238975e-10	2.823937399476506e-6	15	410	78
OMIM:104300	Alzheimer Disease	GO:0051098	regulation of binding	1.2988654596313154e-10	2.864647771216866e-6	13	279	78
OMIM:104300	Alzheimer Disease	GO:1902003	regulation of beta-amyloid formation	1.3891332528714884e-10	3.0637333892080676e-6	5	9	78
OMIM:104300	Alzheimer Disease	GO:0033993	response to lipid	1.8918056010619466e-10	4.172377253142123e-6	20	850	78
OMIM:104300	Alzheimer Disease	GO:0006509	membrane protein ectodomain proteolysis	2.328766068870891e-10	5.13609356489475e-6	7	39	78
OMIM:104300	Alzheimer Disease	GO:0009725	response to hormone	2.604113591431201e-10	5.743372525901513e-6	20	865	78
OMIM:104300	Alzheimer Disease	GO:0022603	regulation of anatomical structure morphogenesis	3.8006975344728744e-10	8.382438412279924e-6	21	986	78
OMIM:104300	Alzheimer Disease	GO:0048545	response to steroid hormone	4.1129422090335765e-10	9.071094042023553e-6	15	446	78
OMIM:104300	Alzheimer Disease	GO:0016485	protein processing	4.3817871553386567e-10	9.664031571099407e-6	13	308	78
OMIM:104300	Alzheimer Disease	GO:0040008	regulation of growth	5.183230511462966e-10	1.1431614893031572e-5	17	617	78
OMIM:104300	Alzheimer Disease	GO:0070482	response to oxygen levels	7.280338554238597e-10	1.6056786681373225e-5	13	321	78
OMIM:104300	Alzheimer Disease	GO:0048471	perinuclear region of cytoplasm	8.207742263621753e-10	1.8102175562417777e-5	17	636	78
OMIM:104300	Alzheimer Disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.0649165993470433e-9	2.348673559859904e-5	17	647	78
OMIM:104300	Alzheimer Disease	GO:0055114	oxidation-reduction process	1.2997680709503356e-9	2.8666384804809653e-5	20	949	78
OMIM:104300	Alzheimer Disease	GO:1902430	negative regulation of beta-amyloid formation	1.4044857499229124e-9	3.0975933214549833e-5	4	5	78
OMIM:104300	Alzheimer Disease	GO:0051384	response to glucocorticoid	1.8631329812279773e-9	4.109139790098304e-5	10	167	78
OMIM:104300	Alzheimer Disease	GO:0043269	regulation of ion transport	1.905223978582171e-9	4.2019714847629785e-5	16	583	78
OMIM:104300	Alzheimer Disease	GO:1903409	reactive oxygen species biosynthetic process	1.9685372221189823e-9	4.3416088433834155e-5	8	83	78
OMIM:104300	Alzheimer Disease	GO:0034774	secretory granule lumen	2.3855231123803833e-9	5.261271224354935e-5	8	85	78
OMIM:104300	Alzheimer Disease	GO:0010942	positive regulation of cell death	2.6138327058333743e-9	5.764808032715507e-5	16	596	78
OMIM:104300	Alzheimer Disease	GO:0042493	response to drug	2.7995072926501052e-9	6.174313333939807e-5	14	433	78
OMIM:104300	Alzheimer Disease	GO:0007417	central nervous system development	2.920436781295166e-9	6.441023321146488e-5	19	889	78
OMIM:104300	Alzheimer Disease	GO:0001666	response to hypoxia	2.9595826900319366e-9	6.527359622865436e-5	12	292	78
OMIM:104300	Alzheimer Disease	GO:1901699	cellular response to nitrogen compound	3.183468932910216e-9	7.021140731533482e-5	15	518	78
OMIM:104300	Alzheimer Disease	GO:0043270	positive regulation of ion transport	3.369106993389437e-9	7.430565473920403e-5	11	233	78
OMIM:104300	Alzheimer Disease	GO:0032768	regulation of monooxygenase activity	3.771286616327529e-9	8.317572632310366e-5	7	57	78
DOID:854	collagen disease	GO:0005578	proteinaceous extracellular matrix	1.5480949855373183e-12	3.4143234906025555e-8	20	354	79
DOID:854	collagen disease	GO:0044236	multicellular organismal metabolic process	7.049916206369744e-13	1.554859019314847e-8	15	127	79
DOID:854	collagen disease	GO:0044420	extracellular matrix component	5.964118088286341e-13	1.3153862443715525e-8	14	125	79
DOID:854	collagen disease	GO:0005788	endoplasmic reticulum lumen	5.906386491005833e-13	1.3026535405913364e-8	14	199	79
DOID:854	collagen disease	GO:0044243	multicellular organismal catabolic process	1.4588330543574557e-13	3.2174563013853685e-9	13	72	79
DOID:854	collagen disease	GO:0098644	complex of collagen trimers	2.220446049250313e-16	4.8971937616215655e-12	12	23	79
DOID:854	collagen disease	GO:0005604	basement membrane	1.9648427329599372e-10	4.333460647543141e-6	9	93	79
DOID:854	collagen disease	GO:0009611	response to wounding	2.831541556780337e-9	6.244964903479033e-5	19	875	79
DOID:10575	calcium metabolism disease	GO:0007584	response to nutrient	6.954437026251981e-13	1.5338010861398743e-8	14	197	79
DOID:10575	calcium metabolism disease	GO:0030278	regulation of ossification	1.2967404927621828e-13	2.8599611567869943e-9	13	177	79
DOID:10575	calcium metabolism disease	GO:0072502	cellular trivalent inorganic anion homeostasis	4.015676680069191e-13	8.856574917892601e-9	6	9	79
DOID:10575	calcium metabolism disease	GO:0030643	cellular phosphate ion homeostasis	4.015676680069191e-13	8.856574917892601e-9	6	9	79
DOID:10575	calcium metabolism disease	GO:0001649	osteoblast differentiation	2.973954416063407e-12	6.559056464627844e-8	13	206	79
DOID:10575	calcium metabolism disease	GO:0071407	cellular response to organic cyclic compound	3.2807090377673376e-12	7.235603782795863e-8	17	416	79
DOID:10575	calcium metabolism disease	GO:0001501	skeletal system development	5.28355137419112e-12	1.1652872555778515e-7	19	482	79
DOID:10575	calcium metabolism disease	GO:0072507	divalent inorganic cation homeostasis	5.877409670063116e-12	1.2962627027324203e-7	16	393	79
DOID:10575	calcium metabolism disease	GO:0016337	single organismal cell-cell adhesion	1.0763168134531043e-11	2.3738167320708214e-7	20	697	79
DOID:10575	calcium metabolism disease	GO:0005315	inorganic phosphate transmembrane transporter activity	2.4885205007763034e-11	5.488431964462137e-7	5	7	79
DOID:10575	calcium metabolism disease	GO:0055074	calcium ion homeostasis	2.8527624706953247e-11	6.291767629118539e-7	15	364	79
DOID:10575	calcium metabolism disease	GO:0045785	positive regulation of cell adhesion	3.329370112936658e-11	7.3429257840818e-7	15	368	79
DOID:10575	calcium metabolism disease	GO:0022407	regulation of cell-cell adhesion	4.4629300255394355e-11	9.842992171327225e-7	15	376	79
DOID:10575	calcium metabolism disease	GO:0071295	cellular response to vitamin	5.721823015392147e-11	1.261948066044738e-6	7	32	79
DOID:10575	calcium metabolism disease	GO:0071305	cellular response to vitamin D	1.7483892111869181e-10	3.856072405272748e-6	6	20	79
DOID:10575	calcium metabolism disease	GO:0006817	phosphate ion transport	2.4394752884404625e-10	5.38026274865544e-6	6	21	79
DOID:10575	calcium metabolism disease	GO:0015321	sodium-dependent phosphate transmembrane transporter activity	2.9560276448847844e-10	6.519518970793392e-6	5	10	79
DOID:10575	calcium metabolism disease	GO:0005436	sodium:phosphate symporter activity	2.9560276448847844e-10	6.519518970793392e-6	5	10	79
DOID:10575	calcium metabolism disease	GO:0022409	positive regulation of cell-cell adhesion	3.529611047881076e-10	7.784557166101713e-6	12	239	79
DOID:10575	calcium metabolism disease	GO:0030097	hemopoiesis	5.005048597794826e-10	1.1038634682436488e-5	18	695	79
DOID:10575	calcium metabolism disease	GO:0042368	vitamin D biosynthetic process	5.401393776693908e-10	1.1912773974498414e-5	5	11	79
DOID:10575	calcium metabolism disease	GO:0051353	positive regulation of oxidoreductase activity	7.380729361017302e-10	1.627819860572366e-5	7	45	79
DOID:10575	calcium metabolism disease	GO:0050870	positive regulation of T cell activation	8.597760281503497e-10	1.8962360300855963e-5	11	202	79
DOID:10575	calcium metabolism disease	GO:0044341	sodium-dependent phosphate transport	9.22888876431216e-10	2.035431416969047e-5	5	12	79
DOID:10575	calcium metabolism disease	GO:0032101	regulation of response to external stimulus	9.661947908412571e-10	2.1309426112003926e-5	20	920	79
DOID:10575	calcium metabolism disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.243487284836476e-9	4.948011206706848e-5	10	168	79
DOID:10575	calcium metabolism disease	GO:1901652	response to peptide	2.4697068834456104e-9	5.446938531439294e-5	14	423	79
DOID:10575	calcium metabolism disease	GO:0010035	response to inorganic substance	2.506726937134829e-9	5.528586259850865e-5	15	502	79
DOID:10575	calcium metabolism disease	GO:0030001	metal ion transport	3.939639947603268e-9	8.688875904439008e-5	18	792	79
DOID:1428	endocrine pancreas disease	GO:0042886	amide transport	1.3995471448424723e-12	3.086701227950073e-8	22	329	79
DOID:1428	endocrine pancreas disease	GO:0050708	regulation of protein secretion	1.1146639167236572e-12	2.458391268334026e-8	21	380	79
DOID:1428	endocrine pancreas disease	GO:0006869	lipid transport	1.0120793092482927e-12	2.2321409165471096e-8	17	300	79
DOID:1428	endocrine pancreas disease	GO:0002791	regulation of peptide secretion	7.94475596421762e-13	1.752215927908196e-8	19	204	79
DOID:1428	endocrine pancreas disease	GO:0051048	negative regulation of secretion	6.963318810448982e-13	1.535759963644523e-8	14	195	79
DOID:1428	endocrine pancreas disease	GO:0071383	cellular response to steroid hormone stimulus	3.0698776853910203e-12	6.770615235129895e-8	12	162	79
DOID:1428	endocrine pancreas disease	GO:0055114	oxidation-reduction process	3.945954674122731e-12	8.702803033777684e-8	23	949	79
DOID:1428	endocrine pancreas disease	GO:0019395	fatty acid oxidation	5.029643368459347e-12	1.1092878449137089e-7	10	91	79
DOID:1428	endocrine pancreas disease	GO:0032368	regulation of lipid transport	5.029643368459347e-12	1.1092878449137089e-7	10	91	79
DOID:1428	endocrine pancreas disease	GO:0043627	response to estrogen	6.327161017338767e-12	1.395455362374065e-7	13	217	79
DOID:1428	endocrine pancreas disease	GO:0009611	response to wounding	8.164802167698326e-12	1.8007471180858658e-7	22	875	79
DOID:1428	endocrine pancreas disease	GO:0060548	negative regulation of cell death	4.785594143186245e-11	1.0554627882797263e-6	21	867	79
DOID:1428	endocrine pancreas disease	GO:0009062	fatty acid catabolic process	9.611722529001554e-11	2.1198654037712927e-6	9	86	79
DOID:1428	endocrine pancreas disease	GO:0031331	positive regulation of cellular catabolic process	1.0740419664756473e-10	2.36879955706204e-6	14	333	79
DOID:1428	endocrine pancreas disease	GO:0000302	response to reactive oxygen species	1.088449330666208e-10	2.4005749987843217e-6	12	216	79
DOID:1428	endocrine pancreas disease	GO:1900076	regulation of cellular response to insulin stimulus	1.3297596357375596e-10	2.9327848766191877e-6	8	59	79
DOID:1428	endocrine pancreas disease	GO:0071229	cellular response to acid chemical	1.745416033926972e-10	3.849515062825937e-6	11	174	79
DOID:1428	endocrine pancreas disease	GO:0045981	positive regulation of nucleotide metabolic process	2.094748818848302e-10	4.61996851996993e-6	10	132	79
DOID:1428	endocrine pancreas disease	GO:1900544	positive regulation of purine nucleotide metabolic process	2.094748818848302e-10	4.61996851996993e-6	10	132	79
DOID:1428	endocrine pancreas disease	GO:0050727	regulation of inflammatory response	2.371217666663483e-10	5.229720563826312e-6	13	289	79
DOID:1428	endocrine pancreas disease	GO:0045471	response to ethanol	3.0316993360202105e-10	6.686412885592574e-6	10	137	79
DOID:1428	endocrine pancreas disease	GO:1900078	positive regulation of cellular response to insulin stimulus	4.507845208223671e-10	9.942052606737306e-6	6	23	79
DOID:1428	endocrine pancreas disease	GO:0051222	positive regulation of protein transport	5.128756308536708e-10	1.131147203847771e-5	15	447	79
DOID:1428	endocrine pancreas disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.896474419841979e-10	1.3004674332961486e-5	21	996	79
DOID:1428	endocrine pancreas disease	GO:0006694	steroid biosynthetic process	6.944832486865948e-10	1.531682804978285e-5	10	149	79
DOID:1428	endocrine pancreas disease	GO:0033674	positive regulation of kinase activity	1.3628869144355349e-9	3.0058470897875722e-5	15	480	79
DOID:1428	endocrine pancreas disease	GO:0051897	positive regulation of protein kinase B signaling	1.4631962308442326e-9	3.227079287126955e-5	8	79	79
DOID:1428	endocrine pancreas disease	GO:0032370	positive regulation of lipid transport	1.8449003436060707e-9	4.068927707823189e-5	7	51	79
DOID:1428	endocrine pancreas disease	GO:0015908	fatty acid transport	1.978753716436188e-9	4.3641413216000124e-5	8	82	79
DOID:1428	endocrine pancreas disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.243487284836476e-9	4.948011206706848e-5	10	168	79
DOID:1428	endocrine pancreas disease	GO:0048732	gland development	2.325603043473734e-9	5.1291175123813204e-5	14	421	79
DOID:1428	endocrine pancreas disease	GO:0006953	acute-phase response	2.439617063920707e-9	5.3805754344771195e-5	7	53	79
DOID:1428	endocrine pancreas disease	GO:0007568	aging	3.1844863412899826e-9	7.023384625715057e-5	12	290	79
DOID:1428	endocrine pancreas disease	GO:0042306	regulation of protein import into nucleus	3.3332587801027103e-9	7.351502239516527e-5	10	175	79
DOID:1428	endocrine pancreas disease	GO:0001666	response to hypoxia	3.4414944227734168e-9	7.590215949426771e-5	12	292	79
DOID:1428	endocrine pancreas disease	GO:0009749	response to glucose	3.5219673844011368e-9	7.767699066296707e-5	10	176	79
DOID:1428	endocrine pancreas disease	GO:0045923	positive regulation of fatty acid metabolic process	3.926265090825609e-9	8.659377657815881e-5	6	32	79
DOID:1428	endocrine pancreas disease	GO:0016337	single organismal cell-cell adhesion	4.023197108793397e-9	8.873161223443837e-5	17	697	79
DOID:543	dystonia	GO:0007270	neuron-neuron synaptic transmission	7.552292125012627e-12	1.665658028171535e-7	11	130	80
DOID:543	dystonia	GO:0044708	single-organism behavior	1.6242417411049814e-9	3.5822651600070365e-5	14	404	80
DOID:543	dystonia	GO:1901698	response to nitrogen compound	3.2336923139197893e-9	7.131908398350095e-5	19	870	80
DOID:543	dystonia	GO:0010243	response to organonitrogen compound	3.848620200308517e-9	8.488131851780434e-5	18	780	80
DOID:10652	Alzheimer's disease	GO:0042982	amyloid precursor protein metabolic process	7.327471962526033e-15	1.6160739413351166e-10	10	31	80
DOID:10652	Alzheimer's disease	GO:0001558	regulation of cell growth	7.102620713794749e-10	1.566482998427432e-5	14	379	80
DOID:10652	Alzheimer's disease	GO:0008284	positive regulation of cell proliferation	1.1065706129187447e-9	2.4405414867922914e-5	19	815	80
DOID:10652	Alzheimer's disease	GO:0030334	regulation of cell migration	2.1784357651100095e-9	4.804540079950126e-5	17	660	80
DOID:10652	Alzheimer's disease	GO:0001775	cell activation	2.3830140083447304e-9	5.255737395404303e-5	19	854	80
DOID:302	substance abuse	GO:0014070	response to organic cyclic compound	7.878142582740111e-13	1.7375243466233314e-8	24	873	80
DOID:302	substance abuse	GO:0051580	regulation of neurotransmitter uptake	1.290079154614432e-13	2.8452695755021296e-9	7	15	80
DOID:302	substance abuse	GO:0045761	regulation of adenylate cyclase activity	1.3923084907219163e-11	3.0707363762871864e-7	9	69	80
DOID:302	substance abuse	GO:0033993	response to lipid	3.1123525978671296e-10	6.864293654595954e-6	20	850	80
DOID:302	substance abuse	GO:0010959	regulation of metal ion transport	1.0091451008165109e-9	2.2256695198508147e-5	13	321	80
DOID:302	substance abuse	GO:0051924	regulation of calcium ion transport	1.2798468951302766e-9	2.822702327209825e-5	11	207	80
DOID:302	substance abuse	GO:0008015	blood circulation	2.1096155933264527e-9	4.652757191081491e-5	15	489	80
DOID:302	substance abuse	GO:0001975	response to amphetamine	2.7968261040456355e-9	6.168399972472649e-5	6	30	80
DOID:302	substance abuse	GO:0044057	regulation of system process	3.532713122034181e-9	7.791398790646387e-5	15	508	80
MESH:D012878	Skin Neoplasms	GO:0009790	embryo development	4.947819931544473e-12	1.0912416859021334e-7	24	932	81
MESH:D012878	Skin Neoplasms	GO:0006259	DNA metabolic process	4.158229316431061e-12	9.170974757388706e-8	24	937	81
MESH:D012878	Skin Neoplasms	GO:0051052	regulation of DNA metabolic process	1.7128520823916915e-12	3.7776952677148756e-8	16	335	81
MESH:D012878	Skin Neoplasms	GO:0050673	epithelial cell proliferation	1.7128520823916915e-12	3.7776952677148756e-8	16	335	81
MESH:D012878	Skin Neoplasms	GO:0050679	positive regulation of epithelial cell proliferation	1.3060663661690342e-12	2.8805293705858048e-8	13	155	81
MESH:D012878	Skin Neoplasms	GO:0009411	response to UV	8.006928453596629e-13	1.7659280704407365e-8	15	125	81
MESH:D012878	Skin Neoplasms	GO:0001503	ossification	3.843592111252292e-13	8.47704240136693e-9	18	363	81
MESH:D012878	Skin Neoplasms	GO:0008544	epidermis development	5.5289106626332796e-14	1.2194012466437698e-9	16	296	81
MESH:D012878	Skin Neoplasms	GO:0097190	apoptotic signaling pathway	7.048805983345119e-13	1.554614159626766e-8	21	564	81
MESH:D012878	Skin Neoplasms	GO:0042633	hair cycle	7.361888876289413e-13	1.62366459166563e-8	11	101	81
MESH:D012878	Skin Neoplasms	GO:0043588	skin development	1.0219602941674566e-12	2.2539334287863255e-8	15	241	81
MESH:D012878	Skin Neoplasms	GO:0008285	negative regulation of cell proliferation	1.2242429292541601e-12	2.70006778047005e-8	21	634	81
MESH:D012878	Skin Neoplasms	GO:0051726	regulation of cell cycle	1.457389764425443e-12	3.2142731254403145e-8	23	930	81
MESH:D012878	Skin Neoplasms	GO:0030855	epithelial cell differentiation	1.5157874955207262e-12	3.343069321370962e-8	21	568	81
MESH:D012878	Skin Neoplasms	GO:0060548	negative regulation of cell death	1.5579759704564822e-12	3.4361160028417714e-8	24	867	81
MESH:D012878	Skin Neoplasms	GO:0048732	gland development	3.275602011854062e-12	7.224340237144133e-8	19	421	81
MESH:D012878	Skin Neoplasms	GO:0043069	negative regulation of programmed cell death	4.455213975518291e-12	9.82597442300559e-8	24	806	81
MESH:D012878	Skin Neoplasms	GO:0001701	in utero embryonic development	5.055511564933113e-12	1.114993075645998e-7	15	312	81
MESH:D012878	Skin Neoplasms	GO:0048534	hematopoietic or lymphoid organ development	6.77569111928733e-12	1.4943786763588207e-7	23	739	81
MESH:D012878	Skin Neoplasms	GO:0043066	negative regulation of apoptotic process	7.753353514772243e-12	1.7100021176830182e-7	24	795	81
MESH:D012878	Skin Neoplasms	GO:0045786	negative regulation of cell cycle	1.0117906512618902e-11	2.2315042813580988e-7	17	449	81
MESH:D012878	Skin Neoplasms	GO:0051241	negative regulation of multicellular organismal process	1.3246959085222443e-11	2.92161682624581e-7	23	966	81
MESH:D012878	Skin Neoplasms	GO:0030097	hemopoiesis	1.516831105163874e-11	3.345371002438924e-7	20	695	81
MESH:D012878	Skin Neoplasms	GO:0051093	negative regulation of developmental process	1.9801160711097054e-11	4.3671459948324554e-7	21	788	81
MESH:D012878	Skin Neoplasms	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.4765189898801054e-11	5.461962632180573e-7	23	996	81
MESH:D012878	Skin Neoplasms	GO:0045597	positive regulation of cell differentiation	3.0133451289771074e-11	6.64593268195901e-7	21	815	81
MESH:D012878	Skin Neoplasms	GO:0032880	regulation of protein localization	3.39582806319072e-11	7.489498793367133e-7	22	933	81
MESH:D012878	Skin Neoplasms	GO:0097285	cell-type specific apoptotic process	4.188660529536037e-11	9.238090797891729e-7	16	429	81
MESH:D012878	Skin Neoplasms	GO:0010035	response to inorganic substance	4.644429285605156e-11	1.0243288789402172e-6	17	502	81
MESH:D012878	Skin Neoplasms	GO:0097305	response to alcohol	5.092692934027809e-11	1.1231934265998333e-6	15	369	81
MESH:D012878	Skin Neoplasms	GO:0002521	leukocyte differentiation	7.650546862691954e-11	1.6873281105667104e-6	16	448	81
MESH:D012878	Skin Neoplasms	GO:0001649	osteoblast differentiation	8.511813476275165e-11	1.8772804621924877e-6	12	206	81
MESH:D012878	Skin Neoplasms	GO:0014070	response to organic cyclic compound	8.553258101784422e-11	1.8864210743485543e-6	21	873	81
MESH:D012878	Skin Neoplasms	GO:0007346	regulation of mitotic cell cycle	9.052270044662691e-11	1.9964781583503566e-6	16	453	81
MESH:D012878	Skin Neoplasms	GO:0009612	response to mechanical stimulus	1.0697287500249786e-10	2.3592867581800903e-6	12	210	81
MESH:D012878	Skin Neoplasms	GO:0003006	developmental process involved in reproduction	1.2008050109812984e-10	2.6483754517192537e-6	18	619	81
MESH:D012878	Skin Neoplasms	GO:1900180	regulation of protein localization to nucleus	1.2576306662737124e-10	2.773704434466673e-6	12	213	81
MESH:D012878	Skin Neoplasms	GO:0072091	regulation of stem cell proliferation	1.494845358607222e-10	3.296881438408228e-6	9	88	81
MESH:D012878	Skin Neoplasms	GO:0010038	response to metal ion	1.6600476548944698e-10	3.661235102869753e-6	14	335	81
MESH:D012878	Skin Neoplasms	GO:0072358	cardiovascular system development	1.8245405186689823e-10	4.02402411392444e-6	21	910	81
MESH:D012878	Skin Neoplasms	GO:0043065	positive regulation of apoptotic process	2.0100632269759444e-10	4.433194447095445e-6	17	556	81
MESH:D012878	Skin Neoplasms	GO:0032403	protein complex binding	2.451044922580081e-10	5.405779576750369e-6	21	924	81
MESH:D012878	Skin Neoplasms	GO:0051338	regulation of transferase activity	2.6475643899459556e-10	5.839203262025805e-6	21	928	81
MESH:D012878	Skin Neoplasms	GO:0061180	mammary gland epithelium development	3.2023061979913336e-10	7.062686319669886e-6	8	64	81
MESH:D012878	Skin Neoplasms	GO:0007568	aging	3.4259572956329976e-10	7.555948815518576e-6	13	290	81
MESH:D012878	Skin Neoplasms	GO:0051054	positive regulation of DNA metabolic process	3.953072313933603e-10	8.718500988380562e-6	11	183	81
MESH:D012878	Skin Neoplasms	GO:2001233	regulation of apoptotic signaling pathway	4.1724135257936723e-10	9.202258031137944e-6	14	359	81
MESH:D012878	Skin Neoplasms	GO:0045596	negative regulation of cell differentiation	5.854220441747771e-10	1.2911483184274708e-5	17	597	81
MESH:D012878	Skin Neoplasms	GO:0008134	transcription factor binding	6.294547105767379e-10	1.3882623641769953e-5	16	518	81
MESH:D012878	Skin Neoplasms	GO:1903706	regulation of hemopoiesis	6.339703206847958e-10	1.398221542270317e-5	13	305	81
MESH:D012878	Skin Neoplasms	GO:0051270	regulation of cellular component movement	7.79707853837408e-10	1.7196456716384034e-5	19	787	81
MESH:D012878	Skin Neoplasms	GO:0001667	ameboidal-type cell migration	9.406856404936548e-10	2.0746821801087556e-5	13	315	81
MESH:D012878	Skin Neoplasms	GO:2000145	regulation of cell motility	1.059002885384075e-9	2.3356308637145773e-5	18	709	81
MESH:D012878	Skin Neoplasms	GO:0070482	response to oxygen levels	1.183556808115327e-9	2.6103345402983535e-5	13	321	81
MESH:D012878	Skin Neoplasms	GO:0030099	myeloid cell differentiation	1.4800242142953834e-9	3.264193404628468e-5	13	327	81
MESH:D012878	Skin Neoplasms	GO:0042476	odontogenesis	1.5469954206537295e-9	3.4118984002518005e-5	9	114	81
MESH:D012878	Skin Neoplasms	GO:2000147	positive regulation of cell motility	1.6399844815495612e-9	3.616985774057557e-5	14	399	81
MESH:D012878	Skin Neoplasms	GO:0072594	establishment of protein localization to organelle	1.7179796474309228e-9	3.7890041124089e-5	17	641	81
MESH:D012878	Skin Neoplasms	GO:0000075	cell cycle checkpoint	1.7954437936396062e-9	3.9598512868721514e-5	11	211	81
MESH:D012878	Skin Neoplasms	GO:0097193	intrinsic apoptotic signaling pathway	2.077724881033305e-9	4.582422225118954e-5	12	272	81
MESH:D012878	Skin Neoplasms	GO:0040007	growth	2.0974407766161107e-9	4.625905632826832e-5	20	936	81
MESH:D012878	Skin Neoplasms	GO:0043408	regulation of MAPK cascade	2.170438495596727e-9	4.7869021020385816e-5	17	651	81
MESH:D012878	Skin Neoplasms	GO:0048568	embryonic organ development	2.186218983624144e-9	4.82170596838305e-5	14	408	81
MESH:D012878	Skin Neoplasms	GO:0001568	blood vessel development	2.412842925458847e-9	5.321525072099487e-5	16	569	81
MESH:D012878	Skin Neoplasms	GO:0030334	regulation of cell migration	2.6677086095716618e-9	5.8836313384103e-5	17	660	81
MESH:D012878	Skin Neoplasms	GO:0071407	cellular response to organic cyclic compound	2.80571255117934e-9	6.187999031626035e-5	14	416	81
MESH:D012878	Skin Neoplasms	GO:0048608	reproductive structure development	2.982330937761901e-9	6.577530883233873e-5	14	418	81
MESH:D012878	Skin Neoplasms	GO:1902533	positive regulation of intracellular signal transduction	3.349814314823618e-9	7.38801547134349e-5	19	860	81
MESH:D012878	Skin Neoplasms	GO:0071214	cellular response to abiotic stimulus	3.5175738988257876e-9	7.758009233860275e-5	12	285	81
MESH:D012878	Skin Neoplasms	GO:0002009	morphogenesis of an epithelium	4.008602561000885e-9	8.840972948287451e-5	15	506	81
MESH:D012878	Skin Neoplasms	GO:0042063	gliogenesis	4.051258772896915e-9	8.935051223624146e-5	11	228	81
MESH:D012878	Skin Neoplasms	GO:0009913	epidermal cell differentiation	4.5179623375801725e-9	9.96436593553307e-5	10	176	81
DOID:14330	Parkinson's disease	GO:0010038	response to metal ion	2.6569857425329246e-12	5.859982055156365e-8	19	335	81
DOID:14330	Parkinson's disease	GO:0006979	response to oxidative stress	1.849853603630436e-12	4.079852122806926e-8	23	386	81
DOID:14330	Parkinson's disease	GO:0009991	response to extracellular stimulus	1.113997782908882e-12	2.4569221102055394e-8	22	573	81
DOID:14330	Parkinson's disease	GO:1990267	response to transition metal nanoparticle	1.0134115768778429e-12	2.2350792328040825e-8	13	150	81
DOID:14330	Parkinson's disease	GO:0043279	response to alkaloid	2.673417043297377e-13	5.896221288992365e-9	12	140	81
DOID:14330	Parkinson's disease	GO:0009712	catechol-containing compound metabolic process	8.193445921733655e-14	1.8070644980383577e-9	10	50	81
DOID:14330	Parkinson's disease	GO:0006584	catecholamine metabolic process	8.193445921733655e-14	1.8070644980383577e-9	10	50	81
DOID:14330	Parkinson's disease	GO:0000302	response to reactive oxygen species	3.6415315207705135e-14	8.031397769059367e-10	15	216	81
DOID:14330	Parkinson's disease	GO:1903409	reactive oxygen species biosynthetic process	2.0938806244430452e-13	4.618053717209136e-9	12	83	81
DOID:14330	Parkinson's disease	GO:0044708	single-organism behavior	2.7777780076121417e-13	6.1263893957885784e-9	18	404	81
DOID:14330	Parkinson's disease	GO:2000377	regulation of reactive oxygen species metabolic process	6.830092047493963e-13	1.5063768010747935e-8	12	147	81
DOID:14330	Parkinson's disease	GO:0034599	cellular response to oxidative stress	8.911760218666132e-13	1.9654887162268153e-8	16	219	81
DOID:14330	Parkinson's disease	GO:1901214	regulation of neuron death	5.057620988679901e-12	1.1154583090533521e-7	14	250	81
DOID:14330	Parkinson's disease	GO:0031667	response to nutrient levels	5.324851670707176e-12	1.1743960359744676e-7	20	546	81
DOID:14330	Parkinson's disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	6.787015394138507e-12	1.4968762451772477e-7	9	63	81
DOID:14330	Parkinson's disease	GO:0015696	ammonium transport	7.39885930300943e-12	1.63181841927873e-7	10	92	81
DOID:14330	Parkinson's disease	GO:0001504	neurotransmitter uptake	1.0003886607989898e-11	2.206357191392172e-7	7	25	81
DOID:14330	Parkinson's disease	GO:0051051	negative regulation of transport	1.0566880703777315e-11	2.3305255392180868e-7	17	452	81
DOID:14330	Parkinson's disease	GO:0015844	monoamine transport	1.8001933277389526e-11	3.97032638432826e-7	9	70	81
DOID:14330	Parkinson's disease	GO:0023061	signal release	2.7158830739892892e-11	5.989880119683377e-7	16	416	81
DOID:14330	Parkinson's disease	GO:0014070	response to organic cyclic compound	8.553258101784422e-11	1.8864210743485543e-6	21	873	81
DOID:14330	Parkinson's disease	GO:0015872	dopamine transport	8.643663562679649e-11	1.9063599987489965e-6	7	33	81
DOID:14330	Parkinson's disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	8.760525638251693e-11	1.932133929516411e-6	9	83	81
DOID:14330	Parkinson's disease	GO:0043066	negative regulation of apoptotic process	1.2998868648139705e-10	2.866900480347212e-6	20	795	81
DOID:14330	Parkinson's disease	GO:1903530	regulation of secretion by cell	1.3735190762531602e-10	3.0292963226763447e-6	18	624	81
DOID:14330	Parkinson's disease	GO:1900407	regulation of cellular response to oxidative stress	1.4167067519110788e-10	3.124546741339884e-6	8	58	81
DOID:14330	Parkinson's disease	GO:1901215	negative regulation of neuron death	1.7923595940771975e-10	3.953049084737259e-6	11	170	81
DOID:14330	Parkinson's disease	GO:0060359	response to ammonium ion	2.2406732025359588e-10	4.941804748193057e-6	9	92	81
DOID:14330	Parkinson's disease	GO:0036473	cell death in response to oxidative stress	2.4645796514732865e-10	5.435630421324333e-6	8	62	81
DOID:14330	Parkinson's disease	GO:0006809	nitric oxide biosynthetic process	2.4645796514732865e-10	5.435630421324333e-6	8	62	81
DOID:14330	Parkinson's disease	GO:0043408	regulation of MAPK cascade	2.708478996638064e-10	5.97355042708525e-6	18	651	81
DOID:14330	Parkinson's disease	GO:0051588	regulation of neurotransmitter transport	2.8125446416282784e-10	6.203067207111168e-6	8	63	81
DOID:14330	Parkinson's disease	GO:0045471	response to ethanol	3.906008849696718e-10	8.614702518006112e-6	10	137	81
DOID:14330	Parkinson's disease	GO:0055114	oxidation-reduction process	4.022904231959501e-10	8.87251528358668e-6	21	949	81
DOID:14330	Parkinson's disease	GO:0043549	regulation of kinase activity	4.497582306584036e-10	9.919417777171091e-6	19	761	81
DOID:14330	Parkinson's disease	GO:0051934	catecholamine uptake involved in synaptic transmission	6.137383934401441e-10	1.3536000267322379e-5	5	11	81
DOID:14330	Parkinson's disease	GO:0051583	dopamine uptake involved in synaptic transmission	6.137383934401441e-10	1.3536000267322379e-5	5	11	81
DOID:14330	Parkinson's disease	GO:0010506	regulation of autophagy	6.953072562154716e-10	1.5335001535832227e-5	12	247	81
DOID:14330	Parkinson's disease	GO:0048545	response to steroid hormone	7.183253991627225e-10	1.5842666678533845e-5	15	446	81
DOID:14330	Parkinson's disease	GO:0009636	response to toxic substance	7.620396536012208e-10	1.6806784560174926e-5	12	249	81
DOID:14330	Parkinson's disease	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	8.820773000906001e-10	1.9454214853498186e-5	7	45	81
DOID:14330	Parkinson's disease	GO:2001234	negative regulation of apoptotic signaling pathway	9.65922786200224e-10	2.130342704964594e-5	11	199	81
DOID:14330	Parkinson's disease	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	1.0367402492050815e-9	2.286530619621807e-5	7	46	81
DOID:14330	Parkinson's disease	GO:0010563	negative regulation of phosphorus metabolic process	1.0544504158715995e-9	2.3255903922048127e-5	16	537	81
DOID:14330	Parkinson's disease	GO:0045936	negative regulation of phosphate metabolic process	1.0544504158715995e-9	2.3255903922048127e-5	16	537	81
DOID:14330	Parkinson's disease	GO:0045859	regulation of protein kinase activity	1.059002885384075e-9	2.3356308637145773e-5	18	709	81
DOID:14330	Parkinson's disease	GO:0042420	dopamine catabolic process	1.6379422262957632e-9	3.612481580095306e-5	4	5	81
DOID:14330	Parkinson's disease	GO:0035094	response to nicotine	3.3363596330104883e-9	7.358341170604632e-5	7	54	81
DOID:14330	Parkinson's disease	GO:0051580	regulation of neurotransmitter uptake	3.935335168847587e-9	8.679381714893353e-5	5	15	81
DOID:14330	Parkinson's disease	GO:1903531	negative regulation of secretion by cell	4.045818791098554e-9	8.923053343767862e-5	10	174	81
DOID:14330	Parkinson's disease	GO:1901701	cellular response to oxygen-containing compound	4.273000731025434e-9	9.424103112276594e-5	19	873	81
DOID:2316	brain ischemia	GO:0009607	response to biotic stimulus	6.256328788367682e-12	1.3798333142744923e-7	39	934	81
DOID:2316	brain ischemia	GO:0032101	regulation of response to external stimulus	4.844125101044483e-12	1.0683717910353607e-7	34	920	81
DOID:2316	brain ischemia	GO:0042327	positive regulation of phosphorylation	4.8407944319706075e-12	1.0676372119711175e-7	32	910	81
DOID:2316	brain ischemia	GO:0051050	positive regulation of transport	4.837907852106582e-12	1.0670005767821067e-7	26	920	81
DOID:2316	brain ischemia	GO:0002237	response to molecule of bacterial origin	2.5335289421946072e-12	5.587698082010206e-8	28	333	81
DOID:2316	brain ischemia	GO:0002684	positive regulation of immune system process	2.3097079804301757e-12	5.0940609508387524e-8	30	872	81
DOID:2316	brain ischemia	GO:0006979	response to oxidative stress	1.849853603630436e-12	4.079852122806926e-8	21	386	81
DOID:2316	brain ischemia	GO:0030335	positive regulation of cell migration	1.7887913372760522e-12	3.945179294362333e-8	20	387	81
DOID:2316	brain ischemia	GO:0014070	response to organic cyclic compound	1.7696955012524995e-12	3.903063428012388e-8	28	873	81
DOID:2316	brain ischemia	GO:1901701	cellular response to oxygen-containing compound	1.7696955012524995e-12	3.903063428012388e-8	30	873	81
DOID:2316	brain ischemia	GO:0050673	epithelial cell proliferation	1.7128520823916915e-12	3.7776952677148756e-8	16	335	81
DOID:2316	brain ischemia	GO:0072358	cardiovascular system development	1.5982770662503754e-12	3.525000069615203e-8	23	910	81
DOID:2316	brain ischemia	GO:0030099	myeloid cell differentiation	1.431965657161527e-12	3.1582002568697476e-8	17	327	81
DOID:2316	brain ischemia	GO:0071219	cellular response to molecule of bacterial origin	9.85211912052364e-13	2.1728848720314886e-8	17	158	81
DOID:2316	brain ischemia	GO:0001775	cell activation	9.530154443382344e-13	2.101875562487976e-8	25	854	81
DOID:2316	brain ischemia	GO:0071222	cellular response to lipopolysaccharide	8.502087922579449e-13	1.8751354913248974e-8	17	152	81
DOID:2316	brain ischemia	GO:0031960	response to corticosteroid	7.946976410266871e-13	1.7527056472843583e-8	14	179	81
DOID:2316	brain ischemia	GO:0009991	response to extracellular stimulus	7.915890165577366e-13	1.745849576018088e-8	20	573	81
DOID:2316	brain ischemia	GO:1903036	positive regulation of response to wounding	7.820410985459603e-13	1.7247916428431154e-8	16	162	81
DOID:2316	brain ischemia	GO:0036293	response to decreased oxygen levels	7.425171588693047e-13	1.6376215938862515e-8	17	302	81
DOID:2316	brain ischemia	GO:0070997	neuron death	6.918909889463976e-13	1.5259655761212798e-8	17	281	81
DOID:2316	brain ischemia	GO:0001819	positive regulation of cytokine production	6.603606550470431e-13	1.4564254247062536e-8	17	381	81
DOID:2316	brain ischemia	GO:0050900	leukocyte migration	5.924150059399835e-13	1.3065712956006337e-8	17	354	81
DOID:2316	brain ischemia	GO:0051384	response to glucocorticoid	5.124789481669723e-13	1.1302723201822573e-8	14	167	81
DOID:2316	brain ischemia	GO:0032103	positive regulation of response to external stimulus	4.716227408607665e-13	1.0401639549684205e-8	21	285	81
DOID:2316	brain ischemia	GO:0070555	response to interleukin-1	4.3454129183828627e-13	9.583808191493404e-9	16	119	81
DOID:2316	brain ischemia	GO:0009612	response to mechanical stimulus	1.3078427230084344e-13	2.884447125595102e-9	16	210	81
DOID:2316	brain ischemia	GO:0010573	vascular endothelial growth factor production	1.2279066652354231e-13	2.7081481501767257e-9	9	33	81
DOID:2316	brain ischemia	GO:0050729	positive regulation of inflammatory response	1.0880185641326534e-13	2.399624943194567e-9	15	114	81
DOID:2316	brain ischemia	GO:0010574	regulation of vascular endothelial growth factor production	6.417089082333405e-14	1.4152889971086324e-9	9	31	81
DOID:2316	brain ischemia	GO:0000302	response to reactive oxygen species	5.81756864903582e-14	1.2830647655448502e-9	16	216	81
DOID:2316	brain ischemia	GO:0002573	myeloid leukocyte differentiation	9.992007221626409e-15	2.2037371927297045e-10	13	183	81
DOID:2316	brain ischemia	GO:0031663	lipopolysaccharide-mediated signaling pathway	3.5083047578154947e-14	7.737566143362073e-10	10	49	81
DOID:2316	brain ischemia	GO:0001934	positive regulation of protein phosphorylation	6.195044477408373e-14	1.3663170594924168e-9	30	870	81
DOID:2316	brain ischemia	GO:1901698	response to nitrogen compound	7.782663402622347e-14	1.7164664134483587e-9	25	870	81
DOID:2316	brain ischemia	GO:0001101	response to acid chemical	1.1146639167236572e-13	2.458391268334026e-9	17	315	81
DOID:2316	brain ischemia	GO:0070848	response to growth factor	1.1290968160437842e-13	2.490223027784566e-9	21	621	81
DOID:2316	brain ischemia	GO:0071347	cellular response to interleukin-1	1.9761969838327786e-13	4.358502447843193e-9	14	92	81
DOID:2316	brain ischemia	GO:0071363	cellular response to growth factor stimulus	2.4635848916432224e-13	5.433436478519127e-9	21	594	81
DOID:2316	brain ischemia	GO:0001944	vasculature development	2.582378755278114e-13	5.695436344765881e-9	20	588	81
DOID:2316	brain ischemia	GO:0007568	aging	5.002664948960955e-13	1.1033377544933387e-8	18	290	81
DOID:2316	brain ischemia	GO:0097190	apoptotic signaling pathway	7.048805983345119e-13	1.554614159626766e-8	21	564	81
DOID:2316	brain ischemia	GO:0009636	response to toxic substance	9.71445146547012e-13	2.142522270709435e-8	18	249	81
DOID:2316	brain ischemia	GO:0001568	blood vessel development	9.81992265280951e-13	2.1657839410771373e-8	20	569	81
DOID:2316	brain ischemia	GO:0010942	positive regulation of cell death	1.067479438177088e-12	2.3543259008995676e-8	22	596	81
DOID:2316	brain ischemia	GO:0005125	cytokine activity	1.1007861289158427e-12	2.427783807323891e-8	15	222	81
DOID:2316	brain ischemia	GO:0006953	acute-phase response	1.130540105975797e-12	2.49340620372962e-8	9	53	81
DOID:2316	brain ischemia	GO:0043408	regulation of MAPK cascade	1.1322054405127346e-12	2.4970790990508362e-8	23	651	81
DOID:2316	brain ischemia	GO:0070371	ERK1 and ERK2 cascade	1.2148060335448463e-12	2.6792547069831585e-8	16	247	81
DOID:2316	brain ischemia	GO:0005126	cytokine receptor binding	1.230682222796986e-12	2.7142696423787527e-8	19	270	81
DOID:2316	brain ischemia	GO:0002687	positive regulation of leukocyte migration	1.3522516439934407e-12	2.9823910008275334e-8	11	109	81
DOID:2316	brain ischemia	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.4085399513419361e-12	3.10653486268464e-8	13	195	81
DOID:2316	brain ischemia	GO:0060548	negative regulation of cell death	1.4210854715202004e-12	3.134204007437802e-8	29	867	81
DOID:2316	brain ischemia	GO:0009266	response to temperature stimulus	1.4503953593703045e-12	3.1988469650912066e-8	14	219	81
DOID:2316	brain ischemia	GO:0001666	response to hypoxia	1.6230350396995163e-12	3.579603780057283e-8	17	292	81
DOID:2316	brain ischemia	GO:0034612	response to tumor necrosis factor	1.7854606682021767e-12	3.937833503719901e-8	15	265	81
DOID:2316	brain ischemia	GO:1901214	regulation of neuron death	1.853517339611699e-12	4.087932492513602e-8	15	250	81
DOID:2316	brain ischemia	GO:0070098	chemokine-mediated signaling pathway	1.9283463714714344e-12	4.2529679222802486e-8	10	80	81
DOID:2316	brain ischemia	GO:1901342	regulation of vasculature development	2.0498047703654265e-12	4.520844421040948e-8	14	228	81
DOID:2316	brain ischemia	GO:0070372	regulation of ERK1 and ERK2 cascade	2.208344618281899e-12	4.870504055620728e-8	14	233	81
DOID:2316	brain ischemia	GO:0071407	cellular response to organic cyclic compound	2.5478508192122717e-12	5.6192849817726653e-8	18	416	81
DOID:2316	brain ischemia	GO:0042493	response to drug	2.5992541452524165e-12	5.7326550173542046e-8	18	433	81
DOID:2316	brain ischemia	GO:1903706	regulation of hemopoiesis	2.818079103406035e-12	6.21527346256201e-8	15	305	81
DOID:2316	brain ischemia	GO:0097285	cell-type specific apoptotic process	2.9986013672100853e-12	6.613415315381843e-8	18	429	81
DOID:2316	brain ischemia	GO:0032386	regulation of intracellular transport	3.3132385723888547e-12	7.307347671403619e-8	19	575	81
DOID:2316	brain ischemia	GO:0043068	positive regulation of programmed cell death	3.805844528415037e-12	8.393790107419363e-8	20	561	81
DOID:2316	brain ischemia	GO:0043069	negative regulation of programmed cell death	4.427236355297737e-12	9.764269781609158e-8	29	806	81
DOID:2316	brain ischemia	GO:0043065	positive regulation of apoptotic process	4.85855800036461e-12	1.0715549669804147e-7	20	556	81
DOID:2316	brain ischemia	GO:0043410	positive regulation of MAPK cascade	5.117795076614584e-12	1.1287297041473465e-7	21	464	81
DOID:2316	brain ischemia	GO:0008284	positive regulation of cell proliferation	5.763500787736575e-12	1.2711400987353016e-7	28	815	81
DOID:2316	brain ischemia	GO:0009314	response to radiation	6.033062938115563e-12	1.3305920310013875e-7	17	431	81
DOID:2316	brain ischemia	GO:0010035	response to inorganic substance	6.2021499047659745e-12	1.3678841614961357e-7	21	502	81
DOID:2316	brain ischemia	GO:0031667	response to nutrient levels	6.667888463596228e-12	1.470602800646148e-7	19	546	81
DOID:2316	brain ischemia	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	7.168265980794786e-12	1.58096106206429e-7	24	996	81
DOID:2316	brain ischemia	GO:0070374	positive regulation of ERK1 and ERK2 cascade	7.350897668345624e-12	1.6212404807536274e-7	12	168	81
DOID:2316	brain ischemia	GO:0010243	response to organonitrogen compound	7.511768984613809e-12	1.6567206495565756e-7	25	780	81
DOID:2316	brain ischemia	GO:0043066	negative regulation of apoptotic process	7.732592344211753e-12	1.705423241515902e-7	29	795	81
DOID:2316	brain ischemia	GO:0051604	protein maturation	9.91484672141496e-12	2.1867194444080695e-7	15	332	81
DOID:2316	brain ischemia	GO:0010038	response to metal ion	1.0491496560405267e-11	2.3138995663973816e-7	15	335	81
DOID:2316	brain ischemia	GO:0071496	cellular response to external stimulus	1.0822787110953414e-11	2.3869656973207753e-7	14	270	81
DOID:2316	brain ischemia	GO:0097191	extrinsic apoptotic signaling pathway	1.2149503625380476e-11	2.679573024577664e-7	13	220	81
DOID:2316	brain ischemia	GO:0048660	regulation of smooth muscle cell proliferation	1.7151169373619268e-11	3.7826904053517296e-7	10	100	81
DOID:2316	brain ischemia	GO:0010950	positive regulation of endopeptidase activity	1.780964264952445e-11	3.927916686352617e-7	11	138	81
DOID:2316	brain ischemia	GO:0070201	regulation of establishment of protein localization	2.2965962465093526e-11	5.065143021676377e-7	21	803	81
DOID:2316	brain ischemia	GO:0048514	blood vessel morphogenesis	2.7697399929138555e-11	6.108661554371508e-7	17	484	81
DOID:2316	brain ischemia	GO:0051223	regulation of protein transport	3.2133962157843143e-11	7.087145353912305e-7	20	730	81
DOID:2316	brain ischemia	GO:0007167	enzyme linked receptor protein signaling pathway	3.450406627081293e-11	7.609871816027791e-7	22	935	81
DOID:2316	brain ischemia	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	3.496236633537819e-11	7.71094989526766e-7	15	359	81
DOID:2316	brain ischemia	GO:2000377	regulation of reactive oxygen species metabolic process	3.6433411843006525e-11	8.035388981975089e-7	11	147	81
DOID:2316	brain ischemia	GO:0034349	glial cell apoptotic process	4.2689296542164357e-11	9.415124352374349e-7	6	16	81
DOID:2316	brain ischemia	GO:0043200	response to amino acid	5.2926441007628e-11	1.1672926564232355e-6	10	112	81
DOID:2316	brain ischemia	GO:0016485	protein processing	5.475619957451272e-11	1.207647981615878e-6	14	308	81
DOID:2316	brain ischemia	GO:0097529	myeloid leukocyte migration	5.6535331971474534e-11	1.2468867466308708e-6	11	153	81
DOID:2316	brain ischemia	GO:0002252	immune effector process	5.893929788669539e-11	1.2999062148910667e-6	20	757	81
DOID:2316	brain ischemia	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	6.286349218953546e-11	1.3864543202402047e-6	10	114	81
DOID:2316	brain ischemia	GO:0051222	positive regulation of protein transport	7.39823757811564e-11	1.6316812978534045e-6	16	447	81
DOID:2316	brain ischemia	GO:0009408	response to heat	8.660583361574936e-11	1.910091660395352e-6	11	159	81
DOID:2316	brain ischemia	GO:2000379	positive regulation of reactive oxygen species metabolic process	8.760525638251693e-11	1.932133929516411e-6	9	83	81
DOID:2316	brain ischemia	GO:0045765	regulation of angiogenesis	9.543321688454398e-11	2.1047795983886175e-6	12	208	81
DOID:2316	brain ischemia	GO:0006935	chemotaxis	9.724376859310269e-11	2.1447113163208797e-6	17	530	81
DOID:2316	brain ischemia	GO:0051402	neuron apoptotic process	1.1331924287816264e-10	2.499255901677877e-6	12	211	81
DOID:2316	brain ischemia	GO:0071417	cellular response to organonitrogen compound	1.2205503274742568e-10	2.6919237472444735e-6	16	462	81
DOID:2316	brain ischemia	GO:0042379	chemokine receptor binding	1.223807721828507e-10	2.6991079304927723e-6	8	57	81
DOID:2316	brain ischemia	GO:0007610	behavior	1.5509260542501124e-10	3.420567412648623e-6	19	714	81
DOID:2316	brain ischemia	GO:0097193	intrinsic apoptotic signaling pathway	1.5572632072746728e-10	3.434544003644291e-6	13	272	81
DOID:2316	brain ischemia	GO:0048661	positive regulation of smooth muscle cell proliferation	1.8777490673471675e-10	4.141375568034178e-6	8	60	81
DOID:2316	brain ischemia	GO:0045597	positive regulation of cell differentiation	1.9527068850777596e-10	4.306695035038999e-6	20	815	81
DOID:2316	brain ischemia	GO:1902105	regulation of leukocyte differentiation	2.3885116107180693e-10	5.267862357438702e-6	12	225	81
DOID:2316	brain ischemia	GO:0006809	nitric oxide biosynthetic process	2.4645796514732865e-10	5.435630421324333e-6	8	62	81
DOID:2316	brain ischemia	GO:1904018	positive regulation of vasculature development	2.5046498208780577e-10	5.524005179946556e-6	10	131	81
DOID:2316	brain ischemia	GO:0032388	positive regulation of intracellular transport	2.6585889045804834e-10	5.863517829052256e-6	14	347	81
DOID:2316	brain ischemia	GO:0010638	positive regulation of organelle organization	3.1082603157983613e-10	6.855268126493286e-6	17	573	81
DOID:2316	brain ischemia	GO:0071456	cellular response to hypoxia	3.136495507760628e-10	6.917540842366066e-6	10	134	81
DOID:2316	brain ischemia	GO:1901652	response to peptide	3.4757485778413866e-10	7.665763488429178e-6	15	423	81
DOID:2316	brain ischemia	GO:0044419	interspecies interaction between organisms	4.497582306584036e-10	9.919417777171091e-6	19	761	81
DOID:2316	brain ischemia	GO:0044403	symbiosis, encompassing mutualism through parasitism	4.497582306584036e-10	9.919417777171091e-6	19	761	81
DOID:2316	brain ischemia	GO:1903649	regulation of cytoplasmic transport	5.427478466657476e-10	1.1970303758213063e-5	15	437	81
DOID:2316	brain ischemia	GO:0071356	cellular response to tumor necrosis factor	5.771986222313785e-10	1.2730115613313053e-5	12	243	81
DOID:2316	brain ischemia	GO:0032870	cellular response to hormone stimulus	6.457754331279375e-10	1.4242577177636662e-5	16	519	81
DOID:2316	brain ischemia	GO:0032846	positive regulation of homeostatic process	6.599197854839645e-10	1.4554530868848836e-5	11	192	81
DOID:2316	brain ischemia	GO:0010212	response to ionizing radiation	6.839040445072442e-10	1.508350370160727e-5	10	145	81
DOID:2316	brain ischemia	GO:0097530	granulocyte migration	9.53322865093753e-10	2.1025535789642724e-5	9	108	81
DOID:2316	brain ischemia	GO:0043434	response to peptide hormone	1.1813686695560932e-9	2.6055086007059636e-5	14	389	81
DOID:2316	brain ischemia	GO:0010575	positive regulation of vascular endothelial growth factor production	1.1861126525403165e-9	2.615971455177668e-5	6	26	81
DOID:2316	brain ischemia	GO:0016032	viral process	1.544128269692635e-9	3.4055748988071066e-5	18	726	81
DOID:2316	brain ischemia	GO:1903708	positive regulation of hemopoiesis	1.5855847745882556e-9	3.497007220354398e-5	10	158	81
DOID:2316	brain ischemia	GO:0008009	chemokine activity	1.6466488172994787e-9	3.631683966554e-5	7	49	81
DOID:2316	brain ischemia	GO:0006606	protein import into nucleus	1.7583479117178058e-9	3.878036319293621e-5	12	268	81
DOID:2316	brain ischemia	GO:0002675	positive regulation of acute inflammatory response	1.927611514851435e-9	4.25134719600484e-5	6	28	81
DOID:2316	brain ischemia	GO:0002690	positive regulation of leukocyte chemotaxis	1.9839900833318325e-9	4.3756901287883565e-5	8	80	81
DOID:2316	brain ischemia	GO:0045766	positive regulation of angiogenesis	2.268357279788802e-9	5.0028619805742025e-5	9	119	81
DOID:2316	brain ischemia	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	2.4223265615574974e-9	5.3424412315150605e-5	8	82	81
DOID:2316	brain ischemia	GO:0034599	cellular response to oxidative stress	2.6564948019114354e-9	5.858899285615671e-5	11	219	81
DOID:2316	brain ischemia	GO:0002443	leukocyte mediated immunity	2.768191342816806e-9	6.105246006582465e-5	12	279	81
DOID:2316	brain ischemia	GO:1901215	negative regulation of neuron death	3.2303776320574684e-9	7.124597867502747e-5	10	170	81
DOID:2316	brain ischemia	GO:0071214	cellular response to abiotic stimulus	3.5175738988257876e-9	7.758009233860275e-5	12	285	81
DOID:2316	brain ischemia	GO:0019725	cellular homeostasis	3.9697820586326316e-9	8.755354330314269e-5	18	771	81
DOID:2316	brain ischemia	GO:1902107	positive regulation of leukocyte differentiation	4.041847634361773e-9	8.91429495758489e-5	9	127	81
DOID:2316	brain ischemia	GO:0042063	gliogenesis	4.051258772896915e-9	8.935051223624146e-5	11	228	81
Orphanet:98142	Partial autosomal monosomy	GO:0045165	cell fate commitment	1.3129497489217101e-12	2.8957106712468317e-8	16	243	81
Orphanet:98142	Partial autosomal monosomy	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.3989920333301598e-12	3.0854769295096673e-8	22	623	81
Orphanet:98142	Partial autosomal monosomy	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	4.8197001945027296e-12	1.062984877897577e-7	25	996	81
Orphanet:98142	Partial autosomal monosomy	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	6.438183319801283e-12	1.419941331182173e-7	22	732	81
Orphanet:98142	Partial autosomal monosomy	GO:0048589	developmental growth	2.5624169452953538e-11	5.651410572848903e-7	18	558	81
Orphanet:98142	Partial autosomal monosomy	GO:0009887	organ morphogenesis	5.814382308955146e-11	1.2823620182400575e-6	22	950	81
Orphanet:98142	Partial autosomal monosomy	GO:0044212	transcription regulatory region DNA binding	1.6328227658846117e-10	3.601190610158511e-6	20	807	81
Orphanet:98142	Partial autosomal monosomy	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.0164049601968372e-9	2.2416811397141245e-5	13	317	81
Orphanet:98142	Partial autosomal monosomy	GO:0035295	tube development	2.6651552076373264e-9	5.8779998104441233e-5	16	573	81
DOID:5656	cranial nerve disease	GO:0022904	respiratory electron transport chain	1.1465273175303992e-12	2.5286659988132953e-8	11	105	81
DOID:5656	cranial nerve disease	GO:0005740	mitochondrial envelope	1.5002332709457278e-11	3.3087644790708026e-7	20	694	81
DOID:5656	cranial nerve disease	GO:0007601	visual perception	9.022316227458305e-11	1.989871843965929e-6	12	207	81
MESH:D018213	Neoplasms, Bone Tissue	GO:1902533	positive regulation of intracellular signal transduction	4.914130213862222e-10	1.0838114186673131e-5	20	860	81
MESH:D018213	Neoplasms, Bone Tissue	GO:0005694	chromosome	4.52335258138703e-9	9.976254118249095e-5	19	876	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0044282	small molecule catabolic process	2.6911806116913795e-13	5.935398839085337e-9	16	345	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:1901698	response to nitrogen compound	1.350808354061428e-12	2.9792078248824794e-8	23	870	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0001101	response to acid chemical	5.5605520188350965e-12	1.2263797477540805e-7	15	315	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0033993	response to lipid	5.8906213240561556e-12	1.299176533020585e-7	22	850	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0010817	regulation of hormone levels	7.326583784106333e-12	1.6158780535846518e-7	18	473	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0008202	steroid metabolic process	1.2888246025966055e-11	2.8425026610268134e-7	14	275	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0010243	response to organonitrogen compound	1.8221313347055457e-11	4.018710658693081e-7	21	780	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0042445	hormone metabolic process	2.6428970123504314e-11	5.828909360738876e-7	12	187	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0048545	response to steroid hormone	7.077871622129805e-11	1.5610245862607286e-6	16	446	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0044283	small molecule biosynthetic process	9.724376859310269e-11	2.1447113163208797e-6	17	530	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:1901615	organic hydroxy compound metabolic process	1.1100520502793643e-10	2.448219796891138e-6	17	534	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0030728	ovulation	3.8975667138174686e-10	8.596083387324427e-6	6	22	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0055114	oxidation-reduction process	4.022904231959501e-10	8.87251528358668e-6	21	949	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0007565	female pregnancy	5.901891197979126e-10	1.3016621037142961e-5	11	190	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0097305	response to alcohol	5.961365845408295e-10	1.3147792372047995e-5	14	369	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0009611	response to wounding	6.576007516301274e-10	1.450338457720246e-5	20	875	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0009636	response to toxic substance	7.620396536012208e-10	1.6806784560174926e-5	12	249	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0006066	alcohol metabolic process	9.333742667649858e-10	2.0585569453501762e-5	14	382	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0032496	response to lipopolysaccharide	1.096930213329017e-9	2.419279585497147e-5	13	319	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0043434	response to peptide hormone	1.1813686695560932e-9	2.6055086007059636e-5	14	389	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0051384	response to glucocorticoid	2.7184753337294865e-9	5.9955973485403824e-5	10	167	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0045834	positive regulation of lipid metabolic process	3.270244075537221e-9	7.21252330859734e-5	9	124	81
MESH:D008106	Liver Cirrhosis, Experimental	GO:0019752	carboxylic acid metabolic process	3.679820892443786e-9	8.11584497828477e-5	20	967	81
DOID:341	peripheral vascular disease	GO:0009607	response to biotic stimulus	6.256328788367682e-12	1.3798333142744923e-7	28	934	81
DOID:341	peripheral vascular disease	GO:0072358	cardiovascular system development	4.8403503427607575e-12	1.067539268095885e-7	27	910	81
DOID:341	peripheral vascular disease	GO:0014070	response to organic cyclic compound	1.7696955012524995e-12	3.903063428012388e-8	28	873	81
DOID:341	peripheral vascular disease	GO:0071219	cellular response to molecule of bacterial origin	8.268941087408166e-13	1.823714956827871e-8	13	158	81
DOID:341	peripheral vascular disease	GO:0032103	positive regulation of response to external stimulus	3.927969061123804e-13	8.66313576430855e-9	16	285	81
DOID:341	peripheral vascular disease	GO:0001944	vasculature development	2.6134649999676185e-13	5.763997057428583e-9	22	588	81
DOID:341	peripheral vascular disease	GO:0045765	regulation of angiogenesis	1.3344880755994382e-13	2.943213450734561e-9	14	208	81
DOID:341	peripheral vascular disease	GO:2001057	reactive nitrogen species metabolic process	8.1601392309949e-14	1.7997187073959253e-9	11	68	81
DOID:341	peripheral vascular disease	GO:0045428	regulation of nitric oxide biosynthetic process	8.367750936599805e-13	1.845507469067087e-8	9	51	81
DOID:341	peripheral vascular disease	GO:0005126	cytokine receptor binding	1.2646550473505158e-12	2.7891967069315626e-8	16	270	81
DOID:341	peripheral vascular disease	GO:0030334	regulation of cell migration	1.2727596754302795e-12	2.8070714641614813e-8	22	660	81
DOID:341	peripheral vascular disease	GO:0090130	tissue migration	1.7544854458151349e-12	3.86951765074528e-8	14	227	81
DOID:341	peripheral vascular disease	GO:0007584	response to nutrient	1.937561222575823e-12	4.273291276390978e-8	13	197	81
DOID:341	peripheral vascular disease	GO:0070555	response to interleukin-1	3.2333025146158434e-12	7.131048695985243e-8	11	119	81
DOID:341	peripheral vascular disease	GO:0071345	cellular response to cytokine stimulus	8.478107105247545e-12	1.8698465220623461e-7	20	677	81
DOID:341	peripheral vascular disease	GO:0010035	response to inorganic substance	1.0005662964829298e-11	2.2067489668931017e-7	18	502	81
DOID:341	peripheral vascular disease	GO:0010631	epithelial cell migration	1.044486719337101e-11	2.3036154594979763e-7	13	218	81
DOID:341	peripheral vascular disease	GO:0023014	signal transduction by protein phosphorylation	1.414535155674912e-11	3.1197572858410183e-7	22	879	81
DOID:341	peripheral vascular disease	GO:0050865	regulation of cell activation	1.4386825064605091e-11	3.173014267998653e-7	17	458	81
DOID:341	peripheral vascular disease	GO:0001666	response to hypoxia	2.898192796862986e-11	6.391964213481316e-7	14	292	81
DOID:341	peripheral vascular disease	GO:0043542	endothelial cell migration	4.898970118460966e-11	1.080467859626566e-6	11	151	81
DOID:341	peripheral vascular disease	GO:0032940	secretion by cell	6.682576714212018e-11	1.4738422943194607e-6	22	956	81
DOID:341	peripheral vascular disease	GO:1990748	cellular detoxification	7.831368886712653e-11	1.7272084079644756e-6	9	82	81
DOID:341	peripheral vascular disease	GO:0098771	inorganic ion homeostasis	9.315881399629689e-11	2.054617642688328e-6	18	609	81
DOID:341	peripheral vascular disease	GO:0009897	external side of plasma membrane	1.1913536823726645e-10	2.6275305464729115e-6	12	212	81
DOID:341	peripheral vascular disease	GO:0010632	regulation of epithelial cell migration	1.213862343973915e-10	2.6771733996344693e-6	11	164	81
DOID:341	peripheral vascular disease	GO:0030155	regulation of cell adhesion	1.2584300268514426e-10	2.7754674242208566e-6	18	621	81
DOID:341	peripheral vascular disease	GO:0043066	negative regulation of apoptotic process	1.2998868648139705e-10	2.866900480347212e-6	20	795	81
DOID:341	peripheral vascular disease	GO:0006606	protein import into nucleus	1.3111056684778077e-10	2.891643551827805e-6	13	268	81
DOID:341	peripheral vascular disease	GO:0010876	lipid localization	1.5336054648429354e-10	3.382366852711094e-6	14	333	81
DOID:341	peripheral vascular disease	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	4.1724135257936723e-10	9.202258031137944e-6	14	359	81
DOID:341	peripheral vascular disease	GO:1903522	regulation of blood circulation	4.5819747995778926e-10	1.0105545420469042e-5	13	297	81
DOID:341	peripheral vascular disease	GO:0042311	vasodilation	5.275473391463947e-10	1.1635056564873736e-5	8	68	81
DOID:341	peripheral vascular disease	GO:0055065	metal ion homeostasis	5.961924287589682e-10	1.3149024016279043e-5	16	516	81
DOID:341	peripheral vascular disease	GO:0030003	cellular cation homeostasis	6.457754331279375e-10	1.4242577177636662e-5	16	519	81
DOID:341	peripheral vascular disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	6.792243434361467e-10	1.4980292894484215e-5	9	104	81
DOID:341	peripheral vascular disease	GO:0070371	ERK1 and ERK2 cascade	6.953072562154716e-10	1.5335001535832227e-5	12	247	81
DOID:341	peripheral vascular disease	GO:0001101	response to acid chemical	9.406856404936548e-10	2.0746821801087556e-5	13	315	81
DOID:341	peripheral vascular disease	GO:0046427	positive regulation of JAK-STAT cascade	1.3086240979731656e-9	2.8861704480798167e-5	8	76	81
DOID:341	peripheral vascular disease	GO:0010594	regulation of endothelial cell migration	1.320835774087925e-9	2.9131032997509188e-5	9	112	81
DOID:341	peripheral vascular disease	GO:0098869	cellular oxidant detoxification	1.7918516670434315e-9	3.951928851664288e-5	8	79	81
DOID:341	peripheral vascular disease	GO:0045766	positive regulation of angiogenesis	2.268357279788802e-9	5.0028619805742025e-5	9	119	81
DOID:341	peripheral vascular disease	GO:0008202	steroid metabolic process	2.3521784520141864e-9	5.187729575917288e-5	12	275	81
DOID:341	peripheral vascular disease	GO:0030855	epithelial cell differentiation	2.353686801015442e-9	5.1910562396395576e-5	16	568	81
DOID:341	peripheral vascular disease	GO:0006801	superoxide metabolic process	2.537813847958148e-9	5.5971484416716955e-5	7	52	81
DOID:341	peripheral vascular disease	GO:0050678	regulation of epithelial cell proliferation	2.5519981683430615e-9	5.628431960280622e-5	12	277	81
DOID:341	peripheral vascular disease	GO:0034599	cellular response to oxidative stress	2.6564948019114354e-9	5.858899285615671e-5	11	219	81
DOID:341	peripheral vascular disease	GO:0035295	tube development	2.6651552076373264e-9	5.8779998104441233e-5	16	573	81
DOID:341	peripheral vascular disease	GO:0008217	regulation of blood pressure	2.8805771101758637e-9	6.353112816492867e-5	10	168	81
DOID:341	peripheral vascular disease	GO:0005125	cytokine activity	3.0642495207899856e-9	6.758202318102313e-5	11	222	81
DOID:341	peripheral vascular disease	GO:0044419	interspecies interaction between organisms	3.2363498547738345e-9	7.137769604703692e-5	18	761	81
DOID:341	peripheral vascular disease	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.2363498547738345e-9	7.137769604703692e-5	18	761	81
DOID:341	peripheral vascular disease	GO:0002694	regulation of leukocyte activation	3.6891643073744262e-9	8.136451879914297e-5	14	425	81
DOID:341	peripheral vascular disease	GO:0042306	regulation of protein import into nucleus	4.2763730334627326e-9	9.431540725302057e-5	10	175	81
MESH:D004342	Drug Hypersensitivity	GO:0009607	response to biotic stimulus	6.98530122633656e-12	1.5406081854685283e-7	30	934	82
MESH:D004342	Drug Hypersensitivity	GO:0002237	response to molecule of bacterial origin	2.6632029914708255e-12	5.8736941976889057e-8	21	333	82
MESH:D004342	Drug Hypersensitivity	GO:0033993	response to lipid	1.16995302334999e-12	2.580331392998403e-8	29	850	82
MESH:D004342	Drug Hypersensitivity	GO:0032496	response to lipopolysaccharide	1.2034817586936697e-13	2.6542790187988885e-9	20	319	82
MESH:D004342	Drug Hypersensitivity	GO:0002673	regulation of acute inflammatory response	1.3000711618360583e-13	2.8673069474294266e-9	11	74	82
MESH:D004342	Drug Hypersensitivity	GO:0002700	regulation of production of molecular mediator of immune response	8.496536807456323e-13	1.873911192884492e-8	11	99	82
MESH:D004342	Drug Hypersensitivity	GO:1901568	fatty acid derivative metabolic process	8.496536807456323e-13	1.873911192884492e-8	11	99	82
MESH:D004342	Drug Hypersensitivity	GO:0006690	icosanoid metabolic process	8.496536807456323e-13	1.873911192884492e-8	11	99	82
MESH:D004342	Drug Hypersensitivity	GO:0001816	cytokine production	1.006528194125167e-12	2.2198979321430556e-8	21	613	82
MESH:D004342	Drug Hypersensitivity	GO:0002443	leukocyte mediated immunity	1.2067014054650826e-12	2.6613799497532398e-8	15	279	82
MESH:D004342	Drug Hypersensitivity	GO:0033559	unsaturated fatty acid metabolic process	2.03848049551425e-12	4.495868732856678e-8	11	111	82
MESH:D004342	Drug Hypersensitivity	GO:0007584	response to nutrient	2.5057733665789783e-12	5.5264831599899367e-8	13	197	82
MESH:D004342	Drug Hypersensitivity	GO:0071345	cellular response to cytokine stimulus	2.931765941127651e-12	6.466009783157034e-8	21	677	82
MESH:D004342	Drug Hypersensitivity	GO:0032386	regulation of intracellular transport	4.418465593403198e-12	9.744925866250753e-8	19	575	82
MESH:D004342	Drug Hypersensitivity	GO:0001817	regulation of cytokine production	5.188627305585669e-12	1.1443517522469193e-7	21	556	82
MESH:D004342	Drug Hypersensitivity	GO:0001819	positive regulation of cytokine production	6.872946656244494e-12	1.5158283850347232e-7	16	381	82
MESH:D004342	Drug Hypersensitivity	GO:0050778	positive regulation of immune response	1.0420442286829257e-11	2.2982285463601926e-7	19	603	82
MESH:D004342	Drug Hypersensitivity	GO:0014070	response to organic cyclic compound	1.2446155217560317e-11	2.744999533232928e-7	22	873	82
MESH:D004342	Drug Hypersensitivity	GO:1902533	positive regulation of intracellular signal transduction	1.61268776111001e-11	3.556782857128127e-7	22	860	82
MESH:D004342	Drug Hypersensitivity	GO:0002696	positive regulation of leukocyte activation	1.7957635378706982e-11	3.960556482773825e-7	14	280	82
MESH:D004342	Drug Hypersensitivity	GO:1903530	regulation of secretion by cell	2.0683788015674054e-11	4.5618094468569126e-7	19	624	82
MESH:D004342	Drug Hypersensitivity	GO:0046456	icosanoid biosynthetic process	3.193689757097218e-11	7.043682759277914e-7	8	48	82
MESH:D004342	Drug Hypersensitivity	GO:0051050	positive regulation of transport	3.5424552180529645e-11	7.812884983415813e-7	22	920	82
MESH:D004342	Drug Hypersensitivity	GO:0032880	regulation of protein localization	4.555333887878987e-11	1.0046788889717106e-6	22	933	82
MESH:D004342	Drug Hypersensitivity	GO:0019369	arachidonic acid metabolic process	5.321243445877144e-11	1.1736002419882041e-6	8	51	82
MESH:D004342	Drug Hypersensitivity	GO:0002703	regulation of leukocyte mediated immunity	5.644329448273311e-11	1.2448568598166787e-6	11	151	82
MESH:D004342	Drug Hypersensitivity	GO:0044057	regulation of system process	6.725586754185997e-11	1.4833281586357216e-6	17	508	82
MESH:D004342	Drug Hypersensitivity	GO:0051249	regulation of lymphocyte activation	6.857092671452847e-11	1.5123317886889254e-6	15	372	82
MESH:D004342	Drug Hypersensitivity	GO:0002705	positive regulation of leukocyte mediated immunity	9.8039576457154e-11	2.1622628587625314e-6	9	83	82
MESH:D004342	Drug Hypersensitivity	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.1727951942930304e-10	2.5865998010132785e-6	12	209	82
MESH:D004342	Drug Hypersensitivity	GO:0002449	lymphocyte mediated immunity	1.1727951942930304e-10	2.5865998010132785e-6	12	209	82
MESH:D004342	Drug Hypersensitivity	GO:0045087	innate immune response	1.2749101774289784e-10	2.811814396319612e-6	20	783	82
MESH:D004342	Drug Hypersensitivity	GO:0070201	regulation of establishment of protein localization	1.9016099805924114e-10	4.194000812196563e-6	20	803	82
MESH:D004342	Drug Hypersensitivity	GO:0006636	unsaturated fatty acid biosynthetic process	2.075055682837501e-10	4.576535308498109e-6	8	60	82
MESH:D004342	Drug Hypersensitivity	GO:0006809	nitric oxide biosynthetic process	2.7234936528230946e-10	6.006665251301335e-6	8	62	82
MESH:D004342	Drug Hypersensitivity	GO:0051223	regulation of protein transport	2.806495036367096e-10	6.18972480270763e-6	19	730	82
MESH:D004342	Drug Hypersensitivity	GO:0097190	apoptotic signaling pathway	3.009928972730336e-10	6.6383983493567555e-6	17	564	82
MESH:D004342	Drug Hypersensitivity	GO:0032388	positive regulation of intracellular transport	3.153384220411226e-10	6.954788898116959e-6	14	347	82
MESH:D004342	Drug Hypersensitivity	GO:0002889	regulation of immunoglobulin mediated immune response	3.3325031623121504e-10	7.349835724479448e-6	7	39	82
MESH:D004342	Drug Hypersensitivity	GO:0003013	circulatory system process	3.767395284626218e-10	8.308990300243124e-6	16	493	82
MESH:D004342	Drug Hypersensitivity	GO:0002367	cytokine production involved in immune response	8.298000064854705e-10	1.830123914303705e-5	8	71	82
MESH:D004342	Drug Hypersensitivity	GO:0022407	regulation of cell-cell adhesion	8.997789180398286e-10	1.984462403736842e-5	14	376	82
MESH:D004342	Drug Hypersensitivity	GO:0032602	chemokine production	9.30373333929424e-10	2.0519383879813446e-5	8	72	82
MESH:D004342	Drug Hypersensitivity	GO:0019221	cytokine-mediated signaling pathway	1.1778800157458136e-9	2.597814374727392e-5	16	534	82
MESH:D004342	Drug Hypersensitivity	GO:0071222	cellular response to lipopolysaccharide	1.2287392214815895e-9	2.7099843529776457e-5	10	152	82
MESH:D004342	Drug Hypersensitivity	GO:0051251	positive regulation of lymphocyte activation	1.2657079828670703e-9	2.7915189562133236e-5	12	257	82
MESH:D004342	Drug Hypersensitivity	GO:0002891	positive regulation of immunoglobulin mediated immune response	1.278572359098007e-9	2.8198913379906543e-5	6	26	82
MESH:D004342	Drug Hypersensitivity	GO:0007159	leukocyte cell-cell adhesion	1.3549050770222948e-9	2.988243147372671e-5	15	461	82
MESH:D004342	Drug Hypersensitivity	GO:0050729	positive regulation of inflammatory response	1.7290591181051695e-9	3.8134398849809514e-5	9	114	82
MESH:D004342	Drug Hypersensitivity	GO:0070661	leukocyte proliferation	1.8676441504439367e-9	4.1190891738041024e-5	12	266	82
MESH:D004342	Drug Hypersensitivity	GO:0002675	positive regulation of acute inflammatory response	2.077689575941122e-9	4.582344359738144e-5	6	28	82
MESH:D004342	Drug Hypersensitivity	GO:0050663	cytokine secretion	2.2872699290132914e-9	5.044573828438814e-5	10	162	82
MESH:D004342	Drug Hypersensitivity	GO:0045428	regulation of nitric oxide biosynthetic process	2.404543786305169e-9	5.30322132069605e-5	7	51	82
MESH:D004342	Drug Hypersensitivity	GO:0008015	blood circulation	3.0185818289396593e-9	6.657482223726419e-5	15	489	82
MESH:D004342	Drug Hypersensitivity	GO:0005125	cytokine activity	3.502148016032436e-9	7.723987449359537e-5	11	222	82
MESH:D004342	Drug Hypersensitivity	GO:0034109	homotypic cell-cell adhesion	3.558550010218653e-9	7.848382047537239e-5	15	495	82
MESH:D004342	Drug Hypersensitivity	GO:0020037	heme binding	3.9226180081897155e-9	8.651334017062418e-5	9	125	82
MESH:D004342	Drug Hypersensitivity	GO:0070489	T cell aggregation	4.227202587969714e-9	9.323095307767204e-5	14	424	82
MESH:D004342	Drug Hypersensitivity	GO:0042110	T cell activation	4.227202587969714e-9	9.323095307767204e-5	14	424	82
DOID:0060123	connective tissue benign neoplasm	GO:0050918	positive chemotaxis	4.974887168884834e-11	1.0972113650975501e-6	8	50	83
DOID:0060123	connective tissue benign neoplasm	GO:0001822	kidney development	1.3601275661301315e-10	2.999761347100005e-6	13	262	83
DOID:0060123	connective tissue benign neoplasm	GO:0007050	cell cycle arrest	7.369829191361532e-10	1.625415828154786e-5	12	242	83
DOID:0060123	connective tissue benign neoplasm	GO:0036293	response to decreased oxygen levels	7.69199370864726e-10	1.6964692124421532e-5	13	302	83
DOID:0060123	connective tissue benign neoplasm	GO:0045859	regulation of protein kinase activity	1.6124426238661727e-9	3.556242206936844e-5	18	709	83
DOID:0060123	connective tissue benign neoplasm	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	2.021627087955835e-9	4.4586985424865944e-5	13	327	83
DOID:0060123	connective tissue benign neoplasm	GO:0061061	muscle structure development	2.2198415328134047e-9	4.895860500619964e-5	16	551	83
DOID:0060123	connective tissue benign neoplasm	GO:0048729	tissue morphogenesis	2.222385053762821e-9	4.9014702360739015e-5	17	635	83
DOID:0060123	connective tissue benign neoplasm	GO:0009790	embryo development	3.0905501491318432e-9	6.81620835391028e-5	20	932	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0043583	ear development	9.909850717804147e-13	2.1856175758117047e-8	22	196	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0035315	hair cell differentiation	6.628031457012185e-14	1.4618123378440373e-9	9	39	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0042472	inner ear morphogenesis	4.348743587456738e-13	9.591153982135836e-9	11	92	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0032426	stereocilium tip	8.514200455778109e-11	1.877806910521862e-6	5	8	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0003779	actin binding	1.3287992928212589e-10	2.9306668403172864e-6	15	385	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0031941	filamentous actin	2.3676560712004857e-10	5.221865465032671e-6	6	20	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0016459	myosin complex	5.033170547008581e-10	1.1100657641427425e-5	8	66	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0030898	actin-dependent ATPase activity	1.922891845751451e-9	4.240937965804825e-5	5	13	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0050885	neuromuscular process controlling balance	2.6206318226584813e-9	5.7798034848732804e-5	7	51	83
Orphanet:90635	Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0098590	plasma membrane region	2.7701080318465188e-9	6.109473264237497e-5	20	926	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0019842	vitamin binding	2.601252546696742e-13	5.737062491739664e-9	13	79	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0071705	nitrogen compound transport	2.4289459332749175e-11	5.35704025583783e-7	21	777	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0072511	divalent inorganic cation transport	3.501521295135035e-11	7.72260521642032e-7	16	413	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0044283	small molecule biosynthetic process	1.2734162613270428e-9	2.808519564356793e-5	16	530	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0006898	receptor-mediated endocytosis	1.2783281100325894e-9	2.819352646676876e-5	12	254	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0051188	cofactor biosynthetic process	1.9027549535977073e-9	4.1965260501597434e-5	10	157	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0042886	amide transport	2.1766757285490712e-9	4.8006583193149766e-5	13	329	83
Orphanet:309824	Disorder of metabolite absorption and transport	GO:0050667	homocysteine metabolic process	2.9806949131128135e-9	6.57392263087031e-5	5	14	83
Orphanet:165655	Genetic intestinal disease	GO:0048864	stem cell development	5.619948950652542e-13	1.2394797410664182e-8	16	175	83
Orphanet:165655	Genetic intestinal disease	GO:0010769	regulation of cell morphogenesis involved in differentiation	2.244227026437784e-10	4.9496427068085325e-6	14	334	83
Orphanet:165655	Genetic intestinal disease	GO:0016324	apical plasma membrane	3.949625071442142e-10	8.710898095065644e-6	13	286	83
MESH:D057177	TDP-43 Proteinopathies	GO:0031175	neuron projection development	1.4626980737730833e-9	3.225980601706535e-5	19	796	83
Orphanet:98687	Supranuclear oculomotor palsy	GO:0034622	cellular macromolecular complex assembly	4.155342736567036e-12	9.164608405498598e-8	31	926	83
Orphanet:98687	Supranuclear oculomotor palsy	GO:0046128	purine ribonucleoside metabolic process	1.667110893777135e-12	3.6768130762254714e-8	30	342	83
Orphanet:98687	Supranuclear oculomotor palsy	GO:0055114	oxidation-reduction process	7.198686091669515e-13	1.5876702175177115e-8	36	949	83
Orphanet:98687	Supranuclear oculomotor palsy	GO:0006979	response to oxidative stress	1.4934201653105106e-9	3.293738174592331e-5	14	386	83
DOID:10907	microcephaly	GO:0000278	mitotic cell cycle	2.722044811775959e-12	6.003469832371877e-8	25	927	84
DOID:10907	microcephaly	GO:0007098	centrosome cycle	1.4231948952669882e-12	3.1388563415113424e-8	10	75	84
DOID:10907	microcephaly	GO:1903047	mitotic cell cycle process	2.3102630919424882e-12	5.095285249279158e-8	25	857	84
DOID:10907	microcephaly	GO:0051298	centrosome duplication	5.903388888839345e-12	1.3019924194335175e-7	9	60	84
DOID:10907	microcephaly	GO:0007051	spindle organization	8.70470362457354e-12	1.9198223843996942e-7	11	125	84
DOID:10907	microcephaly	GO:0005815	microtubule organizing center	2.7248536760282605e-11	6.009664782480328e-7	19	617	84
DOID:10907	microcephaly	GO:0044450	microtubule organizing center part	3.500422174340656e-11	7.720181105508317e-7	11	141	84
DOID:10907	microcephaly	GO:0005813	centrosome	4.579403523052861e-11	1.0099874470093084e-6	17	482	84
DOID:10907	microcephaly	GO:0070925	organelle assembly	5.293254723426344e-11	1.1674273292516801e-6	18	565	84
DOID:10907	microcephaly	GO:0000922	spindle pole	1.6483259202004774e-10	3.635382817002153e-6	10	121	84
DOID:10907	microcephaly	GO:0000086	G2/M transition of mitotic cell cycle	5.908635802853723e-10	1.3031496263193887e-5	11	183	84
DOID:10907	microcephaly	GO:0007099	centriole replication	1.898010970613484e-9	4.186063195688039e-5	6	27	84
DOID:10907	microcephaly	GO:0060322	head development	1.9355788083430525e-9	4.268919061800602e-5	18	708	84
DOID:10907	microcephaly	GO:0005874	microtubule	2.075949079305417e-9	4.578505694408097e-5	14	391	84
DOID:10907	microcephaly	GO:0007052	mitotic spindle organization	2.4039652490870367e-9	5.3019453568614594e-5	8	79	84
OMIM:133239	Esophageal Cancer	GO:1902806	regulation of cell cycle G1/S phase transition	3.500422174340656e-11	7.720181105508317e-7	11	141	84
OMIM:133239	Esophageal Cancer	GO:0043627	response to estrogen	2.428636181051047e-10	5.356357097308084e-6	12	217	84
OMIM:133239	Esophageal Cancer	GO:2000045	regulation of G1/S transition of mitotic cell cycle	3.62427421407574e-10	7.993336779144045e-6	10	131	84
Orphanet:90771	Disorder of sex development	GO:0046660	female sex differentiation	5.917488721252084e-13	1.3051021374721472e-8	12	127	85
Orphanet:90771	Disorder of sex development	GO:0009725	response to hormone	4.5075054799781356e-12	9.941303336091778e-8	23	865	85
Orphanet:90771	Disorder of sex development	GO:0035265	organ growth	1.886713008047991e-11	4.161145539249844e-7	11	132	85
Orphanet:90771	Disorder of sex development	GO:0050810	regulation of steroid biosynthetic process	4.288369659377622e-11	9.457999283757346e-7	8	48	85
Orphanet:90771	Disorder of sex development	GO:0048732	gland development	6.617164594047154e-10	1.4594156512170997e-5	15	421	85
Orphanet:90771	Disorder of sex development	GO:0060541	respiratory system development	1.919309267073288e-9	4.233036588530137e-5	11	202	85
Orphanet:90771	Disorder of sex development	GO:0021536	diencephalon development	2.148806577118023e-9	4.7391929058338e-5	8	77	85
MESH:D007569	Jaw Abnormalities	GO:0072358	cardiovascular system development	4.371392137159091e-12	9.641105358504376e-8	25	910	85
MESH:D007569	Jaw Abnormalities	GO:0060537	muscle tissue development	2.7831070781303424e-12	6.13814266081647e-8	17	336	85
MESH:D007569	Jaw Abnormalities	GO:0072089	stem cell proliferation	8.535394613318203e-13	1.8824812819673298e-8	13	139	85
MESH:D007569	Jaw Abnormalities	GO:0030323	respiratory tube development	6.989964163039986e-13	1.5416365961584688e-8	14	179	85
MESH:D007569	Jaw Abnormalities	GO:0001655	urogenital system development	2.227107387398064e-13	4.91188534290643e-9	17	313	85
MESH:D007569	Jaw Abnormalities	GO:0007507	heart development	9.029443859276398e-12	1.9914438431634096e-7	19	487	85
MESH:D007569	Jaw Abnormalities	GO:0043010	camera-type eye development	3.4489855416097726e-11	7.606737612020353e-7	14	283	85
MESH:D007569	Jaw Abnormalities	GO:0001568	blood vessel development	7.1996186790102e-11	1.5878758996556996e-6	18	569	85
MESH:D007569	Jaw Abnormalities	GO:0060688	regulation of morphogenesis of a branching structure	9.869816075536164e-11	2.176787935459501e-6	8	53	85
MESH:D007569	Jaw Abnormalities	GO:0060425	lung morphogenesis	9.869816075536164e-11	2.176787935459501e-6	8	53	85
MESH:D007569	Jaw Abnormalities	GO:0048566	embryonic digestive tract development	1.2216527789377096e-10	2.6943552039471186e-6	7	33	85
MESH:D007569	Jaw Abnormalities	GO:0051241	negative regulation of multicellular organismal process	2.2635571195195325e-10	4.992275227100329e-6	22	966	85
MESH:D007569	Jaw Abnormalities	GO:0051093	negative regulation of developmental process	2.729567682990819e-10	6.020061524836251e-6	20	788	85
MESH:D007569	Jaw Abnormalities	GO:0060602	branch elongation of an epithelium	2.739957150055261e-10	6.042975494446878e-6	6	20	85
MESH:D007569	Jaw Abnormalities	GO:0008589	regulation of smoothened signaling pathway	3.648923385668468e-10	8.047700527091806e-6	8	62	85
MESH:D007569	Jaw Abnormalities	GO:0060174	limb bud formation	4.296499822586952e-10	9.475930358715523e-6	5	10	85
MESH:D007569	Jaw Abnormalities	GO:0048514	blood vessel morphogenesis	4.997079416924066e-10	1.1021058654026028e-5	16	484	85
MESH:D007569	Jaw Abnormalities	GO:0060740	prostate gland epithelium morphogenesis	1.229524038137697e-9	2.711715266112691e-5	6	25	85
MESH:D007569	Jaw Abnormalities	GO:0048701	embryonic cranial skeleton morphogenesis	1.4609883303151605e-9	3.2222097625100865e-5	7	46	85
MESH:D007569	Jaw Abnormalities	GO:0045667	regulation of osteoblast differentiation	1.8859375172652904e-9	4.159435194328598e-5	9	111	85
MESH:D007569	Jaw Abnormalities	GO:0050680	negative regulation of epithelial cell proliferation	2.0433349456894234e-9	4.5065752227180234e-5	9	112	85
Orphanet:98685	Oculomotor palsy	GO:0009117	nucleotide metabolic process	4.169997680492088e-13	9.1969298843253e-9	31	641	85
Orphanet:98685	Oculomotor palsy	GO:0009161	ribonucleoside monophosphate metabolic process	2.1360690993788012e-13	4.711100398679946e-9	29	279	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0034622	cellular macromolecular complex assembly	2.608580018659268e-12	5.753223231153015e-8	28	926	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0046128	purine ribonucleoside metabolic process	2.2792878695554464e-12	5.026969396304537e-8	30	342	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0009108	coenzyme biosynthetic process	9.128253708468037e-13	2.0132363554026256e-8	14	132	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0009117	nucleotide metabolic process	4.169997680492088e-13	9.1969298843253e-9	35	641	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0009161	ribonucleoside monophosphate metabolic process	2.1360690993788012e-13	4.711100398679946e-9	30	279	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0045239	tricarboxylic acid cycle enzyme complex	3.3775204855146512e-12	7.449121430802563e-8	6	11	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	1.925252179901804e-10	4.246143682773429e-6	6	19	85
Orphanet:225703	Mitochondrial disease with peripheral neuropathy	GO:1902600	hydrogen ion transmembrane transport	1.6029868543654402e-9	3.5353875073029783e-5	9	109	85
DOID:363	uterine cancer	GO:0009790	embryo development	4.2801318045349035e-12	9.43983069490173e-8	24	932	85
DOID:363	uterine cancer	GO:0050673	epithelial cell proliferation	3.0175861809311755e-12	6.655286322043708e-8	17	335	85
DOID:363	uterine cancer	GO:0014070	response to organic cyclic compound	1.6704415628510105e-12	3.684158866867904e-8	27	873	85
DOID:363	uterine cancer	GO:0097305	response to alcohol	7.474021401776554e-13	1.648395420161819e-8	18	369	85
DOID:363	uterine cancer	GO:0050678	regulation of epithelial cell proliferation	7.154277170684509e-13	1.5778758299944684e-8	17	277	85
DOID:363	uterine cancer	GO:0030900	forebrain development	5.03375119365046e-13	1.1101938257596089e-8	18	357	85
DOID:363	uterine cancer	GO:0001655	urogenital system development	2.227107387398064e-13	4.91188534290643e-9	17	313	85
DOID:363	uterine cancer	GO:0033993	response to lipid	7.682743330406083e-14	1.6944290415210617e-9	26	850	85
DOID:363	uterine cancer	GO:0060548	negative regulation of cell death	4.937161790508071e-13	1.0888910328965551e-8	28	867	85
DOID:363	uterine cancer	GO:0001890	placenta development	6.236122729319504e-13	1.3753768679514167e-8	12	138	85
DOID:363	uterine cancer	GO:0043627	response to estrogen	9.35473920549157e-13	2.0631877317711655e-8	14	217	85
DOID:363	uterine cancer	GO:0008285	negative regulation of cell proliferation	1.4381829060994278e-12	3.171912399402288e-8	21	634	85
DOID:363	uterine cancer	GO:0032355	response to estradiol	1.6074919173547642e-12	3.5453234237259323e-8	12	145	85
DOID:363	uterine cancer	GO:0071407	cellular response to organic cyclic compound	2.509548124862704e-12	5.534808389384693e-8	18	416	85
DOID:363	uterine cancer	GO:0009887	organ morphogenesis	2.574829238710663e-12	5.6787858859763674e-8	27	950	85
DOID:363	uterine cancer	GO:0040008	regulation of growth	2.781108676686017e-12	6.133735186431011e-8	21	617	85
DOID:363	uterine cancer	GO:0048589	developmental growth	3.333555653739495e-12	7.352156994322456e-8	21	558	85
DOID:363	uterine cancer	GO:0043069	negative regulation of programmed cell death	4.5217163346933376e-12	9.972645376166156e-8	26	806	85
DOID:363	uterine cancer	GO:0043566	structure-specific DNA binding	4.9996673467944674e-12	1.1026766333355198e-7	11	116	85
DOID:363	uterine cancer	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.4074522637392874e-12	1.1926135967676998e-7	25	996	85
DOID:363	uterine cancer	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	6.737499447240225e-12	1.4859555030888316e-7	22	732	85
DOID:363	uterine cancer	GO:0051093	negative regulation of developmental process	6.889155912404021e-12	1.519403336480707e-7	23	788	85
DOID:363	uterine cancer	GO:0035295	tube development	7.201683693836003e-12	1.5883313386755304e-7	19	573	85
DOID:363	uterine cancer	GO:0048732	gland development	8.870792989057463e-12	1.9564533937366235e-7	17	421	85
DOID:363	uterine cancer	GO:0003690	double-stranded DNA binding	1.0011880213767199e-11	2.2081201811463558e-7	22	756	85
DOID:363	uterine cancer	GO:0003682	chromatin binding	1.154598638919424e-11	2.54646729813679e-7	17	433	85
DOID:363	uterine cancer	GO:0032870	cellular response to hormone stimulus	2.0537793687935846e-11	4.529610397874251e-7	18	519	85
DOID:363	uterine cancer	GO:0000228	nuclear chromosome	2.136324450674465e-11	4.7116635759625325e-7	18	520	85
DOID:363	uterine cancer	GO:0001934	positive regulation of protein phosphorylation	2.9668711931662983e-11	6.543434416528271e-7	22	870	85
DOID:363	uterine cancer	GO:0030850	prostate gland development	3.588551678035401e-11	7.914550725907077e-7	8	47	85
DOID:363	uterine cancer	GO:0044212	transcription regulatory region DNA binding	5.910727463032117e-11	1.3036109419717334e-6	21	807	85
DOID:363	uterine cancer	GO:0007423	sensory organ development	7.804790147503127e-11	1.7213464670318146e-6	17	494	85
DOID:363	uterine cancer	GO:0055123	digestive system development	7.855838202175391e-11	1.7326051154897826e-6	11	150	85
DOID:363	uterine cancer	GO:0046661	male sex differentiation	8.45881142907956e-11	1.865590860683497e-6	11	151	85
DOID:363	uterine cancer	GO:0097285	cell-type specific apoptotic process	8.654288397025311e-11	1.9087033059639325e-6	16	429	85
DOID:363	uterine cancer	GO:0007167	enzyme linked receptor protein signaling pathway	1.1292844437349459e-10	2.490636840657423e-6	22	935	85
DOID:363	uterine cancer	GO:0001101	response to acid chemical	1.4686252214346496e-10	3.2390529258741196e-6	14	315	85
DOID:363	uterine cancer	GO:0010942	positive regulation of cell death	1.5216006232776635e-10	3.355890174638887e-6	18	596	85
DOID:363	uterine cancer	GO:0045786	negative regulation of cell cycle	1.683184702727658e-10	3.71226386186585e-6	16	449	85
DOID:363	uterine cancer	GO:0014706	striated muscle tissue development	2.0304780079527518e-10	4.478219246539794e-6	14	323	85
DOID:363	uterine cancer	GO:0044427	chromosomal part	2.1171042696721543e-10	4.669273466761936e-6	20	776	85
DOID:363	uterine cancer	GO:1901698	response to nitrogen compound	2.1820834028574154e-10	4.81258494500203e-6	21	870	85
DOID:363	uterine cancer	GO:0097306	cellular response to alcohol	2.1882595735434052e-10	4.82620648944998e-6	10	123	85
DOID:363	uterine cancer	GO:0072001	renal system development	3.4759650713311885e-10	7.666240964820936e-6	13	276	85
DOID:363	uterine cancer	GO:0046546	development of primary male sexual characteristics	3.5046354707191085e-10	7.729473530670994e-6	10	129	85
DOID:363	uterine cancer	GO:0008584	male gonad development	3.5046354707191085e-10	7.729473530670994e-6	10	129	85
DOID:363	uterine cancer	GO:0035239	tube morphogenesis	3.678573001764107e-10	8.113092755390738e-6	14	338	85
DOID:363	uterine cancer	GO:0007610	behavior	3.7115899242934347e-10	8.18591157802917e-6	19	714	85
DOID:363	uterine cancer	GO:0061061	muscle structure development	3.831480688276656e-10	8.450330657994165e-6	17	551	85
DOID:363	uterine cancer	GO:0043009	chordate embryonic development	3.939507609018733e-10	8.688584031690816e-6	17	552	85
DOID:363	uterine cancer	GO:0048638	regulation of developmental growth	4.712129575423774e-10	1.0392601778597133e-5	13	283	85
DOID:363	uterine cancer	GO:0044454	nuclear chromosome part	5.312027484549731e-10	1.1715676617174431e-5	16	486	85
DOID:363	uterine cancer	GO:0045926	negative regulation of growth	5.458987706319363e-10	1.2039797386287354e-5	12	230	85
DOID:363	uterine cancer	GO:0060284	regulation of cell development	6.382477879540716e-10	1.4076554963327048e-5	20	828	85
DOID:363	uterine cancer	GO:0048565	digestive tract development	6.830134235968899e-10	1.5063861057429406e-5	10	138	85
DOID:363	uterine cancer	GO:0010638	positive regulation of organelle organization	6.907125982280604e-10	1.5233666353919872e-5	17	573	85
DOID:363	uterine cancer	GO:0050767	regulation of neurogenesis	7.433907933673822e-10	1.6395483947717615e-5	18	658	85
DOID:363	uterine cancer	GO:0032354	response to follicle-stimulating hormone	7.848585115155515e-10	1.731005447147549e-5	5	11	85
DOID:363	uterine cancer	GO:0042493	response to drug	9.711725867944665e-10	2.141921140175196e-5	15	433	85
DOID:363	uterine cancer	GO:0050795	regulation of behavior	1.0246554715820366e-9	2.2598776425741818e-5	12	243	85
DOID:363	uterine cancer	GO:0000785	chromatin	1.1361217522320999e-9	2.5057165245478963e-5	15	438	85
DOID:363	uterine cancer	GO:0071363	cellular response to growth factor stimulus	1.195386234442708e-9	2.6364243400633924e-5	17	594	85
DOID:363	uterine cancer	GO:0045596	negative regulation of cell differentiation	1.2908925040022723e-9	2.8470634175770115e-5	17	597	85
DOID:363	uterine cancer	GO:1990837	sequence-specific double-stranded DNA binding	1.3438298251955416e-9	2.963816679468767e-5	18	683	85
DOID:363	uterine cancer	GO:1901214	regulation of neuron death	1.415562778106505e-9	3.122023707113897e-5	12	250	85
DOID:363	uterine cancer	GO:0001558	regulation of cell growth	1.6334695818187583e-9	3.6026171627012715e-5	14	379	85
DOID:363	uterine cancer	GO:0033002	muscle cell proliferation	1.6506276345751303e-9	3.64045924805545e-5	10	151	85
DOID:363	uterine cancer	GO:0050679	positive regulation of epithelial cell proliferation	2.130048804005469e-9	4.6978226372340615e-5	10	155	85
DOID:363	uterine cancer	GO:0070482	response to oxygen levels	2.1890704804405914e-9	4.827994944611724e-5	13	321	85
DOID:363	uterine cancer	GO:0001822	kidney development	2.4062830616955466e-9	5.307057292569528e-5	12	262	85
DOID:363	uterine cancer	GO:0001654	eye development	2.736470272601821e-9	6.035285186223316e-5	13	327	85
DOID:363	uterine cancer	GO:0048729	tissue morphogenesis	3.2672093919217104e-9	7.205830313883332e-5	17	635	85
DOID:363	uterine cancer	GO:0071383	cellular response to steroid hormone stimulus	3.272285442612599e-9	7.217025543682087e-5	10	162	85
DOID:363	uterine cancer	GO:0043065	positive regulation of apoptotic process	3.6388840829459923e-9	8.025558844937386e-5	16	556	85
DOID:363	uterine cancer	GO:0030308	negative regulation of cell growth	4.144064202904474e-9	9.139733599505817e-5	10	166	85
DOID:680	tauopathy	GO:1901698	response to nitrogen compound	1.007638417149792e-12	2.2223465290238664e-8	25	870	86
DOID:680	tauopathy	GO:0050776	regulation of immune response	6.215252756902601e-10	1.3707739955348686e-5	20	816	86
DOID:680	tauopathy	GO:0045321	leukocyte activation	2.1141883799202787e-9	4.662842471914175e-5	18	694	86
DOID:680	tauopathy	GO:1901615	organic hydroxy compound metabolic process	2.4471032977757545e-9	5.3970863232444266e-5	16	534	86
MESH:D038901	Mental Retardation, X-Linked	GO:0016358	dendrite development	9.100677988982397e-10	2.0071545304700678e-5	11	186	86
Orphanet:98026	Rare odontologic disease	GO:0009790	embryo development	3.9817038555156614e-12	8.781647853339791e-8	24	932	86
Orphanet:98026	Rare odontologic disease	GO:0043062	extracellular structure organization	8.320011346540923e-13	1.8349785024796006e-8	19	321	86
Orphanet:98026	Rare odontologic disease	GO:0001503	ossification	8.046896482483135e-13	1.7747430192116553e-8	22	363	86
Orphanet:98026	Rare odontologic disease	GO:0048705	skeletal system morphogenesis	4.707345624410664e-14	1.0382050774637719e-9	14	204	86
Orphanet:98026	Rare odontologic disease	GO:0034505	tooth mineralization	1.0436096431476471e-14	2.3016810679621358e-10	9	19	86
Orphanet:98026	Rare odontologic disease	GO:0001649	osteoblast differentiation	1.4521717162097048e-13	3.202764720100504e-9	14	206	86
Orphanet:98026	Rare odontologic disease	GO:0060349	bone morphogenesis	3.4654501490649636e-12	7.643050303762777e-8	10	80	86
Orphanet:98026	Rare odontologic disease	GO:0048598	embryonic morphogenesis	3.957056904368983e-12	8.727289002585792e-8	21	560	86
Orphanet:98026	Rare odontologic disease	GO:0051216	cartilage development	3.572808715546216e-11	7.87982962213718e-7	12	180	86
Orphanet:98026	Rare odontologic disease	GO:0072358	cardiovascular system development	8.671197093690353e-11	1.9124325190134073e-6	22	910	86
Orphanet:98026	Rare odontologic disease	GO:0007423	sensory organ development	9.351919239009021e-11	2.0625657881634396e-6	17	494	86
Orphanet:98026	Rare odontologic disease	GO:0071363	cellular response to growth factor stimulus	1.7630397142198717e-10	3.888384089711927e-6	18	594	86
Orphanet:98026	Rare odontologic disease	GO:0048736	appendage development	3.0745628265549385e-10	6.780948313966917e-6	11	168	86
Orphanet:98026	Rare odontologic disease	GO:0060173	limb development	3.0745628265549385e-10	6.780948313966917e-6	11	168	86
Orphanet:98026	Rare odontologic disease	GO:0048729	tissue morphogenesis	5.166106431531148e-10	1.1393847734741946e-5	18	635	86
Orphanet:98026	Rare odontologic disease	GO:0002062	chondrocyte differentiation	5.175481154751083e-10	1.1414523686803513e-5	9	95	86
Orphanet:98026	Rare odontologic disease	GO:0007507	heart development	6.570581856379931e-10	1.4491418284245938e-5	16	487	86
Orphanet:98026	Rare odontologic disease	GO:0007389	pattern specification process	1.1163528990110194e-9	2.4621163187688033e-5	15	432	86
Orphanet:98026	Rare odontologic disease	GO:0051093	negative regulation of developmental process	2.3391495407310003e-9	5.158994312082221e-5	19	788	86
Orphanet:98026	Rare odontologic disease	GO:0022405	hair cycle process	3.217116018028321e-9	7.095349377761462e-5	8	80	86
Orphanet:98026	Rare odontologic disease	GO:0001942	hair follicle development	3.217116018028321e-9	7.095349377761462e-5	8	80	86
Orphanet:98026	Rare odontologic disease	GO:0001704	formation of primary germ layer	3.35000871487523e-9	7.38844422065732e-5	9	117	86
Orphanet:98026	Rare odontologic disease	GO:0003007	heart morphogenesis	4.4067589577423405e-9	9.719106881300732e-5	11	216	86
Orphanet:98127	Autosomal anomaly	GO:0072089	stem cell proliferation	8.246343607964945e-10	1.8187310827366687e-5	10	139	86
Orphanet:98127	Autosomal anomaly	GO:0060322	head development	2.8910666083348247e-9	6.376247404682456e-5	18	708	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0051052	regulation of DNA metabolic process	3.178346474896898e-12	7.009843150385109e-8	18	335	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0051249	regulation of lymphocyte activation	1.0627054791711998e-12	2.3437969343120812e-8	17	372	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000784	nuclear chromosome, telomeric region	8.22675261247241e-13	1.81441028868079e-8	13	132	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000723	telomere maintenance	8.126832540256146e-13	1.792372916753493e-8	14	133	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0006302	double-strand break repair	8.124612094206896e-13	1.7918831973773308e-8	22	192	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0010212	response to ionizing radiation	7.66275931596283e-13	1.6900215671356023e-8	16	145	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0004518	nuclease activity	6.916689443414725e-13	1.5254758567451177e-8	14	189	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002440	production of molecular mediator of immune response	6.3860028376439e-13	1.4084329258423622e-8	13	148	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0007126	meiotic nuclear division	3.6703973194107675e-13	8.095061287960448e-9	13	161	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0071897	DNA biosynthetic process	2.3447910280083306e-13	5.171436612272373e-9	15	167	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000732	strand displacement	6.261657858885883e-14	1.3810086407772815e-9	10	26	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	3.574918139293004e-14	7.88448195621072e-10	12	52	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0004003	ATP-dependent DNA helicase activity	1.9539925233402755e-14	4.3095305102269776e-10	9	33	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000731	DNA synthesis involved in DNA repair	3.1308289294429414e-14	6.905043203886407e-10	11	37	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000217	DNA secondary structure binding	4.451994328746878e-14	9.818873492051239e-10	8	24	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000726	non-recombinational repair	6.272760089132134e-14	1.3834572376580923e-9	11	72	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0006260	DNA replication	6.59472476627343e-14	1.454466547201605e-9	16	337	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0051053	negative regulation of DNA metabolic process	1.4199752484955752e-13	3.131755410556991e-9	13	108	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0032508	DNA duplex unwinding	2.4935609133081016e-13	5.499548594301018e-9	12	76	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002377	immunoglobulin production	3.2518432391270835e-13	7.171940263894783e-9	12	81	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0006289	nucleotide-excision repair	3.254063685176334e-13	7.176837457656404e-9	16	115	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0006303	double-strand break repair via nonhomologous end joining	5.259126467649367e-13	1.1599003424400678e-8	10	65	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0044773	mitotic DNA damage checkpoint	7.288614156664153e-13	1.607503852252279e-8	11	92	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0016445	somatic diversification of immunoglobulins	8.985034938291392e-13	1.9816494556401665e-8	9	48	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0010332	response to gamma radiation	1.2526646386845641e-12	2.7627518606188062e-8	9	50	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	1.3287149158713873e-12	2.9304807469543448e-8	11	101	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0010165	response to X-ray	1.3601342274682793e-12	2.99977603868129e-8	8	32	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002696	positive regulation of leukocyte activation	1.503019930737537e-12	3.314910457241638e-8	15	280	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0090305	nucleic acid phosphodiester bond hydrolysis	1.8846035843012032e-12	4.156493205176304e-8	16	252	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0051251	positive regulation of lymphocyte activation	2.4534818621191334e-12	5.411154246903749e-8	15	257	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0022409	positive regulation of cell-cell adhesion	4.822586774366755e-12	1.0636215130865878e-7	14	239	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0004519	endonuclease activity	5.682565529241401e-12	1.253289827474191e-7	11	116	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000724	double-strand break repair via homologous recombination	1.3628320694181184e-11	3.00572612910166e-7	10	92	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0016447	somatic recombination of immunoglobulin gene segments	1.5165646516379638e-11	3.344783339187529e-7	8	42	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0045132	meiotic chromosome segregation	1.8288370817742816e-11	4.033500183853178e-7	9	66	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0006312	mitotic recombination	2.263389475842814e-11	4.991905488971327e-7	8	44	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000109	nucleotide-excision repair complex	2.3314905561733212e-11	5.14210242164026e-7	6	14	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002443	leukocyte mediated immunity	3.43255424084532e-11	7.570498378184354e-7	14	279	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000405	bubble DNA binding	3.8431702265029344e-11	8.476111934552222e-7	5	7	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000014	single-stranded DNA endodeoxyribonuclease activity	3.8431702265029344e-11	8.476111934552222e-7	5	7	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0007568	aging	5.84789994206858e-11	1.2897543322232252e-6	14	290	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.0843837766904016e-10	4.597108419490681e-6	12	209	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002449	lymphocyte mediated immunity	2.0843837766904016e-10	4.597108419490681e-6	12	209	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000018	regulation of DNA recombination	2.308845337140042e-10	5.0921583910623625e-6	8	58	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002312	B cell activation involved in immune response	2.308845337140042e-10	5.0921583910623625e-6	8	58	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0007569	cell aging	3.504803114395827e-10	7.729843268799996e-6	9	91	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002208	somatic diversification of immunoglobulins involved in immune response	3.8565184379280026e-10	8.50555141485021e-6	7	38	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	3.8565184379280026e-10	8.50555141485021e-6	7	38	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0045190	isotype switching	3.8565184379280026e-10	8.50555141485021e-6	7	38	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0000729	DNA double-strand break processing	4.105935591525167e-10	9.055640947108756e-6	6	21	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0032204	regulation of telomere maintenance	6.716085465541255e-10	1.4812326494251238e-5	8	66	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0008022	protein C-terminus binding	6.809204311508665e-10	1.5017700109032361e-5	11	181	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:1901990	regulation of mitotic cell cycle phase transition	8.058673728328358e-10	1.7773404907828194e-5	13	292	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0010225	response to UV-C	8.330660605793128e-10	1.8373271966076743e-5	5	11	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0072331	signal transduction by p53 class mediator	1.7790042772247716e-9	3.923593933419234e-5	12	252	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0032206	positive regulation of telomere maintenance	1.85835680177604e-9	4.098605926317056e-5	7	47	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0016233	telomere capping	2.167595214430662e-9	4.780631245426825e-5	7	48	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0071478	cellular response to radiation	2.7114762657376446e-9	5.980160904084375e-5	10	157	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:1901796	regulation of signal transduction by p53 class mediator	3.461228414991524e-9	7.633739269263806e-5	10	161	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0007095	mitotic G2 DNA damage checkpoint	3.5710034929081758e-9	7.875848203608982e-5	5	14	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0070192	chromosome organization involved in meiotic cell cycle	3.880472276840408e-9	8.558381606571519e-5	7	52	86
MESH:D049914	DNA Repair-Deficiency Disorders	GO:0010259	multicellular organismal aging	4.346860427162369e-9	9.587000672106605e-5	6	30	86
MESH:D010003	Osteoarthritis	GO:0043209	myelin sheath	1.860844811574225e-11	4.104093231926953e-7	12	168	87
MESH:D010003	Osteoarthritis	GO:0055114	oxidation-reduction process	1.6777531586242844e-9	3.700284591345859e-5	21	949	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0007600	sensory perception	2.6687541065939513e-12	5.8859371820929596e-8	25	902	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0048593	camera-type eye morphogenesis	3.2795988147427124e-13	7.233155185915052e-9	15	100	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0044212	transcription regulatory region DNA binding	9.265010980641364e-11	2.043398171780453e-6	21	807	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	4.652503937663255e-10	1.0261097434516309e-5	18	623	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0048562	embryonic organ morphogenesis	5.576363815151808e-10	1.2298670394317313e-5	13	280	87
Orphanet:108985	Non-syndromic developmental defect of the eye	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	2.5275066484198305e-9	5.574415913089936e-5	13	317	87
DOID:9452	fatty liver disease	GO:0002237	response to molecule of bacterial origin	3.5011993304578937e-12	7.721895123324884e-8	18	333	87
DOID:9452	fatty liver disease	GO:0032496	response to lipopolysaccharide	1.1595169269185135e-12	2.5573145823187815e-8	18	319	87
DOID:9452	fatty liver disease	GO:0071219	cellular response to molecule of bacterial origin	7.047695760320494e-13	1.554369299938685e-8	15	158	87
DOID:9452	fatty liver disease	GO:1903035	negative regulation of response to wounding	1.978417429882029e-13	4.363399641604815e-9	13	159	87
DOID:9452	fatty liver disease	GO:0016125	sterol metabolic process	1.4099832412739488e-13	3.109718038629694e-9	12	132	87
DOID:9452	fatty liver disease	GO:0050727	regulation of inflammatory response	5.0888182556718675e-12	1.1223388662884304e-7	15	289	87
DOID:9452	fatty liver disease	GO:0097190	apoptotic signaling pathway	1.0908163261547088e-11	2.4057954073342103e-7	19	564	87
DOID:9452	fatty liver disease	GO:1902533	positive regulation of intracellular signal transduction	1.1320611115195334e-11	2.496760781456331e-7	23	860	87
DOID:9452	fatty liver disease	GO:0001817	regulation of cytokine production	1.2688849970743377e-11	2.7985258610474517e-7	19	556	87
DOID:9452	fatty liver disease	GO:0001101	response to acid chemical	1.5532353181413328e-11	3.4256604941607094e-7	15	315	87
DOID:9452	fatty liver disease	GO:0001819	positive regulation of cytokine production	1.918931680222613e-11	4.232203820730973e-7	16	381	87
DOID:9452	fatty liver disease	GO:0032102	negative regulation of response to external stimulus	3.313349594691317e-11	7.3075925310917e-7	14	275	87
DOID:9452	fatty liver disease	GO:0050728	negative regulation of inflammatory response	3.520772562382035e-11	7.765063886333579e-7	10	100	87
DOID:9452	fatty liver disease	GO:0060548	negative regulation of cell death	4.6798342978604524e-11	1.0321374543931228e-6	22	867	87
DOID:9452	fatty liver disease	GO:1901698	response to nitrogen compound	4.934552766400202e-11	1.0883156126295646e-6	22	870	87
DOID:9452	fatty liver disease	GO:0014070	response to organic cyclic compound	5.1794235567115265e-11	1.1423218654327272e-6	22	873	87
DOID:9452	fatty liver disease	GO:0051241	negative regulation of multicellular organismal process	5.675049319364689e-11	1.2516321273858821e-6	23	966	87
DOID:9452	fatty liver disease	GO:1903530	regulation of secretion by cell	5.920497425648819e-11	1.305765707226847e-6	19	624	87
DOID:9452	fatty liver disease	GO:0002683	negative regulation of immune system process	1.0114054038723452e-10	2.2306546182404574e-6	15	359	87
DOID:9452	fatty liver disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.684994366257797e-10	3.7162550747815715e-6	9	83	87
DOID:9452	fatty liver disease	GO:0008203	cholesterol metabolic process	1.8323786932228359e-10	4.0413112079029645e-6	10	118	87
DOID:9452	fatty liver disease	GO:0050708	regulation of protein secretion	2.2335222560343482e-10	4.926033335683755e-6	15	380	87
DOID:9452	fatty liver disease	GO:0002521	leukocyte differentiation	2.3251423009185146e-10	5.128101344675784e-6	16	448	87
DOID:9452	fatty liver disease	GO:0009743	response to carbohydrate	2.6801294517042606e-10	5.911025505733747e-6	12	211	87
DOID:9452	fatty liver disease	GO:0046890	regulation of lipid biosynthetic process	3.511188007010446e-10	7.743925149461539e-6	10	126	87
DOID:9452	fatty liver disease	GO:0010876	lipid localization	4.1646652793048133e-10	9.185169273506766e-6	14	333	87
DOID:9452	fatty liver disease	GO:0043066	negative regulation of apoptotic process	4.939508801982129e-10	1.0894086662771585e-5	20	795	87
DOID:9452	fatty liver disease	GO:0010817	regulation of hormone levels	5.134366265480139e-10	1.1323844798516447e-5	16	473	87
DOID:9452	fatty liver disease	GO:1902105	regulation of leukocyte differentiation	5.598415064866913e-10	1.2347304425563976e-5	12	225	87
DOID:9452	fatty liver disease	GO:0048878	chemical homeostasis	5.619347209773196e-10	1.2393470271154783e-5	22	988	87
DOID:9452	fatty liver disease	GO:0006641	triglyceride metabolic process	8.341670687528335e-10	1.8397554701343743e-5	9	99	87
DOID:9452	fatty liver disease	GO:0034284	response to monosaccharide	1.157222762060428e-9	2.552254801724274e-5	11	188	87
DOID:9452	fatty liver disease	GO:0006869	lipid transport	1.2951678618478013e-9	2.8564927193053258e-5	13	300	87
DOID:9452	fatty liver disease	GO:0009725	response to hormone	2.0910769782389593e-9	4.611870275506025e-5	20	865	87
DOID:9452	fatty liver disease	GO:2001234	negative regulation of apoptotic signaling pathway	2.1118664594865777e-9	4.657721476397647e-5	11	199	87
DOID:9452	fatty liver disease	GO:0010243	response to organonitrogen compound	2.4328151715380386e-9	5.365573860827144e-5	19	780	87
DOID:9452	fatty liver disease	GO:0006979	response to oxidative stress	2.834586010358464e-9	6.251679445845593e-5	14	386	87
DOID:9452	fatty liver disease	GO:0051093	negative regulation of developmental process	2.874326998636434e-9	6.339328195492655e-5	19	788	87
DOID:9452	fatty liver disease	GO:0006749	glutathione metabolic process	4.211170634427219e-9	9.287736834229232e-5	7	52	87
MESH:D019767	Maxillofacial Abnormalities	GO:0051302	regulation of cell division	2.042810365310288e-14	4.5054182606918403e-10	17	293	88
MESH:D019767	Maxillofacial Abnormalities	GO:0072001	renal system development	1.900701818158268e-13	4.19199785994806e-9	16	276	88
MESH:D019767	Maxillofacial Abnormalities	GO:0007224	smoothened signaling pathway	1.8921841871133438e-10	4.17321222467848e-6	10	117	88
MESH:D019767	Maxillofacial Abnormalities	GO:0003006	developmental process involved in reproduction	5.10305797618571e-10	1.1254794366477583e-5	18	619	88
MESH:D019767	Maxillofacial Abnormalities	GO:0016055	Wnt signaling pathway	4.223942084990995e-9	9.315904268447639e-5	15	465	88
DOID:9884	muscular dystrophy	GO:0060537	muscle tissue development	2.687183808802729e-12	5.9265838903144186e-8	18	336	88
DOID:9884	muscular dystrophy	GO:0003009	skeletal muscle contraction	1.2033707363912072e-11	2.6540341591108074e-7	8	40	88
DOID:9884	muscular dystrophy	GO:0048747	muscle fiber development	8.039136023541005e-11	1.7730314499919686e-6	8	50	88
DOID:9884	muscular dystrophy	GO:0046716	muscle cell cellular homeostasis	2.3811652649641246e-10	5.251659991878377e-6	6	19	88
DOID:9884	muscular dystrophy	GO:0014819	regulation of skeletal muscle contraction	9.366263320487178e-10	2.065729375333447e-5	5	11	88
MESH:D019970	Cocaine-Related Disorders	GO:0043005	neuron projection	3.651301483387215e-12	8.052945421610502e-8	36	941	89
MESH:D019970	Cocaine-Related Disorders	GO:0044463	cell projection part	2.51909604287448e-12	5.555866322559666e-8	27	939	89
MESH:D019970	Cocaine-Related Disorders	GO:0098794	postsynapse	1.6393553181615061e-12	3.615598154205202e-8	22	381	89
MESH:D019970	Cocaine-Related Disorders	GO:0014070	response to organic cyclic compound	1.1783907183371412e-12	2.5989407292925648e-8	27	873	89
MESH:D019970	Cocaine-Related Disorders	GO:0007270	neuron-neuron synaptic transmission	9.341416529196067e-13	2.0602494155141926e-8	13	130	89
MESH:D019970	Cocaine-Related Disorders	GO:0015850	organic hydroxy compound transport	6.907807659217724e-13	1.523516979240469e-8	17	230	89
MESH:D019970	Cocaine-Related Disorders	GO:0048167	regulation of synaptic plasticity	6.405986852087153e-13	1.4128404002278216e-8	13	140	89
MESH:D019970	Cocaine-Related Disorders	GO:1901698	response to nitrogen compound	5.844214001626824e-13	1.288941398058796e-8	26	870	89
MESH:D019970	Cocaine-Related Disorders	GO:0044708	single-organism behavior	4.5297099404706387e-13	9.990275273707994e-9	26	404	89
MESH:D019970	Cocaine-Related Disorders	GO:0007631	feeding behavior	9.126033262418787e-14	2.0127466360264634e-9	16	106	89
MESH:D019970	Cocaine-Related Disorders	GO:0007611	learning or memory	5.5067062021407764e-14	1.2145040528821482e-9	18	218	89
MESH:D019970	Cocaine-Related Disorders	GO:0051937	catecholamine transport	8.104628079763643e-14	1.7874757229918714e-9	11	58	89
MESH:D019970	Cocaine-Related Disorders	GO:0007612	learning	1.8884893648873913e-13	4.1650632942591415e-9	12	130	89
MESH:D019970	Cocaine-Related Disorders	GO:0015696	ammonium transport	3.687050664780145e-13	8.13179024117261e-9	12	92	89
MESH:D019970	Cocaine-Related Disorders	GO:0050432	catecholamine secretion	9.504619313815965e-13	2.096243789662111e-8	9	46	89
MESH:D019970	Cocaine-Related Disorders	GO:0060359	response to ammonium ion	9.50572953684059e-13	2.0964886493501922e-8	11	92	89
MESH:D019970	Cocaine-Related Disorders	GO:0042220	response to cocaine	1.0340617251358708e-12	2.280623134787163e-8	9	47	89
MESH:D019970	Cocaine-Related Disorders	GO:0030424	axon	1.3703482792948307e-12	3.022303129984749e-8	22	414	89
MESH:D019970	Cocaine-Related Disorders	GO:0030425	dendrite	1.4939161019356106e-12	3.294831962818989e-8	19	451	89
MESH:D019970	Cocaine-Related Disorders	GO:0097060	synaptic membrane	1.6807666369800245e-12	3.706930817859444e-8	15	256	89
MESH:D019970	Cocaine-Related Disorders	GO:0019233	sensory perception of pain	1.921574011021221e-12	4.238031481307303e-8	11	101	89
MESH:D019970	Cocaine-Related Disorders	GO:0023061	signal release	2.0587975768648903e-12	4.5406780557755155e-8	20	416	89
MESH:D019970	Cocaine-Related Disorders	GO:0015872	dopamine transport	2.4110713425784525e-12	5.317617846056777e-8	8	33	89
MESH:D019970	Cocaine-Related Disorders	GO:0043269	regulation of ion transport	2.4789059693830495e-12	5.467227115474316e-8	20	583	89
MESH:D019970	Cocaine-Related Disorders	GO:0044057	regulation of system process	9.281353463563846e-12	2.0470025063890063e-7	19	508	89
MESH:D019970	Cocaine-Related Disorders	GO:0045211	postsynaptic membrane	1.6108114841983934e-11	3.5526447283995566e-7	13	206	89
MESH:D019970	Cocaine-Related Disorders	GO:0044297	cell body	2.209676885911449e-11	4.873442371877701e-7	18	494	89
MESH:D019970	Cocaine-Related Disorders	GO:0043025	neuronal cell body	2.336553173165612e-11	5.153268023416757e-7	17	434	89
MESH:D019970	Cocaine-Related Disorders	GO:0050433	regulation of catecholamine secretion	2.4607760273909207e-11	5.427241528410676e-7	8	43	89
MESH:D019970	Cocaine-Related Disorders	GO:0007613	memory	4.0142777990581635e-11	8.85348968582278e-7	10	99	89
MESH:D019970	Cocaine-Related Disorders	GO:0030534	adult behavior	4.1431857944473904e-11	9.13779626965372e-7	11	135	89
MESH:D019970	Cocaine-Related Disorders	GO:0033993	response to lipid	5.081945975149438e-11	1.1208231848192085e-6	22	850	89
MESH:D019970	Cocaine-Related Disorders	GO:0044706	multi-multicellular organism process	9.661860200793626e-11	2.1309232672850342e-6	13	237	89
MESH:D019970	Cocaine-Related Disorders	GO:0050795	regulation of behavior	1.3177436919420416e-10	2.9062837125781726e-6	13	243	89
MESH:D019970	Cocaine-Related Disorders	GO:0060291	long-term synaptic potentiation	1.4382006696678218e-10	3.171951576952381e-6	8	53	89
MESH:D019970	Cocaine-Related Disorders	GO:0006816	calcium ion transport	1.856849118908599e-10	4.095280731752915e-6	15	366	89
MESH:D019970	Cocaine-Related Disorders	GO:0097305	response to alcohol	2.07029060561581e-10	4.566025930685669e-6	15	369	89
MESH:D019970	Cocaine-Related Disorders	GO:0051051	negative regulation of transport	3.753622968005743e-10	8.278615455936666e-6	16	452	89
MESH:D019970	Cocaine-Related Disorders	GO:0030431	sleep	4.0323000494169037e-10	8.893237758988981e-6	7	37	89
MESH:D019970	Cocaine-Related Disorders	GO:0033267	axon part	4.840804423977829e-10	1.0676394157083102e-5	12	217	89
MESH:D019970	Cocaine-Related Disorders	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	6.131658514263449e-10	1.3523372853208038e-5	11	173	89
MESH:D019970	Cocaine-Related Disorders	GO:0014046	dopamine secretion	6.937816987573342e-10	1.5301355366093006e-5	6	22	89
MESH:D019970	Cocaine-Related Disorders	GO:0014059	regulation of dopamine secretion	6.937816987573342e-10	1.5301355366093006e-5	6	22	89
MESH:D019970	Cocaine-Related Disorders	GO:0060259	regulation of feeding behavior	6.937816987573342e-10	1.5301355366093006e-5	6	22	89
MESH:D019970	Cocaine-Related Disorders	GO:0001505	regulation of neurotransmitter levels	8.812739427099814e-10	1.943649680646864e-5	11	179	89
MESH:D019970	Cocaine-Related Disorders	GO:0007218	neuropeptide signaling pathway	9.35240884736288e-10	2.0626737712858834e-5	9	98	89
MESH:D019970	Cocaine-Related Disorders	GO:0043270	positive regulation of ion transport	1.0928821181366288e-9	2.410351511550335e-5	12	233	89
MESH:D019970	Cocaine-Related Disorders	GO:0007215	glutamate receptor signaling pathway	1.132253291125096e-9	2.4971846335763992e-5	8	68	89
MESH:D019970	Cocaine-Related Disorders	GO:0035249	synaptic transmission, glutamatergic	1.434605656491783e-9	3.1640227753926276e-5	8	70	89
MESH:D019970	Cocaine-Related Disorders	GO:0042749	regulation of circadian sleep/wake cycle	1.627949774984927e-9	3.5904432287292565e-5	6	25	89
MESH:D019970	Cocaine-Related Disorders	GO:0044060	regulation of endocrine process	1.7231864823941123e-9	3.800487786920215e-5	7	45	89
MESH:D019970	Cocaine-Related Disorders	GO:0007188	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	1.8801044054939098e-9	4.146570266316818e-5	10	146	89
MESH:D019970	Cocaine-Related Disorders	GO:0008306	associative learning	2.0192697514076485e-9	4.453499436729569e-5	8	73	89
MESH:D019970	Cocaine-Related Disorders	GO:0051048	negative regulation of secretion	2.182881875256726e-9	4.814345975878709e-5	11	195	89
MESH:D019970	Cocaine-Related Disorders	GO:0043204	perikaryon	2.2353981998790573e-9	4.930170729833261e-5	9	108	89
MESH:D019970	Cocaine-Related Disorders	GO:0046883	regulation of hormone secretion	2.663207876452134e-9	5.873704971515181e-5	12	252	89
MESH:D019970	Cocaine-Related Disorders	GO:1901699	cellular response to nitrogen compound	2.676297072845557e-9	5.902573194160876e-5	16	518	89
MESH:D019970	Cocaine-Related Disorders	GO:0048545	response to steroid hormone	2.823944522667432e-9	6.228209644743021e-5	15	446	89
MESH:D019970	Cocaine-Related Disorders	GO:0001664	G-protein coupled receptor binding	3.043608809427667e-9	6.71267922919272e-5	12	255	89
MESH:D019970	Cocaine-Related Disorders	GO:0048168	regulation of neuronal synaptic plasticity	3.2118436799066785e-9	7.08372123603418e-5	7	49	89
MESH:D019970	Cocaine-Related Disorders	GO:0060986	endocrine hormone secretion	3.2118436799066785e-9	7.08372123603418e-5	7	49	89
MESH:D019970	Cocaine-Related Disorders	GO:1900542	regulation of purine nucleotide metabolic process	3.332970455183215e-9	7.350866338906581e-5	11	203	89
MESH:D019970	Cocaine-Related Disorders	GO:0030817	regulation of cAMP biosynthetic process	3.346717791785636e-9	7.38118608978322e-5	9	113	89
MESH:D019970	Cocaine-Related Disorders	GO:0022410	circadian sleep/wake cycle process	3.4236639079310294e-9	7.550890748941885e-5	6	28	89
MESH:D019970	Cocaine-Related Disorders	GO:0051966	regulation of synaptic transmission, glutamatergic	3.7203390368389933e-9	8.2052077457484e-5	7	50	89
MESH:D019970	Cocaine-Related Disorders	GO:0043679	axon terminus	4.224124161567033e-9	9.316305838336092e-5	9	116	89
MESH:D009423	Nervous System Neoplasms	GO:0007417	central nervous system development	2.2947421740582286e-11	5.061053864885423e-7	23	889	89
MESH:D009423	Nervous System Neoplasms	GO:0051338	regulation of transferase activity	2.7024527060603987e-10	5.960259443216209e-6	22	928	89
MESH:D009423	Nervous System Neoplasms	GO:0051961	negative regulation of nervous system development	2.8876034896541114e-10	6.368609496432143e-6	13	259	89
MESH:D009423	Nervous System Neoplasms	GO:0045859	regulation of protein kinase activity	7.552010128364373e-10	1.6655958338107624e-5	19	709	89
MESH:D009423	Nervous System Neoplasms	GO:0045597	positive regulation of cell differentiation	1.1571856806114056e-9	2.552173018588455e-5	20	815	89
MESH:D009423	Nervous System Neoplasms	GO:0072089	stem cell proliferation	1.1623321194420555e-9	2.5635234894294534e-5	10	139	89
MESH:D009423	Nervous System Neoplasms	GO:0050768	negative regulation of neurogenesis	1.3932309750330774e-9	3.072770915435452e-5	12	238	89
MESH:D009423	Nervous System Neoplasms	GO:0048534	hematopoietic or lymphoid organ development	1.5033253530916113e-9	3.315584066243549e-5	19	739	89
MESH:D009423	Nervous System Neoplasms	GO:0071900	regulation of protein serine/threonine kinase activity	1.7754456793639406e-9	3.915745445837171e-5	15	431	89
MESH:D009423	Nervous System Neoplasms	GO:0007167	enzyme linked receptor protein signaling pathway	1.9971284626052466e-9	4.404666824275871e-5	21	935	89
MESH:D009423	Nervous System Neoplasms	GO:0048715	negative regulation of oligodendrocyte differentiation	2.7430453464205584e-9	6.0497865115305416e-5	5	13	89
MESH:D009423	Nervous System Neoplasms	GO:0021782	glial cell development	2.7998924290173477e-9	6.17516275219776e-5	8	76	89
MESH:D009423	Nervous System Neoplasms	GO:1902533	positive regulation of intracellular signal transduction	2.900353401891209e-9	6.396729427871062e-5	20	860	89
MESH:D009423	Nervous System Neoplasms	GO:1902692	regulation of neuroblast proliferation	3.4236639079310294e-9	7.550890748941885e-5	6	28	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0040007	growth	6.714628852932947e-13	1.4809113935143614e-8	24	936	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048608	reproductive structure development	1.032174345994008e-12	2.2764605200897847e-8	21	418	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0007548	sex differentiation	2.419175970658216e-12	5.3354926032866956e-8	15	274	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048732	gland development	1.5385692719860344e-11	3.393314529365199e-7	17	421	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0008406	gonad development	3.8221648068770264e-11	8.429784481567282e-7	13	220	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0021761	limbic system development	4.4301340373920084e-11	9.770660619468075e-7	10	100	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048638	regulation of developmental growth	6.652622897007632e-11	1.4672359799350332e-6	14	283	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0009887	organ morphogenesis	4.32594737809211e-10	9.540876942382148e-6	22	950	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0043473	pigmentation	4.787065188693873e-10	1.0557872273664337e-5	9	91	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0046661	male sex differentiation	2.6104446382291258e-9	5.757335649614337e-5	10	151	89
Orphanet:400011	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048639	positive regulation of developmental growth	2.966761170064558e-9	6.543191760577383e-5	10	153	89
MESH:D003389	Cranial Nerve Diseases	GO:0007423	sensory organ development	1.5819012766371543e-10	3.488883265623244e-6	17	494	89
MESH:D003389	Cranial Nerve Diseases	GO:0001654	eye development	4.5026093964395386e-10	9.930505023847402e-6	14	327	89
DOID:699	mitochondrial myopathy	GO:0046034	ATP metabolic process	5.81534820298657e-13	1.282575046168688e-8	28	230	90
DOID:699	mitochondrial myopathy	GO:0005759	mitochondrial matrix	1.5131229602616258e-12	3.337192688857016e-8	27	412	90
DOID:4138	bile duct disease	GO:0033993	response to lipid	2.9185257544028786e-9	6.436808551335549e-5	20	850	90
DOID:4138	bile duct disease	GO:0071222	cellular response to lipopolysaccharide	3.110120827543028e-9	6.859371485146148e-5	10	152	90
DOID:50	thyroid gland disease	GO:0014070	response to organic cyclic compound	8.100187187665142e-13	1.786496284239547e-8	25	873	90
DOID:50	thyroid gland disease	GO:0033993	response to lipid	7.708278459972462e-13	1.7000608143469265e-8	24	850	90
DOID:50	thyroid gland disease	GO:0048545	response to steroid hormone	5.217049015016073e-12	1.1506201602617949e-7	18	446	90
DOID:50	thyroid gland disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	3.492794942161481e-11	7.703359244937147e-7	21	732	90
DOID:50	thyroid gland disease	GO:0060548	negative regulation of cell death	9.54382128881548e-11	2.104889785248254e-6	22	867	90
DOID:50	thyroid gland disease	GO:0043066	negative regulation of apoptotic process	1.4081746879668344e-10	3.1057292743108533e-6	21	795	90
DOID:50	thyroid gland disease	GO:0010035	response to inorganic substance	2.39690600700726e-10	5.286376198454512e-6	17	502	90
DOID:50	thyroid gland disease	GO:0031667	response to nutrient levels	8.50233550231394e-10	1.8751900950353395e-5	17	546	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0009790	embryo development	5.784706047506916e-12	1.2758169187776502e-7	30	932	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0072358	cardiovascular system development	4.74909001013657e-12	1.0474118017356204e-7	26	910	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0040007	growth	4.682698673263985e-12	1.032769192388372e-7	25	936	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0051726	regulation of cell cycle	4.433786671143025e-12	9.778716503205942e-8	29	930	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0006259	DNA metabolic process	3.0802027595200343e-12	6.793387186121436e-8	25	937	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0050673	epithelial cell proliferation	2.4069635173873394e-12	5.308558037597777e-8	17	335	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0050678	regulation of epithelial cell proliferation	6.037392807911601e-13	1.3315469837849037e-8	16	277	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001655	urogenital system development	5.326850072151501e-13	1.1748367834130136e-8	19	313	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0008285	negative regulation of cell proliferation	1.1879386363489175e-13	2.6199986624675375e-9	27	634	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0072001	renal system development	2.950972799453666e-13	6.5083705091950605e-9	16	276	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001822	kidney development	8.802958362252866e-13	1.9414924667948696e-8	16	262	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0051052	regulation of DNA metabolic process	2.4142909893498654e-12	5.324718777011128e-8	16	335	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0043009	chordate embryonic development	2.479683125500287e-12	5.468941133290883e-8	23	552	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0048732	gland development	2.7954305537036817e-12	6.16532208619347e-8	20	421	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0034504	protein localization to nucleus	5.4003468363816864e-12	1.191046494763981e-7	16	344	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007507	heart development	8.666622974828897e-12	1.9114236970985132e-7	20	487	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007224	smoothened signaling pathway	9.815703805315934e-12	2.1648534742624292e-7	11	117	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007050	cell cycle arrest	1.129307758418463e-11	2.49068826119192e-7	14	242	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0040008	regulation of growth	1.297451035497943e-11	2.861528258790713e-7	20	617	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:1903827	regulation of cellular protein localization	1.3231638007482616e-11	2.918237762550291e-7	19	543	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001503	ossification	1.668876148386289e-11	3.6807063452659605e-7	16	363	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0051241	negative regulation of multicellular organismal process	1.84323667440367e-11	4.065258485397294e-7	24	966	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0051093	negative regulation of developmental process	2.1270318839583524e-11	4.691168820070146e-7	22	788	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001701	in utero embryonic development	2.288136347061709e-11	5.046484713444599e-7	15	312	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007346	regulation of mitotic cell cycle	4.986577817334137e-11	1.0997897376130439e-6	17	453	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0043549	regulation of kinase activity	6.81928957746436e-11	1.5039943163097647e-6	21	761	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0045926	negative regulation of growth	7.559330938988751e-11	1.667210438593969e-6	13	230	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0030155	regulation of cell adhesion	9.940381850981339e-11	2.1923512172339343e-6	19	621	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001934	positive regulation of protein phosphorylation	1.0149459050978749e-10	2.238463193693363e-6	22	870	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0002520	immune system development	1.0508260928077107e-10	2.317596947687406e-6	21	782	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0014070	response to organic cyclic compound	1.0777090331259842e-10	2.376887272559358e-6	22	873	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0045165	cell fate commitment	1.5240886330758485e-10	3.361377480248784e-6	13	243	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0050680	negative regulation of epithelial cell proliferation	1.5378542883581758e-10	3.391737632973957e-6	10	112	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0048598	embryonic morphogenesis	1.5383383455969124e-10	3.3928052212139903e-6	18	560	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0022603	regulation of anatomical structure morphogenesis	1.7677803665350211e-10	3.898839598392989e-6	23	986	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0097285	cell-type specific apoptotic process	2.0936075095789874e-10	4.617451362376457e-6	16	429	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0035295	tube development	2.1600288224732367e-10	4.7639435679647235e-6	18	573	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0009314	response to radiation	2.2434321067521523e-10	4.947889511441872e-6	16	431	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0045787	positive regulation of cell cycle	2.398505838385745e-10	5.2899046265597605e-6	14	308	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0048645	organ formation	3.8501424270975804e-10	8.491489122963713e-6	8	59	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001656	metanephros development	3.9084724345883615e-10	8.620135954484631e-6	9	88	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007167	enzyme linked receptor protein signaling pathway	3.9268410745307847e-10	8.660647989877646e-6	22	935	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0000228	nuclear chromosome	4.0654968280762205e-10	8.966453254322104e-6	17	520	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:1900180	regulation of protein localization to nucleus	4.4690817713188835e-10	9.856559846643798e-6	12	213	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0009725	response to hormone	6.177178768496105e-10	1.362376777391816e-5	21	865	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0035270	endocrine system development	6.232470095568488e-10	1.37457127957763e-5	10	129	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0045859	regulation of protein kinase activity	9.235433529042325e-10	2.0368748648302848e-5	19	709	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001657	ureteric bud development	9.433454017937493e-10	2.080548283656114e-5	9	97	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0007417	central nervous system development	1.0176176568066353e-9	2.244355742087034e-5	21	889	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0048729	tissue morphogenesis	1.126889359603922e-9	2.48535448260645e-5	18	635	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0000904	cell morphogenesis involved in differentiation	1.1971510449626521e-9	2.6403166296651293e-5	19	720	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0010564	regulation of cell cycle process	1.2787328973473677e-9	2.8202454050996195e-5	17	561	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0048608	reproductive structure development	1.373544500360424e-9	3.0293523955449153e-5	15	418	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0060284	regulation of cell development	1.8682924096680154e-9	4.120518909522808e-5	20	828	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0010212	response to ionizing radiation	1.964631679562956e-9	4.332995169276099e-5	10	145	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0060562	epithelial tube morphogenesis	2.0748436302397977e-9	4.576067626493874e-5	13	301	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0042493	response to drug	2.2213292316664024e-9	4.8991416204402505e-5	15	433	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0051053	negative regulation of DNA metabolic process	2.471883253640783e-9	5.451738515904747e-5	9	108	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0072331	signal transduction by p53 class mediator	3.0364728509368888e-9	6.696940872741308e-5	12	252	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0010942	positive regulation of cell death	3.1733494720853628e-9	6.998822260684268e-5	17	596	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0019900	kinase binding	3.336034559708878e-9	7.35762422143793e-5	17	598	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0044427	chromosomal part	4.081606608252741e-9	9.001983374501421e-5	19	776	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0001649	osteoblast differentiation	4.386707774806098e-9	9.674883997334849e-5	11	206	90
MESH:D009386	Neoplastic Syndromes, Hereditary	GO:0006913	nucleocytoplasmic transport	4.388934438104286e-9	9.679794903239003e-5	16	530	90
Orphanet:101940	Rare metabolic liver disease	GO:0008206	bile acid metabolic process	8.959499808725013e-14	1.9760176828143017e-9	10	41	90
Orphanet:101940	Rare metabolic liver disease	GO:0044723	single-organism carbohydrate metabolic process	8.066880496926387e-13	1.7791504935971147e-8	31	665	90
Orphanet:101940	Rare metabolic liver disease	GO:0006012	galactose metabolic process	9.550804591640372e-12	2.106429952686284e-7	6	12	90
Orphanet:101940	Rare metabolic liver disease	GO:0046916	cellular transition metal ion homeostasis	1.8360724052257638e-10	4.049457689725422e-6	9	81	90
Orphanet:101940	Rare metabolic liver disease	GO:0055114	oxidation-reduction process	5.339280129135204e-10	1.1775782324807693e-5	22	949	90
Orphanet:101940	Rare metabolic liver disease	GO:0044724	single-organism carbohydrate catabolic process	1.210892608405345e-9	2.6706236478379886e-5	10	138	90
Orphanet:101940	Rare metabolic liver disease	GO:0005319	lipid transporter activity	1.9217843982843874e-9	4.2384954904162164e-5	9	105	90
Orphanet:101940	Rare metabolic liver disease	GO:1990267	response to transition metal nanoparticle	2.7340438801815026e-9	6.029933777740304e-5	10	150	90
Orphanet:101940	Rare metabolic liver disease	GO:0005980	glycogen catabolic process	3.664541670111987e-9	8.082146653431987e-5	6	28	90
Orphanet:68416	Rare infectious disease	GO:0050778	positive regulation of immune response	1.5845103007450234e-12	3.494637468293149e-8	27	603	91
Orphanet:68416	Rare infectious disease	GO:0001819	positive regulation of cytokine production	1.4506174039752295e-12	3.199336684467369e-8	23	381	91
Orphanet:68416	Rare infectious disease	GO:0032496	response to lipopolysaccharide	1.3351542094142133e-12	2.9446826088630473e-8	23	319	91
Orphanet:68416	Rare infectious disease	GO:0032101	regulation of response to external stimulus	1.1011191958232303e-12	2.4285183863881343e-8	25	920	91
Orphanet:68416	Rare infectious disease	GO:0045088	regulation of innate immune response	1.0473844014313727e-12	2.3100062973568924e-8	21	351	91
Orphanet:68416	Rare infectious disease	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	8.166800569142652e-13	1.8011878655244118e-8	14	180	91
Orphanet:68416	Rare infectious disease	GO:2000377	regulation of reactive oxygen species metabolic process	4.338751580235112e-13	9.569116610208539e-9	14	147	91
Orphanet:68416	Rare infectious disease	GO:0031349	positive regulation of defense response	3.6859404417555197e-13	8.129341644291799e-9	26	398	91
Orphanet:68416	Rare infectious disease	GO:0045089	positive regulation of innate immune response	3.0375701953744283e-13	6.699361065898302e-9	17	289	91
Orphanet:68416	Rare infectious disease	GO:0002221	pattern recognition receptor signaling pathway	1.4144241333724494e-13	3.1195124261529372e-9	13	155	91
Orphanet:68416	Rare infectious disease	GO:0071706	tumor necrosis factor superfamily cytokine production	3.720912467031212e-12	8.206472446037338e-8	11	106	91
Orphanet:68416	Rare infectious disease	GO:0046649	lymphocyte activation	5.936140468065787e-12	1.3092157802319093e-7	20	594	91
Orphanet:68416	Rare infectious disease	GO:0032760	positive regulation of tumor necrosis factor production	6.510569861006843e-12	1.4359061828450592e-7	9	56	91
Orphanet:68416	Rare infectious disease	GO:0050729	positive regulation of inflammatory response	8.303246978869083e-12	1.8312811211895763e-7	11	114	91
Orphanet:68416	Rare infectious disease	GO:0098552	side of membrane	8.397393891357297e-12	1.8520452227388517e-7	17	402	91
Orphanet:68416	Rare infectious disease	GO:0032677	regulation of interleukin-8 production	9.123368727159686e-12	2.0121589727750688e-7	9	58	91
Orphanet:68416	Rare infectious disease	GO:0002224	toll-like receptor signaling pathway	9.41879907401244e-12	2.0773161357734438e-7	11	115	91
Orphanet:68416	Rare infectious disease	GO:0044419	interspecies interaction between organisms	9.94748727833894e-12	2.1939183192376532e-7	23	761	91
Orphanet:68416	Rare infectious disease	GO:0044403	symbiosis, encompassing mutualism through parasitism	9.94748727833894e-12	2.1939183192376532e-7	23	761	91
Orphanet:68416	Rare infectious disease	GO:0050830	defense response to Gram-positive bacterium	4.0611847218485764e-11	8.956942904037035e-7	9	68	91
Orphanet:68416	Rare infectious disease	GO:0045408	regulation of interleukin-6 biosynthetic process	8.728939793201107e-11	1.925167671390504e-6	6	16	91
Orphanet:68416	Rare infectious disease	GO:0002440	production of molecular mediator of immune response	1.4630807676496715e-10	3.2268246330513506e-6	11	148	91
Orphanet:68416	Rare infectious disease	GO:0071356	cellular response to tumor necrosis factor	1.7562962195682985e-10	3.873511312257882e-6	13	243	91
Orphanet:68416	Rare infectious disease	GO:0070489	T cell aggregation	2.0834178826589778e-10	4.5949781402043754e-6	16	424	91
Orphanet:68416	Rare infectious disease	GO:0042110	T cell activation	2.0834178826589778e-10	4.5949781402043754e-6	16	424	91
Orphanet:68416	Rare infectious disease	GO:0030139	endocytic vesicle	2.610898164334685e-10	5.758335901440148e-6	13	251	91
Orphanet:68416	Rare infectious disease	GO:0032943	mononuclear cell proliferation	2.735918158691675e-10	6.034067498994489e-6	13	252	91
Orphanet:68416	Rare infectious disease	GO:0042348	NF-kappaB import into nucleus	2.773216323248562e-9	6.116328600924703e-5	7	47	91
Orphanet:68416	Rare infectious disease	GO:0042345	regulation of NF-kappaB import into nucleus	2.773216323248562e-9	6.116328600924703e-5	7	47	91
Orphanet:68416	Rare infectious disease	GO:0046651	lymphocyte proliferation	3.018920669006775e-9	6.658229535494442e-5	12	249	91
Orphanet:68416	Rare infectious disease	GO:0051249	regulation of lymphocyte activation	3.2410424344320177e-9	7.148119089139815e-5	14	372	91
Orphanet:68416	Rare infectious disease	GO:0031663	lipopolysaccharide-mediated signaling pathway	3.758114042184957e-9	8.288520520038922e-5	7	49	91
Orphanet:68416	Rare infectious disease	GO:0034341	response to interferon-gamma	4.193914771022378e-9	9.249679027489854e-5	10	155	91
DOID:0060260	ptosis	GO:0048589	developmental growth	5.199729535831921e-12	1.1468003491277301e-7	20	558	92
Orphanet:98063	Rare gynecological tumor	GO:0003006	developmental process involved in reproduction	7.988054662178001e-13	1.7617654557433582e-8	24	619	92
Orphanet:98063	Rare gynecological tumor	GO:0045786	negative regulation of cell cycle	8.75721717363831e-12	1.9314042476459292e-7	18	449	92
Orphanet:98063	Rare gynecological tumor	GO:0043069	negative regulation of programmed cell death	1.0101253167249524e-11	2.2278313860368826e-7	23	806	92
Orphanet:98063	Rare gynecological tumor	GO:0043566	structure-specific DNA binding	1.1420975276621448e-11	2.5188960972588603e-7	11	116	92
Orphanet:98063	Rare gynecological tumor	GO:0043066	negative regulation of apoptotic process	1.175648467466317e-11	2.592892694996962e-7	23	795	92
Orphanet:98063	Rare gynecological tumor	GO:0000217	DNA secondary structure binding	1.8013923686055477e-11	3.9729708689595356e-7	7	24	92
Orphanet:98063	Rare gynecological tumor	GO:0044427	chromosomal part	1.4000389736423813e-10	3.087785956368272e-6	21	776	92
Orphanet:98063	Rare gynecological tumor	GO:0043523	regulation of neuron apoptotic process	1.542406202759139e-10	3.401776880185281e-6	12	190	92
Orphanet:98063	Rare gynecological tumor	GO:0001934	positive regulation of protein phosphorylation	1.6266243907381295e-10	3.5875200937729446e-6	22	870	92
Orphanet:98063	Rare gynecological tumor	GO:0097190	apoptotic signaling pathway	2.4749224891706945e-10	5.458441549865967e-6	18	564	92
Orphanet:98063	Rare gynecological tumor	GO:0042493	response to drug	3.365703271640541e-10	7.423058565603213e-6	16	433	92
Orphanet:98063	Rare gynecological tumor	GO:1902533	positive regulation of intracellular signal transduction	8.64078586459982e-10	1.9057253224374904e-5	21	860	92
Orphanet:98063	Rare gynecological tumor	GO:0043009	chordate embryonic development	1.4283090266076215e-9	3.150135558183109e-5	17	552	92
Orphanet:98063	Rare gynecological tumor	GO:0008285	negative regulation of cell proliferation	1.5973624645226892e-9	3.522982915504791e-5	18	634	92
Orphanet:98063	Rare gynecological tumor	GO:0051053	negative regulation of DNA metabolic process	3.0117477400892767e-9	6.6424096407669e-5	9	108	92
Orphanet:98063	Rare gynecological tumor	GO:0003690	double-stranded DNA binding	3.930532344043058e-9	8.668789084786965e-5	19	756	92
Orphanet:223727	Bone sarcoma	GO:0060548	negative regulation of cell death	1.7817969322209137e-12	3.929753134013225e-8	27	867	93
Orphanet:223727	Bone sarcoma	GO:1902533	positive regulation of intracellular signal transduction	5.794031920913767e-12	1.2778737401575313e-7	26	860	93
Orphanet:223727	Bone sarcoma	GO:0043405	regulation of MAP kinase activity	7.25053350691951e-12	1.599105164951098e-7	15	278	93
Orphanet:223727	Bone sarcoma	GO:0070997	neuron death	8.278489005419942e-12	1.8258207501453683e-7	15	281	93
Orphanet:223727	Bone sarcoma	GO:0048145	regulation of fibroblast proliferation	9.42712574669713e-12	2.0791525834340518e-7	10	82	93
Orphanet:223727	Bone sarcoma	GO:0061564	axon development	9.69502256253918e-12	2.138237226168016e-7	18	440	93
Orphanet:223727	Bone sarcoma	GO:0043410	positive regulation of MAPK cascade	1.8681056701552734e-11	4.1201070555274555e-7	18	464	93
Orphanet:223727	Bone sarcoma	GO:0070848	response to growth factor	2.2414181621854823e-11	4.943447756700081e-7	20	621	93
Orphanet:223727	Bone sarcoma	GO:1901214	regulation of neuron death	2.507349883273946e-11	5.529960167560688e-7	14	250	93
Orphanet:223727	Bone sarcoma	GO:0014070	response to organic cyclic compound	3.198852294161725e-11	7.055068734773684e-7	23	873	93
Orphanet:223727	Bone sarcoma	GO:0009887	organ morphogenesis	3.343891830098755e-11	7.374953431282805e-7	24	950	93
Orphanet:223727	Bone sarcoma	GO:0051402	neuron apoptotic process	4.044609092090923e-11	8.92038535260653e-7	13	211	93
Orphanet:223727	Bone sarcoma	GO:0071363	cellular response to growth factor stimulus	8.54126769311847e-11	1.8837765897172787e-6	19	594	93
Orphanet:223727	Bone sarcoma	GO:0043523	regulation of neuron apoptotic process	1.7556500697679667e-10	3.8720862288732505e-6	12	190	93
Orphanet:223727	Bone sarcoma	GO:0009611	response to wounding	2.2883384076521907e-10	5.0469303580769065e-6	22	875	93
Orphanet:223727	Bone sarcoma	GO:0005694	chromosome	2.354884065525198e-10	5.193696806515824e-6	22	876	93
Orphanet:223727	Bone sarcoma	GO:0007610	behavior	2.717364111504139e-10	5.993146547922379e-6	20	714	93
Orphanet:223727	Bone sarcoma	GO:0007417	central nervous system development	3.12394665691329e-10	6.889864351822261e-6	22	889	93
Orphanet:223727	Bone sarcoma	GO:0000904	cell morphogenesis involved in differentiation	3.150040228661055e-10	6.947413724311957e-6	20	720	93
Orphanet:223727	Bone sarcoma	GO:0035295	tube development	3.8257430556853933e-10	8.437676309314135e-6	18	573	93
Orphanet:223727	Bone sarcoma	GO:0042493	response to drug	3.979463425451968e-10	8.776706584834315e-6	16	433	93
Orphanet:223727	Bone sarcoma	GO:0010035	response to inorganic substance	4.0724301708650046e-10	8.981744741842768e-6	17	502	93
Orphanet:223727	Bone sarcoma	GO:0008284	positive regulation of cell proliferation	4.093395622462026e-10	9.027984045339998e-6	21	815	93
Orphanet:223727	Bone sarcoma	GO:0051726	regulation of cell cycle	7.08977876406891e-10	1.563650706415398e-5	22	930	93
Orphanet:223727	Bone sarcoma	GO:0007346	regulation of mitotic cell cycle	7.638968346768138e-10	1.6847744688797128e-5	16	453	93
Orphanet:223727	Bone sarcoma	GO:0000302	response to reactive oxygen species	7.738659713041329e-10	1.7067613997112652e-5	12	216	93
Orphanet:223727	Bone sarcoma	GO:0004714	transmembrane receptor protein tyrosine kinase activity	8.630162140477182e-10	1.9033822600822425e-5	8	63	93
Orphanet:223727	Bone sarcoma	GO:0048511	rhythmic process	8.923395355964203e-10	1.968054845757905e-5	14	329	93
Orphanet:223727	Bone sarcoma	GO:0006935	chemotaxis	9.216380991716733e-10	2.0326728277231254e-5	17	530	93
Orphanet:223727	Bone sarcoma	GO:0044427	chromosomal part	1.134982552386532e-9	2.5032040192884963e-5	20	776	93
Orphanet:223727	Bone sarcoma	GO:0009725	response to hormone	1.1793988008435008e-9	2.601164055260341e-5	21	865	93
Orphanet:223727	Bone sarcoma	GO:0030097	hemopoiesis	1.1968676050244653e-9	2.6396915028814583e-5	19	695	93
Orphanet:223727	Bone sarcoma	GO:1901701	cellular response to oxygen-containing compound	1.3894116968060644e-9	3.064347497305775e-5	21	873	93
Orphanet:223727	Bone sarcoma	GO:0007409	axonogenesis	1.4818861693299823e-9	3.268299946457276e-5	15	406	93
Orphanet:223727	Bone sarcoma	GO:0060322	head development	1.621867862233728e-9	3.577029570156487e-5	19	708	93
Orphanet:223727	Bone sarcoma	GO:0002573	myeloid leukocyte differentiation	1.7992590750637305e-9	3.9682658900530576e-5	11	183	93
Orphanet:223727	Bone sarcoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.6441183686998215e-9	5.8316030621674564e-5	18	647	93
Orphanet:223727	Bone sarcoma	GO:0009314	response to radiation	3.3388459774741364e-9	7.363824803319208e-5	15	431	93
Orphanet:223727	Bone sarcoma	GO:0000785	chromatin	4.151643473448985e-9	9.156449680691736e-5	15	438	93
Orphanet:223727	Bone sarcoma	GO:0007420	brain development	4.4616698113841835e-9	9.840212769007817e-5	18	669	93
Orphanet:101954	Rare adrenal disease	GO:0009991	response to extracellular stimulus	6.403766406037903e-13	1.4123506808516595e-8	21	573	94
Orphanet:101954	Rare adrenal disease	GO:0014070	response to organic cyclic compound	1.2005951788296443e-12	2.6479126669087805e-8	25	873	94
Orphanet:101954	Rare adrenal disease	GO:0009725	response to hormone	1.7472689961550714e-12	3.85360177102001e-8	30	865	94
Orphanet:101954	Rare adrenal disease	GO:0055114	oxidation-reduction process	7.830514014983692e-12	1.7270198660046532e-7	28	949	94
Orphanet:101954	Rare adrenal disease	GO:0043434	response to peptide hormone	7.930323064897493e-12	1.749032751963142e-7	17	389	94
Orphanet:101954	Rare adrenal disease	GO:1901699	cellular response to nitrogen compound	1.57720503324299e-11	3.478525700817414e-7	19	518	94
Orphanet:101954	Rare adrenal disease	GO:0071417	cellular response to organonitrogen compound	2.0618506901826095e-11	4.547411697197745e-7	18	462	94
Orphanet:101954	Rare adrenal disease	GO:0031667	response to nutrient levels	2.9878877150224525e-11	6.589786355482019e-7	19	546	94
Orphanet:101954	Rare adrenal disease	GO:0051412	response to corticosterone	3.97202271074093e-11	8.760296088539121e-7	7	26	94
Orphanet:101954	Rare adrenal disease	GO:0010035	response to inorganic substance	6.022460308230393e-11	1.3282536209802132e-6	18	502	94
Orphanet:101954	Rare adrenal disease	GO:0010038	response to metal ion	1.1818190870371836e-10	2.6065019964605085e-6	15	335	94
Orphanet:101954	Rare adrenal disease	GO:0048608	reproductive structure development	2.794440234765716e-10	6.163137937775787e-6	16	418	94
Orphanet:101954	Rare adrenal disease	GO:0016491	oxidoreductase activity	2.998199466475171e-10	6.61252892331099e-6	20	710	94
Orphanet:101954	Rare adrenal disease	GO:0018958	phenol-containing compound metabolic process	1.2720555719880622e-9	2.805518564019671e-5	9	96	94
Orphanet:101954	Rare adrenal disease	GO:0030325	adrenal gland development	1.305022645503584e-9	2.8782274446581546e-5	6	23	94
Orphanet:101954	Rare adrenal disease	GO:0044708	single-organism behavior	1.615255262876758e-9	3.56244548227469e-5	15	404	94
Orphanet:101954	Rare adrenal disease	GO:1901701	cellular response to oxygen-containing compound	1.7115546757651146e-9	3.77483383739996e-5	21	873	94
Orphanet:101954	Rare adrenal disease	GO:0045471	response to ethanol	1.7385334283304132e-9	3.8343354761827264e-5	10	137	94
Orphanet:101954	Rare adrenal disease	GO:0071375	cellular response to peptide hormone stimulus	1.8567275494874025e-9	4.095012610394466e-5	13	285	94
Orphanet:101954	Rare adrenal disease	GO:0008015	blood circulation	2.700300094637953e-9	5.955511858724005e-5	16	489	94
Orphanet:101954	Rare adrenal disease	GO:0003014	renal system process	3.964549133428363e-9	8.743813113776255e-5	9	109	94
Orphanet:93551	Secondary glomerular disease	GO:0009607	response to biotic stimulus	4.055200619745847e-12	8.943744966849465e-8	35	934	94
Orphanet:93551	Secondary glomerular disease	GO:0002250	adaptive immune response	3.723243935382925e-12	8.211614499487041e-8	20	334	94
Orphanet:93551	Secondary glomerular disease	GO:0002237	response to molecule of bacterial origin	3.0329072586710026e-12	6.689076958998896e-8	23	333	94
Orphanet:93551	Secondary glomerular disease	GO:0051249	regulation of lymphocyte activation	2.334576976181779e-12	5.148909520968914e-8	20	372	94
Orphanet:93551	Secondary glomerular disease	GO:0032101	regulation of response to external stimulus	2.2182256032010628e-12	4.892296567859944e-8	31	920	94
Orphanet:93551	Secondary glomerular disease	GO:0022407	regulation of cell-cell adhesion	2.211786309658237e-12	4.8780947059512414e-8	21	376	94
Orphanet:93551	Secondary glomerular disease	GO:0051050	positive regulation of transport	2.178257574314557e-12	4.804147080150756e-8	27	920	94
Orphanet:93551	Secondary glomerular disease	GO:0045785	positive regulation of cell adhesion	1.7346124536743446e-12	3.825687766578767e-8	19	368	94
Orphanet:93551	Secondary glomerular disease	GO:0032496	response to lipopolysaccharide	1.2918555114538322e-12	2.8491873305114268e-8	21	319	94
Orphanet:93551	Secondary glomerular disease	GO:0001819	positive regulation of cytokine production	1.2250200853713977e-12	2.7017817982866177e-8	24	381	94
Orphanet:93551	Secondary glomerular disease	GO:0050778	positive regulation of immune response	1.219246925643347e-12	2.6890490945064016e-8	24	603	94
Orphanet:93551	Secondary glomerular disease	GO:0034110	regulation of homotypic cell-cell adhesion	9.43911615536308e-13	2.0817970680653275e-8	18	304	94
Orphanet:93551	Secondary glomerular disease	GO:0071216	cellular response to biotic stimulus	7.145395386487507e-13	1.5759169524898198e-8	17	175	94
Orphanet:93551	Secondary glomerular disease	GO:0050867	positive regulation of cell activation	7.038813976123492e-13	1.5524104224340363e-8	17	288	94
Orphanet:93551	Secondary glomerular disease	GO:1903037	regulation of leukocyte cell-cell adhesion	5.542233338928781e-13	1.2223395629007427e-8	18	294	94
Orphanet:93551	Secondary glomerular disease	GO:0071219	cellular response to molecule of bacterial origin	5.353495424742505e-13	1.1807134159269594e-8	17	158	94
Orphanet:93551	Secondary glomerular disease	GO:0034341	response to interferon-gamma	4.769518113789672e-13	1.0519172199963123e-8	14	155	94
Orphanet:93551	Secondary glomerular disease	GO:0071222	cellular response to lipopolysaccharide	3.532729664357248e-13	7.79143527473991e-9	17	152	94
Orphanet:93551	Secondary glomerular disease	GO:0050727	regulation of inflammatory response	1.6209256159527285e-14	3.574951445983743e-10	18	289	94
Orphanet:93551	Secondary glomerular disease	GO:0072593	reactive oxygen species metabolic process	4.796163466380676e-14	1.0577938525102581e-9	15	223	94
Orphanet:93551	Secondary glomerular disease	GO:0007568	aging	1.1268763699945339e-13	2.4853258340229445e-9	17	290	94
Orphanet:93551	Secondary glomerular disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.8618440122963875e-13	4.106296969119683e-9	16	209	94
Orphanet:93551	Secondary glomerular disease	GO:0002443	leukocyte mediated immunity	3.455014052633487e-13	7.620033493083156e-9	17	279	94
Orphanet:93551	Secondary glomerular disease	GO:0006809	nitric oxide biosynthetic process	7.706058013923212e-13	1.6995710949707643e-8	10	62	94
Orphanet:93551	Secondary glomerular disease	GO:0006897	endocytosis	1.025068918636407e-12	2.2607895000525957e-8	22	593	94
Orphanet:93551	Secondary glomerular disease	GO:0002697	regulation of immune effector process	1.0483836021535353e-12	2.312210034549622e-8	19	418	94
Orphanet:93551	Secondary glomerular disease	GO:0051241	negative regulation of multicellular organismal process	2.1229684676882243e-12	4.682206955486379e-8	29	966	94
Orphanet:93551	Secondary glomerular disease	GO:0060548	negative regulation of cell death	2.859046333014703e-12	6.305626687463928e-8	25	867	94
Orphanet:93551	Secondary glomerular disease	GO:0098542	defense response to other organism	2.947975197287178e-12	6.501759297616871e-8	21	550	94
Orphanet:93551	Secondary glomerular disease	GO:0071345	cellular response to cytokine stimulus	2.9534152901078414e-12	6.513757422332844e-8	25	677	94
Orphanet:93551	Secondary glomerular disease	GO:0031960	response to corticosteroid	4.884426196838376e-12	1.0772601977127039e-7	13	179	94
Orphanet:93551	Secondary glomerular disease	GO:0042089	cytokine biosynthetic process	5.067168906691677e-12	1.1175641023708494e-7	11	105	94
Orphanet:93551	Secondary glomerular disease	GO:1902533	positive regulation of intracellular signal transduction	5.7549520704469614e-12	1.2692546791370773e-7	27	860	94
Orphanet:93551	Secondary glomerular disease	GO:0019221	cytokine-mediated signaling pathway	5.8372195965716855e-12	1.2873987820238852e-7	21	534	94
Orphanet:93551	Secondary glomerular disease	GO:0010035	response to inorganic substance	5.936806601880562e-12	1.309362696044758e-7	21	502	94
Orphanet:93551	Secondary glomerular disease	GO:0001568	blood vessel development	6.290079568316287e-12	1.387277048792157e-7	20	569	94
Orphanet:93551	Secondary glomerular disease	GO:0010038	response to metal ion	7.046030425783556e-12	1.5540020104065633e-7	16	335	94
Orphanet:93551	Secondary glomerular disease	GO:0043069	negative regulation of programmed cell death	7.303824212101517e-12	1.6108584299789896e-7	24	806	94
Orphanet:93551	Secondary glomerular disease	GO:0042493	response to drug	7.890799125220838e-12	1.7403157470674557e-7	18	433	94
Orphanet:93551	Secondary glomerular disease	GO:0009986	cell surface	8.769096560001799e-12	1.9340242463083968e-7	23	715	94
Orphanet:93551	Secondary glomerular disease	GO:0002285	lymphocyte activation involved in immune response	8.86579698544665e-12	1.9553515251402587e-7	12	146	94
Orphanet:93551	Secondary glomerular disease	GO:0043408	regulation of MAPK cascade	9.217182572740512e-12	2.03284961641792e-7	21	651	94
Orphanet:93551	Secondary glomerular disease	GO:0043066	negative regulation of apoptotic process	9.243716903029053e-12	2.0387017629630577e-7	24	795	94
Orphanet:93551	Secondary glomerular disease	GO:0002440	production of molecular mediator of immune response	1.0326406396643506e-11	2.2774889307797253e-7	12	148	94
Orphanet:93551	Secondary glomerular disease	GO:0048514	blood vessel morphogenesis	1.0874856570808333e-11	2.398449616691778e-7	19	484	94
Orphanet:93551	Secondary glomerular disease	GO:0032103	positive regulation of response to external stimulus	1.1886047701636926e-11	2.621467820596024e-7	15	285	94
Orphanet:93551	Secondary glomerular disease	GO:0051093	negative regulation of developmental process	1.1923462217566794e-11	2.6297195920843563e-7	23	788	94
Orphanet:93551	Secondary glomerular disease	GO:0001525	angiogenesis	2.5388802171733005e-11	5.599500318975714e-7	17	413	94
Orphanet:93551	Secondary glomerular disease	GO:0050663	cytokine secretion	3.101818801809486e-11	6.841061367390822e-7	12	162	94
Orphanet:93551	Secondary glomerular disease	GO:0043065	positive regulation of apoptotic process	3.8150149705984404e-11	8.41401551765486e-7	19	556	94
Orphanet:93551	Secondary glomerular disease	GO:0045765	regulation of angiogenesis	3.827138606027347e-11	8.440754195593314e-7	13	208	94
Orphanet:93551	Secondary glomerular disease	GO:0001934	positive regulation of protein phosphorylation	3.9228398307500356e-11	8.651823246719204e-7	23	870	94
Orphanet:93551	Secondary glomerular disease	GO:0002449	lymphocyte mediated immunity	4.065636716177323e-11	8.966761777529086e-7	13	209	94
Orphanet:93551	Secondary glomerular disease	GO:0097305	response to alcohol	4.2483572215701315e-11	9.369751852172925e-7	16	369	94
Orphanet:93551	Secondary glomerular disease	GO:0051384	response to glucocorticoid	4.4186654335476305e-11	9.7453666136893e-7	12	167	94
Orphanet:93551	Secondary glomerular disease	GO:0042035	regulation of cytokine biosynthetic process	4.568245781655378e-11	1.0075266071440936e-6	10	95	94
Orphanet:93551	Secondary glomerular disease	GO:0071346	cellular response to interferon-gamma	6.52091713959635e-11	1.4381882751379749e-6	11	133	94
Orphanet:93551	Secondary glomerular disease	GO:0008284	positive regulation of cell proliferation	8.003997464811619e-11	1.7652816408642025e-6	22	815	94
Orphanet:93551	Secondary glomerular disease	GO:0002367	cytokine production involved in immune response	8.097134074347423e-11	1.7858229200973241e-6	9	71	94
Orphanet:93551	Secondary glomerular disease	GO:0002521	leukocyte differentiation	8.525646855161995e-11	1.880331413905978e-6	17	448	94
Orphanet:93551	Secondary glomerular disease	GO:0050707	regulation of cytokine secretion	1.3338208315616384e-10	2.9417418440091936e-6	11	142	94
Orphanet:93551	Secondary glomerular disease	GO:0031349	positive regulation of defense response	1.3556844535855817e-10	2.9899620623830003e-6	16	398	94
Orphanet:93551	Secondary glomerular disease	GO:0043410	positive regulation of MAPK cascade	1.488180689790397e-10	3.2821825113327208e-6	17	464	94
Orphanet:93551	Secondary glomerular disease	GO:0070372	regulation of ERK1 and ERK2 cascade	1.5754297866266143e-10	3.4746103944049977e-6	13	233	94
Orphanet:93551	Secondary glomerular disease	GO:0045428	regulation of nitric oxide biosynthetic process	1.6250967238562453e-10	3.584150824464949e-6	8	51	94
Orphanet:93551	Secondary glomerular disease	GO:0050670	regulation of lymphocyte proliferation	1.8777368548938966e-10	4.141348633468489e-6	12	189	94
Orphanet:93551	Secondary glomerular disease	GO:2001234	negative regulation of apoptotic signaling pathway	3.4178337937618153e-10	7.538032432141684e-6	12	199	94
Orphanet:93551	Secondary glomerular disease	GO:0030139	endocytic vesicle	3.949143234649455e-10	8.709835404019373e-6	13	251	94
Orphanet:93551	Secondary glomerular disease	GO:0045766	positive regulation of angiogenesis	4.336754289013811e-10	9.56471158441996e-6	10	119	94
Orphanet:93551	Secondary glomerular disease	GO:1903035	negative regulation of response to wounding	4.528847297180505e-10	9.988372713931604e-6	11	159	94
Orphanet:93551	Secondary glomerular disease	GO:0050714	positive regulation of protein secretion	4.825809751807242e-10	1.0643323407610872e-5	12	205	94
Orphanet:93551	Secondary glomerular disease	GO:0002286	T cell activation involved in immune response	5.223050880687197e-10	1.1519438717355612e-5	9	87	94
Orphanet:93551	Secondary glomerular disease	GO:0042108	positive regulation of cytokine biosynthetic process	5.47445533349844e-10	1.207391123803081e-5	8	59	94
Orphanet:93551	Secondary glomerular disease	GO:0050829	defense response to Gram-negative bacterium	5.947122794225379e-10	1.3116379322664073e-5	7	37	94
Orphanet:93551	Secondary glomerular disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	8.156336717135559e-10	1.7988800629642476e-5	11	168	94
Orphanet:93551	Secondary glomerular disease	GO:0030335	positive regulation of cell migration	8.954242902703413e-10	1.9748582721912378e-5	15	387	94
Orphanet:93551	Secondary glomerular disease	GO:0032637	interleukin-8 production	1.0706066033705497e-9	2.3612228637337473e-5	8	64	94
Orphanet:93551	Secondary glomerular disease	GO:0097191	extrinsic apoptotic signaling pathway	1.0838406838686865e-9	2.390410628272388e-5	12	220	94
Orphanet:93551	Secondary glomerular disease	GO:0006959	humoral immune response	1.114017211811813e-9	2.4569649606509536e-5	11	173	94
Orphanet:93551	Secondary glomerular disease	GO:0005125	cytokine activity	1.2014894634759798e-9	2.6498850116962736e-5	12	222	94
Orphanet:93551	Secondary glomerular disease	GO:0032612	interleukin-1 production	1.3779870577934616e-9	3.0391504559634797e-5	8	66	94
Orphanet:93551	Secondary glomerular disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1.3965220091449737e-9	3.0800292911692395e-5	9	97	94
Orphanet:93551	Secondary glomerular disease	GO:0010243	response to organonitrogen compound	1.5107568529515447e-9	3.331974239184632e-5	20	780	94
Orphanet:93551	Secondary glomerular disease	GO:0002253	activation of immune response	1.7824742792882375e-9	3.931247022970208e-5	16	475	94
Orphanet:93551	Secondary glomerular disease	GO:0050710	negative regulation of cytokine secretion	1.8164113546603744e-9	4.006095242703456e-5	7	43	94
Orphanet:93551	Secondary glomerular disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.082720884644118e-9	4.5934409110826024e-5	12	233	94
Orphanet:93551	Secondary glomerular disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	2.6080628767743974e-9	5.7520826747259335e-5	9	104	94
Orphanet:93551	Secondary glomerular disease	GO:0045597	positive regulation of cell differentiation	3.1964645375026635e-9	7.049802537462124e-5	20	815	94
Orphanet:93551	Secondary glomerular disease	GO:0043112	receptor metabolic process	3.4563113482377616e-9	7.622894678538383e-5	10	147	94
Orphanet:93551	Secondary glomerular disease	GO:0036293	response to decreased oxygen levels	3.737875897691367e-9	8.24388529235831e-5	13	302	94
Orphanet:93551	Secondary glomerular disease	GO:0002687	positive regulation of leukocyte migration	3.964549133428363e-9	8.743813113776255e-5	9	109	94
Orphanet:93551	Secondary glomerular disease	GO:0002699	positive regulation of immune effector process	4.204982362310261e-9	9.274088600075281e-5	10	150	94
Orphanet:93551	Secondary glomerular disease	GO:0007584	response to nutrient	4.3904230251357035e-9	9.683077981936794e-5	11	197	94
Orphanet:93551	Secondary glomerular disease	GO:0002703	regulation of leukocyte mediated immunity	4.484845606000931e-9	9.891326984035054e-5	10	151	94
DOID:6000	congestive heart failure	GO:0040007	growth	4.242828310907498e-12	9.357557839706487e-8	26	936	95
DOID:6000	congestive heart failure	GO:0072358	cardiovascular system development	4.0107916987608405e-12	8.845801091617034e-8	31	910	95
DOID:6000	congestive heart failure	GO:0042327	positive regulation of phosphorylation	4.0107916987608405e-12	8.845801091617034e-8	37	910	95
DOID:6000	congestive heart failure	GO:0002237	response to molecule of bacterial origin	3.2678304506816858e-12	7.207200058978458e-8	19	333	95
DOID:6000	congestive heart failure	GO:0032101	regulation of response to external stimulus	3.050670827065005e-12	6.728254509091869e-8	29	920	95
DOID:6000	congestive heart failure	GO:0051050	positive regulation of transport	2.6341151482256464e-12	5.809540959411663e-8	26	920	95
DOID:6000	congestive heart failure	GO:0010038	response to metal ion	2.5712765250318625e-12	5.670950375957773e-8	17	335	95
DOID:6000	congestive heart failure	GO:0006936	muscle contraction	2.099653784171096e-12	4.6307864209893523e-8	19	323	95
DOID:6000	congestive heart failure	GO:0097305	response to alcohol	1.977973340672179e-12	4.3624202028524905e-8	21	369	95
DOID:6000	congestive heart failure	GO:0036293	response to decreased oxygen levels	1.7432721932664208e-12	3.844786822249091e-8	21	302	95
DOID:6000	congestive heart failure	GO:0032496	response to lipopolysaccharide	1.5647483309066956e-12	3.451052443814717e-8	19	319	95
DOID:6000	congestive heart failure	GO:0006979	response to oxidative stress	1.4375167722846527e-12	3.1704432412738015e-8	24	386	95
DOID:6000	congestive heart failure	GO:0048871	multicellular organismal homeostasis	1.4213075161251254e-12	3.134693726813964e-8	19	321	95
DOID:6000	congestive heart failure	GO:0009187	cyclic nucleotide metabolic process	1.1075584893660562e-12	2.442720248296837e-8	15	188	95
DOID:6000	congestive heart failure	GO:0032103	positive regulation of response to external stimulus	8.766321002440236e-13	1.933412097088194e-8	18	285	95
DOID:6000	congestive heart failure	GO:0030335	positive regulation of cell migration	8.766321002440236e-13	1.933412097088194e-8	18	387	95
DOID:6000	congestive heart failure	GO:0035150	regulation of tube size	7.529532553007812e-13	1.660638404565873e-8	29	140	95
DOID:6000	congestive heart failure	GO:0000302	response to reactive oxygen species	7.214229214014267e-13	1.5910982531508466e-8	18	216	95
DOID:6000	congestive heart failure	GO:0008016	regulation of heart contraction	6.303846333821639e-13	1.3903133089243624e-8	16	224	95
DOID:6000	congestive heart failure	GO:0071216	cellular response to biotic stimulus	5.879741138414829e-13	1.2967769080773905e-8	15	175	95
DOID:6000	congestive heart failure	GO:0033002	muscle cell proliferation	4.1033842990145786e-13	9.050014071476653e-9	14	151	95
DOID:6000	congestive heart failure	GO:0072593	reactive oxygen species metabolic process	4.027889133340068e-13	8.88350948358152e-9	27	223	95
DOID:6000	congestive heart failure	GO:0031960	response to corticosteroid	4.0034642267983145e-13	8.829640352203683e-9	14	179	95
DOID:6000	congestive heart failure	GO:0008217	regulation of blood pressure	3.7414515929867775e-13	8.251771488332338e-9	23	168	95
DOID:6000	congestive heart failure	GO:0009190	cyclic nucleotide biosynthetic process	3.0819791163594346e-13	6.797304941130733e-9	14	149	95
DOID:6000	congestive heart failure	GO:0006937	regulation of muscle contraction	2.866595849582154e-13	6.322277146253441e-9	14	165	95
DOID:6000	congestive heart failure	GO:2000377	regulation of reactive oxygen species metabolic process	2.7355895326763857e-13	6.033342714317769e-9	17	147	95
DOID:6000	congestive heart failure	GO:0052652	cyclic purine nucleotide metabolic process	2.5135449277513544e-13	5.543623338155612e-9	14	147	95
DOID:6000	congestive heart failure	GO:0071219	cellular response to molecule of bacterial origin	1.9273471707492718e-13	4.250764185087519e-9	14	158	95
DOID:6000	congestive heart failure	GO:0071222	cellular response to lipopolysaccharide	1.580957587066223e-13	3.4868019582745546e-9	14	152	95
DOID:6000	congestive heart failure	GO:0019216	regulation of lipid metabolic process	1.4410694859634532e-13	3.178278751292396e-9	16	272	95
DOID:6000	congestive heart failure	GO:0009991	response to extracellular stimulus	1.2390088954816747e-13	2.7326341189848335e-9	21	573	95
DOID:6000	congestive heart failure	GO:0006801	superoxide metabolic process	4.529709940470639e-14	9.990275273707994e-10	13	52	95
DOID:6000	congestive heart failure	GO:0071496	cellular response to external stimulus	4.374278717023117e-14	9.647471710394484e-10	17	270	95
DOID:6000	congestive heart failure	GO:0055078	sodium ion homeostasis	4.9404924595819466e-14	1.0896256119607983e-9	10	52	95
DOID:6000	congestive heart failure	GO:1901342	regulation of vasculature development	6.117328865684613e-14	1.3491768813267413e-9	15	228	95
DOID:6000	congestive heart failure	GO:0048659	smooth muscle cell proliferation	6.983302824892235e-14	1.5401674380299823e-9	13	104	95
DOID:6000	congestive heart failure	GO:0032846	positive regulation of homeostatic process	1.1368683772161603e-13	2.5073632059502415e-9	14	192	95
DOID:6000	congestive heart failure	GO:0042312	regulation of vasodilation	1.290079154614432e-13	2.8452695755021296e-9	11	46	95
DOID:6000	congestive heart failure	GO:0005125	cytokine activity	1.4410694859634532e-13	3.178278751292396e-9	15	222	95
DOID:6000	congestive heart failure	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	1.503241975342462e-13	3.3154001766178e-9	10	49	95
DOID:6000	congestive heart failure	GO:0006809	nitric oxide biosynthetic process	1.6053824936079764e-13	3.540671089652392e-9	12	62	95
DOID:6000	congestive heart failure	GO:0034599	cellular response to oxidative stress	1.645350522494482e-13	3.62882057736158e-9	15	219	95
DOID:6000	congestive heart failure	GO:1900542	regulation of purine nucleotide metabolic process	1.6686652060116103e-13	3.6802411118586065e-9	15	203	95
DOID:6000	congestive heart failure	GO:0051353	positive regulation of oxidoreductase activity	1.7352785874891197e-13	3.8271569247072534e-9	10	45	95
DOID:6000	congestive heart failure	GO:0035813	regulation of renal sodium excretion	1.9406698470447736e-13	4.280147347657248e-9	8	24	95
DOID:6000	congestive heart failure	GO:0071260	cellular response to mechanical stimulus	2.2071233729548112e-13	4.867810599051836e-9	12	80	95
DOID:6000	congestive heart failure	GO:1903524	positive regulation of blood circulation	2.2803980925800715e-13	5.029417993185348e-9	18	89	95
DOID:6000	congestive heart failure	GO:0048660	regulation of smooth muscle cell proliferation	2.665645482125001e-13	5.879081110826689e-9	12	100	95
DOID:6000	congestive heart failure	GO:0009636	response to toxic substance	3.89910326248355e-13	8.599472245407469e-9	19	249	95
DOID:6000	congestive heart failure	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.949063298591682e-13	8.709659105043954e-9	13	83	95
DOID:6000	congestive heart failure	GO:0055082	cellular chemical homeostasis	4.50417481090426e-13	9.933957545449346e-9	29	661	95
DOID:6000	congestive heart failure	GO:0001664	G-protein coupled receptor binding	5.46451772720502e-13	1.2051993847350673e-8	18	255	95
DOID:6000	congestive heart failure	GO:0098869	cellular oxidant detoxification	5.596634267135414e-13	1.2343376876167156e-8	11	79	95
DOID:6000	congestive heart failure	GO:0001666	response to hypoxia	6.586953205101054e-13	1.4527525293850374e-8	20	292	95
DOID:6000	congestive heart failure	GO:0043500	muscle adaptation	7.112088695748753e-13	1.5685711618473874e-8	11	84	95
DOID:6000	congestive heart failure	GO:1903034	regulation of response to wounding	7.965850201685498e-13	1.7568682619817366e-8	21	407	95
DOID:6000	congestive heart failure	GO:0045834	positive regulation of lipid metabolic process	8.675282714420973e-13	1.9133336026655456e-8	12	124	95
DOID:6000	congestive heart failure	GO:0006874	cellular calcium ion homeostasis	8.79740724712974e-13	1.9402681683544643e-8	17	352	95
DOID:6000	congestive heart failure	GO:0006954	inflammatory response	8.987255384340642e-13	1.9821391750163286e-8	30	637	95
DOID:6000	congestive heart failure	GO:0050900	leukocyte migration	9.117151478221786e-13	2.0107877585218148e-8	17	354	95
DOID:6000	congestive heart failure	GO:1901698	response to nitrogen compound	1.2040368702059823e-12	2.655503317239294e-8	30	870	95
DOID:6000	congestive heart failure	GO:0001934	positive regulation of protein phosphorylation	1.2040368702059823e-12	2.655503317239294e-8	36	870	95
DOID:6000	congestive heart failure	GO:0050727	regulation of inflammatory response	1.3624656958199921e-12	3.0049180921309926e-8	16	289	95
DOID:6000	congestive heart failure	GO:0007568	aging	1.3679057886406554e-12	3.0169162168469654e-8	16	290	95
DOID:6000	congestive heart failure	GO:0043408	regulation of MAPK cascade	1.6262546864709293e-12	3.5867047110116346e-8	27	651	95
DOID:6000	congestive heart failure	GO:0001816	cytokine production	1.7680301667155618e-12	3.8993905326911715e-8	23	613	95
DOID:6000	congestive heart failure	GO:0071407	cellular response to organic cyclic compound	1.8379742172669467e-12	4.053652136182251e-8	23	416	95
DOID:6000	congestive heart failure	GO:0060548	negative regulation of cell death	1.9800827644189667e-12	4.367072536926031e-8	30	867	95
DOID:6000	congestive heart failure	GO:0001525	angiogenesis	2.0172752357439094e-12	4.449100532433192e-8	21	413	95
DOID:6000	congestive heart failure	GO:0051384	response to glucocorticoid	2.415734279281878e-12	5.327901952956182e-8	13	167	95
DOID:6000	congestive heart failure	GO:0009260	ribonucleotide biosynthetic process	2.5053292773691282e-12	5.5255037212376124e-8	15	253	95
DOID:6000	congestive heart failure	GO:0009152	purine ribonucleotide biosynthetic process	2.644773289262048e-12	5.8330474894674467e-8	15	240	95
DOID:6000	congestive heart failure	GO:0045765	regulation of angiogenesis	3.0059288391726113e-12	6.629576054795194e-8	14	208	95
DOID:6000	congestive heart failure	GO:0040008	regulation of growth	3.657518732325116e-12	8.066657564143043e-8	22	617	95
DOID:6000	congestive heart failure	GO:0045428	regulation of nitric oxide biosynthetic process	3.962052907979796e-12	8.73830768854944e-8	9	51	95
DOID:6000	congestive heart failure	GO:0070848	response to growth factor	4.512279438984024e-12	9.951832302679264e-8	21	621	95
DOID:6000	congestive heart failure	GO:0001775	cell activation	4.651723450876943e-12	1.0259376070909099e-7	24	854	95
DOID:6000	congestive heart failure	GO:1902533	positive regulation of intracellular signal transduction	5.1882942386782815e-12	1.144278294340495e-7	34	860	95
DOID:6000	congestive heart failure	GO:0001817	regulation of cytokine production	5.235478717224851e-12	1.1546848310839408e-7	21	556	95
DOID:6000	congestive heart failure	GO:0009266	response to temperature stimulus	5.277445147555682e-12	1.1639405272934056e-7	14	219	95
DOID:6000	congestive heart failure	GO:0006953	acute-phase response	5.61806157151068e-12	1.2390634795966804e-7	9	53	95
DOID:6000	congestive heart failure	GO:0031667	response to nutrient levels	5.865086194489777e-12	1.2935447601947203e-7	21	546	95
DOID:6000	congestive heart failure	GO:0050878	regulation of body fluid levels	6.01263483446246e-12	1.3260866127406956e-7	25	504	95
DOID:6000	congestive heart failure	GO:0032940	secretion by cell	6.235567617807192e-12	1.375254438107376e-7	28	956	95
DOID:6000	congestive heart failure	GO:0043410	positive regulation of MAPK cascade	6.50823839265513e-12	1.435391977500089e-7	21	464	95
DOID:6000	congestive heart failure	GO:0005126	cytokine receptor binding	6.746936342949539e-12	1.4880368104375208e-7	15	270	95
DOID:6000	congestive heart failure	GO:0043069	negative regulation of programmed cell death	6.782907568947394e-12	1.4959702643313477e-7	28	806	95
DOID:6000	congestive heart failure	GO:0071417	cellular response to organonitrogen compound	7.007283642224138e-12	1.5454564072925336e-7	20	462	95
DOID:6000	congestive heart failure	GO:0008284	positive regulation of cell proliferation	7.5396355825319e-12	1.6628666277274107e-7	29	815	95
DOID:6000	congestive heart failure	GO:0007610	behavior	7.7134965081882e-12	1.7012116548809075e-7	25	714	95
DOID:6000	congestive heart failure	GO:0097285	cell-type specific apoptotic process	7.929878975687643e-12	1.7489348080879097e-7	18	429	95
DOID:6000	congestive heart failure	GO:0042060	wound healing	7.983946836986888e-12	1.7608594748974582e-7	20	534	95
DOID:6000	congestive heart failure	GO:0051093	negative regulation of developmental process	8.19011525265978e-12	1.8063299189741144e-7	24	788	95
DOID:6000	congestive heart failure	GO:0035637	multicellular organismal signaling	8.39228686544402e-12	1.8509188681736788e-7	13	184	95
DOID:6000	congestive heart failure	GO:0043066	negative regulation of apoptotic process	8.858358491181662e-12	1.9537109652301154e-7	28	795	95
DOID:6000	congestive heart failure	GO:0043068	positive regulation of programmed cell death	9.063638728434853e-12	1.9989855215563068e-7	20	561	95
DOID:6000	congestive heart failure	GO:0043065	positive regulation of apoptotic process	9.347411733529043e-12	2.0615716578298304e-7	20	556	95
DOID:6000	congestive heart failure	GO:0043405	regulation of MAP kinase activity	1.0338729872216845e-11	2.2802068733174252e-7	15	278	95
DOID:6000	congestive heart failure	GO:0032768	regulation of monooxygenase activity	1.13518083821873e-11	2.503641338691409e-7	9	57	95
DOID:6000	congestive heart failure	GO:0050729	positive regulation of inflammatory response	1.3421708189298442e-11	2.9601577411497715e-7	11	114	95
DOID:6000	congestive heart failure	GO:0071453	cellular response to oxygen levels	1.3750889316099801e-11	3.032758638665811e-7	12	150	95
DOID:6000	congestive heart failure	GO:0071363	cellular response to growth factor stimulus	1.5807133380008054e-11	3.486263266960776e-7	20	594	95
DOID:6000	congestive heart failure	GO:0042554	superoxide anion generation	1.6179613204769794e-11	3.568413692311978e-7	7	23	95
DOID:6000	congestive heart failure	GO:0050886	endocrine process	1.657096682095016e-11	3.654726732360558e-7	10	85	95
DOID:6000	congestive heart failure	GO:0044706	multi-multicellular organism process	1.7050028056075917e-11	3.7603836877675434e-7	14	237	95
DOID:6000	congestive heart failure	GO:0032870	cellular response to hormone stimulus	1.779998370921021e-11	3.925786407066312e-7	19	519	95
DOID:6000	congestive heart failure	GO:0001990	regulation of systemic arterial blood pressure by hormone	1.8059331807762646e-11	3.9829856302020517e-7	8	39	95
DOID:6000	congestive heart failure	GO:0048661	positive regulation of smooth muscle cell proliferation	1.8598456108520622e-11	4.101889494734223e-7	9	60	95
DOID:6000	congestive heart failure	GO:0014074	response to purine-containing compound	2.0500379172005978e-11	4.5213586263859185e-7	12	155	95
DOID:6000	congestive heart failure	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.2448709557920665e-11	4.951062892999403e-7	8	40	95
DOID:6000	congestive heart failure	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3.26032534303522e-11	7.190647544064177e-7	12	161	95
DOID:6000	congestive heart failure	GO:0007589	body fluid secretion	3.296396489105291e-11	7.270202456721719e-7	10	91	95
DOID:6000	congestive heart failure	GO:0046889	positive regulation of lipid biosynthetic process	3.401046111406458e-11	7.501007198706944e-7	9	64	95
DOID:6000	congestive heart failure	GO:1901652	response to peptide	4.2515768683415445e-11	9.376852783127276e-7	17	423	95
DOID:6000	congestive heart failure	GO:0055114	oxidation-reduction process	4.909139761366532e-11	1.0827107743693887e-6	24	949	95
DOID:6000	congestive heart failure	GO:0097190	apoptotic signaling pathway	5.3251514309238246e-11	1.1744621480902495e-6	19	564	95
DOID:6000	congestive heart failure	GO:0006939	smooth muscle contraction	6.291722698392732e-11	1.387639441130517e-6	10	97	95
DOID:6000	congestive heart failure	GO:0045981	positive regulation of nucleotide metabolic process	6.750378034325877e-11	1.4887958754705721e-6	11	132	95
DOID:6000	congestive heart failure	GO:1900544	positive regulation of purine nucleotide metabolic process	6.750378034325877e-11	1.4887958754705721e-6	11	132	95
DOID:6000	congestive heart failure	GO:0014823	response to activity	6.844325106669658e-11	1.509515902275993e-6	9	69	95
DOID:6000	congestive heart failure	GO:0043627	response to estrogen	7.367506604794016e-11	1.6249035816873203e-6	13	217	95
DOID:6000	congestive heart failure	GO:0046068	cGMP metabolic process	7.419109770978594e-11	1.6362846599893288e-6	8	46	95
DOID:6000	congestive heart failure	GO:0001819	positive regulation of cytokine production	8.273304263894943e-11	1.8246772554020296e-6	16	381	95
DOID:6000	congestive heart failure	GO:0019932	second-messenger-mediated signaling	8.312628363427166e-11	1.8333501855538614e-6	13	219	95
DOID:6000	congestive heart failure	GO:0043434	response to peptide hormone	1.1314249537264232e-10	2.4953577354436263e-6	16	389	95
DOID:6000	congestive heart failure	GO:0030808	regulation of nucleotide biosynthetic process	1.1885725736959785e-10	2.6213968112864805e-6	11	139	95
DOID:6000	congestive heart failure	GO:1900371	regulation of purine nucleotide biosynthetic process	1.1885725736959785e-10	2.6213968112864805e-6	11	139	95
DOID:6000	congestive heart failure	GO:0060326	cell chemotaxis	1.3695067302421648e-10	3.0204470935490946e-6	13	228	95
DOID:6000	congestive heart failure	GO:0007167	enzyme linked receptor protein signaling pathway	1.9067492029734012e-10	4.205335367157836e-6	23	935	95
DOID:6000	congestive heart failure	GO:0006182	cGMP biosynthetic process	2.1398705030151177e-10	4.719484394399842e-6	7	32	95
DOID:6000	congestive heart failure	GO:0016049	cell growth	2.843109081496209e-10	6.270477079239889e-6	17	479	95
DOID:6000	congestive heart failure	GO:1903530	regulation of secretion by cell	2.914269936482583e-10	6.427422344912337e-6	19	624	95
DOID:6000	congestive heart failure	GO:0033674	positive regulation of kinase activity	2.9401359125103e-10	6.4844697550414665e-6	17	480	95
DOID:6000	congestive heart failure	GO:0050795	regulation of behavior	3.044458019019203e-10	6.714552160946852e-6	13	243	95
DOID:6000	congestive heart failure	GO:0034097	response to cytokine	3.1014479873192613e-10	6.840243536032631e-6	21	784	95
DOID:6000	congestive heart failure	GO:0046879	hormone secretion	3.1400371192091825e-10	6.925351866415852e-6	14	297	95
DOID:6000	congestive heart failure	GO:0097529	myeloid leukocyte migration	3.3660774167998397e-10	7.4238837427520465e-6	11	153	95
DOID:6000	congestive heart failure	GO:0045907	positive regulation of vasoconstriction	3.3921065956121765e-10	7.481291096622655e-6	7	34	95
DOID:6000	congestive heart failure	GO:0030799	regulation of cyclic nucleotide metabolic process	3.610501897455265e-10	7.962961934837587e-6	11	154	95
DOID:6000	congestive heart failure	GO:0031649	heat generation	3.803038994831809e-10	8.387602503101554e-6	6	19	95
DOID:6000	congestive heart failure	GO:0043406	positive regulation of MAP kinase activity	5.471876285412236e-10	1.2068223147476687e-5	12	205	95
DOID:6000	congestive heart failure	GO:0045597	positive regulation of cell differentiation	6.198059843143255e-10	1.366982098405245e-5	21	815	95
DOID:6000	congestive heart failure	GO:0001101	response to acid chemical	6.781063488503491e-10	1.495563552389445e-5	14	315	95
DOID:6000	congestive heart failure	GO:0045940	positive regulation of steroid metabolic process	7.543388136355134e-10	1.6636942534731247e-5	6	21	95
DOID:6000	congestive heart failure	GO:0019430	removal of superoxide radicals	7.543388136355134e-10	1.6636942534731247e-5	6	21	95
DOID:6000	congestive heart failure	GO:0097191	extrinsic apoptotic signaling pathway	1.227576595930202e-9	2.7074201823240607e-5	12	220	95
DOID:6000	congestive heart failure	GO:0007159	leukocyte cell-cell adhesion	1.3640986118446108e-9	3.008519488423289e-5	16	461	95
DOID:6000	congestive heart failure	GO:0010876	lipid localization	1.3925914865708933e-9	3.071360523632105e-5	14	333	95
DOID:6000	congestive heart failure	GO:0030802	regulation of cyclic nucleotide biosynthetic process	1.4449353935575004e-9	3.186805010491067e-5	10	133	95
DOID:6000	congestive heart failure	GO:0050673	epithelial cell proliferation	1.5044888668214185e-9	3.3181501957746384e-5	14	335	95
DOID:6000	congestive heart failure	GO:0071456	cellular response to hypoxia	1.5549304066553304e-9	3.429399011878331e-5	10	134	95
DOID:6000	congestive heart failure	GO:0030595	leukocyte chemotaxis	1.5929830787797528e-9	3.513324180248745e-5	11	177	95
DOID:6000	congestive heart failure	GO:0045121	membrane raft	1.867296872681834e-9	4.118323252699785e-5	13	282	95
DOID:6000	congestive heart failure	GO:0031644	regulation of neurological system process	1.9151844554698982e-9	4.2239393165388606e-5	8	68	95
DOID:6000	congestive heart failure	GO:0030155	regulation of cell adhesion	1.98492999814448e-9	4.377763110907651e-5	18	621	95
DOID:6000	congestive heart failure	GO:1901654	response to ketone	2.017766509432306e-9	4.450184036552951e-5	11	181	95
DOID:6000	congestive heart failure	GO:0045926	negative regulation of growth	2.0350122698076234e-9	4.4882195610607134e-5	12	230	95
DOID:6000	congestive heart failure	GO:0045073	regulation of chemokine biosynthetic process	2.3607289456606395e-9	5.2065876896545404e-5	5	12	95
DOID:6000	congestive heart failure	GO:0030141	secretory granule	2.747689076265658e-9	6.060028257703909e-5	14	351	95
DOID:6000	congestive heart failure	GO:0030810	positive regulation of nucleotide biosynthetic process	2.867829862474025e-9	6.324998761686462e-5	9	104	95
DOID:6000	congestive heart failure	GO:1900373	positive regulation of purine nucleotide biosynthetic process	2.867829862474025e-9	6.324998761686462e-5	9	104	95
DOID:6000	congestive heart failure	GO:0043491	protein kinase B signaling	3.1402723754681006e-9	6.925870724094896e-5	10	144	95
DOID:6000	congestive heart failure	GO:0050999	regulation of nitric-oxide synthase activity	3.2113425252333627e-9	7.082615939402181e-5	7	46	95
DOID:6000	congestive heart failure	GO:0048520	positive regulation of behavior	3.358969435929282e-9	7.408207090942032e-5	10	145	95
DOID:6000	congestive heart failure	GO:0007565	female pregnancy	3.3657355791305577e-9	7.423129819772445e-5	11	190	95
DOID:6000	congestive heart failure	GO:0007599	hemostasis	3.4145486438319494e-9	7.530787033971365e-5	14	357	95
DOID:6000	congestive heart failure	GO:2001233	regulation of apoptotic signaling pathway	3.667708470267428e-9	8.089131031174812e-5	14	359	95
DOID:6000	congestive heart failure	GO:0002673	regulation of acute inflammatory response	3.808731774412877e-9	8.4001579284676e-5	8	74	95
DOID:6000	congestive heart failure	GO:0032770	positive regulation of monooxygenase activity	4.015276666713419e-9	8.855692688436445e-5	6	27	95
DOID:6000	congestive heart failure	GO:0051047	positive regulation of secretion	4.224487537562993e-9	9.317107264095181e-5	14	363	95
DOID:6000	congestive heart failure	GO:0002687	positive regulation of leukocyte migration	4.358439276153092e-9	9.612537823555645e-5	9	109	95
Orphanet:95502	Acquired pituitary hormone deficiency	GO:0034109	homotypic cell-cell adhesion	1.203936950133766e-11	2.655282943520021e-7	19	495	95
Orphanet:95502	Acquired pituitary hormone deficiency	GO:0050863	regulation of T cell activation	1.3490986106035052e-11	2.975436985686031e-7	15	284	95
Orphanet:95502	Acquired pituitary hormone deficiency	GO:0042129	regulation of T cell proliferation	1.501698765338233e-10	3.311996626953473e-6	11	142	95
Orphanet:95502	Acquired pituitary hormone deficiency	GO:0033993	response to lipid	2.0400803268927348e-10	4.4993971609619265e-6	22	850	95
Orphanet:95502	Acquired pituitary hormone deficiency	GO:0008284	positive regulation of cell proliferation	6.198059843143255e-10	1.366982098405245e-5	21	815	95
DOID:104	bacterial infectious disease	GO:0009607	response to biotic stimulus	4.640954287538079e-12	1.0235624681165234e-7	28	934	95
DOID:104	bacterial infectious disease	GO:0002237	response to molecule of bacterial origin	3.204991827487902e-12	7.068609475524568e-8	18	333	95
DOID:104	bacterial infectious disease	GO:0051604	protein maturation	1.5760726057578722e-12	3.476028131998987e-8	17	332	95
DOID:104	bacterial infectious disease	GO:0016485	protein processing	1.3924417174848713e-12	3.071030207912884e-8	17	308	95
DOID:104	bacterial infectious disease	GO:0001816	cytokine production	2.8461455414685588e-11	6.277173991708906e-7	20	613	95
DOID:104	bacterial infectious disease	GO:0006959	humoral immune response	7.578715432998706e-11	1.6714856887478646e-6	12	173	95
DOID:104	bacterial infectious disease	GO:0032101	regulation of response to external stimulus	1.4043943785679858e-10	3.0973918019316926e-6	23	920	95
DOID:104	bacterial infectious disease	GO:0001775	cell activation	2.218005779042187e-10	4.891811745677543e-6	22	854	95
DOID:104	bacterial infectious disease	GO:0072376	protein activation cascade	2.38692510201588e-10	5.264363312496023e-6	9	79	95
DOID:104	bacterial infectious disease	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	3.3921065956121765e-10	7.481291096622655e-6	7	34	95
DOID:104	bacterial infectious disease	GO:0001817	regulation of cytokine production	3.46461637157347e-10	7.641211407505288e-6	18	556	95
DOID:104	bacterial infectious disease	GO:0002705	positive regulation of leukocyte mediated immunity	3.7478320447092983e-10	8.265843574606357e-6	9	83	95
DOID:104	bacterial infectious disease	GO:0006956	complement activation	3.867755005160234e-10	8.530333663880896e-6	8	56	95
DOID:104	bacterial infectious disease	GO:0009636	response to toxic substance	4.0882697227573317e-10	9.016678873541295e-6	13	249	95
DOID:104	bacterial infectious disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	6.831324395051297e-10	1.5066485953285635e-5	12	209	95
DOID:104	bacterial infectious disease	GO:0001819	positive regulation of cytokine production	8.423212127794955e-10	1.8577394347851772e-5	15	381	95
DOID:104	bacterial infectious disease	GO:0016064	immunoglobulin mediated immune response	1.536122451462063e-9	3.38791806669958e-5	9	97	95
DOID:104	bacterial infectious disease	GO:0045321	leukocyte activation	1.7061129176099143e-9	3.762832039788666e-5	19	694	95
DOID:104	bacterial infectious disease	GO:0002455	humoral immune response mediated by circulating immunoglobulin	1.9575127074844545e-9	4.3172942763569644e-5	7	43	95
DOID:104	bacterial infectious disease	GO:0030155	regulation of cell adhesion	1.98492999814448e-9	4.377763110907651e-5	18	621	95
DOID:104	bacterial infectious disease	GO:1903034	regulation of response to wounding	2.0805270839474588e-9	4.58860248364612e-5	15	407	95
DOID:530	eyelid disease	GO:0050803	regulation of synapse structure or activity	2.665106912935755e-9	5.877893296479808e-5	12	233	96
MESH:D007571	Jaw Diseases	GO:0051302	regulation of cell division	4.738431869100168e-13	1.045061148730042e-8	17	293	96
MESH:D007571	Jaw Diseases	GO:1902533	positive regulation of intracellular signal transduction	5.814237979961945e-12	1.282330186480607e-7	26	860	96
MESH:D007571	Jaw Diseases	GO:0021915	neural tube development	3.275438809069442e-10	7.223980293402654e-6	11	151	96
MESH:D007571	Jaw Diseases	GO:0043066	negative regulation of apoptotic process	4.885479798488745e-10	1.0774925695566928e-5	21	795	96
MESH:D007571	Jaw Diseases	GO:0061180	mammary gland epithelium development	1.2685820172109175e-9	2.7978576389586785e-5	8	64	96
MESH:D007571	Jaw Diseases	GO:0035148	tube formation	1.381873393491162e-9	3.0477217693447578e-5	10	131	96
MESH:D007571	Jaw Diseases	GO:0002062	chondrocyte differentiation	1.3992779157590007e-9	3.086107443206476e-5	9	95	96
MESH:D007571	Jaw Diseases	GO:0060601	lateral sprouting from an epithelium	2.4896595895995688e-9	5.490944224861849e-5	5	12	96
MESH:D065703	Malformations of Cortical Development, Group I	GO:0007420	brain development	2.234123996913695e-11	4.927360475193154e-7	21	669	96
MESH:D065703	Malformations of Cortical Development, Group I	GO:0010638	positive regulation of organelle organization	6.608518177131373e-10	1.4575086839663243e-5	18	573	96
MESH:D004392	Dwarfism	GO:0021983	pituitary gland development	7.683853553430708e-13	1.6946739012091427e-8	9	42	96
MESH:D004392	Dwarfism	GO:0048589	developmental growth	3.1674662892555716e-12	6.985846900953163e-8	22	558	96
MESH:D004392	Dwarfism	GO:0035264	multicellular organism growth	4.78705963757875e-12	1.0557860030679933e-7	12	137	96
MESH:D004392	Dwarfism	GO:0009887	organ morphogenesis	3.47256889909886e-10	7.658750706962536e-6	23	950	96
MESH:D004392	Dwarfism	GO:0001501	skeletal system development	3.7034064703789227e-10	8.167862970420714e-6	17	482	96
MESH:D004392	Dwarfism	GO:0048568	embryonic organ development	2.49947418318186e-9	5.5125903110075924e-5	15	408	96
MESH:D004392	Dwarfism	GO:0060126	somatotropin secreting cell differentiation	3.268347592566556e-9	7.20834061540554e-5	4	5	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0009607	response to biotic stimulus	4.043210211079895e-12	8.917300120536709e-8	37	934	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0032101	regulation of response to external stimulus	2.7895463716731683e-12	6.152344522725173e-8	38	920	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0050778	positive regulation of immune response	1.3500311979441904e-12	2.9774938070659118e-8	45	603	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0045088	regulation of innate immune response	8.091305403468141e-13	1.7845374067348985e-8	21	351	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0002526	acute inflammatory response	4.75397499144492e-13	1.0484891843631772e-8	17	141	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0006909	phagocytosis	2.2113422204483868e-12	4.877115267198917e-8	14	204	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0009617	response to bacterium	6.7382766033574626e-12	1.4861269048704884e-7	21	517	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0042742	defense response to bacterium	7.471689933424841e-12	1.6478812148168487e-7	14	222	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0002520	immune system development	3.6307712392158464e-10	8.00766596809055e-6	21	782	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0048534	hematopoietic or lymphoid organ development	8.853321409318937e-10	1.9526000368252916e-5	20	739	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0019955	cytokine binding	1.0478614642650541e-9	2.311058459436577e-5	9	92	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0002237	response to molecule of bacterial origin	1.6048914419641847e-9	3.539588075252009e-5	14	333	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0030097	hemopoiesis	2.101509744001362e-9	4.634879740395004e-5	19	695	96
Orphanet:101988	Primary immunodeficiency due to a defect in innate immunity	GO:0050766	positive regulation of phagocytosis	4.045647816752762e-9	8.922676259848217e-5	7	47	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032880	regulation of protein localization	5.359490629075481e-12	1.1820356582425973e-7	30	933	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009607	response to biotic stimulus	4.043210211079895e-12	8.917300120536709e-8	31	934	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0040007	growth	3.764988321108831e-12	8.303681742205526e-8	27	936	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0002237	response to molecule of bacterial origin	3.2720492981752614e-12	7.216504727125539e-8	21	333	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042327	positive regulation of phosphorylation	3.2105429426110277e-12	7.080852459928622e-8	31	910	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0072358	cardiovascular system development	3.15591996979947e-12	6.960381493392731e-8	27	910	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051050	positive regulation of transport	2.7895463716731683e-12	6.152344522725173e-8	30	920	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1901653	cellular response to peptide	1.914690628268545e-12	4.222850180646276e-8	20	301	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0097305	response to alcohol	1.9093615577503442e-12	4.211096915618384e-8	19	369	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0036293	response to decreased oxygen levels	1.574296248918472e-12	3.47211037698969e-8	24	302	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048511	rhythmic process	1.55964130499342e-12	3.4397888981629876e-8	21	329	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042886	amide transport	1.55964130499342e-12	3.4397888981629876e-8	21	329	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032496	response to lipopolysaccharide	1.4774848011711583e-12	3.25859272898299e-8	21	319	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006631	fatty acid metabolic process	1.3871126469666706e-12	3.059276942884992e-8	18	348	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006979	response to oxidative stress	1.3453682612407647e-12	2.9672097001665065e-8	26	386	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009991	response to extracellular stimulus	1.3060663661690342e-12	2.8805293705858048e-8	31	573	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0015833	peptide transport	1.1961542867311437e-12	2.6381182793855373e-8	21	307	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009914	hormone transport	1.1961542867311437e-12	2.6381182793855373e-8	22	307	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0034284	response to monosaccharide	1.1599610161283636e-12	2.5582940210711058e-8	19	188	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032869	cellular response to insulin stimulus	1.1475265182525618e-12	2.530869736006025e-8	16	186	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001101	response to acid chemical	9.778844400898379e-13	2.1567241326181374e-8	22	315	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0046879	hormone secretion	9.585665594613602e-13	2.1141185468920298e-8	22	297	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1903522	regulation of blood circulation	9.472422846101836e-13	2.08914285870776e-8	18	297	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009746	response to hexose	9.265921363521556e-13	2.0435989567246793e-8	19	181	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1901654	response to ketone	9.254819133275305e-13	2.0411503598438685e-8	16	181	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050708	regulation of protein secretion	8.317790900491673e-13	1.8344887831034384e-8	22	380	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043279	response to alkaloid	8.164580123093401e-13	1.8006981461482496e-8	17	140	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009749	response to glucose	8.077982727172639e-13	1.7815990904779255e-8	18	176	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001678	cellular glucose homeostasis	8.038014698286133e-13	1.7727841417070067e-8	13	125	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045834	positive regulation of lipid metabolic process	7.87592213669086e-13	1.7370346272471693e-8	15	124	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0090276	regulation of peptide hormone secretion	7.7982065249671e-13	1.7198944490814938e-8	18	199	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006006	glucose metabolic process	7.7982065249671e-13	1.7198944490814938e-8	19	199	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0030073	insulin secretion	7.7982065249671e-13	1.7198944490814938e-8	18	199	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0031960	response to corticosteroid	7.713829575095588e-13	1.701285112787332e-8	15	179	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001234	negative regulation of apoptotic signaling pathway	6.861178292183467e-13	1.5132328723410637e-8	15	199	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0000302	response to reactive oxygen species	6.501466032204917e-13	1.4338983334027944e-8	21	216	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071453	cellular response to oxygen levels	5.937472735695337e-13	1.3095096118576066e-8	15	150	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0030335	positive regulation of cell migration	5.491163079796024e-13	1.2110760172490131e-8	18	387	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050880	regulation of blood vessel size	5.289102489314246e-13	1.1665115540182569e-8	13	139	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050796	regulation of insulin secretion	5.064837438339964e-13	1.1170498970258791e-8	18	169	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.405364961712621e-13	9.716032423057186e-9	15	151	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071216	cellular response to biotic stimulus	4.036770917537069e-13	8.903098258628006e-9	14	175	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010565	regulation of cellular ketone metabolic process	3.730349362740526e-13	8.22728551952423e-9	14	188	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2000377	regulation of reactive oxygen species metabolic process	3.2795988147427124e-13	7.233155185915052e-9	17	147	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0008217	regulation of blood pressure	3.2507330161024584e-13	7.169491667013972e-9	14	168	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051384	response to glucocorticoid	2.7911006839076435e-13	6.155772558358308e-9	14	167	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0034599	cellular response to oxidative stress	1.0258460747536446e-13	2.2625035178691633e-9	17	219	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0036294	cellular response to decreased oxygen levels	4.5075054799781356e-14	9.941303336091778e-10	13	142	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043200	response to amino acid	4.3520742565306136e-14	9.598499772778268e-10	13	112	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006801	superoxide metabolic process	2.886579864025407e-14	6.366351890108035e-10	12	52	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045428	regulation of nitric oxide biosynthetic process	5.3179682879545e-14	1.172877905908365e-9	10	51	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0007568	aging	9.037215420448774e-14	1.993157860979977e-9	27	290	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071496	cellular response to external stimulus	1.0458300891968975e-13	2.3065782617237574e-9	19	270	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0060047	heart contraction	1.4266365866433262e-13	3.146446991841856e-9	16	253	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0046677	response to antibiotic	1.4954704141700859e-13	3.2982599984521244e-9	10	45	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	1.574296248918472e-13	3.47211037698969e-9	10	46	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042554	superoxide anion generation	1.6919798895287386e-13	3.731661646355633e-9	8	23	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043269	regulation of ion transport	2.823297151621773e-13	6.2267818679018205e-9	22	583	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0070542	response to fatty acid	4.275468867831478e-13	9.429546588002324e-9	12	82	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045429	positive regulation of nitric oxide biosynthetic process	4.4164671919588727e-13	9.740518391865294e-9	9	40	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0070997	neuron death	5.891953591685706e-13	1.2994703646462824e-8	16	281	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001666	response to hypoxia	6.459277557269161e-13	1.4245936652557134e-8	23	292	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010942	positive regulation of cell death	6.590283874174929e-13	1.4534871084492806e-8	28	596	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071222	cellular response to lipopolysaccharide	8.456568778569817e-13	1.8650962441135732e-8	13	152	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043408	regulation of MAPK cascade	1.1253220577600587e-12	2.4818977983898094e-8	24	651	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001934	positive regulation of protein phosphorylation	1.7337242752546445e-12	3.8237288890741183e-8	29	870	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0031329	regulation of cellular catabolic process	1.8450796446245477e-12	4.06932315621944e-8	22	624	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071407	cellular response to organic cyclic compound	1.851185871259986e-12	4.082790439063899e-8	22	416	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0097285	cell-type specific apoptotic process	2.727484904596622e-12	6.01546795708785e-8	24	429	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	2.8486102365832267e-12	6.282609876784306e-8	11	97	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051051	negative regulation of transport	3.017919247838563e-12	6.656020901107951e-8	20	452	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043068	positive regulation of programmed cell death	3.178568519501823e-12	7.010332869761271e-8	26	561	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032844	regulation of homeostatic process	3.2064351174199146e-12	7.071792651469622e-8	22	427	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048732	gland development	3.33377769834442e-12	7.352646713698618e-8	19	421	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009611	response to wounding	3.432143458326209e-12	7.569592397338454e-8	28	875	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071456	cellular response to hypoxia	3.502975687297294e-12	7.725812878334182e-8	12	134	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1903034	regulation of response to wounding	3.530953307517848e-12	7.787517519730613e-8	18	407	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042493	response to drug	3.625100220006061e-12	7.995158535223368e-8	32	433	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051241	negative regulation of multicellular organismal process	3.961608818769946e-12	8.737328249797116e-8	26	966	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009612	response to mechanical stimulus	4.12947454009327e-12	9.107556098175706e-8	14	210	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050801	ion homeostasis	4.3014480866077065e-12	9.486843755013297e-8	22	668	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043065	positive regulation of apoptotic process	4.337086245698174e-12	9.565443714887323e-8	26	556	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071229	cellular response to acid chemical	4.352740390345389e-12	9.599968930906755e-8	13	174	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0031667	response to nutrient levels	5.058398144797138e-12	1.1156297108350088e-7	31	546	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001525	angiogenesis	5.268452341056218e-12	1.1619571638199488e-7	18	413	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010035	response to inorganic substance	5.416223025633826e-12	1.1945479883035404e-7	27	502	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048659	smooth muscle cell proliferation	5.646927370150934e-12	1.2454298314867884e-7	11	104	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1902533	positive regulation of intracellular signal transduction	5.698663763098466e-12	1.2568402929513667e-7	30	860	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0034612	response to tumor necrosis factor	5.967559779662679e-12	1.3161453094046038e-7	15	265	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0044283	small molecule biosynthetic process	6.4144245470743044e-12	1.4147013338572378e-7	20	530	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0008284	positive regulation of cell proliferation	7.275735569578501e-12	1.6046634798705384e-7	30	815	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0035094	response to nicotine	7.610911900712836e-12	1.678586619702216e-7	9	54	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0052547	regulation of peptidase activity	8.083533842295765e-12	1.782823388918331e-7	17	382	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0008585	female gonad development	8.32123259186801e-12	1.8352478481364898e-7	11	108	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0019217	regulation of fatty acid metabolic process	8.938960682769448e-12	1.9714877785848017e-7	10	79	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0055114	oxidation-reduction process	8.993139566371156e-12	1.9834369313631584e-7	33	949	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0030855	epithelial cell differentiation	9.57456336436735e-12	2.111669950011219e-7	20	568	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010876	lipid localization	1.0072276346306808e-11	2.2214405481779664e-7	16	333	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010038	response to metal ion	1.1160072865834536e-11	2.461354070559807e-7	16	335	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006875	cellular metal ion homeostasis	1.591771159326072e-11	3.5106512918936517e-7	18	450	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043500	muscle adaptation	1.646061065230242e-11	3.630387679365299e-7	10	84	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0007623	circadian rhythm	2.2902679752689892e-11	5.051186019455756e-7	13	196	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045597	positive regulation of cell differentiation	2.3387958236753548e-11	5.158214189115995e-7	23	815	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032101	regulation of response to external stimulus	2.4728441516685962e-11	5.453857776505089e-7	24	920	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043410	positive regulation of MAPK cascade	2.7767010912782553e-11	6.124014256814192e-7	18	464	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071345	cellular response to cytokine stimulus	2.8073099400671708e-11	6.191522072818145e-7	21	677	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042542	response to hydrogen peroxide	3.790290303840038e-11	8.359485265119204e-7	11	124	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1901214	regulation of neuron death	3.826694516817497e-11	8.43977475684099e-7	14	250	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006091	generation of precursor metabolites and energy	4.5272230408954783e-11	9.984790416694977e-7	16	362	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0052548	regulation of endopeptidase activity	4.5272230408954783e-11	9.984790416694977e-7	16	362	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0046890	regulation of lipid biosynthetic process	4.5319969999013665e-11	9.995319383282464e-7	11	126	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051924	regulation of calcium ion transport	4.7349568710330914e-11	1.0442947379063483e-6	13	207	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0034614	cellular response to reactive oxygen species	4.941969056204698e-11	1.0899512753459462e-6	11	127	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0031669	cellular response to nutrient levels	5.700750982384761e-11	1.257300629164959e-6	12	167	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045454	cell redox homeostasis	5.7408300335737295e-11	1.266140063904686e-6	9	67	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001235	positive regulation of apoptotic signaling pathway	6.110889572141787e-11	1.347756695135871e-6	12	168	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0002684	positive regulation of immune system process	6.236777760904033e-11	1.3755213351673845e-6	23	872	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006954	inflammatory response	6.556521991996078e-11	1.446040925334735e-6	20	637	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0090257	regulation of muscle system process	6.754630188510191e-11	1.4897336880759227e-6	13	213	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0072521	purine-containing compound metabolic process	7.273526225759497e-11	1.604176209091257e-6	19	568	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043627	response to estrogen	8.453793221008254e-11	1.8644840948933705e-6	13	217	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048660	regulation of smooth muscle cell proliferation	9.475387141577585e-11	2.0897966340749363e-6	10	100	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	9.819778323816308e-11	2.165752109317687e-6	9	71	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0044262	cellular carbohydrate metabolic process	1.0860512489330176e-10	2.3952860295217704e-6	14	271	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0097193	intrinsic apoptotic signaling pathway	1.1403777921970004e-10	2.5151032206904844e-6	14	272	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0008016	regulation of heart contraction	1.256681425587658e-10	2.7716108841335796e-6	13	224	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	1.3772494256159007e-10	3.037523608195869e-6	8	49	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.505362501319496e-10	3.3200769966601484e-6	24	996	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006163	purine nucleotide metabolic process	1.5316381496432996e-10	3.3780279390382972e-6	18	522	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0060284	regulation of cell development	1.5840251332832622e-10	3.493567431456235e-6	22	828	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071398	cellular response to fatty acid	1.63174695977375e-10	3.5988179197810055e-6	8	50	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010332	response to gamma radiation	1.63174695977375e-10	3.5988179197810055e-6	8	50	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032930	positive regulation of superoxide anion generation	1.7892654025075672e-10	3.946224845230439e-6	5	8	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042391	regulation of membrane potential	2.0134416356398788e-10	4.440645527403753e-6	15	340	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0007204	positive regulation of cytosolic calcium ion concentration	2.179200153662464e-10	4.806225938902564e-6	13	234	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010563	negative regulation of phosphorus metabolic process	2.381650432425886e-10	5.252730028715291e-6	18	537	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045936	negative regulation of phosphate metabolic process	2.381650432425886e-10	5.252730028715291e-6	18	537	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0044706	multi-multicellular organism process	2.5558455352125975e-10	5.636917327911384e-6	13	237	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0040008	regulation of growth	2.92537105650581e-10	6.451905865123564e-6	19	617	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071333	cellular response to glucose stimulus	2.937765586352725e-10	6.4792420007009355e-6	10	112	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0030155	regulation of cell adhesion	3.230259393305346e-10	7.12433709193494e-6	19	621	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3.4764569001310974e-10	7.667325693239135e-6	12	195	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042594	response to starvation	3.5201197512435556e-10	7.763624111367662e-6	11	152	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045444	fat cell differentiation	3.686179139705814e-10	8.129868092621173e-6	12	196	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0015908	fatty acid transport	3.689707428478073e-10	8.13764973350839e-6	9	82	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0014074	response to purine-containing compound	4.3355063983341324e-10	9.561959361525929e-6	11	155	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0007610	behavior	4.905579276126559e-10	1.0819255093497127e-5	20	714	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042698	ovulation cycle	4.928000230108864e-10	1.08687045075051e-5	10	118	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	5.115868839666859e-10	1.1283048725885259e-5	9	85	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043271	negative regulation of ion transport	6.320431955586514e-10	1.3939712678046057e-5	10	121	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0009150	purine ribonucleotide metabolic process	6.596460044860919e-10	1.4548492628940757e-5	17	501	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010638	positive regulation of organelle organization	6.608518177131373e-10	1.4575086839663243e-5	18	573	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1903649	regulation of cytoplasmic transport	7.388916145600888e-10	1.6296254559122758e-5	16	437	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006109	regulation of carbohydrate metabolic process	7.433407223089716e-10	1.639437963052437e-5	11	163	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	7.512015454125276e-10	1.6567750084073296e-5	20	732	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1903524	positive regulation of blood circulation	7.764100473650615e-10	1.712372359463643e-5	9	89	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045940	positive regulation of steroid metabolic process	8.040554888566476e-10	1.7733443806733362e-5	6	21	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048871	multicellular organismal homeostasis	9.991605320891495e-10	2.203648553522619e-5	14	321	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0002521	leukocyte differentiation	1.0576072240198187e-9	2.33255273257571e-5	16	448	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043502	regulation of muscle adaptation	1.1147791578736133e-9	2.458645432690254e-5	8	63	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0031347	regulation of defense response	1.1197552884922857e-9	2.469620288769736e-5	20	749	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010631	epithelial cell migration	1.2509590030518325e-9	2.7589900812308166e-5	12	218	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0044703	multi-organism reproductive process	1.2543849292612208e-9	2.7665459614856225e-5	22	926	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0046889	positive regulation of lipid biosynthetic process	1.2685820172109175e-9	2.7978576389586785e-5	8	64	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0022602	ovulation cycle process	1.2720637876384444e-9	2.805536683636589e-5	9	94	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051338	regulation of transferase activity	1.3052919856093581e-9	2.8788214742614393e-5	22	928	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0019229	regulation of vasoconstriction	1.440733865543109e-9	3.177538540455327e-5	8	65	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0043549	regulation of kinase activity	1.4654778501821397e-9	3.232111398576709e-5	20	761	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051235	maintenance of location	1.5028273070427645e-9	3.314485625682817e-5	13	274	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050673	epithelial cell proliferation	1.7338076530037938e-9	3.823912778699867e-5	14	335	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.7923940109909609e-9	3.953124991240564e-5	12	225	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050996	positive regulation of lipid catabolic process	1.9698735975737236e-9	4.3445562194488474e-5	6	24	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006641	triglyceride metabolic process	2.02697303386401e-9	4.4704890261870744e-5	9	99	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0006090	pyruvate metabolic process	2.02697303386401e-9	4.4704890261870744e-5	9	99	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010720	positive regulation of cell development	2.042643276745082e-9	4.505049746861278e-5	16	469	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042743	hydrogen peroxide metabolic process	2.107940710871503e-9	4.6490632378271e-5	7	43	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045121	membrane raft	2.1309378706035886e-9	4.699783473616215e-5	13	282	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045926	negative regulation of growth	2.300948986899698e-9	5.074742990607284e-5	12	230	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071214	cellular response to abiotic stimulus	2.42108189052459e-9	5.3396961095519835e-5	13	285	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010634	positive regulation of epithelial cell migration	2.4246523677717846e-9	5.347570797120671e-5	9	101	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0048771	tissue remodeling	2.468083404316701e-9	5.443357948220484e-5	10	139	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0044282	small molecule catabolic process	2.534696008638093e-9	5.5902720470513145e-5	14	345	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0051093	negative regulation of developmental process	2.655142550267442e-9	5.855916894614843e-5	20	788	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0033674	positive regulation of kinase activity	2.848834279589596e-9	6.283104003634854e-5	16	480	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0050727	regulation of inflammatory response	2.8664148832291403e-9	6.321878024961869e-5	13	289	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0045859	regulation of protein kinase activity	2.913014718330942e-9	6.424653961278892e-5	19	709	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	2.943706500779797e-9	6.492344687469842e-5	7	45	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0030141	secretory granule	3.162991313310215e-9	6.975977341505679e-5	14	351	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010906	regulation of glucose metabolic process	3.4310304597440222e-9	7.567137678965441e-5	9	105	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0042326	negative regulation of phosphorylation	3.7015703835407976e-9	8.163813480899229e-5	15	420	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0001776	leukocyte homeostasis	3.7096568039629574e-9	8.181648081140303e-5	8	73	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:2001242	regulation of intrinsic apoptotic signaling pathway	3.724912933655844e-9	8.215295475177964e-5	10	145	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0007565	female pregnancy	3.768021894501317e-9	8.310372288322654e-5	11	190	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0010893	positive regulation of steroid biosynthetic process	4.029292122176287e-9	8.8866037754598e-5	5	13	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0046888	negative regulation of hormone secretion	4.141853415795538e-9	9.134857708537059e-5	8	74	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032846	positive regulation of homeostatic process	4.2058446725334875e-9	9.275990425272607e-5	11	192	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0071356	cellular response to tumor necrosis factor	4.284394061748742e-9	9.44923110318685e-5	12	243	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:0032409	regulation of transporter activity	4.441623513429249e-9	9.796000658868209e-5	11	193	96
MESH:D003921	Diabetes Mellitus, Experimental	GO:1902532	negative regulation of intracellular signal transduction	4.483590942960802e-9	9.88855982470005e-5	15	426	96
MESH:D010182	Pancreatic Diseases	GO:0042886	amide transport	1.7430501486614958e-12	3.844297102872929e-8	18	329	97
MESH:D010182	Pancreatic Diseases	GO:0009914	hormone transport	1.3709033908071433e-12	3.0235274284251545e-8	21	307	97
MESH:D010182	Pancreatic Diseases	GO:0015833	peptide transport	1.3464784842653899e-12	2.9696582970473173e-8	18	307	97
MESH:D010182	Pancreatic Diseases	GO:0046879	hormone secretion	1.2148060335448463e-12	2.6792547069831585e-8	21	297	97
MESH:D010182	Pancreatic Diseases	GO:0050708	regulation of protein secretion	8.786305016883489e-13	1.9378195714736535e-8	19	380	97
MESH:D010182	Pancreatic Diseases	GO:0009991	response to extracellular stimulus	3.7969627442180354e-13	8.374201332372877e-9	21	573	97
MESH:D010182	Pancreatic Diseases	GO:1901698	response to nitrogen compound	2.1967982988257972e-12	4.845038648060296e-8	29	870	97
MESH:D010182	Pancreatic Diseases	GO:0051051	negative regulation of transport	4.803935027553052e-12	1.0595078703268257e-7	19	452	97
MESH:D010182	Pancreatic Diseases	GO:0031667	response to nutrient levels	5.666134228476949e-12	1.249665904090591e-7	21	546	97
MESH:D010182	Pancreatic Diseases	GO:0072593	reactive oxygen species metabolic process	8.765321801718073e-12	1.933191723368921e-7	14	223	97
MESH:D010182	Pancreatic Diseases	GO:0034284	response to monosaccharide	1.511357705652472e-11	3.3332994198165267e-7	13	188	97
MESH:D010182	Pancreatic Diseases	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.62178048768169e-11	3.576836865581967e-7	10	83	97
MESH:D010182	Pancreatic Diseases	GO:0051050	positive regulation of transport	3.2421287876616134e-11	7.150515041187688e-7	24	920	97
MESH:D010182	Pancreatic Diseases	GO:0040007	growth	4.6890602511950874e-11	1.0341722384010765e-6	24	936	97
MESH:D010182	Pancreatic Diseases	GO:1901701	cellular response to oxygen-containing compound	8.118161698433823e-11	1.7904605625895798e-6	23	873	97
MESH:D010182	Pancreatic Diseases	GO:1903531	negative regulation of secretion by cell	1.0426703944688143e-10	2.29960955500097e-6	12	174	97
MESH:D010182	Pancreatic Diseases	GO:1901699	cellular response to nitrogen compound	1.6301304750498957e-10	3.595252762722545e-6	18	518	97
MESH:D010182	Pancreatic Diseases	GO:0009746	response to hexose	1.6561774174306265e-10	3.652699294143247e-6	12	181	97
MESH:D010182	Pancreatic Diseases	GO:0033993	response to lipid	3.141602533673904e-10	6.928804388017795e-6	22	850	97
MESH:D010182	Pancreatic Diseases	GO:0003006	developmental process involved in reproduction	3.7026959276431626e-10	8.166295868416995e-6	19	619	97
MESH:D010182	Pancreatic Diseases	GO:0007584	response to nutrient	4.423029720257432e-10	9.754992048027766e-6	12	197	97
MESH:D010182	Pancreatic Diseases	GO:0014070	response to organic cyclic compound	5.171649775093101e-10	1.1406073578967835e-5	22	873	97
MESH:D010182	Pancreatic Diseases	GO:0032844	regulation of homeostatic process	6.206002378661424e-10	1.368733824613777e-5	16	427	97
MESH:D010182	Pancreatic Diseases	GO:0048871	multicellular organismal homeostasis	1.149787487442211e-9	2.5358563035537962e-5	14	321	97
MESH:D010182	Pancreatic Diseases	GO:0048545	response to steroid hormone	1.160957996404477e-9	2.560492861070074e-5	16	446	97
MESH:D010182	Pancreatic Diseases	GO:0009749	response to glucose	1.8805066392957315e-9	4.147457392966736e-5	11	176	97
MESH:D010182	Pancreatic Diseases	GO:0040008	regulation of growth	2.5497142175368026e-9	5.623394706777418e-5	18	617	97
MESH:D010182	Pancreatic Diseases	GO:0051093	negative regulation of developmental process	3.213150079339755e-9	7.08660249998383e-5	20	788	97
MESH:D010182	Pancreatic Diseases	GO:0051241	negative regulation of multicellular organismal process	3.384952540486097e-9	7.465512828042087e-5	22	966	97
DOID:326	ischemia	GO:0032496	response to lipopolysaccharide	1.6922019341336636e-12	3.732151365731795e-8	30	319	97
DOID:326	ischemia	GO:0052547	regulation of peptidase activity	1.4359624600501775e-12	3.1670152056406664e-8	19	382	97
DOID:326	ischemia	GO:0052548	regulation of endopeptidase activity	1.3784529073745944e-12	3.040177887214668e-8	19	362	97
DOID:326	ischemia	GO:0071216	cellular response to biotic stimulus	5.553335569175033e-13	1.2247881597815535e-8	19	175	97
DOID:326	ischemia	GO:0002685	regulation of leukocyte migration	2.8110846983508964e-13	6.199847302212902e-9	14	149	97
DOID:326	ischemia	GO:2001233	regulation of apoptotic signaling pathway	3.4707792195831644e-12	7.654803568790669e-8	17	359	97
DOID:326	ischemia	GO:0001664	G-protein coupled receptor binding	4.3688386242024535e-12	9.635473585678511e-8	15	255	97
DOID:326	ischemia	GO:0002521	leukocyte differentiation	4.489075777769358e-12	9.900656627870319e-8	19	448	97
DOID:326	ischemia	GO:1902533	positive regulation of intracellular signal transduction	6.122546913900351e-12	1.3503277218607224e-7	37	860	97
DOID:326	ischemia	GO:0050880	regulation of blood vessel size	6.724398815549648e-12	1.483066158769475e-7	12	139	97
DOID:326	ischemia	GO:1901654	response to ketone	9.227840713776914e-12	2.0352002694234983e-7	13	181	97
DOID:326	ischemia	GO:0043270	positive regulation of ion transport	1.7304047084110152e-11	3.816407584400494e-7	14	233	97
DOID:326	ischemia	GO:0022603	regulation of anatomical structure morphogenesis	2.8027580256662077e-11	6.181482825606821e-7	25	986	97
DOID:326	ischemia	GO:0001525	angiogenesis	4.112488127816505e-11	9.070092565899301e-7	17	413	97
DOID:326	ischemia	GO:0050878	regulation of body fluid levels	1.0603018463228864e-10	2.338495722065126e-6	18	504	97
DOID:326	ischemia	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	1.1595702176236955e-10	2.5574321149690604e-6	10	101	97
DOID:326	ischemia	GO:0030595	leukocyte chemotaxis	1.2761913747993958e-10	2.8146400771200675e-6	12	177	97
DOID:326	ischemia	GO:0055082	cellular chemical homeostasis	1.5278411868990815e-10	3.3696537377059244e-6	20	661	97
DOID:326	ischemia	GO:0043279	response to alkaloid	1.619478995351642e-10	3.5717609242480464e-6	11	140	97
DOID:326	ischemia	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	1.886238942816476e-10	4.160099988381738e-6	5	8	97
DOID:326	ischemia	GO:0044706	multi-multicellular organism process	2.9174085369731984e-10	6.434344528294389e-6	13	237	97
DOID:326	ischemia	GO:0042310	vasoconstriction	3.234006396013456e-10	7.132601106407677e-6	9	80	97
DOID:326	ischemia	GO:2001234	negative regulation of apoptotic signaling pathway	4.970596156894658e-10	1.0962649824031168e-5	12	199	97
DOID:326	ischemia	GO:0051047	positive regulation of secretion	5.845448569630207e-10	1.2892136820319422e-5	15	363	97
DOID:326	ischemia	GO:0002548	monocyte chemotaxis	8.107550186764456e-10	1.7881201936909008e-5	8	60	97
DOID:326	ischemia	GO:0044057	regulation of system process	9.61216550798838e-10	2.119963102786837e-5	17	508	97
DOID:326	ischemia	GO:1903426	regulation of reactive oxygen species biosynthetic process	1.2117830072710944e-9	2.6725874225363988e-5	8	63	97
DOID:326	ischemia	GO:0055065	metal ion homeostasis	1.2150582762160411e-9	2.6798110281944787e-5	17	516	97
DOID:326	ischemia	GO:0006875	cellular metal ion homeostasis	1.320986986463879e-9	2.9134367986460852e-5	16	450	97
DOID:326	ischemia	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.3289137568150977e-9	2.930919290655698e-5	7	40	97
DOID:326	ischemia	GO:0019229	regulation of vasoconstriction	1.5658784269234616e-9	3.4535448705796945e-5	8	65	97
DOID:326	ischemia	GO:0007159	leukocyte cell-cell adhesion	1.870674948278861e-9	4.125773598429028e-5	16	461	97
DOID:326	ischemia	GO:0050678	regulation of epithelial cell proliferation	1.9548086482856775e-9	4.3113304737940616e-5	13	277	97
DOID:326	ischemia	GO:1901568	fatty acid derivative metabolic process	2.224562756225623e-9	4.906273158855612e-5	9	99	97
DOID:326	ischemia	GO:0006690	icosanoid metabolic process	2.224562756225623e-9	4.906273158855612e-5	9	99	97
DOID:326	ischemia	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	3.2172160491228396e-9	7.095569996340423e-5	8	71	97
DOID:326	ischemia	GO:0006874	cellular calcium ion homeostasis	3.768645395751946e-9	8.311747420330917e-5	14	352	97
DOID:326	ischemia	GO:0032355	response to estradiol	4.1259418104289125e-9	9.099764662900967e-5	10	145	97
DOID:326	ischemia	GO:0043523	regulation of neuron apoptotic process	4.2128672772534514e-9	9.291478779982487e-5	11	190	97
DOID:326	ischemia	GO:0007565	female pregnancy	4.2128672772534514e-9	9.291478779982487e-5	11	190	97
DOID:326	ischemia	GO:0051403	stress-activated MAPK cascade	4.404037801108984e-9	9.713105370345865e-5	12	241	97
DOID:326	ischemia	GO:0048732	gland development	4.43133607586077e-9	9.773311715310928e-5	15	421	97
DOID:120	female reproductive organ cancer	GO:0051726	regulation of cell cycle	1.9766410730426287e-12	4.3594818865955176e-8	27	930	97
DOID:120	female reproductive organ cancer	GO:0042327	positive regulation of phosphorylation	1.57862611871451e-12	3.481659904824852e-8	25	910	97
DOID:120	female reproductive organ cancer	GO:0010243	response to organonitrogen compound	6.769773630566078e-11	1.4930735742213486e-6	22	780	97
DOID:120	female reproductive organ cancer	GO:0001701	in utero embryonic development	6.991529577504707e-11	1.5419818483186631e-6	15	312	97
DOID:120	female reproductive organ cancer	GO:0097190	apoptotic signaling pathway	7.745137864390017e-11	1.7081901559912183e-6	19	564	97
DOID:120	female reproductive organ cancer	GO:0072358	cardiovascular system development	1.79170012160057e-10	3.951594618190057e-6	23	910	97
DOID:120	female reproductive organ cancer	GO:0043523	regulation of neuron apoptotic process	2.9116031807774334e-10	6.421540815204629e-6	12	190	97
DOID:120	female reproductive organ cancer	GO:0007568	aging	3.0659230709773055e-10	6.761893333040447e-6	14	290	97
DOID:120	female reproductive organ cancer	GO:0060249	anatomical structure homeostasis	3.675795223756495e-10	8.10696636599495e-6	15	351	97
DOID:120	female reproductive organ cancer	GO:0045597	positive regulation of cell differentiation	9.287433044846694e-10	2.0483433580409383e-5	21	815	97
DOID:120	female reproductive organ cancer	GO:0009411	response to UV	9.659421040808525e-10	2.13038531055032e-5	10	125	97
DOID:120	female reproductive organ cancer	GO:1901215	negative regulation of neuron death	1.301945329323928e-9	2.8714404238239233e-5	11	170	97
DOID:120	female reproductive organ cancer	GO:0051338	regulation of transferase activity	1.61120672359516e-9	3.553516428889125e-5	22	928	97
DOID:120	female reproductive organ cancer	GO:0043549	regulation of kinase activity	1.7749879344108876e-9	3.914735889343213e-5	20	761	97
DOID:120	female reproductive organ cancer	GO:0071417	cellular response to organonitrogen compound	1.9302002218779535e-9	4.2570565893518264e-5	16	462	97
DOID:120	female reproductive organ cancer	GO:0010720	positive regulation of cell development	2.3903592438756505e-9	5.271937312367747e-5	16	469	97
DOID:120	female reproductive organ cancer	GO:0045321	leukocyte activation	2.4644887242075697e-9	5.435429881239795e-5	19	694	97
DOID:120	female reproductive organ cancer	GO:1903827	regulation of cellular protein localization	2.6117110696333157e-9	5.760128764076278e-5	17	543	97
DOID:120	female reproductive organ cancer	GO:0002520	immune system development	2.8212504554758766e-9	6.222267879552046e-5	20	782	97
DOID:120	female reproductive organ cancer	GO:0001666	response to hypoxia	3.697434358684859e-9	8.154691478079457e-5	13	292	97
DOID:120	female reproductive organ cancer	GO:0071396	cellular response to lipid	3.7698631993876575e-9	8.314433286249479e-5	15	416	97
DOID:120	female reproductive organ cancer	GO:0040029	regulation of gene expression, epigenetic	4.5335166731774734e-9	9.998671022692918e-5	13	297	97
MESH:D020734	Parkinsonian Disorders	GO:0070997	neuron death	1.0438316877525722e-12	2.302170787338298e-8	18	281	98
MESH:D020734	Parkinsonian Disorders	GO:0072593	reactive oxygen species metabolic process	7.769340726326845e-13	1.7135280971913858e-8	19	223	98
MESH:D020734	Parkinsonian Disorders	GO:0097164	ammonium ion metabolic process	3.730349362740526e-13	8.22728551952423e-9	14	178	98
MESH:D020734	Parkinsonian Disorders	GO:0001505	regulation of neurotransmitter levels	8.992806499463768e-14	1.983363473456734e-9	14	179	98
MESH:D020734	Parkinsonian Disorders	GO:0007268	synaptic transmission	5.523359547510154e-13	1.2181769482033644e-8	22	605	98
MESH:D020734	Parkinsonian Disorders	GO:0042493	response to drug	5.115352585960409e-12	1.1281910128335682e-7	19	433	98
MESH:D020734	Parkinsonian Disorders	GO:0097305	response to alcohol	5.645039991009071e-12	1.2450135700170506e-7	17	369	98
MESH:D020734	Parkinsonian Disorders	GO:0030424	axon	5.69000402350639e-12	1.2549303873843343e-7	18	414	98
MESH:D020734	Parkinsonian Disorders	GO:0044297	cell body	7.243095012654521e-12	1.5974646050409547e-7	20	494	98
MESH:D020734	Parkinsonian Disorders	GO:1901699	cellular response to nitrogen compound	8.529177364380303e-12	1.8811100677140757e-7	20	518	98
MESH:D020734	Parkinsonian Disorders	GO:0043069	negative regulation of programmed cell death	9.27313781318162e-12	2.0451905446972063e-7	24	806	98
MESH:D020734	Parkinsonian Disorders	GO:0043523	regulation of neuron apoptotic process	2.0380142018439074e-11	4.4948403221667377e-7	13	190	98
MESH:D020734	Parkinsonian Disorders	GO:0007270	neuron-neuron synaptic transmission	8.076372903786933e-11	1.781244043930208e-6	11	130	98
MESH:D020734	Parkinsonian Disorders	GO:0001963	synaptic transmission, dopaminergic	9.551848201283519e-11	2.10666012079308e-6	7	28	98
MESH:D020734	Parkinsonian Disorders	GO:0016491	oxidoreductase activity	9.83650938479741e-11	2.1694421448170687e-6	21	710	98
MESH:D020734	Parkinsonian Disorders	GO:0043524	negative regulation of neuron apoptotic process	1.125990412020883e-10	2.4833718537120575e-6	11	134	98
MESH:D020734	Parkinsonian Disorders	GO:0036477	somatodendritic compartment	1.357265411172648e-10	2.993448864341275e-6	20	649	98
MESH:D020734	Parkinsonian Disorders	GO:0048878	chemical homeostasis	1.97284633074446e-10	4.351112582456906e-6	24	988	98
MESH:D020734	Parkinsonian Disorders	GO:0009713	catechol-containing compound biosynthetic process	4.5972881057565473e-10	1.0139318917246065e-5	6	19	98
MESH:D020734	Parkinsonian Disorders	GO:0042423	catecholamine biosynthetic process	4.5972881057565473e-10	1.0139318917246065e-5	6	19	98
MESH:D020734	Parkinsonian Disorders	GO:1902533	positive regulation of intracellular signal transduction	4.870397418699213e-10	1.0741661506941114e-5	22	860	98
MESH:D020734	Parkinsonian Disorders	GO:0043025	neuronal cell body	9.191645222728084e-10	2.027217353872679e-5	16	434	98
MESH:D020734	Parkinsonian Disorders	GO:1903524	positive regulation of blood circulation	9.350124008378202e-10	2.0621698500478125e-5	9	89	98
MESH:D020734	Parkinsonian Disorders	GO:0044306	neuron projection terminus	1.4581874596686362e-9	3.216032442299177e-5	10	129	98
MESH:D020734	Parkinsonian Disorders	GO:0043195	terminal bouton	1.4974569362280477e-9	3.302641272850959e-5	8	64	98
MESH:D020734	Parkinsonian Disorders	GO:0042416	dopamine biosynthetic process	1.6192767127165553e-9	3.5713147898963626e-5	5	11	98
MESH:D020734	Parkinsonian Disorders	GO:0010942	positive regulation of cell death	1.7545092045878619e-9	3.869570050718529e-5	18	596	98
MESH:D020734	Parkinsonian Disorders	GO:0071248	cellular response to metal ion	2.4463797654306063e-9	5.395490572657202e-5	10	136	98
MESH:D020734	Parkinsonian Disorders	GO:0019725	cellular homeostasis	2.6774817918351346e-9	5.905186091892389e-5	20	771	98
MESH:D020734	Parkinsonian Disorders	GO:0050804	modulation of synaptic transmission	3.1370965825061603e-9	6.918866512717337e-5	13	285	98
MESH:D020734	Parkinsonian Disorders	GO:0007568	aging	3.869335851724998e-9	8.533820220979482e-5	13	290	98
MESH:D009361	Neoplasm Invasiveness	GO:0007167	enzyme linked receptor protein signaling pathway	3.5647040874664526e-12	7.861954864907261e-8	27	935	98
MESH:D009361	Neoplasm Invasiveness	GO:0030335	positive regulation of cell migration	1.729949516970919e-12	3.815403659679362e-8	25	387	98
MESH:D009361	Neoplasm Invasiveness	GO:0072358	cardiovascular system development	1.439959262938828e-12	3.175830154411585e-8	28	910	98
MESH:D009361	Neoplasm Invasiveness	GO:0042327	positive regulation of phosphorylation	1.439959262938828e-12	3.175830154411585e-8	28	910	98
MESH:D009361	Neoplasm Invasiveness	GO:0030055	cell-substrate junction	2.8466118351389014e-13	6.278202402398847e-9	19	395	98
MESH:D009361	Neoplasm Invasiveness	GO:0071363	cellular response to growth factor stimulus	2.630118345336996e-13	5.800726010640744e-9	22	594	98
MESH:D009361	Neoplasm Invasiveness	GO:0005924	cell-substrate adherens junction	3.5649261320713777e-13	7.862444584283423e-9	18	391	98
MESH:D009361	Neoplasm Invasiveness	GO:0051098	regulation of binding	1.3476997295924775e-12	2.9723517536162092e-8	16	279	98
MESH:D009361	Neoplasm Invasiveness	GO:0005925	focal adhesion	1.4911405443740477e-12	3.288710470616962e-8	18	388	98
MESH:D009361	Neoplasm Invasiveness	GO:0002684	positive regulation of immune system process	1.5231149674832523e-12	3.359230060784313e-8	26	872	98
MESH:D009361	Neoplasm Invasiveness	GO:1901701	cellular response to oxygen-containing compound	1.8607337892717624e-12	4.103848372238872e-8	29	873	98
MESH:D009361	Neoplasm Invasiveness	GO:0051101	regulation of DNA binding	1.925903880817259e-12	4.247581009142465e-8	11	92	98
MESH:D009361	Neoplasm Invasiveness	GO:2001234	negative regulation of apoptotic signaling pathway	1.9416690477669363e-12	4.282351084849978e-8	14	199	98
MESH:D009361	Neoplasm Invasiveness	GO:0014070	response to organic cyclic compound	2.138400567730514e-12	4.7162424521296487e-8	26	873	98
MESH:D009361	Neoplasm Invasiveness	GO:0034614	cellular response to reactive oxygen species	2.2543078515013804e-12	4.9718759664862944e-8	12	127	98
MESH:D009361	Neoplasm Invasiveness	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.8447244559970386e-12	6.274039787701469e-8	26	647	98
MESH:D009361	Neoplasm Invasiveness	GO:0080135	regulation of cellular response to stress	2.919109398646924e-12	6.438095778715791e-8	23	681	98
MESH:D009361	Neoplasm Invasiveness	GO:0001934	positive regulation of protein phosphorylation	2.9570790260891044e-12	6.52183779203952e-8	27	870	98
MESH:D009361	Neoplasm Invasiveness	GO:0009725	response to hormone	3.746558618900053e-12	8.263035033984067e-8	29	865	98
MESH:D009361	Neoplasm Invasiveness	GO:0033993	response to lipid	3.804845327692874e-12	8.391586370226634e-8	25	850	98
MESH:D009361	Neoplasm Invasiveness	GO:0048732	gland development	3.8904435228914735e-12	8.580373189737145e-8	19	421	98
MESH:D009361	Neoplasm Invasiveness	GO:0009611	response to wounding	4.57478499527042e-12	1.0089688307068911e-7	30	875	98
MESH:D009361	Neoplasm Invasiveness	GO:0042060	wound healing	4.605760217657462e-12	1.0158004160043532e-7	22	534	98
MESH:D009361	Neoplasm Invasiveness	GO:0045860	positive regulation of protein kinase activity	4.686695476152636e-12	1.0336506872654638e-7	19	450	98
MESH:D009361	Neoplasm Invasiveness	GO:1901698	response to nitrogen compound	4.85944617878431e-12	1.0717508547308796e-7	25	870	98
MESH:D009361	Neoplasm Invasiveness	GO:0014031	mesenchymal cell development	4.862887870160648e-12	1.072509919763931e-7	13	171	98
MESH:D009361	Neoplasm Invasiveness	GO:0009612	response to mechanical stimulus	5.080380560684716e-12	1.1204779326590142e-7	14	210	98
MESH:D009361	Neoplasm Invasiveness	GO:0010035	response to inorganic substance	5.219602527972711e-12	1.1511833375443814e-7	21	502	98
MESH:D009361	Neoplasm Invasiveness	GO:0000165	MAPK cascade	5.258793400741979e-12	1.1598268845336435e-7	25	843	98
MESH:D009361	Neoplasm Invasiveness	GO:0060284	regulation of cell development	5.751843445978011e-12	1.2685690720104503e-7	25	828	98
MESH:D009361	Neoplasm Invasiveness	GO:0001525	angiogenesis	6.160516541342531e-12	1.3587019231930952e-7	18	413	98
MESH:D009361	Neoplasm Invasiveness	GO:1902533	positive regulation of intracellular signal transduction	6.8013372711561715e-12	1.5000349351534936e-7	27	860	98
MESH:D009361	Neoplasm Invasiveness	GO:0008284	positive regulation of cell proliferation	7.709166638392162e-12	1.7002567020973913e-7	32	815	98
MESH:D009361	Neoplasm Invasiveness	GO:0045597	positive regulation of cell differentiation	7.7099437945094e-12	1.700428103879048e-7	28	815	98
MESH:D009361	Neoplasm Invasiveness	GO:0010720	positive regulation of cell development	7.858935724414096e-12	1.7332882740195288e-7	19	469	98
MESH:D009361	Neoplasm Invasiveness	GO:0000904	cell morphogenesis involved in differentiation	8.392952999258796e-12	1.8510657839865274e-7	25	720	98
MESH:D009361	Neoplasm Invasiveness	GO:0001501	skeletal system development	9.18798370719287e-12	2.0264098066213876e-7	20	482	98
MESH:D009361	Neoplasm Invasiveness	GO:0043410	positive regulation of MAPK cascade	9.309553128389325e-12	2.0532219424662657e-7	19	464	98
MESH:D009361	Neoplasm Invasiveness	GO:0022603	regulation of anatomical structure morphogenesis	1.0645262449315851e-11	2.347812633196611e-7	26	986	98
MESH:D009361	Neoplasm Invasiveness	GO:0032963	collagen metabolic process	1.1606826610943699e-11	2.559885609043633e-7	11	109	98
MESH:D009361	Neoplasm Invasiveness	GO:0038127	ERBB signaling pathway	1.2488121647891148e-11	2.754255229442393e-7	12	144	98
MESH:D009361	Neoplasm Invasiveness	GO:0009887	organ morphogenesis	1.293920526279635e-11	2.853741720709735e-7	26	950	98
MESH:D009361	Neoplasm Invasiveness	GO:0048729	tissue morphogenesis	1.384348191635354e-11	3.053179936651773e-7	21	635	98
MESH:D009361	Neoplasm Invasiveness	GO:0034329	cell junction assembly	1.646371927677137e-11	3.631073286491926e-7	13	187	98
MESH:D009361	Neoplasm Invasiveness	GO:0045121	membrane raft	1.926214743264154e-11	4.248266616269092e-7	15	282	98
MESH:D009361	Neoplasm Invasiveness	GO:0009986	cell surface	2.2056689807925522e-11	4.864602937137974e-7	22	715	98
MESH:D009361	Neoplasm Invasiveness	GO:0050767	regulation of neurogenesis	2.271016708021989e-11	5.008727349542497e-7	21	658	98
MESH:D009361	Neoplasm Invasiveness	GO:0045596	negative regulation of cell differentiation	3.03297387205248e-11	6.689223874811745e-7	20	597	98
MESH:D009361	Neoplasm Invasiveness	GO:0070371	ERK1 and ERK2 cascade	4.2740033734389726e-11	9.426314440119654e-7	14	247	98
MESH:D009361	Neoplasm Invasiveness	GO:0043388	positive regulation of DNA binding	4.4034442758800196e-11	9.711796350453383e-7	8	42	98
MESH:D009361	Neoplasm Invasiveness	GO:0071396	cellular response to lipid	5.360700772172322e-11	1.1823025553026056e-6	17	416	98
MESH:D009361	Neoplasm Invasiveness	GO:0001503	ossification	6.493539039809093e-11	1.4321500352298955e-6	16	363	98
MESH:D009361	Neoplasm Invasiveness	GO:0019725	cellular homeostasis	6.875311431286946e-11	1.5163499361703359e-6	22	771	98
MESH:D009361	Neoplasm Invasiveness	GO:0030574	collagen catabolic process	6.93198831669406e-11	1.528850023246875e-6	9	67	98
MESH:D009361	Neoplasm Invasiveness	GO:0010243	response to organonitrogen compound	8.190692568632585e-11	1.8064572460119166e-6	22	780	98
MESH:D009361	Neoplasm Invasiveness	GO:0030198	extracellular matrix organization	1.164390805996618e-10	2.568063922625541e-6	15	320	98
MESH:D009361	Neoplasm Invasiveness	GO:0010631	epithelial cell migration	1.1685152845331004e-10	2.577160460037753e-6	13	218	98
MESH:D009361	Neoplasm Invasiveness	GO:0070482	response to oxygen levels	1.2173295704798193e-10	2.6848203676932414e-6	15	321	98
MESH:D009361	Neoplasm Invasiveness	GO:0051241	negative regulation of multicellular organismal process	1.2362910695173923e-10	2.7266399538206088e-6	24	966	98
MESH:D009361	Neoplasm Invasiveness	GO:0002009	morphogenesis of an epithelium	1.3506318286005126e-10	2.9788184979784305e-6	18	506	98
MESH:D009361	Neoplasm Invasiveness	GO:0007417	central nervous system development	1.4957801663939563e-10	3.2989431569818706e-6	23	889	98
MESH:D009361	Neoplasm Invasiveness	GO:0048545	response to steroid hormone	1.5557410915079117e-10	3.4311869773206993e-6	17	446	98
MESH:D009361	Neoplasm Invasiveness	GO:0006875	cellular metal ion homeostasis	1.790506631849098e-10	3.948962376543186e-6	17	450	98
MESH:D009361	Neoplasm Invasiveness	GO:0042063	gliogenesis	2.0506252251806245e-10	4.522653934135867e-6	13	228	98
MESH:D009361	Neoplasm Invasiveness	GO:0050673	epithelial cell proliferation	2.2050195003231465e-10	4.8631705079627e-6	15	335	98
MESH:D009361	Neoplasm Invasiveness	GO:0043491	protein kinase B signaling	2.4629565054112845e-10	5.432050572684588e-6	11	144	98
MESH:D009361	Neoplasm Invasiveness	GO:0071902	positive regulation of protein serine/threonine kinase activity	2.5450175300534283e-10	5.613036162532836e-6	14	283	98
MESH:D009361	Neoplasm Invasiveness	GO:0006935	chemotaxis	2.7410873570943295e-10	6.045468166071544e-6	18	530	98
MESH:D009361	Neoplasm Invasiveness	GO:0050778	positive regulation of immune response	2.847098112823687e-10	6.279274887832642e-6	19	603	98
MESH:D009361	Neoplasm Invasiveness	GO:0051897	positive regulation of protein kinase B signaling	3.1639657560589285e-10	6.978126474987967e-6	9	79	98
MESH:D009361	Neoplasm Invasiveness	GO:0034504	protein localization to nucleus	3.2132629890213593e-10	7.086851522286608e-6	15	344	98
MESH:D009361	Neoplasm Invasiveness	GO:0032147	activation of protein kinase activity	3.2163605112600635e-10	7.09368310758407e-6	14	288	98
MESH:D009361	Neoplasm Invasiveness	GO:0001666	response to hypoxia	3.863507291868018e-10	8.520965332214914e-6	14	292	98
MESH:D009361	Neoplasm Invasiveness	GO:0048015	phosphatidylinositol-mediated signaling	3.944320425830483e-10	8.69919869916913e-6	12	193	98
MESH:D009361	Neoplasm Invasiveness	GO:0046916	cellular transition metal ion homeostasis	3.9746073099422574e-10	8.765996422077649e-6	9	81	98
MESH:D009361	Neoplasm Invasiveness	GO:0022617	extracellular matrix disassembly	6.162296228851005e-10	1.3590944332730892e-5	9	85	98
MESH:D009361	Neoplasm Invasiveness	GO:0060322	head development	6.195796098396045e-10	1.3664828295012477e-5	20	708	98
MESH:D009361	Neoplasm Invasiveness	GO:0031012	extracellular matrix	6.326874579798414e-10	1.3953921885745402e-5	16	423	98
MESH:D009361	Neoplasm Invasiveness	GO:1900407	regulation of cellular response to oxidative stress	6.654683470941336e-10	1.4676904395161117e-5	8	58	98
MESH:D009361	Neoplasm Invasiveness	GO:0043406	positive regulation of MAP kinase activity	7.902869469944562e-10	1.7429778615962732e-5	12	205	98
MESH:D009361	Neoplasm Invasiveness	GO:0097305	response to alcohol	8.498864945138962e-10	1.874424663650398e-5	15	369	98
MESH:D009361	Neoplasm Invasiveness	GO:0007173	epidermal growth factor receptor signaling pathway	9.128829914217818e-10	2.0133634375807397e-5	10	123	98
MESH:D009361	Neoplasm Invasiveness	GO:0010638	positive regulation of organelle organization	9.394930389206024e-10	2.0720518973393887e-5	18	573	98
MESH:D009361	Neoplasm Invasiveness	GO:0051962	positive regulation of nervous system development	9.481176954651005e-10	2.091073577348279e-5	16	435	98
MESH:D009361	Neoplasm Invasiveness	GO:0050769	positive regulation of neurogenesis	1.100440294443672e-9	2.4270210693955185e-5	15	376	98
MESH:D009361	Neoplasm Invasiveness	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	1.142989813907036e-9	2.520864034571968e-5	9	91	98
MESH:D009361	Neoplasm Invasiveness	GO:0009897	external side of plasma membrane	1.1597612870062335e-9	2.557853518492248e-5	12	212	98
MESH:D009361	Neoplasm Invasiveness	GO:0032496	response to lipopolysaccharide	1.2180436659292582e-9	2.686395305206979e-5	14	319	98
MESH:D009361	Neoplasm Invasiveness	GO:0048534	hematopoietic or lymphoid organ development	1.2979876062857443e-9	2.862711665663209e-5	20	739	98
MESH:D009361	Neoplasm Invasiveness	GO:0006606	protein import into nucleus	1.4900963796193878e-9	3.28640756525056e-5	13	268	98
MESH:D009361	Neoplasm Invasiveness	GO:0043627	response to estrogen	1.5118692964222191e-9	3.334427733259204e-5	12	217	98
MESH:D009361	Neoplasm Invasiveness	GO:1901699	cellular response to nitrogen compound	1.517172942833156e-9	3.3461249254185255e-5	17	518	98
MESH:D009361	Neoplasm Invasiveness	GO:0032870	cellular response to hormone stimulus	1.5602671377124011e-9	3.4411691722247006e-5	17	519	98
MESH:D009361	Neoplasm Invasiveness	GO:0032101	regulation of response to external stimulus	1.6883641151821394e-9	3.7236870560342084e-5	22	920	98
MESH:D009361	Neoplasm Invasiveness	GO:0051050	positive regulation of transport	1.6883641151821394e-9	3.7236870560342084e-5	22	920	98
MESH:D009361	Neoplasm Invasiveness	GO:0022604	regulation of cell morphogenesis	1.8022837666720193e-9	3.9749368473951385e-5	17	524	98
MESH:D009361	Neoplasm Invasiveness	GO:0098590	plasma membrane region	1.9053906230581674e-9	4.202339019154788e-5	22	926	98
MESH:D009361	Neoplasm Invasiveness	GO:0009790	embryo development	2.144797117686892e-9	4.73035004305844e-5	22	932	98
MESH:D009361	Neoplasm Invasiveness	GO:0051052	regulation of DNA metabolic process	2.2898520857239646e-9	5.050268775064204e-5	14	335	98
MESH:D009361	Neoplasm Invasiveness	GO:0040007	growth	2.3227113565837954e-9	5.1227398969455606e-5	22	936	98
MESH:D009361	Neoplasm Invasiveness	GO:0035239	tube morphogenesis	2.569337631541657e-9	5.666674146365125e-5	14	338	98
MESH:D009361	Neoplasm Invasiveness	GO:0001816	cytokine production	2.7327372587038212e-9	6.027052024071278e-5	18	613	98
MESH:D009361	Neoplasm Invasiveness	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	2.820938260761352e-9	6.221579334109162e-5	10	138	98
MESH:D009361	Neoplasm Invasiveness	GO:0002573	myeloid leukocyte differentiation	3.1706816061571885e-9	6.992938282379679e-5	11	183	98
MESH:D009361	Neoplasm Invasiveness	GO:0051054	positive regulation of DNA metabolic process	3.1706816061571885e-9	6.992938282379679e-5	11	183	98
MESH:D009361	Neoplasm Invasiveness	GO:0030155	regulation of cell adhesion	3.3475378025116242e-9	7.382994623439387e-5	18	621	98
MESH:D009361	Neoplasm Invasiveness	GO:0045664	regulation of neuron differentiation	3.5250922181262467e-9	7.774590887077437e-5	17	548	98
MESH:D009361	Neoplasm Invasiveness	GO:0031252	cell leading edge	3.7348485415478194e-9	8.237208458383716e-5	14	348	98
MESH:D009361	Neoplasm Invasiveness	GO:0001817	regulation of cytokine production	4.377231244134805e-9	9.653983508939312e-5	17	556	98
MESH:D009361	Neoplasm Invasiveness	GO:0031983	vesicle lumen	4.48883374914999e-9	9.900122833750302e-5	9	106	98
Orphanet:98038	Cranial malformation	GO:0001654	eye development	2.1247448245276246e-12	4.686124710495676e-8	18	327	98
Orphanet:98038	Cranial malformation	GO:0035148	tube formation	2.5868196473766147e-13	5.705230732289124e-9	13	131	98
Orphanet:98038	Cranial malformation	GO:0014020	primary neural tube formation	2.0272672429655358e-13	4.471137904360489e-9	12	86	98
Orphanet:98038	Cranial malformation	GO:0048863	stem cell differentiation	2.2171153801764376e-13	4.889847970979133e-9	16	266	98
Orphanet:98038	Cranial malformation	GO:0007224	smoothened signaling pathway	9.343636975245317e-13	2.0607391348903548e-8	12	117	98
Orphanet:98038	Cranial malformation	GO:0043583	ear development	3.027411654699108e-11	6.676956404438883e-7	13	196	98
Orphanet:98038	Cranial malformation	GO:0008589	regulation of smoothened signaling pathway	3.376365853569041e-11	7.44657489004652e-7	9	62	98
Orphanet:98038	Cranial malformation	GO:0048701	embryonic cranial skeleton morphogenesis	9.549394608399098e-11	2.106118980882421e-6	8	46	98
Orphanet:98038	Cranial malformation	GO:0030278	regulation of ossification	1.4433521045020825e-10	3.183313066479343e-6	12	177	98
Orphanet:98038	Cranial malformation	GO:2000027	regulation of organ morphogenesis	3.1535662969872646e-10	6.955190468005412e-6	13	236	98
Orphanet:98038	Cranial malformation	GO:0055123	digestive system development	3.824343064451341e-10	8.434588628647433e-6	11	150	98
Orphanet:98038	Cranial malformation	GO:0009952	anterior/posterior pattern specification	5.614531062292372e-10	1.2382848257885826e-5	12	199	98
Orphanet:98038	Cranial malformation	GO:0009855	determination of bilateral symmetry	7.764463516579667e-10	1.7124524285816456e-5	10	121	98
Orphanet:98038	Cranial malformation	GO:0001822	kidney development	1.1311559466875565e-9	2.4947644404194058e-5	13	262	98
Orphanet:98038	Cranial malformation	GO:0014031	mesenchymal cell development	1.5485311921636935e-9	3.415285544317026e-5	11	171	98
Orphanet:98038	Cranial malformation	GO:0048565	digestive tract development	2.820938260761352e-9	6.221579334109162e-5	10	138	98
MESH:D002471	Cell Transformation, Neoplastic	GO:0030855	epithelial cell differentiation	2.9768409959274322e-12	6.565422816517952e-8	21	568	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0060548	negative regulation of cell death	4.1953107654535415e-12	9.252757893207786e-8	26	867	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0043069	negative regulation of programmed cell death	1.0118461624131214e-11	2.2316267112021393e-7	24	806	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0043066	negative regulation of apoptotic process	1.1550094214385354e-11	2.5473732789826897e-7	24	795	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0033993	response to lipid	4.772470196812151e-10	1.0525683019069199e-5	22	850	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0009887	organ morphogenesis	6.627517423751783e-10	1.4616989678084558e-5	23	950	99
MESH:D002471	Cell Transformation, Neoplastic	GO:1901701	cellular response to oxygen-containing compound	7.84548981336286e-10	1.730322778337179e-5	22	873	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0008284	positive regulation of cell proliferation	1.3775294238627112e-9	3.0381411443292095e-5	21	815	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.6325015783635877e-9	3.6004822310808926e-5	23	996	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0030335	positive regulation of cell migration	1.89007043349676e-9	4.168550341077104e-5	15	387	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0071216	cellular response to biotic stimulus	2.207843685653188e-9	4.869399248708106e-5	11	175	99
MESH:D002471	Cell Transformation, Neoplastic	GO:0072593	reactive oxygen species metabolic process	2.322123937581466e-9	5.1214443443359237e-5	12	223	99
MESH:D001851	Bone Diseases, Metabolic	GO:0006066	alcohol metabolic process	1.4197532038906502e-12	3.131265691180829e-8	20	382	99
MESH:D001851	Bone Diseases, Metabolic	GO:0009991	response to extracellular stimulus	9.080514118409155e-13	2.0027073888151392e-8	21	573	99
MESH:D001851	Bone Diseases, Metabolic	GO:0044723	single-organism carbohydrate metabolic process	2.7372548672133235e-12	6.037015609638985e-8	23	665	99
MESH:D001851	Bone Diseases, Metabolic	GO:0001501	skeletal system development	1.6026846516581372e-11	3.5347209992320217e-7	19	482	99
MESH:D001851	Bone Diseases, Metabolic	GO:0001649	osteoblast differentiation	6.621125869799016e-11	1.460289310584173e-6	13	206	99
MESH:D001851	Bone Diseases, Metabolic	GO:0019725	cellular homeostasis	8.30352453462524e-11	1.8313423361115966e-6	22	771	99
MESH:D001851	Bone Diseases, Metabolic	GO:0097305	response to alcohol	9.793132971225305e-11	2.159875476803741e-6	16	369	99
MESH:D001851	Bone Diseases, Metabolic	GO:0043627	response to estrogen	1.2559786544130702e-10	2.7700609223080264e-6	13	217	99
MESH:D001851	Bone Diseases, Metabolic	GO:0030278	regulation of ossification	1.6292933668893284e-10	3.5934065206744137e-6	12	177	99
MESH:D001851	Bone Diseases, Metabolic	GO:0048771	tissue remodeling	1.877256128324234e-10	4.140288391019098e-6	11	139	99
MESH:D001851	Bone Diseases, Metabolic	GO:0033273	response to vitamin	1.909036262404129e-10	4.210379476732307e-6	10	104	99
MESH:D001851	Bone Diseases, Metabolic	GO:0048878	chemical homeostasis	2.4629176476054226e-10	5.43196487179376e-6	24	988	99
MESH:D001851	Bone Diseases, Metabolic	GO:0098771	inorganic ion homeostasis	4.064204528475557e-10	8.96360308755284e-6	19	609	99
MESH:D001851	Bone Diseases, Metabolic	GO:0072502	cellular trivalent inorganic anion homeostasis	4.689161281490328e-10	1.0341945206326919e-5	5	9	99
MESH:D001851	Bone Diseases, Metabolic	GO:0030643	cellular phosphate ion homeostasis	4.689161281490328e-10	1.0341945206326919e-5	5	9	99
MESH:D001851	Bone Diseases, Metabolic	GO:0042368	vitamin D biosynthetic process	1.7049301970217812e-9	3.7602235495315384e-5	5	11	99
MESH:D001851	Bone Diseases, Metabolic	GO:0010038	response to metal ion	2.625204054140795e-9	5.7898875414075235e-5	14	335	99
MESH:D001851	Bone Diseases, Metabolic	GO:0044724	single-organism carbohydrate catabolic process	3.1184579363241482e-9	6.877758978562909e-5	10	138	99
MESH:D001851	Bone Diseases, Metabolic	GO:0051353	positive regulation of oxidoreductase activity	3.6570092509791152e-9	8.065533903034439e-5	7	45	99
MESH:D001851	Bone Diseases, Metabolic	GO:1902930	regulation of alcohol biosynthetic process	3.6570092509791152e-9	8.065533903034439e-5	7	45	99
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0014706	striated muscle tissue development	1.6471268793338822e-12	3.632738332370877e-8	33	323	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0006936	muscle contraction	1.6471268793338822e-12	3.632738332370877e-8	36	323	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:1903522	regulation of blood circulation	1.0746958878371515e-12	2.3702417806248377e-8	17	297	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0060047	heart contraction	5.790923296444817e-13	1.2771881330309043e-8	25	253	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0060538	skeletal muscle organ development	5.46451772720502e-13	1.2051993847350673e-8	15	167	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0030048	actin filament-based movement	4.511946372076636e-13	9.951097723615021e-9	23	114	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0031032	actomyosin structure organization	3.581579477440755e-13	7.899173537495585e-9	17	145	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0090665	glycoprotein complex	7.227551890309769e-14	1.5940365694078196e-9	8	21	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0016010	dystrophin-associated glycoprotein complex	7.227551890309769e-14	1.5940365694078196e-9	8	21	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0003009	skeletal muscle contraction	7.271960811294775e-13	1.6038309569310627e-8	9	40	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0007519	skeletal muscle tissue development	2.17970086424657e-12	4.80733025609581e-8	13	158	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0046716	muscle cell cellular homeostasis	4.880318371647263e-12	1.0763542168668039e-7	7	19	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0003205	cardiac chamber development	1.3688938871325718e-11	3.019095468070887e-7	12	142	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0016011	dystroglycan complex	8.294553932586268e-11	1.8293638698319015e-6	5	7	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0006942	regulation of striated muscle contraction	1.0506329140014259e-10	2.317170891830145e-6	10	97	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0043500	muscle adaptation	6.641837080323398e-10	1.4648571680653255e-5	9	84	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0035995	detection of muscle stretch	7.746485675141912e-10	1.7084874156525487e-5	4	4	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0014819	regulation of skeletal muscle contraction	1.7941891305994773e-9	3.957084127537147e-5	5	11	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0016528	sarcoplasm	2.890457428961213e-9	6.374903859573955e-5	8	68	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0030240	skeletal muscle thin filament assembly	3.8572802729675004e-9	8.507231642029822e-5	4	5	100
Orphanet:207049	Qualitative or quantitative protein defects in neuromuscular diseases	GO:0030315	T-tubule	3.9252541217393855e-9	8.657147965496215e-5	7	45	100
Orphanet:216452	Postlingual non-syndromic genetic deafness	GO:0048562	embryonic organ morphogenesis	8.333334022836425e-13	1.8379168187365735e-8	17	280	100
Orphanet:216452	Postlingual non-syndromic genetic deafness	GO:0090102	cochlea development	1.3658154607298911e-9	3.012305998639775e-5	7	39	100
Orphanet:216445	Prelingual non-syndromic genetic deafness	GO:0048562	embryonic organ morphogenesis	8.333334022836425e-13	1.8379168187365735e-8	17	280	100
Orphanet:216445	Prelingual non-syndromic genetic deafness	GO:0090102	cochlea development	1.3658154607298911e-9	3.012305998639775e-5	7	39	100
MESH:D018908	Muscle Weakness	GO:1901661	quinone metabolic process	2.0092816299666083e-12	4.4314706348913546e-8	8	29	100
Orphanet:206953	Muscular lipidosis	GO:0006091	generation of precursor metabolites and energy	1.3766765505351941e-12	3.0362601322053706e-8	36	362	100
Orphanet:206953	Muscular lipidosis	GO:0009167	purine ribonucleoside monophosphate metabolic process	2.9665159217984183e-13	6.5426508655264115e-9	29	266	100
Orphanet:206953	Muscular lipidosis	GO:0046395	carboxylic acid catabolic process	1.065270094358084e-11	2.3494531931067542e-7	14	219	100
Orphanet:206953	Muscular lipidosis	GO:0044242	cellular lipid catabolic process	1.8382806388217432e-10	4.054327948921355e-6	12	177	100
Orphanet:206953	Muscular lipidosis	GO:0009062	fatty acid catabolic process	8.221160419097373e-10	1.8131769304319256e-5	9	86	100
Orphanet:206953	Muscular lipidosis	GO:0006635	fatty acid beta-oxidation	1.999782450745613e-9	4.4105201951194495e-5	8	65	100
Orphanet:206953	Muscular lipidosis	GO:0050662	coenzyme binding	4.417321619598624e-9	9.742402832024766e-5	11	185	100
Orphanet:68411	Rare bone tumor	GO:0048545	response to steroid hormone	2.162376944170319e-10	4.769122350367638e-6	17	446	100
Orphanet:68411	Rare bone tumor	GO:0001503	ossification	9.088317876049246e-10	2.004428507562661e-5	15	363	100
Orphanet:68411	Rare bone tumor	GO:0007167	enzyme linked receptor protein signaling pathway	3.411369187134028e-9	7.523774742224099e-5	22	935	100
Orphanet:68411	Rare bone tumor	GO:0031099	regeneration	3.720017849317969e-9	8.204499366670781e-5	11	182	100
Orphanet:68411	Rare bone tumor	GO:0048812	neuron projection morphogenesis	3.79435705077924e-9	8.368454475493614e-5	17	539	100
DOID:3602	toxic encephalopathy	GO:0036293	response to decreased oxygen levels	4.083733351478713e-12	9.006673906686302e-8	16	302	100
DOID:3602	toxic encephalopathy	GO:0001666	response to hypoxia	4.100386696848091e-12	9.043402859898464e-8	16	292	100
DOID:3602	toxic encephalopathy	GO:0042493	response to drug	4.527156427514001e-12	9.984643500882129e-8	21	433	100
DOID:3602	toxic encephalopathy	GO:0014070	response to organic cyclic compound	4.5742298837581075e-12	1.0088464008628506e-7	25	873	100
DOID:3602	toxic encephalopathy	GO:1901698	response to nitrogen compound	5.665801161569561e-12	1.2495924461841668e-7	25	870	100
DOID:3602	toxic encephalopathy	GO:0010243	response to organonitrogen compound	8.969713860551565e-12	1.9782703919446476e-7	24	780	100
DOID:3602	toxic encephalopathy	GO:0043279	response to alkaloid	1.1366241281507428e-11	2.506824514636463e-7	12	140	100
DOID:3602	toxic encephalopathy	GO:0010035	response to inorganic substance	2.343270022464594e-11	5.168082034545662e-7	19	502	100
DOID:3602	toxic encephalopathy	GO:0010038	response to metal ion	2.496225448567202e-11	5.505425226814964e-7	16	335	100
DOID:3602	toxic encephalopathy	GO:0009314	response to radiation	1.3010370558674822e-10	2.869437226715732e-6	17	431	100
DOID:3602	toxic encephalopathy	GO:2000379	positive regulation of reactive oxygen species metabolic process	5.956269921725266e-10	1.3136553312365074e-5	9	83	100
DOID:3602	toxic encephalopathy	GO:0010942	positive regulation of cell death	2.4642561324839107e-9	5.434916900193265e-5	18	596	100
DOID:3602	toxic encephalopathy	GO:1902533	positive regulation of intracellular signal transduction	4.323507218906286e-9	9.535495171297814e-5	21	860	100
DOID:3908	non-small cell lung carcinoma	GO:0060548	negative regulation of cell death	3.185007813044649e-12	7.024534731669974e-8	29	867	100
DOID:3908	non-small cell lung carcinoma	GO:2001233	regulation of apoptotic signaling pathway	5.716316309190006e-12	1.2607335619918558e-7	17	359	100
DOID:3908	non-small cell lung carcinoma	GO:0043069	negative regulation of programmed cell death	6.661005080843552e-12	1.4690846705800453e-7	28	806	100
DOID:3908	non-small cell lung carcinoma	GO:0008284	positive regulation of cell proliferation	8.143707930230448e-12	1.7960947840123254e-7	26	815	100
DOID:3908	non-small cell lung carcinoma	GO:0043066	negative regulation of apoptotic process	9.104828002648446e-12	2.0080698159841148e-7	26	795	100
DOID:3908	non-small cell lung carcinoma	GO:0030162	regulation of proteolysis	1.931643733854571e-11	4.2602402550162566e-7	22	701	100
DOID:3908	non-small cell lung carcinoma	GO:1902533	positive regulation of intracellular signal transduction	2.3664847859095062e-11	5.219282195323416e-7	24	860	100
DOID:3908	non-small cell lung carcinoma	GO:0043408	regulation of MAPK cascade	2.8207547408953815e-11	6.221174581044764e-7	21	651	100
DOID:3908	non-small cell lung carcinoma	GO:1902532	negative regulation of intracellular signal transduction	1.0736322941795606e-10	2.367896024813021e-6	17	426	100
DOID:3908	non-small cell lung carcinoma	GO:0009725	response to hormone	1.3220502470545625e-10	2.9157818198788377e-6	23	865	100
DOID:3908	non-small cell lung carcinoma	GO:0097191	extrinsic apoptotic signaling pathway	1.7028223275872278e-10	3.755574643493631e-6	13	220	100
DOID:3908	non-small cell lung carcinoma	GO:0072593	reactive oxygen species metabolic process	2.0109491849495953e-10	4.435148427406332e-6	13	223	100
DOID:3908	non-small cell lung carcinoma	GO:0006979	response to oxidative stress	2.251847597278811e-10	4.966449875798418e-6	16	386	100
DOID:3908	non-small cell lung carcinoma	GO:2001236	regulation of extrinsic apoptotic signaling pathway	5.120452950535537e-10	1.1293158982406126e-5	11	151	100
DOID:3908	non-small cell lung carcinoma	GO:0018108	peptidyl-tyrosine phosphorylation	6.433430455032862e-10	1.4188930868574978e-5	15	354	100
DOID:3908	non-small cell lung carcinoma	GO:2001234	negative regulation of apoptotic signaling pathway	7.127904932957563e-10	1.5720594329637905e-5	12	199	100
DOID:3908	non-small cell lung carcinoma	GO:0043627	response to estrogen	1.915810177166577e-9	4.2253193457408855e-5	12	217	100
DOID:3908	non-small cell lung carcinoma	GO:0040012	regulation of locomotion	3.4725640141175518e-9	7.65873993313626e-5	20	766	100
DOID:0050815	eye adnexa disease	GO:0007268	synaptic transmission	3.681440929881319e-9	8.119417970853249e-5	18	605	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0031331	positive regulation of cellular catabolic process	2.901234807950459e-12	6.398673368934737e-8	20	333	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051726	regulation of cell cycle	2.3923085734622873e-12	5.276236558771075e-8	29	930	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0034504	protein localization to nucleus	1.801669924361704e-12	3.973583018179738e-8	18	344	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0045862	positive regulation of proteolysis	1.3800072196090696e-12	3.043605922847803e-8	20	357	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051348	negative regulation of transferase activity	1.3298251388960125e-12	2.9329293438351556e-8	19	357	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002768	immune response-regulating cell surface receptor signaling pathway	1.3251622021925868e-12	2.9226452369357503e-8	23	323	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0050778	positive regulation of immune response	1.2747580768746047e-12	2.8114789385469408e-8	34	603	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1901987	regulation of cell cycle phase transition	1.2718714970105793e-12	2.8051125866568327e-8	19	312	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0000278	mitotic cell cycle	1.234123914173324e-12	2.721860292709266e-8	29	927	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903320	regulation of protein modification by small protein conjugation or removal	8.220091274324659e-13	1.8129411305523035e-8	19	286	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0010565	regulation of cellular ketone metabolic process	7.644995747568828e-13	1.686103812126305e-8	18	188	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903322	positive regulation of protein modification by small protein conjugation or removal	7.529532553007812e-13	1.660638404565873e-8	17	191	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903364	positive regulation of cellular protein catabolic process	7.476241847825804e-13	1.648885139537981e-8	16	191	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0045088	regulation of innate immune response	7.100986465502501e-13	1.5661225649665766e-8	23	351	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0090263	positive regulation of canonical Wnt signaling pathway	6.927791673660977e-13	1.5279244536259284e-8	15	119	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0038093	Fc receptor signaling pathway	6.106226635438361e-13	1.3467282844459305e-8	19	185	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0043488	regulation of mRNA stability	5.710987238671805e-13	1.2595582354890666e-8	17	135	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0001738	morphogenesis of a polarized epithelium	5.659916979539048e-13	1.248294689837337e-8	16	127	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	5.000444502911705e-13	1.1028480351171766e-8	19	384	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0031398	positive regulation of protein ubiquitination	4.993783164763954e-13	1.10137887698869e-8	17	179	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0019882	antigen processing and presentation	4.9649173661237e-13	1.095012525098582e-8	19	219	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0048002	antigen processing and presentation of peptide antigen	4.75175454539567e-13	1.047999464987015e-8	17	176	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0038095	Fc-epsilon receptor signaling pathway	4.618527782440651e-13	1.0186163024172856e-8	16	125	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0090090	negative regulation of canonical Wnt signaling pathway	4.602984660095899e-13	1.0151882667841505e-8	15	161	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0019884	antigen processing and presentation of exogenous antigen	4.063416270128073e-13	8.961864583767465e-9	15	164	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0050852	T cell receptor signaling pathway	4.0589753780295723e-13	8.952070196244222e-9	17	165	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	3.608224830031759e-13	7.957939862635044e-9	16	177	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051340	regulation of ligase activity	2.6423307986078726e-13	5.827660576329663e-9	15	139	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002478	antigen processing and presentation of exogenous peptide antigen	2.604583215770617e-13	5.744408282382096e-9	15	157	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051351	positive regulation of ligase activity	2.324807013565078e-13	5.127361868417779e-9	15	110	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	2.320366121466577e-13	5.117567480894536e-9	15	113	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002220	innate immune response activating cell surface receptor signaling pathway	1.7275070263167436e-13	3.810016746541578e-9	17	107	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0034612	response to tumor necrosis factor	1.7141843500212417e-13	3.7806335839718486e-9	24	265	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903321	negative regulation of protein modification by small protein conjugation or removal	1.4832579608992091e-13	3.2713254327632058e-9	14	156	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0090175	regulation of establishment of planar polarity	1.4233059175694507e-13	3.1391012011994235e-9	16	109	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	1.212363542890671e-13	2.6738677938453748e-9	16	108	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051438	regulation of ubiquitin-protein transferase activity	8.126832540256146e-14	1.792372916753493e-9	15	138	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0044106	cellular amine metabolic process	3.219646771412954e-14	7.10093095435127e-10	17	200	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0022624	proteasome accessory complex	2.6645352591003757e-14	5.876632513945879e-10	9	24	101
OMIM:609423	acquired immunodeficiency syndrome	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	5.551115123125783e-15	1.2242984404053914e-10	15	101	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	1.3211653993039363e-14	2.9138302881648315e-10	14	96	101
OMIM:609423	acquired immunodeficiency syndrome	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	2.919886554764162e-14	6.439809796532359e-10	15	93	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0033209	tumor necrosis factor-mediated signaling pathway	5.3179682879545e-14	1.172877905908365e-9	18	154	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	6.972200594645983e-14	1.5377188411491716e-9	15	88	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	7.283063041541027e-14	1.6062795538118735e-9	15	59	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051352	negative regulation of ligase activity	9.303668946358812e-14	2.051924186119436e-9	14	99	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	9.825473767932635e-14	2.1670082395175427e-9	14	92	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051443	positive regulation of ubiquitin-protein transferase activity	1.0380585280245214e-13	2.289438083558082e-9	15	105	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002223	stimulatory C-type lectin receptor signaling pathway	1.0380585280245214e-13	2.289438083558082e-9	17	105	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0038061	NIK/NF-kappaB signaling	1.0380585280245214e-13	2.289438083558082e-9	18	105	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0033238	regulation of cellular amine metabolic process	1.4133139103478243e-13	3.1170638292721264e-9	16	87	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0050727	regulation of inflammatory response	1.5798473640415978e-13	3.484353361393744e-9	17	289	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0006521	regulation of cellular amino acid metabolic process	2.530198273120732e-13	5.580352291367774e-9	16	65	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	2.6434410216324977e-13	5.830109173210474e-9	15	80	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0000209	protein polyubiquitination	8.385514504993807e-13	1.8494252240763842e-8	16	248	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0006913	nucleocytoplasmic transport	2.9986013672100853e-12	6.613415315381843e-8	24	530	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0000165	MAPK cascade	3.81350506728495e-12	8.410685425896958e-8	27	843	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0000060	protein import into nucleus, translocation	5.7263083164116324e-12	1.2629372991845855e-7	9	50	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0016032	viral process	7.642331212309728e-12	1.6855161488749104e-7	29	726	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0031647	regulation of protein stability	9.087730568069219e-12	2.0042989767876662e-7	14	214	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0032880	regulation of protein localization	1.4956702543145184e-11	3.2987007458906703e-7	25	933	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0070098	chemokine-mediated signaling pathway	1.6638246336242446e-11	3.6695652294582715e-7	10	80	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002252	immune effector process	1.9298007636336934e-11	4.2561755841941107e-7	23	757	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0034109	homotypic cell-cell adhesion	2.3244073332762127e-11	5.126480373540687e-7	19	495	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002443	leukocyte mediated immunity	2.6541102648991455e-11	5.853640189235065e-7	15	279	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0007159	leukocyte cell-cell adhesion	5.259948032687589e-11	1.1600815386092478e-6	18	461	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0045321	leukocyte activation	1.1486644968528026e-10	2.533379547808856e-6	21	694	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0070489	T cell aggregation	1.1714007541741012e-10	2.58352436333098e-6	17	424	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0042110	T cell activation	1.1714007541741012e-10	2.58352436333098e-6	17	424	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0009607	response to biotic stimulus	1.173341424021146e-10	2.5878045106786374e-6	24	934	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0030234	enzyme regulator activity	1.5454415525084642e-10	3.4084713440574177e-6	24	944	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0030595	leukocyte chemotaxis	2.0719859161744125e-10	4.569764938122667e-6	12	177	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0070201	regulation of establishment of protein localization	2.510009977640948e-10	5.535827005687111e-6	22	803	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051707	response to other organism	3.345470567239772e-10	7.378435336047318e-6	23	898	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002703	regulation of leukocyte mediated immunity	5.709124284436484e-10	1.2591473609324666e-5	11	151	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903037	regulation of leukocyte cell-cell adhesion	6.355482806696955e-10	1.4017017330170134e-5	14	294	101
OMIM:609423	acquired immunodeficiency syndrome	GO:1903827	regulation of cellular protein localization	6.710616506921951e-10	1.4800264706016364e-5	18	543	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0046651	lymphocyte proliferation	8.899959658137391e-10	1.9628861026022015e-5	13	249	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0009408	response to heat	9.910120501999131e-10	2.1856770767159084e-5	11	159	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002819	regulation of adaptive immune response	1.0481543410989502e-9	2.3117043992937347e-5	10	121	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0005838	proteasome regulatory particle	1.0954658291595365e-9	2.4160498862113577e-5	6	21	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002366	leukocyte activation involved in immune response	1.3297122292144081e-9	2.932680321532377e-5	12	208	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0050821	protein stabilization	1.5610027714885177e-9	3.442791612517926e-5	10	126	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0043069	negative regulation of programmed cell death	1.6594664531410785e-9	3.659953262402649e-5	21	806	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051082	unfolded protein binding	2.0069698125624313e-9	4.426371921606442e-5	9	94	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0006457	protein folding	2.389029307714452e-9	5.269004138164224e-5	12	219	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0051168	nuclear export	3.685801330810534e-9	8.129034835102633e-5	11	180	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0050863	regulation of T cell activation	4.385505181225824e-9	9.672231677193555e-5	13	284	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0002821	positive regulation of adaptive immune response	4.444932089064935e-9	9.803297722432713e-5	8	71	101
OMIM:609423	acquired immunodeficiency syndrome	GO:0001816	cytokine production	4.5211020482938125e-9	9.971290567512003e-5	18	613	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0007167	enzyme linked receptor protein signaling pathway	2.872813098520055e-12	6.335989288785981e-8	31	935	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051338	regulation of transferase activity	2.2872814753327475e-12	5.0445992938463746e-8	30	928	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0022407	regulation of cell-cell adhesion	2.014166611274959e-12	4.442244461166922e-8	22	376	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1903706	regulation of hemopoiesis	1.8340884366807586e-12	4.045082047099413e-8	18	305	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0034504	protein localization to nucleus	1.801669924361704e-12	3.973583018179738e-8	18	344	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0072358	cardiovascular system development	1.7321699630201692e-12	3.820300853440983e-8	29	910	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0097305	response to alcohol	1.553646100660444e-12	3.4265664750066094e-8	21	369	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045785	positive regulation of cell adhesion	1.4743761767022079e-12	3.2517366577167195e-8	20	368	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0001655	urogenital system development	1.3880008253863707e-12	3.0612358203896406e-8	19	313	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0034110	regulation of homotypic cell-cell adhesion	1.2077006061872453e-12	2.6635836869459695e-8	22	304	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0002768	immune response-regulating cell surface receptor signaling pathway	1.2028156248788946e-12	2.652809860670402e-8	18	323	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0071363	cellular response to growth factor stimulus	1.0100809078039674e-12	2.22773344216165e-8	24	594	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0002696	positive regulation of leukocyte activation	9.874323581016142e-13	2.1777820657931102e-8	19	280	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051054	positive regulation of DNA metabolic process	8.391065620116933e-13	1.8506495225167896e-8	18	183	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1903037	regulation of leukocyte cell-cell adhesion	6.52811138479592e-13	1.4397749659167403e-8	22	294	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0048015	phosphatidylinositol-mediated signaling	4.594102875898898e-13	1.0132293892795019e-8	15	193	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045596	negative regulation of cell differentiation	3.0531133177191805e-13	6.7336414222296526e-9	24	597	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0010942	positive regulation of cell death	2.8377300509419e-13	6.258613627352361e-9	23	596	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0009790	embryo development	2.808864252301646e-14	6.19495010845128e-10	26	932	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0042113	B cell activation	3.241851231905457e-14	7.149902891967486e-10	18	212	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	7.183142969324763e-14	1.5842421818845764e-9	10	52	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043408	regulation of MAPK cascade	1.3711254354120683e-13	3.0240171478013167e-9	24	651	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0014065	phosphatidylinositol 3-kinase signaling	1.5576429035490946e-13	3.435381423777528e-9	14	154	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0050673	epithelial cell proliferation	2.9964919434632975e-13	6.608762981308303e-9	17	335	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0001822	kidney development	3.0619951019161817e-13	6.753230197276139e-9	18	262	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0002208	somatic diversification of immunoglobulins involved in immune response	4.376499163072367e-13	9.652368904156106e-9	9	38	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	4.376499163072367e-13	9.652368904156106e-9	9	38	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045190	isotype switching	4.376499163072367e-13	9.652368904156106e-9	9	38	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901214	regulation of neuron death	5.667688540711424e-13	1.2500087076539046e-8	17	250	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0000018	regulation of DNA recombination	6.327161017338767e-13	1.3954553623740651e-8	10	58	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0097191	extrinsic apoptotic signaling pathway	6.408207298136404e-13	1.4133301196039838e-8	15	220	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0014070	response to organic cyclic compound	1.0490497359683104e-12	2.3136791926781086e-8	27	873	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0033993	response to lipid	1.0977885267493548e-12	2.421172595745702e-8	27	850	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0000278	mitotic cell cycle	1.1090017792980689e-12	2.445903424241891e-8	26	927	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043523	regulation of neuron apoptotic process	1.237787650154587e-12	2.7299406624159417e-8	14	190	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0050678	regulation of epithelial cell proliferation	1.6349144260630055e-12	3.605803766681959e-8	16	277	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043009	chordate embryonic development	1.82487358557637e-12	4.0247586929886836e-8	23	552	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.3443469387984806e-12	5.170457173520049e-8	25	647	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051241	negative regulation of multicellular organismal process	2.5189850205720177e-12	5.555621462871585e-8	29	966	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043068	positive regulation of programmed cell death	2.9786173527668325e-12	6.569340571527249e-8	22	561	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0009725	response to hormone	3.022027073029676e-12	6.66508070956695e-8	29	865	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0060548	negative regulation of cell death	3.110511848092301e-12	6.86023388096757e-8	31	867	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045786	negative regulation of cell cycle	3.626765554542999e-12	7.998831430544584e-8	22	449	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0007346	regulation of mitotic cell cycle	3.957278948973908e-12	8.727778721961954e-8	20	453	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0035004	phosphatidylinositol 3-kinase activity	4.146571974672497e-12	9.145264490140192e-8	10	70	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0048732	gland development	4.353295501857701e-12	9.60119322934716e-8	19	421	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043065	positive regulation of apoptotic process	4.441225165408014e-12	9.795122102307374e-8	22	556	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0007050	cell cycle arrest	4.996780766930442e-12	1.102039998146509e-7	15	242	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045165	cell fate commitment	5.045297513106561e-12	1.1127403665156521e-7	15	243	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901701	cellular response to oxygen-containing compound	5.296429961276772e-12	1.168127627959592e-7	25	873	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045859	regulation of protein kinase activity	5.780709244618265e-12	1.2749354239005584e-7	24	709	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901698	response to nitrogen compound	6.2725380445272094e-12	1.383408265720476e-7	25	870	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0008284	positive regulation of cell proliferation	7.649103572759941e-12	1.687009792972205e-7	30	815	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051345	positive regulation of hydrolase activity	8.083422819993302e-12	1.7827989029495228e-7	25	900	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0009887	organ morphogenesis	1.0125456029186353e-11	2.23316932723705e-7	28	950	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.1056489057637009e-11	2.4385086616618423e-7	12	138	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0010631	epithelial cell migration	1.1410317135585046e-11	2.516545444253282e-7	14	218	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0032880	regulation of protein localization	1.4956702543145184e-11	3.2987007458906703e-7	25	933	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0070482	response to oxygen levels	1.594868681564776e-11	3.517482877191114e-7	16	321	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0033044	regulation of chromosome organization	1.778410751995807e-11	3.9222849135267523e-7	15	271	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0001817	regulation of cytokine production	1.945543726122878e-11	4.2908966879640076e-7	20	556	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0010564	regulation of cell cycle process	2.061117942986357e-11	4.54579562325641e-7	20	561	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0072594	establishment of protein localization to organelle	2.5673130288339507e-11	5.662208885093278e-7	21	641	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0044427	chromosomal part	2.5779711698703522e-11	5.685715415149062e-7	23	776	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3.21912496659138e-11	7.099780113817289e-7	12	151	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045191	regulation of isotype switching	3.5196401348969175e-11	7.762566317515152e-7	7	24	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	4.427702648968079e-11	9.765298192299099e-7	9	62	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0098552	side of membrane	5.0723536482166764e-11	1.118707597114188e-6	17	402	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051302	regulation of cell division	5.3830939705790115e-11	1.187241375211201e-6	15	293	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043410	positive regulation of MAPK cascade	5.893319166005995e-11	1.2997715420626221e-6	18	464	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0050900	leukocyte migration	7.249512101736855e-11	1.5988798940380633e-6	16	354	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	8.947043106388719e-11	1.973270357114032e-6	16	359	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0048608	reproductive structure development	9.354428343044674e-11	2.063119171058503e-6	17	418	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901652	response to peptide	1.1303391556083398e-10	2.4929630076941933e-6	17	423	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0007507	heart development	1.2274603555795238e-10	2.7071638142306398e-6	18	487	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1900180	regulation of protein localization to nucleus	1.2936751669911928e-10	2.8532005807990757e-6	13	213	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	1.5565759792224299e-10	3.433028322175069e-6	9	71	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043627	response to estrogen	1.62457935992677e-10	3.583009778318491e-6	13	217	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:2000145	regulation of cell motility	1.6810508540743285e-10	3.7075576586609316e-6	21	709	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0001568	blood vessel development	1.8588042216549638e-10	4.099592710860023e-6	19	569	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0006606	protein import into nucleus	1.8987778016565926e-10	4.187754441553615e-6	14	268	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043434	response to peptide hormone	2.9492475128733986e-10	6.504565389642281e-6	16	389	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.97622593237179e-10	6.564066293845983e-6	21	732	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0030334	regulation of cell migration	3.188805886011892e-10	7.032911381599227e-6	20	660	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0032355	response to estradiol	3.693098049595278e-10	8.145127748382386e-6	11	145	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0035239	tube morphogenesis	3.9107972416019265e-10	8.625263316353049e-6	15	338	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0019900	kinase binding	4.265484632171024e-10	9.407526356253193e-6	19	598	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0060284	regulation of cell development	4.4139680799304415e-10	9.735006600286589e-6	22	828	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0006935	chemotaxis	4.5589676478385854e-10	1.0054803147308e-5	18	530	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0072111	cell proliferation involved in kidney development	5.525611079804094e-10	1.2186735236507928e-5	6	19	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0043542	endothelial cell migration	5.709124284436484e-10	1.2591473609324666e-5	11	151	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0050679	positive regulation of epithelial cell proliferation	7.551880232270491e-10	1.665567185227257e-5	11	155	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0060562	epithelial tube morphogenesis	8.620449909457761e-10	1.9012402275309093e-5	14	301	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0031400	negative regulation of protein modification process	9.673493117645648e-10	2.1334889070967478e-5	19	628	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0018209	peptidyl-serine modification	1.134237703759311e-9	2.5015612556411604e-5	13	254	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045787	positive regulation of cell cycle	1.161835849750048e-9	2.562428966623731e-5	14	308	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0009314	response to radiation	1.3133210075011448e-9	2.8965294820437748e-5	16	431	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0001701	in utero embryonic development	1.3743660653986467e-9	3.0311643572367153e-5	14	312	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0046854	phosphatidylinositol phosphorylation	1.4988477126109956e-9	3.305708630163551e-5	9	91	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0070851	growth factor receptor binding	1.5610027714885177e-9	3.442791612517926e-5	10	126	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0010638	positive regulation of organelle organization	1.5651511198200296e-9	3.4519407947630754e-5	18	573	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901215	negative regulation of neuron death	2.0164944158906906e-9	4.447378434246918e-5	11	170	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0045597	positive regulation of cell differentiation	2.022786715905056e-9	4.461256101928601e-5	21	815	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0050767	regulation of neurogenesis	2.0897858998836227e-9	4.60902280219333e-5	19	658	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0070227	lymphocyte apoptotic process	2.165892798444702e-9	4.77687656696979e-5	8	65	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:1901699	cellular response to nitrogen compound	2.452251512963244e-9	5.408440711840434e-5	17	518	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0000228	nuclear chromosome	2.596921788722284e-9	5.727511005026997e-5	17	520	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0019901	protein kinase binding	3.6525826807576323e-9	8.055771102410958e-5	17	532	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3.819427218942906e-9	8.423746731378579e-5	9	101	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	4.209955051237557e-9	9.285055865504432e-5	7	45	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0040007	growth	4.243271289894324e-9	9.358534829861931e-5	22	936	101
Orphanet:79386	Rare skin tumor or hamartoma	GO:0051347	positive regulation of transferase activity	4.5211020482938125e-9	9.971290567512003e-5	18	613	101
DOID:0050890	synucleinopathy	GO:0070997	neuron death	7.669420654110581e-13	1.6914907252640887e-8	18	281	102
DOID:0050890	synucleinopathy	GO:0007268	synaptic transmission	1.5207834991315394e-12	3.35408800733461e-8	22	605	102
DOID:0050890	synucleinopathy	GO:0043069	negative regulation of programmed cell death	6.495248783267016e-12	1.4325271191495403e-7	26	806	102
DOID:0050890	synucleinopathy	GO:0001505	regulation of neurotransmitter levels	1.601263566186617e-11	3.531586795224584e-7	13	179	102
DOID:0050890	synucleinopathy	GO:0044297	cell body	2.6168289757322327e-11	5.771416305977439e-7	19	494	102
DOID:0050890	synucleinopathy	GO:0043523	regulation of neuron apoptotic process	3.450983943054098e-11	7.611145086405813e-7	13	190	102
DOID:0050890	synucleinopathy	GO:0019693	ribose phosphate metabolic process	7.16013914825453e-11	1.5791686891475365e-6	19	531	102
DOID:0050890	synucleinopathy	GO:0043524	negative regulation of neuron apoptotic process	1.75024994497619e-10	3.860176253644987e-6	11	134	102
DOID:0050890	synucleinopathy	GO:0009150	purine ribonucleotide metabolic process	2.2320367776273997e-10	4.92275711305723e-6	18	501	102
DOID:0050890	synucleinopathy	GO:0043005	neuron projection	1.0226381963462927e-9	2.2554285420417486e-5	23	941	102
DOID:0050890	synucleinopathy	GO:1902533	positive regulation of intracellular signal transduction	1.0899899871574803e-9	2.4039729166758228e-5	22	860	102
DOID:0050890	synucleinopathy	GO:0042493	response to drug	1.629537171865536e-9	3.59394423254944e-5	16	433	102
DOID:0050890	synucleinopathy	GO:0036477	somatodendritic compartment	1.9824490937736527e-9	4.372291476317791e-5	19	649	102
DOID:0050890	synucleinopathy	GO:0032104	regulation of response to extracellular stimulus	2.2427167900573863e-9	4.9463118804715656e-5	11	170	102
DOID:0050890	synucleinopathy	GO:0032107	regulation of response to nutrient levels	2.2427167900573863e-9	4.9463118804715656e-5	11	170	102
DOID:0050890	synucleinopathy	GO:0019439	aromatic compound catabolic process	2.5681752280348746e-9	5.664110465430916e-5	16	447	102
DOID:0050890	synucleinopathy	GO:0048878	chemical homeostasis	2.5994036922938335e-9	5.73298484335405e-5	23	988	102
DOID:0050890	synucleinopathy	GO:1901699	cellular response to nitrogen compound	2.867471038392466e-9	6.324207375174584e-5	17	518	102
DOID:0050701	electroclinical syndrome	GO:0033267	axon part	5.551115123125783e-15	1.2242984404053914e-10	15	217	102
DOID:0050701	electroclinical syndrome	GO:0044708	single-organism behavior	7.049694161764819e-12	1.5548100473772308e-7	18	404	102
DOID:0050701	electroclinical syndrome	GO:0051402	neuron apoptotic process	9.616196727790793e-12	2.1208521883142595e-7	14	211	102
DOID:0050701	electroclinical syndrome	GO:0044456	synapse part	1.4353296329261411e-11	3.165619505418604e-7	21	613	102
DOID:0050701	electroclinical syndrome	GO:0042391	regulation of membrane potential	4.89610019194231e-10	1.0798348973328764e-5	15	340	102
DOID:0050701	electroclinical syndrome	GO:0043523	regulation of neuron apoptotic process	5.284330750754407e-10	1.1654591470788844e-5	12	190	102
DOID:0050701	electroclinical syndrome	GO:0060078	regulation of postsynaptic membrane potential	8.836914533461027e-10	1.9489815003548294e-5	9	85	102
DOID:0050701	electroclinical syndrome	GO:0001508	action potential	9.804660416889988e-10	2.1624178549450868e-5	10	119	102
DOID:0050701	electroclinical syndrome	GO:0007417	central nervous system development	2.0067915107446765e-9	4.425978676947384e-5	22	889	102
DOID:0050701	electroclinical syndrome	GO:0043524	negative regulation of neuron apoptotic process	3.142320736948534e-9	6.930388385339992e-5	10	134	102
MESH:D005124	Eye Abnormalities	GO:0003002	regionalization	2.2226664952995634e-12	4.902090955383187e-8	18	327	102
MESH:D005124	Eye Abnormalities	GO:0009790	embryo development	1.7426060594516457e-12	3.8433176641206046e-8	38	932	102
MESH:D005124	Eye Abnormalities	GO:0072358	cardiovascular system development	1.4941381465405357e-12	3.2953216821951514e-8	28	910	102
MESH:D005124	Eye Abnormalities	GO:0048562	embryonic organ morphogenesis	7.840394999902855e-13	1.7291991172285748e-8	18	280	102
MESH:D005124	Eye Abnormalities	GO:0048736	appendage development	4.758415883543421e-13	1.0494686231155015e-8	15	168	102
MESH:D005124	Eye Abnormalities	GO:0060173	limb development	4.758415883543421e-13	1.0494686231155015e-8	15	168	102
MESH:D005124	Eye Abnormalities	GO:0035113	embryonic appendage morphogenesis	3.7192471324942744e-13	8.202799550716122e-9	13	125	102
MESH:D005124	Eye Abnormalities	GO:0030326	embryonic limb morphogenesis	3.7192471324942744e-13	8.202799550716122e-9	13	125	102
MESH:D005124	Eye Abnormalities	GO:0060041	retina development in camera-type eye	3.3950620093037287e-13	7.487809261519374e-9	14	131	102
MESH:D005124	Eye Abnormalities	GO:0001655	urogenital system development	1.9340085088970227e-13	4.2654557663723836e-9	17	313	102
MESH:D005124	Eye Abnormalities	GO:0048593	camera-type eye morphogenesis	1.4077627952246985e-13	3.1048208448680725e-9	14	100	102
MESH:D005124	Eye Abnormalities	GO:0072001	renal system development	1.0421663532156344e-12	2.2984978920170818e-8	17	276	102
MESH:D005124	Eye Abnormalities	GO:0043009	chordate embryonic development	2.245870156514229e-12	4.9532666301921324e-8	22	552	102
MESH:D005124	Eye Abnormalities	GO:0048729	tissue morphogenesis	2.670641485735814e-12	5.890099796790338e-8	28	635	102
MESH:D005124	Eye Abnormalities	GO:0007420	brain development	2.698397061351443e-12	5.9513147188106075e-8	25	669	102
MESH:D005124	Eye Abnormalities	GO:0007507	heart development	7.334466367581172e-12	1.6176165573700274e-7	24	487	102
MESH:D005124	Eye Abnormalities	GO:0048048	embryonic eye morphogenesis	7.383538225269604e-12	1.628439355583211e-7	8	33	102
MESH:D005124	Eye Abnormalities	GO:0002009	morphogenesis of an epithelium	7.445044580833837e-12	1.6420045823029028e-7	24	506	102
MESH:D005124	Eye Abnormalities	GO:0032990	cell part morphogenesis	8.220868430441897e-12	1.8131125323339603e-7	25	787	102
MESH:D005124	Eye Abnormalities	GO:0001501	skeletal system development	8.985145960593854e-12	1.9816739416089746e-7	20	482	102
MESH:D005124	Eye Abnormalities	GO:0048858	cell projection morphogenesis	1.0112577442100701e-11	2.2303289548553096e-7	25	767	102
MESH:D005124	Eye Abnormalities	GO:0001822	kidney development	1.3178791391510458e-11	2.9065824413976316e-7	15	262	102
MESH:D005124	Eye Abnormalities	GO:0001067	regulatory region nucleic acid binding	1.3980483437592284e-11	3.083395622160978e-7	24	811	102
MESH:D005124	Eye Abnormalities	GO:0000975	regulatory region DNA binding	1.4786061264260297e-11	3.2610658118326086e-7	24	810	102
MESH:D005124	Eye Abnormalities	GO:0016331	morphogenesis of embryonic epithelium	1.6230017330087776e-11	3.579530322150859e-7	12	141	102
MESH:D005124	Eye Abnormalities	GO:0021915	neural tube development	3.644073931496905e-11	8.037005055916424e-7	12	151	102
MESH:D005124	Eye Abnormalities	GO:0051093	negative regulation of developmental process	3.8576475347440464e-11	8.508041637877994e-7	23	788	102
MESH:D005124	Eye Abnormalities	GO:0035239	tube morphogenesis	4.124445229791718e-11	9.096463954305634e-7	16	338	102
MESH:D005124	Eye Abnormalities	GO:0044212	transcription regulatory region DNA binding	5.599365415775992e-11	1.234940042449395e-6	23	807	102
MESH:D005124	Eye Abnormalities	GO:0030900	forebrain development	9.613532192531693e-11	2.120264525062865e-6	16	357	102
MESH:D005124	Eye Abnormalities	GO:0048589	developmental growth	1.6219947607254426e-10	3.5773094447799636e-6	19	558	102
MESH:D005124	Eye Abnormalities	GO:0045597	positive regulation of cell differentiation	4.0401015866109447e-10	8.910444049270438e-6	22	815	102
MESH:D005124	Eye Abnormalities	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.528573154833794e-10	1.2193268092985932e-5	24	996	102
MESH:D005124	Eye Abnormalities	GO:0042476	odontogenesis	6.415916686819401e-10	1.4150304252780188e-5	10	114	102
MESH:D005124	Eye Abnormalities	GO:0060021	palate development	8.836914533461027e-10	1.9489815003548294e-5	9	85	102
MESH:D005124	Eye Abnormalities	GO:0060562	epithelial tube morphogenesis	9.852521021258553e-10	2.172973511238574e-5	14	301	102
MESH:D005124	Eye Abnormalities	GO:0009798	axis specification	1.4820883409427665e-9	3.2687458359492716e-5	9	90	102
MESH:D005124	Eye Abnormalities	GO:0046660	female sex differentiation	1.859672971171733e-9	4.101508737919257e-5	10	127	102
MESH:D005124	Eye Abnormalities	GO:0050678	regulation of epithelial cell proliferation	3.6720427809555645e-9	8.098690353397497e-5	13	277	102
MESH:D005124	Eye Abnormalities	GO:0060537	muscle tissue development	4.068032022352952e-9	8.972044625299436e-5	14	336	102
MESH:D005124	Eye Abnormalities	GO:0048666	neuron development	4.238397854905429e-9	9.347786468993924e-5	22	926	102
MESH:D010243	Paralysis	GO:0008088	axon cargo transport	1.060889598392123e-9	2.339792009253827e-5	7	37	102
MESH:D010243	Paralysis	GO:0043209	myelin sheath	1.9787507188340214e-9	4.364134710388434e-5	11	168	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0060537	muscle tissue development	2.113642594281373e-12	4.661638741687568e-8	26	336	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0006936	muscle contraction	1.1930456622621932e-12	2.631262208119267e-8	26	323	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0055002	striated muscle cell development	4.809486142676178e-13	1.0607321687672311e-8	16	127	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0031674	I band	3.681499549657019e-13	8.119547256768556e-9	18	122	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0060047	heart contraction	2.779998453661392e-13	6.1312865895502e-9	23	253	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0030048	actin filament-based movement	2.34035013590983e-13	5.16164222474913e-9	19	114	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0022900	electron transport chain	1.432187701766452e-13	3.1586899762459097e-9	13	107	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0009161	ribonucleoside monophosphate metabolic process	3.774758283725532e-14	8.325229394756661e-10	17	279	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0022904	respiratory electron transport chain	9.736655925962623e-14	2.1474194644710565e-9	13	105	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0019866	organelle inner membrane	3.749778265671466e-12	8.270135964938419e-8	21	531	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0008092	cytoskeletal protein binding	6.450517897604868e-11	1.4226617223167537e-6	23	812	102
OMIM:600884	Familial dilated cardiomyopathy	GO:0048747	muscle fiber development	2.6661528540472546e-10	5.88020011960122e-6	8	50	102
DOID:2841	asthma	GO:0032496	response to lipopolysaccharide	1.5087930904655877e-12	3.327643161021854e-8	27	319	102
DOID:2841	asthma	GO:0097305	response to alcohol	1.3282708266615373e-12	2.9295013082020205e-8	23	369	102
DOID:2841	asthma	GO:0031960	response to corticosteroid	5.881961584464079e-13	1.2972666274535527e-8	18	179	102
DOID:2841	asthma	GO:0008217	regulation of blood pressure	9.992007221626409e-14	2.2037371927297045e-9	14	168	102
DOID:2841	asthma	GO:1903524	positive regulation of blood circulation	2.034372670323137e-12	4.486808924397678e-8	11	89	102
DOID:2841	asthma	GO:0003018	vascular process in circulatory system	3.411271265463256e-12	7.523558775979211e-8	13	159	102
DOID:2841	asthma	GO:0071345	cellular response to cytokine stimulus	3.593014774594394e-12	7.924394085367936e-8	26	677	102
DOID:2841	asthma	GO:0006874	cellular calcium ion homeostasis	6.396883023285227e-12	1.4108325507855568e-7	17	352	102
DOID:2841	asthma	GO:0050776	regulation of immune response	8.436695786429027e-12	1.860713255696922e-7	27	816	102
DOID:2841	asthma	GO:0050880	regulation of blood vessel size	1.3432699397242231e-11	2.962581852061774e-7	12	139	102
DOID:2841	asthma	GO:0006979	response to oxidative stress	3.04902769698856e-11	6.724630585708269e-7	17	386	102
DOID:2841	asthma	GO:0007204	positive regulation of cytosolic calcium ion concentration	3.7685965459388626e-11	8.311639682068162e-7	14	234	102
DOID:2841	asthma	GO:0022603	regulation of anatomical structure morphogenesis	8.21060996969436e-11	1.8108500288160911e-6	25	986	102
DOID:2841	asthma	GO:0045765	regulation of angiogenesis	1.0949585682595853e-10	2.4149311222965153e-6	13	208	102
DOID:2841	asthma	GO:1902533	positive regulation of intracellular signal transduction	1.8301515858354378e-10	4.036399322560058e-6	23	860	102
DOID:2841	asthma	GO:0019233	sensory perception of pain	1.92015514599575e-10	4.234902174493627e-6	10	101	102
DOID:2841	asthma	GO:0006935	chemotaxis	5.386158186126977e-10	1.1879171879503048e-5	18	530	102
DOID:2841	asthma	GO:0070848	response to growth factor	9.557622471234595e-10	2.10793363603079e-5	19	621	102
DOID:2841	asthma	GO:0045766	positive regulation of angiogenesis	9.804660416889988e-10	2.1624178549450868e-5	10	119	102
DOID:2841	asthma	GO:0006816	calcium ion transport	1.3532875930977184e-9	2.984675786577018e-5	15	366	102
DOID:2841	asthma	GO:0032642	regulation of chemokine production	2.655145880936516e-9	5.8559242404054856e-5	8	66	102
DOID:2841	asthma	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	2.69807998165561e-9	5.950615399541448e-5	11	173	102
DOID:2841	asthma	GO:0030595	leukocyte chemotaxis	3.4334709519967532e-9	7.572520184628839e-5	11	177	102
DOID:2841	asthma	GO:0014823	response to activity	3.813327209556405e-9	8.410293160676652e-5	8	69	102
DOID:2841	asthma	GO:0048660	regulation of smooth muscle cell proliferation	3.816086668884111e-9	8.416379148223907e-5	9	100	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0007600	sensory perception	2.007061183917358e-12	4.426573441129733e-8	56	902	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0009790	embryo development	1.2567724638756772e-12	2.771811669077806e-8	27	932	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0048562	embryonic organ morphogenesis	7.964739978660873e-13	1.7566234022936555e-8	22	280	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0098858	actin-based cell projection	5.881961584464079e-13	1.2972666274535527e-8	21	179	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0048839	inner ear development	5.431211036466266e-13	1.197853594092635e-8	29	170	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0045177	apical part of cell	2.4291679778798425e-13	5.357529975213993e-9	18	356	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0042471	ear morphogenesis	1.0347278589506459e-13	2.2820922929156495e-9	20	112	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0060119	inner ear receptor cell development	7.327471962526033e-15	1.6160739413351166e-10	10	35	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0042472	inner ear morphogenesis	8.659739592076221e-14	1.9099055670324105e-9	18	92	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0007601	visual perception	3.9734882051334353e-13	8.763528236421791e-9	15	207	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0035315	hair cell differentiation	6.427081089555031e-13	1.4174927343013621e-8	9	39	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0001895	retina homeostasis	2.7359225995837733e-12	6.034077293382012e-8	10	66	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0060117	auditory receptor cell development	3.5519365226832633e-12	7.833796000777937e-8	7	18	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	2.059541426291389e-11	4.542318615685659e-7	6	12	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0016324	apical plasma membrane	5.066558284028133e-10	1.1174294295424048e-5	14	286	102
MESH:D006319	Hearing Loss, Sensorineural	GO:0060088	auditory receptor cell stereocilium organization	1.086802425831479e-9	2.396942750171327e-5	5	10	102
MESH:D011230	Precancerous Conditions	GO:0009416	response to light stimulus	5.728750807065808e-13	1.2634759904983639e-8	17	297	102
MESH:D018302	Neoplasms, Neuroepithelial	GO:0050673	epithelial cell proliferation	2.3592239273284576e-12	5.2032683717229133e-8	20	335	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0019199	transmembrane receptor protein kinase activity	7.790434963794723e-13	1.7181804312649263e-8	11	79	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0003006	developmental process involved in reproduction	1.0783596238184145e-12	2.3783221503315133e-8	24	619	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0051402	neuron apoptotic process	1.1926015730523432e-12	2.6302827693669428e-8	15	211	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0048754	branching morphogenesis of an epithelial tube	1.5530909891481315e-12	3.425342176566204e-8	13	147	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0004714	transmembrane receptor protein tyrosine kinase activity	1.8536283619141614e-12	4.088177352201683e-8	10	63	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.8721690864254015e-12	4.129068920111223e-8	15	225	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0014070	response to organic cyclic compound	2.490230244234226e-12	5.492202803658586e-8	26	873	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0043009	chordate embryonic development	2.691291633993842e-12	5.9356436987734185e-8	22	552	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0043408	regulation of MAPK cascade	6.71784849970436e-12	1.4816214866097965e-7	22	651	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0042493	response to drug	6.761591286874591e-12	1.491268958320191e-7	19	433	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0010720	positive regulation of cell development	7.048361894135269e-12	1.5545162157515335e-7	20	469	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0050769	positive regulation of neurogenesis	2.2814972133744504e-11	5.03184210409735e-7	17	376	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0048666	neuron development	2.300892809614652e-11	5.074619091605115e-7	25	926	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0043068	positive regulation of programmed cell death	2.935651721713839e-11	6.474579872239872e-7	20	561	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0072091	regulation of stem cell proliferation	5.280520465333893e-11	1.1646187886293902e-6	10	88	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0050679	positive regulation of epithelial cell proliferation	5.5259130604667916e-11	1.218740125485951e-6	12	155	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0031175	neuron projection development	5.758060694915912e-11	1.2699402862637044e-6	23	796	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0001944	vasculature development	6.054057255511225e-11	1.3352223277030006e-6	20	588	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0030856	regulation of epithelial cell differentiation	7.021860870537466e-11	1.5486714149970382e-6	11	122	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0043549	regulation of kinase activity	1.404982796771037e-10	3.0986895582785223e-6	22	761	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0014031	mesenchymal cell development	1.7506363025887595e-10	3.861028365359509e-6	12	171	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0048598	embryonic morphogenesis	2.0607338058198366e-10	4.5449484087356495e-6	19	560	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0048667	cell morphogenesis involved in neuron differentiation	2.1731205723796165e-10	4.792817422383244e-6	18	495	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:2000145	regulation of cell motility	2.4547464061441815e-10	5.413943198750992e-6	21	709	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0045859	regulation of protein kinase activity	2.4547464061441815e-10	5.413943198750992e-6	21	709	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0045786	negative regulation of cell cycle	3.8784431222183e-10	8.553906306052461e-6	17	449	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0048562	embryonic organ morphogenesis	4.385225516045921e-10	9.671614875639278e-6	14	280	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0050804	modulation of synaptic transmission	5.528649760222493e-10	1.2193437046170708e-5	14	285	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0007409	axonogenesis	7.455958073165903e-10	1.6444115530367398e-5	16	406	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0032403	protein complex binding	8.791696259891069e-10	1.9390086101189752e-5	23	924	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0070848	response to growth factor	1.1364150731552058e-9	2.5063634438438065e-5	19	621	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0050890	cognition	1.257550841238242e-9	2.7735283803509425e-5	13	251	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:2000648	positive regulation of stem cell proliferation	1.505587432504285e-9	3.320573082388201e-5	8	61	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0097305	response to alcohol	1.739751565033032e-9	3.837022076680352e-5	15	369	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0009314	response to radiation	1.7670470642272562e-9	3.8972223001532136e-5	16	431	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0071900	regulation of protein serine/threonine kinase activity	1.7670470642272562e-9	3.8972223001532136e-5	16	431	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0072080	nephron tubule development	1.786837344752712e-9	3.940869763852106e-5	9	91	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0007610	behavior	1.8000204660140184e-9	3.969945137793918e-5	20	714	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0045682	regulation of epidermis development	2.2323208836994013e-9	4.9233837089990296e-5	8	64	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0051301	cell division	2.294557432946931e-9	5.060646418364456e-5	19	648	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.7520434819905404e-9	6.069631899530137e-5	20	732	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0007611	learning or memory	2.850446656488259e-9	6.286660100884855e-5	12	218	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0022603	regulation of anatomical structure morphogenesis	3.058919562093365e-9	6.746447094196917e-5	23	986	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0002521	leukocyte differentiation	3.0707867360035834e-9	6.772620146255903e-5	16	448	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0030334	regulation of cell migration	3.098719170147035e-9	6.834225129759286e-5	19	660	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0001570	vasculogenesis	3.245055002487618e-9	7.156968807986441e-5	8	67	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0007346	regulation of mitotic cell cycle	3.5977444357015997e-9	7.934825352939878e-5	16	453	103
MESH:D018302	Neoplasms, Neuroepithelial	GO:0051052	regulation of DNA metabolic process	4.459287050728733e-9	9.83495759038222e-5	14	335	103
DOID:0050865	tongue squamous cell carcinoma	GO:0042493	response to drug	7.412848113119708e-12	1.6349036513485515e-7	19	433	104
DOID:0050865	tongue squamous cell carcinoma	GO:0010035	response to inorganic substance	4.340672266067713e-11	9.573352682812342e-7	19	502	104
DOID:0050865	tongue squamous cell carcinoma	GO:0010038	response to metal ion	4.8966719567999917e-11	1.0799610000722382e-6	16	335	104
DOID:0050865	tongue squamous cell carcinoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	8.400259376983854e-10	1.852677205593789e-5	24	996	104
DOID:0050865	tongue squamous cell carcinoma	GO:0097305	response to alcohol	1.99722149929471e-9	4.404872016694483e-5	15	369	104
DOID:0050865	tongue squamous cell carcinoma	GO:0043066	negative regulation of apoptotic process	2.2814528044534654e-9	5.031744160222118e-5	21	795	104
DOID:0050865	tongue squamous cell carcinoma	GO:0071456	cellular response to hypoxia	3.8044234429435164e-9	8.390655903411925e-5	10	134	104
MESH:D063646	Carcinogenesis	GO:0045597	positive regulation of cell differentiation	2.207556359934415e-11	4.868765551835352e-7	24	815	104
MESH:D063646	Carcinogenesis	GO:2000145	regulation of cell motility	4.746858461857073e-11	1.0469196337625775e-6	22	709	104
MESH:D063646	Carcinogenesis	GO:0002520	immune system development	4.8778647787628415e-11	1.0758130769561447e-6	23	782	104
MESH:D063646	Carcinogenesis	GO:0000165	MAPK cascade	1.8300316817487783e-10	4.0361348740969305e-6	23	843	104
MESH:D063646	Carcinogenesis	GO:1902533	positive regulation of intracellular signal transduction	2.724472869530814e-10	6.00882491375021e-6	23	860	104
MESH:D063646	Carcinogenesis	GO:0043408	regulation of MAPK cascade	4.344749005014137e-10	9.582343930558679e-6	20	651	104
MESH:D063646	Carcinogenesis	GO:0042063	gliogenesis	4.3821346551453644e-10	9.664797981923101e-6	13	228	104
MESH:D063646	Carcinogenesis	GO:0071222	cellular response to lipopolysaccharide	8.425913300413868e-10	1.8583351784062785e-5	11	152	104
MESH:D063646	Carcinogenesis	GO:0010720	positive regulation of cell development	8.774678761369614e-10	1.9352554008200684e-5	17	469	104
MESH:D063646	Carcinogenesis	GO:0050679	positive regulation of epithelial cell proliferation	1.0371817849019749e-9	2.2875044266013056e-5	11	155	104
MESH:D063646	Carcinogenesis	GO:0070201	regulation of establishment of protein localization	2.7201201291404686e-9	5.9992249448193036e-5	21	803	104
MESH:D063646	Carcinogenesis	GO:0050767	regulation of neurogenesis	3.49079987138623e-9	7.69895911634233e-5	19	658	104
MESH:D063646	Carcinogenesis	GO:0030334	regulation of cell migration	3.6679892456703556e-9	8.089750281325969e-5	19	660	104
MESH:D063646	Carcinogenesis	GO:0022603	regulation of anatomical structure morphogenesis	3.7318151901999386e-9	8.230518401985965e-5	23	986	104
MESH:D063646	Carcinogenesis	GO:0048534	hematopoietic or lymphoid organ development	3.8604253127516586e-9	8.514168027273783e-5	20	739	104
MESH:D063646	Carcinogenesis	GO:0010001	glial cell differentiation	3.984338525775399e-9	8.787458618597643e-5	11	176	104
DOID:0050032	mineral metabolism disease	GO:0010038	response to metal ion	2.4167334800040408e-12	5.330105690148912e-8	20	335	104
DOID:0050032	mineral metabolism disease	GO:0009991	response to extracellular stimulus	6.201705815556124e-13	1.3677862176209032e-8	23	573	104
DOID:0050032	mineral metabolism disease	GO:0055076	transition metal ion homeostasis	4.318767565791859e-13	9.525041866353945e-9	15	109	104
DOID:0050032	mineral metabolism disease	GO:0006953	acute-phase response	1.5498713423767185e-13	3.4182412456118527e-9	10	53	104
DOID:0050032	mineral metabolism disease	GO:0048871	multicellular organismal homeostasis	2.645794694444703e-11	5.835300198597793e-7	16	321	104
DOID:0050032	mineral metabolism disease	GO:0009617	response to bacterium	6.820932707540805e-11	1.5043567086481247e-6	19	517	104
DOID:0050032	mineral metabolism disease	GO:0031670	cellular response to nutrient	1.2820233763477518e-10	2.8275025565349665e-6	8	45	104
DOID:0050032	mineral metabolism disease	GO:0071396	cellular response to lipid	1.4091006139693718e-10	3.1077714041094495e-6	17	416	104
DOID:0050032	mineral metabolism disease	GO:0098590	plasma membrane region	1.8900514486830389e-10	4.168508470070442e-6	24	926	104
DOID:0050032	mineral metabolism disease	GO:0070372	regulation of ERK1 and ERK2 cascade	5.729525742736996e-10	1.2636469025606445e-5	13	233	104
DOID:0050032	mineral metabolism disease	GO:0048534	hematopoietic or lymphoid organ development	6.232843130504762e-10	1.3746535524328252e-5	21	739	104
DOID:0050032	mineral metabolism disease	GO:0045177	apical part of cell	1.2234412372080783e-9	2.6982996486624167e-5	15	356	104
DOID:0050032	mineral metabolism disease	GO:0070848	response to growth factor	1.3479477534161788e-9	2.9728987701593823e-5	19	621	104
DOID:0050032	mineral metabolism disease	GO:0007167	enzyme linked receptor protein signaling pathway	1.348735123585243e-9	2.9746353150672533e-5	23	935	104
DOID:0050032	mineral metabolism disease	GO:1902533	positive regulation of intracellular signal transduction	1.6061384444654436e-9	3.542338339268536e-5	22	860	104
DOID:0050032	mineral metabolism disease	GO:0046890	regulation of lipid biosynthetic process	2.085110972771531e-9	4.598712250447612e-5	10	126	104
DOID:0050032	mineral metabolism disease	GO:0001101	response to acid chemical	2.3042979746534797e-9	5.0821291830982496e-5	14	315	104
DOID:0050032	mineral metabolism disease	GO:0051241	negative regulation of multicellular organismal process	2.524372044732104e-9	5.567502544656655e-5	23	966	104
DOID:0050032	mineral metabolism disease	GO:0071363	cellular response to growth factor stimulus	4.495825267625264e-9	9.91554262774752e-5	18	594	104
DOID:5212	congenital disorder of glycosylation	GO:0006643	membrane lipid metabolic process	5.173639294753229e-13	1.1410461464578248e-8	16	191	105
DOID:5212	congenital disorder of glycosylation	GO:0006661	phosphatidylinositol biosynthetic process	4.063416270128073e-13	8.961864583767465e-9	16	127	105
DOID:5212	congenital disorder of glycosylation	GO:0046467	membrane lipid biosynthetic process	2.815525590449397e-13	6.209641689736145e-9	15	126	105
DOID:5212	congenital disorder of glycosylation	GO:1903509	liposaccharide metabolic process	2.0672352718520415e-13	4.5592873920696775e-9	17	118	105
DOID:5212	congenital disorder of glycosylation	GO:0006029	proteoglycan metabolic process	8.715250743307479e-14	1.9221485514364645e-9	12	85	105
DOID:5212	congenital disorder of glycosylation	GO:0009225	nucleotide-sugar metabolic process	2.020605904817785e-13	4.456446323075625e-9	9	34	105
DOID:5212	congenital disorder of glycosylation	GO:0031501	mannosyltransferase complex	7.458478279431802e-13	1.644967384528684e-8	6	8	105
DOID:5212	congenital disorder of glycosylation	GO:0009226	nucleotide-sugar biosynthetic process	7.000082735686419e-10	1.5438682473556398e-5	6	19	105
DOID:5212	congenital disorder of glycosylation	GO:1903510	mucopolysaccharide metabolic process	7.846371330444413e-10	1.7305171969295152e-5	10	113	105
DOID:5212	congenital disorder of glycosylation	GO:0098791	Golgi subcompartment	9.003705558896513e-10	1.985767261014626e-5	14	290	105
DOID:9741	biliary tract disease	GO:0071216	cellular response to biotic stimulus	4.15816703291938e-9	9.170837391103692e-5	11	175	105
Orphanet:98640	Rare cataract	GO:0043010	camera-type eye development	8.348877145181177e-13	1.8413448543697086e-8	29	283	105
DOID:11054	urinary bladder cancer	GO:0042493	response to drug	4.689693078319124e-12	1.0343118084232827e-7	20	433	106
DOID:11054	urinary bladder cancer	GO:0009636	response to toxic substance	1.0993761456745688e-11	2.4246740892852614e-7	15	249	106
DOID:11054	urinary bladder cancer	GO:0051402	neuron apoptotic process	1.5678791598361386e-11	3.4579574870186036e-7	14	211	106
DOID:11054	urinary bladder cancer	GO:0097305	response to alcohol	2.8144042651945256e-11	6.207168606886526e-7	17	369	106
DOID:11054	urinary bladder cancer	GO:0014070	response to organic cyclic compound	9.028144898337587e-11	1.9911573573283547e-6	24	873	106
DOID:11054	urinary bladder cancer	GO:0007568	aging	9.389444777241351e-11	2.07084204562058e-6	15	290	106
DOID:11054	urinary bladder cancer	GO:0006259	DNA metabolic process	3.731770448212046e-10	8.230419723531668e-6	24	937	106
DOID:11054	urinary bladder cancer	GO:0070482	response to oxygen levels	3.864043529588912e-10	8.522148004508345e-6	15	321	106
DOID:11054	urinary bladder cancer	GO:0010035	response to inorganic substance	4.3782721892426935e-10	9.65627931337476e-6	18	502	106
DOID:11054	urinary bladder cancer	GO:0009410	response to xenobiotic stimulus	4.565230415920496e-10	1.0068615682312654e-5	10	106	106
DOID:11054	urinary bladder cancer	GO:0051052	regulation of DNA metabolic process	6.9595640361797e-10	1.5349318481794327e-5	15	335	106
DOID:11054	urinary bladder cancer	GO:0006260	DNA replication	7.557626746645951e-10	1.6668345789727645e-5	15	337	106
DOID:11054	urinary bladder cancer	GO:0016568	chromatin modification	1.3303974588652068e-9	2.9341915955272135e-5	19	608	106
DOID:11054	urinary bladder cancer	GO:0009411	response to UV	2.327350312469889e-9	5.1329711141523404e-5	10	125	106
DOID:11054	urinary bladder cancer	GO:0043627	response to estrogen	3.777186785569597e-9	8.330585455573747e-5	12	217	106
DOID:11054	urinary bladder cancer	GO:0071466	cellular response to xenobiotic stimulus	4.489014049369189e-9	9.900520485883746e-5	9	98	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0050673	epithelial cell proliferation	2.4511503937674206e-12	5.406012193454046e-8	20	335	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0060562	epithelial tube morphogenesis	1.240785252321075e-12	2.7365518739941308e-8	17	301	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0061138	morphogenesis of a branching epithelium	3.9612757518625585e-13	8.736593670732873e-9	15	179	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0019199	transmembrane receptor protein kinase activity	2.686739719592879e-13	5.925604451562094e-9	13	79	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0004714	transmembrane receptor protein tyrosine kinase activity	3.3717473257866004e-13	7.436388727022347e-9	11	63	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0003006	developmental process involved in reproduction	4.0545344859310717e-13	8.942275808720979e-9	27	619	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	7.457368056407176e-13	1.6447225248406028e-8	16	225	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048863	stem cell differentiation	7.487344078072056e-13	1.651333736418792e-8	17	266	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0072358	cardiovascular system development	1.5941692410592623e-12	3.515940261156203e-8	26	910	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0043408	regulation of MAPK cascade	1.6620038678638593e-12	3.665549530573742e-8	23	651	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048754	branching morphogenesis of an epithelial tube	2.4991120284312274e-12	5.511791578705072e-8	13	147	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0072091	regulation of stem cell proliferation	2.5908164502652653e-12	5.7140456810600426e-8	11	88	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0050679	positive regulation of epithelial cell proliferation	4.046984969363621e-12	8.925625349931465e-8	13	155	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048666	neuron development	6.563749543886388e-12	1.447634961904143e-7	26	926	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0051726	regulation of cell cycle	8.467559986513606e-12	1.867520355025576e-7	26	930	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0007409	axonogenesis	1.4786949442679997e-11	3.2612616995830734e-7	18	406	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0014031	mesenchymal cell development	1.5012768805888754e-11	3.311066160138765e-7	13	171	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0010720	positive regulation of cell development	2.2860824344661523e-11	5.041954809215099e-7	19	469	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0070848	response to growth factor	3.6366354372319165e-11	8.020599456814992e-7	21	621	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0042493	response to drug	4.3611669831022937e-11	9.618553781232109e-7	18	433	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048589	developmental growth	4.396882857804485e-11	9.697325142887792e-7	20	558	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048598	embryonic morphogenesis	4.7479797871119445e-11	1.0471669420475394e-6	20	560	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0043068	positive regulation of programmed cell death	4.809663778360118e-11	1.060771346317324e-6	20	561	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:2000648	positive regulation of stem cell proliferation	5.907641043023659e-11	1.302930232038868e-6	9	61	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0050804	modulation of synaptic transmission	7.32025551286597e-11	1.6144823533625896e-6	15	285	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0001944	vasculature development	1.0330614141906835e-10	2.2784169489975525e-6	20	588	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0002053	positive regulation of mesenchymal cell proliferation	1.257258741560463e-10	2.772884154511601e-6	7	27	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0050890	cognition	1.5512580109344754e-10	3.4212995431159854e-6	14	251	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0032403	protein complex binding	2.7961066795256784e-10	6.166813281693884e-6	24	924	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0007611	learning or memory	3.2016933548817406e-10	7.061334694191679e-6	13	218	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0007423	sensory organ development	3.396076753148236e-10	7.490047279068435e-6	18	494	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0030278	regulation of ossification	3.6724201457616346e-10	8.099522631477285e-6	12	177	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0050769	positive regulation of neurogenesis	3.766290612716716e-10	8.306553946346718e-6	16	376	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:2000145	regulation of cell motility	4.25544044446724e-10	9.385373900272498e-6	21	709	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0046777	protein autophosphorylation	5.889595477981402e-10	1.2989502826687982e-5	13	229	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0045786	negative regulation of cell cycle	6.145611797236938e-10	1.3554146818806068e-5	17	449	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048562	embryonic organ morphogenesis	6.478914071905706e-10	1.4289244985588034e-5	14	280	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0045667	regulation of osteoblast differentiation	7.222406006590631e-10	1.5929016447535638e-5	10	111	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048015	phosphatidylinositol-mediated signaling	9.957181745789967e-10	2.1960564340339772e-5	12	193	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0022603	regulation of anatomical structure morphogenesis	1.036801089426831e-9	2.2866648027308756e-5	24	986	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0014065	phosphatidylinositol 3-kinase signaling	1.1900219698546266e-9	2.624593454514379e-5	11	154	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0018108	peptidyl-tyrosine phosphorylation	1.4867452824418592e-9	3.2790167204255205e-5	15	354	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0043549	regulation of kinase activity	1.510014224770373e-9	3.3303363727310575e-5	21	761	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0060541	respiratory system development	1.6758002763239688e-9	3.695977509432513e-5	12	202	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0030856	regulation of epithelial cell differentiation	1.8341239638175466e-9	4.045160402199599e-5	10	122	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0044427	chromosomal part	2.134865062508595e-9	4.708444895362707e-5	21	776	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0051961	negative regulation of nervous system development	2.6386939300238055e-9	5.819639462667503e-5	13	259	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0045859	regulation of protein kinase activity	2.6966626709423736e-9	5.947489520763405e-5	20	709	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0009314	response to radiation	2.720927483323976e-9	6.001005564471029e-5	16	431	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0071900	regulation of protein serine/threonine kinase activity	2.720927483323976e-9	6.001005564471029e-5	16	431	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0003682	chromatin binding	2.9072786400519135e-9	6.412003040634495e-5	16	433	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:1901701	cellular response to oxygen-containing compound	3.087332389739572e-9	6.809111585570626e-5	22	873	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0048483	autonomic nervous system development	3.564073591810768e-9	7.860564306738649e-5	7	42	106
Orphanet:251558	Rare tumor of neuroepithelial tissue	GO:0051301	cell division	3.7872399660798806e-9	8.352757745189177e-5	19	648	106
MESH:D001259	Ataxia	GO:0030425	dendrite	6.554190523644365e-10	1.4455267199897648e-5	17	451	106
MESH:D001259	Ataxia	GO:0007268	synaptic transmission	1.2256937687027403e-9	2.7032676068738937e-5	19	605	106
DOID:0060040	pervasive developmental disorder	GO:0042391	regulation of membrane potential	1.2685408279367039e-12	2.7977667960144004e-8	18	340	107
DOID:0060040	pervasive developmental disorder	GO:0007416	synapse assembly	9.237055564881302e-14	2.0372326048345712e-9	16	140	107
DOID:0060040	pervasive developmental disorder	GO:0007268	synaptic transmission	7.882583474838611e-14	1.7385037853756558e-9	26	605	107
DOID:0060040	pervasive developmental disorder	GO:0030534	adult behavior	4.929390229335695e-14	1.0871770150799875e-9	14	135	107
DOID:0060040	pervasive developmental disorder	GO:0050804	modulation of synaptic transmission	4.574118861455645e-14	1.0088219148940425e-9	18	285	107
DOID:0060040	pervasive developmental disorder	GO:0060078	regulation of postsynaptic membrane potential	1.0957901253050295e-13	2.4167651213602426e-9	13	85	107
DOID:0060040	pervasive developmental disorder	GO:0007611	learning or memory	2.716715741257758e-13	5.991716567343985e-9	19	218	107
DOID:0060040	pervasive developmental disorder	GO:0060079	excitatory postsynaptic potential	6.323830348264892e-13	1.3947207833098219e-8	10	54	107
DOID:0060040	pervasive developmental disorder	GO:0050803	regulation of synapse structure or activity	2.033151424996049e-12	4.4841154678287864e-8	16	233	107
DOID:0060040	pervasive developmental disorder	GO:0050806	positive regulation of synaptic transmission	3.338329612745383e-12	7.362685960909943e-8	12	118	107
DOID:0060040	pervasive developmental disorder	GO:0007417	central nervous system development	3.469002862743764e-12	7.650885813781372e-8	28	889	107
DOID:0060040	pervasive developmental disorder	GO:0098815	modulation of excitatory postsynaptic potential	4.654387986136044e-12	1.0265252703423045e-7	8	30	107
DOID:0060040	pervasive developmental disorder	GO:0044456	synapse part	5.0113246885530316e-12	1.1052476600603711e-7	22	613	107
DOID:0060040	pervasive developmental disorder	GO:0098794	postsynapse	5.655809154347935e-12	1.247388708991437e-7	18	381	107
DOID:0060040	pervasive developmental disorder	GO:0007612	learning	1.0506484571237706e-11	2.3172051721864761e-7	12	130	107
DOID:0060040	pervasive developmental disorder	GO:0036477	somatodendritic compartment	1.397593152319132e-11	3.082391697439846e-7	22	649	107
DOID:0060040	pervasive developmental disorder	GO:2000463	positive regulation of excitatory postsynaptic potential	1.8069323814984273e-11	3.9851893673947814e-7	7	21	107
DOID:0060040	pervasive developmental disorder	GO:0000904	cell morphogenesis involved in differentiation	2.3206991883739647e-11	5.118302059958779e-7	23	720	107
DOID:0060040	pervasive developmental disorder	GO:0016358	dendrite development	4.9161230641914244e-11	1.0842509418074187e-6	13	186	107
DOID:0060040	pervasive developmental disorder	GO:0050807	regulation of synapse organization	5.075373454843657e-11	1.1193736154657685e-6	11	114	107
DOID:0060040	pervasive developmental disorder	GO:0048667	cell morphogenesis involved in neuron differentiation	4.0991376959453873e-10	9.040648188407552e-6	18	495	107
DOID:0060040	pervasive developmental disorder	GO:0048167	regulation of synaptic plasticity	4.750821958054985e-10	1.0477937828490269e-5	11	140	107
DOID:0060040	pervasive developmental disorder	GO:0034220	ion transmembrane transport	7.793957701451859e-10	1.7189573710552075e-5	24	962	107
DOID:0060040	pervasive developmental disorder	GO:0043269	regulation of ion transport	7.823531822381824e-10	1.7254799434263113e-5	19	583	107
DOID:0060040	pervasive developmental disorder	GO:0048813	dendrite morphogenesis	8.66508975683189e-10	1.9110855458692733e-5	10	112	107
DOID:0060040	pervasive developmental disorder	GO:0051960	regulation of nervous system development	1.2108302138713611e-9	2.670486036693287e-5	21	744	107
DOID:0060040	pervasive developmental disorder	GO:0050773	regulation of dendrite development	1.5755067250822208e-9	3.474780082168838e-5	10	119	107
DOID:0060040	pervasive developmental disorder	GO:0097060	synaptic membrane	2.5758797317365634e-9	5.6811027483449905e-5	13	256	107
DOID:0060040	pervasive developmental disorder	GO:0034765	regulation of ion transmembrane transport	2.779634300509315e-9	6.130483449773294e-5	15	367	107
DOID:0060040	pervasive developmental disorder	GO:0035418	protein localization to synapse	2.867305615161797e-9	6.323842534239343e-5	6	23	107
DOID:654	overnutrition	GO:0050873	brown fat cell differentiation	4.7383652557186906e-11	1.0450464571487572e-6	8	39	107
DOID:654	overnutrition	GO:0048511	rhythmic process	6.028388899181891e-11	1.3295611717145661e-6	16	329	107
DOID:654	overnutrition	GO:0040008	regulation of growth	2.9138236268266837e-10	6.426438008966251e-6	20	617	107
DOID:654	overnutrition	GO:0007623	circadian rhythm	1.3257742681460627e-9	2.9239951483961413e-5	12	196	107
DOID:654	overnutrition	GO:0046879	hormone secretion	1.5797305685794072e-9	3.4840957690018826e-5	14	297	107
DOID:654	overnutrition	GO:0060259	regulation of feeding behavior	2.129209919488062e-9	4.695972477430921e-5	6	22	107
DOID:654	overnutrition	GO:0033500	carbohydrate homeostasis	3.2365574664794394e-9	7.138227492320404e-5	12	212	107
DOID:654	overnutrition	GO:0042593	glucose homeostasis	3.2365574664794394e-9	7.138227492320404e-5	12	212	107
DOID:654	overnutrition	GO:0008217	regulation of blood pressure	3.311391827409693e-9	7.303274675352078e-5	11	168	107
DOID:26	pancreas disease	GO:0015833	peptide transport	1.6826540161218873e-12	3.7110934325568223e-8	27	307	107
DOID:26	pancreas disease	GO:0009914	hormone transport	1.6826540161218873e-12	3.7110934325568223e-8	28	307	107
DOID:26	pancreas disease	GO:0009746	response to hexose	4.796163466380676e-13	1.0577938525102581e-8	15	181	107
DOID:26	pancreas disease	GO:0031960	response to corticosteroid	3.339550858072471e-13	7.3653794174788345e-9	15	179	107
DOID:26	pancreas disease	GO:0009636	response to toxic substance	1.2733369914030845e-11	2.808344734539503e-7	15	249	107
DOID:26	pancreas disease	GO:0044708	single-organism behavior	1.542654892716655e-11	3.4023253658865826e-7	18	404	107
DOID:26	pancreas disease	GO:0046683	response to organophosphorus	1.8743229190931743e-11	4.133819198059996e-7	12	136	107
DOID:26	pancreas disease	GO:0006091	generation of precursor metabolites and energy	2.4747648375011977e-11	5.458093849108892e-7	17	362	107
DOID:26	pancreas disease	GO:0044242	cellular lipid catabolic process	2.620814676390637e-11	5.78020676877955e-7	13	177	107
DOID:26	pancreas disease	GO:0043279	response to alkaloid	2.6361468563607104e-11	5.814021891703547e-7	12	140	107
DOID:26	pancreas disease	GO:0048871	multicellular organismal homeostasis	4.1605718870130204e-11	9.176141296807216e-7	16	321	107
DOID:26	pancreas disease	GO:0005179	hormone activity	6.786582407158903e-11	1.496780749898896e-6	11	117	107
DOID:26	pancreas disease	GO:1903532	positive regulation of secretion by cell	7.771616683527327e-11	1.714030059551952e-6	16	335	107
DOID:26	pancreas disease	GO:0046889	positive regulation of lipid biosynthetic process	1.0039802322836522e-10	2.214278402301595e-6	9	64	107
DOID:26	pancreas disease	GO:0007584	response to nutrient	1.0271272721240621e-10	2.265329198669619e-6	13	197	107
DOID:26	pancreas disease	GO:0001678	cellular glucose homeostasis	1.391521342597457e-10	3.0690003210986916e-6	11	125	107
DOID:26	pancreas disease	GO:0033198	response to ATP	2.3401713900028653e-10	5.1612480006513195e-6	7	29	107
DOID:26	pancreas disease	GO:0032496	response to lipopolysaccharide	4.0600023343273506e-10	8.954335148358972e-6	15	319	107
DOID:26	pancreas disease	GO:0098869	cellular oxidant detoxification	6.986310419065944e-10	1.540830762924994e-5	9	79	107
DOID:26	pancreas disease	GO:0050865	regulation of cell activation	9.64326063446208e-10	2.126821132930612e-5	17	458	107
DOID:26	pancreas disease	GO:0044706	multi-multicellular organism process	1.0096684599503192e-9	2.226823788420429e-5	13	237	107
DOID:26	pancreas disease	GO:0050729	positive regulation of inflammatory response	1.0319234355904428e-9	2.2759071371947215e-5	10	114	107
DOID:26	pancreas disease	GO:1903409	reactive oxygen species biosynthetic process	1.094546342450542e-9	2.4140219582746703e-5	9	83	107
DOID:26	pancreas disease	GO:0032768	regulation of monooxygenase activity	1.1682234068999264e-9	2.5765167239177877e-5	8	57	107
DOID:26	pancreas disease	GO:0032094	response to food	1.2116802006190142e-9	2.6723606824652357e-5	7	36	107
DOID:26	pancreas disease	GO:0050995	negative regulation of lipid catabolic process	1.5556755883494588e-9	3.4310425101047315e-5	6	21	107
DOID:26	pancreas disease	GO:0050714	positive regulation of protein secretion	2.2115812514655886e-9	4.8776424501073556e-5	12	205	107
DOID:26	pancreas disease	GO:0006809	nitric oxide biosynthetic process	2.3350004152433712e-9	5.149843415819255e-5	8	62	107
DOID:26	pancreas disease	GO:1900182	positive regulation of protein localization to nucleus	2.552892008900187e-9	5.630403325629363e-5	10	125	107
DOID:26	pancreas disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.655794473227502e-9	5.857354710703255e-5	7	40	107
DOID:26	pancreas disease	GO:0022407	regulation of cell-cell adhesion	3.860032071756336e-9	8.5133007342586e-5	15	376	107
DOID:0060084	cell type benign neoplasm	GO:0042327	positive regulation of phosphorylation	2.639444218743847e-12	5.821294224439555e-8	27	910	108
DOID:0060084	cell type benign neoplasm	GO:0050673	epithelial cell proliferation	2.2817303602096217e-12	5.032356309442321e-8	22	335	108
DOID:0060084	cell type benign neoplasm	GO:0097305	response to alcohol	8.313350008393172e-13	1.833509344351114e-8	20	369	108
DOID:0060084	cell type benign neoplasm	GO:0070997	neuron death	4.669598041573408e-13	1.0298798480690152e-8	18	281	108
DOID:0060084	cell type benign neoplasm	GO:0001503	ossification	4.2366110619695974e-13	9.343845697173947e-9	19	363	108
DOID:0060084	cell type benign neoplasm	GO:0050679	positive regulation of epithelial cell proliferation	3.694822225952521e-13	8.148930419338285e-9	15	155	108
DOID:0060084	cell type benign neoplasm	GO:0051384	response to glucocorticoid	5.085931675807842e-13	1.1217022310994196e-8	14	167	108
DOID:0060084	cell type benign neoplasm	GO:1901214	regulation of neuron death	7.720490913243339e-13	1.7027542709158183e-8	17	250	108
DOID:0060084	cell type benign neoplasm	GO:1901215	negative regulation of neuron death	8.697487174913476e-13	1.9182307964271672e-8	14	170	108
DOID:0060084	cell type benign neoplasm	GO:0051402	neuron apoptotic process	1.9382273563905983e-12	4.2747604345194645e-8	15	211	108
DOID:0060084	cell type benign neoplasm	GO:0042493	response to drug	3.821498673062251e-12	8.428315323438795e-8	23	433	108
DOID:0060084	cell type benign neoplasm	GO:0040007	growth	3.888667166052073e-12	8.576455434727848e-8	27	936	108
DOID:0060084	cell type benign neoplasm	GO:1901698	response to nitrogen compound	3.999911513119514e-12	8.821804842185088e-8	27	870	108
DOID:0060084	cell type benign neoplasm	GO:0043523	regulation of neuron apoptotic process	4.587885626960997e-12	1.0118581750262479e-7	14	190	108
DOID:0060084	cell type benign neoplasm	GO:0001934	positive regulation of protein phosphorylation	6.552425269035211e-12	1.445137393085716e-7	26	870	108
DOID:0060084	cell type benign neoplasm	GO:0051241	negative regulation of multicellular organismal process	7.071232488442547e-12	1.5595603253260037e-7	27	966	108
DOID:0060084	cell type benign neoplasm	GO:0010243	response to organonitrogen compound	8.902212300654355e-12	1.963382922909318e-7	25	780	108
DOID:0060084	cell type benign neoplasm	GO:0043069	negative regulation of programmed cell death	1.0573653064227528e-11	2.3320191833153814e-7	25	806	108
DOID:0060084	cell type benign neoplasm	GO:0043066	negative regulation of apoptotic process	1.2915779556976759e-11	2.848575181291224e-7	25	795	108
DOID:0060084	cell type benign neoplasm	GO:0009790	embryo development	1.4642176360268877e-11	3.229331996257301e-7	26	932	108
DOID:0060084	cell type benign neoplasm	GO:0007610	behavior	2.2321922088508472e-11	4.923099916620544e-7	23	714	108
DOID:0060084	cell type benign neoplasm	GO:0051093	negative regulation of developmental process	2.4002133613976184e-11	5.293670568562447e-7	24	788	108
DOID:0060084	cell type benign neoplasm	GO:0046822	regulation of nucleocytoplasmic transport	2.498035112097341e-11	5.509416439730686e-7	14	215	108
DOID:0060084	cell type benign neoplasm	GO:0001667	ameboidal-type cell migration	3.634803569241285e-11	8.016559271961654e-7	16	315	108
DOID:0060084	cell type benign neoplasm	GO:1903827	regulation of cellular protein localization	3.973754658659345e-11	8.764115899673186e-7	20	543	108
DOID:0060084	cell type benign neoplasm	GO:0031667	response to nutrient levels	4.392652908080663e-11	9.687995988771902e-7	20	546	108
DOID:0060084	cell type benign neoplasm	GO:0032355	response to estradiol	4.494649097352976e-11	9.91294858421199e-7	12	145	108
DOID:0060084	cell type benign neoplasm	GO:0009314	response to radiation	5.403644198764823e-11	1.1917737280375817e-6	18	431	108
DOID:0060084	cell type benign neoplasm	GO:0044057	regulation of system process	9.848699633607794e-11	2.172130704192199e-6	19	508	108
DOID:0060084	cell type benign neoplasm	GO:1902533	positive regulation of intracellular signal transduction	1.0435385888740711e-10	2.301524357761764e-6	24	860	108
DOID:0060084	cell type benign neoplasm	GO:0051270	regulation of cellular component movement	1.1229051022354497e-10	2.4765672029802843e-6	23	787	108
DOID:0060084	cell type benign neoplasm	GO:0023014	signal transduction by protein phosphorylation	1.5740575509681776e-10	3.4715839286603156e-6	24	879	108
DOID:0060084	cell type benign neoplasm	GO:0009416	response to light stimulus	1.7129875296006958e-10	3.7779939965343345e-6	15	297	108
DOID:0060084	cell type benign neoplasm	GO:0010942	positive regulation of cell death	1.878049937786841e-10	4.142039137788878e-6	20	596	108
DOID:0060084	cell type benign neoplasm	GO:1900180	regulation of protein localization to nucleus	3.047786467647029e-10	6.7218930543955224e-6	13	213	108
DOID:0060084	cell type benign neoplasm	GO:0072358	cardiovascular system development	3.057228914471466e-10	6.742718370866818e-6	24	910	108
DOID:0060084	cell type benign neoplasm	GO:0048732	gland development	3.112123891924057e-10	6.863789243638507e-6	17	421	108
DOID:0060084	cell type benign neoplasm	GO:0042306	regulation of protein import into nucleus	4.016642574100615e-10	8.858705197178907e-6	12	175	108
DOID:0060084	cell type benign neoplasm	GO:0000165	MAPK cascade	4.0457270866767203e-10	8.922851089665507e-6	23	843	108
DOID:0060084	cell type benign neoplasm	GO:0032403	protein complex binding	4.220002125521205e-10	9.307214687837018e-6	24	924	108
DOID:0060084	cell type benign neoplasm	GO:0030278	regulation of ossification	4.580927859265671e-10	1.0103236393610437e-5	12	177	108
DOID:0060084	cell type benign neoplasm	GO:0010564	regulation of cell cycle process	4.889399995988697e-10	1.0783571691153071e-5	19	561	108
DOID:0060084	cell type benign neoplasm	GO:0043068	positive regulation of programmed cell death	4.889399995988697e-10	1.0783571691153071e-5	19	561	108
DOID:0060084	cell type benign neoplasm	GO:0070482	response to oxygen levels	5.062191776872282e-10	1.1164663963891819e-5	15	321	108
DOID:0060084	cell type benign neoplasm	GO:0000104	succinate dehydrogenase activity	1.0586939103163218e-9	2.3349494192026476e-5	4	4	108
DOID:0060084	cell type benign neoplasm	GO:0045257	succinate dehydrogenase complex (ubiquinone)	1.0586939103163218e-9	2.3349494192026476e-5	4	4	108
DOID:0060084	cell type benign neoplasm	GO:0045283	fumarate reductase complex	1.0586939103163218e-9	2.3349494192026476e-5	4	4	108
DOID:0060084	cell type benign neoplasm	GO:0005749	mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)	1.0586939103163218e-9	2.3349494192026476e-5	4	4	108
DOID:0060084	cell type benign neoplasm	GO:0044706	multi-multicellular organism process	1.1347984774090492e-9	2.502798041925658e-5	13	237	108
DOID:0060084	cell type benign neoplasm	GO:0044708	single-organism behavior	1.4235765899428543e-9	3.139698169118965e-5	16	404	108
DOID:0060084	cell type benign neoplasm	GO:0009636	response to toxic substance	2.0676256262674997e-9	4.5601483187329706e-5	13	249	108
DOID:0060084	cell type benign neoplasm	GO:0043549	regulation of kinase activity	2.155777778511947e-9	4.754567890508099e-5	21	761	108
DOID:0060084	cell type benign neoplasm	GO:0071407	cellular response to organic cyclic compound	2.1696503482715457e-9	4.785163843112894e-5	16	416	108
DOID:0060084	cell type benign neoplasm	GO:0050890	cognition	2.279130550952857e-9	5.026622430126526e-5	13	251	108
DOID:0060084	cell type benign neoplasm	GO:0040008	regulation of growth	2.3526958159436617e-9	5.188870622063746e-5	19	617	108
DOID:0060084	cell type benign neoplasm	GO:0030155	regulation of cell adhesion	2.6133447628140516e-9	5.763731874386391e-5	19	621	108
DOID:0060084	cell type benign neoplasm	GO:0007507	heart development	2.814487642943675e-9	6.207352496512275e-5	17	487	108
DOID:0060084	cell type benign neoplasm	GO:0000910	cytokinesis	2.836944568151978e-9	6.256881245059187e-5	11	164	108
DOID:0060084	cell type benign neoplasm	GO:0043065	positive regulation of apoptotic process	2.994320902338643e-9	6.603974750107877e-5	18	556	108
DOID:0060084	cell type benign neoplasm	GO:0001655	urogenital system development	3.514273205773577e-9	7.750729555333624e-5	14	313	108
DOID:0060084	cell type benign neoplasm	GO:2000145	regulation of cell motility	3.787576030589435e-9	8.353498935464998e-5	20	709	108
DOID:0060084	cell type benign neoplasm	GO:0045859	regulation of protein kinase activity	3.787576030589435e-9	8.353498935464998e-5	20	709	108
DOID:0060084	cell type benign neoplasm	GO:0009887	organ morphogenesis	4.004264253509859e-9	8.831404811115995e-5	23	950	108
DOID:2786	cerebellar disease	GO:0035869	ciliary transition zone	7.844969118764311e-11	1.7302079391434688e-6	7	25	108
DOID:2786	cerebellar disease	GO:0060271	cilium morphogenesis	4.0671754852894537e-10	8.97015553280589e-6	13	218	108
DOID:2786	cerebellar disease	GO:0036038	TCTN-B9D complex	4.52322812538597e-9	9.975979630538756e-5	5	12	108
DOID:526	Human immunodeficiency virus infectious disease	GO:0042180	cellular ketone metabolic process	5.133671265866724e-13	1.132231197686906e-8	19	253	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0051050	positive regulation of transport	4.707345624410664e-13	1.0382050774637719e-8	27	920	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0001775	cell activation	4.363176486776865e-13	9.622985741586376e-9	27	854	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0022407	regulation of cell-cell adhesion	4.027889133340068e-13	8.88350948358152e-9	19	376	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0051170	nuclear import	3.921307722976053e-13	8.648444183023685e-9	19	287	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0072594	establishment of protein localization to organelle	3.5083047578154947e-13	7.737566143362073e-9	25	641	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0017038	protein import	2.34035013590983e-13	5.16164222474913e-9	18	315	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0035567	non-canonical Wnt signaling pathway	2.255973186038318e-13	4.9755488618075105e-9	16	154	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0001819	positive regulation of cytokine production	7.949196856316121e-13	1.7531953666605204e-8	19	381	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.7287282716438312e-12	3.81271020311047e-8	12	111	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0051251	positive regulation of lymphocyte activation	2.8989033395987462e-12	6.393531315485035e-8	16	257	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0060548	negative regulation of cell death	4.343525539241e-12	9.579645576796025e-8	27	867	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	5.714317907745681e-12	1.26029281455331e-7	10	67	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0044419	interspecies interaction between organisms	7.259970402628824e-12	1.601186472299787e-7	35	761	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0044403	symbiosis, encompassing mutualism through parasitism	7.259970402628824e-12	1.601186472299787e-7	35	761	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0022409	positive regulation of cell-cell adhesion	9.911182985433697e-12	2.185911407437402e-7	15	239	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0043066	negative regulation of apoptotic process	1.0318523813168667e-11	2.2757504269943496e-7	26	795	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0050870	positive regulation of T cell activation	1.2261969217775004e-11	2.704377310980277e-7	14	202	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0032386	regulation of intracellular transport	1.4264589509593861e-11	3.146055216340926e-7	21	575	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0042098	T cell proliferation	1.590361176084798e-11	3.507541573855022e-7	13	167	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0051222	positive regulation of protein transport	1.5956236332215212e-11	3.519147923070065e-7	19	447	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0009636	response to toxic substance	1.6450951711988182e-11	3.6282574000789936e-7	15	249	109
DOID:526	Human immunodeficiency virus infectious disease	GO:1903829	positive regulation of cellular protein localization	1.9941159834502287e-11	4.3980228014994793e-7	17	351	109
DOID:526	Human immunodeficiency virus infectious disease	GO:1900180	regulation of protein localization to nucleus	2.496891582381977e-11	5.50689438494345e-7	14	213	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0042108	positive regulation of cytokine biosynthetic process	5.562239557832527e-11	1.2267519344799638e-6	9	59	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0097285	cell-type specific apoptotic process	5.834654981384801e-11	1.286833156144418e-6	18	429	109
DOID:526	Human immunodeficiency virus infectious disease	GO:2000377	regulation of reactive oxygen species metabolic process	5.900424593363596e-11	1.301338644066341e-6	12	147	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0050729	positive regulation of inflammatory response	6.234102123414687e-11	1.3749312233191091e-6	11	114	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002440	production of molecular mediator of immune response	6.371692062856482e-11	1.4052766844629971e-6	12	148	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002699	positive regulation of immune effector process	7.417777503349043e-11	1.6359908283636315e-6	12	150	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0050670	regulation of lymphocyte proliferation	7.727840589666357e-11	1.704375242050915e-6	13	189	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0033993	response to lipid	9.441825099543166e-11	2.0823945257042453e-6	24	850	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002521	leukocyte differentiation	1.1474965422308969e-10	2.530803623890243e-6	18	448	109
DOID:526	Human immunodeficiency virus infectious disease	GO:1902533	positive regulation of intracellular signal transduction	1.2666134807659546e-10	2.793516031829313e-6	24	860	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0032388	positive regulation of intracellular transport	1.7747414648994209e-10	3.914192300835673e-6	16	347	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0080135	regulation of cellular response to stress	3.513819235578808e-10	7.74972832406906e-6	21	681	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0070665	positive regulation of leukocyte proliferation	3.928297687139093e-10	8.66386054898527e-6	11	135	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0034605	cellular response to heat	6.027736088043412e-10	1.3294171942179744e-5	10	106	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0035821	modification of morphology or physiology of other organism	6.027736088043412e-10	1.3294171942179744e-5	10	106	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0097190	apoptotic signaling pathway	6.261114959826841e-10	1.3808889043898098e-5	19	564	109
DOID:526	Human immunodeficiency virus infectious disease	GO:1903649	regulation of cytoplasmic transport	6.33612717848564e-10	1.3974328492150079e-5	17	437	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002705	positive regulation of leukocyte mediated immunity	1.292275286779443e-9	2.8501131449920614e-5	9	83	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0071222	cellular response to lipopolysaccharide	1.3996991343745435e-9	3.087036440863056e-5	11	152	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0097529	myeloid leukocyte migration	1.5006458298216785e-9	3.309674377671712e-5	11	153	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0010942	positive regulation of cell death	1.562251994435826e-9	3.445546773728214e-5	19	596	109
DOID:526	Human immunodeficiency virus infectious disease	GO:2001234	negative regulation of apoptotic signaling pathway	1.9563376474351912e-9	4.314702681418314e-5	12	199	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002548	monocyte chemotaxis	2.0686296009486682e-9	4.562362584892288e-5	8	60	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002437	inflammatory response to antigenic stimulus	3.025418582325301e-9	6.672560683318451e-5	7	40	109
DOID:526	Human immunodeficiency virus infectious disease	GO:1900182	positive regulation of protein localization to nucleus	3.0629280223237743e-9	6.755287753235084e-5	10	125	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0002449	lymphocyte mediated immunity	3.4139797655541315e-9	7.529532372929637e-5	12	209	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0050671	positive regulation of lymphocyte proliferation	3.5765539418974868e-9	7.888089718854907e-5	10	127	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0071887	leukocyte apoptotic process	3.964591321903299e-9	8.743906160457726e-5	9	94	109
DOID:526	Human immunodeficiency virus infectious disease	GO:0043068	positive regulation of programmed cell death	4.010514254026987e-9	8.845189187256519e-5	18	561	109
DOID:8649	tongue cancer	GO:0033993	response to lipid	7.416289804496046e-14	1.6356627163816029e-9	27	850	109
DOID:8649	tongue cancer	GO:0044843	cell cycle G1/S phase transition	8.201994639023269e-12	1.808949917636582e-7	15	234	109
DOID:8649	tongue cancer	GO:0000082	G1/S transition of mitotic cell cycle	5.076294939954096e-11	1.1195768490068758e-6	14	224	109
DOID:8649	tongue cancer	GO:0032355	response to estradiol	8.464946521513639e-10	1.866943955319833e-5	11	145	109
DOID:8649	tongue cancer	GO:0009887	organ morphogenesis	9.062702810425094e-10	1.9987791048392545e-5	24	950	109
DOID:8649	tongue cancer	GO:0001666	response to hypoxia	1.6277088565885833e-9	3.5899118832061205e-5	14	292	109
DOID:8649	tongue cancer	GO:0043086	negative regulation of catalytic activity	1.7787314954276212e-9	3.9229923131656186e-5	22	822	109
DOID:8649	tongue cancer	GO:0009636	response to toxic substance	2.319954672813651e-9	5.1166600308905075e-5	13	249	109
DOID:8649	tongue cancer	GO:0040007	growth	3.6443398299113028e-9	8.037591494869378e-5	23	936	109
DOID:8649	tongue cancer	GO:0008285	negative regulation of cell proliferation	4.305160339335146e-9	9.495031128403664e-5	19	634	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0046879	hormone secretion	1.5898393712632242e-13	3.506390733321041e-9	17	297	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0001085	RNA polymerase II transcription factor binding	7.406297797274419e-13	1.6334589791888732e-8	12	104	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0072358	cardiovascular system development	6.419642595290043e-12	1.415852174391219e-7	26	910	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:1901699	cellular response to nitrogen compound	2.4190205394347686e-11	5.335149799723382e-7	20	518	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0001501	skeletal system development	5.100220246134768e-11	1.124853575285023e-6	19	482	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0048871	multicellular organismal homeostasis	5.5497384465752475e-11	1.2239948143921708e-6	16	321	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0009887	organ morphogenesis	1.6677648151386393e-10	3.678255299788269e-6	25	950	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0044320	cellular response to leptin stimulus	2.630567985661969e-10	5.801717692377473e-6	6	16	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0048598	embryonic morphogenesis	5.591275220595548e-10	1.2331557499023482e-5	19	560	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0040007	growth	6.694050869171519e-10	1.4763729191957786e-5	24	936	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0033210	leptin-mediated signaling pathway	7.64574514811045e-10	1.6862690924157597e-5	5	9	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0045927	positive regulation of growth	1.1483755057994927e-9	2.532742178040781e-5	13	235	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0001894	tissue homeostasis	1.74395564656038e-9	3.846294178488918e-5	12	197	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0048568	embryonic organ development	1.885367306719843e-9	4.1581775949706135e-5	16	408	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0007507	heart development	3.2539181349378055e-9	7.17651644660533e-5	17	487	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0048589	developmental growth	3.6879718168236764e-9	8.133821842004618e-5	18	558	109
Orphanet:139024	Overgrowth/obesity syndrome	GO:0071514	genetic imprinting	4.256788810330647e-9	9.388347721184243e-5	6	24	109
Orphanet:166463	Epilepsy syndrome	GO:0030534	adult behavior	2.2870594307278225e-14	5.044109574470212e-10	14	135	109
Orphanet:166463	Epilepsy syndrome	GO:0050804	modulation of synaptic transmission	5.525579993559404e-13	1.2186666675795266e-8	17	285	109
Orphanet:166463	Epilepsy syndrome	GO:0007611	learning or memory	2.76711986657574e-12	6.102882865732795e-8	15	218	109
Orphanet:166463	Epilepsy syndrome	GO:0008076	voltage-gated potassium channel complex	3.851363672424668e-12	8.494182579532605e-8	11	89	109
Orphanet:166463	Epilepsy syndrome	GO:0007417	central nervous system development	8.539169371601929e-12	1.8833138049068054e-7	26	889	109
Orphanet:166463	Epilepsy syndrome	GO:0010243	response to organonitrogen compound	9.166223335910217e-12	2.0216105567349985e-7	25	780	109
Orphanet:166463	Epilepsy syndrome	GO:0007612	learning	1.3460121905950473e-11	2.968629886357377e-7	12	130	109
Orphanet:166463	Epilepsy syndrome	GO:0008344	adult locomotory behavior	3.543232374170202e-11	7.814599001232381e-7	10	80	109
Orphanet:166463	Epilepsy syndrome	GO:0050806	positive regulation of synaptic transmission	9.103684472933082e-11	2.0078176105053913e-6	11	118	109
Orphanet:166463	Epilepsy syndrome	GO:0071705	nitrogen compound transport	1.0550649243157295e-10	2.3269456905783414e-6	23	777	109
Orphanet:166463	Epilepsy syndrome	GO:0050905	neuromuscular process	2.487280381657797e-10	5.4856968817462715e-6	10	97	109
Orphanet:166463	Epilepsy syndrome	GO:0023061	signal release	2.995752534928897e-10	6.607132215785683e-6	17	416	109
Orphanet:166463	Epilepsy syndrome	GO:0006813	potassium ion transport	3.4245528635068467e-10	7.5528513404643505e-6	13	213	109
Orphanet:166463	Epilepsy syndrome	GO:0051952	regulation of amine transport	3.5289882127642613e-10	7.783183503251578e-6	9	72	109
Orphanet:166463	Epilepsy syndrome	GO:0008306	associative learning	4.005775711135584e-10	8.83473833090953e-6	9	73	109
Orphanet:166463	Epilepsy syndrome	GO:0071805	potassium ion transmembrane transport	5.106306488755763e-10	1.1261958960950835e-5	12	177	109
Orphanet:166463	Epilepsy syndrome	GO:0050803	regulation of synapse structure or activity	1.0348277790228622e-9	2.2823126666349225e-5	13	233	109
Orphanet:166463	Epilepsy syndrome	GO:0006820	anion transport	1.2484544509305806e-9	2.7534662915273955e-5	19	588	109
Orphanet:166463	Epilepsy syndrome	GO:0051046	regulation of secretion	1.9370637316384887e-9	4.272194060128687e-5	20	675	109
Orphanet:166463	Epilepsy syndrome	GO:1903530	regulation of secretion by cell	3.3219325068500893e-9	7.326522143857872e-5	19	624	109
Orphanet:166463	Epilepsy syndrome	GO:0051402	neuron apoptotic process	3.802766102012356e-9	8.387000637988251e-5	12	211	109
Orphanet:166463	Epilepsy syndrome	GO:0060322	head development	4.369224870792721e-9	9.636325452533345e-5	20	708	109
Orphanet:166463	Epilepsy syndrome	GO:0007270	neuron-neuron synaptic transmission	4.490967042691807e-9	9.90482781265678e-5	10	130	109
MESH:D002292	Carcinoma, Renal Cell	GO:0036293	response to decreased oxygen levels	2.8179947264561633e-10	6.215087369199068e-6	15	302	110
MESH:D002292	Carcinoma, Renal Cell	GO:0001666	response to hypoxia	1.8390057254791259e-9	4.055927127544212e-5	14	292	110
DOID:2320	obstructive lung disease	GO:0030155	regulation of cell adhesion	2.660094367001875e-13	5.8668381264226355e-9	27	621	112
DOID:2320	obstructive lung disease	GO:0001816	cytokine production	2.580158309228864e-13	5.690539151004259e-9	24	613	112
DOID:2320	obstructive lung disease	GO:0070489	T cell aggregation	1.0483391932325503e-11	2.3121120906743897e-7	19	424	112
DOID:2320	obstructive lung disease	GO:0042110	T cell activation	1.0483391932325503e-11	2.3121120906743897e-7	19	424	112
DOID:2320	obstructive lung disease	GO:0032940	secretion by cell	1.831288232168049e-9	4.038906196046632e-5	24	956	112
Orphanet:156601	Rare genetic hepatic disease	GO:0019318	hexose metabolic process	1.361399881716352e-11	3.002567439125414e-7	15	237	112
Orphanet:156601	Rare genetic hepatic disease	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	3.400157932986758e-11	7.499048321202295e-7	27	997	112
Orphanet:156601	Rare genetic hepatic disease	GO:0010817	regulation of hormone levels	3.224231326370841e-9	7.11104219031089e-5	17	473	112
DOID:184	bone cancer	GO:0033993	response to lipid	1.6101564526138645e-12	3.551200056239878e-8	27	850	112
DOID:184	bone cancer	GO:0048863	stem cell differentiation	6.342359970545886e-11	1.398807491503895e-6	15	266	112
DOID:184	bone cancer	GO:0001101	response to acid chemical	6.449918377171571e-11	1.42252949808519e-6	16	315	112
DOID:184	bone cancer	GO:0050673	epithelial cell proliferation	1.5970713640456324e-10	3.5223408934026423e-6	16	335	112
DOID:184	bone cancer	GO:1901698	response to nitrogen compound	2.8169788723886313e-10	6.212846903053126e-6	24	870	112
DOID:184	bone cancer	GO:0045597	positive regulation of cell differentiation	4.546290011120391e-10	1.0026842619526022e-5	23	815	112
DOID:184	bone cancer	GO:0001667	ameboidal-type cell migration	6.58327725666652e-10	1.451941798957801e-5	15	315	112
DOID:184	bone cancer	GO:0008285	negative regulation of cell proliferation	1.0842077236006276e-9	2.391220134401184e-5	20	634	112
DOID:184	bone cancer	GO:0009790	embryo development	1.1058045590317533e-9	2.438851954944532e-5	24	932	112
DOID:184	bone cancer	GO:0050678	regulation of epithelial cell proliferation	1.1824268231208634e-9	2.6078423583930643e-5	14	277	112
DOID:184	bone cancer	GO:0006979	response to oxidative stress	1.2771785851128925e-9	2.8168173694664844e-5	16	386	112
DOID:184	bone cancer	GO:0030335	positive regulation of cell migration	1.3254627395653529e-9	2.9233080721113858e-5	16	387	112
DOID:184	bone cancer	GO:0050804	modulation of synaptic transmission	1.7091371651289933e-9	3.769502017691995e-5	14	285	112
DOID:184	bone cancer	GO:0001944	vasculature development	2.008853527968313e-9	4.430526455934114e-5	19	588	112
DOID:184	bone cancer	GO:0050890	cognition	3.5849017088196433e-9	7.906500718801723e-5	13	251	112
Orphanet:156610	Rare genetic respiratory disease	GO:0072358	cardiovascular system development	2.6842972289387035e-12	5.9202175384243105e-8	30	910	112
Orphanet:156610	Rare genetic respiratory disease	GO:0032838	cell projection cytoplasm	1.8030021919912542e-13	3.976521334436711e-9	18	110	112
Orphanet:156610	Rare genetic respiratory disease	GO:0007017	microtubule-based process	7.549516567451064e-14	1.6650458789513323e-9	28	591	112
Orphanet:156610	Rare genetic respiratory disease	GO:0097014	ciliary cytoplasm	4.884981308350689e-14	1.0773826275567444e-9	18	90	112
Orphanet:156610	Rare genetic respiratory disease	GO:0005930	axoneme	4.884981308350689e-14	1.0773826275567444e-9	18	90	112
Orphanet:156610	Rare genetic respiratory disease	GO:0007507	heart development	7.668976564900731e-12	1.6913927813888563e-7	21	487	112
Orphanet:156610	Rare genetic respiratory disease	GO:0060541	respiratory system development	1.78118630955737e-11	3.9284064057287793e-7	14	202	112
Orphanet:156610	Rare genetic respiratory disease	GO:0048729	tissue morphogenesis	2.4761637185122254e-11	5.461179081178713e-7	22	635	112
Orphanet:156610	Rare genetic respiratory disease	GO:0002009	morphogenesis of an epithelium	2.655331510226233e-11	5.856333645803957e-7	20	506	112
Orphanet:156610	Rare genetic respiratory disease	GO:0072001	renal system development	1.0574996434087325e-10	2.3323154635379595e-6	15	276	112
Orphanet:156610	Rare genetic respiratory disease	GO:0048598	embryonic morphogenesis	1.2737788601668854e-10	2.8093192760980656e-6	20	560	112
Orphanet:156610	Rare genetic respiratory disease	GO:0060322	head development	1.9150891983343854e-10	4.223729226926487e-6	22	708	112
Orphanet:156610	Rare genetic respiratory disease	GO:0001822	kidney development	5.747106124331935e-10	1.2675242557214084e-5	14	262	112
Orphanet:156610	Rare genetic respiratory disease	GO:0030324	lung development	6.162944599097386e-10	1.3592374313309286e-5	12	175	112
Orphanet:156610	Rare genetic respiratory disease	GO:0048565	digestive tract development	6.682783215694599e-10	1.4738878382214438e-5	11	138	112
Orphanet:156610	Rare genetic respiratory disease	GO:0050801	ion homeostasis	2.657820186158233e-9	5.861822420571983e-5	20	668	112
Orphanet:156610	Rare genetic respiratory disease	GO:0098771	inorganic ion homeostasis	3.573001672307896e-9	7.880255188275065e-5	19	609	112
Orphanet:156619	Rare genetic urogenital disease	GO:0030900	forebrain development	1.8984813721090177e-13	4.1871006661864385e-9	19	357	112
Orphanet:156619	Rare genetic urogenital disease	GO:0048732	gland development	3.959499395023158e-12	8.732675915723576e-8	21	421	112
Orphanet:156619	Rare genetic urogenital disease	GO:0046660	female sex differentiation	1.4073964216265722e-11	3.104012807897405e-7	12	127	112
Orphanet:156619	Rare genetic urogenital disease	GO:0009725	response to hormone	4.606992565214796e-11	1.0160722102581232e-6	25	865	112
Orphanet:156619	Rare genetic urogenital disease	GO:0001655	urogenital system development	5.879507991579658e-11	1.2967254875428935e-6	16	313	112
Orphanet:156619	Rare genetic urogenital disease	GO:0021537	telencephalon development	8.364853254505533e-11	1.8448683852811953e-6	14	226	112
Orphanet:156619	Rare genetic urogenital disease	GO:0048511	rhythmic process	1.2307410646172912e-10	2.7143994180134356e-6	16	329	112
Orphanet:156619	Rare genetic urogenital disease	GO:0000904	cell morphogenesis involved in differentiation	2.651241448603514e-10	5.84731301489505e-6	22	720	112
Orphanet:156619	Rare genetic urogenital disease	GO:0035270	endocrine system development	3.2288383078338256e-10	7.1212028879275024e-6	11	129	112
Orphanet:156619	Rare genetic urogenital disease	GO:0050810	regulation of steroid biosynthetic process	4.0229175546357965e-10	8.872544666749249e-6	8	48	112
Orphanet:156619	Rare genetic urogenital disease	GO:0035265	organ growth	4.13998835213647e-10	9.130744310636985e-6	11	132	112
Orphanet:156619	Rare genetic urogenital disease	GO:0006704	glucocorticoid biosynthetic process	4.772632289373746e-10	1.0526040514213797e-5	6	17	112
Orphanet:156619	Rare genetic urogenital disease	GO:0021536	diencephalon development	8.330955925117678e-10	1.837392329284704e-5	9	77	112
Orphanet:156619	Rare genetic urogenital disease	GO:0008585	female gonad development	9.497141961745115e-10	2.094594659662885e-5	10	108	112
Orphanet:156619	Rare genetic urogenital disease	GO:0035295	tube development	1.311244002266676e-9	2.891948646999154e-5	19	573	112
Orphanet:156619	Rare genetic urogenital disease	GO:0014070	response to organic cyclic compound	1.6896245513819963e-9	3.726466948072993e-5	23	873	112
Orphanet:156619	Rare genetic urogenital disease	GO:0030539	male genitalia development	2.0522564758707063e-9	4.5262516575328426e-5	6	21	112
Orphanet:156619	Rare genetic urogenital disease	GO:0030325	adrenal gland development	3.780855739599076e-9	8.338677333685762e-5	6	23	112
DOID:1324	lung cancer	GO:0045859	regulation of protein kinase activity	8.923750627332083e-12	1.968133200858091e-7	24	709	112
DOID:1324	lung cancer	GO:0042327	positive regulation of phosphorylation	1.168433128029278e-10	2.576979263868573e-6	25	910	112
DOID:1324	lung cancer	GO:0051093	negative regulation of developmental process	2.403691690133769e-10	5.301342022590028e-6	23	788	112
DOID:1324	lung cancer	GO:0001934	positive regulation of protein phosphorylation	2.8169788723886313e-10	6.212846903053126e-6	24	870	112
DOID:1324	lung cancer	GO:0080135	regulation of cellular response to stress	5.9266236362987e-10	1.3071168429856783e-5	21	681	112
DOID:1324	lung cancer	GO:0097285	cell-type specific apoptotic process	7.39253658288419e-10	1.6304239433551082e-5	17	429	112
DOID:1324	lung cancer	GO:0042493	response to drug	8.515036453715652e-10	1.877991289866987e-5	17	433	112
DOID:1324	lung cancer	GO:0008285	negative regulation of cell proliferation	1.0842077236006276e-9	2.391220134401184e-5	20	634	112
DOID:1324	lung cancer	GO:0010035	response to inorganic substance	1.0989922305526534e-9	2.423827364483877e-5	18	502	112
DOID:1324	lung cancer	GO:2000145	regulation of cell motility	1.2225185308523123e-9	2.6962646197947748e-5	21	709	112
DOID:1324	lung cancer	GO:2000377	regulation of reactive oxygen species metabolic process	1.3132105403101946e-9	2.896285846654134e-5	11	147	112
DOID:1324	lung cancer	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.5379133522230859e-9	3.391867898328016e-5	20	647	112
DOID:1324	lung cancer	GO:0014070	response to organic cyclic compound	1.6896245513819963e-9	3.726466948072993e-5	23	873	112
DOID:1324	lung cancer	GO:0043410	positive regulation of MAPK cascade	2.4204797055560334e-9	5.338367990603832e-5	17	464	112
DOID:1324	lung cancer	GO:0045596	negative regulation of cell differentiation	2.5801275560510817e-9	5.6904713248706607e-5	19	597	112
DOID:1324	lung cancer	GO:0009636	response to toxic substance	3.253924463209046e-9	7.17653040360755e-5	13	249	112
Orphanet:98039	Digestive tract malformation	GO:0060562	epithelial tube morphogenesis	2.135180920959101e-12	4.7091415211752974e-8	18	301	113
Orphanet:98039	Digestive tract malformation	GO:0003002	regionalization	1.2827516826519059e-12	2.8291088360887784e-8	20	327	113
Orphanet:98039	Digestive tract malformation	GO:0048736	appendage development	4.476419235288631e-13	9.872742623429076e-9	17	168	113
Orphanet:98039	Digestive tract malformation	GO:0060173	limb development	4.476419235288631e-13	9.872742623429076e-9	17	168	113
Orphanet:98039	Digestive tract malformation	GO:0009799	specification of symmetry	4.247713292215849e-13	9.368331665982055e-9	14	122	113
Orphanet:98039	Digestive tract malformation	GO:0009855	determination of bilateral symmetry	3.028688411177427e-13	6.679772290851815e-9	14	121	113
Orphanet:98039	Digestive tract malformation	GO:0043009	chordate embryonic development	1.0436096431476471e-12	2.3016810679621358e-8	23	552	113
Orphanet:98039	Digestive tract malformation	GO:0048565	digestive tract development	2.272959598315083e-12	5.0130123940839155e-8	13	138	113
Orphanet:98039	Digestive tract malformation	GO:0003007	heart morphogenesis	3.5315084190301604e-12	7.788741818171019e-8	15	216	113
Orphanet:98039	Digestive tract malformation	GO:0007417	central nervous system development	4.197309166897867e-12	9.257165367593245e-8	28	889	113
Orphanet:98039	Digestive tract malformation	GO:0048589	developmental growth	4.3220982348657344e-12	9.532387656996377e-8	22	558	113
Orphanet:98039	Digestive tract malformation	GO:0060322	head development	5.2050586063501214e-12	1.1479756756305193e-7	25	708	113
Orphanet:98039	Digestive tract malformation	GO:0007420	brain development	1.3228418360711203e-11	2.917527669454856e-7	23	669	113
Orphanet:98039	Digestive tract malformation	GO:0001654	eye development	1.28645649688508e-10	2.837279803880044e-6	16	327	113
Orphanet:98039	Digestive tract malformation	GO:0002065	columnar/cuboidal epithelial cell differentiation	3.2698543872555774e-10	7.211663851092176e-6	11	128	113
Orphanet:98039	Digestive tract malformation	GO:0030900	forebrain development	4.702906952758212e-10	1.0372261284308237e-5	16	357	113
Orphanet:98039	Digestive tract malformation	GO:0048732	gland development	6.408553687720087e-10	1.4134065158266651e-5	17	421	113
Orphanet:98039	Digestive tract malformation	GO:0032838	cell projection cytoplasm	1.2436630614232058e-9	2.7428988819688804e-5	10	110	113
Orphanet:98039	Digestive tract malformation	GO:0060021	palate development	2.2116253273196662e-9	4.877739659403524e-5	9	85	113
Orphanet:98039	Digestive tract malformation	GO:0007224	smoothened signaling pathway	2.2838267943470214e-9	5.036979994932356e-5	10	117	113
Orphanet:98039	Digestive tract malformation	GO:0043583	ear development	2.501655438358341e-9	5.5174010692993214e-5	12	196	113
Orphanet:98039	Digestive tract malformation	GO:0042733	embryonic digit morphogenesis	2.7587182538368893e-9	6.084353108837259e-5	8	60	113
Orphanet:98039	Digestive tract malformation	GO:0097014	ciliary cytoplasm	3.699585082728163e-9	8.159434899956963e-5	9	90	113
Orphanet:98039	Digestive tract malformation	GO:0005930	axoneme	3.699585082728163e-9	8.159434899956963e-5	9	90	113
Orphanet:98039	Digestive tract malformation	GO:0021953	central nervous system neuron differentiation	3.7899768878801865e-9	8.358794026219751e-5	11	161	113
DOID:303	substance-related disorder	GO:0043279	response to alkaloid	5.3512749786932545e-14	1.1802236965507973e-9	17	140	113
DOID:303	substance-related disorder	GO:0030534	adult behavior	9.50350909079134e-14	2.09599892997403e-9	14	135	113
DOID:303	substance-related disorder	GO:1900542	regulation of purine nucleotide metabolic process	1.2960743589474077e-12	2.8584919986585078e-8	15	203	113
DOID:303	substance-related disorder	GO:0046058	cAMP metabolic process	3.8540282076837684e-12	8.500059212046551e-8	13	144	113
DOID:303	substance-related disorder	GO:0050805	negative regulation of synaptic transmission	6.236677840831817e-12	1.3754992977954572e-7	10	65	113
DOID:303	substance-related disorder	GO:0043271	negative regulation of ion transport	8.647860205712732e-12	1.907285568369943e-7	12	121	113
DOID:303	substance-related disorder	GO:0030799	regulation of cyclic nucleotide metabolic process	8.70203908931444e-12	1.9192347211482996e-7	13	154	113
DOID:303	substance-related disorder	GO:0006816	calcium ion transport	7.347222830134115e-11	1.620429995186079e-6	17	366	113
DOID:303	substance-related disorder	GO:0042493	response to drug	1.2201328836169978e-10	2.6910030748172886e-6	18	433	113
DOID:303	substance-related disorder	GO:0007613	memory	4.3652603753940866e-10	9.627581757931658e-6	10	99	113
DOID:303	substance-related disorder	GO:0030424	axon	4.950263532421673e-10	1.0917806220755999e-5	17	414	113
DOID:303	substance-related disorder	GO:0034702	ion channel complex	1.1571096303342188e-9	2.5520052897021195e-5	14	274	113
DOID:303	substance-related disorder	GO:0030818	negative regulation of cAMP biosynthetic process	1.4409593518394104e-9	3.1780358504818196e-5	7	35	113
DOID:303	substance-related disorder	GO:0030425	dendrite	1.8115894340198224e-9	3.9954604967307183e-5	17	451	113
DOID:303	substance-related disorder	GO:0032409	regulation of transporter activity	2.0993353722076336e-9	4.630084163403936e-5	12	193	113
DOID:303	substance-related disorder	GO:2001257	regulation of cation channel activity	2.2116253273196662e-9	4.877739659403524e-5	9	85	113
DOID:303	substance-related disorder	GO:0007194	negative regulation of adenylate cyclase activity	2.9635001119743265e-9	6.535999496959377e-5	6	22	113
DOID:303	substance-related disorder	GO:0014046	dopamine secretion	2.9635001119743265e-9	6.535999496959377e-5	6	22	113
DOID:303	substance-related disorder	GO:0014059	regulation of dopamine secretion	2.9635001119743265e-9	6.535999496959377e-5	6	22	113
DOID:303	substance-related disorder	GO:0032410	negative regulation of transporter activity	3.1593243576821806e-9	6.967889870868049e-5	8	61	113
MESH:D018307	Neoplasms, Squamous Cell	GO:0050673	epithelial cell proliferation	4.312106227644108e-13	9.51035028506908e-9	18	335	114
MESH:D018307	Neoplasms, Squamous Cell	GO:1901987	regulation of cell cycle phase transition	2.2426505097428162e-13	4.946165699237781e-9	18	312	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0032355	response to estradiol	4.700462241657988e-12	1.0366869473976692e-7	13	145	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0008285	negative regulation of cell proliferation	4.895528427084628e-12	1.0797087945935147e-7	23	634	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0045786	negative regulation of cell cycle	7.463030193832765e-12	1.6459713092498163e-7	20	449	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0050678	regulation of epithelial cell proliferation	1.2367662449719319e-11	2.727687953285596e-7	16	277	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0045787	positive regulation of cell cycle	5.912936806851121e-11	1.3040982127510148e-6	16	308	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0010942	positive regulation of cell death	7.316192096595842e-11	1.6135861669042129e-6	21	596	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0007093	mitotic cell cycle checkpoint	7.847089644741345e-11	1.7306756211477037e-6	12	144	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0043068	positive regulation of programmed cell death	1.8129242551623292e-10	3.998404444760517e-6	20	561	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0007568	aging	2.7025148785497777e-10	5.960396564641535e-6	15	290	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0040007	growth	3.27163851565615e-10	7.215598746279639e-6	25	936	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0051093	negative regulation of developmental process	3.4576164154032085e-10	7.625773004171776e-6	23	788	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0009636	response to toxic substance	3.7343161896075117e-10	8.236034356179367e-6	14	249	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0009887	organ morphogenesis	4.490888771968571e-10	9.904655186576683e-6	25	950	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0048732	gland development	7.372418231454958e-10	1.625986840947391e-5	17	421	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0010165	response to X-ray	7.791106648724622e-10	1.7183285713762153e-5	7	32	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0031667	response to nutrient levels	8.086514791116883e-10	1.7834808371808286e-5	19	546	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0048565	digestive tract development	8.092587711061583e-10	1.784820219674632e-5	11	138	114
MESH:D018307	Neoplasms, Squamous Cell	GO:1901991	negative regulation of mitotic cell cycle phase transition	8.742787604987257e-10	1.9282218062799394e-5	11	139	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0043065	positive regulation of apoptotic process	1.0918150827876616e-9	2.4079981650881876e-5	19	556	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0070482	response to oxygen levels	1.0995534482916014e-9	2.425065130207127e-5	15	321	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0051338	regulation of transferase activity	1.4845933371532283e-9	3.274270605091445e-5	24	928	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0090068	positive regulation of cell cycle process	2.4691860778247587e-9	5.4457898946425054e-5	13	239	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0007050	cell cycle arrest	2.8728256440402333e-9	6.336016957930735e-5	13	242	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0001666	response to hypoxia	2.9581421756574855e-9	6.524182568412584e-5	14	292	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0045597	positive regulation of cell differentiation	3.677942173041515e-9	8.111701462643062e-5	22	815	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0008284	positive regulation of cell proliferation	3.677942173041515e-9	8.111701462643062e-5	22	815	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0043086	negative regulation of catalytic activity	4.300747091789958e-9	9.485297710942753e-5	22	822	114
MESH:D018307	Neoplasms, Squamous Cell	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	4.417661680911067e-9	9.743152837249358e-5	9	91	114
MESH:D018307	Neoplasms, Squamous Cell	GO:0007569	cell aging	4.417661680911067e-9	9.743152837249358e-5	9	91	114
Orphanet:400008	Rare genetic female infertility	GO:0035270	endocrine system development	1.2723155862204294e-13	2.806092025409157e-9	14	129	114
Orphanet:400008	Rare genetic female infertility	GO:0001085	RNA polymerase II transcription factor binding	1.3626877404249171e-12	3.005407811507155e-8	12	104	114
Orphanet:400008	Rare genetic female infertility	GO:0010817	regulation of hormone levels	7.405187574249794e-12	1.633214119500792e-7	21	473	114
Orphanet:400008	Rare genetic female infertility	GO:0042445	hormone metabolic process	7.941980406656057e-12	1.7516037786879934e-7	14	187	114
Orphanet:400008	Rare genetic female infertility	GO:0035239	tube morphogenesis	2.2659651932599445e-11	4.997586233734808e-7	17	338	114
Orphanet:400008	Rare genetic female infertility	GO:0035265	organ growth	2.7977287153646557e-11	6.170390681736748e-7	12	132	114
Orphanet:400008	Rare genetic female infertility	GO:0044703	multi-organism reproductive process	4.8970605348586105e-11	1.0800467009630665e-6	26	926	114
Orphanet:400008	Rare genetic female infertility	GO:0048511	rhythmic process	1.6156154192259464e-10	3.563239807102825e-6	16	329	114
Orphanet:400008	Rare genetic female infertility	GO:0048609	multicellular organismal reproductive process	2.0738410988485612e-10	4.573856543510502e-6	23	767	114
Orphanet:400008	Rare genetic female infertility	GO:0022602	ovulation cycle process	2.835092161035391e-10	6.252795761163554e-6	10	94	114
Orphanet:400008	Rare genetic female infertility	GO:0008209	androgen metabolic process	4.759772576079513e-10	1.0497678416543366e-5	7	30	114
Orphanet:400008	Rare genetic female infertility	GO:0072358	cardiovascular system development	1.000613147894569e-9	2.206852297681472e-5	24	910	114
Orphanet:400008	Rare genetic female infertility	GO:0007423	sensory organ development	1.1458928250718259e-9	2.527266625695912e-5	18	494	114
Orphanet:400008	Rare genetic female infertility	GO:0001763	morphogenesis of a branching structure	2.3252922920491415e-9	5.1284321501143815e-5	12	193	114
Orphanet:400008	Rare genetic female infertility	GO:0030325	adrenal gland development	4.20814638690814e-9	9.281066856325904e-5	6	23	114
Orphanet:400008	Rare genetic female infertility	GO:0007276	gamete generation	4.3567797147758824e-9	9.608877660938209e-5	19	605	114
Orphanet:400008	Rare genetic female infertility	GO:0060562	epithelial tube morphogenesis	4.362078254160906e-9	9.620563589551878e-5	14	301	114
DOID:1037	lymphoblastic leukemia	GO:0034110	regulation of homotypic cell-cell adhesion	1.922462189440921e-12	4.2399903588119514e-8	21	304	114
DOID:1037	lymphoblastic leukemia	GO:0030098	lymphocyte differentiation	1.794786541609028e-12	3.9584017175187114e-8	28	299	114
DOID:1037	lymphoblastic leukemia	GO:1903037	regulation of leukocyte cell-cell adhesion	1.099120794378905e-12	2.424110912002675e-8	21	294	114
DOID:1037	lymphoblastic leukemia	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	6.820100040272337e-13	1.504173063882064e-8	10	52	114
DOID:1037	lymphoblastic leukemia	GO:0042493	response to drug	5.639155808978558e-12	1.243715813670221e-7	20	433	114
DOID:1037	lymphoblastic leukemia	GO:0097285	cell-type specific apoptotic process	1.6552537118741384e-11	3.650662061538412e-7	19	429	114
DOID:1037	lymphoblastic leukemia	GO:0002377	immunoglobulin production	6.297662391574477e-11	1.3889494404617508e-6	10	81	114
DOID:1037	lymphoblastic leukemia	GO:0002706	regulation of lymphocyte mediated immunity	8.444855925660022e-11	1.8625129744043178e-6	11	112	114
DOID:1037	lymphoblastic leukemia	GO:0042100	B cell proliferation	1.0267620087489604e-10	2.264523610295832e-6	10	85	114
DOID:1037	lymphoblastic leukemia	GO:0033044	regulation of chromosome organization	1.0529976890438775e-10	2.3223864031862718e-6	15	271	114
DOID:1037	lymphoblastic leukemia	GO:0016447	somatic recombination of immunoglobulin gene segments	1.4963430494674412e-10	3.3001845956004416e-6	8	42	114
DOID:1037	lymphoblastic leukemia	GO:0051052	regulation of DNA metabolic process	2.0992696470045757e-10	4.629939206468592e-6	16	335	114
DOID:1037	lymphoblastic leukemia	GO:0051726	regulation of cell cycle	2.869557924611854e-10	6.328810002731444e-6	25	930	114
DOID:1037	lymphoblastic leukemia	GO:0002429	immune response-activating cell surface receptor signaling pathway	2.977975643858599e-10	6.56792528253014e-6	15	292	114
DOID:1037	lymphoblastic leukemia	GO:0060548	negative regulation of cell death	3.866869047186583e-10	8.528379683570009e-6	24	867	114
DOID:1037	lymphoblastic leukemia	GO:0010942	positive regulation of cell death	5.147915427272665e-10	1.1353727474849862e-5	20	596	114
DOID:1037	lymphoblastic leukemia	GO:0008284	positive regulation of cell proliferation	6.554530251889901e-10	1.4456016470543176e-5	23	815	114
DOID:1037	lymphoblastic leukemia	GO:0042089	cytokine biosynthetic process	8.559489783621643e-10	1.8877954717777534e-5	10	105	114
DOID:1037	lymphoblastic leukemia	GO:0046631	alpha-beta T cell activation	9.399169220714043e-10	2.0729867716284822e-5	10	106	114
DOID:1037	lymphoblastic leukemia	GO:0046632	alpha-beta T cell differentiation	1.2330610976718503e-9	2.719516250915266e-5	9	79	114
DOID:1037	lymphoblastic leukemia	GO:0030099	myeloid cell differentiation	1.4163183958970649e-9	3.1236902221509766e-5	15	327	114
DOID:1037	lymphoblastic leukemia	GO:0010638	positive regulation of organelle organization	1.7874520752414469e-9	3.942225551945011e-5	19	573	114
DOID:1037	lymphoblastic leukemia	GO:0045786	negative regulation of cell cycle	1.9495878245123777e-9	4.299815946962049e-5	17	449	114
DOID:1037	lymphoblastic leukemia	GO:0002262	myeloid cell homeostasis	2.2892636675209133e-9	5.048971018717374e-5	10	116	114
DOID:1037	lymphoblastic leukemia	GO:0043066	negative regulation of apoptotic process	2.335659554653091e-9	5.1512971477873926e-5	22	795	114
DOID:1037	lymphoblastic leukemia	GO:0008134	transcription factor binding	2.4171424861663127e-9	5.3310077532398026e-5	18	518	114
DOID:1037	lymphoblastic leukemia	GO:0014070	response to organic cyclic compound	2.4293955735998907e-9	5.358031937574559e-5	23	873	114
DOID:1037	lymphoblastic leukemia	GO:0007568	aging	2.707641999499799e-9	5.971704429896807e-5	14	290	114
DOID:1037	lymphoblastic leukemia	GO:0007050	cell cycle arrest	2.8728256440402333e-9	6.336016957930735e-5	13	242	114
DOID:1037	lymphoblastic leukemia	GO:1903708	positive regulation of hemopoiesis	3.414506788423921e-9	7.530694721868958e-5	11	158	114
DOID:1037	lymphoblastic leukemia	GO:0018108	peptidyl-tyrosine phosphorylation	4.170567113881418e-9	9.198185769665468e-5	15	354	114
DOID:1037	lymphoblastic leukemia	GO:0007569	cell aging	4.417661680911067e-9	9.743152837249358e-5	9	91	114
DOID:0050589	inflammatory bowel disease	GO:0034504	protein localization to nucleus	2.645217378471898e-12	5.834026928219771e-8	22	344	115
DOID:0050589	inflammatory bowel disease	GO:1903533	regulation of protein targeting	2.5299762285158067e-12	5.579862571991612e-8	20	303	115
DOID:0050589	inflammatory bowel disease	GO:0042327	positive regulation of phosphorylation	2.136069099378801e-12	4.711100398679946e-8	32	910	115
DOID:0050589	inflammatory bowel disease	GO:0034110	regulation of homotypic cell-cell adhesion	2.077005234468743e-12	4.5808350446208124e-8	22	304	115
DOID:0050589	inflammatory bowel disease	GO:0018108	peptidyl-tyrosine phosphorylation	1.6218137943724287e-12	3.5769103234883914e-8	21	354	115
DOID:0050589	inflammatory bowel disease	GO:0017038	protein import	1.3347101202043632e-12	2.943703170110723e-8	22	315	115
DOID:0050589	inflammatory bowel disease	GO:0009991	response to extracellular stimulus	1.2687628725416289e-12	2.7982565153905625e-8	24	573	115
DOID:0050589	inflammatory bowel disease	GO:1903037	regulation of leukocyte cell-cell adhesion	1.219468970248272e-12	2.6895388138825638e-8	23	294	115
DOID:0050589	inflammatory bowel disease	GO:0002696	positive regulation of leukocyte activation	5.946354519892338e-13	1.3114684893622552e-8	20	280	115
DOID:0050589	inflammatory bowel disease	GO:1904589	regulation of protein import	5.757616605706062e-13	1.269842342388472e-8	19	179	115
DOID:0050589	inflammatory bowel disease	GO:0071219	cellular response to molecule of bacterial origin	4.707345624410664e-13	1.0382050774637719e-8	17	158	115
DOID:0050589	inflammatory bowel disease	GO:0032103	positive regulation of response to external stimulus	4.374278717023117e-13	9.647471710394484e-9	19	285	115
DOID:0050589	inflammatory bowel disease	GO:0071706	tumor necrosis factor superfamily cytokine production	4.221067939624845e-13	9.309565340842596e-9	15	106	115
DOID:0050589	inflammatory bowel disease	GO:1904591	positive regulation of protein import	4.1255887595070817e-13	9.098986009092869e-9	15	101	115
DOID:0050589	inflammatory bowel disease	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	3.397282455352979e-13	7.492706455280995e-9	15	103	115
DOID:0050589	inflammatory bowel disease	GO:0070663	regulation of leukocyte proliferation	2.9887203822909214e-13	6.591622803142627e-9	17	200	115
DOID:0050589	inflammatory bowel disease	GO:0032944	regulation of mononuclear cell proliferation	2.915445662665661e-13	6.4300154090091155e-9	17	191	115
DOID:0050589	inflammatory bowel disease	GO:0050727	regulation of inflammatory response	3.352873534367973e-14	7.394762580048564e-10	23	289	115
DOID:0050589	inflammatory bowel disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.4876988529977098e-14	3.281119820286449e-10	12	83	115
DOID:0050589	inflammatory bowel disease	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	2.73003841755326e-13	6.021099729913715e-9	10	46	115
DOID:0050589	inflammatory bowel disease	GO:0032612	interleukin-1 production	3.352873534367973e-13	7.394762580048564e-9	11	66	115
DOID:0050589	inflammatory bowel disease	GO:0010942	positive regulation of cell death	3.5427216715788745e-13	7.813472646667208e-9	24	596	115
DOID:0050589	inflammatory bowel disease	GO:0045621	positive regulation of lymphocyte differentiation	1.940336780137386e-12	4.279412768593005e-8	11	79	115
DOID:0050589	inflammatory bowel disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.2171153801764376e-12	4.889847970979133e-8	9	40	115
DOID:0050589	inflammatory bowel disease	GO:0050708	regulation of protein secretion	2.311706381874501e-12	5.098468425224212e-8	19	380	115
DOID:0050589	inflammatory bowel disease	GO:0071407	cellular response to organic cyclic compound	2.5867086250741522e-12	5.704985872601043e-8	21	416	115
DOID:0050589	inflammatory bowel disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.8332891588433995e-12	6.248819239829118e-8	24	647	115
DOID:0050589	inflammatory bowel disease	GO:0090087	regulation of peptide transport	3.3103519925248293e-12	7.300981319513511e-8	16	250	115
DOID:0050589	inflammatory bowel disease	GO:0043068	positive regulation of programmed cell death	3.4077185517844555e-12	7.515723265960617e-8	23	561	115
DOID:0050589	inflammatory bowel disease	GO:0031667	response to nutrient levels	3.7442271505483404e-12	8.257892980534365e-8	24	546	115
DOID:0050589	inflammatory bowel disease	GO:1901699	cellular response to nitrogen compound	4.6918025020659115e-12	1.0347770418306368e-7	25	518	115
DOID:0050589	inflammatory bowel disease	GO:0032729	positive regulation of interferon-gamma production	7.253531109085998e-12	1.5997662861089168e-7	10	65	115
DOID:0050589	inflammatory bowel disease	GO:0001101	response to acid chemical	7.94164733974867e-12	1.751530320781569e-7	17	315	115
DOID:0050589	inflammatory bowel disease	GO:0045582	positive regulation of T cell differentiation	9.769851594398915e-12	2.1547407691446807e-7	10	67	115
DOID:0050589	inflammatory bowel disease	GO:0042990	regulation of transcription factor import into nucleus	1.0264677996474347e-11	2.2638747321224173e-7	11	92	115
DOID:0050589	inflammatory bowel disease	GO:0097305	response to alcohol	1.0989209542344724e-11	2.423670164564129e-7	18	369	115
DOID:0050589	inflammatory bowel disease	GO:0032755	positive regulation of interleukin-6 production	1.1468936911285255e-11	2.529474035783963e-7	10	68	115
DOID:0050589	inflammatory bowel disease	GO:1901652	response to peptide	1.5572432232602296e-11	3.4344999289004363e-7	19	423	115
DOID:0050589	inflammatory bowel disease	GO:0042993	positive regulation of transcription factor import into nucleus	1.559075091250861e-11	3.438540113753774e-7	9	49	115
DOID:0050589	inflammatory bowel disease	GO:0060548	negative regulation of cell death	1.947475514185726e-11	4.2951572465366183e-7	26	867	115
DOID:0050589	inflammatory bowel disease	GO:0032735	positive regulation of interleukin-12 production	1.96707095057036e-11	4.3383749814829287e-7	8	33	115
DOID:0050589	inflammatory bowel disease	GO:0043066	negative regulation of apoptotic process	2.2158830326191037e-11	4.887130028441433e-7	25	795	115
DOID:0050589	inflammatory bowel disease	GO:0031349	positive regulation of defense response	4.088851479622235e-11	9.01796193830684e-7	18	398	115
DOID:0050589	inflammatory bowel disease	GO:0032611	interleukin-1 beta production	6.512290706695012e-11	1.4362857153615849e-6	9	57	115
DOID:0050589	inflammatory bowel disease	GO:0043408	regulation of MAPK cascade	6.547762332331786e-11	1.4441089823957753e-6	22	651	115
DOID:0050589	inflammatory bowel disease	GO:0002526	acute inflammatory response	6.854206091588821e-11	1.5116951534999146e-6	12	141	115
DOID:0050589	inflammatory bowel disease	GO:0042108	positive regulation of cytokine biosynthetic process	9.019274216370832e-11	1.989200928420587e-6	9	59	115
DOID:0050589	inflammatory bowel disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.1152589962648563e-10	2.4597037162621405e-6	14	225	115
DOID:0050589	inflammatory bowel disease	GO:0050729	positive regulation of inflammatory response	1.1248824094423071e-10	2.4809281540250083e-6	11	114	115
DOID:0050589	inflammatory bowel disease	GO:0070482	response to oxygen levels	1.2911727242936877e-10	2.847681443429728e-6	16	321	115
DOID:0050589	inflammatory bowel disease	GO:0071900	regulation of protein serine/threonine kinase activity	1.519484538192728e-10	3.3512231489840616e-6	18	431	115
DOID:0050589	inflammatory bowel disease	GO:0050678	regulation of epithelial cell proliferation	1.6149637183104915e-10	3.561802480733789e-6	15	277	115
DOID:0050589	inflammatory bowel disease	GO:0042346	positive regulation of NF-kappaB import into nucleus	1.6690238080485642e-10	3.6810320086511084e-6	7	26	115
DOID:0050589	inflammatory bowel disease	GO:0030099	myeloid cell differentiation	1.6847567785305273e-10	3.715731075049078e-6	16	327	115
DOID:0050589	inflammatory bowel disease	GO:0070372	regulation of ERK1 and ERK2 cascade	1.7610179980920293e-10	3.883925194791971e-6	14	233	115
DOID:0050589	inflammatory bowel disease	GO:0070555	response to interleukin-1	1.7925938511353934e-10	3.95356573867911e-6	11	119	115
DOID:0050589	inflammatory bowel disease	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	2.289640699260076e-10	5.0498025622180975e-6	6	15	115
DOID:0050589	inflammatory bowel disease	GO:0051224	negative regulation of protein transport	2.5709889772684846e-10	5.670316189365643e-6	13	197	115
DOID:0050589	inflammatory bowel disease	GO:0007584	response to nutrient	2.5709889772684846e-10	5.670316189365643e-6	13	197	115
DOID:0050589	inflammatory bowel disease	GO:0045860	positive regulation of protein kinase activity	3.012623484011101e-10	6.644341093986483e-6	18	450	115
DOID:0050589	inflammatory bowel disease	GO:0001666	response to hypoxia	3.37333383448879e-10	7.439887771965026e-6	15	292	115
DOID:0050589	inflammatory bowel disease	GO:0032870	cellular response to hormone stimulus	4.0643677312601767e-10	8.96396303129432e-6	19	519	115
DOID:0050589	inflammatory bowel disease	GO:0071346	cellular response to interferon-gamma	5.985354434301371e-10	1.3200699204851674e-5	11	133	115
DOID:0050589	inflammatory bowel disease	GO:0002253	activation of immune response	7.138031277165169e-10	1.574292798178778e-5	18	475	115
DOID:0050589	inflammatory bowel disease	GO:1903531	negative regulation of secretion by cell	7.861196138492232e-10	1.733786808344462e-5	12	174	115
DOID:0050589	inflammatory bowel disease	GO:0050709	negative regulation of protein secretion	9.330736183699173e-10	2.0578938653148526e-5	10	105	115
DOID:0050589	inflammatory bowel disease	GO:0043279	response to alkaloid	1.0373444325750825e-9	2.2878631460443444e-5	11	140	115
DOID:0050589	inflammatory bowel disease	GO:0040008	regulation of growth	1.1037890601528488e-9	2.434406772167108e-5	20	617	115
DOID:0050589	inflammatory bowel disease	GO:0001906	cell killing	1.1248664222307525e-9	2.4808928942299247e-5	10	107	115
DOID:0050589	inflammatory bowel disease	GO:0042508	tyrosine phosphorylation of Stat1 protein	1.2165163321142813e-9	2.6830267704780475e-5	6	19	115
DOID:0050589	inflammatory bowel disease	GO:0098797	plasma membrane protein complex	1.5530281505249377e-9	3.42520358598275e-5	18	499	115
DOID:0050589	inflammatory bowel disease	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.6169181549230416e-9	3.566112990682768e-5	10	111	115
DOID:0050589	inflammatory bowel disease	GO:0032732	positive regulation of interleukin-1 production	1.6304622096896537e-9	3.595984403470531e-5	7	35	115
DOID:0050589	inflammatory bowel disease	GO:0052547	regulation of peptidase activity	1.635530266774765e-9	3.6071620033717444e-5	16	382	115
DOID:0050589	inflammatory bowel disease	GO:0042522	regulation of tyrosine phosphorylation of Stat5 protein	1.7291647003148114e-9	3.8136727465443165e-5	6	20	115
DOID:0050589	inflammatory bowel disease	GO:0002706	regulation of lymphocyte mediated immunity	1.766483181953049e-9	3.89597865779745e-5	10	112	115
DOID:0050589	inflammatory bowel disease	GO:0042517	positive regulation of tyrosine phosphorylation of Stat3 protein	2.0137540523990083e-9	4.441334562566013e-5	7	36	115
DOID:0050589	inflammatory bowel disease	GO:0010952	positive regulation of peptidase activity	2.014637123792795e-9	4.44328217652501e-5	11	149	115
DOID:0050589	inflammatory bowel disease	GO:0031341	regulation of cell killing	2.40136355245113e-9	5.2962073149309674e-5	8	58	115
DOID:0050589	inflammatory bowel disease	GO:0032147	activation of protein kinase activity	2.781221253300714e-9	6.133983474154725e-5	14	288	115
DOID:0050589	inflammatory bowel disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.8927482631502244e-9	6.37995629437782e-5	12	195	115
DOID:0050589	inflammatory bowel disease	GO:0014074	response to purine-containing compound	3.0610310952638997e-9	6.751104080604531e-5	11	155	115
DOID:0050589	inflammatory bowel disease	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	3.6427981742193083e-9	8.034191373240684e-5	5	11	115
DOID:0050589	inflammatory bowel disease	GO:0043410	positive regulation of MAPK cascade	3.665107217720731e-9	8.083393968683072e-5	17	464	115
DOID:0050589	inflammatory bowel disease	GO:0006935	chemotaxis	3.993631869647629e-9	8.807955088507846e-5	18	530	115
DOID:2952	inner ear disease	GO:0042490	mechanoreceptor differentiation	1.1168843627729075e-13	2.4632884620956474e-9	13	55	115
DOID:3683	lung benign neoplasm	GO:0043549	regulation of kinase activity	1.153754869420709e-11	2.5446063645073735e-7	25	761	115
DOID:3683	lung benign neoplasm	GO:0045859	regulation of protein kinase activity	1.2718381903198406e-11	2.8050391287504084e-7	24	709	115
DOID:3683	lung benign neoplasm	GO:0051093	negative regulation of developmental process	7.535827517557436e-11	1.6620267589972926e-6	24	788	115
DOID:3683	lung benign neoplasm	GO:0080135	regulation of cellular response to stress	1.5581502754713483e-10	3.4365004325520587e-6	22	681	115
DOID:3683	lung benign neoplasm	GO:0042327	positive regulation of phosphorylation	2.163286216827487e-10	4.771127751213022e-6	25	910	115
DOID:3683	lung benign neoplasm	GO:0001934	positive regulation of protein phosphorylation	4.976079548413281e-10	1.0974743444025492e-5	24	870	115
DOID:3683	lung benign neoplasm	GO:0045596	negative regulation of cell differentiation	6.228317861456389e-10	1.3736555043442067e-5	20	597	115
DOID:3683	lung benign neoplasm	GO:0097285	cell-type specific apoptotic process	1.1256175991292139e-9	2.4825496148794812e-5	17	429	115
DOID:3683	lung benign neoplasm	GO:0042493	response to drug	1.2956902217808874e-9	2.8576447841377473e-5	17	433	115
DOID:3683	lung benign neoplasm	GO:0010035	response to inorganic substance	1.7060433066262704e-9	3.762678512764239e-5	18	502	115
DOID:3683	lung benign neoplasm	GO:2000377	regulation of reactive oxygen species metabolic process	1.745237954153822e-9	3.8491223078862546e-5	11	147	115
DOID:3683	lung benign neoplasm	GO:0008285	negative regulation of cell proliferation	1.7579099287345912e-9	3.877070347824141e-5	20	634	115
DOID:3683	lung benign neoplasm	GO:2000145	regulation of cell motility	2.0202464146024113e-9	4.455653467405618e-5	21	709	115
DOID:3683	lung benign neoplasm	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.4889771355063317e-9	5.4894390723592146e-5	20	647	115
DOID:3683	lung benign neoplasm	GO:0014070	response to organic cyclic compound	2.903846385571285e-9	6.404433203377469e-5	23	873	115
DOID:3683	lung benign neoplasm	GO:0043410	positive regulation of MAPK cascade	3.665107217720731e-9	8.083393968683072e-5	17	464	115
DOID:3683	lung benign neoplasm	GO:0051241	negative regulation of multicellular organismal process	3.931158731873552e-9	8.670170583147119e-5	24	966	115
DOID:3683	lung benign neoplasm	GO:0009636	response to toxic substance	4.516091500761377e-9	9.960239804929216e-5	13	249	115
MESH:D001145	Arrhythmias, Cardiac	GO:0060537	muscle tissue development	2.2364332608049153e-12	4.932453556705241e-8	22	336	115
MESH:D001145	Arrhythmias, Cardiac	GO:0009914	hormone transport	1.9837465004002297e-12	4.3751529066327066e-8	22	307	115
MESH:D001145	Arrhythmias, Cardiac	GO:0015833	peptide transport	1.454392162258955e-12	3.2076619138621254e-8	18	307	115
MESH:D001145	Arrhythmias, Cardiac	GO:0006874	cellular calcium ion homeostasis	1.3036238755148588e-12	2.875142457448021e-8	19	352	115
MESH:D001145	Arrhythmias, Cardiac	GO:0014706	striated muscle tissue development	6.696865284538944e-13	1.4769936385050642e-8	22	323	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003018	vascular process in circulatory system	4.292122213200855e-13	9.466275541214486e-9	21	159	115
MESH:D001145	Arrhythmias, Cardiac	GO:0034764	positive regulation of transmembrane transport	3.397282455352979e-13	7.492706455280995e-9	19	103	115
MESH:D001145	Arrhythmias, Cardiac	GO:0006942	regulation of striated muscle contraction	2.382538610845586e-13	5.25468890621994e-9	38	97	115
MESH:D001145	Arrhythmias, Cardiac	GO:0070588	calcium ion transmembrane transport	2.2248869413488137e-13	4.906988149144809e-9	16	188	115
MESH:D001145	Arrhythmias, Cardiac	GO:0031674	I band	1.694200335577989e-13	3.7365588401172545e-9	14	122	115
MESH:D001145	Arrhythmias, Cardiac	GO:0098801	regulation of renal system process	9.259260025373806e-14	2.042129798596193e-9	11	38	115
MESH:D001145	Arrhythmias, Cardiac	GO:1901385	regulation of voltage-gated calcium channel activity	1.7541523789077473e-14	3.868783071681037e-10	9	26	115
MESH:D001145	Arrhythmias, Cardiac	GO:0042310	vasoconstriction	1.2878587085651816e-14	2.840372381740508e-10	12	80	115
MESH:D001145	Arrhythmias, Cardiac	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	1.6986412276764895e-14	3.7463532276404976e-10	8	13	115
MESH:D001145	Arrhythmias, Cardiac	GO:0002790	peptide secretion	6.605826996519681e-14	1.4569151440824157e-9	17	247	115
MESH:D001145	Arrhythmias, Cardiac	GO:1901021	positive regulation of calcium ion transmembrane transporter activity	9.348077867343818e-14	2.061718573642679e-9	9	30	115
MESH:D001145	Arrhythmias, Cardiac	GO:0042311	vasodilation	1.0558220964185239e-13	2.3286156336510544e-9	12	68	115
MESH:D001145	Arrhythmias, Cardiac	GO:0043267	negative regulation of potassium ion transport	1.5343282200319663e-13	3.3839608892805018e-9	9	31	115
MESH:D001145	Arrhythmias, Cardiac	GO:2001258	negative regulation of cation channel activity	2.0605739337042905e-13	4.544595810784813e-9	9	32	115
MESH:D001145	Arrhythmias, Cardiac	GO:0086069	bundle of His cell to Purkinje myocyte communication	2.1871393585115584e-13	4.823735855197242e-9	7	12	115
MESH:D001145	Arrhythmias, Cardiac	GO:0045823	positive regulation of heart contraction	2.248201624865942e-13	4.958408683641835e-9	9	33	115
MESH:D001145	Arrhythmias, Cardiac	GO:0042312	regulation of vasodilation	2.73003841755326e-13	6.021099729913715e-9	10	46	115
MESH:D001145	Arrhythmias, Cardiac	GO:0005267	potassium channel activity	3.084199562408685e-13	6.8022021348923545e-9	13	121	115
MESH:D001145	Arrhythmias, Cardiac	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	3.320677066653843e-13	7.323753270505051e-9	6	7	115
MESH:D001145	Arrhythmias, Cardiac	GO:0019229	regulation of vasoconstriction	3.4416913763379853e-13	7.590650330513427e-9	11	65	115
MESH:D001145	Arrhythmias, Cardiac	GO:0055001	muscle cell development	4.638511796883904e-13	1.023023776802745e-8	14	140	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003205	cardiac chamber development	4.92828000631107e-13	1.0869321553919065e-8	14	142	115
MESH:D001145	Arrhythmias, Cardiac	GO:0051480	cytosolic calcium ion homeostasis	5.010436510133331e-13	1.1050517723099063e-8	19	255	115
MESH:D001145	Arrhythmias, Cardiac	GO:0010460	positive regulation of heart rate	5.203615316418109e-13	1.1476573580360139e-8	8	22	115
MESH:D001145	Arrhythmias, Cardiac	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	5.203615316418109e-13	1.1476573580360139e-8	8	22	115
MESH:D001145	Arrhythmias, Cardiac	GO:0055013	cardiac muscle cell development	7.808198532188726e-13	1.7220981862742235e-8	10	53	115
MESH:D001145	Arrhythmias, Cardiac	GO:0001664	G-protein coupled receptor binding	8.101297410689767e-13	1.7867411439276282e-8	17	255	115
MESH:D001145	Arrhythmias, Cardiac	GO:0007204	positive regulation of cytosolic calcium ion concentration	9.190426197847046e-13	2.026948497935166e-8	18	234	115
MESH:D001145	Arrhythmias, Cardiac	GO:0014070	response to organic cyclic compound	1.3614664950978295e-12	3.002714354938263e-8	28	873	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003206	cardiac chamber morphogenesis	1.4969137041020986e-12	3.3014431743971784e-8	12	104	115
MESH:D001145	Arrhythmias, Cardiac	GO:0098911	regulation of ventricular cardiac muscle cell action potential	3.97104571447926e-12	8.758141323284008e-8	6	9	115
MESH:D001145	Arrhythmias, Cardiac	GO:0005184	neuropeptide hormone activity	4.563793787326631e-12	1.0065447197948885e-7	8	28	115
MESH:D001145	Arrhythmias, Cardiac	GO:1901698	response to nitrogen compound	4.99755792304768e-12	1.1022113999281657e-7	28	870	115
MESH:D001145	Arrhythmias, Cardiac	GO:0051241	negative regulation of multicellular organismal process	6.5998317921867056e-12	1.455592901766778e-7	28	966	115
MESH:D001145	Arrhythmias, Cardiac	GO:0015459	potassium channel regulator activity	6.944778085937742e-12	1.531670806853569e-7	9	45	115
MESH:D001145	Arrhythmias, Cardiac	GO:0010243	response to organonitrogen compound	7.632672271995489e-12	1.683385869588605e-7	27	780	115
MESH:D001145	Arrhythmias, Cardiac	GO:0008284	positive regulation of cell proliferation	7.78366260334451e-12	1.7166867871676317e-7	28	815	115
MESH:D001145	Arrhythmias, Cardiac	GO:0050878	regulation of body fluid levels	8.310241383924222e-12	1.832823737224487e-7	21	504	115
MESH:D001145	Arrhythmias, Cardiac	GO:1901841	regulation of high voltage-gated calcium channel activity	9.865441796819141e-12	2.1758231882884616e-7	6	10	115
MESH:D001145	Arrhythmias, Cardiac	GO:0032846	positive regulation of homeostatic process	1.2798984094786192e-11	2.8228159421050947e-7	14	192	115
MESH:D001145	Arrhythmias, Cardiac	GO:0009725	response to hormone	1.8904322551804853e-11	4.1693483388005603e-7	26	865	115
MESH:D001145	Arrhythmias, Cardiac	GO:0002791	regulation of peptide secretion	2.9566460391095006e-11	6.520882839256004e-7	14	204	115
MESH:D001145	Arrhythmias, Cardiac	GO:0002028	regulation of sodium ion transport	3.5894065497643624e-11	7.916436145505301e-7	10	76	115
MESH:D001145	Arrhythmias, Cardiac	GO:0009612	response to mechanical stimulus	4.453104551771503e-11	9.82132208893205e-7	14	210	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003231	cardiac ventricle development	4.53939108524537e-11	1.0011627038508664e-6	11	105	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003300	cardiac muscle hypertrophy	6.512290706695012e-11	1.4362857153615849e-6	9	57	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003073	regulation of systemic arterial blood pressure	8.796485762019302e-11	1.940064934813357e-6	10	83	115
MESH:D001145	Arrhythmias, Cardiac	GO:0051341	regulation of oxidoreductase activity	1.1195788740536727e-10	2.4692312067253752e-6	10	85	115
MESH:D001145	Arrhythmias, Cardiac	GO:0050886	endocrine process	1.1195788740536727e-10	2.4692312067253752e-6	10	85	115
MESH:D001145	Arrhythmias, Cardiac	GO:0035815	positive regulation of renal sodium excretion	1.3807366361362483e-10	3.0452146509984956e-6	6	14	115
MESH:D001145	Arrhythmias, Cardiac	GO:0060419	heart growth	1.9264234651927836e-10	4.248726952482684e-6	9	64	115
MESH:D001145	Arrhythmias, Cardiac	GO:0045121	membrane raft	2.07258543660771e-10	4.571087180438305e-6	15	282	115
MESH:D001145	Arrhythmias, Cardiac	GO:0048545	response to steroid hormone	2.604942928030596e-10	5.745201627771479e-6	18	446	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003229	ventricular cardiac muscle tissue development	2.8868474277743417e-10	6.3669420019563105e-6	8	45	115
MESH:D001145	Arrhythmias, Cardiac	GO:0090276	regulation of peptide hormone secretion	2.912241559016593e-10	6.422948758411096e-6	13	199	115
MESH:D001145	Arrhythmias, Cardiac	GO:0071855	neuropeptide receptor binding	2.974960278123717e-10	6.561274893401858e-6	7	28	115
MESH:D001145	Arrhythmias, Cardiac	GO:1902305	regulation of sodium ion transmembrane transport	4.1673564599165047e-10	9.191104672345851e-6	8	47	115
MESH:D001145	Arrhythmias, Cardiac	GO:0045909	positive regulation of vasodilation	6.506472027822952e-10	1.435002405736352e-5	7	31	115
MESH:D001145	Arrhythmias, Cardiac	GO:0003230	cardiac atrium development	6.506472027822952e-10	1.435002405736352e-5	7	31	115
MESH:D001145	Arrhythmias, Cardiac	GO:0017080	sodium channel regulator activity	6.506472027822952e-10	1.435002405736352e-5	7	31	115
MESH:D001145	Arrhythmias, Cardiac	GO:0042493	response to drug	1.2956902217808874e-9	2.8576447841377473e-5	17	433	115
MESH:D001145	Arrhythmias, Cardiac	GO:0055008	cardiac muscle tissue morphogenesis	1.3304759516330478e-9	2.934364711326687e-5	8	54	115
MESH:D001145	Arrhythmias, Cardiac	GO:0001568	blood vessel development	1.8565532444725363e-9	4.094628180684179e-5	19	569	115
MESH:D001145	Arrhythmias, Cardiac	GO:0030817	regulation of cAMP biosynthetic process	1.9279369212199526e-9	4.2520648797506055e-5	10	113	115
MESH:D001145	Arrhythmias, Cardiac	GO:0055017	cardiac muscle tissue growth	2.0806025791131333e-9	4.5887689882340155e-5	8	57	115
MESH:D001145	Arrhythmias, Cardiac	GO:0032768	regulation of monooxygenase activity	2.0806025791131333e-9	4.5887689882340155e-5	8	57	115
MESH:D001145	Arrhythmias, Cardiac	GO:0033002	muscle cell proliferation	2.3208249766426547e-9	5.118579485985375e-5	11	151	115
MESH:D001145	Arrhythmias, Cardiac	GO:0036477	somatodendritic compartment	2.6229022287438397e-9	5.7848108654945385e-5	20	649	115
MESH:D001145	Arrhythmias, Cardiac	GO:0009611	response to wounding	3.0340945311735368e-9	6.691695488503235e-5	23	875	115
MESH:D001145	Arrhythmias, Cardiac	GO:0001666	response to hypoxia	3.3210599825750364e-9	7.324597791569243e-5	14	292	115
MESH:D001145	Arrhythmias, Cardiac	GO:0071417	cellular response to organonitrogen compound	3.436232520748206e-9	7.578610824510168e-5	17	462	115
MESH:D001145	Arrhythmias, Cardiac	GO:0030073	insulin secretion	3.641625778705304e-9	8.031605654934548e-5	12	199	115
MESH:D001145	Arrhythmias, Cardiac	GO:0055010	ventricular cardiac muscle tissue morphogenesis	3.6545424464407006e-9	8.060093365624965e-5	7	39	115
MESH:D001145	Arrhythmias, Cardiac	GO:0002793	positive regulation of peptide secretion	3.911222234975753e-9	8.626200639239023e-5	9	89	115
MESH:D001145	Arrhythmias, Cardiac	GO:0006112	energy reserve metabolic process	3.911222234975753e-9	8.626200639239023e-5	9	89	115
MESH:D001145	Arrhythmias, Cardiac	GO:0019900	kinase binding	4.189598334924938e-9	9.24015912767695e-5	19	598	115
MESH:D001145	Arrhythmias, Cardiac	GO:0019901	protein kinase binding	4.235641171135285e-9	9.34170660293887e-5	18	532	115
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0046128	purine ribonucleoside metabolic process	2.4227286843370166e-12	5.34332811330529e-8	34	342	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0009117	nucleotide metabolic process	7.94475596421762e-13	1.752215927908196e-8	38	641	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0042775	mitochondrial ATP synthesis coupled electron transport	2.915445662665661e-13	6.4300154090091155e-9	29	88	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0016651	oxidoreductase activity, acting on NAD(P)H	2.3381296898605797e-13	5.1567450309875085e-9	23	98	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0017004	cytochrome complex assembly	5.329070518200751e-15	1.1753265027891757e-10	9	26	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0043038	amino acid activation	7.438494264988549e-15	1.6405599101432244e-10	13	51	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0043039	tRNA aminoacylation	7.438494264988549e-15	1.6405599101432244e-10	13	51	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0006418	tRNA aminoacylation for protein translation	4.9960036108132044e-14	1.1018685963648522e-9	13	48	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0032543	mitochondrial translation	1.7896795156957523e-13	3.947138171866982e-9	16	116	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:1902600	hydrogen ion transmembrane transport	7.554679104515571e-11	1.6661844765009093e-6	11	109	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	1.282090655863044e-9	2.8276509415059436e-5	6	19	116
Orphanet:2443	Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies	GO:0051536	iron-sulfur cluster binding	3.8925836998160435e-9	8.585093349944284e-5	8	61	116
DOID:0080005	bone remodeling disease	GO:0030278	regulation of ossification	5.366818101038007e-13	1.1836517321839324e-8	17	177	116
DOID:0080005	bone remodeling disease	GO:0034103	regulation of tissue remodeling	4.159006472548299e-12	9.172688775205273e-8	10	61	116
DOID:0080005	bone remodeling disease	GO:0001501	skeletal system development	8.816058993943443e-12	1.9443818111142264e-7	21	482	116
DOID:0080005	bone remodeling disease	GO:0001649	osteoblast differentiation	4.984654911055486e-10	1.0993656406332875e-5	13	206	116
DOID:0080005	bone remodeling disease	GO:0001934	positive regulation of protein phosphorylation	5.988176621229968e-10	1.3206923538122695e-5	24	870	116
DOID:0080005	bone remodeling disease	GO:0071345	cellular response to cytokine stimulus	1.0456044918782936e-9	2.3060807068375766e-5	21	677	116
DOID:0080005	bone remodeling disease	GO:0072502	cellular trivalent inorganic anion homeostasis	1.0483282020246065e-9	2.3120878495652697e-5	5	9	116
DOID:0080005	bone remodeling disease	GO:0030643	cellular phosphate ion homeostasis	1.0483282020246065e-9	2.3120878495652697e-5	5	9	116
DOID:0080005	bone remodeling disease	GO:0048871	multicellular organismal homeostasis	1.4085695942966936e-9	3.106600240221358e-5	15	321	116
DOID:0080005	bone remodeling disease	GO:0070848	response to growth factor	1.4424684779967833e-9	3.181364228221906e-5	20	621	116
DOID:0080005	bone remodeling disease	GO:0030155	regulation of cell adhesion	1.4424684779967833e-9	3.181364228221906e-5	20	621	116
DOID:0080005	bone remodeling disease	GO:0032101	regulation of response to external stimulus	1.810165906057648e-9	3.992320905810143e-5	24	920	116
DOID:0080005	bone remodeling disease	GO:1902533	positive regulation of intracellular signal transduction	2.6131371511084467e-9	5.763273986769679e-5	23	860	116
DOID:0080005	bone remodeling disease	GO:0016051	carbohydrate biosynthetic process	3.5894255345780834e-9	7.916478016511963e-5	12	197	116
DOID:0080005	bone remodeling disease	GO:0042368	vitamin D biosynthetic process	3.805858961314357e-9	8.393821939178814e-5	5	11	116
DOID:0080005	bone remodeling disease	GO:1903708	positive regulation of hemopoiesis	4.111380791371744e-9	9.067650335370381e-5	11	158	116
DOID:0080005	bone remodeling disease	GO:0071363	cellular response to growth factor stimulus	4.360213190501838e-9	9.616450191651804e-5	19	594	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0060562	epithelial tube morphogenesis	2.8623770020885786e-12	6.31297247810636e-8	20	301	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0072358	cardiovascular system development	1.9024781749976682e-12	4.195915614957357e-8	34	910	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001654	eye development	1.5922818619173995e-12	3.5117776464588246e-8	22	327	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048562	embryonic organ morphogenesis	5.606626274357041e-13	1.2365414248094453e-8	23	280	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048736	appendage development	4.4986236957811343e-13	9.921714561045292e-9	18	168	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0060173	limb development	4.4986236957811343e-13	9.921714561045292e-9	18	168	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0043583	ear development	4.1655567883935873e-13	9.187135496802057e-9	17	196	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048839	inner ear development	3.1796787425264483e-13	7.012781466642082e-9	17	170	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0009855	determination of bilateral symmetry	1.3367085216486885e-13	2.9481106444961824e-9	14	121	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0035107	appendage morphogenesis	2.2382096176443156e-13	4.936371311714538e-9	15	146	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0035108	limb morphogenesis	2.2382096176443156e-13	4.936371311714538e-9	15	146	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0090596	sensory organ morphogenesis	4.4142467459096224e-13	9.735621198103672e-9	17	239	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0043009	chordate embryonic development	1.492916901213448e-12	3.2926282256262596e-8	24	552	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0007417	central nervous system development	4.22173407343962e-12	9.311034498971082e-8	28	889	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0003007	heart morphogenesis	5.3547166700695925e-12	1.1809827615838486e-7	15	216	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0007420	brain development	6.072364833187294e-12	1.3392600639594576e-7	24	669	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001501	skeletal system development	6.886269332539996e-12	1.518766701291696e-7	26	482	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0007224	smoothened signaling pathway	8.360423464637279e-12	1.8438913951257518e-7	12	117	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0042472	inner ear morphogenesis	1.1319167825263321e-11	2.4964424638618254e-7	11	92	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0035113	embryonic appendage morphogenesis	1.7977508370847772e-11	3.964939471190476e-7	12	125	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0030326	embryonic limb morphogenesis	1.7977508370847772e-11	3.964939471190476e-7	12	125	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0043010	camera-type eye development	2.1737833755253178e-11	4.794279234721088e-7	16	283	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0030900	forebrain development	7.603195850691691e-11	1.6768848448700524e-6	17	357	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048732	gland development	1.2167400420537433e-10	2.683520162749531e-6	18	421	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0060021	palate development	1.2219947276292942e-10	2.6951093717864083e-6	10	85	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0061371	determination of heart left/right asymmetry	1.333736454611767e-10	2.941555750646252e-6	9	61	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0072091	regulation of stem cell proliferation	1.7340617830541305e-10	3.824473262525885e-6	10	88	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0003143	embryonic heart tube morphogenesis	1.8006796054237384e-10	3.971398869762055e-6	9	63	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048589	developmental growth	2.2769675034339798e-10	5.0218518288236424e-6	20	558	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0043473	pigmentation	2.433072632257449e-10	5.366141690443804e-6	10	91	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048666	neuron development	3.8772751675963946e-10	8.551330382133848e-6	25	926	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0060541	respiratory system development	3.9106262672561343e-10	8.624886232433404e-6	13	202	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0048705	skeletal system morphogenesis	4.4180403779847666e-10	9.743988053645403e-6	13	204	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0061564	axon development	1.8930065293076836e-9	4.175025900388096e-5	17	440	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001568	blood vessel development	2.1581814113602604e-9	4.7598691027550544e-5	19	569	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0021915	neural tube development	2.546211685938715e-9	5.615669873337836e-5	11	151	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001947	heart looping	2.573120161386555e-9	5.675016515938047e-5	8	58	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001763	morphogenesis of a branching structure	2.8440813037988733e-9	6.272621315528415e-5	12	193	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0042733	embryonic digit morphogenesis	3.399387105140761e-9	7.497348260387948e-5	8	60	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:0001894	tissue homeostasis	3.5894255345780834e-9	7.916478016511963e-5	12	197	116
Orphanet:102284	Multiple congenital anomalies/dysmorphic syndrome - variable intellectual disability	GO:2000648	positive regulation of stem cell proliferation	3.8925836998160435e-9	8.585093349944284e-5	8	61	116
DOID:235	colonic benign neoplasm	GO:0010038	response to metal ion	2.0459189897792385e-12	4.5122743319581105e-8	19	335	116
DOID:235	colonic benign neoplasm	GO:0042327	positive regulation of phosphorylation	1.8989254613188677e-12	4.188080104938763e-8	31	910	116
DOID:235	colonic benign neoplasm	GO:0072358	cardiovascular system development	1.8764989562214396e-12	4.138618447946385e-8	30	910	116
DOID:235	colonic benign neoplasm	GO:0009991	response to extracellular stimulus	1.1464162952279366e-12	2.5284211391252143e-8	29	573	116
DOID:235	colonic benign neoplasm	GO:0035295	tube development	1.1357581541915351e-12	2.5049146090694308e-8	25	573	116
DOID:235	colonic benign neoplasm	GO:0001944	vasculature development	9.71889235756862e-13	2.1435017094617592e-8	25	588	116
DOID:235	colonic benign neoplasm	GO:0097305	response to alcohol	3.779199175824033e-13	8.335023782279904e-9	21	369	116
DOID:235	colonic benign neoplasm	GO:0007584	response to nutrient	3.084199562408685e-13	6.8022021348923545e-9	17	197	116
DOID:235	colonic benign neoplasm	GO:2000377	regulation of reactive oxygen species metabolic process	3.4439118223872356e-13	7.595547524275048e-9	14	147	116
DOID:235	colonic benign neoplasm	GO:0001568	blood vessel development	3.914646384828302e-13	8.63375260173882e-9	24	569	116
DOID:235	colonic benign neoplasm	GO:0014070	response to organic cyclic compound	4.127809205556332e-13	9.10388320285449e-9	41	873	116
DOID:235	colonic benign neoplasm	GO:0070482	response to oxygen levels	1.245115122117113e-12	2.746101401829293e-8	18	321	116
DOID:235	colonic benign neoplasm	GO:0008285	negative regulation of cell proliferation	1.3002932064409833e-12	2.8677966668055888e-8	24	634	116
DOID:235	colonic benign neoplasm	GO:0035239	tube morphogenesis	1.3832268663804825e-12	3.050706853802154e-8	18	338	116
DOID:235	colonic benign neoplasm	GO:0033273	response to vitamin	1.7067458557562531e-12	3.764227984870416e-8	12	104	116
DOID:235	colonic benign neoplasm	GO:0071496	cellular response to external stimulus	1.8446355554146976e-12	4.0683437174671155e-8	17	270	116
DOID:235	colonic benign neoplasm	GO:0033993	response to lipid	1.858291298617587e-12	4.098461459101088e-8	34	850	116
DOID:235	colonic benign neoplasm	GO:0048729	tissue morphogenesis	2.235100993175365e-12	4.929515240448268e-8	24	635	116
DOID:235	colonic benign neoplasm	GO:0060562	epithelial tube morphogenesis	2.3320234632251413e-12	5.143277748143049e-8	17	301	116
DOID:235	colonic benign neoplasm	GO:0007568	aging	2.470579296698361e-12	5.448862638868235e-8	17	290	116
DOID:235	colonic benign neoplasm	GO:0048545	response to steroid hormone	2.90789614609821e-12	6.413364950219602e-8	24	446	116
DOID:235	colonic benign neoplasm	GO:0001934	positive regulation of protein phosphorylation	4.281242027559529e-12	9.44227929178254e-8	31	870	116
DOID:235	colonic benign neoplasm	GO:0042493	response to drug	4.337641357210487e-12	9.566668013327728e-8	33	433	116
DOID:235	colonic benign neoplasm	GO:1901698	response to nitrogen compound	4.6844750301033855e-12	1.0331609678893017e-7	28	870	116
DOID:235	colonic benign neoplasm	GO:0031960	response to corticosteroid	5.2339244049903755e-12	1.1543420275206273e-7	14	179	116
DOID:235	colonic benign neoplasm	GO:0048732	gland development	5.672240455112387e-12	1.251012632375037e-7	20	421	116
DOID:235	colonic benign neoplasm	GO:0010212	response to ionizing radiation	5.9375837579978e-12	1.3095340978264147e-7	13	145	116
DOID:235	colonic benign neoplasm	GO:0060548	negative regulation of cell death	6.7343908227712745e-12	1.4852698959622046e-7	30	867	116
DOID:235	colonic benign neoplasm	GO:0043069	negative regulation of programmed cell death	7.020828363124565e-12	1.5484436954871228e-7	30	806	116
DOID:235	colonic benign neoplasm	GO:0010243	response to organonitrogen compound	7.644107569149128e-12	1.6859079243758401e-7	28	780	116
DOID:235	colonic benign neoplasm	GO:0009607	response to biotic stimulus	7.90634224756559e-12	1.7437437827005908e-7	28	934	116
DOID:235	colonic benign neoplasm	GO:0051726	regulation of cell cycle	8.068212764555938e-12	1.779444325222812e-7	28	930	116
DOID:235	colonic benign neoplasm	GO:1902533	positive regulation of intracellular signal transduction	8.776979143476638e-12	1.9357627500937724e-7	32	860	116
DOID:235	colonic benign neoplasm	GO:0051707	response to other organism	8.89754936395093e-12	1.9623545122193775e-7	27	898	116
DOID:235	colonic benign neoplasm	GO:0043066	negative regulation of apoptotic process	9.937828338024701e-12	2.1917880399513479e-7	29	795	116
DOID:235	colonic benign neoplasm	GO:0032496	response to lipopolysaccharide	1.2352452394281954e-11	2.724333375558885e-7	17	319	116
DOID:235	colonic benign neoplasm	GO:0010942	positive regulation of cell death	1.4269141423994824e-11	3.1470591410620585e-7	22	596	116
DOID:235	colonic benign neoplasm	GO:0034097	response to cytokine	1.990119180561578e-11	4.3892078527285605e-7	25	784	116
DOID:235	colonic benign neoplasm	GO:0010332	response to gamma radiation	2.0445867221496883e-11	4.5093360157011375e-7	9	50	116
DOID:235	colonic benign neoplasm	GO:0048514	blood vessel morphogenesis	2.386779662799654e-11	5.264042546304637e-7	20	484	116
DOID:235	colonic benign neoplasm	GO:0071214	cellular response to abiotic stimulus	2.4889201810651684e-11	5.489313459339229e-7	16	285	116
DOID:235	colonic benign neoplasm	GO:0030335	positive regulation of cell migration	2.9381053145982605e-11	6.479991271346464e-7	18	387	116
DOID:235	colonic benign neoplasm	GO:0008284	positive regulation of cell proliferation	3.3818059463897043e-11	7.458573014762493e-7	25	815	116
DOID:235	colonic benign neoplasm	GO:0043068	positive regulation of programmed cell death	3.672839810064943e-11	8.100448201098231e-7	21	561	116
DOID:235	colonic benign neoplasm	GO:0030855	epithelial cell differentiation	4.333378100795926e-11	9.557265401305415e-7	21	568	116
DOID:235	colonic benign neoplasm	GO:0043549	regulation of kinase activity	4.581701684713835e-11	1.0104943065636363e-6	24	761	116
DOID:235	colonic benign neoplasm	GO:0045471	response to ethanol	5.3819948497846326e-11	1.1869989641200007e-6	12	137	116
DOID:235	colonic benign neoplasm	GO:0022603	regulation of anatomical structure morphogenesis	5.535449876248322e-11	1.2208434702065674e-6	27	986	116
DOID:235	colonic benign neoplasm	GO:0045859	regulation of protein kinase activity	6.618616765763363e-11	1.4597359276891098e-6	23	709	116
DOID:235	colonic benign neoplasm	GO:0071417	cellular response to organonitrogen compound	7.50459694387473e-11	1.6551388559715718e-6	19	462	116
DOID:235	colonic benign neoplasm	GO:2001233	regulation of apoptotic signaling pathway	8.314826605015924e-11	1.833835007736262e-6	17	359	116
DOID:235	colonic benign neoplasm	GO:0001655	urogenital system development	1.006347227772153e-10	2.2194988108514835e-6	16	313	116
DOID:235	colonic benign neoplasm	GO:0031099	regeneration	1.0685208273741864e-10	2.356622684773768e-6	13	182	116
DOID:235	colonic benign neoplasm	GO:0009611	response to wounding	1.1863876547835162e-10	2.616577972625045e-6	25	875	116
DOID:235	colonic benign neoplasm	GO:0048754	branching morphogenesis of an epithelial tube	1.2291134776631907e-10	2.710809774986167e-6	12	147	116
DOID:235	colonic benign neoplasm	GO:0009887	organ morphogenesis	1.2786616210291868e-10	2.8200882051798715e-6	26	950	116
DOID:235	colonic benign neoplasm	GO:0023014	signal transduction by protein phosphorylation	1.3141387977810837e-10	2.89833311850618e-6	25	879	116
DOID:235	colonic benign neoplasm	GO:0007417	central nervous system development	1.6654988499453793e-10	3.673257713554534e-6	25	889	116
DOID:235	colonic benign neoplasm	GO:0072001	renal system development	1.750894984553497e-10	3.861598888432738e-6	15	276	116
DOID:235	colonic benign neoplasm	GO:0007423	sensory organ development	2.1049606502288043e-10	4.642490714079628e-6	19	494	116
DOID:235	colonic benign neoplasm	GO:0043065	positive regulation of apoptotic process	2.1525392579491154e-10	4.747425333406774e-6	20	556	116
DOID:235	colonic benign neoplasm	GO:0070848	response to growth factor	2.190493342268951e-10	4.831133066374171e-6	21	621	116
DOID:235	colonic benign neoplasm	GO:0060485	mesenchyme development	2.478761640389848e-10	5.46690879787981e-6	14	237	116
DOID:235	colonic benign neoplasm	GO:0050673	epithelial cell proliferation	2.747133631686438e-10	6.058803224684439e-6	16	335	116
DOID:235	colonic benign neoplasm	GO:0060070	canonical Wnt signaling pathway	2.9998215023141483e-10	6.616106323353854e-6	15	287	116
DOID:235	colonic benign neoplasm	GO:2001234	negative regulation of apoptotic signaling pathway	3.2476754618926407e-10	7.162748231204219e-6	13	199	116
DOID:235	colonic benign neoplasm	GO:0009411	response to UV	3.363955780599781e-10	7.419204474112817e-6	11	125	116
DOID:235	colonic benign neoplasm	GO:0045860	positive regulation of protein kinase activity	3.4861835640498384e-10	7.688777850511919e-6	18	450	116
DOID:235	colonic benign neoplasm	GO:0001666	response to hypoxia	3.8203196162100994e-10	8.425714913551374e-6	15	292	116
DOID:235	colonic benign neoplasm	GO:0009636	response to toxic substance	4.723638147297038e-10	1.0417983933863617e-5	14	249	116
DOID:235	colonic benign neoplasm	GO:0043408	regulation of MAPK cascade	5.15486098251472e-10	1.1369045896936214e-5	21	651	116
DOID:235	colonic benign neoplasm	GO:0051384	response to glucocorticoid	5.416923576362365e-10	1.1947024947667195e-5	12	167	116
DOID:235	colonic benign neoplasm	GO:0009612	response to mechanical stimulus	6.3269145478273e-10	1.3954010035233111e-5	13	210	116
DOID:235	colonic benign neoplasm	GO:1901701	cellular response to oxygen-containing compound	6.373923611135979e-10	1.4057688524360401e-5	24	873	116
DOID:235	colonic benign neoplasm	GO:0071363	cellular response to growth factor stimulus	6.688469778026729e-10	1.475142009543795e-5	20	594	116
DOID:235	colonic benign neoplasm	GO:0001525	angiogenesis	7.251752531800548e-10	1.599374020888611e-5	17	413	116
DOID:235	colonic benign neoplasm	GO:0071407	cellular response to organic cyclic compound	8.097329473599757e-10	1.7858660154024264e-5	17	416	116
DOID:235	colonic benign neoplasm	GO:0048608	reproductive structure development	8.702126796933385e-10	1.919254065063658e-5	17	418	116
DOID:235	colonic benign neoplasm	GO:0001822	kidney development	9.197341777067436e-10	2.028473728932223e-5	14	262	116
DOID:235	colonic benign neoplasm	GO:0050678	regulation of epithelial cell proliferation	1.8896193498818548e-9	4.167555476164431e-5	14	277	116
DOID:235	colonic benign neoplasm	GO:0010623	developmental programmed cell death	2.1401622696259892e-9	4.720127885660119e-5	7	36	116
DOID:235	colonic benign neoplasm	GO:0006954	inflammatory response	2.2295366663982463e-9	4.917243117741332e-5	20	637	116
DOID:235	colonic benign neoplasm	GO:2000379	positive regulation of reactive oxygen species metabolic process	2.25321994395955e-9	4.969476586402788e-5	9	83	116
DOID:235	colonic benign neoplasm	GO:0045927	positive regulation of growth	2.4985383761944036e-9	5.510526388696757e-5	13	235	116
DOID:235	colonic benign neoplasm	GO:0043410	positive regulation of MAPK cascade	4.196339831175067e-9	9.25502749765661e-5	17	464	116
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0072358	cardiovascular system development	2.5126567493316543e-12	5.5416644606509635e-8	33	910	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048562	embryonic organ morphogenesis	6.141753772226366e-13	1.354563794464525e-8	18	280	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0055123	digestive system development	7.494005416219807e-14	1.6528028945472784e-9	14	150	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0090596	sensory organ morphogenesis	2.025157819218748e-12	4.466485570286949e-8	16	239	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048589	developmental growth	3.222644373579442e-12	7.107542165929459e-8	24	558	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048732	gland development	4.629296945779515e-12	1.0209914413916721e-7	21	421	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0035295	tube development	6.955991338486456e-12	1.5341438897031878e-7	22	573	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0001501	skeletal system development	6.969980148596733e-12	1.5372291217730094e-7	24	482	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0007507	heart development	7.2306605147787195e-12	1.5947221765344466e-7	27	487	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0035107	appendage morphogenesis	7.494116438522269e-12	1.6528273805160865e-7	13	146	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0035108	limb morphogenesis	7.494116438522269e-12	1.6528273805160865e-7	13	146	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048729	tissue morphogenesis	9.400924483315976e-12	2.0733738947953384e-7	23	635	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0002009	morphogenesis of an epithelium	1.2659207015985885e-11	2.791988107375687e-7	21	506	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048566	embryonic digestive tract development	2.266742349377182e-11	4.999300251551375e-7	8	33	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0003007	heart morphogenesis	8.109690696755933e-11	1.7885922831695211e-6	14	216	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0003205	cardiac chamber development	9.078093832215473e-11	2.0021735946951225e-6	12	142	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0001655	urogenital system development	1.1472545136115286e-10	2.5302698297702264e-6	16	313	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0003279	cardiac septum development	1.181716946518918e-10	2.606276725547474e-6	10	84	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0043009	chordate embryonic development	2.1992696552786128e-10	4.850489224716981e-6	20	552	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0060485	mesenchyme development	2.781536112550498e-10	6.134677896230123e-6	14	237	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0043583	ear development	3.000671933151011e-10	6.617981948564555e-6	13	196	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0032808	lacrimal gland development	4.890786664546454e-10	1.0786629988657204e-5	5	8	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048608	reproductive structure development	9.971118375418087e-10	2.199130157698459e-5	17	418	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0001822	kidney development	1.0312474207907485e-9	2.2744161865539958e-5	14	262	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0061061	muscle structure development	1.4775217715978783e-9	3.258674267259121e-5	19	551	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0048762	mesenchymal cell differentiation	1.8236968601925696e-9	4.022163425154712e-5	12	184	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.0848299753239985e-9	4.598092510577079e-5	25	996	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0035239	tube morphogenesis	3.2111235892529066e-9	7.082133076097286e-5	15	338	117
Orphanet:102285	Multiple congenital anomalies/dysmorphic syndrome without intellectual disability	GO:0043066	negative regulation of apoptotic process	3.883989130315513e-9	8.566138026910863e-5	22	795	117
DOID:4610	intestinal benign neoplasm	GO:0009743	response to carbohydrate	7.473432983573502e-10	1.648265644527136e-5	13	211	117
DOID:4610	intestinal benign neoplasm	GO:0071900	regulation of protein serine/threonine kinase activity	1.586360931504771e-9	3.4987190344337726e-5	17	431	117
DOID:4610	intestinal benign neoplasm	GO:0034284	response to monosaccharide	2.330584836229832e-9	5.1401048563048946e-5	12	188	117
DOID:4610	intestinal benign neoplasm	GO:0007565	female pregnancy	2.6287757526333166e-9	5.79776492243278e-5	12	190	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0008544	epidermis development	2.02082794942271e-12	4.456936042451787e-8	21	296	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0042633	hair cycle	2.950972799453666e-13	6.5083705091950605e-9	15	101	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0022405	hair cycle process	9.103828801926284e-15	2.0078494422648419e-10	12	80	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0001942	hair follicle development	9.103828801926284e-15	2.0078494422648419e-10	12	80	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0042476	odontogenesis	2.950972799453666e-13	6.5083705091950605e-9	13	114	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0048736	appendage development	2.4089619188316647e-12	5.3129655119832364e-8	14	168	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0060173	limb development	2.4089619188316647e-12	5.3129655119832364e-8	14	168	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0042475	odontogenesis of dentin-containing tooth	2.97983859809392e-12	6.572034028096141e-8	11	81	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0009790	embryo development	5.1405546486194e-12	1.1337493277530086e-7	31	932	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0007507	heart development	7.542744207000851e-12	1.6635522348540377e-7	22	487	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0050673	epithelial cell proliferation	3.011046967316133e-11	6.640864086415732e-7	17	335	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0043009	chordate embryonic development	3.121047864595994e-11	6.883471065366464e-7	21	552	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0007417	central nervous system development	3.692346428607607e-11	8.143470048294077e-7	26	889	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0048598	embryonic morphogenesis	4.2649994647092626e-11	9.406456319416279e-7	21	560	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0030855	epithelial cell differentiation	5.130773583772452e-11	1.1315921139010143e-6	21	568	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0008285	negative regulation of cell proliferation	5.6040283524794177e-11	1.2359684531393356e-6	22	634	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0035295	tube development	5.80892001167399e-11	1.2811573085746986e-6	21	573	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0048729	tissue morphogenesis	5.864175811609584e-11	1.2933439752504938e-6	22	635	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0060322	head development	7.651601574565348e-11	1.6875607272703874e-6	23	708	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0035107	appendage morphogenesis	1.2578194041878987e-10	2.7741206959364106e-6	12	146	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0035108	limb morphogenesis	1.2578194041878987e-10	2.7741206959364106e-6	12	146	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0050678	regulation of epithelial cell proliferation	2.0710522186107028e-10	4.567705668145905e-6	15	277	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0007389	pattern specification process	2.11261452776057e-10	4.659371340975937e-6	18	432	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0003002	regionalization	2.1966339858181527e-10	4.844676255721936e-6	16	327	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0007423	sensory organ development	2.4440038881579085e-10	5.390250575332267e-6	19	494	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0048858	cell projection morphogenesis	3.5253677754809587e-10	7.775198628823254e-6	23	767	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0035239	tube morphogenesis	3.577205198723732e-10	7.88952606578519e-6	16	338	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0051338	regulation of transferase activity	4.904032735453256e-10	1.0815844198042157e-5	25	928	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0007420	brain development	9.953121660188913e-10	2.1951609821546647e-5	21	669	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0048732	gland development	1.1135641297954635e-9	2.4559656882638947e-5	17	421	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0051054	positive regulation of DNA metabolic process	1.7138763741542107e-9	3.7799543431971117e-5	12	183	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0002009	morphogenesis of an epithelium	2.5722957097684684e-9	5.673198187894357e-5	18	506	117
Orphanet:79373	Ectodermal dysplasia syndrome	GO:0006275	regulation of DNA replication	4.213689730470094e-9	9.293292700551792e-5	11	157	117
DOID:2477	motor peripheral neuropathy	GO:0030705	cytoskeleton-dependent intracellular transport	2.092862105840254e-9	4.6158073744306805e-5	10	112	117
DOID:2477	motor peripheral neuropathy	GO:0008088	axon cargo transport	2.7892730347645056e-9	6.151741678173117e-5	7	37	117
DOID:0050624	gastrointestinal system benign neoplasm	GO:0042063	gliogenesis	2.14075290827509e-9	4.7214305392007105e-5	13	228	118
Orphanet:79377	Dermis disorder	GO:0001944	vasculature development	4.68292071786891e-13	1.0328181643259882e-8	24	588	118
Orphanet:79377	Dermis disorder	GO:0001568	blood vessel development	5.6710192097853e-13	1.2507432867181478e-8	24	569	118
Orphanet:79377	Dermis disorder	GO:0001775	cell activation	5.954126081064715e-13	1.3131825071788228e-8	29	854	118
Orphanet:79377	Dermis disorder	GO:0009611	response to wounding	9.016121182980896e-13	1.9885055269064367e-8	32	875	118
Orphanet:79377	Dermis disorder	GO:0030198	extracellular matrix organization	1.3092860129404471e-12	2.887630301540156e-8	18	320	118
Orphanet:79377	Dermis disorder	GO:0031012	extracellular matrix	2.309408220213527e-11	5.093399829680934e-7	19	423	118
Orphanet:79377	Dermis disorder	GO:1902533	positive regulation of intracellular signal transduction	2.903177698243553e-11	6.402958413476156e-7	26	860	118
Orphanet:79377	Dermis disorder	GO:0042060	wound healing	1.4735046516278771e-10	3.249814509165283e-6	20	534	118
Orphanet:79377	Dermis disorder	GO:1901701	cellular response to oxygen-containing compound	9.1892293774265e-10	2.0266845391914146e-5	24	873	118
Orphanet:79377	Dermis disorder	GO:0060840	artery development	1.045807884736405e-9	2.306529289786141e-5	9	75	118
Orphanet:79377	Dermis disorder	GO:0007507	heart development	1.6233451249902942e-9	3.580287673166094e-5	18	487	118
Orphanet:79377	Dermis disorder	GO:0022603	regulation of anatomical structure morphogenesis	2.0439120396176236e-9	4.507848003376669e-5	25	986	118
Orphanet:79377	Dermis disorder	GO:0045321	leukocyte activation	2.251523079088713e-9	4.965734150930157e-5	21	694	118
Orphanet:79377	Dermis disorder	GO:0035295	tube development	3.252944136278302e-9	7.174368292561795e-5	19	573	118
DOID:1100	ovarian disease	GO:0022602	ovulation cycle process	1.9984014443252818e-13	4.407474385459409e-9	13	94	118
DOID:1100	ovarian disease	GO:0046660	female sex differentiation	1.3344880755994382e-13	2.943213450734561e-9	14	127	118
DOID:1100	ovarian disease	GO:0008585	female gonad development	6.705747068735946e-14	1.4789525160097128e-9	13	108	118
DOID:1100	ovarian disease	GO:0001541	ovarian follicle development	4.326539126964235e-13	9.54218204451962e-9	11	65	118
DOID:1100	ovarian disease	GO:0008202	steroid metabolic process	1.7681411890180243e-12	3.8996353923792526e-8	17	275	118
DOID:1100	ovarian disease	GO:0071396	cellular response to lipid	1.323251508367207e-10	2.918431201703875e-6	18	416	118
DOID:1100	ovarian disease	GO:1901698	response to nitrogen compound	1.5502177319604016e-10	3.4190052078386657e-6	25	870	118
DOID:1100	ovarian disease	GO:0071383	cellular response to steroid hormone stimulus	4.658112784383661e-10	1.0273467745958165e-5	12	162	118
DOID:1100	ovarian disease	GO:0010243	response to organonitrogen compound	5.757342380618979e-10	1.2697818620455159e-5	23	780	118
DOID:1100	ovarian disease	GO:0006694	steroid biosynthetic process	2.654300002014054e-9	5.854058654441996e-5	11	149	118
DOID:1074	kidney failure	GO:0036293	response to decreased oxygen levels	2.8697044740511046e-12	6.329133217519711e-8	19	302	118
DOID:1074	kidney failure	GO:0042327	positive regulation of phosphorylation	2.4382718066817688e-12	5.377608469636641e-8	32	910	118
DOID:1074	kidney failure	GO:0002237	response to molecule of bacterial origin	2.405409205152864e-12	5.305130001964642e-8	26	333	118
DOID:1074	kidney failure	GO:1903522	regulation of blood circulation	1.7532642004880472e-12	3.866824194176388e-8	18	297	118
DOID:1074	kidney failure	GO:0050727	regulation of inflammatory response	7.358558207215538e-13	1.6229300126013868e-8	19	289	118
DOID:1074	kidney failure	GO:0071219	cellular response to molecule of bacterial origin	5.595524044110789e-13	1.2340928279286345e-8	17	158	118
DOID:1074	kidney failure	GO:0003018	vascular process in circulatory system	4.3010039973978564e-13	9.485864316260972e-9	16	159	118
DOID:1074	kidney failure	GO:0071363	cellular response to growth factor stimulus	3.9190872769268026e-13	8.643546989262063e-9	27	594	118
DOID:1074	kidney failure	GO:0030335	positive regulation of cell migration	3.8680170177940454e-13	8.530911532744767e-9	22	387	118
DOID:1074	kidney failure	GO:0048659	smooth muscle cell proliferation	2.304822999121825e-13	5.083287124563185e-9	14	104	118
DOID:1074	kidney failure	GO:0019216	regulation of lipid metabolic process	2.284838984678572e-13	5.039212380708591e-9	23	272	118
DOID:1074	kidney failure	GO:2000377	regulation of reactive oxygen species metabolic process	1.6719958750854857e-13	3.687586902501039e-9	18	147	118
DOID:1074	kidney failure	GO:0009636	response to toxic substance	1.3677947663381929e-13	3.0166713571588843e-9	17	249	118
DOID:1074	kidney failure	GO:0033273	response to vitamin	1.3566925360919413e-13	2.9921853883507765e-9	13	104	118
DOID:1074	kidney failure	GO:0035150	regulation of tube size	5.706546346573305e-14	1.2585787967367423e-9	15	140	118
DOID:1074	kidney failure	GO:0051235	maintenance of location	9.547918011776346e-15	2.1057933174972732e-10	20	274	118
DOID:1074	kidney failure	GO:0046890	regulation of lipid biosynthetic process	1.3988810110276972e-14	3.0852320698215863e-10	14	126	118
DOID:1074	kidney failure	GO:0001666	response to hypoxia	1.9872992140790302e-14	4.382988416651301e-10	19	292	118
DOID:1074	kidney failure	GO:0050880	regulation of blood vessel size	7.09432512735475e-14	1.5646534068380902e-9	15	139	118
DOID:1074	kidney failure	GO:0046209	nitric oxide metabolic process	1.7130741269966165e-13	3.778184987091038e-9	12	65	118
DOID:1074	kidney failure	GO:0034612	response to tumor necrosis factor	3.3995029014022293e-13	7.497603649042617e-9	18	265	118
DOID:1074	kidney failure	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	3.405054016525355e-13	7.50984663344667e-9	10	46	118
DOID:1074	kidney failure	GO:0001819	positive regulation of cytokine production	4.831690603168681e-13	1.0656293625288527e-8	20	381	118
DOID:1074	kidney failure	GO:0019218	regulation of steroid metabolic process	6.152856002472618e-13	1.3570123913453358e-8	11	71	118
DOID:1074	kidney failure	GO:0071356	cellular response to tumor necrosis factor	6.272760089132134e-13	1.3834572376580923e-8	17	243	118
DOID:1074	kidney failure	GO:0045428	regulation of nitric oxide biosynthetic process	7.19979631469414e-13	1.5879150772057926e-8	10	51	118
DOID:1074	kidney failure	GO:0010038	response to metal ion	1.1286527268339341e-12	2.4892435890322417e-8	18	335	118
DOID:1074	kidney failure	GO:0071496	cellular response to external stimulus	1.7187362644222048e-12	3.790672831183173e-8	17	270	118
DOID:1074	kidney failure	GO:0097191	extrinsic apoptotic signaling pathway	2.2190027593183004e-12	4.8940105856765115e-8	16	220	118
DOID:1074	kidney failure	GO:0001934	positive regulation of protein phosphorylation	2.3047119768193625e-12	5.083042264875104e-8	31	870	118
DOID:1074	kidney failure	GO:0051384	response to glucocorticoid	2.44670950166892e-12	5.396217805930803e-8	14	167	118
DOID:1074	kidney failure	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.7633451082920146e-12	6.094557636338038e-8	9	40	118
DOID:1074	kidney failure	GO:1990748	cellular detoxification	3.849587315585268e-12	8.490264824523308e-8	11	82	118
DOID:1074	kidney failure	GO:0000165	MAPK cascade	4.492961558355546e-12	9.909226716953157e-8	27	843	118
DOID:1074	kidney failure	GO:0043279	response to alkaloid	4.71556127479289e-12	1.0400170391555719e-7	13	140	118
DOID:1074	kidney failure	GO:0002526	acute inflammatory response	5.3936854982339355e-12	1.1895773366354945e-7	13	141	118
DOID:1074	kidney failure	GO:0051341	regulation of oxidoreductase activity	5.619282816837767e-12	1.2393328252535696e-7	11	85	118
DOID:1074	kidney failure	GO:0032940	secretion by cell	5.803690861228006e-12	1.2800040194438367e-7	30	956	118
DOID:1074	kidney failure	GO:0010817	regulation of hormone levels	7.421729897316709e-12	1.6368625288532002e-7	23	473	118
DOID:1074	kidney failure	GO:0046889	positive regulation of lipid biosynthetic process	7.916889366299529e-12	1.746069949737361e-7	10	64	118
DOID:1074	kidney failure	GO:0051046	regulation of secretion	8.212763802362133e-12	1.8113250566109684e-7	24	675	118
DOID:1074	kidney failure	GO:1902533	positive regulation of intracellular signal transduction	9.0392138218931e-12	1.993598608418523e-7	33	860	118
DOID:1074	kidney failure	GO:0045597	positive regulation of cell differentiation	9.595990668742616e-12	2.1163957419911839e-7	27	815	118
DOID:1074	kidney failure	GO:0051093	negative regulation of developmental process	1.0079270751361946e-11	2.2229831642128772e-7	27	788	118
DOID:1074	kidney failure	GO:1990267	response to transition metal nanoparticle	1.0940692796168605e-11	2.412969796194986e-7	13	150	118
DOID:1074	kidney failure	GO:0042311	vasodilation	1.4969581130230836e-11	3.301541118272411e-7	10	68	118
DOID:1074	kidney failure	GO:0050810	regulation of steroid biosynthetic process	1.6210255360249448e-11	3.575171819703016e-7	9	48	118
DOID:1074	kidney failure	GO:0030162	regulation of proteolysis	1.70228275919726e-11	3.754384625409557e-7	24	701	118
DOID:1074	kidney failure	GO:0016491	oxidoreductase activity	2.0380253040741536e-11	4.494864808135546e-7	24	710	118
DOID:1074	kidney failure	GO:0002443	leukocyte mediated immunity	2.3739010757140022e-11	5.235638822487232e-7	16	279	118
DOID:1074	kidney failure	GO:0009986	cell surface	2.3930635251190324e-11	5.277901604650026e-7	24	715	118
DOID:1074	kidney failure	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.7900792787249884e-11	6.153519849227962e-7	13	161	118
DOID:1074	kidney failure	GO:0048514	blood vessel morphogenesis	3.0821900587341133e-11	6.797770174538087e-7	20	484	118
DOID:1074	kidney failure	GO:0050673	epithelial cell proliferation	3.4921066038862136e-11	7.701841114871044e-7	17	335	118
DOID:1074	kidney failure	GO:0035094	response to nicotine	4.9612314256819445e-11	1.0941995909341529e-6	9	54	118
DOID:1074	kidney failure	GO:1903530	regulation of secretion by cell	5.038647277189057e-11	1.1112736569840465e-6	22	624	118
DOID:1074	kidney failure	GO:0090322	regulation of superoxide metabolic process	5.3081095074958284e-11	1.170703551878205e-6	7	22	118
DOID:1074	kidney failure	GO:0046879	hormone secretion	5.862477170381908e-11	1.2929693399277298e-6	16	297	118
DOID:1074	kidney failure	GO:0097006	regulation of plasma lipoprotein particle levels	5.885936182892237e-11	1.298143225136883e-6	9	55	118
DOID:1074	kidney failure	GO:0006875	cellular metal ion homeostasis	6.189637691278449e-11	1.365124592811462e-6	19	450	118
DOID:1074	kidney failure	GO:0045471	response to ethanol	6.596578838724554e-11	1.4548754628807004e-6	12	137	118
DOID:1074	kidney failure	GO:0019217	regulation of fatty acid metabolic process	6.896205828610391e-11	1.5209581955000218e-6	10	79	118
DOID:1074	kidney failure	GO:0098869	cellular oxidant detoxification	6.896205828610391e-11	1.5209581955000218e-6	10	79	118
DOID:1074	kidney failure	GO:0042803	protein homodimerization activity	8.16953171778323e-11	1.8017902203570912e-6	23	703	118
DOID:1074	kidney failure	GO:0032768	regulation of monooxygenase activity	8.230416348453673e-11	1.8152183256514576e-6	9	57	118
DOID:1074	kidney failure	GO:0032870	cellular response to hormone stimulus	9.038991777288174e-11	1.993549636480907e-6	20	519	118
DOID:1074	kidney failure	GO:0071417	cellular response to organonitrogen compound	9.888601049112822e-11	2.180930961381833e-6	19	462	118
DOID:1074	kidney failure	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.0159784125107763e-10	2.240740388792517e-6	27	996	118
DOID:1074	kidney failure	GO:0043408	regulation of MAPK cascade	1.1092327056871909e-10	2.4464127323930995e-6	22	651	118
DOID:1074	kidney failure	GO:0001525	angiogenesis	1.174748076593346e-10	2.5909068829266246e-6	18	413	118
DOID:1074	kidney failure	GO:0043200	response to amino acid	1.229328860929968e-10	2.7112848027810443e-6	11	112	118
DOID:1074	kidney failure	GO:0019221	cytokine-mediated signaling pathway	1.4735046516278771e-10	3.249814509165283e-6	20	534	118
DOID:1074	kidney failure	GO:0044433	cytoplasmic vesicle part	1.5681156373403837e-10	3.4584790381542163e-6	21	599	118
DOID:1074	kidney failure	GO:1901342	regulation of vasculature development	1.8724122252677944e-10	4.1296051628281205e-6	14	228	118
DOID:1074	kidney failure	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.0539947520603619e-10	4.530085425669128e-6	12	151	118
DOID:1074	kidney failure	GO:1903524	positive regulation of blood circulation	2.3064572474140732e-10	5.0868914591717385e-6	10	89	118
DOID:1074	kidney failure	GO:0040008	regulation of growth	2.7388047385557e-10	6.040433850884597e-6	21	617	118
DOID:1074	kidney failure	GO:0048511	rhythmic process	2.743778537706021e-10	6.051403564910629e-6	16	329	118
DOID:1074	kidney failure	GO:0043086	negative regulation of catalytic activity	2.844700031090497e-10	6.273985918570091e-6	24	822	118
DOID:1074	kidney failure	GO:0051353	positive regulation of oxidoreductase activity	3.550467697621684e-10	7.830556507104625e-6	8	45	118
DOID:1074	kidney failure	GO:1902930	regulation of alcohol biosynthetic process	3.550467697621684e-10	7.830556507104625e-6	8	45	118
DOID:1074	kidney failure	GO:0044419	interspecies interaction between organisms	3.583036090049063e-10	7.902386096603209e-6	23	761	118
DOID:1074	kidney failure	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.583036090049063e-10	7.902386096603209e-6	23	761	118
DOID:1074	kidney failure	GO:0006805	xenobiotic metabolic process	3.587038444052837e-10	7.911213288358532e-6	10	93	118
DOID:1074	kidney failure	GO:1903035	negative regulation of response to wounding	3.7493952387279705e-10	8.269291199014539e-6	12	159	118
DOID:1074	kidney failure	GO:0016337	single organismal cell-cell adhesion	4.0718850513599136e-10	8.98054248077429e-6	22	697	118
DOID:1074	kidney failure	GO:0072521	purine-containing compound metabolic process	4.222617810967222e-10	9.312983582088208e-6	20	568	118
DOID:1074	kidney failure	GO:0042312	regulation of vasodilation	4.2759995544372487e-10	9.430717017311352e-6	8	46	118
DOID:1074	kidney failure	GO:0035690	cellular response to drug	4.869640246596418e-10	1.07399915638684e-5	9	69	118
DOID:1074	kidney failure	GO:0006109	regulation of carbohydrate metabolic process	5.00025132410542e-10	1.1028054295314504e-5	12	163	118
DOID:1074	kidney failure	GO:0032930	positive regulation of superoxide anion generation	5.106463030202235e-10	1.126230421311103e-5	5	8	118
DOID:1074	kidney failure	GO:0032386	regulation of intracellular transport	5.203275588172573e-10	1.147582430971461e-5	20	575	118
DOID:1074	kidney failure	GO:0070371	ERK1 and ERK2 cascade	5.350484499899721e-10	1.1800493564528836e-5	14	247	118
DOID:1074	kidney failure	GO:0045859	regulation of protein kinase activity	5.5600246628984e-10	1.226263439402242e-5	22	709	118
DOID:1074	kidney failure	GO:0001775	cell activation	5.933564750648657e-10	1.3086477057555612e-5	24	854	118
DOID:1074	kidney failure	GO:0045087	innate immune response	6.214517789260299e-10	1.3706118984213589e-5	23	783	118
DOID:1074	kidney failure	GO:0030139	endocytic vesicle	6.610262337503059e-10	1.4578933585362996e-5	14	251	118
DOID:1074	kidney failure	GO:0007159	leukocyte cell-cell adhesion	6.847687972211247e-10	1.5102575822711906e-5	18	461	118
DOID:1074	kidney failure	GO:0046883	regulation of hormone secretion	6.95882240719925e-10	1.5347682819077946e-5	14	252	118
DOID:1074	kidney failure	GO:0045765	regulation of angiogenesis	6.968550181341016e-10	1.536913742494761e-5	13	208	118
DOID:1074	kidney failure	GO:0032680	regulation of tumor necrosis factor production	7.412345182089553e-10	1.6347927299098508e-5	10	100	118
DOID:1074	kidney failure	GO:0033500	carbohydrate homeostasis	8.805641771303385e-10	1.9420842926609616e-5	13	212	118
DOID:1074	kidney failure	GO:0042593	glucose homeostasis	8.805641771303385e-10	1.9420842926609616e-5	13	212	118
DOID:1074	kidney failure	GO:0009894	regulation of catabolic process	8.89470497256184e-10	1.9617271816985138e-5	22	727	118
DOID:1074	kidney failure	GO:0002684	positive regulation of immune system process	8.981754229253625e-10	1.980925895261887e-5	24	872	118
DOID:1074	kidney failure	GO:0051223	regulation of protein transport	9.578210447003244e-10	2.1124743140865654e-5	22	730	118
DOID:1074	kidney failure	GO:0010942	positive regulation of cell death	9.709738568730586e-10	2.1414828413335307e-5	20	596	118
DOID:1074	kidney failure	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	9.827862967881629e-10	2.1675351775662932e-5	16	359	118
DOID:1074	kidney failure	GO:1903531	negative regulation of secretion by cell	1.0617058343598273e-9	2.3415922176805992e-5	12	174	118
DOID:1074	kidney failure	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	1.0942337036468075e-9	2.413332433393034e-5	10	104	118
DOID:1074	kidney failure	GO:0048037	cofactor binding	1.099384583369556e-9	2.4246926986215556e-5	14	261	118
DOID:1074	kidney failure	GO:0048534	hematopoietic or lymphoid organ development	1.2015163308731758e-9	2.6499442677407892e-5	22	739	118
DOID:1074	kidney failure	GO:0010631	epithelial cell migration	1.2398144733083427e-9	2.73441082088155e-5	13	218	118
DOID:1074	kidney failure	GO:0016049	cell growth	1.248859238245359e-9	2.754359049950139e-5	18	479	118
DOID:1074	kidney failure	GO:0005125	cytokine activity	1.5480738912998504e-9	3.41427696726182e-5	13	222	118
DOID:1074	kidney failure	GO:0032844	regulation of homeostatic process	1.5766876693135146e-9	3.4773846546709564e-5	17	427	118
DOID:1074	kidney failure	GO:0001935	endothelial cell proliferation	1.741002675359482e-9	3.839781400505338e-5	10	109	118
DOID:1074	kidney failure	GO:0043491	protein kinase B signaling	1.8473005347630078e-9	4.074221329419814e-5	11	144	118
DOID:1074	kidney failure	GO:0043065	positive regulation of apoptotic process	1.9900695535923774e-9	4.389098400447988e-5	19	556	118
DOID:1074	kidney failure	GO:0010874	regulation of cholesterol efflux	2.0211252671487046e-9	4.457591776696468e-5	6	20	118
DOID:1074	kidney failure	GO:0034109	homotypic cell-cell adhesion	2.0952071189128674e-9	4.620979300762329e-5	18	495	118
DOID:1074	kidney failure	GO:0031329	regulation of cellular catabolic process	2.1387592807897704e-9	4.7170335937818386e-5	20	624	118
DOID:1074	kidney failure	GO:0001558	regulation of cell growth	2.1483491652318776e-9	4.738184083918906e-5	16	379	118
DOID:1074	kidney failure	GO:0030097	hemopoiesis	2.3094068879458973e-9	5.0933968913646765e-5	21	695	118
DOID:1074	kidney failure	GO:0050678	regulation of epithelial cell proliferation	2.371403184930898e-9	5.230129724365096e-5	14	277	118
DOID:1074	kidney failure	GO:0003073	regulation of systemic arterial blood pressure	2.623794292944126e-9	5.78677831308827e-5	9	83	118
DOID:1074	kidney failure	GO:0008285	negative regulation of cell proliferation	2.804073306883481e-9	6.184383678331518e-5	20	634	118
DOID:1074	kidney failure	GO:0045940	positive regulation of steroid metabolic process	2.8150376474300742e-9	6.208565531407029e-5	6	21	118
DOID:1074	kidney failure	GO:0031331	positive regulation of cellular catabolic process	2.9561255665555564e-9	6.51973493703828e-5	15	333	118
DOID:1074	kidney failure	GO:0005996	monosaccharide metabolic process	2.9856284111673403e-9	6.584803460829569e-5	14	282	118
DOID:1074	kidney failure	GO:0043542	endothelial cell migration	3.0568766407057524e-9	6.741941431076537e-5	11	151	118
DOID:1074	kidney failure	GO:0034774	secretory granule lumen	3.2519522630281017e-9	7.172180716108478e-5	9	85	118
DOID:1074	kidney failure	GO:0050886	endocrine process	3.2519522630281017e-9	7.172180716108478e-5	9	85	118
DOID:1074	kidney failure	GO:0031668	cellular response to extracellular stimulus	3.4652194447204465e-9	7.642541485330945e-5	12	193	118
DOID:1074	kidney failure	GO:0045860	positive regulation of protein kinase activity	3.465781217570907e-9	7.643780475352635e-5	17	450	118
DOID:1074	kidney failure	GO:0001990	regulation of systemic arterial blood pressure by hormone	4.377808004996098e-9	9.655255555018893e-5	7	39	118
Orphanet:183426	Genetic epidermal disorder	GO:0005198	structural molecule activity	7.906215682140783e-10	1.7437158686961496e-5	22	716	119
Orphanet:183426	Genetic epidermal disorder	GO:0042633	hair cycle	8.893367153817167e-10	1.961432125774376e-5	10	101	119
MESH:D000022	Abortion, Spontaneous	GO:0005578	proteinaceous extracellular matrix	1.4641621248756564e-12	3.22920956641326e-8	27	354	119
MESH:D000022	Abortion, Spontaneous	GO:0043062	extracellular structure organization	5.451195050909519e-13	1.2022610684780943e-8	23	321	119
MESH:D000022	Abortion, Spontaneous	GO:0030198	extracellular matrix organization	4.589661983800397e-13	1.0122499505271776e-8	23	320	119
MESH:D000022	Abortion, Spontaneous	GO:0044236	multicellular organismal metabolic process	2.0650148258027912e-13	4.554390198308056e-9	17	127	119
MESH:D000022	Abortion, Spontaneous	GO:0032963	collagen metabolic process	1.8496315590255108e-13	4.079362403430764e-9	16	109	119
MESH:D000022	Abortion, Spontaneous	GO:0044243	multicellular organismal catabolic process	2.2648549702353193e-14	4.995137636853997e-10	15	72	119
MESH:D000022	Abortion, Spontaneous	GO:0030574	collagen catabolic process	1.5776269179923474e-13	3.4794561676321223e-9	14	67	119
MESH:D000022	Abortion, Spontaneous	GO:0009611	response to wounding	1.372568725344081e-12	3.027200323746371e-8	31	875	119
MESH:D000022	Abortion, Spontaneous	GO:0005126	cytokine receptor binding	1.8504087151427484e-12	4.0810764212473316e-8	17	270	119
MESH:D000022	Abortion, Spontaneous	GO:0005125	cytokine activity	1.2712719765772817e-11	2.803790344341195e-7	15	222	119
MESH:D000022	Abortion, Spontaneous	GO:0044420	extracellular matrix component	2.4436785928116933e-11	5.38953313644619e-7	12	125	119
MESH:D000022	Abortion, Spontaneous	GO:0042060	wound healing	2.643851804151609e-11	5.831015154056374e-7	21	534	119
MESH:D000022	Abortion, Spontaneous	GO:0098644	complex of collagen trimers	8.05576716444989e-11	1.7766994481194232e-6	7	23	119
MESH:D000022	Abortion, Spontaneous	GO:0001775	cell activation	1.262714377503471e-10	2.7849165595839054e-6	25	854	119
MESH:D000022	Abortion, Spontaneous	GO:0071345	cellular response to cytokine stimulus	2.773615781492822e-10	6.117209606082419e-6	22	677	119
MESH:D000022	Abortion, Spontaneous	GO:0008083	growth factor activity	4.1409997653119035e-10	9.132974982395403e-6	12	159	119
MESH:D000022	Abortion, Spontaneous	GO:0005201	extracellular matrix structural constituent	9.977292325658027e-10	2.200491822423878e-5	9	74	119
MESH:D000022	Abortion, Spontaneous	GO:0008284	positive regulation of cell proliferation	1.5828679478246954e-9	3.491015258927366e-5	23	815	119
MESH:D000022	Abortion, Spontaneous	GO:0001501	skeletal system development	1.5855322610391909e-9	3.4968914017219355e-5	18	482	119
MESH:D000022	Abortion, Spontaneous	GO:0072358	cardiovascular system development	2.5037913964354175e-9	5.522111924838313e-5	24	910	119
Orphanet:98486	Metabolic myopathy	GO:0044282	small molecule catabolic process	1.5618617510426702e-12	3.444686091924609e-8	19	345	119
Orphanet:98486	Metabolic myopathy	GO:0009117	nucleotide metabolic process	9.043876758596525e-13	1.9946270191084636e-8	38	641	119
Orphanet:98486	Metabolic myopathy	GO:0016651	oxidoreductase activity, acting on NAD(P)H	1.2967404927621828e-13	2.8599611567869943e-9	20	98	119
Orphanet:98486	Metabolic myopathy	GO:0032787	monocarboxylic acid metabolic process	5.125899704694348e-13	1.1305171798703384e-8	23	572	119
Orphanet:98486	Metabolic myopathy	GO:0048037	cofactor binding	1.1598211280272608e-10	2.5579854978641237e-6	15	261	119
Orphanet:98683	Syndrome with a symptomatic strabismus	GO:0046128	purine ribonucleoside metabolic process	2.9041213878144845e-12	6.405039720824846e-8	27	342	120
Orphanet:98683	Syndrome with a symptomatic strabismus	GO:0009117	nucleotide metabolic process	4.085620730620576e-13	9.01083652138368e-9	32	641	120
Orphanet:98683	Syndrome with a symptomatic strabismus	GO:0022900	electron transport chain	3.717026686445024e-13	8.1979023569545e-9	26	107	120
Orphanet:98683	Syndrome with a symptomatic strabismus	GO:0042775	mitochondrial ATP synthesis coupled electron transport	2.3092638912203256e-13	5.093081512086428e-9	24	88	120
Orphanet:98683	Syndrome with a symptomatic strabismus	GO:0016651	oxidoreductase activity, acting on NAD(P)H	9.592326932761353e-14	2.1155877050205163e-9	22	98	120
DOID:193	reproductive organ cancer	GO:0005694	chromosome	2.7658986212486525e-12	6.100189409163903e-8	30	876	120
DOID:193	reproductive organ cancer	GO:0007050	cell cycle arrest	4.5156212102881454e-11	9.959202579290505e-7	15	242	120
DOID:193	reproductive organ cancer	GO:0007346	regulation of mitotic cell cycle	9.291578617620644e-11	2.049257664116233e-6	19	453	120
DOID:193	reproductive organ cancer	GO:0006275	regulation of DNA replication	3.94203447662278e-10	8.694157038191541e-6	12	157	120
DOID:193	reproductive organ cancer	GO:0030855	epithelial cell differentiation	5.752460729979703e-10	1.2687052139970234e-5	20	568	120
DOID:193	reproductive organ cancer	GO:0005667	transcription factor complex	9.399085953987196e-10	2.072968407151876e-5	15	301	120
DOID:193	reproductive organ cancer	GO:0043408	regulation of MAPK cascade	9.865479544401978e-10	2.1758315135178563e-5	21	651	120
DOID:193	reproductive organ cancer	GO:0045787	positive regulation of cell cycle	1.2906776758470073e-9	2.8465896140805746e-5	15	308	120
DOID:193	reproductive organ cancer	GO:0001085	RNA polymerase II transcription factor binding	1.2914155300691732e-9	2.8482169515675615e-5	10	104	120
DOID:193	reproductive organ cancer	GO:0016049	cell growth	1.649030578754207e-9	3.6369369414424035e-5	18	479	120
DOID:193	reproductive organ cancer	GO:0061138	morphogenesis of a branching epithelium	1.7861148116082859e-9	3.9392762170020745e-5	12	179	120
DOID:193	reproductive organ cancer	GO:0051053	negative regulation of DNA metabolic process	1.8751212804701822e-9	4.135579984076987e-5	10	108	120
DOID:193	reproductive organ cancer	GO:1901654	response to ketone	2.0275288115101375e-9	4.471714793785608e-5	12	181	120
DOID:193	reproductive organ cancer	GO:0006281	DNA repair	3.5518686880564587e-9	7.83364639150852e-5	18	503	120
DOID:193	reproductive organ cancer	GO:0003684	damaged DNA binding	3.878942056445567e-9	8.555006705490698e-5	8	59	120
DOID:583	hemolytic anemia	GO:0009410	response to xenobiotic stimulus	2.255973186038318e-13	4.9755488618075105e-9	13	106	121
DOID:583	hemolytic anemia	GO:0002526	acute inflammatory response	5.921929613350585e-13	1.3060815762244715e-8	14	141	121
DOID:583	hemolytic anemia	GO:0010035	response to inorganic substance	5.720424134381119e-12	1.2616395428377558e-7	22	502	121
DOID:583	hemolytic anemia	GO:0015669	gas transport	1.9051760169475074e-11	4.2018657053777275e-7	7	19	121
DOID:2044	drug-induced hepatitis	GO:0014070	response to organic cyclic compound	7.218670106112768e-13	1.592077691903171e-8	29	873	121
DOID:2044	drug-induced hepatitis	GO:0001101	response to acid chemical	5.588862705963038e-13	1.232623669800148e-8	19	315	121
DOID:2044	drug-induced hepatitis	GO:0009991	response to extracellular stimulus	1.383337888682945e-13	3.0509517134902353e-9	23	573	121
DOID:2044	drug-induced hepatitis	GO:0072562	blood microparticle	2.716715741257758e-13	5.991716567343985e-9	13	114	121
DOID:2044	drug-induced hepatitis	GO:0008202	steroid metabolic process	2.1721513476791188e-12	4.7906797973062965e-8	17	275	121
DOID:2044	drug-induced hepatitis	GO:0033993	response to lipid	2.3882007482711742e-12	5.267176750312075e-8	32	850	121
DOID:2044	drug-induced hepatitis	GO:1901698	response to nitrogen compound	2.5497381983541345e-12	5.6234475964700437e-8	28	870	121
DOID:2044	drug-induced hepatitis	GO:0022407	regulation of cell-cell adhesion	3.143263427318743e-12	6.932467488951488e-8	19	376	121
DOID:2044	drug-induced hepatitis	GO:0048545	response to steroid hormone	3.570366224892041e-12	7.874442708999396e-8	22	446	121
DOID:2044	drug-induced hepatitis	GO:0031667	response to nutrient levels	4.422573418594311e-12	9.753985674709753e-8	23	546	121
DOID:2044	drug-induced hepatitis	GO:0042493	response to drug	5.588640661358113e-12	1.2325746978625318e-7	21	433	121
DOID:2044	drug-induced hepatitis	GO:0009636	response to toxic substance	6.042943923034727e-12	1.332771282225309e-7	16	249	121
DOID:2044	drug-induced hepatitis	GO:0009611	response to wounding	1.0543121931050337e-11	2.3252855418931517e-7	27	875	121
DOID:2044	drug-induced hepatitis	GO:0097305	response to alcohol	2.746858296376331e-11	6.058195972657998e-7	18	369	121
DOID:2044	drug-induced hepatitis	GO:0010243	response to organonitrogen compound	3.5486280580698804e-11	7.826499182073121e-7	25	780	121
DOID:2044	drug-induced hepatitis	GO:0007584	response to nutrient	3.707079088144383e-11	8.175962928902436e-7	14	197	121
DOID:2044	drug-induced hepatitis	GO:1903037	regulation of leukocyte cell-cell adhesion	7.531186785314503e-11	1.6610032455011137e-6	16	294	121
DOID:2044	drug-induced hepatitis	GO:0009410	response to xenobiotic stimulus	8.792089278841786e-11	1.939095290448556e-6	11	106	121
DOID:2044	drug-induced hepatitis	GO:0019752	carboxylic acid metabolic process	9.403211542746703e-11	2.0738783057527854e-6	27	967	121
DOID:2044	drug-induced hepatitis	GO:1903034	regulation of response to wounding	1.3978918023127562e-10	3.083050370000784e-6	18	407	121
DOID:2044	drug-induced hepatitis	GO:0001775	cell activation	1.84378401435481e-10	4.066465643659534e-6	25	854	121
DOID:2044	drug-induced hepatitis	GO:0070489	T cell aggregation	2.728756109959818e-10	6.018271600516378e-6	18	424	121
DOID:2044	drug-induced hepatitis	GO:0042110	T cell activation	2.728756109959818e-10	6.018271600516378e-6	18	424	121
DOID:2044	drug-induced hepatitis	GO:0006805	xenobiotic metabolic process	4.6013837184943895e-10	1.0148351791139376e-5	10	93	121
DOID:2044	drug-induced hepatitis	GO:0050863	regulation of T cell activation	4.749136639503604e-10	1.0474220858425198e-5	15	284	121
DOID:2044	drug-induced hepatitis	GO:0010035	response to inorganic substance	5.709823724941998e-10	1.2593016225359577e-5	19	502	121
DOID:2044	drug-induced hepatitis	GO:0051186	cofactor metabolic process	9.919790544543616e-10	2.1878098045990946e-5	16	350	121
DOID:2044	drug-induced hepatitis	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	1.4014031046727382e-9	3.090794547355724e-5	10	104	121
DOID:2044	drug-induced hepatitis	GO:0002684	positive regulation of immune system process	1.5359652438817761e-9	3.387571345381257e-5	24	872	121
DOID:2044	drug-induced hepatitis	GO:0006721	terpenoid metabolic process	1.6915127076799763e-9	3.730631276788188e-5	10	106	121
DOID:2044	drug-induced hepatitis	GO:0031960	response to corticosteroid	1.9664943007313695e-9	4.3371031802630355e-5	12	179	121
DOID:2044	drug-induced hepatitis	GO:0043200	response to amino acid	2.909978480403197e-9	6.417957538529251e-5	10	112	121
DOID:10944	tongue disease	GO:0014070	response to organic cyclic compound	4.18554080283684e-13	9.231210240656651e-9	28	873	121
DOID:10944	tongue disease	GO:0050673	epithelial cell proliferation	5.229805477569016e-10	1.1534335980778465e-5	16	335	121
DOID:10944	tongue disease	GO:0050678	regulation of epithelial cell proliferation	3.306815155035281e-9	7.293180824430312e-5	14	277	121
DOID:10944	tongue disease	GO:0022603	regulation of anatomical structure morphogenesis	3.5343853399538716e-9	7.795086867268264e-5	25	986	121
DOID:10944	tongue disease	GO:0072358	cardiovascular system development	3.5586021907008103e-9	7.848497131590637e-5	24	910	121
DOID:10944	tongue disease	GO:0055123	digestive system development	3.7244720640927653e-9	8.214323137356594e-5	11	150	121
DOID:10944	tongue disease	GO:0002009	morphogenesis of an epithelium	4.4667761711636444e-9	9.851474845501418e-5	18	506	121
DOID:365	bladder disease	GO:0033993	response to lipid	6.955547249276606e-12	1.5340459458279554e-7	27	850	121
DOID:365	bladder disease	GO:0048545	response to steroid hormone	1.2648215808042096e-11	2.789563996463684e-7	20	446	121
DOID:365	bladder disease	GO:0072593	reactive oxygen species metabolic process	1.6173395955831893e-11	3.567042478058724e-7	15	223	121
DOID:365	bladder disease	GO:0035690	cellular response to drug	2.204680882300636e-11	4.862423685914052e-7	10	69	121
DOID:365	bladder disease	GO:0060548	negative regulation of cell death	4.82976991733608e-11	1.0652057552684724e-6	26	867	121
DOID:365	bladder disease	GO:0031960	response to corticosteroid	1.4858048125176992e-10	3.2769425140077857e-6	13	179	121
DOID:365	bladder disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.7770951377116262e-10	3.9193833262229916e-6	27	996	121
DOID:365	bladder disease	GO:0071407	cellular response to organic cyclic compound	2.0136092793165972e-10	4.441015265532755e-6	18	416	121
DOID:365	bladder disease	GO:0043066	negative regulation of apoptotic process	2.518839581355792e-10	5.555300696680199e-6	24	795	121
DOID:365	bladder disease	GO:0043523	regulation of neuron apoptotic process	3.120916858279088e-10	6.883182130934529e-6	13	190	121
DOID:365	bladder disease	GO:0001666	response to hypoxia	6.983535971727406e-10	1.5402188585644794e-5	15	292	121
DOID:365	bladder disease	GO:0051384	response to glucocorticoid	8.87506734770227e-10	1.9573961035357357e-5	12	167	121
DOID:365	bladder disease	GO:0008134	transcription factor binding	9.60222790169496e-10	2.1177713637188234e-5	19	518	121
DOID:365	bladder disease	GO:1901698	response to nitrogen compound	1.4702774553398967e-9	3.242696927752142e-5	24	870	121
DOID:365	bladder disease	GO:0048732	gland development	1.8910014665252106e-9	4.170603734421352e-5	17	421	121
DOID:365	bladder disease	GO:0031667	response to nutrient levels	2.280215016803311e-9	5.029014219559702e-5	19	546	121
DOID:365	bladder disease	GO:0033613	activating transcription factor binding	2.324575643086746e-9	5.126851580827818e-5	8	55	121
DOID:365	bladder disease	GO:0032355	response to estradiol	2.601041604322063e-9	5.73659725833231e-5	11	145	121
DOID:365	bladder disease	GO:0003682	chromatin binding	2.88481671884e-9	6.36246327340162e-5	17	433	121
MESH:D025063	Chromosome Disorders	GO:0003002	regionalization	1.9839685450051547e-12	4.375642626008869e-8	21	327	121
MESH:D025063	Chromosome Disorders	GO:0048638	regulation of developmental growth	1.1894929485833927e-12	2.6234266981006726e-8	18	283	121
MESH:D025063	Chromosome Disorders	GO:0072358	cardiovascular system development	1.1326495297225847e-12	2.4980585378031606e-8	29	910	121
MESH:D025063	Chromosome Disorders	GO:0043583	ear development	5.828670879282072e-13	1.285513362425661e-8	17	196	121
MESH:D025063	Chromosome Disorders	GO:0048839	inner ear development	3.672617765460018e-13	8.09995848172207e-9	16	170	121
MESH:D025063	Chromosome Disorders	GO:0048667	cell morphogenesis involved in neuron differentiation	6.325051593591979e-12	1.394990128966711e-7	22	495	121
MESH:D025063	Chromosome Disorders	GO:0007507	heart development	7.1992412031818276e-12	1.587792647361752e-7	23	487	121
MESH:D025063	Chromosome Disorders	GO:0030900	forebrain development	1.5421885990463124e-11	3.401296955196642e-7	18	357	121
MESH:D025063	Chromosome Disorders	GO:0048858	cell projection morphogenesis	2.8466673462901326e-11	6.278324832242888e-7	25	767	121
MESH:D025063	Chromosome Disorders	GO:0035113	embryonic appendage morphogenesis	2.982114555294402e-11	6.577053651701803e-7	12	125	121
MESH:D025063	Chromosome Disorders	GO:0030326	embryonic limb morphogenesis	2.982114555294402e-11	6.577053651701803e-7	12	125	121
MESH:D025063	Chromosome Disorders	GO:0050767	regulation of neurogenesis	3.576050566778122e-11	7.886979525029147e-7	23	658	121
MESH:D025063	Chromosome Disorders	GO:0048812	neuron projection morphogenesis	4.0258796296654964e-11	8.879077523227252e-7	21	539	121
MESH:D025063	Chromosome Disorders	GO:0090596	sensory organ morphogenesis	4.190736646592086e-11	9.242669674058845e-7	15	239	121
MESH:D025063	Chromosome Disorders	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	5.369249489461936e-11	1.18418797490083e-6	24	732	121
MESH:D025063	Chromosome Disorders	GO:0042471	ear morphogenesis	1.6158907545360535e-10	3.563847059129266e-6	11	112	121
MESH:D025063	Chromosome Disorders	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.7770951377116262e-10	3.9193833262229916e-6	27	996	121
MESH:D025063	Chromosome Disorders	GO:0021537	telencephalon development	2.3399249204913986e-10	5.1607044121437795e-6	14	226	121
MESH:D025063	Chromosome Disorders	GO:0048639	positive regulation of developmental growth	3.2200397903636713e-10	7.101797757647077e-6	12	153	121
MESH:D025063	Chromosome Disorders	GO:0045664	regulation of neuron differentiation	3.613357391074601e-10	7.969259726015032e-6	20	548	121
MESH:D025063	Chromosome Disorders	GO:0043009	chordate embryonic development	4.0815051338682906e-10	9.001759572746515e-6	20	552	121
MESH:D025063	Chromosome Disorders	GO:0042472	inner ear morphogenesis	4.1301984055053254e-10	9.109152583341995e-6	10	92	121
MESH:D025063	Chromosome Disorders	GO:0035295	tube development	7.763382159353682e-10	1.7122139352454546e-5	20	573	121
MESH:D025063	Chromosome Disorders	GO:0007409	axonogenesis	1.0908208780691098e-9	2.4058054465814216e-5	17	406	121
MESH:D025063	Chromosome Disorders	GO:0003007	heart morphogenesis	1.5147527676617756e-9	3.340787229078046e-5	13	216	121
MESH:D025063	Chromosome Disorders	GO:0007605	sensory perception of sound	1.5365790861920914e-9	3.3889251745966575e-5	11	138	121
MESH:D025063	Chromosome Disorders	GO:0001822	kidney development	1.6140373482187442e-9	3.5597593714964404e-5	14	262	121
MESH:D025063	Chromosome Disorders	GO:0001501	skeletal system development	2.0877426454291026e-9	4.604516404493886e-5	18	482	121
MESH:D025063	Chromosome Disorders	GO:0051962	positive regulation of nervous system development	3.090174227615705e-9	6.815379259006438e-5	17	435	121
MESH:D025063	Chromosome Disorders	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	3.273866067132758e-9	7.220511611061298e-5	20	623	121
MESH:D025063	Chromosome Disorders	GO:0048645	organ formation	4.143458465222238e-9	9.138397645047647e-5	8	59	121
MESH:D025063	Chromosome Disorders	GO:0002009	morphogenesis of an epithelium	4.4667761711636444e-9	9.851474845501418e-5	18	506	121
MESH:D025063	Chromosome Disorders	GO:0001568	blood vessel development	4.470530834410624e-9	9.859755755292632e-5	19	569	121
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0046128	purine ribonucleoside metabolic process	3.1883384821185246e-12	7.031880522312406e-8	26	342	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0005773	vacuole	1.842748176272835e-12	4.064181102769737e-8	25	603	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0009123	nucleoside monophosphate metabolic process	6.770140004164205e-13	1.4931543779184153e-8	26	292	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0006091	generation of precursor metabolites and energy	3.4661162828797387e-13	7.644519461891264e-9	29	362	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0006665	sphingolipid metabolic process	2.453592884421596e-13	5.41139910659183e-9	15	144	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0042775	mitochondrial ATP synthesis coupled electron transport	2.2026824808563106e-13	4.858016211528593e-9	24	88	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0005775	vacuolar lumen	1.9384494009955233e-13	4.275250153895627e-9	15	91	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0016651	oxidoreductase activity, acting on NAD(P)H	2.220446049250313e-15	4.8971937616215655e-11	22	98	123
Orphanet:98666	Unclassified primitive or secondary maculopathy	GO:0005929	cilium	3.0561220221159147e-11	6.74027711977665e-7	20	461	123
DOID:225	syndrome	GO:0035239	tube morphogenesis	3.2314151354739806e-12	7.126886081287864e-8	23	338	123
DOID:225	syndrome	GO:0060562	epithelial tube morphogenesis	2.9387603461827894e-12	6.481435943506142e-8	21	301	123
DOID:225	syndrome	GO:0050673	epithelial cell proliferation	2.8486102365832267e-12	6.282609876784306e-8	19	335	123
DOID:225	syndrome	GO:0072358	cardiovascular system development	2.2792878695554464e-12	5.026969396304537e-8	30	910	123
DOID:225	syndrome	GO:0061138	morphogenesis of a branching epithelium	8.412159857584811e-13	1.85530185659033e-8	15	179	123
DOID:225	syndrome	GO:0048568	embryonic organ development	8.495426584431698e-13	1.873666333196411e-8	22	408	123
DOID:225	syndrome	GO:0043009	chordate embryonic development	1.9175772081325704e-12	4.229216532536384e-8	27	552	123
DOID:225	syndrome	GO:0043583	ear development	2.64266386551526e-12	5.828395155393906e-8	15	196	123
DOID:225	syndrome	GO:0048589	developmental growth	3.3946179200938786e-12	7.486829822767049e-8	24	558	123
DOID:225	syndrome	GO:0007417	central nervous system development	4.48741044323242e-12	9.896983732549103e-8	29	889	123
DOID:225	syndrome	GO:0060322	head development	5.5138116294983774e-12	1.2160711548858671e-7	27	708	123
DOID:225	syndrome	GO:0048839	inner ear development	6.0210725294496115e-12	1.3279475463701118e-7	14	170	123
DOID:225	syndrome	GO:0007507	heart development	7.294276294089741e-12	1.6087526366614924e-7	25	487	123
DOID:225	syndrome	GO:0009887	organ morphogenesis	8.907541371172556e-12	1.9645582494121072e-7	34	950	123
DOID:225	syndrome	GO:0003007	heart morphogenesis	1.272648653127817e-11	2.8068266044734003e-7	15	216	123
DOID:225	syndrome	GO:0001501	skeletal system development	1.3431478151915144e-11	2.962312506404885e-7	21	482	123
DOID:225	syndrome	GO:0048754	branching morphogenesis of an epithelial tube	1.5045520385115196e-11	3.3182895209371566e-7	13	147	123
DOID:225	syndrome	GO:0048844	artery morphogenesis	4.1977310516472244e-11	9.258095834407953e-7	9	51	123
DOID:225	syndrome	GO:0007389	pattern specification process	6.60032029031754e-11	1.4557006400295336e-6	19	432	123
DOID:225	syndrome	GO:0051960	regulation of nervous system development	9.865530614661111e-11	2.175842777063508e-6	24	744	123
DOID:225	syndrome	GO:0048598	embryonic morphogenesis	1.0684275686401179e-10	2.35641700263578e-6	21	560	123
DOID:225	syndrome	GO:0008285	negative regulation of cell proliferation	1.5385626106478867e-10	3.393299837783914e-6	22	634	123
DOID:225	syndrome	GO:0030900	forebrain development	1.968983864841789e-10	4.342593913908566e-6	17	357	123
DOID:225	syndrome	GO:0022603	regulation of anatomical structure morphogenesis	2.0546719881053832e-10	4.531579069766423e-6	27	986	123
DOID:225	syndrome	GO:0050767	regulation of neurogenesis	3.1311331305516887e-10	6.9057141194317495e-6	22	658	123
DOID:225	syndrome	GO:0009611	response to wounding	4.3844261554681907e-10	9.669851885885095e-6	25	875	123
DOID:225	syndrome	GO:0048534	hematopoietic or lymphoid organ development	4.802608311038625e-10	1.0592152629995688e-5	23	739	123
DOID:225	syndrome	GO:0048562	embryonic organ morphogenesis	4.9287818271182e-10	1.0870428319709191e-5	15	280	123
DOID:225	syndrome	GO:2000027	regulation of organ morphogenesis	5.148692583389902e-10	1.135544149266643e-5	14	236	123
DOID:225	syndrome	GO:0051703	intraspecies interaction between organisms	5.965314908706887e-10	1.3156502031153039e-5	8	46	123
DOID:225	syndrome	GO:0035176	social behavior	5.965314908706887e-10	1.3156502031153039e-5	8	46	123
DOID:225	syndrome	GO:0048732	gland development	2.445632252268126e-9	5.393841932377352e-5	17	421	123
DOID:225	syndrome	GO:0000975	regulatory region DNA binding	2.7563947790909538e-9	6.0792286852850985e-5	23	810	123
DOID:225	syndrome	GO:0050678	regulation of epithelial cell proliferation	4.1053821453473915e-9	9.054420321563672e-5	14	277	123
Orphanet:79353	Epidermal disease	GO:0005198	structural molecule activity	3.113349578143243e-10	6.866492494594922e-6	23	716	124
Orphanet:79353	Epidermal disease	GO:0042633	hair cycle	1.3342899007895426e-9	2.942776376191336e-5	10	101	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0035239	tube morphogenesis	3.1519231669108194e-12	6.951566544621812e-8	20	338	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0048562	embryonic organ morphogenesis	1.2352341371979492e-12	2.724308889590077e-8	21	280	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0048839	inner ear development	4.04121180963557e-13	8.91289264615125e-9	16	170	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0048736	appendage development	2.660094367001875e-13	5.8668381264226355e-9	18	168	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0060173	limb development	2.660094367001875e-13	5.8668381264226355e-9	18	168	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0035113	embryonic appendage morphogenesis	2.3026025530725747e-13	5.0783899308015634e-9	16	125	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0030326	embryonic limb morphogenesis	2.3026025530725747e-13	5.0783899308015634e-9	16	125	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0042471	ear morphogenesis	6.459277557269161e-13	1.4245936652557134e-8	13	112	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0048729	tissue morphogenesis	1.5122347818419257e-12	3.335233811352367e-8	29	635	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0072358	cardiovascular system development	5.361044941309956e-12	1.1823784618059108e-7	28	910	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0002009	morphogenesis of an epithelium	7.14550640878997e-12	1.575941438458628e-7	27	506	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0060021	palate development	9.815592783013471e-12	2.1648289882936211e-7	11	85	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0060562	epithelial tube morphogenesis	1.2671419469256762e-11	2.794681563944579e-7	17	301	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0007389	pattern specification process	1.4507062218171995e-11	3.1995325722178336e-7	20	432	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0007507	heart development	1.6351697773586693e-11	3.606366943964545e-7	21	487	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0042472	inner ear morphogenesis	2.3983925956372332e-11	5.289654869677918e-7	11	92	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0001655	urogenital system development	2.814645183590869e-10	6.207699952409662e-6	16	313	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0050954	sensory perception of mechanical stimulus	4.293245758901776e-10	9.468753521257867e-6	12	153	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0072001	renal system development	4.5445525120868524e-10	1.0023010565407553e-5	15	276	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0007605	sensory perception of sound	1.9974940590472556e-9	4.405473147228722e-5	11	138	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0001822	kidney development	2.2339241567692625e-9	4.9269197277546084e-5	14	262	124
Orphanet:156237	Syndrome or malformation associated with head and neck malformations	GO:0016331	morphogenesis of embryonic epithelium	2.510756047513496e-9	5.5374724627910155e-5	11	141	124
MESH:D012327	RNA Virus Infections	GO:0002250	adaptive immune response	4.312106227644108e-12	9.51035028506908e-8	20	334	125
MESH:D012327	RNA Virus Infections	GO:0002684	positive regulation of immune system process	2.659650277792025e-12	5.865858687670311e-8	51	872	125
MESH:D012327	RNA Virus Infections	GO:0034110	regulation of homotypic cell-cell adhesion	2.5437429940211587e-12	5.6102251733136654e-8	19	304	125
MESH:D012327	RNA Virus Infections	GO:0045089	positive regulation of innate immune response	1.6366907829024058e-12	3.609721521691256e-8	22	289	125
MESH:D012327	RNA Virus Infections	GO:0050867	positive regulation of cell activation	1.2541079286165768e-12	2.7659350365638602e-8	18	288	125
MESH:D012327	RNA Virus Infections	GO:0002696	positive regulation of leukocyte activation	1.1048939541069558e-12	2.436843615782891e-8	18	280	125
MESH:D012327	RNA Virus Infections	GO:0002429	immune response-activating cell surface receptor signaling pathway	1.0804690475652023e-12	2.3829744844050538e-8	27	292	125
MESH:D012327	RNA Virus Infections	GO:1901990	regulation of mitotic cell cycle phase transition	1.0740297540223764e-12	2.3687726224963512e-8	20	292	125
MESH:D012327	RNA Virus Infections	GO:0002758	innate immune response-activating signal transduction	9.949818746690653e-13	2.1944325245826235e-8	21	239	125
MESH:D012327	RNA Virus Infections	GO:0042176	regulation of protein catabolic process	5.686562332130052e-13	1.254171322351283e-8	23	393	125
MESH:D012327	RNA Virus Infections	GO:2000027	regulation of organ morphogenesis	3.6060043839825084e-13	7.953042668873422e-9	20	236	125
MESH:D012327	RNA Virus Infections	GO:0070661	leukocyte proliferation	3.197442310920451e-13	7.051959016735054e-9	20	266	125
MESH:D012327	RNA Virus Infections	GO:0043487	regulation of RNA stability	6.838973831690964e-14	1.5083356785794422e-9	17	139	125
MESH:D012327	RNA Virus Infections	GO:0030177	positive regulation of Wnt signaling pathway	6.80566714095221e-14	1.5009898879370098e-9	15	152	125
MESH:D012327	RNA Virus Infections	GO:0023014	signal transduction by protein phosphorylation	1.6200374375330284e-12	3.572992568479094e-8	33	879	125
MESH:D012327	RNA Virus Infections	GO:0044764	multi-organism cellular process	8.409717366930636e-12	1.8547631652765517e-7	41	740	125
MESH:D012327	RNA Virus Infections	GO:0019058	viral life cycle	1.6739609698390723e-11	3.691920918980074e-7	20	434	125
MESH:D012327	RNA Virus Infections	GO:0042129	regulation of T cell proliferation	1.9786683402855942e-10	4.363953024499878e-6	12	142	125
MESH:D012327	RNA Virus Infections	GO:0030334	regulation of cell migration	4.565372524467648e-10	1.0068929102713398e-5	22	660	125
MESH:D012327	RNA Virus Infections	GO:0001934	positive regulation of protein phosphorylation	5.57133783551933e-10	1.2287585596237882e-5	25	870	125
MESH:D012327	RNA Virus Infections	GO:0071219	cellular response to molecule of bacterial origin	6.841184285732993e-10	1.5088231942184116e-5	12	158	125
MESH:D012327	RNA Virus Infections	GO:0042102	positive regulation of T cell proliferation	7.852832828447731e-10	1.731942280314147e-5	10	95	125
MESH:D012327	RNA Virus Infections	GO:0016064	immunoglobulin mediated immune response	9.665468425623658e-10	2.1317190612712977e-5	10	97	125
MESH:D012327	RNA Virus Infections	GO:0009615	response to virus	2.273384036577397e-9	5.0139484926714495e-5	17	412	125
MESH:D012327	RNA Virus Infections	GO:0097191	extrinsic apoptotic signaling pathway	2.8359252723930695e-9	6.254633188262915e-5	13	220	125
MESH:D012327	RNA Virus Infections	GO:0005125	cytokine activity	3.1645680520497876e-9	6.979454838795807e-5	13	222	125
MESH:D012327	RNA Virus Infections	GO:0002377	immunoglobulin production	3.5123748354237705e-9	7.746542699527126e-5	9	81	125
MESH:D012327	RNA Virus Infections	GO:0005126	cytokine receptor binding	3.6570269035252068e-9	8.065572835724844e-5	14	270	125
MESH:D012327	RNA Virus Infections	GO:1902105	regulation of leukocyte differentiation	3.7226902671605444e-9	8.210393384222581e-5	13	225	125
MESH:D012327	RNA Virus Infections	GO:0002706	regulation of lymphocyte mediated immunity	3.998801845206401e-9	8.819357469602718e-5	10	112	125
MESH:D012327	RNA Virus Infections	GO:0033157	regulation of intracellular protein transport	4.343265636030935e-9	9.579072360266228e-5	16	375	125
MESH:D012327	RNA Virus Infections	GO:0051235	maintenance of location	4.4153987133199735e-9	9.738161862227201e-5	14	274	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002684	positive regulation of immune system process	2.659650277792025e-12	5.865858687670311e-8	43	872	125
MESH:D012130	Respiratory Hypersensitivity	GO:1903037	regulation of leukocyte cell-cell adhesion	2.4285018440650674e-12	5.356060817085506e-8	22	294	125
MESH:D012130	Respiratory Hypersensitivity	GO:0014070	response to organic cyclic compound	2.2932766796657233e-12	5.057821717002753e-8	46	873	125
MESH:D012130	Respiratory Hypersensitivity	GO:1901701	cellular response to oxygen-containing compound	2.2932766796657233e-12	5.057821717002753e-8	35	873	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050867	positive regulation of cell activation	2.0372592501871623e-12	4.4931752762877863e-8	26	288	125
MESH:D012130	Respiratory Hypersensitivity	GO:0072503	cellular divalent inorganic cation homeostasis	1.1151080059335072e-12	2.4593707070863502e-8	22	375	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002443	leukocyte mediated immunity	7.531752999057062e-13	1.661128123942035e-8	19	279	125
MESH:D012130	Respiratory Hypersensitivity	GO:0032944	regulation of mononuclear cell proliferation	5.750955267558311e-13	1.2683731842599855e-8	18	191	125
MESH:D012130	Respiratory Hypersensitivity	GO:0060326	cell chemotaxis	3.863576125695545e-13	8.521117145221524e-9	17	228	125
MESH:D012130	Respiratory Hypersensitivity	GO:1903036	positive regulation of response to wounding	2.0383694732117874e-13	4.495623873168597e-9	18	162	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002440	production of molecular mediator of immune response	1.6919798895287386e-13	3.731661646355633e-9	16	148	125
MESH:D012130	Respiratory Hypersensitivity	GO:0071496	cellular response to external stimulus	6.461498003318411e-14	1.4250833846318756e-9	18	270	125
MESH:D012130	Respiratory Hypersensitivity	GO:2001057	reactive nitrogen species metabolic process	2.4857893521357255e-13	5.4824084161353426e-9	12	68	125
MESH:D012130	Respiratory Hypersensitivity	GO:0046209	nitric oxide metabolic process	2.602362769721367e-13	5.739511088620475e-9	12	65	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	5.040412531798211e-13	1.1116629838880954e-8	17	209	125
MESH:D012130	Respiratory Hypersensitivity	GO:0032722	positive regulation of chemokine production	1.1597389715234385e-12	2.5578043016949437e-8	10	50	125
MESH:D012130	Respiratory Hypersensitivity	GO:0070838	divalent metal ion transport	1.4591661212648432e-12	3.218190880449612e-8	21	410	125
MESH:D012130	Respiratory Hypersensitivity	GO:0097529	myeloid leukocyte migration	1.762257006987511e-12	3.8866578289109555e-8	14	153	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050671	positive regulation of lymphocyte proliferation	2.953526312410304e-12	6.514002282020925e-8	13	127	125
MESH:D012130	Respiratory Hypersensitivity	GO:0032940	secretion by cell	5.2946536044373715e-12	1.1677358524586623e-7	30	956	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002702	positive regulation of production of molecular mediator of immune response	1.0336953515377445e-11	2.2798150978164955e-7	10	62	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.0648149029179876e-11	2.3484492683856217e-7	12	111	125
MESH:D012130	Respiratory Hypersensitivity	GO:0042129	regulation of T cell proliferation	1.200006760626593e-11	2.646614910561951e-7	13	142	125
MESH:D012130	Respiratory Hypersensitivity	GO:0051222	positive regulation of protein transport	2.4233393070005604e-11	5.344674841589736e-7	20	447	125
MESH:D012130	Respiratory Hypersensitivity	GO:0031668	cellular response to extracellular stimulus	4.409428377982749e-11	9.724994287640953e-7	14	193	125
MESH:D012130	Respiratory Hypersensitivity	GO:0045428	regulation of nitric oxide biosynthetic process	4.8591797252584e-11	1.0716920884057402e-6	9	51	125
MESH:D012130	Respiratory Hypersensitivity	GO:0045619	regulation of lymphocyte differentiation	7.047673555860001e-11	1.5543644027449233e-6	12	130	125
MESH:D012130	Respiratory Hypersensitivity	GO:0010038	response to metal ion	9.153533486738752e-11	2.0188118105002317e-6	17	335	125
MESH:D012130	Respiratory Hypersensitivity	GO:0031669	cellular response to nutrient levels	9.404410583613299e-11	2.074142754215913e-6	13	167	125
MESH:D012130	Respiratory Hypersensitivity	GO:0045580	regulation of T cell differentiation	1.1357992324434463e-10	2.5050052071540208e-6	11	105	125
MESH:D012130	Respiratory Hypersensitivity	GO:0042033	chemokine biosynthetic process	1.3176204571863082e-10	2.9060119183244026e-6	6	13	125
MESH:D012130	Respiratory Hypersensitivity	GO:0048520	positive regulation of behavior	2.5236557288366157e-10	5.565922709949156e-6	12	145	125
MESH:D012130	Respiratory Hypersensitivity	GO:0043408	regulation of MAPK cascade	3.5291025657357977e-10	7.783435708730302e-6	22	651	125
MESH:D012130	Respiratory Hypersensitivity	GO:1990267	response to transition metal nanoparticle	3.745936894006263e-10	8.261663819730813e-6	12	150	125
MESH:D012130	Respiratory Hypersensitivity	GO:0070555	response to interleukin-1	4.4389480979845075e-10	9.790100030104831e-6	11	119	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050921	positive regulation of chemotaxis	4.4389480979845075e-10	9.790100030104831e-6	11	119	125
MESH:D012130	Respiratory Hypersensitivity	GO:0032729	positive regulation of interferon-gamma production	4.710103418403833e-10	1.0388133089289653e-5	9	65	125
MESH:D012130	Respiratory Hypersensitivity	GO:0070372	regulation of ERK1 and ERK2 cascade	5.399539704242784e-10	1.190868481770746e-5	14	233	125
MESH:D012130	Respiratory Hypersensitivity	GO:0071347	cellular response to interleukin-1	5.698771454731855e-10	1.2568640443411105e-5	10	92	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002701	negative regulation of production of molecular mediator of immune response	7.026571546830951e-10	1.5497103546535662e-5	7	29	125
MESH:D012130	Respiratory Hypersensitivity	GO:1903649	regulation of cytoplasmic transport	7.588140116254749e-10	1.673564302639985e-5	18	437	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050663	cytokine secretion	9.133479528244948e-10	2.0143889099544232e-5	12	162	125
MESH:D012130	Respiratory Hypersensitivity	GO:0001818	negative regulation of cytokine production	1.0634430003264583e-9	2.345423537220004e-5	13	203	125
MESH:D012130	Respiratory Hypersensitivity	GO:0031663	lipopolysaccharide-mediated signaling pathway	1.1536043231785698e-9	2.5442743347703356e-5	8	49	125
MESH:D012130	Respiratory Hypersensitivity	GO:0071621	granulocyte chemotaxis	1.184000897325177e-9	2.611313979050678e-5	10	99	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050864	regulation of B cell activation	1.3083034655636538e-9	2.8854632933006386e-5	10	100	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002366	leukocyte activation involved in immune response	1.432472140905361e-9	3.1593173067667735e-5	13	208	125
MESH:D012130	Respiratory Hypersensitivity	GO:0007259	JAK-STAT cascade	1.5888362847604753e-9	3.5041784260392284e-5	12	170	125
MESH:D012130	Respiratory Hypersensitivity	GO:0009612	response to mechanical stimulus	1.6105156097623308e-9	3.5519921773308205e-5	13	210	125
MESH:D012130	Respiratory Hypersensitivity	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.8079007180205053e-9	3.9873250335942245e-5	13	212	125
MESH:D012130	Respiratory Hypersensitivity	GO:0046427	positive regulation of JAK-STAT cascade	1.9726867916958213e-9	4.350760719085134e-5	9	76	125
MESH:D012130	Respiratory Hypersensitivity	GO:1903651	positive regulation of cytoplasmic transport	2.484197292318413e-9	5.47889712820826e-5	14	262	125
MESH:D012130	Respiratory Hypersensitivity	GO:0071363	cellular response to growth factor stimulus	2.6069908454218194e-9	5.7497183095778226e-5	20	594	125
MESH:D012130	Respiratory Hypersensitivity	GO:0045621	positive regulation of lymphocyte differentiation	2.802176268801304e-9	6.180199760841276e-5	9	79	125
MESH:D012130	Respiratory Hypersensitivity	GO:0034612	response to tumor necrosis factor	2.875763849274904e-9	6.3424971695758e-5	14	265	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002690	positive regulation of leukocyte chemotaxis	3.139608018010165e-9	6.924405483721419e-5	9	80	125
MESH:D012130	Respiratory Hypersensitivity	GO:0032355	response to estradiol	3.679231586062315e-9	8.114545263060435e-5	11	145	125
MESH:D012130	Respiratory Hypersensitivity	GO:1990748	cellular detoxification	3.923294356056317e-9	8.652825702282207e-5	9	82	125
MESH:D012130	Respiratory Hypersensitivity	GO:0002285	lymphocyte activation involved in immune response	3.956979299779562e-9	8.727117845663823e-5	11	146	125
Orphanet:183518	Rare hereditary ataxia	GO:0036477	somatodendritic compartment	2.34862862491525e-9	5.179900432250584e-5	21	649	126
DOID:4960	bone marrow cancer	GO:0030099	myeloid cell differentiation	2.120303932429124e-12	4.676330322972433e-8	20	327	126
DOID:4960	bone marrow cancer	GO:0071363	cellular response to growth factor stimulus	4.0456527017340704e-13	8.922687033674492e-9	24	594	126
DOID:4960	bone marrow cancer	GO:0014070	response to organic cyclic compound	1.1363132657038477e-12	2.506138907509836e-8	28	873	126
DOID:4960	bone marrow cancer	GO:0018108	peptidyl-tyrosine phosphorylation	1.4379608614945028e-12	3.171422680026126e-8	19	354	126
DOID:4960	bone marrow cancer	GO:0033993	response to lipid	3.5769165407373293e-12	7.88888943059618e-8	28	850	126
DOID:4960	bone marrow cancer	GO:0001775	cell activation	4.1311398746302075e-12	9.111228993496923e-8	28	854	126
DOID:4960	bone marrow cancer	GO:2000145	regulation of cell motility	6.48925357893404e-12	1.4312048768339025e-7	26	709	126
DOID:4960	bone marrow cancer	GO:0043069	negative regulation of programmed cell death	7.791212119911961e-12	1.718351833046583e-7	28	806	126
DOID:4960	bone marrow cancer	GO:0048872	homeostasis of number of cells	1.1058043369871484e-11	2.438851465225156e-7	15	208	126
DOID:4960	bone marrow cancer	GO:0030334	regulation of cell migration	1.4672596471143606e-11	3.2360411517107224e-7	24	660	126
DOID:4960	bone marrow cancer	GO:0097191	extrinsic apoptotic signaling pathway	2.373579111036861e-11	5.234928729391797e-7	15	220	126
DOID:4960	bone marrow cancer	GO:0002521	leukocyte differentiation	2.8017366204835525e-11	6.179230116476475e-7	20	448	126
DOID:4960	bone marrow cancer	GO:0014065	phosphatidylinositol 3-kinase signaling	3.738021003840686e-11	8.244205323970633e-7	13	154	126
DOID:4960	bone marrow cancer	GO:0001934	positive regulation of protein phosphorylation	1.2136525118222607e-10	2.676710614823996e-6	26	870	126
DOID:4960	bone marrow cancer	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.5577761303120496e-10	3.4356752554032255e-6	12	138	126
DOID:4960	bone marrow cancer	GO:2001233	regulation of apoptotic signaling pathway	3.1634861397122904e-10	6.9770686811354565e-6	17	359	126
DOID:4960	bone marrow cancer	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	3.2669789096217983e-10	7.205321985170876e-6	9	62	126
DOID:4960	bone marrow cancer	GO:0022603	regulation of anatomical structure morphogenesis	3.610173271439976e-10	7.962237150160867e-6	27	986	126
DOID:4960	bone marrow cancer	GO:0048732	gland development	4.797808816903171e-10	1.0581567345679943e-5	18	421	126
DOID:4960	bone marrow cancer	GO:0010942	positive regulation of cell death	5.096346678001851e-10	1.1239992598333082e-5	21	596	126
DOID:4960	bone marrow cancer	GO:0045596	negative regulation of cell differentiation	5.252055457205529e-10	1.1583408310866794e-5	21	597	126
DOID:4960	bone marrow cancer	GO:0007167	enzyme linked receptor protein signaling pathway	5.755751431024692e-10	1.2694309781124957e-5	26	935	126
DOID:4960	bone marrow cancer	GO:0048008	platelet-derived growth factor receptor signaling pathway	6.010519859600549e-10	1.3256201550349012e-5	8	45	126
DOID:4960	bone marrow cancer	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	6.010519859600549e-10	1.3256201550349012e-5	8	45	126
DOID:4960	bone marrow cancer	GO:1901698	response to nitrogen compound	6.644814698475443e-10	1.465513881748759e-5	25	870	126
DOID:4960	bone marrow cancer	GO:0071900	regulation of protein serine/threonine kinase activity	6.965992227492279e-10	1.5363495857734222e-5	18	431	126
DOID:4960	bone marrow cancer	GO:0061061	muscle structure development	8.298942644202612e-10	1.830331800178886e-5	20	551	126
DOID:4960	bone marrow cancer	GO:0046834	lipid phosphorylation	8.494679404336125e-10	1.8735015426263324e-5	10	95	126
DOID:4960	bone marrow cancer	GO:0006875	cellular metal ion homeostasis	1.3802011755714716e-9	3.0440336927228806e-5	18	450	126
DOID:4960	bone marrow cancer	GO:0009636	response to toxic substance	1.4293326522363259e-9	3.152393164507217e-5	14	249	126
DOID:4960	bone marrow cancer	GO:0050865	regulation of cell activation	1.8227133136150542e-9	4.019994213178002e-5	18	458	126
DOID:4960	bone marrow cancer	GO:0031958	corticosteroid receptor signaling pathway	2.115407404801317e-9	4.665531031289305e-5	6	19	126
DOID:4960	bone marrow cancer	GO:0004713	protein tyrosine kinase activity	2.2731241333673324e-9	5.013375276141652e-5	12	174	126
DOID:4960	bone marrow cancer	GO:0002244	hematopoietic progenitor cell differentiation	2.369760609965965e-9	5.226507025279936e-5	11	138	126
DOID:4960	bone marrow cancer	GO:0000302	response to reactive oxygen species	2.5040297613188045e-9	5.522637638588623e-5	13	216	126
DOID:4960	bone marrow cancer	GO:1901701	cellular response to oxygen-containing compound	3.687937843999123e-9	8.133746914940065e-5	24	873	126
DOID:4960	bone marrow cancer	GO:0031099	regeneration	3.790830871430728e-9	8.360677486940471e-5	12	182	126
DOID:4960	bone marrow cancer	GO:0048145	regulation of fibroblast proliferation	4.210159665340996e-9	9.285507141909566e-5	9	82	126
DOID:2490	congenital nervous system abnormality	GO:0030900	forebrain development	8.473222123939195e-13	1.8687691394347894e-8	22	357	127
DOID:2490	congenital nervous system abnormality	GO:0021537	telencephalon development	1.745270594710746e-13	3.8491942966345505e-9	17	226	127
DOID:2490	congenital nervous system abnormality	GO:0021543	pallium development	9.769962616701378e-14	2.154765255113489e-9	15	153	127
DOID:2490	congenital nervous system abnormality	GO:0000226	microtubule cytoskeleton organization	3.0645486148728196e-12	6.758861970102004e-8	21	412	127
DOID:2490	congenital nervous system abnormality	GO:0003002	regionalization	7.650731159714041e-10	1.687368757274932e-5	16	327	127
Orphanet:98062	Rare nervous system tumor	GO:0014070	response to organic cyclic compound	2.7036151095671812e-12	5.962823124150418e-8	31	873	127
Orphanet:98062	Rare nervous system tumor	GO:0042063	gliogenesis	5.491163079796024e-13	1.2110760172490131e-8	19	228	127
Orphanet:98062	Rare nervous system tumor	GO:0001763	morphogenesis of a branching structure	8.171241461241152e-14	1.8021673042767361e-9	16	193	127
Orphanet:98062	Rare nervous system tumor	GO:0023014	signal transduction by protein phosphorylation	1.3309353619206377e-12	2.9353779407159664e-8	32	879	127
Orphanet:98062	Rare nervous system tumor	GO:0033993	response to lipid	2.4026336475913013e-12	5.299008509762615e-8	29	850	127
Orphanet:98062	Rare nervous system tumor	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.9604874107747037e-11	6.529354984463609e-7	25	732	127
Orphanet:98062	Rare nervous system tumor	GO:0031175	neuron projection development	3.2043145914428806e-11	7.067115831427273e-7	26	796	127
Orphanet:98062	Rare nervous system tumor	GO:0097305	response to alcohol	6.348710446246741e-11	1.4002080889197188e-6	18	369	127
Orphanet:98062	Rare nervous system tumor	GO:0030879	mammary gland development	7.081135677822203e-11	1.561744473743687e-6	12	128	127
Orphanet:98062	Rare nervous system tumor	GO:0051052	regulation of DNA metabolic process	1.1947232092524018e-10	2.6349620380061722e-6	17	335	127
Orphanet:98062	Rare nervous system tumor	GO:0001649	osteoblast differentiation	1.319614417738535e-10	2.910409598322339e-6	14	206	127
Orphanet:98062	Rare nervous system tumor	GO:0051347	positive regulation of transferase activity	1.5555579047088486e-10	3.4307829588353655e-6	22	613	127
Orphanet:98062	Rare nervous system tumor	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.7082424363934479e-10	3.7675286934657493e-6	12	138	127
Orphanet:98062	Rare nervous system tumor	GO:0007346	regulation of mitotic cell cycle	2.435363022357251e-10	5.371193145808917e-6	19	453	127
Orphanet:98062	Rare nervous system tumor	GO:0045787	positive regulation of cell cycle	3.1771274500158597e-10	7.007154591009979e-6	16	308	127
Orphanet:98062	Rare nervous system tumor	GO:0061180	mammary gland epithelium development	4.704046041581478e-10	1.037477354470795e-5	9	64	127
Orphanet:98062	Rare nervous system tumor	GO:0007610	behavior	4.774570738774742e-10	1.0530315764367693e-5	23	714	127
Orphanet:98062	Rare nervous system tumor	GO:0007548	sex differentiation	5.769362765306596e-10	1.2724329578883697e-5	15	274	127
Orphanet:98062	Rare nervous system tumor	GO:0030334	regulation of cell migration	6.250824302611591e-10	1.3786192999409863e-5	22	660	127
Orphanet:98062	Rare nervous system tumor	GO:0033674	positive regulation of kinase activity	6.319074152827397e-10	1.3936718044060825e-5	19	480	127
Orphanet:98062	Rare nervous system tumor	GO:1901698	response to nitrogen compound	7.915615940490284e-10	1.745789095675132e-5	25	870	127
Orphanet:98062	Rare nervous system tumor	GO:0000785	chromatin	1.0244060044684034e-9	2.2593274428550636e-5	18	438	127
Orphanet:98062	Rare nervous system tumor	GO:0046620	regulation of organ growth	1.388392623091761e-9	3.062099930228879e-5	9	72	127
Orphanet:98062	Rare nervous system tumor	GO:0045860	positive regulation of protein kinase activity	1.5719072710140836e-9	3.466841486221561e-5	18	450	127
Orphanet:98062	Rare nervous system tumor	GO:0000228	nuclear chromosome	2.358904738208878e-9	5.20256440011968e-5	19	520	127
Orphanet:98062	Rare nervous system tumor	GO:0072073	kidney epithelium development	2.3860390330199266e-9	5.262409087325448e-5	11	137	127
Orphanet:98062	Rare nervous system tumor	GO:0060688	regulation of morphogenesis of a branching structure	2.5155557636935555e-9	5.5480582368261366e-5	8	53	127
Orphanet:98062	Rare nervous system tumor	GO:0001890	placenta development	2.5781543566694154e-9	5.6861194336343956e-5	11	138	127
Orphanet:98062	Rare nervous system tumor	GO:0030324	lung development	2.658508413411198e-9	5.863340305778397e-5	12	175	127
Orphanet:98062	Rare nervous system tumor	GO:0007405	neuroblast proliferation	2.936501708461492e-9	6.47645451801182e-5	8	54	127
Orphanet:98062	Rare nervous system tumor	GO:0071396	cellular response to lipid	3.368487044852486e-9	7.429198177422158e-5	17	416	127
Orphanet:98062	Rare nervous system tumor	GO:0001101	response to acid chemical	3.900312628424274e-9	8.602139501989736e-5	15	315	127
Orphanet:98062	Rare nervous system tumor	GO:0019827	stem cell population maintenance	4.355521165955167e-9	9.606101931514122e-5	11	145	127
Orphanet:165652	Rare genetic gastroenterological disease	GO:0060485	mesenchyme development	5.404565683875262e-13	1.191976961578689e-8	21	237	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0014033	neural crest cell differentiation	9.781064846947629e-14	2.1572138519942996e-9	14	75	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0040007	growth	8.445151244984572e-10	1.8625781070813474e-5	26	936	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0022408	negative regulation of cell-cell adhesion	1.7458509082857177e-9	3.85047417822415e-5	11	132	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0048729	tissue morphogenesis	2.142584665243419e-9	4.72547047919436e-5	21	635	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:1900180	regulation of protein localization to nucleus	2.5677623360920165e-9	5.6631998322509425e-5	13	213	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0046822	regulation of nucleocytoplasmic transport	2.876065385848392e-9	6.343162208488629e-5	13	215	128
Orphanet:165652	Rare genetic gastroenterological disease	GO:0042306	regulation of protein import into nucleus	2.9100091225586766e-9	6.418025119803161e-5	12	175	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0035239	tube morphogenesis	2.027267242965536e-12	4.471137904360489e-8	19	338	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007548	sex differentiation	5.131450819817474e-13	1.1317414783107438e-8	18	274	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001085	RNA polymerase II transcription factor binding	3.381739333008227e-13	7.458426098949644e-9	13	104	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009725	response to hormone	7.001066393286237e-13	1.5440851930392796e-8	31	865	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0040007	growth	9.93205517829665e-13	2.1905147695733262e-8	34	936	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048729	tissue morphogenesis	1.6296963778472673e-12	3.594295361342148e-8	26	635	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048608	reproductive structure development	2.426947531830592e-12	5.352632781452371e-8	26	418	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009790	embryo development	2.693623102345555e-12	5.940785752223121e-8	31	932	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0035270	endocrine system development	5.031197680693822e-12	1.1096306484770224e-7	13	129	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048732	gland development	5.564770866328672e-12	1.2273102145687886e-7	21	421	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048638	regulation of developmental growth	7.185252393071551e-12	1.5847074152919305e-7	17	283	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0010817	regulation of hormone levels	1.6385448553535298e-11	3.61381067848221e-7	21	473	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007224	smoothened signaling pathway	2.72130096234946e-11	6.001829272461734e-7	12	117	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0008406	gonad development	2.945466093251525e-11	6.496225468666239e-7	15	220	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0005815	microtubule organizing center	3.41481287691181e-11	7.531369800028997e-7	23	617	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0071375	cellular response to peptide hormone stimulus	1.1276246603131312e-10	2.486976188320611e-6	16	285	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007423	sensory organ development	1.6910173261663886e-10	3.72953871285997e-6	20	494	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0043410	positive regulation of MAPK cascade	4.160928268603925e-10	9.176927296405957e-6	19	464	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0042445	hormone metabolic process	5.202025477046845e-10	1.1473067189626818e-5	13	187	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0046661	male sex differentiation	5.343572251348405e-10	1.1785248600348908e-5	12	151	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0040014	regulation of multicellular organism growth	5.824047910607533e-10	1.2844937666844913e-5	9	65	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048639	positive regulation of developmental growth	6.222029558244913e-10	1.3722686190709155e-5	12	153	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0043473	pigmentation	6.45631770268551e-10	1.4239408693272892e-5	10	91	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048871	multicellular organismal homeostasis	6.581473144251504e-10	1.4515439019646692e-5	16	321	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009799	specification of symmetry	7.502424237415539e-10	1.6546596655619972e-5	11	122	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0003002	regionalization	8.607128343385284e-10	1.8983021561336244e-5	16	327	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0032147	activation of protein kinase activity	1.2805273508220694e-9	2.824203072238074e-5	15	288	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009953	dorsal/ventral pattern formation	1.4948077220466871e-9	3.2967984309739684e-5	10	99	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0021761	limbic system development	1.651388470413906e-9	3.6421372714978695e-5	10	100	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0040018	positive regulation of multicellular organism growth	1.7606004432124678e-9	3.883004277505098e-5	7	32	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048736	appendage development	1.8259636025419468e-9	4.0271627254062636e-5	12	168	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0060173	limb development	1.8259636025419468e-9	4.0271627254062636e-5	12	168	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0060562	epithelial tube morphogenesis	2.34331132276111e-9	5.1681731223496286e-5	15	301	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0072358	cardiovascular system development	2.3586598230096456e-9	5.2020242396477734e-5	25	910	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001764	neuron migration	2.5943165393726986e-9	5.721765127586487e-5	11	137	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.9869517970126935e-9	6.587722188311496e-5	21	647	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0044703	multi-organism reproductive process	3.3641534002981643e-9	7.419640324357601e-5	25	926	128
Orphanet:399831	Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0034754	cellular hormone metabolic process	3.5275172782789355e-9	7.779939357244192e-5	10	108	128
MESH:D057165	Proteostasis Deficiencies	GO:0031099	regeneration	1.6544543512964083e-12	3.6488990717842285e-8	15	182	128
MESH:D057165	Proteostasis Deficiencies	GO:0033993	response to lipid	2.322031456003515e-12	5.121240376215752e-8	29	850	128
MESH:D057165	Proteostasis Deficiencies	GO:0009636	response to toxic substance	1.4860668251515108e-11	3.277520382871657e-7	16	249	128
MESH:D057165	Proteostasis Deficiencies	GO:0060284	regulation of cell development	1.7069790025914244e-11	3.7647421902153866e-7	27	828	128
MESH:D057165	Proteostasis Deficiencies	GO:0034599	cellular response to oxidative stress	2.7244095868184104e-11	6.008685343728004e-7	15	219	128
MESH:D057165	Proteostasis Deficiencies	GO:0045597	positive regulation of cell differentiation	5.2323367860651615e-11	1.1539918781666714e-6	26	815	128
MESH:D057165	Proteostasis Deficiencies	GO:0042327	positive regulation of phosphorylation	8.642853099871672e-11	1.9061812511766973e-6	27	910	128
MESH:D057165	Proteostasis Deficiencies	GO:0010243	response to organonitrogen compound	1.0608802725187161e-10	2.3397714410400283e-6	25	780	128
MESH:D057165	Proteostasis Deficiencies	GO:0022603	regulation of anatomical structure morphogenesis	1.0656564519706535e-10	2.3503053048212763e-6	28	986	128
MESH:D057165	Proteostasis Deficiencies	GO:0043066	negative regulation of apoptotic process	1.552802331161729e-10	3.424705541377193e-6	25	795	128
MESH:D057165	Proteostasis Deficiencies	GO:0001934	positive regulation of protein phosphorylation	1.7494039550314255e-10	3.858310422821809e-6	26	870	128
MESH:D057165	Proteostasis Deficiencies	GO:0048545	response to steroid hormone	2.1563884011754908e-10	4.755914618792545e-6	19	446	128
MESH:D057165	Proteostasis Deficiencies	GO:0008284	positive regulation of cell proliferation	2.5323554364575784e-10	5.585109915107189e-6	25	815	128
MESH:D057165	Proteostasis Deficiencies	GO:0044419	interspecies interaction between organisms	3.444674545605153e-10	7.597229710332165e-6	24	761	128
MESH:D057165	Proteostasis Deficiencies	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.444674545605153e-10	7.597229710332165e-6	24	761	128
MESH:D057165	Proteostasis Deficiencies	GO:0009617	response to bacterium	3.709684781583178e-10	8.181709785781699e-6	20	517	128
MESH:D057165	Proteostasis Deficiencies	GO:0051129	negative regulation of cellular component organization	4.0719805305400314e-10	8.98075306010604e-6	21	579	128
MESH:D057165	Proteostasis Deficiencies	GO:0097305	response to alcohol	6.196154700432999e-10	1.3665619191804979e-5	17	369	128
MESH:D057165	Proteostasis Deficiencies	GO:0010942	positive regulation of cell death	6.883077441344199e-10	1.518062729688463e-5	21	596	128
MESH:D057165	Proteostasis Deficiencies	GO:0050767	regulation of neurogenesis	6.903283500392376e-10	1.5225191760115386e-5	22	658	128
MESH:D057165	Proteostasis Deficiencies	GO:1902533	positive regulation of intracellular signal transduction	7.484663999690611e-10	1.650742645131764e-5	25	860	128
MESH:D057165	Proteostasis Deficiencies	GO:0016032	viral process	7.711904448370888e-10	1.7008605260881993e-5	23	726	128
MESH:D057165	Proteostasis Deficiencies	GO:0009611	response to wounding	1.0582619225374401e-9	2.3339966701563242e-5	25	875	128
MESH:D057165	Proteostasis Deficiencies	GO:0043065	positive regulation of apoptotic process	1.2926948400604488e-9	2.8510384697533198e-5	20	556	128
MESH:D057165	Proteostasis Deficiencies	GO:0007568	aging	1.408657523960244e-9	3.106794169094318e-5	15	290	128
MESH:D057165	Proteostasis Deficiencies	GO:0009991	response to extracellular stimulus	2.158148437736429e-9	4.759796379427694e-5	20	573	128
MESH:D057165	Proteostasis Deficiencies	GO:0034097	response to cytokine	3.3207534499979374e-9	7.323921733970451e-5	23	784	128
MESH:D057165	Proteostasis Deficiencies	GO:0010720	positive regulation of cell development	3.4191283138085282e-9	7.540887496104709e-5	18	469	128
MESH:D057165	Proteostasis Deficiencies	GO:0034358	plasma lipoprotein particle	4.268288167352807e-9	9.413709553096616e-5	7	36	128
Orphanet:101433	Rare urogenital disease	GO:0008610	lipid biosynthetic process	3.9745984281580604e-13	8.765976833302602e-9	26	627	129
Orphanet:101433	Rare urogenital disease	GO:0040007	growth	1.3166134849029731e-12	2.9037910409535073e-8	31	936	129
Orphanet:101433	Rare urogenital disease	GO:0021537	telencephalon development	3.5408342924370118e-12	7.80931003196983e-8	16	226	129
Orphanet:101433	Rare urogenital disease	GO:0001655	urogenital system development	4.139688591919821e-12	9.130083189479166e-8	18	313	129
Orphanet:101433	Rare urogenital disease	GO:0035295	tube development	6.458389378849461e-12	1.4243977775052485e-7	23	573	129
Orphanet:101433	Rare urogenital disease	GO:0060485	mesenchyme development	7.736589147100403e-12	1.706304736392994e-7	16	237	129
Orphanet:101433	Rare urogenital disease	GO:0048511	rhythmic process	1.0012102258372124e-11	2.208169153083972e-7	18	329	129
Orphanet:101433	Rare urogenital disease	GO:0048609	multicellular organismal reproductive process	2.3924862091462273e-11	5.276628334272004e-7	26	767	129
Orphanet:101433	Rare urogenital disease	GO:0009790	embryo development	3.5524805319653296e-11	7.834995813249535e-7	28	932	129
Orphanet:101433	Rare urogenital disease	GO:0014070	response to organic cyclic compound	3.771116752204762e-11	8.317197996987602e-7	27	873	129
Orphanet:101433	Rare urogenital disease	GO:0030855	epithelial cell differentiation	4.9674486746198454e-11	1.095570805187407e-6	22	568	129
Orphanet:101433	Rare urogenital disease	GO:0051241	negative regulation of multicellular organismal process	8.00227661912345e-11	1.7649021083476768e-6	28	966	129
Orphanet:101433	Rare urogenital disease	GO:0035270	endocrine system development	9.287970392790612e-11	2.0484618701299695e-6	12	129	129
Orphanet:101433	Rare urogenital disease	GO:0051093	negative regulation of developmental process	1.534945504033658e-10	3.3853223091462326e-6	25	788	129
Orphanet:101433	Rare urogenital disease	GO:1901698	response to nitrogen compound	2.09906425574502e-10	4.629486216045642e-6	26	870	129
Orphanet:101433	Rare urogenital disease	GO:0051960	regulation of nervous system development	2.61169863513544e-10	5.760101339791213e-6	24	744	129
Orphanet:101433	Rare urogenital disease	GO:0060284	regulation of cell development	4.0942804702126523e-10	9.029935577054005e-6	25	828	129
Orphanet:101433	Rare urogenital disease	GO:0048729	tissue morphogenesis	4.137613585086797e-10	9.12550676190893e-6	22	635	129
Orphanet:101433	Rare urogenital disease	GO:0050767	regulation of neurogenesis	8.050053956765169e-10	1.775439400164558e-5	22	658	129
Orphanet:101433	Rare urogenital disease	GO:0022602	ovulation cycle process	9.637506348525449e-10	2.1255520251672877e-5	10	94	129
Orphanet:101433	Rare urogenital disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.0545303519293725e-9	2.325766691180231e-5	23	732	129
Orphanet:101433	Rare urogenital disease	GO:0009887	organ morphogenesis	1.3854967173543287e-9	3.055713010124972e-5	26	950	129
Orphanet:101433	Rare urogenital disease	GO:0048598	embryonic morphogenesis	1.6814069025983258e-9	3.7083429236806076e-5	20	560	129
Orphanet:101433	Rare urogenital disease	GO:0007411	axon guidance	3.1663699440187543e-9	6.983428911533363e-5	13	215	129
Orphanet:101433	Rare urogenital disease	GO:0048568	embryonic organ development	3.210392063301981e-9	7.08051969561252e-5	17	408	129
Orphanet:101433	Rare urogenital disease	GO:0010243	response to organonitrogen compound	3.5247518237468967e-9	7.77384014727378e-5	23	780	129
OMIM:125853	type 2 diabetes mellitus	GO:1901653	cellular response to peptide	3.870903597658071e-12	8.537277884634875e-8	26	301	129
OMIM:125853	type 2 diabetes mellitus	GO:0010038	response to metal ion	3.825162409043514e-12	8.436395693145471e-8	20	335	129
OMIM:125853	type 2 diabetes mellitus	GO:0014070	response to organic cyclic compound	3.391065206415078e-12	7.478994312748455e-8	40	873	129
OMIM:125853	type 2 diabetes mellitus	GO:0036293	response to decreased oxygen levels	3.3657521214536246e-12	7.423166303865969e-8	19	302	129
OMIM:125853	type 2 diabetes mellitus	GO:0048511	rhythmic process	2.6618707238412753e-12	5.870755881431933e-8	23	329	129
OMIM:125853	type 2 diabetes mellitus	GO:0042886	amide transport	2.6618707238412753e-12	5.870755881431933e-8	27	329	129
OMIM:125853	type 2 diabetes mellitus	GO:0046879	hormone secretion	2.5799362646239388e-12	5.690049431628097e-8	29	297	129
OMIM:125853	type 2 diabetes mellitus	GO:0002237	response to molecule of bacterial origin	2.2930546350607983e-12	5.057331997626591e-8	19	333	129
OMIM:125853	type 2 diabetes mellitus	GO:0071375	cellular response to peptide hormone stimulus	2.276845378901271e-12	5.021582483166753e-8	25	285	129
OMIM:125853	type 2 diabetes mellitus	GO:0007568	aging	1.970645868709653e-12	4.3462594634391394e-8	19	290	129
OMIM:125853	type 2 diabetes mellitus	GO:0009991	response to extracellular stimulus	1.8107737531636303e-12	3.9936615126023867e-8	27	573	129
OMIM:125853	type 2 diabetes mellitus	GO:0005996	monosaccharide metabolic process	1.7830181775480014e-12	3.932446590582117e-8	25	282	129
OMIM:125853	type 2 diabetes mellitus	GO:0098857	membrane microdomain	1.5689671784002712e-12	3.460357111961798e-8	18	283	129
OMIM:125853	type 2 diabetes mellitus	GO:0042180	cellular ketone metabolic process	1.1743939154484906e-12	2.590125780521646e-8	18	253	129
OMIM:125853	type 2 diabetes mellitus	GO:0001666	response to hypoxia	9.798828415341632e-13	2.161131607003597e-8	19	292	129
OMIM:125853	type 2 diabetes mellitus	GO:0006979	response to oxidative stress	8.870681966755001e-13	1.9564289077678154e-8	21	386	129
OMIM:125853	type 2 diabetes mellitus	GO:0045121	membrane raft	8.293365993949919e-13	1.8291018699656547e-8	18	282	129
OMIM:125853	type 2 diabetes mellitus	GO:0032496	response to lipopolysaccharide	7.867040352493859e-13	1.7350757497425207e-8	19	319	129
OMIM:125853	type 2 diabetes mellitus	GO:0034284	response to monosaccharide	7.58948459633757e-13	1.673860827722251e-8	22	188	129
OMIM:125853	type 2 diabetes mellitus	GO:0010565	regulation of cellular ketone metabolic process	7.580602812140569e-13	1.6719019502176025e-8	18	188	129
OMIM:125853	type 2 diabetes mellitus	GO:0044262	cellular carbohydrate metabolic process	6.87894186057747e-13	1.517150627350361e-8	20	271	129
OMIM:125853	type 2 diabetes mellitus	GO:0001101	response to acid chemical	6.803446694902959e-13	1.5005001685608477e-8	19	315	129
OMIM:125853	type 2 diabetes mellitus	GO:0032869	cellular response to insulin stimulus	6.787903572558207e-13	1.4970721329277126e-8	18	186	129
OMIM:125853	type 2 diabetes mellitus	GO:0072593	reactive oxygen species metabolic process	6.756817327868703e-13	1.4902160616614424e-8	18	223	129
OMIM:125853	type 2 diabetes mellitus	GO:0008643	carbohydrate transport	5.968558980384842e-13	1.3163656831238768e-8	22	184	129
OMIM:125853	type 2 diabetes mellitus	GO:0097305	response to alcohol	5.950795411990839e-13	1.3124479281145796e-8	22	369	129
OMIM:125853	type 2 diabetes mellitus	GO:0009746	response to hexose	5.526690216584029e-13	1.2189115272676077e-8	22	181	129
OMIM:125853	type 2 diabetes mellitus	GO:0046883	regulation of hormone secretion	4.640732242933154e-13	1.0235134961789072e-8	28	252	129
OMIM:125853	type 2 diabetes mellitus	GO:0019318	hexose metabolic process	4.3431924723336124e-13	9.578910997731782e-9	24	237	129
OMIM:125853	type 2 diabetes mellitus	GO:0010675	regulation of cellular carbohydrate metabolic process	4.141131881851834e-13	9.13326636542422e-9	17	153	129
OMIM:125853	type 2 diabetes mellitus	GO:0043279	response to alkaloid	3.1885605267234496e-13	7.032370241688568e-9	16	140	129
OMIM:125853	type 2 diabetes mellitus	GO:0019216	regulation of lipid metabolic process	3.1019631308026874e-13	6.841379684985327e-9	18	272	129
OMIM:125853	type 2 diabetes mellitus	GO:0015758	glucose transport	2.8488322811881517e-13	6.2830995961604685e-9	22	144	129
OMIM:125853	type 2 diabetes mellitus	GO:0006006	glucose metabolic process	2.347011474057581e-13	5.176333806033995e-9	24	199	129
OMIM:125853	type 2 diabetes mellitus	GO:0043255	regulation of carbohydrate biosynthetic process	2.2737367544323206e-13	5.014726411900483e-9	16	87	129
OMIM:125853	type 2 diabetes mellitus	GO:2001234	negative regulation of apoptotic signaling pathway	1.9761969838327786e-13	4.358502447843193e-9	17	199	129
OMIM:125853	type 2 diabetes mellitus	GO:1903409	reactive oxygen species biosynthetic process	4.3298697960381105e-14	9.549527835162053e-10	13	83	129
OMIM:125853	type 2 diabetes mellitus	GO:0010827	regulation of glucose transport	7.66053886991358e-15	1.68953184775944e-10	15	99	129
OMIM:125853	type 2 diabetes mellitus	GO:0046323	glucose import	8.326672684688674e-15	1.836447660608087e-10	13	72	129
OMIM:125853	type 2 diabetes mellitus	GO:0010907	positive regulation of glucose metabolic process	1.687538997430238e-14	3.72186725883239e-10	10	36	129
OMIM:125853	type 2 diabetes mellitus	GO:0034612	response to tumor necrosis factor	3.019806626980426e-14	6.660183515805329e-10	18	265	129
OMIM:125853	type 2 diabetes mellitus	GO:0045444	fat cell differentiation	1.0869083411080283e-13	2.3971763463137563e-9	16	196	129
OMIM:125853	type 2 diabetes mellitus	GO:0032881	regulation of polysaccharide metabolic process	3.331779296900095e-13	7.348239239313159e-9	10	42	129
OMIM:125853	type 2 diabetes mellitus	GO:0046324	regulation of glucose import	4.699574063238288e-13	1.0364910596472043e-8	11	60	129
OMIM:125853	type 2 diabetes mellitus	GO:0043200	response to amino acid	5.537792446830281e-13	1.2213601241484184e-8	15	112	129
OMIM:125853	type 2 diabetes mellitus	GO:0001678	cellular glucose homeostasis	5.544453784978032e-13	1.2228292822769049e-8	14	125	129
OMIM:125853	type 2 diabetes mellitus	GO:0045912	negative regulation of carbohydrate metabolic process	6.090683513093609e-13	1.3433002488127954e-8	10	45	129
OMIM:125853	type 2 diabetes mellitus	GO:0045923	positive regulation of fatty acid metabolic process	6.737943536450075e-13	1.486053446964064e-8	9	32	129
OMIM:125853	type 2 diabetes mellitus	GO:1900542	regulation of purine nucleotide metabolic process	8.045786259458509e-13	1.7744981595235743e-8	16	203	129
OMIM:125853	type 2 diabetes mellitus	GO:0042327	positive regulation of phosphorylation	9.00834962180852e-13	1.986791509089869e-8	30	910	129
OMIM:125853	type 2 diabetes mellitus	GO:0000302	response to reactive oxygen species	9.445777493510832e-13	2.083266226193814e-8	16	216	129
OMIM:125853	type 2 diabetes mellitus	GO:0046321	positive regulation of fatty acid oxidation	2.0676793610618915e-12	4.560266830822002e-8	7	14	129
OMIM:125853	type 2 diabetes mellitus	GO:0097191	extrinsic apoptotic signaling pathway	2.5359714328487826e-12	5.59308499514799e-8	16	220	129
OMIM:125853	type 2 diabetes mellitus	GO:0032885	regulation of polysaccharide biosynthetic process	2.9403146584172646e-12	6.484863979139277e-8	9	37	129
OMIM:125853	type 2 diabetes mellitus	GO:0071407	cellular response to organic cyclic compound	3.482769628249116e-12	7.681248415103425e-8	23	416	129
OMIM:125853	type 2 diabetes mellitus	GO:0035094	response to nicotine	3.5194069880617462e-12	7.762052112170181e-8	10	54	129
OMIM:125853	type 2 diabetes mellitus	GO:0071322	cellular response to carbohydrate stimulus	3.680167282027469e-12	8.116608940511583e-8	13	124	129
OMIM:125853	type 2 diabetes mellitus	GO:0031667	response to nutrient levels	4.250266805172487e-12	9.37396343880792e-8	26	546	129
OMIM:125853	type 2 diabetes mellitus	GO:0048732	gland development	4.758859972753271e-12	1.0495665669907339e-7	22	421	129
OMIM:125853	type 2 diabetes mellitus	GO:0010677	negative regulation of cellular carbohydrate metabolic process	4.902855899047154e-12	1.0813248685348498e-7	9	39	129
OMIM:125853	type 2 diabetes mellitus	GO:0006111	regulation of gluconeogenesis	4.902855899047154e-12	1.0813248685348498e-7	9	39	129
OMIM:125853	type 2 diabetes mellitus	GO:0097285	cell-type specific apoptotic process	5.176081785407405e-12	1.1415848377716031e-7	23	429	129
OMIM:125853	type 2 diabetes mellitus	GO:0042493	response to drug	5.249467527335128e-12	1.1577700631537624e-7	29	433	129
OMIM:125853	type 2 diabetes mellitus	GO:0001934	positive regulation of protein phosphorylation	5.33739719088544e-12	1.1771629504497838e-7	28	870	129
OMIM:125853	type 2 diabetes mellitus	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	5.448086426440568e-12	1.2015754613514673e-7	19	359	129
OMIM:125853	type 2 diabetes mellitus	GO:0007623	circadian rhythm	6.007971897759035e-12	1.325058202050755e-7	15	196	129
OMIM:125853	type 2 diabetes mellitus	GO:0048545	response to steroid hormone	6.209588399030963e-12	1.369524721406279e-7	25	446	129
OMIM:125853	type 2 diabetes mellitus	GO:1902533	positive regulation of intracellular signal transduction	6.302180999284701e-12	1.3899460193922408e-7	29	860	129
OMIM:125853	type 2 diabetes mellitus	GO:0051050	positive regulation of transport	6.3974381347975395e-12	1.4109549806295973e-7	34	920	129
OMIM:125853	type 2 diabetes mellitus	GO:0051051	negative regulation of transport	6.663891660707577e-12	1.469721305769056e-7	23	452	129
OMIM:125853	type 2 diabetes mellitus	GO:0030855	epithelial cell differentiation	7.121303546853142e-12	1.5706034972584604e-7	23	568	129
OMIM:125853	type 2 diabetes mellitus	GO:2000674	regulation of type B pancreatic cell apoptotic process	7.991607375856802e-12	1.7625490067452176e-7	6	9	129
OMIM:125853	type 2 diabetes mellitus	GO:0003013	circulatory system process	8.721134925337992e-12	1.9234463077832942e-7	22	493	129
OMIM:125853	type 2 diabetes mellitus	GO:0008015	blood circulation	8.927081296405959e-12	1.9688677799223342e-7	22	489	129
OMIM:125853	type 2 diabetes mellitus	GO:0051384	response to glucocorticoid	9.591216709736727e-12	2.1153428453324352e-7	14	167	129
OMIM:125853	type 2 diabetes mellitus	GO:0010828	positive regulation of glucose transport	1.0069167721837857e-11	2.2207549410513394e-7	9	42	129
OMIM:125853	type 2 diabetes mellitus	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.1707412816974738e-11	2.5820698967837785e-7	11	83	129
OMIM:125853	type 2 diabetes mellitus	GO:0071356	cellular response to tumor necrosis factor	1.2139733662763774e-11	2.6774182593225504e-7	16	243	129
OMIM:125853	type 2 diabetes mellitus	GO:0071396	cellular response to lipid	1.2291279105625108e-11	2.7108416067456176e-7	20	416	129
OMIM:125853	type 2 diabetes mellitus	GO:0006809	nitric oxide biosynthetic process	1.4109713397658652e-11	3.1118972898536157e-7	10	62	129
OMIM:125853	type 2 diabetes mellitus	GO:0008284	positive regulation of cell proliferation	1.8401280499347195e-11	4.058402414131024e-7	27	815	129
OMIM:125853	type 2 diabetes mellitus	GO:0043467	regulation of generation of precursor metabolites and energy	1.9717005805830468e-11	4.3485856304759096e-7	11	87	129
OMIM:125853	type 2 diabetes mellitus	GO:0010563	negative regulation of phosphorus metabolic process	2.1162183116985034e-11	4.667319486451049e-7	22	537	129
OMIM:125853	type 2 diabetes mellitus	GO:0045936	negative regulation of phosphate metabolic process	2.1162183116985034e-11	4.667319486451049e-7	22	537	129
OMIM:125853	type 2 diabetes mellitus	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	2.42014186468964e-11	5.337622882573001e-7	9	46	129
OMIM:125853	type 2 diabetes mellitus	GO:0046887	positive regulation of hormone secretion	2.4340529591881932e-11	5.36830380148956e-7	12	115	129
OMIM:125853	type 2 diabetes mellitus	GO:0040007	growth	3.759081934617825e-11	8.290655206799613e-7	28	936	129
OMIM:125853	type 2 diabetes mellitus	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	3.877043130984248e-11	8.550818625385759e-7	25	732	129
OMIM:125853	type 2 diabetes mellitus	GO:0009611	response to wounding	4.216793580980038e-11	9.300138242851475e-7	27	875	129
OMIM:125853	type 2 diabetes mellitus	GO:0070873	regulation of glycogen metabolic process	6.505407323942336e-11	1.4347675852954822e-6	8	34	129
OMIM:125853	type 2 diabetes mellitus	GO:0032101	regulation of response to external stimulus	1.399473870122847e-10	3.0865396205559392e-6	27	920	129
OMIM:125853	type 2 diabetes mellitus	GO:0010876	lipid localization	1.4081447119451695e-10	3.1056631621950714e-6	17	333	129
OMIM:125853	type 2 diabetes mellitus	GO:0031016	pancreas development	1.4720202834439533e-10	3.246540735135639e-6	10	78	129
OMIM:125853	type 2 diabetes mellitus	GO:0008217	regulation of blood pressure	1.515394476570009e-10	3.3422025180751547e-6	13	168	129
OMIM:125853	type 2 diabetes mellitus	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.581680342255254e-10	3.4883959948439625e-6	28	996	129
OMIM:125853	type 2 diabetes mellitus	GO:0009894	regulation of catabolic process	1.6831147586771067e-10	3.712109600262359e-6	24	727	129
OMIM:125853	type 2 diabetes mellitus	GO:0046326	positive regulation of glucose import	1.7137857799554013e-10	3.7797545376916375e-6	8	38	129
OMIM:125853	type 2 diabetes mellitus	GO:0003014	renal system process	2.4053703473470023e-10	5.3050443010738135e-6	11	109	129
OMIM:125853	type 2 diabetes mellitus	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.6645707862371637e-10	5.8767108690460645e-6	8	40	129
OMIM:125853	type 2 diabetes mellitus	GO:0044057	regulation of system process	3.1652835907891586e-10	6.981032959485489e-6	20	508	129
OMIM:125853	type 2 diabetes mellitus	GO:0071333	cellular response to glucose stimulus	3.2369784630503773e-10	7.139156000257607e-6	11	112	129
OMIM:125853	type 2 diabetes mellitus	GO:0010883	regulation of lipid storage	3.291266148508498e-10	7.258887490535493e-6	8	41	129
OMIM:125853	type 2 diabetes mellitus	GO:0090277	positive regulation of peptide hormone secretion	3.513268564958594e-10	7.748513820016178e-6	10	85	129
OMIM:125853	type 2 diabetes mellitus	GO:0008286	insulin receptor signaling pathway	3.563520589722202e-10	7.859344660632317e-6	11	113	129
OMIM:125853	type 2 diabetes mellitus	GO:0032024	positive regulation of insulin secretion	4.0333514306212237e-10	8.895556580235109e-6	9	62	129
OMIM:125853	type 2 diabetes mellitus	GO:0006954	inflammatory response	4.3756298584440856e-10	9.65045165279843e-6	22	637	129
OMIM:125853	type 2 diabetes mellitus	GO:0045725	positive regulation of glycogen biosynthetic process	4.601476977228458e-10	1.0148557473277364e-5	6	15	129
OMIM:125853	type 2 diabetes mellitus	GO:0000165	MAPK cascade	5.862440533022095e-10	1.2929612595580231e-5	25	843	129
OMIM:125853	type 2 diabetes mellitus	GO:0071496	cellular response to external stimulus	5.883062925704508e-10	1.2975095282641291e-5	15	270	129
OMIM:125853	type 2 diabetes mellitus	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	6.971170307679131e-10	1.5374916113586323e-5	10	91	129
OMIM:125853	type 2 diabetes mellitus	GO:0010942	positive regulation of cell death	7.980557326092708e-10	1.7601119182697467e-5	21	596	129
OMIM:125853	type 2 diabetes mellitus	GO:0003018	vascular process in circulatory system	1.0618640411408364e-9	2.3419411427361148e-5	12	159	129
OMIM:125853	type 2 diabetes mellitus	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1.317745468298881e-9	2.906287630333182e-5	10	97	129
OMIM:125853	type 2 diabetes mellitus	GO:0050727	regulation of inflammatory response	1.4996510699916143e-9	3.3074804348665054e-5	15	289	129
OMIM:125853	type 2 diabetes mellitus	GO:0009150	purine ribonucleotide metabolic process	1.677543992606445e-9	3.6998232756935145e-5	19	501	129
OMIM:125853	type 2 diabetes mellitus	GO:0032000	positive regulation of fatty acid beta-oxidation	1.7947653363492577e-9	3.958354949318288e-5	5	9	129
OMIM:125853	type 2 diabetes mellitus	GO:0043086	negative regulation of catalytic activity	1.8621941766383543e-9	4.1070692565758904e-5	24	822	129
OMIM:125853	type 2 diabetes mellitus	GO:0045981	positive regulation of nucleotide metabolic process	1.897162871244973e-9	4.1841927125307876e-5	11	132	129
OMIM:125853	type 2 diabetes mellitus	GO:1900544	positive regulation of purine nucleotide metabolic process	1.897162871244973e-9	4.1841927125307876e-5	11	132	129
OMIM:125853	type 2 diabetes mellitus	GO:0046888	negative regulation of hormone secretion	2.0482291418488785e-9	4.5173693723477015e-5	9	74	129
OMIM:125853	type 2 diabetes mellitus	GO:0043549	regulation of kinase activity	2.207920291041887e-9	4.869568201892882e-5	23	761	129
OMIM:125853	type 2 diabetes mellitus	GO:0048659	smooth muscle cell proliferation	2.625607509187944e-9	5.79077736151401e-5	10	104	129
OMIM:125853	type 2 diabetes mellitus	GO:0030141	secretory granule	2.6906284977812334e-9	5.93418115185651e-5	16	351	129
OMIM:125853	type 2 diabetes mellitus	GO:0071312	cellular response to alkaloid	2.937975085437472e-9	6.479704050932344e-5	7	34	129
OMIM:125853	type 2 diabetes mellitus	GO:0031983	vesicle lumen	3.166832684975418e-9	6.984449486713284e-5	10	106	129
OMIM:125853	type 2 diabetes mellitus	GO:0071216	cellular response to biotic stimulus	3.182465291295955e-9	7.018927199953229e-5	12	175	129
OMIM:125853	type 2 diabetes mellitus	GO:0050880	regulation of blood vessel size	3.2871623201202738e-9	7.249836497025264e-5	11	139	129
OMIM:125853	type 2 diabetes mellitus	GO:0043627	response to estrogen	3.541997140033004e-9	7.81187469234279e-5	13	217	129
OMIM:125853	type 2 diabetes mellitus	GO:0008585	female gonad development	3.805654236188616e-9	8.393370417913992e-5	10	108	129
OMIM:125853	type 2 diabetes mellitus	GO:0043408	regulation of MAPK cascade	3.848840579578905e-9	8.488617898261275e-5	21	651	129
OMIM:125853	type 2 diabetes mellitus	GO:0034599	cellular response to oxidative stress	3.958745886656345e-9	8.731014053020569e-5	13	219	129
Orphanet:98639	Lens and zonula anomaly	GO:0048598	embryonic morphogenesis	4.7854054052720585e-11	1.0554211621327525e-6	22	560	130
Orphanet:98639	Lens and zonula anomaly	GO:0072358	cardiovascular system development	3.3020757239654586e-9	7.282728009205819e-5	25	910	130
MESH:D054220	Malformations of Cortical Development	GO:0021543	pallium development	5.491163079796024e-13	1.2110760172490131e-8	18	153	131
MESH:D054220	Malformations of Cortical Development	GO:0007017	microtubule-based process	5.878630915390204e-13	1.2965320483893095e-8	25	591	131
MESH:D054220	Malformations of Cortical Development	GO:0000226	microtubule cytoskeleton organization	4.247713292215849e-12	9.368331665982055e-8	21	412	131
MESH:D054220	Malformations of Cortical Development	GO:0021761	limbic system development	1.1066125793490755e-10	2.440634043754386e-6	11	100	131
MESH:D054220	Malformations of Cortical Development	GO:0021766	hippocampus development	2.0745790640930295e-9	4.5754841258571766e-5	9	73	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0060562	epithelial tube morphogenesis	3.5562663924793014e-12	7.843345528613099e-8	24	301	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001654	eye development	2.694955369975105e-12	5.943724068480094e-8	26	327	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0003002	regionalization	2.694955369975105e-12	5.943724068480094e-8	25	327	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0043010	camera-type eye development	2.4780177909633494e-12	5.465268237969667e-8	23	283	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048562	embryonic organ morphogenesis	1.7423840148467207e-12	3.8428279447444424e-8	25	280	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0050673	epithelial cell proliferation	1.5241141682054149e-12	3.3614337979770426e-8	19	335	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001655	urogenital system development	1.1155520951433573e-12	2.4603501458386745e-8	26	313	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0072001	renal system development	5.53335155473178e-13	1.2203806853960941e-8	24	276	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0055123	digestive system development	5.360156762890256e-13	1.1821825740554459e-8	16	150	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0090596	sensory organ morphogenesis	4.007905118896815e-13	8.839434739726926e-9	21	239	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0021915	neural tube development	3.737010700888277e-13	8.241977100809095e-9	15	151	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0043583	ear development	3.33510996597397e-13	7.355585029955591e-9	20	196	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0035107	appendage morphogenesis	7.061018436615996e-14	1.5573076161956578e-9	18	146	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0035108	limb morphogenesis	7.061018436615996e-14	1.5573076161956578e-9	18	146	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001763	morphogenesis of a branching structure	6.017408793468348e-14	1.3271395093994443e-9	16	193	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048839	inner ear development	3.1530333899354446e-14	6.954015141502623e-10	18	170	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0035113	embryonic appendage morphogenesis	2.3225865675158275e-13	5.1224646746561575e-9	16	125	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0030326	embryonic limb morphogenesis	2.3225865675158275e-13	5.1224646746561575e-9	16	125	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0009855	determination of bilateral symmetry	2.432498646953718e-13	5.364875765856425e-9	19	121	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0008589	regulation of smoothened signaling pathway	2.65898414397725e-13	5.864389529541825e-9	13	62	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0060541	respiratory system development	6.828981824469338e-13	1.5061319413867125e-8	16	202	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001822	kidney development	6.979972155818359e-13	1.539432858965739e-8	22	262	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001656	metanephros development	9.192646643896296e-13	2.027438217311328e-8	12	88	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0016331	morphogenesis of embryonic epithelium	9.992007221626409e-13	2.2037371927297045e-8	14	141	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0072358	cardiovascular system development	1.1441958491786863e-12	2.5235239453635927e-8	46	910	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0042471	ear morphogenesis	1.4804824033376462e-12	3.265203940561179e-8	13	112	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0061138	morphogenesis of a branching epithelium	1.642130875723069e-12	3.621719646407229e-8	15	179	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0060993	kidney morphogenesis	1.7221779557985428e-12	3.798263481513686e-8	12	92	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0007417	central nervous system development	2.510436303282404e-12	5.536767266889342e-8	30	889	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0007420	brain development	4.710787315787002e-12	1.0389641424968232e-7	26	669	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048732	gland development	4.866440583839449e-12	1.0732934707657904e-7	26	421	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0035270	endocrine system development	6.267986130126246e-12	1.3824043409993436e-7	13	129	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001501	skeletal system development	6.571521105058764e-12	1.4493489797207104e-7	25	482	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0007507	heart development	6.7795768998735184e-12	1.4952356852671045e-7	38	487	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0035148	tube formation	7.919886968466017e-12	1.74673107089518e-7	13	131	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001085	RNA polymerase II transcription factor binding	8.429479336768964e-12	1.859121667724395e-7	12	104	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048565	digestive tract development	1.5135892539319684e-11	3.3382210995469563e-7	13	138	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0032838	cell projection cytoplasm	1.7038148669712427e-11	3.757763689105076e-7	12	110	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001944	vasculature development	1.845057440164055e-11	4.0692741842818236e-7	23	588	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0060675	ureteric bud morphogenesis	2.2501667196195285e-11	4.96274270012087e-7	10	64	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001838	embryonic epithelial tube formation	2.895006456782312e-11	6.384936740433389e-7	12	115	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0003007	heart morphogenesis	3.112110569247761e-11	6.863759860475938e-7	15	216	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048754	branching morphogenesis of an epithelial tube	3.4093061707096695e-11	7.519224759500176e-7	13	147	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048538	thymus development	3.4165892337512105e-11	7.535287555038295e-7	9	47	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0097014	ciliary cytoplasm	3.426925410110471e-11	7.558083991998643e-7	11	90	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0005930	axoneme	3.426925410110471e-11	7.558083991998643e-7	11	90	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0022603	regulation of anatomical structure morphogenesis	3.942901560805012e-11	8.696069392355454e-7	29	986	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0042472	inner ear morphogenesis	4.379085982719744e-11	9.658074134888395e-7	11	92	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048589	developmental growth	5.1114112942229895e-11	1.1273217609408803e-6	22	558	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001568	blood vessel development	6.92896851006708e-11	1.5281840048952944e-6	22	569	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:2000027	regulation of organ morphogenesis	1.1194412063986192e-10	2.4689275807121547e-6	15	236	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0000904	cell morphogenesis involved in differentiation	1.9287094144004868e-10	4.253768613460274e-6	24	720	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0043066	negative regulation of apoptotic process	2.5345858745140504e-10	5.590029146240738e-6	25	795	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001658	branching involved in ureteric bud morphogenesis	2.918253416694938e-10	6.436207910520686e-6	9	59	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0032400	melanosome localization	3.080999899651715e-10	6.795145278681858e-6	7	25	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0060021	palate development	4.0910341780886483e-10	9.022775879774514e-6	10	85	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0050678	regulation of epithelial cell proliferation	1.0405564188076255e-9	2.294947181680218e-5	15	277	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0001894	tissue homeostasis	1.3197379855611757e-9	2.910682127155173e-5	13	197	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0009952	anterior/posterior pattern specification	1.4932579617266128e-9	3.2933804345880446e-5	13	199	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048592	eye morphogenesis	3.0712704601754126e-9	6.773686999916873e-5	11	136	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0048854	brain morphogenesis	3.272229487372158e-9	7.216902134399295e-5	7	34	131
Orphanet:93547	Syndromic renal or urinary tract malformation	GO:0030900	forebrain development	4.304113843112134e-9	9.492723080983811e-5	16	357	131
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0009416	response to light stimulus	2.5281998716764065e-12	5.5759448169823145e-8	23	297	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0006302	double-strand break repair	8.189005029635155e-13	1.8060850592860334e-8	17	192	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0032508	DNA duplex unwinding	1.0147438445073931e-13	2.2380175490610554e-9	13	76	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000732	strand displacement	6.084022174945858e-14	1.341831090684309e-9	10	26	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0004003	ATP-dependent DNA helicase activity	1.7319479184152442e-14	3.819811134064821e-10	10	33	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000731	DNA synthesis involved in DNA repair	5.395683899678261e-14	1.1900180840740404e-9	11	37	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:1990391	DNA repair complex	1.1823875212257917e-13	2.6077556780634836e-9	10	37	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0006289	nucleotide-excision repair	4.547473508864641e-13	1.0029452823800966e-8	16	115	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0022626	cytosolic ribosome	5.589972928987663e-13	1.2328685294882291e-8	13	107	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0072358	cardiovascular system development	1.7965628984484283e-12	3.9623194725280086e-8	32	910	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0043009	chordate embryonic development	2.6033619704435296e-12	5.7417148258132045e-8	24	552	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0051726	regulation of cell cycle	5.758504784125762e-12	1.2700382301389368e-7	30	930	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0007507	heart development	6.632472349110685e-12	1.4627917765963616e-7	25	487	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0048534	hematopoietic or lymphoid organ development	8.498868275808036e-12	1.8744253982294623e-7	29	739	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0044419	interspecies interaction between organisms	1.0712430942305673e-11	2.3626266443255162e-7	27	761	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0044403	symbiosis, encompassing mutualism through parasitism	1.0712430942305673e-11	2.3626266443255162e-7	27	761	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0009887	organ morphogenesis	1.0729195309977513e-11	2.3663240256155404e-7	30	950	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0048589	developmental growth	1.1219136730744594e-11	2.4743806059657203e-7	23	558	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0016032	viral process	1.7080892256160496e-11	3.7671907870961974e-7	26	726	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0051052	regulation of DNA metabolic process	2.1747381673264954e-11	4.796385028038586e-7	18	335	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0048732	gland development	2.215638783553686e-11	4.886591337127655e-7	20	421	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0030097	hemopoiesis	2.497191342598626e-11	5.507555506101269e-7	25	695	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0060249	anatomical structure homeostasis	5.4133697524605395e-11	1.193918698905172e-6	18	351	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0045786	negative regulation of cell cycle	6.138922703513572e-11	1.3539394022599183e-6	20	449	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0007346	regulation of mitotic cell cycle	6.826994525255259e-11	1.5056936425450473e-6	20	453	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0005694	chromosome	7.904799037561361e-11	1.7434034277341581e-6	27	876	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0050673	epithelial cell proliferation	2.257910525216289e-10	4.979821663364525e-6	17	335	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0035264	multicellular organism growth	2.4617485827604924e-10	5.429386499278266e-6	12	137	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000075	cell cycle checkpoint	3.058164832481225e-10	6.744782538037342e-6	14	211	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000109	nucleotide-excision repair complex	3.1921676413304567e-10	7.040325732954322e-6	6	14	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000405	bubble DNA binding	3.398351600125693e-10	7.495064454077216e-6	5	7	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0010212	response to ionizing radiation	4.775968509562745e-10	1.0533398547840633e-5	12	145	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0001503	ossification	7.862377415790434e-10	1.73404733905258e-5	17	363	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0007569	cell aging	8.741054546845817e-10	1.927839580306845e-5	10	91	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000724	double-strand break repair via homologous recombination	9.74950231658056e-10	2.1502527359218426e-5	10	92	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000781	chromosome, telomeric region	1.7172865351966493e-9	3.78747545337621e-5	12	162	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0001934	positive regulation of protein phosphorylation	1.8449624050731472e-9	4.069064584388826e-5	25	870	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:1901990	regulation of mitotic cell cycle phase transition	2.3888117040016255e-9	5.268524213175585e-5	15	292	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000784	nuclear chromosome, telomeric region	2.4241113560918848e-9	5.346377595860652e-5	11	132	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0000723	telomere maintenance	2.627108974806447e-9	5.7940888439356186e-5	11	133	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0043549	regulation of kinase activity	3.50603002186034e-9	7.73254921321298e-5	23	761	132
Orphanet:183422	Polymalformative genetic syndrome with increased risk of developing cancer	GO:0008285	negative regulation of cell proliferation	3.6995914109994033e-9	8.159448856959184e-5	21	634	132
Orphanet:93548	Glomerular disease	GO:0002684	positive regulation of immune system process	3.746780663504978e-12	8.26352475336023e-8	37	872	132
Orphanet:93548	Glomerular disease	GO:1901701	cellular response to oxygen-containing compound	3.4270364324129332e-12	7.558328851686724e-8	32	873	132
Orphanet:93548	Glomerular disease	GO:0046649	lymphocyte activation	1.290745288429207e-12	2.846738733630616e-8	29	594	132
Orphanet:93548	Glomerular disease	GO:0001944	vasculature development	7.538414337204813e-13	1.6625972820705215e-8	29	588	132
Orphanet:93548	Glomerular disease	GO:0030155	regulation of cell adhesion	6.037392807911601e-13	1.3315469837849037e-8	34	621	132
Orphanet:93548	Glomerular disease	GO:0050863	regulation of T cell activation	7.083222897108499e-14	1.5622048099572794e-9	18	284	132
Orphanet:93548	Glomerular disease	GO:0022409	positive regulation of cell-cell adhesion	9.144907053837414e-13	2.0169092507238418e-8	17	239	132
Orphanet:93548	Glomerular disease	GO:0022603	regulation of anatomical structure morphogenesis	5.082934073641354e-12	1.1210411099416007e-7	36	986	132
Orphanet:93548	Glomerular disease	GO:1901342	regulation of vasculature development	6.0281779568072125e-12	1.3295146483738307e-7	16	228	132
Orphanet:93548	Glomerular disease	GO:0050839	cell adhesion molecule binding	4.199085523737267e-11	9.261083122602543e-7	14	182	132
Orphanet:93548	Glomerular disease	GO:0060284	regulation of cell development	1.302858931850892e-10	2.8734553741971425e-6	26	828	132
Orphanet:93548	Glomerular disease	GO:0010631	epithelial cell migration	4.682333409888884e-10	1.0326886335509933e-5	14	218	132
Orphanet:93548	Glomerular disease	GO:2000377	regulation of reactive oxygen species metabolic process	5.601585861825242e-10	1.2354297618255572e-5	12	147	132
Orphanet:93548	Glomerular disease	GO:0045596	negative regulation of cell differentiation	1.270798910546489e-9	2.8027469972102814e-5	21	597	132
Orphanet:93548	Glomerular disease	GO:0046651	lymphocyte proliferation	2.6453009782656522e-9	5.834211307564896e-5	14	249	132
Orphanet:93548	Glomerular disease	GO:0000302	response to reactive oxygen species	4.445770973582341e-9	9.805147882235854e-5	13	216	132
MESH:D015427	Reperfusion Injury	GO:0002684	positive regulation of immune system process	3.966604822380759e-12	8.748346935760765e-8	34	872	133
MESH:D015427	Reperfusion Injury	GO:0014070	response to organic cyclic compound	3.5411673593443993e-12	7.810044611034073e-8	32	873	133
MESH:D015427	Reperfusion Injury	GO:0002237	response to molecule of bacterial origin	3.524514013975022e-12	7.773315657821911e-8	32	333	133
MESH:D015427	Reperfusion Injury	GO:1901701	cellular response to oxygen-containing compound	3.483213717458966e-12	7.68222785385575e-8	31	873	133
MESH:D015427	Reperfusion Injury	GO:0032103	positive regulation of response to external stimulus	2.1871393585115584e-12	4.823735855197242e-8	22	285	133
MESH:D015427	Reperfusion Injury	GO:0036293	response to decreased oxygen levels	2.0616841567289157e-12	4.5470444076656236e-8	19	302	133
MESH:D015427	Reperfusion Injury	GO:0050727	regulation of inflammatory response	1.3706813462022183e-12	3.0230377090489924e-8	20	289	133
MESH:D015427	Reperfusion Injury	GO:0001934	positive regulation of protein phosphorylation	1.3420375921668892e-12	2.9598639095240742e-8	31	870	133
MESH:D015427	Reperfusion Injury	GO:0001944	vasculature development	1.057154364048074e-12	2.3315539499080273e-8	28	588	133
MESH:D015427	Reperfusion Injury	GO:0007568	aging	1.0107470416187425e-12	2.2292026002901366e-8	19	290	133
MESH:D015427	Reperfusion Injury	GO:0032496	response to lipopolysaccharide	9.36584143573782e-13	2.0656363286519763e-8	32	319	133
MESH:D015427	Reperfusion Injury	GO:0071363	cellular response to growth factor stimulus	8.411049634560186e-13	1.855056996902249e-8	25	594	133
MESH:D015427	Reperfusion Injury	GO:0030335	positive regulation of cell migration	6.250555628639631e-13	1.3785600438964707e-8	28	387	133
MESH:D015427	Reperfusion Injury	GO:0071219	cellular response to molecule of bacterial origin	6.092903959142859e-13	1.3437899681889576e-8	19	158	133
MESH:D015427	Reperfusion Injury	GO:0000302	response to reactive oxygen species	5.81312775693732e-13	1.2820853267925258e-8	17	216	133
MESH:D015427	Reperfusion Injury	GO:0001568	blood vessel development	5.411227022023013e-13	1.1934461197071755e-8	28	569	133
MESH:D015427	Reperfusion Injury	GO:1901342	regulation of vasculature development	5.32018873400375e-13	1.1733676252845271e-8	18	228	133
MESH:D015427	Reperfusion Injury	GO:0009636	response to toxic substance	5.007105841059456e-13	1.104317193245663e-8	20	249	133
MESH:D015427	Reperfusion Injury	GO:1903036	positive regulation of response to wounding	4.851674617611934e-13	1.070036836914312e-8	16	162	133
MESH:D015427	Reperfusion Injury	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.3165471197426086e-13	9.520144672592323e-9	15	151	133
MESH:D015427	Reperfusion Injury	GO:0072593	reactive oxygen species metabolic process	3.3018032752352156e-13	7.282127123531268e-9	22	223	133
MESH:D015427	Reperfusion Injury	GO:0071222	cellular response to lipopolysaccharide	3.1596947280831955e-13	6.968706722787488e-9	19	152	133
MESH:D015427	Reperfusion Injury	GO:2000377	regulation of reactive oxygen species metabolic process	2.873257187729905e-13	6.336968727538306e-9	17	147	133
MESH:D015427	Reperfusion Injury	GO:0090130	tissue migration	2.3159252293680765e-13	5.107773093371293e-9	17	227	133
MESH:D015427	Reperfusion Injury	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.3026025530725747e-13	5.0783899308015634e-9	17	195	133
MESH:D015427	Reperfusion Injury	GO:0010631	epithelial cell migration	2.2537527399890678e-13	4.970651668045889e-9	17	218	133
MESH:D015427	Reperfusion Injury	GO:0048520	positive regulation of behavior	2.0938806244430452e-13	4.618053717209136e-9	15	145	133
MESH:D015427	Reperfusion Injury	GO:0001819	positive regulation of cytokine production	1.5054624213917123e-13	3.3202973703794214e-9	24	381	133
MESH:D015427	Reperfusion Injury	GO:1903409	reactive oxygen species biosynthetic process	5.3512749786932545e-14	1.1802236965507973e-9	16	83	133
MESH:D015427	Reperfusion Injury	GO:2000379	positive regulation of reactive oxygen species metabolic process	5.284661597215745e-14	1.1655321152659326e-9	14	83	133
MESH:D015427	Reperfusion Injury	GO:0002687	positive regulation of leukocyte migration	7.760458942129844e-14	1.7115692196867371e-9	14	109	133
MESH:D015427	Reperfusion Injury	GO:0005126	cytokine receptor binding	9.403589018575076e-14	2.073961558046733e-9	20	270	133
MESH:D015427	Reperfusion Injury	GO:0070555	response to interleukin-1	9.792167077193881e-14	2.1596624488751104e-9	14	119	133
MESH:D015427	Reperfusion Injury	GO:0001666	response to hypoxia	1.283417816466681e-13	2.830577994217265e-9	19	292	133
MESH:D015427	Reperfusion Injury	GO:0046209	nitric oxide metabolic process	1.3444800828210646e-13	2.965250822661858e-9	13	65	133
MESH:D015427	Reperfusion Injury	GO:0097305	response to alcohol	1.4377388168895777e-13	3.1709329606499637e-9	21	369	133
MESH:D015427	Reperfusion Injury	GO:1903426	regulation of reactive oxygen species biosynthetic process	1.4832579608992091e-13	3.2713254327632058e-9	12	63	133
MESH:D015427	Reperfusion Injury	GO:0010942	positive regulation of cell death	1.8041124150158794e-13	3.978969931317522e-9	25	596	133
MESH:D015427	Reperfusion Injury	GO:0006809	nitric oxide biosynthetic process	1.9384494009955233e-13	4.275250153895627e-9	13	62	133
MESH:D015427	Reperfusion Injury	GO:0070851	growth factor receptor binding	2.09277040141842e-13	4.6156051203283255e-9	14	126	133
MESH:D015427	Reperfusion Injury	GO:0010634	positive regulation of epithelial cell migration	2.1449508835758024e-13	4.730689173726432e-9	13	101	133
MESH:D015427	Reperfusion Injury	GO:0045428	regulation of nitric oxide biosynthetic process	2.318145675417327e-13	5.112670287132914e-9	11	51	133
MESH:D015427	Reperfusion Injury	GO:0045429	positive regulation of nitric oxide biosynthetic process	3.297362383136715e-13	7.272332736008025e-9	10	40	133
MESH:D015427	Reperfusion Injury	GO:1904018	positive regulation of vasculature development	3.5849101465146305e-13	7.906519328138017e-9	14	131	133
MESH:D015427	Reperfusion Injury	GO:0009612	response to mechanical stimulus	4.4375614294267507e-13	9.787041732600699e-9	20	210	133
MESH:D015427	Reperfusion Injury	GO:0060548	negative regulation of cell death	5.704325900524054e-13	1.2580890773605802e-8	34	867	133
MESH:D015427	Reperfusion Injury	GO:0031349	positive regulation of defense response	1.3004042287434459e-12	2.86804152649367e-8	21	398	133
MESH:D015427	Reperfusion Injury	GO:0045765	regulation of angiogenesis	2.2173374247813626e-12	4.890337690355295e-8	16	208	133
MESH:D015427	Reperfusion Injury	GO:0007167	enzyme linked receptor protein signaling pathway	2.6395552410463097e-12	5.821539084127636e-8	30	935	133
MESH:D015427	Reperfusion Injury	GO:0045766	positive regulation of angiogenesis	2.7184920980971583e-12	5.995634322353283e-8	13	119	133
MESH:D015427	Reperfusion Injury	GO:0050921	positive regulation of chemotaxis	2.7184920980971583e-12	5.995634322353283e-8	13	119	133
MESH:D015427	Reperfusion Injury	GO:0043068	positive regulation of programmed cell death	2.7355895326763857e-12	6.033342714317769e-8	25	561	133
MESH:D015427	Reperfusion Injury	GO:1902533	positive regulation of intracellular signal transduction	3.808509063674137e-12	8.399666739933309e-8	39	860	133
MESH:D015427	Reperfusion Injury	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	4.479860926664969e-12	9.88033327375959e-8	12	97	133
MESH:D015427	Reperfusion Injury	GO:0043065	positive regulation of apoptotic process	5.4821702732965605e-12	1.2090926537755564e-7	24	556	133
MESH:D015427	Reperfusion Injury	GO:0042493	response to drug	5.626721311102756e-12	1.2409733851637128e-7	23	433	133
MESH:D015427	Reperfusion Injury	GO:0060326	cell chemotaxis	6.725842105481661e-12	1.4833844763639803e-7	16	228	133
MESH:D015427	Reperfusion Injury	GO:0008284	positive regulation of cell proliferation	1.2713385899587593e-11	2.8039372601540435e-7	28	815	133
MESH:D015427	Reperfusion Injury	GO:0048545	response to steroid hormone	1.2774226121337051e-11	2.8173555710608866e-7	21	446	133
MESH:D015427	Reperfusion Injury	GO:0009991	response to extracellular stimulus	1.4160228545279097e-11	3.123038405661305e-7	23	573	133
MESH:D015427	Reperfusion Injury	GO:0051384	response to glucocorticoid	1.464983689913879e-11	3.2310215281050603e-7	14	167	133
MESH:D015427	Reperfusion Injury	GO:0044057	regulation of system process	1.7711832001054972e-11	3.906344547832674e-7	22	508	133
MESH:D015427	Reperfusion Injury	GO:0032635	interleukin-6 production	1.8014811864475178e-11	3.9731667567100004e-7	12	109	133
MESH:D015427	Reperfusion Injury	GO:0050880	regulation of blood vessel size	1.9881096768870066e-11	4.384775892374293e-7	13	139	133
MESH:D015427	Reperfusion Injury	GO:0050729	positive regulation of inflammatory response	3.0890845437170356e-11	6.812975961167922e-7	12	114	133
MESH:D015427	Reperfusion Injury	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	3.142330839978058e-11	6.930410667571607e-7	24	647	133
MESH:D015427	Reperfusion Injury	GO:1903524	positive regulation of blood circulation	3.565969741714525e-11	7.864746265351386e-7	11	89	133
MESH:D015427	Reperfusion Injury	GO:0031667	response to nutrient levels	4.720068780272868e-11	1.041011169489181e-6	22	546	133
MESH:D015427	Reperfusion Injury	GO:0034599	cellular response to oxidative stress	4.8221204806964124e-11	1.0635186720175938e-6	15	219	133
MESH:D015427	Reperfusion Injury	GO:0019932	second-messenger-mediated signaling	4.8221204806964124e-11	1.0635186720175938e-6	15	219	133
MESH:D015427	Reperfusion Injury	GO:1901698	response to nitrogen compound	7.839873195081282e-11	1.7290840331751767e-6	27	870	133
MESH:D015427	Reperfusion Injury	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	8.995393319111145e-11	1.983933996529963e-6	18	359	133
MESH:D015427	Reperfusion Injury	GO:0045597	positive regulation of cell differentiation	1.1403844535351482e-10	2.5151179122717693e-6	26	815	133
MESH:D015427	Reperfusion Injury	GO:0043410	positive regulation of MAPK cascade	1.1875633809665942e-10	2.6191710367218235e-6	20	464	133
MESH:D015427	Reperfusion Injury	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.2985923447672576e-10	2.8640454163841866e-6	13	161	133
MESH:D015427	Reperfusion Injury	GO:0032675	regulation of interleukin-6 production	1.8014367775265328e-10	3.973068812834768e-6	11	103	133
MESH:D015427	Reperfusion Injury	GO:0097285	cell-type specific apoptotic process	2.1875823374983838e-10	4.8247128453526855e-6	19	429	133
MESH:D015427	Reperfusion Injury	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.2267565569222825e-10	4.911111586292094e-6	13	168	133
MESH:D015427	Reperfusion Injury	GO:0010243	response to organonitrogen compound	2.384662467491694e-10	5.259373072052931e-6	25	780	133
MESH:D015427	Reperfusion Injury	GO:0071260	cellular response to mechanical stimulus	2.5764479438805665e-10	5.6823559402285895e-6	10	80	133
MESH:D015427	Reperfusion Injury	GO:0002690	positive regulation of leukocyte chemotaxis	2.5764479438805665e-10	5.6823559402285895e-6	10	80	133
MESH:D015427	Reperfusion Injury	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	3.3077829364458466e-10	7.295315266331315e-6	10	82	133
MESH:D015427	Reperfusion Injury	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	4.751770088518015e-10	1.0480028930226482e-5	10	85	133
MESH:D015427	Reperfusion Injury	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	5.242660749971151e-10	1.1562688284061373e-5	13	180	133
MESH:D015427	Reperfusion Injury	GO:0032940	secretion by cell	6.518181550063673e-10	1.4375849408665431e-5	27	956	133
MESH:D015427	Reperfusion Injury	GO:0005125	cytokine activity	6.578355637998357e-10	1.4508563359605375e-5	14	222	133
MESH:D015427	Reperfusion Injury	GO:0043542	endothelial cell migration	8.340580448518153e-10	1.8395150179206787e-5	12	151	133
MESH:D015427	Reperfusion Injury	GO:0033002	muscle cell proliferation	8.340580448518153e-10	1.8395150179206787e-5	12	151	133
MESH:D015427	Reperfusion Injury	GO:0032642	regulation of chemokine production	9.436865733292166e-10	2.081300737477587e-5	9	66	133
MESH:D015427	Reperfusion Injury	GO:0071407	cellular response to organic cyclic compound	9.69623492608207e-10	2.1385046129474006e-5	18	416	133
MESH:D015427	Reperfusion Injury	GO:0071347	cellular response to interleukin-1	1.0501530756101829e-9	2.3161126082582584e-5	10	92	133
MESH:D015427	Reperfusion Injury	GO:0032755	positive regulation of interleukin-6 production	1.2415265482346172e-9	2.738186802131448e-5	9	68	133
MESH:D015427	Reperfusion Injury	GO:0050678	regulation of epithelial cell proliferation	1.2891140377391253e-9	2.8431410102336407e-5	15	277	133
MESH:D015427	Reperfusion Injury	GO:0032844	regulation of homeostatic process	1.4666522440975882e-9	3.234701524357231e-5	18	427	133
MESH:D015427	Reperfusion Injury	GO:0008083	growth factor activity	1.5120464880169493e-9	3.334818529321382e-5	12	159	133
MESH:D015427	Reperfusion Injury	GO:0034614	cellular response to reactive oxygen species	1.7397657758877472e-9	3.8370534187204264e-5	11	127	133
MESH:D015427	Reperfusion Injury	GO:0010574	regulation of vascular endothelial growth factor production	1.8102118692908675e-9	3.992422277721008e-5	7	31	133
MESH:D015427	Reperfusion Injury	GO:0050663	cytokine secretion	1.8736971973964955e-9	4.132439168857971e-5	12	162	133
MESH:D015427	Reperfusion Injury	GO:0031663	lipopolysaccharide-mediated signaling pathway	1.8917655220107576e-9	4.172288858794726e-5	8	49	133
MESH:D015427	Reperfusion Injury	GO:0050918	positive chemotaxis	2.238622620609476e-9	4.9372821897541996e-5	8	50	133
MESH:D015427	Reperfusion Injury	GO:0032722	positive regulation of chemokine production	2.238622620609476e-9	4.9372821897541996e-5	8	50	133
MESH:D015427	Reperfusion Injury	GO:0050776	regulation of immune response	3.050732999554384e-9	6.728391630517194e-5	24	816	133
MESH:D015427	Reperfusion Injury	GO:0006801	superoxide metabolic process	3.1005353839930194e-9	6.838230789396604e-5	8	52	133
MESH:D015427	Reperfusion Injury	GO:0006953	acute-phase response	3.6299053762789413e-9	8.005756307383205e-5	8	53	133
MESH:D015427	Reperfusion Injury	GO:0051241	negative regulation of multicellular organismal process	3.878590004724458e-9	8.554230255419792e-5	26	966	133
MESH:D015427	Reperfusion Injury	GO:0051767	nitric-oxide synthase biosynthetic process	4.164994460431615e-9	9.185895282481926e-5	6	20	133
MESH:D015427	Reperfusion Injury	GO:0051769	regulation of nitric-oxide synthase biosynthetic process	4.164994460431615e-9	9.185895282481926e-5	6	20	133
Orphanet:98692	Nervous system anomaly with eye involvement	GO:0051298	centrosome duplication	1.5519030505117826e-11	3.4227221779037365e-7	10	60	135
Orphanet:98692	Nervous system anomaly with eye involvement	GO:0060322	head development	4.847977574939932e-11	1.069221454153002e-6	25	708	135
Orphanet:98692	Nervous system anomaly with eye involvement	GO:0007420	brain development	4.711461221162949e-10	1.0391127723274884e-5	23	669	135
DOID:2326	gastroenteritis	GO:2000377	regulation of reactive oxygen species metabolic process	5.102585021177219e-13	1.1253751264206358e-8	16	147	136
DOID:2326	gastroenteritis	GO:0046822	regulation of nucleocytoplasmic transport	2.582378755278114e-13	5.695436344765881e-9	21	215	136
DOID:2326	gastroenteritis	GO:0007260	tyrosine phosphorylation of STAT protein	1.1901590823981678e-13	2.624895856229159e-9	12	71	136
DOID:2326	gastroenteritis	GO:1900182	positive regulation of protein localization to nucleus	1.0191847366058937e-13	2.2478119365842986e-9	17	125	136
DOID:2326	gastroenteritis	GO:2001057	reactive nitrogen species metabolic process	1.7641443861293737e-13	3.890820443608334e-9	12	68	136
DOID:2326	gastroenteritis	GO:0006809	nitric oxide biosynthetic process	2.0228263508670352e-13	4.461343516837246e-9	12	62	136
DOID:2326	gastroenteritis	GO:0006801	superoxide metabolic process	2.438049762076844e-13	5.377118750260479e-9	11	52	136
DOID:2326	gastroenteritis	GO:0032609	interferon-gamma production	5.504485756091526e-13	1.2140143335059861e-8	13	102	136
DOID:2326	gastroenteritis	GO:1903708	positive regulation of hemopoiesis	8.716471988634567e-12	1.9224178970933536e-7	14	158	136
DOID:2326	gastroenteritis	GO:0043069	negative regulation of programmed cell death	8.728795464207906e-12	1.9251358396310536e-7	30	806	136
DOID:2326	gastroenteritis	GO:0046364	monosaccharide biosynthetic process	5.85091974869556e-11	1.2904203505748058e-6	11	91	136
DOID:2326	gastroenteritis	GO:0001910	regulation of leukocyte mediated cytotoxicity	1.038844565925956e-10	2.291171690149696e-6	9	51	136
DOID:2326	gastroenteritis	GO:0070851	growth factor receptor binding	1.3106482565916622e-10	2.890634729912911e-6	12	126	136
DOID:2326	gastroenteritis	GO:0019318	hexose metabolic process	2.0456170091165404e-10	4.51160831360653e-6	15	237	136
DOID:2326	gastroenteritis	GO:0006006	glucose metabolic process	2.096487428104865e-10	4.62380302268528e-6	14	199	136
DOID:2326	gastroenteritis	GO:0009895	negative regulation of catabolic process	3.771468692903568e-10	8.317974202198819e-6	14	208	136
DOID:2326	gastroenteritis	GO:0002705	positive regulation of leukocyte mediated immunity	4.660297703296123e-10	1.02782865846196e-5	10	83	136
DOID:2326	gastroenteritis	GO:0032757	positive regulation of interleukin-8 production	7.536261614760065e-10	1.6621224991353323e-5	8	43	136
DOID:2326	gastroenteritis	GO:0097191	extrinsic apoptotic signaling pathway	7.869590534781423e-10	1.735638192446043e-5	14	220	136
DOID:2326	gastroenteritis	GO:0005125	cytokine activity	8.854290634019435e-10	1.9528137993329864e-5	14	222	136
DOID:2326	gastroenteritis	GO:0032102	negative regulation of response to external stimulus	1.5984028545190654e-9	3.525277495641799e-5	15	275	136
DOID:2326	gastroenteritis	GO:1903035	negative regulation of response to wounding	1.9561048336669273e-9	4.314189210652408e-5	12	159	136
DOID:2326	gastroenteritis	GO:0031663	lipopolysaccharide-mediated signaling pathway	2.258858655679319e-9	4.981912765100738e-5	8	49	136
DOID:2326	gastroenteritis	GO:0051092	positive regulation of NF-kappaB transcription factor activity	2.8306336163907986e-9	6.242962440949906e-5	11	130	136
DOID:2326	gastroenteritis	GO:0006979	response to oxidative stress	3.17877080213691e-9	7.010779004112955e-5	17	386	136
DOID:2326	gastroenteritis	GO:0070374	positive regulation of ERK1 and ERK2 cascade	3.668676362700296e-9	8.091265717935503e-5	12	168	136
DOID:2773	contact dermatitis	GO:0002684	positive regulation of immune system process	2.5839330675125893e-12	5.698864380399016e-8	30	872	136
DOID:2773	contact dermatitis	GO:0072593	reactive oxygen species metabolic process	2.1538326677728037e-13	4.7502779487729185e-9	18	223	136
DOID:2773	contact dermatitis	GO:0070663	regulation of leukocyte proliferation	7.260858581048524e-14	1.601382360050252e-9	17	200	136
DOID:2773	contact dermatitis	GO:0006979	response to oxidative stress	1.2156942119645464e-13	2.681213584487807e-9	22	386	136
DOID:2773	contact dermatitis	GO:0032944	regulation of mononuclear cell proliferation	1.566524687746096e-13	3.4549701988240145e-9	16	191	136
DOID:2773	contact dermatitis	GO:0009636	response to toxic substance	4.758415883543421e-13	1.0494686231155015e-8	18	249	136
DOID:2773	contact dermatitis	GO:0042108	positive regulation of cytokine biosynthetic process	5.205835762467359e-13	1.148147077412176e-8	11	59	136
DOID:2773	contact dermatitis	GO:0033993	response to lipid	1.956435013994451e-12	4.3149174233647614e-8	32	850	136
DOID:2773	contact dermatitis	GO:0014070	response to organic cyclic compound	1.970645868709653e-12	4.3462594634391394e-8	29	873	136
DOID:2773	contact dermatitis	GO:0097305	response to alcohol	3.2303049124493555e-12	7.124437484407053e-8	20	369	136
DOID:2773	contact dermatitis	GO:0000302	response to reactive oxygen species	3.6742830999969556e-12	8.103631377043286e-8	16	216	136
DOID:2773	contact dermatitis	GO:0010035	response to inorganic substance	6.0426108561273395e-12	1.3326978243188847e-7	23	502	136
DOID:2773	contact dermatitis	GO:1902533	positive regulation of intracellular signal transduction	7.032485704883129e-12	1.551014722211974e-7	29	860	136
DOID:2773	contact dermatitis	GO:0050670	regulation of lymphocyte proliferation	7.65965069149388e-12	1.6893359600089752e-7	15	189	136
DOID:2773	contact dermatitis	GO:0050671	positive regulation of lymphocyte proliferation	8.299472220585358e-12	1.8304485982501006e-7	13	127	136
DOID:2773	contact dermatitis	GO:0050900	leukocyte migration	1.1330492100114498e-11	2.4989400326802524e-7	19	354	136
DOID:2773	contact dermatitis	GO:0031347	regulation of defense response	1.1683765066550222e-11	2.5768543854276516e-7	28	749	136
DOID:2773	contact dermatitis	GO:1903409	reactive oxygen species biosynthetic process	2.0979884496341583e-11	4.627113525668136e-7	11	83	136
DOID:2773	contact dermatitis	GO:0032103	positive regulation of response to external stimulus	2.795408349243189e-11	6.165273114255854e-7	17	285	136
DOID:2773	contact dermatitis	GO:0050727	regulation of inflammatory response	3.638955803353383e-11	8.025717024295886e-7	17	289	136
DOID:2773	contact dermatitis	GO:2000377	regulation of reactive oxygen species metabolic process	5.460920604605235e-11	1.2044060393456846e-6	13	147	136
DOID:2773	contact dermatitis	GO:0032602	chemokine production	1.0972889263882735e-10	2.420070727149337e-6	10	72	136
DOID:2773	contact dermatitis	GO:0007159	leukocyte cell-cell adhesion	1.5582024559535057e-10	3.436615516605457e-6	20	461	136
DOID:2773	contact dermatitis	GO:0098869	cellular oxidant detoxification	2.82906698068075e-10	6.239507225891394e-6	10	79	136
DOID:2773	contact dermatitis	GO:0009410	response to xenobiotic stimulus	3.138012072412266e-10	6.920885625705253e-6	11	106	136
DOID:2773	contact dermatitis	GO:0034109	homotypic cell-cell adhesion	5.228442123694776e-10	1.153132910380883e-5	20	495	136
DOID:2773	contact dermatitis	GO:0002521	leukocyte differentiation	6.595630708261524e-10	1.4546663527070791e-5	19	448	136
DOID:2773	contact dermatitis	GO:0071345	cellular response to cytokine stimulus	6.901139659731825e-10	1.522046351953854e-5	23	677	136
DOID:2773	contact dermatitis	GO:0030155	regulation of cell adhesion	7.710895255641503e-10	1.7006379486317336e-5	22	621	136
DOID:2773	contact dermatitis	GO:0050776	regulation of immune response	9.646902165982851e-10	2.127624272707518e-5	25	816	136
DOID:2773	contact dermatitis	GO:0032612	interleukin-1 production	1.1511204212055759e-9	2.5387960889688976e-5	9	66	136
DOID:2773	contact dermatitis	GO:0060326	cell chemotaxis	1.2532785920171818e-9	2.7641059346938945e-5	14	228	136
DOID:2773	contact dermatitis	GO:0042104	positive regulation of activated T cell proliferation	1.2715324348988588e-9	2.804364785169433e-5	7	29	136
DOID:2773	contact dermatitis	GO:1902107	positive regulation of leukocyte differentiation	2.206955507233488e-9	4.8674403712034575e-5	11	127	136
DOID:2773	contact dermatitis	GO:0097285	cell-type specific apoptotic process	2.274121668754958e-9	5.01557534043906e-5	18	429	136
DOID:2773	contact dermatitis	GO:0051050	positive regulation of transport	2.309248126053376e-9	5.0930467420107206e-5	26	920	136
DOID:2773	contact dermatitis	GO:0009725	response to hormone	3.133241666120057e-9	6.910364494627785e-5	25	865	136
DOID:2773	contact dermatitis	GO:0046427	positive regulation of JAK-STAT cascade	4.166574640862564e-9	9.189380370422384e-5	9	76	136
DOID:2773	contact dermatitis	GO:0048545	response to steroid hormone	4.181559876137442e-9	9.222430306821128e-5	18	446	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002250	adaptive immune response	2.980060642698845e-12	6.572523747472303e-8	20	334	136
MESH:D006969	Hypersensitivity, Immediate	GO:0034341	response to interferon-gamma	2.582378755278114e-13	5.695436344765881e-9	15	155	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002673	regulation of acute inflammatory response	5.704325900524054e-12	1.2580890773605802e-7	11	74	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042098	T cell proliferation	2.0017876245503885e-11	4.414942605945882e-7	14	167	136
MESH:D006969	Hypersensitivity, Immediate	GO:0032386	regulation of intracellular transport	2.5934587810638732e-11	5.719873341636372e-7	23	575	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002449	lymphocyte mediated immunity	3.480660204502328e-11	7.676596081029885e-7	15	209	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002367	cytokine production involved in immune response	9.501555098268e-11	2.0955679769230073e-6	10	71	136
MESH:D006969	Hypersensitivity, Immediate	GO:1903035	negative regulation of response to wounding	1.476289090973637e-10	3.2559555901423565e-6	13	159	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002698	negative regulation of immune effector process	1.4861645247776778e-10	3.2777358593971684e-6	11	99	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042088	T-helper 1 type immune response	2.620373917849861e-10	5.779234675817868e-6	8	38	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002675	positive regulation of acute inflammatory response	9.704702597090886e-10	2.140372157788395e-5	7	28	136
MESH:D006969	Hypersensitivity, Immediate	GO:0051047	positive regulation of secretion	1.2584813191551802e-9	2.77558054939675e-5	17	363	136
MESH:D006969	Hypersensitivity, Immediate	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.3215543104294625e-9	2.9146880316521795e-5	9	67	136
MESH:D006969	Hypersensitivity, Immediate	GO:0045582	positive regulation of T cell differentiation	1.3215543104294625e-9	2.9146880316521795e-5	9	67	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	1.3215543104294625e-9	2.9146880316521795e-5	9	67	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042348	NF-kappaB import into nucleus	1.594475218524849e-9	3.5166150944565544e-5	8	47	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042345	regulation of NF-kappaB import into nucleus	1.594475218524849e-9	3.5166150944565544e-5	8	47	136
MESH:D006969	Hypersensitivity, Immediate	GO:0032102	negative regulation of response to external stimulus	1.5984028545190654e-9	3.525277495641799e-5	15	275	136
MESH:D006969	Hypersensitivity, Immediate	GO:0048871	multicellular organismal homeostasis	1.6311275663483116e-9	3.597451847581201e-5	16	321	136
MESH:D006969	Hypersensitivity, Immediate	GO:0016064	immunoglobulin mediated immune response	2.210945759806293e-9	4.8762408732527796e-5	10	97	136
MESH:D006969	Hypersensitivity, Immediate	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.2571465807530444e-9	4.9781367838508395e-5	12	161	136
MESH:D006969	Hypersensitivity, Immediate	GO:0042832	defense response to protozoan	2.3093212897506987e-9	5.093208104545166e-5	6	18	136
MESH:D006969	Hypersensitivity, Immediate	GO:1903532	positive regulation of secretion by cell	3.0109337245676215e-9	6.640614329533889e-5	16	335	136
MESH:D006969	Hypersensitivity, Immediate	GO:0050714	positive regulation of protein secretion	3.4087703770779854e-9	7.518043066645497e-5	13	205	136
MESH:D006969	Hypersensitivity, Immediate	GO:0003012	muscle system process	4.160685240783835e-9	9.176391298548747e-5	17	393	136
MESH:D011115	Polyneuropathies	GO:0030424	axon	1.2966246965007144e-9	2.8597057681323257e-5	18	414	136
MESH:D009062	Mouth Neoplasms	GO:0014070	response to organic cyclic compound	3.1163960301228144e-12	6.873211444435867e-8	31	873	137
MESH:D009062	Mouth Neoplasms	GO:0060548	negative regulation of cell death	1.9317880628477724e-13	4.260558572610762e-9	31	867	137
MESH:D009062	Mouth Neoplasms	GO:0043069	negative regulation of programmed cell death	8.89754936395093e-12	1.9623545122193775e-7	30	806	137
MESH:D009062	Mouth Neoplasms	GO:0043209	myelin sheath	3.2325553345202707e-10	7.129400790284457e-6	13	168	137
MESH:D009062	Mouth Neoplasms	GO:0072358	cardiovascular system development	4.417790577804226e-10	9.74343711934722e-6	27	910	137
MESH:D009062	Mouth Neoplasms	GO:0031667	response to nutrient levels	5.193421248606001e-10	1.1454090563800534e-5	21	546	137
MESH:D009062	Mouth Neoplasms	GO:0036294	cellular response to decreased oxygen levels	5.779055012311574e-10	1.2745705829653176e-5	12	142	137
MESH:D009062	Mouth Neoplasms	GO:0051338	regulation of transferase activity	6.797845619743725e-10	1.4992648514344786e-5	27	928	137
MESH:D009062	Mouth Neoplasms	GO:1990267	response to transition metal nanoparticle	1.0893529411859504e-9	2.4025679117856136e-5	12	150	137
MESH:D009062	Mouth Neoplasms	GO:0005912	adherens junction	1.385060399705651e-9	3.054750711550813e-5	19	465	137
MESH:D009062	Mouth Neoplasms	GO:0048732	gland development	1.906852564736994e-9	4.20556333152744e-5	18	421	137
MESH:D009062	Mouth Neoplasms	GO:0022603	regulation of anatomical structure morphogenesis	2.5169504258570896e-9	5.551134164227811e-5	27	986	137
MESH:D012509	Sarcoma	GO:0014070	response to organic cyclic compound	3.277822457903312e-12	7.229237430905755e-8	37	873	137
MESH:D012509	Sarcoma	GO:0050673	epithelial cell proliferation	2.673861132507227e-12	5.897200727744689e-8	21	335	137
MESH:D012509	Sarcoma	GO:1901701	cellular response to oxygen-containing compound	2.2890578321721478e-12	5.048517048855672e-8	30	873	137
MESH:D012509	Sarcoma	GO:0070997	neuron death	1.9524382111058003e-12	4.3061024745938425e-8	19	281	137
MESH:D012509	Sarcoma	GO:1901698	response to nitrogen compound	1.7397194795876203e-12	3.8369513122304966e-8	32	870	137
MESH:D012509	Sarcoma	GO:0001944	vasculature development	1.6053824936079764e-12	3.540671089652392e-8	29	588	137
MESH:D012509	Sarcoma	GO:0050678	regulation of epithelial cell proliferation	1.127098414599459e-12	2.4858155533991066e-8	19	277	137
MESH:D012509	Sarcoma	GO:0071363	cellular response to growth factor stimulus	7.769340726326845e-13	1.7135280971913858e-8	26	594	137
MESH:D012509	Sarcoma	GO:0031099	regeneration	7.081002451059248e-13	1.5617150905811172e-8	17	182	137
MESH:D012509	Sarcoma	GO:0045787	positive regulation of cell cycle	6.223910276048628e-13	1.3726834113825248e-8	19	308	137
MESH:D012509	Sarcoma	GO:0048144	fibroblast proliferation	6.439293542825908e-14	1.420186190870254e-9	13	84	137
MESH:D012509	Sarcoma	GO:0048145	regulation of fibroblast proliferation	3.907985046680551e-14	8.619061020453955e-10	13	82	137
MESH:D012509	Sarcoma	GO:0060548	negative regulation of cell death	5.895284260759581e-14	1.3002049437105256e-9	36	867	137
MESH:D012509	Sarcoma	GO:0010942	positive regulation of cell death	1.6397994073713562e-13	3.616577592957526e-9	28	596	137
MESH:D012509	Sarcoma	GO:0023014	signal transduction by protein phosphorylation	4.951594689828198e-13	1.0920742088416091e-8	34	879	137
MESH:D012509	Sarcoma	GO:0071902	positive regulation of protein serine/threonine kinase activity	5.272449143944868e-13	1.1628386586970407e-8	18	283	137
MESH:D012509	Sarcoma	GO:0009725	response to hormone	5.467848396278896e-13	1.2059339637993105e-8	32	865	137
MESH:D012509	Sarcoma	GO:0033993	response to lipid	8.317790900491673e-13	1.8344887831034384e-8	32	850	137
MESH:D012509	Sarcoma	GO:0008285	negative regulation of cell proliferation	8.415490526658687e-13	1.8560364356545733e-8	27	634	137
MESH:D012509	Sarcoma	GO:0007167	enzyme linked receptor protein signaling pathway	8.798517470154366e-13	1.9405130280425453e-8	31	935	137
MESH:D012509	Sarcoma	GO:0097305	response to alcohol	9.926504063173525e-13	2.189290471132921e-8	21	369	137
MESH:D012509	Sarcoma	GO:0004714	transmembrane receptor protein tyrosine kinase activity	1.1166623181679824e-12	2.4627987427194853e-8	11	63	137
MESH:D012509	Sarcoma	GO:0043405	regulation of MAP kinase activity	1.130984195185647e-12	2.4943856424819444e-8	18	278	137
MESH:D012509	Sarcoma	GO:1901214	regulation of neuron death	1.1833867219479544e-12	2.6099594152562133e-8	18	250	137
MESH:D012509	Sarcoma	GO:0045930	negative regulation of mitotic cell cycle	1.4236389844768382e-12	3.139835780263667e-8	16	200	137
MESH:D012509	Sarcoma	GO:0043068	positive regulation of programmed cell death	2.0633494912658534e-12	4.55071730298684e-8	27	561	137
MESH:D012509	Sarcoma	GO:0032355	response to estradiol	2.637001728089672e-12	5.815907311301771e-8	14	145	137
MESH:D012509	Sarcoma	GO:0001503	ossification	2.8738122992422177e-12	6.338193025978711e-8	20	363	137
MESH:D012509	Sarcoma	GO:0043065	positive regulation of apoptotic process	4.093947403305265e-12	9.029200997989761e-8	26	556	137
MESH:D012509	Sarcoma	GO:0000302	response to reactive oxygen species	4.29012381175653e-12	9.461868066829027e-8	16	216	137
MESH:D012509	Sarcoma	GO:0051402	neuron apoptotic process	4.4467762805311395e-12	9.807365086711428e-8	16	211	137
MESH:D012509	Sarcoma	GO:1901990	regulation of mitotic cell cycle phase transition	4.629407968081978e-12	1.0210159273604802e-7	18	292	137
MESH:D012509	Sarcoma	GO:0010035	response to inorganic substance	4.74909001013657e-12	1.0474118017356204e-7	28	502	137
MESH:D012509	Sarcoma	GO:0009314	response to radiation	5.46052092431637e-12	1.2043178898579754e-7	23	431	137
MESH:D012509	Sarcoma	GO:0009611	response to wounding	5.490830012888637e-12	1.2110025593425888e-7	29	875	137
MESH:D012509	Sarcoma	GO:0042493	response to drug	6.4678262745587745e-12	1.4264790848539377e-7	33	433	137
MESH:D012509	Sarcoma	GO:0005694	chromosome	7.439604488013174e-12	1.6408047698313055e-7	29	876	137
MESH:D012509	Sarcoma	GO:0009887	organ morphogenesis	8.321121569565548e-12	1.8352233621676817e-7	36	950	137
MESH:D012509	Sarcoma	GO:0006935	chemotaxis	8.613998403461665e-12	1.89981734788347e-7	23	530	137
MESH:D012509	Sarcoma	GO:0043523	regulation of neuron apoptotic process	9.240608278560103e-12	2.0380161558364307e-7	15	190	137
MESH:D012509	Sarcoma	GO:0045597	positive regulation of cell differentiation	9.864886685306828e-12	2.175700758444421e-7	30	815	137
MESH:D012509	Sarcoma	GO:0007610	behavior	1.0384026971621552e-11	2.2901971485911332e-7	28	714	137
MESH:D012509	Sarcoma	GO:0010243	response to organonitrogen compound	1.2079781619434016e-11	2.664195836166172e-7	28	780	137
MESH:D012509	Sarcoma	GO:0018108	peptidyl-tyrosine phosphorylation	1.3152146038919454e-11	2.9007058088836857e-7	19	354	137
MESH:D012509	Sarcoma	GO:0000785	chromatin	1.6564083438197486e-11	3.6532086022944554e-7	21	438	137
MESH:D012509	Sarcoma	GO:0001101	response to acid chemical	1.7144397013169055e-11	3.781196761254435e-7	18	315	137
MESH:D012509	Sarcoma	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.9236279236167775e-11	4.2425613855368027e-7	18	317	137
MESH:D012509	Sarcoma	GO:0090068	positive regulation of cell cycle process	2.4203083981433338e-11	5.337990172105123e-7	16	239	137
MESH:D012509	Sarcoma	GO:0000904	cell morphogenesis involved in differentiation	2.5192847807886665e-11	5.556282584029404e-7	26	720	137
MESH:D012509	Sarcoma	GO:0035295	tube development	2.8445357180828523e-11	6.273623526231731e-7	23	573	137
MESH:D012509	Sarcoma	GO:0007050	cell cycle arrest	2.9534152901078414e-11	6.513757422332844e-7	16	242	137
MESH:D012509	Sarcoma	GO:0008134	transcription factor binding	3.353073374512405e-11	7.39520332748711e-7	22	518	137
MESH:D012509	Sarcoma	GO:0010720	positive regulation of cell development	3.5958125366164495e-11	7.930564549507579e-7	21	469	137
MESH:D012509	Sarcoma	GO:0007093	mitotic cell cycle checkpoint	4.612166204509549e-11	1.017213256404581e-6	13	144	137
MESH:D012509	Sarcoma	GO:0007417	central nervous system development	5.15971709802443e-11	1.137975605969288e-6	28	889	137
MESH:D012509	Sarcoma	GO:0003682	chromatin binding	6.264722074433848e-11	1.3816844535163852e-6	20	433	137
MESH:D012509	Sarcoma	GO:0045931	positive regulation of mitotic cell cycle	8.056377787113433e-11	1.7768341209478677e-6	12	120	137
MESH:D012509	Sarcoma	GO:0048863	stem cell differentiation	1.1682221856545993e-10	2.576514030461219e-6	16	266	137
MESH:D012509	Sarcoma	GO:0042542	response to hydrogen peroxide	1.1842471447920389e-10	2.6118570778388417e-6	12	124	137
MESH:D012509	Sarcoma	GO:0042063	gliogenesis	1.3107925855848634e-10	2.8909530475074163e-6	15	228	137
MESH:D012509	Sarcoma	GO:0001667	ameboidal-type cell migration	1.6015633264032658e-10	3.5322479163824028e-6	17	315	137
MESH:D012509	Sarcoma	GO:0070482	response to oxygen levels	2.1379065184845558e-10	4.715152826517688e-6	17	321	137
MESH:D012509	Sarcoma	GO:0071407	cellular response to organic cyclic compound	2.1884472012345668e-10	4.826620302322837e-6	19	416	137
MESH:D012509	Sarcoma	GO:0003690	double-stranded DNA binding	2.3808954807691407e-10	5.25106498283634e-6	25	756	137
MESH:D012509	Sarcoma	GO:0030097	hemopoiesis	2.4031365786214565e-10	5.300117724149622e-6	24	695	137
MESH:D012509	Sarcoma	GO:1901215	negative regulation of neuron death	3.7423109056078374e-10	8.253666702318085e-6	13	170	137
MESH:D012509	Sarcoma	GO:0048514	blood vessel morphogenesis	4.0580006022139514e-10	8.94992032818287e-6	20	484	137
MESH:D012509	Sarcoma	GO:0007568	aging	4.1538272821384226e-10	9.161266070756291e-6	16	290	137
MESH:D012509	Sarcoma	GO:1901991	negative regulation of mitotic cell cycle phase transition	4.505776862728794e-10	9.937490870748356e-6	12	139	137
MESH:D012509	Sarcoma	GO:0050767	regulation of neurogenesis	4.599676195482516e-10	1.0144585849136689e-5	23	658	137
MESH:D012509	Sarcoma	GO:0031667	response to nutrient levels	5.193421248606001e-10	1.1454090563800534e-5	21	546	137
MESH:D012509	Sarcoma	GO:0051093	negative regulation of developmental process	5.561795468622677e-10	1.2266539906047313e-5	25	788	137
MESH:D012509	Sarcoma	GO:0061564	axon development	5.582758699773649e-10	1.2312774312350783e-5	19	440	137
MESH:D012509	Sarcoma	GO:0010001	glial cell differentiation	5.7538762643361e-10	1.2690174100993268e-5	13	176	137
MESH:D012509	Sarcoma	GO:0007423	sensory organ development	5.766508381910285e-10	1.2718034236303133e-5	20	494	137
MESH:D012509	Sarcoma	GO:0016568	chromatin modification	6.014668763043574e-10	1.3265351956892601e-5	22	608	137
MESH:D012509	Sarcoma	GO:0061061	muscle structure development	6.093778814886264e-10	1.3439829176231655e-5	21	551	137
MESH:D012509	Sarcoma	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	6.679258257591414e-10	1.4731104087117863e-5	24	732	137
MESH:D012509	Sarcoma	GO:0009790	embryo development	7.443413663210663e-10	1.6416448834211117e-5	27	932	137
MESH:D012509	Sarcoma	GO:0034599	cellular response to oxidative stress	8.170637499915756e-10	1.80203410060642e-5	14	219	137
MESH:D012509	Sarcoma	GO:2000377	regulation of reactive oxygen species metabolic process	8.626340752826422e-10	1.9025394530358675e-5	12	147	137
MESH:D012509	Sarcoma	GO:0080135	regulation of cellular response to stress	8.945552076866647e-10	1.972941510552939e-5	23	681	137
MESH:D012509	Sarcoma	GO:0002573	myeloid leukocyte differentiation	9.309326642892302e-10	2.053171991089897e-5	13	183	137
MESH:D012509	Sarcoma	GO:0000082	G1/S transition of mitotic cell cycle	1.0965424124265155e-9	2.41842429060668e-5	14	224	137
MESH:D012509	Sarcoma	GO:0000989	transcription factor activity, transcription factor binding	1.2644526536931266e-9	2.7887503277201908e-5	21	574	137
MESH:D012509	Sarcoma	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	1.3041319135709273e-9	2.87626293538068e-5	14	227	137
MESH:D012509	Sarcoma	GO:0048729	tissue morphogenesis	1.3513479224513958e-9	2.9803978429665534e-5	22	635	137
MESH:D012509	Sarcoma	GO:1901342	regulation of vasculature development	1.381153968971205e-9	3.0461350785659924e-5	14	228	137
MESH:D012509	Sarcoma	GO:0048871	multicellular organismal homeostasis	1.818389661067954e-9	4.0104583974853725e-5	16	321	137
MESH:D012509	Sarcoma	GO:0060485	mesenchyme development	2.283257805046901e-9	5.03572508903094e-5	14	237	137
MESH:D012509	Sarcoma	GO:0034614	cellular response to reactive oxygen species	2.3858921505137687e-9	5.262085137958117e-5	11	127	137
MESH:D012509	Sarcoma	GO:0043535	regulation of blood vessel endothelial cell migration	2.394237252900666e-9	5.280490261272419e-5	8	49	137
MESH:D012509	Sarcoma	GO:0045596	negative regulation of cell differentiation	2.550392452782546e-9	5.6248905546119055e-5	21	597	137
MESH:D012509	Sarcoma	GO:0048511	rhythmic process	2.589681691311796e-9	5.711542970188166e-5	16	329	137
MESH:D012509	Sarcoma	GO:0050918	positive chemotaxis	2.8327006296180457e-9	6.2475212386226e-5	8	50	137
MESH:D012509	Sarcoma	GO:0007507	heart development	2.9550317748316957e-9	6.517322579391305e-5	19	487	137
MESH:D012509	Sarcoma	GO:1904018	positive regulation of vasculature development	3.3195541870867373e-9	7.321276759619799e-5	11	131	137
MESH:D012509	Sarcoma	GO:0072006	nephron development	3.3195541870867373e-9	7.321276759619799e-5	11	131	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0001654	eye development	2.3452351172181807e-12	5.1724160510246975e-8	23	327	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0035295	tube development	1.4217516053349755e-12	3.1356731655662884e-8	28	573	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048562	embryonic organ morphogenesis	6.292744103575387e-13	1.3878647120435517e-8	18	280	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048729	tissue morphogenesis	2.0069501616148955e-12	4.426328581441652e-8	27	635	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0072358	cardiovascular system development	2.3923085734622873e-12	5.276236558771075e-8	41	910	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0003007	heart morphogenesis	4.29012381175653e-12	9.461868066829027e-8	16	216	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0002009	morphogenesis of an epithelium	6.692757459347831e-12	1.4760876576591642e-7	25	506	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048736	appendage development	2.400946108593871e-11	5.295286642503783e-7	14	168	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0060173	limb development	2.400946108593871e-11	5.295286642503783e-7	14	168	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0090596	sensory organ morphogenesis	2.4203083981433338e-11	5.337990172105123e-7	16	239	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0043010	camera-type eye development	2.7661206658535775e-11	6.100679128540065e-7	17	283	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048839	inner ear development	2.7893798382194745e-11	6.151977233193051e-7	14	170	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0035239	tube morphogenesis	5.333056218859156e-11	1.1762055490693868e-6	18	338	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0000904	cell morphogenesis involved in differentiation	9.417677748757569e-11	2.077068827488482e-6	25	720	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0043066	negative regulation of apoptotic process	1.3182888114471325e-10	2.9074859736466507e-6	26	795	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0002065	columnar/cuboidal epithelial cell differentiation	1.71661795889122e-10	3.786000908334586e-6	12	128	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0001894	tissue homeostasis	2.0223811514341605e-10	4.460361629488041e-6	14	197	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048732	gland development	2.675741850310942e-10	5.901348650860783e-6	19	421	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0031012	extracellular matrix	2.8831781406779555e-10	6.358849389265231e-6	19	423	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0060322	head development	3.4549563210362066e-10	7.619906166045354e-6	24	708	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0001501	skeletal system development	3.786840840902528e-10	8.351877474610525e-6	20	482	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0007389	pattern specification process	4.109863560586291e-10	9.064304082873065e-6	19	432	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0060021	palate development	6.362861348918614e-10	1.4033290705040002e-5	10	85	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0009799	specification of symmetry	1.5529048047469018e-9	3.424931546869292e-5	11	122	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0060563	neuroepithelial cell differentiation	3.491335665017914e-9	7.700140809197009e-5	9	74	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0043009	chordate embryonic development	3.855267438623855e-9	8.502792335884912e-5	20	552	137
Orphanet:108987	Syndromic developmental defect of the eye	GO:0048854	brain morphogenesis	4.475345982690726e-9	9.870375564824396e-5	7	34	137
DOID:1107	esophageal carcinoma	GO:0014070	response to organic cyclic compound	2.929212428171013e-12	6.460378010331169e-8	31	873	138
DOID:1107	esophageal carcinoma	GO:0060548	negative regulation of cell death	1.5298873279334657e-13	3.3741665017572586e-9	31	867	138
DOID:1107	esophageal carcinoma	GO:0033993	response to lipid	2.949862576429041e-13	6.50592191231425e-9	34	850	138
DOID:1107	esophageal carcinoma	GO:0009636	response to toxic substance	4.653388785413881e-12	1.0263048966230315e-7	17	249	138
DOID:1107	esophageal carcinoma	GO:0010035	response to inorganic substance	4.7376547129829305e-12	1.0448897469483853e-7	25	502	138
DOID:1107	esophageal carcinoma	GO:0048545	response to steroid hormone	4.846012480186346e-12	1.0687880525050986e-7	25	446	138
DOID:1107	esophageal carcinoma	GO:0043069	negative regulation of programmed cell death	8.67383942448896e-12	1.9130152850710402e-7	31	806	138
DOID:1107	esophageal carcinoma	GO:0043066	negative regulation of apoptotic process	1.1006751066133802e-11	2.42753894763581e-7	30	795	138
DOID:1107	esophageal carcinoma	GO:0008285	negative regulation of cell proliferation	4.2301717684267715e-11	9.329643835265244e-7	24	634	138
DOID:1107	esophageal carcinoma	GO:0050673	epithelial cell proliferation	5.146660875254838e-11	1.1350960560374546e-6	18	335	138
DOID:1107	esophageal carcinoma	GO:0006979	response to oxidative stress	6.838740684855793e-11	1.5082842580449451e-6	19	386	138
DOID:1107	esophageal carcinoma	GO:0042493	response to drug	7.11357639460175e-11	1.568899273829416e-6	20	433	138
DOID:1107	esophageal carcinoma	GO:0040012	regulation of locomotion	7.539791013755348e-11	1.662900908083742e-6	26	766	138
DOID:1107	esophageal carcinoma	GO:2000145	regulation of cell motility	7.799971779576254e-11	1.7202837759855427e-6	25	709	138
DOID:1107	esophageal carcinoma	GO:0045786	negative regulation of cell cycle	1.2826351092343202e-10	2.8288517334162933e-6	20	449	138
DOID:1107	esophageal carcinoma	GO:0045597	positive regulation of cell differentiation	2.5457924657246167e-10	5.614745283155642e-6	26	815	138
DOID:1107	esophageal carcinoma	GO:0010038	response to metal ion	4.6263692876635787e-10	1.0203457463942023e-5	17	335	138
DOID:1107	esophageal carcinoma	GO:0072358	cardiovascular system development	5.242054568199705e-10	1.156135135016445e-5	27	910	138
DOID:1107	esophageal carcinoma	GO:0030335	positive regulation of cell migration	5.614513298723978e-10	1.2382809080335733e-5	18	387	138
DOID:1107	esophageal carcinoma	GO:0022603	regulation of anatomical structure morphogenesis	6.368191529659839e-10	1.4045046418664775e-5	28	986	138
DOID:1107	esophageal carcinoma	GO:1902533	positive regulation of intracellular signal transduction	7.756542075298967e-10	1.710705354707187e-5	26	860	138
DOID:1107	esophageal carcinoma	GO:0051338	regulation of transferase activity	8.051606048553595e-10	1.7757817140084953e-5	27	928	138
DOID:1107	esophageal carcinoma	GO:0034599	cellular response to oxidative stress	8.998228828716037e-10	1.984559368173322e-5	14	219	138
DOID:1107	esophageal carcinoma	GO:0040007	growth	9.661998978671704e-10	2.1309538747460444e-5	27	936	138
DOID:1107	esophageal carcinoma	GO:0002009	morphogenesis of an epithelium	9.952088042552987e-10	2.1949330177850612e-5	20	506	138
DOID:1107	esophageal carcinoma	GO:0002684	positive regulation of immune system process	1.0323810695211932e-9	2.2769164488289917e-5	26	872	138
DOID:1107	esophageal carcinoma	GO:0080135	regulation of cellular response to stress	1.0363871982832507e-9	2.2857519658137093e-5	23	681	138
DOID:1107	esophageal carcinoma	GO:0030162	regulation of proteolysis	1.803528548727229e-9	3.9776822142179036e-5	23	701	138
DOID:1107	esophageal carcinoma	GO:0097305	response to alcohol	2.026351086925615e-9	4.469117322214444e-5	17	369	138
DOID:1107	esophageal carcinoma	GO:0050678	regulation of epithelial cell proliferation	2.1654537052384626e-9	4.775908146903429e-5	15	277	138
DOID:1107	esophageal carcinoma	GO:0016049	cell growth	2.5492050692577095e-9	5.622271780247878e-5	19	479	138
DOID:1107	esophageal carcinoma	GO:0032101	regulation of response to external stimulus	3.1930350585795964e-9	7.0422388216973e-5	26	920	138
MESH:D003110	Colonic Neoplasms	GO:0002237	response to molecule of bacterial origin	2.1318502518852256e-12	4.701795730532865e-8	20	333	139
MESH:D003110	Colonic Neoplasms	GO:0072593	reactive oxygen species metabolic process	5.38680211548126e-13	1.1880592065693918e-8	20	223	139
MESH:D003110	Colonic Neoplasms	GO:0009725	response to hormone	1.8918200339612667e-13	4.172409084901574e-9	35	865	139
MESH:D003110	Colonic Neoplasms	GO:0097190	apoptotic signaling pathway	6.576961197879427e-13	1.4505487921923077e-8	25	564	139
MESH:D003110	Colonic Neoplasms	GO:0040008	regulation of growth	2.4766855233337992e-12	5.462329921712694e-8	26	617	139
MESH:D003110	Colonic Neoplasms	GO:0051338	regulation of transferase activity	4.4075854077618715e-12	9.720929616818808e-8	32	928	139
MESH:D003110	Colonic Neoplasms	GO:0030334	regulation of cell migration	4.970912570456676e-12	1.0963347674142199e-7	26	660	139
MESH:D003110	Colonic Neoplasms	GO:0033674	positive regulation of kinase activity	1.3713252755565009e-11	3.0244578952398626e-7	22	480	139
MESH:D003110	Colonic Neoplasms	GO:0002684	positive regulation of immune system process	4.1666226024972275e-11	9.189486149807635e-7	28	872	139
MESH:D003110	Colonic Neoplasms	GO:0007167	enzyme linked receptor protein signaling pathway	4.370925843488749e-11	9.640076947814435e-7	29	935	139
MESH:D003110	Colonic Neoplasms	GO:0051302	regulation of cell division	6.463740653828154e-11	1.4255780012017993e-6	17	293	139
MESH:D003110	Colonic Neoplasms	GO:0016049	cell growth	6.686051712279095e-11	1.4746087051431545e-6	21	479	139
MESH:D003110	Colonic Neoplasms	GO:0045787	positive regulation of cell cycle	1.4067358389269202e-10	3.1025558927533226e-6	17	308	139
MESH:D003110	Colonic Neoplasms	GO:0070372	regulation of ERK1 and ERK2 cascade	2.1924950743823501e-10	4.835547886550273e-6	15	233	139
MESH:D003110	Colonic Neoplasms	GO:0071260	cellular response to mechanical stimulus	3.9851189015394084e-10	8.789179737345165e-6	10	80	139
MESH:D003110	Colonic Neoplasms	GO:0001558	regulation of cell growth	4.5383474756022224e-10	1.0009325357440702e-5	18	379	139
MESH:D003110	Colonic Neoplasms	GO:0071900	regulation of protein serine/threonine kinase activity	5.069960007375585e-10	1.1181796796266852e-5	19	431	139
MESH:D003110	Colonic Neoplasms	GO:0006979	response to oxidative stress	6.073993530364419e-10	1.3396192731218726e-5	18	386	139
MESH:D003110	Colonic Neoplasms	GO:0009743	response to carbohydrate	6.092152338155188e-10	1.3436241981801267e-5	14	211	139
MESH:D003110	Colonic Neoplasms	GO:0071216	cellular response to biotic stimulus	6.426451593100069e-10	1.4173538988582202e-5	13	175	139
MESH:D003110	Colonic Neoplasms	GO:0010001	glial cell differentiation	6.893404735919262e-10	1.5203404145069932e-5	13	176	139
MESH:D003110	Colonic Neoplasms	GO:0051050	positive regulation of transport	7.886591379957508e-10	1.7393877288496284e-5	27	920	139
MESH:D003110	Colonic Neoplasms	GO:0043491	protein kinase B signaling	8.036891152585213e-10	1.7725363437026687e-5	12	144	139
MESH:D003110	Colonic Neoplasms	GO:0032880	regulation of protein localization	1.0655359927724817e-9	2.3500396320597083e-5	27	933	139
MESH:D003110	Colonic Neoplasms	GO:0003006	developmental process involved in reproduction	1.1160353752259766e-9	2.4614160200608914e-5	22	619	139
MESH:D003110	Colonic Neoplasms	GO:0007346	regulation of mitotic cell cycle	1.1528432652951892e-9	2.5425958216085398e-5	19	453	139
MESH:D003110	Colonic Neoplasms	GO:1990267	response to transition metal nanoparticle	1.2881146149723577e-9	2.840936783321535e-5	12	150	139
MESH:D003110	Colonic Neoplasms	GO:0071222	cellular response to lipopolysaccharide	1.500590984804262e-9	3.3095534169858e-5	12	152	139
MESH:D003110	Colonic Neoplasms	GO:0045597	positive regulation of cell differentiation	1.5070501513392287e-9	3.323799108778669e-5	25	815	139
MESH:D003110	Colonic Neoplasms	GO:0034284	response to monosaccharide	1.5523151652985234e-9	3.4236310970658934e-5	13	188	139
MESH:D003110	Colonic Neoplasms	GO:0090130	tissue migration	1.5795919017236315e-9	3.483789939251469e-5	14	227	139
MESH:D003110	Colonic Neoplasms	GO:0052548	regulation of endopeptidase activity	1.698445495357248e-9	3.745921540010411e-5	17	362	139
MESH:D003110	Colonic Neoplasms	GO:0001101	response to acid chemical	1.718068021183683e-9	3.789199020720613e-5	16	315	139
MESH:D003110	Colonic Neoplasms	GO:0033044	regulation of chromosome organization	1.7758334802664422e-9	3.916600740727638e-5	15	271	139
MESH:D003110	Colonic Neoplasms	GO:0046688	response to copper ion	1.920914427522291e-9	4.236576769900413e-5	7	30	139
MESH:D003110	Colonic Neoplasms	GO:0032465	regulation of cytokinesis	2.0039974124586024e-9	4.4198162931774476e-5	10	94	139
MESH:D003110	Colonic Neoplasms	GO:0042326	negative regulation of phosphorylation	2.3256312431385595e-9	5.129179706742093e-5	18	420	139
MESH:D003110	Colonic Neoplasms	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.4272046594830954e-9	5.353199876489967e-5	13	195	139
MESH:D003110	Colonic Neoplasms	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	2.4659156938611204e-9	5.438577062810701e-5	7	31	139
MESH:D003110	Colonic Neoplasms	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.5300256334404025e-9	5.579971534552808e-5	22	647	139
MESH:D003110	Colonic Neoplasms	GO:0055086	nucleobase-containing small molecule metabolic process	2.585325176163167e-9	5.7019346760278644e-5	23	709	139
MESH:D003110	Colonic Neoplasms	GO:0060541	respiratory system development	3.727211317361423e-9	8.220364560440618e-5	13	202	139
MESH:D003110	Colonic Neoplasms	GO:1903827	regulation of cellular protein localization	3.77441733423467e-9	8.324477430654564e-5	20	543	139
MESH:D003110	Colonic Neoplasms	GO:0051093	negative regulation of developmental process	3.848106611137325e-9	8.486999130863371e-5	24	788	139
MESH:D003110	Colonic Neoplasms	GO:2000045	regulation of G1/S transition of mitotic cell cycle	3.871071685423999e-9	8.53764860220263e-5	11	131	139
MESH:D003110	Colonic Neoplasms	GO:1903649	regulation of cytoplasmic transport	4.333905900821833e-9	9.558429464262552e-5	18	437	139
MESH:D001171	Arthritis, Juvenile	GO:0009611	response to wounding	4.801314901214937e-11	1.0589300014629544e-6	28	875	139
MESH:D001171	Arthritis, Juvenile	GO:0006954	inflammatory response	1.897424994901087e-9	4.184770826254347e-5	22	637	139
MESH:D001171	Arthritis, Juvenile	GO:0001775	cell activation	3.859493391544788e-9	8.51211267505203e-5	25	854	139
MESH:D003704	Dementia	GO:1901698	response to nitrogen compound	1.8822721159494904e-12	4.151351151726601e-8	35	870	139
MESH:D003704	Dementia	GO:0009991	response to extracellular stimulus	1.2938539128981574e-12	2.8535948048968862e-8	27	573	139
MESH:D003704	Dementia	GO:0043523	regulation of neuron apoptotic process	4.978240042419202e-13	1.097950841355555e-8	17	190	139
MESH:D003704	Dementia	GO:0030426	growth cone	2.6756374893466273e-12	5.9011184827539864e-8	14	142	139
MESH:D003704	Dementia	GO:0043068	positive regulation of programmed cell death	5.9678928465700665e-12	1.3162187673110282e-7	24	561	139
MESH:D003704	Dementia	GO:0031329	regulation of cellular catabolic process	6.498579452340891e-12	1.4332616982137836e-7	25	624	139
MESH:D003704	Dementia	GO:0005768	endosome	9.315992421932151e-12	2.054642128657136e-7	30	789	139
MESH:D003704	Dementia	GO:0072593	reactive oxygen species metabolic process	9.797385125409619e-12	2.1608132894090915e-7	16	223	139
MESH:D003704	Dementia	GO:0010720	positive regulation of cell development	1.0083600621157984e-11	2.2239381169963934e-7	22	469	139
MESH:D003704	Dementia	GO:0050767	regulation of neurogenesis	1.9708568110843316e-11	4.3467246968464934e-7	25	658	139
MESH:D003704	Dementia	GO:0043065	positive regulation of apoptotic process	2.5969559835914424e-11	5.727586421810926e-7	23	556	139
MESH:D003704	Dementia	GO:0019725	cellular homeostasis	2.6038060596533796e-11	5.742694264565529e-7	27	771	139
MESH:D003704	Dementia	GO:1901215	negative regulation of neuron death	3.386835256691256e-11	7.469665158632566e-7	14	170	139
MESH:D003704	Dementia	GO:0097305	response to alcohol	3.628974898362003e-11	8.003704138337397e-7	19	369	139
MESH:D003704	Dementia	GO:0050769	positive regulation of neurogenesis	4.8944959196717264e-11	1.0794810750835993e-6	19	376	139
MESH:D003704	Dementia	GO:0031331	positive regulation of cellular catabolic process	5.2736037758904786e-11	1.163093312772645e-6	18	333	139
MESH:D003704	Dementia	GO:0031960	response to corticosteroid	6.79378775458872e-11	1.4983698892745423e-6	14	179	139
MESH:D003704	Dementia	GO:1901615	organic hydroxy compound metabolic process	7.314737704433583e-11	1.6132654007128266e-6	22	534	139
MESH:D003704	Dementia	GO:0045664	regulation of neuron differentiation	1.1612821815276675e-10	2.5612078513592706e-6	22	548	139
MESH:D003704	Dementia	GO:0045862	positive regulation of proteolysis	1.730180443360041e-10	3.81591296783057e-6	18	357	139
MESH:D003704	Dementia	GO:0007613	memory	1.8825818681733608e-10	4.152034310256347e-6	11	99	139
MESH:D003704	Dementia	GO:0045321	leukocyte activation	3.162915485077633e-10	6.97581010233872e-6	24	694	139
MESH:D003704	Dementia	GO:0050804	modulation of synaptic transmission	3.997412401091083e-10	8.816293050606383e-6	16	285	139
MESH:D003704	Dementia	GO:0036477	somatodendritic compartment	4.744529213951409e-10	1.0464059181369834e-5	23	649	139
MESH:D003704	Dementia	GO:0051241	negative regulation of multicellular organismal process	4.808059506089535e-10	1.0604175240680469e-5	28	966	139
MESH:D003704	Dementia	GO:0007568	aging	5.160761817890602e-10	1.1382060189357723e-5	16	290	139
MESH:D003704	Dementia	GO:0043627	response to estrogen	8.776994686598982e-10	1.9357661781294055e-5	14	217	139
MESH:D003704	Dementia	GO:0010952	positive regulation of peptidase activity	1.192748677603106e-9	2.6306072084536503e-5	12	149	139
MESH:D003704	Dementia	GO:0052548	regulation of endopeptidase activity	1.698445495357248e-9	3.745921540010411e-5	17	362	139
MESH:D003704	Dementia	GO:0071241	cellular response to inorganic substance	2.021551481767858e-9	4.458531793039011e-5	12	156	139
MESH:D003704	Dementia	GO:0050803	regulation of synapse structure or activity	2.216387184894586e-9	4.8882419362850094e-5	14	233	139
MESH:D003704	Dementia	GO:0048660	regulation of smooth muscle cell proliferation	3.6946111725555397e-9	8.148464941071243e-5	10	100	139
MESH:D003704	Dementia	GO:0006066	alcohol metabolic process	3.813594107171525e-9	8.410881803366799e-5	17	382	139
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0007017	microtubule-based process	1.0570433417456115e-12	2.3313090902199463e-8	26	591	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0007417	central nervous system development	4.9544812696922236e-12	1.0927108440306199e-7	30	889	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0007420	brain development	6.9173555772295e-12	1.5256227725579663e-7	30	669	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0009790	embryo development	1.3409828802934953e-11	2.957537742487304e-7	30	932	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0030900	forebrain development	2.6966207045120427e-11	5.94739696380131e-7	19	357	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0000086	G2/M transition of mitotic cell cycle	1.3310151869561082e-9	2.9355539948316967e-5	13	183	141
Orphanet:108991	Syndrome with a central nervous system malformation as major feature	GO:0048729	tissue morphogenesis	2.362753770412951e-9	5.211053440645763e-5	22	635	141
MESH:D017443	Skin Diseases, Eczematous	GO:0001775	cell activation	4.799605157757014e-12	1.0585529175433095e-7	29	854	142
MESH:D017443	Skin Diseases, Eczematous	GO:0070486	leukocyte aggregation	7.62989782465695e-10	1.6827739652280904e-5	19	432	142
MESH:D017443	Skin Diseases, Eczematous	GO:1903035	negative regulation of response to wounding	3.212678900688104e-9	7.085563315467613e-5	12	159	142
MESH:D017443	Skin Diseases, Eczematous	GO:0019221	cytokine-mediated signaling pathway	4.150875643205154e-9	9.154756231088967e-5	20	534	142
Orphanet:93545	Renal or urinary tract malformation	GO:0072073	kidney epithelium development	4.503064587879635e-13	9.931508948568535e-9	15	137	143
Orphanet:93545	Renal or urinary tract malformation	GO:0009799	specification of symmetry	3.623767952376511e-13	7.992220218966395e-9	20	122	143
Orphanet:93545	Renal or urinary tract malformation	GO:0072175	epithelial tube formation	4.0900616227190767e-13	9.020630908906924e-9	14	116	143
Orphanet:93545	Renal or urinary tract malformation	GO:0048645	organ formation	2.3128388093596186e-11	5.100965994042639e-7	10	59	143
Orphanet:93545	Renal or urinary tract malformation	GO:0070848	response to growth factor	5.952949244658612e-11	1.3129229559094568e-6	24	621	143
Orphanet:93545	Renal or urinary tract malformation	GO:0021675	nerve development	1.0064948874344282e-10	2.2198244742366313e-6	10	68	143
Orphanet:93545	Renal or urinary tract malformation	GO:0071363	cellular response to growth factor stimulus	1.5052670221393782e-10	3.3198664173283987e-6	23	594	143
Orphanet:93545	Renal or urinary tract malformation	GO:0072189	ureter development	1.6158796523058072e-10	3.563822573160458e-6	6	12	143
Orphanet:93545	Renal or urinary tract malformation	GO:0048666	neuron development	3.7015612797119957e-10	8.163793402404806e-6	28	926	143
Orphanet:93545	Renal or urinary tract malformation	GO:0007167	enzyme linked receptor protein signaling pathway	4.5292991579515274e-10	9.989369292862094e-6	28	935	143
Orphanet:93545	Renal or urinary tract malformation	GO:0021532	neural tube patterning	4.896031358114783e-10	1.0798197160322154e-5	8	39	143
Orphanet:93545	Renal or urinary tract malformation	GO:0023014	signal transduction by protein phosphorylation	5.620365284286777e-10	1.2395715634494486e-5	27	879	143
Orphanet:93545	Renal or urinary tract malformation	GO:0042733	embryonic digit morphogenesis	7.46533834750096e-10	1.646480372541337e-5	9	60	143
Orphanet:93545	Renal or urinary tract malformation	GO:0090184	positive regulation of kidney development	7.505017718401064e-10	1.6552316577933546e-5	8	41	143
Orphanet:93545	Renal or urinary tract malformation	GO:0061217	regulation of mesonephros development	7.765799114878291e-10	1.712746994786407e-5	7	26	143
Orphanet:93545	Renal or urinary tract malformation	GO:2000145	regulation of cell motility	8.717384591960808e-10	1.9226191717569563e-5	24	709	143
Orphanet:93545	Renal or urinary tract malformation	GO:0021545	cranial nerve development	1.1244108977237488e-9	2.479888234929728e-5	8	43	143
Orphanet:93545	Renal or urinary tract malformation	GO:0061564	axon development	1.1634805341387278e-9	2.566056318042964e-5	19	440	143
Orphanet:93545	Renal or urinary tract malformation	GO:0030323	respiratory tube development	1.207812405645825e-9	2.663830260651867e-5	13	179	143
Orphanet:93545	Renal or urinary tract malformation	GO:0048667	cell morphogenesis involved in neuron differentiation	1.2906313795468805e-9	2.846487507590645e-5	20	495	143
Orphanet:93545	Renal or urinary tract malformation	GO:0090185	negative regulation of kidney development	2.0971964165283907e-9	4.625366696653366e-5	6	17	143
Orphanet:93545	Renal or urinary tract malformation	GO:0051960	regulation of nervous system development	2.250507891154996e-9	4.963495153942343e-5	24	744	143
Orphanet:93545	Renal or urinary tract malformation	GO:0030855	epithelial cell differentiation	2.3406689919625023e-9	5.162345461773299e-5	21	568	143
DOID:201	connective tissue cancer	GO:0072358	cardiovascular system development	1.2923551118149135e-11	2.8502891991077917e-7	30	910	143
DOID:201	connective tissue cancer	GO:0010942	positive regulation of cell death	2.663447240536243e-11	5.874232889002684e-7	24	596	143
DOID:201	connective tissue cancer	GO:0043549	regulation of kinase activity	3.2197133847944315e-11	7.101077870164119e-7	27	761	143
DOID:201	connective tissue cancer	GO:0045859	regulation of protein kinase activity	3.546896110151465e-11	7.822679370939056e-7	26	709	143
DOID:201	connective tissue cancer	GO:0045786	negative regulation of cell cycle	3.979916396446015e-11	8.777705612361686e-7	21	449	143
DOID:201	connective tissue cancer	GO:0043068	positive regulation of programmed cell death	5.139766390271916e-11	1.133575477374471e-6	23	561	143
DOID:201	connective tissue cancer	GO:0008134	transcription factor binding	7.342182417602316e-11	1.619318332202191e-6	22	518	143
DOID:201	connective tissue cancer	GO:1990837	sequence-specific double-stranded DNA binding	7.894129794294713e-11	1.741050326131699e-6	25	683	143
DOID:201	connective tissue cancer	GO:0044212	transcription regulatory region DNA binding	9.380662913116566e-11	2.0689052054878587e-6	27	807	143
DOID:201	connective tissue cancer	GO:0071900	regulation of protein serine/threonine kinase activity	1.2260636950145454e-10	2.70408347935458e-6	20	431	143
DOID:201	connective tissue cancer	GO:0042542	response to hydrogen peroxide	1.9508938908785467e-10	4.302696476332635e-6	12	124	143
DOID:201	connective tissue cancer	GO:0010243	response to organonitrogen compound	2.2625346041138528e-10	4.990020069373102e-6	26	780	143
DOID:201	connective tissue cancer	GO:0042063	gliogenesis	2.4243729246364865e-10	5.346954485285771e-6	15	228	143
DOID:201	connective tissue cancer	GO:0043065	positive regulation of apoptotic process	2.65255595266467e-10	5.85021215360193e-6	22	556	143
DOID:201	connective tissue cancer	GO:0046982	protein heterodimerization activity	3.5366731765407167e-10	7.80013269086055e-6	20	459	143
DOID:201	connective tissue cancer	GO:0001568	blood vessel development	4.0439074311393597e-10	8.918837839377858e-6	22	569	143
DOID:201	connective tissue cancer	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	4.595998026601933e-10	1.0136473647670563e-5	22	573	143
DOID:201	connective tissue cancer	GO:0097305	response to alcohol	4.729134861491957e-10	1.0430106937020511e-5	18	369	143
DOID:201	connective tissue cancer	GO:0000989	transcription factor activity, transcription factor binding	4.74015826590346e-10	1.0454419055450082e-5	22	574	143
DOID:201	connective tissue cancer	GO:0000228	nuclear chromosome	4.849002310791661e-10	1.0694474596451009e-5	21	520	143
DOID:201	connective tissue cancer	GO:0048729	tissue morphogenesis	5.546926251653872e-10	1.2233745848022615e-5	23	635	143
DOID:201	connective tissue cancer	GO:0000790	nuclear chromatin	7.508625943231095e-10	1.656027451779618e-5	16	289	143
DOID:201	connective tissue cancer	GO:1901990	regulation of mitotic cell cycle phase transition	8.743029633606625e-10	1.928275185691941e-5	16	292	143
DOID:201	connective tissue cancer	GO:0003682	chromatin binding	8.940256313039185e-10	1.9717735298407923e-5	19	433	143
DOID:201	connective tissue cancer	GO:0007507	heart development	9.77688596748294e-10	2.1562922001283624e-5	20	487	143
DOID:201	connective tissue cancer	GO:0010001	glial cell differentiation	9.809860701537332e-10	2.1635647777240585e-5	13	176	143
DOID:201	connective tissue cancer	GO:0010948	negative regulation of cell cycle process	1.1335261618228287e-9	2.4999919499002488e-5	14	215	143
DOID:201	connective tissue cancer	GO:0034599	cellular response to oxidative stress	1.4415094673481121e-9	3.179249130236261e-5	14	219	143
DOID:201	connective tissue cancer	GO:0002521	leukocyte differentiation	1.5621965943068972e-9	3.445424588743862e-5	19	448	143
DOID:201	connective tissue cancer	GO:0045787	positive regulation of cell cycle	1.8900465637017305e-9	4.168497696244167e-5	16	308	143
DOID:201	connective tissue cancer	GO:0048568	embryonic organ development	2.3398829540610677e-9	5.160611855181685e-5	18	408	143
DOID:201	connective tissue cancer	GO:0071407	cellular response to organic cyclic compound	3.1761314689404685e-9	7.004957954748203e-5	18	416	143
DOID:201	connective tissue cancer	GO:0071396	cellular response to lipid	3.1761314689404685e-9	7.004957954748203e-5	18	416	143
DOID:201	connective tissue cancer	GO:0010720	positive regulation of cell development	3.308493812248514e-9	7.296883102914098e-5	19	469	143
DOID:201	connective tissue cancer	GO:0034614	cellular response to reactive oxygen species	3.759965006011612e-9	8.29260282075861e-5	11	127	143
DOID:201	connective tissue cancer	GO:0003712	transcription cofactor activity	3.879263243966591e-9	8.555715084568316e-5	20	528	143
Orphanet:98664	Genetic macular dystrophy	GO:0009141	nucleoside triphosphate metabolic process	1.4570566975180554e-12	3.213538546376071e-8	26	274	145
Orphanet:98664	Genetic macular dystrophy	GO:0009161	ribonucleoside monophosphate metabolic process	6.841194277740215e-13	1.5088253979556043e-8	27	279	145
Orphanet:98664	Genetic macular dystrophy	GO:0009167	purine ribonucleoside monophosphate metabolic process	4.0190073491430667e-13	8.863920708535034e-9	27	266	145
Orphanet:98664	Genetic macular dystrophy	GO:0022900	electron transport chain	1.5143442055887135e-13	3.3398861454259077e-9	26	107	145
Orphanet:98664	Genetic macular dystrophy	GO:0042773	ATP synthesis coupled electron transport	7.638334409421077e-14	1.6846346539978185e-9	24	89	145
Orphanet:98664	Genetic macular dystrophy	GO:0009583	detection of light stimulus	3.1446778514521156e-10	6.935587001377641e-6	10	75	145
Orphanet:98664	Genetic macular dystrophy	GO:0009584	detection of visible light	1.144196959401711e-9	2.5235263939604735e-5	9	62	145
Orphanet:98664	Genetic macular dystrophy	GO:0006720	isoprenoid metabolic process	4.355134364253388e-9	9.605248840360847e-5	11	127	145
Orphanet:68335	Chromosomal anomaly	GO:0040007	growth	2.1049828546892968e-13	4.642539686017244e-9	35	936	145
Orphanet:68335	Chromosomal anomaly	GO:0021537	telencephalon development	4.655165142253281e-13	1.0266966721239612e-8	18	226	145
Orphanet:68335	Chromosomal anomaly	GO:0048638	regulation of developmental growth	5.5836446577473e-12	1.231472829266167e-7	18	283	145
Orphanet:68335	Chromosomal anomaly	GO:0009790	embryo development	6.849965039634753e-12	1.5107597894914448e-7	31	932	145
Orphanet:68335	Chromosomal anomaly	GO:0007507	heart development	7.440492666432874e-12	1.6410006575817704e-7	24	487	145
Orphanet:68335	Chromosomal anomaly	GO:0042493	response to drug	8.868794587613138e-12	1.9560126462980776e-7	25	433	145
Orphanet:68335	Chromosomal anomaly	GO:0048667	cell morphogenesis involved in neuron differentiation	4.332678660290412e-11	9.555722785270504e-7	22	495	145
Orphanet:68335	Chromosomal anomaly	GO:0048732	gland development	1.0388068183431187e-10	2.2910884378557483e-6	20	421	145
Orphanet:68335	Chromosomal anomaly	GO:0003690	double-stranded DNA binding	1.6028345317664616e-10	3.535051559810931e-6	26	756	145
Orphanet:68335	Chromosomal anomaly	GO:0046620	regulation of organ growth	2.073317073580938e-10	4.572700805782759e-6	10	72	145
Orphanet:68335	Chromosomal anomaly	GO:0051093	negative regulation of developmental process	3.798794612208667e-10	8.378241517226215e-6	26	788	145
Orphanet:68335	Chromosomal anomaly	GO:0070848	response to growth factor	4.756961491381162e-10	1.0491478569241153e-5	23	621	145
Orphanet:68335	Chromosomal anomaly	GO:0072091	regulation of stem cell proliferation	1.5714356482732228e-9	3.465801322266593e-5	10	88	145
Orphanet:68335	Chromosomal anomaly	GO:0009792	embryo development ending in birth or egg hatching	2.2115389519683504e-9	4.877549158566197e-5	21	558	145
Orphanet:68335	Chromosomal anomaly	GO:0048598	embryonic morphogenesis	2.3572401808280574e-9	5.1988932188162806e-5	21	560	145
Orphanet:68335	Chromosomal anomaly	GO:0021543	pallium development	2.6303569322649878e-9	5.8012522141104306e-5	12	153	145
Orphanet:68335	Chromosomal anomaly	GO:1990837	sequence-specific double-stranded DNA binding	2.961426326386629e-9	6.53142576284571e-5	23	683	145
Orphanet:68335	Chromosomal anomaly	GO:0051960	regulation of nervous system development	2.9980593563294633e-9	6.612219910384631e-5	24	744	145
Orphanet:183583	Genetic head and neck malformation	GO:0061138	morphogenesis of a branching epithelium	7.251976796851523e-13	1.5994234825456033e-8	17	179	146
Orphanet:183583	Genetic head and neck malformation	GO:0048706	embryonic skeletal system development	5.768718835952313e-13	1.2722909392692827e-8	19	122	146
Orphanet:183583	Genetic head and neck malformation	GO:0003002	regionalization	5.200284647344233e-13	1.1469227789717706e-8	20	327	146
Orphanet:183583	Genetic head and neck malformation	GO:0042733	embryonic digit morphogenesis	1.0934586569533167e-12	2.41162306791054e-8	11	60	146
Orphanet:183583	Genetic head and neck malformation	GO:0042474	middle ear morphogenesis	1.3142820165512603e-12	2.8986489875038046e-8	8	20	146
Orphanet:183583	Genetic head and neck malformation	GO:2000027	regulation of organ morphogenesis	5.3835824687098466e-12	1.1873491134739567e-7	17	236	146
Orphanet:183583	Genetic head and neck malformation	GO:0048732	gland development	2.1049606502288043e-11	4.642490714079628e-7	21	421	146
Orphanet:183583	Genetic head and neck malformation	GO:0008589	regulation of smoothened signaling pathway	4.7572057404465795e-11	1.0492017260554931e-6	10	62	146
Orphanet:183583	Genetic head and neck malformation	GO:0048701	embryonic cranial skeleton morphogenesis	7.361711240605473e-11	1.623625414115537e-6	9	46	146
Orphanet:183583	Genetic head and neck malformation	GO:0055123	digestive system development	1.7355461512380543e-10	3.827747036555529e-6	13	150	146
Orphanet:183583	Genetic head and neck malformation	GO:0001944	vasculature development	1.8819390490421029e-10	4.150616572662358e-6	23	588	146
Orphanet:183583	Genetic head and neck malformation	GO:0048863	stem cell differentiation	3.0485347579656263e-10	6.723543408693189e-6	16	266	146
Orphanet:183583	Genetic head and neck malformation	GO:0050678	regulation of epithelial cell proliferation	5.514045886556573e-10	1.2161228202800523e-5	16	277	146
Orphanet:183583	Genetic head and neck malformation	GO:0060485	mesenchyme development	5.591843654784157e-10	1.2332811180626457e-5	15	237	146
Orphanet:183583	Genetic head and neck malformation	GO:0001568	blood vessel development	6.072297109582792e-10	1.3392451275184847e-5	22	569	146
Orphanet:183583	Genetic head and neck malformation	GO:0001654	eye development	7.798995893537608e-10	1.7200685443197195e-5	17	327	146
Orphanet:183583	Genetic head and neck malformation	GO:0048565	digestive tract development	8.672506046636386e-10	1.912721208585655e-5	12	138	146
Orphanet:183583	Genetic head and neck malformation	GO:0007368	determination of left/right symmetry	1.2213143829598039e-9	2.6936088716178475e-5	11	112	146
Orphanet:183583	Genetic head and neck malformation	GO:0042476	odontogenesis	1.4773572365456289e-9	3.2583113852013845e-5	11	114	146
Orphanet:183583	Genetic head and neck malformation	GO:0071599	otic vesicle development	1.5480580151105983e-9	3.4142419523264245e-5	6	16	146
Orphanet:183583	Genetic head and neck malformation	GO:0003007	heart morphogenesis	1.5838224065589657e-9	3.493120317665799e-5	14	216	146
Orphanet:183583	Genetic head and neck malformation	GO:0035116	embryonic hindlimb morphogenesis	2.09065997847091e-9	4.610950582517592e-5	7	29	146
Orphanet:183583	Genetic head and neck malformation	GO:0048762	mesenchymal cell differentiation	2.1888614254450545e-9	4.8275338738190676e-5	13	184	146
Orphanet:183583	Genetic head and neck malformation	GO:0060872	semicircular canal development	3.353547661788525e-9	7.396249368074592e-5	5	9	146
Orphanet:183583	Genetic head and neck malformation	GO:0042473	outer ear morphogenesis	3.353547661788525e-9	7.396249368074592e-5	5	9	146
Orphanet:183583	Genetic head and neck malformation	GO:0030855	epithelial cell differentiation	3.4362920287023258e-9	7.57874206930298e-5	21	568	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0009141	nucleoside triphosphate metabolic process	1.1890488593735427e-12	2.6224472593483483e-8	34	274	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0051188	cofactor biosynthetic process	3.894662370385049e-13	8.589677857884226e-9	21	157	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0009167	purine ribonucleoside monophosphate metabolic process	1.538769112130467e-13	3.393755276803745e-9	33	266	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0050812	regulation of acyl-CoA biosynthetic process	2.573719015686038e-12	5.6763372890955566e-8	7	13	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0006979	response to oxidative stress	3.2229774404868294e-12	7.108276744993702e-8	21	386	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0046395	carboxylic acid catabolic process	1.665834137298816e-11	3.673997189812539e-7	16	219	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0042493	response to drug	3.31381588836166e-11	7.308620941781641e-7	21	433	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	5.96352967008329e-11	1.3152564687368695e-6	9	45	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0016042	lipid catabolic process	7.342004781918376e-11	1.619279154652098e-6	17	281	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:0044242	cellular lipid catabolic process	1.1372924824115671e-10	2.5082985699587113e-6	14	177	146
Orphanet:207018	Rare hereditary metabolic disease with peripheral neuropathy	GO:1901565	organonitrogen compound catabolic process	2.1001879124682432e-9	4.6319644409487104e-5	17	349	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0014070	response to organic cyclic compound	3.2731595211998865e-12	7.21895332400635e-8	31	873	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0033993	response to lipid	2.5515145551935348e-12	5.627365351479341e-8	32	850	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0007167	enzyme linked receptor protein signaling pathway	7.73159314348959e-13	1.705202867796629e-8	33	935	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0040007	growth	1.1063372440389685e-12	2.440026791727945e-8	32	936	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0009725	response to hormone	1.3137269050389477e-12	2.8974246890633992e-8	34	865	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0060548	negative regulation of cell death	2.0252688415212106e-12	4.46673042997503e-8	31	867	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	4.409583809206197e-12	9.725337091204267e-8	28	647	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0050678	regulation of epithelial cell proliferation	4.974132217228089e-12	1.097044860509655e-7	18	277	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0048545	response to steroid hormone	5.587308393728563e-12	1.2322808662368345e-7	23	446	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0032870	cellular response to hormone stimulus	6.011635633740298e-12	1.3258662390214226e-7	24	519	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0048732	gland development	6.6846528312680675e-12	1.4743001819361723e-7	23	421	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0032355	response to estradiol	7.0108363559029385e-12	1.546239958294393e-7	14	145	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0048146	positive regulation of fibroblast proliferation	1.1302292435289019e-11	2.492720596602993e-7	10	54	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:1901701	cellular response to oxygen-containing compound	2.6098567751375867e-11	5.756039117565948e-7	29	873	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0043066	negative regulation of apoptotic process	3.083755473198835e-11	6.80122269614003e-7	28	795	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0032941	secretion by tissue	3.4682257066265265e-11	7.649171795964804e-7	11	81	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0007595	lactation	3.85479426157076e-11	8.501748743894311e-7	9	43	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:2000145	regulation of cell motility	5.1739501572001245e-11	1.1411147071704875e-6	26	709	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0071407	cellular response to organic cyclic compound	9.458656080596484e-11	2.0861065985755545e-6	20	416	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0009611	response to wounding	1.644165914527207e-10	3.626207924489755e-6	28	875	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0010243	response to organonitrogen compound	3.562159456294012e-10	7.856342680856443e-6	26	780	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0030155	regulation of cell adhesion	5.470138786378698e-10	1.2064391093358218e-5	23	621	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:1902533	positive regulation of intracellular signal transduction	5.675260261739368e-10	1.2516786507266175e-5	27	860	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0071396	cellular response to lipid	6.551567066637176e-10	1.4449481165468292e-5	19	416	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0005925	focal adhesion	1.4845286111508926e-9	3.274127851893294e-5	18	388	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0000165	MAPK cascade	1.7975840815864785e-9	3.9645716919389784e-5	26	843	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0048589	developmental growth	2.511555852180436e-9	5.5392364319839515e-5	21	558	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0032403	protein complex binding	2.6859695578806964e-9	5.923905859905876e-5	27	924	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0040008	regulation of growth	2.7277257119706633e-9	6.015999057751298e-5	22	617	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0051272	positive regulation of cellular component movement	3.279245652798579e-9	7.232376287247266e-5	18	408	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0001934	positive regulation of protein phosphorylation	3.4661037373595605e-9	7.64449179274651e-5	26	870	146
MESH:D008325	Mammary Neoplasms, Experimental	GO:0008134	transcription factor binding	4.04965216915798e-9	8.931507859077925e-5	20	518	146
MESH:D010009	Osteochondrodysplasias	GO:0030278	regulation of ossification	8.51096970677645e-13	1.877094368829546e-8	17	177	147
MESH:D010009	Osteochondrodysplasias	GO:0031214	biomineral tissue development	3.999023334699814e-13	8.81984596468044e-9	16	131	147
MESH:D010009	Osteochondrodysplasias	GO:0035107	appendage morphogenesis	1.4988010832439613e-14	3.3056057890945567e-10	15	146	147
MESH:D010009	Osteochondrodysplasias	GO:0035108	limb morphogenesis	1.4988010832439613e-14	3.3056057890945567e-10	15	146	147
MESH:D010009	Osteochondrodysplasias	GO:0030282	bone mineralization	1.397770788003072e-13	3.0827834729407755e-9	14	100	147
MESH:D010009	Osteochondrodysplasias	GO:0071363	cellular response to growth factor stimulus	8.695266728864226e-13	1.917741077051005e-8	26	594	147
MESH:D010009	Osteochondrodysplasias	GO:0009790	embryo development	2.257638520575256e-12	4.979221757128727e-8	33	932	147
MESH:D010009	Osteochondrodysplasias	GO:0048598	embryonic morphogenesis	3.97104571447926e-12	8.758141323284008e-8	26	560	147
MESH:D010009	Osteochondrodysplasias	GO:0030500	regulation of bone mineralization	1.534254945312341e-10	3.3837992818863682e-6	10	69	147
MESH:D010009	Osteochondrodysplasias	GO:0007167	enzyme linked receptor protein signaling pathway	1.8298329518273704e-10	4.035696575255265e-6	29	935	147
MESH:D010009	Osteochondrodysplasias	GO:0035113	embryonic appendage morphogenesis	2.956996869585282e-10	6.52165659587034e-6	12	125	147
MESH:D010009	Osteochondrodysplasias	GO:0030326	embryonic limb morphogenesis	2.956996869585282e-10	6.52165659587034e-6	12	125	147
MESH:D010009	Osteochondrodysplasias	GO:0035265	organ growth	5.598015384578048e-10	1.2346422930686884e-5	12	132	147
MESH:D010009	Osteochondrodysplasias	GO:0001649	osteoblast differentiation	9.345454410336629e-10	2.0611399701997435e-5	14	206	147
MESH:D010009	Osteochondrodysplasias	GO:0061035	regulation of cartilage development	1.4974079753926617e-9	3.3025332897285153e-5	9	63	147
MESH:D010009	Osteochondrodysplasias	GO:0072358	cardiovascular system development	2.2584065728636915e-9	4.9809156964508716e-5	27	910	147
DOID:171	neuroectodermal tumor	GO:1901701	cellular response to oxygen-containing compound	2.8195223933380476e-12	6.218456638507064e-8	31	873	147
DOID:171	neuroectodermal tumor	GO:0033993	response to lipid	2.4511503937674206e-12	5.406012193454046e-8	36	850	147
DOID:171	neuroectodermal tumor	GO:0070997	neuron death	6.852296507986466e-13	1.511273994836415e-8	19	281	147
DOID:171	neuroectodermal tumor	GO:0023014	signal transduction by protein phosphorylation	2.3118174041769635e-12	5.098713284912293e-8	31	879	147
DOID:171	neuroectodermal tumor	GO:1901214	regulation of neuron death	1.4122258917836916e-11	3.114664204328932e-7	17	250	147
DOID:171	neuroectodermal tumor	GO:0044427	chromosomal part	2.3798296666655006e-11	5.248714329830761e-7	28	776	147
DOID:171	neuroectodermal tumor	GO:0002065	columnar/cuboidal epithelial cell differentiation	2.478439675712707e-11	5.466198704784375e-7	13	128	147
DOID:171	neuroectodermal tumor	GO:0021700	developmental maturation	4.213551729748133e-11	9.292988339959507e-7	16	231	147
DOID:171	neuroectodermal tumor	GO:0018108	peptidyl-tyrosine phosphorylation	4.8149817466480727e-11	1.0619442242232324e-6	19	354	147
DOID:171	neuroectodermal tumor	GO:0007423	sensory organ development	5.329148233812475e-11	1.1753436429673414e-6	22	494	147
DOID:171	neuroectodermal tumor	GO:0010243	response to organonitrogen compound	8.634282178121566e-11	1.9042909343847114e-6	27	780	147
DOID:171	neuroectodermal tumor	GO:0048511	rhythmic process	1.1602574456759385e-10	2.5589477964382823e-6	18	329	147
DOID:171	neuroectodermal tumor	GO:0048469	cell maturation	1.5977119627308412e-10	3.52375373380287e-6	13	148	147
DOID:171	neuroectodermal tumor	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.0594093097514587e-10	4.542027232656842e-6	13	151	147
DOID:171	neuroectodermal tumor	GO:1903827	regulation of cellular protein localization	2.924313013963342e-10	6.449572352296151e-6	22	543	147
DOID:171	neuroectodermal tumor	GO:0001101	response to acid chemical	4.903204509076886e-10	1.0814017544769072e-5	17	315	147
DOID:171	neuroectodermal tumor	GO:0071396	cellular response to lipid	7.368258225781688e-10	1.6250693516961512e-5	19	416	147
DOID:171	neuroectodermal tumor	GO:1901699	cellular response to nitrogen compound	7.594700424107259e-10	1.675011178536856e-5	21	518	147
DOID:171	neuroectodermal tumor	GO:0007050	cell cycle arrest	8.223354219794032e-10	1.813660773175574e-5	15	242	147
DOID:171	neuroectodermal tumor	GO:0043005	neuron projection	1.019539563884564e-9	2.2485945081474057e-5	28	941	147
DOID:171	neuroectodermal tumor	GO:0048609	multicellular organismal reproductive process	1.4679792936789227e-9	3.237628332208864e-5	25	767	147
DOID:171	neuroectodermal tumor	GO:0000785	chromatin	1.726625953324401e-9	3.8080735400569665e-5	19	438	147
DOID:171	neuroectodermal tumor	GO:0010035	response to inorganic substance	2.6804179986683607e-9	5.9116618960630696e-5	20	502	147
DOID:171	neuroectodermal tumor	GO:0051347	positive regulation of transferase activity	2.758210992936938e-9	6.083234344922417e-5	22	613	147
DOID:171	neuroectodermal tumor	GO:0045787	positive regulation of cell cycle	2.8399409490731387e-9	6.263489763180807e-5	16	308	147
DOID:171	neuroectodermal tumor	GO:0071392	cellular response to estradiol stimulus	2.841584301194189e-9	6.267114176283783e-5	7	30	147
DOID:171	neuroectodermal tumor	GO:0048589	developmental growth	2.8496447423975724e-9	6.284891479357846e-5	21	558	147
DOID:171	neuroectodermal tumor	GO:0030850	prostate gland development	2.9568569814841794e-9	6.521348072663358e-5	8	47	147
DOID:171	neuroectodermal tumor	GO:0035690	cellular response to drug	3.4447684704730364e-9	7.597436861628282e-5	9	69	147
DOID:171	neuroectodermal tumor	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	3.6463995156665874e-9	8.042134131802658e-5	7	31	147
DOID:171	neuroectodermal tumor	GO:0046777	protein autophosphorylation	3.693953809502659e-9	8.147015126858115e-5	14	229	147
Orphanet:180821	Rare gastroesophageal tumor	GO:0031960	response to corticosteroid	1.1960210599681886e-11	2.63782444775984e-7	15	179	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0098609	cell-cell adhesion	3.816846838589072e-11	8.418055702508198e-7	29	867	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0009611	response to wounding	4.4741432780881496e-11	9.867722999823414e-7	29	875	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0030097	hemopoiesis	4.8790527173991904e-11	1.0760750768223915e-6	26	695	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0051384	response to glucocorticoid	6.238687344506388e-11	1.375942493830884e-6	14	167	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0048732	gland development	1.4906409440129664e-10	3.2876086020205975e-6	20	421	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0002521	leukocyte differentiation	4.293710942349094e-10	9.469779483350926e-6	20	448	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0040008	regulation of growth	6.390087348151496e-10	1.4093337646348125e-5	23	617	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0030155	regulation of cell adhesion	7.213172281694824e-10	1.5908651467277934e-5	23	621	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0097285	cell-type specific apoptotic process	1.3785751429296056e-9	3.040447477731245e-5	19	429	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0045859	regulation of protein kinase activity	1.7790969808473278e-9	3.9237983912587815e-5	24	709	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0010212	response to ionizing radiation	1.7962746845512356e-9	3.96168381677775e-5	12	145	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0000302	response to reactive oxygen species	1.895120615991175e-9	4.179688518568536e-5	14	216	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0042327	positive regulation of phosphorylation	2.6365455374488533e-9	5.814901182843446e-5	27	910	148
Orphanet:180821	Rare gastroesophageal tumor	GO:0051347	positive regulation of transferase activity	3.1414860712786208e-9	6.928547530204998e-5	22	613	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0044441	ciliary part	1.2325696019388488e-12	2.718432257076131e-8	26	303	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0048839	inner ear development	9.36140054363932e-13	2.064656889899652e-8	18	170	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0035113	embryonic appendage morphogenesis	6.905587213168474e-13	1.523027259864307e-8	15	125	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0030326	embryonic limb morphogenesis	6.905587213168474e-13	1.523027259864307e-8	15	125	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0009799	specification of symmetry	6.654676809603188e-13	1.4676889703579832e-8	19	122	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0001655	urogenital system development	6.292744103575387e-13	1.3878647120435517e-8	21	313	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0009855	determination of bilateral symmetry	5.999645225074346e-13	1.323221754390147e-8	19	121	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0035148	tube formation	5.220268661787486e-13	1.15133025335723e-8	17	131	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0014020	primary neural tube formation	1.9095836023552692e-13	4.211586634994546e-9	15	86	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0061371	determination of heart left/right asymmetry	2.786659791809143e-14	6.145978170835065e-10	12	61	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0001654	eye development	2.0794477251229182e-13	4.586221957758596e-9	20	327	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0072001	renal system development	3.622657729351886e-13	7.989771622085584e-9	21	276	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0001822	kidney development	1.0904610547868288e-12	2.4050118563323508e-8	19	262	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0021537	telencephalon development	1.3692380562702056e-12	3.0198545331039384e-8	20	226	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0048565	digestive tract development	4.268585485078802e-12	9.414365287341298e-8	14	138	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0043010	camera-type eye development	9.1354701581281e-12	2.0148279433751526e-7	18	283	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0021532	neural tube patterning	1.687183726062358e-11	3.7210837078305303e-7	9	39	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0048546	digestive tract morphogenesis	1.5179102419438095e-10	3.347751038607072e-6	9	49	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0001944	vasculature development	2.4924062813624914e-10	5.497002053544975e-6	23	588	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0021871	forebrain regionalization	7.271986346424342e-10	1.6038365887038886e-5	7	25	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0090596	sensory organ morphogenesis	7.608780272505555e-10	1.6781164891011002e-5	15	239	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0060541	respiratory system development	7.903714349666302e-10	1.743164199818903e-5	14	202	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0001568	blood vessel development	7.921969746860213e-10	1.74719042767002e-5	22	569	148
Orphanet:108989	Non-syndromic central nervous system malformation	GO:0048754	branching morphogenesis of an epithelial tube	2.1028677688050834e-9	4.6378748640996115e-5	12	147	148
OMIM:601626	acute myeloid leukemia	GO:0048872	homeostasis of number of cells	2.1949109196839345e-13	4.8408760333629175e-9	18	208	148
OMIM:601626	acute myeloid leukemia	GO:0008285	negative regulation of cell proliferation	1.5983880885528379e-12	3.525244929303284e-8	28	634	148
OMIM:601626	acute myeloid leukemia	GO:0060548	negative regulation of cell death	1.6895373988745632e-12	3.726274733217849e-8	34	867	148
OMIM:601626	acute myeloid leukemia	GO:0002521	leukocyte differentiation	5.855205209570613e-12	1.2913655089707987e-7	24	448	148
OMIM:601626	acute myeloid leukemia	GO:0009725	response to hormone	8.637979220793568e-12	1.9051063171460214e-7	30	865	148
OMIM:601626	acute myeloid leukemia	GO:0043069	negative regulation of programmed cell death	8.821610109066569e-12	1.9456061095546318e-7	34	806	148
OMIM:601626	acute myeloid leukemia	GO:0051241	negative regulation of multicellular organismal process	9.228395825289226e-12	2.0353226992675388e-7	32	966	148
OMIM:601626	acute myeloid leukemia	GO:0045637	regulation of myeloid cell differentiation	1.1960210599681886e-11	2.63782444775984e-7	15	179	148
OMIM:601626	acute myeloid leukemia	GO:0043066	negative regulation of apoptotic process	1.2639889135357407e-11	2.787727548803076e-7	31	795	148
OMIM:601626	acute myeloid leukemia	GO:0033993	response to lipid	2.0897061858704546e-11	4.6088469929372877e-7	29	850	148
OMIM:601626	acute myeloid leukemia	GO:0035295	tube development	2.2037704994204432e-11	4.860415836471788e-7	24	573	148
OMIM:601626	acute myeloid leukemia	GO:0072358	cardiovascular system development	2.6392443785994146e-11	5.820853477001009e-7	30	910	148
OMIM:601626	acute myeloid leukemia	GO:0051093	negative regulation of developmental process	3.259159608859363e-11	7.188076517339326e-7	28	788	148
OMIM:601626	acute myeloid leukemia	GO:0010942	positive regulation of cell death	5.3846371805832405e-11	1.1875817301776337e-6	24	596	148
OMIM:601626	acute myeloid leukemia	GO:0002573	myeloid leukocyte differentiation	2.1368529168341865e-10	4.712829108077798e-6	14	183	148
OMIM:601626	acute myeloid leukemia	GO:0014070	response to organic cyclic compound	2.1647950099179525e-10	4.774455394374044e-6	28	873	148
OMIM:601626	acute myeloid leukemia	GO:1901701	cellular response to oxygen-containing compound	2.1647950099179525e-10	4.774455394374044e-6	28	873	148
OMIM:601626	acute myeloid leukemia	GO:0030879	mammary gland development	4.226293759401756e-10	9.321090886360572e-6	12	128	148
OMIM:601626	acute myeloid leukemia	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	6.542086872229902e-10	1.4428572596703049e-5	25	732	148
OMIM:601626	acute myeloid leukemia	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	7.690358350131987e-10	1.6961085341216098e-5	23	623	148
OMIM:601626	acute myeloid leukemia	GO:0032870	cellular response to hormone stimulus	8.903725534636919e-10	1.9637166666641725e-5	21	519	148
OMIM:601626	acute myeloid leukemia	GO:1901698	response to nitrogen compound	9.956986346537633e-10	2.196013338728875e-5	27	870	148
OMIM:601626	acute myeloid leukemia	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	2.1675699013457006e-9	4.780575417417943e-5	8	45	148
OMIM:601626	acute myeloid leukemia	GO:0010243	response to organonitrogen compound	2.3798186754575568e-9	5.2486900887216414e-5	25	780	148
OMIM:601626	acute myeloid leukemia	GO:0034097	response to cytokine	2.6388914386998863e-9	5.820075068052599e-5	25	784	148
OMIM:601626	acute myeloid leukemia	GO:0043065	positive regulation of apoptotic process	3.0317274246627335e-9	6.686474835093659e-5	21	556	148
Orphanet:104011	Rare tumor of intestine	GO:0000165	MAPK cascade	1.3717915692268434e-12	3.025486305929803e-8	33	843	151
Orphanet:104011	Rare tumor of intestine	GO:0007167	enzyme linked receptor protein signaling pathway	1.913802449848845e-12	4.220891303141627e-8	33	935	151
Orphanet:104011	Rare tumor of intestine	GO:0009725	response to hormone	2.7118307599494074e-12	5.980942741068418e-8	37	865	151
Orphanet:104011	Rare tumor of intestine	GO:0097190	apoptotic signaling pathway	4.3257619708469974e-12	9.540468026703053e-8	25	564	151
Orphanet:104011	Rare tumor of intestine	GO:0051347	positive regulation of transferase activity	4.3337555766242986e-12	9.55809792424489e-8	26	613	151
Orphanet:104011	Rare tumor of intestine	GO:0030334	regulation of cell migration	5.202616115695946e-12	1.1474369843167409e-7	29	660	151
Orphanet:104011	Rare tumor of intestine	GO:0033674	positive regulation of kinase activity	5.81756864903582e-12	1.2830647655448502e-7	24	480	151
Orphanet:104011	Rare tumor of intestine	GO:0040008	regulation of growth	7.387424005855792e-12	1.6292963644914948e-7	26	617	151
Orphanet:104011	Rare tumor of intestine	GO:0042326	negative regulation of phosphorylation	3.2861824372787396e-11	7.24767536541826e-7	21	420	151
Orphanet:104011	Rare tumor of intestine	GO:0070372	regulation of ERK1 and ERK2 cascade	7.201117480093444e-11	1.588206460234609e-6	16	233	151
Orphanet:104011	Rare tumor of intestine	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	9.913170284647776e-11	2.186349706279067e-6	19	359	151
Orphanet:104011	Rare tumor of intestine	GO:0061061	muscle structure development	1.0615397449953434e-10	2.34122590758723e-6	23	551	151
Orphanet:104011	Rare tumor of intestine	GO:0051302	regulation of cell division	2.4649582375246837e-10	5.43646539286069e-6	17	293	151
Orphanet:104011	Rare tumor of intestine	GO:0048878	chemical homeostasis	2.807184484865388e-10	6.191245381370614e-6	30	988	151
Orphanet:104011	Rare tumor of intestine	GO:0016049	cell growth	3.0820590524172076e-10	6.797481240106151e-6	21	479	151
Orphanet:104011	Rare tumor of intestine	GO:0001933	negative regulation of protein phosphorylation	3.1995073257462536e-10	7.056513406933362e-6	19	385	151
Orphanet:104011	Rare tumor of intestine	GO:0006979	response to oxidative stress	3.3409297550690553e-10	7.3684205748048015e-6	19	386	151
Orphanet:104011	Rare tumor of intestine	GO:0002684	positive regulation of immune system process	3.4589131558959707e-10	7.628632965328563e-6	28	872	151
Orphanet:104011	Rare tumor of intestine	GO:0006259	DNA metabolic process	3.8196823481939646e-10	8.424309418941789e-6	29	937	151
Orphanet:104011	Rare tumor of intestine	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	4.4001424726047844e-10	9.704514223329852e-6	24	647	151
Orphanet:104011	Rare tumor of intestine	GO:0090130	tissue migration	4.941376197109548e-10	1.0898205202725109e-5	15	227	151
Orphanet:104011	Rare tumor of intestine	GO:0055086	nucleobase-containing small molecule metabolic process	5.254214840988425e-10	1.1588170831799971e-5	25	709	151
Orphanet:104011	Rare tumor of intestine	GO:0045787	positive regulation of cell cycle	5.287738025216981e-10	1.1662106214616053e-5	17	308	151
Orphanet:104011	Rare tumor of intestine	GO:0051241	negative regulation of multicellular organismal process	7.707930960165754e-10	1.699984173264557e-5	29	966	151
Orphanet:104011	Rare tumor of intestine	GO:0019752	carboxylic acid metabolic process	7.912243082941472e-10	1.7450452119427418e-5	29	967	151
Orphanet:104011	Rare tumor of intestine	GO:0071260	cellular response to mechanical stimulus	8.995978406645122e-10	1.9840630375855817e-5	10	80	151
Orphanet:104011	Rare tumor of intestine	GO:0051093	negative regulation of developmental process	9.316279969695529e-10	2.054705547316349e-5	26	788	151
Orphanet:104011	Rare tumor of intestine	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.0858077770237173e-9	2.3947490522258086e-5	13	168	151
Orphanet:104011	Rare tumor of intestine	GO:0051050	positive regulation of transport	1.1684178069515383e-9	2.5769454732316177e-5	28	920	151
Orphanet:104011	Rare tumor of intestine	GO:0048565	digestive tract development	1.279416128596722e-9	2.8217522716200705e-5	12	138	151
Orphanet:104011	Rare tumor of intestine	GO:0032870	cellular response to hormone stimulus	1.294055196332522e-9	2.8540387355113772e-5	21	519	151
Orphanet:104011	Rare tumor of intestine	GO:0032880	regulation of protein localization	1.589423592740502e-9	3.505473733789177e-5	28	933	151
Orphanet:104011	Rare tumor of intestine	GO:1902806	regulation of cell cycle G1/S phase transition	1.6397562196956983e-9	3.6164823425388626e-5	12	141	151
Orphanet:104011	Rare tumor of intestine	GO:0001558	regulation of cell growth	1.7739720803433556e-9	3.912495423197271e-5	18	379	151
Orphanet:104011	Rare tumor of intestine	GO:0071216	cellular response to biotic stimulus	1.7943523333840972e-9	3.957444071278626e-5	13	175	151
Orphanet:104011	Rare tumor of intestine	GO:0042692	muscle cell differentiation	1.8225150277828561e-9	4.019556893775089e-5	17	334	151
Orphanet:104011	Rare tumor of intestine	GO:0045597	positive regulation of cell differentiation	1.8779046095929175e-9	4.1417186164571795e-5	26	815	151
Orphanet:104011	Rare tumor of intestine	GO:0051052	regulation of DNA metabolic process	1.90743354444578e-9	4.206844682275168e-5	17	335	151
Orphanet:104011	Rare tumor of intestine	GO:0010001	glial cell differentiation	1.924046921786271e-9	4.243485485999621e-5	13	176	151
Orphanet:104011	Rare tumor of intestine	GO:0043491	protein kinase B signaling	2.089024842000242e-9	4.607344289031534e-5	12	144	151
Orphanet:104011	Rare tumor of intestine	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	2.6111023343489137e-9	5.758786198406529e-5	10	89	151
Orphanet:104011	Rare tumor of intestine	GO:1903649	regulation of cytoplasmic transport	2.6219333371102493e-9	5.782673974996655e-5	19	437	151
Orphanet:104011	Rare tumor of intestine	GO:0009986	cell surface	3.1765809982431392e-9	7.005949391625244e-5	24	715	151
Orphanet:104011	Rare tumor of intestine	GO:1990267	response to transition metal nanoparticle	3.335752229993716e-9	7.35700154325114e-5	12	150	151
Orphanet:104011	Rare tumor of intestine	GO:0046688	response to copper ion	3.4275746685352715e-9	7.559515931454541e-5	7	30	151
Orphanet:104011	Rare tumor of intestine	GO:0071222	cellular response to lipopolysaccharide	3.880857302185348e-9	8.559230779969784e-5	12	152	151
Orphanet:104011	Rare tumor of intestine	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	4.180060186875778e-9	9.219122742154529e-5	14	225	151
Orphanet:104011	Rare tumor of intestine	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	4.397507469278139e-9	9.698702723492936e-5	7	31	151
DOID:9455	lipid storage disease	GO:0005773	vacuole	2.460920356384122e-12	5.427559846005181e-8	35	603	151
DOID:9455	lipid storage disease	GO:0016042	lipid catabolic process	1.723732268033018e-12	3.801691517146821e-8	25	281	151
DOID:9455	lipid storage disease	GO:0006665	sphingolipid metabolic process	8.186784583585904e-13	1.8055953399098712e-8	19	144	151
DOID:9455	lipid storage disease	GO:0044242	cellular lipid catabolic process	6.254996520738132e-13	1.379539482648795e-8	22	177	151
DOID:9455	lipid storage disease	GO:0033993	response to lipid	5.866418462119327e-13	1.2938385918204176e-8	38	850	151
DOID:9455	lipid storage disease	GO:1902652	secondary alcohol metabolic process	5.655476087440547e-13	1.2473152510850127e-8	17	121	151
DOID:9455	lipid storage disease	GO:1903509	liposaccharide metabolic process	4.907185768843192e-13	1.082279821318366e-8	15	118	151
DOID:9455	lipid storage disease	GO:0019915	lipid storage	1.27675647831893e-14	2.8158864129324e-10	12	61	151
DOID:9455	lipid storage disease	GO:0006638	neutral lipid metabolic process	2.5013324744804777e-13	5.5166887724666935e-9	14	111	151
DOID:9455	lipid storage disease	GO:0006631	fatty acid metabolic process	1.120659121056633e-12	2.471613691490404e-8	21	348	151
DOID:9455	lipid storage disease	GO:1901565	organonitrogen compound catabolic process	1.2796430581829554e-12	2.8222527648225082e-8	21	349	151
DOID:9455	lipid storage disease	GO:0006672	ceramide metabolic process	2.300937218535637e-12	5.074717035480347e-8	12	81	151
DOID:9455	lipid storage disease	GO:0030301	cholesterol transport	6.93189949885209e-12	1.5288304344718284e-7	11	68	151
DOID:9455	lipid storage disease	GO:0008610	lipid biosynthetic process	7.586486994171082e-12	1.6731997065644322e-7	26	627	151
DOID:9455	lipid storage disease	GO:0043069	negative regulation of programmed cell death	1.0428768959513945e-11	2.3000649940208007e-7	30	806	151
DOID:9455	lipid storage disease	GO:0048545	response to steroid hormone	1.5943246722827098e-11	3.5162830647195165e-7	22	446	151
DOID:9455	lipid storage disease	GO:0000302	response to reactive oxygen species	2.211841820809468e-11	4.878217135795282e-7	16	216	151
DOID:9455	lipid storage disease	GO:0010883	regulation of lipid storage	3.28161942064753e-11	7.237611632238128e-7	9	41	151
DOID:9455	lipid storage disease	GO:0010888	negative regulation of lipid storage	3.571420936765435e-11	7.876768876036166e-7	7	17	151
DOID:9455	lipid storage disease	GO:0009636	response to toxic substance	1.917113134908277e-10	4.228193019040205e-6	16	249	151
DOID:9455	lipid storage disease	GO:0032940	secretion by cell	6.112008676950609e-10	1.3480035137014568e-5	29	956	151
DOID:9455	lipid storage disease	GO:0010035	response to inorganic substance	7.138856172872465e-10	1.5744747289270222e-5	21	502	151
DOID:9455	lipid storage disease	GO:0031329	regulation of cellular catabolic process	1.1889895734640277e-9	2.622316504274913e-5	23	624	151
DOID:9455	lipid storage disease	GO:0032870	cellular response to hormone stimulus	1.294055196332522e-9	2.8540387355113772e-5	21	519	151
DOID:9455	lipid storage disease	GO:0048732	gland development	1.4232960365845315e-9	3.139079408687184e-5	19	421	151
DOID:9455	lipid storage disease	GO:0055088	lipid homeostasis	1.5869375813437614e-9	3.499990835653666e-5	11	111	151
DOID:9455	lipid storage disease	GO:0030162	regulation of proteolysis	2.1577023501251347e-9	4.7588125332009845e-5	24	701	151
DOID:9455	lipid storage disease	GO:0006897	endocytosis	2.512700381096522e-9	5.5417606905083794e-5	22	593	151
DOID:9455	lipid storage disease	GO:0043408	regulation of MAPK cascade	2.6687748677645118e-9	5.885982970854631e-5	23	651	151
DOID:9455	lipid storage disease	GO:0006694	steroid biosynthetic process	3.0902753689332485e-9	6.81560232618228e-5	12	149	151
DOID:9455	lipid storage disease	GO:0046503	glycerolipid catabolic process	4.358596039644169e-9	9.612883565435215e-5	8	48	151
DOID:9455	lipid storage disease	GO:0010742	macrophage derived foam cell differentiation	4.397507469278139e-9	9.698702723492936e-5	7	31	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035295	tube development	2.0594637106796654e-12	4.542147213904002e-8	39	573	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0043010	camera-type eye development	1.5212275883413895e-12	3.3550674460869345e-8	21	283	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0003002	regionalization	1.2956302697375577e-12	2.8575125599061835e-8	31	327	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0030323	respiratory tube development	7.667200208061331e-13	1.6910010058879266e-8	17	179	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035270	endocrine system development	7.169820293029261e-13	1.5813038656276035e-8	19	129	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021953	central nervous system neuron differentiation	6.954437026251981e-13	1.5338010861398743e-8	16	161	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0097485	neuron projection guidance	6.938893903907228e-13	1.5303730505067392e-8	19	216	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021915	neural tube development	4.261035968511351e-13	9.397714828551784e-9	17	151	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0060541	respiratory system development	4.0589753780295723e-13	8.952070196244222e-9	20	202	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001568	blood vessel development	3.936850845320805e-13	8.682724539355036e-9	30	569	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.9939605522267811e-13	4.397679997936166e-9	21	317	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0007411	axon guidance	1.9562129693895258e-13	4.314427703988599e-9	19	215	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021536	diencephalon development	1.0325074129013956e-13	2.277195099154028e-9	15	77	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048645	organ formation	6.94999613415348e-14	1.53282164738755e-9	12	59	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0061053	somite development	3.697042672001771e-14	8.153827613099907e-10	13	85	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001701	in utero embryonic development	1.0413891970983968e-13	2.2967838742005142e-9	20	312	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048663	neuron fate commitment	1.2223555501122974e-13	2.695905165772672e-9	12	67	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001655	urogenital system development	2.973177259946169e-13	6.557342446811276e-9	20	313	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0030324	lung development	3.731459585765151e-13	8.22973411640504e-9	16	175	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0070848	response to growth factor	5.092593013955593e-13	1.123171389227906e-8	28	621	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0090596	sensory organ morphogenesis	5.401235014801387e-13	1.1912423825144458e-8	20	239	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035107	appendage morphogenesis	6.110667527536862e-13	1.3477077231982548e-8	15	146	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035108	limb morphogenesis	6.110667527536862e-13	1.3477077231982548e-8	15	146	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035113	embryonic appendage morphogenesis	8.369971382649055e-13	1.845997188443249e-8	14	125	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0030326	embryonic limb morphogenesis	8.369971382649055e-13	1.845997188443249e-8	14	125	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001503	ossification	1.1251000131551336e-12	2.4814080790136472e-8	22	363	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.2827516826519059e-12	2.8291088360887784e-8	41	996	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0061351	neural precursor cell proliferation	2.4571455981003965e-12	5.4192346166104244e-8	14	132	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0040007	growth	2.7221558340784213e-12	6.003714692059958e-8	38	936	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0045664	regulation of neuron differentiation	2.9062308115612723e-12	6.409692054898386e-8	26	548	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	3.589573083218056e-12	7.916803435037423e-8	25	573	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021537	telencephalon development	5.381139978055671e-12	1.1868104221601783e-7	17	226	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0003006	developmental process involved in reproduction	6.245892691936206e-12	1.3775316332065302e-7	26	619	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048608	reproductive structure development	8.306244581035571e-12	1.8319422423473952e-7	22	418	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0008284	positive regulation of cell proliferation	9.814926649198696e-12	2.1646820724807725e-7	33	815	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0072001	renal system development	1.0336842493074982e-11	2.2797906118476874e-7	18	276	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.379629743780697e-11	3.0427733999083273e-7	28	732	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048638	regulation of developmental growth	1.3911094498553211e-11	3.068091891655911e-7	18	283	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0007167	enzyme linked receptor protein signaling pathway	1.6168510974523542e-11	3.565965095431167e-7	31	935	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035050	embryonic heart tube development	1.8132606527387907e-11	3.999146369615403e-7	11	74	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0055123	digestive system development	1.8833379300531305e-11	4.1537018047321794e-7	14	150	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0030855	epithelial cell differentiation	3.0874525158708366e-11	6.80937652375313e-7	24	568	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021983	pituitary gland development	4.148414944893375e-11	9.149329160962338e-7	9	42	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001822	kidney development	4.364630878939124e-11	9.626193403500238e-7	17	262	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0051093	negative regulation of developmental process	4.652644935987382e-11	1.0261408406320172e-6	28	788	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0003682	chromatin binding	5.496569865925949e-11	1.212268483929968e-6	21	433	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021510	spinal cord development	5.742095687821802e-11	1.2664192039490985e-6	12	106	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0045596	negative regulation of cell differentiation	8.56463788778683e-11	1.8889308861513854e-6	24	597	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048565	digestive tract development	9.270595402455228e-11	2.0446298160115006e-6	13	138	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0060485	mesenchyme development	9.308609438818394e-11	2.0530138117313967e-6	16	237	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0042471	ear morphogenesis	1.1120038223566553e-10	2.4525244302076032e-6	12	112	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001756	somitogenesis	1.2689949091537756e-10	2.798768272138652e-6	10	66	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0051241	negative regulation of multicellular organismal process	1.6983603412512593e-10	3.7457337326296525e-6	30	966	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0019827	stem cell population maintenance	1.7309376154628353e-10	3.817582910903283e-6	13	145	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0042472	inner ear morphogenesis	2.0562518354694248e-10	4.535063423127816e-6	11	92	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0022612	gland morphogenesis	2.266873355694088e-10	4.999589185983311e-6	12	119	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048854	brain morphogenesis	2.3074209209994478e-10	5.089016841264282e-6	8	34	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0043066	negative regulation of apoptotic process	2.3213631017426906e-10	5.119766320893504e-6	27	795	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:2000177	regulation of neural precursor cell proliferation	3.0929148131519923e-10	6.821423620406719e-6	10	72	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021515	cell differentiation in spinal cord	4.5405423865219063e-10	1.0014166233474064e-5	9	54	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0042063	gliogenesis	5.253221191381385e-10	1.1585979337591645e-5	15	228	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0007442	hindgut morphogenesis	6.710749733684906e-10	1.4800558537642061e-5	5	7	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001667	ameboidal-type cell migration	7.481422148458705e-10	1.6500276548425674e-5	17	315	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0090102	cochlea development	7.557285908177391e-10	1.6667594070485237e-5	8	39	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0035265	organ growth	7.637568355534086e-10	1.6844657008130426e-5	12	132	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0072132	mesenchyme morphogenesis	9.38225275248783e-10	2.0692558445611908e-5	8	40	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0072009	nephron epithelium development	9.646807797025758e-10	2.127603459634031e-5	11	106	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0003151	outflow tract morphogenesis	1.0365417413282785e-9	2.2860928104995182e-5	9	59	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0030155	regulation of cell adhesion	1.082419043285654e-9	2.38727519996651e-5	23	621	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0014706	striated muscle tissue development	1.0970829800172055e-9	2.4196165124279467e-5	17	323	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0042733	embryonic digit morphogenesis	1.211091116282148e-9	2.6710614569602775e-5	9	60	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0001649	osteoblast differentiation	1.3325337500091905e-9	2.9389031856452696e-5	14	206	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0050769	positive regulation of neurogenesis	1.563205453969374e-9	3.4476496287294545e-5	18	376	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0016331	morphogenesis of embryonic epithelium	1.6397562196956983e-9	3.6164823425388626e-5	12	141	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0003205	cardiac chamber development	1.7786421224741389e-9	3.922795201116713e-5	12	142	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0010001	glial cell differentiation	1.924046921786271e-9	4.243485485999621e-5	13	176	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0007517	muscle organ development	2.386356667827272e-9	5.263109630893048e-5	17	340	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0010721	negative regulation of cell development	2.7527825574580334e-9	6.0712619304736926e-5	16	299	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021517	ventral spinal cord development	3.0554215824096786e-9	6.738732300004546e-5	8	46	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0072080	nephron tubule development	3.2550578898948856e-9	7.17903017616317e-5	10	91	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021954	central nervous system neuron development	3.822038130429917e-9	8.429505096663181e-5	9	68	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0021543	pallium development	4.18197232399109e-9	9.223339960562349e-5	12	153	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0051270	regulation of cellular component movement	4.365341088607977e-9	9.627759770924893e-5	25	787	151
Orphanet:95495	Disease associated with non-acquired combined pituitary hormone deficiency	GO:0048665	neuron fate specification	4.397507469278139e-9	9.698702723492936e-5	7	31	151
MESH:D017880	Limb Deformities, Congenital	GO:0030111	regulation of Wnt signaling pathway	1.609601341101552e-12	3.549975757799473e-8	22	306	152
MESH:D017880	Limb Deformities, Congenital	GO:0060562	epithelial tube morphogenesis	1.5762946503627973e-12	3.4765178513751493e-8	32	301	152
MESH:D017880	Limb Deformities, Congenital	GO:0022603	regulation of anatomical structure morphogenesis	1.4941381465405357e-12	3.2953216821951514e-8	35	986	152
MESH:D017880	Limb Deformities, Congenital	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1.4861445407632345e-12	3.277691784653314e-8	24	307	152
MESH:D017880	Limb Deformities, Congenital	GO:0050673	epithelial cell proliferation	1.1937117960769683e-12	2.6327313662477536e-8	28	335	152
MESH:D017880	Limb Deformities, Congenital	GO:0008544	epidermis development	1.049382802875698e-12	2.314413771742352e-8	22	296	152
MESH:D017880	Limb Deformities, Congenital	GO:0007517	muscle organ development	9.530154443382344e-13	2.101875562487976e-8	24	340	152
MESH:D017880	Limb Deformities, Congenital	GO:0050678	regulation of epithelial cell proliferation	9.141576384763539e-13	2.0161746716595985e-8	27	277	152
MESH:D017880	Limb Deformities, Congenital	GO:0048839	inner ear development	8.981704269217516e-13	1.9809148765759232e-8	21	170	152
MESH:D017880	Limb Deformities, Congenital	GO:0060348	bone development	8.613110225041964e-13	1.8996214601330053e-8	21	172	152
MESH:D017880	Limb Deformities, Congenital	GO:0061138	morphogenesis of a branching epithelium	8.322231792590173e-13	1.8354682218557627e-8	22	179	152
MESH:D017880	Limb Deformities, Congenital	GO:0048762	mesenchymal cell differentiation	7.713829575095588e-13	1.701285112787332e-8	19	184	152
MESH:D017880	Limb Deformities, Congenital	GO:0050679	positive regulation of epithelial cell proliferation	7.651657085716579e-13	1.6875729702547915e-8	18	155	152
MESH:D017880	Limb Deformities, Congenital	GO:0030323	respiratory tube development	7.311928840181281e-13	1.6126459057019815e-8	17	179	152
MESH:D017880	Limb Deformities, Congenital	GO:0022612	gland morphogenesis	6.956657472301231e-13	1.5342908055160365e-8	16	119	152
MESH:D017880	Limb Deformities, Congenital	GO:0048738	cardiac muscle tissue development	6.821210263296962e-13	1.504417923570145e-8	17	168	152
MESH:D017880	Limb Deformities, Congenital	GO:0072073	kidney epithelium development	6.337153024560394e-13	1.3976590995667948e-8	17	137	152
MESH:D017880	Limb Deformities, Congenital	GO:0009952	anterior/posterior pattern specification	5.966338534335591e-13	1.3158759637477146e-8	18	199	152
MESH:D017880	Limb Deformities, Congenital	GO:0035148	tube formation	5.111466805374221e-13	1.1273340039252844e-8	15	131	152
MESH:D017880	Limb Deformities, Congenital	GO:0016331	morphogenesis of embryonic epithelium	5.100364575127969e-13	1.1248854070444736e-8	18	141	152
MESH:D017880	Limb Deformities, Congenital	GO:0048706	embryonic skeletal system development	4.953815135877448e-13	1.0925639282177713e-8	17	122	152
MESH:D017880	Limb Deformities, Congenital	GO:0003007	heart morphogenesis	4.662936703425657e-13	1.0284106899405288e-8	22	216	152
MESH:D017880	Limb Deformities, Congenital	GO:0055123	digestive system development	4.654054919228656e-13	1.0264518124358801e-8	23	150	152
MESH:D017880	Limb Deformities, Congenital	GO:0009799	specification of symmetry	4.2943426592501055e-13	9.471172734976108e-9	15	122	152
MESH:D017880	Limb Deformities, Congenital	GO:0030509	BMP signaling pathway	4.18554080283684e-13	9.231210240656651e-9	18	136	152
MESH:D017880	Limb Deformities, Congenital	GO:0048864	stem cell development	3.907985046680551e-13	8.619061020453955e-9	17	175	152
MESH:D017880	Limb Deformities, Congenital	GO:0048565	digestive tract development	3.6193270602780103e-13	7.982425831443152e-9	22	138	152
MESH:D017880	Limb Deformities, Congenital	GO:0021915	neural tube development	3.459454944731988e-13	7.629827880606399e-9	18	151	152
MESH:D017880	Limb Deformities, Congenital	GO:0014031	mesenchymal cell development	2.6401103525586223e-13	5.822763382568041e-9	16	171	152
MESH:D017880	Limb Deformities, Congenital	GO:0048754	branching morphogenesis of an epithelial tube	2.509104035652854e-13	5.533828950632369e-9	19	147	152
MESH:D017880	Limb Deformities, Congenital	GO:0045596	negative regulation of cell differentiation	1.971756091734278e-13	4.34870806031995e-9	30	597	152
MESH:D017880	Limb Deformities, Congenital	GO:0072009	nephron epithelium development	1.9029222642075183e-13	4.196895053709682e-9	14	106	152
MESH:D017880	Limb Deformities, Congenital	GO:0060021	palate development	1.7053025658242404e-13	3.761044808925362e-9	15	85	152
MESH:D017880	Limb Deformities, Congenital	GO:0072089	stem cell proliferation	1.4988010832439613e-13	3.3056057890945567e-9	15	139	152
MESH:D017880	Limb Deformities, Congenital	GO:0001658	branching involved in ureteric bud morphogenesis	1.4144241333724494e-13	3.1195124261529372e-9	12	59	152
MESH:D017880	Limb Deformities, Congenital	GO:0060541	respiratory system development	1.2789769243681803e-13	2.8207836066940217e-9	18	202	152
MESH:D017880	Limb Deformities, Congenital	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1.0813572259849025e-13	2.3849333619097024e-9	19	204	152
MESH:D017880	Limb Deformities, Congenital	GO:0045778	positive regulation of ossification	9.015010959956271e-14	1.9882606672183556e-9	14	84	152
MESH:D017880	Limb Deformities, Congenital	GO:0060512	prostate gland morphogenesis	4.707345624410664e-14	1.0382050774637719e-9	11	27	152
MESH:D017880	Limb Deformities, Congenital	GO:0001568	blood vessel development	2.886579864025407e-15	6.366351890108035e-11	26	569	152
MESH:D017880	Limb Deformities, Congenital	GO:0048546	digestive tract morphogenesis	2.042810365310288e-14	4.5054182606918403e-10	12	49	152
MESH:D017880	Limb Deformities, Congenital	GO:0035137	hindlimb morphogenesis	4.207745263329343e-14	9.280182178272867e-10	12	37	152
MESH:D017880	Limb Deformities, Congenital	GO:0048704	embryonic skeletal system morphogenesis	4.363176486776865e-14	9.622985741586376e-10	14	93	152
MESH:D017880	Limb Deformities, Congenital	GO:0098773	skin epidermis development	6.628031457012185e-14	1.4618123378440373e-9	13	82	152
MESH:D017880	Limb Deformities, Congenital	GO:0060513	prostatic bud formation	7.083222897108499e-14	1.5622048099572794e-9	7	9	152
MESH:D017880	Limb Deformities, Congenital	GO:0035136	forelimb morphogenesis	8.43769498715119e-14	1.8609336294161949e-9	12	40	152
MESH:D017880	Limb Deformities, Congenital	GO:0042471	ear morphogenesis	1.2634338020234281e-13	2.7865032503626708e-9	15	112	152
MESH:D017880	Limb Deformities, Congenital	GO:0022405	hair cycle process	1.3422596367718143e-13	2.9603536289002363e-9	13	80	152
MESH:D017880	Limb Deformities, Congenital	GO:0001942	hair follicle development	1.3422596367718143e-13	2.9603536289002363e-9	13	80	152
MESH:D017880	Limb Deformities, Congenital	GO:0001837	epithelial to mesenchymal transition	1.4632739464559563e-13	3.2272506889086117e-9	14	109	152
MESH:D017880	Limb Deformities, Congenital	GO:0030279	negative regulation of ossification	2.5368596112684827e-13	5.5950438726526386e-9	12	68	152
MESH:D017880	Limb Deformities, Congenital	GO:0072091	regulation of stem cell proliferation	2.595701431573616e-13	5.72481950733561e-9	13	88	152
MESH:D017880	Limb Deformities, Congenital	GO:0050680	negative regulation of epithelial cell proliferation	4.79061235125755e-13	1.0565695540698528e-8	14	112	152
MESH:D017880	Limb Deformities, Congenital	GO:0007368	determination of left/right symmetry	4.79061235125755e-13	1.0565695540698528e-8	14	112	152
MESH:D017880	Limb Deformities, Congenital	GO:0030324	lung development	5.467848396278896e-13	1.2059339637993105e-8	16	175	152
MESH:D017880	Limb Deformities, Congenital	GO:0030855	epithelial cell differentiation	6.441513988875158e-13	1.4206759102464162e-8	26	568	152
MESH:D017880	Limb Deformities, Congenital	GO:0072132	mesenchyme morphogenesis	7.360778653264788e-13	1.623419731977549e-8	10	40	152
MESH:D017880	Limb Deformities, Congenital	GO:0035116	embryonic hindlimb morphogenesis	1.0468292899190601e-12	2.308781998916487e-8	9	29	152
MESH:D017880	Limb Deformities, Congenital	GO:0030510	regulation of BMP signaling pathway	1.2252421299763228e-12	2.70227151766278e-8	12	77	152
MESH:D017880	Limb Deformities, Congenital	GO:0045165	cell fate commitment	1.489697254442035e-12	3.285527294671908e-8	24	243	152
MESH:D017880	Limb Deformities, Congenital	GO:0045669	positive regulation of osteoblast differentiation	1.5806245201588354e-12	3.4860673792103114e-8	11	60	152
MESH:D017880	Limb Deformities, Congenital	GO:0030282	bone mineralization	1.638689184346731e-12	3.6141289960767153e-8	13	100	152
MESH:D017880	Limb Deformities, Congenital	GO:0030900	forebrain development	1.7574830479816228e-12	3.876128862323469e-8	25	357	152
MESH:D017880	Limb Deformities, Congenital	GO:0060602	branch elongation of an epithelium	1.861732989993925e-12	4.1060521094316016e-8	8	20	152
MESH:D017880	Limb Deformities, Congenital	GO:0042692	muscle cell differentiation	1.918798453459658e-12	4.231909989105276e-8	20	334	152
MESH:D017880	Limb Deformities, Congenital	GO:2000648	positive regulation of stem cell proliferation	2.077893412888443e-12	4.582793922125461e-8	11	61	152
MESH:D017880	Limb Deformities, Congenital	GO:0003156	regulation of organ formation	2.1740387268209815e-12	4.794842412003675e-8	9	31	152
MESH:D017880	Limb Deformities, Congenital	GO:0035115	embryonic forelimb morphogenesis	2.993605363599272e-12	6.602396629418195e-8	9	32	152
MESH:D017880	Limb Deformities, Congenital	GO:0003197	endocardial cushion development	2.993605363599272e-12	6.602396629418195e-8	9	32	152
MESH:D017880	Limb Deformities, Congenital	GO:0021510	spinal cord development	3.0483393587132923e-12	6.723112455642166e-8	13	106	152
MESH:D017880	Limb Deformities, Congenital	GO:0032330	regulation of chondrocyte differentiation	3.089639655229348e-12	6.814200259608327e-8	10	46	152
MESH:D017880	Limb Deformities, Congenital	GO:0048566	embryonic digestive tract development	3.972600026713735e-12	8.761569358917143e-8	9	33	152
MESH:D017880	Limb Deformities, Congenital	GO:0055024	regulation of cardiac muscle tissue development	4.750533300068582e-12	1.0477301193301258e-7	10	48	152
MESH:D017880	Limb Deformities, Congenital	GO:0048592	eye morphogenesis	5.133893310471649e-12	1.1322801696245222e-7	14	136	152
MESH:D017880	Limb Deformities, Congenital	GO:0060284	regulation of cell development	7.401523838268531e-12	1.6324060825301245e-7	35	828	152
MESH:D017880	Limb Deformities, Congenital	GO:0010720	positive regulation of cell development	7.806977286861638e-12	1.7218288406173343e-7	23	469	152
MESH:D017880	Limb Deformities, Congenital	GO:0050767	regulation of neurogenesis	8.803402451462716e-12	1.941590410670102e-7	27	658	152
MESH:D017880	Limb Deformities, Congenital	GO:0001701	in utero embryonic development	9.084066832087956e-12	2.0034909398169987e-7	19	312	152
MESH:D017880	Limb Deformities, Congenital	GO:0060828	regulation of canonical Wnt signaling pathway	9.549583346313284e-12	2.1061606070293948e-7	17	235	152
MESH:D017880	Limb Deformities, Congenital	GO:0007548	sex differentiation	9.886536034287019e-12	2.180475522362002e-7	18	274	152
MESH:D017880	Limb Deformities, Congenital	GO:0000975	regulatory region DNA binding	1.1370682173605928e-11	2.5078039533887875e-7	30	810	152
MESH:D017880	Limb Deformities, Congenital	GO:0045664	regulation of neuron differentiation	1.905420266012925e-11	4.202404396691506e-7	24	548	152
MESH:D017880	Limb Deformities, Congenital	GO:0051270	regulation of cellular component movement	1.929612025719507e-11	4.255759322724373e-7	29	787	152
MESH:D017880	Limb Deformities, Congenital	GO:0035050	embryonic heart tube development	1.9479973190072997e-11	4.2963080870705994e-7	11	74	152
MESH:D017880	Limb Deformities, Congenital	GO:0030177	positive regulation of Wnt signaling pathway	2.5322077767953033e-11	5.584784251722041e-7	14	152	152
MESH:D017880	Limb Deformities, Congenital	GO:0040012	regulation of locomotion	3.2636671143393414e-11	7.198017820675418e-7	28	766	152
MESH:D017880	Limb Deformities, Congenital	GO:0031012	extracellular matrix	4.225175764815958e-11	9.318625149301596e-7	21	423	152
MESH:D017880	Limb Deformities, Congenital	GO:0021983	pituitary gland development	4.399014486011765e-11	9.702026448898948e-7	9	42	152
MESH:D017880	Limb Deformities, Congenital	GO:0060174	limb bud formation	5.38973310426627e-11	1.1887056361459258e-6	6	10	152
MESH:D017880	Limb Deformities, Congenital	GO:0042063	gliogenesis	5.7668647635011894e-11	1.2718820235901873e-6	16	228	152
MESH:D017880	Limb Deformities, Congenital	GO:0010092	specification of organ identity	5.948586068171835e-11	1.3119606573352982e-6	8	29	152
MESH:D017880	Limb Deformities, Congenital	GO:0051146	striated muscle cell differentiation	6.511302608203096e-11	1.4360677902391927e-6	16	230	152
MESH:D017880	Limb Deformities, Congenital	GO:0060606	tube closure	7.04957203723211e-11	1.554783112811542e-6	11	83	152
MESH:D017880	Limb Deformities, Congenital	GO:0048666	neuron development	7.745326602304203e-11	1.708231782138192e-6	30	926	152
MESH:D017880	Limb Deformities, Congenital	GO:2000145	regulation of cell motility	1.1789247356119859e-10	2.600118504392235e-6	26	709	152
MESH:D017880	Limb Deformities, Congenital	GO:0009954	proximal/distal pattern formation	1.429104612427068e-10	3.151890222707898e-6	8	32	152
MESH:D017880	Limb Deformities, Congenital	GO:0003205	cardiac chamber development	1.444953046103592e-10	3.186843943181472e-6	13	142	152
MESH:D017880	Limb Deformities, Congenital	GO:0048663	neuron fate commitment	1.5805501352161855e-10	3.485903323219297e-6	10	67	152
MESH:D017880	Limb Deformities, Congenital	GO:0048638	regulation of developmental growth	1.582177722170286e-10	3.4894929662465657e-6	17	283	152
MESH:D017880	Limb Deformities, Congenital	GO:0001838	embryonic epithelial tube formation	1.6404522185098358e-10	3.618017367923443e-6	12	115	152
MESH:D017880	Limb Deformities, Congenital	GO:0009798	axis specification	1.7322143719411542e-10	3.820398797316216e-6	11	90	152
MESH:D017880	Limb Deformities, Congenital	GO:0010001	glial cell differentiation	1.8210777330551764e-10	4.0163869402531915e-6	14	176	152
MESH:D017880	Limb Deformities, Congenital	GO:0030500	regulation of bone mineralization	2.1362633884081106e-10	4.711528903134088e-6	10	69	152
MESH:D017880	Limb Deformities, Congenital	GO:0098743	cell aggregation	2.179649793987437e-10	4.8072176206392925e-6	7	21	152
MESH:D017880	Limb Deformities, Congenital	GO:0001502	cartilage condensation	2.179649793987437e-10	4.8072176206392925e-6	7	21	152
MESH:D017880	Limb Deformities, Congenital	GO:0042472	inner ear morphogenesis	2.2076473982224343e-10	4.868966336779579e-6	11	92	152
MESH:D017880	Limb Deformities, Congenital	GO:0098727	maintenance of cell number	2.2394275323023294e-10	4.9390574224927875e-6	13	147	152
MESH:D017880	Limb Deformities, Congenital	GO:2000738	positive regulation of stem cell differentiation	2.332017912110018e-10	5.143265505158645e-6	9	50	152
MESH:D017880	Limb Deformities, Congenital	GO:0051148	negative regulation of muscle cell differentiation	2.332017912110018e-10	5.143265505158645e-6	9	50	152
MESH:D017880	Limb Deformities, Congenital	GO:0031175	neuron projection development	2.7656843482049e-10	6.099716829965907e-6	27	796	152
MESH:D017880	Limb Deformities, Congenital	GO:0014855	striated muscle cell proliferation	2.8122515427497774e-10	6.202420777534634e-6	9	51	152
MESH:D017880	Limb Deformities, Congenital	GO:0001841	neural tube formation	3.138684867565189e-10	6.9223694754150245e-6	11	95	152
MESH:D017880	Limb Deformities, Congenital	GO:0003203	endocardial cushion morphogenesis	3.1753888407592967e-10	7.003320088294629e-6	7	22	152
MESH:D017880	Limb Deformities, Congenital	GO:0051961	negative regulation of nervous system development	3.7843916889102047e-10	8.346475869891457e-6	16	259	152
MESH:D017880	Limb Deformities, Congenital	GO:1901862	negative regulation of muscle tissue development	3.998643638425392e-10	8.819008544547202e-6	8	36	152
MESH:D017880	Limb Deformities, Congenital	GO:0048636	positive regulation of muscle organ development	4.815774445887655e-10	1.0621190540405223e-5	9	54	152
MESH:D017880	Limb Deformities, Congenital	GO:0045844	positive regulation of striated muscle tissue development	4.815774445887655e-10	1.0621190540405223e-5	9	54	152
MESH:D017880	Limb Deformities, Congenital	GO:0048593	camera-type eye morphogenesis	5.50006040711537e-10	1.2130383227892949e-5	11	100	152
MESH:D017880	Limb Deformities, Congenital	GO:2000826	regulation of heart morphogenesis	6.356349890879187e-10	1.4018929684334047e-5	7	24	152
MESH:D017880	Limb Deformities, Congenital	GO:0060038	cardiac muscle cell proliferation	6.374392125252371e-10	1.4058721832244103e-5	8	38	152
MESH:D017880	Limb Deformities, Congenital	GO:0005578	proteinaceous extracellular matrix	6.678861907971623e-10	1.4730229938031414e-5	18	354	152
MESH:D017880	Limb Deformities, Congenital	GO:0060592	mammary gland formation	6.938373209308679e-10	1.5302582113130292e-5	5	7	152
MESH:D017880	Limb Deformities, Congenital	GO:0007442	hindgut morphogenesis	6.938373209308679e-10	1.5302582113130292e-5	5	7	152
MESH:D017880	Limb Deformities, Congenital	GO:0021953	central nervous system neuron differentiation	6.959938181338998e-10	1.535014365894316e-5	13	161	152
MESH:D017880	Limb Deformities, Congenital	GO:0001667	ameboidal-type cell migration	8.29854851502887e-10	1.8302448749896172e-5	17	315	152
MESH:D017880	Limb Deformities, Congenital	GO:0035051	cardiocyte differentiation	1.1457799153902215e-9	2.5270176033931335e-5	11	107	152
MESH:D017880	Limb Deformities, Congenital	GO:0061037	negative regulation of cartilage development	1.1917202780153957e-9	2.6283390731629552e-5	7	26	152
MESH:D017880	Limb Deformities, Congenital	GO:0048806	genitalia development	1.2200639387671686e-9	2.6908510169509903e-5	8	41	152
MESH:D017880	Limb Deformities, Congenital	GO:0001843	neural tube closure	1.2295278128959808e-9	2.7117235913420856e-5	10	82	152
MESH:D017880	Limb Deformities, Congenital	GO:0061371	determination of heart left/right asymmetry	1.4961583083561436e-9	3.299777149079475e-5	9	61	152
MESH:D017880	Limb Deformities, Congenital	GO:0010463	mesenchymal cell proliferation	1.4968600803300092e-9	3.301324907167835e-5	8	42	152
MESH:D017880	Limb Deformities, Congenital	GO:0003279	cardiac septum development	1.5649714857346453e-9	3.45154461178776e-5	10	84	152
MESH:D017880	Limb Deformities, Congenital	GO:0003143	embryonic heart tube morphogenesis	2.0138657408352856e-9	4.4415808914122223e-5	9	63	152
MESH:D017880	Limb Deformities, Congenital	GO:0019827	stem cell population maintenance	2.44001618909806e-9	5.381455705055771e-5	12	145	152
MESH:D017880	Limb Deformities, Congenital	GO:0001656	metanephros development	2.4885032923194217e-9	5.4883940112104845e-5	10	88	152
MESH:D017880	Limb Deformities, Congenital	GO:0031128	developmental induction	2.7704685212626146e-9	6.110268323644696e-5	7	29	152
MESH:D017880	Limb Deformities, Congenital	GO:0055025	positive regulation of cardiac muscle tissue development	2.7704685212626146e-9	6.110268323644696e-5	7	29	152
MESH:D017880	Limb Deformities, Congenital	GO:0003179	heart valve morphogenesis	2.7704685212626146e-9	6.110268323644696e-5	7	29	152
MESH:D017880	Limb Deformities, Congenital	GO:0010631	epithelial cell migration	3.0308030529724306e-9	6.684436133330696e-5	14	218	152
MESH:D017880	Limb Deformities, Congenital	GO:0010721	negative regulation of cell development	3.033059803314586e-9	6.68941339621032e-5	16	299	152
MESH:D017880	Limb Deformities, Congenital	GO:0060350	endochondral bone morphogenesis	3.2192513099715825e-9	7.100058764142325e-5	8	46	152
MESH:D017880	Limb Deformities, Congenital	GO:0002011	morphogenesis of an epithelial sheet	3.852976826479448e-9	8.497740390800423e-5	8	47	152
MESH:D017880	Limb Deformities, Congenital	GO:0030334	regulation of cell migration	3.947136395510142e-9	8.705409320297619e-5	23	660	152
MESH:D017880	Limb Deformities, Congenital	GO:0060039	pericardium development	4.514908447106336e-9	9.957630580093024e-5	6	18	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0022900	electron transport chain	2.4491519923230953e-13	5.401604719068587e-9	16	107	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0030048	actin filament-based movement	2.3581137043038325e-13	5.2008197748421026e-9	21	114	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0060048	cardiac muscle contraction	7.815970093361102e-14	1.723812204090791e-9	21	115	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0070252	actin-mediated cell contraction	5.46229728115577e-14	1.2047096653589051e-9	20	95	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0060415	muscle tissue morphogenesis	4.6407322429331543e-14	1.0235134961789072e-9	12	64	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0055008	cardiac muscle tissue morphogenesis	2.4646951146678475e-14	5.435885075399938e-10	12	54	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0022904	respiratory electron transport chain	1.674216321134736e-13	3.6924840962626604e-9	16	105	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0003229	ventricular cardiac muscle tissue development	2.477906768660887e-12	5.465023378281586e-8	10	45	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0019866	organelle inner membrane	3.6339820042030624e-12	8.014747310269854e-8	25	531	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0010035	response to inorganic substance	6.552536291337674e-12	1.445161879054524e-7	24	502	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0006942	regulation of striated muscle contraction	2.1613266731890235e-11	4.7668059777183913e-7	12	97	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0007568	aging	2.604261251093476e-11	5.743698189286661e-7	18	290	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0010038	response to metal ion	3.225220090996572e-11	7.11322291069294e-7	19	335	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0014070	response to organic cyclic compound	8.3488105317997e-11	1.8413301627884238e-6	29	873	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0043069	negative regulation of programmed cell death	1.7214345504612538e-9	3.796623901042295e-5	26	806	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0019901	protein kinase binding	2.269953114364398e-9	5.00638159373068e-5	21	532	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0042493	response to drug	2.5244190071660455e-9	5.5676061203047134e-5	19	433	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0043549	regulation of kinase activity	2.551857836152749e-9	5.6281224576348876e-5	25	761	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0044455	mitochondrial membrane part	2.56602628034841e-9	5.6593709613084187e-5	13	179	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0045859	regulation of protein kinase activity	3.0824642838211957e-9	6.798374977967647e-5	24	709	152
Orphanet:99739	Rare familial disorder with hypertrophic cardiomyopathy	GO:0016491	oxidoreductase activity	3.1695841506973466e-9	6.990517844362998e-5	24	710	152
DOID:8618	oral cavity cancer	GO:0014070	response to organic cyclic compound	6.645795025406187e-13	1.4657300928533346e-8	32	873	152
DOID:8618	oral cavity cancer	GO:0060548	negative regulation of cell death	2.564060075371799e-12	5.655034496232503e-8	33	867	152
DOID:8618	oral cavity cancer	GO:0051726	regulation of cell cycle	8.357203817865866e-12	1.8431813020303167e-7	32	930	152
DOID:8618	oral cavity cancer	GO:0045786	negative regulation of cell cycle	2.0398793765252776e-11	4.4989539649265e-7	22	449	152
DOID:8618	oral cavity cancer	GO:0043069	negative regulation of programmed cell death	2.062405801694922e-11	4.5486359956381506e-7	29	806	152
DOID:8618	oral cavity cancer	GO:0045597	positive regulation of cell differentiation	2.5721202945305777e-11	5.672811309587189e-7	29	815	152
DOID:8618	oral cavity cancer	GO:0072358	cardiovascular system development	2.3020285677688435e-10	5.077124006214184e-6	29	910	152
DOID:8618	oral cavity cancer	GO:0030162	regulation of proteolysis	4.825906341210384e-10	1.0643536435539502e-5	25	701	152
DOID:8618	oral cavity cancer	GO:0001101	response to acid chemical	8.29854851502887e-10	1.8302448749896172e-5	17	315	152
DOID:8618	oral cavity cancer	GO:0052548	regulation of endopeptidase activity	9.542966417086518e-10	2.1047012432884316e-5	18	362	152
DOID:8618	oral cavity cancer	GO:0022603	regulation of anatomical structure morphogenesis	1.4369219147880585e-9	3.169131283065063e-5	29	986	152
DOID:8618	oral cavity cancer	GO:0050673	epithelial cell proliferation	2.1135020400464555e-9	4.6613287493224576e-5	17	335	152
DOID:8618	oral cavity cancer	GO:0031960	response to corticosteroid	2.56602628034841e-9	5.6593709613084187e-5	13	179	152
MESH:D034381	Hearing Loss	GO:0030855	epithelial cell differentiation	3.8902214782865485e-13	8.579883470360983e-9	28	568	153
MESH:D034381	Hearing Loss	GO:0042490	mechanoreceptor differentiation	2.3359092438113294e-13	5.151847837225887e-9	15	55	153
MESH:D034381	Hearing Loss	GO:0060563	neuroepithelial cell differentiation	7.880363028789361e-13	1.7380140659994936e-8	12	74	153
MESH:D034381	Hearing Loss	GO:0042491	auditory receptor cell differentiation	3.1650237986013963e-12	6.98045998781538e-8	9	32	153
MESH:D034381	Hearing Loss	GO:0048704	embryonic skeletal system morphogenesis	2.6660262886224473e-10	5.8799209795568075e-6	11	93	153
MESH:D034381	Hearing Loss	GO:0090102	cochlea development	8.392262440537479e-10	1.850913481260541e-5	8	39	153
MESH:D002561	Cerebrovascular Disorders	GO:0035150	regulation of tube size	6.559197629485425e-13	1.4466310371830104e-8	17	140	153
MESH:D002561	Cerebrovascular Disorders	GO:0072521	purine-containing compound metabolic process	4.04343225568482e-13	8.91778983991287e-9	29	568	153
MESH:D002561	Cerebrovascular Disorders	GO:0048659	smooth muscle cell proliferation	2.9451996397256153e-12	6.495637805414844e-8	13	104	153
MESH:D002561	Cerebrovascular Disorders	GO:0052548	regulation of endopeptidase activity	3.4662273051822012e-12	7.644764321579345e-8	21	362	153
MESH:D002561	Cerebrovascular Disorders	GO:0006163	purine nucleotide metabolic process	3.764877298806368e-12	8.303436882517445e-8	26	522	153
MESH:D002561	Cerebrovascular Disorders	GO:0050878	regulation of body fluid levels	3.957500993578833e-12	8.728268441338116e-8	27	504	153
MESH:D002561	Cerebrovascular Disorders	GO:1901699	cellular response to nitrogen compound	4.4078074523667965e-12	9.72141933619497e-8	26	518	153
MESH:D002561	Cerebrovascular Disorders	GO:0051241	negative regulation of multicellular organismal process	5.633493671552969e-12	1.2424670292610074e-7	36	966	153
MESH:D002561	Cerebrovascular Disorders	GO:0009150	purine ribonucleotide metabolic process	7.754130670889481e-12	1.710173519464675e-7	24	501	153
MESH:D002561	Cerebrovascular Disorders	GO:0048878	chemical homeostasis	1.680566796835592e-11	3.706490070420898e-7	32	988	153
MESH:D002561	Cerebrovascular Disorders	GO:0055082	cellular chemical homeostasis	3.22848414668897e-11	7.120421785522524e-7	26	661	153
MESH:D002561	Cerebrovascular Disorders	GO:0001664	G-protein coupled receptor binding	3.4798386394641057e-11	7.674784119338085e-7	17	255	153
MESH:D002561	Cerebrovascular Disorders	GO:1903035	negative regulation of response to wounding	5.0573545351539906e-11	1.1153995427282126e-6	14	159	153
MESH:D002561	Cerebrovascular Disorders	GO:0032844	regulation of homeostatic process	5.501832323062672e-11	1.2134291188514723e-6	21	427	153
MESH:D002561	Cerebrovascular Disorders	GO:0008217	regulation of blood pressure	1.0652734250271578e-10	2.3494605388973966e-6	14	168	153
MESH:D002561	Cerebrovascular Disorders	GO:2001233	regulation of apoptotic signaling pathway	1.2426704110168885e-10	2.7407095914977475e-6	19	359	153
MESH:D002561	Cerebrovascular Disorders	GO:0043279	response to alkaloid	1.3112666508163784e-10	2.8919985983755225e-6	13	140	153
MESH:D002561	Cerebrovascular Disorders	GO:0042311	vasodilation	1.9643775495126192e-10	4.332434685450082e-6	10	68	153
MESH:D002561	Cerebrovascular Disorders	GO:0030595	leukocyte chemotaxis	2.1451629361735058e-10	4.731156855730667e-6	14	177	153
MESH:D002561	Cerebrovascular Disorders	GO:0010952	positive regulation of peptidase activity	2.8807578544842727e-10	6.353511448065063e-6	13	149	153
MESH:D002561	Cerebrovascular Disorders	GO:0043627	response to estrogen	3.1664681987564336e-10	6.983645612357314e-6	15	217	153
MESH:D002561	Cerebrovascular Disorders	GO:0002673	regulation of acute inflammatory response	4.6548276344537953e-10	1.0266222347787846e-5	10	74	153
MESH:D002561	Cerebrovascular Disorders	GO:0042554	superoxide anion generation	4.747394699577967e-10	1.0470379009919206e-5	7	23	153
MESH:D002561	Cerebrovascular Disorders	GO:0016337	single organismal cell-cell adhesion	4.952963594817561e-10	1.092376120837013e-5	25	697	153
MESH:D002561	Cerebrovascular Disorders	GO:0043523	regulation of neuron apoptotic process	5.49253753590051e-10	1.2113791535428575e-5	14	190	153
MESH:D002561	Cerebrovascular Disorders	GO:0055114	oxidation-reduction process	7.149003611317539e-10	1.5767127464760833e-5	29	949	153
MESH:D002561	Cerebrovascular Disorders	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	7.551201886002445e-10	1.6654175759578393e-5	13	161	153
MESH:D002561	Cerebrovascular Disorders	GO:0032940	secretion by cell	8.41521519134858e-10	1.8559757104519292e-5	29	956	153
MESH:D002561	Cerebrovascular Disorders	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	8.538397766599815e-10	1.883143627423589e-5	15	233	153
MESH:D002561	Cerebrovascular Disorders	GO:0032102	negative regulation of response to external stimulus	9.978654569309242e-10	2.2007922652611533e-5	16	275	153
MESH:D002561	Cerebrovascular Disorders	GO:0042310	vasoconstriction	1.0231988589737284e-9	2.256665083466558e-5	10	80	153
MESH:D002561	Cerebrovascular Disorders	GO:0050801	ion homeostasis	1.0942826644821935e-9	2.4134404165154777e-5	24	668	153
MESH:D002561	Cerebrovascular Disorders	GO:0050678	regulation of epithelial cell proliferation	1.108043101716305e-9	2.4437890608353108e-5	16	277	153
MESH:D002561	Cerebrovascular Disorders	GO:0045471	response to ethanol	1.3685307331812169e-9	3.0182945320311738e-5	12	137	153
MESH:D002561	Cerebrovascular Disorders	GO:0030155	regulation of cell adhesion	1.4098311407195752e-9	3.109382580857023e-5	23	621	153
MESH:D002561	Cerebrovascular Disorders	GO:0045121	membrane raft	1.4370767908999937e-9	3.169472862329936e-5	16	282	153
MESH:D002561	Cerebrovascular Disorders	GO:0001935	endothelial cell proliferation	1.500780388852263e-9	3.309971147613666e-5	11	109	153
MESH:D002561	Cerebrovascular Disorders	GO:0035295	tube development	1.7172393507181027e-9	3.7873713880087756e-5	22	573	153
MESH:D002561	Cerebrovascular Disorders	GO:0022407	regulation of cell-cell adhesion	1.9373008752765486e-9	4.272717080422428e-5	18	376	153
MESH:D002561	Cerebrovascular Disorders	GO:0009897	external side of plasma membrane	2.30129892919706e-9	5.0755147883441154e-5	14	212	153
MESH:D002561	Cerebrovascular Disorders	GO:0048520	positive regulation of behavior	2.6304521894005006e-9	5.801462303722804e-5	12	145	153
MESH:D002561	Cerebrovascular Disorders	GO:0043549	regulation of kinase activity	2.9335018858489548e-9	6.46983840923987e-5	25	761	153
MESH:D002561	Cerebrovascular Disorders	GO:0010563	negative regulation of phosphorus metabolic process	3.025104833298542e-9	6.671868709839934e-5	21	537	153
MESH:D002561	Cerebrovascular Disorders	GO:0045936	negative regulation of phosphate metabolic process	3.025104833298542e-9	6.671868709839934e-5	21	537	153
MESH:D002561	Cerebrovascular Disorders	GO:0045859	regulation of protein kinase activity	3.5260542263770844e-9	7.77671259627466e-5	24	709	153
MESH:D002561	Cerebrovascular Disorders	GO:0016491	oxidoreductase activity	3.6253887669701612e-9	7.99579492555269e-5	24	710	153
MESH:D002561	Cerebrovascular Disorders	GO:0050921	positive regulation of chemotaxis	3.844273677167109e-9	8.47854559499206e-5	11	119	153
MESH:D002561	Cerebrovascular Disorders	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.18212653396921e-9	9.223680070669094e-5	12	151	153
Orphanet:98049	Rare female infertility	GO:0046660	female sex differentiation	3.608224830031759e-13	7.957939862635044e-9	15	127	153
Orphanet:98049	Rare female infertility	GO:2000241	regulation of reproductive process	3.608224830031759e-13	7.957939862635044e-9	15	127	153
Orphanet:98049	Rare female infertility	GO:0006694	steroid biosynthetic process	1.2606582444618653e-12	2.7803817581606438e-8	15	149	153
Orphanet:98049	Rare female infertility	GO:0043408	regulation of MAPK cascade	2.28739249763521e-11	5.044844153534456e-7	26	651	153
Orphanet:98049	Rare female infertility	GO:0048511	rhythmic process	2.7019164683395047e-11	5.959076770922778e-7	19	329	153
Orphanet:98049	Rare female infertility	GO:0048609	multicellular organismal reproductive process	3.729516695472057e-11	8.225449071863622e-7	28	767	153
Orphanet:98049	Rare female infertility	GO:1901699	cellular response to nitrogen compound	4.481315318827228e-11	9.883540935673452e-7	23	518	153
Orphanet:98049	Rare female infertility	GO:0010243	response to organonitrogen compound	4.7170489736458876e-11	1.0403451511376005e-6	28	780	153
Orphanet:98049	Rare female infertility	GO:0001763	morphogenesis of a branching structure	6.044420519657479e-11	1.3330969456104569e-6	15	193	153
Orphanet:98049	Rare female infertility	GO:0035265	organ growth	6.20020701447288e-11	1.3674556570419938e-6	13	132	153
Orphanet:98049	Rare female infertility	GO:0007507	heart development	8.706002585512351e-11	1.920108870234749e-6	22	487	153
Orphanet:98049	Rare female infertility	GO:0060541	respiratory system development	1.1568757063429302e-10	2.5514893703393327e-6	15	202	153
Orphanet:98049	Rare female infertility	GO:0001503	ossification	1.4932799441425004e-10	3.2934289168062847e-6	19	363	153
Orphanet:98049	Rare female infertility	GO:0071417	cellular response to organonitrogen compound	2.087140460460546e-10	4.603188285545734e-6	21	462	153
Orphanet:98049	Rare female infertility	GO:0061138	morphogenesis of a branching epithelium	2.489540795735934e-10	5.490682224995602e-6	14	179	153
Orphanet:98049	Rare female infertility	GO:0022602	ovulation cycle process	2.998981063484507e-10	6.61425273551508e-6	11	94	153
Orphanet:98049	Rare female infertility	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	4.78956319049928e-10	1.0563381616646161e-5	30	996	153
Orphanet:98049	Rare female infertility	GO:0007167	enzyme linked receptor protein signaling pathway	5.004500147620661e-10	1.1037425075577367e-5	29	935	153
Orphanet:98049	Rare female infertility	GO:0071363	cellular response to growth factor stimulus	5.978452177757276e-10	1.3185476278043673e-5	23	594	153
Orphanet:98049	Rare female infertility	GO:0007276	gamete generation	8.518294958292927e-10	1.878709953051505e-5	23	605	153
Orphanet:98049	Rare female infertility	GO:0048839	inner ear development	1.478121069986571e-9	3.2599960198553823e-5	13	170	153
Orphanet:98049	Rare female infertility	GO:0060548	negative regulation of cell death	1.9864910827394056e-9	4.381206082981759e-5	27	867	153
Orphanet:98049	Rare female infertility	GO:0042446	hormone biosynthetic process	2.1341635125793346e-9	4.7068976269937224e-5	9	63	153
Orphanet:98049	Rare female infertility	GO:0045995	regulation of embryonic development	2.21111784437511e-9	4.876620405769305e-5	11	113	153
Orphanet:98049	Rare female infertility	GO:0014070	response to organic cyclic compound	2.300199364313471e-9	5.0730896979933604e-5	27	873	153
Orphanet:98049	Rare female infertility	GO:0001501	skeletal system development	2.723030467777221e-9	6.005643696682661e-5	20	482	153
Orphanet:98049	Rare female infertility	GO:0008209	androgen metabolic process	3.757154809491681e-9	8.286404932333902e-5	7	30	153
Orphanet:207015	Rare hereditary disease with peripheral neuropathy	GO:0072521	purine-containing compound metabolic process	4.2876813211023546e-13	9.456481153691243e-9	39	568	154
Orphanet:207015	Rare hereditary disease with peripheral neuropathy	GO:1990267	response to transition metal nanoparticle	1.3468115511727774e-12	2.9703928761115606e-8	15	150	154
Orphanet:207015	Rare hereditary disease with peripheral neuropathy	GO:0006783	heme biosynthetic process	1.6042145389860707e-10	3.538095165733779e-6	7	20	154
Orphanet:467	Non-acquired combined pituitary hormone deficiency	GO:0001654	eye development	7.229772336359019e-13	1.5945262887839817e-8	23	327	154
Orphanet:467	Non-acquired combined pituitary hormone deficiency	GO:0048853	forebrain morphogenesis	8.119190875177651e-10	1.790687547520431e-5	6	14	154
Orphanet:467	Non-acquired combined pituitary hormone deficiency	GO:0030097	hemopoiesis	2.733364867779642e-9	6.028436215888e-5	24	695	154
Orphanet:467	Non-acquired combined pituitary hormone deficiency	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	3.691869698840833e-9	8.142418620793457e-5	17	343	154
DOID:987	alopecia	GO:0035295	tube development	2.816413768869097e-12	6.211600567240794e-8	30	573	155
DOID:987	alopecia	GO:0007423	sensory organ development	6.8469674374682654e-12	1.510098668333626e-7	24	494	155
DOID:987	alopecia	GO:0043588	skin development	1.7578061228817887e-10	3.876841404015785e-6	16	241	155
DOID:987	alopecia	GO:0008544	epidermis development	4.3362913260125424e-10	9.563690519520662e-6	17	296	155
DOID:987	alopecia	GO:0044212	transcription regulatory region DNA binding	2.715155211774345e-9	5.988274819568318e-5	26	807	155
DOID:5082	liver cirrhosis	GO:0009991	response to extracellular stimulus	1.2656542480726785e-12	2.7914004441242923e-8	26	573	155
DOID:5082	liver cirrhosis	GO:0002237	response to molecule of bacterial origin	1.1610712391529887e-12	2.5607426179519166e-8	28	333	155
DOID:5082	liver cirrhosis	GO:0071363	cellular response to growth factor stimulus	1.1579626146840383e-12	2.5538865466856464e-8	28	594	155
DOID:5082	liver cirrhosis	GO:0014070	response to organic cyclic compound	1.106004177131581e-12	2.4392922126637018e-8	43	873	155
DOID:5082	liver cirrhosis	GO:1901701	cellular response to oxygen-containing compound	9.372502773885572e-13	2.0671054867804628e-8	33	873	155
DOID:5082	liver cirrhosis	GO:0010038	response to metal ion	7.818190539410352e-13	1.7243019234669532e-8	21	335	155
DOID:5082	liver cirrhosis	GO:0031960	response to corticosteroid	5.653255641391297e-13	1.2468255317088506e-8	18	179	155
DOID:5082	liver cirrhosis	GO:0032355	response to estradiol	2.517985819849855e-13	5.553417725678855e-9	17	145	155
DOID:5082	liver cirrhosis	GO:0001568	blood vessel development	1.751931932858497e-13	3.863885877919415e-9	26	569	155
DOID:5082	liver cirrhosis	GO:0070482	response to oxygen levels	1.6076029396572267e-13	3.5455682834140134e-9	22	321	155
DOID:5082	liver cirrhosis	GO:0072593	reactive oxygen species metabolic process	9.198197759019422e-13	2.0286625157517335e-8	19	223	155
DOID:5082	liver cirrhosis	GO:0030335	positive regulation of cell migration	1.4528378500244798e-12	3.20423387822899e-8	27	387	155
DOID:5082	liver cirrhosis	GO:0045765	regulation of angiogenesis	1.8641754806481003e-12	4.111439022569385e-8	17	208	155
DOID:5082	liver cirrhosis	GO:0001934	positive regulation of protein phosphorylation	2.068678561784054e-12	4.5624705680147315e-8	32	870	155
DOID:5082	liver cirrhosis	GO:0001823	mesonephros development	2.8949065367100957e-12	6.384716366714116e-8	13	102	155
DOID:5082	liver cirrhosis	GO:0031667	response to nutrient levels	3.036015883139953e-12	6.695933030265167e-8	26	546	155
DOID:5082	liver cirrhosis	GO:0007167	enzyme linked receptor protein signaling pathway	3.3244518249375687e-12	7.332078499899808e-8	35	935	155
DOID:5082	liver cirrhosis	GO:0060548	negative regulation of cell death	3.6316505358513496e-12	8.009605256820151e-8	32	867	155
DOID:5082	liver cirrhosis	GO:0048878	chemical homeostasis	4.263256414560601e-12	9.402612022313406e-8	33	988	155
DOID:5082	liver cirrhosis	GO:1903034	regulation of response to wounding	4.271250020337902e-12	9.420241919855243e-8	23	407	155
DOID:5082	liver cirrhosis	GO:1902533	positive regulation of intracellular signal transduction	5.766720434507988e-12	1.2718501918307368e-7	33	860	155
DOID:5082	liver cirrhosis	GO:0001763	morphogenesis of a branching structure	5.827449633954984e-12	1.2852440167687718e-7	16	193	155
DOID:5082	liver cirrhosis	GO:0036293	response to decreased oxygen levels	5.859535079366651e-12	1.292320461754315e-7	19	302	155
DOID:5082	liver cirrhosis	GO:0042493	response to drug	5.93980420404705e-12	1.310023817202577e-7	28	433	155
DOID:5082	liver cirrhosis	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	7.42350625415611e-12	1.63725430435413e-7	27	647	155
DOID:5082	liver cirrhosis	GO:0032101	regulation of response to external stimulus	7.794542788985837e-12	1.7190864121108262e-7	34	920	155
DOID:5082	liver cirrhosis	GO:0001819	positive regulation of cytokine production	8.987255384340642e-12	1.9821391750163286e-7	21	381	155
DOID:5082	liver cirrhosis	GO:0008284	positive regulation of cell proliferation	9.152345548102403e-12	2.018549810633985e-7	32	815	155
DOID:5082	liver cirrhosis	GO:0032964	collagen biosynthetic process	1.1477374606272406e-11	2.531334969413379e-7	9	36	155
DOID:5082	liver cirrhosis	GO:0048732	gland development	1.4160561612186484e-11	3.123111863567729e-7	22	421	155
DOID:5082	liver cirrhosis	GO:0048520	positive regulation of behavior	1.71958003392092e-11	3.792533764812589e-7	14	145	155
DOID:5082	liver cirrhosis	GO:0006954	inflammatory response	1.809519201145804e-11	3.9908945981270705e-7	26	637	155
DOID:5082	liver cirrhosis	GO:0050921	positive regulation of chemotaxis	1.9121038086211684e-11	4.217144949913987e-7	13	119	155
DOID:5082	liver cirrhosis	GO:0034097	response to cytokine	2.1833868046883254e-11	4.815459597740102e-7	29	784	155
DOID:5082	liver cirrhosis	GO:0061138	morphogenesis of a branching epithelium	2.435496249120206e-11	5.371486977434614e-7	15	179	155
DOID:5082	liver cirrhosis	GO:0001657	ureteric bud development	2.7247648581862904e-11	6.009468894729864e-7	12	97	155
DOID:5082	liver cirrhosis	GO:0001666	response to hypoxia	4.12144762762523e-11	9.089852742727444e-7	18	292	155
DOID:5082	liver cirrhosis	GO:0014074	response to purine-containing compound	4.237865613987424e-11	9.346612611649263e-7	14	155	155
DOID:5082	liver cirrhosis	GO:0097191	extrinsic apoptotic signaling pathway	4.623779137347128e-11	1.0197744887419091e-6	16	220	155
DOID:5082	liver cirrhosis	GO:2000379	positive regulation of reactive oxygen species metabolic process	8.730127731837456e-11	1.925429671256751e-6	11	83	155
DOID:5082	liver cirrhosis	GO:0042060	wound healing	1.0100476011132287e-10	2.227659984255226e-6	23	534	155
DOID:5082	liver cirrhosis	GO:0046683	response to organophosphorus	1.0722367438376068e-10	2.364818138533842e-6	13	136	155
DOID:5082	liver cirrhosis	GO:0043069	negative regulation of programmed cell death	1.1666467791826562e-10	2.5730394714873484e-6	28	806	155
DOID:5082	liver cirrhosis	GO:0018108	peptidyl-tyrosine phosphorylation	1.2217182820961625e-10	2.6944996711630864e-6	19	354	155
DOID:5082	liver cirrhosis	GO:0043200	response to amino acid	1.5091317084880984e-10	3.328389983070501e-6	12	112	155
DOID:5082	liver cirrhosis	GO:0009612	response to mechanical stimulus	2.409431543171081e-10	5.314001268463819e-6	15	210	155
DOID:5082	liver cirrhosis	GO:0006694	steroid biosynthetic process	3.3886859984733064e-10	7.473746969632877e-6	13	149	155
DOID:5082	liver cirrhosis	GO:0050673	epithelial cell proliferation	3.783037216820162e-10	8.343488581696867e-6	18	335	155
DOID:5082	liver cirrhosis	GO:0043066	negative regulation of apoptotic process	4.1710057629984476e-10	9.199153210293076e-6	27	795	155
DOID:5082	liver cirrhosis	GO:0006953	acute-phase response	4.807824138808314e-10	1.0603656138141737e-5	9	53	155
DOID:5082	liver cirrhosis	GO:0060688	regulation of morphogenesis of a branching structure	4.807824138808314e-10	1.0603656138141737e-5	9	53	155
DOID:5082	liver cirrhosis	GO:0031093	platelet alpha granule lumen	6.803405616651048e-10	1.5004911087523887e-5	9	55	155
DOID:5082	liver cirrhosis	GO:0040007	growth	7.070889429527938e-10	1.5594846636823867e-5	29	936	155
DOID:5082	liver cirrhosis	GO:0010634	positive regulation of epithelial cell migration	7.555327474761953e-10	1.6663274745587486e-5	11	101	155
DOID:5082	liver cirrhosis	GO:0008083	growth factor activity	7.601247409283474e-10	1.67645511611747e-5	13	159	155
DOID:5082	liver cirrhosis	GO:1903036	positive regulation of response to wounding	9.579368409617928e-10	2.112729702741234e-5	13	162	155
DOID:5082	liver cirrhosis	GO:0007584	response to nutrient	1.0491714164118093e-9	2.3139475588962455e-5	14	197	155
DOID:5082	liver cirrhosis	GO:0032868	response to insulin	1.3729172243515109e-9	3.0279689383072572e-5	15	238	155
DOID:5082	liver cirrhosis	GO:0070838	divalent metal ion transport	1.4323697783424905e-9	3.159091546134363e-5	19	410	155
DOID:5082	liver cirrhosis	GO:0006816	calcium ion transport	1.5638493833236566e-9	3.449069814920325e-5	18	366	155
DOID:5082	liver cirrhosis	GO:0045471	response to ethanol	1.5889297655391488e-9	3.5043845978965926e-5	12	137	155
DOID:5082	liver cirrhosis	GO:0040008	regulation of growth	1.6187681195489745e-9	3.570193087665263e-5	23	617	155
DOID:5082	liver cirrhosis	GO:1903409	reactive oxygen species biosynthetic process	1.6801794400223002e-9	3.705635754969183e-5	10	83	155
DOID:5082	liver cirrhosis	GO:0043410	positive regulation of MAPK cascade	1.7910426475253871e-9	3.950144559117241e-5	20	464	155
DOID:5082	liver cirrhosis	GO:0001775	cell activation	1.9256216621243993e-9	4.246958575815363e-5	27	854	155
DOID:5082	liver cirrhosis	GO:1901699	cellular response to nitrogen compound	2.0303793091258626e-9	4.47800156627709e-5	21	518	155
DOID:5082	liver cirrhosis	GO:0009895	negative regulation of catabolic process	2.1311615805430506e-9	4.700276865887698e-5	14	208	155
DOID:5082	liver cirrhosis	GO:0045597	positive regulation of cell differentiation	3.333522791137966e-9	7.352084515854784e-5	26	815	155
DOID:5082	liver cirrhosis	GO:0032965	regulation of collagen biosynthetic process	4.113253737614286e-9	9.071781118308309e-5	7	30	155
DOID:3082	interstitial lung disease	GO:0034110	regulation of homotypic cell-cell adhesion	1.6426859872353816e-12	3.622943944847634e-8	22	304	155
DOID:3082	interstitial lung disease	GO:0001568	blood vessel development	1.4985790386390363e-12	3.3051160697183946e-8	31	569	155
DOID:3082	interstitial lung disease	GO:1901701	cellular response to oxygen-containing compound	1.1013412404281553e-12	2.4290081057642965e-8	35	873	155
DOID:3082	interstitial lung disease	GO:0002696	positive regulation of leukocyte activation	8.861800182558e-13	1.9544700302631668e-8	24	280	155
DOID:3082	interstitial lung disease	GO:0032946	positive regulation of mononuclear cell proliferation	7.316369732279782e-13	1.6136253444543058e-8	17	129	155
DOID:3082	interstitial lung disease	GO:0032103	positive regulation of response to external stimulus	5.282441151166495e-13	1.1650423958897704e-8	23	285	155
DOID:3082	interstitial lung disease	GO:0070555	response to interleukin-1	4.1655567883935873e-13	9.187135496802057e-9	15	119	155
DOID:3082	interstitial lung disease	GO:1903037	regulation of leukocyte cell-cell adhesion	4.027889133340068e-13	8.88350948358152e-9	22	294	155
DOID:3082	interstitial lung disease	GO:0033993	response to lipid	3.943512183468556e-13	8.6974161206399e-9	40	850	155
DOID:3082	interstitial lung disease	GO:0032496	response to lipopolysaccharide	3.772537837676282e-13	8.32033220099504e-9	29	319	155
DOID:3082	interstitial lung disease	GO:0050727	regulation of inflammatory response	1.7719159473017498e-13	3.907960621774009e-9	23	289	155
DOID:3082	interstitial lung disease	GO:0050863	regulation of T cell activation	1.6253665080512292e-13	3.584745833506986e-9	22	284	155
DOID:3082	interstitial lung disease	GO:0001816	cytokine production	2.877698079828406e-13	6.346763115061549e-9	32	613	155
DOID:3082	interstitial lung disease	GO:0060326	cell chemotaxis	1.1330936189324348e-12	2.499037976555485e-8	18	228	155
DOID:3082	interstitial lung disease	GO:0072593	reactive oxygen species metabolic process	1.3177237079275983e-12	2.906239637834318e-8	18	223	155
DOID:3082	interstitial lung disease	GO:0031960	response to corticosteroid	1.3629097850298422e-12	3.005897530883317e-8	16	179	155
DOID:3082	interstitial lung disease	GO:0030141	secretory granule	1.4820367155721215e-12	3.268631976194314e-8	24	351	155
DOID:3082	interstitial lung disease	GO:0007167	enzyme linked receptor protein signaling pathway	3.492872657773205e-12	7.703530646718804e-8	34	935	155
DOID:3082	interstitial lung disease	GO:0001763	morphogenesis of a branching structure	5.827449633954984e-12	1.2852440167687718e-7	16	193	155
DOID:3082	interstitial lung disease	GO:0042493	response to drug	6.1134430850984245e-12	1.3483198724184575e-7	24	433	155
DOID:3082	interstitial lung disease	GO:0032635	interleukin-6 production	6.181166689600559e-12	1.3632563133914033e-7	13	109	155
DOID:3082	interstitial lung disease	GO:0051384	response to glucocorticoid	8.455902644755042e-12	1.8649493283007246e-7	15	167	155
DOID:3082	interstitial lung disease	GO:0070848	response to growth factor	9.491074592915538e-12	2.093256501467522e-7	26	621	155
DOID:3082	interstitial lung disease	GO:0043405	regulation of MAP kinase activity	1.715783071176702e-11	3.784159563480216e-7	18	278	155
DOID:3082	interstitial lung disease	GO:0002683	negative regulation of immune system process	2.0741186546047174e-11	4.5744686927307043e-7	20	359	155
DOID:3082	interstitial lung disease	GO:0045087	innate immune response	2.2276513966801303e-11	4.913085155378027e-7	29	783	155
DOID:3082	interstitial lung disease	GO:0002521	leukocyte differentiation	2.519751074459009e-11	5.557310994719344e-7	22	448	155
DOID:3082	interstitial lung disease	GO:1901698	response to nitrogen compound	2.6465163394107094e-11	5.83689178657032e-7	30	870	155
DOID:3082	interstitial lung disease	GO:0071407	cellular response to organic cyclic compound	4.374411943786072e-11	9.647765542020181e-7	21	416	155
DOID:3082	interstitial lung disease	GO:1903409	reactive oxygen species biosynthetic process	8.730127731837456e-11	1.925429671256751e-6	11	83	155
DOID:3082	interstitial lung disease	GO:0051222	positive regulation of protein transport	1.450536357694432e-10	3.1991579368950696e-6	21	447	155
DOID:3082	interstitial lung disease	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	1.91717863806673e-10	4.228337486256173e-6	10	67	155
DOID:3082	interstitial lung disease	GO:0009887	organ morphogenesis	2.286044686883315e-10	5.041871556921151e-6	30	950	155
DOID:3082	interstitial lung disease	GO:1901214	regulation of neuron death	3.011405569353087e-10	6.641654983208234e-6	16	250	155
DOID:3082	interstitial lung disease	GO:0002440	production of molecular mediator of immune response	3.1152469492923274e-10	6.870677146664228e-6	13	148	155
DOID:3082	interstitial lung disease	GO:0035295	tube development	3.8475589381192776e-10	8.485791238022067e-6	23	573	155
DOID:3082	interstitial lung disease	GO:0006801	superoxide metabolic process	4.0202274842471297e-10	8.866611716507045e-6	9	52	155
DOID:3082	interstitial lung disease	GO:0031091	platelet alpha granule	5.29011168204363e-10	1.1667341314747226e-5	10	74	155
DOID:3082	interstitial lung disease	GO:0048878	chemical homeostasis	5.476226139222717e-10	1.2077816750055703e-5	30	988	155
DOID:3082	interstitial lung disease	GO:0034341	response to interferon-gamma	5.537027503166314e-10	1.2211914158233306e-5	13	155	155
DOID:3082	interstitial lung disease	GO:0006875	cellular metal ion homeostasis	1.057471665788512e-9	2.332253758896563e-5	20	450	155
DOID:3082	interstitial lung disease	GO:0030217	T cell differentiation	1.197432819566302e-9	2.640938083553479e-5	14	199	155
DOID:3082	interstitial lung disease	GO:0032102	negative regulation of response to external stimulus	1.2092640222505224e-9	2.6670318010735272e-5	16	275	155
DOID:3082	interstitial lung disease	GO:0042108	positive regulation of cytokine biosynthetic process	1.307221886293064e-9	2.8830778702193527e-5	9	59	155
DOID:3082	interstitial lung disease	GO:0051047	positive regulation of secretion	1.3722543101835072e-9	3.026506881109725e-5	18	363	155
DOID:3082	interstitial lung disease	GO:0048771	tissue remodeling	1.877896282920233e-9	4.1417002519805735e-5	12	139	155
DOID:3082	interstitial lung disease	GO:1901699	cellular response to nitrogen compound	2.0303793091258626e-9	4.47800156627709e-5	21	518	155
DOID:3082	interstitial lung disease	GO:0002366	leukocyte activation involved in immune response	2.1311615805430506e-9	4.700276865887698e-5	14	208	155
DOID:3082	interstitial lung disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.267917520448748e-9	5.0018920913497134e-5	14	209	155
DOID:3082	interstitial lung disease	GO:0072503	cellular divalent inorganic cation homeostasis	2.294280210257682e-9	5.060035003723318e-5	18	375	155
DOID:3082	interstitial lung disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	2.393895193186779e-9	5.2797358485734414e-5	9	63	155
DOID:3082	interstitial lung disease	GO:0030139	endocytic vesicle	2.8454829603674625e-9	6.275712669090439e-5	15	251	155
DOID:3082	interstitial lung disease	GO:1903532	positive regulation of secretion by cell	2.8596506274070066e-9	6.306959458746153e-5	17	335	155
DOID:3082	interstitial lung disease	GO:0046209	nitric oxide metabolic process	3.188038277812666e-9	7.031218421715835e-5	9	65	155
DOID:3082	interstitial lung disease	GO:0032729	positive regulation of interferon-gamma production	3.188038277812666e-9	7.031218421715835e-5	9	65	155
DOID:3082	interstitial lung disease	GO:0050871	positive regulation of B cell activation	3.66536956342145e-9	8.083972572126008e-5	9	66	155
DOID:3082	interstitial lung disease	GO:0007585	respiratory gaseous exchange	3.66536956342145e-9	8.083972572126008e-5	9	66	155
DOID:0060309	syndromic X-linked intellectual disability	GO:0009141	nucleoside triphosphate metabolic process	8.240075288767912e-13	1.817348604937763e-8	23	274	156
DOID:0060309	syndromic X-linked intellectual disability	GO:0098798	mitochondrial protein complex	3.6770586575585185e-13	8.109752869245312e-9	23	144	156
DOID:0060309	syndromic X-linked intellectual disability	GO:0098800	inner mitochondrial membrane protein complex	3.643751966819764e-13	8.036294962820989e-9	19	114	156
DOID:0060309	syndromic X-linked intellectual disability	GO:0022900	electron transport chain	2.5268676040468563e-13	5.5730065007253415e-9	22	107	156
DOID:0060309	syndromic X-linked intellectual disability	GO:0009167	purine ribonucleoside monophosphate metabolic process	2.1160850849355484e-13	4.667025654825352e-9	26	266	156
MESH:D006311	Hearing Disorders	GO:0043583	ear development	5.822009541134321e-13	1.2840442042971745e-8	39	196	156
MESH:D006311	Hearing Disorders	GO:0048701	embryonic cranial skeleton morphogenesis	3.9532831452859796e-9	8.718965976928228e-5	8	46	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0097305	response to alcohol	1.5475398740250057e-12	3.41309919216215e-8	22	369	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0007589	body fluid secretion	1.3568701717758813e-11	2.992577163851706e-7	12	91	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0042060	wound healing	1.1506051666998474e-10	2.5376596951565134e-6	23	534	156
MESH:D015674	Mammary Neoplasms, Animal	GO:2000147	positive regulation of cell motility	1.0187288790319826e-9	2.2468065427050377e-5	19	399	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0030334	regulation of cell migration	1.288415929501241e-9	2.841601332514987e-5	24	660	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0005912	adherens junction	2.081795735797698e-9	4.591400495301823e-5	20	465	156
MESH:D015674	Mammary Neoplasms, Animal	GO:0030335	positive regulation of cell migration	4.177793666571006e-9	9.214123931622353e-5	18	387	156
DOID:0060100	musculoskeletal system cancer	GO:0003690	double-stranded DNA binding	9.489187213773675e-12	2.092840239997784e-7	30	756	157
DOID:0060100	musculoskeletal system cancer	GO:0045930	negative regulation of mitotic cell cycle	1.4511858381638376e-10	3.200590366070344e-6	15	200	157
DOID:0060100	musculoskeletal system cancer	GO:1901991	negative regulation of mitotic cell cycle phase transition	1.660183102103474e-10	3.661533831689212e-6	13	139	157
DOID:0060100	musculoskeletal system cancer	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.9258250549825107e-10	4.247407158763927e-6	18	317	157
DOID:0060100	musculoskeletal system cancer	GO:0061061	muscle structure development	2.349330729956023e-10	5.1814489249180085e-6	23	551	157
DOID:0060100	musculoskeletal system cancer	GO:0032355	response to estradiol	2.8278279717852683e-10	6.236774591772409e-6	13	145	157
DOID:0060100	musculoskeletal system cancer	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	4.675391185315902e-10	1.0311575259214223e-5	26	732	157
DOID:0060100	musculoskeletal system cancer	GO:0001501	skeletal system development	7.13323067280669e-10	1.5732340248875154e-5	21	482	157
DOID:0060100	musculoskeletal system cancer	GO:0016568	chromatin modification	1.5758784277508653e-9	3.4755998724045334e-5	23	608	157
DOID:0060100	musculoskeletal system cancer	GO:0048871	multicellular organismal homeostasis	1.8314566530008847e-9	4.039277648193451e-5	17	321	157
DOID:0060100	musculoskeletal system cancer	GO:0070482	response to oxygen levels	1.8314566530008847e-9	4.039277648193451e-5	17	321	157
DOID:0060100	musculoskeletal system cancer	GO:1901215	negative regulation of neuron death	2.0318466908975097e-9	4.4812378767744576e-5	13	170	157
DOID:0060100	musculoskeletal system cancer	GO:0007050	cell cycle arrest	2.063866411106119e-9	4.551857369694545e-5	15	242	157
DOID:0060100	musculoskeletal system cancer	GO:0007568	aging	3.1442759507172013e-9	6.934700609306788e-5	16	290	157
DOID:0060100	musculoskeletal system cancer	GO:0007093	mitotic cell cycle checkpoint	3.2635727453822483e-9	7.197809689940549e-5	12	144	157
DOID:0060100	musculoskeletal system cancer	GO:0035239	tube morphogenesis	3.984364393971873e-9	8.787515670904966e-5	17	338	157
DOID:0060100	musculoskeletal system cancer	GO:2000377	regulation of reactive oxygen species metabolic process	4.131260555872984e-9	9.111495155977867e-5	12	147	157
DOID:0060100	musculoskeletal system cancer	GO:0040007	growth	4.24630219875155e-9	9.365219499346544e-5	28	936	157
DOID:263	kidney cancer	GO:0014070	response to organic cyclic compound	2.0983215165415459e-13	4.627848104732379e-9	32	873	158
DOID:263	kidney cancer	GO:0008285	negative regulation of cell proliferation	1.5307755063531658e-12	3.376125379261907e-8	30	634	158
DOID:263	kidney cancer	GO:0060548	negative regulation of cell death	3.783529045620071e-12	8.344573310115067e-8	32	867	158
DOID:263	kidney cancer	GO:1901698	response to nitrogen compound	8.702594200826752e-12	1.9193571509923402e-7	31	870	158
DOID:263	kidney cancer	GO:0043069	negative regulation of programmed cell death	9.071632334212154e-12	2.0007485113104906e-7	31	806	158
DOID:263	kidney cancer	GO:0009725	response to hormone	9.365730413435358e-12	2.0656118426831682e-7	31	865	158
DOID:263	kidney cancer	GO:0043066	negative regulation of apoptotic process	1.6123991031236073e-11	3.556146221939116e-7	30	795	158
DOID:263	kidney cancer	GO:0010243	response to organonitrogen compound	2.671474153004283e-11	5.891936244450946e-7	29	780	158
DOID:263	kidney cancer	GO:0009991	response to extracellular stimulus	9.5129570887309e-11	2.0980826859196e-6	24	573	158
DOID:263	kidney cancer	GO:0071496	cellular response to external stimulus	1.4174339479922082e-10	3.1261505722968153e-6	17	270	158
DOID:263	kidney cancer	GO:0031667	response to nutrient levels	2.2597235194155019e-10	4.983820222070889e-6	23	546	158
DOID:263	kidney cancer	GO:0048732	gland development	4.751478099862538e-10	1.0479384949246828e-5	20	421	158
DOID:263	kidney cancer	GO:0007584	response to nutrient	1.3510129681648664e-9	2.9796591012876128e-5	14	197	158
DOID:374	nutrition disease	GO:0009991	response to extracellular stimulus	2.3778756741421603e-12	5.2444047993205345e-8	34	573	159
DOID:374	nutrition disease	GO:0048878	chemical homeostasis	2.2220003614847883e-12	4.9006217972547006e-8	35	988	159
DOID:374	nutrition disease	GO:0008202	steroid metabolic process	4.700684286262913e-13	1.0367359193352854e-8	20	275	159
DOID:374	nutrition disease	GO:0048771	tissue remodeling	8.770761894538737e-13	1.9343915358405184e-8	15	139	159
DOID:374	nutrition disease	GO:0009725	response to hormone	2.430167178602005e-12	5.3597337124067224e-8	39	865	159
DOID:374	nutrition disease	GO:0032870	cellular response to hormone stimulus	2.9887203822909214e-12	6.591622803142627e-8	29	519	159
DOID:374	nutrition disease	GO:0019915	lipid storage	3.5285108168636725e-12	7.78213060659283e-8	11	61	159
DOID:374	nutrition disease	GO:0033993	response to lipid	4.2837955405161665e-12	9.447911064608405e-8	31	850	159
DOID:374	nutrition disease	GO:0010035	response to inorganic substance	1.0386913551485577e-11	2.290833783780144e-7	24	502	159
DOID:374	nutrition disease	GO:0005929	cilium	6.599598645351534e-11	1.4555414812322809e-6	22	461	159
DOID:374	nutrition disease	GO:0072358	cardiovascular system development	1.51331835951396e-10	3.3376236419080385e-6	30	910	159
DOID:374	nutrition disease	GO:0001101	response to acid chemical	2.1409662931404227e-10	4.721901159521202e-6	18	315	159
DOID:374	nutrition disease	GO:1901701	cellular response to oxygen-containing compound	2.596145520783466e-10	5.725798946087934e-6	29	873	159
DOID:374	nutrition disease	GO:0032368	regulation of lipid transport	3.1752211970825783e-10	7.0029503501656265e-6	11	91	159
DOID:374	nutrition disease	GO:0046883	regulation of hormone secretion	4.942857234624398e-10	1.090147163096411e-5	16	252	159
DOID:374	nutrition disease	GO:1902652	secondary alcohol metabolic process	5.037298356214137e-10	1.110976152463028e-5	12	121	159
DOID:374	nutrition disease	GO:0000302	response to reactive oxygen species	5.116530532589536e-10	1.1284508089626222e-5	15	216	159
DOID:374	nutrition disease	GO:0046890	regulation of lipid biosynthetic process	8.077197799494229e-10	1.7814259746784522e-5	12	126	159
DOID:374	nutrition disease	GO:0042362	fat-soluble vitamin biosynthetic process	9.847788140504576e-10	2.1719296743882843e-5	6	14	159
DOID:374	nutrition disease	GO:0014070	response to organic cyclic compound	1.221842738097223e-9	2.6947741588734253e-5	28	873	159
DOID:374	nutrition disease	GO:0033273	response to vitamin	1.361069812411131e-9	3.0018394712727492e-5	11	104	159
DOID:374	nutrition disease	GO:0048545	response to steroid hormone	1.4256634761622422e-9	3.144300796675825e-5	20	446	159
DOID:374	nutrition disease	GO:0010883	regulation of lipid storage	1.744316913132593e-9	3.847090951913934e-5	8	41	159
DOID:374	nutrition disease	GO:0019725	cellular homeostasis	1.8395863721210048e-9	4.057207743712876e-5	26	771	159
DOID:374	nutrition disease	GO:0034103	regulation of tissue remodeling	2.2285564504898048e-9	4.9150812515552644e-5	9	61	159
DOID:374	nutrition disease	GO:0044057	regulation of system process	2.299102130898234e-9	5.070669749696055e-5	21	508	159
DOID:374	nutrition disease	GO:0051093	negative regulation of developmental process	2.895837236671639e-9	6.3867690254793e-5	26	788	159
DOID:374	nutrition disease	GO:0009636	response to toxic substance	3.629293199303163e-9	8.004406151063126e-5	15	249	159
DOID:374	nutrition disease	GO:0007568	aging	3.782978374999857e-9	8.343358806062184e-5	16	290	159
DOID:374	nutrition disease	GO:0098590	plasma membrane region	4.502425543506661e-9	9.93009953620394e-5	28	926	159
DOID:4535	hypotrichosis	GO:0042633	hair cycle	8.637535131583718e-14	1.905008373270789e-9	14	101	160
DOID:4535	hypotrichosis	GO:0022405	hair cycle process	3.931965864012454e-12	8.671950713079468e-8	12	80	160
DOID:4535	hypotrichosis	GO:0001942	hair follicle development	3.931965864012454e-12	8.671950713079468e-8	12	80	160
DOID:4535	hypotrichosis	GO:0030855	epithelial cell differentiation	6.216002157444223e-10	1.3709392758243233e-5	23	568	160
DOID:4535	hypotrichosis	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.4700695105673844e-9	3.2422383055563664e-5	30	996	160
DOID:0060060	non-Hodgkin lymphoma	GO:1903706	regulation of hemopoiesis	2.397637643980488e-12	5.2879898237989664e-8	22	305	162
DOID:0060060	non-Hodgkin lymphoma	GO:0034110	regulation of homotypic cell-cell adhesion	2.0528023725319144e-12	4.527455632619137e-8	28	304	162
DOID:0060060	non-Hodgkin lymphoma	GO:0014070	response to organic cyclic compound	1.5185630530822891e-12	3.3491908135729886e-8	36	873	162
DOID:0060060	non-Hodgkin lymphoma	GO:1901701	cellular response to oxygen-containing compound	1.5023537969227618e-12	3.313441299113151e-8	35	873	162
DOID:0060060	non-Hodgkin lymphoma	GO:0022603	regulation of anatomical structure morphogenesis	1.3431478151915144e-12	2.962312506404885e-8	34	986	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002696	positive regulation of leukocyte activation	9.305889392408062e-13	2.052413905495598e-8	26	280	162
DOID:0060060	non-Hodgkin lymphoma	GO:0030099	myeloid cell differentiation	8.586464872450961e-13	1.8937448276190594e-8	23	327	162
DOID:0060060	non-Hodgkin lymphoma	GO:0046631	alpha-beta T cell activation	3.7259084706420253e-13	8.217491132000987e-9	15	106	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002699	positive regulation of immune effector process	1.1901590823981678e-13	2.624895856229159e-9	16	150	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051251	positive regulation of lymphocyte activation	9.303668946358812e-14	2.051924186119436e-9	26	257	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002237	response to molecule of bacterial origin	6.7390537594747e-14	1.4862983066521451e-9	21	333	162
DOID:0060060	non-Hodgkin lymphoma	GO:0010038	response to metal ion	1.6286971771251046e-13	3.5920916241494183e-9	21	335	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002443	leukocyte mediated immunity	2.2726265314076954e-13	5.012277815019672e-9	20	279	162
DOID:0060060	non-Hodgkin lymphoma	GO:0001101	response to acid chemical	2.403632848313464e-13	5.301212246955345e-9	21	315	162
DOID:0060060	non-Hodgkin lymphoma	GO:0046632	alpha-beta T cell differentiation	4.2932324362254803e-13	9.468724138095297e-9	13	79	162
DOID:0060060	non-Hodgkin lymphoma	GO:0097305	response to alcohol	8.854028621385623e-13	1.9527560124465992e-8	23	369	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045471	response to ethanol	1.0080825063596421e-12	2.2233259677761907e-8	15	137	162
DOID:0060060	non-Hodgkin lymphoma	GO:0070848	response to growth factor	1.2815304373248182e-12	2.8264153795198865e-8	28	621	162
DOID:0060060	non-Hodgkin lymphoma	GO:0007249	I-kappaB kinase/NF-kappaB signaling	1.7706947019746622e-12	3.9052671652051174e-8	19	260	162
DOID:0060060	non-Hodgkin lymphoma	GO:0043068	positive regulation of programmed cell death	1.7921220063499277e-12	3.9525250850047655e-8	30	561	162
DOID:0060060	non-Hodgkin lymphoma	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.2609691896491313e-12	4.986567547771159e-8	18	233	162
DOID:0060060	non-Hodgkin lymphoma	GO:0050769	positive regulation of neurogenesis	2.7363666887936233e-12	6.035056732134336e-8	22	376	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002440	production of molecular mediator of immune response	2.761679773755077e-12	6.090884741016822e-8	15	148	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002260	lymphocyte homeostasis	2.818079103406035e-12	6.21527346256201e-8	11	59	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045664	regulation of neuron differentiation	3.024802630591239e-12	6.671202201768978e-8	27	548	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002703	regulation of leukocyte mediated immunity	3.761102540522643e-12	8.295111653122689e-8	15	151	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002294	CD4-positive, alpha-beta T cell differentiation involved in immune response	5.662137425588298e-12	1.2487844092134992e-7	10	46	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045786	negative regulation of cell cycle	6.674216734836591e-12	1.4719985008682102e-7	24	449	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002705	positive regulation of leukocyte mediated immunity	7.112643807261065e-12	1.568693591691428e-7	12	83	162
DOID:0060060	non-Hodgkin lymphoma	GO:0071363	cellular response to growth factor stimulus	7.761680187456932e-12	1.7118385653436263e-7	26	594	162
DOID:0060060	non-Hodgkin lymphoma	GO:0019900	kinase binding	9.407030709951414e-12	2.0747206230797843e-7	26	598	162
DOID:0060060	non-Hodgkin lymphoma	GO:0010243	response to organonitrogen compound	1.1868173110940461e-11	2.6175255796179187e-7	37	780	162
DOID:0060060	non-Hodgkin lymphoma	GO:0007346	regulation of mitotic cell cycle	1.3421486144693517e-11	2.9601087692121553e-7	23	453	162
DOID:0060060	non-Hodgkin lymphoma	GO:0010332	response to gamma radiation	1.3827716749403862e-11	3.049702929081022e-7	10	50	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	2.100009055538976e-11	4.631569971991212e-7	10	52	162
DOID:0060060	non-Hodgkin lymphoma	GO:0032880	regulation of protein localization	2.3730795106757796e-11	5.233826860795432e-7	32	933	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051338	regulation of transferase activity	2.3781865365890553e-11	5.245090406447162e-7	32	928	162
DOID:0060060	non-Hodgkin lymphoma	GO:1901699	cellular response to nitrogen compound	2.543676380639681e-11	5.610078257500817e-7	24	518	162
DOID:0060060	non-Hodgkin lymphoma	GO:0032844	regulation of homeostatic process	2.622801975604716e-11	5.784589757196201e-7	22	427	162
DOID:0060060	non-Hodgkin lymphoma	GO:0018108	peptidyl-tyrosine phosphorylation	3.4608094168220305e-11	7.632815168800988e-7	20	354	162
DOID:0060060	non-Hodgkin lymphoma	GO:1902275	regulation of chromatin organization	3.4913960611504535e-11	7.700274012867325e-7	14	146	162
DOID:0060060	non-Hodgkin lymphoma	GO:0032496	response to lipopolysaccharide	4.436728762158282e-11	9.78520528494009e-7	19	319	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002683	negative regulation of immune system process	4.574174372606876e-11	1.0088341578784465e-6	20	359	162
DOID:0060060	non-Hodgkin lymphoma	GO:2001233	regulation of apoptotic signaling pathway	4.574174372606876e-11	1.0088341578784465e-6	20	359	162
DOID:0060060	non-Hodgkin lymphoma	GO:2001252	positive regulation of chromosome organization	4.576339307504895e-11	1.0093116342702046e-6	14	149	162
DOID:0060060	non-Hodgkin lymphoma	GO:0048545	response to steroid hormone	5.055156293565233e-11	1.114914720545812e-6	22	446	162
DOID:0060060	non-Hodgkin lymphoma	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	5.070399655693336e-11	1.1182766440631653e-6	15	180	162
DOID:0060060	non-Hodgkin lymphoma	GO:0071214	cellular response to abiotic stimulus	5.619715803817371e-11	1.2394283205319212e-6	18	285	162
DOID:0060060	non-Hodgkin lymphoma	GO:0031056	regulation of histone modification	5.810352199375757e-11	1.2814731775723232e-6	13	124	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002700	regulation of production of molecular mediator of immune response	5.8204441266695994e-11	1.2836989521369802e-6	12	99	162
DOID:0060060	non-Hodgkin lymphoma	GO:0070201	regulation of establishment of protein localization	6.640155092441091e-11	1.4644862056378827e-6	29	803	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002312	B cell activation involved in immune response	6.663158913511324e-11	1.4695596983749226e-6	10	58	162
DOID:0060060	non-Hodgkin lymphoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	7.119405065481033e-11	1.5701847871918417e-6	26	647	162
DOID:0060060	non-Hodgkin lymphoma	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	7.385847489160824e-11	1.6289486637344197e-6	12	101	162
DOID:0060060	non-Hodgkin lymphoma	GO:0016447	somatic recombination of immunoglobulin gene segments	7.779976662902754e-11	1.7158738530032025e-6	9	42	162
DOID:0060060	non-Hodgkin lymphoma	GO:0042108	positive regulation of cytokine biosynthetic process	7.961409309586998e-11	1.7558888232294123e-6	10	59	162
DOID:0060060	non-Hodgkin lymphoma	GO:0071417	cellular response to organonitrogen compound	9.871892192592213e-11	2.1772458230762126e-6	22	462	162
DOID:0060060	non-Hodgkin lymphoma	GO:0040007	growth	1.0447986920070207e-10	2.304303515221484e-6	31	936	162
DOID:0060060	non-Hodgkin lymphoma	GO:0048732	gland development	1.158496631958883e-10	2.5550643217853164e-6	21	421	162
DOID:0060060	non-Hodgkin lymphoma	GO:0042093	T-helper cell differentiation	1.2185019659938234e-10	2.6874060859993776e-6	9	44	162
DOID:0060060	non-Hodgkin lymphoma	GO:0016301	kinase activity	1.297925100729458e-10	2.8625738096588194e-6	29	829	162
DOID:0060060	non-Hodgkin lymphoma	GO:0040008	regulation of growth	1.367548296826726e-10	3.0161277686513444e-6	25	617	162
DOID:0060060	non-Hodgkin lymphoma	GO:0009887	organ morphogenesis	1.5801437935891727e-10	3.4850071367609203e-6	31	950	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045666	positive regulation of neuron differentiation	1.6200218944106837e-10	3.572958288122763e-6	18	304	162
DOID:0060060	non-Hodgkin lymphoma	GO:0032743	positive regulation of interleukin-2 production	1.7975576582784925e-10	3.964513415333215e-6	8	31	162
DOID:0060060	non-Hodgkin lymphoma	GO:0032388	positive regulation of intracellular transport	1.871827137733817e-10	4.128314752271933e-6	19	347	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051270	regulation of cellular component movement	1.963910145619252e-10	4.33140382616326e-6	28	787	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045787	positive regulation of cell cycle	2.0089441221671223e-10	4.430726261439588e-6	18	308	162
DOID:0060060	non-Hodgkin lymphoma	GO:1901216	positive regulation of neuron death	2.1725810039896487e-10	4.79162740429917e-6	10	65	162
DOID:0060060	non-Hodgkin lymphoma	GO:0019901	protein kinase binding	2.2586044146066797e-10	4.981352036415032e-6	23	532	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051222	positive regulation of protein transport	3.3030478352458204e-10	7.284872000634657e-6	21	447	162
DOID:0060060	non-Hodgkin lymphoma	GO:0098552	side of membrane	3.304316820162967e-10	7.2876707468694235e-6	20	402	162
DOID:0060060	non-Hodgkin lymphoma	GO:0070482	response to oxygen levels	3.9610803526102245e-10	8.73616271768185e-6	18	321	162
DOID:0060060	non-Hodgkin lymphoma	GO:0016773	phosphotransferase activity, alcohol group as acceptor	4.543487808206237e-10	1.0020662360998855e-5	27	762	162
DOID:0060060	non-Hodgkin lymphoma	GO:2000145	regulation of cell motility	4.770205341841915e-10	1.0520687881432345e-5	26	709	162
DOID:0060060	non-Hodgkin lymphoma	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	5.357291277263698e-10	1.1815505912005086e-5	10	71	162
DOID:0060060	non-Hodgkin lymphoma	GO:0001666	response to hypoxia	7.06208758138871e-10	1.55754341607528e-5	17	292	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051054	positive regulation of DNA metabolic process	7.146967462290377e-10	1.5762636738081426e-5	14	183	162
DOID:0060060	non-Hodgkin lymphoma	GO:1901652	response to peptide	8.014057195637747e-10	1.767500314497905e-5	20	423	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045087	innate immune response	8.195162326529726e-10	1.807443051116131e-5	27	783	162
DOID:0060060	non-Hodgkin lymphoma	GO:0035295	tube development	9.455365379551495e-10	2.085380834460082e-5	23	573	162
DOID:0060060	non-Hodgkin lymphoma	GO:0000082	G1/S transition of mitotic cell cycle	1.1020407919559716e-9	2.4305509666588954e-5	15	224	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.1721104087314416e-9	2.5850895064571944e-5	15	225	162
DOID:0060060	non-Hodgkin lymphoma	GO:1904019	epithelial cell apoptotic process	1.2176262220719991e-9	2.685474632779794e-5	10	77	162
DOID:0060060	non-Hodgkin lymphoma	GO:0043434	response to peptide hormone	1.2732800369619213e-9	2.8082191215195174e-5	19	389	162
DOID:0060060	non-Hodgkin lymphoma	GO:0001782	B cell homeostasis	1.370055513483237e-9	3.0216574349872793e-5	7	25	162
DOID:0060060	non-Hodgkin lymphoma	GO:0006606	protein import into nucleus	1.597950993748043e-9	3.524280916711309e-5	16	268	162
DOID:0060060	non-Hodgkin lymphoma	GO:0031349	positive regulation of defense response	1.8589306760574686e-9	4.099871606044747e-5	19	398	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045622	regulation of T-helper cell differentiation	1.8612014152097345e-9	4.1048797212450694e-5	7	26	162
DOID:0060060	non-Hodgkin lymphoma	GO:0071706	tumor necrosis factor superfamily cytokine production	2.037974233815021e-9	4.4947521726790285e-5	11	106	162
DOID:0060060	non-Hodgkin lymphoma	GO:0043549	regulation of kinase activity	2.1093820024020715e-9	4.652242006297769e-5	26	761	162
DOID:0060060	non-Hodgkin lymphoma	GO:2001234	negative regulation of apoptotic signaling pathway	2.139634580622385e-9	4.71896406756267e-5	14	199	162
DOID:0060060	non-Hodgkin lymphoma	GO:0045930	negative regulation of mitotic cell cycle	2.2837058910596397e-9	5.0367133427320354e-5	14	200	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051384	response to glucocorticoid	2.400840970473439e-9	5.29505476037917e-5	13	167	162
DOID:0060060	non-Hodgkin lymphoma	GO:0001764	neuron migration	2.636251661414235e-9	5.8142530392490954e-5	12	137	162
DOID:0060060	non-Hodgkin lymphoma	GO:0030334	regulation of cell migration	2.803329901546192e-9	6.182744097860127e-5	24	660	162
DOID:0060060	non-Hodgkin lymphoma	GO:0051098	regulation of binding	2.8546512931271195e-9	6.295933426991862e-5	16	279	162
DOID:0060060	non-Hodgkin lymphoma	GO:0007259	JAK-STAT cascade	2.9848447047342574e-9	6.583074996291405e-5	13	170	162
DOID:0060060	non-Hodgkin lymphoma	GO:1901215	negative regulation of neuron death	2.9848447047342574e-9	6.583074996291405e-5	13	170	162
DOID:0060060	non-Hodgkin lymphoma	GO:0002702	positive regulation of production of molecular mediator of immune response	3.052054609042898e-9	6.731306440244111e-5	9	62	162
DOID:0060060	non-Hodgkin lymphoma	GO:0007050	cell cycle arrest	3.18694515222262e-9	7.028807533226988e-5	15	242	162
DOID:0060060	non-Hodgkin lymphoma	GO:0000165	MAPK cascade	3.967145167926844e-9	8.749538667862655e-5	27	843	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0072521	purine-containing compound metabolic process	7.056577544517495e-13	1.5563281774433335e-8	44	568	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0009167	purine ribonucleoside monophosphate metabolic process	5.140332604014475e-13	1.1337003558153924e-8	36	266	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0015980	energy derivation by oxidation of organic compounds	5.140332604014475e-13	1.1337003558153924e-8	39	266	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0009141	nucleoside triphosphate metabolic process	4.447553436648377e-13	9.809079104527996e-9	37	274	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0009144	purine nucleoside triphosphate metabolic process	2.3581137043038325e-13	5.2008197748421026e-9	36	252	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0022900	electron transport chain	2.2604140781368187e-13	4.985343249330754e-9	34	107	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0006979	response to oxidative stress	2.3705482021796342e-11	5.228244059907183e-7	21	386	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0006066	alcohol metabolic process	1.3504752871540404e-10	2.978473245818236e-6	20	382	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0016042	lipid catabolic process	3.897239198025204e-10	8.595361051244588e-6	17	281	162
Orphanet:98710	Metabolic disease associated with ocular features	GO:0008610	lipid biosynthetic process	1.0181916421103665e-9	2.2456216666744133e-5	24	627	162
Orphanet:90642	Syndromic genetic deafness	GO:0048562	embryonic organ morphogenesis	1.418642980866025e-12	3.128817094300018e-8	25	280	164
Orphanet:90642	Syndromic genetic deafness	GO:0090596	sensory organ morphogenesis	3.277378368693462e-13	7.228257992153431e-9	25	239	164
Orphanet:90642	Syndromic genetic deafness	GO:0048839	inner ear development	9.414691248821327e-14	2.0764101549275438e-9	28	170	164
Orphanet:90642	Syndromic genetic deafness	GO:0042472	inner ear morphogenesis	1.2179146580137967e-13	2.6861107782494287e-9	20	92	164
Orphanet:90642	Syndromic genetic deafness	GO:0001895	retina homeostasis	4.5219383792982626e-13	9.973135095542318e-9	12	66	164
Orphanet:90642	Syndromic genetic deafness	GO:0030855	epithelial cell differentiation	2.998801207354518e-11	6.613856062820389e-7	25	568	164
Orphanet:90642	Syndromic genetic deafness	GO:0098644	complex of collagen trimers	7.726669304375378e-10	1.7041169150799895e-5	7	23	164
Orphanet:90642	Syndromic genetic deafness	GO:0072358	cardiovascular system development	1.459914966694953e-9	3.2198424590457186e-5	29	910	164
Orphanet:90642	Syndromic genetic deafness	GO:0001501	skeletal system development	1.5993167901129368e-9	3.527293180594082e-5	21	482	164
Orphanet:90642	Syndromic genetic deafness	GO:0043009	chordate embryonic development	3.2737527133619437e-9	7.220261609319767e-5	22	552	164
MESH:D012559	Schizophrenia	GO:0050804	modulation of synaptic transmission	1.2709833185908792e-12	2.803153709152184e-8	31	285	164
MESH:D012559	Schizophrenia	GO:0007611	learning or memory	7.893685705084863e-13	1.7409523822564665e-8	22	218	164
MESH:D012559	Schizophrenia	GO:0007270	neuron-neuron synaptic transmission	3.306244167333716e-13	7.291921511054511e-9	20	130	164
MESH:D012559	Schizophrenia	GO:0051952	regulation of amine transport	1.474376176702208e-13	3.2517366577167195e-9	13	72	164
MESH:D012559	Schizophrenia	GO:0042220	response to cocaine	6.461498003318411e-14	1.4250833846318756e-9	12	47	164
MESH:D012559	Schizophrenia	GO:0050806	positive regulation of synaptic transmission	5.773159728050814e-15	1.273270378021607e-10	16	118	164
MESH:D012559	Schizophrenia	GO:0006820	anion transport	7.416289804496046e-14	1.6356627163816029e-9	27	588	164
MESH:D012559	Schizophrenia	GO:0007613	memory	2.02171612784241e-13	4.458894919956435e-9	14	99	164
MESH:D012559	Schizophrenia	GO:0044070	regulation of anion transport	2.6501023597802487e-13	5.8448007544953384e-9	18	135	164
MESH:D012559	Schizophrenia	GO:0051966	regulation of synaptic transmission, glutamatergic	3.5704772471945034e-13	7.874687568687477e-9	11	50	164
MESH:D012559	Schizophrenia	GO:0050795	regulation of behavior	4.438671652451376e-13	9.78949032948151e-9	19	243	164
MESH:D012559	Schizophrenia	GO:0015844	monoamine transport	7.52065076881081e-13	1.6586795270612242e-8	12	70	164
MESH:D012559	Schizophrenia	GO:0044456	synapse part	9.71667191151937e-13	2.143011990085597e-8	38	613	164
MESH:D012559	Schizophrenia	GO:0045471	response to ethanol	1.301292407163146e-12	2.8700004039983185e-8	15	137	164
MESH:D012559	Schizophrenia	GO:0098794	postsynapse	2.172373392284044e-12	4.7911695166824586e-8	26	381	164
MESH:D012559	Schizophrenia	GO:0044297	cell body	4.0288883340622306e-12	8.88571322077425e-8	27	494	164
MESH:D012559	Schizophrenia	GO:0030425	dendrite	4.079514503985138e-12	8.997369238539221e-8	31	451	164
MESH:D012559	Schizophrenia	GO:0001505	regulation of neurotransmitter levels	4.629741034989365e-12	1.0210893852669045e-7	16	179	164
MESH:D012559	Schizophrenia	GO:0030424	axon	6.048717082762778e-12	1.3340445526033307e-7	30	414	164
MESH:D012559	Schizophrenia	GO:0006836	neurotransmitter transport	6.36612984550311e-12	1.404049937425711e-7	16	183	164
MESH:D012559	Schizophrenia	GO:0051703	intraspecies interaction between organisms	6.448286349325372e-12	1.4221695543437107e-7	10	46	164
MESH:D012559	Schizophrenia	GO:0035176	social behavior	6.448286349325372e-12	1.4221695543437107e-7	10	46	164
MESH:D012559	Schizophrenia	GO:0043025	neuronal cell body	7.4504846736545e-12	1.6432043947745e-7	25	434	164
MESH:D012559	Schizophrenia	GO:0007612	learning	8.094969139449404e-12	1.785345443705566e-7	14	130	164
MESH:D012559	Schizophrenia	GO:0007420	brain development	1.2348566613695766e-11	2.723476366650601e-7	28	669	164
MESH:D012559	Schizophrenia	GO:0051046	regulation of secretion	1.425570772539686e-11	3.1440963388362775e-7	28	675	164
MESH:D012559	Schizophrenia	GO:0021537	telencephalon development	1.567013185876931e-11	3.456047581451571e-7	17	226	164
MESH:D012559	Schizophrenia	GO:0032940	secretion by cell	1.8597678952403385e-11	4.1017180929525665e-7	33	956	164
MESH:D012559	Schizophrenia	GO:0051960	regulation of nervous system development	2.3458457398817245e-11	5.173762779309143e-7	29	744	164
MESH:D012559	Schizophrenia	GO:0050803	regulation of synapse structure or activity	2.514455310631547e-11	5.545631187597877e-7	17	233	164
MESH:D012559	Schizophrenia	GO:0051050	positive regulation of transport	2.5486834864807406e-11	5.621121429433273e-7	32	920	164
MESH:D012559	Schizophrenia	GO:0040008	regulation of growth	3.399258652336812e-11	7.497064957728838e-7	26	617	164
MESH:D012559	Schizophrenia	GO:0097285	cell-type specific apoptotic process	3.4281466554375584e-11	7.560777448567535e-7	22	429	164
MESH:D012559	Schizophrenia	GO:0023014	signal transduction by protein phosphorylation	3.60721452707935e-11	7.955711639473506e-7	31	879	164
MESH:D012559	Schizophrenia	GO:0044463	cell projection part	3.993683161951367e-11	8.80806821368374e-7	32	939	164
MESH:D012559	Schizophrenia	GO:0042493	response to drug	4.0189518379918354e-11	8.863798278690993e-7	22	433	164
MESH:D012559	Schizophrenia	GO:1903530	regulation of secretion by cell	4.1754488755429975e-11	9.208952495010081e-7	26	624	164
MESH:D012559	Schizophrenia	GO:0000165	MAPK cascade	5.244360501421852e-11	1.1566437085885894e-6	30	843	164
MESH:D012559	Schizophrenia	GO:1901214	regulation of neuron death	7.649259003983389e-11	1.6870440733285363e-6	17	250	164
MESH:D012559	Schizophrenia	GO:0051051	negative regulation of transport	8.180567334648003e-11	1.8042241256566172e-6	22	452	164
MESH:D012559	Schizophrenia	GO:0033267	axon part	8.477862856182128e-11	1.8697926529309683e-6	16	217	164
MESH:D012559	Schizophrenia	GO:0044057	regulation of system process	1.218029010985333e-10	2.686362983728152e-6	23	508	164
MESH:D012559	Schizophrenia	GO:0050767	regulation of neurogenesis	1.301514451768071e-10	2.8704901233744806e-6	26	658	164
MESH:D012559	Schizophrenia	GO:0046717	acid secretion	1.5148360343886225e-10	3.340970873844107e-6	12	106	164
MESH:D012559	Schizophrenia	GO:1903792	negative regulation of anion transport	1.983129216398538e-10	4.373791486766976e-6	8	31	164
MESH:D012559	Schizophrenia	GO:0042417	dopamine metabolic process	2.6248558882002726e-10	5.789119661425701e-6	8	32	164
MESH:D012559	Schizophrenia	GO:0015872	dopamine transport	3.437794493521551e-10	7.582055755461781e-6	8	33	164
MESH:D012559	Schizophrenia	GO:0048148	behavioral response to cocaine	3.706415174775657e-10	8.174498667967711e-6	6	12	164
MESH:D012559	Schizophrenia	GO:0043679	axon terminus	4.4012937738813207e-10	9.707053418295253e-6	12	116	164
MESH:D012559	Schizophrenia	GO:0048666	neuron development	4.988797153160363e-10	1.100279212129518e-5	30	926	164
MESH:D012559	Schizophrenia	GO:0007212	dopamine receptor signaling pathway	5.741901398792493e-10	1.2663763535036843e-5	8	35	164
MESH:D012559	Schizophrenia	GO:0043197	dendritic spine	5.926854562687822e-10	1.3071677738007992e-5	12	119	164
MESH:D012559	Schizophrenia	GO:0023061	signal release	7.48168971220764e-10	1.650086666027395e-5	20	416	164
MESH:D012559	Schizophrenia	GO:0007568	aging	7.68547891993876e-10	1.6950323757924934e-5	17	290	164
MESH:D012559	Schizophrenia	GO:0035094	response to nicotine	9.463846373236606e-10	2.0872513176173335e-5	9	54	164
MESH:D012559	Schizophrenia	GO:0097060	synaptic membrane	9.836548242603271e-10	2.1694507149061515e-5	16	256	164
MESH:D012559	Schizophrenia	GO:0030799	regulation of cyclic nucleotide metabolic process	1.0292589003313424e-9	2.2700305046807756e-5	13	154	164
MESH:D012559	Schizophrenia	GO:0014069	postsynaptic density	1.1161297441830698e-9	2.4616241507957604e-5	14	187	164
MESH:D012559	Schizophrenia	GO:0001504	neurotransmitter uptake	1.4928639435751734e-9	3.292511427555045e-5	7	25	164
MESH:D012559	Schizophrenia	GO:0031175	neuron projection development	1.5400268837950648e-9	3.3965292922100154e-5	27	796	164
MESH:D012559	Schizophrenia	GO:0051048	negative regulation of secretion	1.929623572038963e-9	4.255784788131933e-5	14	195	164
MESH:D012559	Schizophrenia	GO:0007623	circadian rhythm	2.0621884200267004e-9	4.548156560368888e-5	14	196	164
MESH:D012559	Schizophrenia	GO:0008015	blood circulation	2.0660219091084286e-9	4.5566113205386394e-5	21	489	164
MESH:D012559	Schizophrenia	GO:0006874	cellular calcium ion homeostasis	2.109118990567538e-9	4.651661933696705e-5	18	352	164
MESH:D012559	Schizophrenia	GO:0030802	regulation of cyclic nucleotide biosynthetic process	2.157080736253647e-9	4.7574415638074186e-5	12	133	164
MESH:D012559	Schizophrenia	GO:0001934	positive regulation of protein phosphorylation	2.3449885366844114e-9	5.1718722176574694e-5	28	870	164
MESH:D012559	Schizophrenia	GO:0043549	regulation of kinase activity	2.7579539763067373e-9	6.082667494744509e-5	26	761	164
MESH:D012559	Schizophrenia	GO:0045859	regulation of protein kinase activity	3.0610883827719704e-9	6.75123042820358e-5	25	709	164
MESH:D012559	Schizophrenia	GO:1900542	regulation of purine nucleotide metabolic process	3.2512100789361398e-9	7.170543829093656e-5	14	203	164
MESH:D012559	Schizophrenia	GO:1900371	regulation of purine nucleotide biosynthetic process	3.5808527254488354e-9	7.897570685977406e-5	12	139	164
MESH:D012559	Schizophrenia	GO:0030334	regulation of cell migration	3.6021476912395656e-9	7.944536733028862e-5	24	660	164
MESH:D012559	Schizophrenia	GO:0048167	regulation of synaptic plasticity	3.887063670937607e-9	8.572918926252893e-5	12	140	164
MESH:D012559	Schizophrenia	GO:0048638	regulation of developmental growth	4.1861275557053546e-9	9.23250432410816e-5	16	283	164
DOID:2237	hepatitis	GO:0048878	chemical homeostasis	3.850919583214818e-12	8.493203140780281e-8	37	988	164
DOID:2237	hepatitis	GO:0046649	lymphocyte activation	2.050359881877739e-12	4.5220687194813536e-8	31	594	164
DOID:2237	hepatitis	GO:0010038	response to metal ion	1.354028000832841e-12	2.9863087558368306e-8	22	335	164
DOID:2237	hepatitis	GO:0070661	leukocyte proliferation	1.1759482276829658e-12	2.593553816154781e-8	23	266	164
DOID:2237	hepatitis	GO:0070997	neuron death	1.0937917238607042e-12	2.412357646974783e-8	20	281	164
DOID:2237	hepatitis	GO:0051235	maintenance of location	5.706546346573305e-13	1.2585787967367423e-8	21	274	164
DOID:2237	hepatitis	GO:0043627	response to estrogen	4.405364961712621e-13	9.716032423057186e-9	18	217	164
DOID:2237	hepatitis	GO:0000302	response to reactive oxygen species	4.389821839367869e-13	9.681752066725835e-9	18	216	164
DOID:2237	hepatitis	GO:0031983	vesicle lumen	2.1005419625907962e-13	4.632745298494001e-9	15	106	164
DOID:2237	hepatitis	GO:0002443	leukocyte mediated immunity	1.3677947663381929e-13	3.0166713571588843e-9	20	279	164
DOID:2237	hepatitis	GO:0042098	T cell proliferation	4.8183679268731794e-14	1.0626910462718797e-9	17	167	164
DOID:2237	hepatitis	GO:0022409	positive regulation of cell-cell adhesion	1.7208456881689926e-14	3.7953251652567133e-10	19	239	164
DOID:2237	hepatitis	GO:0072593	reactive oxygen species metabolic process	6.572520305780927e-14	1.4495693534399834e-9	21	223	164
DOID:2237	hepatitis	GO:0002637	regulation of immunoglobulin production	1.8407497748285095e-13	4.059773628384278e-9	11	46	164
DOID:2237	hepatitis	GO:1901214	regulation of neuron death	2.020605904817785e-13	4.456446323075625e-9	19	250	164
DOID:2237	hepatitis	GO:0048771	tissue remodeling	3.361755318564974e-13	7.41435135509505e-9	16	139	164
DOID:2237	hepatitis	GO:0007568	aging	5.162537064506978e-13	1.138597549577014e-8	20	290	164
DOID:2237	hepatitis	GO:0051251	positive regulation of lymphocyte activation	8.512079929801075e-13	1.877339228517627e-8	19	257	164
DOID:2237	hepatitis	GO:0050663	cytokine secretion	8.811840146449867e-13	1.9434513442995183e-8	16	162	164
DOID:2237	hepatitis	GO:1901701	cellular response to oxygen-containing compound	1.2656542480726785e-12	2.7914004441242923e-8	33	873	164
DOID:2237	hepatitis	GO:0060548	negative regulation of cell death	3.2988056730687276e-12	7.275515911953079e-8	38	867	164
DOID:2237	hepatitis	GO:0098771	inorganic ion homeostasis	3.741784659894165e-12	8.252506067396581e-8	27	609	164
DOID:2237	hepatitis	GO:0002521	leukocyte differentiation	5.714984041560456e-12	1.2604397303661585e-7	24	448	164
DOID:2237	hepatitis	GO:0071407	cellular response to organic cyclic compound	6.416200903913705e-12	1.4150931093581676e-7	25	416	164
DOID:2237	hepatitis	GO:1990748	cellular detoxification	6.936673457857978e-12	1.529883331130577e-7	12	82	164
DOID:2237	hepatitis	GO:0033273	response to vitamin	6.994960166650799e-12	1.5427384647548337e-7	13	104	164
DOID:2237	hepatitis	GO:0043069	negative regulation of programmed cell death	7.996603379467615e-12	1.7636508753415825e-7	37	806	164
DOID:2237	hepatitis	GO:0055082	cellular chemical homeostasis	8.996248190840106e-12	1.9841225384897854e-7	28	661	164
DOID:2237	hepatitis	GO:0006873	cellular ion homeostasis	9.09528008463667e-12	2.0059640226666176e-7	25	532	164
DOID:2237	hepatitis	GO:1903035	negative regulation of response to wounding	9.650280574646786e-12	2.1283693807383486e-7	15	159	164
DOID:2237	hepatitis	GO:0097191	extrinsic apoptotic signaling pathway	1.0475065259640814e-11	2.3102756430137816e-7	17	220	164
DOID:2237	hepatitis	GO:0034774	secretory granule lumen	1.0623502078033198e-11	2.3430133833102218e-7	12	85	164
DOID:2237	hepatitis	GO:0050776	regulation of immune response	1.1366241281507428e-11	2.506824514636463e-7	32	816	164
DOID:2237	hepatitis	GO:0043066	negative regulation of apoptotic process	1.1435297153639112e-11	2.522054787235106e-7	36	795	164
DOID:2237	hepatitis	GO:1903036	positive regulation of response to wounding	1.3267720255782933e-11	2.926195702412926e-7	15	162	164
DOID:2237	hepatitis	GO:0055080	cation homeostasis	1.36484157309269e-11	3.0101580894559277e-7	26	595	164
DOID:2237	hepatitis	GO:0051241	negative regulation of multicellular organismal process	1.4166334771914535e-11	3.1243851339457507e-7	33	966	164
DOID:2237	hepatitis	GO:0006875	cellular metal ion homeostasis	1.509692371115534e-11	3.3296265244953105e-7	23	450	164
DOID:2237	hepatitis	GO:0072358	cardiovascular system development	1.9387602634424184e-11	4.2759357610222537e-7	32	910	164
DOID:2237	hepatitis	GO:0071396	cellular response to lipid	2.1871060518208196e-11	4.823662397290818e-7	22	416	164
DOID:2237	hepatitis	GO:0050707	regulation of cytokine secretion	2.8481106362221453e-11	6.281508008187942e-7	14	142	164
DOID:2237	hepatitis	GO:0001568	blood vessel development	3.070621534817519e-11	6.772255795040039e-7	25	569	164
DOID:2237	hepatitis	GO:0032355	response to estradiol	3.727318453883299e-11	8.220600850039617e-7	14	145	164
DOID:2237	hepatitis	GO:0031329	regulation of cellular catabolic process	4.1754488755429975e-11	9.208952495010081e-7	26	624	164
DOID:2237	hepatitis	GO:0002449	lymphocyte mediated immunity	4.9266257740043784e-11	1.0865673144566657e-6	16	209	164
DOID:2237	hepatitis	GO:0031099	regeneration	7.106781829691045e-11	1.5674007325383599e-6	15	182	164
DOID:2237	hepatitis	GO:0010942	positive regulation of cell death	8.317913025024382e-11	1.8345157176691274e-6	25	596	164
DOID:2237	hepatitis	GO:0034599	cellular response to oxidative stress	9.829659308735472e-11	2.1679313605416084e-6	16	219	164
DOID:2237	hepatitis	GO:0030162	regulation of proteolysis	1.0188827559431957e-10	2.247145918232718e-6	27	701	164
DOID:2237	hepatitis	GO:0050673	epithelial cell proliferation	1.2594603138182947e-10	2.777739722126249e-6	19	335	164
DOID:2237	hepatitis	GO:0003018	vascular process in circulatory system	1.2949841199372258e-10	2.8560874765215516e-6	14	159	164
DOID:2237	hepatitis	GO:0002576	platelet degranulation	1.5148360343886225e-10	3.340970873844107e-6	12	106	164
DOID:2237	hepatitis	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.6041046269066328e-10	3.5378527546425786e-6	11	83	164
DOID:2237	hepatitis	GO:0071383	cellular response to steroid hormone stimulus	1.6692724980060802e-10	3.68158049435241e-6	14	162	164
DOID:2237	hepatitis	GO:1901699	cellular response to nitrogen compound	1.7484158565395092e-10	3.8561311715978874e-6	23	518	164
DOID:2237	hepatitis	GO:0030335	positive regulation of cell migration	2.1084434198570534e-10	4.650171962494731e-6	20	387	164
DOID:2237	hepatitis	GO:0030217	T cell differentiation	2.51486165225856e-10	5.546527374056254e-6	15	199	164
DOID:2237	hepatitis	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.620026418043153e-10	5.778468264994174e-6	12	111	164
DOID:2237	hepatitis	GO:0044283	small molecule biosynthetic process	2.6876467718039976e-10	5.927604955213717e-6	23	530	164
DOID:2237	hepatitis	GO:0050880	regulation of blood vessel size	2.874075422099054e-10	6.338773343439463e-6	13	139	164
DOID:2237	hepatitis	GO:0048514	blood vessel morphogenesis	2.882166727502522e-10	6.356618717506812e-6	22	484	164
DOID:2237	hepatitis	GO:0002706	regulation of lymphocyte mediated immunity	2.9141655755182683e-10	6.427192176805541e-6	12	112	164
DOID:2237	hepatitis	GO:0032868	response to insulin	3.388480607213751e-10	7.473293979209927e-6	16	238	164
DOID:2237	hepatitis	GO:0032102	negative regulation of response to external stimulus	3.3932523457735897e-10	7.483818048603652e-6	17	275	164
DOID:2237	hepatitis	GO:0002526	acute inflammatory response	3.439456497389415e-10	7.585721304992354e-6	13	141	164
DOID:2237	hepatitis	GO:0050777	negative regulation of immune response	3.977111973085812e-10	8.771520456640758e-6	12	115	164
DOID:2237	hepatitis	GO:0001525	angiogenesis	6.607586700013712e-10	1.4573032466880242e-5	20	413	164
DOID:2237	hepatitis	GO:0043065	positive regulation of apoptotic process	6.811329278377798e-10	1.5022386723462233e-5	23	556	164
DOID:2237	hepatitis	GO:1990267	response to transition metal nanoparticle	7.426985693115284e-10	1.638021694616576e-5	13	150	164
DOID:2237	hepatitis	GO:0006953	acute-phase response	7.94432630790709e-10	1.7521211672089088e-5	9	53	164
DOID:2237	hepatitis	GO:0005507	copper ion binding	7.94432630790709e-10	1.7521211672089088e-5	9	53	164
DOID:2237	hepatitis	GO:0016064	immunoglobulin mediated immune response	8.8887519567038e-10	1.960414244051023e-5	11	97	164
DOID:2237	hepatitis	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	8.8887519567038e-10	1.960414244051023e-5	11	97	164
DOID:2237	hepatitis	GO:0048732	gland development	9.192925309875477e-10	2.0274996770930365e-5	20	421	164
DOID:2237	hepatitis	GO:0002673	regulation of acute inflammatory response	9.192991923256955e-10	2.0275143686743213e-5	10	74	164
DOID:2237	hepatitis	GO:0033591	response to L-ascorbic acid	1.0184086907116807e-9	2.2461003673646118e-5	5	7	164
DOID:2237	hepatitis	GO:0045087	innate immune response	1.0817712281507852e-9	2.3858464436865567e-5	27	783	164
DOID:2237	hepatitis	GO:0046890	regulation of lipid biosynthetic process	1.1540516320351912e-9	2.5452608744536143e-5	12	126	164
DOID:2237	hepatitis	GO:0032787	monocarboxylic acid metabolic process	1.1702584457040643e-9	2.581005002000314e-5	23	572	164
DOID:2237	hepatitis	GO:0032844	regulation of homeostatic process	1.1719673009835674e-9	2.584773882319258e-5	20	427	164
DOID:2237	hepatitis	GO:0071345	cellular response to cytokine stimulus	1.203431909679864e-9	2.65416907679894e-5	25	677	164
DOID:2237	hepatitis	GO:0002889	regulation of immunoglobulin mediated immune response	1.4570218365150822e-9	3.213461660434014e-5	8	39	164
DOID:2237	hepatitis	GO:0098869	cellular oxidant detoxification	1.775645963597583e-9	3.916187172714469e-5	10	79	164
DOID:2237	hepatitis	GO:0002891	positive regulation of immunoglobulin mediated immune response	2.0277775014676536e-9	4.47226327948691e-5	7	26	164
DOID:2237	hepatitis	GO:0006109	regulation of carbohydrate metabolic process	2.073128890778264e-9	4.5722857686114615e-5	13	163	164
DOID:2237	hepatitis	GO:0045580	regulation of T cell differentiation	2.0962273028501954e-9	4.623229316436106e-5	11	105	164
DOID:2237	hepatitis	GO:0045862	positive regulation of proteolysis	2.6358741855858625e-9	5.81342051630962e-5	18	357	164
DOID:2237	hepatitis	GO:1903409	reactive oxygen species biosynthetic process	2.908731255857333e-9	6.415206784793348e-5	10	83	164
DOID:2237	hepatitis	GO:0002687	positive regulation of leukocyte migration	3.1322597848770783e-9	6.908198955546396e-5	11	109	164
DOID:2237	hepatitis	GO:0032635	interleukin-6 production	3.1322597848770783e-9	6.908198955546396e-5	11	109	164
DOID:2237	hepatitis	GO:1901215	negative regulation of neuron death	3.468190512556646e-9	7.649094175443683e-5	13	170	164
DOID:2237	hepatitis	GO:0002675	positive regulation of acute inflammatory response	3.596659303717331e-9	7.932432094348574e-5	7	28	164
DOID:2237	hepatitis	GO:0009986	cell surface	3.630382550134925e-9	8.006808714322577e-5	25	715	164
DOID:2237	hepatitis	GO:0051341	regulation of oxidoreductase activity	3.6860361429802424e-9	8.129552713342925e-5	10	85	164
DOID:2237	hepatitis	GO:1903426	regulation of reactive oxygen species biosynthetic process	3.937531301012598e-9	8.684225284383285e-5	9	63	164
DOID:2237	hepatitis	GO:0005996	monosaccharide metabolic process	3.980010765403108e-9	8.777913743096555e-5	16	282	164
DOID:2237	hepatitis	GO:0045765	regulation of angiogenesis	4.451236823577176e-9	9.817202814399462e-5	14	208	164
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0009167	purine ribonucleoside monophosphate metabolic process	1.2514433933574765e-12	2.7600584040499143e-8	50	266	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0015980	energy derivation by oxidation of organic compounds	1.2514433933574765e-12	2.7600584040499143e-8	55	266	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0009144	purine nucleoside triphosphate metabolic process	9.401368572525826e-13	2.0734718386705708e-8	51	252	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0015992	proton transport	1.241229341530925e-13	2.737531312746455e-9	18	152	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0016675	oxidoreductase activity, acting on a heme group of donors	2.3314683517128287e-14	5.142053449702644e-10	11	28	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0045277	respiratory chain complex IV	7.08896497059186e-10	1.5634712242640347e-5	6	13	165
Orphanet:223713	Mitochondrial oxidative phosphorylation disorder	GO:0005758	mitochondrial intermembrane space	9.756088159562637e-10	2.1517052435915396e-5	10	74	165
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0000165	MAPK cascade	1.5044632206695496e-12	3.318093633186692e-8	33	843	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0005694	chromosome	1.2251422099041065e-11	2.702051143943507e-7	32	876	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0032504	multicellular organism reproduction	2.2382540265653006e-11	4.93646925558977e-7	30	780	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0097191	extrinsic apoptotic signaling pathway	1.269935268055633e-10	2.8008422336966987e-6	16	220	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0000228	nuclear chromosome	2.3879154209538456e-10	5.266547460913706e-6	23	520	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0009991	response to extracellular stimulus	2.7750746145471794e-10	6.120427062383804e-6	24	573	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0014032	neural crest cell development	3.7687575282774333e-10	8.311994728615879e-6	10	67	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0007548	sex differentiation	3.8788339207229683e-10	8.554768212154507e-6	17	274	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0044454	nuclear chromosome part	3.9330816381522027e-10	8.674411552944683e-6	22	486	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0031667	response to nutrient levels	6.125151497116121e-10	1.3509021626889606e-5	23	546	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0001755	neural crest cell migration	6.16664941333056e-10	1.3600545281100551e-5	9	51	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0016568	chromatin modification	9.153386937299501e-10	2.018779489021405e-5	24	608	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0060563	neuroepithelial cell differentiation	1.0349818779786801e-9	2.282652531881979e-5	10	74	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0009411	response to UV	1.2092200574187473e-9	2.666934836637047e-5	12	125	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0044087	regulation of cellular component biogenesis	1.744181021834379e-9	3.846791243655723e-5	26	735	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0000988	transcription factor activity, protein binding	1.8211253616229328e-9	4.016491985059378e-5	23	578	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0060249	anatomical structure homeostasis	2.453811043245935e-9	5.411880255878909e-5	18	351	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0003690	double-stranded DNA binding	3.133213910544441e-9	6.910303279705765e-5	26	756	166
MESH:D009373	Neoplasms, Germ Cell and Embryonal	GO:0051053	negative regulation of DNA metabolic process	3.2247823300579626e-9	7.112257428942836e-5	11	108	166
MESH:D014777	Virus Diseases	GO:0022603	regulation of anatomical structure morphogenesis	6.733280599746649e-12	1.4850250362741235e-7	45	986	166
MESH:D014777	Virus Diseases	GO:0046649	lymphocyte activation	1.6546763959013333e-12	3.6493887911603906e-8	35	594	166
MESH:D014777	Virus Diseases	GO:0002218	activation of innate immune response	8.473222123939195e-13	1.8687691394347894e-8	26	247	166
MESH:D014777	Virus Diseases	GO:0031396	regulation of protein ubiquitination	6.750155989720952e-13	1.4887469035329559e-8	21	267	166
MESH:D014777	Virus Diseases	GO:0006606	protein import into nucleus	3.723688024592775e-13	8.212593938239365e-9	21	268	166
MESH:D014777	Virus Diseases	GO:0034341	response to interferon-gamma	1.9761969838327786e-14	4.3585024478431933e-10	16	155	166
MESH:D014777	Virus Diseases	GO:0000502	proteasome complex	2.6623148130511254e-13	5.871735320184257e-9	16	75	166
MESH:D014777	Virus Diseases	GO:0042107	cytokine metabolic process	5.723199691942682e-13	1.2622516920579585e-8	14	107	166
MESH:D014777	Virus Diseases	GO:0042089	cytokine biosynthetic process	7.366329768387914e-13	1.6246440304179544e-8	14	105	166
MESH:D014777	Virus Diseases	GO:0098542	defense response to other organism	4.5100589929347734e-12	9.946935108917643e-8	26	550	166
MESH:D014777	Virus Diseases	GO:0032729	positive regulation of interferon-gamma production	1.1806888799981152e-11	2.604009324835843e-7	11	65	166
MESH:D014777	Virus Diseases	GO:0051817	modification of morphology or physiology of other organism involved in symbiotic interaction	1.6325385487903077e-11	3.6005637693570236e-7	12	87	166
MESH:D014777	Virus Diseases	GO:0001959	regulation of cytokine-mediated signaling pathway	1.8766765919053796e-11	4.1390102234473147e-7	14	136	166
MESH:D014777	Virus Diseases	GO:0030098	lymphocyte differentiation	1.975641872320466e-11	4.357278149402788e-7	19	299	166
MESH:D014777	Virus Diseases	GO:0045597	positive regulation of cell differentiation	4.0882408569586914e-11	9.016615210022394e-7	30	815	166
MESH:D014777	Virus Diseases	GO:0042113	B cell activation	7.293698978116936e-11	1.6086253096236902e-6	16	212	166
MESH:D014777	Virus Diseases	GO:0051241	negative regulation of multicellular organismal process	9.000000744663339e-11	1.9849501642354994e-6	32	966	166
MESH:D014777	Virus Diseases	GO:0090316	positive regulation of intracellular protein transport	1.1807588240486666e-10	2.604163586439334e-6	17	254	166
MESH:D014777	Virus Diseases	GO:0009266	response to temperature stimulus	1.1826517543056525e-10	2.6083384441211166e-6	16	219	166
MESH:D014777	Virus Diseases	GO:0014070	response to organic cyclic compound	1.6245826905958438e-10	3.5830171241091335e-6	30	873	166
MESH:D014777	Virus Diseases	GO:0051701	interaction with host	1.6603884933630297e-10	3.661986822112162e-6	14	160	166
MESH:D014777	Virus Diseases	GO:0043900	regulation of multi-organism process	1.8680101909751556e-10	4.119896476195706e-6	22	467	166
MESH:D014777	Virus Diseases	GO:1903651	positive regulation of cytoplasmic transport	1.940221316942825e-10	4.279158114517401e-6	17	262	166
MESH:D014777	Virus Diseases	GO:0001906	cell killing	1.9520918215221172e-10	4.30533851236703e-6	12	107	166
MESH:D014777	Virus Diseases	GO:1903533	regulation of protein targeting	2.3040003238605777e-10	5.081472714274504e-6	18	303	166
MESH:D014777	Virus Diseases	GO:0030217	T cell differentiation	2.985383051878898e-10	6.58426232091891e-6	15	199	166
MESH:D014777	Virus Diseases	GO:0002708	positive regulation of lymphocyte mediated immunity	3.7687575282774333e-10	8.311994728615879e-6	10	67	166
MESH:D014777	Virus Diseases	GO:0045582	positive regulation of T cell differentiation	3.7687575282774333e-10	8.311994728615879e-6	10	67	166
MESH:D014777	Virus Diseases	GO:0002683	negative regulation of immune system process	5.07472841526635e-10	1.1192313519869934e-5	19	359	166
MESH:D014777	Virus Diseases	GO:0043065	positive regulation of apoptotic process	8.682945473736936e-10	1.9150236242326812e-5	23	556	166
MESH:D014777	Virus Diseases	GO:0009986	cell surface	9.798178934872226e-10	2.1609883640860694e-5	26	715	166
MESH:D014777	Virus Diseases	GO:0032760	positive regulation of tumor necrosis factor production	1.4784982127480362e-9	3.260827808215794e-5	9	56	166
MESH:D014777	Virus Diseases	GO:0043903	regulation of symbiosis, encompassing mutualism through parasitism	4.055792590662577e-9	8.945050558706313e-5	14	204	166
Orphanet:206656	Non-dystrophic myopathy	GO:0015980	energy derivation by oxidation of organic compounds	1.2951861805277076e-12	2.856533121153859e-8	44	266	167
Orphanet:206656	Non-dystrophic myopathy	GO:0009144	purine nucleoside triphosphate metabolic process	1.2232437285319975e-12	2.6978640432773204e-8	36	252	167
Orphanet:206656	Non-dystrophic myopathy	GO:0009199	ribonucleoside triphosphate metabolic process	7.889244812986362e-13	1.7399729435041422e-8	35	251	167
Orphanet:206656	Non-dystrophic myopathy	GO:0006936	muscle contraction	5.948574965941589e-13	1.3119582087384174e-8	26	323	167
Orphanet:206656	Non-dystrophic myopathy	GO:0046716	muscle cell cellular homeostasis	2.423061751244404e-12	5.3440626923695334e-8	8	19	167
Orphanet:206656	Non-dystrophic myopathy	GO:0048747	muscle fiber development	1.8760215603208508e-11	4.1375655512876364e-7	10	50	167
Orphanet:206656	Non-dystrophic myopathy	GO:0003009	skeletal muscle contraction	2.0868549110986123e-9	4.6025585064279895e-5	8	40	167
MESH:D009362	Neoplasm Metastasis	GO:0050673	epithelial cell proliferation	1.0471623568264476e-12	2.3095165779807303e-8	22	335	168
MESH:D009362	Neoplasm Metastasis	GO:0050678	regulation of epithelial cell proliferation	4.438671652451376e-13	9.78949032948151e-9	20	277	168
MESH:D009362	Neoplasm Metastasis	GO:0018108	peptidyl-tyrosine phosphorylation	1.3440359936112145e-12	2.9642713839095336e-8	22	354	168
MESH:D009362	Neoplasm Metastasis	GO:2001233	regulation of apoptotic signaling pathway	2.2528645615693677e-12	4.9686927905412404e-8	22	359	168
MESH:D009362	Neoplasm Metastasis	GO:0030335	positive regulation of cell migration	2.3113733149671134e-12	5.0977338461599686e-8	23	387	168
MESH:D009362	Neoplasm Metastasis	GO:0000165	MAPK cascade	2.381650432425886e-12	5.252730028715291e-8	33	843	168
MESH:D009362	Neoplasm Metastasis	GO:0001934	positive regulation of protein phosphorylation	2.492117623376089e-12	5.496365418355964e-8	39	870	168
MESH:D009362	Neoplasm Metastasis	GO:0060548	negative regulation of cell death	3.3332225868321075e-12	7.351422415258213e-8	40	867	168
MESH:D009362	Neoplasm Metastasis	GO:1902533	positive regulation of intracellular signal transduction	4.357403327048814e-12	9.61025303780616e-8	37	860	168
MESH:D009362	Neoplasm Metastasis	GO:2000377	regulation of reactive oxygen species metabolic process	4.444000722969577e-12	9.801243594509401e-8	15	147	168
MESH:D009362	Neoplasm Metastasis	GO:0043408	regulation of MAPK cascade	5.520139900738741e-12	1.2174668551079293e-7	31	651	168
MESH:D009362	Neoplasm Metastasis	GO:0043410	positive regulation of MAPK cascade	7.57183205024603e-12	1.669967558681762e-7	28	464	168
MESH:D009362	Neoplasm Metastasis	GO:0043069	negative regulation of programmed cell death	9.068412687440741e-12	2.0000384182150555e-7	39	806	168
MESH:D009362	Neoplasm Metastasis	GO:0050679	positive regulation of epithelial cell proliferation	9.27580234844072e-12	2.045778207948601e-7	15	155	168
MESH:D009362	Neoplasm Metastasis	GO:0048732	gland development	1.1264544852451763e-11	2.4843953672082364e-7	23	421	168
MESH:D009362	Neoplasm Metastasis	GO:0030055	cell-substrate junction	1.1944778499639597e-11	2.634420898095513e-7	22	395	168
MESH:D009362	Neoplasm Metastasis	GO:0043066	negative regulation of apoptotic process	1.2247314273849952e-11	2.701145163097607e-7	38	795	168
MESH:D009362	Neoplasm Metastasis	GO:0009986	cell surface	1.8965384818159237e-11	4.1828156216450196e-7	29	715	168
MESH:D009362	Neoplasm Metastasis	GO:0052547	regulation of peptidase activity	3.753697352948393e-11	8.278779511927681e-7	21	382	168
MESH:D009362	Neoplasm Metastasis	GO:0014070	response to organic cyclic compound	4.766331773708998e-11	1.0512144726915196e-6	31	873	168
MESH:D009362	Neoplasm Metastasis	GO:0046824	positive regulation of nucleocytoplasmic transport	4.893785376935966e-11	1.0793243648832274e-6	13	118	168
MESH:D009362	Neoplasm Metastasis	GO:0005925	focal adhesion	5.109523915081127e-11	1.1269054994711425e-6	21	388	168
MESH:D009362	Neoplasm Metastasis	GO:0045597	positive regulation of cell differentiation	5.255529345049581e-11	1.159106997050685e-6	30	815	168
MESH:D009362	Neoplasm Metastasis	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	8.700873355138583e-11	1.9189776184758145e-6	16	212	168
MESH:D009362	Neoplasm Metastasis	GO:0070371	ERK1 and ERK2 cascade	9.255340938096879e-11	2.0412654438972666e-6	17	247	168
MESH:D009362	Neoplasm Metastasis	GO:0052548	regulation of endopeptidase activity	1.0059930666272976e-10	2.218717708446505e-6	20	362	168
MESH:D009362	Neoplasm Metastasis	GO:0033993	response to lipid	1.1415368650347091e-10	2.517659555834051e-6	30	850	168
MESH:D009362	Neoplasm Metastasis	GO:0045596	negative regulation of cell differentiation	1.487274747802303e-10	3.280184456277979e-6	25	597	168
MESH:D009362	Neoplasm Metastasis	GO:2000379	positive regulation of reactive oxygen species metabolic process	2.0787382926101827e-10	4.584657304351758e-6	11	83	168
MESH:D009362	Neoplasm Metastasis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.1171875363990011e-10	4.669457111527997e-6	14	161	168
MESH:D009362	Neoplasm Metastasis	GO:0007584	response to nutrient	3.070109722003167e-10	6.771126991877985e-6	15	197	168
MESH:D009362	Neoplasm Metastasis	GO:0033674	positive regulation of kinase activity	3.9272951557478564e-10	8.661649466001897e-6	22	480	168
MESH:D009362	Neoplasm Metastasis	GO:0050900	leukocyte migration	4.922516838590241e-10	1.0856610887510776e-5	19	354	168
MESH:D009362	Neoplasm Metastasis	GO:0043406	positive regulation of MAP kinase activity	5.359597210485845e-10	1.182059164772653e-5	15	205	168
MESH:D009362	Neoplasm Metastasis	GO:0022612	gland morphogenesis	7.829514814261529e-10	1.7267994922853802e-5	12	119	168
MESH:D009362	Neoplasm Metastasis	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	7.979924498968671e-10	1.7599723482475405e-5	25	647	168
MESH:D009362	Neoplasm Metastasis	GO:0097305	response to alcohol	9.854290716759806e-10	2.1733638175813752e-5	19	369	168
MESH:D009362	Neoplasm Metastasis	GO:0042307	positive regulation of protein import into nucleus	1.2840886132181595e-9	2.8320574364526507e-5	11	98	168
MESH:D009362	Neoplasm Metastasis	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.6436480782265903e-9	5.830565836528745e-5	14	195	168
MESH:D009362	Neoplasm Metastasis	GO:0016337	single organismal cell-cell adhesion	3.6117320245665496e-9	7.965674980181525e-5	25	697	168
MESH:D009362	Neoplasm Metastasis	GO:0048545	response to steroid hormone	3.7678281605835195e-9	8.309945008166952e-5	20	446	168
MESH:D009362	Neoplasm Metastasis	GO:0044706	multi-multicellular organism process	3.959507721695843e-9	8.732694280200182e-5	15	237	168
OMIM:180300	Rheumatoid Arthritis	GO:0001775	cell activation	2.7782220968219917e-12	6.127368834540903e-8	49	854	168
OMIM:180300	Rheumatoid Arthritis	GO:0030098	lymphocyte differentiation	2.6652013929151508e-12	5.878101672074365e-8	23	299	168
OMIM:180300	Rheumatoid Arthritis	GO:0034110	regulation of homotypic cell-cell adhesion	1.909139513145419e-12	4.210607196242222e-8	32	304	168
OMIM:180300	Rheumatoid Arthritis	GO:0033993	response to lipid	1.8827162051593405e-12	4.1523305904789254e-8	43	850	168
OMIM:180300	Rheumatoid Arthritis	GO:1903037	regulation of leukocyte cell-cell adhesion	1.7359447213038948e-12	3.82862608283574e-8	32	294	168
OMIM:180300	Rheumatoid Arthritis	GO:1903706	regulation of hemopoiesis	1.6997514507011147e-12	3.7488018245213084e-8	21	305	168
OMIM:180300	Rheumatoid Arthritis	GO:0046651	lymphocyte proliferation	1.410871419693649e-12	3.111676916134343e-8	28	249	168
OMIM:180300	Rheumatoid Arthritis	GO:0050867	positive regulation of cell activation	1.347588707290015e-12	2.972106893928128e-8	33	288	168
OMIM:180300	Rheumatoid Arthritis	GO:0002696	positive regulation of leukocyte activation	1.3435919044013644e-12	2.9632919451572093e-8	31	280	168
OMIM:180300	Rheumatoid Arthritis	GO:0050778	positive regulation of immune response	1.3100631690576847e-12	2.8893443193567236e-8	33	603	168
OMIM:180300	Rheumatoid Arthritis	GO:0002237	response to molecule of bacterial origin	1.2876366639602566e-12	2.8398826623643458e-8	27	333	168
OMIM:180300	Rheumatoid Arthritis	GO:0032103	positive regulation of response to external stimulus	9.954259638789154e-13	2.1954119633349478e-8	21	285	168
OMIM:180300	Rheumatoid Arthritis	GO:0050863	regulation of T cell activation	9.043876758596525e-13	1.9946270191084636e-8	31	284	168
OMIM:180300	Rheumatoid Arthritis	GO:0022409	positive regulation of cell-cell adhesion	8.766321002440236e-13	1.933412097088194e-8	28	239	168
OMIM:180300	Rheumatoid Arthritis	GO:0050671	positive regulation of lymphocyte proliferation	2.0605739337042905e-13	4.544595810784813e-9	18	127	168
OMIM:180300	Rheumatoid Arthritis	GO:0071219	cellular response to molecule of bacterial origin	1.7763568394002505e-13	3.917755009297252e-9	19	158	168
OMIM:180300	Rheumatoid Arthritis	GO:0032496	response to lipopolysaccharide	1.7141843500212417e-13	3.7806335839718486e-9	26	319	168
OMIM:180300	Rheumatoid Arthritis	GO:1902105	regulation of leukocyte differentiation	1.6076029396572267e-13	3.5455682834140134e-9	20	225	168
OMIM:180300	Rheumatoid Arthritis	GO:0071222	cellular response to lipopolysaccharide	1.2367884494324244e-13	2.727736925223212e-9	19	152	168
OMIM:180300	Rheumatoid Arthritis	GO:0030217	T cell differentiation	9.747758156208874e-14	2.1498680613518673e-9	19	199	168
OMIM:180300	Rheumatoid Arthritis	GO:0031663	lipopolysaccharide-mediated signaling pathway	6.039613253960852e-14	1.3320367031610658e-9	12	49	168
OMIM:180300	Rheumatoid Arthritis	GO:0005126	cytokine receptor binding	3.9968028886505635e-15	8.814948770918818e-11	25	270	168
OMIM:180300	Rheumatoid Arthritis	GO:0042102	positive regulation of T cell proliferation	1.887379141862766e-15	4.1626146973783307e-11	16	95	168
OMIM:180300	Rheumatoid Arthritis	GO:0046634	regulation of alpha-beta T cell activation	3.8413716652030416e-14	8.472145207605308e-10	13	67	168
OMIM:180300	Rheumatoid Arthritis	GO:0032649	regulation of interferon-gamma production	4.4075854077618715e-14	9.720929616818808e-10	14	93	168
OMIM:180300	Rheumatoid Arthritis	GO:0005125	cytokine activity	9.070522111187529e-14	2.0005036516224095e-9	20	222	168
OMIM:180300	Rheumatoid Arthritis	GO:0045619	regulation of lymphocyte differentiation	1.8385293287792592e-13	4.054876434622656e-9	16	130	168
OMIM:180300	Rheumatoid Arthritis	GO:0002819	regulation of adaptive immune response	3.9812597663058114e-13	8.780668414587467e-9	15	121	168
OMIM:180300	Rheumatoid Arthritis	GO:0045580	regulation of T cell differentiation	9.771072839726003e-13	2.15501011480157e-8	14	105	168
OMIM:180300	Rheumatoid Arthritis	GO:0032623	interleukin-2 production	1.482147737874584e-12	3.268876835882395e-8	11	54	168
OMIM:180300	Rheumatoid Arthritis	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.663003068586022e-12	3.6677532677664715e-8	14	111	168
OMIM:180300	Rheumatoid Arthritis	GO:0001819	positive regulation of cytokine production	2.202793503158773e-12	4.858261071216674e-8	33	381	168
OMIM:180300	Rheumatoid Arthritis	GO:0001934	positive regulation of protein phosphorylation	2.5016655413878652e-12	5.517423351530937e-8	36	870	168
OMIM:180300	Rheumatoid Arthritis	GO:0007249	I-kappaB kinase/NF-kappaB signaling	2.62412314100402e-12	5.787503587484366e-8	19	260	168
OMIM:180300	Rheumatoid Arthritis	GO:0006954	inflammatory response	3.2346347822453936e-12	7.133987012242216e-8	38	637	168
OMIM:180300	Rheumatoid Arthritis	GO:0098552	side of membrane	3.5935698861067067e-12	7.925618383808342e-8	26	402	168
OMIM:180300	Rheumatoid Arthritis	GO:0006935	chemotaxis	3.6566305539054156e-12	8.064698686638394e-8	26	530	168
OMIM:180300	Rheumatoid Arthritis	GO:0019221	cytokine-mediated signaling pathway	3.736122522468577e-12	8.240018223304446e-8	33	534	168
OMIM:180300	Rheumatoid Arthritis	GO:1902533	positive regulation of intracellular signal transduction	4.356404126326652e-12	9.60804930061343e-8	41	860	168
OMIM:180300	Rheumatoid Arthritis	GO:0002440	production of molecular mediator of immune response	4.898081940041266e-12	1.0802719718761011e-7	15	148	168
OMIM:180300	Rheumatoid Arthritis	GO:0050864	regulation of B cell activation	5.88862292261183e-12	1.2987357855820392e-7	13	100	168
OMIM:180300	Rheumatoid Arthritis	GO:0002764	immune response-regulating signaling pathway	6.842193478462377e-12	1.5090457716748773e-7	24	451	168
OMIM:180300	Rheumatoid Arthritis	GO:0009897	external side of plasma membrane	8.038902876705833e-12	1.7729800294574716e-7	17	212	168
OMIM:180300	Rheumatoid Arthritis	GO:0050900	leukocyte migration	8.90643114814793e-12	1.9643133897240261e-7	21	354	168
OMIM:180300	Rheumatoid Arthritis	GO:0002757	immune response-activating signal transduction	1.031597030021203e-11	2.275187249711763e-7	23	419	168
OMIM:180300	Rheumatoid Arthritis	GO:0051223	regulation of protein transport	1.1164291713328112e-11	2.462284537374515e-7	30	730	168
OMIM:180300	Rheumatoid Arthritis	GO:0045087	innate immune response	1.3129608511519564e-11	2.89573515721564e-7	34	783	168
OMIM:180300	Rheumatoid Arthritis	GO:0032729	positive regulation of interferon-gamma production	1.3455014880037197e-11	2.967503531792204e-7	11	65	168
OMIM:180300	Rheumatoid Arthritis	GO:0007167	enzyme linked receptor protein signaling pathway	1.504441016209057e-11	3.3180446612490755e-7	33	935	168
OMIM:180300	Rheumatoid Arthritis	GO:0002252	immune effector process	1.6521228829446954e-11	3.643757018334526e-7	30	757	168
OMIM:180300	Rheumatoid Arthritis	GO:0050663	cytokine secretion	1.877265010108431e-11	4.1403079797941444e-7	15	162	168
OMIM:180300	Rheumatoid Arthritis	GO:0046635	positive regulation of alpha-beta T cell activation	1.9884649482548866e-11	4.3855594433761524e-7	10	50	168
OMIM:180300	Rheumatoid Arthritis	GO:0002821	positive regulation of adaptive immune response	3.6100678002526365e-11	7.96200453345719e-7	11	71	168
OMIM:180300	Rheumatoid Arthritis	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	3.727917974316597e-11	8.221923092355254e-7	17	233	168
OMIM:180300	Rheumatoid Arthritis	GO:0006606	protein import into nucleus	3.828626304880345e-11	8.4440353154136e-7	18	268	168
OMIM:180300	Rheumatoid Arthritis	GO:0050707	regulation of cytokine secretion	3.911992951799448e-11	8.627900455193682e-7	14	142	168
OMIM:180300	Rheumatoid Arthritis	GO:0009725	response to hormone	3.972722151246444e-11	8.761838704574032e-7	31	865	168
OMIM:180300	Rheumatoid Arthritis	GO:0060548	negative regulation of cell death	4.238986939242295e-11	9.349085694498882e-7	31	867	168
OMIM:180300	Rheumatoid Arthritis	GO:0051050	positive regulation of transport	4.3450909537057214e-11	9.583098098397969e-7	32	920	168
OMIM:180300	Rheumatoid Arthritis	GO:0030335	positive regulation of cell migration	4.736078196287963e-11	1.0445420461913102e-6	21	387	168
OMIM:180300	Rheumatoid Arthritis	GO:0002699	positive regulation of immune effector process	8.15703060652595e-11	1.7990331002692983e-6	14	150	168
OMIM:180300	Rheumatoid Arthritis	GO:0002700	regulation of production of molecular mediator of immune response	8.920297833725499e-11	1.967371687228159e-6	12	99	168
OMIM:180300	Rheumatoid Arthritis	GO:0000165	MAPK cascade	9.66549063008415e-11	2.1317239584650594e-6	30	843	168
OMIM:180300	Rheumatoid Arthritis	GO:0008285	negative regulation of cell proliferation	9.8888119914875e-11	2.1809774847225682e-6	26	634	168
OMIM:180300	Rheumatoid Arthritis	GO:0048660	regulation of smooth muscle cell proliferation	1.0058454069650224e-10	2.218392045061357e-6	12	100	168
OMIM:180300	Rheumatoid Arthritis	GO:0032680	regulation of tumor necrosis factor production	1.0058454069650224e-10	2.218392045061357e-6	12	100	168
OMIM:180300	Rheumatoid Arthritis	GO:0002768	immune response-regulating cell surface receptor signaling pathway	1.0392453564378457e-10	2.2920556336236686e-6	19	323	168
OMIM:180300	Rheumatoid Arthritis	GO:1902107	positive regulation of leukocyte differentiation	1.24093291198335e-10	2.7368775373792786e-6	13	127	168
OMIM:180300	Rheumatoid Arthritis	GO:0043066	negative regulation of apoptotic process	1.2655276826478712e-10	2.79112130407988e-6	29	795	168
OMIM:180300	Rheumatoid Arthritis	GO:0002429	immune response-activating cell surface receptor signaling pathway	1.5532342079183081e-10	3.4256580455638286e-6	18	292	168
OMIM:180300	Rheumatoid Arthritis	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.5671663966543292e-10	3.456385487821123e-6	26	647	168
OMIM:180300	Rheumatoid Arthritis	GO:0031347	regulation of defense response	1.5755596827204954e-10	3.4748968802400526e-6	28	749	168
OMIM:180300	Rheumatoid Arthritis	GO:0072593	reactive oxygen species metabolic process	1.8531332024451785e-10	4.087085277992841e-6	16	223	168
OMIM:180300	Rheumatoid Arthritis	GO:0002702	positive regulation of production of molecular mediator of immune response	1.91140325789263e-10	4.215599885282195e-6	10	62	168
OMIM:180300	Rheumatoid Arthritis	GO:0031664	regulation of lipopolysaccharide-mediated signaling pathway	1.9380441695915351e-10	4.274356416034131e-6	7	19	168
OMIM:180300	Rheumatoid Arthritis	GO:1901652	response to peptide	2.42773912084715e-10	5.354378631028389e-6	21	423	168
OMIM:180300	Rheumatoid Arthritis	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.7290114612554817e-10	6.018834777798965e-6	32	996	168
OMIM:180300	Rheumatoid Arthritis	GO:0002687	positive regulation of leukocyte migration	2.79542056169646e-10	6.165300048821543e-6	12	109	168
OMIM:180300	Rheumatoid Arthritis	GO:0002706	regulation of lymphocyte mediated immunity	3.8532899093723927e-10	8.498430895120812e-6	12	112	168
OMIM:180300	Rheumatoid Arthritis	GO:0032663	regulation of interleukin-2 production	3.8687719694507905e-10	8.532576578623718e-6	9	48	168
OMIM:180300	Rheumatoid Arthritis	GO:0032735	positive regulation of interleukin-12 production	4.16584544637999e-10	9.187772131991068e-6	8	33	168
OMIM:180300	Rheumatoid Arthritis	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.2378611730953253e-10	9.34660281726174e-6	10	67	168
OMIM:180300	Rheumatoid Arthritis	GO:0007259	JAK-STAT cascade	4.373623685438588e-10	9.646027038234806e-6	14	170	168
OMIM:180300	Rheumatoid Arthritis	GO:0050851	antigen receptor-mediated signaling pathway	4.674191034226283e-10	1.0308928325986066e-5	15	203	168
OMIM:180300	Rheumatoid Arthritis	GO:0042306	regulation of protein import into nucleus	6.417351094967216e-10	1.4153467839950196e-5	14	175	168
OMIM:180300	Rheumatoid Arthritis	GO:0042990	regulation of transcription factor import into nucleus	6.451932321738241e-10	1.422973673559369e-5	11	92	168
OMIM:180300	Rheumatoid Arthritis	GO:0051222	positive regulation of protein transport	6.492389958978606e-10	1.4318966054527316e-5	21	447	168
OMIM:180300	Rheumatoid Arthritis	GO:1903034	regulation of response to wounding	7.861296058564449e-10	1.733808845716389e-5	20	407	168
OMIM:180300	Rheumatoid Arthritis	GO:0071887	leukocyte apoptotic process	8.160478959240436e-10	1.799793634460478e-5	11	94	168
OMIM:180300	Rheumatoid Arthritis	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	8.54442405717748e-10	1.8844727258104932e-5	15	212	168
OMIM:180300	Rheumatoid Arthritis	GO:0043408	regulation of MAPK cascade	9.033835901561815e-10	1.9924125080894584e-5	25	651	168
OMIM:180300	Rheumatoid Arthritis	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	9.292306923924798e-10	2.0494182920716142e-5	14	180	168
OMIM:180300	Rheumatoid Arthritis	GO:0050727	regulation of inflammatory response	1.0608454115157429e-9	2.339694555097971e-5	17	289	168
OMIM:180300	Rheumatoid Arthritis	GO:0042307	positive regulation of protein import into nucleus	1.2840886132181595e-9	2.8320574364526507e-5	11	98	168
OMIM:180300	Rheumatoid Arthritis	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	1.4126131375746809e-9	3.115518274920959e-5	8	38	168
OMIM:180300	Rheumatoid Arthritis	GO:0031295	T cell costimulation	1.735480759101904e-9	3.827602814199249e-5	10	77	168
OMIM:180300	Rheumatoid Arthritis	GO:0002437	inflammatory response to antigenic stimulus	2.1878091560623147e-9	4.825213093695435e-5	8	40	168
OMIM:180300	Rheumatoid Arthritis	GO:0045621	positive regulation of lymphocyte differentiation	2.244302188536551e-9	4.9498084768173634e-5	10	79	168
OMIM:180300	Rheumatoid Arthritis	GO:0060326	cell chemotaxis	2.332044779507214e-9	5.143324761203161e-5	15	228	168
OMIM:180300	Rheumatoid Arthritis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.3938616644514354e-9	5.279661900947641e-5	13	161	168
OMIM:180300	Rheumatoid Arthritis	GO:0042346	positive regulation of NF-kappaB import into nucleus	2.399301091138284e-9	5.291658556505485e-5	7	26	168
OMIM:180300	Rheumatoid Arthritis	GO:0051241	negative regulation of multicellular organismal process	2.4100658135850495e-9	5.3154001518618266e-5	30	966	168
OMIM:180300	Rheumatoid Arthritis	GO:0042089	cytokine biosynthetic process	2.7048432382770216e-9	5.965531762019971e-5	11	105	168
OMIM:180300	Rheumatoid Arthritis	GO:0050852	T cell receptor signaling pathway	3.2331178845268482e-9	7.130641494323964e-5	13	165	168
OMIM:180300	Rheumatoid Arthritis	GO:0048545	response to steroid hormone	3.7678281605835195e-9	8.309945008166952e-5	20	446	168
OMIM:180300	Rheumatoid Arthritis	GO:0010942	positive regulation of cell death	4.13219047867841e-9	9.113546100725234e-5	23	596	168
OMIM:180300	Rheumatoid Arthritis	GO:0001818	negative regulation of cytokine production	4.447365142823401e-9	9.80866382249701e-5	14	203	168
DOID:11984	hypertrophic cardiomyopathy	GO:0060047	heart contraction	1.6004975122996257e-12	3.5298972633768244e-8	26	253	169
DOID:11984	hypertrophic cardiomyopathy	GO:0009144	purine nucleoside triphosphate metabolic process	8.01136934569513e-13	1.7669075091930608e-8	21	252	169
DOID:11984	hypertrophic cardiomyopathy	GO:0015980	energy derivation by oxidation of organic compounds	4.938272013532696e-13	1.0891358925846362e-8	29	266	169
DOID:11984	hypertrophic cardiomyopathy	GO:0009199	ribonucleoside triphosphate metabolic process	4.82502926502093e-13	1.0641602044003662e-8	21	251	169
DOID:11984	hypertrophic cardiomyopathy	GO:0014706	striated muscle tissue development	2.3381296898605797e-13	5.1567450309875085e-9	23	323	169
DOID:11984	hypertrophic cardiomyopathy	GO:0002026	regulation of the force of heart contraction	2.745137450688162e-12	6.054400647492741e-8	9	29	169
DOID:11984	hypertrophic cardiomyopathy	GO:0043066	negative regulation of apoptotic process	3.886613253456517e-11	8.571925530498348e-7	30	795	169
DOID:11984	hypertrophic cardiomyopathy	GO:0086003	cardiac muscle cell contraction	4.0789882582714654e-10	8.996208603617717e-6	9	48	169
DOID:11984	hypertrophic cardiomyopathy	GO:0010243	response to organonitrogen compound	1.961740658806832e-9	4.326619022998468e-5	27	780	169
DOID:11984	hypertrophic cardiomyopathy	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	2.807542864857737e-9	6.19203578844374e-5	9	59	169
DOID:6050	esophageal disease	GO:0010212	response to ionizing radiation	5.594524843388626e-11	1.2338724542093615e-6	14	145	169
DOID:6050	esophageal disease	GO:0098609	cell-cell adhesion	9.968772474167054e-10	2.1986127691775437e-5	29	867	169
DOID:6050	esophageal disease	GO:1901990	regulation of mitotic cell cycle phase transition	1.362144952388178e-9	3.0042106924921264e-5	17	292	169
DOID:6050	esophageal disease	GO:0048608	reproductive structure development	1.381883718565291e-9	3.0477445412957493e-5	20	418	169
DOID:6050	esophageal disease	GO:0009887	organ morphogenesis	1.9039967380507505e-9	4.19926480577093e-5	30	950	169
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0055123	digestive system development	5.53335155473178e-13	1.2203806853960941e-8	17	150	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0030323	respiratory tube development	2.284838984678572e-13	5.039212380708591e-9	18	179	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0060537	muscle tissue development	2.1294077612310502e-13	4.696408817395081e-9	22	336	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0030278	regulation of ossification	2.098321516541546e-14	4.6278481047323794e-10	22	177	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0072001	renal system development	1.525446435834965e-13	3.3643721142340155e-9	21	276	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0030324	lung development	5.661027202563673e-13	1.2485395495254181e-8	17	175	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0014706	striated muscle tissue development	1.830313678397033e-12	4.0367568177046564e-8	21	323	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0048754	branching morphogenesis of an epithelial tube	5.13922238098985e-12	1.1334554961273113e-7	15	147	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0045596	negative regulation of cell differentiation	5.877631714668041e-12	1.2963116746700365e-7	27	597	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0007507	heart development	6.551537090615511e-12	1.444941505335251e-7	32	487	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0061061	muscle structure development	7.078782005009998e-12	1.561225371204955e-7	26	551	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:2000648	positive regulation of stem cell proliferation	7.51620987671231e-12	1.6577000883089e-7	11	61	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.4739098830318653e-11	3.250708247026779e-7	34	996	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0048546	digestive tract morphogenesis	1.8077761509971424e-11	3.9870503010241976e-7	10	49	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0035137	hindlimb morphogenesis	3.464672992947726e-11	7.64133628594621e-7	9	37	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0016331	morphogenesis of embryonic epithelium	4.177402868066338e-11	9.213262025520308e-7	14	141	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0010927	cellular component assembly involved in morphogenesis	5.278133485830949e-11	1.1640923403000158e-6	18	270	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0060348	bone development	5.316136419963868e-11	1.1724738874230312e-6	15	172	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:2000027	regulation of organ morphogenesis	5.548228543261757e-11	1.2236618052163806e-6	17	236	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0035136	forelimb morphogenesis	7.457157114032498e-11	1.6446760014998674e-6	9	40	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.2245904290608678e-10	2.700834191293744e-6	28	732	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0042633	hair cycle	1.2992851239346237e-10	2.8655733408378126e-6	12	101	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0035116	embryonic hindlimb morphogenesis	1.4594725428196398e-10	3.2188666931887155e-6	8	29	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0050679	positive regulation of epithelial cell proliferation	1.489478540506184e-10	3.2850449210863886e-6	14	155	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0022405	hair cycle process	1.5689671784002712e-10	3.460357111961798e-6	11	80	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0001942	hair follicle development	1.5689671784002712e-10	3.460357111961798e-6	11	80	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0061035	regulation of cartilage development	2.532792864329281e-10	5.586074662278229e-6	10	63	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0007517	muscle organ development	3.052110786327944e-10	6.7314303392462804e-6	19	340	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0035115	embryonic forelimb morphogenesis	3.4955105476797144e-10	7.70934851290761e-6	8	32	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0009952	anterior/posterior pattern specification	4.175524370708672e-10	9.209118999597976e-6	15	199	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0060601	lateral sprouting from an epithelium	4.605495984577601e-10	1.01574213939859e-5	6	12	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0001701	in utero embryonic development	5.537703628988311e-10	1.221340535373372e-5	18	312	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0030279	negative regulation of ossification	5.538612901645479e-10	1.2215410754579104e-5	10	68	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0003205	cardiac chamber development	5.862286212021672e-10	1.2929272240613798e-5	13	142	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0014855	striated muscle cell proliferation	7.618992103886058e-10	1.68036870851207e-5	9	51	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0001654	eye development	1.1736668303896636e-9	2.588522194424403e-5	18	327	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0003007	heart morphogenesis	1.3055330150280042e-9	2.8793530646442633e-5	15	216	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0060038	cardiac muscle cell proliferation	1.551522688103546e-9	3.421883288612371e-5	8	38	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0009953	dorsal/ventral pattern formation	1.625170331642778e-9	3.584313166438147e-5	11	99	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0016202	regulation of striated muscle tissue development	1.8118074818218588e-9	3.9959414011581096e-5	11	100	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0006661	phosphatidylinositol biosynthetic process	1.9094115177864524e-9	4.2112071024780207e-5	12	127	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0035148	tube formation	2.7305928629317577e-9	6.022322559195992e-5	12	131	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	3.1837854574945368e-9	7.021838826504201e-5	17	307	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0008285	negative regulation of cell proliferation	3.4152765060468937e-9	7.532392334086424e-5	24	634	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0045669	positive regulation of osteoblast differentiation	3.4522397163172514e-9	7.613914694337698e-5	9	60	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0060572	morphogenesis of an epithelial bud	3.872639542379375e-9	8.541106510717711e-5	6	16	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0030509	BMP signaling pathway	4.1971069952850826e-9	9.25671947810125e-5	12	136	170
Orphanet:109009	Syndrome with limb malformations as a major feature	GO:0007548	sex differentiation	4.446803592017545e-9	9.807425322194696e-5	16	274	170
MESH:D006332	Cardiomegaly	GO:0048878	chemical homeostasis	7.887246411542037e-12	1.7395321960655963e-7	45	988	171
MESH:D006332	Cardiomegaly	GO:0051241	negative regulation of multicellular organismal process	3.4139358007223564e-12	7.529435408493157e-8	38	966	171
MESH:D006332	Cardiomegaly	GO:0036293	response to decreased oxygen levels	2.048361480433414e-12	4.517661245095894e-8	27	302	171
MESH:D006332	Cardiomegaly	GO:1903522	regulation of blood circulation	1.9910739723627557e-12	4.391313646046058e-8	37	297	171
MESH:D006332	Cardiomegaly	GO:0033993	response to lipid	1.2969625373671079e-12	2.8604508761631564e-8	33	850	171
MESH:D006332	Cardiomegaly	GO:0007568	aging	9.583445148564351e-13	2.1136288275158677e-8	22	290	171
MESH:D006332	Cardiomegaly	GO:0071363	cellular response to growth factor stimulus	6.556977183436175e-13	1.4461413178068483e-8	32	594	171
MESH:D006332	Cardiomegaly	GO:0001944	vasculature development	5.593303598061539e-13	1.2336031085524723e-8	28	588	171
MESH:D006332	Cardiomegaly	GO:0009141	nucleoside triphosphate metabolic process	3.3573144264664734e-13	7.404556967571807e-9	21	274	171
MESH:D006332	Cardiomegaly	GO:0003018	vascular process in circulatory system	2.7977620220553945e-13	6.1704641396431725e-9	18	159	171
MESH:D006332	Cardiomegaly	GO:0003300	cardiac muscle hypertrophy	9.015010959956271e-14	1.9882606672183556e-9	16	57	171
MESH:D006332	Cardiomegaly	GO:0050880	regulation of blood vessel size	1.5543122344752192e-15	3.428035633135096e-11	16	139	171
MESH:D006332	Cardiomegaly	GO:0001666	response to hypoxia	1.4099832412739488e-14	3.109718038629694e-10	27	292	171
MESH:D006332	Cardiomegaly	GO:0009144	purine nucleoside triphosphate metabolic process	6.250555628639631e-14	1.3785600438964707e-9	20	252	171
MESH:D006332	Cardiomegaly	GO:0033002	muscle cell proliferation	8.903988657493755e-14	1.9637746984102478e-9	16	151	171
MESH:D006332	Cardiomegaly	GO:0009612	response to mechanical stimulus	9.114931032172535e-14	2.0102980391456526e-9	25	210	171
MESH:D006332	Cardiomegaly	GO:2000021	regulation of ion homeostasis	1.1890488593735427e-13	2.6224472593483483e-9	18	189	171
MESH:D006332	Cardiomegaly	GO:0006942	regulation of striated muscle contraction	1.850741782050136e-13	4.081811000311575e-9	17	97	171
MESH:D006332	Cardiomegaly	GO:0055117	regulation of cardiac muscle contraction	3.220756994437579e-13	7.103379551232081e-9	14	84	171
MESH:D006332	Cardiomegaly	GO:0015980	energy derivation by oxidation of organic compounds	3.3295588508508445e-13	7.3433420455515375e-9	25	266	171
MESH:D006332	Cardiomegaly	GO:0008217	regulation of blood pressure	3.6637359812630166e-13	8.080369706675583e-9	17	168	171
MESH:D006332	Cardiomegaly	GO:0034504	protein localization to nucleus	3.6703973194107675e-13	8.095061287960448e-9	22	344	171
MESH:D006332	Cardiomegaly	GO:0043502	regulation of muscle adaptation	5.142553050063725e-13	1.1341900751915546e-8	12	63	171
MESH:D006332	Cardiomegaly	GO:0048660	regulation of smooth muscle cell proliferation	6.259437412836633e-13	1.3805189214011193e-8	14	100	171
MESH:D006332	Cardiomegaly	GO:0071560	cellular response to transforming growth factor beta stimulus	7.530642776032437e-13	1.660883264253954e-8	18	208	171
MESH:D006332	Cardiomegaly	GO:0000302	response to reactive oxygen species	1.0336176359260207e-12	2.2796436960348387e-8	18	216	171
MESH:D006332	Cardiomegaly	GO:0000165	MAPK cascade	1.1615153283628388e-12	2.561722056704241e-8	36	843	171
MESH:D006332	Cardiomegaly	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.2535528171042642e-12	2.7647107381234548e-8	18	212	171
MESH:D006332	Cardiomegaly	GO:0098771	inorganic ion homeostasis	1.2793099912755679e-12	2.821518185758265e-8	30	609	171
MESH:D006332	Cardiomegaly	GO:1900180	regulation of protein localization to nucleus	1.3162804179955856e-12	2.903056461889264e-8	18	213	171
MESH:D006332	Cardiomegaly	GO:0055080	cation homeostasis	1.5234480343906398e-12	3.359964639848556e-8	29	595	171
MESH:D006332	Cardiomegaly	GO:0014070	response to organic cyclic compound	1.6936452240656763e-12	3.735334541676849e-8	42	873	171
MESH:D006332	Cardiomegaly	GO:1901701	cellular response to oxygen-containing compound	1.7128520823916915e-12	3.7776952677148756e-8	36	873	171
MESH:D006332	Cardiomegaly	GO:0032386	regulation of intracellular transport	2.1256330029473247e-12	4.6880835880003247e-8	27	575	171
MESH:D006332	Cardiomegaly	GO:0006873	cellular ion homeostasis	2.3943069749066126e-12	5.280644033156534e-8	28	532	171
MESH:D006332	Cardiomegaly	GO:0006874	cellular calcium ion homeostasis	2.438715895891619e-12	5.3785879083889654e-8	22	352	171
MESH:D006332	Cardiomegaly	GO:0097305	response to alcohol	2.564282119976724e-12	5.655524215608665e-8	23	369	171
MESH:D006332	Cardiomegaly	GO:0042327	positive regulation of phosphorylation	2.841171742318238e-12	6.266204277682874e-8	36	910	171
MESH:D006332	Cardiomegaly	GO:1901698	response to nitrogen compound	3.3149039069257924e-12	7.311020566724835e-8	36	870	171
MESH:D006332	Cardiomegaly	GO:0001934	positive regulation of protein phosphorylation	3.3950620093037287e-12	7.487809261519374e-8	35	870	171
MESH:D006332	Cardiomegaly	GO:0007167	enzyme linked receptor protein signaling pathway	3.5759173400151667e-12	7.88668569340345e-8	38	935	171
MESH:D006332	Cardiomegaly	GO:0009725	response to hormone	3.606337450889896e-12	7.953777247937666e-8	34	865	171
MESH:D006332	Cardiomegaly	GO:1902533	positive regulation of intracellular signal transduction	3.658517933047278e-12	8.068861301335772e-8	36	860	171
MESH:D006332	Cardiomegaly	GO:0042060	wound healing	3.970046513757097e-12	8.755937586091278e-8	33	534	171
MESH:D006332	Cardiomegaly	GO:0060548	negative regulation of cell death	4.048095192388246e-12	8.928073946812276e-8	36	867	171
MESH:D006332	Cardiomegaly	GO:0010035	response to inorganic substance	4.3264281046617725e-12	9.541937184831539e-8	31	502	171
MESH:D006332	Cardiomegaly	GO:0048545	response to steroid hormone	4.513056595101261e-12	9.953546320495832e-8	26	446	171
MESH:D006332	Cardiomegaly	GO:0040007	growth	4.8433479449272454e-12	1.068200389253704e-7	36	936	171
MESH:D006332	Cardiomegaly	GO:0040008	regulation of growth	5.182521078950231e-12	1.1430050239624734e-7	29	617	171
MESH:D006332	Cardiomegaly	GO:0030334	regulation of cell migration	5.728084673251033e-12	1.2633290746855153e-7	32	660	171
MESH:D006332	Cardiomegaly	GO:0043408	regulation of MAPK cascade	5.899836175160544e-12	1.301208868431658e-7	32	651	171
MESH:D006332	Cardiomegaly	GO:0016049	cell growth	6.091793736118234e-12	1.3435451085008765e-7	25	479	171
MESH:D006332	Cardiomegaly	GO:0071407	cellular response to organic cyclic compound	6.555533893504162e-12	1.445823000212343e-7	27	416	171
MESH:D006332	Cardiomegaly	GO:0042493	response to drug	6.642686400937237e-12	1.4650444857267075e-7	26	433	171
MESH:D006332	Cardiomegaly	GO:0051050	positive regulation of transport	7.174150162825299e-12	1.5822588184111197e-7	36	920	171
MESH:D006332	Cardiomegaly	GO:0031960	response to corticosteroid	8.514855487362638e-12	1.8779513777378298e-7	16	179	171
MESH:D006332	Cardiomegaly	GO:0043069	negative regulation of programmed cell death	9.385381360971223e-12	2.0699458591622033e-7	35	806	171
MESH:D006332	Cardiomegaly	GO:0043066	negative regulation of apoptotic process	1.246081016148537e-11	2.748231681115598e-7	34	795	171
MESH:D006332	Cardiomegaly	GO:0010243	response to organonitrogen compound	1.267974614194145e-11	2.796518011605187e-7	35	780	171
MESH:D006332	Cardiomegaly	GO:0008284	positive regulation of cell proliferation	1.3233192319717091e-11	2.9185805661136044e-7	32	815	171
MESH:D006332	Cardiomegaly	GO:0001568	blood vessel development	1.3745449223279138e-11	3.031558826194214e-7	26	569	171
MESH:D006332	Cardiomegaly	GO:0061337	cardiac conduction	1.6803336500004207e-11	3.705975865075928e-7	14	131	171
MESH:D006332	Cardiomegaly	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	2.1756707546671805e-11	4.798441849418467e-7	15	161	171
MESH:D006332	Cardiomegaly	GO:0050879	multicellular organismal movement	2.3809398896901257e-11	5.251162926711572e-7	10	50	171
MESH:D006332	Cardiomegaly	GO:0050881	musculoskeletal movement	2.3809398896901257e-11	5.251162926711572e-7	10	50	171
MESH:D006332	Cardiomegaly	GO:0006816	calcium ion transport	2.5004442960607776e-11	5.514729894962045e-7	21	366	171
MESH:D006332	Cardiomegaly	GO:1903524	positive regulation of blood circulation	3.038802542931762e-11	6.702079008436002e-7	12	89	171
MESH:D006332	Cardiomegaly	GO:0003205	cardiac chamber development	4.9654280687150276e-11	1.0951251605550993e-6	14	142	171
MESH:D006332	Cardiomegaly	GO:0043410	positive regulation of MAPK cascade	5.2741810918632837e-11	1.1632206398104472e-6	23	464	171
MESH:D006332	Cardiomegaly	GO:0043491	protein kinase B signaling	5.959688298418087e-11	1.314409254216109e-6	14	144	171
MESH:D006332	Cardiomegaly	GO:0022603	regulation of anatomical structure morphogenesis	6.877065583665853e-11	1.516736814477504e-6	33	986	171
MESH:D006332	Cardiomegaly	GO:0003009	skeletal muscle contraction	7.861478135140487e-11	1.7338490027052345e-6	9	40	171
MESH:D006332	Cardiomegaly	GO:1901654	response to ketone	1.1890999296326754e-10	2.6225598948048656e-6	15	181	171
MESH:D006332	Cardiomegaly	GO:0002026	regulation of the force of heart contraction	1.5292567212554786e-10	3.372775698728958e-6	8	29	171
MESH:D006332	Cardiomegaly	GO:0032940	secretion by cell	1.6114665157829222e-10	3.554089400559235e-6	32	956	171
MESH:D006332	Cardiomegaly	GO:0009266	response to temperature stimulus	1.8510026844609229e-10	4.082386420578565e-6	16	219	171
MESH:D006332	Cardiomegaly	GO:0003206	cardiac chamber morphogenesis	1.9692369956914035e-10	4.3431521939973905e-6	12	104	171
MESH:D006332	Cardiomegaly	GO:0005740	mitochondrial envelope	2.0916057774655883e-10	4.613036542200355e-6	27	694	171
MESH:D006332	Cardiomegaly	GO:0003231	cardiac ventricle development	2.2071067196094418e-10	4.867773870098624e-6	12	105	171
MESH:D006332	Cardiomegaly	GO:0003208	cardiac ventricle morphogenesis	2.275497568149376e-10	5.018609886553449e-6	10	62	171
MESH:D006332	Cardiomegaly	GO:1903409	reactive oxygen species biosynthetic process	2.5157154137644966e-10	5.548410345057597e-6	11	83	171
MESH:D006332	Cardiomegaly	GO:0010038	response to metal ion	2.630733408892638e-10	5.8020825333127135e-6	19	335	171
MESH:D006332	Cardiomegaly	GO:0071417	cellular response to organonitrogen compound	2.738064219798275e-10	6.038800636765096e-6	22	462	171
MESH:D006332	Cardiomegaly	GO:0031966	mitochondrial membrane	3.078181043392192e-10	6.788928291201479e-6	26	656	171
MESH:D006332	Cardiomegaly	GO:0086004	regulation of cardiac muscle cell contraction	3.7088176974009457e-10	8.179797431617786e-6	9	47	171
MESH:D006332	Cardiomegaly	GO:0097190	apoptotic signaling pathway	3.7895608873128594e-10	8.357876536968512e-6	24	564	171
MESH:D006332	Cardiomegaly	GO:0007584	response to nutrient	3.9374958848981123e-10	8.684147174142787e-6	15	197	171
MESH:D006332	Cardiomegaly	GO:0051384	response to glucocorticoid	4.367139982974777e-10	9.63172723245087e-6	14	167	171
MESH:D006332	Cardiomegaly	GO:0006606	protein import into nucleus	4.40864122985829e-10	9.723258232452459e-6	17	268	171
MESH:D006332	Cardiomegaly	GO:1903779	regulation of cardiac conduction	5.041783657233623e-10	1.1119653856028755e-5	10	67	171
MESH:D006332	Cardiomegaly	GO:0098662	inorganic cation transmembrane transport	5.562387217494802e-10	1.2267845008184786e-5	24	575	171
MESH:D006332	Cardiomegaly	GO:0044706	multi-multicellular organism process	5.928811885880236e-10	1.3075994614308861e-5	16	237	171
MESH:D006332	Cardiomegaly	GO:1903649	regulation of cytoplasmic transport	6.005222985550063e-10	1.3244519294630663e-5	21	437	171
MESH:D006332	Cardiomegaly	GO:0048514	blood vessel morphogenesis	6.456730705650671e-10	1.4240319571312554e-5	22	484	171
MESH:D006332	Cardiomegaly	GO:0019901	protein kinase binding	6.715504818899376e-10	1.4811045878082574e-5	23	532	171
MESH:D006332	Cardiomegaly	GO:0043405	regulation of MAP kinase activity	7.724451078772177e-10	1.7036276854232035e-5	17	278	171
MESH:D006332	Cardiomegaly	GO:0042306	regulation of protein import into nucleus	8.103624438149382e-10	1.787254369833846e-5	14	175	171
MESH:D006332	Cardiomegaly	GO:0046824	positive regulation of nucleocytoplasmic transport	8.699754250329761e-10	1.9187307999102288e-5	12	118	171
MESH:D006332	Cardiomegaly	GO:0001775	cell activation	9.311141857537564e-10	2.0535723366799097e-5	29	854	171
MESH:D006332	Cardiomegaly	GO:2000377	regulation of reactive oxygen species metabolic process	9.688581048550304e-10	2.1368165502577696e-5	13	147	171
MESH:D006332	Cardiomegaly	GO:0043501	skeletal muscle adaptation	1.035379115776891e-9	2.283528639845933e-5	7	23	171
MESH:D006332	Cardiomegaly	GO:0045597	positive regulation of cell differentiation	1.4742661536004675e-9	3.251494001765831e-5	28	815	171
MESH:D006332	Cardiomegaly	GO:1900182	positive regulation of protein localization to nucleus	1.699368201713014e-9	3.7479565688780525e-5	12	125	171
MESH:D006332	Cardiomegaly	GO:0097191	extrinsic apoptotic signaling pathway	1.8257164668966652e-9	4.026617667740595e-5	15	220	171
MESH:D006332	Cardiomegaly	GO:0050679	positive regulation of epithelial cell proliferation	1.8648703692392132e-9	4.112971599357085e-5	13	155	171
MESH:D006332	Cardiomegaly	GO:0001558	regulation of cell growth	2.073600069429915e-9	4.5733249531276776e-5	19	379	171
MESH:D006332	Cardiomegaly	GO:0032768	regulation of monooxygenase activity	2.264576193233836e-9	4.994522794177225e-5	9	57	171
MESH:D006332	Cardiomegaly	GO:0007565	female pregnancy	2.3763132572796053e-9	5.2409588889301695e-5	14	190	171
MESH:D006332	Cardiomegaly	GO:0042391	regulation of membrane potential	2.3960959882884936e-9	5.2845897021702726e-5	18	340	171
MESH:D006332	Cardiomegaly	GO:0061049	cell growth involved in cardiac muscle cell development	2.5263949821052734e-9	5.5719641330331804e-5	6	15	171
MESH:D006332	Cardiomegaly	GO:0009408	response to heat	2.5504904854756205e-9	5.625106765716481e-5	13	159	171
MESH:D006332	Cardiomegaly	GO:0090287	regulation of cellular response to growth factor stimulus	2.6411794973313363e-9	5.825121381364262e-5	15	226	171
MESH:D006332	Cardiomegaly	GO:0051046	regulation of secretion	2.7473970876101816e-9	6.0593842767242556e-5	25	675	171
MESH:D006332	Cardiomegaly	GO:0033273	response to vitamin	2.9414944924255337e-9	6.487466103044515e-5	11	104	171
MESH:D006332	Cardiomegaly	GO:0043434	response to peptide hormone	3.1802886990561774e-9	7.014126725768399e-5	19	389	171
MESH:D006332	Cardiomegaly	GO:0048661	positive regulation of smooth muscle cell proliferation	3.63506302836214e-9	8.0171315090527e-5	9	60	171
MESH:D006332	Cardiomegaly	GO:0007204	positive regulation of cytosolic calcium ion concentration	4.247536877777236e-9	9.367942583937694e-5	15	234	171
MESH:D006332	Cardiomegaly	GO:0007179	transforming growth factor beta receptor signaling pathway	4.318727819807577e-9	9.524954206585612e-5	13	166	171
DOID:4961	bone marrow disease	GO:0060249	anatomical structure homeostasis	1.2953971229023864e-11	2.856998354561213e-7	21	351	172
DOID:4961	bone marrow disease	GO:0051054	positive regulation of DNA metabolic process	1.5129320019013903e-10	3.3367715301935164e-6	15	183	172
DOID:4961	bone marrow disease	GO:0051272	positive regulation of cellular component movement	1.9579160515093008e-10	4.318183851603763e-6	21	408	172
DOID:4961	bone marrow disease	GO:1901099	negative regulation of signal transduction in absence of ligand	2.900411022466187e-10	6.396856510049176e-6	8	31	172
DOID:4961	bone marrow disease	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	2.900411022466187e-10	6.396856510049176e-6	8	31	172
DOID:4961	bone marrow disease	GO:0070848	response to growth factor	5.658468138491912e-10	1.2479751479443912e-5	25	621	172
DOID:4961	bone marrow disease	GO:0002573	myeloid leukocyte differentiation	1.5720459378698592e-9	3.4671473159719746e-5	14	183	172
DOID:4961	bone marrow disease	GO:0034101	erythrocyte homeostasis	1.6481547238100802e-9	3.635005243363132e-5	11	98	172
DOID:4961	bone marrow disease	GO:0006260	DNA replication	2.2888474449089813e-9	5.048053039746758e-5	18	337	172
DOID:4961	bone marrow disease	GO:0005925	focal adhesion	3.3636947671666917e-9	7.418628808986139e-5	19	388	172
DOID:4961	bone marrow disease	GO:0008285	negative regulation of cell proliferation	4.332176395394072e-9	9.554615040041625e-5	24	634	172
DOID:4961	bone marrow disease	GO:0070372	regulation of ERK1 and ERK2 cascade	4.341107806560274e-9	9.574313267368684e-5	15	233	172
DOID:0060058	lymphoma	GO:0050867	positive regulation of cell activation	1.816102823681831e-12	4.0054147776302784e-8	26	288	174
DOID:0060058	lymphoma	GO:1903037	regulation of leukocyte cell-cell adhesion	1.4381829060994278e-12	3.171912399402288e-8	29	294	174
DOID:0060058	lymphoma	GO:0022409	positive regulation of cell-cell adhesion	8.202327705930657e-13	1.8090233755430063e-8	23	239	174
DOID:0060058	lymphoma	GO:0002429	immune response-activating cell surface receptor signaling pathway	4.007905118896815e-13	8.839434739726926e-9	26	292	174
DOID:0060058	lymphoma	GO:1902105	regulation of leukocyte differentiation	9.14823772291129e-14	2.017643829788085e-9	22	225	174
DOID:0060058	lymphoma	GO:0050673	epithelial cell proliferation	5.001443703633868e-12	1.1030684088364495e-7	21	335	174
DOID:0060058	lymphoma	GO:0002449	lymphocyte mediated immunity	1.1613154882184062e-11	2.561281309265695e-7	17	209	174
DOID:0060058	lymphoma	GO:0007167	enzyme linked receptor protein signaling pathway	1.2072343125169027e-11	2.662555276256029e-7	34	935	174
DOID:0060058	lymphoma	GO:0050678	regulation of epithelial cell proliferation	1.2843281993468736e-11	2.8325858436595297e-7	19	277	174
DOID:0060058	lymphoma	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	4.8913650907422834e-11	1.0787905707632106e-6	12	91	174
DOID:0060058	lymphoma	GO:0002208	somatic diversification of immunoglobulins involved in immune response	5.561051619196178e-11	1.226489934613717e-6	9	38	174
DOID:0060058	lymphoma	GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	5.561051619196178e-11	1.226489934613717e-6	9	38	174
DOID:0060058	lymphoma	GO:0045190	isotype switching	5.561051619196178e-11	1.226489934613717e-6	9	38	174
DOID:0060058	lymphoma	GO:0045859	regulation of protein kinase activity	1.0080192236472385e-10	2.2231863977539845e-6	28	709	174
DOID:0060058	lymphoma	GO:0031960	response to corticosteroid	1.3032552814706833e-10	2.874329523283592e-6	15	179	174
DOID:0060058	lymphoma	GO:0002902	regulation of B cell apoptotic process	1.578510655519949e-10	3.4814052507492477e-6	7	18	174
DOID:0060058	lymphoma	GO:0031099	regeneration	1.6506673805594119e-10	3.640546907823783e-6	15	182	174
DOID:0060058	lymphoma	GO:0007417	central nervous system development	1.9478429980068768e-10	4.295967732104167e-6	31	889	174
DOID:0060058	lymphoma	GO:0035239	tube morphogenesis	4.130907838018061e-10	9.110717236748833e-6	19	338	174
DOID:0060058	lymphoma	GO:0048538	thymus development	4.330394931528758e-10	9.550686021486676e-6	9	47	174
DOID:0060058	lymphoma	GO:0060562	epithelial tube morphogenesis	4.5288339745042094e-10	9.988343330769034e-6	18	301	174
DOID:0060058	lymphoma	GO:0002244	hematopoietic progenitor cell differentiation	5.474657394088922e-10	1.2074356882663118e-5	13	138	174
DOID:0060058	lymphoma	GO:0007569	cell aging	8.322886824174702e-10	1.8356126890717306e-5	11	91	174
DOID:0060058	lymphoma	GO:0050900	leukocyte migration	8.977030230283845e-10	1.979884017289102e-5	19	354	174
DOID:0060058	lymphoma	GO:0045165	cell fate commitment	1.1040671710205174e-9	2.4350201456857512e-5	16	243	174
DOID:0060058	lymphoma	GO:0051272	positive regulation of cellular component movement	1.5262953123595935e-9	3.3662443114090834e-5	20	408	174
DOID:0060058	lymphoma	GO:0071453	cellular response to oxygen levels	1.540717775583289e-9	3.398053054048944e-5	13	150	174
DOID:0060058	lymphoma	GO:0009636	response to toxic substance	1.573298158419334e-9	3.469909088393841e-5	16	249	174
DOID:0060058	lymphoma	GO:0033002	muscle cell proliferation	1.6727356166867935e-9	3.689218402602723e-5	13	151	174
DOID:0060058	lymphoma	GO:0043408	regulation of MAPK cascade	1.9043855381539743e-9	4.20012230439859e-5	25	651	174
DOID:0060058	lymphoma	GO:0043627	response to estrogen	1.922213943572615e-9	4.239442852549402e-5	15	217	174
DOID:0060058	lymphoma	GO:0072593	reactive oxygen species metabolic process	2.796332276844282e-9	6.167310836580064e-5	15	223	174
DOID:0060058	lymphoma	GO:1903651	positive regulation of cytoplasmic transport	3.2824600815217764e-9	7.239465709796278e-5	16	262	174
DOID:0060058	lymphoma	GO:0009991	response to extracellular stimulus	3.910688994857026e-9	8.62502457815717e-5	23	573	174
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0035249	synaptic transmission, glutamatergic	3.3306690738754696e-15	7.345790642432348e-11	14	70	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0008306	associative learning	2.2437607327674414e-13	4.948614296118592e-9	13	73	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0001975	response to amphetamine	5.400235814079224e-12	1.1910220087951728e-7	9	30	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0042310	vasoconstriction	1.1091683127517626e-11	2.4462707137740125e-7	12	80	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0044706	multi-multicellular organism process	9.35115318512203e-11	2.0623968349786637e-6	17	237	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0052652	cyclic purine nucleotide metabolic process	1.0761413982152135e-10	2.3734298537636533e-6	14	147	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0007618	mating	2.4287538646916573e-10	5.35661664857745e-6	9	44	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0014072	response to isoquinoline alkaloid	2.489333184030329e-10	5.490224337378891e-6	8	30	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0043278	response to morphine	2.489333184030329e-10	5.490224337378891e-6	8	30	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0035240	dopamine binding	2.7650159939440755e-10	6.0982427746436585e-6	6	11	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0043195	terminal bouton	3.9554581832135227e-10	8.723763023077424e-6	10	64	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0030534	adult behavior	4.4631642825976314e-10	9.843508825269076e-6	13	135	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0060134	prepulse inhibition	5.486869847359799e-10	1.2101291448352036e-5	6	12	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0030817	regulation of cAMP biosynthetic process	6.846357925027746e-10	1.5099642403648694e-5	12	113	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0033555	multicellular organismal response to stress	8.52844461718405e-10	1.8809484603199422e-5	10	69	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0051932	synaptic transmission, GABAergic	1.227208334952934e-9	2.7066079827386957e-5	8	36	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0004952	dopamine neurotransmitter receptor activity	1.4130443481974453e-9	3.1164693099494656e-5	5	7	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0001659	temperature homeostasis	1.9520102201298073e-9	4.30515854049629e-5	8	38	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0008277	regulation of G-protein coupled receptor protein signaling pathway	2.426960188373073e-9	5.352660695456812e-5	12	126	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0010876	lipid localization	2.505008978026524e-9	5.5247973010374984e-5	18	333	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0019233	sensory perception of pain	2.7399339463940464e-9	6.0429243187720694e-5	11	101	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0043523	regulation of neuron apoptotic process	3.2113439685232947e-9	7.082619122578127e-5	14	190	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0046942	carboxylic acid transport	3.336117382346515e-9	7.357806886765239e-5	17	299	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0021987	cerebral cortex development	4.158688615696349e-9	9.171987741918297e-5	11	105	175
MESH:D019967	Schizophrenia Spectrum and Other Psychotic Disorders	GO:0008066	glutamate receptor activity	4.271715869919035e-9	9.421269351106432e-5	7	27	175
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0060537	muscle tissue development	1.3027356970951587e-12	2.8731835799433725e-8	23	336	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0003007	heart morphogenesis	7.047695760320494e-13	1.554369299938685e-8	19	216	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001654	eye development	4.707345624410664e-13	1.0382050774637719e-8	23	327	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0055123	digestive system development	2.879918525877656e-13	6.3516603088231705e-9	19	150	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001763	morphogenesis of a branching structure	1.0946799022804043e-13	2.4143165244794318e-9	19	193	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0048565	digestive tract development	3.0531133177191805e-14	6.733641422229653e-10	18	138	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0035115	embryonic forelimb morphogenesis	3.1530333899354446e-14	6.954015141502623e-10	11	32	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0072001	renal system development	8.215650382226158e-14	1.8119616917999792e-9	21	276	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001701	in utero embryonic development	1.5976109324356003e-13	3.5235309114867164e-9	22	312	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0048754	branching morphogenesis of an epithelial tube	3.540501225529624e-13	7.808575452905586e-9	16	147	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0009799	specification of symmetry	3.687050664780145e-13	8.13179024117261e-9	16	122	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0009855	determination of bilateral symmetry	3.9901415505028126e-13	8.800257189633953e-9	16	121	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0014706	striated muscle tissue development	5.727640584041183e-13	1.2632311308102828e-8	22	323	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0042633	hair cycle	7.4495964952348e-13	1.6430085070240352e-8	14	101	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0022405	hair cycle process	7.465139617579553e-13	1.6464365426571703e-8	13	80	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001942	hair follicle development	7.465139617579553e-13	1.6464365426571703e-8	13	80	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0007548	sex differentiation	8.378853166846056e-13	1.8479560659478977e-8	20	274	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0030324	lung development	8.874012635828876e-13	1.9571634868320587e-8	17	175	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0035137	hindlimb morphogenesis	1.234345958778249e-12	2.7223500120854283e-8	10	37	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0035116	embryonic hindlimb morphogenesis	4.245936935376449e-12	9.364413910972758e-8	9	29	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0035050	embryonic heart tube development	4.856559598920285e-12	1.0711142195418688e-7	12	74	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0048732	gland development	7.490452702541006e-12	1.652019343545419e-7	25	421	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0060348	bone development	8.025025088898019e-12	1.769919283356458e-7	16	172	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:2000648	positive regulation of stem cell proliferation	1.1372458530445329e-11	2.508195728889717e-7	11	61	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0045165	cell fate commitment	1.739219879226539e-11	3.8358494436341317e-7	18	243	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0006661	phosphatidylinositol biosynthetic process	1.739797195199344e-11	3.8371227140121533e-7	14	127	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.2501334129287898e-11	4.962669242214446e-7	30	732	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0060021	palate development	2.6065261060637113e-11	5.748693326923515e-7	12	85	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0048546	digestive tract morphogenesis	2.716005198521998e-11	5.990149465340266e-7	10	49	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0030279	negative regulation of ossification	3.9235392712555495e-11	8.653365862754114e-7	11	68	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0014855	striated muscle cell proliferation	4.145361831575656e-11	9.142595519540109e-7	10	51	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0060038	cardiac muscle cell proliferation	6.485456616189822e-11	1.4303674567006652e-6	9	38	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0061371	determination of heart left/right asymmetry	2.698251622135217e-10	5.950993952619221e-6	10	61	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0035148	tube formation	3.5248592933356804e-10	7.774077171451843e-6	13	131	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0003143	embryonic heart tube morphogenesis	3.762010702956786e-10	8.297114605371192e-6	10	63	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0061053	somite development	4.725373425884527e-10	1.0421811090788324e-5	11	85	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0009952	anterior/posterior pattern specification	7.353010422761486e-10	1.6217064487400457e-5	15	199	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0003205	cardiac chamber development	9.648040144583092e-10	2.127875253887801e-5	13	142	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0000785	chromatin	1.1833044544218296e-9	2.6097779742273453e-5	21	438	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001944	vasculature development	1.7722266987263424e-9	3.908645984040948e-5	24	588	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0000975	regulatory region DNA binding	2.8564657306162644e-9	6.299935168874171e-5	28	810	177
Orphanet:364568	Dysostosis with limb anomaly as a major feature	GO:0001947	heart looping	3.6028138250543407e-9	7.946005891157348e-5	9	58	177
MESH:D006505	Hepatitis	GO:0050867	positive regulation of cell activation	2.0590196214698153e-12	4.541167775151678e-8	23	288	177
MESH:D006505	Hepatitis	GO:0002696	positive regulation of leukocyte activation	1.5909495942878493e-12	3.508839330201852e-8	22	280	177
MESH:D006505	Hepatitis	GO:0070663	regulation of leukocyte proliferation	4.2299497238218464e-13	9.329154115889082e-9	23	200	177
MESH:D006505	Hepatitis	GO:0051050	positive regulation of transport	1.0004219674897286e-11	2.2064306492985963e-7	36	920	177
MESH:D006505	Hepatitis	GO:0050778	positive regulation of immune response	1.8565593506991718e-11	4.0946416479670233e-7	27	603	177
MESH:D006505	Hepatitis	GO:0043434	response to peptide hormone	9.062340877719066e-10	1.99869928058094e-5	20	389	177
MESH:D006505	Hepatitis	GO:0002698	negative regulation of immune effector process	2.4900376205394537e-9	5.491777972099765e-5	11	99	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0060537	muscle tissue development	1.3027356970951587e-12	2.8731835799433725e-8	23	336	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0003007	heart morphogenesis	7.047695760320494e-13	1.554369299938685e-8	19	216	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001654	eye development	4.707345624410664e-13	1.0382050774637719e-8	23	327	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0055123	digestive system development	2.879918525877656e-13	6.3516603088231705e-9	19	150	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001763	morphogenesis of a branching structure	1.0946799022804043e-13	2.4143165244794318e-9	19	193	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0048565	digestive tract development	3.0531133177191805e-14	6.733641422229653e-10	18	138	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0035115	embryonic forelimb morphogenesis	3.1530333899354446e-14	6.954015141502623e-10	11	32	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0072001	renal system development	8.215650382226158e-14	1.8119616917999792e-9	21	276	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001701	in utero embryonic development	1.5976109324356003e-13	3.5235309114867164e-9	22	312	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0048754	branching morphogenesis of an epithelial tube	3.540501225529624e-13	7.808575452905586e-9	16	147	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0009799	specification of symmetry	3.687050664780145e-13	8.13179024117261e-9	16	122	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0009855	determination of bilateral symmetry	3.9901415505028126e-13	8.800257189633953e-9	16	121	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0014706	striated muscle tissue development	5.727640584041183e-13	1.2632311308102828e-8	22	323	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0042633	hair cycle	7.4495964952348e-13	1.6430085070240352e-8	14	101	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0022405	hair cycle process	7.465139617579553e-13	1.6464365426571703e-8	13	80	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001942	hair follicle development	7.465139617579553e-13	1.6464365426571703e-8	13	80	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0007548	sex differentiation	8.378853166846056e-13	1.8479560659478977e-8	20	274	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0030324	lung development	8.874012635828876e-13	1.9571634868320587e-8	17	175	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0035137	hindlimb morphogenesis	1.234345958778249e-12	2.7223500120854283e-8	10	37	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0035116	embryonic hindlimb morphogenesis	4.245936935376449e-12	9.364413910972758e-8	9	29	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0035050	embryonic heart tube development	4.856559598920285e-12	1.0711142195418688e-7	12	74	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0048608	reproductive structure development	5.540123915181994e-12	1.2218743294933887e-7	27	418	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0048732	gland development	7.490452702541006e-12	1.652019343545419e-7	25	421	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0060348	bone development	8.025025088898019e-12	1.769919283356458e-7	16	172	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:2000648	positive regulation of stem cell proliferation	1.1372458530445329e-11	2.508195728889717e-7	11	61	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0045165	cell fate commitment	1.739219879226539e-11	3.8358494436341317e-7	18	243	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0006661	phosphatidylinositol biosynthetic process	1.739797195199344e-11	3.8371227140121533e-7	14	127	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.2501334129287898e-11	4.962669242214446e-7	30	732	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0060021	palate development	2.6065261060637113e-11	5.748693326923515e-7	12	85	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0048546	digestive tract morphogenesis	2.716005198521998e-11	5.990149465340266e-7	10	49	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0030279	negative regulation of ossification	3.9235392712555495e-11	8.653365862754114e-7	11	68	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0014855	striated muscle cell proliferation	4.145361831575656e-11	9.142595519540109e-7	10	51	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0060038	cardiac muscle cell proliferation	6.485456616189822e-11	1.4303674567006652e-6	9	38	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0061371	determination of heart left/right asymmetry	2.698251622135217e-10	5.950993952619221e-6	10	61	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0035148	tube formation	3.5248592933356804e-10	7.774077171451843e-6	13	131	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0003143	embryonic heart tube morphogenesis	3.762010702956786e-10	8.297114605371192e-6	10	63	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0061053	somite development	4.725373425884527e-10	1.0421811090788324e-5	11	85	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0009952	anterior/posterior pattern specification	7.353010422761486e-10	1.6217064487400457e-5	15	199	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0003205	cardiac chamber development	9.648040144583092e-10	2.127875253887801e-5	13	142	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0000785	chromatin	1.1833044544218296e-9	2.6097779742273453e-5	21	438	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0019827	stem cell population maintenance	1.2500760426803481e-9	2.7570427121315078e-5	13	145	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001944	vasculature development	1.7722266987263424e-9	3.908645984040948e-5	24	588	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0000975	regulatory region DNA binding	2.8564657306162644e-9	6.299935168874171e-5	28	810	177
Orphanet:404571	Dysostosis of genetic origin with limb anomaly as a major feature	GO:0001947	heart looping	3.6028138250543407e-9	7.946005891157348e-5	9	58	177
Orphanet:171898	Lymphoid hemopathy	GO:0070227	lymphocyte apoptotic process	1.1368683772161603e-12	2.5073632059502415e-8	12	65	177
Orphanet:171898	Lymphoid hemopathy	GO:0097193	intrinsic apoptotic signaling pathway	1.2569945084806022e-11	2.772301388453968e-7	19	272	177
Orphanet:171898	Lymphoid hemopathy	GO:2001235	positive regulation of apoptotic signaling pathway	6.770350946538883e-11	1.4932009012591507e-6	15	168	177
Orphanet:171898	Lymphoid hemopathy	GO:1903827	regulation of cellular protein localization	3.6574210326989487e-10	8.066442087617531e-6	24	543	177
Orphanet:171898	Lymphoid hemopathy	GO:0072594	establishment of protein localization to organelle	4.0150893720891645e-10	8.855279610142652e-6	26	641	177
Orphanet:171898	Lymphoid hemopathy	GO:1902532	negative regulation of intracellular signal transduction	7.197284990212438e-10	1.5873612045913532e-5	21	426	177
Orphanet:171898	Lymphoid hemopathy	GO:0090559	regulation of membrane permeability	9.52730672132418e-10	2.101247497388048e-5	10	69	177
Orphanet:171898	Lymphoid hemopathy	GO:1903829	positive regulation of cellular protein localization	1.0429574981429823e-9	2.3002427621543475e-5	19	351	177
Orphanet:171898	Lymphoid hemopathy	GO:0045088	regulation of innate immune response	1.0429574981429823e-9	2.3002427621543475e-5	19	351	177
Orphanet:171898	Lymphoid hemopathy	GO:0071345	cellular response to cytokine stimulus	1.2756736778030131e-9	2.8134982963945454e-5	26	677	177
Orphanet:171898	Lymphoid hemopathy	GO:0046824	positive regulation of nucleocytoplasmic transport	1.2924609160691602e-9	2.850522550390533e-5	12	118	177
Orphanet:171898	Lymphoid hemopathy	GO:0045862	positive regulation of proteolysis	1.3828630462953129e-9	3.0499044486043125e-5	19	357	177
Orphanet:171898	Lymphoid hemopathy	GO:0080135	regulation of cellular response to stress	1.4414361926284869e-9	3.179087522842128e-5	26	681	177
Orphanet:171898	Lymphoid hemopathy	GO:2000377	regulation of reactive oxygen species metabolic process	1.48112277997825e-9	3.2666162912420305e-5	13	147	177
Orphanet:171898	Lymphoid hemopathy	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.7677619368328124e-9	3.8987989516847676e-5	15	212	177
Orphanet:171898	Lymphoid hemopathy	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.0628229124852737e-9	4.549555933486271e-5	13	151	177
Orphanet:171898	Lymphoid hemopathy	GO:0072358	cardiovascular system development	2.172652169285527e-9	4.79178435935923e-5	30	910	177
Orphanet:171898	Lymphoid hemopathy	GO:0034599	cellular response to oxidative stress	2.76264788823255e-9	6.093019917496889e-5	15	219	177
Orphanet:171898	Lymphoid hemopathy	GO:0044419	interspecies interaction between organisms	3.2617029077641746e-9	7.193685763073887e-5	27	761	177
Orphanet:171898	Lymphoid hemopathy	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.2617029077641746e-9	7.193685763073887e-5	27	761	177
Orphanet:171898	Lymphoid hemopathy	GO:0042326	negative regulation of phosphorylation	3.3829612444691293e-9	7.461121024676665e-5	20	420	177
Orphanet:171898	Lymphoid hemopathy	GO:0043086	negative regulation of catalytic activity	3.9401598650457e-9	8.690022582358292e-5	28	822	177
Orphanet:183521	Rare genetic movement disorder	GO:0048878	chemical homeostasis	6.247224959565756e-12	1.3778254648322275e-7	37	988	178
Orphanet:183521	Rare genetic movement disorder	GO:0007270	neuron-neuron synaptic transmission	1.4455103780619538e-13	3.188073138815639e-9	19	130	178
Orphanet:183521	Rare genetic movement disorder	GO:0098793	presynapse	1.0088596624768797e-12	2.2250399855927583e-8	18	205	178
Orphanet:183521	Rare genetic movement disorder	GO:0071241	cellular response to inorganic substance	1.5843992784425609e-12	3.494392608605068e-8	16	156	178
Orphanet:183521	Rare genetic movement disorder	GO:0006836	neurotransmitter transport	1.855515741056024e-12	4.092339966899061e-8	17	183	178
Orphanet:183521	Rare genetic movement disorder	GO:0032940	secretion by cell	1.861732989993925e-12	4.1060521094316016e-8	39	956	178
Orphanet:183521	Rare genetic movement disorder	GO:0015844	monoamine transport	2.4804602816175247e-12	5.470655151107451e-8	12	70	178
Orphanet:183521	Rare genetic movement disorder	GO:0055080	cation homeostasis	2.488675931999751e-12	5.4887747680254506e-8	29	595	178
Orphanet:183521	Rare genetic movement disorder	GO:0034599	cellular response to oxidative stress	3.151812144608357e-12	6.951321684933731e-8	18	219	178
Orphanet:183521	Rare genetic movement disorder	GO:0030003	cellular cation homeostasis	3.3171243529750427e-12	7.315917760486457e-8	28	519	178
Orphanet:183521	Rare genetic movement disorder	GO:0044297	cell body	4.835909450662257e-12	1.0665598293435608e-7	27	494	178
Orphanet:183521	Rare genetic movement disorder	GO:0072521	purine-containing compound metabolic process	6.565636923028251e-12	1.4480512233738807e-7	27	568	178
Orphanet:183521	Rare genetic movement disorder	GO:0051937	catecholamine transport	6.643574579356937e-12	1.4652403734771724e-7	11	58	178
Orphanet:183521	Rare genetic movement disorder	GO:0036477	somatodendritic compartment	6.846634370560878e-12	1.5100252104272016e-7	32	649	178
Orphanet:183521	Rare genetic movement disorder	GO:0043005	neuron projection	7.350231534530849e-12	1.6210935649407787e-7	41	941	178
Orphanet:183521	Rare genetic movement disorder	GO:0006163	purine nucleotide metabolic process	8.392064820839096e-12	1.8508698962360626e-7	26	522	178
Orphanet:183521	Rare genetic movement disorder	GO:0090659	walking behavior	8.914535776227694e-12	1.966100865447018e-7	9	31	178
Orphanet:183521	Rare genetic movement disorder	GO:0007628	adult walking behavior	8.914535776227694e-12	1.966100865447018e-7	9	31	178
Orphanet:183521	Rare genetic movement disorder	GO:1901698	response to nitrogen compound	1.6530887769761193e-11	3.645887297620831e-7	33	870	178
Orphanet:183521	Rare genetic movement disorder	GO:0030424	axon	1.6647461187346835e-11	3.6715975648693444e-7	23	414	178
Orphanet:183521	Rare genetic movement disorder	GO:0031667	response to nutrient levels	1.700872775955986e-11	3.7512749073709273e-7	26	546	178
Orphanet:183521	Rare genetic movement disorder	GO:0009150	purine ribonucleotide metabolic process	1.857891618328722e-11	4.0975799642239963e-7	25	501	178
Orphanet:183521	Rare genetic movement disorder	GO:0070997	neuron death	2.3811064231438195e-11	5.251530216243694e-7	19	281	178
Orphanet:183521	Rare genetic movement disorder	GO:0010243	response to organonitrogen compound	2.5277113735455714e-11	5.574867434354758e-7	31	780	178
Orphanet:183521	Rare genetic movement disorder	GO:0009636	response to toxic substance	2.880007343719626e-11	6.351856196573635e-7	18	249	178
Orphanet:183521	Rare genetic movement disorder	GO:1901214	regulation of neuron death	3.1272096023826634e-11	6.897060778054964e-7	18	250	178
Orphanet:183521	Rare genetic movement disorder	GO:0007611	learning or memory	3.216771293779175e-11	7.09458908842997e-7	17	218	178
Orphanet:183521	Rare genetic movement disorder	GO:0043025	neuronal cell body	3.5249803076453645e-11	7.774344068511851e-7	23	434	178
Orphanet:183521	Rare genetic movement disorder	GO:0071248	cellular response to metal ion	4.734679315276935e-11	1.044233522984328e-6	14	136	178
Orphanet:183521	Rare genetic movement disorder	GO:1903530	regulation of secretion by cell	5.0784931815428536e-11	1.1200616711892764e-6	27	624	178
Orphanet:183521	Rare genetic movement disorder	GO:0030425	dendrite	6.41106057130969e-11	1.4139594090023522e-6	23	451	178
Orphanet:183521	Rare genetic movement disorder	GO:0098794	postsynapse	1.0601108879626508e-10	2.3380745634016264e-6	21	381	178
Orphanet:183521	Rare genetic movement disorder	GO:0071287	cellular response to manganese ion	1.4039858164949237e-10	3.0964907182795542e-6	6	10	178
Orphanet:183521	Rare genetic movement disorder	GO:0043068	positive regulation of programmed cell death	1.4660905822694303e-10	3.2334627791952286e-6	25	561	178
Orphanet:183521	Rare genetic movement disorder	GO:0098660	inorganic ion transmembrane transport	1.719642206410299e-10	3.7926708862379144e-6	27	660	178
Orphanet:183521	Rare genetic movement disorder	GO:0032880	regulation of protein localization	2.563171896952099e-10	5.653075618727854e-6	32	933	178
Orphanet:183521	Rare genetic movement disorder	GO:0031329	regulation of cellular catabolic process	2.565401224785546e-10	5.657992401264522e-6	26	624	178
Orphanet:183521	Rare genetic movement disorder	GO:0051588	regulation of neurotransmitter transport	3.9753766944983226e-10	8.76769329971605e-6	10	63	178
Orphanet:183521	Rare genetic movement disorder	GO:0030162	regulation of proteolysis	6.343000569231094e-10	1.3989487755439178e-5	27	701	178
Orphanet:183521	Rare genetic movement disorder	GO:0043065	positive regulation of apoptotic process	6.594522705682948e-10	1.4544219827383742e-5	24	556	178
Orphanet:183521	Rare genetic movement disorder	GO:0042391	regulation of membrane potential	6.734305335598378e-10	1.4852510417662224e-5	19	340	178
Orphanet:183521	Rare genetic movement disorder	GO:0046128	purine ribonucleoside metabolic process	7.433246240751146e-10	1.6394024583976652e-5	19	342	178
Orphanet:183521	Rare genetic movement disorder	GO:0015833	peptide transport	9.053572336270577e-10	1.9967653787644757e-5	18	307	178
Orphanet:183521	Rare genetic movement disorder	GO:0014070	response to organic cyclic compound	9.491746277845436e-10	2.093404641578811e-5	30	873	178
Orphanet:183521	Rare genetic movement disorder	GO:0097193	intrinsic apoptotic signaling pathway	1.0311288489717185e-9	2.2741546764071252e-5	17	272	178
Orphanet:183521	Rare genetic movement disorder	GO:0044463	cell projection part	1.2594628673312513e-9	2.777745353899075e-5	31	939	178
Orphanet:183521	Rare genetic movement disorder	GO:0051223	regulation of protein transport	1.519452119680409e-9	3.351151649955142e-5	27	730	178
Orphanet:183521	Rare genetic movement disorder	GO:0043269	regulation of ion transport	1.67986202725956e-9	3.7049357011209594e-5	24	583	178
Orphanet:183521	Rare genetic movement disorder	GO:0097480	establishment of synaptic vesicle localization	1.8949980473692563e-9	4.179418193472895e-5	11	96	178
Orphanet:183521	Rare genetic movement disorder	GO:0048489	synaptic vesicle transport	1.8949980473692563e-9	4.179418193472895e-5	11	96	178
Orphanet:183521	Rare genetic movement disorder	GO:0006820	anion transport	1.9889683233742517e-9	4.386669637201912e-5	24	588	178
Orphanet:183521	Rare genetic movement disorder	GO:0043066	negative regulation of apoptotic process	2.1596058275008545e-9	4.7630106525531346e-5	28	795	178
Orphanet:183521	Rare genetic movement disorder	GO:0000302	response to reactive oxygen species	2.4706802159712993e-9	5.4490852163247006e-5	15	216	178
Orphanet:183521	Rare genetic movement disorder	GO:0034976	response to endoplasmic reticulum stress	3.662098069234787e-9	8.076757291697323e-5	16	258	178
Orphanet:183521	Rare genetic movement disorder	GO:0072593	reactive oxygen species metabolic process	3.8247843781036295e-9	8.435561945907555e-5	15	223	178
Orphanet:183521	Rare genetic movement disorder	GO:0015837	amine transport	3.928996017421582e-9	8.6654007164233e-5	10	79	178
Orphanet:183521	Rare genetic movement disorder	GO:0043086	negative regulation of catalytic activity	4.482221926949137e-9	9.885540459886322e-5	28	822	178
Orphanet:183521	Rare genetic movement disorder	GO:0002020	protease binding	4.487349380966066e-9	9.896849059720658e-5	11	104	178
DOID:7148	rheumatoid arthritis	GO:0070663	regulation of leukocyte proliferation	4.474198789239381e-13	9.867845429667454e-9	29	200	178
DOID:7148	rheumatoid arthritis	GO:0050870	positive regulation of T cell activation	4.434230760352875e-13	9.779695941958266e-9	28	202	178
DOID:7148	rheumatoid arthritis	GO:0032944	regulation of mononuclear cell proliferation	3.927969061123804e-13	8.66313576430855e-9	27	191	178
DOID:7148	rheumatoid arthritis	GO:0050670	regulation of lymphocyte proliferation	2.2448709557920665e-13	4.951062892999403e-9	27	189	178
DOID:7148	rheumatoid arthritis	GO:0042129	regulation of T cell proliferation	1.723066134218243e-13	3.800222359018335e-9	20	142	178
DOID:7148	rheumatoid arthritis	GO:0032946	positive regulation of mononuclear cell proliferation	1.1057821325266559e-13	2.4388024932875396e-9	19	129	178
DOID:7148	rheumatoid arthritis	GO:0042327	positive regulation of phosphorylation	5.076050690888678e-12	1.119522979875498e-7	39	910	178
DOID:7148	rheumatoid arthritis	GO:0002443	leukocyte mediated immunity	2.2293278334473143e-11	4.916782536668052e-7	19	279	178
DOID:7148	rheumatoid arthritis	GO:0042832	defense response to protozoan	1.852175079974927e-10	4.0849721388847016e-6	7	18	178
DOID:7148	rheumatoid arthritis	GO:0009611	response to wounding	2.33127184223747e-10	5.14162004805474e-6	31	875	178
DOID:7148	rheumatoid arthritis	GO:0043065	positive regulation of apoptotic process	6.594522705682948e-10	1.4544219827383742e-5	24	556	178
DOID:7148	rheumatoid arthritis	GO:0002708	positive regulation of lymphocyte mediated immunity	7.463598628021373e-10	1.6460966774101138e-5	10	67	178
DOID:7148	rheumatoid arthritis	GO:0045582	positive regulation of T cell differentiation	7.463598628021373e-10	1.6460966774101138e-5	10	67	178
DOID:7148	rheumatoid arthritis	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	7.463598628021373e-10	1.6460966774101138e-5	10	67	178
DOID:7148	rheumatoid arthritis	GO:0043434	response to peptide hormone	1.0015887008663071e-9	2.2090038797606404e-5	20	389	178
DOID:7148	rheumatoid arthritis	GO:0071594	thymocyte aggregation	1.1646773545592737e-9	2.568695905480478e-5	10	70	178
DOID:7148	rheumatoid arthritis	GO:0033077	T cell differentiation in thymus	1.1646773545592737e-9	2.568695905480478e-5	10	70	178
DOID:7148	rheumatoid arthritis	GO:0031349	positive regulation of defense response	1.4878228649095604e-9	3.2813933285580354e-5	20	398	178
DOID:7148	rheumatoid arthritis	GO:0030595	leukocyte chemotaxis	1.592785126014462e-9	3.512887595424896e-5	14	177	178
DOID:7148	rheumatoid arthritis	GO:0070482	response to oxygen levels	1.84495396737816e-9	4.069045975052532e-5	18	321	178
DOID:7148	rheumatoid arthritis	GO:0046427	positive regulation of JAK-STAT cascade	2.6680959663849535e-9	5.884485653862015e-5	10	76	178
DOID:7148	rheumatoid arthritis	GO:0009615	response to virus	2.690262568272317e-9	5.933374094324595e-5	20	412	178
DOID:7148	rheumatoid arthritis	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	3.785655122712228e-9	8.349262373141819e-5	9	58	178
DOID:7148	rheumatoid arthritis	GO:0002690	positive regulation of leukocyte chemotaxis	4.45343040222923e-9	9.822040752116568e-5	10	80	178
DOID:7148	rheumatoid arthritis	GO:0097190	apoptotic signaling pathway	4.527829444711529e-9	9.986127840311276e-5	23	564	178
Orphanet:79363	Hair anomaly	GO:0042633	hair cycle	8.428813202954188e-13	1.8589747519115463e-8	14	101	179
Orphanet:79363	Hair anomaly	GO:0001568	blood vessel development	3.920441749016845e-11	8.646534277456652e-7	26	569	179
Orphanet:79363	Hair anomaly	GO:0030855	epithelial cell differentiation	2.106528285139575e-10	4.645948132875333e-6	25	568	179
Orphanet:79363	Hair anomaly	GO:0022405	hair cycle process	2.727783554590246e-10	6.016126629648788e-6	11	80	179
Orphanet:79363	Hair anomaly	GO:0001942	hair follicle development	2.727783554590246e-10	6.016126629648788e-6	11	80	179
Orphanet:79363	Hair anomaly	GO:0098609	cell-cell adhesion	9.307877801845166e-10	2.0528524491969513e-5	30	867	179
Orphanet:79363	Hair anomaly	GO:0009913	epidermal cell differentiation	1.5912527961958745e-9	3.509508042010001e-5	14	176	179
Orphanet:79363	Hair anomaly	GO:0048638	regulation of developmental growth	2.0548576173951005e-9	4.531988475164894e-5	17	283	179
Orphanet:79363	Hair anomaly	GO:0016337	single organismal cell-cell adhesion	2.9835940384970172e-9	6.580316651905171e-5	26	697	179
Orphanet:79363	Hair anomaly	GO:0035270	endocrine system development	4.11336931183115e-9	9.072036017243601e-5	12	129	179
Orphanet:79363	Hair anomaly	GO:0008284	positive regulation of cell proliferation	4.227678207513463e-9	9.324144286670943e-5	28	815	179
DOID:3211	lysosomal storage disease	GO:0008202	steroid metabolic process	5.03375119365046e-13	1.1101938257596089e-8	26	275	179
DOID:3211	lysosomal storage disease	GO:0019752	carboxylic acid metabolic process	2.0872192862952943e-14	4.6033621359242716e-10	38	967	179
DOID:3211	lysosomal storage disease	GO:0006790	sulfur compound metabolic process	2.834732448775412e-12	6.252002415774172e-8	23	360	179
DOID:3211	lysosomal storage disease	GO:0098852	lytic vacuole membrane	1.575439778633836e-11	3.474632431776925e-7	19	272	179
DOID:3211	lysosomal storage disease	GO:0005765	lysosomal membrane	1.575439778633836e-11	3.474632431776925e-7	19	272	179
DOID:3211	lysosomal storage disease	GO:0044723	single-organism carbohydrate metabolic process	2.3246771174711967e-10	5.127075382582724e-6	27	665	179
DOID:3211	lysosomal storage disease	GO:0098857	membrane microdomain	2.0548576173951005e-9	4.531988475164894e-5	17	283	179
DOID:3211	lysosomal storage disease	GO:0015929	hexosaminidase activity	3.3260842968729776e-9	7.335678916753352e-5	6	15	179
Orphanet:183651	Rare constitutional anemia	GO:0006766	vitamin metabolic process	2.349231920106831e-13	5.181230999795616e-9	16	128	181
Orphanet:183651	Rare constitutional anemia	GO:0042440	pigment metabolic process	2.9941160661905997e-11	6.603522983983368e-7	11	65	181
Orphanet:183651	Rare constitutional anemia	GO:0015669	gas transport	3.271281023842221e-10	7.214810298084018e-6	7	19	181
Orphanet:183651	Rare constitutional anemia	GO:0010035	response to inorganic substance	6.852184375460979e-10	1.511249264007919e-5	23	502	181
Orphanet:183651	Rare constitutional anemia	GO:0002262	myeloid cell homeostasis	1.368638535836908e-9	3.0185322907883005e-5	12	116	181
Orphanet:183651	Rare constitutional anemia	GO:0006778	porphyrin-containing compound metabolic process	1.6029713112430954e-9	3.535353226946647e-5	8	36	181
Orphanet:183651	Rare constitutional anemia	GO:0034101	erythrocyte homeostasis	2.825056188981989e-9	6.230661424799777e-5	11	98	181
DOID:417	hypersensitivity reaction type II disease	GO:0051241	negative regulation of multicellular organismal process	3.1254998589247407e-12	6.893289938858516e-8	42	966	182
DOID:417	hypersensitivity reaction type II disease	GO:0002696	positive regulation of leukocyte activation	2.178257574314557e-12	4.804147080150756e-8	30	280	182
DOID:417	hypersensitivity reaction type II disease	GO:0022409	positive regulation of cell-cell adhesion	1.624700374236454e-12	3.5832766753784995e-8	27	239	182
DOID:417	hypersensitivity reaction type II disease	GO:0030098	lymphocyte differentiation	1.5309975509580909e-12	3.3766150986380694e-8	23	299	182
DOID:417	hypersensitivity reaction type II disease	GO:1903706	regulation of hemopoiesis	1.382893799473095e-12	3.049972274737911e-8	23	305	182
DOID:417	hypersensitivity reaction type II disease	GO:1902105	regulation of leukocyte differentiation	9.272582701669307e-13	2.0450681148531658e-8	20	225	182
DOID:417	hypersensitivity reaction type II disease	GO:0002699	positive regulation of immune effector process	4.4786396813378815e-13	9.877639817190698e-9	17	150	182
DOID:417	hypersensitivity reaction type II disease	GO:0002449	lymphocyte mediated immunity	2.369215934550084e-13	5.22530574365021e-9	28	209	182
DOID:417	hypersensitivity reaction type II disease	GO:0007259	JAK-STAT cascade	1.4166445794216997e-13	3.1244096199145588e-9	21	170	182
DOID:417	hypersensitivity reaction type II disease	GO:0071219	cellular response to molecule of bacterial origin	1.4077627952246985e-13	3.1048208448680725e-9	19	158	182
DOID:417	hypersensitivity reaction type II disease	GO:0046425	regulation of JAK-STAT cascade	8.903988657493755e-14	1.9637746984102478e-9	19	143	182
DOID:417	hypersensitivity reaction type II disease	GO:0045619	regulation of lymphocyte differentiation	2.7533531010703882e-14	6.072520264410741e-10	16	130	182
DOID:417	hypersensitivity reaction type II disease	GO:0006959	humoral immune response	5.895284260759581e-14	1.3002049437105256e-9	19	173	182
DOID:417	hypersensitivity reaction type II disease	GO:0042113	B cell activation	9.325873406851315e-14	2.0568213798810575e-9	19	212	182
DOID:417	hypersensitivity reaction type II disease	GO:0002708	positive regulation of lymphocyte mediated immunity	1.1834977442504169e-13	2.6102042749442944e-9	13	67	182
DOID:417	hypersensitivity reaction type II disease	GO:0019724	B cell mediated immunity	1.2645440250480533e-13	2.7889518472434816e-9	18	100	182
DOID:417	hypersensitivity reaction type II disease	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.199351811782435e-13	4.850670420886161e-9	15	111	182
DOID:417	hypersensitivity reaction type II disease	GO:0030217	T cell differentiation	2.5790480862042386e-13	5.688090554123448e-9	18	199	182
DOID:417	hypersensitivity reaction type II disease	GO:0050729	positive regulation of inflammatory response	5.113687251423471e-13	1.1278237233014465e-8	15	114	182
DOID:417	hypersensitivity reaction type II disease	GO:0002637	regulation of immunoglobulin production	5.958566973163215e-13	1.3141619459311471e-8	11	46	182
DOID:417	hypersensitivity reaction type II disease	GO:0045621	positive regulation of lymphocyte differentiation	7.760458942129844e-13	1.711569219686737e-8	13	79	182
DOID:417	hypersensitivity reaction type II disease	GO:0032729	positive regulation of interferon-gamma production	1.5096812688852879e-12	3.3296020385265024e-8	12	65	182
DOID:417	hypersensitivity reaction type II disease	GO:0045428	regulation of nitric oxide biosynthetic process	1.8458568007417853e-12	4.0710371740360074e-8	11	51	182
DOID:417	hypersensitivity reaction type II disease	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1.965316798191452e-12	4.3345061984112476e-8	12	67	182
DOID:417	hypersensitivity reaction type II disease	GO:0098542	defense response to other organism	2.6317836798739336e-12	5.8043989059619605e-8	31	550	182
DOID:417	hypersensitivity reaction type II disease	GO:0009897	external side of plasma membrane	2.7464697183177122e-12	6.057338963749714e-8	18	212	182
DOID:417	hypersensitivity reaction type II disease	GO:0050900	leukocyte migration	6.2658767063794585e-12	1.3819391075919896e-7	22	354	182
DOID:417	hypersensitivity reaction type II disease	GO:0009615	response to virus	6.430966870141219e-12	1.418349743209646e-7	25	412	182
DOID:417	hypersensitivity reaction type II disease	GO:0002455	humoral immune response mediated by circulating immunoglobulin	8.89666118553123e-12	1.9621586244689126e-7	10	43	182
DOID:417	hypersensitivity reaction type II disease	GO:0051050	positive regulation of transport	1.2914669333952133e-11	2.848330321603143e-7	35	920	182
DOID:417	hypersensitivity reaction type II disease	GO:0048660	regulation of smooth muscle cell proliferation	1.5965229138714676e-11	3.521131286543522e-7	13	100	182
DOID:417	hypersensitivity reaction type II disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	2.7239321909178216e-11	6.007632447069255e-7	12	83	182
DOID:417	hypersensitivity reaction type II disease	GO:0034341	response to interferon-gamma	3.136357840105575e-11	6.917237216352845e-7	15	155	182
DOID:417	hypersensitivity reaction type II disease	GO:0045088	regulation of innate immune response	3.547806493031658e-11	7.824687220381321e-7	21	351	182
DOID:417	hypersensitivity reaction type II disease	GO:0031663	lipopolysaccharide-mediated signaling pathway	3.575451046344824e-11	7.88565728271351e-7	10	49	182
DOID:417	hypersensitivity reaction type II disease	GO:0001906	cell killing	3.791955638376976e-11	8.36315816044042e-7	13	107	182
DOID:417	hypersensitivity reaction type II disease	GO:0048514	blood vessel morphogenesis	6.902767246685926e-11	1.522405316256581e-6	24	484	182
DOID:417	hypersensitivity reaction type II disease	GO:0060548	negative regulation of cell death	8.114098282163695e-11	1.789564376131203e-6	32	867	182
DOID:417	hypersensitivity reaction type II disease	GO:0051607	defense response to virus	9.132461453731366e-11	2.014164373620453e-6	20	332	182
DOID:417	hypersensitivity reaction type II disease	GO:0031348	negative regulation of defense response	9.401013301157946e-11	2.073393483570385e-6	14	140	182
DOID:417	hypersensitivity reaction type II disease	GO:0001525	angiogenesis	1.141806649229693e-10	2.518254564876088e-6	22	413	182
DOID:417	hypersensitivity reaction type II disease	GO:0051093	negative regulation of developmental process	1.5717671608683759e-10	3.466532473295203e-6	30	788	182
DOID:417	hypersensitivity reaction type II disease	GO:0043900	regulation of multi-organism process	1.9118584493327262e-10	4.216603810003328e-6	23	467	182
DOID:417	hypersensitivity reaction type II disease	GO:0002685	regulation of leukocyte migration	2.1813761907907292e-10	4.811025188788953e-6	14	149	182
DOID:417	hypersensitivity reaction type II disease	GO:0002366	leukocyte activation involved in immune response	2.1820922846416124e-10	4.812604533777076e-6	16	208	182
DOID:417	hypersensitivity reaction type II disease	GO:0045765	regulation of angiogenesis	2.1820922846416124e-10	4.812604533777076e-6	16	208	182
DOID:417	hypersensitivity reaction type II disease	GO:0032102	negative regulation of response to external stimulus	2.199749271625251e-10	4.851547018569491e-6	18	275	182
DOID:417	hypersensitivity reaction type II disease	GO:0031960	response to corticosteroid	2.464358717091386e-10	5.435143150545052e-6	15	179	182
DOID:417	hypersensitivity reaction type II disease	GO:0042104	positive regulation of activated T cell proliferation	2.516519215234325e-10	5.550183129199304e-6	8	29	182
DOID:417	hypersensitivity reaction type II disease	GO:0043069	negative regulation of programmed cell death	2.5693636107604334e-10	5.666731443532136e-6	30	806	182
DOID:417	hypersensitivity reaction type II disease	GO:0002690	positive regulation of leukocyte chemotaxis	3.2582259112956535e-10	7.186017247362564e-6	11	80	182
DOID:417	hypersensitivity reaction type II disease	GO:1901698	response to nitrogen compound	3.567089956746372e-10	7.867216899604124e-6	31	870	182
DOID:417	hypersensitivity reaction type II disease	GO:0097191	extrinsic apoptotic signaling pathway	5.005195147234076e-10	1.1038957897224755e-5	16	220	182
DOID:417	hypersensitivity reaction type II disease	GO:1903035	negative regulation of response to wounding	5.192589691560556e-10	1.1452256564736807e-5	14	159	182
DOID:417	hypersensitivity reaction type II disease	GO:0007568	aging	5.211550080375105e-10	1.1494073702267293e-5	18	290	182
DOID:417	hypersensitivity reaction type II disease	GO:0042107	cytokine metabolic process	5.665156121992254e-10	1.2494501827053917e-5	12	107	182
DOID:417	hypersensitivity reaction type II disease	GO:0032846	positive regulation of homeostatic process	6.588302126075973e-10	1.453050033906056e-5	15	192	182
DOID:417	hypersensitivity reaction type II disease	GO:0050663	cytokine secretion	6.65134058941419e-10	1.4669531669952995e-5	14	162	182
DOID:417	hypersensitivity reaction type II disease	GO:0006958	complement activation, classical pathway	7.875722296546428e-10	1.7369905525033147e-5	8	33	182
DOID:417	hypersensitivity reaction type II disease	GO:0043066	negative regulation of apoptotic process	8.279654739595799e-10	1.8260778528178534e-5	29	795	182
DOID:417	hypersensitivity reaction type II disease	GO:0046634	regulation of alpha-beta T cell activation	9.27013243945396e-10	2.0445277095215708e-5	10	67	182
DOID:417	hypersensitivity reaction type II disease	GO:0032740	positive regulation of interleukin-17 production	1.280797801150868e-9	2.8247995504382395e-5	6	13	182
DOID:417	hypersensitivity reaction type II disease	GO:0050707	regulation of cytokine secretion	1.35891020658363e-9	2.997076460620196e-5	13	142	182
DOID:417	hypersensitivity reaction type II disease	GO:0006909	phagocytosis	1.529699700242304e-9	3.3737526888844016e-5	15	204	182
DOID:417	hypersensitivity reaction type II disease	GO:0002285	lymphocyte activation involved in immune response	1.9160195652290213e-9	4.2257811511126064e-5	13	146	182
DOID:417	hypersensitivity reaction type II disease	GO:0070482	response to oxygen levels	2.6395251540023423e-9	5.821472727152166e-5	18	321	182
DOID:417	hypersensitivity reaction type II disease	GO:0043901	negative regulation of multi-organism process	2.671610044302497e-9	5.892235952709157e-5	13	150	182
DOID:417	hypersensitivity reaction type II disease	GO:0008285	negative regulation of cell proliferation	2.8735122059586615e-9	6.337531170241828e-5	25	634	182
DOID:417	hypersensitivity reaction type II disease	GO:0050728	negative regulation of inflammatory response	3.7210109438134964e-9	8.206689636580666e-5	11	100	182
DOID:417	hypersensitivity reaction type II disease	GO:0031295	T cell costimulation	3.769942691356221e-9	8.314608605786145e-5	10	77	182
DOID:417	hypersensitivity reaction type II disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	4.116573193435613e-9	9.079102178122245e-5	8	40	182
DOID:417	hypersensitivity reaction type II disease	GO:0002891	positive regulation of immunoglobulin mediated immune response	4.190388813718471e-9	9.241902528656087e-5	7	26	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0043627	response to estrogen	6.992184609089236e-13	1.542126315534631e-8	19	217	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0035239	tube morphogenesis	1.5393242236427795e-12	3.39497957524415e-8	22	338	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0000165	MAPK cascade	2.0786705690056806e-12	4.5845079399420285e-8	36	843	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0051347	positive regulation of transferase activity	3.6518565948995274e-12	8.054169720050908e-8	32	613	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0033674	positive regulation of kinase activity	5.534572800058868e-12	1.2206500310529833e-7	27	480	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0048598	embryonic morphogenesis	6.163514143509019e-12	1.3593630443509142e-7	28	560	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0048732	gland development	7.927214440428543e-12	1.748347144836515e-7	25	421	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0090130	tissue migration	8.050782263069323e-12	1.775600028119939e-7	18	227	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0045860	positive regulation of protein kinase activity	8.177680754783978e-12	1.8035874904676064e-7	25	450	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0036293	response to decreased oxygen levels	1.4640288981127014e-11	3.228915734787563e-7	20	302	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0001501	skeletal system development	1.572086905099468e-11	3.4672376691968765e-7	25	482	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0014065	phosphatidylinositol 3-kinase signaling	2.876832105869198e-11	6.344853209494516e-7	15	154	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0043009	chordate embryonic development	3.1284863588609824e-11	6.899876664467897e-7	26	552	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0002009	morphogenesis of an epithelium	3.297273565294745e-11	7.27213684825756e-7	25	506	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0010631	epithelial cell migration	4.616917959054945e-11	1.018261255869568e-6	17	218	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:1901699	cellular response to nitrogen compound	4.826572475025159e-11	1.0645005593667989e-6	25	518	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0001666	response to hypoxia	7.506528731937578e-11	1.655564911828833e-6	19	292	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	7.765865728259769e-11	1.712761686367692e-6	14	138	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0019901	protein kinase binding	7.950495817254932e-11	1.7534818524955753e-6	25	532	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0060562	epithelial tube morphogenesis	1.2388912118410644e-10	2.7323745677154676e-6	19	301	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0050769	positive regulation of neurogenesis	1.2532164195278028e-10	2.763968813268569e-6	21	376	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0001655	urogenital system development	2.4555046884700005e-10	5.415615590420586e-6	19	313	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0030855	epithelial cell differentiation	3.0179059251622675e-10	6.655991517945381e-6	25	568	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0022603	regulation of anatomical structure morphogenesis	4.219385951742538e-10	9.305855716568168e-6	33	986	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0032147	activation of protein kinase activity	4.65290361795212e-10	1.02619789293934e-5	18	288	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0040007	growth	4.930755803655984e-10	1.0874781924963273e-5	32	936	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0051302	regulation of cell division	6.161546828309383e-10	1.3589291529836345e-5	18	293	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0042692	muscle cell differentiation	7.301188542641057e-10	1.610277133079485e-5	19	334	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0051241	negative regulation of multicellular organismal process	1.0622639434743064e-9	2.3428231273325828e-5	32	966	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0048589	developmental growth	1.1185252724033035e-9	2.4669074882854858e-5	24	558	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	1.3413831156938727e-9	2.9584204616628362e-5	11	91	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0032870	cellular response to hormone stimulus	1.4458080288548558e-9	3.1887296076393845e-5	23	519	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0010810	regulation of cell-substrate adhesion	1.4635457290523846e-9	3.227850105425034e-5	14	172	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0045165	cell fate commitment	2.13489548261947e-9	4.708511986917241e-5	16	243	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0030900	forebrain development	2.2144833744519588e-9	4.884043082353795e-5	19	357	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2.42822018048372e-9	5.3554396080568445e-5	19	359	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0043542	endothelial cell migration	2.898917439431159e-9	6.393562412665421e-5	13	151	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0014706	striated muscle tissue development	2.9109392674087076e-9	6.420076554269905e-5	18	323	182
MESH:D018204	Neoplasms, Connective and Soft Tissue	GO:0007611	learning or memory	3.808144244388245e-9	8.398862130998275e-5	15	218	182
Orphanet:155832	Rare head and neck malformation	GO:0022603	regulation of anatomical structure morphogenesis	8.128608897095546e-12	1.7927646922544227e-7	39	986	183
Orphanet:155832	Rare head and neck malformation	GO:0043010	camera-type eye development	2.419842104472991e-12	5.336961761415182e-8	21	283	183
Orphanet:155832	Rare head and neck malformation	GO:0061448	connective tissue development	1.5925039065223245e-12	3.512267365834987e-8	22	233	183
Orphanet:155832	Rare head and neck malformation	GO:0003007	heart morphogenesis	1.0826894936144527e-12	2.3878716781666753e-8	19	216	183
Orphanet:155832	Rare head and neck malformation	GO:0051302	regulation of cell division	4.864997293907436e-13	1.072975153171285e-8	24	293	183
Orphanet:155832	Rare head and neck malformation	GO:0001763	morphogenesis of a branching structure	4.4564352208453784e-13	9.828667879574482e-9	27	193	183
Orphanet:155832	Rare head and neck malformation	GO:0072089	stem cell proliferation	4.3010039973978564e-13	9.485864316260972e-9	17	139	183
Orphanet:155832	Rare head and neck malformation	GO:0072073	kidney epithelium development	4.0034642267983145e-13	8.829640352203683e-9	17	137	183
Orphanet:155832	Rare head and neck malformation	GO:0072009	nephron epithelium development	9.9253938401489e-14	2.1890456114448398e-9	15	106	183
Orphanet:155832	Rare head and neck malformation	GO:0061326	renal tubule development	8.43769498715119e-14	1.8609336294161949e-9	15	93	183
Orphanet:155832	Rare head and neck malformation	GO:0035116	embryonic hindlimb morphogenesis	8.304468224196171e-14	1.8315504668464655e-9	11	29	183
Orphanet:155832	Rare head and neck malformation	GO:0061333	renal tubule morphogenesis	4.596323321948148e-14	1.013719108655664e-9	14	77	183
Orphanet:155832	Rare head and neck malformation	GO:0072028	nephron morphogenesis	4.596323321948148e-14	1.013719108655664e-9	14	77	183
Orphanet:155832	Rare head and neck malformation	GO:0030323	respiratory tube development	2.7755575615628914e-15	6.121492202026957e-11	18	179	183
Orphanet:155832	Rare head and neck malformation	GO:0072080	nephron tubule development	3.4861002973229915e-14	7.688594205745858e-10	15	91	183
Orphanet:155832	Rare head and neck malformation	GO:0060675	ureteric bud morphogenesis	8.670841822322473e-14	1.9123541639132213e-9	14	64	183
Orphanet:155832	Rare head and neck malformation	GO:0048701	embryonic cranial skeleton morphogenesis	9.203748874142548e-14	2.029886814192139e-9	12	46	183
Orphanet:155832	Rare head and neck malformation	GO:0042733	embryonic digit morphogenesis	1.2223555501122974e-13	2.695905165772672e-9	13	60	183
Orphanet:155832	Rare head and neck malformation	GO:0001656	metanephros development	1.34781075189494e-13	2.9725966133042903e-9	14	88	183
Orphanet:155832	Rare head and neck malformation	GO:0001568	blood vessel development	3.455014052633487e-13	7.620033493083156e-9	31	569	183
Orphanet:155832	Rare head and neck malformation	GO:0060537	muscle tissue development	6.729061752253074e-13	1.4840945694594154e-8	22	336	183
Orphanet:155832	Rare head and neck malformation	GO:0008589	regulation of smoothened signaling pathway	1.006528194125167e-12	2.2198979321430556e-8	12	62	183
Orphanet:155832	Rare head and neck malformation	GO:0030855	epithelial cell differentiation	2.9622970743048427e-12	6.53334619737933e-8	28	568	183
Orphanet:155832	Rare head and neck malformation	GO:0072091	regulation of stem cell proliferation	3.152700323028057e-12	6.95328056243838e-8	13	88	183
Orphanet:155832	Rare head and neck malformation	GO:0048514	blood vessel morphogenesis	7.826850279002429e-12	1.7262118290339856e-7	26	484	183
Orphanet:155832	Rare head and neck malformation	GO:0060602	branch elongation of an epithelium	8.324563260941886e-12	1.835982427200733e-7	8	20	183
Orphanet:155832	Rare head and neck malformation	GO:0043069	negative regulation of programmed cell death	1.2097878254735406e-11	2.668187049081894e-7	33	806	183
Orphanet:155832	Rare head and neck malformation	GO:0032990	cell part morphogenesis	1.4815482174412864e-11	3.267554593566757e-7	33	787	183
Orphanet:155832	Rare head and neck malformation	GO:0043066	negative regulation of apoptotic process	1.5469625580522006e-11	3.4118259217841285e-7	33	795	183
Orphanet:155832	Rare head and neck malformation	GO:0048858	cell projection morphogenesis	1.6151968651456627e-11	3.562316686078759e-7	33	767	183
Orphanet:155832	Rare head and neck malformation	GO:0048864	stem cell development	1.78127512739934e-11	3.928602293479244e-7	16	175	183
Orphanet:155832	Rare head and neck malformation	GO:0048566	embryonic digestive tract development	2.142019894790792e-11	4.724224877961092e-7	9	33	183
Orphanet:155832	Rare head and neck malformation	GO:0021915	neural tube development	2.3189117293043182e-11	5.114359818980674e-7	15	151	183
Orphanet:155832	Rare head and neck malformation	GO:0007420	brain development	2.6868618441255876e-11	5.925873797218983e-7	29	669	183
Orphanet:155832	Rare head and neck malformation	GO:0001667	ameboidal-type cell migration	4.014255594597671e-11	8.853440713885163e-7	20	315	183
Orphanet:155832	Rare head and neck malformation	GO:0031214	biomineral tissue development	4.1158187968903803e-11	9.077438356541734e-7	14	131	183
Orphanet:155832	Rare head and neck malformation	GO:0014706	striated muscle tissue development	6.240474803576035e-11	1.3763367179286945e-6	20	323	183
Orphanet:155832	Rare head and neck malformation	GO:0042060	wound healing	9.746115026132429e-11	2.1495056690135073e-6	25	534	183
Orphanet:155832	Rare head and neck malformation	GO:0014031	mesenchymal cell development	1.3947254462465253e-10	3.0760669716967115e-6	15	171	183
Orphanet:155832	Rare head and neck malformation	GO:0009799	specification of symmetry	2.1776680458884812e-10	4.802846875207045e-6	13	122	183
Orphanet:155832	Rare head and neck malformation	GO:0048645	organ formation	2.6515833972950986e-10	5.84806718273434e-6	10	59	183
Orphanet:155832	Rare head and neck malformation	GO:0016202	regulation of striated muscle tissue development	2.714982683116318e-10	5.98789430761304e-6	12	100	183
Orphanet:155832	Rare head and neck malformation	GO:0030282	bone mineralization	2.714982683116318e-10	5.98789430761304e-6	12	100	183
Orphanet:155832	Rare head and neck malformation	GO:0000904	cell morphogenesis involved in differentiation	4.629276961765072e-10	1.0209870339172866e-5	28	720	183
Orphanet:155832	Rare head and neck malformation	GO:0060606	tube closure	5.189698670804432e-10	1.1445880418459176e-5	11	83	183
Orphanet:155832	Rare head and neck malformation	GO:0007368	determination of left/right symmetry	1.0310541309621613e-9	2.2739898858370466e-5	12	112	183
Orphanet:155832	Rare head and neck malformation	GO:0031012	extracellular matrix	1.1719752945893447e-9	2.5847915122167997e-5	21	423	183
Orphanet:155832	Rare head and neck malformation	GO:0010927	cellular component assembly involved in morphogenesis	1.4147650828633118e-9	3.120264390255034e-5	17	270	183
Orphanet:155832	Rare head and neck malformation	GO:0014855	striated muscle cell proliferation	1.462880705460634e-9	3.2263833958934285e-5	9	51	183
Orphanet:155832	Rare head and neck malformation	GO:0007548	sex differentiation	1.7686486719625805e-9	3.900754646013471e-5	17	274	183
Orphanet:155832	Rare head and neck malformation	GO:0060688	regulation of morphogenesis of a branching structure	2.09527306616053e-9	4.621124747417049e-5	9	53	183
Orphanet:155832	Rare head and neck malformation	GO:0030900	forebrain development	2.4280647492602725e-9	5.355096804493531e-5	19	357	183
Orphanet:155832	Rare head and neck malformation	GO:0051093	negative regulation of developmental process	3.3613745120675276e-9	7.413511486364932e-5	28	788	183
Orphanet:155832	Rare head and neck malformation	GO:0009880	embryonic pattern specification	4.113019147489183e-9	9.071263729787393e-5	9	57	183
Orphanet:155832	Rare head and neck malformation	GO:0051960	regulation of nervous system development	4.234096850908031e-9	9.338300604677663e-5	27	744	183
Orphanet:155832	Rare head and neck malformation	GO:0030878	thyroid gland development	4.353159499537185e-9	9.600893276229261e-5	7	26	183
DOID:1712	aortic valve stenosis	GO:0009161	ribonucleoside monophosphate metabolic process	1.6895373988745632e-12	3.726274733217849e-8	22	279	183
DOID:1712	aortic valve stenosis	GO:0006119	oxidative phosphorylation	4.907185768843192e-14	1.082279821318366e-9	16	110	183
DOID:1712	aortic valve stenosis	GO:0019900	kinase binding	3.5752956151213766e-11	7.885314479150196e-7	27	598	183
DOID:1712	aortic valve stenosis	GO:0050673	epithelial cell proliferation	8.43150438356588e-10	1.8595682917954548e-5	19	335	183
DOID:1712	aortic valve stenosis	GO:0051146	striated muscle cell differentiation	1.0391751903426893e-9	2.2919008823008014e-5	16	230	183
DOID:1712	aortic valve stenosis	GO:0042391	regulation of membrane potential	1.0802382321983828e-9	2.3824654211135332e-5	19	340	183
DOID:1712	aortic valve stenosis	GO:0009725	response to hormone	1.5168305500523616e-9	3.3453697781404834e-5	30	865	183
DOID:1712	aortic valve stenosis	GO:0048878	chemical homeostasis	2.125667641905693e-9	4.688159984223006e-5	32	988	183
DOID:1712	aortic valve stenosis	GO:0055006	cardiac cell development	2.956263012166005e-9	6.520038073332124e-5	9	55	183
DOID:1712	aortic valve stenosis	GO:0048545	response to steroid hormone	3.0004461137878025e-9	6.617483903958998e-5	21	446	183
DOID:574	peripheral nervous system disease	GO:0048666	neuron development	3.772004930624462e-11	8.319156874492251e-7	34	926	184
DOID:574	peripheral nervous system disease	GO:0005768	endosome	2.071782745360906e-10	4.5693168448934784e-6	30	789	184
DOID:574	peripheral nervous system disease	GO:0060284	regulation of cell development	6.226799076358702e-10	1.3733205362909118e-5	30	828	184
DOID:574	peripheral nervous system disease	GO:0051960	regulation of nervous system development	1.077534728111118e-9	2.376502842849071e-5	28	744	184
DOID:574	peripheral nervous system disease	GO:0007422	peripheral nervous system development	1.6079225728660163e-9	3.546273234455999e-5	10	70	184
Orphanet:98724	Congenital great vessels anomaly	GO:0009141	nucleoside triphosphate metabolic process	1.6118217871508023e-12	3.5548729515610944e-8	22	274	185
Orphanet:98724	Congenital great vessels anomaly	GO:0016459	myosin complex	9.326871497350453e-10	2.0570415087406424e-5	10	66	185
DOID:0050736	autosomal dominant disease	GO:0022603	regulation of anatomical structure morphogenesis	9.522160837605043e-12	2.1001125727337921e-7	43	986	187
DOID:0050736	autosomal dominant disease	GO:0051241	negative regulation of multicellular organismal process	3.7212455339386e-12	8.207207025101582e-8	37	966	187
DOID:0050736	autosomal dominant disease	GO:0043010	camera-type eye development	2.367883666920534e-12	5.2223674273932374e-8	23	283	187
DOID:0050736	autosomal dominant disease	GO:0048562	embryonic organ morphogenesis	2.2715163083830703e-12	5.0098292181388615e-8	29	280	187
DOID:0050736	autosomal dominant disease	GO:0060562	epithelial tube morphogenesis	1.965982932006227e-12	4.335975356539734e-8	31	301	187
DOID:0050736	autosomal dominant disease	GO:0050678	regulation of epithelial cell proliferation	1.8758328224066645e-12	4.1371492898178985e-8	30	277	187
DOID:0050736	autosomal dominant disease	GO:0008544	epidermis development	1.6431300764452317e-12	3.6239233835999585e-8	26	296	187
DOID:0050736	autosomal dominant disease	GO:0051170	nuclear import	1.5565326805244695e-12	3.4329328268967174e-8	23	287	187
DOID:0050736	autosomal dominant disease	GO:0061448	connective tissue development	1.5165646516379638e-12	3.344783339187529e-8	24	233	187
DOID:0050736	autosomal dominant disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.4015455462867976e-12	3.091108702335532e-8	51	996	187
DOID:0050736	autosomal dominant disease	GO:0003007	heart morphogenesis	1.2376766278521245e-12	2.7296958027278606e-8	25	216	187
DOID:0050736	autosomal dominant disease	GO:0090130	tissue migration	1.163069640597314e-12	2.565150092337376e-8	20	227	187
DOID:0050736	autosomal dominant disease	GO:0051052	regulation of DNA metabolic process	1.0813572259849025e-12	2.3849333619097024e-8	24	335	187
DOID:0050736	autosomal dominant disease	GO:0060537	muscle tissue development	1.0089706847793423e-12	2.2252848452808394e-8	26	336	187
DOID:0050736	autosomal dominant disease	GO:0007568	aging	1.0025313912365164e-12	2.2110829833721368e-8	27	290	187
DOID:0050736	autosomal dominant disease	GO:0010631	epithelial cell migration	8.417710972707937e-13	1.8565261550307355e-8	20	218	187
DOID:0050736	autosomal dominant disease	GO:0034504	protein localization to nucleus	7.831513215705854e-13	1.727240239723926e-8	27	344	187
DOID:0050736	autosomal dominant disease	GO:0090596	sensory organ morphogenesis	7.400746682151293e-13	1.6322346807484678e-8	20	239	187
DOID:0050736	autosomal dominant disease	GO:0043588	skin development	6.263878304935133e-13	1.3814983601534436e-8	21	241	187
DOID:0050736	autosomal dominant disease	GO:0048762	mesenchymal cell differentiation	6.121769757783113e-13	1.3501563200790656e-8	21	184	187
DOID:0050736	autosomal dominant disease	GO:0043583	ear development	6.021849685566849e-13	1.3281189481517686e-8	20	196	187
DOID:0050736	autosomal dominant disease	GO:0007050	cell cycle arrest	5.935252289646087e-13	1.3090198924814445e-8	24	242	187
DOID:0050736	autosomal dominant disease	GO:0001568	blood vessel development	5.309086503757499e-13	1.1709190284037163e-8	30	569	187
DOID:0050736	autosomal dominant disease	GO:0060541	respiratory system development	5.224709553885987e-13	1.1523096921095544e-8	21	202	187
DOID:0050736	autosomal dominant disease	GO:0001763	morphogenesis of a branching structure	5.084821452783217e-13	1.1214573714113385e-8	26	193	187
DOID:0050736	autosomal dominant disease	GO:1900180	regulation of protein localization to nucleus	4.4164671919588727e-13	9.740518391865294e-9	21	213	187
DOID:0050736	autosomal dominant disease	GO:0032386	regulation of intracellular transport	4.32542890393961e-13	9.53973344763881e-9	29	575	187
DOID:0050736	autosomal dominant disease	GO:0051216	cartilage development	4.189981694935341e-13	9.241004628179894e-9	21	180	187
DOID:0050736	autosomal dominant disease	GO:0072073	kidney epithelium development	4.1233683134578314e-13	9.094088815331247e-9	18	137	187
DOID:0050736	autosomal dominant disease	GO:0035270	endocrine system development	3.885780586188048e-13	8.57008908283774e-9	19	129	187
DOID:0050736	autosomal dominant disease	GO:0001649	osteoblast differentiation	3.8036240823657863e-13	8.388892913657742e-9	20	206	187
DOID:0050736	autosomal dominant disease	GO:0048705	skeletal system morphogenesis	3.113065361048939e-13	6.865865653793435e-9	19	204	187
DOID:0050736	autosomal dominant disease	GO:0055123	digestive system development	1.6719958750854857e-13	3.687586902501039e-9	20	150	187
DOID:0050736	autosomal dominant disease	GO:0061138	morphogenesis of a branching epithelium	1.5654144647214707e-13	3.4525216019432037e-9	26	179	187
DOID:0050736	autosomal dominant disease	GO:0048754	branching morphogenesis of an epithelial tube	1.1679546219056647e-13	2.5759239186129435e-9	23	147	187
DOID:0050736	autosomal dominant disease	GO:0035113	embryonic appendage morphogenesis	8.104628079763643e-14	1.7874757229918714e-9	20	125	187
DOID:0050736	autosomal dominant disease	GO:0030326	embryonic limb morphogenesis	8.104628079763643e-14	1.7874757229918714e-9	20	125	187
DOID:0050736	autosomal dominant disease	GO:0046822	regulation of nucleocytoplasmic transport	6.217248937900877e-14	1.3712142532540383e-9	19	215	187
DOID:0050736	autosomal dominant disease	GO:0048645	organ formation	5.417888360170764e-14	1.194915277835662e-9	15	59	187
DOID:0050736	autosomal dominant disease	GO:0001657	ureteric bud development	2.375877272697835e-14	5.239997324935075e-10	16	97	187
DOID:0050736	autosomal dominant disease	GO:0001656	metanephros development	2.4313884239290928e-14	5.362427168975614e-10	14	88	187
DOID:0050736	autosomal dominant disease	GO:0043523	regulation of neuron apoptotic process	9.936496070395151e-14	2.1914942083256506e-9	18	190	187
DOID:0050736	autosomal dominant disease	GO:0048565	digestive tract development	1.000310945187266e-13	2.2061857896105153e-9	19	138	187
DOID:0050736	autosomal dominant disease	GO:0048864	stem cell development	1.0313971898767704e-13	2.274746502273217e-9	20	175	187
DOID:0050736	autosomal dominant disease	GO:0050679	positive regulation of epithelial cell proliferation	1.2878587085651816e-13	2.840372381740508e-9	17	155	187
DOID:0050736	autosomal dominant disease	GO:0009913	epidermal cell differentiation	1.588729148238599e-13	3.50394213644023e-9	18	176	187
DOID:0050736	autosomal dominant disease	GO:0006606	protein import into nucleus	1.6853185513809876e-13	3.7169700650707682e-9	23	268	187
DOID:0050736	autosomal dominant disease	GO:0048839	inner ear development	2.2248869413488137e-13	4.906988149144809e-9	18	170	187
DOID:0050736	autosomal dominant disease	GO:0001701	in utero embryonic development	3.326228181776969e-13	7.335996254909105e-9	26	312	187
DOID:0050736	autosomal dominant disease	GO:0042063	gliogenesis	4.247713292215849e-13	9.368331665982055e-9	19	228	187
DOID:0050736	autosomal dominant disease	GO:0002062	chondrocyte differentiation	5.127009927718973e-13	1.1307620395584195e-8	14	95	187
DOID:0050736	autosomal dominant disease	GO:0014706	striated muscle tissue development	5.173639294753229e-13	1.1410461464578248e-8	23	323	187
DOID:0050736	autosomal dominant disease	GO:0003002	regionalization	9.648948307017235e-13	2.1280755491126513e-8	22	327	187
DOID:0050736	autosomal dominant disease	GO:0042476	odontogenesis	9.733325256888747e-13	2.1466848854068132e-8	15	114	187
DOID:0050736	autosomal dominant disease	GO:0071363	cellular response to growth factor stimulus	9.905409825705647e-13	2.1846381370593804e-8	33	594	187
DOID:0050736	autosomal dominant disease	GO:0016331	morphogenesis of embryonic epithelium	1.048938713665848e-12	2.3134343329900275e-8	16	141	187
DOID:0050736	autosomal dominant disease	GO:0022612	gland morphogenesis	1.0684786388992507e-12	2.3565296380922973e-8	15	119	187
DOID:0050736	autosomal dominant disease	GO:0097190	apoptotic signaling pathway	1.1889378370710801e-12	2.6222023996602672e-8	35	564	187
DOID:0050736	autosomal dominant disease	GO:0048706	embryonic skeletal system development	1.3531398224131408e-12	2.984349878332182e-8	15	122	187
DOID:0050736	autosomal dominant disease	GO:0007224	smoothened signaling pathway	1.4303003226245892e-12	3.1545273615485314e-8	15	117	187
DOID:0050736	autosomal dominant disease	GO:0042633	hair cycle	1.4810375148499588e-12	3.266428239001584e-8	14	101	187
DOID:0050736	autosomal dominant disease	GO:0036293	response to decreased oxygen levels	1.5893952820533741e-12	3.5054112945687166e-8	21	302	187
DOID:0050736	autosomal dominant disease	GO:0010942	positive regulation of cell death	2.0090595853616833e-12	4.4309809155151925e-8	30	596	187
DOID:0050736	autosomal dominant disease	GO:0051302	regulation of cell division	2.0967672043070706e-12	4.624420069099244e-8	21	293	187
DOID:0050736	autosomal dominant disease	GO:0030324	lung development	2.224331829836501e-12	4.905763850704403e-8	17	175	187
DOID:0050736	autosomal dominant disease	GO:0010001	glial cell differentiation	2.2978285940666865e-12	5.067860964214077e-8	17	176	187
DOID:0050736	autosomal dominant disease	GO:0021915	neural tube development	2.4481527916009327e-12	5.399400981875857e-8	16	151	187
DOID:0050736	autosomal dominant disease	GO:0007167	enzyme linked receptor protein signaling pathway	2.701838752727781e-12	5.958905369141121e-8	41	935	187
DOID:0050736	autosomal dominant disease	GO:0007548	sex differentiation	2.9685143232427436e-12	6.547058339911871e-8	20	274	187
DOID:0050736	autosomal dominant disease	GO:0050954	sensory perception of mechanical stimulus	3.1301627956281664e-12	6.903574045757921e-8	16	153	187
DOID:0050736	autosomal dominant disease	GO:0040007	growth	3.1622482410398334e-12	6.974338495613353e-8	46	936	187
DOID:0050736	autosomal dominant disease	GO:0045787	positive regulation of cell cycle	3.735900477863652e-12	8.239528503928284e-8	21	308	187
DOID:0050736	autosomal dominant disease	GO:0010564	regulation of cell cycle process	3.834488282450366e-12	8.456963906944281e-8	31	561	187
DOID:0050736	autosomal dominant disease	GO:0048589	developmental growth	3.920197499951428e-12	8.645995586142874e-8	34	558	187
DOID:0050736	autosomal dominant disease	GO:0072091	regulation of stem cell proliferation	3.995026531811163e-12	8.81103101590952e-8	13	88	187
DOID:0050736	autosomal dominant disease	GO:0045165	cell fate commitment	4.258926544764563e-12	9.393062494478244e-8	19	243	187
DOID:0050736	autosomal dominant disease	GO:0030155	regulation of cell adhesion	4.5884407384733095e-12	1.0119806048702884e-7	32	621	187
DOID:0050736	autosomal dominant disease	GO:2001233	regulation of apoptotic signaling pathway	4.5951020766210604e-12	1.0134497629987749e-7	23	359	187
DOID:0050736	autosomal dominant disease	GO:0008285	negative regulation of cell proliferation	5.348943510341542e-12	1.179709491205827e-7	43	634	187
DOID:0050736	autosomal dominant disease	GO:0000165	MAPK cascade	5.351163956390792e-12	1.1801992105819892e-7	34	843	187
DOID:0050736	autosomal dominant disease	GO:0007346	regulation of mitotic cell cycle	5.458633545174507e-12	1.2039016283882376e-7	27	453	187
DOID:0050736	autosomal dominant disease	GO:0048608	reproductive structure development	5.854983164965688e-12	1.2913165370331825e-7	30	418	187
DOID:0050736	autosomal dominant disease	GO:0040008	regulation of growth	5.969336136502079e-12	1.3165370849055336e-7	32	617	187
DOID:0050736	autosomal dominant disease	GO:0046332	SMAD binding	6.311173805784165e-12	1.3919293828656976e-7	12	72	187
DOID:0050736	autosomal dominant disease	GO:0009314	response to radiation	6.435296739937257e-12	1.419304695993162e-7	27	431	187
DOID:0050736	autosomal dominant disease	GO:0060284	regulation of cell development	6.654454764998263e-12	1.467639998420367e-7	36	828	187
DOID:0050736	autosomal dominant disease	GO:0019901	protein kinase binding	6.873168700849419e-12	1.5158773569723394e-7	27	532	187
DOID:0050736	autosomal dominant disease	GO:0042327	positive regulation of phosphorylation	7.01971814009994e-12	1.5481988357990417e-7	46	910	187
DOID:0050736	autosomal dominant disease	GO:0043408	regulation of MAPK cascade	7.115419364822628e-12	1.5693057409116307e-7	33	651	187
DOID:0050736	autosomal dominant disease	GO:0042471	ear morphogenesis	7.142064717413632e-12	1.5751823734255765e-7	14	112	187
DOID:0050736	autosomal dominant disease	GO:0033674	positive regulation of kinase activity	7.225442466562981e-12	1.5935713360004655e-7	26	480	187
DOID:0050736	autosomal dominant disease	GO:2000145	regulation of cell motility	7.732370299606828e-12	1.7053742695782859e-7	39	709	187
DOID:0050736	autosomal dominant disease	GO:0060322	head development	7.850164962519557e-12	1.7313538824836883e-7	34	708	187
DOID:0050736	autosomal dominant disease	GO:0045859	regulation of protein kinase activity	7.868705687030797e-12	1.7354430392746423e-7	33	709	187
DOID:0050736	autosomal dominant disease	GO:0097191	extrinsic apoptotic signaling pathway	8.185119249048967e-12	1.8052280503777496e-7	18	220	187
DOID:0050736	autosomal dominant disease	GO:0043069	negative regulation of programmed cell death	8.55115978026788e-12	1.885958289538081e-7	49	806	187
DOID:0050736	autosomal dominant disease	GO:0030334	regulation of cell migration	8.657852212934358e-12	1.9094893055626727e-7	36	660	187
DOID:0050736	autosomal dominant disease	GO:0001934	positive regulation of protein phosphorylation	8.864575740119562e-12	1.9550821794833695e-7	46	870	187
DOID:0050736	autosomal dominant disease	GO:0009611	response to wounding	9.046430271553163e-12	1.99519019639105e-7	35	875	187
DOID:0050736	autosomal dominant disease	GO:0045597	positive regulation of cell differentiation	1.0190293053824462e-11	2.247469133020985e-7	38	815	187
DOID:0050736	autosomal dominant disease	GO:0007417	central nervous system development	1.0448641951654736e-11	2.304447982437452e-7	41	889	187
DOID:0050736	autosomal dominant disease	GO:0048534	hematopoietic or lymphoid organ development	1.205924249347845e-11	2.659665931936672e-7	39	739	187
DOID:0050736	autosomal dominant disease	GO:0030097	hemopoiesis	1.2651324432511046e-11	2.7902496035903113e-7	31	695	187
DOID:0050736	autosomal dominant disease	GO:0003690	double-stranded DNA binding	1.274946814788791e-11	2.8118952000166786e-7	35	756	187
DOID:0050736	autosomal dominant disease	GO:0051093	negative regulation of developmental process	1.3546164190358922e-11	2.9876065121836604e-7	38	788	187
DOID:0050736	autosomal dominant disease	GO:0043066	negative regulation of apoptotic process	1.3588130620689753e-11	2.996862208393125e-7	48	795	187
DOID:0050736	autosomal dominant disease	GO:0014070	response to organic cyclic compound	1.3839818180372276e-11	3.0523718996811056e-7	34	873	187
DOID:0050736	autosomal dominant disease	GO:1901701	cellular response to oxygen-containing compound	1.3839818180372276e-11	3.0523718996811056e-7	34	873	187
DOID:0050736	autosomal dominant disease	GO:0032990	cell part morphogenesis	1.3862799796982017e-11	3.057440495224384e-7	34	787	187
DOID:0050736	autosomal dominant disease	GO:0000904	cell morphogenesis involved in differentiation	1.3978151969240571e-11	3.082881416816008e-7	35	720	187
DOID:0050736	autosomal dominant disease	GO:0001666	response to hypoxia	1.520195080928488e-11	3.3527902509877805e-7	20	292	187
DOID:0050736	autosomal dominant disease	GO:0048858	cell projection morphogenesis	1.52442503065231e-11	3.3621194051036696e-7	34	767	187
DOID:0050736	autosomal dominant disease	GO:1902533	positive regulation of intracellular signal transduction	1.6080248244065842e-11	3.5464987502287215e-7	34	860	187
DOID:0050736	autosomal dominant disease	GO:0006974	cellular response to DNA damage stimulus	1.6217249765304587e-11	3.5767144357379266e-7	33	767	187
DOID:0050736	autosomal dominant disease	GO:0045926	negative regulation of growth	1.6543766356846845e-11	3.6487276700025717e-7	18	230	187
DOID:0050736	autosomal dominant disease	GO:0042733	embryonic digit morphogenesis	1.690891870964606e-11	3.7292620214124383e-7	11	60	187
DOID:0050736	autosomal dominant disease	GO:0043068	positive regulation of programmed cell death	1.7337131730243982e-11	3.82370440310531e-7	27	561	187
DOID:0050736	autosomal dominant disease	GO:0003682	chromatin binding	1.7592260981302843e-11	3.879973159426342e-7	24	433	187
DOID:0050736	autosomal dominant disease	GO:0019199	transmembrane receptor protein kinase activity	2.0459967053909622e-11	4.512445733739767e-7	12	79	187
DOID:0050736	autosomal dominant disease	GO:0044087	regulation of cellular component biogenesis	2.2582047343178147e-11	4.98047054153794e-7	31	735	187
DOID:0050736	autosomal dominant disease	GO:0042306	regulation of protein import into nucleus	2.4571567003306427e-11	5.419259102579232e-7	16	175	187
DOID:0050736	autosomal dominant disease	GO:0031657	regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	2.5659807612044006e-11	5.659270568836305e-7	6	8	187
DOID:0050736	autosomal dominant disease	GO:0007369	gastrulation	2.665256904066382e-11	5.878224101918406e-7	16	176	187
DOID:0050736	autosomal dominant disease	GO:0051960	regulation of nervous system development	2.702105206253691e-11	5.959493032392515e-7	31	744	187
DOID:0050736	autosomal dominant disease	GO:0009411	response to UV	2.901412443634399e-11	6.399065144435667e-7	14	125	187
DOID:0050736	autosomal dominant disease	GO:0061035	regulation of cartilage development	2.959743561348205e-11	6.527714424553466e-7	11	63	187
DOID:0050736	autosomal dominant disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3.189737363129552e-11	7.034965754382227e-7	15	151	187
DOID:0050736	autosomal dominant disease	GO:0002065	columnar/cuboidal epithelial cell differentiation	3.993150254899547e-11	8.80689288718095e-7	14	128	187
DOID:0050736	autosomal dominant disease	GO:0005057	receptor signaling protein activity	4.644695739131066e-11	1.0243876452653566e-6	15	155	187
DOID:0050736	autosomal dominant disease	GO:0046649	lymphocyte activation	5.051148388446336e-11	1.1140307770718394e-6	27	594	187
DOID:0050736	autosomal dominant disease	GO:0045596	negative regulation of cell differentiation	5.724443141730262e-11	1.2625259349086093e-6	27	597	187
DOID:0050736	autosomal dominant disease	GO:0010948	negative regulation of cell cycle process	5.7248539242493734e-11	1.2626165329931993e-6	17	215	187
DOID:0050736	autosomal dominant disease	GO:0070371	ERK1 and ERK2 cascade	5.859157603538279e-11	1.2922372094603674e-6	18	247	187
DOID:0050736	autosomal dominant disease	GO:0051053	negative regulation of DNA metabolic process	6.022393694848915e-11	1.3282389293989283e-6	13	108	187
DOID:0050736	autosomal dominant disease	GO:0035265	organ growth	6.084166503939059e-11	1.3418629224437595e-6	14	132	187
DOID:0050736	autosomal dominant disease	GO:0043065	positive regulation of apoptotic process	6.783251738085028e-11	1.4960461708346529e-6	26	556	187
DOID:0050736	autosomal dominant disease	GO:0014855	striated muscle cell proliferation	7.137090918263311e-11	1.5740854020229733e-6	10	51	187
DOID:0050736	autosomal dominant disease	GO:0042493	response to drug	7.878653285331438e-11	1.7376369820798487e-6	23	433	187
DOID:0050736	autosomal dominant disease	GO:0045667	regulation of osteoblast differentiation	8.611567015037735e-11	1.8992811051665726e-6	13	111	187
DOID:0050736	autosomal dominant disease	GO:0098602	single organism cell adhesion	8.983880306345782e-11	1.981394801564562e-6	30	746	187
DOID:0050736	autosomal dominant disease	GO:0050680	negative regulation of epithelial cell proliferation	9.678480239472265e-11	2.134588816815608e-6	13	112	187
DOID:0050736	autosomal dominant disease	GO:0050767	regulation of neurogenesis	1.0546286066670518e-10	2.325983392004183e-6	28	658	187
DOID:0050736	autosomal dominant disease	GO:0007605	sensory perception of sound	1.1185363746335497e-10	2.466931974254294e-6	14	138	187
DOID:0050736	autosomal dominant disease	GO:0007569	cell aging	1.1312850656253204e-10	2.495049212236644e-6	12	91	187
DOID:0050736	autosomal dominant disease	GO:0030878	thyroid gland development	1.1659628817994871e-10	2.571531135808769e-6	8	26	187
DOID:0050736	autosomal dominant disease	GO:0048514	blood vessel morphogenesis	1.1722289805504715e-10	2.585351016604065e-6	24	484	187
DOID:0050736	autosomal dominant disease	GO:0060993	kidney morphogenesis	1.289999218556659e-10	2.845093276526711e-6	12	92	187
DOID:0050736	autosomal dominant disease	GO:0002521	leukocyte differentiation	1.4662682179533704e-10	3.2338545546961583e-6	23	448	187
DOID:0050736	autosomal dominant disease	GO:0048704	embryonic skeletal system morphogenesis	1.4677248305616786e-10	3.237067113803782e-6	12	93	187
DOID:0050736	autosomal dominant disease	GO:0051050	positive regulation of transport	1.6209700248737136e-10	3.5750493898589752e-6	33	920	187
DOID:0050736	autosomal dominant disease	GO:0014033	neural crest cell differentiation	2.1245993853113987e-10	4.68580394430429e-6	11	75	187
DOID:0050736	autosomal dominant disease	GO:0044441	ciliary part	2.2429902379883515e-10	4.946914969883309e-6	19	303	187
DOID:0050736	autosomal dominant disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.4375712559532303e-10	5.3760634050048495e-6	29	732	187
DOID:0050736	autosomal dominant disease	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2.4463020498188826e-10	5.3953191708755455e-6	16	204	187
DOID:0050736	autosomal dominant disease	GO:2000027	regulation of organ morphogenesis	2.4873614279385947e-10	5.485875629318571e-6	17	236	187
DOID:0050736	autosomal dominant disease	GO:0006281	DNA repair	2.4880553173289854e-10	5.487406002369077e-6	24	503	187
DOID:0050736	autosomal dominant disease	GO:0071417	cellular response to organonitrogen compound	2.6760516025348124e-10	5.902031809390529e-6	23	462	187
DOID:0050736	autosomal dominant disease	GO:0048483	autonomic nervous system development	2.804910748110956e-10	6.186230654958713e-6	9	42	187
DOID:0050736	autosomal dominant disease	GO:0061061	muscle structure development	2.8912550131821035e-10	6.376662931573129e-6	25	551	187
DOID:0050736	autosomal dominant disease	GO:0007498	mesoderm development	3.1572600089901925e-10	6.96333694982787e-6	13	123	187
DOID:0050736	autosomal dominant disease	GO:0016337	single organismal cell-cell adhesion	3.697196993002194e-10	8.15416796806634e-6	28	697	187
DOID:0050736	autosomal dominant disease	GO:0009612	response to mechanical stimulus	3.7632530425213417e-10	8.29985458528082e-6	16	210	187
DOID:0050736	autosomal dominant disease	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3.920588298456096e-10	8.64685749224492e-6	12	101	187
DOID:0050736	autosomal dominant disease	GO:0033993	response to lipid	3.9581782296238543e-10	8.72976208543541e-6	31	850	187
DOID:0050736	autosomal dominant disease	GO:0022405	hair cycle process	4.351835558580319e-10	9.597973324448894e-6	11	80	187
DOID:0050736	autosomal dominant disease	GO:0001942	hair follicle development	4.351835558580319e-10	9.597973324448894e-6	11	80	187
DOID:0050736	autosomal dominant disease	GO:2000648	positive regulation of stem cell proliferation	4.6232240258348156e-10	1.0196520588978686e-5	10	61	187
DOID:0050736	autosomal dominant disease	GO:0014065	phosphatidylinositol 3-kinase signaling	4.85907647451711e-10	1.0716693164547486e-5	14	154	187
DOID:0050736	autosomal dominant disease	GO:0009725	response to hormone	6.162506061002659e-10	1.3591407117541365e-5	31	865	187
DOID:0050736	autosomal dominant disease	GO:0006275	regulation of DNA replication	6.275510111564131e-10	1.384063755105469e-5	14	157	187
DOID:0050736	autosomal dominant disease	GO:0060389	pathway-restricted SMAD protein phosphorylation	6.438390931506888e-10	1.419987119943844e-5	10	63	187
DOID:0050736	autosomal dominant disease	GO:0030029	actin filament-based process	6.656549755845731e-10	1.468102048651776e-5	26	620	187
DOID:0050736	autosomal dominant disease	GO:0007420	brain development	7.048137629084295e-10	1.554466754094541e-5	27	669	187
DOID:0050736	autosomal dominant disease	GO:0060601	lateral sprouting from an epithelium	8.187327482644946e-10	1.805715076297343e-5	6	12	187
DOID:0050736	autosomal dominant disease	GO:0048538	thymus development	8.207624579981143e-10	1.810191601114841e-5	9	47	187
DOID:0050736	autosomal dominant disease	GO:0043524	negative regulation of neuron apoptotic process	9.225817887426047e-10	2.0347541350718146e-5	13	134	187
DOID:0050736	autosomal dominant disease	GO:0080135	regulation of cellular response to stress	1.0318230714290166e-9	2.2756857840366962e-5	27	681	187
DOID:0050736	autosomal dominant disease	GO:0048546	digestive tract morphogenesis	1.216302836226646e-9	2.6825559052978676e-5	9	49	187
DOID:0050736	autosomal dominant disease	GO:0007179	transforming growth factor beta receptor signaling pathway	1.3091701056566762e-9	2.8873746680257995e-5	14	166	187
DOID:0050736	autosomal dominant disease	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.3303239621009766e-9	2.934029498413704e-5	13	138	187
DOID:0050736	autosomal dominant disease	GO:0035272	exocrine system development	1.4705335837916778e-9	3.243261819052545e-5	9	50	187
DOID:0050736	autosomal dominant disease	GO:0048738	cardiac muscle tissue development	1.5323916580101127e-9	3.3796898017413035e-5	14	168	187
DOID:0050736	autosomal dominant disease	GO:0070372	regulation of ERK1 and ERK2 cascade	1.7241036376347552e-9	3.8025105728034525e-5	16	233	187
DOID:0050736	autosomal dominant disease	GO:0072080	nephron tubule development	1.786672920722765e-9	3.940507126654058e-5	11	91	187
DOID:0050736	autosomal dominant disease	GO:0003205	cardiac chamber development	1.8944966706513355e-9	4.1783124071215205e-5	13	142	187
DOID:0050736	autosomal dominant disease	GO:0060571	morphogenesis of an epithelial fold	1.933963655886828e-9	4.265356843058399e-5	7	23	187
DOID:0050736	autosomal dominant disease	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	1.9738994883056193e-9	4.3534353214580435e-5	5	7	187
DOID:0050736	autosomal dominant disease	GO:0010720	positive regulation of cell development	1.9875839862848466e-9	4.383616481751229e-5	22	469	187
DOID:0050736	autosomal dominant disease	GO:0042472	inner ear morphogenesis	2.011810162905192e-9	4.437047314287401e-5	11	92	187
DOID:0050736	autosomal dominant disease	GO:0060348	bone development	2.084814210157049e-9	4.598057740501371e-5	14	172	187
DOID:0050736	autosomal dominant disease	GO:0001704	formation of primary germ layer	2.1942565542332204e-9	4.8394328303613676e-5	12	117	187
DOID:0050736	autosomal dominant disease	GO:0060425	lung morphogenesis	2.5347599574843116e-9	5.590413086231649e-5	9	53	187
DOID:0050736	autosomal dominant disease	GO:0072078	nephron tubule morphogenesis	2.870751858452536e-9	6.331443223817068e-5	10	73	187
DOID:0050736	autosomal dominant disease	GO:0060563	neuroepithelial cell differentiation	3.2908610281268125e-9	7.257993997533685e-5	10	74	187
DOID:0050736	autosomal dominant disease	GO:0006935	chemotaxis	3.6677578751920237e-9	8.089239993736008e-5	23	530	187
DOID:0050736	autosomal dominant disease	GO:2000147	positive regulation of cell motility	3.684994753783144e-9	8.127255929468724e-5	20	399	187
DOID:0050736	autosomal dominant disease	GO:0060840	artery development	3.764547562568055e-9	8.302709649243845e-5	10	75	187
DOID:0050736	autosomal dominant disease	GO:0045121	membrane raft	3.807780979414588e-9	8.398060950098873e-5	17	282	187
DOID:0050736	autosomal dominant disease	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	3.824661143347896e-9	8.435290151653785e-5	19	359	187
DOID:0050736	autosomal dominant disease	GO:0048638	regulation of developmental growth	4.015552113045828e-9	8.856300185322574e-5	17	283	187
DOID:0050736	autosomal dominant disease	GO:0048871	multicellular organismal homeostasis	4.074960924249638e-9	8.987326318432576e-5	18	321	187
DOID:0050736	autosomal dominant disease	GO:0008015	blood circulation	4.277009746367355e-9	9.432944995613202e-5	22	489	187
DOID:421	hair disease	GO:0098773	skin epidermis development	2.5979218776228663e-14	5.729716701097232e-10	16	82	189
DOID:421	hair disease	GO:0001568	blood vessel development	2.3676172133946238e-11	5.221779764141843e-7	27	569	189
DOID:421	hair disease	GO:0009913	epidermal cell differentiation	3.30534488668377e-10	7.289938147581054e-6	15	176	189
DOID:421	hair disease	GO:0035270	endocrine system development	6.54129195254427e-10	1.4426819401336388e-5	13	129	189
DOID:421	hair disease	GO:0048514	blood vessel morphogenesis	8.021706632277414e-10	1.7691873977487838e-5	23	484	189
DOID:421	hair disease	GO:0098609	cell-cell adhesion	8.503975301721312e-10	1.8755517527946353e-5	31	867	189
DOID:421	hair disease	GO:0016337	single organismal cell-cell adhesion	2.1573254294082744e-9	4.757981234559949e-5	27	697	189
DOID:421	hair disease	GO:0060541	respiratory system development	2.250929664882051e-9	4.964425375897363e-5	15	202	189
DOID:421	hair disease	GO:0001701	in utero embryonic development	3.08742786891969e-9	6.809322164902376e-5	18	312	189
DOID:421	hair disease	GO:0030323	respiratory tube development	4.021614041782584e-9	8.869669769151489e-5	14	179	189
DOID:421	hair disease	GO:0055123	digestive system development	4.229662842192283e-9	9.328521398455081e-5	13	150	189
DOID:8692	myeloid leukemia	GO:0051726	regulation of cell cycle	9.080403096106693e-12	2.002682902846331e-7	38	930	189
DOID:8692	myeloid leukemia	GO:0018205	peptidyl-lysine modification	1.4933054792720668e-11	3.2934852345345433e-7	23	388	189
DOID:8692	myeloid leukemia	GO:0097305	response to alcohol	2.8590130263239644e-11	6.305553229557503e-7	22	369	189
DOID:8692	myeloid leukemia	GO:0044212	transcription regulatory region DNA binding	3.971389883616894e-11	8.758900388317059e-7	32	807	189
DOID:8692	myeloid leukemia	GO:0005925	focal adhesion	7.32363059086083e-11	1.615226726814356e-6	22	388	189
DOID:8692	myeloid leukemia	GO:0045596	negative regulation of cell differentiation	7.33737515190569e-11	1.6182580897527998e-6	27	597	189
DOID:8692	myeloid leukemia	GO:0016569	covalent chromatin modification	8.810063789610467e-11	1.9430595687985885e-6	23	431	189
DOID:8692	myeloid leukemia	GO:0045321	leukocyte activation	9.683565060925048e-11	2.1357102741870193e-6	29	694	189
DOID:8692	myeloid leukemia	GO:0070482	response to oxygen levels	1.0130840610855785e-10	2.2343568967242433e-6	20	321	189
DOID:8692	myeloid leukemia	GO:1901699	cellular response to nitrogen compound	1.0409539896727438e-10	2.2958240242232364e-6	25	518	189
DOID:8692	myeloid leukemia	GO:0009611	response to wounding	2.52090348595857e-10	5.559852638281626e-6	32	875	189
DOID:8692	myeloid leukemia	GO:0009887	organ morphogenesis	4.670612785417916e-10	1.0301036498239213e-5	33	950	189
DOID:8692	myeloid leukemia	GO:0051345	positive regulation of hydrolase activity	5.038817141311824e-10	1.1113111205163229e-5	32	900	189
DOID:8692	myeloid leukemia	GO:0032496	response to lipopolysaccharide	6.465634694308164e-10	1.4259957318296657e-5	19	319	189
DOID:8692	myeloid leukemia	GO:0034599	cellular response to oxidative stress	8.161420428365318e-10	1.800001275475971e-5	16	219	189
DOID:8692	myeloid leukemia	GO:0045597	positive regulation of cell differentiation	8.347279534248742e-10	1.84099250127856e-5	30	815	189
DOID:8692	myeloid leukemia	GO:0045471	response to ethanol	1.3848627800072677e-9	3.054314861306029e-5	13	137	189
DOID:8692	myeloid leukemia	GO:0071407	cellular response to organic cyclic compound	1.5706117517666485e-9	3.463984218521343e-5	21	416	189
DOID:8692	myeloid leukemia	GO:0030098	lymphocyte differentiation	1.5720976742628068e-9	3.4672614205866203e-5	18	299	189
DOID:8692	myeloid leukemia	GO:0051270	regulation of cellular component movement	1.6101626698628024e-9	3.551213768382411e-5	29	787	189
DOID:8692	myeloid leukemia	GO:0010035	response to inorganic substance	1.61221347383389e-9	3.5557368165406444e-5	23	502	189
DOID:8692	myeloid leukemia	GO:0016570	histone modification	1.7094521354010794e-9	3.770196684627081e-5	21	418	189
DOID:8692	myeloid leukemia	GO:0050878	regulation of body fluid levels	1.739236199505001e-9	3.8358854380082796e-5	23	504	189
DOID:8692	myeloid leukemia	GO:0071417	cellular response to organonitrogen compound	1.8468182538811106e-9	4.0731576589347895e-5	22	462	189
DOID:8692	myeloid leukemia	GO:0002262	myeloid cell homeostasis	2.242445673594773e-9	4.9457139331132716e-5	12	116	189
DOID:8692	myeloid leukemia	GO:0000976	transcription regulatory region sequence-specific DNA binding	2.49352072323461e-9	5.499459955093933e-5	26	653	189
DOID:8692	myeloid leukemia	GO:2000145	regulation of cell motility	3.1032192371327483e-9	6.844150027496276e-5	27	709	189
DOID:8692	myeloid leukemia	GO:0010001	glial cell differentiation	3.229762568501826e-9	7.123241344830777e-5	14	176	189
DOID:8692	myeloid leukemia	GO:0018108	peptidyl-tyrosine phosphorylation	3.6295086935922427e-9	8.004881423717691e-5	19	354	189
Orphanet:98560	Rare palpebral disease	GO:0040007	growth	2.819411371035585e-12	6.218211778818983e-8	38	936	189
Orphanet:98560	Rare palpebral disease	GO:0035295	tube development	3.901878820045113e-12	8.605593737609496e-8	28	573	189
Orphanet:98560	Rare palpebral disease	GO:0009887	organ morphogenesis	6.73594513500575e-12	1.485612699525518e-7	37	950	189
Orphanet:98560	Rare palpebral disease	GO:0007507	heart development	7.19801995785474e-12	1.587523301704863e-7	30	487	189
Orphanet:98560	Rare palpebral disease	GO:0009790	embryo development	2.893129069647671e-10	6.380796163107938e-6	33	932	189
Orphanet:98560	Rare palpebral disease	GO:0048666	neuron development	1.0138411221660704e-9	2.2360265949372682e-5	32	926	189
Orphanet:98560	Rare palpebral disease	GO:0050673	epithelial cell proliferation	1.4592074215613593e-9	3.218281968253578e-5	19	335	189
Orphanet:98560	Rare palpebral disease	GO:0048732	gland development	1.943021632477837e-9	4.28533421042987e-5	21	421	189
Orphanet:98560	Rare palpebral disease	GO:0032403	protein complex binding	3.849519480958463e-9	8.49011521525389e-5	31	924	189
Orphanet:98560	Rare palpebral disease	GO:0000904	cell morphogenesis involved in differentiation	4.312445733845038e-9	9.511099065995232e-5	27	720	189
Orphanet:57146	Rare hepatic disease	GO:0048878	chemical homeostasis	5.468070440883821e-12	1.2059829357369267e-7	40	988	190
Orphanet:57146	Rare hepatic disease	GO:0019752	carboxylic acid metabolic process	2.4225066397320916e-12	5.342838393929128e-8	38	967	190
Orphanet:57146	Rare hepatic disease	GO:0008202	steroid metabolic process	9.22595333463505e-13	2.0347840079537605e-8	21	275	190
Orphanet:57146	Rare hepatic disease	GO:0046427	positive regulation of JAK-STAT cascade	5.362377208939506e-14	1.182672293431608e-9	14	76	190
Orphanet:57146	Rare hepatic disease	GO:0010817	regulation of hormone levels	6.38289421317495e-12	1.4077473187157352e-7	27	473	190
Orphanet:57146	Rare hepatic disease	GO:0055082	cellular chemical homeostasis	1.4531265080108824e-11	3.204870513418001e-7	30	661	190
Orphanet:57146	Rare hepatic disease	GO:0042098	T cell proliferation	1.5478507364719007e-11	3.413784799288777e-7	16	167	190
Orphanet:57146	Rare hepatic disease	GO:0048732	gland development	1.6085799359188968e-11	3.547723048669127e-7	24	421	190
Orphanet:57146	Rare hepatic disease	GO:0032388	positive regulation of intracellular transport	6.336797753192513e-11	1.3975807444666088e-6	21	347	190
Orphanet:57146	Rare hepatic disease	GO:0032880	regulation of protein localization	8.328593370521276e-11	1.8368712678684673e-6	34	933	190
Orphanet:57146	Rare hepatic disease	GO:0034284	response to monosaccharide	9.102529840987472e-11	2.007562956429787e-6	16	188	190
Orphanet:57146	Rare hepatic disease	GO:0006091	generation of precursor metabolites and energy	1.4104939438652764e-10	3.110844393194867e-6	21	362	190
Orphanet:57146	Rare hepatic disease	GO:0043069	negative regulation of programmed cell death	1.7044843314550917e-10	3.7592401930242048e-6	31	806	190
Orphanet:57146	Rare hepatic disease	GO:0009725	response to hormone	2.2316248848852638e-10	4.921848683614449e-6	32	865	190
Orphanet:57146	Rare hepatic disease	GO:0046824	positive regulation of nucleocytoplasmic transport	2.276671073886405e-10	5.021198053456466e-6	13	118	190
Orphanet:57146	Rare hepatic disease	GO:1901698	response to nitrogen compound	2.533058207632166e-10	5.5866598769327425e-6	32	870	190
Orphanet:57146	Rare hepatic disease	GO:0015980	energy derivation by oxidation of organic compounds	2.607439819612978e-10	5.7507085221564225e-6	18	266	190
Orphanet:57146	Rare hepatic disease	GO:0009611	response to wounding	2.8957902742376973e-10	6.386665449831241e-6	32	875	190
Orphanet:57146	Rare hepatic disease	GO:0051223	regulation of protein transport	3.321928288002596e-10	7.326512839189725e-6	29	730	190
Orphanet:57146	Rare hepatic disease	GO:0019318	hexose metabolic process	3.410554061389348e-10	7.521976982394207e-6	17	237	190
Orphanet:57146	Rare hepatic disease	GO:0010243	response to organonitrogen compound	3.450671970384178e-10	7.610457030682305e-6	30	780	190
Orphanet:57146	Rare hepatic disease	GO:0009914	hormone transport	3.699024420100727e-10	8.158198358532154e-6	19	307	190
Orphanet:57146	Rare hepatic disease	GO:0009746	response to hexose	5.26840238102011e-10	1.1619461451339852e-5	15	181	190
Orphanet:57146	Rare hepatic disease	GO:0043066	negative regulation of apoptotic process	5.359939159177429e-10	1.182134581556582e-5	30	795	190
Orphanet:57146	Rare hepatic disease	GO:0031347	regulation of defense response	5.995931529056975e-10	1.3224026987335158e-5	29	749	190
Orphanet:57146	Rare hepatic disease	GO:0032940	secretion by cell	6.259315288303924e-10	1.3804919868354304e-5	33	956	190
Orphanet:57146	Rare hepatic disease	GO:0090316	positive regulation of intracellular protein transport	9.931120370509916e-10	2.190308597715962e-5	17	254	190
Orphanet:57146	Rare hepatic disease	GO:0006873	cellular ion homeostasis	1.0483488521728646e-9	2.3121333934672528e-5	24	532	190
Orphanet:57146	Rare hepatic disease	GO:0006875	cellular metal ion homeostasis	1.254626957880589e-9	2.7670797556056392e-5	22	450	190
Orphanet:57146	Rare hepatic disease	GO:0006606	protein import into nucleus	2.2511108532796698e-9	4.9648249869083116e-5	17	268	190
Orphanet:57146	Rare hepatic disease	GO:0043065	positive regulation of apoptotic process	2.5061661634850907e-9	5.5273494735663675e-5	24	556	190
Orphanet:57146	Rare hepatic disease	GO:0015833	peptide transport	2.6023382337925227e-9	5.739456974629409e-5	18	307	190
Orphanet:57146	Rare hepatic disease	GO:0006953	acute-phase response	2.9156032033128554e-9	6.430362864906503e-5	9	53	190
Orphanet:57146	Rare hepatic disease	GO:0051241	negative regulation of multicellular organismal process	3.2220057732956775e-9	7.106133733003617e-5	32	966	190
Orphanet:57146	Rare hepatic disease	GO:0032620	interleukin-17 production	4.1648470228139445e-9	9.185570108816155e-5	7	25	190
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0022603	regulation of anatomical structure morphogenesis	7.469802554282978e-12	1.6474649533471108e-7	44	986	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0061448	connective tissue development	9.64117674584486e-13	2.1263615312960837e-8	24	233	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0003007	heart morphogenesis	9.321432514752814e-13	2.0558419411287332e-8	19	216	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001763	morphogenesis of a branching structure	5.25135490647699e-13	1.1581863246235002e-8	28	193	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0043010	camera-type eye development	4.698463840213662e-13	1.0362461999591233e-8	21	283	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0030323	respiratory tube development	3.5793590313915047e-13	7.894276343733964e-9	20	179	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0072089	stem cell proliferation	1.6364687382974807e-13	3.6092318023150938e-9	17	139	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0072073	kidney epithelium development	1.305622276959184e-13	2.8795499318334805e-9	17	137	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0061326	renal tubule development	1.1390888232654106e-13	2.512260399711863e-9	15	93	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0035116	embryonic hindlimb morphogenesis	2.0872192862952943e-14	4.6033621359242716e-10	11	29	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0031214	biomineral tissue development	3.6637359812630166e-15	8.080369706675583e-11	16	131	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0042733	embryonic digit morphogenesis	6.8833827526759706e-15	1.5181300661026853e-10	13	60	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048701	embryonic cranial skeleton morphogenesis	9.803269307440132e-14	2.162111045755921e-9	12	46	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001656	metanephros development	2.347011474057581e-13	5.176333806033995e-9	14	88	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001568	blood vessel development	2.3725466036239595e-13	5.232651534292643e-9	36	569	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048566	embryonic digestive tract development	7.90589815835574e-13	1.7436458388253584e-8	10	33	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0030855	epithelial cell differentiation	1.0187406473960436e-12	2.2468324978319743e-8	30	568	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001667	ameboidal-type cell migration	1.493583035028223e-12	3.294097383754746e-8	24	315	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0008589	regulation of smoothened signaling pathway	1.5571988143392446e-12	3.434401985025204e-8	12	62	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048864	stem cell development	3.22653015416563e-12	7.116112255012297e-8	17	175	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060537	muscle tissue development	4.262146191535976e-12	9.400163425432595e-8	22	336	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0042060	wound healing	4.6351811278100286e-12	1.0222891977385018e-7	29	534	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0072091	regulation of stem cell proliferation	5.780265155408415e-12	1.274837480025326e-7	13	88	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048514	blood vessel morphogenesis	6.689870879483806e-12	1.4754510224701534e-7	28	484	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0034504	protein localization to nucleus	8.96727136989739e-12	1.9777317006308692e-7	22	344	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0043069	negative regulation of programmed cell death	9.355960450818657e-12	2.0634570774280547e-7	36	806	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060602	branch elongation of an epithelium	1.2217005185277685e-11	2.6944604936129934e-7	8	20	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0042474	middle ear morphogenesis	1.2217005185277685e-11	2.6944604936129934e-7	8	20	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0006605	protein targeting	1.2394973936125098e-11	2.7337115016123903e-7	31	675	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0043066	negative regulation of apoptotic process	1.4099721390437026e-11	3.109693552660886e-7	36	795	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048858	cell projection morphogenesis	1.787681114251427e-11	3.9427306974815224e-7	33	767	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0051270	regulation of cellular component movement	1.9671375639518374e-11	4.3385218972957773e-7	33	787	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0051093	negative regulation of developmental process	1.9954815577705176e-11	4.4010345756628766e-7	33	788	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0014031	mesenchymal cell development	2.5625834787490476e-11	5.651777862381024e-7	16	171	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0030282	bone mineralization	3.133182602255147e-11	6.910234229273726e-7	13	100	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0010634	positive regulation of epithelial cell migration	3.54800633317609e-11	7.825127967819867e-7	13	101	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0021915	neural tube development	4.658462504636418e-11	1.027423905397562e-6	15	151	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0051241	negative regulation of multicellular organismal process	5.6709192897130833e-11	1.2507212493462205e-6	35	966	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0007420	brain development	6.421241316445503e-11	1.4162047723420557e-6	29	669	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0071599	otic vesicle development	1.1524814436114639e-10	2.5417978238850836e-6	7	16	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060688	regulation of morphogenesis of a branching structure	1.3874268400826395e-10	3.0599698958022614e-6	10	53	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0014706	striated muscle tissue development	1.4921774926790476e-10	3.2909974601036396e-6	20	323	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001525	angiogenesis	3.1293889701800026e-10	6.901867373731996e-6	22	413	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0000904	cell morphogenesis involved in differentiation	3.150606442403614e-10	6.948662508721171e-6	29	720	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0009799	specification of symmetry	3.946264426346602e-10	8.70348619230743e-6	13	122	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0048645	organ formation	4.241857975983976e-10	9.355417766032659e-6	10	59	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0016202	regulation of striated muscle tissue development	4.726982139047209e-10	1.042535910766862e-5	12	100	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0001101	response to acid chemical	6.849374400985653e-10	1.5106295241373857e-5	19	315	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0033993	response to lipid	7.787999134478696e-10	1.7176432091092764e-5	31	850	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060606	tube closure	8.646688920421752e-10	1.9070272413990175e-5	11	83	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0045667	regulation of osteoblast differentiation	1.6082807308137603e-9	3.5470631518097484e-5	12	111	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060284	regulation of cell development	1.7657016959660154e-9	3.894255090453047e-5	30	828	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0007368	determination of left/right symmetry	1.7854212552848026e-9	3.937746578530632e-5	12	112	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0060324	face development	1.855844589115918e-9	4.0930652412951574e-5	9	50	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0014855	striated muscle cell proliferation	2.2336876792650173e-9	4.926398176618996e-5	9	51	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0045596	negative regulation of cell differentiation	2.6138415876175713e-9	5.7648276214905536e-5	25	597	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0006606	protein import into nucleus	2.6425537313912173e-9	5.82815225458333e-5	17	268	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0051960	regulation of nervous system development	2.865528592188582e-9	6.319923310071918e-5	28	744	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0010927	cellular component assembly involved in morphogenesis	2.956495603889664e-9	6.520551054378654e-5	17	270	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0097285	cell-type specific apoptotic process	3.608631948814889e-9	7.958837763111237e-5	21	429	192
Orphanet:68329	Rare maxillo-facial surgical disease	GO:0007548	sex differentiation	3.69077535200546e-9	8.140005038848042e-5	17	274	192
DOID:62	aortic valve disease	GO:0009141	nucleoside triphosphate metabolic process	1.4008794124720225e-12	3.089639544207046e-8	23	274	194
DOID:62	aortic valve disease	GO:0048644	muscle organ morphogenesis	1.709743457922741e-13	3.7708391964486054e-9	14	70	194
DOID:62	aortic valve disease	GO:0070482	response to oxygen levels	3.718803043284424e-12	8.201820111963798e-8	22	321	194
DOID:62	aortic valve disease	GO:1901698	response to nitrogen compound	9.67559365960824e-12	2.1339521816265972e-7	36	870	194
DOID:62	aortic valve disease	GO:0070848	response to growth factor	1.774169700041739e-11	3.912931273442055e-7	29	621	194
DOID:62	aortic valve disease	GO:0036293	response to decreased oxygen levels	5.269729097534537e-11	1.162238752461242e-6	20	302	194
DOID:62	aortic valve disease	GO:0035051	cardiocyte differentiation	8.48742187642415e-11	1.8719008948453464e-6	13	107	194
DOID:62	aortic valve disease	GO:0071363	cellular response to growth factor stimulus	1.1907674846156624e-10	2.6262376873198434e-6	27	594	194
DOID:62	aortic valve disease	GO:0001666	response to hypoxia	2.2805368704581497e-10	5.029724067795449e-6	19	292	194
DOID:62	aortic valve disease	GO:0001568	blood vessel development	2.3885204925022663e-10	5.267881946213748e-6	26	569	194
DOID:62	aortic valve disease	GO:0040008	regulation of growth	2.806338494920624e-10	6.189379550547436e-6	27	617	194
DOID:62	aortic valve disease	GO:0008284	positive regulation of cell proliferation	3.73517994312067e-10	8.237939364552638e-6	31	815	194
DOID:62	aortic valve disease	GO:0007167	enzyme linked receptor protein signaling pathway	6.19921558531189e-10	1.3672369973405374e-5	33	935	194
DOID:62	aortic valve disease	GO:0009612	response to mechanical stimulus	6.482125947115946e-10	1.429632877636422e-5	16	210	194
DOID:62	aortic valve disease	GO:0051093	negative regulation of developmental process	7.248177613661255e-10	1.59858557269299e-5	30	788	194
DOID:62	aortic valve disease	GO:0002576	platelet degranulation	1.0564576991001218e-9	2.3300174553653186e-5	12	106	194
DOID:62	aortic valve disease	GO:0016049	cell growth	1.0999325894545109e-9	2.4259013260419238e-5	23	479	194
DOID:62	aortic valve disease	GO:0055117	regulation of cardiac muscle contraction	1.100616264793075e-9	2.427409172001127e-5	11	84	194
DOID:62	aortic valve disease	GO:2000145	regulation of cell motility	1.2563927676012554e-9	2.7709742489445688e-5	28	709	194
DOID:62	aortic valve disease	GO:0030155	regulation of cell adhesion	1.5373124995221588e-9	3.390542717696121e-5	26	621	194
DOID:62	aortic valve disease	GO:0055007	cardiac muscle cell differentiation	1.615009237454501e-9	3.561902873205902e-5	11	87	194
DOID:62	aortic valve disease	GO:0097305	response to alcohol	1.8394663570120429e-9	4.0569430503900605e-5	20	369	194
DOID:62	aortic valve disease	GO:0055001	muscle cell development	2.490507022834265e-9	5.492813238860972e-5	13	140	194
DOID:62	aortic valve disease	GO:0043065	positive regulation of apoptotic process	3.818272142908086e-9	8.421199211183783e-5	24	556	194
MESH:D006349	Heart Valve Diseases	GO:0030334	regulation of cell migration	4.128573038997274e-10	9.105567837508488e-6	28	660	198
MESH:D006349	Heart Valve Diseases	GO:0050678	regulation of epithelial cell proliferation	9.845541049102735e-10	2.1714340783796082e-5	18	277	198
MESH:D006349	Heart Valve Diseases	GO:0043500	muscle adaptation	1.3659458009129821e-9	3.012593463913582e-5	11	84	198
MESH:D006349	Heart Valve Diseases	GO:0051241	negative regulation of multicellular organismal process	2.4080494265277252e-9	5.310953010206898e-5	33	966	198
MESH:D006349	Heart Valve Diseases	GO:0008285	negative regulation of cell proliferation	3.67652897015347e-9	8.108584643673478e-5	26	634	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0048854	brain morphogenesis	5.894440491260866e-11	1.300018850347584e-6	9	34	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0032400	melanosome localization	1.2862100273736132e-10	2.836736215372504e-6	8	25	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0001894	tissue homeostasis	3.402365056359713e-10	7.503916131801347e-6	16	197	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0061564	axon development	1.8122888745253363e-9	3.997003112765629e-5	22	440	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0001654	eye development	2.1424628737776175e-9	4.725201868116535e-5	19	327	198
Orphanet:181387	Rare disorder with hypogonadotropic hypogonadism	GO:0046982	protein heterodimerization activity	3.936236003809768e-9	8.681368506402443e-5	22	459	198
Orphanet:108997	Rare anemia	GO:0006766	vitamin metabolic process	1.0957901253050295e-13	2.4167651213602426e-9	16	128	199
Orphanet:108997	Rare anemia	GO:0042440	pigment metabolic process	8.288336683648367e-11	1.8279926555786474e-6	11	65	199
Orphanet:108997	Rare anemia	GO:0015669	gas transport	6.355820314496441e-10	1.40177617036219e-5	7	19	199
Orphanet:108997	Rare anemia	GO:0006778	porphyrin-containing compound metabolic process	3.389075020621135e-9	7.474604957979913e-5	8	36	199
Orphanet:108997	Rare anemia	GO:0002262	myeloid cell homeostasis	4.024658273316106e-9	8.876383821798672e-5	12	116	199
Orphanet:108997	Rare anemia	GO:0010035	response to inorganic substance	4.416563448295108e-9	9.74073068521486e-5	23	502	199
DOID:679	basal ganglia disease	GO:0032940	secretion by cell	3.3644198538240744e-12	7.420227987608996e-8	44	956	200
DOID:679	basal ganglia disease	GO:0043005	neuron projection	1.9346746427117978e-12	4.26692492450087e-8	44	941	200
DOID:679	basal ganglia disease	GO:0006836	neurotransmitter transport	9.57456336436735e-13	2.111669950011219e-8	20	183	200
DOID:679	basal ganglia disease	GO:0051048	negative regulation of secretion	7.633893517322576e-13	1.6836552152454942e-8	19	195	200
DOID:679	basal ganglia disease	GO:0042220	response to cocaine	2.065236870407716e-12	4.554879917684218e-8	11	47	200
DOID:679	basal ganglia disease	GO:0072521	purine-containing compound metabolic process	3.096745082586949e-12	6.829871279645516e-8	32	568	200
DOID:679	basal ganglia disease	GO:0050890	cognition	3.788191982323497e-12	8.354857417014472e-8	20	251	200
DOID:679	basal ganglia disease	GO:0019693	ribose phosphate metabolic process	4.30644409021852e-12	9.497862440976945e-8	31	531	200
DOID:679	basal ganglia disease	GO:0006163	purine nucleotide metabolic process	5.928590951498336e-12	1.307550734352958e-7	31	522	200
DOID:679	basal ganglia disease	GO:1900542	regulation of purine nucleotide metabolic process	6.159406318317906e-12	1.3584570635050142e-7	18	203	200
DOID:679	basal ganglia disease	GO:0009150	purine ribonucleotide metabolic process	6.9966255011877365e-12	1.5431057542869553e-7	30	501	200
DOID:679	basal ganglia disease	GO:0044456	synapse part	7.864597861839684e-12	1.7345370584287423e-7	33	613	200
DOID:679	basal ganglia disease	GO:0006873	cellular ion homeostasis	8.135714324453147e-12	1.7943317942581416e-7	28	532	200
DOID:679	basal ganglia disease	GO:0098771	inorganic ion homeostasis	9.283462887310634e-12	2.0474677397963603e-7	30	609	200
DOID:679	basal ganglia disease	GO:0044057	regulation of system process	9.651057730764023e-12	2.1285407825200053e-7	28	508	200
DOID:679	basal ganglia disease	GO:0071241	cellular response to inorganic substance	1.1348366690810963e-11	2.502882273658358e-7	16	156	200
DOID:679	basal ganglia disease	GO:0051402	neuron apoptotic process	1.3225975870057027e-11	2.9169889781410774e-7	18	211	200
DOID:679	basal ganglia disease	GO:0031329	regulation of cellular catabolic process	1.4192091946085839e-11	3.1300658787092317e-7	30	624	200
DOID:679	basal ganglia disease	GO:0030072	peptide hormone secretion	1.4293788375141503e-11	3.1524950261374585e-7	19	241	200
DOID:679	basal ganglia disease	GO:0055080	cation homeostasis	1.4656276192681617e-11	3.2324417142959305e-7	29	595	200
DOID:679	basal ganglia disease	GO:0044070	regulation of anion transport	1.6398438162923412e-11	3.6166755368327586e-7	15	135	200
DOID:679	basal ganglia disease	GO:0030003	cellular cation homeostasis	1.7068124691377307e-11	3.764374900683265e-7	27	519	200
DOID:679	basal ganglia disease	GO:0043068	positive regulation of programmed cell death	1.7103096716653e-11	3.772087980857819e-7	28	561	200
DOID:679	basal ganglia disease	GO:0055065	metal ion homeostasis	1.7734813617664713e-11	3.9114131433759525e-7	27	516	200
DOID:679	basal ganglia disease	GO:0007611	learning or memory	2.1484702905638642e-11	4.7384512258386025e-7	18	218	200
DOID:679	basal ganglia disease	GO:0006875	cellular metal ion homeostasis	2.4385826691286638e-11	5.378294076763268e-7	25	450	200
DOID:679	basal ganglia disease	GO:0015837	amine transport	4.493794225624015e-11	9.911063164613765e-7	12	79	200
DOID:679	basal ganglia disease	GO:0032101	regulation of response to external stimulus	6.245504113877587e-11	1.3774459323157018e-6	35	920	200
DOID:679	basal ganglia disease	GO:0051050	positive regulation of transport	6.245504113877587e-11	1.3774459323157018e-6	35	920	200
DOID:679	basal ganglia disease	GO:0032880	regulation of protein localization	7.714850980278243e-11	1.7015103837003664e-6	35	933	200
DOID:679	basal ganglia disease	GO:0050709	negative regulation of protein secretion	9.778067244781141e-11	2.1565527308364807e-6	13	105	200
DOID:679	basal ganglia disease	GO:0043086	negative regulation of catalytic activity	2.377678054443777e-10	5.24396894907575e-6	32	822	200
DOID:679	basal ganglia disease	GO:0046883	regulation of hormone secretion	2.520560427043961e-10	5.5590960218454555e-6	18	252	200
DOID:679	basal ganglia disease	GO:0032225	regulation of synaptic transmission, dopaminergic	2.587121628039313e-10	5.705896750640704e-6	7	17	200
DOID:679	basal ganglia disease	GO:0043065	positive regulation of apoptotic process	2.913600471998734e-10	6.425945840993208e-6	26	556	200
DOID:679	basal ganglia disease	GO:0043679	axon terminus	3.462279352106634e-10	7.636057111071182e-6	13	116	200
DOID:679	basal ganglia disease	GO:0030425	dendrite	6.324004653279758e-10	1.3947592262808506e-5	23	451	200
DOID:679	basal ganglia disease	GO:0007613	memory	6.713579692174676e-10	1.4806800011091248e-5	12	99	200
DOID:679	basal ganglia disease	GO:0042327	positive regulation of phosphorylation	7.103616583847838e-10	1.5667026375676407e-5	33	910	200
DOID:679	basal ganglia disease	GO:0098793	presynapse	7.119697054136509e-10	1.570249185289807e-5	16	205	200
DOID:679	basal ganglia disease	GO:0001975	response to amphetamine	7.204552510131634e-10	1.588964056109532e-5	8	30	200
DOID:679	basal ganglia disease	GO:0046128	purine ribonucleoside metabolic process	8.44606051764174e-10	1.8627786471658858e-5	20	342	200
DOID:679	basal ganglia disease	GO:0048148	behavioral response to cocaine	1.2274794514155474e-9	2.7072059300969897e-5	6	12	200
DOID:679	basal ganglia disease	GO:0009205	purine ribonucleoside triphosphate metabolic process	1.2633355472857488e-9	2.786286549538719e-5	17	245	200
DOID:679	basal ganglia disease	GO:0043627	response to estrogen	1.6357994958582367e-9	3.607755788115341e-5	16	217	200
DOID:679	basal ganglia disease	GO:0008144	drug binding	1.6694587934296123e-9	3.68199136890901e-5	12	107	200
DOID:679	basal ganglia disease	GO:0051341	regulation of oxidoreductase activity	1.7285297637670283e-9	3.812272393988181e-5	11	85	200
DOID:679	basal ganglia disease	GO:0070482	response to oxygen levels	1.8686282521329645e-9	4.121259610079253e-5	19	321	200
DOID:679	basal ganglia disease	GO:0014046	dopamine secretion	2.16813433873142e-9	4.781820284072147e-5	7	22	200
DOID:679	basal ganglia disease	GO:0014059	regulation of dopamine secretion	2.16813433873142e-9	4.781820284072147e-5	7	22	200
DOID:679	basal ganglia disease	GO:0051966	regulation of synaptic transmission, glutamatergic	2.658031239555214e-9	5.862287898839025e-5	9	50	200
DOID:679	basal ganglia disease	GO:0050880	regulation of blood vessel size	3.3030788104682074e-9	7.284940316487631e-5	13	139	200
DOID:679	basal ganglia disease	GO:0070838	divalent metal ion transport	3.389909131179536e-9	7.476444588816467e-5	21	410	200
DOID:679	basal ganglia disease	GO:0046034	ATP metabolic process	3.800057268854573e-9	8.381026306458761e-5	16	230	200
DOID:679	basal ganglia disease	GO:0090276	regulation of peptide hormone secretion	3.9880966307137555e-9	8.795747119039188e-5	15	199	200
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0006259	DNA metabolic process	3.2325253584986058e-12	7.129334678168675e-8	41	937	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0044420	extracellular matrix component	9.037215420448774e-14	1.993157860979977e-9	17	125	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0098773	skin epidermis development	6.772360450213455e-14	1.4936440972945775e-9	16	82	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0034330	cell junction organization	1.5543122344752192e-15	3.428035633135096e-11	21	240	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0005578	proteinaceous extracellular matrix	2.9450886174231528e-12	6.495392945726763e-8	25	354	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0071897	DNA biosynthetic process	3.2481795031458205e-12	7.163859894188107e-8	17	167	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0072358	cardiovascular system development	6.799671936619234e-12	1.499667645621372e-7	47	910	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0001501	skeletal system development	9.989564730972234e-12	2.203198501415926e-7	27	482	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0051052	regulation of DNA metabolic process	1.4717338459036e-11	3.24590899714039e-7	22	335	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0006974	cellular response to DNA damage stimulus	1.822364481540717e-11	4.019224864038051e-7	34	767	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0006289	nucleotide-excision repair	2.6290303267728632e-11	5.79832638569755e-7	14	115	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0032403	protein complex binding	2.6513680140283213e-11	5.847592154939463e-7	36	924	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0051053	negative regulation of DNA metabolic process	1.579473218882299e-10	3.4835281842449106e-6	13	108	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:1990391	DNA repair complex	1.6259160684484186e-10	3.5859578889629873e-6	9	37	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0000784	nuclear chromosome, telomeric region	1.7108015004652088e-10	3.773172709276018e-6	14	132	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0050680	negative regulation of epithelial cell proliferation	2.5137614212411563e-10	5.54410081454737e-6	13	112	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0007568	aging	4.04831945743922e-10	8.9285685633822e-6	19	290	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0001503	ossification	4.599504110913699e-10	1.0144206316620163e-5	21	363	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0051093	negative regulation of developmental process	4.6318882063189903e-10	1.0215629439036533e-5	31	788	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0061448	connective tissue development	6.807521213403334e-10	1.5013988036161052e-5	17	233	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0031589	cell-substrate adhesion	7.150449121695601e-10	1.577031553789965e-5	19	300	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0060562	epithelial tube morphogenesis	7.557076076025737e-10	1.6667131285674763e-5	19	301	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0060548	negative regulation of cell death	1.1161358504097052e-9	2.4616376180786048e-5	32	867	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0008022	protein C-terminus binding	1.2358483125751718e-9	2.7256634533845414e-5	15	181	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0048762	mesenchymal cell differentiation	1.5528354158078628e-9	3.4247785095642413e-5	15	184	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0003007	heart morphogenesis	1.768577728711307e-9	3.9005981806727874e-5	16	216	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0032204	regulation of telomere maintenance	2.1901447322392187e-9	4.830364206953597e-5	10	66	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0003203	endocardial cushion morphogenesis	2.3237346491455924e-9	5.124996768690604e-5	7	22	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0001568	blood vessel development	2.858451475518109e-9	6.304314729255189e-5	25	569	202
Orphanet:139027	Malformation syndrome with skin/mucosae involvement	GO:0007569	cell aging	4.025049404887682e-9	8.877246462479782e-5	11	91	202
MESH:D040181	Genetic Diseases, X-Linked	GO:1990204	oxidoreductase complex	4.349298698969051e-12	9.592378280576241e-8	14	100	203
Orphanet:102003	Rare movement disorder	GO:0048878	chemical homeostasis	5.687672555154677e-12	1.254416182039364e-7	39	988	204
Orphanet:102003	Rare movement disorder	GO:0032940	secretion by cell	5.140332604014475e-12	1.1337003558153924e-7	41	956	204
Orphanet:102003	Rare movement disorder	GO:0043005	neuron projection	3.219646771412954e-12	7.10093095435127e-8	44	941	204
Orphanet:102003	Rare movement disorder	GO:0007270	neuron-neuron synaptic transmission	5.728750807065808e-14	1.263475990498364e-9	19	130	204
Orphanet:102003	Rare movement disorder	GO:0030003	cellular cation homeostasis	4.559685962135518e-12	1.0056387389489885e-7	30	519	204
Orphanet:102003	Rare movement disorder	GO:0044297	cell body	5.88862292261183e-12	1.2987357855820392e-7	28	494	204
Orphanet:102003	Rare movement disorder	GO:0098771	inorganic ion homeostasis	6.054712287095754e-12	1.3353667949189685e-7	32	609	204
Orphanet:102003	Rare movement disorder	GO:0044456	synapse part	6.476041924941001e-12	1.4282910465457377e-7	37	613	204
Orphanet:102003	Rare movement disorder	GO:0072521	purine-containing compound metabolic process	6.953659870134743e-12	1.5336296843582176e-7	29	568	204
Orphanet:102003	Rare movement disorder	GO:0006163	purine nucleotide metabolic process	7.911560295781328e-12	1.744894623234572e-7	28	522	204
Orphanet:102003	Rare movement disorder	GO:0036477	somatodendritic compartment	1.063815702195825e-11	2.346245531192892e-7	34	649	204
Orphanet:102003	Rare movement disorder	GO:0098793	presynapse	1.0982215137289586e-11	2.422127548529218e-7	18	205	204
Orphanet:102003	Rare movement disorder	GO:0015844	monoamine transport	1.2609246979877753e-11	2.7809694214120384e-7	12	70	204
Orphanet:102003	Rare movement disorder	GO:0009150	purine ribonucleotide metabolic process	1.4107159884702014e-11	3.111334112571029e-7	27	501	204
Orphanet:102003	Rare movement disorder	GO:0071241	cellular response to inorganic substance	1.5694667787613525e-11	3.461458980558163e-7	16	156	204
Orphanet:102003	Rare movement disorder	GO:0006836	neurotransmitter transport	1.7077450564784158e-11	3.766431722063146e-7	17	183	204
Orphanet:102003	Rare movement disorder	GO:1901698	response to nitrogen compound	2.7621793741161582e-11	6.091986609613187e-7	35	870	204
Orphanet:102003	Rare movement disorder	GO:0051937	catecholamine transport	2.929267939322244e-11	6.46050044017521e-7	11	58	204
Orphanet:102003	Rare movement disorder	GO:0090659	walking behavior	3.0433100484117404e-11	6.712020311772093e-7	9	31	204
Orphanet:102003	Rare movement disorder	GO:0007628	adult walking behavior	3.0433100484117404e-11	6.712020311772093e-7	9	31	204
Orphanet:102003	Rare movement disorder	GO:0030425	dendrite	3.3153924050566275e-11	7.312097949352392e-7	25	451	204
Orphanet:102003	Rare movement disorder	GO:0034599	cellular response to oxidative stress	3.3973490687344565e-11	7.492853371093844e-7	18	219	204
Orphanet:102003	Rare movement disorder	GO:0009636	response to toxic substance	3.524613934047238e-11	7.773536031541184e-7	19	249	204
Orphanet:102003	Rare movement disorder	GO:0030424	axon	3.576106077929353e-11	7.887101954873188e-7	24	414	204
Orphanet:102003	Rare movement disorder	GO:0010243	response to organonitrogen compound	3.705202811232766e-11	8.171824800173866e-7	33	780	204
Orphanet:102003	Rare movement disorder	GO:0098794	postsynapse	3.824884853287358e-11	8.435783543925268e-7	23	381	204
Orphanet:102003	Rare movement disorder	GO:1903530	regulation of secretion by cell	5.365941024848553e-11	1.1834582930303483e-6	29	624	204
Orphanet:102003	Rare movement disorder	GO:0031667	response to nutrient levels	6.19523321532256e-11	1.3663586856393906e-6	27	546	204
Orphanet:102003	Rare movement disorder	GO:0043025	neuronal cell body	8.33195734628589e-11	1.837613192723353e-6	24	434	204
Orphanet:102003	Rare movement disorder	GO:0042391	regulation of membrane potential	1.6655021806144532e-10	3.6732650593451766e-6	21	340	204
Orphanet:102003	Rare movement disorder	GO:0098660	inorganic ion transmembrane transport	1.8141232960289244e-10	4.001048929391793e-6	29	660	204
Orphanet:102003	Rare movement disorder	GO:0043269	regulation of ion transport	2.478489635748815e-10	5.466308891644012e-6	27	583	204
Orphanet:102003	Rare movement disorder	GO:0070997	neuron death	2.8009694563735366e-10	6.177538136031835e-6	19	281	204
Orphanet:102003	Rare movement disorder	GO:0007611	learning or memory	2.820249589419177e-10	6.220060469463995e-6	17	218	204
Orphanet:102003	Rare movement disorder	GO:0071248	cellular response to metal ion	2.918805197538177e-10	6.437424863170449e-6	14	136	204
Orphanet:102003	Rare movement disorder	GO:1901214	regulation of neuron death	3.0673008577508654e-10	6.7649320417695336e-6	18	250	204
Orphanet:102003	Rare movement disorder	GO:0071287	cellular response to manganese ion	3.2008173889153113e-10	7.059402751252719e-6	6	10	204
Orphanet:102003	Rare movement disorder	GO:0070838	divalent metal ion transport	8.629070791243976e-10	1.903141563008859e-5	22	410	204
Orphanet:102003	Rare movement disorder	GO:0015837	amine transport	9.552308943838739e-10	2.1067617375636338e-5	11	79	204
Orphanet:102003	Rare movement disorder	GO:0051588	regulation of neurotransmitter transport	1.5014997023499177e-9	3.3115575935327435e-5	10	63	204
Orphanet:102003	Rare movement disorder	GO:0014070	response to organic cyclic compound	1.691818463100958e-9	3.731305620369163e-5	32	873	204
Orphanet:102003	Rare movement disorder	GO:0032880	regulation of protein localization	2.2146189326832655e-9	4.884342056032942e-5	33	933	204
Orphanet:102003	Rare movement disorder	GO:0072507	divalent inorganic cation homeostasis	2.2890719320045605e-9	5.048548146036058e-5	21	393	204
Orphanet:102003	Rare movement disorder	GO:0044463	cell projection part	2.599351289767071e-9	5.7328692695812755e-5	33	939	204
Orphanet:102003	Rare movement disorder	GO:0043068	positive regulation of programmed cell death	2.6389894713929607e-9	5.820291279157175e-5	25	561	204
Orphanet:102003	Rare movement disorder	GO:0030162	regulation of proteolysis	3.0945478401989135e-9	6.825025261558704e-5	28	701	204
Orphanet:102003	Rare movement disorder	GO:0034976	response to endoplasmic reticulum stress	3.749351829007708e-9	8.269195458876499e-5	17	258	204
Orphanet:102003	Rare movement disorder	GO:0006816	calcium ion transport	3.844936369290508e-9	8.480007162470216e-5	20	366	204
Orphanet:102003	Rare movement disorder	GO:0097305	response to alcohol	4.417994858840757e-9	9.74388766117329e-5	20	369	204
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0019752	carboxylic acid metabolic process	7.744471730575242e-12	1.7080432401783696e-7	60	967	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0046395	carboxylic acid catabolic process	4.070077608275824e-13	8.97655616505233e-9	29	219	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0051188	cofactor biosynthetic process	1.4988010832439613e-13	3.3056057890945567e-9	21	157	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:1990267	response to transition metal nanoparticle	1.4943601911454607e-13	3.2958114015713136e-9	18	150	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:1901605	alpha-amino acid metabolic process	7.405187574249794e-14	1.633214119500792e-9	28	258	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0009108	coenzyme biosynthetic process	7.693845560652335e-14	1.6968776384018724e-9	18	132	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0009063	cellular amino acid catabolic process	1.226796442210798e-13	2.705699553295915e-9	26	113	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0044283	small molecule biosynthetic process	3.780087354243733e-12	8.336982659784553e-8	35	530	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0006790	sulfur compound metabolic process	4.456435220845378e-12	9.828667879574482e-8	25	360	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0043603	cellular amide metabolic process	1.1604606164894449e-11	2.5593958896674707e-7	37	955	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0050812	regulation of acyl-CoA biosynthetic process	2.8182345346294824e-11	6.215616266125323e-7	7	13	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0043209	myelin sheath	5.259714885852418e-11	1.1600301180747508e-6	16	168	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0043648	dicarboxylic acid metabolic process	1.0366751901358384e-10	2.2863871318445916e-6	13	103	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0008652	cellular amino acid biosynthetic process	2.5180113549794214e-10	5.553474043407114e-6	12	89	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0006979	response to oxidative stress	3.069055010129773e-10	6.768800824841215e-6	22	386	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0006766	vitamin metabolic process	1.6104351185930454e-9	3.551814654056962e-5	13	128	205
MESH:D020739	Brain Diseases, Metabolic, Inborn	GO:0072593	reactive oxygen species metabolic process	3.479949106655056e-9	7.675027754727726e-5	16	223	205
DOID:2742	auditory system disease	GO:0009887	organ morphogenesis	1.7275070263167436e-13	3.810016746541578e-9	47	950	205
DOID:2742	auditory system disease	GO:0090596	sensory organ morphogenesis	1.3011813848606835e-13	2.8697555443102374e-9	32	239	205
DOID:319	spinal cord disease	GO:0036293	response to decreased oxygen levels	2.4555912858659212e-12	5.415806580977289e-8	22	302	205
DOID:319	spinal cord disease	GO:0036477	somatodendritic compartment	1.093691803788488e-11	2.41213727325551e-7	33	649	205
DOID:319	spinal cord disease	GO:0043025	neuronal cell body	1.0941247907680918e-11	2.4130922260390264e-7	26	434	205
DOID:319	spinal cord disease	GO:0000302	response to reactive oxygen species	2.8461011325475738e-11	6.277076047833674e-7	18	216	205
DOID:319	spinal cord disease	GO:0071363	cellular response to growth factor stimulus	8.556055863806478e-11	1.8870381207625186e-6	28	594	205
DOID:319	spinal cord disease	GO:0009792	embryo development ending in birth or egg hatching	1.0779699355367711e-10	2.3774626928263487e-6	27	558	205
DOID:319	spinal cord disease	GO:0010038	response to metal ion	1.3866519044114511e-10	3.0582607751794555e-6	21	335	205
DOID:319	spinal cord disease	GO:0051402	neuron apoptotic process	1.8353829567274715e-10	4.0479371110624385e-6	17	211	205
DOID:319	spinal cord disease	GO:0009991	response to extracellular stimulus	1.8851953331733284e-10	4.157798307313776e-6	27	573	205
DOID:319	spinal cord disease	GO:0007417	central nervous system development	1.9169277276631647e-10	4.22778410336111e-6	34	889	205
DOID:319	spinal cord disease	GO:0031175	neuron projection development	2.0754331586658736e-10	4.577367831437584e-6	32	796	205
DOID:319	spinal cord disease	GO:0009636	response to toxic substance	3.109220658714662e-10	6.857386162795187e-6	18	249	205
DOID:319	spinal cord disease	GO:0034599	cellular response to oxidative stress	3.277518256794565e-10	7.228566515360413e-6	17	219	205
DOID:319	spinal cord disease	GO:0031667	response to nutrient levels	3.397818693073873e-10	7.493889127574427e-6	26	546	205
DOID:319	spinal cord disease	GO:0043009	chordate embryonic development	4.2464620708670964e-10	9.365572097297381e-6	26	552	205
DOID:319	spinal cord disease	GO:0043279	response to alkaloid	4.5843062679296054e-10	1.0110687473918745e-5	14	140	205
DOID:319	spinal cord disease	GO:0019725	cellular homeostasis	1.660362403121951e-9	3.661929280085463e-5	30	771	205
DOID:319	spinal cord disease	GO:0002009	morphogenesis of an epithelium	1.8358381481675679e-9	4.048941035783571e-5	24	506	205
DOID:319	spinal cord disease	GO:0048566	embryonic digestive tract development	2.020802081226236e-9	4.456878990144464e-5	8	33	205
DOID:319	spinal cord disease	GO:1901214	regulation of neuron death	2.5089561539459737e-9	5.533502797527845e-5	17	250	205
DOID:319	spinal cord disease	GO:0044463	cell projection part	2.951622057878467e-9	6.509802448650959e-5	33	939	205
DOID:319	spinal cord disease	GO:0043523	regulation of neuron apoptotic process	2.963984613302273e-9	6.537068064638163e-5	15	190	205
Orphanet:183512	Rare genetic epilepsy	GO:0043005	neuron projection	4.721112389916016e-12	1.0412413375959773e-7	51	941	207
Orphanet:183512	Rare genetic epilepsy	GO:0044463	cell projection part	3.552491634195576e-12	7.835020299218343e-8	40	939	207
Orphanet:183512	Rare genetic epilepsy	GO:0010001	glial cell differentiation	4.0900616227190767e-13	9.020630908906924e-9	19	176	207
Orphanet:183512	Rare genetic epilepsy	GO:0021537	telencephalon development	2.0605739337042905e-13	4.544595810784813e-9	25	226	207
Orphanet:183512	Rare genetic epilepsy	GO:0048666	neuron development	1.71940239823698e-12	3.792141989311659e-8	46	926	207
Orphanet:183512	Rare genetic epilepsy	GO:0048667	cell morphogenesis involved in neuron differentiation	5.4714011099576965e-12	1.20671751480117e-7	30	495	207
Orphanet:183512	Rare genetic epilepsy	GO:0070997	neuron death	5.849987161354875e-12	1.2902146684368176e-7	21	281	207
Orphanet:183512	Rare genetic epilepsy	GO:0007409	axonogenesis	6.390221685137476e-12	1.4093633926570703e-7	30	406	207
Orphanet:183512	Rare genetic epilepsy	GO:0097285	cell-type specific apoptotic process	9.280909374353996e-12	2.0469045625137738e-7	26	429	207
Orphanet:183512	Rare genetic epilepsy	GO:0021954	central nervous system neuron development	1.0683454121362956e-11	2.3562358064666e-7	12	68	207
Orphanet:183512	Rare genetic epilepsy	GO:0036477	somatodendritic compartment	1.2500223078859563e-11	2.7569242000424765e-7	32	649	207
Orphanet:183512	Rare genetic epilepsy	GO:0060284	regulation of cell development	4.50550707853381e-11	9.936895861706319e-7	34	828	207
Orphanet:183512	Rare genetic epilepsy	GO:0048167	regulation of synaptic plasticity	4.576683476642529e-11	1.0093875407735098e-6	15	140	207
Orphanet:183512	Rare genetic epilepsy	GO:1901214	regulation of neuron death	4.920652774131895e-11	1.0852499693347895e-6	19	250	207
Orphanet:183512	Rare genetic epilepsy	GO:0035270	endocrine system development	1.736133459218081e-10	3.829042344305478e-6	14	129	207
Orphanet:183512	Rare genetic epilepsy	GO:0050767	regulation of neurogenesis	2.3922375191887113e-10	5.276079848570703e-6	29	658	207
Orphanet:183512	Rare genetic epilepsy	GO:0021782	glial cell development	7.273707192112511e-10	1.6042161212204142e-5	11	76	207
Orphanet:183512	Rare genetic epilepsy	GO:0060627	regulation of vesicle-mediated transport	7.762207543393629e-10	1.711954873695465e-5	23	440	207
Orphanet:183512	Rare genetic epilepsy	GO:0043408	regulation of MAPK cascade	8.461928935332708e-10	1.8662784266876287e-5	28	651	207
Orphanet:183512	Rare genetic epilepsy	GO:0021761	limbic system development	1.1200763649910073e-9	2.4703284229876665e-5	12	100	207
Orphanet:183512	Rare genetic epilepsy	GO:0030425	dendrite	1.2434627771895634e-9	2.742457155091582e-5	23	451	207
Orphanet:183512	Rare genetic epilepsy	GO:0044297	cell body	1.3911384266762639e-9	3.0681558000345e-5	24	494	207
Orphanet:183512	Rare genetic epilepsy	GO:0048708	astrocyte differentiation	1.4693937178122951e-9	3.240747844635017e-5	10	62	207
Orphanet:183512	Rare genetic epilepsy	GO:0072358	cardiovascular system development	1.7482630898513207e-9	3.855794244667088e-5	33	910	207
Orphanet:183512	Rare genetic epilepsy	GO:0045664	regulation of neuron differentiation	2.2265929100484527e-9	4.9107506631118625e-5	25	548	207
Orphanet:183512	Rare genetic epilepsy	GO:0080135	regulation of cellular response to stress	2.28520047329539e-9	5.040009643852983e-5	28	681	207
Orphanet:183512	Rare genetic epilepsy	GO:0043523	regulation of neuron apoptotic process	3.3862190829125893e-9	7.468306187363716e-5	15	190	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0048644	muscle organ morphogenesis	1.270095140171179e-13	2.8011948316475355e-9	19	70	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0070848	response to growth factor	9.533263067851294e-12	2.102561169614603e-7	31	621	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0048514	blood vessel morphogenesis	1.2595480214372401e-11	2.777933161279833e-7	27	484	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0035265	organ growth	1.954902906220468e-11	4.3115383596692425e-7	15	132	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0051093	negative regulation of developmental process	5.769940081279401e-11	1.272560284926172e-6	33	788	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0086004	regulation of cardiac muscle cell contraction	8.181610944291151e-11	1.8044542937634134e-6	10	47	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0010623	developmental programmed cell death	1.543338790099824e-10	3.403833701565162e-6	9	36	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0007167	enzyme linked receptor protein signaling pathway	2.161467671513151e-10	4.767116949522254e-6	35	935	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0040008	regulation of growth	1.1958106727050222e-9	2.6373604386509264e-5	27	617	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0045765	regulation of angiogenesis	1.4589850438895269e-9	3.2177915142983515e-5	16	208	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0048538	thymus development	2.0122495891783387e-9	4.438016468932826e-5	9	47	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0048638	regulation of developmental growth	2.833290047021819e-9	6.248821198706622e-5	18	283	207
Orphanet:98717	Transposition of the great arteries and conotruncal cardiac anomaly	GO:0070482	response to oxygen levels	3.3225177054063693e-9	7.327812799273747e-5	19	321	207
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0009887	organ morphogenesis	1.8767210008263646e-12	4.139108167322547e-8	49	950	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0055114	oxidation-reduction process	1.3591350267461166e-12	2.99757230148856e-8	41	949	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0048644	muscle organ morphogenesis	1.2634338020234281e-13	2.7865032503626708e-9	15	70	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0070482	response to oxygen levels	3.0526692285093304e-12	6.732661983477328e-8	23	321	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0036293	response to decreased oxygen levels	3.2223113066720543e-12	7.106807586865216e-8	22	302	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0001666	response to hypoxia	3.777422818984633e-12	8.331106027270607e-8	22	292	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0009611	response to wounding	5.4322102371884284e-12	1.198073967811908e-7	37	875	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0060548	negative regulation of cell death	7.992606576578964e-12	1.7627693804644906e-7	40	867	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0070848	response to growth factor	9.396927680427325e-12	2.0724923999182465e-7	31	621	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0023014	signal transduction by protein phosphorylation	1.5652257268072844e-11	3.452105340473466e-7	36	879	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0071363	cellular response to growth factor stimulus	2.573941060290963e-11	5.676827008471719e-7	29	594	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:1901698	response to nitrogen compound	4.1656456062355574e-11	9.187331384552522e-7	35	870	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0001568	blood vessel development	4.536160336243711e-11	1.0004501621585504e-6	28	569	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0007167	enzyme linked receptor protein signaling pathway	5.519706913759137e-11	1.2173713598295777e-6	36	935	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0008285	negative regulation of cell proliferation	1.1568546121054624e-10	2.5514428469985972e-6	29	634	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0051093	negative regulation of developmental process	2.337778859384798e-10	5.155971274373172e-6	32	788	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0050678	regulation of epithelial cell proliferation	3.0725044730672835e-10	6.776408615349894e-6	19	277	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:2000145	regulation of cell motility	3.360564049259551e-10	7.41172401064194e-6	30	709	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0030198	extracellular matrix organization	5.31561350491927e-10	1.172358558509945e-5	20	320	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0072593	reactive oxygen species metabolic process	5.441612715983979e-10	1.2001476845102665e-5	17	223	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:2001233	regulation of apoptotic signaling pathway	6.460865176194375e-10	1.4249438146096693e-5	21	359	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0043065	positive regulation of apoptotic process	6.841187616402067e-10	1.5088239287974758e-5	26	556	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0032403	protein complex binding	7.488194508908919e-10	1.651521298939862e-5	34	924	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0040007	growth	1.0338885303440293e-9	2.2802411536737566e-5	34	936	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0030334	regulation of cell migration	1.2780634328635188e-9	2.8187689011804906e-5	28	660	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0030155	regulation of cell adhesion	1.5263315056301963e-9	3.366324135667398e-5	27	621	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0007423	sensory organ development	1.5335347436362667e-9	3.382210877089786e-5	24	494	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0034109	homotypic cell-cell adhesion	1.595933718512299e-9	3.5198318161788755e-5	24	495	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0051241	negative regulation of multicellular organismal process	2.3210741106893806e-9	5.119128951125429e-5	34	966	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0016459	myosin complex	2.9061759665438558e-9	6.409571094212474e-5	10	66	208
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	GO:0016049	cell growth	4.294213873379249e-9	9.470888697737934e-5	23	479	208
Orphanet:165711	Rare abdominal surgical disease	GO:0030323	respiratory tube development	5.873079800267078e-13	1.295307749948904e-8	21	179	208
Orphanet:165711	Rare abdominal surgical disease	GO:0044463	cell projection part	4.489741911584133e-13	9.902125785998805e-9	38	939	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001085	RNA polymerase II transcription factor binding	1.0791367799356522e-13	2.380036168148081e-9	17	104	208
Orphanet:165711	Rare abdominal surgical disease	GO:0090596	sensory organ morphogenesis	1.9628743075372768e-13	4.329119285273464e-9	21	239	208
Orphanet:165711	Rare abdominal surgical disease	GO:0043010	camera-type eye development	6.319389456166391e-13	1.3937413445574975e-8	22	283	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001822	kidney development	7.553957459549565e-13	1.6660253177036566e-8	23	262	208
Orphanet:165711	Rare abdominal surgical disease	GO:0010721	negative regulation of cell development	9.616751839303106e-13	2.1209746181583e-8	23	299	208
Orphanet:165711	Rare abdominal surgical disease	GO:0003151	outflow tract morphogenesis	1.858513343222512e-12	4.09895117847725e-8	12	59	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048592	eye morphogenesis	2.981503932630858e-12	6.575706923417357e-8	16	136	208
Orphanet:165711	Rare abdominal surgical disease	GO:0031016	pancreas development	3.298694650766265e-12	7.275271052264998e-8	13	78	208
Orphanet:165711	Rare abdominal surgical disease	GO:0060411	cardiac septum morphogenesis	5.0959236830294685e-12	1.1239059682921493e-7	11	49	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001701	in utero embryonic development	8.134604101428522e-12	1.7940869345700605e-7	22	312	208
Orphanet:165711	Rare abdominal surgical disease	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	8.166356479932801e-12	1.8010899216491794e-7	34	623	208
Orphanet:165711	Rare abdominal surgical disease	GO:2000145	regulation of cell motility	1.1201595206955517e-11	2.470511822894039e-7	35	709	208
Orphanet:165711	Rare abdominal surgical disease	GO:0003231	cardiac ventricle development	1.1290079982018142e-11	2.490027140034101e-7	14	105	208
Orphanet:165711	Rare abdominal surgical disease	GO:0030334	regulation of cell migration	1.1323719739664284e-11	2.497446388582958e-7	32	660	208
Orphanet:165711	Rare abdominal surgical disease	GO:0040008	regulation of growth	1.1634471164256865e-11	2.5659826152768517e-7	31	617	208
Orphanet:165711	Rare abdominal surgical disease	GO:2000027	regulation of organ morphogenesis	2.0039747639089e-11	4.419766341801079e-7	19	236	208
Orphanet:165711	Rare abdominal surgical disease	GO:0045664	regulation of neuron differentiation	2.195643666880187e-11	4.842492107304253e-7	28	548	208
Orphanet:165711	Rare abdominal surgical disease	GO:0009798	axis specification	2.200317705813859e-11	4.852800700172466e-7	13	90	208
Orphanet:165711	Rare abdominal surgical disease	GO:0044212	transcription regulatory region DNA binding	2.939970489279631e-11	6.484104914106226e-7	34	807	208
Orphanet:165711	Rare abdominal surgical disease	GO:0035050	embryonic heart tube development	3.1877611661457195e-11	7.030607251934384e-7	12	74	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001947	heart looping	3.625633127057881e-11	7.996333861726157e-7	11	58	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048638	regulation of developmental growth	5.966926952538643e-11	1.3160057393823976e-6	20	283	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	6.739686586598737e-11	1.4864378766743513e-6	21	317	208
Orphanet:165711	Rare abdominal surgical disease	GO:0002067	glandular epithelial cell differentiation	8.57408588572639e-11	1.8910146420969554e-6	10	47	208
Orphanet:165711	Rare abdominal surgical disease	GO:0051961	negative regulation of nervous system development	9.837419767677602e-11	2.169642929761295e-6	19	259	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048546	digestive tract morphogenesis	1.3347112304273878e-10	2.943705618707604e-6	10	49	208
Orphanet:165711	Rare abdominal surgical disease	GO:0035272	exocrine system development	1.6519541290449524e-10	3.6433848316086426e-6	10	50	208
Orphanet:165711	Rare abdominal surgical disease	GO:0050768	negative regulation of neurogenesis	1.8920331967819948e-10	4.1728792155026895e-6	18	238	208
Orphanet:165711	Rare abdominal surgical disease	GO:0008585	female gonad development	2.2734236715393763e-10	5.0140359075800944e-6	13	108	208
Orphanet:165711	Rare abdominal surgical disease	GO:0043066	negative regulation of apoptotic process	2.8818902819693903e-10	6.35600901688349e-6	32	795	208
Orphanet:165711	Rare abdominal surgical disease	GO:0014829	vascular smooth muscle contraction	3.405524751087796e-10	7.5108848385241345e-6	7	17	208
Orphanet:165711	Rare abdominal surgical disease	GO:0045995	regulation of embryonic development	4.0397696299265817e-10	8.909711918803076e-6	13	113	208
Orphanet:165711	Rare abdominal surgical disease	GO:0016331	morphogenesis of embryonic epithelium	6.103658689582403e-10	1.346161923987399e-5	14	141	208
Orphanet:165711	Rare abdominal surgical disease	GO:0003682	chromatin binding	6.275191477556064e-10	1.3839934803749898e-5	23	433	208
Orphanet:165711	Rare abdominal surgical disease	GO:0021537	telencephalon development	6.694931276030047e-10	1.476567092928427e-5	17	226	208
Orphanet:165711	Rare abdominal surgical disease	GO:0001657	ureteric bud development	8.270908402607802e-10	1.8241488481951507e-5	12	97	208
Orphanet:165711	Rare abdominal surgical disease	GO:0000976	transcription regulatory region sequence-specific DNA binding	1.0105938308413442e-9	2.2288646939205847e-5	28	653	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048705	skeletal system morphogenesis	1.1783470865722734e-9	2.598844499435149e-5	16	204	208
Orphanet:165711	Rare abdominal surgical disease	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	1.2857153119938403e-9	2.8356451206024147e-5	26	573	208
Orphanet:165711	Rare abdominal surgical disease	GO:0021915	neural tube development	1.5115118046082898e-9	3.333639285063583e-5	14	151	208
Orphanet:165711	Rare abdominal surgical disease	GO:0031018	endocrine pancreas development	1.713881481180124e-9	3.7799656067427634e-5	9	46	208
Orphanet:165711	Rare abdominal surgical disease	GO:0000904	cell morphogenesis involved in differentiation	2.059853176916704e-9	4.5430061816897904e-5	29	720	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048566	embryonic digestive tract development	2.2662159926412073e-9	4.998139371770183e-5	8	33	208
Orphanet:165711	Rare abdominal surgical disease	GO:0035148	tube formation	2.562237200187667e-9	5.6510141450138995e-5	13	131	208
Orphanet:165711	Rare abdominal surgical disease	GO:0097285	cell-type specific apoptotic process	2.8749994607224494e-9	6.340811310623362e-5	22	429	208
Orphanet:165711	Rare abdominal surgical disease	GO:0014824	artery smooth muscle contraction	3.3728073667305125e-9	7.438726647324145e-5	5	7	208
Orphanet:165711	Rare abdominal surgical disease	GO:0048663	neuron fate commitment	3.3831139001350152e-9	7.461457706747776e-5	10	67	208
Orphanet:165711	Rare abdominal surgical disease	GO:0060324	face development	3.750054489159993e-9	8.270745175842364e-5	9	50	208
Orphanet:165711	Rare abdominal surgical disease	GO:0072091	regulation of stem cell proliferation	3.8075034236584315e-9	8.397448800878671e-5	11	88	208
Orphanet:165711	Rare abdominal surgical disease	GO:0021675	nerve development	3.928302794165006e-9	8.663871812530921e-5	10	68	208
Orphanet:165711	Rare abdominal surgical disease	GO:0016049	cell growth	4.294213873379249e-9	9.470888697737934e-5	23	479	208
DOID:480	movement disease	GO:0019693	ribose phosphate metabolic process	6.043388012244577e-12	1.3328692261005415e-7	29	531	209
DOID:480	movement disease	GO:0043279	response to alkaloid	5.2462922894847e-11	1.1570697644458505e-6	15	140	209
DOID:480	movement disease	GO:0072503	cellular divalent inorganic cation homeostasis	2.5889945742818554e-10	5.710027533578632e-6	22	375	209
DOID:480	movement disease	GO:0060359	response to ammonium ion	4.672172648767514e-10	1.0304476776856752e-5	12	92	209
DOID:480	movement disease	GO:0006874	cellular calcium ion homeostasis	4.937836806107043e-10	1.0890399075869084e-5	21	352	209
DOID:480	movement disease	GO:0042220	response to cocaine	2.1897462731956807e-9	4.829485405533074e-5	9	47	209
DOID:480	movement disease	GO:0007612	learning	2.470459059544794e-9	5.448597455826043e-5	13	130	209
DOID:480	movement disease	GO:0044057	regulation of system process	2.929586906397219e-9	6.461203922059067e-5	24	508	209
DOID:480	movement disease	GO:0044070	regulation of anion transport	3.934657488713356e-9	8.677887091357306e-5	13	135	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.8617555254159015e-12	1.292810181130477e-7	43	996	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0009887	organ morphogenesis	1.857847209407737e-12	4.097482020348764e-8	50	950	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0003007	heart morphogenesis	9.530154443382344e-13	2.101875562487976e-8	21	216	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0060562	epithelial tube morphogenesis	2.3425705819590803e-13	5.166539418510752e-9	25	301	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0033044	regulation of chromosome organization	2.4280577548552174e-13	5.355081378333182e-9	23	271	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0060541	respiratory system development	4.692912725090537e-13	1.0350219015187179e-8	19	202	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000278	mitotic cell cycle	8.629763570411342e-13	1.9032943554542214e-8	41	927	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0043414	macromolecule methylation	8.896217096321379e-13	1.9620606805936802e-8	21	248	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0043009	chordate embryonic development	2.3195889653493396e-12	5.1158534630779684e-8	31	552	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:1903308	regulation of chromatin modification	3.974931495065448e-12	8.766711412366845e-8	16	139	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0030900	forebrain development	4.651612428574481e-12	1.0259131211221018e-7	27	357	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0048589	developmental growth	4.810374321095878e-12	1.060928056517696e-7	32	558	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0005694	chromosome	4.947597886939548e-12	1.0911927139645172e-7	44	876	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000228	nuclear chromosome	5.47817347040791e-12	1.2082111588984645e-7	29	520	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0016570	histone modification	7.182254790905063e-12	1.5840462941341116e-7	30	418	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0003682	chromatin binding	8.161915587834301e-12	1.800110482896855e-7	36	433	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0016571	histone methylation	8.263500994587503e-12	1.8225151443562737e-7	15	123	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0001067	regulatory region nucleic acid binding	8.659184480563908e-12	1.90978313718837e-7	37	811	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0031056	regulation of histone modification	9.11692943361686e-12	2.0107387865841986e-7	15	124	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0044212	transcription regulatory region DNA binding	9.153677815731953e-12	2.0188436422596823e-7	37	807	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0098727	maintenance of cell number	9.245271215263529e-12	2.0390445665263712e-7	16	147	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0044454	nuclear chromosome part	1.3888445948850858e-11	3.063096754019057e-7	27	486	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.5388912366631757e-11	3.394024622460634e-7	35	732	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000904	cell morphogenesis involved in differentiation	1.6942780511897126e-11	3.736730241898911e-7	34	720	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0031175	neuron projection development	1.7508550165246106e-11	3.8615107389450287e-7	35	796	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0061564	axon development	3.52999851571667e-11	7.785411726413116e-7	25	440	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0060284	regulation of cell development	5.637057487462016e-11	1.2432530288597476e-6	34	828	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0034968	histone lysine methylation	6.123790363687931e-11	1.3506019647113732e-6	13	97	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0006259	DNA metabolic process	7.086187192584248e-11	1.5628585853244559e-6	36	937	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0019827	stem cell population maintenance	8.685907548766636e-11	1.9156769098804816e-6	15	145	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0021537	telencephalon development	8.765888015460632e-11	1.9333166018098424e-6	18	226	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0003690	double-stranded DNA binding	1.0124978633285764e-10	2.2330640375711752e-6	32	756	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0030324	lung development	1.3002032783759887e-10	2.867598330458243e-6	16	175	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0021915	neural tube development	1.5517453988422858e-10	3.4223744771466613e-6	15	151	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:1990837	sequence-specific double-stranded DNA binding	1.6103807176648388e-10	3.551694672809802e-6	30	683	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0001501	skeletal system development	2.0012980161965288e-10	4.413862774721444e-6	25	482	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0001656	metanephros development	2.7516666722959826e-10	6.06880084574879e-6	12	88	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0050767	regulation of neurogenesis	2.988737035636291e-10	6.591659532095839e-6	29	658	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000989	transcription factor activity, transcription factor binding	3.0411062557078594e-10	6.707159846963684e-6	27	574	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0072080	nephron tubule development	4.1033010322877317e-10	9.049830426710592e-6	12	91	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0031060	regulation of histone methylation	4.695719368896789e-10	1.0356409068101868e-5	10	55	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0016331	morphogenesis of embryonic epithelium	6.4993688209114e-10	1.4334357934520092e-5	14	141	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000785	chromatin	8.583357358205035e-10	1.8930594653521204e-5	23	438	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0001658	branching involved in ureteric bud morphogenesis	9.703111647496598e-10	2.1400212738553748e-5	10	59	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0035107	appendage morphogenesis	1.031875251911174e-9	2.2758008680900943e-5	14	146	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0035108	limb morphogenesis	1.031875251911174e-9	2.2758008680900943e-5	14	146	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0000976	transcription regulatory region sequence-specific DNA binding	1.1280613110287163e-9	2.487939221473834e-5	28	653	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0003712	transcription cofactor activity	1.2790700720799464e-9	2.8209890439723218e-5	25	528	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0009948	anterior/posterior axis specification	2.6691502341691375e-9	5.886810841460033e-5	9	48	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0061053	somite development	2.748198890678566e-9	6.061152653391577e-5	11	85	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0032403	protein complex binding	3.2765470336926228e-9	7.22642448280908e-5	33	924	209
Orphanet:102283	Multiple congenital anomalies/dysmorphic syndrome-intellectual disability	GO:0051568	histone H3-K4 methylation	3.910972878884422e-9	8.625650684379593e-5	9	50	209
Orphanet:68378	Congenital limb malformation	GO:0009799	specification of symmetry	6.439293542825908e-15	1.420186190870254e-10	17	122	209
Orphanet:68378	Congenital limb malformation	GO:0009855	determination of bilateral symmetry	1.1801670751765414e-13	2.602858484301862e-9	17	121	209
Orphanet:68378	Congenital limb malformation	GO:0048732	gland development	1.936839577609817e-11	4.271699688418451e-7	25	421	209
Orphanet:68378	Congenital limb malformation	GO:0007417	central nervous system development	2.6546431719509656e-11	5.854815515737855e-7	36	889	209
Orphanet:68378	Congenital limb malformation	GO:0007420	brain development	1.0103284875384588e-10	2.228279479266071e-6	30	669	209
Orphanet:68378	Congenital limb malformation	GO:0061371	determination of heart left/right asymmetry	1.3659624542583515e-9	3.0126301928667942e-5	10	61	209
Orphanet:68378	Congenital limb malformation	GO:0003143	embryonic heart tube morphogenesis	1.8986016092625846e-9	4.18736584922863e-5	10	63	209
Orphanet:68378	Congenital limb malformation	GO:0060606	tube closure	2.1203540034875346e-9	4.6764407546917575e-5	11	83	209
Orphanet:68378	Congenital limb malformation	GO:0003279	cardiac septum development	2.416067901300778e-9	5.328637756318866e-5	11	84	209
Orphanet:68378	Congenital limb malformation	GO:0021510	spinal cord development	2.468873105954117e-9	5.445099635181805e-5	12	106	209
Orphanet:68378	Congenital limb malformation	GO:0061053	somite development	2.748198890678566e-9	6.061152653391577e-5	11	85	209
DOID:2723	dermatitis	GO:0009607	response to biotic stimulus	3.905098466816526e-12	8.612694668563847e-8	42	934	210
DOID:2723	dermatitis	GO:0043627	response to estrogen	1.1450840275983865e-12	2.5254828228682413e-8	21	217	210
DOID:2723	dermatitis	GO:0002526	acute inflammatory response	3.4372504842394846e-13	7.580855942990183e-9	18	141	210
DOID:2723	dermatitis	GO:0010038	response to metal ion	1.2044809594158323e-12	2.6564827559916182e-8	28	335	210
DOID:2723	dermatitis	GO:0002237	response to molecule of bacterial origin	1.2350120925930241e-12	2.7238191702139147e-8	28	333	210
DOID:2723	dermatitis	GO:0097190	apoptotic signaling pathway	3.639644141628651e-12	8.027235154361989e-8	31	564	210
DOID:2723	dermatitis	GO:0050663	cytokine secretion	3.699818229563334e-12	8.159949105301934e-8	17	162	210
DOID:2723	dermatitis	GO:0006809	nitric oxide biosynthetic process	4.1737724387758135e-12	9.205255113720057e-8	12	62	210
DOID:2723	dermatitis	GO:0050778	positive regulation of immune response	4.501732320250085e-12	9.928570632311562e-8	35	603	210
DOID:2723	dermatitis	GO:0034110	regulation of homotypic cell-cell adhesion	4.863887070882811e-12	1.0727302934832039e-7	22	304	210
DOID:2723	dermatitis	GO:0031349	positive regulation of defense response	6.173839217638033e-12	1.3616402394500682e-7	27	398	210
DOID:2723	dermatitis	GO:0002253	activation of immune response	7.980283101005625e-12	1.7600514379267906e-7	28	475	210
DOID:2723	dermatitis	GO:0032355	response to estradiol	7.981948435542563e-12	1.7604187274589123e-7	16	145	210
DOID:2723	dermatitis	GO:0019221	cytokine-mediated signaling pathway	8.31634761055966e-12	1.834170465508933e-7	29	534	210
DOID:2723	dermatitis	GO:0031667	response to nutrient levels	8.5149665096651e-12	1.877975863706638e-7	29	546	210
DOID:2723	dermatitis	GO:0070486	leukocyte aggregation	8.968825682131865e-12	1.9780745041941827e-7	27	432	210
DOID:2723	dermatitis	GO:1990267	response to transition metal nanoparticle	1.3366197038067185e-11	2.9479147567457176e-7	16	150	210
DOID:2723	dermatitis	GO:0002764	immune response-regulating signaling pathway	1.4482415267025317e-11	3.1940966871424337e-7	26	451	210
DOID:2723	dermatitis	GO:0045087	innate immune response	1.4508505508104008e-11	3.199850889812339e-7	38	783	210
DOID:2723	dermatitis	GO:0002252	immune effector process	1.82700521378365e-11	4.0294599989998403e-7	34	757	210
DOID:2723	dermatitis	GO:0002757	immune response-activating signal transduction	1.9178991728097117e-11	4.229926625631819e-7	25	419	210
DOID:2723	dermatitis	GO:1903037	regulation of leukocyte cell-cell adhesion	2.041833369048618e-11	4.503263495436727e-7	21	294	210
DOID:2723	dermatitis	GO:0070489	T cell aggregation	2.116018471554071e-11	4.6668787390125033e-7	25	424	210
DOID:2723	dermatitis	GO:0042110	T cell activation	2.116018471554071e-11	4.6668787390125033e-7	25	424	210
DOID:2723	dermatitis	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2.5159319072542985e-11	5.548887821449355e-7	18	209	210
DOID:2723	dermatitis	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	3.2224889423559944e-11	7.107199362366146e-7	18	212	210
DOID:2723	dermatitis	GO:1903035	negative regulation of response to wounding	3.2642333280819e-11	7.199266605084631e-7	16	159	210
DOID:2723	dermatitis	GO:0051046	regulation of secretion	3.695221906241386e-11	8.149811914215377e-7	31	675	210
DOID:2723	dermatitis	GO:0050729	positive regulation of inflammatory response	3.911904133957478e-11	8.627704567443217e-7	14	114	210
DOID:2723	dermatitis	GO:0050707	regulation of cytokine secretion	6.904865568202467e-11	1.5228681010670542e-6	15	142	210
DOID:2723	dermatitis	GO:0002697	regulation of immune effector process	7.070621865779003e-11	1.5594256524975592e-6	24	418	210
DOID:2723	dermatitis	GO:0050863	regulation of T cell activation	7.638945032084621e-11	1.6847693268262631e-6	20	284	210
DOID:2723	dermatitis	GO:0002700	regulation of production of molecular mediator of immune response	8.42608205431361e-11	1.8583723970788668e-6	13	99	210
DOID:2723	dermatitis	GO:0007584	response to nutrient	9.030054481939942e-11	1.991578515991854e-6	17	197	210
DOID:2723	dermatitis	GO:0050728	negative regulation of inflammatory response	9.58791934735359e-11	2.1146156120588344e-6	13	100	210
DOID:2723	dermatitis	GO:0048871	multicellular organismal homeostasis	1.0025580365891074e-10	2.2111417496972763e-6	21	321	210
DOID:2723	dermatitis	GO:0007568	aging	1.1142797795571369e-10	2.4575440538132654e-6	20	290	210
DOID:2723	dermatitis	GO:0030099	myeloid cell differentiation	1.3978995738739286e-10	3.0830675101789495e-6	21	327	210
DOID:2723	dermatitis	GO:0002699	positive regulation of immune effector process	1.5082646243058662e-10	3.326477628906588e-6	15	150	210
DOID:2723	dermatitis	GO:0045785	positive regulation of cell adhesion	2.0035195724688037e-10	4.418762417079947e-6	22	368	210
DOID:2723	dermatitis	GO:1901701	cellular response to oxygen-containing compound	2.22420193374262e-10	4.905477364869348e-6	34	873	210
DOID:2723	dermatitis	GO:0002573	myeloid leukocyte differentiation	2.7216429110410445e-10	6.002583440301024e-6	16	183	210
DOID:2723	dermatitis	GO:0002443	leukocyte mediated immunity	4.094052874492604e-10	9.029433614693438e-6	19	279	210
DOID:2723	dermatitis	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	4.1146608342756963e-10	9.074884469995048e-6	15	161	210
DOID:2723	dermatitis	GO:0045471	response to ethanol	4.713170964620872e-10	1.0394898562471333e-5	14	137	210
DOID:2723	dermatitis	GO:0002675	positive regulation of acute inflammatory response	5.741205288956053e-10	1.2662228264792574e-5	8	28	210
DOID:2723	dermatitis	GO:0032652	regulation of interleukin-1 production	5.931611868348341e-10	1.3082169975642266e-5	10	56	210
DOID:2723	dermatitis	GO:0006898	receptor-mediated endocytosis	6.341929204012331e-10	1.3987124859449196e-5	18	254	210
DOID:2723	dermatitis	GO:0019725	cellular homeostasis	7.235430032892509e-10	1.595774093754443e-5	31	771	210
DOID:2723	dermatitis	GO:1902105	regulation of leukocyte differentiation	7.246914179859232e-10	1.5983069223679536e-5	17	225	210
DOID:2723	dermatitis	GO:0046425	regulation of JAK-STAT cascade	8.341410895340573e-10	1.8396981729673634e-5	14	143	210
DOID:2723	dermatitis	GO:0071466	cellular response to xenobiotic stimulus	1.0410633466406694e-9	2.2960652110159963e-5	12	98	210
DOID:2723	dermatitis	GO:0071216	cellular response to biotic stimulus	1.324318987805384e-9	2.9207855276047745e-5	15	175	210
DOID:2723	dermatitis	GO:0000165	MAPK cascade	1.513162373179e-9	3.3372796140462846e-5	32	843	210
DOID:2723	dermatitis	GO:0034112	positive regulation of homotypic cell-cell adhesion	1.67731473155186e-9	3.699317640437627e-5	16	207	210
DOID:2723	dermatitis	GO:0002703	regulation of leukocyte mediated immunity	1.7117786077491814e-9	3.77532771939082e-5	14	151	210
DOID:2723	dermatitis	GO:1903039	positive regulation of leukocyte cell-cell adhesion	1.7993408985006454e-9	3.9684463516431734e-5	16	208	210
DOID:2723	dermatitis	GO:0031960	response to corticosteroid	1.8121779632451762e-9	3.996758497937236e-5	15	179	210
DOID:2723	dermatitis	GO:0071222	cellular response to lipopolysaccharide	1.867185739357069e-9	4.118078148152016e-5	14	152	210
DOID:2723	dermatitis	GO:0016491	oxidoreductase activity	1.877273891892628e-9	4.140327568569191e-5	29	710	210
DOID:2723	dermatitis	GO:0097193	intrinsic apoptotic signaling pathway	1.902183299762328e-9	4.195265267625814e-5	18	272	210
DOID:2723	dermatitis	GO:1903426	regulation of reactive oxygen species biosynthetic process	1.988370690320096e-9	4.3853515575009716e-5	10	63	210
DOID:2723	dermatitis	GO:0032729	positive regulation of interferon-gamma production	2.73100098091561e-9	6.023222663409378e-5	10	65	210
DOID:2723	dermatitis	GO:0060548	negative regulation of cell death	2.9924777100731603e-9	6.599909589566355e-5	32	867	210
DOID:2723	dermatitis	GO:0045088	regulation of innate immune response	3.1126509147938464e-9	6.864951592577828e-5	20	351	210
DOID:2723	dermatitis	GO:0000715	nucleotide-excision repair, DNA damage recognition	4.3352397227636175e-9	9.561371208555158e-5	7	23	210
Orphanet:233655	Rare genetic vascular disease	GO:0001503	ossification	2.220843509093129e-10	4.898070359304896e-6	22	363	214
Orphanet:233655	Rare genetic vascular disease	GO:0097305	response to alcohol	1.7759823611740444e-9	3.916929097569355e-5	21	369	214
Orphanet:233655	Rare genetic vascular disease	GO:0071560	cellular response to transforming growth factor beta stimulus	2.367064211306058e-9	5.220560118035511e-5	16	208	214
Orphanet:233655	Rare genetic vascular disease	GO:0040008	regulation of growth	2.4992796721079458e-9	5.5121613168340744e-5	27	617	214
Orphanet:233655	Rare genetic vascular disease	GO:0009612	response to mechanical stimulus	2.7196666030349093e-9	5.9982246929934924e-5	16	210	214
DOID:3093	nervous system cancer	GO:0006259	DNA metabolic process	5.597744490160039e-12	1.2345825473047967e-7	44	937	216
DOID:3093	nervous system cancer	GO:0043627	response to estrogen	1.48903112062726e-12	3.284058136543422e-8	22	217	216
DOID:3093	nervous system cancer	GO:0006275	regulation of DNA replication	4.0034642267983145e-13	8.829640352203683e-9	20	157	216
DOID:3093	nervous system cancer	GO:0071897	DNA biosynthetic process	3.9057646006313007e-13	8.614163826692334e-9	20	167	216
DOID:3093	nervous system cancer	GO:2000278	regulation of DNA biosynthetic process	1.7319479184152442e-12	3.819811134064821e-8	13	72	216
DOID:3093	nervous system cancer	GO:0044454	nuclear chromosome part	6.296296817254188e-12	1.388648263045411e-7	30	486	216
DOID:3093	nervous system cancer	GO:0009991	response to extracellular stimulus	6.7621463983869035e-12	1.4913913881642316e-7	30	573	216
DOID:3093	nervous system cancer	GO:0097285	cell-type specific apoptotic process	7.456257833382551e-12	1.6444776651525217e-7	31	429	216
DOID:3093	nervous system cancer	GO:0000165	MAPK cascade	7.550959857383077e-12	1.6653641965458377e-7	39	843	216
DOID:3093	nervous system cancer	GO:0097191	extrinsic apoptotic signaling pathway	1.1341705352663212e-11	2.5014131155298713e-7	19	220	216
DOID:3093	nervous system cancer	GO:0031667	response to nutrient levels	1.236200031229373e-11	2.7264391688763823e-7	29	546	216
DOID:3093	nervous system cancer	GO:1903707	negative regulation of hemopoiesis	1.3265499809733683e-11	2.925705983036764e-7	15	123	216
DOID:3093	nervous system cancer	GO:0048638	regulation of developmental growth	1.5602408254267175e-11	3.4411111404786254e-7	21	283	216
DOID:3093	nervous system cancer	GO:2001252	positive regulation of chromosome organization	1.857103359981238e-11	4.0958414604386206e-7	16	149	216
DOID:3093	nervous system cancer	GO:0001501	skeletal system development	1.9185875110849793e-11	4.231444755697922e-7	27	482	216
DOID:3093	nervous system cancer	GO:0045740	positive regulation of DNA replication	1.931377280328661e-11	4.259652591764862e-7	13	86	216
DOID:3093	nervous system cancer	GO:0070482	response to oxygen levels	2.6681101772396687e-11	5.884516995902089e-7	22	321	216
DOID:3093	nervous system cancer	GO:0051053	negative regulation of DNA metabolic process	2.6893154370100092e-11	5.931285196325575e-7	14	108	216
DOID:3093	nervous system cancer	GO:0031960	response to corticosteroid	2.998135073539743e-11	6.612386904691903e-7	17	179	216
DOID:3093	nervous system cancer	GO:0044843	cell cycle G1/S phase transition	3.2754021717096293e-11	7.223899489705587e-7	19	234	216
DOID:3093	nervous system cancer	GO:0003002	regionalization	3.6237013389950334e-11	7.992073303153546e-7	22	327	216
DOID:3093	nervous system cancer	GO:0010463	mesenchymal cell proliferation	3.7277292364024106e-11	8.221506830885517e-7	10	42	216
DOID:3093	nervous system cancer	GO:0050680	negative regulation of epithelial cell proliferation	4.5238701673611104e-11	9.977395654114929e-7	14	112	216
DOID:3093	nervous system cancer	GO:0060563	neuroepithelial cell differentiation	4.958566890422844e-11	1.0936119276827583e-6	12	74	216
DOID:3093	nervous system cancer	GO:0003690	double-stranded DNA binding	6.080747017023214e-11	1.3411087546044698e-6	33	756	216
DOID:3093	nervous system cancer	GO:2000980	regulation of inner ear receptor cell differentiation	6.143052733165177e-11	1.3548502802995799e-6	6	8	216
DOID:3093	nervous system cancer	GO:0045607	regulation of auditory receptor cell differentiation	6.143052733165177e-11	1.3548502802995799e-6	6	8	216
DOID:3093	nervous system cancer	GO:0007219	Notch signaling pathway	6.616152070648695e-11	1.4591923391815698e-6	16	162	216
DOID:3093	nervous system cancer	GO:0001657	ureteric bud development	9.191469807490193e-11	2.027178666041962e-6	13	97	216
DOID:3093	nervous system cancer	GO:0051384	response to glucocorticoid	1.0504952463463724e-10	2.3168672658169243e-6	16	167	216
DOID:3093	nervous system cancer	GO:0010464	regulation of mesenchymal cell proliferation	1.2825196460397592e-10	2.828597079340689e-6	9	34	216
DOID:3093	nervous system cancer	GO:0000082	G1/S transition of mitotic cell cycle	1.297678631217991e-10	2.8620302211512794e-6	18	224	216
DOID:3093	nervous system cancer	GO:1901652	response to peptide	1.5410395182158254e-10	3.398762657425003e-6	24	423	216
DOID:3093	nervous system cancer	GO:0048145	regulation of fibroblast proliferation	1.7259882412190564e-10	3.806667066008629e-6	12	82	216
DOID:3093	nervous system cancer	GO:0033002	muscle cell proliferation	2.462804404856911e-10	5.431715114911917e-6	15	151	216
DOID:3093	nervous system cancer	GO:0006974	cellular response to DNA damage stimulus	3.166188422554228e-10	6.98302856594335e-6	32	767	216
DOID:3093	nervous system cancer	GO:0016049	cell growth	3.486065880409228e-10	7.688518299242553e-6	25	479	216
DOID:3093	nervous system cancer	GO:0036293	response to decreased oxygen levels	3.748318322394084e-10	8.266916060040153e-6	20	302	216
DOID:3093	nervous system cancer	GO:0043086	negative regulation of catalytic activity	4.231837102963709e-10	9.33331673058646e-6	33	822	216
DOID:3093	nervous system cancer	GO:0008156	negative regulation of DNA replication	4.4029679902024554e-10	9.710745902391515e-6	10	53	216
DOID:3093	nervous system cancer	GO:0021953	central nervous system neuron differentiation	6.094036386627977e-10	1.3440397250708003e-5	15	161	216
DOID:3093	nervous system cancer	GO:0071383	cellular response to steroid hormone stimulus	6.650973105593039e-10	1.4668721184385447e-5	15	162	216
DOID:3093	nervous system cancer	GO:1902692	regulation of neuroblast proliferation	7.178756478154469e-10	1.583274741256968e-5	8	28	216
DOID:3093	nervous system cancer	GO:0071902	positive regulation of protein serine/threonine kinase activity	8.374144710998621e-10	1.846917616010746e-5	19	283	216
DOID:3093	nervous system cancer	GO:0043434	response to peptide hormone	9.591424321442332e-10	2.1153886340941064e-5	22	389	216
DOID:3093	nervous system cancer	GO:0032844	regulation of homeostatic process	1.006583927321003e-9	2.2200208517064723e-5	23	427	216
DOID:3093	nervous system cancer	GO:0051348	negative regulation of transferase activity	1.1647628417321698e-9	2.5688844474403005e-5	21	357	216
DOID:3093	nervous system cancer	GO:0048645	organ formation	1.3358218975412228e-9	2.946155195027167e-5	10	59	216
DOID:3093	nervous system cancer	GO:0001666	response to hypoxia	1.4156353866923155e-9	3.122183845349902e-5	19	292	216
DOID:3093	nervous system cancer	GO:2001234	negative regulation of apoptotic signaling pathway	1.4218418664668775e-9	3.135872236492698e-5	16	199	216
DOID:3093	nervous system cancer	GO:0010212	response to ionizing radiation	1.4474546006226774e-9	3.192361121673315e-5	14	145	216
DOID:3093	nervous system cancer	GO:0030099	myeloid cell differentiation	1.5044127055219292e-9	3.317982222028615e-5	20	327	216
DOID:3093	nervous system cancer	GO:0045930	negative regulation of mitotic cell cycle	1.5300920530592066e-9	3.37461802302208e-5	16	200	216
DOID:3093	nervous system cancer	GO:0035107	appendage morphogenesis	1.5850588619414907e-9	3.495847320011958e-5	14	146	216
DOID:3093	nervous system cancer	GO:0035108	limb morphogenesis	1.5850588619414907e-9	3.495847320011958e-5	14	146	216
DOID:3093	nervous system cancer	GO:0098727	maintenance of cell number	1.7339660818294078e-9	3.824262193474759e-5	14	147	216
DOID:3093	nervous system cancer	GO:0002064	epithelial cell development	1.7692891596254867e-9	3.902167241554011e-5	16	202	216
DOID:3093	nervous system cancer	GO:0048660	regulation of smooth muscle cell proliferation	1.818930006614039e-9	4.011650129587263e-5	12	100	216
DOID:3093	nervous system cancer	GO:0010721	negative regulation of cell development	2.094433626531611e-9	4.619273363315468e-5	19	299	216
DOID:3093	nervous system cancer	GO:0048708	astrocyte differentiation	2.2182985448537806e-9	4.892457440675013e-5	10	62	216
DOID:3093	nervous system cancer	GO:0002052	positive regulation of neuroblast proliferation	2.5498080313823834e-9	5.623601613213847e-5	7	21	216
DOID:3093	nervous system cancer	GO:0050768	negative regulation of neurogenesis	2.6383348838976417e-9	5.818847586436249e-5	17	238	216
DOID:3093	nervous system cancer	GO:0090068	positive regulation of cell cycle process	2.8110290761773626e-9	6.199724627509173e-5	17	239	216
DOID:3093	nervous system cancer	GO:0035270	endocrine system development	3.350117405709341e-9	7.388683938291951e-5	13	129	216
DOID:3093	nervous system cancer	GO:0033500	carbohydrate homeostasis	3.567990569663948e-9	7.869203201393837e-5	16	212	216
DOID:3093	nervous system cancer	GO:0042593	glucose homeostasis	3.567990569663948e-9	7.869203201393837e-5	16	212	216
DOID:3093	nervous system cancer	GO:0048715	negative regulation of oligodendrocyte differentiation	3.58692542334893e-9	7.910964021196065e-5	6	13	216
DOID:3093	nervous system cancer	GO:0051974	negative regulation of telomerase activity	3.58692542334893e-9	7.910964021196065e-5	6	13	216
DOID:3093	nervous system cancer	GO:1900180	regulation of protein localization to nucleus	3.818501848051881e-9	8.421705825878423e-5	16	213	216
DOID:3093	nervous system cancer	GO:0032204	regulation of telomere maintenance	4.18089840525937e-9	9.220971432799541e-5	10	66	216
DOID:3093	nervous system cancer	GO:0008593	regulation of Notch signaling pathway	4.18089840525937e-9	9.220971432799541e-5	10	66	216
DOID:3093	nervous system cancer	GO:0001775	cell activation	4.217053262145498e-9	9.300710969661896e-5	32	854	216
DOID:3093	nervous system cancer	GO:0010948	negative regulation of cell cycle process	4.369132167170164e-9	9.636120994693798e-5	16	215	216
DOID:3093	nervous system cancer	GO:0000784	nuclear chromosome, telomeric region	4.4465408022276165e-9	9.806845739313008e-5	13	132	216
DOID:4079	heart valve disease	GO:0051338	regulation of transferase activity	2.6797453145377403e-12	5.910178291212986e-8	39	928	217
DOID:4079	heart valve disease	GO:0001775	cell activation	4.524380869952438e-12	9.978522008680102e-8	38	854	217
DOID:4079	heart valve disease	GO:0034109	homotypic cell-cell adhesion	1.0114242776637639e-11	2.2306962443874312e-7	28	495	217
DOID:4079	heart valve disease	GO:0071900	regulation of protein serine/threonine kinase activity	4.737576997371207e-11	1.0448726067702196e-6	25	431	217
DOID:4079	heart valve disease	GO:0072593	reactive oxygen species metabolic process	1.3036938195654102e-10	2.875296719051512e-6	18	223	217
DOID:4079	heart valve disease	GO:1901701	cellular response to oxygen-containing compound	1.373993141484675e-10	3.030341873544451e-6	35	873	217
DOID:4079	heart valve disease	GO:0031960	response to corticosteroid	3.181569452337385e-10	7.0169514271301026e-6	16	179	217
DOID:4079	heart valve disease	GO:0019725	cellular homeostasis	4.018297916630331e-10	8.862356055128195e-6	32	771	217
DOID:4079	heart valve disease	GO:0048514	blood vessel morphogenesis	4.758519134284711e-10	1.049491395066493e-5	25	484	217
DOID:4079	heart valve disease	GO:0097190	apoptotic signaling pathway	4.873036418828747e-10	1.0747481821726801e-5	27	564	217
DOID:4079	heart valve disease	GO:0006875	cellular metal ion homeostasis	5.716519480003512e-10	1.2607783713147747e-5	24	450	217
DOID:4079	heart valve disease	GO:0032403	protein complex binding	6.118171524960303e-10	1.3493627298299948e-5	35	924	217
DOID:4079	heart valve disease	GO:0007159	leukocyte cell-cell adhesion	9.249545573908335e-10	2.0399872763254834e-5	24	461	217
DOID:4079	heart valve disease	GO:0070489	T cell aggregation	9.618579266401639e-10	2.1213776572048815e-5	23	424	217
DOID:4079	heart valve disease	GO:0042110	T cell activation	9.618579266401639e-10	2.1213776572048815e-5	23	424	217
DOID:4079	heart valve disease	GO:2001233	regulation of apoptotic signaling pathway	1.4005471227207522e-9	3.088906679160619e-5	21	359	217
DOID:4079	heart valve disease	GO:2000377	regulation of reactive oxygen species metabolic process	1.8411103752669078e-9	4.060568932651165e-5	14	147	217
DOID:4079	heart valve disease	GO:0043086	negative regulation of catalytic activity	1.887475176154396e-9	4.162826501008521e-5	32	822	217
DOID:4079	heart valve disease	GO:0002520	immune system development	2.2652961728653054e-9	4.996110709254431e-5	31	782	217
DOID:4079	heart valve disease	GO:0048534	hematopoietic or lymphoid organ development	2.444048852190406e-9	5.39034974350594e-5	30	739	217
DOID:4079	heart valve disease	GO:0071901	negative regulation of protein serine/threonine kinase activity	3.2185686338337405e-9	7.098553121920315e-5	13	128	217
DOID:4079	heart valve disease	GO:0050865	regulation of cell activation	4.1792755922642755e-9	9.21739231873886e-5	23	458	217
DOID:934	viral infectious disease	GO:0032944	regulation of mononuclear cell proliferation	1.3133938381315602e-12	2.896690109999156e-8	20	191	219
DOID:934	viral infectious disease	GO:0050851	antigen receptor-mediated signaling pathway	8.752998326144734e-13	1.930473780831221e-8	26	203	219
DOID:934	viral infectious disease	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	7.638334409421077e-13	1.6846346539978185e-8	22	209	219
DOID:934	viral infectious disease	GO:0019079	viral genome replication	3.219646771412954e-14	7.10093095435127e-10	17	96	219
DOID:934	viral infectious disease	GO:0048525	negative regulation of viral process	1.433297924791077e-13	3.1611385731267205e-9	15	88	219
DOID:934	viral infectious disease	GO:0032101	regulation of response to external stimulus	6.135092434078615e-13	1.3530946363360385e-8	41	920	219
DOID:934	viral infectious disease	GO:1903706	regulation of hemopoiesis	1.6575629757653587e-12	3.6557551430504986e-8	23	305	219
DOID:934	viral infectious disease	GO:0032649	regulation of interferon-gamma production	4.015232590859341e-12	8.855595479140277e-8	14	93	219
DOID:934	viral infectious disease	GO:0032479	regulation of type I interferon production	4.243938533932123e-12	9.360006436587298e-8	15	112	219
DOID:934	viral infectious disease	GO:0032647	regulation of interferon-alpha production	1.2435052987314066e-11	2.742550936352117e-7	8	18	219
DOID:934	viral infectious disease	GO:0032727	positive regulation of interferon-alpha production	1.6486978449137268e-10	3.6362030969572245e-6	7	15	219
DOID:934	viral infectious disease	GO:0032496	response to lipopolysaccharide	1.9516732674418336e-10	4.304415391342964e-6	21	319	219
DOID:934	viral infectious disease	GO:0001818	negative regulation of cytokine production	2.80738654545587e-10	6.191691026002921e-6	17	203	219
DOID:934	viral infectious disease	GO:0046822	regulation of nucleocytoplasmic transport	6.864683266272209e-10	1.5140058943763357e-5	17	215	219
DOID:934	viral infectious disease	GO:0032480	negative regulation of type I interferon production	7.111657929215198e-10	1.568476156288412e-5	9	40	219
DOID:934	viral infectious disease	GO:0019955	cytokine binding	7.978866456426204e-10	1.7597389969647992e-5	12	92	219
DOID:934	viral infectious disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.2917826808234167e-9	2.8490267025560456e-5	16	195	219
DOID:934	viral infectious disease	GO:0039528	cytoplasmic pattern recognition receptor signaling pathway in response to virus	1.8897914344506717e-9	4.1679350086809563e-5	7	20	219
DOID:934	viral infectious disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.3573186735958984e-9	5.199066334615754e-5	17	233	219
DOID:934	viral infectious disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.948829735949232e-9	6.503643982636031e-5	14	151	219
DOID:700	mitochondrial metabolism disease	GO:0019752	carboxylic acid metabolic process	4.9402704149770216e-12	1.0895766400231821e-7	49	967	220
DOID:700	mitochondrial metabolism disease	GO:0051188	cofactor biosynthetic process	7.37410132956029e-13	1.626358048234522e-8	22	157	220
DOID:700	mitochondrial metabolism disease	GO:0043209	myelin sheath	1.5098156058712675e-10	3.3298983187490805e-6	16	168	220
DOID:700	mitochondrial metabolism disease	GO:0048037	cofactor binding	2.931093145974728e-10	6.464525933447263e-6	19	261	220
DOID:700	mitochondrial metabolism disease	GO:0050660	flavin adenine dinucleotide binding	1.032380070320471e-9	2.276914245091799e-5	11	74	220
DOID:700	mitochondrial metabolism disease	GO:0051537	2 iron, 2 sulfur cluster binding	2.8968731857759167e-9	6.389053811228784e-5	7	21	220
DOID:700	mitochondrial metabolism disease	GO:0006635	fatty acid beta-oxidation	4.2754860762883595e-9	9.429584541253977e-5	10	65	220
Orphanet:98553	Developmental defect of the eye	GO:0043583	ear development	1.2521095271722515e-12	2.7615275621784008e-8	20	196	220
Orphanet:98553	Developmental defect of the eye	GO:0008134	transcription factor binding	1.0360823310406886e-11	2.2850795811102387e-7	29	518	220
Orphanet:98553	Developmental defect of the eye	GO:0060541	respiratory system development	3.056921382693645e-11	6.742040109530834e-7	18	202	220
Orphanet:98553	Developmental defect of the eye	GO:0072001	renal system development	1.0667022820598504e-10	2.352611883083e-6	20	276	220
Orphanet:98553	Developmental defect of the eye	GO:0048589	developmental growth	1.1093526097738504e-10	2.446677180856227e-6	28	558	220
Orphanet:98553	Developmental defect of the eye	GO:0035107	appendage morphogenesis	1.9742774082232017e-10	4.3542688238362715e-6	15	146	220
Orphanet:98553	Developmental defect of the eye	GO:0035108	limb morphogenesis	1.9742774082232017e-10	4.3542688238362715e-6	15	146	220
Orphanet:98553	Developmental defect of the eye	GO:0060284	regulation of cell development	2.0821544488569543e-10	4.592191636954013e-6	34	828	220
Orphanet:98553	Developmental defect of the eye	GO:0048666	neuron development	2.4417434740797717e-10	5.385265232082936e-6	36	926	220
Orphanet:98553	Developmental defect of the eye	GO:0035113	embryonic appendage morphogenesis	2.539862764550094e-10	5.601667327215232e-6	14	125	220
Orphanet:98553	Developmental defect of the eye	GO:0030326	embryonic limb morphogenesis	2.539862764550094e-10	5.601667327215232e-6	14	125	220
Orphanet:98553	Developmental defect of the eye	GO:0001085	RNA polymerase II transcription factor binding	2.814743993440061e-10	6.207917877532054e-6	13	104	220
Orphanet:98553	Developmental defect of the eye	GO:0001895	retina homeostasis	2.880297111929053e-10	6.352495280359527e-6	11	66	220
Orphanet:98553	Developmental defect of the eye	GO:0051093	negative regulation of developmental process	9.580273241382997e-10	2.11292926338702e-5	32	788	220
Orphanet:98553	Developmental defect of the eye	GO:0030900	forebrain development	1.6260123247846536e-9	3.5861701823125536e-5	21	357	220
Orphanet:98553	Developmental defect of the eye	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.731769283530582e-9	3.8194171548266986e-5	36	996	220
Orphanet:98553	Developmental defect of the eye	GO:0001822	kidney development	2.2094501783698206e-9	4.8729423683946393e-5	18	262	220
Orphanet:98553	Developmental defect of the eye	GO:0045596	negative regulation of cell differentiation	2.2698272150734056e-9	5.006103922844396e-5	27	597	220
Orphanet:98553	Developmental defect of the eye	GO:0021915	neural tube development	3.1274359768573845e-9	6.897560046958962e-5	14	151	220
Orphanet:98553	Developmental defect of the eye	GO:0050673	epithelial cell proliferation	3.1385612997425483e-9	6.92209694658219e-5	20	335	220
Orphanet:98553	Developmental defect of the eye	GO:0048048	embryonic eye morphogenesis	3.5255602881534287e-9	7.775623215522387e-5	8	33	220
Orphanet:98553	Developmental defect of the eye	GO:0051960	regulation of nervous system development	3.959786720741931e-9	8.73330961259633e-5	30	744	220
DOID:170	endocrine gland cancer	GO:0022603	regulation of anatomical structure morphogenesis	1.2331913268326389e-11	2.719803471329385e-7	43	986	220
DOID:170	endocrine gland cancer	GO:0007167	enzyme linked receptor protein signaling pathway	7.939204849094494e-12	1.7509916294677907e-7	45	935	220
DOID:170	endocrine gland cancer	GO:0051241	negative regulation of multicellular organismal process	7.4442674247166e-12	1.641833180521246e-7	46	966	220
DOID:170	endocrine gland cancer	GO:0007584	response to nutrient	1.3926637620897964e-12	3.071519927289046e-8	22	197	220
DOID:170	endocrine gland cancer	GO:0043523	regulation of neuron apoptotic process	1.340705324537339e-12	2.9569255932671012e-8	21	190	220
DOID:170	endocrine gland cancer	GO:0031960	response to corticosteroid	1.219246925643347e-12	2.6890490945064016e-8	24	179	220
DOID:170	endocrine gland cancer	GO:0009887	organ morphogenesis	9.205969320191798e-13	2.030376533568301e-8	43	950	220
DOID:170	endocrine gland cancer	GO:1901215	negative regulation of neuron death	8.786305016883489e-13	1.9378195714736535e-8	20	170	220
DOID:170	endocrine gland cancer	GO:0043627	response to estrogen	8.253397965063414e-13	1.820286921194736e-8	30	217	220
DOID:170	endocrine gland cancer	GO:0071383	cellular response to steroid hormone stimulus	7.811529201262601e-13	1.7228327653384667e-8	20	162	220
DOID:170	endocrine gland cancer	GO:0006275	regulation of DNA replication	7.347455976969286e-13	1.620481415720576e-8	20	157	220
DOID:170	endocrine gland cancer	GO:0051054	positive regulation of DNA metabolic process	6.903366767119223e-13	1.5225375404881447e-8	19	183	220
DOID:170	endocrine gland cancer	GO:0051384	response to glucocorticoid	6.448175327022909e-13	1.4221450683749026e-8	22	167	220
DOID:170	endocrine gland cancer	GO:0046661	male sex differentiation	5.544453784978032e-13	1.2228292822769049e-8	22	151	220
DOID:170	endocrine gland cancer	GO:1901653	cellular response to peptide	4.447553436648377e-13	9.809079104527996e-9	26	301	220
DOID:170	endocrine gland cancer	GO:0032355	response to estradiol	2.879918525877656e-13	6.3516603088231705e-9	25	145	220
DOID:170	endocrine gland cancer	GO:0045787	positive regulation of cell cycle	1.6342482922482304e-13	3.6043346085534722e-9	25	308	220
DOID:170	endocrine gland cancer	GO:0009411	response to UV	9.281464485866309e-14	2.0470269923578144e-9	18	125	220
DOID:170	endocrine gland cancer	GO:0072089	stem cell proliferation	5.1736392947532295e-14	1.1410461464578248e-9	18	139	220
DOID:170	endocrine gland cancer	GO:0050678	regulation of epithelial cell proliferation	3.3439917501709715e-13	7.375173805002078e-9	30	277	220
DOID:170	endocrine gland cancer	GO:0045471	response to ethanol	3.980149543281186e-13	8.778219817706656e-9	17	137	220
DOID:170	endocrine gland cancer	GO:0050680	negative regulation of epithelial cell proliferation	5.174749517777855e-13	1.1412910061459058e-8	16	112	220
DOID:170	endocrine gland cancer	GO:0043566	structure-specific DNA binding	8.623102232263591e-13	1.901825197325735e-8	16	116	220
DOID:170	endocrine gland cancer	GO:0071375	cellular response to peptide hormone stimulus	9.65005853004186e-13	2.1283204088007324e-8	25	285	220
DOID:170	endocrine gland cancer	GO:0010212	response to ionizing radiation	1.0690337504115632e-12	2.3577539365327027e-8	17	145	220
DOID:170	endocrine gland cancer	GO:0042327	positive regulation of phosphorylation	1.3311574065255627e-12	2.9358676600921285e-8	46	910	220
DOID:170	endocrine gland cancer	GO:0044703	multi-organism reproductive process	1.3595791159559667e-12	2.9985517402408846e-8	41	926	220
DOID:170	endocrine gland cancer	GO:0072358	cardiovascular system development	1.4268586312482512e-12	3.146936711218018e-8	41	910	220
DOID:170	endocrine gland cancer	GO:2001252	positive regulation of chromosome organization	1.6182610806936282e-12	3.569074813469797e-8	17	149	220
DOID:170	endocrine gland cancer	GO:0033002	muscle cell proliferation	2.0907719999740948e-12	4.611197645942866e-8	17	151	220
DOID:170	endocrine gland cancer	GO:0035295	tube development	2.284394895468722e-12	5.0382329419562666e-8	37	573	220
DOID:170	endocrine gland cancer	GO:0048511	rhythmic process	2.440714297335944e-12	5.382995382774425e-8	28	329	220
DOID:170	endocrine gland cancer	GO:0001101	response to acid chemical	2.935873766318764e-12	6.475069591616034e-8	24	315	220
DOID:170	endocrine gland cancer	GO:0070482	response to oxygen levels	3.5612623960901146e-12	7.854364214576748e-8	24	321	220
DOID:170	endocrine gland cancer	GO:0032403	protein complex binding	3.642308676887751e-12	8.033111786875935e-8	40	924	220
DOID:170	endocrine gland cancer	GO:0097190	apoptotic signaling pathway	3.824718319833664e-12	8.435416254393147e-8	32	564	220
DOID:170	endocrine gland cancer	GO:0000723	telomere maintenance	4.312328272249033e-12	9.510840004445242e-8	16	133	220
DOID:170	endocrine gland cancer	GO:0048762	mesenchymal cell differentiation	5.12334619173771e-12	1.1299540025877519e-7	18	184	220
DOID:170	endocrine gland cancer	GO:0033674	positive regulation of kinase activity	5.696554339351678e-12	1.2563750595440126e-7	29	480	220
DOID:170	endocrine gland cancer	GO:0030900	forebrain development	5.90272275502457e-12	1.3018455036206689e-7	30	357	220
DOID:170	endocrine gland cancer	GO:0007568	aging	6.002864871845759e-12	1.323931847485582e-7	22	290	220
DOID:170	endocrine gland cancer	GO:0010564	regulation of cell cycle process	6.032840893510638e-12	1.3305430590637712e-7	32	561	220
DOID:170	endocrine gland cancer	GO:0001822	kidney development	6.503686478254167e-12	1.4343880527789565e-7	21	262	220
DOID:170	endocrine gland cancer	GO:0002009	morphogenesis of an epithelium	6.540212815764335e-12	1.442443936516824e-7	30	506	220
DOID:170	endocrine gland cancer	GO:0007346	regulation of mitotic cell cycle	6.609823799408332e-12	1.4577966389595076e-7	28	453	220
DOID:170	endocrine gland cancer	GO:0045786	negative regulation of cell cycle	6.675993091675991e-12	1.47239027636914e-7	32	449	220
DOID:170	endocrine gland cancer	GO:0018958	phenol-containing compound metabolic process	6.7050809349211704e-12	1.4788056001968641e-7	14	96	220
DOID:170	endocrine gland cancer	GO:0010035	response to inorganic substance	6.72006894575361e-12	1.4821112059859587e-7	29	502	220
DOID:170	endocrine gland cancer	GO:0090068	positive regulation of cell cycle process	6.91335877434085e-12	1.5247412776808744e-7	20	239	220
DOID:170	endocrine gland cancer	GO:0042493	response to drug	7.225553488865444e-12	1.5935958219692736e-7	32	433	220
DOID:170	endocrine gland cancer	GO:0003682	chromatin binding	7.478462293875054e-12	1.6493748589141433e-7	28	433	220
DOID:170	endocrine gland cancer	GO:0000165	MAPK cascade	7.64333041303189e-12	1.6857365225941834e-7	43	843	220
DOID:170	endocrine gland cancer	GO:0001934	positive regulation of protein phosphorylation	7.738143459334879e-12	1.7066475399563075e-7	45	870	220
DOID:170	endocrine gland cancer	GO:0048732	gland development	8.321010547263086e-12	1.8351988761988736e-7	35	421	220
DOID:170	endocrine gland cancer	GO:0043069	negative regulation of programmed cell death	8.878675572532302e-12	1.9581918975219992e-7	41	806	220
DOID:170	endocrine gland cancer	GO:0001558	regulation of cell growth	8.996470235445031e-12	1.9841715104274016e-7	25	379	220
DOID:170	endocrine gland cancer	GO:0050767	regulation of neurogenesis	9.111045251586347e-12	2.0094410302373689e-7	36	658	220
DOID:170	endocrine gland cancer	GO:0043410	positive regulation of MAPK cascade	9.211742479919849e-12	2.0316498039463227e-7	29	464	220
DOID:170	endocrine gland cancer	GO:0010948	negative regulation of cell cycle process	9.600653605446041e-12	2.1174241526811244e-7	19	215	220
DOID:170	endocrine gland cancer	GO:0045860	positive regulation of protein kinase activity	1.0143774709092668e-11	2.237209512090388e-7	27	450	220
DOID:170	endocrine gland cancer	GO:0070848	response to growth factor	1.019062612073185e-11	2.2475425909274094e-7	32	621	220
DOID:170	endocrine gland cancer	GO:0036293	response to decreased oxygen levels	1.0285772233942225e-11	2.2685270661959578e-7	22	302	220
DOID:170	endocrine gland cancer	GO:0008134	transcription factor binding	1.0360823310406886e-11	2.2850795811102387e-7	29	518	220
DOID:170	endocrine gland cancer	GO:0044454	nuclear chromosome part	1.0498824032367793e-11	2.3155156403387167e-7	28	486	220
DOID:170	endocrine gland cancer	GO:0030334	regulation of cell migration	1.0547340778543912e-11	2.3262160087078598e-7	33	660	220
DOID:170	endocrine gland cancer	GO:0008284	positive regulation of cell proliferation	1.1234901897694272e-11	2.4778576135364716e-7	43	815	220
DOID:170	endocrine gland cancer	GO:0045597	positive regulation of cell differentiation	1.1237122343743522e-11	2.478347332912634e-7	41	815	220
DOID:170	endocrine gland cancer	GO:0007507	heart development	1.1796008614339826e-11	2.6016096998926486e-7	28	487	220
DOID:170	endocrine gland cancer	GO:0043066	negative regulation of apoptotic process	1.2802758853069918e-11	2.8236484650445703e-7	41	795	220
DOID:170	endocrine gland cancer	GO:0001763	morphogenesis of a branching structure	1.3512857499620168e-11	2.980260721541228e-7	18	193	220
DOID:170	endocrine gland cancer	GO:0002520	immune system development	1.3933187936743252e-11	3.072964599448724e-7	44	782	220
DOID:170	endocrine gland cancer	GO:0032504	multicellular organism reproduction	1.3997358827566586e-11	3.0871174894198106e-7	41	780	220
DOID:170	endocrine gland cancer	GO:0030097	hemopoiesis	1.4328871422719658e-11	3.1602325922808205e-7	37	695	220
DOID:170	endocrine gland cancer	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.4972578732397324e-11	3.3022022394302297e-7	47	732	220
DOID:170	endocrine gland cancer	GO:0010720	positive regulation of cell development	1.5588752511064285e-11	3.438099366315228e-7	27	469	220
DOID:170	endocrine gland cancer	GO:0048666	neuron development	1.5812462450526255e-11	3.4874385934635654e-7	38	926	220
DOID:170	endocrine gland cancer	GO:0048609	multicellular organismal reproductive process	1.628441825829441e-11	3.591528446866832e-7	41	767	220
DOID:170	endocrine gland cancer	GO:0035239	tube morphogenesis	1.6432966098989255e-11	3.62429067313208e-7	23	338	220
DOID:170	endocrine gland cancer	GO:0007623	circadian rhythm	1.7692958209636345e-11	3.902181933135296e-7	18	196	220
DOID:170	endocrine gland cancer	GO:0003690	double-stranded DNA binding	1.7748247316262677e-11	3.9143759456017335e-7	35	756	220
DOID:170	endocrine gland cancer	GO:0000904	cell morphogenesis involved in differentiation	1.8634871423728327e-11	4.1099208925032826e-7	35	720	220
DOID:170	endocrine gland cancer	GO:0014031	mesenchymal cell development	1.8972934334726688e-11	4.184480667523971e-7	17	171	220
DOID:170	endocrine gland cancer	GO:0048568	embryonic organ development	2.3409829630338663e-11	5.163037924971192e-7	25	408	220
DOID:170	endocrine gland cancer	GO:0071363	cellular response to growth factor stimulus	2.395295073398529e-11	5.282823284380456e-7	30	594	220
DOID:170	endocrine gland cancer	GO:2000241	regulation of reproductive process	2.6184387991179392e-11	5.774966771454615e-7	15	127	220
DOID:170	endocrine gland cancer	GO:0002065	columnar/cuboidal epithelial cell differentiation	2.943500998497939e-11	6.491891452187204e-7	15	128	220
DOID:170	endocrine gland cancer	GO:0072091	regulation of stem cell proliferation	3.256950265040359e-11	7.183203809546512e-7	13	88	220
DOID:170	endocrine gland cancer	GO:0045926	negative regulation of growth	3.287292660303365e-11	7.250123962299071e-7	19	230	220
DOID:170	endocrine gland cancer	GO:0051053	negative regulation of DNA metabolic process	3.447020446856186e-11	7.602403595541318e-7	14	108	220
DOID:170	endocrine gland cancer	GO:0007423	sensory organ development	3.9956593589351996e-11	8.812426716131583e-7	27	494	220
DOID:170	endocrine gland cancer	GO:0061138	morphogenesis of a branching epithelium	4.028244404707948e-11	8.884293034583379e-7	17	179	220
DOID:170	endocrine gland cancer	GO:0018108	peptidyl-tyrosine phosphorylation	4.0647152310668844e-11	8.964729442118013e-7	23	354	220
DOID:170	endocrine gland cancer	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	4.1213810142437524e-11	9.089705826914596e-7	31	647	220
DOID:170	endocrine gland cancer	GO:0001666	response to hypoxia	4.260924946208888e-11	9.397469968863703e-7	21	292	220
DOID:170	endocrine gland cancer	GO:0050679	positive regulation of epithelial cell proliferation	4.4058201531527175e-11	9.717036347778318e-7	16	155	220
DOID:170	endocrine gland cancer	GO:0051302	regulation of cell division	4.5118353497741737e-11	9.95085286392694e-7	21	293	220
DOID:170	endocrine gland cancer	GO:1901654	response to ketone	4.814282306142559e-11	1.0617899626197413e-6	17	181	220
DOID:170	endocrine gland cancer	GO:0051348	negative regulation of transferase activity	4.835265521307974e-11	1.0664178107244737e-6	23	357	220
DOID:170	endocrine gland cancer	GO:2000027	regulation of organ morphogenesis	5.2119086824120586e-11	1.1494864599059795e-6	19	236	220
DOID:170	endocrine gland cancer	GO:0044706	multi-multicellular organism process	5.590150564671603e-11	1.232907707038322e-6	19	237	220
DOID:170	endocrine gland cancer	GO:0009611	response to wounding	5.811207071104718e-11	1.2816617195321456e-6	36	875	220
DOID:170	endocrine gland cancer	GO:0071900	regulation of protein serine/threonine kinase activity	6.163825005955914e-11	1.3594316050635769e-6	25	431	220
DOID:170	endocrine gland cancer	GO:0060562	epithelial tube morphogenesis	7.113742928055444e-11	1.5689360027826282e-6	21	301	220
DOID:170	endocrine gland cancer	GO:0001944	vasculature development	7.585787553665568e-11	1.673045444960941e-6	29	588	220
DOID:170	endocrine gland cancer	GO:0072073	kidney epithelium development	7.919742639472815e-11	1.7466992391357294e-6	15	137	220
DOID:170	endocrine gland cancer	GO:0043005	neuron projection	8.8286267185822e-11	1.947153622783304e-6	37	941	220
DOID:170	endocrine gland cancer	GO:0010942	positive regulation of cell death	1.0502976266479891e-10	2.31643141557214e-6	29	596	220
DOID:170	endocrine gland cancer	GO:0001657	ureteric bud development	1.1542744537962335e-10	2.545752307847593e-6	13	97	220
DOID:170	endocrine gland cancer	GO:0048598	embryonic morphogenesis	1.2110679126209334e-10	2.6710102812854686e-6	28	560	220
DOID:170	endocrine gland cancer	GO:0043068	positive regulation of programmed cell death	1.252206116575394e-10	2.7617405901070313e-6	28	561	220
DOID:170	endocrine gland cancer	GO:1903047	mitotic cell cycle process	1.2563372564500241e-10	2.7708518191005282e-6	35	857	220
DOID:170	endocrine gland cancer	GO:0006974	cellular response to DNA damage stimulus	1.293884999142847e-10	2.853663365609549e-6	33	767	220
DOID:170	endocrine gland cancer	GO:0030850	prostate gland development	1.487084899665092e-10	3.2797657462113605e-6	10	47	220
DOID:170	endocrine gland cancer	GO:0050890	cognition	1.50425449874092e-10	3.3176332969730993e-6	19	251	220
DOID:170	endocrine gland cancer	GO:0048660	regulation of smooth muscle cell proliferation	1.7068080282456322e-10	3.7643651062957417e-6	13	100	220
DOID:170	endocrine gland cancer	GO:0030856	regulation of epithelial cell differentiation	1.8312862337666047e-10	4.038901788572247e-6	14	122	220
DOID:170	endocrine gland cancer	GO:0048754	branching morphogenesis of an epithelial tube	2.172968471825243e-10	4.792481964610573e-6	15	147	220
DOID:170	endocrine gland cancer	GO:0042063	gliogenesis	2.347922967160798e-10	5.17834410407314e-6	18	228	220
DOID:170	endocrine gland cancer	GO:0045930	negative regulation of mitotic cell cycle	2.3827972928103236e-10	5.255259429293169e-6	17	200	220
DOID:170	endocrine gland cancer	GO:0055123	digestive system development	2.893493222799748e-10	6.381599302884844e-6	15	150	220
DOID:170	endocrine gland cancer	GO:0044843	cell cycle G1/S phase transition	3.588306318746959e-10	7.914009585996418e-6	18	234	220
DOID:170	endocrine gland cancer	GO:0007610	behavior	3.6789948865134647e-10	8.114023222205446e-6	31	714	220
DOID:170	endocrine gland cancer	GO:0045740	positive regulation of DNA replication	3.768787504299098e-10	8.312060840731661e-6	12	86	220
DOID:170	endocrine gland cancer	GO:0035270	endocrine system development	3.8786285294634126e-10	8.554315221731557e-6	14	129	220
DOID:170	endocrine gland cancer	GO:0044212	transcription regulatory region DNA binding	4.2736725269776343e-10	9.425584758249173e-6	33	807	220
DOID:170	endocrine gland cancer	GO:0010721	negative regulation of cell development	4.365243722048717e-10	9.627545028978446e-6	20	299	220
DOID:170	endocrine gland cancer	GO:0072006	nephron development	4.770301931245058e-10	1.0520900909360975e-5	14	131	220
DOID:170	endocrine gland cancer	GO:0042692	muscle cell differentiation	4.876024028988013e-10	1.0754070995933063e-5	21	334	220
DOID:170	endocrine gland cancer	GO:0043065	positive regulation of apoptotic process	4.882936277539329e-10	1.076931596011299e-5	27	556	220
DOID:170	endocrine gland cancer	GO:0050769	positive regulation of neurogenesis	7.208890151488845e-10	1.5899207229108647e-5	22	376	220
DOID:170	endocrine gland cancer	GO:0072080	nephron tubule development	7.384851619107735e-10	1.628729024594211e-5	12	91	220
DOID:170	endocrine gland cancer	GO:0001568	blood vessel development	8.027531972487623e-10	1.7704721765321452e-5	27	569	220
DOID:170	endocrine gland cancer	GO:0007611	learning or memory	9.1250329514736e-10	2.0125260174475024e-5	17	218	220
DOID:170	endocrine gland cancer	GO:0071391	cellular response to estrogen stimulus	9.389578004004306e-10	2.0708714287831498e-5	9	41	220
DOID:170	endocrine gland cancer	GO:0007565	female pregnancy	9.427113534243858e-10	2.079149889977483e-5	16	190	220
DOID:170	endocrine gland cancer	GO:0048565	digestive tract development	9.55384771295087e-10	2.1071011130913142e-5	14	138	220
DOID:170	endocrine gland cancer	GO:0009636	response to toxic substance	9.784139054502816e-10	2.157891868470596e-5	18	249	220
DOID:170	endocrine gland cancer	GO:0033673	negative regulation of kinase activity	1.0441493225599174e-9	2.302871330905898e-5	18	250	220
DOID:170	endocrine gland cancer	GO:0000988	transcription factor activity, protein binding	1.1282907941279063e-9	2.4884453464490974e-5	27	578	220
DOID:170	endocrine gland cancer	GO:0043010	camera-type eye development	1.1418141987462604e-9	2.5182712153348774e-5	19	283	220
DOID:170	endocrine gland cancer	GO:0007131	reciprocal meiotic recombination	1.182931752552463e-9	2.608955980254457e-5	9	42	220
DOID:170	endocrine gland cancer	GO:0030308	negative regulation of cell growth	1.2067221666356431e-9	2.661425738514911e-5	15	166	220
DOID:170	endocrine gland cancer	GO:0019887	protein kinase regulator activity	1.2067221666356431e-9	2.661425738514911e-5	15	166	220
DOID:170	endocrine gland cancer	GO:0031175	neuron projection development	1.2245457980952779e-9	2.7007357576991353e-5	32	796	220
DOID:170	endocrine gland cancer	GO:0019748	secondary metabolic process	1.3390101250010389e-9	2.9531868306897913e-5	10	58	220
DOID:170	endocrine gland cancer	GO:1902532	negative regulation of intracellular signal transduction	1.3757940342529196e-9	3.034313742544814e-5	23	426	220
DOID:170	endocrine gland cancer	GO:1903827	regulation of cellular protein localization	1.4014428506570198e-9	3.090882207124057e-5	26	543	220
DOID:170	endocrine gland cancer	GO:0032844	regulation of homeostatic process	1.4397872893923136e-9	3.1754508667547476e-5	23	427	220
DOID:170	endocrine gland cancer	GO:0051145	smooth muscle cell differentiation	1.4808384518616435e-9	3.265989205580855e-5	9	43	220
DOID:170	endocrine gland cancer	GO:0071392	cellular response to estradiol stimulus	1.5320554824782562e-9	3.378948366605794e-5	8	30	220
DOID:170	endocrine gland cancer	GO:0031400	negative regulation of protein modification process	1.5373021744480297e-9	3.3905199457451296e-5	28	628	220
DOID:170	endocrine gland cancer	GO:0003684	damaged DNA binding	1.595806708998282e-9	3.519551696695711e-5	10	59	220
DOID:170	endocrine gland cancer	GO:0045664	regulation of neuron differentiation	1.6986858586420794e-9	3.746451661235106e-5	26	548	220
DOID:170	endocrine gland cancer	GO:0001775	cell activation	1.7525504381055157e-9	3.865249991241715e-5	33	854	220
DOID:170	endocrine gland cancer	GO:0007389	pattern specification process	1.7979637778609003e-9	3.965409112072216e-5	23	432	220
DOID:170	endocrine gland cancer	GO:0030099	myeloid cell differentiation	2.0731459882128433e-9	4.572323477003426e-5	20	327	220
DOID:170	endocrine gland cancer	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	2.143158428502545e-9	4.726735914062363e-5	15	173	220
DOID:170	endocrine gland cancer	GO:2000147	positive regulation of cell motility	2.1698519647728176e-9	4.785608508306449e-5	22	399	220
DOID:170	endocrine gland cancer	GO:0080135	regulation of cellular response to stress	2.173099034052939e-9	4.7927699196037565e-5	29	681	220
DOID:170	endocrine gland cancer	GO:0021700	developmental maturation	2.215764238755469e-9	4.8868680285751864e-5	17	231	220
DOID:170	endocrine gland cancer	GO:2000648	positive regulation of stem cell proliferation	2.244033847631499e-9	4.9492166509512714e-5	10	61	220
DOID:170	endocrine gland cancer	GO:0002064	epithelial cell development	2.3096266010824706e-9	5.093881468687389e-5	16	202	220
DOID:170	endocrine gland cancer	GO:0048469	cell maturation	2.404457855043063e-9	5.303031799297475e-5	14	148	220
DOID:170	endocrine gland cancer	GO:0008544	epidermis development	2.4086560523883804e-9	5.312290923542573e-5	19	296	220
DOID:170	endocrine gland cancer	GO:0006469	negative regulation of protein kinase activity	2.6968312027975117e-9	5.947861217769912e-5	17	234	220
DOID:170	endocrine gland cancer	GO:0010001	glial cell differentiation	2.7185343975943965e-9	5.9957276138944415e-5	15	176	220
DOID:170	endocrine gland cancer	GO:0071453	cellular response to oxygen levels	2.8668489804317687e-9	6.322835426342266e-5	14	150	220
DOID:170	endocrine gland cancer	GO:0010769	regulation of cell morphogenesis involved in differentiation	2.9815552249345956e-9	6.57582004859325e-5	20	334	220
DOID:170	endocrine gland cancer	GO:0010038	response to metal ion	3.1385612997425483e-9	6.92209694658219e-5	20	335	220
DOID:170	endocrine gland cancer	GO:0045321	leukocyte activation	3.3278786393253768e-9	7.339636339032118e-5	29	694	220
DOID:170	endocrine gland cancer	GO:0046660	female sex differentiation	3.45015538361082e-9	7.609317698553664e-5	13	127	220
DOID:170	endocrine gland cancer	GO:0033273	response to vitamin	3.5373735052246502e-9	7.801677265772966e-5	12	104	220
DOID:170	endocrine gland cancer	GO:0060675	ureteric bud morphogenesis	3.6548694071214527e-9	8.060814477406364e-5	10	64	220
DOID:170	endocrine gland cancer	GO:1903706	regulation of hemopoiesis	3.94613586252035e-9	8.703202644788632e-5	19	305	220
DOID:170	endocrine gland cancer	GO:0044772	mitotic cell cycle phase transition	4.2103110997615545e-9	9.285841130524108e-5	24	491	220
DOID:170	endocrine gland cancer	GO:0000075	cell cycle checkpoint	4.3420963491414e-9	9.576493498031358e-5	16	211	220
DOID:170	endocrine gland cancer	GO:0007050	cell cycle arrest	4.48466430658101e-9	9.890927128164417e-5	17	242	220
Orphanet:166481	Metabolic diseases with epilepsy	GO:0019752	carboxylic acid metabolic process	4.685363208523086e-12	1.0333568556397665e-7	54	967	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0009063	cellular amino acid catabolic process	3.5693670241698783e-13	7.872238971806667e-9	22	113	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:1901605	alpha-amino acid metabolic process	1.3850032232198828e-12	3.0546246088114515e-8	22	258	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0044283	small molecule biosynthetic process	3.3066882565435662e-12	7.292900949806835e-8	32	530	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0006790	sulfur compound metabolic process	5.902389688117182e-12	1.3017720457142445e-7	26	360	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0016620	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	6.522005158160482e-12	1.4384282376322943e-7	10	35	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0022904	respiratory electron transport chain	2.6729618518572806e-11	5.895217364271232e-7	14	105	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0050812	regulation of acyl-CoA biosynthetic process	4.937683595329645e-11	1.0890061169499532e-6	7	13	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0008652	cellular amino acid biosynthetic process	6.292210086300543e-10	1.3877469345335847e-5	12	89	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0006979	response to oxidative stress	1.3940522070043926e-9	3.074582142548188e-5	22	386	222
Orphanet:166481	Metabolic diseases with epilepsy	GO:0009311	oligosaccharide metabolic process	3.987626229218222e-9	8.794709648540788e-5	10	64	222
MESH:D020820	Dyskinesias	GO:0048878	chemical homeostasis	1.358091417102969e-11	2.995270620420598e-7	52	988	223
MESH:D020820	Dyskinesias	GO:0043005	neuron projection	7.379208355473565e-12	1.6274844027996949e-7	55	941	223
MESH:D020820	Dyskinesias	GO:0044463	cell projection part	6.623812609518609e-12	1.4608818710293292e-7	44	939	223
MESH:D020820	Dyskinesias	GO:0034220	ion transmembrane transport	3.197220266315526e-12	7.051469297358892e-8	42	962	223
MESH:D020820	Dyskinesias	GO:0032940	secretion by cell	3.183009411600324e-12	7.020127257284514e-8	41	956	223
MESH:D020820	Dyskinesias	GO:1900542	regulation of purine nucleotide metabolic process	6.816769371198461e-13	1.5034384848178206e-8	21	203	223
MESH:D020820	Dyskinesias	GO:0009187	cyclic nucleotide metabolic process	2.48245868306185e-13	5.47506262549291e-9	19	188	223
MESH:D020820	Dyskinesias	GO:0009190	cyclic nucleotide biosynthetic process	1.894040480010517e-13	4.177306278663195e-9	18	149	223
MESH:D020820	Dyskinesias	GO:0046058	cAMP metabolic process	1.2456702336294256e-13	2.7473257002696982e-9	18	144	223
MESH:D020820	Dyskinesias	GO:0030799	regulation of cyclic nucleotide metabolic process	9.126033262418787e-14	2.0127466360264634e-9	18	154	223
MESH:D020820	Dyskinesias	GO:0052652	cyclic purine nucleotide metabolic process	5.995204332975845e-14	1.3222423156378227e-9	18	147	223
MESH:D020820	Dyskinesias	GO:0043279	response to alkaloid	4.574118861455645e-14	1.0088219148940425e-9	20	140	223
MESH:D020820	Dyskinesias	GO:0015844	monoamine transport	4.4075854077618715e-14	9.720929616818808e-10	14	70	223
MESH:D020820	Dyskinesias	GO:0030534	adult behavior	2.5279778270714814e-13	5.575455097606152e-9	19	135	223
MESH:D020820	Dyskinesias	GO:0060359	response to ammonium ion	2.799982468104645e-13	6.175361333404794e-9	15	92	223
MESH:D020820	Dyskinesias	GO:0048666	neuron development	6.610267888618182e-13	1.45789458283474e-8	43	926	223
MESH:D020820	Dyskinesias	GO:0006873	cellular ion homeostasis	3.1039615322470127e-12	6.845787159370786e-8	35	532	223
MESH:D020820	Dyskinesias	GO:0043269	regulation of ion transport	3.483657806668816e-12	7.683207292608074e-8	37	583	223
MESH:D020820	Dyskinesias	GO:0098662	inorganic cation transmembrane transport	4.416023102749023e-12	9.73953895311297e-8	31	575	223
MESH:D020820	Dyskinesias	GO:0030003	cellular cation homeostasis	5.219158438762861e-12	1.151085393669149e-7	35	519	223
MESH:D020820	Dyskinesias	GO:0044297	cell body	5.275557768413819e-12	1.1635242658236677e-7	36	494	223
MESH:D020820	Dyskinesias	GO:0098794	postsynapse	5.464184660297633e-12	1.205125926828643e-7	28	381	223
MESH:D020820	Dyskinesias	GO:0006816	calcium ion transport	5.551337167730708e-12	1.2243474123430076e-7	26	366	223
MESH:D020820	Dyskinesias	GO:0014070	response to organic cyclic compound	6.178835221248846e-12	1.362742108046433e-7	42	873	223
MESH:D020820	Dyskinesias	GO:0042220	response to cocaine	6.5739635957129394e-12	1.4498876710344888e-7	11	47	223
MESH:D020820	Dyskinesias	GO:0044057	regulation of system process	7.384093336781916e-12	1.6285617854272516e-7	30	508	223
MESH:D020820	Dyskinesias	GO:0045762	positive regulation of adenylate cyclase activity	8.4222628871089e-12	1.857530079751868e-7	11	48	223
MESH:D020820	Dyskinesias	GO:0043679	axon terminus	9.036327242029074e-12	1.9929619732295123e-7	15	116	223
MESH:D020820	Dyskinesias	GO:0051588	regulation of neurotransmitter transport	9.815148693803621e-12	2.1647310444183887e-7	12	63	223
MESH:D020820	Dyskinesias	GO:1903530	regulation of secretion by cell	1.0939915640051368e-11	2.412798394413329e-7	33	624	223
MESH:D020820	Dyskinesias	GO:0031175	neuron projection development	1.3030465595420537e-11	2.8738691870699995e-7	38	796	223
MESH:D020820	Dyskinesias	GO:0008015	blood circulation	1.3373413487727248e-11	2.9495063447182446e-7	28	489	223
MESH:D020820	Dyskinesias	GO:0072507	divalent inorganic cation homeostasis	1.5507151118754336e-11	3.420102179241269e-7	25	393	223
MESH:D020820	Dyskinesias	GO:0072503	cellular divalent inorganic cation homeostasis	2.867905912751212e-11	6.325166490572798e-7	24	375	223
MESH:D020820	Dyskinesias	GO:0035249	synaptic transmission, glutamatergic	3.618905175528653e-11	7.981495364628444e-7	12	70	223
MESH:D020820	Dyskinesias	GO:0007417	central nervous system development	3.9933611972742256e-11	8.807358120588304e-7	37	889	223
MESH:D020820	Dyskinesias	GO:0006874	cellular calcium ion homeostasis	4.7297943339685844e-11	1.0431561403567713e-6	23	352	223
MESH:D020820	Dyskinesias	GO:0007189	adenylate cyclase-activating G-protein coupled receptor signaling pathway	5.1353254981734153e-11	1.1325960386221468e-6	12	72	223
MESH:D020820	Dyskinesias	GO:0009991	response to extracellular stimulus	5.6087356981038283e-11	1.2370066582167993e-6	29	573	223
MESH:D020820	Dyskinesias	GO:0044070	regulation of anion transport	7.797262835396168e-11	1.7196863183466249e-6	15	135	223
MESH:D020820	Dyskinesias	GO:0031667	response to nutrient levels	9.339984341494301e-11	2.059933546516568e-6	28	546	223
MESH:D020820	Dyskinesias	GO:0034765	regulation of ion transmembrane transport	1.0184530996326657e-10	2.2461983112398443e-6	23	367	223
MESH:D020820	Dyskinesias	GO:0022836	gated channel activity	1.0540857076080101e-10	2.3247860281294663e-6	22	335	223
MESH:D020820	Dyskinesias	GO:0010996	response to auditory stimulus	1.535096494365007e-10	3.385655318322023e-6	8	23	223
MESH:D020820	Dyskinesias	GO:0008344	adult locomotory behavior	1.8502832599409658e-10	4.0807997297998e-6	12	80	223
MESH:D020820	Dyskinesias	GO:0046883	regulation of hormone secretion	2.0261969879697972e-10	4.468777456967388e-6	19	252	223
MESH:D020820	Dyskinesias	GO:0051051	negative regulation of transport	2.0806556477737104e-10	4.588886031164918e-6	25	452	223
MESH:D020820	Dyskinesias	GO:0009725	response to hormone	2.329462178707331e-10	5.137628835139019e-6	35	865	223
MESH:D020820	Dyskinesias	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	4.6529080588442184e-10	1.0261988723780924e-5	11	68	223
MESH:D020820	Dyskinesias	GO:0007190	activation of adenylate cyclase activity	5.078388820578539e-10	1.1200386543785967e-5	9	38	223
MESH:D020820	Dyskinesias	GO:0033555	multicellular organismal response to stress	5.475413455968692e-10	1.207602437713895e-5	11	69	223
MESH:D020820	Dyskinesias	GO:0033993	response to lipid	5.704592354049964e-10	1.2581478436857196e-5	34	850	223
MESH:D020820	Dyskinesias	GO:0051235	maintenance of location	8.355730551912188e-10	1.842856373224233e-5	19	274	223
MESH:D020820	Dyskinesias	GO:0070588	calcium ion transmembrane transport	9.835888770126644e-10	2.1693052682514313e-5	16	188	223
MESH:D020820	Dyskinesias	GO:0046873	metal ion transmembrane transporter activity	1.0858406396252462e-9	2.3948215306934806e-5	23	415	223
MESH:D020820	Dyskinesias	GO:1901701	cellular response to oxygen-containing compound	1.1345583361688227e-9	2.5022684104203385e-5	34	873	223
MESH:D020820	Dyskinesias	GO:0051934	catecholamine uptake involved in synaptic transmission	1.1929284227107928e-9	2.6310036362886535e-5	6	11	223
MESH:D020820	Dyskinesias	GO:0051583	dopamine uptake involved in synaptic transmission	1.1929284227107928e-9	2.6310036362886535e-5	6	11	223
MESH:D020820	Dyskinesias	GO:0009636	response to toxic substance	1.2171312846476212e-9	2.6843830482903286e-5	18	249	223
MESH:D020820	Dyskinesias	GO:0060322	head development	1.7418990694295644e-9	3.841758397626904e-5	30	708	223
MESH:D020820	Dyskinesias	GO:0007623	circadian rhythm	1.8118401223787828e-9	3.9960133899064054e-5	16	196	223
MESH:D020820	Dyskinesias	GO:0010959	regulation of metal ion transport	1.9093465697395118e-9	4.211063859560493e-5	20	321	223
MESH:D020820	Dyskinesias	GO:0007420	brain development	1.9951750251934186e-9	4.400358518064085e-5	29	669	223
MESH:D020820	Dyskinesias	GO:0007191	adenylate cyclase-activating dopamine receptor signaling pathway	2.3621219424896367e-9	5.209659944160894e-5	6	12	223
MESH:D020820	Dyskinesias	GO:0019233	sensory perception of pain	2.9333542261866796e-9	6.469512745854722e-5	12	101	223
MESH:D020820	Dyskinesias	GO:0098793	presynapse	3.479506793802045e-9	7.67405223373041e-5	16	205	223
MESH:D020820	Dyskinesias	GO:0051924	regulation of calcium ion transport	4.0036284287836565e-9	8.830002499682355e-5	16	207	223
MESH:D020820	Dyskinesias	GO:0048545	response to steroid hormone	4.280236276521521e-9	9.440061107868214e-5	23	446	223
DOID:1176	bronchial disease	GO:0048878	chemical homeostasis	1.4861001318422495e-11	3.2775938407780814e-7	45	988	225
DOID:1176	bronchial disease	GO:0032880	regulation of protein localization	5.8493210275401e-12	1.290067752623969e-7	40	933	225
DOID:1176	bronchial disease	GO:0071216	cellular response to biotic stimulus	7.003286839335487e-13	1.5445749124154418e-8	21	175	225
DOID:1176	bronchial disease	GO:0035082	axoneme assembly	2.531308496145357e-14	5.582800888248585e-10	15	43	225
DOID:1176	bronchial disease	GO:0050867	positive regulation of cell activation	1.45328193923433e-13	3.2052133169813146e-9	24	288	225
DOID:1176	bronchial disease	GO:0036293	response to decreased oxygen levels	1.2011502903419569e-12	2.649136965349186e-8	23	302	225
DOID:1176	bronchial disease	GO:0032355	response to estradiol	1.745270594710746e-12	3.8491942966345505e-8	17	145	225
DOID:1176	bronchial disease	GO:0002440	production of molecular mediator of immune response	2.446931546273845e-12	5.396707525306965e-8	17	148	225
DOID:1176	bronchial disease	GO:0060326	cell chemotaxis	4.717559676237215e-12	1.0404577865941178e-7	20	228	225
DOID:1176	bronchial disease	GO:0000165	MAPK cascade	8.388512107160295e-12	1.850086345234203e-7	39	843	225
DOID:1176	bronchial disease	GO:0098771	inorganic ion homeostasis	8.548717289613705e-12	1.8854195982243027e-7	32	609	225
DOID:1176	bronchial disease	GO:0001816	cytokine production	1.0148215601191168e-11	2.2381889508427122e-7	32	613	225
DOID:1176	bronchial disease	GO:0055065	metal ion homeostasis	1.2931877790833823e-11	2.8521256467684e-7	29	516	225
DOID:1176	bronchial disease	GO:0006873	cellular ion homeostasis	1.4337864229219122e-11	3.1622159557542773e-7	29	532	225
DOID:1176	bronchial disease	GO:0050921	positive regulation of chemotaxis	1.4347634191835823e-11	3.164370721009391e-7	15	119	225
DOID:1176	bronchial disease	GO:0046209	nitric oxide metabolic process	1.618782885515202e-11	3.570225654003778e-7	12	65	225
DOID:1176	bronchial disease	GO:1990748	cellular detoxification	1.7242762773150844e-11	3.8028913296184186e-7	13	82	225
DOID:1176	bronchial disease	GO:0010193	response to ozone	1.98552285723963e-11	4.379070661642004e-7	6	7	225
DOID:1176	bronchial disease	GO:0097285	cell-type specific apoptotic process	2.079614258576612e-11	4.5865892472907177e-7	26	429	225
DOID:1176	bronchial disease	GO:0009986	cell surface	2.3224977496738575e-11	5.122268786905693e-7	34	715	225
DOID:1176	bronchial disease	GO:0045859	regulation of protein kinase activity	3.829880856898171e-11	8.446802229888917e-7	33	709	225
DOID:1176	bronchial disease	GO:0030003	cellular cation homeostasis	3.897449030176858e-11	8.595823836055061e-7	28	519	225
DOID:1176	bronchial disease	GO:0051222	positive regulation of protein transport	3.9829028963822566e-11	8.784292337971067e-7	26	447	225
DOID:1176	bronchial disease	GO:0033002	muscle cell proliferation	4.177824752815695e-11	9.214192492335016e-7	16	151	225
DOID:1176	bronchial disease	GO:0043410	positive regulation of MAPK cascade	8.739775569921449e-11	1.9275575019461755e-6	26	464	225
DOID:1176	bronchial disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.0245482240378578e-10	2.2596411081154955e-6	18	212	225
DOID:1176	bronchial disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.1090195428664629e-10	2.445942601791984e-6	16	161	225
DOID:1176	bronchial disease	GO:1903532	positive regulation of secretion by cell	1.2491685463800195e-10	2.755041229041133e-6	22	335	225
DOID:1176	bronchial disease	GO:1903706	regulation of hemopoiesis	1.3882939242648717e-10	3.0618822499661746e-6	21	305	225
DOID:1176	bronchial disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1.525606307950511e-10	3.3647247121848523e-6	13	97	225
DOID:1176	bronchial disease	GO:0002526	acute inflammatory response	1.649378411627822e-10	3.6377040868451616e-6	15	141	225
DOID:1176	bronchial disease	GO:0008285	negative regulation of cell proliferation	1.664143267632312e-10	3.670267976763064e-6	30	634	225
DOID:1176	bronchial disease	GO:0072503	cellular divalent inorganic cation homeostasis	1.8281809399667281e-10	4.032053063096619e-6	23	375	225
DOID:1176	bronchial disease	GO:0032722	positive regulation of chemokine production	3.5633385131461637e-10	7.858943090743864e-6	10	50	225
DOID:1176	bronchial disease	GO:0097529	myeloid leukocyte migration	5.248450563044571e-10	1.1575457716794801e-5	15	153	225
DOID:1176	bronchial disease	GO:0002274	myeloid leukocyte activation	5.248450563044571e-10	1.1575457716794801e-5	15	153	225
DOID:1176	bronchial disease	GO:0098552	side of membrane	7.006710767143431e-10	1.5453300596934838e-5	23	402	225
DOID:1176	bronchial disease	GO:0071363	cellular response to growth factor stimulus	7.452064521018542e-10	1.6435528301106395e-5	28	594	225
DOID:1176	bronchial disease	GO:0032838	cell projection cytoplasm	7.563347725891845e-10	1.6680963409454463e-5	13	110	225
DOID:1176	bronchial disease	GO:0071496	cellular response to external stimulus	7.593631279334545e-10	1.674775378657234e-5	19	270	225
DOID:1176	bronchial disease	GO:0050673	epithelial cell proliferation	7.779212829461812e-10	1.7157053895378027e-5	21	335	225
DOID:1176	bronchial disease	GO:0010942	positive regulation of cell death	8.039454657549072e-10	1.773101724722448e-5	28	596	225
DOID:1176	bronchial disease	GO:0097014	ciliary cytoplasm	8.376062066162149e-10	1.847340488692062e-5	12	90	225
DOID:1176	bronchial disease	GO:0005930	axoneme	8.376062066162149e-10	1.847340488692062e-5	12	90	225
DOID:1176	bronchial disease	GO:0033674	positive regulation of kinase activity	8.577926147168569e-10	1.8918616117580278e-5	25	480	225
DOID:1176	bronchial disease	GO:0072358	cardiovascular system development	1.1039477110230678e-9	2.434756676661376e-5	35	910	225
DOID:1176	bronchial disease	GO:0045860	positive regulation of protein kinase activity	1.1914699227233427e-9	2.6277869145663324e-5	24	450	225
DOID:1176	bronchial disease	GO:0070371	ERK1 and ERK2 cascade	1.2347162181569615e-9	2.7231666191451787e-5	18	247	225
DOID:1176	bronchial disease	GO:0002443	leukocyte mediated immunity	1.3148718780442437e-9	2.8999499270265794e-5	19	279	225
DOID:1176	bronchial disease	GO:0034599	cellular response to oxidative stress	1.3825324218785795e-9	3.049175256453207e-5	17	219	225
DOID:1176	bronchial disease	GO:0006937	regulation of muscle contraction	1.5130472430513464e-9	3.3370256945497445e-5	15	165	225
DOID:1176	bronchial disease	GO:0032386	regulation of intracellular transport	1.6617982545596988e-9	3.6650960504314156e-5	27	575	225
DOID:1176	bronchial disease	GO:0051093	negative regulation of developmental process	1.6898720200941852e-9	3.7270127403177256e-5	32	788	225
DOID:1176	bronchial disease	GO:1903827	regulation of cellular protein localization	2.2726351911472875e-9	5.0122969140753426e-5	26	543	225
DOID:1176	bronchial disease	GO:0006940	regulation of smooth muscle contraction	2.3550212890910416e-9	5.193999453090292e-5	10	60	225
DOID:1176	bronchial disease	GO:0098869	cellular oxidant detoxification	2.684465427726934e-9	5.9205885008517534e-5	11	79	225
DOID:1176	bronchial disease	GO:0002683	negative regulation of immune system process	2.6960281784838003e-9	5.9460901476460215e-5	21	359	225
DOID:1176	bronchial disease	GO:0031670	cellular response to nutrient	2.7769396782062472e-9	6.124540460283878e-5	9	45	225
DOID:1176	bronchial disease	GO:0071295	cellular response to vitamin	3.220204436438223e-9	7.102160884564501e-5	8	32	225
DOID:1176	bronchial disease	GO:0042886	amide transport	3.4005668281267276e-9	7.499950139433498e-5	20	329	225
DOID:1176	bronchial disease	GO:1903649	regulation of cytoplasmic transport	3.458707320547205e-9	7.628178995466861e-5	23	437	225
DOID:1176	bronchial disease	GO:0070372	regulation of ERK1 and ERK2 cascade	3.5539396980865945e-9	7.838214004129984e-5	17	233	225
DOID:1176	bronchial disease	GO:0043065	positive regulation of apoptotic process	3.718564567378735e-9	8.2012941533538e-5	26	556	225
DOID:1176	bronchial disease	GO:0034612	response to tumor necrosis factor	3.783728996786806e-9	8.3450143024133e-5	18	265	225
DOID:1176	bronchial disease	GO:0050671	positive regulation of lymphocyte proliferation	4.5279837657119515e-9	9.986468195277709e-5	13	127	225
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0042327	positive regulation of phosphorylation	2.1249668691325496e-12	4.686614429871838e-8	41	910	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0035239	tube morphogenesis	2.46391795855061e-12	5.43417105758337e-8	25	338	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0030855	epithelial cell differentiation	6.408873431951179e-12	1.4134770354168325e-7	31	568	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0001934	positive regulation of protein phosphorylation	8.5987883480243e-12	1.8964627701567593e-7	40	870	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0002009	morphogenesis of an epithelium	1.0446532527907948e-11	2.303982749030098e-7	29	506	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0008544	epidermis development	1.2013168237956506e-11	2.6495042548813075e-7	22	296	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0048598	embryonic morphogenesis	1.5409451492587323e-11	3.398554526690134e-7	30	560	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0001944	vasculature development	3.3693270395929176e-11	7.43105078582218e-7	30	588	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0001568	blood vessel development	6.684042208604524e-11	1.4741655091077277e-6	29	569	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0033044	regulation of chromosome organization	1.2376588642837305e-10	2.7296566251777676e-6	20	271	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0043009	chordate embryonic development	1.5929657593005686e-10	3.513285982137404e-6	28	552	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0050678	regulation of epithelial cell proliferation	1.8288648373498972e-10	4.033561398775198e-6	20	277	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0001655	urogenital system development	2.4620350203008456e-10	5.430018237273515e-6	21	313	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0002520	immune system development	3.971033502025989e-10	8.758114388718319e-6	33	782	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0060562	epithelial tube morphogenesis	7.877493102270705e-10	1.737381103705804e-5	20	301	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0043549	regulation of kinase activity	8.099412251993954e-10	1.7863253721772665e-5	32	761	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0048534	hematopoietic or lymphoid organ development	1.6139121150615665e-9	3.559483169768285e-5	31	739	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0016331	morphogenesis of embryonic epithelium	1.8022395797956392e-9	3.974839393239282e-5	14	141	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0035107	appendage morphogenesis	2.849212532574086e-9	6.283938240592146e-5	14	146	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0035108	limb morphogenesis	2.849212532574086e-9	6.283938240592146e-5	14	146	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0008285	negative regulation of cell proliferation	3.485414623582983e-9	7.687081952312269e-5	28	634	226
Orphanet:183598	Rare genetic palpebral, lacrimal system and conjunctival disease	GO:0008284	positive regulation of cell proliferation	4.259953390040039e-9	9.395327201733306e-5	32	815	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0042327	positive regulation of phosphorylation	2.1249668691325496e-12	4.686614429871838e-8	41	910	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0035239	tube morphogenesis	2.46391795855061e-12	5.43417105758337e-8	25	338	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0030855	epithelial cell differentiation	6.408873431951179e-12	1.4134770354168325e-7	31	568	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0001934	positive regulation of protein phosphorylation	8.5987883480243e-12	1.8964627701567593e-7	40	870	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0002009	morphogenesis of an epithelium	1.0446532527907948e-11	2.303982749030098e-7	29	506	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0008544	epidermis development	1.2013168237956506e-11	2.6495042548813075e-7	22	296	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0048598	embryonic morphogenesis	1.5409451492587323e-11	3.398554526690134e-7	30	560	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0001944	vasculature development	3.3693270395929176e-11	7.43105078582218e-7	30	588	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0001568	blood vessel development	6.684042208604524e-11	1.4741655091077277e-6	29	569	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0033044	regulation of chromosome organization	1.2376588642837305e-10	2.7296566251777676e-6	20	271	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0043009	chordate embryonic development	1.5929657593005686e-10	3.513285982137404e-6	28	552	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0050678	regulation of epithelial cell proliferation	1.8288648373498972e-10	4.033561398775198e-6	20	277	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0001655	urogenital system development	2.4620350203008456e-10	5.430018237273515e-6	21	313	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0002520	immune system development	3.971033502025989e-10	8.758114388718319e-6	33	782	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0060562	epithelial tube morphogenesis	7.877493102270705e-10	1.737381103705804e-5	20	301	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0043549	regulation of kinase activity	8.099412251993954e-10	1.7863253721772665e-5	32	761	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0048534	hematopoietic or lymphoid organ development	1.6139121150615665e-9	3.559483169768285e-5	31	739	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0016331	morphogenesis of embryonic epithelium	1.8022395797956392e-9	3.974839393239282e-5	14	141	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0035107	appendage morphogenesis	2.849212532574086e-9	6.283938240592146e-5	14	146	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0035108	limb morphogenesis	2.849212532574086e-9	6.283938240592146e-5	14	146	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0008285	negative regulation of cell proliferation	3.485414623582983e-9	7.687081952312269e-5	28	634	226
Orphanet:98559	Rare palpebral, lacrimal system and conjunctival disease	GO:0008284	positive regulation of cell proliferation	4.259953390040039e-9	9.395327201733306e-5	32	815	226
Orphanet:404568	Dysostosis of genetic origin	GO:0040007	growth	9.868994510497942e-12	2.176606739290321e-7	45	936	226
Orphanet:404568	Dysostosis of genetic origin	GO:0051241	negative regulation of multicellular organismal process	6.092681914537934e-12	1.3437409962513414e-7	41	966	226
Orphanet:404568	Dysostosis of genetic origin	GO:0030323	respiratory tube development	2.753353101070388e-13	6.072520264410741e-9	19	179	226
Orphanet:404568	Dysostosis of genetic origin	GO:0071773	cellular response to BMP stimulus	1.7186252421197423e-13	3.790427971495092e-9	19	147	226
Orphanet:404568	Dysostosis of genetic origin	GO:0009798	axis specification	2.1260770921571748e-13	4.689063026752649e-9	15	90	226
Orphanet:404568	Dysostosis of genetic origin	GO:0009880	embryonic pattern specification	2.9928282074820345e-12	6.600682611601627e-8	12	57	226
Orphanet:404568	Dysostosis of genetic origin	GO:0032330	regulation of chondrocyte differentiation	5.894729149247269e-12	1.300082513866485e-7	11	46	226
Orphanet:404568	Dysostosis of genetic origin	GO:0061061	muscle structure development	9.651834886881261e-12	2.128712184301662e-7	30	551	226
Orphanet:404568	Dysostosis of genetic origin	GO:0060485	mesenchyme development	9.914513654507573e-12	2.1866459865016452e-7	20	237	226
Orphanet:404568	Dysostosis of genetic origin	GO:0007498	mesoderm development	2.4873325621399545e-11	5.48581196579967e-7	15	123	226
Orphanet:404568	Dysostosis of genetic origin	GO:0048863	stem cell differentiation	8.903777715119077e-11	1.9637281750695124e-6	20	266	226
Orphanet:404568	Dysostosis of genetic origin	GO:0030510	regulation of BMP signaling pathway	1.3598344672516305e-10	2.999114917523471e-6	12	77	226
Orphanet:404568	Dysostosis of genetic origin	GO:0022612	gland morphogenesis	1.8663470768842672e-10	4.116228478068251e-6	14	119	226
Orphanet:404568	Dysostosis of genetic origin	GO:0030855	epithelial cell differentiation	3.027061934446351e-10	6.6761850964214275e-6	28	568	226
Orphanet:404568	Dysostosis of genetic origin	GO:0001568	blood vessel development	3.1409197465137595e-10	6.9272985009360966e-6	28	569	226
Orphanet:404568	Dysostosis of genetic origin	GO:0060606	tube closure	3.358164857303336e-10	7.406432592782508e-6	12	83	226
Orphanet:404568	Dysostosis of genetic origin	GO:0003279	cardiac septum development	3.875546550347053e-10	8.547517916790426e-6	12	84	226
Orphanet:404568	Dysostosis of genetic origin	GO:0060284	regulation of cell development	4.2336134598031094e-10	9.337234485595758e-6	34	828	226
Orphanet:404568	Dysostosis of genetic origin	GO:0048557	embryonic digestive tract morphogenesis	6.087123027853636e-10	1.3425149837931194e-5	7	17	226
Orphanet:404568	Dysostosis of genetic origin	GO:0045668	negative regulation of osteoblast differentiation	7.35280503150193e-10	1.6216611496977507e-5	9	39	226
Orphanet:404568	Dysostosis of genetic origin	GO:0032332	positive regulation of chondrocyte differentiation	1.5449644896747827e-9	3.407419181977733e-5	7	19	226
Orphanet:404568	Dysostosis of genetic origin	GO:0001841	neural tube formation	1.6675103520213952e-9	3.677694081383187e-5	12	95	226
Orphanet:404568	Dysostosis of genetic origin	GO:0009954	proximal/distal pattern formation	3.334483134054267e-9	7.354202552156686e-5	8	32	226
Orphanet:404568	Dysostosis of genetic origin	GO:0044212	transcription regulatory region DNA binding	3.3568007262729793e-9	7.403424001795056e-5	32	807	226
Orphanet:404568	Dysostosis of genetic origin	GO:0048864	stem cell development	3.632403600128953e-9	8.011266140084405e-5	15	175	226
Orphanet:404568	Dysostosis of genetic origin	GO:0001823	mesonephros development	3.826322481081945e-9	8.43895423202623e-5	12	102	226
Orphanet:404568	Dysostosis of genetic origin	GO:0001843	neural tube closure	4.220867433346598e-9	9.309123124245922e-5	11	82	226
DOID:299	adenocarcinoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.0392575688911165e-11	2.2920825681893575e-7	44	996	226
DOID:299	adenocarcinoma	GO:0009790	embryo development	4.5925485636644225e-12	1.0128865857161884e-7	40	932	226
DOID:299	adenocarcinoma	GO:0060562	epithelial tube morphogenesis	1.036060126580196e-12	2.2850306091726225e-8	24	301	226
DOID:299	adenocarcinoma	GO:0001763	morphogenesis of a branching structure	8.779643678735738e-13	1.936350413345167e-8	20	193	226
DOID:299	adenocarcinoma	GO:0009887	organ morphogenesis	8.080203173221889e-13	1.7820888098540877e-8	41	950	226
DOID:299	adenocarcinoma	GO:0070997	neuron death	9.50350909079134e-14	2.09599892997403e-9	24	281	226
DOID:299	adenocarcinoma	GO:1901214	regulation of neuron death	2.2115642650533118e-13	4.877604986575079e-9	22	250	226
DOID:299	adenocarcinoma	GO:0001890	placenta development	4.055644708955697e-13	8.94472440560179e-9	21	138	226
DOID:299	adenocarcinoma	GO:0009991	response to extracellular stimulus	2.441935542663032e-12	5.3856888393433167e-8	33	573	226
DOID:299	adenocarcinoma	GO:0071496	cellular response to external stimulus	2.5249802249049935e-12	5.568843886027963e-8	22	270	226
DOID:299	adenocarcinoma	GO:0033993	response to lipid	3.3183455983021304e-12	7.318611217055349e-8	42	850	226
DOID:299	adenocarcinoma	GO:0001101	response to acid chemical	3.517630631222346e-12	7.758134357160884e-8	24	315	226
DOID:299	adenocarcinoma	GO:0042692	muscle cell differentiation	3.664957226590104e-12	8.083063163244475e-8	24	334	226
DOID:299	adenocarcinoma	GO:0043009	chordate embryonic development	4.792832797306801e-12	1.0570592734460149e-7	31	552	226
DOID:299	adenocarcinoma	GO:0010035	response to inorganic substance	4.908740081077667e-12	1.0826226248816795e-7	31	502	226
DOID:299	adenocarcinoma	GO:0097305	response to alcohol	5.261679980606004e-12	1.1604635197226543e-7	26	369	226
DOID:299	adenocarcinoma	GO:0061138	morphogenesis of a branching epithelium	5.588640661358113e-12	1.2325746978625318e-7	18	179	226
DOID:299	adenocarcinoma	GO:0031667	response to nutrient levels	5.83300074907811e-12	1.2864683152091771e-7	33	546	226
DOID:299	adenocarcinoma	GO:0030855	epithelial cell differentiation	6.408873431951179e-12	1.4134770354168325e-7	31	568	226
DOID:299	adenocarcinoma	GO:0043068	positive regulation of programmed cell death	6.430633803233832e-12	1.4182762853032216e-7	34	561	226
DOID:299	adenocarcinoma	GO:0032870	cellular response to hormone stimulus	6.826650356117625e-12	1.5056177360417422e-7	30	519	226
DOID:299	adenocarcinoma	GO:0043065	positive regulation of apoptotic process	6.952549647110118e-12	1.5333848246701365e-7	32	556	226
DOID:299	adenocarcinoma	GO:0097285	cell-type specific apoptotic process	7.185252393071551e-12	1.5847074152919305e-7	32	429	226
DOID:299	adenocarcinoma	GO:0048732	gland development	7.73558994637824e-12	1.706084362673721e-7	29	421	226
DOID:299	adenocarcinoma	GO:1902533	positive regulation of intracellular signal transduction	7.796985279640012e-12	1.7196251034246046e-7	44	860	226
DOID:299	adenocarcinoma	GO:1901698	response to nitrogen compound	8.339218204866938e-12	1.8392145750834032e-7	43	870	226
DOID:299	adenocarcinoma	GO:0071407	cellular response to organic cyclic compound	8.642642157496994e-12	1.906134727835962e-7	27	416	226
DOID:299	adenocarcinoma	GO:0008285	negative regulation of cell proliferation	9.437561843128606e-12	2.081454264502014e-7	36	634	226
DOID:299	adenocarcinoma	GO:0060548	negative regulation of cell death	9.586775817638227e-12	2.114363406580111e-7	50	867	226
DOID:299	adenocarcinoma	GO:0043069	negative regulation of programmed cell death	9.59443635650814e-12	2.1160529384278703e-7	45	806	226
DOID:299	adenocarcinoma	GO:0030334	regulation of cell migration	9.860223748603403e-12	2.1746723477544805e-7	34	660	226
DOID:299	adenocarcinoma	GO:0045859	regulation of protein kinase activity	1.2204903754309271e-11	2.6917915230129097e-7	38	709	226
DOID:299	adenocarcinoma	GO:0043066	negative regulation of apoptotic process	1.2543854843727331e-11	2.766547185784063e-7	44	795	226
DOID:299	adenocarcinoma	GO:0001934	positive regulation of protein phosphorylation	1.3644307905735786e-11	3.0092521086100277e-7	38	870	226
DOID:299	adenocarcinoma	GO:0006979	response to oxidative stress	1.3722467606669397e-11	3.0264902306509356e-7	25	386	226
DOID:299	adenocarcinoma	GO:0010243	response to organonitrogen compound	1.414846018121807e-11	3.1204428929676453e-7	40	780	226
DOID:299	adenocarcinoma	GO:0051093	negative regulation of developmental process	1.9359847058808555e-11	4.269814268820227e-7	36	788	226
DOID:299	adenocarcinoma	GO:0050678	regulation of epithelial cell proliferation	2.541111765452797e-11	5.604421998706144e-7	21	277	226
DOID:299	adenocarcinoma	GO:0042493	response to drug	2.627698059143313e-11	5.795388069440577e-7	26	433	226
DOID:299	adenocarcinoma	GO:0008284	positive regulation of cell proliferation	2.76667577736589e-11	6.101903426980471e-7	36	815	226
DOID:299	adenocarcinoma	GO:0000904	cell morphogenesis involved in differentiation	2.8064106594172245e-11	6.189538709344689e-7	34	720	226
DOID:299	adenocarcinoma	GO:0002520	immune system development	3.457656383432095e-11	7.625861153659486e-7	35	782	226
DOID:299	adenocarcinoma	GO:0071453	cellular response to oxygen levels	4.0223602226774346e-11	8.871315471115082e-7	16	150	226
DOID:299	adenocarcinoma	GO:0000165	MAPK cascade	4.732614300451132e-11	1.0437780839644972e-6	36	843	226
DOID:299	adenocarcinoma	GO:0045786	negative regulation of cell cycle	4.914246787279808e-11	1.0838371289345616e-6	26	449	226
DOID:299	adenocarcinoma	GO:0007417	central nervous system development	5.2600035438388204e-11	1.1600937815936518e-6	37	889	226
DOID:299	adenocarcinoma	GO:0097190	apoptotic signaling pathway	5.602684982619621e-11	1.2356721729167575e-6	29	564	226
DOID:299	adenocarcinoma	GO:0031960	response to corticosteroid	6.258760176791611e-11	1.3803695569913899e-6	17	179	226
DOID:299	adenocarcinoma	GO:0030335	positive regulation of cell migration	6.515243899940515e-11	1.4369370421318806e-6	24	387	226
DOID:299	adenocarcinoma	GO:1901652	response to peptide	7.336764529242146e-11	1.6181234169243552e-6	25	423	226
DOID:299	adenocarcinoma	GO:0045597	positive regulation of cell differentiation	7.776013166704843e-11	1.714999703916753e-6	35	815	226
DOID:299	adenocarcinoma	GO:0043408	regulation of MAPK cascade	8.138145712877076e-11	1.7948680369750392e-6	31	651	226
DOID:299	adenocarcinoma	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	8.738465506752391e-11	1.92726856751424e-6	23	359	226
DOID:299	adenocarcinoma	GO:0051402	neuron apoptotic process	1.0234058045455185e-10	2.257121501925141e-6	18	211	226
DOID:299	adenocarcinoma	GO:0050767	regulation of neurogenesis	1.0358891522344038e-10	2.2846535252529776e-6	31	658	226
DOID:299	adenocarcinoma	GO:0030155	regulation of cell adhesion	1.1602474536687168e-10	2.558925759066355e-6	30	621	226
DOID:299	adenocarcinoma	GO:0043627	response to estrogen	1.6084289455875478e-10	3.5473900394933366e-6	18	217	226
DOID:299	adenocarcinoma	GO:0007167	enzyme linked receptor protein signaling pathway	1.6635692823285808e-10	3.669002052175685e-6	37	935	226
DOID:299	adenocarcinoma	GO:0007610	behavior	1.772134661237601e-10	3.908442995359529e-6	32	714	226
DOID:299	adenocarcinoma	GO:0022603	regulation of anatomical structure morphogenesis	1.89988136334307e-10	4.190188346853141e-6	38	986	226
DOID:299	adenocarcinoma	GO:1901699	cellular response to nitrogen compound	1.928457393773897e-10	4.25321278196833e-6	27	518	226
DOID:299	adenocarcinoma	GO:0036294	cellular response to decreased oxygen levels	1.9390822281195597e-10	4.276645854117689e-6	15	142	226
DOID:299	adenocarcinoma	GO:0080135	regulation of cellular response to stress	2.3328972087455213e-10	5.145204793888247e-6	31	681	226
DOID:299	adenocarcinoma	GO:0045121	membrane raft	2.513490526823148e-10	5.543503356908452e-6	20	282	226
DOID:299	adenocarcinoma	GO:0007584	response to nutrient	2.8657565209755376e-10	6.320426007011548e-6	17	197	226
DOID:299	adenocarcinoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.96154989420927e-10	6.531698291678545e-6	30	647	226
DOID:299	adenocarcinoma	GO:0048754	branching morphogenesis of an epithelial tube	3.1699420866004857e-10	6.991307271997371e-6	15	147	226
DOID:299	adenocarcinoma	GO:0072358	cardiovascular system development	3.2367941660282895e-10	7.1387495331753925e-6	36	910	226
DOID:299	adenocarcinoma	GO:0048667	cell morphogenesis involved in neuron differentiation	3.5689196042909543e-10	7.8712521872637e-6	26	495	226
DOID:299	adenocarcinoma	GO:0030097	hemopoiesis	3.777472779020741e-10	8.331216214130244e-6	31	695	226
DOID:299	adenocarcinoma	GO:0032386	regulation of intracellular transport	3.9670133844538213e-10	8.749248019412903e-6	28	575	226
DOID:299	adenocarcinoma	GO:0007568	aging	4.114854013081981e-10	9.07531052585231e-6	20	290	226
DOID:299	adenocarcinoma	GO:0048864	stem cell development	4.148905663470259e-10	9.150411440783657e-6	16	175	226
DOID:299	adenocarcinoma	GO:0034097	response to cytokine	4.219675719951965e-10	9.30649480035406e-6	33	784	226
DOID:299	adenocarcinoma	GO:0071417	cellular response to organonitrogen compound	4.3331038757088436e-10	9.556660597875855e-6	25	462	226
DOID:299	adenocarcinoma	GO:0040008	regulation of growth	4.367581851738578e-10	9.632701774009433e-6	29	617	226
DOID:299	adenocarcinoma	GO:0030162	regulation of proteolysis	4.6140402609751163e-10	1.0176265795580619e-5	31	701	226
DOID:299	adenocarcinoma	GO:0043410	positive regulation of MAPK cascade	4.736350200928996e-10	1.04460203681489e-5	25	464	226
DOID:299	adenocarcinoma	GO:1903827	regulation of cellular protein localization	5.321586504791753e-10	1.1736759036318212e-5	27	543	226
DOID:299	adenocarcinoma	GO:0001944	vasculature development	6.581849509856852e-10	1.4516269093989287e-5	28	588	226
DOID:299	adenocarcinoma	GO:2000116	regulation of cysteine-type endopeptidase activity	6.690147325016937e-10	1.4755119925324856e-5	17	208	226
DOID:299	adenocarcinoma	GO:0035148	tube formation	6.792694184909465e-10	1.4981287024817824e-5	14	131	226
DOID:299	adenocarcinoma	GO:0010038	response to metal ion	8.435007137208572e-10	1.8603408241113506e-5	21	335	226
DOID:299	adenocarcinoma	GO:0051345	positive regulation of hydrolase activity	9.395787481381035e-10	2.0722409290185873e-5	35	900	226
DOID:299	adenocarcinoma	GO:0048568	embryonic organ development	1.0160859931218624e-9	2.2409776578302676e-5	23	408	226
DOID:299	adenocarcinoma	GO:0048514	blood vessel morphogenesis	1.116651882071551e-9	2.4627757259088057e-5	25	484	226
DOID:299	adenocarcinoma	GO:0045471	response to ethanol	1.2318571718239468e-9	2.7168609924577147e-5	14	137	226
DOID:299	adenocarcinoma	GO:0043523	regulation of neuron apoptotic process	1.396737614456356e-9	3.080504808683493e-5	16	190	226
DOID:299	adenocarcinoma	GO:0034599	cellular response to oxidative stress	1.4794661051809044e-9	3.2629624949764846e-5	17	219	226
DOID:299	adenocarcinoma	GO:0097191	extrinsic apoptotic signaling pathway	1.5868564240406613e-9	3.4998118432216785e-5	17	220	226
DOID:299	adenocarcinoma	GO:0032403	protein complex binding	1.8611947538715867e-9	4.1048650296637845e-5	35	924	226
DOID:299	adenocarcinoma	GO:0051384	response to glucocorticoid	1.901677371130006e-9	4.1941494420272285e-5	15	167	226
DOID:299	adenocarcinoma	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.0421090374256323e-9	4.503871482042232e-5	16	195	226
DOID:299	adenocarcinoma	GO:0043434	response to peptide hormone	2.250224229172204e-9	4.962869537439296e-5	22	389	226
DOID:299	adenocarcinoma	GO:0018108	peptidyl-tyrosine phosphorylation	2.274576305083542e-9	5.016578040861752e-5	21	354	226
DOID:299	adenocarcinoma	GO:0060322	head development	2.399493381766149e-9	5.2920826534852417e-5	30	708	226
DOID:299	adenocarcinoma	GO:1901215	negative regulation of neuron death	2.4340455206939282e-9	5.368287395890459e-5	15	170	226
DOID:299	adenocarcinoma	GO:0032355	response to estradiol	2.60336019408669e-9	5.741710908058195e-5	14	145	226
DOID:299	adenocarcinoma	GO:0014031	mesenchymal cell development	2.6397904973052277e-9	5.82205794180668e-5	15	171	226
DOID:299	adenocarcinoma	GO:0045862	positive regulation of proteolysis	2.643969154725312e-9	5.8312739707466754e-5	21	357	226
DOID:299	adenocarcinoma	GO:0030900	forebrain development	2.643969154725312e-9	5.8312739707466754e-5	21	357	226
DOID:299	adenocarcinoma	GO:0042063	gliogenesis	2.7358472154404012e-9	6.033911033653805e-5	17	228	226
DOID:299	adenocarcinoma	GO:0009314	response to radiation	2.9002841239744725e-9	6.396576635425699e-5	23	431	226
DOID:299	adenocarcinoma	GO:0071900	regulation of protein serine/threonine kinase activity	2.9002841239744725e-9	6.396576635425699e-5	23	431	226
DOID:299	adenocarcinoma	GO:2001233	regulation of apoptotic signaling pathway	2.9200051265831917e-9	6.440071306679229e-5	21	359	226
DOID:299	adenocarcinoma	GO:0045930	negative regulation of mitotic cell cycle	2.9509235055513727e-9	6.508261791493553e-5	16	200	226
DOID:299	adenocarcinoma	GO:0045664	regulation of neuron differentiation	3.024622552416645e-9	6.67080503935491e-5	26	548	226
DOID:299	adenocarcinoma	GO:0048660	regulation of smooth muscle cell proliferation	3.0389077920744967e-9	6.702311135420302e-5	12	100	226
DOID:299	adenocarcinoma	GO:0003682	chromatin binding	3.167163975525966e-9	6.985180148022518e-5	23	433	226
DOID:299	adenocarcinoma	GO:0004714	transmembrane receptor protein tyrosine kinase activity	4.037225331821048e-9	8.904100469331322e-5	10	63	226
DOID:299	adenocarcinoma	GO:0008134	transcription factor binding	4.416496501846723e-9	9.740583034822947e-5	25	518	226
Orphanet:182130	Tumor of endocrine glands	GO:0045137	development of primary sexual characteristics	4.907185768843192e-13	1.082279821318366e-8	26	225	227
Orphanet:182130	Tumor of endocrine glands	GO:0010638	positive regulation of organelle organization	2.5889290711234025e-12	5.709883066362664e-8	33	573	227
Orphanet:182130	Tumor of endocrine glands	GO:0060249	anatomical structure homeostasis	5.576761274994624e-12	1.2299546992000643e-7	26	351	227
Orphanet:182130	Tumor of endocrine glands	GO:1902533	positive regulation of intracellular signal transduction	8.11595235461482e-12	1.7899732918102984e-7	48	860	227
Orphanet:182130	Tumor of endocrine glands	GO:0043408	regulation of MAPK cascade	9.321987626265127e-12	2.0559643709727737e-7	41	651	227
Orphanet:182130	Tumor of endocrine glands	GO:0040008	regulation of growth	1.1780465491995074e-11	2.5981816642595135e-7	37	617	227
Orphanet:182130	Tumor of endocrine glands	GO:0001503	ossification	6.773734906317941e-10	1.4939472335884219e-5	22	363	227
Orphanet:182130	Tumor of endocrine glands	GO:0070371	ERK1 and ERK2 cascade	1.4234429190906894e-9	3.1394033580545155e-5	18	247	227
Orphanet:182130	Tumor of endocrine glands	GO:0036294	cellular response to decreased oxygen levels	2.094339035529913e-9	4.619064742861223e-5	14	142	227
Orphanet:182130	Tumor of endocrine glands	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.1950408157778156e-9	4.8411625191979724e-5	15	168	227
Orphanet:182130	Tumor of endocrine glands	GO:0055114	oxidation-reduction process	4.181349599896578e-9	9.221966542571902e-5	35	949	227
MESH:D011248	Pregnancy Complications	GO:0051241	negative regulation of multicellular organismal process	7.285949621405052e-12	1.6069161890008843e-7	43	966	227
MESH:D011248	Pregnancy Complications	GO:0042327	positive regulation of phosphorylation	2.176703262080082e-12	4.8007190445176207e-8	41	910	227
MESH:D011248	Pregnancy Complications	GO:0007565	female pregnancy	1.3864465131518955e-12	3.0578077847565055e-8	23	190	227
MESH:D011248	Pregnancy Complications	GO:0007584	response to nutrient	6.632472349110685e-13	1.4627917765963616e-8	20	197	227
MESH:D011248	Pregnancy Complications	GO:0072593	reactive oxygen species metabolic process	2.1938006966593093e-13	4.838427436482107e-9	23	223	227
MESH:D011248	Pregnancy Complications	GO:0008202	steroid metabolic process	6.222800053024002e-13	1.3724385516944437e-8	26	275	227
MESH:D011248	Pregnancy Complications	GO:1903409	reactive oxygen species biosynthetic process	1.4988010832439613e-12	3.305605789094557e-8	14	83	227
MESH:D011248	Pregnancy Complications	GO:0036293	response to decreased oxygen levels	1.6119328094532648e-12	3.5551178112491755e-8	23	302	227
MESH:D011248	Pregnancy Complications	GO:0007167	enzyme linked receptor protein signaling pathway	1.975863916925391e-12	4.35776786877895e-8	39	935	227
MESH:D011248	Pregnancy Complications	GO:0007568	aging	2.0126122990404838e-12	4.438816425533787e-8	23	290	227
MESH:D011248	Pregnancy Complications	GO:0002237	response to molecule of bacterial origin	2.0762280783515052e-12	4.579121026804245e-8	25	333	227
MESH:D011248	Pregnancy Complications	GO:0001101	response to acid chemical	3.105737889086413e-12	6.849704914380084e-8	25	315	227
MESH:D011248	Pregnancy Complications	GO:0032496	response to lipopolysaccharide	3.1294966618133913e-12	6.902104887629434e-8	25	319	227
MESH:D011248	Pregnancy Complications	GO:0044283	small molecule biosynthetic process	3.401834369753942e-12	7.50274570249232e-8	31	530	227
MESH:D011248	Pregnancy Complications	GO:0001568	blood vessel development	3.5330627312646357e-12	7.792169853804154e-8	35	569	227
MESH:D011248	Pregnancy Complications	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3.859024211294582e-12	8.5110778980102e-8	17	151	227
MESH:D011248	Pregnancy Complications	GO:0030335	positive regulation of cell migration	4.629852057291828e-12	1.0211138712357126e-7	27	387	227
MESH:D011248	Pregnancy Complications	GO:0097305	response to alcohol	5.061284724661164e-12	1.1162663460240196e-7	27	369	227
MESH:D011248	Pregnancy Complications	GO:0014070	response to organic cyclic compound	5.32107691242345e-12	1.173563513034992e-7	49	873	227
MESH:D011248	Pregnancy Complications	GO:1901701	cellular response to oxygen-containing compound	5.660583113353823e-12	1.2484416056501857e-7	40	873	227
MESH:D011248	Pregnancy Complications	GO:0048545	response to steroid hormone	6.17150774928632e-12	1.361126034105098e-7	28	446	227
MESH:D011248	Pregnancy Complications	GO:0006979	response to oxidative stress	6.2307936588013035e-12	1.3742015414486275e-7	26	386	227
MESH:D011248	Pregnancy Complications	GO:0042493	response to drug	7.530864820637362e-12	1.6609322361915702e-7	32	433	227
MESH:D011248	Pregnancy Complications	GO:1902533	positive regulation of intracellular signal transduction	8.11772871145422e-12	1.790365067311228e-7	43	860	227
MESH:D011248	Pregnancy Complications	GO:0001525	angiogenesis	8.607559109918839e-12	1.8983971616925999e-7	27	413	227
MESH:D011248	Pregnancy Complications	GO:1901698	response to nitrogen compound	8.973266574230365e-12	1.979053942946507e-7	40	870	227
MESH:D011248	Pregnancy Complications	GO:0001934	positive regulation of protein phosphorylation	8.973266574230365e-12	1.979053942946507e-7	40	870	227
MESH:D011248	Pregnancy Complications	GO:0006954	inflammatory response	9.511502696568641e-12	2.0977619197282138e-7	34	637	227
MESH:D011248	Pregnancy Complications	GO:0006809	nitric oxide biosynthetic process	1.0061285138363019e-11	2.2190164372659638e-7	12	62	227
MESH:D011248	Pregnancy Complications	GO:0001666	response to hypoxia	1.2062129073342476e-11	2.660302567125683e-7	22	292	227
MESH:D011248	Pregnancy Complications	GO:0010243	response to organonitrogen compound	1.516786696242889e-11	3.3452730585636914e-7	37	780	227
MESH:D011248	Pregnancy Complications	GO:0008285	negative regulation of cell proliferation	1.8080759112137912e-11	3.9877114221820165e-7	32	634	227
MESH:D011248	Pregnancy Complications	GO:1901615	organic hydroxy compound metabolic process	2.0587198612531665e-11	4.540506653993859e-7	29	534	227
MESH:D011248	Pregnancy Complications	GO:0060548	negative regulation of cell death	3.3681946121078e-11	7.428553217003753e-7	37	867	227
MESH:D011248	Pregnancy Complications	GO:0006694	steroid biosynthetic process	3.890820998719846e-11	8.581205712676621e-7	16	149	227
MESH:D011248	Pregnancy Complications	GO:0009790	embryo development	3.946987181535633e-11	8.705080228876838e-7	38	932	227
MESH:D011248	Pregnancy Complications	GO:1901342	regulation of vasculature development	4.886757665190089e-11	1.0777744030576741e-6	19	228	227
MESH:D011248	Pregnancy Complications	GO:0000165	MAPK cascade	5.276168391077363e-11	1.1636589386521123e-6	36	843	227
MESH:D011248	Pregnancy Complications	GO:0071396	cellular response to lipid	5.882738740581317e-11	1.2974380292352095e-6	25	416	227
MESH:D011248	Pregnancy Complications	GO:0050900	leukocyte migration	7.245659627841405e-11	1.598030230920422e-6	23	354	227
MESH:D011248	Pregnancy Complications	GO:0045765	regulation of angiogenesis	8.629330583431738e-11	1.9031988601758698e-6	18	208	227
MESH:D011248	Pregnancy Complications	GO:0043200	response to amino acid	8.728906486510368e-11	1.9251603255998617e-6	14	112	227
MESH:D011248	Pregnancy Complications	GO:0043408	regulation of MAPK cascade	9.021061675440478e-11	1.9895951525183975e-6	31	651	227
MESH:D011248	Pregnancy Complications	GO:0032844	regulation of homeostatic process	9.71827063267483e-11	2.143364588036434e-6	25	427	227
MESH:D011248	Pregnancy Complications	GO:0010817	regulation of hormone levels	1.5163070798962508e-10	3.344215264711181e-6	26	473	227
MESH:D011248	Pregnancy Complications	GO:0000302	response to reactive oxygen species	1.6039158889924465e-10	3.537436493172841e-6	18	216	227
MESH:D011248	Pregnancy Complications	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1.703046592638202e-10	3.756069260063555e-6	13	97	227
MESH:D011248	Pregnancy Complications	GO:0010942	positive regulation of cell death	2.1798352012325495e-10	4.807626536318388e-6	29	596	227
MESH:D011248	Pregnancy Complications	GO:0009636	response to toxic substance	2.2331358984217786e-10	4.925181223969233e-6	19	249	227
MESH:D011248	Pregnancy Complications	GO:0008217	regulation of blood pressure	2.4060009540249894e-10	5.306435104102114e-6	16	168	227
MESH:D011248	Pregnancy Complications	GO:0051048	negative regulation of secretion	2.616176164593753e-10	5.7699765310115225e-6	17	195	227
MESH:D011248	Pregnancy Complications	GO:2000377	regulation of reactive oxygen species metabolic process	3.3710900737560223e-10	7.434939157668907e-6	15	147	227
MESH:D011248	Pregnancy Complications	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.5334069004022695e-10	7.792928918837205e-6	12	83	227
MESH:D011248	Pregnancy Complications	GO:0032940	secretion by cell	3.703127804399742e-10	8.16724837260363e-6	37	956	227
MESH:D011248	Pregnancy Complications	GO:0020037	heme binding	3.8397429680259165e-10	8.468553115981159e-6	14	125	227
MESH:D011248	Pregnancy Complications	GO:0048659	smooth muscle cell proliferation	4.1464676137081824e-10	9.145034322033396e-6	13	104	227
MESH:D011248	Pregnancy Complications	GO:0018108	peptidyl-tyrosine phosphorylation	4.236205830565609e-10	9.342951959312451e-6	22	354	227
MESH:D011248	Pregnancy Complications	GO:0034097	response to cytokine	4.729319158514045e-10	1.0430513404102726e-5	33	784	227
MESH:D011248	Pregnancy Complications	GO:0046394	carboxylic acid biosynthetic process	5.032947392180631e-10	1.1100165473454382e-5	20	292	227
MESH:D011248	Pregnancy Complications	GO:0030199	collagen fibril organization	5.942560887817194e-10	1.3106318038080822e-5	9	38	227
MESH:D011248	Pregnancy Complications	GO:0031960	response to corticosteroid	6.189895263020162e-10	1.3651814002590967e-5	16	179	227
MESH:D011248	Pregnancy Complications	GO:0001503	ossification	6.773734906317941e-10	1.4939472335884219e-5	22	363	227
MESH:D011248	Pregnancy Complications	GO:0044057	regulation of system process	6.817574282891314e-10	1.5036160080916794e-5	26	508	227
MESH:D011248	Pregnancy Complications	GO:0005581	collagen trimer	7.098912568892501e-10	1.5656651670692412e-5	12	88	227
MESH:D011248	Pregnancy Complications	GO:0001990	regulation of systemic arterial blood pressure by hormone	7.644459509847934e-10	1.685985544896962e-5	9	39	227
MESH:D011248	Pregnancy Complications	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.2135632498910809e-9	2.676513747634779e-5	15	161	227
MESH:D011248	Pregnancy Complications	GO:0043627	response to estrogen	1.3746337401698838e-9	3.0317547139446788e-5	17	217	227
MESH:D011248	Pregnancy Complications	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.4187462316073152e-9	3.1290448138099336e-5	29	647	227
MESH:D011248	Pregnancy Complications	GO:0019221	cytokine-mediated signaling pathway	1.938053717509547e-9	4.274377473967306e-5	26	534	227
MESH:D011248	Pregnancy Complications	GO:0050865	regulation of cell activation	2.0190558114308033e-9	4.4530275921106366e-5	24	458	227
MESH:D011248	Pregnancy Complications	GO:0019838	growth factor binding	2.7718450867908473e-9	6.113304338917214e-5	13	121	227
MESH:D011248	Pregnancy Complications	GO:0040007	growth	2.921194619531775e-9	6.44269473337733e-5	35	936	227
MESH:D011248	Pregnancy Complications	GO:0098869	cellular oxidant detoxification	2.9456007633044123e-9	6.496522483467881e-5	11	79	227
MESH:D011248	Pregnancy Complications	GO:0003012	muscle system process	2.9509833465724e-9	6.508393770865428e-5	22	393	227
MESH:D011248	Pregnancy Complications	GO:0051353	positive regulation of oxidoreductase activity	3.00094149530139e-9	6.618576467887216e-5	9	45	227
MESH:D011248	Pregnancy Complications	GO:0048660	regulation of smooth muscle cell proliferation	3.1945561751456353e-9	7.045593644283699e-5	12	100	227
MESH:D011248	Pregnancy Complications	GO:0048878	chemical homeostasis	3.3332336890623537e-9	7.351446901227021e-5	36	988	227
MESH:D011248	Pregnancy Complications	GO:1903531	negative regulation of secretion by cell	3.565028716678853e-9	7.86267083463521e-5	15	174	227
MESH:D011248	Pregnancy Complications	GO:0055065	metal ion homeostasis	4.475827486416506e-9	9.871437521291604e-5	25	516	227
MESH:D011248	Pregnancy Complications	GO:0043065	positive regulation of apoptotic process	4.4882182415051375e-9	9.898765331639581e-5	26	556	227
DOID:780	placenta disease	GO:0051046	regulation of secretion	2.341470350941677e-10	5.164112859001868e-6	31	675	228
DOID:780	placenta disease	GO:0070851	growth factor receptor binding	4.528790675806249e-10	9.988247835490682e-6	14	126	228
DOID:780	placenta disease	GO:0006953	acute-phase response	7.456002482086888e-10	1.644421347424263e-5	10	53	228
DOID:780	placenta disease	GO:0001816	cytokine production	2.0301356151719574e-9	4.477464099261752e-5	28	613	228
DOID:780	placenta disease	GO:0010574	regulation of vascular endothelial growth factor production	2.7086011211707728e-9	5.9738197727421394e-5	8	31	228
DOID:780	placenta disease	GO:0043410	positive regulation of MAPK cascade	2.8476293545409703e-9	6.28044654144011e-5	24	464	228
DOID:780	placenta disease	GO:1903530	regulation of secretion by cell	3.0036110265641014e-9	6.624464119087126e-5	28	624	228
DOID:780	placenta disease	GO:0051047	positive regulation of secretion	4.1623059443551824e-9	9.179965760275355e-5	21	363	228
DOID:2355	anemia	GO:0019752	carboxylic acid metabolic process	1.3848922009174203e-12	3.0543797491233704e-8	41	967	228
DOID:2355	anemia	GO:0048872	homeostasis of number of cells	1.8829382497642655e-13	4.1528203098550875e-9	21	208	228
DOID:2355	anemia	GO:0034101	erythrocyte homeostasis	1.4645507029342753e-11	3.230066575321544e-7	14	98	228
DOID:2355	anemia	GO:0010038	response to metal ion	2.5809021586553627e-11	5.692179710914402e-7	23	335	228
DOID:2355	anemia	GO:0046906	tetrapyrrole binding	9.564571357145724e-11	2.1094662128184893e-6	15	134	228
DOID:2355	anemia	GO:0002520	immune system development	1.2973966345697363e-10	2.8614082775435534e-6	34	782	228
DOID:2355	anemia	GO:0043603	cellular amide metabolic process	4.1008396678421377e-10	9.044401887425835e-6	37	955	228
DOID:2355	anemia	GO:0048534	hematopoietic or lymphoid organ development	2.003210930467958e-9	4.418081707147081e-5	31	739	228
DOID:2355	anemia	GO:0098869	cellular oxidant detoxification	3.0844130582963203e-9	6.802673000072534e-5	11	79	228
DOID:2355	anemia	GO:0009116	nucleoside metabolic process	3.356545041910408e-9	7.402860089933405e-5	22	394	228
DOID:2355	anemia	GO:0009123	nucleoside monophosphate metabolic process	3.488449196176191e-9	7.693774702166589e-5	19	292	228
Orphanet:364526	Primary bone dysplasia	GO:0007167	enzyme linked receptor protein signaling pathway	8.013367747139455e-12	1.7673482566316068e-7	41	935	230
Orphanet:364526	Primary bone dysplasia	GO:0009790	embryo development	5.909717160079708e-12	1.3033881196555797e-7	53	932	230
Orphanet:364526	Primary bone dysplasia	GO:0072358	cardiovascular system development	1.546096584092993e-12	3.409916016217096e-8	44	910	230
Orphanet:364526	Primary bone dysplasia	GO:0043583	ear development	1.142419492339286e-12	2.5196061903542954e-8	21	196	230
Orphanet:364526	Primary bone dysplasia	GO:0048705	skeletal system morphogenesis	1.050270981295398e-12	2.3163726492470005e-8	36	204	230
Orphanet:364526	Primary bone dysplasia	GO:0030278	regulation of ossification	8.384404281969182e-13	1.849180364388303e-8	22	177	230
Orphanet:364526	Primary bone dysplasia	GO:0048736	appendage development	7.507328092515309e-13	1.6557412108042513e-8	24	168	230
Orphanet:364526	Primary bone dysplasia	GO:0060173	limb development	7.507328092515309e-13	1.6557412108042513e-8	24	168	230
Orphanet:364526	Primary bone dysplasia	GO:0001649	osteoblast differentiation	6.930012119710227e-13	1.5284141730020906e-8	22	206	230
Orphanet:364526	Primary bone dysplasia	GO:0035107	appendage morphogenesis	1.7918999617450027e-13	3.952035365628603e-9	22	146	230
Orphanet:364526	Primary bone dysplasia	GO:0035108	limb morphogenesis	1.7918999617450027e-13	3.952035365628603e-9	22	146	230
Orphanet:364526	Primary bone dysplasia	GO:0036075	replacement ossification	3.042011087472929e-14	6.709155453421545e-10	12	26	230
Orphanet:364526	Primary bone dysplasia	GO:0001958	endochondral ossification	3.042011087472929e-14	6.709155453421545e-10	12	26	230
Orphanet:364526	Primary bone dysplasia	GO:0002062	chondrocyte differentiation	7.294165271787278e-14	1.6087281506926843e-9	21	95	230
Orphanet:364526	Primary bone dysplasia	GO:0048562	embryonic organ morphogenesis	2.241540286718191e-13	4.94371710235697e-9	26	280	230
Orphanet:364526	Primary bone dysplasia	GO:0035113	embryonic appendage morphogenesis	2.8888003100746573e-13	6.371249083869657e-9	17	125	230
Orphanet:364526	Primary bone dysplasia	GO:0030326	embryonic limb morphogenesis	2.8888003100746573e-13	6.371249083869657e-9	17	125	230
Orphanet:364526	Primary bone dysplasia	GO:0030282	bone mineralization	3.489430966396867e-13	7.69593999638829e-9	19	100	230
Orphanet:364526	Primary bone dysplasia	GO:0048839	inner ear development	2.764677375921565e-12	6.097495952595011e-8	18	170	230
Orphanet:364526	Primary bone dysplasia	GO:0071773	cellular response to BMP stimulus	3.0578872767250687e-12	6.744170388817139e-8	17	147	230
Orphanet:364526	Primary bone dysplasia	GO:0043009	chordate embryonic development	3.5976777112978198e-12	7.934678192267342e-8	35	552	230
Orphanet:364526	Primary bone dysplasia	GO:0007369	gastrulation	5.638156608256395e-12	1.243495439950948e-7	18	176	230
Orphanet:364526	Primary bone dysplasia	GO:0002063	chondrocyte development	9.608647211223342e-12	2.1191871424353081e-7	9	25	230
Orphanet:364526	Primary bone dysplasia	GO:0007389	pattern specification process	1.1443956893231189e-11	2.5239646928021386e-7	27	432	230
Orphanet:364526	Primary bone dysplasia	GO:0030509	BMP signaling pathway	1.1940892719053409e-11	2.6335638891872293e-7	16	136	230
Orphanet:364526	Primary bone dysplasia	GO:0003002	regionalization	1.9828028108292983e-11	4.3730715992840175e-7	23	327	230
Orphanet:364526	Primary bone dysplasia	GO:0048706	embryonic skeletal system development	2.7823299220131048e-11	6.136428642999903e-7	15	122	230
Orphanet:364526	Primary bone dysplasia	GO:0045597	positive regulation of cell differentiation	3.8322789386313616e-11	8.452091199151468e-7	36	815	230
Orphanet:364526	Primary bone dysplasia	GO:0030500	regulation of bone mineralization	4.3817616202090903e-11	9.663975253371149e-7	12	69	230
Orphanet:364526	Primary bone dysplasia	GO:0044236	multicellular organismal metabolic process	4.972733336217061e-11	1.0967363373026728e-6	15	127	230
Orphanet:364526	Primary bone dysplasia	GO:0032963	collagen metabolic process	7.125267043051053e-11	1.5714776463449098e-6	14	109	230
Orphanet:364526	Primary bone dysplasia	GO:0001704	formation of primary germ layer	1.872656474333212e-10	4.130143854141899e-6	14	117	230
Orphanet:364526	Primary bone dysplasia	GO:0009953	dorsal/ventral pattern formation	2.604032545150403e-10	5.743193778329214e-6	13	99	230
Orphanet:364526	Primary bone dysplasia	GO:0048729	tissue morphogenesis	2.913632668466448e-10	6.4260168503027515e-6	30	635	230
Orphanet:364526	Primary bone dysplasia	GO:0048589	developmental growth	3.064997144974768e-10	6.759851203241851e-6	28	558	230
Orphanet:364526	Primary bone dysplasia	GO:0009725	response to hormone	5.42180966789374e-10	1.1957801222539644e-5	35	865	230
Orphanet:364526	Primary bone dysplasia	GO:0030574	collagen catabolic process	5.475428999091037e-10	1.2076058657495281e-5	11	67	230
Orphanet:364526	Primary bone dysplasia	GO:0035295	tube development	5.499298794120477e-10	1.2128703490432713e-5	28	573	230
Orphanet:364526	Primary bone dysplasia	GO:0035265	organ growth	9.44933464808173e-10	2.0840507566344257e-5	14	132	230
Orphanet:364526	Primary bone dysplasia	GO:0045667	regulation of osteoblast differentiation	1.1090712792594104e-9	2.4460567064066296e-5	13	111	230
Orphanet:364526	Primary bone dysplasia	GO:0050680	negative regulation of epithelial cell proliferation	1.2413621242046702e-9	2.7378241649334e-5	13	112	230
Orphanet:364526	Primary bone dysplasia	GO:0003416	endochondral bone growth	2.6576595368865696e-9	5.8614681086033293e-5	7	20	230
Orphanet:364526	Primary bone dysplasia	GO:0030166	proteoglycan biosynthetic process	2.9114245458927712e-9	6.421146835966507e-5	10	60	230
Orphanet:364526	Primary bone dysplasia	GO:0090287	regulation of cellular response to growth factor stimulus	3.123824976469791e-9	6.889595985604124e-5	17	226	230
Orphanet:364526	Primary bone dysplasia	GO:0060351	cartilage development involved in endochondral bone morphogenesis	3.944855664350655e-9	8.70037916772537e-5	7	21	230
Orphanet:271853	Genetic cardiac anomaly	GO:0072358	cardiovascular system development	1.5505374761914936e-12	3.419710403740339e-8	67	910	230
Orphanet:271853	Genetic cardiac anomaly	GO:0032838	cell projection cytoplasm	6.5851768482616535e-12	1.4523607538841077e-7	15	110	230
Orphanet:271853	Genetic cardiac anomaly	GO:0031966	mitochondrial membrane	9.82081083122921e-12	2.1659798288276022e-7	36	656	230
Orphanet:271853	Genetic cardiac anomaly	GO:0035265	organ growth	8.6957885336858e-11	1.917856161104403e-6	15	132	230
Orphanet:271853	Genetic cardiac anomaly	GO:0001568	blood vessel development	4.705322798059797e-10	1.0377589431120882e-5	28	569	230
Orphanet:271853	Genetic cardiac anomaly	GO:0070482	response to oxygen levels	5.388915980120146e-10	1.1885254194154982e-5	21	321	230
Orphanet:271853	Genetic cardiac anomaly	GO:0001666	response to hypoxia	6.342870673137213e-10	1.3989201269604123e-5	20	292	230
Orphanet:271853	Genetic cardiac anomaly	GO:0070848	response to growth factor	7.598802698183249e-10	1.6759159350843156e-5	29	621	230
Orphanet:271853	Genetic cardiac anomaly	GO:0008284	positive regulation of cell proliferation	1.740970478891768e-9	3.839710391195794e-5	33	815	230
Orphanet:271853	Genetic cardiac anomaly	GO:0003230	cardiac atrium development	2.901375473207679e-9	6.398983606159536e-5	8	31	230
MESH:D012868	Skin Abnormalities	GO:0034330	cell junction organization	6.561418075534675e-13	1.4471207565591726e-8	22	240	231
MESH:D012868	Skin Abnormalities	GO:0009887	organ morphogenesis	1.7108536809473662e-13	3.773287793329416e-9	49	950	231
MESH:D012868	Skin Abnormalities	GO:0098773	skin epidermis development	2.637889906509372e-13	5.81786618880642e-9	15	82	231
MESH:D012868	Skin Abnormalities	GO:0044420	extracellular matrix component	3.446354313041411e-12	7.600934437412832e-8	16	125	231
MESH:D012868	Skin Abnormalities	GO:0072358	cardiovascular system development	3.704614393029715e-11	8.170527043827036e-7	38	910	231
MESH:D012868	Skin Abnormalities	GO:0005198	structural molecule activity	1.3064545001384431e-9	2.8813854000553363e-5	31	716	231
MESH:D012868	Skin Abnormalities	GO:0001501	skeletal system development	1.6192251983682127e-9	3.571201175001093e-5	25	482	231
MESH:D012868	Skin Abnormalities	GO:0009314	response to radiation	4.423725052937755e-9	9.756525604254218e-5	23	431	231
DOID:2277	gonadal disease	GO:0044703	multi-organism reproductive process	2.4216184613123914e-12	5.3408795164244793e-8	46	926	231
DOID:2277	gonadal disease	GO:0022412	cellular process involved in reproduction in multicellular organism	2.9700686354772188e-12	6.550486375545006e-8	22	266	231
DOID:2277	gonadal disease	GO:0030855	epithelial cell differentiation	3.637756762486788e-12	8.023072539664611e-8	34	568	231
DOID:2277	gonadal disease	GO:0048568	embryonic organ development	6.795675133730583e-12	1.49878615074428e-7	27	408	231
DOID:2277	gonadal disease	GO:0048638	regulation of developmental growth	7.189360218262664e-12	1.5856133961378305e-7	22	283	231
DOID:2277	gonadal disease	GO:0035295	tube development	7.420730696594546e-12	1.6366421551339272e-7	31	573	231
DOID:2277	gonadal disease	GO:0009991	response to extracellular stimulus	7.420730696594546e-12	1.6366421551339272e-7	31	573	231
DOID:2277	gonadal disease	GO:0003682	chromatin binding	7.617240171953199e-12	1.679982319924278e-7	28	433	231
DOID:2277	gonadal disease	GO:0042493	response to drug	7.617240171953199e-12	1.679982319924278e-7	28	433	231
DOID:2277	gonadal disease	GO:0048477	oogenesis	7.741474128408754e-12	1.7073821190205507e-7	13	75	231
DOID:2277	gonadal disease	GO:0043069	negative regulation of programmed cell death	1.0945799822081881e-11	2.414096150760159e-7	38	806	231
DOID:2277	gonadal disease	GO:0007167	enzyme linked receptor protein signaling pathway	1.1813106048919053e-11	2.605380539089097e-7	39	935	231
DOID:2277	gonadal disease	GO:0043066	negative regulation of apoptotic process	1.309019559414537e-11	2.8870426382887615e-7	38	795	231
DOID:2277	gonadal disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.5755063920153134e-11	3.4747793475897737e-7	36	732	231
DOID:2277	gonadal disease	GO:0021761	limbic system development	2.324374026585474e-11	5.126406915634263e-7	14	100	231
DOID:2277	gonadal disease	GO:0051093	negative regulation of developmental process	2.3959723094435503e-11	5.28431692847775e-7	36	788	231
DOID:2277	gonadal disease	GO:0003690	double-stranded DNA binding	2.9820590441431705e-11	6.576931221857762e-7	35	756	231
DOID:2277	gonadal disease	GO:0071417	cellular response to organonitrogen compound	3.188393993269756e-11	7.032002952156446e-7	27	462	231
DOID:2277	gonadal disease	GO:0009887	organ morphogenesis	3.5173863821569284e-11	7.757595665847106e-7	39	950	231
DOID:2277	gonadal disease	GO:0044057	regulation of system process	4.627975780380211e-11	1.0207000583628556e-6	28	508	231
DOID:2277	gonadal disease	GO:0070848	response to growth factor	4.8562820431641285e-11	1.0710530046198485e-6	31	621	231
DOID:2277	gonadal disease	GO:0001101	response to acid chemical	6.645650696412986e-11	1.465698261093884e-6	22	315	231
DOID:2277	gonadal disease	GO:0071363	cellular response to growth factor stimulus	6.844935729333201e-11	1.5096505751044376e-6	30	594	231
DOID:2277	gonadal disease	GO:0008285	negative regulation of cell proliferation	7.418110570256431e-11	1.6360642862700558e-6	31	634	231
DOID:2277	gonadal disease	GO:0045597	positive regulation of cell differentiation	1.3456114000831576e-10	2.967745942883404e-6	35	815	231
DOID:2277	gonadal disease	GO:1902533	positive regulation of intracellular signal transduction	1.3911982676972912e-10	3.0682877794063756e-6	36	860	231
DOID:2277	gonadal disease	GO:0072358	cardiovascular system development	1.5492085392310173e-10	3.4167794332740087e-6	37	910	231
DOID:2277	gonadal disease	GO:0042327	positive regulation of phosphorylation	1.5492085392310173e-10	3.4167794332740087e-6	37	910	231
DOID:2277	gonadal disease	GO:0001934	positive regulation of protein phosphorylation	1.872887400722334e-10	4.1306531622931075e-6	36	870	231
DOID:2277	gonadal disease	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	2.0925228216839287e-10	4.615059083223905e-6	30	623	231
DOID:2277	gonadal disease	GO:0051241	negative regulation of multicellular organismal process	2.1530810467851325e-10	4.74862024868461e-6	38	966	231
DOID:2277	gonadal disease	GO:0023014	signal transduction by protein phosphorylation	2.456524983429631e-10	5.417865850954051e-6	36	879	231
DOID:2277	gonadal disease	GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	3.015340199752359e-10	6.650332810553827e-6	8	24	231
DOID:2277	gonadal disease	GO:0048598	embryonic morphogenesis	3.6802283442938233e-10	8.116743613340027e-6	28	560	231
DOID:2277	gonadal disease	GO:0042562	hormone binding	4.082703064511861e-10	9.00440160878091e-6	11	65	231
DOID:2277	gonadal disease	GO:1990837	sequence-specific double-stranded DNA binding	4.2567871449961103e-10	9.388344048288921e-6	31	683	231
DOID:2277	gonadal disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	4.995370783689168e-10	1.101729026342646e-5	30	647	231
DOID:2277	gonadal disease	GO:0008284	positive regulation of cell proliferation	5.061575603093615e-10	1.1163304992622969e-5	34	815	231
DOID:2277	gonadal disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.185286644504572e-10	1.1436149694454834e-5	38	996	231
DOID:2277	gonadal disease	GO:0007423	sensory organ development	5.486251453135083e-10	1.2099927579889425e-5	26	494	231
DOID:2277	gonadal disease	GO:1901654	response to ketone	9.418261726068522e-10	2.0771976236844125e-5	16	181	231
DOID:2277	gonadal disease	GO:0001944	vasculature development	1.0858877130814903e-9	2.394925351201227e-5	28	588	231
DOID:2277	gonadal disease	GO:0044212	transcription regulatory region DNA binding	1.5211245596447043e-9	3.354840216296395e-5	33	807	231
DOID:2277	gonadal disease	GO:0043627	response to estrogen	1.7957074716079546e-9	3.960432828631344e-5	17	217	231
DOID:2277	gonadal disease	GO:0043523	regulation of neuron apoptotic process	1.91999960375e-9	4.234559126070625e-5	16	190	231
DOID:2277	gonadal disease	GO:0001655	urogenital system development	2.2821674550144166e-9	5.033320322034296e-5	20	313	231
DOID:2277	gonadal disease	GO:0001568	blood vessel development	2.373863772220375e-9	5.2355565496320366e-5	27	569	231
DOID:2277	gonadal disease	GO:0000976	transcription regulatory region sequence-specific DNA binding	2.6237884087620955e-9	5.7867653355248017e-5	29	653	231
DOID:2277	gonadal disease	GO:0060008	Sertoli cell differentiation	2.7390066881238795e-9	6.040879250657216e-5	7	20	231
DOID:2277	gonadal disease	GO:2000194	regulation of female gonad development	2.9188186312367748e-9	6.437454491192707e-5	6	12	231
DOID:2277	gonadal disease	GO:0000165	MAPK cascade	4.474269621468352e-9	9.86800165014845e-5	33	843	231
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0040007	growth	8.96771545910724e-12	1.9778296445061017e-7	45	936	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0009790	embryo development	6.447287148603209e-12	1.4219491806244378e-7	52	932	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0048666	neuron development	2.481792549247075e-12	5.473593467364424e-8	45	926	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0021536	diencephalon development	1.858513343222512e-13	4.09895117847725e-9	15	77	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0048638	regulation of developmental growth	4.524158825347513e-13	9.97803228930394e-9	23	283	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0035270	endocrine system development	4.851674617611934e-13	1.070036836914312e-8	17	129	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0097485	neuron projection guidance	1.6712187189682481e-12	3.685872884684471e-8	20	216	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0007411	axon guidance	1.9649837312840646e-12	4.3337716193470044e-8	20	215	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0003002	regionalization	2.242206420532966e-12	4.945186260485457e-8	25	327	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0060541	respiratory system development	7.676304036863257e-12	1.6930088553301914e-7	19	202	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0003006	developmental process involved in reproduction	1.2598810883446276e-11	2.778667740344076e-7	33	619	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0021761	limbic system development	2.463840242938886e-11	5.433999655801713e-7	14	100	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0021954	central nervous system neuron development	4.071532000438083e-11	8.979763826966192e-7	12	68	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0042472	inner ear morphogenesis	1.1282041967319856e-10	2.488254355892394e-6	13	92	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0021537	telencephalon development	4.823846877499705e-10	1.0638994288325598e-5	18	226	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0048608	reproductive structure development	5.123590440803127e-10	1.1300078717191298e-5	24	418	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0021915	neural tube development	6.672974395272036e-10	1.4717245028772474e-5	15	151	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0030323	respiratory tube development	8.519018823704982e-10	1.878869601568134e-5	16	179	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0035050	embryonic heart tube development	1.807667793229939e-9	3.9868113179686304e-5	11	74	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0001947	heart looping	2.238372709406633e-9	4.936731010596329e-5	10	58	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0048645	organ formation	2.6660663676736363e-9	5.880009373904205e-5	10	59	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0048736	appendage development	2.958929656848852e-9	6.525919358180143e-5	15	168	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0060173	limb development	2.958929656848852e-9	6.525919358180143e-5	15	168	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0051270	regulation of cellular component movement	3.53413820430859e-9	7.794541809602595e-5	32	787	232
Orphanet:174590	Congenital hypogonadotropic hypogonadism	GO:0009952	anterior/posterior pattern specification	4.0036490789319146e-9	8.830048043584338e-5	16	199	232
Orphanet:117569	Rare intestinal disease	GO:0040007	growth	7.481570918344005e-12	1.6500604660407703e-7	41	936	232
Orphanet:117569	Rare intestinal disease	GO:0051338	regulation of transferase activity	2.5015545190854027e-12	5.517178491842856e-8	41	928	232
Orphanet:117569	Rare intestinal disease	GO:0072593	reactive oxygen species metabolic process	4.3809400551708677e-13	9.662163291679349e-9	26	223	232
Orphanet:117569	Rare intestinal disease	GO:0014033	neural crest cell differentiation	3.8347103270552907e-13	8.457453626320444e-9	15	75	232
Orphanet:117569	Rare intestinal disease	GO:0001763	morphogenesis of a branching structure	2.9151125957582735e-12	6.429280829944872e-8	19	193	232
Orphanet:117569	Rare intestinal disease	GO:0002009	morphogenesis of an epithelium	7.487455100374518e-12	1.6513582223876e-7	33	506	232
Orphanet:117569	Rare intestinal disease	GO:0061138	morphogenesis of a branching epithelium	9.02955488157886e-12	1.9914683291322177e-7	18	179	232
Orphanet:117569	Rare intestinal disease	GO:0030155	regulation of cell adhesion	1.1526446463960838e-11	2.542157767626563e-7	33	621	232
Orphanet:117569	Rare intestinal disease	GO:0016337	single organismal cell-cell adhesion	1.5207057835198157e-11	3.3539166055529535e-7	36	697	232
Orphanet:117569	Rare intestinal disease	GO:0001816	cytokine production	1.539790517313122e-11	3.396007985934091e-7	32	613	232
Orphanet:117569	Rare intestinal disease	GO:0022604	regulation of cell morphogenesis	2.067745974443369e-11	4.5604137466348504e-7	29	524	232
Orphanet:117569	Rare intestinal disease	GO:0019725	cellular homeostasis	2.213729199951331e-11	4.88237975049266e-7	36	771	232
Orphanet:117569	Rare intestinal disease	GO:0045177	apical part of cell	2.3862356535175877e-11	5.26284273383304e-7	24	356	232
Orphanet:117569	Rare intestinal disease	GO:0034109	homotypic cell-cell adhesion	2.7911006839076435e-11	6.155772558358308e-7	28	495	232
Orphanet:117569	Rare intestinal disease	GO:0016324	apical plasma membrane	7.48499040525985e-11	1.65081463388006e-6	21	286	232
Orphanet:117569	Rare intestinal disease	GO:0072006	nephron development	8.82987016836978e-11	1.947427865633955e-6	15	131	232
Orphanet:117569	Rare intestinal disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.5278378562300077e-10	3.369646391915282e-6	39	996	232
Orphanet:117569	Rare intestinal disease	GO:0070486	leukocyte aggregation	1.8981738403311965e-10	4.186422404850454e-6	25	432	232
Orphanet:117569	Rare intestinal disease	GO:0010720	positive regulation of cell development	2.0028512182079794e-10	4.4172883617576986e-6	26	469	232
Orphanet:117569	Rare intestinal disease	GO:0001817	regulation of cytokine production	3.460352004935885e-10	7.631806346886094e-6	28	556	232
Orphanet:117569	Rare intestinal disease	GO:1903409	reactive oxygen species biosynthetic process	4.5373582668872814e-10	1.0007143657619899e-5	12	83	232
Orphanet:117569	Rare intestinal disease	GO:0050900	leukocyte migration	6.397194995955147e-10	1.4109013563579076e-5	22	354	232
Orphanet:117569	Rare intestinal disease	GO:0070489	T cell aggregation	6.810911834520539e-10	1.5021466051035048e-5	24	424	232
Orphanet:117569	Rare intestinal disease	GO:0042110	T cell activation	6.810911834520539e-10	1.5021466051035048e-5	24	424	232
Orphanet:117569	Rare intestinal disease	GO:0006766	vitamin metabolic process	7.021478953816995e-10	1.5485871832643383e-5	14	128	232
Orphanet:117569	Rare intestinal disease	GO:1902532	negative regulation of intracellular signal transduction	7.474322272216227e-10	1.648461777137289e-5	24	426	232
Orphanet:117569	Rare intestinal disease	GO:0009790	embryo development	1.295989204841419e-9	2.8583041912777496e-5	36	932	232
Orphanet:117569	Rare intestinal disease	GO:0090183	regulation of kidney development	1.296166618480754e-9	2.858695477059303e-5	10	55	232
Orphanet:117569	Rare intestinal disease	GO:0072073	kidney epithelium development	1.731336962684793e-9	3.818463671201311e-5	14	137	232
Orphanet:117569	Rare intestinal disease	GO:0061326	renal tubule development	1.7489413250970642e-9	3.857290092501575e-5	12	93	232
Orphanet:117569	Rare intestinal disease	GO:0022407	regulation of cell-cell adhesion	1.9634446291050267e-9	4.3303771294911364e-5	22	376	232
Orphanet:117569	Rare intestinal disease	GO:0002521	leukocyte differentiation	2.0228009267597713e-9	4.4612874439686756e-5	24	448	232
Orphanet:117569	Rare intestinal disease	GO:0055114	oxidation-reduction process	2.108266450306928e-9	4.64978165615193e-5	36	949	232
Orphanet:117569	Rare intestinal disease	GO:0007507	heart development	2.1849523301753493e-9	4.818912364201733e-5	25	487	232
Orphanet:117569	Rare intestinal disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.4473980619887925e-9	5.397736425716282e-5	31	732	232
Orphanet:117569	Rare intestinal disease	GO:0006753	nucleoside phosphate metabolic process	2.5263198200065062e-9	5.5717983630243495e-5	29	649	232
Orphanet:117569	Rare intestinal disease	GO:0006935	chemotaxis	2.6382696027837937e-9	5.818703608939657e-5	26	530	232
Orphanet:117569	Rare intestinal disease	GO:0048638	regulation of developmental growth	2.7761672960480155e-9	6.122836971433898e-5	19	283	232
Orphanet:117569	Rare intestinal disease	GO:0042803	protein homodimerization activity	3.805998738393157e-9	8.394130217526108e-5	30	703	232
Orphanet:117569	Rare intestinal disease	GO:0055082	cellular chemical homeostasis	3.8132389468259476e-9	8.410098497224627e-5	29	661	232
Orphanet:117569	Rare intestinal disease	GO:0030307	positive regulation of cell growth	3.993908204158458e-9	8.80856454427148e-5	14	146	232
Orphanet:117569	Rare intestinal disease	GO:0048066	developmental pigmentation	4.467037628685944e-9	9.852051490066849e-5	9	46	232
Orphanet:96210	Rare genetic deafness	GO:0009790	embryo development	5.857758722527251e-12	1.2919286862533852e-7	51	932	236
Orphanet:96210	Rare genetic deafness	GO:0002064	epithelial cell development	7.169820293029261e-13	1.5813038656276035e-8	21	202	236
Orphanet:96210	Rare genetic deafness	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	3.319029162618392e-9	7.320118818154864e-5	6	12	236
MESH:D001928	Brain Diseases, Metabolic	GO:0050662	coenzyme binding	1.2749801214795298e-12	2.811968657923103e-8	21	185	236
MESH:D001928	Brain Diseases, Metabolic	GO:0014070	response to organic cyclic compound	3.055655728445572e-11	6.739248709086709e-7	38	873	236
MESH:D001928	Brain Diseases, Metabolic	GO:0033013	tetrapyrrole metabolic process	9.424405700286798e-11	2.078552677198253e-6	11	56	236
MESH:D001928	Brain Diseases, Metabolic	GO:0042493	response to drug	2.828758338679904e-10	6.238826515958529e-6	25	433	236
MESH:D001928	Brain Diseases, Metabolic	GO:0010243	response to organonitrogen compound	2.9333047102397813e-10	6.469403538433838e-6	34	780	236
MESH:D001928	Brain Diseases, Metabolic	GO:0002439	chronic inflammatory response to antigenic stimulus	3.093372225038138e-10	6.822432442321613e-6	5	5	236
MESH:D001928	Brain Diseases, Metabolic	GO:1903409	reactive oxygen species biosynthetic process	5.518897561174185e-10	1.2171928571169666e-5	12	83	236
MESH:D001928	Brain Diseases, Metabolic	GO:0009991	response to extracellular stimulus	9.963619929109768e-10	2.1974763753651594e-5	28	573	236
MESH:D001928	Brain Diseases, Metabolic	GO:0031667	response to nutrient levels	1.5707092293482106e-9	3.4641992053274784e-5	27	546	236
MESH:D001928	Brain Diseases, Metabolic	GO:0044723	single-organism carbohydrate metabolic process	1.5840365685804159e-9	3.493592652004107e-5	30	665	236
MESH:D001928	Brain Diseases, Metabolic	GO:0050660	flavin adenine dinucleotide binding	2.1633017599498316e-9	4.771162031569354e-5	11	74	236
MESH:D001928	Brain Diseases, Metabolic	GO:0005996	monosaccharide metabolic process	3.4792162484365008e-9	7.673411435926702e-5	19	282	236
DOID:1934	dysostosis	GO:0040007	growth	9.604761430637154e-12	2.1183301335270244e-7	46	936	237
DOID:1934	dysostosis	GO:0051241	negative regulation of multicellular organismal process	5.115685652867796e-12	1.1282644707399925e-7	42	966	237
DOID:1934	dysostosis	GO:0030323	respiratory tube development	1.2505552149377763e-12	2.7580995265452657e-8	21	179	237
DOID:1934	dysostosis	GO:0071773	cellular response to BMP stimulus	4.0034642267983145e-13	8.829640352203683e-9	19	147	237
DOID:1934	dysostosis	GO:0009798	axis specification	6.09734485124136e-13	1.3447694069412819e-8	15	90	237
DOID:1934	dysostosis	GO:0060485	mesenchyme development	2.7505775435088253e-12	6.066398772208714e-8	21	237	237
DOID:1934	dysostosis	GO:0007498	mesoderm development	4.4962922274294215e-12	9.916572507595589e-8	16	123	237
DOID:1934	dysostosis	GO:0009880	embryonic pattern specification	5.74251757257116e-12	1.2665122506305693e-7	12	57	237
DOID:1934	dysostosis	GO:0032330	regulation of chondrocyte differentiation	9.910183784711535e-12	2.185691033718129e-7	11	46	237
DOID:1934	dysostosis	GO:0007417	central nervous system development	1.8418599978531347e-11	4.0622222252650886e-7	39	889	237
DOID:1934	dysostosis	GO:0001067	regulatory region nucleic acid binding	2.4132473797067178e-11	5.322417095943166e-7	37	811	237
DOID:1934	dysostosis	GO:0007420	brain development	3.639577528247173e-11	8.02708823854914e-7	33	669	237
DOID:1934	dysostosis	GO:0030855	epithelial cell differentiation	4.4120040953998796e-11	9.730675032404434e-7	30	568	237
DOID:1934	dysostosis	GO:0001568	blood vessel development	4.5411341353940315e-11	1.0015471335611537e-6	30	569	237
DOID:1934	dysostosis	GO:0000987	core promoter proximal region sequence-specific DNA binding	4.73303618520049e-11	1.043871130645968e-6	24	362	237
DOID:1934	dysostosis	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	9.05043817667206e-11	1.996074139865023e-6	23	343	237
DOID:1934	dysostosis	GO:0030510	regulation of BMP signaling pathway	2.3506385726790313e-10	5.1843333720436036e-6	12	77	237
DOID:1934	dysostosis	GO:0022612	gland morphogenesis	3.4890801359210855e-10	7.695166239773954e-6	14	119	237
DOID:1934	dysostosis	GO:2000826	regulation of heart morphogenesis	3.696587480561675e-10	8.152823688378774e-6	8	24	237
DOID:1934	dysostosis	GO:0001708	cell fate specification	4.326088376416237e-10	9.541187914186011e-6	12	81	237
DOID:1934	dysostosis	GO:0060606	tube closure	5.793336921300352e-10	1.2777204579927925e-5	12	83	237
DOID:1934	dysostosis	GO:0003279	cardiac septum development	6.682986386508105e-10	1.4739326475443626e-5	12	84	237
DOID:1934	dysostosis	GO:0048663	neuron fate commitment	7.519895817154065e-10	1.658513022473329e-5	11	67	237
DOID:1934	dysostosis	GO:0002053	positive regulation of mesenchymal cell proliferation	1.07988373798662e-9	2.3816835841294903e-5	8	27	237
DOID:1934	dysostosis	GO:0045668	negative regulation of osteoblast differentiation	1.1182414993982093e-9	2.4662816269227505e-5	9	39	237
DOID:1934	dysostosis	GO:0003682	chromatin binding	1.5869867642237523e-9	3.500099308495486e-5	24	433	237
DOID:1934	dysostosis	GO:0042692	muscle cell differentiation	1.898612711492831e-9	4.1873903351974384e-5	21	334	237
DOID:1934	dysostosis	GO:0060993	kidney morphogenesis	1.9621519964374556e-9	4.3275262281428084e-5	12	92	237
DOID:1934	dysostosis	GO:0032332	positive regulation of chondrocyte differentiation	2.1507211567239892e-9	4.743415511154758e-5	7	19	237
DOID:1934	dysostosis	GO:0001838	embryonic epithelial tube formation	2.486362005171827e-9	5.483671402406465e-5	13	115	237
DOID:1934	dysostosis	GO:0001841	neural tube formation	2.8583210243127155e-9	6.304027019121694e-5	12	95	237
Orphanet:79200	Disorder of energy metabolism	GO:0006637	acyl-CoA metabolic process	8.449463351212216e-12	1.8635291421098543e-7	14	90	239
Orphanet:79200	Disorder of energy metabolism	GO:0045239	tricarboxylic acid cycle enzyme complex	1.8094733489348869e-9	3.990793471075893e-5	6	11	239
DOID:10763	hypertension	GO:0022603	regulation of anatomical structure morphogenesis	1.613886801976605e-11	3.5594273417594025e-7	47	986	239
DOID:10763	hypertension	GO:0048878	chemical homeostasis	1.463829057968269e-11	3.228474987349017e-7	83	988	239
DOID:10763	hypertension	GO:0040007	growth	8.412603946794661e-12	1.8553998004655625e-7	45	936	239
DOID:10763	hypertension	GO:0009607	response to biotic stimulus	6.809441899235935e-12	1.5018224108764855e-7	47	934	239
DOID:10763	hypertension	GO:0032101	regulation of response to external stimulus	3.0671021278294575e-12	6.764493742927868e-8	53	920	239
DOID:10763	hypertension	GO:0051050	positive regulation of transport	3.0671021278294575e-12	6.764493742927868e-8	49	920	239
DOID:10763	hypertension	GO:0072358	cardiovascular system development	2.1320722964901506e-12	4.702285449909027e-8	58	910	239
DOID:10763	hypertension	GO:0042327	positive regulation of phosphorylation	2.1320722964901506e-12	4.702285449909027e-8	48	910	239
DOID:10763	hypertension	GO:0008016	regulation of heart contraction	1.934896687316723e-12	4.267414643877032e-8	33	224	239
DOID:10763	hypertension	GO:0000302	response to reactive oxygen species	1.801891968966629e-12	3.9740727375559004e-8	27	216	239
DOID:10763	hypertension	GO:0015850	organic hydroxy compound transport	1.6782131240233866e-12	3.701299045033579e-8	23	230	239
DOID:10763	hypertension	GO:0072593	reactive oxygen species metabolic process	1.546762717907768e-12	3.4113851743455825e-8	34	223	239
DOID:10763	hypertension	GO:1901654	response to ketone	1.3997691894473974e-12	3.087190947326235e-8	24	181	239
DOID:10763	hypertension	GO:0009187	cyclic nucleotide metabolic process	1.3302692281058626e-12	2.93390878258748e-8	26	188	239
DOID:10763	hypertension	GO:0034284	response to monosaccharide	1.326716514427062e-12	2.9260732725688854e-8	22	188	239
DOID:10763	hypertension	GO:0043270	positive regulation of ion transport	1.2989609388114332e-12	2.8648583505486158e-8	24	233	239
DOID:10763	hypertension	GO:0034220	ion transmembrane transport	1.2940759575030825e-12	2.8540845242730484e-8	45	962	239
DOID:10763	hypertension	GO:0031960	response to corticosteroid	1.2394529846915248e-12	2.733613557737158e-8	30	179	239
DOID:10763	hypertension	GO:0009746	response to hexose	1.1999290450148692e-12	2.646443508780294e-8	20	181	239
DOID:10763	hypertension	GO:2000021	regulation of ion homeostasis	1.1810552535962415e-12	2.6048173618065107e-8	30	189	239
DOID:10763	hypertension	GO:1903531	negative regulation of secretion by cell	1.1604051053382136e-12	2.55927345982343e-8	21	174	239
DOID:10763	hypertension	GO:0009152	purine ribonucleotide biosynthetic process	1.0615952561465747e-12	2.3413483374312705e-8	26	240	239
DOID:10763	hypertension	GO:0090257	regulation of muscle system process	1.0162981567418683e-12	2.2414455846941905e-8	28	213	239
DOID:10763	hypertension	GO:0007204	positive regulation of cytosolic calcium ion concentration	9.909850717804147e-13	2.1856175758117047e-8	25	234	239
DOID:10763	hypertension	GO:0007584	response to nutrient	9.183764859699295e-13	2.0254793398066795e-8	24	197	239
DOID:10763	hypertension	GO:0009749	response to glucose	9.174883075502294e-13	2.023520462302031e-8	20	176	239
DOID:10763	hypertension	GO:1990267	response to transition metal nanoparticle	7.995826223350377e-13	1.7634794735599257e-8	20	150	239
DOID:10763	hypertension	GO:0007565	female pregnancy	7.509548538564559e-13	1.6562309301804135e-8	20	190	239
DOID:10763	hypertension	GO:0030799	regulation of cyclic nucleotide metabolic process	6.981082378842984e-13	1.5396777186538202e-8	22	154	239
DOID:10763	hypertension	GO:2001236	regulation of extrinsic apoptotic signaling pathway	6.932232565759477e-13	1.5289038923782527e-8	20	151	239
DOID:10763	hypertension	GO:1900542	regulation of purine nucleotide metabolic process	6.297184995673888e-13	1.388844150795876e-8	25	203	239
DOID:10763	hypertension	GO:0033002	muscle cell proliferation	6.237232952344129e-13	1.3756217276394977e-8	19	151	239
DOID:10763	hypertension	GO:1903035	negative regulation of response to wounding	6.175060462965121e-13	1.3619095851069574e-8	19	159	239
DOID:10763	hypertension	GO:0006937	regulation of muscle contraction	6.17061957086662e-13	1.360930146354633e-8	20	165	239
DOID:10763	hypertension	GO:0051384	response to glucocorticoid	6.161737786669619e-13	1.3589712688499844e-8	27	167	239
DOID:10763	hypertension	GO:0009190	cyclic nucleotide biosynthetic process	5.691003224228552e-13	1.2551507611036072e-8	25	149	239
DOID:10763	hypertension	GO:0051924	regulation of calcium ion transport	5.120348589571222e-13	1.129292881429933e-8	23	207	239
DOID:10763	hypertension	GO:0009612	response to mechanical stimulus	5.102585021177219e-13	1.1253751264206358e-8	22	210	239
DOID:10763	hypertension	GO:2000377	regulation of reactive oxygen species metabolic process	3.765876499528531e-13	8.305640619710175e-9	22	147	239
DOID:10763	hypertension	GO:0052652	cyclic purine nucleotide metabolic process	3.765876499528531e-13	8.305640619710175e-9	25	147	239
DOID:10763	hypertension	GO:0035150	regulation of tube size	3.0953017926549364e-13	6.826688103700462e-9	42	140	239
DOID:10763	hypertension	GO:0030808	regulation of nucleotide biosynthetic process	2.446931546273845e-13	5.396707525306965e-9	21	139	239
DOID:10763	hypertension	GO:1900371	regulation of purine nucleotide biosynthetic process	2.446931546273845e-13	5.396707525306965e-9	21	139	239
DOID:10763	hypertension	GO:0045471	response to ethanol	2.0738966099997924e-13	4.573978973354542e-9	20	137	239
DOID:10763	hypertension	GO:0055067	monovalent inorganic cation homeostasis	1.9695356456850277e-13	4.343810866558329e-9	21	142	239
DOID:10763	hypertension	GO:0009636	response to toxic substance	1.8962609260597674e-13	4.182203472424817e-9	30	249	239
DOID:10763	hypertension	GO:0044062	regulation of excretion	1.2390088954816747e-13	2.7326341189848335e-9	14	29	239
DOID:10763	hypertension	GO:0070371	ERK1 and ERK2 cascade	1.0258460747536446e-13	2.2625035178691633e-9	24	247	239
DOID:10763	hypertension	GO:0045777	positive regulation of blood pressure	8.659739592076221e-14	1.9099055670324105e-9	12	36	239
DOID:10763	hypertension	GO:0036293	response to decreased oxygen levels	4.39648317751562e-14	9.6964436480107e-10	44	302	239
DOID:10763	hypertension	GO:0045981	positive regulation of nucleotide metabolic process	4.196643033083092e-14	9.255696209464759e-10	20	132	239
DOID:10763	hypertension	GO:1900544	positive regulation of purine nucleotide metabolic process	4.196643033083092e-14	9.255696209464759e-10	20	132	239
DOID:10763	hypertension	GO:0035813	regulation of renal sodium excretion	4.1522341120980855e-14	9.157752334232327e-10	13	24	239
DOID:10763	hypertension	GO:0051341	regulation of oxidoreductase activity	3.952393967665557e-14	8.717004895686387e-10	17	85	239
DOID:10763	hypertension	GO:0071453	cellular response to oxygen levels	5.329070518200751e-15	1.1753265027891757e-10	18	150	239
DOID:10763	hypertension	GO:0032102	negative regulation of response to external stimulus	1.0658141036401503e-14	2.3506530055783514e-10	25	275	239
DOID:10763	hypertension	GO:0002027	regulation of heart rate	2.2870594307278225e-14	5.044109574470212e-10	16	87	239
DOID:10763	hypertension	GO:0046879	hormone secretion	7.538414337204813e-14	1.6625972820705215e-9	27	297	239
DOID:10763	hypertension	GO:0006801	superoxide metabolic process	8.271161533457416e-14	1.8242046762040331e-9	15	52	239
DOID:10763	hypertension	GO:0003073	regulation of systemic arterial blood pressure	1.0391687510491465e-13	2.2918866804388927e-9	24	83	239
DOID:10763	hypertension	GO:1903409	reactive oxygen species biosynthetic process	1.042499420123022e-13	2.299232471081325e-9	17	83	239
DOID:10763	hypertension	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	1.092459456231154e-13	2.4094193307178102e-9	17	49	239
DOID:10763	hypertension	GO:0007568	aging	1.1113332476497817e-13	2.4510454776915935e-9	31	290	239
DOID:10763	hypertension	GO:0001990	regulation of systemic arterial blood pressure by hormone	1.1468603844377867e-13	2.5294005778775386e-9	15	39	239
DOID:10763	hypertension	GO:0030802	regulation of cyclic nucleotide biosynthetic process	1.4488410471358293e-13	3.1954189294580715e-9	21	133	239
DOID:10763	hypertension	GO:0050727	regulation of inflammatory response	1.6064927166326015e-13	3.5431196865332026e-9	25	289	239
DOID:10763	hypertension	GO:1903524	positive regulation of blood circulation	1.637578961322106e-13	3.6116803991959046e-9	25	89	239
DOID:10763	hypertension	GO:1900046	regulation of hemostasis	1.7219559111936178e-13	3.797773762137524e-9	15	85	239
DOID:10763	hypertension	GO:0030193	regulation of blood coagulation	1.7219559111936178e-13	3.797773762137524e-9	15	85	239
DOID:10763	hypertension	GO:0033555	multicellular organismal response to stress	1.7708057242771247e-13	3.9055120248931985e-9	14	69	239
DOID:10763	hypertension	GO:0045776	negative regulation of blood pressure	2.498001805406602e-13	5.509342981824261e-9	12	43	239
DOID:10763	hypertension	GO:2000379	positive regulation of reactive oxygen species metabolic process	2.5079938126282286e-13	5.531380353751558e-9	15	83	239
DOID:10763	hypertension	GO:0015837	amine transport	2.559064071760986e-13	5.644015810268854e-9	15	79	239
DOID:10763	hypertension	GO:0030801	positive regulation of cyclic nucleotide metabolic process	2.9032332093947844e-13	6.403080843320197e-9	18	108	239
DOID:10763	hypertension	GO:0003081	regulation of systemic arterial blood pressure by renin-angiotensin	3.745892485085278e-13	8.261565875855581e-9	10	26	239
DOID:10763	hypertension	GO:0051353	positive regulation of oxidoreductase activity	4.072298054325074e-13	8.981453358813951e-9	12	45	239
DOID:10763	hypertension	GO:2001057	reactive nitrogen species metabolic process	4.1366909897533333e-13	9.123471977900977e-9	14	68	239
DOID:10763	hypertension	GO:0046209	nitric oxide metabolic process	4.89608353859694e-13	1.0798312244375552e-8	14	65	239
DOID:10763	hypertension	GO:0030804	positive regulation of cyclic nucleotide biosynthetic process	5.100364575127969e-13	1.1248854070444736e-8	17	99	239
DOID:10763	hypertension	GO:0006939	smooth muscle contraction	5.452305273934144e-13	1.2025059281661754e-8	16	97	239
DOID:10763	hypertension	GO:0046883	regulation of hormone secretion	5.651035195342047e-13	1.2463358123326884e-8	23	252	239
DOID:10763	hypertension	GO:0048659	smooth muscle cell proliferation	5.686562332130052e-13	1.254171322351283e-8	17	104	239
DOID:10763	hypertension	GO:1900373	positive regulation of purine nucleotide biosynthetic process	5.686562332130052e-13	1.254171322351283e-8	17	104	239
DOID:10763	hypertension	GO:0030814	regulation of cAMP metabolic process	6.551426068313049e-13	1.4449170193664429e-8	17	128	239
DOID:10763	hypertension	GO:0043271	negative regulation of ion transport	6.823430709346212e-13	1.504907642946307e-8	17	121	239
DOID:10763	hypertension	GO:0005179	hormone activity	7.925882172798993e-13	1.7480533132108178e-8	17	117	239
DOID:10763	hypertension	GO:0098590	plasma membrane region	8.36664071357518e-13	1.845262609379006e-8	41	926	239
DOID:10763	hypertension	GO:0071496	cellular response to external stimulus	9.865441796819141e-13	2.1758231882884616e-8	28	270	239
DOID:10763	hypertension	GO:1900047	negative regulation of hemostasis	1.000532989792191e-12	2.2066755089866774e-8	12	49	239
DOID:10763	hypertension	GO:0030195	negative regulation of blood coagulation	1.000532989792191e-12	2.2066755089866774e-8	12	49	239
DOID:10763	hypertension	GO:0061337	cardiac conduction	1.0521583604372609e-12	2.3205352639443788e-8	17	131	239
DOID:10763	hypertension	GO:0019216	regulation of lipid metabolic process	1.0822454044046026e-12	2.386892239414351e-8	23	272	239
DOID:10763	hypertension	GO:0050678	regulation of epithelial cell proliferation	1.2170264795940966e-12	2.68415190074478e-8	23	277	239
DOID:10763	hypertension	GO:0001666	response to hypoxia	1.2995160503237457e-12	2.8660826489890212e-8	43	292	239
DOID:10763	hypertension	GO:0071456	cellular response to hypoxia	1.3171685964152857e-12	2.9050153393939127e-8	17	134	239
DOID:10763	hypertension	GO:0006809	nitric oxide biosynthetic process	1.3349321648092882e-12	2.9441928894868852e-8	13	62	239
DOID:10763	hypertension	GO:0070372	regulation of ERK1 and ERK2 cascade	1.3921086505774838e-12	3.0702956288486405e-8	21	233	239
DOID:10763	hypertension	GO:0055114	oxidation-reduction process	1.6956436255100016e-12	3.7397420160623085e-8	44	949	239
DOID:10763	hypertension	GO:0009887	organ morphogenesis	1.7554846465372975e-12	3.87172138793801e-8	44	950	239
DOID:10763	hypertension	GO:0035815	positive regulation of renal sodium excretion	1.797784143775516e-12	3.9650129290969005e-8	8	14	239
DOID:10763	hypertension	GO:0030817	regulation of cAMP biosynthetic process	1.8057777495528171e-12	3.982642826638738e-8	16	113	239
DOID:10763	hypertension	GO:0001664	G-protein coupled receptor binding	2.025379863823673e-12	4.466975289663111e-8	22	255	239
DOID:10763	hypertension	GO:0002237	response to molecule of bacterial origin	2.4653612484826226e-12	5.437354233528424e-8	33	333	239
DOID:10763	hypertension	GO:0010038	response to metal ion	2.5613955401126987e-12	5.649157863718557e-8	33	335	239
DOID:10763	hypertension	GO:0043279	response to alkaloid	2.5901503164504902e-12	5.712576522931556e-8	17	140	239
DOID:10763	hypertension	GO:1903779	regulation of cardiac conduction	2.7196023211217835e-12	5.998082919234093e-8	13	67	239
DOID:10763	hypertension	GO:0032496	response to lipopolysaccharide	3.086420008457935e-12	6.807099328653976e-8	33	319	239
DOID:10763	hypertension	GO:0048660	regulation of smooth muscle cell proliferation	3.0918601012785984e-12	6.819097453369949e-8	15	100	239
DOID:10763	hypertension	GO:0001655	urogenital system development	3.2032154706485017e-12	7.06469172051527e-8	25	313	239
DOID:10763	hypertension	GO:0048871	multicellular organismal homeostasis	3.302580431352453e-12	7.283841141347835e-8	26	321	239
DOID:10763	hypertension	GO:0035094	response to nicotine	3.340661081097096e-12	7.367828014359645e-8	12	54	239
DOID:10763	hypertension	GO:0001101	response to acid chemical	3.367972567502875e-12	7.42806349762759e-8	29	315	239
DOID:10763	hypertension	GO:0045909	positive regulation of vasodilation	3.4269254101104707e-12	7.558083991998643e-8	10	31	239
DOID:10763	hypertension	GO:0090322	regulation of superoxide metabolic process	3.453681785003937e-12	7.617095176826183e-8	9	22	239
DOID:10763	hypertension	GO:0032870	cellular response to hormone stimulus	3.854361274591156e-12	8.500793791110794e-8	40	519	239
DOID:10763	hypertension	GO:0050900	leukocyte migration	4.1843195575097525e-12	9.228516784087759e-8	31	354	239
DOID:10763	hypertension	GO:0043434	response to peptide hormone	4.4756420791713936e-12	9.871028605612508e-8	30	389	239
DOID:10763	hypertension	GO:0015672	monovalent inorganic cation transport	4.997779967652605e-12	1.102260371865782e-7	33	572	239
DOID:10763	hypertension	GO:0001775	cell activation	5.064615393735039e-12	1.1170009250882629e-7	46	854	239
DOID:10763	hypertension	GO:1901699	cellular response to nitrogen compound	5.28577182024037e-12	1.1657769749540137e-7	33	518	239
DOID:10763	hypertension	GO:0045834	positive regulation of lipid metabolic process	5.4005688809866115e-12	1.1910954667015972e-7	16	124	239
DOID:10763	hypertension	GO:0048514	blood vessel morphogenesis	5.713873818535831e-12	1.2601948706780775e-7	38	484	239
DOID:10763	hypertension	GO:0009314	response to radiation	5.920930412628422e-12	1.3058612025051985e-7	31	431	239
DOID:10763	hypertension	GO:0007631	feeding behavior	6.178613176643921e-12	1.3626931361088168e-7	15	106	239
DOID:10763	hypertension	GO:0050795	regulation of behavior	6.184386336371972e-12	1.3639664064868384e-7	21	243	239
DOID:10763	hypertension	GO:0097285	cell-type specific apoptotic process	6.371014826811461e-12	1.4051273200532677e-7	30	429	239
DOID:10763	hypertension	GO:0032768	regulation of monooxygenase activity	6.472600233564663e-12	1.4275319815126863e-7	12	57	239
DOID:10763	hypertension	GO:0051952	regulation of amine transport	6.530553875450096e-12	1.4403136572305186e-7	13	72	239
DOID:10763	hypertension	GO:0044708	single-organism behavior	6.821210263296962e-12	1.504417923570145e-7	27	404	239
DOID:10763	hypertension	GO:0071407	cellular response to organic cyclic compound	6.909695038359587e-12	1.5239332407102069e-7	33	416	239
DOID:10763	hypertension	GO:0071396	cellular response to lipid	6.909695038359587e-12	1.5239332407102069e-7	33	416	239
DOID:10763	hypertension	GO:0045823	positive regulation of heart contraction	6.928457807475752e-12	1.528071369438777e-7	10	33	239
DOID:10763	hypertension	GO:0001525	angiogenesis	6.975975352929709e-12	1.5385513640886472e-7	33	413	239
DOID:10763	hypertension	GO:0048732	gland development	7.1341821339387934e-12	1.573443869640201e-7	30	421	239
DOID:10763	hypertension	GO:0071417	cellular response to organonitrogen compound	7.229106202544244e-12	1.594379372971133e-7	32	462	239
DOID:10763	hypertension	GO:0006941	striated muscle contraction	8.169687149006677e-12	1.8018245007134226e-7	17	150	239
DOID:10763	hypertension	GO:0034762	regulation of transmembrane transport	8.366751735877642e-12	1.845287095347814e-7	26	383	239
DOID:10763	hypertension	GO:1901701	cellular response to oxygen-containing compound	8.394840378400659e-12	1.8514820454562653e-7	53	873	239
DOID:10763	hypertension	GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	8.73912053833692e-12	1.9274130347302076e-7	9	24	239
DOID:10763	hypertension	GO:0030334	regulation of cell migration	9.33142452197444e-12	2.058045678321463e-7	37	660	239
DOID:10763	hypertension	GO:0006820	anion transport	1.0008438522390861e-11	2.2073611161133044e-7	32	588	239
DOID:10763	hypertension	GO:0043069	negative regulation of programmed cell death	1.1156853219063123e-11	2.460643977464372e-7	45	806	239
DOID:10763	hypertension	GO:0001934	positive regulation of protein phosphorylation	1.1643574993058792e-11	2.5679904647191165e-7	44	870	239
DOID:10763	hypertension	GO:0050890	cognition	1.2000733740080705e-11	2.6467618263747994e-7	21	251	239
DOID:10763	hypertension	GO:1902533	positive regulation of intracellular signal transduction	1.2279177674656694e-11	2.708172636145534e-7	43	860	239
DOID:10763	hypertension	GO:0040008	regulation of growth	1.2650991365603659e-11	2.790176145683887e-7	34	617	239
DOID:10763	hypertension	GO:0043066	negative regulation of apoptotic process	1.2875589483485328e-11	2.839711260582689e-7	45	795	239
DOID:10763	hypertension	GO:0030155	regulation of cell adhesion	1.3275602839257772e-11	2.9279342061983016e-7	33	621	239
DOID:10763	hypertension	GO:1903523	negative regulation of blood circulation	1.346267541890711e-11	2.9691930636399633e-7	10	35	239
DOID:10763	hypertension	GO:0008284	positive regulation of cell proliferation	1.4049095220514118e-11	3.098527950884389e-7	47	815	239
DOID:10763	hypertension	GO:0045597	positive regulation of cell differentiation	1.4094059253011437e-11	3.1084447682516725e-7	41	815	239
DOID:10763	hypertension	GO:0045121	membrane raft	1.438416052934599e-11	3.172426604747258e-7	22	282	239
DOID:10763	hypertension	GO:0008285	negative regulation of cell proliferation	1.5049406165701384e-11	3.3191465298454403e-7	33	634	239
DOID:10763	hypertension	GO:2000147	positive regulation of cell motility	1.514988134942996e-11	3.341306331616778e-7	26	399	239
DOID:10763	hypertension	GO:0034765	regulation of ion transmembrane transport	1.5579426637657434e-11	3.436042544935347e-7	25	367	239
DOID:10763	hypertension	GO:0002016	regulation of blood volume by renin-angiotensin	1.6293855154003722e-11	3.593609754215521e-7	7	11	239
DOID:10763	hypertension	GO:0009306	protein secretion	1.6593282303745127e-11	3.659648412090988e-7	28	462	239
DOID:10763	hypertension	GO:0034097	response to cytokine	1.7780665828581732e-11	3.921525848493701e-7	37	784	239
DOID:10763	hypertension	GO:0060048	cardiac muscle contraction	2.0900170483173497e-11	4.609532600063915e-7	15	115	239
DOID:10763	hypertension	GO:0036477	somatodendritic compartment	2.2741253324909394e-11	5.015583420808767e-7	33	649	239
DOID:10763	hypertension	GO:0050708	regulation of protein secretion	2.8061775125820532e-11	6.189024503999718e-7	25	380	239
DOID:10763	hypertension	GO:0030029	actin filament-based process	2.901501261476369e-11	6.399261032186132e-7	32	620	239
DOID:10763	hypertension	GO:0030141	secretory granule	3.077882393398568e-11	6.788269618640541e-7	24	351	239
DOID:10763	hypertension	GO:0030335	positive regulation of cell migration	3.7550851317291745e-11	8.281840258028694e-7	25	387	239
DOID:10763	hypertension	GO:0048589	developmental growth	3.807409942879758e-11	8.397242629021306e-7	30	558	239
DOID:10763	hypertension	GO:0045859	regulation of protein kinase activity	4.437616940577982e-11	9.78716416244474e-7	34	709	239
DOID:10763	hypertension	GO:0016491	oxidoreductase activity	4.6523895846917185e-11	1.0260845229037585e-6	34	710	239
DOID:10763	hypertension	GO:0043627	response to estrogen	4.899125549684413e-11	1.0805021399828973e-6	19	217	239
DOID:10763	hypertension	GO:0046982	protein heterodimerization activity	5.097977595625025e-11	1.1243589587150993e-6	27	459	239
DOID:10763	hypertension	GO:0007611	learning or memory	5.3432369639949684e-11	1.1784509124090903e-6	19	218	239
DOID:10763	hypertension	GO:0031668	cellular response to extracellular stimulus	5.7523208418786e-11	1.2686743616763252e-6	18	193	239
DOID:10763	hypertension	GO:0034599	cellular response to oxidative stress	5.824229987183571e-11	1.2845339236733366e-6	19	219	239
DOID:10763	hypertension	GO:0010876	lipid localization	5.916223067004012e-11	1.3048229974277348e-6	23	333	239
DOID:10763	hypertension	GO:0048265	response to pain	6.348732650707234e-11	1.4002129861134804e-6	9	29	239
DOID:10763	hypertension	GO:0072001	renal system development	6.805089824979405e-11	1.5008625608992077e-6	21	276	239
DOID:10763	hypertension	GO:0020037	heme binding	6.818512421347123e-11	1.503822914528108e-6	15	125	239
DOID:10763	hypertension	GO:0098662	inorganic cation transmembrane transport	7.164502324741306e-11	1.5801309877216951e-6	30	575	239
DOID:10763	hypertension	GO:0015844	monoamine transport	8.10774780646284e-11	1.7881637787153792e-6	12	70	239
DOID:10763	hypertension	GO:0030816	positive regulation of cAMP metabolic process	9.1825658188327e-11	2.025214891343552e-6	13	88	239
DOID:10763	hypertension	GO:0016049	cell growth	1.2142131744496965e-10	2.6779471562488055e-6	27	479	239
DOID:10763	hypertension	GO:0001558	regulation of cell growth	1.3330359038832285e-10	2.9400106860144604e-6	24	379	239
DOID:10763	hypertension	GO:0045926	negative regulation of growth	1.3738621351677693e-10	3.0300529391125153e-6	19	230	239
DOID:10763	hypertension	GO:0002684	positive regulation of immune system process	1.3752132765887382e-10	3.033032881516462e-6	37	872	239
DOID:10763	hypertension	GO:0007589	body fluid secretion	1.418518635887267e-10	3.1285428514493674e-6	13	91	239
DOID:10763	hypertension	GO:0006897	endocytosis	1.474674826695832e-10	3.2523953302776576e-6	30	593	239
DOID:10763	hypertension	GO:0030198	extracellular matrix organization	1.6870016494863194e-10	3.7206821379420774e-6	22	320	239
DOID:10763	hypertension	GO:0043200	response to amino acid	1.7207757441184413e-10	3.795170903653222e-6	14	112	239
DOID:10763	hypertension	GO:0006182	cGMP biosynthetic process	1.7229284665631894e-10	3.7999187330051143e-6	9	32	239
DOID:10763	hypertension	GO:0048608	reproductive structure development	1.784686842754013e-10	3.936126831693976e-6	25	418	239
DOID:10763	hypertension	GO:0001822	kidney development	1.8568180326639094e-10	4.095212171040252e-6	20	262	239
DOID:10763	hypertension	GO:0016323	basolateral plasma membrane	1.8625601061472707e-10	4.107876314107806e-6	18	207	239
DOID:10763	hypertension	GO:0045765	regulation of angiogenesis	2.0166412983968485e-10	4.447702383614249e-6	18	208	239
DOID:10763	hypertension	GO:0044070	regulation of anion transport	2.060270842818568e-10	4.5439273438363514e-6	15	135	239
DOID:10763	hypertension	GO:0009790	embryo development	2.1436952213349514e-10	4.727919810654235e-6	38	932	239
DOID:10763	hypertension	GO:0007263	nitric oxide mediated signal transduction	2.664027887178122e-10	5.875513505171348e-6	8	23	239
DOID:10763	hypertension	GO:0042554	superoxide anion generation	2.664027887178122e-10	5.875513505171348e-6	8	23	239
DOID:10763	hypertension	GO:0033500	carbohydrate homeostasis	2.754603212196116e-10	6.075277384498534e-6	18	212	239
DOID:10763	hypertension	GO:0042593	glucose homeostasis	2.754603212196116e-10	6.075277384498534e-6	18	212	239
DOID:10763	hypertension	GO:0043005	neuron projection	2.837717838488629e-10	6.258586692786672e-6	38	941	239
DOID:10763	hypertension	GO:0006813	potassium ion transport	2.97351587796868e-10	6.5580892688599235e-6	18	213	239
DOID:10763	hypertension	GO:0043410	positive regulation of MAPK cascade	3.072759824362947e-10	6.77697179263248e-6	26	464	239
DOID:10763	hypertension	GO:0030072	peptide hormone secretion	3.0884539370390485e-10	6.811585158139621e-6	19	241	239
DOID:10763	hypertension	GO:0001816	cytokine production	3.218936228677194e-10	7.099363852347551e-6	30	613	239
DOID:10763	hypertension	GO:0006942	regulation of striated muscle contraction	3.2222335910603306e-10	7.106636185083559e-6	13	97	239
DOID:10763	hypertension	GO:0045321	leukocyte activation	3.5536928955082203e-10	7.83766968104338e-6	32	694	239
DOID:10763	hypertension	GO:0016337	single organismal cell-cell adhesion	3.944977677861061e-10	8.70064826852257e-6	32	697	239
DOID:10763	hypertension	GO:0008202	steroid metabolic process	4.345251936044292e-10	9.583453144945686e-6	20	275	239
DOID:10763	hypertension	GO:0031669	cellular response to nutrient levels	4.711629975062692e-10	1.0391499910000768e-5	16	167	239
DOID:10763	hypertension	GO:0030819	positive regulation of cAMP biosynthetic process	4.763320848866215e-10	1.0505504132174437e-5	12	81	239
DOID:10763	hypertension	GO:0060284	regulation of cell development	4.932729780193768e-10	1.0879135530217354e-5	35	828	239
DOID:10763	hypertension	GO:0032409	regulation of transporter activity	4.959117561043058e-10	1.0937333780880465e-5	17	193	239
DOID:10763	hypertension	GO:0070374	positive regulation of ERK1 and ERK2 cascade	5.150143644883087e-10	1.1358641808789649e-5	16	168	239
DOID:10763	hypertension	GO:0086009	membrane repolarization	5.530143010190613e-10	1.2196730408975398e-5	9	36	239
DOID:10763	hypertension	GO:0010212	response to ionizing radiation	5.688679527438012e-10	1.2546382697764535e-5	15	145	239
DOID:10763	hypertension	GO:0051953	negative regulation of amine transport	5.747811115952572e-10	1.2676797416233399e-5	8	25	239
DOID:10763	hypertension	GO:0019752	carboxylic acid metabolic process	6.208558112064111e-10	1.3692974916157397e-5	38	967	239
DOID:10763	hypertension	GO:0043112	receptor metabolic process	6.904233851301456e-10	1.522728775904536e-5	15	147	239
DOID:10763	hypertension	GO:0043500	muscle adaptation	7.354935549486186e-10	1.6221310354391782e-5	12	84	239
DOID:10763	hypertension	GO:0055117	regulation of cardiac muscle contraction	7.354935549486186e-10	1.6221310354391782e-5	12	84	239
DOID:10763	hypertension	GO:0033273	response to vitamin	7.808569346678951e-10	1.7221799694100426e-5	13	104	239
DOID:10763	hypertension	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	7.952257741195012e-10	1.75387044482056e-5	16	173	239
DOID:10763	hypertension	GO:2001234	negative regulation of apoptotic signaling pathway	7.981888483499233e-10	1.760405505035756e-5	17	199	239
DOID:10763	hypertension	GO:0030073	insulin secretion	7.981888483499233e-10	1.760405505035756e-5	17	199	239
DOID:10763	hypertension	GO:0046890	regulation of lipid biosynthetic process	8.388633121469979e-10	1.850113034940204e-5	14	126	239
DOID:10763	hypertension	GO:0030425	dendrite	8.464547951447798e-10	1.866856050691812e-5	25	451	239
DOID:10763	hypertension	GO:0007507	heart development	8.490622649404145e-10	1.872606825326084e-5	26	487	239
DOID:10763	hypertension	GO:0007167	enzyme linked receptor protein signaling pathway	8.879061930144871e-10	1.9582771086934514e-5	37	935	239
DOID:10763	hypertension	GO:0018108	peptidyl-tyrosine phosphorylation	1.1217783368877576e-9	2.4740821220059495e-5	22	354	239
DOID:10763	hypertension	GO:0050865	regulation of cell activation	1.1619952777763842e-9	2.5627805851358154e-5	25	458	239
DOID:10763	hypertension	GO:0022898	regulation of transmembrane transporter activity	1.2104296454040764e-9	2.6696025829386905e-5	16	178	239
DOID:10763	hypertension	GO:0007612	learning	1.2714216346410012e-9	2.8041204152007282e-5	14	130	239
DOID:10763	hypertension	GO:0001935	endothelial cell proliferation	1.4098521239347406e-9	3.1094288593380703e-5	13	109	239
DOID:10763	hypertension	GO:0032970	regulation of actin filament-based process	1.4311631879593278e-9	3.1564304110442976e-5	21	326	239
DOID:10763	hypertension	GO:0001991	regulation of systemic arterial blood pressure by circulatory renin-angiotensin	1.4558927396990384e-9	3.210971437406229e-5	7	18	239
DOID:10763	hypertension	GO:0001974	blood vessel remodeling	1.5366433681052172e-9	3.3890669483560565e-5	9	40	239
DOID:10763	hypertension	GO:0009416	response to light stimulus	1.6662766721964317e-9	3.67497320052923e-5	20	297	239
DOID:10763	hypertension	GO:0048511	rhythmic process	1.6876305908297695e-9	3.722069268075057e-5	21	329	239
DOID:10763	hypertension	GO:0070848	response to growth factor	1.863224574627509e-9	4.109341799340971e-5	29	621	239
DOID:10763	hypertension	GO:0008131	primary amine oxidase activity	1.9574373233410824e-9	4.317128016628757e-5	5	6	239
DOID:10763	hypertension	GO:0006869	lipid transport	1.982552899626455e-9	4.372520420126147e-5	20	300	239
DOID:10763	hypertension	GO:1903532	positive regulation of secretion by cell	2.3315448460792254e-9	5.1422221580277316e-5	21	335	239
DOID:10763	hypertension	GO:0071385	cellular response to glucocorticoid stimulus	2.4950805865842085e-9	5.502900233711472e-5	10	57	239
DOID:10763	hypertension	GO:0072073	kidney epithelium development	2.543550370326386e-9	5.609800341754845e-5	14	137	239
DOID:10763	hypertension	GO:0030168	platelet activation	2.685979993977128e-9	5.9239288767165554e-5	15	162	239
DOID:10763	hypertension	GO:0071326	cellular response to monosaccharide stimulus	2.7530365764860676e-9	6.071822169440022e-5	13	115	239
DOID:10763	hypertension	GO:0071363	cellular response to growth factor stimulus	2.946086485877686e-9	6.497593744603236e-5	28	594	239
DOID:10763	hypertension	GO:0051937	catecholamine transport	2.9814872792854885e-9	6.575670194464145e-5	10	58	239
DOID:10763	hypertension	GO:0033674	positive regulation of kinase activity	3.0109089665941724e-9	6.640559725823447e-5	25	480	239
DOID:10763	hypertension	GO:0050433	regulation of catecholamine secretion	3.064914988470946e-9	6.759670007072671e-5	9	43	239
DOID:10763	hypertension	GO:0009651	response to salt stress	3.4698020012768893e-9	7.65264831381618e-5	7	20	239
DOID:10763	hypertension	GO:0002526	acute inflammatory response	3.7115228668227473e-9	8.185763682777569e-5	14	141	239
DOID:10763	hypertension	GO:0010742	macrophage derived foam cell differentiation	3.923616986867273e-9	8.653537264535771e-5	8	31	239
DOID:10763	hypertension	GO:0045860	positive regulation of protein kinase activity	3.999967912449165e-9	8.821929230906633e-5	24	450	239
DOID:10763	hypertension	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	4.007939202743671e-9	8.839509911651167e-5	12	97	239
DOID:10763	hypertension	GO:0046873	metal ion transmembrane transporter activity	4.164523614846871e-9	9.184856832544774e-5	23	415	239
DOID:10763	hypertension	GO:0070555	response to interleukin-1	4.205460757411572e-9	9.275143700471222e-5	13	119	239
Orphanet:98534	Neurodegenerative disease with dementia	GO:0043005	neuron projection	4.771738559838923e-13	1.0524069393724744e-8	41	941	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0042982	amyloid precursor protein metabolic process	6.483702463810914e-14	1.4299805783934971e-9	11	31	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0051402	neuron apoptotic process	3.684941241033357e-12	8.127137907099069e-8	20	211	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0009991	response to extracellular stimulus	4.3541836802774014e-12	9.603152106851809e-8	34	573	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0044708	single-organism behavior	4.654054919228656e-12	1.0264518124358801e-7	29	404	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0010035	response to inorganic substance	5.0067727741520685e-12	1.1042437353392387e-7	32	502	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0036477	somatodendritic compartment	9.731881966956735e-12	2.1463665678123078e-7	35	649	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0019725	cellular homeostasis	1.4708456674839e-11	3.243950119635741e-7	38	771	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0030003	cellular cation homeostasis	3.4458991216013146e-11	7.599930512691699e-7	29	519	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0036293	response to decreased oxygen levels	5.90467674754791e-11	1.3022764566716916e-6	22	302	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0009314	response to radiation	7.178557748233061e-11	1.5832309113728016e-6	26	431	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0005768	endosome	1.600004573276692e-10	3.5288100863617444e-6	35	789	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0030425	dendrite	1.8270418511434627e-10	4.029540802696907e-6	26	451	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0043523	regulation of neuron apoptotic process	4.140501275173847e-10	9.131875562395919e-6	17	190	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0009636	response to toxic substance	5.775250278006183e-10	1.2737314488142637e-5	19	249	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0007568	aging	1.1852309134141592e-9	2.614026779534928e-5	20	290	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0043254	regulation of protein complex assembly	2.490693540302402e-9	5.493224603136948e-5	22	368	240
Orphanet:98534	Neurodegenerative disease with dementia	GO:0043065	positive regulation of apoptotic process	3.3550013878169693e-9	7.399455560830326e-5	27	556	240
DOID:8501	fundus dystrophy	GO:0007600	sensory perception	3.0904168113465857e-12	6.815914277424895e-8	83	902	248
DOID:8501	fundus dystrophy	GO:0048592	eye morphogenesis	3.574918139293004e-13	7.88448195621072e-9	21	136	248
DOID:8501	fundus dystrophy	GO:0016056	rhodopsin mediated signaling pathway	2.930988785010413e-14	6.464295765340466e-10	13	33	248
DOID:8501	fundus dystrophy	GO:0042462	eye photoreceptor cell development	1.9206858326015208e-14	4.236072603802654e-10	14	30	248
DOID:8501	fundus dystrophy	GO:0006721	terpenoid metabolic process	1.3164702661327965e-10	2.9034751719558827e-6	14	106	248
DOID:8501	fundus dystrophy	GO:0001085	RNA polymerase II transcription factor binding	1.2262021398257161e-9	2.704388819385617e-5	13	104	248
DOID:8501	fundus dystrophy	GO:0050908	detection of light stimulus involved in visual perception	1.883078581954578e-9	4.153129812500822e-5	7	18	248
DOID:8501	fundus dystrophy	GO:0009642	response to light intensity	2.2592870907445217e-9	4.9828576786370427e-5	6	11	248
Orphanet:98044	Central nervous system malformation	GO:0048736	appendage development	1.106670310946356e-12	2.4407613707921882e-8	20	168	249
Orphanet:98044	Central nervous system malformation	GO:0060173	limb development	1.106670310946356e-12	2.4407613707921882e-8	20	168	249
Orphanet:98044	Central nervous system malformation	GO:0035107	appendage morphogenesis	9.001688283660769e-13	1.9853223509613827e-8	20	146	249
Orphanet:98044	Central nervous system malformation	GO:0035108	limb morphogenesis	9.001688283660769e-13	1.9853223509613827e-8	20	146	249
Orphanet:98044	Central nervous system malformation	GO:0001841	neural tube formation	4.438671652451376e-13	9.78949032948151e-9	16	95	249
Orphanet:98044	Central nervous system malformation	GO:0055123	digestive system development	1.589706144500269e-11	3.5060969016953436e-7	17	150	249
Orphanet:98044	Central nervous system malformation	GO:0000904	cell morphogenesis involved in differentiation	1.972022545260188e-11	4.349295723571345e-7	37	720	249
Orphanet:98044	Central nervous system malformation	GO:0048666	neuron development	1.6198498098418668e-10	3.572578755606237e-6	39	926	249
Orphanet:98044	Central nervous system malformation	GO:0042063	gliogenesis	2.4076585170007547e-10	5.3100908592451646e-6	19	228	249
Orphanet:98044	Central nervous system malformation	GO:0021761	limbic system development	7.849727534647855e-10	1.7312574077665843e-5	13	100	249
Orphanet:98044	Central nervous system malformation	GO:0061564	axon development	1.2022387529952994e-9	2.6515375697311327e-5	25	440	249
Orphanet:98044	Central nervous system malformation	GO:0021846	cell proliferation in forebrain	1.5949646048341037e-9	3.517694435961616e-5	8	27	249
Orphanet:98044	Central nervous system malformation	GO:0051301	cell division	3.1198705841006813e-9	6.880874573234053e-5	30	648	249
Orphanet:98044	Central nervous system malformation	GO:0021766	hippocampus development	3.2677545114268014e-9	7.20703257495181e-5	11	73	249
Orphanet:98044	Central nervous system malformation	GO:0045995	regulation of embryonic development	3.6340594977701812e-9	8.014918222332135e-5	13	113	249
Orphanet:98044	Central nervous system malformation	GO:0021953	central nervous system neuron differentiation	4.31201030437478e-9	9.510138726298578e-5	15	161	249
MESH:D012678	Sensation Disorders	GO:0048878	chemical homeostasis	2.0646817588954036e-11	4.5536556192438127e-7	55	988	250
MESH:D012678	Sensation Disorders	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.6455503626389145e-11	3.629261324800126e-7	46	996	250
MESH:D012678	Sensation Disorders	GO:0098590	plasma membrane region	5.695888205536903e-12	1.256228143731164e-7	45	926	250
MESH:D012678	Sensation Disorders	GO:0044463	cell projection part	3.079314581100334e-12	6.791428308616787e-8	42	939	250
MESH:D012678	Sensation Disorders	GO:0072358	cardiovascular system development	1.631805801594055e-12	3.5989476954156885e-8	41	910	250
MESH:D012678	Sensation Disorders	GO:0009887	organ morphogenesis	1.7319479184152442e-13	3.819811134064821e-9	57	950	250
MESH:D012678	Sensation Disorders	GO:0090596	sensory organ morphogenesis	1.3566925360919413e-13	2.9921853883507765e-9	37	239	250
MESH:D012678	Sensation Disorders	GO:0050974	detection of mechanical stimulus involved in sensory perception	3.8968828164342995e-13	8.594575051645847e-9	10	25	250
MESH:D012678	Sensation Disorders	GO:2001234	negative regulation of apoptotic signaling pathway	1.2383427616668996e-12	2.731164960856347e-8	20	199	250
MESH:D012678	Sensation Disorders	GO:0071214	cellular response to abiotic stimulus	1.6771029009987615e-12	3.6988504481527684e-8	24	285	250
MESH:D012678	Sensation Disorders	GO:0070838	divalent metal ion transport	5.538458580645056e-12	1.221507039961267e-7	29	410	250
MESH:D012678	Sensation Disorders	GO:0007610	behavior	1.487043821413181e-11	3.2796751481267705e-7	41	714	250
MESH:D012678	Sensation Disorders	GO:0048871	multicellular organismal homeostasis	1.5085599436304165e-11	3.3271289556768835e-7	24	321	250
MESH:D012678	Sensation Disorders	GO:0015267	channel activity	3.104760892824743e-11	6.84755014912497e-7	28	459	250
MESH:D012678	Sensation Disorders	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	4.357469940430292e-11	9.610399953619009e-7	14	97	250
MESH:D012678	Sensation Disorders	GO:0055067	monovalent inorganic cation homeostasis	7.938671942042674e-11	1.7508740968175118e-6	16	142	250
MESH:D012678	Sensation Disorders	GO:0023061	signal release	8.270539808563626e-11	1.8240675547787077e-6	26	416	250
MESH:D012678	Sensation Disorders	GO:0051046	regulation of secretion	1.4217127475291136e-10	3.13558746467546e-6	33	675	250
MESH:D012678	Sensation Disorders	GO:0009611	response to wounding	1.4241929857661262e-10	3.1410576301071913e-6	38	875	250
MESH:D012678	Sensation Disorders	GO:0009314	response to radiation	1.706997876382843e-10	3.7647838163623604e-6	26	431	250
MESH:D012678	Sensation Disorders	GO:0002064	epithelial cell development	2.591300507504002e-10	5.715113269300076e-6	18	202	250
MESH:D012678	Sensation Disorders	GO:0005216	ion channel activity	4.356145444361914e-10	9.607478777540202e-6	25	417	250
MESH:D012678	Sensation Disorders	GO:0001503	ossification	7.702175564006097e-10	1.6987148206415448e-5	23	363	250
MESH:D012678	Sensation Disorders	GO:0001763	morphogenesis of a branching structure	9.919309817973954e-10	2.1877037803541555e-5	17	193	250
MESH:D012678	Sensation Disorders	GO:0098660	inorganic ion transmembrane transport	1.3064941351004222e-9	2.8814728149639812e-5	31	660	250
MESH:D012678	Sensation Disorders	GO:0001501	skeletal system development	1.7938164287301106e-9	3.956262133564259e-5	26	482	250
MESH:D012678	Sensation Disorders	GO:0061138	morphogenesis of a branching epithelium	2.523481978933262e-9	5.565539504537309e-5	16	179	250
MESH:D012678	Sensation Disorders	GO:0009150	purine ribonucleotide metabolic process	4.013817278547549e-9	8.852474007836619e-5	26	501	250
MESH:D009374	Neoplasms, Experimental	GO:0043627	response to estrogen	1.7279511155265936e-12	3.810996185293902e-8	22	217	251
MESH:D009374	Neoplasms, Experimental	GO:0048145	regulation of fibroblast proliferation	4.530820163495264e-13	9.992723870588804e-9	15	82	251
MESH:D009374	Neoplasms, Experimental	GO:0050679	positive regulation of epithelial cell proliferation	1.9730883593638282e-12	4.351646376576923e-8	18	155	251
MESH:D009374	Neoplasms, Experimental	GO:0010035	response to inorganic substance	4.9398263257671715e-12	1.0894786961479497e-7	33	502	251
MESH:D009374	Neoplasms, Experimental	GO:1901698	response to nitrogen compound	9.421574631574003e-12	2.0779282849936465e-7	41	870	251
MESH:D009374	Neoplasms, Experimental	GO:0043069	negative regulation of programmed cell death	1.300892726874281e-11	2.8691189091212266e-7	45	806	251
MESH:D009374	Neoplasms, Experimental	GO:0018108	peptidyl-tyrosine phosphorylation	1.9635293391218056e-11	4.330563957433142e-7	25	354	251
MESH:D009374	Neoplasms, Experimental	GO:0097285	cell-type specific apoptotic process	1.6867340857373847e-10	3.720092026093802e-6	26	429	251
MESH:D009374	Neoplasms, Experimental	GO:2000147	positive regulation of cell motility	1.901389046210511e-10	4.193513541417282e-6	25	399	251
MESH:D009374	Neoplasms, Experimental	GO:1901214	regulation of neuron death	1.9292911712653904e-10	4.2550516782258185e-6	20	250	251
MESH:D009374	Neoplasms, Experimental	GO:1990267	response to transition metal nanoparticle	1.9335522072339018e-10	4.26444939305437e-6	16	150	251
MESH:D009374	Neoplasms, Experimental	GO:0042493	response to drug	2.0477930462448057e-10	4.516407563492919e-6	26	433	251
MESH:D009374	Neoplasms, Experimental	GO:0030334	regulation of cell migration	3.54588913786813e-10	7.820458493568161e-6	32	660	251
MESH:D009374	Neoplasms, Experimental	GO:0042327	positive regulation of phosphorylation	4.675805298504088e-10	1.0312488585850765e-5	38	910	251
MESH:D009374	Neoplasms, Experimental	GO:0051093	negative regulation of developmental process	5.125904145586446e-10	1.1305181593090907e-5	35	788	251
MESH:D009374	Neoplasms, Experimental	GO:0030335	positive regulation of cell migration	5.409842573911305e-10	1.1931407796761384e-5	24	387	251
MESH:D009374	Neoplasms, Experimental	GO:0051241	negative regulation of multicellular organismal process	7.051929040713389e-10	1.555302949929338e-5	39	966	251
MESH:D009374	Neoplasms, Experimental	GO:0001503	ossification	8.327857292655949e-10	1.8367089258952696e-5	23	363	251
MESH:D009374	Neoplasms, Experimental	GO:0038127	ERBB signaling pathway	1.0160464691821858e-9	2.2408904877813107e-5	15	144	251
MESH:D009374	Neoplasms, Experimental	GO:0043408	regulation of MAPK cascade	1.038277352982675e-9	2.2899207020032897e-5	31	651	251
MESH:D009374	Neoplasms, Experimental	GO:0070371	ERK1 and ERK2 cascade	1.0732638111576875e-9	2.36708333550828e-5	19	247	251
MESH:D009374	Neoplasms, Experimental	GO:0007173	epidermal growth factor receptor signaling pathway	1.1506960939655642e-9	2.5378602352410518e-5	14	123	251
MESH:D009374	Neoplasms, Experimental	GO:0031100	organ regeneration	1.285757500468776e-9	2.8357381672838855e-5	12	84	251
MESH:D009374	Neoplasms, Experimental	GO:0070848	response to growth factor	1.4078862520250368e-9	3.105093128841219e-5	30	621	251
MESH:D009374	Neoplasms, Experimental	GO:0071363	cellular response to growth factor stimulus	2.1265542660131587e-9	4.6901154336920214e-5	29	594	251
MESH:D009374	Neoplasms, Experimental	GO:0006979	response to oxidative stress	2.7025824911319773e-9	5.960545684191576e-5	23	386	251
MESH:D009374	Neoplasms, Experimental	GO:0071417	cellular response to organonitrogen compound	3.816791327437841e-9	8.417933272664158e-5	25	462	251
MESH:D009374	Neoplasms, Experimental	GO:0001889	liver development	3.940298753946081e-9	8.690328901828082e-5	14	135	251
MESH:D009374	Neoplasms, Experimental	GO:0043410	positive regulation of MAPK cascade	4.163841382798239e-9	9.183352169761516e-5	25	464	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048667	cell morphogenesis involved in neuron differentiation	5.480171871852235e-12	1.2086519063370105e-7	33	495	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0009725	response to hormone	1.2161727180881599e-10	2.6822689297434366e-6	38	865	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0007610	behavior	1.6146461945254487e-10	3.561102182025877e-6	34	714	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0043473	pigmentation	2.600467619018332e-10	5.735331333744931e-6	13	91	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0021543	pallium development	2.611315608191944e-10	5.759256573867333e-6	16	153	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0001655	urogenital system development	2.8243085647972066e-10	6.229012539660239e-6	22	313	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0035265	organ growth	2.9571023407726216e-10	6.521889212574017e-6	15	132	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048871	multicellular organismal homeostasis	4.54934312443811e-10	1.0033576260948252e-5	22	321	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0042445	hormone metabolic process	6.459220935894905e-10	1.4245811774116213e-5	17	187	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0007548	sex differentiation	9.663103650581206e-10	2.131197510135685e-5	20	274	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0051962	positive regulation of nervous system development	1.123370618749675e-9	2.4775938996524083e-5	25	435	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0008284	positive regulation of cell proliferation	1.227150270288746e-9	2.7064799211218293e-5	35	815	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0050769	positive regulation of neurogenesis	1.6369934296989186e-9	3.610389009200965e-5	23	376	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0044344	cellular response to fibroblast growth factor stimulus	1.953142647614925e-9	4.307656109314717e-5	14	128	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0034754	cellular hormone metabolic process	2.2783123165837083e-9	5.0248178142253686e-5	13	108	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0044703	multi-organism reproductive process	2.753604566585466e-9	6.073074871604245e-5	37	926	251
Orphanet:399983	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin	GO:0048806	genitalia development	2.991815795105879e-9	6.598449736106016e-5	9	41	251
Orphanet:88991	Congenital heart malformation	GO:0001578	microtubule bundle formation	7.771561172376096e-14	1.714017816567548e-9	15	66	252
Orphanet:88991	Congenital heart malformation	GO:0046620	regulation of organ growth	1.2360779066966643e-11	2.726169823219493e-7	13	72	252
Orphanet:88991	Congenital heart malformation	GO:0031966	mitochondrial membrane	1.2854606268319912e-11	2.8350834124779567e-7	37	656	252
Orphanet:88991	Congenital heart malformation	GO:0001947	heart looping	1.4489853761290306e-11	3.195737247052577e-7	12	58	252
Orphanet:88991	Congenital heart malformation	GO:0032838	cell projection cytoplasm	2.250100106238051e-11	4.962595784308022e-7	15	110	252
Orphanet:88991	Congenital heart malformation	GO:0023014	signal transduction by protein phosphorylation	5.3695492496785846e-11	1.1842540870166118e-6	39	879	252
Orphanet:88991	Congenital heart malformation	GO:0003230	cardiac atrium development	2.0049517601705702e-10	4.4219211070561926e-6	9	31	252
Orphanet:88991	Congenital heart malformation	GO:0008284	positive regulation of cell proliferation	3.713552798600972e-10	8.190240697314444e-6	36	815	252
Orphanet:88991	Congenital heart malformation	GO:2000145	regulation of cell motility	5.734048791339319e-10	1.2646444609298868e-5	33	709	252
Orphanet:88991	Congenital heart malformation	GO:0022603	regulation of anatomical structure morphogenesis	1.4298806583212809e-9	3.153601791927585e-5	39	986	252
Orphanet:88991	Congenital heart malformation	GO:0030334	regulation of cell migration	1.5877904546712784e-9	3.5018718477775046e-5	31	660	252
Orphanet:88991	Congenital heart malformation	GO:0060976	coronary vasculature development	1.918448178095389e-9	4.23113745678938e-5	9	39	252
Orphanet:88991	Congenital heart malformation	GO:0009792	embryo development ending in birth or egg hatching	2.4625514960519013e-9	5.431157324542468e-5	28	558	252
Orphanet:88991	Congenital heart malformation	GO:0051241	negative regulation of multicellular organismal process	2.8050302081084055e-9	6.186494123983088e-5	38	966	252
Orphanet:88991	Congenital heart malformation	GO:0001666	response to hypoxia	3.118599267715183e-9	6.878070684945836e-5	20	292	252
Orphanet:88991	Congenital heart malformation	GO:0009612	response to mechanical stimulus	4.081475379891231e-9	9.001693950350109e-5	17	210	252
Orphanet:171895	Myeloid hemopathy	GO:0048878	chemical homeostasis	1.2098100299340331e-11	2.66823602101951e-7	43	988	253
Orphanet:171895	Myeloid hemopathy	GO:0042327	positive regulation of phosphorylation	6.559197629485425e-12	1.4466310371830104e-7	42	910	253
Orphanet:171895	Myeloid hemopathy	GO:0051726	regulation of cell cycle	5.824896120998346e-12	1.2846808394861853e-7	49	930	253
Orphanet:171895	Myeloid hemopathy	GO:0023014	signal transduction by protein phosphorylation	1.0131895322729179e-12	2.2345895134279203e-8	44	879	253
Orphanet:171895	Myeloid hemopathy	GO:1903706	regulation of hemopoiesis	1.592392884219862e-12	3.512022506146906e-8	26	305	253
Orphanet:171895	Myeloid hemopathy	GO:0007568	aging	3.553823901825126e-12	7.837958615475316e-8	24	290	253
Orphanet:171895	Myeloid hemopathy	GO:0030098	lymphocyte differentiation	4.62907490117459e-12	1.0209424694540559e-7	24	299	253
Orphanet:171895	Myeloid hemopathy	GO:0051345	positive regulation of hydrolase activity	5.184297435789631e-12	1.1433967994634031e-7	41	900	253
Orphanet:171895	Myeloid hemopathy	GO:0034109	homotypic cell-cell adhesion	5.8867355434699675e-12	1.2983195241123013e-7	32	495	253
Orphanet:171895	Myeloid hemopathy	GO:0051272	positive regulation of cellular component movement	6.920797268605838e-12	1.5263818375910176e-7	28	408	253
Orphanet:171895	Myeloid hemopathy	GO:0070482	response to oxygen levels	7.080780406454323e-12	1.561666118643501e-7	25	321	253
Orphanet:171895	Myeloid hemopathy	GO:0000165	MAPK cascade	8.703926468456302e-12	1.9196509826180375e-7	44	843	253
Orphanet:171895	Myeloid hemopathy	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	9.76474456848564e-12	2.1536144145795078e-7	20	212	253
Orphanet:171895	Myeloid hemopathy	GO:0070848	response to growth factor	1.2862266807189826e-11	2.836772944325716e-7	34	621	253
Orphanet:171895	Myeloid hemopathy	GO:0007159	leukocyte cell-cell adhesion	1.3910317342435974e-11	3.067920489874254e-7	29	461	253
Orphanet:171895	Myeloid hemopathy	GO:0070486	leukocyte aggregation	1.4775736190131283e-11	3.2587886167334545e-7	28	432	253
Orphanet:171895	Myeloid hemopathy	GO:0045597	positive regulation of cell differentiation	1.5479839632348558e-11	3.4140786309144744e-7	42	815	253
Orphanet:171895	Myeloid hemopathy	GO:0019221	cytokine-mediated signaling pathway	1.5680012843688473e-11	3.458226832675493e-7	31	534	253
Orphanet:171895	Myeloid hemopathy	GO:0009986	cell surface	1.6103340882978046e-11	3.551591831740808e-7	39	715	253
Orphanet:171895	Myeloid hemopathy	GO:0005925	focal adhesion	2.6566193689347983e-11	5.859174018185698e-7	26	388	253
Orphanet:171895	Myeloid hemopathy	GO:0051098	regulation of binding	3.6310288109575595e-11	8.008234042566897e-7	22	279	253
Orphanet:171895	Myeloid hemopathy	GO:0045787	positive regulation of cell cycle	3.9314329569606343e-11	8.670775386576679e-7	23	308	253
Orphanet:171895	Myeloid hemopathy	GO:0009887	organ morphogenesis	4.088440697103124e-11	9.01705595746094e-7	41	950	253
Orphanet:171895	Myeloid hemopathy	GO:0061138	morphogenesis of a branching epithelium	4.1199266220814934e-11	9.086498165000734e-7	18	179	253
Orphanet:171895	Myeloid hemopathy	GO:0002262	myeloid cell homeostasis	5.148625970008425e-11	1.135529457685358e-6	15	116	253
Orphanet:171895	Myeloid hemopathy	GO:0001568	blood vessel development	5.175693207348786e-11	1.1414991368807748e-6	31	569	253
Orphanet:171895	Myeloid hemopathy	GO:0050878	regulation of body fluid levels	6.041001032741633e-11	1.3323427777711672e-6	29	504	253
Orphanet:171895	Myeloid hemopathy	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	6.97727431386852e-11	1.538837849923702e-6	33	647	253
Orphanet:171895	Myeloid hemopathy	GO:0032496	response to lipopolysaccharide	8.042488897075373e-11	1.7737709262499735e-6	23	319	253
Orphanet:171895	Myeloid hemopathy	GO:0050767	regulation of neurogenesis	1.0290934771006732e-10	2.269665663745535e-6	33	658	253
Orphanet:171895	Myeloid hemopathy	GO:1901699	cellular response to nitrogen compound	1.139496275115448e-10	2.5131590347671207e-6	29	518	253
Orphanet:171895	Myeloid hemopathy	GO:0050817	coagulation	1.2165835006072712e-10	2.6831749105893365e-6	24	356	253
Orphanet:171895	Myeloid hemopathy	GO:0007507	heart development	1.3312817515043207e-10	2.9361419029427793e-6	28	487	253
Orphanet:171895	Myeloid hemopathy	GO:0042542	response to hydrogen peroxide	1.3472223336918887e-10	2.9712988569574605e-6	15	124	253
Orphanet:171895	Myeloid hemopathy	GO:0070489	T cell aggregation	1.563479345989549e-10	3.4482536975799505e-6	26	424	253
Orphanet:171895	Myeloid hemopathy	GO:0042110	T cell activation	1.563479345989549e-10	3.4482536975799505e-6	26	424	253
Orphanet:171895	Myeloid hemopathy	GO:0001503	ossification	1.7811518926436065e-10	3.928330499225474e-6	24	363	253
Orphanet:171895	Myeloid hemopathy	GO:0042330	taxis	1.9654067262564467e-10	4.334704534758593e-6	29	531	253
Orphanet:171895	Myeloid hemopathy	GO:2001234	negative regulation of apoptotic signaling pathway	2.4573731938204446e-10	5.419736578970991e-6	18	199	253
Orphanet:171895	Myeloid hemopathy	GO:0030217	T cell differentiation	2.4573731938204446e-10	5.419736578970991e-6	18	199	253
Orphanet:171895	Myeloid hemopathy	GO:1902105	regulation of leukocyte differentiation	2.5158897187793627e-10	5.5487947747678845e-6	19	225	253
Orphanet:171895	Myeloid hemopathy	GO:0001776	leukocyte homeostasis	2.6107160877586466e-10	5.757934331551695e-6	12	73	253
Orphanet:171895	Myeloid hemopathy	GO:0055065	metal ion homeostasis	4.750320137247854e-10	1.0476831062700143e-5	28	516	253
Orphanet:171895	Myeloid hemopathy	GO:1903708	positive regulation of hemopoiesis	4.75450789849674e-10	1.0486067170134561e-5	16	158	253
Orphanet:171895	Myeloid hemopathy	GO:0007596	blood coagulation	5.364014787900828e-10	1.1830334614715277e-5	23	352	253
Orphanet:171895	Myeloid hemopathy	GO:0001666	response to hypoxia	5.523218549186026e-10	1.2181458510229781e-5	21	292	253
Orphanet:171895	Myeloid hemopathy	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	6.288644049945447e-10	1.3869604452154682e-5	11	62	253
Orphanet:171895	Myeloid hemopathy	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	6.292203424962395e-10	1.3877454653754562e-5	16	161	253
Orphanet:171895	Myeloid hemopathy	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	6.482777648031401e-10	1.4297766102733256e-5	13	97	253
Orphanet:171895	Myeloid hemopathy	GO:0002683	negative regulation of immune system process	7.853943051472356e-10	1.7321871400022282e-5	23	359	253
Orphanet:171895	Myeloid hemopathy	GO:0006935	chemotaxis	8.585957500528707e-10	1.8936329267416063e-5	28	530	253
Orphanet:171895	Myeloid hemopathy	GO:0080135	regulation of cellular response to stress	9.30804211485281e-10	2.0528886884307873e-5	32	681	253
Orphanet:171895	Myeloid hemopathy	GO:0042692	muscle cell differentiation	1.1067334826364572e-9	2.4409006959547064e-5	22	334	253
Orphanet:171895	Myeloid hemopathy	GO:0010563	negative regulation of phosphorus metabolic process	1.153695139421984e-9	2.544474629995186e-5	28	537	253
Orphanet:171895	Myeloid hemopathy	GO:0045936	negative regulation of phosphate metabolic process	1.153695139421984e-9	2.544474629995186e-5	28	537	253
Orphanet:171895	Myeloid hemopathy	GO:0010038	response to metal ion	1.1705636460135338e-9	2.5816781212828488e-5	22	335	253
Orphanet:171895	Myeloid hemopathy	GO:0050673	epithelial cell proliferation	1.1705636460135338e-9	2.5816781212828488e-5	22	335	253
Orphanet:171895	Myeloid hemopathy	GO:0070371	ERK1 and ERK2 cascade	1.2256655690379148e-9	2.703205412513121e-5	19	247	253
Orphanet:171895	Myeloid hemopathy	GO:0045444	fat cell differentiation	1.5100579675575432e-9	3.3304328474481615e-5	17	196	253
Orphanet:171895	Myeloid hemopathy	GO:2000377	regulation of reactive oxygen species metabolic process	1.5143789555693843e-9	3.339962786508277e-5	15	147	253
Orphanet:171895	Myeloid hemopathy	GO:0097028	dendritic cell differentiation	1.9862979039331208e-9	4.380780027124498e-5	9	39	253
Orphanet:171895	Myeloid hemopathy	GO:1901342	regulation of vasculature development	2.240323482283202e-9	4.941033440175602e-5	18	228	253
Orphanet:171895	Myeloid hemopathy	GO:0060326	cell chemotaxis	2.240323482283202e-9	4.941033440175602e-5	18	228	253
Orphanet:171895	Myeloid hemopathy	GO:0048146	positive regulation of fibroblast proliferation	2.477552718538334e-9	5.4642425207362955e-5	10	54	253
Orphanet:171895	Myeloid hemopathy	GO:0048514	blood vessel morphogenesis	2.5221619237569826e-9	5.562628122846025e-5	26	484	253
Orphanet:171895	Myeloid hemopathy	GO:0045786	negative regulation of cell cycle	2.522300257545851e-9	5.562933218017374e-5	25	449	253
Orphanet:171895	Myeloid hemopathy	GO:0050866	negative regulation of cell activation	2.646238006498436e-9	5.8362779233323e-5	15	153	253
Orphanet:171895	Myeloid hemopathy	GO:0045619	regulation of lymphocyte differentiation	2.6562171351329766e-9	5.85828689153578e-5	14	130	253
Orphanet:171895	Myeloid hemopathy	GO:0071407	cellular response to organic cyclic compound	2.667861043192943e-9	5.8839675307620354e-5	24	416	253
Orphanet:171895	Myeloid hemopathy	GO:0030198	extracellular matrix organization	2.8702709098382684e-9	6.330382491648301e-5	21	320	253
Orphanet:171895	Myeloid hemopathy	GO:0051050	positive regulation of transport	2.8845368316154918e-9	6.361845982127967e-5	37	920	253
Orphanet:171895	Myeloid hemopathy	GO:0070372	regulation of ERK1 and ERK2 cascade	3.1650601028943015e-9	6.980540056933382e-5	18	233	253
Orphanet:171895	Myeloid hemopathy	GO:0030218	erythrocyte differentiation	3.1743296879938043e-9	7.000984126870335e-5	12	90	253
Orphanet:171895	Myeloid hemopathy	GO:0042326	negative regulation of phosphorylation	3.218186606090967e-9	7.097710559733628e-5	24	420	253
Orphanet:171895	Myeloid hemopathy	GO:0050900	leukocyte migration	3.2569944519167393e-9	7.183301263702369e-5	22	354	253
Orphanet:171895	Myeloid hemopathy	GO:0002366	leukocyte activation involved in immune response	3.746878807220355e-9	8.263741209324493e-5	17	208	253
Orphanet:171895	Myeloid hemopathy	GO:0051054	positive regulation of DNA metabolic process	4.132088893271657e-9	9.11332205411064e-5	16	183	253
Orphanet:171895	Myeloid hemopathy	GO:0044212	transcription regulatory region DNA binding	4.300027889314606e-9	9.483711509883364e-5	34	807	253
Orphanet:171895	Myeloid hemopathy	GO:0016568	chromatin modification	4.315194757076313e-9	9.517162036731808e-5	29	608	253
Orphanet:171895	Myeloid hemopathy	GO:0071417	cellular response to organonitrogen compound	4.490488758612798e-9	9.903772957120527e-5	25	462	253
DOID:11934	head and neck cancer	GO:0042327	positive regulation of phosphorylation	9.623413177450857e-12	2.1224437762867865e-7	51	910	255
DOID:11934	head and neck cancer	GO:0023014	signal transduction by protein phosphorylation	3.979039320256561e-13	8.775771220825845e-9	47	879	255
DOID:11934	head and neck cancer	GO:0009790	embryo development	2.2448709557920665e-13	4.951062892999403e-9	42	932	255
DOID:11934	head and neck cancer	GO:0070374	positive regulation of ERK1 and ERK2 cascade	7.91033905045424e-13	1.7446252775776827e-8	19	168	255
DOID:11934	head and neck cancer	GO:1901701	cellular response to oxygen-containing compound	8.347766922156552e-13	1.8410999946816275e-8	45	873	255
DOID:11934	head and neck cancer	GO:0009611	response to wounding	1.0520473381347983e-12	2.3202904042562977e-8	45	875	255
DOID:11934	head and neck cancer	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.6624479570737094e-12	3.666528969326066e-8	18	151	255
DOID:11934	head and neck cancer	GO:2001234	negative regulation of apoptotic signaling pathway	2.330469150990666e-12	5.139849712509914e-8	20	199	255
DOID:11934	head and neck cancer	GO:0061138	morphogenesis of a branching epithelium	4.007905118896815e-12	8.839434739726926e-8	19	179	255
DOID:11934	head and neck cancer	GO:0035295	tube development	4.9719117711788385e-12	1.0965551411334928e-7	36	573	255
DOID:11934	head and neck cancer	GO:0045860	positive regulation of protein kinase activity	5.155209592544452e-12	1.1369814756356789e-7	31	450	255
DOID:11934	head and neck cancer	GO:0036293	response to decreased oxygen levels	5.654476886718385e-12	1.2470948773657398e-7	24	302	255
DOID:11934	head and neck cancer	GO:1901698	response to nitrogen compound	5.735412145213559e-12	1.2649451486268504e-7	46	870	255
DOID:11934	head and neck cancer	GO:0048608	reproductive structure development	6.4426242118997834e-12	1.4209207699344972e-7	29	418	255
DOID:11934	head and neck cancer	GO:0097285	cell-type specific apoptotic process	6.704858890316245e-12	1.478756628259248e-7	30	429	255
DOID:11934	head and neck cancer	GO:0010942	positive regulation of cell death	9.18087827983527e-12	2.0248427046176687e-7	36	596	255
DOID:11934	head and neck cancer	GO:0043068	positive regulation of programmed cell death	9.27002918871267e-12	2.0445049375705793e-7	35	561	255
DOID:11934	head and neck cancer	GO:0043065	positive regulation of apoptotic process	9.29079035927316e-12	2.0490838137376954e-7	34	556	255
DOID:11934	head and neck cancer	GO:0071396	cellular response to lipid	1.056665865917239e-11	2.3304765672804706e-7	28	416	255
DOID:11934	head and neck cancer	GO:0035239	tube morphogenesis	1.1001533017918064e-11	2.426388107101829e-7	25	338	255
DOID:11934	head and neck cancer	GO:0010212	response to ionizing radiation	1.354738543568601e-11	2.9878758578405495e-7	17	145	255
DOID:11934	head and neck cancer	GO:0010243	response to organonitrogen compound	1.3712808666355158e-11	3.02435995136463e-7	43	780	255
DOID:11934	head and neck cancer	GO:0048534	hematopoietic or lymphoid organ development	1.4764411915280107e-11	3.2562910479150275e-7	39	739	255
DOID:11934	head and neck cancer	GO:0008284	positive regulation of cell proliferation	1.5000001241105565e-11	3.3082502737258324e-7	42	815	255
DOID:11934	head and neck cancer	GO:0007568	aging	1.5329293390209386e-11	3.38087565721068e-7	23	290	255
DOID:11934	head and neck cancer	GO:0001101	response to acid chemical	1.559774531756375e-11	3.440082729788685e-7	24	315	255
DOID:11934	head and neck cancer	GO:0051093	negative regulation of developmental process	1.7611356817326396e-11	3.8841847460613366e-7	39	788	255
DOID:11934	head and neck cancer	GO:0034097	response to cytokine	2.3737345422603084e-11	5.23527153295511e-7	38	784	255
DOID:11934	head and neck cancer	GO:0071453	cellular response to oxygen levels	2.395827980450349e-11	5.283998610883245e-7	17	150	255
DOID:11934	head and neck cancer	GO:0097193	intrinsic apoptotic signaling pathway	2.5430768602063836e-11	5.608756015185179e-7	22	272	255
DOID:11934	head and neck cancer	GO:0071407	cellular response to organic cyclic compound	2.8220314973737004e-11	6.223990467457696e-7	27	416	255
DOID:11934	head and neck cancer	GO:0060562	epithelial tube morphogenesis	2.879252392062881e-11	6.350191150694684e-7	23	301	255
DOID:11934	head and neck cancer	GO:0040008	regulation of growth	3.1600499994510756e-11	6.969490273789347e-7	33	617	255
DOID:11934	head and neck cancer	GO:0030097	hemopoiesis	4.235845008082606e-11	9.342156165326188e-7	35	695	255
DOID:11934	head and neck cancer	GO:0031960	response to corticosteroid	4.73205918893882e-11	1.0436556541204567e-6	18	179	255
DOID:11934	head and neck cancer	GO:0070997	neuron death	4.792011232268578e-11	1.056878077276835e-6	22	281	255
DOID:11934	head and neck cancer	GO:0045596	negative regulation of cell differentiation	4.983624624088634e-11	1.0991384108427482e-6	32	597	255
DOID:11934	head and neck cancer	GO:0071900	regulation of protein serine/threonine kinase activity	5.386813217711506e-11	1.1880616551662726e-6	27	431	255
DOID:11934	head and neck cancer	GO:0009894	regulation of catabolic process	1.0514389359173038e-10	2.3189485731656134e-6	35	727	255
DOID:11934	head and neck cancer	GO:0001525	angiogenesis	1.0727907451268948e-10	2.3660399883773664e-6	26	413	255
DOID:11934	head and neck cancer	GO:0030155	regulation of cell adhesion	1.1948197986555442e-10	2.6351750659348028e-6	32	621	255
DOID:11934	head and neck cancer	GO:0031647	regulation of protein stability	1.2091327938890117e-10	2.6667423769222154e-6	19	214	255
DOID:11934	head and neck cancer	GO:0051384	response to glucocorticoid	1.3913892260575267e-10	3.068708938069875e-6	17	167	255
DOID:11934	head and neck cancer	GO:0000302	response to reactive oxygen species	1.4150869365181507e-10	3.1209742384907813e-6	19	216	255
DOID:11934	head and neck cancer	GO:0051348	negative regulation of transferase activity	1.50195966774902e-10	3.3125720472204634e-6	24	357	255
DOID:11934	head and neck cancer	GO:0007507	heart development	1.5781709272744138e-10	3.4806559801037196e-6	28	487	255
DOID:11934	head and neck cancer	GO:0048511	rhythmic process	1.682021188997851e-10	3.70969773233476e-6	23	329	255
DOID:11934	head and neck cancer	GO:0048754	branching morphogenesis of an epithelial tube	1.8043455618510507e-10	3.979484136662492e-6	16	147	255
DOID:11934	head and neck cancer	GO:0098609	cell-cell adhesion	2.0127544075876358e-10	4.439129845934531e-6	38	867	255
DOID:11934	head and neck cancer	GO:0001503	ossification	2.087332529043806e-10	4.603611892806114e-6	24	363	255
DOID:11934	head and neck cancer	GO:0060284	regulation of cell development	2.1332036137522437e-10	4.704780570130573e-6	37	828	255
DOID:11934	head and neck cancer	GO:1901214	regulation of neuron death	2.554558786727057e-10	5.634079404126524e-6	20	250	255
DOID:11934	head and neck cancer	GO:0000904	cell morphogenesis involved in differentiation	2.991369374427677e-10	6.597465155300242e-6	34	720	255
DOID:11934	head and neck cancer	GO:0070848	response to growth factor	4.942918296890753e-10	1.0901606303792555e-5	31	621	255
DOID:11934	head and neck cancer	GO:0031329	regulation of cellular catabolic process	5.556903825976178e-10	1.2255751388190461e-5	31	624	255
DOID:11934	head and neck cancer	GO:0018108	peptidyl-tyrosine phosphorylation	6.97760071943776e-10	1.538909838671998e-5	23	354	255
DOID:11934	head and neck cancer	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	7.137939128654125e-10	1.5742724748246673e-5	13	97	255
DOID:11934	head and neck cancer	GO:0048471	perinuclear region of cytoplasm	8.75801653421604e-10	1.9315805466213476e-5	31	636	255
DOID:11934	head and neck cancer	GO:0030855	epithelial cell differentiation	1.1113612252700023e-9	2.45110718233299e-5	29	568	255
DOID:11934	head and neck cancer	GO:0010631	epithelial cell migration	1.2366511148442783e-9	2.7274340337890557e-5	18	218	255
DOID:11934	head and neck cancer	GO:0010638	positive regulation of organelle organization	1.3552674538175324e-9	2.9890423693945678e-5	29	573	255
DOID:11934	head and neck cancer	GO:0030878	thyroid gland development	1.370159208313737e-9	3.021886133935947e-5	8	26	255
DOID:11934	head and neck cancer	GO:0042542	response to hydrogen peroxide	1.573281616096267e-9	3.469872604300317e-5	14	124	255
DOID:11934	head and neck cancer	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.5742149805930694e-9	3.4719311396980146e-5	17	195	255
DOID:11934	head and neck cancer	GO:0007167	enzyme linked receptor protein signaling pathway	1.6004499947541717e-9	3.529792463430326e-5	38	935	255
DOID:11934	head and neck cancer	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.7701832222272174e-9	3.904139096622128e-5	12	85	255
DOID:11934	head and neck cancer	GO:0030522	intracellular receptor signaling pathway	1.9725224786881768e-9	4.350398326746774e-5	20	281	255
DOID:11934	head and neck cancer	GO:1903034	regulation of response to wounding	2.0280792600857467e-9	4.472928808119114e-5	24	407	255
DOID:11934	head and neck cancer	GO:0034614	cellular response to reactive oxygen species	2.1598084432028486e-9	4.7634575214838826e-5	14	127	255
DOID:11934	head and neck cancer	GO:0042063	gliogenesis	2.539347176977458e-9	5.600530198823783e-5	18	228	255
DOID:11934	head and neck cancer	GO:0001558	regulation of cell growth	2.587738801018702e-9	5.707257925646747e-5	23	379	255
DOID:11934	head and neck cancer	GO:0002521	leukocyte differentiation	2.833653423017779e-9	6.249622624465712e-5	25	448	255
DOID:11934	head and neck cancer	GO:0032870	cellular response to hormone stimulus	2.8966670173602438e-9	6.388599106788018e-5	27	519	255
DOID:11934	head and neck cancer	GO:0045926	negative regulation of growth	2.9180199367928594e-9	6.435692970596651e-5	18	230	255
DOID:11934	head and neck cancer	GO:0032147	activation of protein kinase activity	3.0161759756452966e-9	6.652176114285702e-5	20	288	255
DOID:11934	head and neck cancer	GO:0032496	response to lipopolysaccharide	3.1263911459689098e-9	6.89525567243443e-5	21	319	255
DOID:11934	head and neck cancer	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	3.2276719075241544e-9	7.118630392044523e-5	10	55	255
DOID:11934	head and neck cancer	GO:0007610	behavior	3.5646716689541336e-9	7.861883365878342e-5	32	714	255
DOID:11934	head and neck cancer	GO:0005925	focal adhesion	4.0436416437472644e-9	8.918251645284592e-5	23	388	255
DOID:11934	head and neck cancer	GO:0031099	regeneration	4.2731579386057206e-9	9.424449833594917e-5	16	182	255
DOID:11934	head and neck cancer	GO:0048666	neuron development	4.2822155821298225e-9	9.444426466387323e-5	37	926	255
DOID:612	primary immunodeficiency disease	GO:0022603	regulation of anatomical structure morphogenesis	2.3246293778811378e-11	5.126970092916849e-7	49	986	255
DOID:612	primary immunodeficiency disease	GO:0042327	positive regulation of phosphorylation	9.61297708101938e-12	2.1201420952188244e-7	46	910	255
DOID:612	primary immunodeficiency disease	GO:0051338	regulation of transferase activity	5.163647287531603e-12	1.138842409265095e-7	48	928	255
DOID:612	primary immunodeficiency disease	GO:0006909	phagocytosis	1.6258105972610792e-12	3.58572527225931e-8	26	204	255
DOID:612	primary immunodeficiency disease	GO:0070663	regulation of leukocyte proliferation	1.5218937221561646e-12	3.356536604215421e-8	35	200	255
DOID:612	primary immunodeficiency disease	GO:0006959	humoral immune response	1.227240531420648e-12	2.7066789920482393e-8	31	173	255
DOID:612	primary immunodeficiency disease	GO:0048872	homeostasis of number of cells	1.1881606809538425e-12	2.6204883818436997e-8	22	208	255
DOID:612	primary immunodeficiency disease	GO:0043487	regulation of RNA stability	8.333334022836425e-13	1.8379168187365735e-8	20	139	255
DOID:612	primary immunodeficiency disease	GO:0042129	regulation of T cell proliferation	7.411848912397545e-13	1.6346832776292786e-8	24	142	255
DOID:612	primary immunodeficiency disease	GO:0002526	acute inflammatory response	6.659117701701689e-13	1.4686684091103075e-8	22	141	255
DOID:612	primary immunodeficiency disease	GO:0002285	lymphocyte activation involved in immune response	6.530331830845171e-13	1.4402646852929024e-8	21	146	255
DOID:612	primary immunodeficiency disease	GO:1902105	regulation of leukocyte differentiation	6.088463067044358e-13	1.3428105294366333e-8	26	225	255
DOID:612	primary immunodeficiency disease	GO:0045619	regulation of lymphocyte differentiation	5.351274978693255e-13	1.1802236965507973e-8	20	130	255
DOID:612	primary immunodeficiency disease	GO:0023014	signal transduction by protein phosphorylation	3.9834802123550617e-13	8.785565608349089e-9	50	879	255
DOID:612	primary immunodeficiency disease	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3.3995029014022293e-13	7.497603649042617e-9	18	130	255
DOID:612	primary immunodeficiency disease	GO:0002758	innate immune response-activating signal transduction	2.637889906509372e-13	5.81786618880642e-9	37	239	255
DOID:612	primary immunodeficiency disease	GO:0002708	positive regulation of lymphocyte mediated immunity	1.1945999744966684e-13	2.6346902437524022e-9	15	67	255
DOID:612	primary immunodeficiency disease	GO:0002200	somatic diversification of immune receptors	4.374278717023117e-14	9.647471710394484e-10	17	59	255
DOID:612	primary immunodeficiency disease	GO:0030890	positive regulation of B cell proliferation	9.769962616701378e-15	2.1547652551134888e-10	13	36	255
DOID:612	primary immunodeficiency disease	GO:0002260	lymphocyte homeostasis	1.5543122344752192e-15	3.428035633135096e-11	14	59	255
DOID:612	primary immunodeficiency disease	GO:0001906	cell killing	1.4432899320127035e-15	3.1831759450540176e-11	18	107	255
DOID:612	primary immunodeficiency disease	GO:0046631	alpha-beta T cell activation	1.4765966227514582e-14	3.256633851478341e-10	17	106	255
DOID:612	primary immunodeficiency disease	GO:0000502	proteasome complex	2.000621890374532e-13	4.4123715792210305e-9	16	75	255
DOID:612	primary immunodeficiency disease	GO:0016445	somatic diversification of immunoglobulins	2.382538610845586e-13	5.25468890621994e-9	13	48	255
DOID:612	primary immunodeficiency disease	GO:0045058	T cell selection	2.751132655021138e-13	6.06762307064912e-9	13	44	255
DOID:612	primary immunodeficiency disease	GO:0016447	somatic recombination of immunoglobulin gene segments	3.3939517862791035e-13	7.485360664638563e-9	13	42	255
DOID:612	primary immunodeficiency disease	GO:0002700	regulation of production of molecular mediator of immune response	3.6715075424353927e-13	8.097509884841259e-9	18	99	255
DOID:612	primary immunodeficiency disease	GO:0002637	regulation of immunoglobulin production	1.0529355165544985e-12	2.3222492817609464e-8	12	46	255
DOID:612	primary immunodeficiency disease	GO:0005126	cytokine receptor binding	1.2210232824827472e-12	2.692966849515699e-8	25	270	255
DOID:612	primary immunodeficiency disease	GO:0050766	positive regulation of phagocytosis	1.2788659020657178e-12	2.8205387470059406e-8	12	47	255
DOID:612	primary immunodeficiency disease	GO:0004896	cytokine receptor activity	1.394329096626734e-12	3.075192822610262e-8	15	89	255
DOID:612	primary immunodeficiency disease	GO:2000106	regulation of leukocyte apoptotic process	1.928235349168972e-12	4.2527230625921675e-8	14	76	255
DOID:612	primary immunodeficiency disease	GO:0006606	protein import into nucleus	2.09099404457902e-12	4.611687365319028e-8	24	268	255
DOID:612	primary immunodeficiency disease	GO:0007249	I-kappaB kinase/NF-kappaB signaling	2.2254420528611263e-12	4.908212447585214e-8	24	260	255
DOID:612	primary immunodeficiency disease	GO:0046635	positive regulation of alpha-beta T cell activation	2.598254944530254e-12	5.730451280161475e-8	12	50	255
DOID:612	primary immunodeficiency disease	GO:0002237	response to molecule of bacterial origin	3.158473482756108e-12	6.966013266218596e-8	27	333	255
DOID:612	primary immunodeficiency disease	GO:0002224	toll-like receptor signaling pathway	4.488187599349658e-12	9.89869775036567e-8	16	115	255
DOID:612	primary immunodeficiency disease	GO:0098542	defense response to other organism	5.290878846153646e-12	1.1669033295191866e-7	36	550	255
DOID:612	primary immunodeficiency disease	GO:0001934	positive regulation of protein phosphorylation	5.742739617176085e-12	1.2665612225681855e-7	45	870	255
DOID:612	primary immunodeficiency disease	GO:0009615	response to virus	6.257661055997232e-12	1.3801271459001896e-7	35	412	255
DOID:612	primary immunodeficiency disease	GO:0002683	negative regulation of immune system process	6.364020421756322e-12	1.403584704018357e-7	28	359	255
DOID:612	primary immunodeficiency disease	GO:0043900	regulation of multi-organism process	7.283729175355802e-12	1.606426469624722e-7	30	467	255
DOID:612	primary immunodeficiency disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	9.404921286204626e-12	2.0742553896724303e-7	21	233	255
DOID:612	primary immunodeficiency disease	GO:0044764	multi-organism cellular process	1.3910761431645824e-11	3.0680184337494865e-7	58	740	255
DOID:612	primary immunodeficiency disease	GO:0032496	response to lipopolysaccharide	1.9024337660766832e-11	4.195817671082125e-7	24	319	255
DOID:612	primary immunodeficiency disease	GO:0032649	regulation of interferon-gamma production	3.149958072157233e-11	6.947232528142777e-7	14	93	255
DOID:612	primary immunodeficiency disease	GO:0051607	defense response to virus	3.5789482488723934e-11	7.893370362888064e-7	24	332	255
DOID:612	primary immunodeficiency disease	GO:0042832	defense response to protozoan	4.214917304068422e-11	9.296000114122904e-7	8	18	255
DOID:612	primary immunodeficiency disease	GO:0071219	cellular response to molecule of bacterial origin	5.673739256195631e-11	1.2513431929539465e-6	17	158	255
DOID:612	primary immunodeficiency disease	GO:0045086	positive regulation of interleukin-2 biosynthetic process	6.097822247141949e-11	1.3448746966071567e-6	7	12	255
DOID:612	primary immunodeficiency disease	GO:0070227	lymphocyte apoptotic process	6.902811655606911e-11	1.5224151106441042e-6	12	65	255
DOID:612	primary immunodeficiency disease	GO:0032729	positive regulation of interferon-gamma production	6.902811655606911e-11	1.5224151106441042e-6	12	65	255
DOID:612	primary immunodeficiency disease	GO:0070228	regulation of lymphocyte apoptotic process	7.318023964586473e-11	1.6139901853895466e-6	11	51	255
DOID:612	primary immunodeficiency disease	GO:0032615	interleukin-12 production	7.318023964586473e-11	1.6139901853895466e-6	11	51	255
DOID:612	primary immunodeficiency disease	GO:0051241	negative regulation of multicellular organismal process	7.344291841349104e-11	1.619783565609545e-6	41	966	255
DOID:612	primary immunodeficiency disease	GO:0043368	positive T cell selection	7.902778431656543e-11	1.7429577831018506e-6	9	28	255
DOID:612	primary immunodeficiency disease	GO:0002712	regulation of B cell mediated immunity	1.1215184336776929e-10	2.4735089054761517e-6	10	40	255
DOID:612	primary immunodeficiency disease	GO:0033674	positive regulation of kinase activity	1.1312040193445227e-10	2.494870464664345e-6	28	480	255
DOID:612	primary immunodeficiency disease	GO:0002360	T cell lineage commitment	1.185916920221075e-10	2.615539767547581e-6	8	20	255
DOID:612	primary immunodeficiency disease	GO:0010212	response to ionizing radiation	1.4644707668765022e-10	3.2298902763461257e-6	16	145	255
DOID:612	primary immunodeficiency disease	GO:0031341	regulation of cell killing	3.2117719594992877e-10	7.083563056675679e-6	11	58	255
DOID:612	primary immunodeficiency disease	GO:0034341	response to interferon-gamma	4.0067515971742296e-10	8.836890647567763e-6	16	155	255
DOID:612	primary immunodeficiency disease	GO:0071346	cellular response to interferon-gamma	4.1094683211895244e-10	9.063432382383496e-6	15	133	255
DOID:612	primary immunodeficiency disease	GO:0050777	negative regulation of immune response	5.746166875653103e-10	1.2673171044252918e-5	14	115	255
DOID:612	primary immunodeficiency disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	8.17980794209916e-10	1.8040566416299697e-5	11	63	255
DOID:612	primary immunodeficiency disease	GO:0032844	regulation of homeostatic process	1.0683036677505697e-9	2.3561437392238815e-5	25	427	255
DOID:612	primary immunodeficiency disease	GO:0001909	leukocyte mediated cytotoxicity	1.155860518409213e-9	2.5492503733515193e-5	12	82	255
DOID:612	primary immunodeficiency disease	GO:0032655	regulation of interleukin-12 production	1.2036550645078137e-9	2.654661244771983e-5	10	50	255
DOID:612	primary immunodeficiency disease	GO:0051235	maintenance of location	1.2731800058674025e-9	2.8079985029405563e-5	20	274	255
DOID:612	primary immunodeficiency disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.3350397454203744e-9	2.9444301585246357e-5	12	83	255
DOID:612	primary immunodeficiency disease	GO:0002891	positive regulation of immunoglobulin mediated immune response	1.370159208313737e-9	3.021886133935947e-5	8	26	255
DOID:612	primary immunodeficiency disease	GO:0042742	defense response to bacterium	1.6577326178435214e-9	3.6561292886538865e-5	18	222	255
DOID:612	primary immunodeficiency disease	GO:0005125	cytokine activity	1.6577326178435214e-9	3.6561292886538865e-5	18	222	255
DOID:612	primary immunodeficiency disease	GO:0043029	T cell homeostasis	2.1284296547463555e-9	4.694251603543087e-5	9	39	255
DOID:612	primary immunodeficiency disease	GO:0002902	regulation of B cell apoptotic process	2.285294509185576e-9	5.0402170400087876e-5	7	18	255
DOID:612	primary immunodeficiency disease	GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	2.642077223669048e-9	5.827101316802086e-5	11	70	255
DOID:612	primary immunodeficiency disease	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	2.642077223669048e-9	5.827101316802086e-5	11	70	255
DOID:612	primary immunodeficiency disease	GO:0002367	cytokine production involved in immune response	3.0890484614687352e-9	6.812896381769296e-5	11	71	255
DOID:612	primary immunodeficiency disease	GO:0045860	positive regulation of protein kinase activity	3.1018451140951697e-9	6.841119399136897e-5	25	450	255
DOID:612	primary immunodeficiency disease	GO:0043903	regulation of symbiosis, encompassing mutualism through parasitism	3.1406778289166937e-9	6.926764951675768e-5	17	204	255
DOID:612	primary immunodeficiency disease	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	3.6397962421830243e-9	8.02757061213466e-5	16	180	255
DOID:612	primary immunodeficiency disease	GO:0018108	peptidyl-tyrosine phosphorylation	3.769688783350489e-9	8.314048611679503e-5	22	354	255
DOID:612	primary immunodeficiency disease	GO:0032760	positive regulation of tumor necrosis factor production	3.882592802817442e-9	8.563058426613868e-5	10	56	255
DOID:3996	urinary system cancer	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	9.79438752324313e-13	2.1601521682512725e-8	21	195	259
DOID:3996	urinary system cancer	GO:0032355	response to estradiol	7.862599460395359e-13	1.7340963109901963e-8	19	145	259
DOID:3996	urinary system cancer	GO:0070997	neuron death	7.667200208061331e-13	1.6910010058879266e-8	27	281	259
DOID:3996	urinary system cancer	GO:1901214	regulation of neuron death	2.208566662886824e-12	4.87099377499689e-8	23	250	259
DOID:3996	urinary system cancer	GO:0010038	response to metal ion	4.15156797828331e-12	9.156283176103841e-8	26	335	259
DOID:3996	urinary system cancer	GO:0051726	regulation of cell cycle	5.558442595088309e-12	1.2259145143467265e-7	42	930	259
DOID:3996	urinary system cancer	GO:0036294	cellular response to decreased oxygen levels	1.2643441849036208e-11	2.7885110998049356e-7	17	142	259
DOID:3996	urinary system cancer	GO:1902533	positive regulation of intracellular signal transduction	1.2737921828431809e-11	2.8093486592606354e-7	41	860	259
DOID:3996	urinary system cancer	GO:0035295	tube development	2.6480595494149384e-11	5.840295336234647e-7	32	573	259
DOID:3996	urinary system cancer	GO:2000045	regulation of G1/S transition of mitotic cell cycle	3.89919208032552e-11	8.599668133157934e-7	16	131	259
DOID:3996	urinary system cancer	GO:0048608	reproductive structure development	3.9837799725717105e-11	8.786226729506907e-7	27	418	259
DOID:3996	urinary system cancer	GO:0040007	growth	4.6459835978396313e-11	1.0246716825035307e-6	41	936	259
DOID:3996	urinary system cancer	GO:0071456	cellular response to hypoxia	5.5224713690904537e-11	1.2179810604528996e-6	16	134	259
DOID:3996	urinary system cancer	GO:0050673	epithelial cell proliferation	5.657829760252753e-11	1.2478343536237446e-6	24	335	259
DOID:3996	urinary system cancer	GO:0045787	positive regulation of cell cycle	6.239608829616827e-11	1.3761457273719913e-6	23	308	259
DOID:3996	urinary system cancer	GO:0010942	positive regulation of cell death	6.816391895370089e-11	1.503355232523873e-6	32	596	259
DOID:3996	urinary system cancer	GO:0045471	response to ethanol	7.756262299096761e-11	1.7106436500657907e-6	16	137	259
DOID:3996	urinary system cancer	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	8.62313553895433e-11	1.9018325431163774e-6	42	996	259
DOID:3996	urinary system cancer	GO:0032403	protein complex binding	1.3787693209366125e-10	3.040875737325699e-6	40	924	259
DOID:3996	urinary system cancer	GO:0040008	regulation of growth	1.5278522891293278e-10	3.3696782236747325e-6	32	617	259
DOID:3996	urinary system cancer	GO:1901699	cellular response to nitrogen compound	1.9541701590242155e-10	4.309922285727907e-6	29	518	259
DOID:3996	urinary system cancer	GO:0060322	head development	2.895960138360465e-10	6.3870400851540055e-6	34	708	259
DOID:3996	urinary system cancer	GO:1990267	response to transition metal nanoparticle	3.0791946770136747e-10	6.7911638601536595e-6	16	150	259
DOID:3996	urinary system cancer	GO:0048471	perinuclear region of cytoplasm	3.140414595037555e-10	6.926184389355328e-6	32	636	259
DOID:3996	urinary system cancer	GO:0001934	positive regulation of protein phosphorylation	3.4019309591570845e-10	7.50295873042095e-6	38	870	259
DOID:3996	urinary system cancer	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	3.825347816288627e-10	8.436804608824566e-6	13	91	259
DOID:3996	urinary system cancer	GO:0045121	membrane raft	4.479002724266934e-10	9.878440508370723e-6	21	282	259
DOID:3996	urinary system cancer	GO:0071214	cellular response to abiotic stimulus	5.43347811188255e-10	1.1983535975756965e-5	21	285	259
DOID:3996	urinary system cancer	GO:0007417	central nervous system development	6.179857736654526e-10	1.3629676238191557e-5	38	889	259
DOID:3996	urinary system cancer	GO:0008134	transcription factor binding	8.816282148771393e-10	1.9444310279115307e-5	28	518	259
DOID:3996	urinary system cancer	GO:0090068	positive regulation of cell cycle process	1.0438804265433532e-9	2.3022782807413655e-5	19	239	259
DOID:3996	urinary system cancer	GO:0009792	embryo development ending in birth or egg hatching	1.0685535789534129e-9	2.356694918381752e-5	29	558	259
DOID:3996	urinary system cancer	GO:0043068	positive regulation of programmed cell death	1.207365429856111e-9	2.6628444555476527e-5	29	561	259
DOID:3996	urinary system cancer	GO:0043523	regulation of neuron apoptotic process	1.3377077223708511e-9	2.950314381688912e-5	17	190	259
DOID:3996	urinary system cancer	GO:1901701	cellular response to oxygen-containing compound	1.3498226980601657e-9	2.9770339605716956e-5	37	873	259
DOID:3996	urinary system cancer	GO:0043491	protein kinase B signaling	1.5655369223210869e-9	3.452791682179157e-5	15	144	259
DOID:3996	urinary system cancer	GO:0009314	response to radiation	1.7824295373003451e-9	3.931148344515911e-5	25	431	259
DOID:3996	urinary system cancer	GO:0097191	extrinsic apoptotic signaling pathway	1.8378633059867866e-9	4.053407521353858e-5	18	220	259
DOID:3996	urinary system cancer	GO:0034504	protein localization to nucleus	2.9690733205356423e-9	6.548291208441359e-5	22	344	259
DOID:3996	urinary system cancer	GO:0048534	hematopoietic or lymphoid organ development	3.232561440746906e-9	7.129414257567301e-5	33	739	259
DOID:3996	urinary system cancer	GO:0043009	chordate embryonic development	3.5903996442598896e-9	7.918626415415186e-5	28	552	259
DOID:3996	urinary system cancer	GO:0045926	negative regulation of growth	3.733489517543376e-9	8.234211130941915e-5	18	230	259
DOID:3996	urinary system cancer	GO:0009887	organ morphogenesis	3.888186772549318e-9	8.575395926857521e-5	38	950	259
DOID:3996	urinary system cancer	GO:0032870	cellular response to hormone stimulus	4.06703826172361e-9	8.969852886231422e-5	27	519	259
DOID:3996	urinary system cancer	GO:0031960	response to corticosteroid	4.197724279286774e-9	9.25808089796698e-5	16	179	259
DOID:3996	urinary system cancer	GO:0071407	cellular response to organic cyclic compound	4.251074825489809e-9	9.375745527617774e-5	24	416	259
DOID:3996	urinary system cancer	GO:0045859	regulation of protein kinase activity	4.424062893804148e-9	9.757270712285049e-5	32	709	259
Orphanet:158124	Genetic dementia	GO:0043005	neuron projection	9.976020010071807e-12	2.200211213221337e-7	45	941	263
Orphanet:158124	Genetic dementia	GO:0043523	regulation of neuron apoptotic process	1.184385922670117e-12	2.612163152448943e-8	21	190	263
Orphanet:158124	Genetic dementia	GO:0009991	response to extracellular stimulus	4.6737058667645215e-12	1.0307858289149152e-7	39	573	263
Orphanet:158124	Genetic dementia	GO:0006873	cellular ion homeostasis	4.7594150842655836e-12	1.0496889968347745e-7	38	532	263
Orphanet:158124	Genetic dementia	GO:1901615	organic hydroxy compound metabolic process	6.48925357893404e-12	1.4312048768339025e-7	34	534	263
Orphanet:158124	Genetic dementia	GO:0000323	lytic vacuole	7.897238418763664e-12	1.741735933258326e-7	34	515	263
Orphanet:158124	Genetic dementia	GO:0005764	lysosome	7.897238418763664e-12	1.741735933258326e-7	34	515	263
Orphanet:158124	Genetic dementia	GO:0031329	regulation of cellular catabolic process	1.2056911025126738e-11	2.659151726591702e-7	35	624	263
Orphanet:158124	Genetic dementia	GO:0036477	somatodendritic compartment	1.3221868044865914e-11	2.9160829972951774e-7	36	649	263
Orphanet:158124	Genetic dementia	GO:0005768	endosome	1.582556308221683e-11	3.490327937782922e-7	41	789	263
Orphanet:158124	Genetic dementia	GO:0006066	alcohol metabolic process	4.039102385888782e-11	8.908240312077709e-7	26	382	263
Orphanet:158124	Genetic dementia	GO:0044456	synapse part	4.8045567524468424e-11	1.059644991752151e-6	33	613	263
Orphanet:158124	Genetic dementia	GO:0008202	steroid metabolic process	5.830802507489352e-11	1.2859834930267766e-6	22	275	263
Orphanet:158124	Genetic dementia	GO:0009636	response to toxic substance	5.962452753749403e-11	1.3150189548394309e-6	21	249	263
Orphanet:158124	Genetic dementia	GO:0043627	response to estrogen	2.6143243125886784e-10	5.76589227141433e-6	19	217	263
Orphanet:158124	Genetic dementia	GO:0036293	response to decreased oxygen levels	3.4627134493092626e-10	7.637014512451579e-6	22	302	263
Orphanet:158124	Genetic dementia	GO:0060322	head development	4.3064174448659287e-10	9.497803674651806e-6	34	708	263
Orphanet:158124	Genetic dementia	GO:0005770	late endosome	5.021131288529546e-10	1.1074105056851913e-5	18	200	263
Orphanet:158124	Genetic dementia	GO:0006898	receptor-mediated endocytosis	5.80671399852406e-10	1.2806707723744815e-5	20	254	263
Orphanet:158124	Genetic dementia	GO:0007568	aging	9.859727478911395e-10	2.1745628954739082e-5	21	290	263
Orphanet:158124	Genetic dementia	GO:0030425	dendrite	1.3112653185487488e-9	2.8919956600592656e-5	26	451	263
Orphanet:158124	Genetic dementia	GO:0043065	positive regulation of apoptotic process	1.4063447073553448e-9	3.101693252072213e-5	29	556	263
Orphanet:158124	Genetic dementia	GO:0046916	cellular transition metal ion homeostasis	1.4190902897226465e-9	3.129803633983297e-5	12	81	263
Orphanet:158124	Genetic dementia	GO:0000302	response to reactive oxygen species	1.7472714386457255e-9	3.853607157933148e-5	18	216	263
Orphanet:158124	Genetic dementia	GO:0010876	lipid localization	2.1661529236993715e-9	4.777450273218964e-5	22	333	263
Orphanet:158124	Genetic dementia	GO:0051052	regulation of DNA metabolic process	2.419898503802642e-9	5.337086150136727e-5	22	335	263
Orphanet:158124	Genetic dementia	GO:0009314	response to radiation	2.444627833497748e-9	5.391626686779283e-5	25	431	263
Orphanet:158124	Genetic dementia	GO:0080135	regulation of cellular response to stress	2.4517994301476165e-9	5.407443643190568e-5	32	681	263
Orphanet:158124	Genetic dementia	GO:1901215	negative regulation of neuron death	2.468377169329017e-9	5.444005846955147e-5	16	170	263
Orphanet:158124	Genetic dementia	GO:0043025	neuronal cell body	2.8149841346802873e-9	6.208447509037374e-5	25	434	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0001763	morphogenesis of a branching structure	1.3948842081390467e-12	3.0764171210506674e-8	23	193	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0007548	sex differentiation	2.2588597659023435e-12	4.9819152136976186e-8	24	274	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0048667	cell morphogenesis involved in neuron differentiation	3.820721516945014e-12	8.426601305622228e-8	33	495	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0044703	multi-organism reproductive process	1.1550982392805054e-11	2.5475691667331546e-7	42	926	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0090596	sensory organ morphogenesis	2.744604543636342e-11	6.053225320989952e-7	21	239	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0009725	response to hormone	3.4938718584953676e-11	7.705734383911533e-7	40	865	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0035265	organ growth	5.5124904640990735e-11	1.2157797718570507e-6	16	132	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0070848	response to growth factor	6.464251356419481e-11	1.4256906366583166e-6	33	621	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0048609	multicellular organismal reproductive process	7.008682523235166e-11	1.5457649304995158e-6	37	767	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0001503	ossification	7.367984000694605e-11	1.6250088713531952e-6	25	363	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0007167	enzyme linked receptor protein signaling pathway	7.734302087669676e-11	1.705800325435547e-6	41	935	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0071363	cellular response to growth factor stimulus	8.881873014843222e-11	1.9588970934236727e-6	32	594	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0001655	urogenital system development	1.1851686299024777e-10	2.6138894132499146e-6	23	313	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0007610	behavior	1.4348278121190106e-10	3.164512739628478e-6	35	714	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0010817	regulation of hormone levels	1.644242519915906e-10	3.626376877674531e-6	28	473	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0042445	hormone metabolic process	1.6573564742827784e-10	3.655299704030668e-6	18	187	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0044344	cellular response to fibroblast growth factor stimulus	3.653761737609784e-10	8.058371512298379e-6	15	128	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0008202	steroid metabolic process	3.7457104085092396e-10	8.261164305967128e-6	21	275	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0044706	multi-multicellular organism process	1.17258913689966e-9	2.5861453414322e-5	19	237	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0030855	epithelial cell differentiation	2.2783656072888903e-9	5.0249353468756475e-5	29	568	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0003682	chromatin binding	2.6853865797704657e-9	5.922620101683762e-5	25	433	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	2.7750427511463727e-9	6.120356787653325e-5	29	573	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0030324	lung development	3.767002598742408e-9	8.308124231526381e-5	16	175	263
Orphanet:202940	Anomaly of puberty or/and menstrual cycle of genetic origin	GO:0021543	pallium development	4.487223148608166e-9	9.89657065425531e-5	15	153	263
DOID:2978	carbohydrate metabolic disorder	GO:0019752	carboxylic acid metabolic process	1.372701952107036e-11	3.027494155372068e-7	56	967	264
DOID:2978	carbohydrate metabolic disorder	GO:0055114	oxidation-reduction process	7.098321930243401e-12	1.565534901715182e-7	78	949	264
DOID:2978	carbohydrate metabolic disorder	GO:0072524	pyridine-containing compound metabolic process	7.314149286230531e-13	1.6131356250781437e-8	25	130	264
DOID:2978	carbohydrate metabolic disorder	GO:0016052	carbohydrate catabolic process	6.3815619455454e-13	1.407453487090038e-8	39	146	264
DOID:2978	carbohydrate metabolic disorder	GO:0044724	single-organism carbohydrate catabolic process	3.5704772471945034e-13	7.874687568687477e-9	39	138	264
DOID:2978	carbohydrate metabolic disorder	GO:0046365	monosaccharide catabolic process	1.9895196601282805e-13	4.387885610412923e-9	17	60	264
DOID:2978	carbohydrate metabolic disorder	GO:0016798	hydrolase activity, acting on glycosyl bonds	4.907185768843192e-14	1.082279821318366e-9	23	120	264
DOID:2978	carbohydrate metabolic disorder	GO:0033692	cellular polysaccharide biosynthetic process	2.90878432451791e-14	6.415323827724251e-10	17	63	264
DOID:2978	carbohydrate metabolic disorder	GO:0006757	ATP generation from ADP	4.796163466380676e-14	1.0577938525102581e-9	16	66	264
DOID:2978	carbohydrate metabolic disorder	GO:0046364	monosaccharide biosynthetic process	2.2615243011614439e-13	4.9877918462115645e-9	19	91	264
DOID:2978	carbohydrate metabolic disorder	GO:0008643	carbohydrate transport	2.849942504212777e-13	6.285548193041279e-9	20	184	264
DOID:2978	carbohydrate metabolic disorder	GO:0019319	hexose biosynthetic process	3.7336800318144014e-13	8.234631310166662e-9	17	84	264
DOID:2978	carbohydrate metabolic disorder	GO:0048029	monosaccharide binding	8.001377338473503e-13	1.764703772000331e-8	14	70	264
DOID:2978	carbohydrate metabolic disorder	GO:0061615	glycolytic process through fructose-6-phosphate	1.7705836796721997e-12	3.905022305517036e-8	10	27	264
DOID:2978	carbohydrate metabolic disorder	GO:0061620	glycolytic process through glucose-6-phosphate	1.7705836796721997e-12	3.905022305517036e-8	10	27	264
DOID:2978	carbohydrate metabolic disorder	GO:0051196	regulation of coenzyme metabolic process	2.8774760352234807e-12	6.346273395685387e-8	12	49	264
DOID:2978	carbohydrate metabolic disorder	GO:0042180	cellular ketone metabolic process	1.2231216039992887e-11	2.697594697620431e-7	22	253	264
DOID:2978	carbohydrate metabolic disorder	GO:0006012	galactose metabolic process	7.783163002983429e-11	1.7165766003079952e-6	7	12	264
DOID:2978	carbohydrate metabolic disorder	GO:0044272	sulfur compound biosynthetic process	1.4607670628663527e-10	3.221721757151741e-6	19	209	264
DOID:2978	carbohydrate metabolic disorder	GO:0019682	glyceraldehyde-3-phosphate metabolic process	5.864286833912047e-10	1.293368461219302e-5	8	23	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0001763	morphogenesis of a branching structure	1.3926637620897964e-12	3.071519927289046e-8	23	193	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0007548	sex differentiation	2.497335671591827e-12	5.507873823695775e-8	24	274	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0048667	cell morphogenesis involved in neuron differentiation	4.269695708103427e-12	9.416813884222108e-8	33	495	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0044703	multi-organism reproductive process	1.4468093390007652e-11	3.190937997166188e-7	42	926	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0090596	sensory organ morphogenesis	2.9629076969683865e-11	6.534692925663776e-7	21	239	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0009725	response to hormone	3.896960532046023e-11	8.594746453427504e-7	40	865	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0035265	organ growth	5.833333815985497e-11	1.2865417731156015e-6	16	132	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0070848	response to growth factor	7.12829795190828e-11	1.5721461132933712e-6	33	621	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0048609	multicellular organismal reproductive process	7.732625650902492e-11	1.7054305873065445e-6	37	767	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0001503	ossification	7.952438707548026e-11	1.7539103569497172e-6	25	363	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0007167	enzyme linked receptor protein signaling pathway	8.921485772361848e-11	1.9676336870944056e-6	41	935	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0071363	cellular response to growth factor stimulus	9.765577235754108e-11	2.1537980593455686e-6	32	594	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0001655	urogenital system development	1.2750689393214998e-10	2.8121645456735678e-6	23	313	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0007610	behavior	1.5848233836379677e-10	3.4953279726135378e-6	35	714	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0042445	hormone metabolic process	1.7645007677202784e-10	3.891606443207074e-6	18	187	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0044344	cellular response to fibroblast growth factor stimulus	3.8513303657339293e-10	8.494109121626181e-6	15	128	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0008202	steroid metabolic process	4.016708077259068e-10	8.858849664394874e-6	21	275	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0003682	chromatin binding	6.030719257310579e-10	1.3300751321998483e-5	26	433	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	7.183582617642514e-10	1.5843391463210565e-5	30	573	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0044706	multi-multicellular organism process	1.249509273826277e-9	2.755792703423854e-5	19	237	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.2530777526720271e-9	2.763662983518156e-5	31	623	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0030855	epithelial cell differentiation	2.487624772840036e-9	5.486456436498699e-5	29	568	264
Orphanet:180208	Anomaly of puberty or/and menstrual cycle	GO:0030324	lung development	3.977708273872338e-9	8.772835598025441e-5	16	175	264
DOID:0060036	intrinsic cardiomyopathy	GO:0048878	chemical homeostasis	1.939493010638671e-11	4.277551834963589e-7	45	988	268
DOID:0060036	intrinsic cardiomyopathy	GO:0009887	organ morphogenesis	7.569722626499242e-12	1.669502325274408e-7	50	950	268
DOID:0060036	intrinsic cardiomyopathy	GO:0055114	oxidation-reduction process	7.404299395830094e-12	1.6330182317503272e-7	47	949	268
DOID:0060036	intrinsic cardiomyopathy	GO:0023014	signal transduction by protein phosphorylation	3.1870062144889744e-12	7.028942206055433e-8	45	879	268
DOID:0060036	intrinsic cardiomyopathy	GO:0035637	multicellular organismal signaling	1.609823385706477e-12	3.550465477175635e-8	22	184	268
DOID:0060036	intrinsic cardiomyopathy	GO:0009612	response to mechanical stimulus	8.675282714420973e-13	1.9133336026655456e-8	23	210	268
DOID:0060036	intrinsic cardiomyopathy	GO:0061337	cardiac conduction	4.4164671919588727e-13	9.740518391865294e-9	20	131	268
DOID:0060036	intrinsic cardiomyopathy	GO:0055006	cardiac cell development	2.113864638886298e-13	4.66212846106373e-9	15	55	268
DOID:0060036	intrinsic cardiomyopathy	GO:0098900	regulation of action potential	2.398081733190338e-14	5.288969262551291e-10	13	38	268
DOID:0060036	intrinsic cardiomyopathy	GO:0098901	regulation of cardiac muscle cell action potential	7.438494264988549e-15	1.6405599101432244e-10	10	19	268
DOID:0060036	intrinsic cardiomyopathy	GO:0086069	bundle of His cell to Purkinje myocyte communication	7.538414337204813e-13	1.6625972820705215e-8	8	12	268
DOID:0060036	intrinsic cardiomyopathy	GO:0060548	negative regulation of cell death	2.655320407995987e-12	5.856309159835149e-8	45	867	268
DOID:0060036	intrinsic cardiomyopathy	GO:0034109	homotypic cell-cell adhesion	4.13347134298192e-12	9.116371046946625e-8	35	495	268
DOID:0060036	intrinsic cardiomyopathy	GO:0070482	response to oxygen levels	1.199085275516154e-11	2.644582575150878e-7	25	321	268
DOID:0060036	intrinsic cardiomyopathy	GO:0006875	cellular metal ion homeostasis	2.0160539904168218e-11	4.4464070758643004e-7	29	450	268
DOID:0060036	intrinsic cardiomyopathy	GO:0070848	response to growth factor	2.964117840065228e-11	6.53736189626386e-7	34	621	268
DOID:0060036	intrinsic cardiomyopathy	GO:0071900	regulation of protein serine/threonine kinase activity	3.351174893140296e-11	7.391016226820923e-7	28	431	268
DOID:0060036	intrinsic cardiomyopathy	GO:0048545	response to steroid hormone	6.728773094266671e-11	1.4840309059405143e-6	28	446	268
DOID:0060036	intrinsic cardiomyopathy	GO:0036293	response to decreased oxygen levels	8.271106022306185e-11	1.824192433219629e-6	23	302	268
DOID:0060036	intrinsic cardiomyopathy	GO:0051050	positive regulation of transport	9.188494409784198e-11	2.026522442077905e-6	41	920	268
DOID:0060036	intrinsic cardiomyopathy	GO:0030155	regulation of cell adhesion	1.0283163209834356e-10	2.2679516459289673e-6	33	621	268
DOID:0060036	intrinsic cardiomyopathy	GO:0071363	cellular response to growth factor stimulus	1.4002188297723706e-10	3.0881826290629633e-6	32	594	268
DOID:0060036	intrinsic cardiomyopathy	GO:0097305	response to alcohol	1.4886181176620994e-10	3.2831472585037602e-6	25	369	268
DOID:0060036	intrinsic cardiomyopathy	GO:0043270	positive regulation of ion transport	1.7520729311826244e-10	3.864196849723278e-6	20	233	268
DOID:0060036	intrinsic cardiomyopathy	GO:0001666	response to hypoxia	2.639161111872568e-10	5.820669832234948e-6	22	292	268
DOID:0060036	intrinsic cardiomyopathy	GO:0010959	regulation of metal ion transport	2.766450402091891e-10	6.101406361813666e-6	23	321	268
DOID:0060036	intrinsic cardiomyopathy	GO:0033674	positive regulation of kinase activity	3.4944702687056406e-10	7.70705417763029e-6	28	480	268
DOID:0060036	intrinsic cardiomyopathy	GO:0040012	regulation of locomotion	3.857483221736402e-10	8.507679245539634e-6	36	766	268
DOID:0060036	intrinsic cardiomyopathy	GO:0070489	T cell aggregation	5.344016340558255e-10	1.1786228039101232e-5	26	424	268
DOID:0060036	intrinsic cardiomyopathy	GO:0042110	T cell activation	5.344016340558255e-10	1.1786228039101232e-5	26	424	268
DOID:0060036	intrinsic cardiomyopathy	GO:2000145	regulation of cell motility	7.306575344756538e-10	1.6114651922860546e-5	34	709	268
DOID:0060036	intrinsic cardiomyopathy	GO:0055003	cardiac myofibril assembly	1.1892220541653842e-9	2.6228292404617548e-5	7	16	268
DOID:0060036	intrinsic cardiomyopathy	GO:0030334	regulation of cell migration	1.8313348615350833e-9	4.039009037115626e-5	32	660	268
DOID:0060036	intrinsic cardiomyopathy	GO:0007167	enzyme linked receptor protein signaling pathway	1.9630125303038426e-9	4.329424135585125e-5	39	935	268
DOID:0060036	intrinsic cardiomyopathy	GO:0043065	positive regulation of apoptotic process	2.1753666645807357e-9	4.7977711787328126e-5	29	556	268
DOID:0060036	intrinsic cardiomyopathy	GO:0000302	response to reactive oxygen species	2.3583510699864974e-9	5.20134328485522e-5	18	216	268
DOID:0060036	intrinsic cardiomyopathy	GO:0050865	regulation of cell activation	2.706419977016594e-9	5.9690092593100985e-5	26	458	268
DOID:0060036	intrinsic cardiomyopathy	GO:0042060	wound healing	3.728211850351215e-9	8.222571235949605e-5	28	534	268
DOID:0060036	intrinsic cardiomyopathy	GO:0043405	regulation of MAP kinase activity	3.869774500842027e-9	8.53478766160709e-5	20	278	268
DOID:0060036	intrinsic cardiomyopathy	GO:0072593	reactive oxygen species metabolic process	3.921778457538494e-9	8.649482388101148e-5	18	223	268
DOID:0060036	intrinsic cardiomyopathy	GO:0003009	skeletal muscle contraction	4.192043157047465e-9	9.245551182868184e-5	9	40	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032101	regulation of response to external stimulus	6.3933303096064265e-12	1.4100489997836974e-7	48	920	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0002366	leukocyte activation involved in immune response	9.903189379656396e-13	2.1841484176832182e-8	26	208	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032946	positive regulation of mononuclear cell proliferation	7.671641100159832e-13	1.691980444640251e-8	21	129	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	3.6548541970660153e-13	8.060780931629097e-9	22	212	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0002819	regulation of adaptive immune response	1.6187051699034782e-13	3.5700542522221212e-9	19	121	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032623	interleukin-2 production	4.524158825347513e-13	9.97803228930394e-9	13	54	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0019724	B cell mediated immunity	4.762856775641922e-13	1.0504480618678258e-8	17	100	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0036293	response to decreased oxygen levels	1.8907098109366416e-12	4.169960488020763e-8	28	302	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0045088	regulation of innate immune response	5.854983164965688e-12	1.2913165370331825e-7	28	351	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0045089	positive regulation of innate immune response	7.627565246082213e-12	1.682259515023432e-7	24	289	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032660	regulation of interleukin-17 production	9.560574554257073e-12	2.1085847179413975e-7	9	22	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0044419	interspecies interaction between organisms	1.4670820114304206e-11	3.2356493762097926e-7	39	761	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0044403	symbiosis, encompassing mutualism through parasitism	1.4670820114304206e-11	3.2356493762097926e-7	39	761	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:1903308	regulation of chromatin modification	1.553956963107339e-11	3.4272520821332364e-7	17	139	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.735511734324291e-11	3.8276711300522237e-7	18	161	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0080135	regulation of cellular response to stress	1.851052644497031e-11	4.082496607438202e-7	37	681	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0044764	multi-organism cellular process	2.200806203944694e-11	4.853878082800023e-7	38	740	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0044843	cell cycle G1/S phase transition	2.654443331806533e-11	5.854374768299309e-7	21	234	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0016032	viral process	3.6230907163314896e-11	7.9907265748691e-7	37	726	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:2001235	positive regulation of apoptotic signaling pathway	3.759959010807279e-11	8.292589598335454e-7	18	168	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:1902107	positive regulation of leukocyte differentiation	4.013100962652061e-11	8.85089417312912e-7	16	127	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:1903829	positive regulation of cellular protein localization	5.543010495046019e-11	1.2225109646823995e-6	25	351	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0030890	positive regulation of B cell proliferation	5.741440656237273e-11	1.2662747367331306e-6	10	36	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0072358	cardiovascular system development	6.057232493361653e-11	1.3359226264109125e-6	41	910	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0071345	cellular response to cytokine stimulus	6.75706157693412e-11	1.4902699307928202e-6	35	677	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0097193	intrinsic apoptotic signaling pathway	6.770106697473466e-11	1.4931470321277729e-6	22	272	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0071216	cellular response to biotic stimulus	7.476352870128267e-11	1.6489096255067892e-6	18	175	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0045621	positive regulation of lymphocyte differentiation	9.372524978346064e-11	2.0671103839742244e-6	13	79	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0006909	phagocytosis	1.2380463321193247e-10	2.7305111854891706e-6	19	204	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0009792	embryo development ending in birth or egg hatching	1.318462006238974e-10	2.9078679547600572e-6	31	558	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0046824	positive regulation of nucleocytoplasmic transport	1.4788625879447181e-10	3.261631437712076e-6	15	118	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0042094	interleukin-2 biosynthetic process	1.761477630424224e-10	3.884938913900626e-6	8	20	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032740	positive regulation of interleukin-17 production	1.851084840964745e-10	4.082567616747745e-6	7	13	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0002292	T cell differentiation involved in immune response	2.4066193482497056e-10	5.307798972564726e-6	11	54	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0002758	innate immune response-activating signal transduction	2.7588997753014155e-10	6.084753454427272e-6	20	239	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0060249	anatomical structure homeostasis	2.902706963681112e-10	6.401920208398693e-6	24	351	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:1900182	positive regulation of protein localization to nucleus	3.382428781506519e-10	7.459946677612628e-6	15	125	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0071407	cellular response to organic cyclic compound	3.573445983562351e-10	7.881235116746765e-6	26	416	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0002367	cytokine production involved in immune response	3.6116165613719886e-10	7.965420326105921e-6	12	71	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0043009	chordate embryonic development	4.301612399615351e-10	9.487206147351657e-6	30	552	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0019216	regulation of lipid metabolic process	4.326029534595932e-10	9.541058138551328e-6	21	272	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0042326	negative regulation of phosphorylation	4.3646453118384443e-10	9.626225235259689e-6	26	420	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032870	cellular response to hormone stimulus	4.513599494160303e-10	9.954743684370548e-6	29	519	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0006959	humoral immune response	5.269062963719762e-10	1.1620918366483934e-5	17	173	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0007584	response to nutrient	5.319972240513948e-10	1.1733198776453513e-5	18	197	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0000018	regulation of DNA recombination	5.442869488447855e-10	1.2004248656771743e-5	11	58	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	5.442869488447855e-10	1.2004248656771743e-5	11	58	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0042803	protein homodimerization activity	5.919015277910944e-10	1.3054388195432587e-5	34	703	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0071222	cellular response to lipopolysaccharide	6.212335090793886e-10	1.3701305042745915e-5	16	152	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0050866	negative regulation of cell activation	6.849215639093131e-10	1.5105945092019901e-5	16	153	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0043410	positive regulation of MAPK cascade	7.728168105458622e-10	1.704447475658899e-5	27	464	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0019221	cytokine-mediated signaling pathway	8.671924289771482e-10	1.9125929021091004e-5	29	534	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032103	positive regulation of response to external stimulus	1.01224284509982e-9	2.232501594867653e-5	21	285	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0021700	developmental maturation	1.0435478037251755e-9	2.3015446811158746e-5	19	231	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0031058	positive regulation of histone modification	1.120974535417929e-9	2.4723093378642425e-5	12	78	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0090344	negative regulation of cell aging	1.1892220541653842e-9	2.6228292404617548e-5	7	16	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0042307	positive regulation of protein import into nucleus	1.490335743703497e-9	3.2869354827380626e-5	13	98	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0038093	Fc receptor signaling pathway	1.4929277813990893e-9	3.2926522218756915e-5	17	185	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0003006	developmental process involved in reproduction	1.5515194684567746e-9	3.421876187681416e-5	31	619	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:2000773	negative regulation of cellular senescence	1.6553092230253696e-9	3.650784491382453e-5	6	10	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0001933	negative regulation of protein phosphorylation	1.8282267921776452e-9	4.0321541901477964e-5	24	385	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0001944	vasculature development	1.8853413275010666e-9	4.1581202978036025e-5	30	588	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0045931	positive regulation of mitotic cell cycle	1.9362559333657714e-9	4.270412461038209e-5	14	120	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0036294	cellular response to decreased oxygen levels	2.0565007474715458e-9	4.535612398548494e-5	15	142	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0005126	cytokine receptor binding	2.3407612514958487e-9	5.162548940174094e-5	20	270	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032609	interferon-gamma production	2.464689452530422e-9	5.4358725875558456e-5	13	102	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0043086	negative regulation of catalytic activity	2.494373041450615e-9	5.501339742919331e-5	36	822	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0032355	response to estradiol	2.7526803059174654e-9	6.07103641470097e-5	15	145	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:1902532	negative regulation of intracellular signal transduction	2.8422690867557776e-9	6.268624470839868e-5	25	426	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0034599	cellular response to oxidative stress	2.9404730872428786e-9	6.485213393914169e-5	18	219	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0045834	positive regulation of lipid metabolic process	2.989610115022856e-9	6.593585108682909e-5	14	124	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0043029	T cell homeostasis	3.2898308521822628e-9	7.25572194448798e-5	9	39	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:2000377	regulation of reactive oxygen species metabolic process	3.330486997299431e-9	7.345389072543895e-5	15	147	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0071900	regulation of protein serine/threonine kinase activity	3.5979027535049113e-9	7.935174522855082e-5	25	431	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0001568	blood vessel development	3.657890101926853e-9	8.067476619799674e-5	29	569	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0043368	positive T cell selection	3.935169634594615e-9	8.679016629098424e-5	8	28	268
Orphanet:2442	X-linked lymphoproliferative disease	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	4.280613974394498e-9	9.440894120527066e-5	29	573	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0001763	morphogenesis of a branching structure	1.5836221223253233e-12	3.4926785907885005e-8	26	193	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0009799	specification of symmetry	2.8554936193359026e-13	6.297791177445333e-9	19	122	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0009855	determination of bilateral symmetry	1.6187051699034782e-13	3.5700542522221212e-9	19	121	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0048639	positive regulation of developmental growth	6.915357175785175e-12	1.5251820251194204e-7	18	153	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.069377919549197e-11	2.358513001565754e-7	36	623	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0001067	regulatory region nucleic acid binding	1.2928436099457485e-11	2.8513665817353484e-7	43	811	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0044212	transcription regulatory region DNA binding	1.3398171461176389e-11	2.9549667157624526e-7	42	807	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0009725	response to hormone	1.7240653349404056e-11	3.8024260962110645e-7	41	865	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0045995	regulation of embryonic development	7.911327148946157e-11	1.7448432027000749e-6	15	113	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0051962	positive regulation of nervous system development	1.8894685815951107e-10	4.1672229567080166e-6	27	435	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0061525	hindgut development	2.261121290203505e-10	4.98690300554383e-6	6	8	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0007610	behavior	2.3315493979936264e-10	5.142232197274943e-6	35	714	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0048871	multicellular organismal homeostasis	2.766450402091891e-10	6.101406361813666e-6	23	321	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0021987	cerebral cortex development	3.2193103738364925e-10	7.100189029496384e-6	14	105	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0002065	columnar/cuboidal epithelial cell differentiation	4.7458903473796e-10	1.0467061161145708e-5	15	128	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0040018	positive regulation of multicellular organism growth	4.754486804259273e-10	1.0486020646793826e-5	9	32	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0043473	pigmentation	5.815367076777989e-10	1.2825792087833854e-5	13	91	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0060563	neuroepithelial cell differentiation	5.961540150423161e-10	1.3148176801758282e-5	12	74	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0035148	tube formation	6.60292709397936e-10	1.456275570577148e-5	15	131	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0001525	angiogenesis	1.5141240483629304e-9	3.339400588664443e-5	25	413	268
Orphanet:95488	Non-acquired pituitary hormone deficiency	GO:0048546	digestive tract morphogenesis	1.5764249905458882e-9	3.4768053166489565e-5	10	49	268
DOID:2916	hypersensitivity reaction type IV disease	GO:0050767	regulation of neurogenesis	1.2392087356261072e-11	2.7330748664233795e-7	38	658	269
Orphanet:238510	Lymphoproliferative syndrome	GO:0016064	immunoglobulin mediated immune response	1.0893508317622036e-12	2.40256325945154e-8	16	97	269
Orphanet:238510	Lymphoproliferative syndrome	GO:0023014	signal transduction by protein phosphorylation	2.887245997840182e-12	6.367821048236522e-8	42	879	269
Orphanet:238510	Lymphoproliferative syndrome	GO:0050767	regulation of neurogenesis	1.2392087356261072e-11	2.7330748664233795e-7	38	658	269
Orphanet:79362	Epidermal appendage anomaly	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	9.206857498611498e-12	2.030572421318766e-7	45	996	270
Orphanet:79362	Epidermal appendage anomaly	GO:0035148	tube formation	2.8954616482224083e-13	6.385940665154521e-9	20	131	270
Orphanet:79362	Epidermal appendage anomaly	GO:0021915	neural tube development	2.404743071338089e-13	5.3036608438361554e-9	19	151	270
Orphanet:79362	Epidermal appendage anomaly	GO:0016331	morphogenesis of embryonic epithelium	1.5720758028692217e-13	3.4672131832280684e-9	19	141	270
Orphanet:79362	Epidermal appendage anomaly	GO:0098773	skin epidermis development	3.5482727867020003e-13	7.825715631071262e-9	22	82	270
Orphanet:79362	Epidermal appendage anomaly	GO:0060606	tube closure	1.2109202529586582e-12	2.6706846179003207e-8	15	83	270
Orphanet:79362	Epidermal appendage anomaly	GO:0040007	growth	4.210409798588444e-12	9.286058810786813e-8	43	936	270
Orphanet:79362	Epidermal appendage anomaly	GO:0001838	embryonic epithelial tube formation	1.0255019056160108e-11	2.261744452836112e-7	16	115	270
Orphanet:79362	Epidermal appendage anomaly	GO:0001843	neural tube closure	1.1773804153847323e-11	2.596712506131027e-7	14	82	270
Orphanet:79362	Epidermal appendage anomaly	GO:0048608	reproductive structure development	2.1867063715319546e-11	4.822780902413726e-7	28	418	270
Orphanet:79362	Epidermal appendage anomaly	GO:0001701	in utero embryonic development	3.3876346172689864e-11	7.47142814838675e-7	24	312	270
Orphanet:79362	Epidermal appendage anomaly	GO:0035113	embryonic appendage morphogenesis	3.525268965631767e-11	7.774980703700862e-7	16	125	270
Orphanet:79362	Epidermal appendage anomaly	GO:0030326	embryonic limb morphogenesis	3.525268965631767e-11	7.774980703700862e-7	16	125	270
Orphanet:79362	Epidermal appendage anomaly	GO:0030216	keratinocyte differentiation	3.996836195341302e-11	8.815022228825242e-7	16	126	270
Orphanet:79362	Epidermal appendage anomaly	GO:0055123	digestive system development	6.078038072843128e-11	1.340511296965552e-6	17	150	270
Orphanet:79362	Epidermal appendage anomaly	GO:0042471	ear morphogenesis	7.744516139496227e-11	1.7080530345658929e-6	15	112	270
Orphanet:79362	Epidermal appendage anomaly	GO:0001503	ossification	1.245420433448885e-10	2.746774765971516e-6	25	363	270
Orphanet:79362	Epidermal appendage anomaly	GO:0023014	signal transduction by protein phosphorylation	4.2008496681233964e-10	9.264973943046151e-6	39	879	270
Orphanet:79362	Epidermal appendage anomaly	GO:0042733	embryonic digit morphogenesis	8.640429483008916e-10	1.9056467224776164e-5	11	60	270
Orphanet:79362	Epidermal appendage anomaly	GO:0031069	hair follicle morphogenesis	2.1500200508839384e-9	4.741869222224526e-5	8	26	270
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0016064	immunoglobulin mediated immune response	1.1747269823558781e-12	2.5908603595858892e-8	16	97	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0023014	signal transduction by protein phosphorylation	9.957479285560566e-12	2.196122056430383e-7	42	879	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0050767	regulation of neurogenesis	1.2443934771511067e-11	2.744509813856766e-7	38	658	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0002286	T cell activation involved in immune response	3.376454671411011e-11	7.446770777796985e-7	14	87	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0046637	regulation of alpha-beta T cell differentiation	4.90126828012194e-11	1.0809747191808938e-6	11	46	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0001906	cell killing	5.818188153483561e-10	1.2832013972507994e-5	14	107	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0046635	positive regulation of alpha-beta T cell activation	2.494640716221852e-9	5.5019300996272946e-5	10	50	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0001909	leukocyte mediated cytotoxicity	2.719201863676801e-9	5.997199710339185e-5	12	82	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0098542	defense response to other organism	3.081890187495162e-9	6.79710880852058e-5	29	550	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:1903409	reactive oxygen species biosynthetic process	3.1375356757123996e-9	6.919834932783697e-5	12	83	275
Orphanet:158038	Primary hemophagocytic lymphohistiocytosis	GO:0042832	defense response to protozoan	3.860209929484881e-9	8.513692999478906e-5	7	18	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007167	enzyme linked receptor protein signaling pathway	5.960343330002615e-12	1.3145537214320768e-7	44	935	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001763	morphogenesis of a branching structure	1.4936940573306856e-12	3.294342243442827e-8	24	193	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	9.814371537686384e-13	2.164559642636732e-8	45	996	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009725	response to hormone	6.185052470186747e-13	1.364113322299687e-8	45	865	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001085	RNA polymerase II transcription factor binding	2.8602675783417908e-12	6.30832014403282e-8	16	104	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048871	multicellular organismal homeostasis	6.416978060030942e-12	1.4152645111398243e-7	26	321	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0055123	digestive system development	7.650990951901804e-12	1.6874260544419428e-7	18	150	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001503	ossification	9.455103366917683e-12	2.085323047573695e-7	27	363	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0021543	pallium development	1.129973892233238e-11	2.4921574193204066e-7	18	153	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0008284	positive regulation of cell proliferation	1.6665446800345762e-11	3.675564291816258e-7	42	815	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007548	sex differentiation	2.0461743410749023e-11	4.512837509240697e-7	23	274	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0010243	response to organonitrogen compound	3.915712198931942e-11	8.636103254744398e-7	39	780	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0001655	urogenital system development	4.99015273547343e-11	1.100578185808665e-6	24	313	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0090596	sensory organ morphogenesis	6.204514679808426e-11	1.3684057126317484e-6	21	239	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0043473	pigmentation	6.329969881591069e-11	1.3960748573849102e-6	14	91	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0010817	regulation of hormone levels	9.93169990692877e-11	2.1904364144731403e-6	29	473	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0035265	organ growth	1.0801626260104058e-10	2.38229867166595e-6	16	132	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0030324	lung development	1.1454071024985524e-10	2.5261953645605573e-6	18	175	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0007610	behavior	1.2699341578326084e-10	2.800839785099818e-6	36	714	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0014070	response to organic cyclic compound	1.6248502543447785e-10	3.583607235957409e-6	40	873	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0043066	negative regulation of apoptotic process	1.6863088703189533e-10	3.7191542134884514e-6	38	795	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0032870	cellular response to hormone stimulus	1.8823953507052238e-10	4.151622945980371e-6	30	519	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0070848	response to growth factor	1.965222429234359e-10	4.334298067676379e-6	33	621	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048565	digestive tract development	2.125537523767207e-10	4.687873008668575e-6	16	138	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0071363	cellular response to growth factor stimulus	2.646721730670265e-10	5.83734477699327e-6	32	594	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0048806	genitalia development	3.059693609586134e-10	6.748154255942218e-6	10	41	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0032147	activation of protein kinase activity	3.288653793731555e-10	7.253125942074945e-6	22	288	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0051962	positive regulation of nervous system development	3.3452618453111427e-10	7.377974999833725e-6	27	435	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009799	specification of symmetry	3.4205605015102947e-10	7.544046186080955e-6	15	122	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0042445	hormone metabolic process	3.437208295764549e-10	7.580762896308713e-6	18	187	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0050769	positive regulation of neurogenesis	3.741639220677939e-10	8.252185301205195e-6	25	376	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0035113	embryonic appendage morphogenesis	4.842477530075939e-10	1.0680084192582484e-5	15	125	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0030326	embryonic limb morphogenesis	4.842477530075939e-10	1.0680084192582484e-5	15	125	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0044344	cellular response to fibroblast growth factor stimulus	6.787829187615557e-10	1.4970557273286111e-5	15	128	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0044703	multi-organism reproductive process	9.367239206525824e-10	2.0659446069992704e-5	40	926	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0035148	tube formation	9.4298790997982e-10	2.079759835460493e-5	15	131	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0042733	embryonic digit morphogenesis	1.0485257107006873e-9	2.312523454950366e-5	11	60	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0045995	regulation of embryonic development	1.2129580673203577e-9	2.675179017475049e-5	14	113	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0030850	prostate gland development	1.3073170324062744e-9	2.8832877149720382e-5	10	47	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:2000145	regulation of cell motility	1.434709351322283e-9	3.164251474341295e-5	34	709	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0003682	chromatin binding	1.4444163642934882e-9	3.185660291449288e-5	26	433	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0016331	morphogenesis of embryonic epithelium	2.6502281480489387e-9	5.845078180521934e-5	15	141	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0009855	determination of bilateral symmetry	3.0132397688120705e-9	6.645700310115021e-5	14	121	275
Orphanet:399572	Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder	GO:0008015	blood circulation	4.199099512547377e-9	9.261113974923241e-5	27	489	275
DOID:731	urinary system benign neoplasm	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.5592638291650474e-11	3.438956375223512e-7	47	996	276
DOID:731	urinary system benign neoplasm	GO:0051726	regulation of cell cycle	5.113465206818546e-12	1.1277747513638303e-7	46	930	276
DOID:731	urinary system benign neoplasm	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.2296830220748234e-12	2.712065905186023e-8	22	195	276
DOID:731	urinary system benign neoplasm	GO:0032355	response to estradiol	8.235634396669411e-13	1.8163691661854386e-8	21	145	276
DOID:731	urinary system benign neoplasm	GO:1901214	regulation of neuron death	5.834221994405198e-13	1.2867376608660663e-8	24	250	276
DOID:731	urinary system benign neoplasm	GO:0010038	response to metal ion	3.26272342476841e-12	7.195936513326728e-8	27	335	276
DOID:731	urinary system benign neoplasm	GO:0007346	regulation of mitotic cell cycle	5.771827460421264e-12	1.2729765463959097e-7	31	453	276
DOID:731	urinary system benign neoplasm	GO:0048608	reproductive structure development	5.894618126944806e-12	1.300058027897677e-7	30	418	276
DOID:731	urinary system benign neoplasm	GO:2000045	regulation of G1/S transition of mitotic cell cycle	9.419021118617366e-12	2.07736510771106e-7	17	131	276
DOID:731	urinary system benign neoplasm	GO:1902533	positive regulation of intracellular signal transduction	1.0608292022595833e-11	2.339658805583511e-7	42	860	276
DOID:731	urinary system benign neoplasm	GO:0071407	cellular response to organic cyclic compound	1.070965538474411e-11	2.3620144951053135e-7	29	416	276
DOID:731	urinary system benign neoplasm	GO:0045786	negative regulation of cell cycle	1.101019275751014e-11	2.4282980126688614e-7	30	449	276
DOID:731	urinary system benign neoplasm	GO:0010942	positive regulation of cell death	1.1766698726489722e-11	2.595145404127308e-7	35	596	276
DOID:731	urinary system benign neoplasm	GO:1901699	cellular response to nitrogen compound	1.6574075445419112e-11	3.655412339487185e-7	32	518	276
DOID:731	urinary system benign neoplasm	GO:0045930	negative regulation of mitotic cell cycle	1.7246426509132107e-11	3.803699366589086e-7	20	200	276
DOID:731	urinary system benign neoplasm	GO:0035295	tube development	3.277422777614447e-11	7.228355936028663e-7	33	573	276
DOID:731	urinary system benign neoplasm	GO:0036294	cellular response to decreased oxygen levels	3.5536240616806936e-11	7.83751786803677e-7	17	142	276
DOID:731	urinary system benign neoplasm	GO:0050673	epithelial cell proliferation	3.6916247836416005e-11	8.14187846032155e-7	25	335	276
DOID:731	urinary system benign neoplasm	GO:0045787	positive regulation of cell cycle	3.779510038270928e-11	8.335709389406531e-7	24	308	276
DOID:731	urinary system benign neoplasm	GO:0060322	head development	3.802769210636825e-11	8.387007494059517e-7	37	708	276
DOID:731	urinary system benign neoplasm	GO:1901701	cellular response to oxygen-containing compound	4.6370352002611526e-11	1.0226981134175972e-6	41	873	276
DOID:731	urinary system benign neoplasm	GO:0008134	transcription factor binding	4.8806070296336657e-11	1.076417880385705e-6	31	518	276
DOID:731	urinary system benign neoplasm	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	6.639999661217644e-11	1.4644519252815513e-6	14	91	276
DOID:731	urinary system benign neoplasm	GO:0043068	positive regulation of programmed cell death	7.608191854302504e-11	1.6779867134664173e-6	32	561	276
DOID:731	urinary system benign neoplasm	GO:0007417	central nervous system development	8.273326468355435e-11	1.8246821525957913e-6	41	889	276
DOID:731	urinary system benign neoplasm	GO:0097190	apoptotic signaling pathway	8.419553942928815e-11	1.85693262211295e-6	32	564	276
DOID:731	urinary system benign neoplasm	GO:0040007	growth	1.0457357202398043e-10	2.3063701309888884e-6	42	936	276
DOID:731	urinary system benign neoplasm	GO:0071456	cellular response to hypoxia	1.4326040354006864e-10	3.159608200076214e-6	16	134	276
DOID:731	urinary system benign neoplasm	GO:0001934	positive regulation of protein phosphorylation	1.6813017644778938e-10	3.708111041555995e-6	40	870	276
DOID:731	urinary system benign neoplasm	GO:0006275	regulation of DNA replication	1.7958434739284712e-10	3.960732781749243e-6	17	157	276
DOID:731	urinary system benign neoplasm	GO:0045471	response to ethanol	2.0050805460414267e-10	4.422205144294367e-6	16	137	276
DOID:731	urinary system benign neoplasm	GO:0032870	cellular response to hormone stimulus	2.0544910217523693e-10	4.5311799484748505e-6	30	519	276
DOID:731	urinary system benign neoplasm	GO:0045121	membrane raft	2.36349717575024e-10	5.212693021117154e-6	22	282	276
DOID:731	urinary system benign neoplasm	GO:0032403	protein complex binding	2.8193358758699105e-10	6.218045274231088e-6	41	924	276
DOID:731	urinary system benign neoplasm	GO:0071214	cellular response to abiotic stimulus	2.888982386650696e-10	6.37165065375811e-6	22	285	276
DOID:731	urinary system benign neoplasm	GO:0071417	cellular response to organonitrogen compound	2.930858888916532e-10	6.464009279505412e-6	28	462	276
DOID:731	urinary system benign neoplasm	GO:0048534	hematopoietic or lymphoid organ development	3.344206023214724e-10	7.375646384200074e-6	36	739	276
DOID:731	urinary system benign neoplasm	GO:0034504	protein localization to nucleus	3.481970267671386e-10	7.679485425349242e-6	24	344	276
DOID:731	urinary system benign neoplasm	GO:0048471	perinuclear region of cytoplasm	3.925086922151877e-10	8.656779206805965e-6	33	636	276
DOID:731	urinary system benign neoplasm	GO:0007093	mitotic cell cycle checkpoint	4.2537684485921545e-10	9.381686313369997e-6	16	144	276
DOID:731	urinary system benign neoplasm	GO:0090068	positive regulation of cell cycle process	4.622727756142808e-10	1.0195426066172963e-5	20	239	276
DOID:731	urinary system benign neoplasm	GO:0043523	regulation of neuron apoptotic process	4.735385417120597e-10	1.0443892537459476e-5	18	190	276
DOID:731	urinary system benign neoplasm	GO:0007050	cell cycle arrest	5.776864542283988e-10	1.2740874748007336e-5	20	242	276
DOID:731	urinary system benign neoplasm	GO:0033044	regulation of chromosome organization	6.917225681135619e-10	1.5255941239744608e-5	21	271	276
DOID:731	urinary system benign neoplasm	GO:0040008	regulation of growth	7.398499590749452e-10	1.6317390847397917e-5	32	617	276
DOID:731	urinary system benign neoplasm	GO:0097191	extrinsic apoptotic signaling pathway	7.499939558286428e-10	1.6541116695800717e-5	19	220	276
DOID:731	urinary system benign neoplasm	GO:1990267	response to transition metal nanoparticle	7.833226289832851e-10	1.7276180582226353e-5	16	150	276
DOID:731	urinary system benign neoplasm	GO:0043434	response to peptide hormone	8.138552054504089e-10	1.794957655620877e-5	25	389	276
DOID:731	urinary system benign neoplasm	GO:0043065	positive regulation of apoptotic process	1.0338829792289062e-9	2.2802289106893525e-5	30	556	276
DOID:731	urinary system benign neoplasm	GO:0009792	embryo development ending in birth or egg hatching	1.1233711738611873e-9	2.4775951239508487e-5	30	558	276
DOID:731	urinary system benign neoplasm	GO:0007420	brain development	1.39074285421259e-9	3.067283364965867e-5	33	669	276
DOID:731	urinary system benign neoplasm	GO:0031960	response to corticosteroid	1.4049664764925751e-9	3.0986535639043744e-5	17	179	276
DOID:731	urinary system benign neoplasm	GO:0009314	response to radiation	1.4155500105417218e-9	3.1219955482497674e-5	26	431	276
DOID:731	urinary system benign neoplasm	GO:0009887	organ morphogenesis	2.1780637293744576e-9	4.803719555135366e-5	40	950	276
DOID:731	urinary system benign neoplasm	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2.351366767960883e-9	5.1859394067377274e-5	32	647	276
DOID:731	urinary system benign neoplasm	GO:0048660	regulation of smooth muscle cell proliferation	2.744370508622751e-9	6.052709156767477e-5	13	100	276
DOID:731	urinary system benign neoplasm	GO:0009894	regulation of catabolic process	2.9753527419629222e-9	6.562140472399225e-5	34	727	276
DOID:731	urinary system benign neoplasm	GO:1900180	regulation of protein localization to nucleus	3.007231019758194e-9	6.632448014076697e-5	18	213	276
DOID:731	urinary system benign neoplasm	GO:0043009	chordate embryonic development	3.6343476006450715e-9	8.015553633222705e-5	29	552	276
DOID:731	urinary system benign neoplasm	GO:0043491	protein kinase B signaling	3.7319825008097496e-9	8.230887405535903e-5	15	144	276
DOID:731	urinary system benign neoplasm	GO:0051338	regulation of transferase activity	3.746925547609692e-9	8.263844295253175e-5	39	928	276
DOID:731	urinary system benign neoplasm	GO:0051384	response to glucocorticoid	3.808980242325788e-9	8.400705924449525e-5	16	167	276
DOID:4330	non-langerhans-cell histiocytosis	GO:0071396	cellular response to lipid	9.123649613584917e-10	2.0122209222761533e-5	26	416	280
DOID:4330	non-langerhans-cell histiocytosis	GO:0032635	interleukin-6 production	9.444025561577973e-10	2.082879837606022e-5	14	109	280
DOID:4330	non-langerhans-cell histiocytosis	GO:0045121	membrane raft	1.8437888993361184e-9	4.066476417485809e-5	21	282	280
Orphanet:97965	Rare surgical cardiac disease	GO:0035082	axoneme assembly	3.086420008457935e-14	6.807099328653976e-10	15	43	281
Orphanet:97965	Rare surgical cardiac disease	GO:0050678	regulation of epithelial cell proliferation	1.4241826606919972e-9	3.1410348581562e-5	21	277	281
Orphanet:97965	Rare surgical cardiac disease	GO:0007423	sensory organ development	1.9407087048506355e-9	4.2802330485480766e-5	28	494	281
Orphanet:97965	Rare surgical cardiac disease	GO:0008285	negative regulation of cell proliferation	2.2419343048696305e-9	4.94458610938997e-5	32	634	281
Orphanet:97965	Rare surgical cardiac disease	GO:0003283	atrial septum development	4.483226456741818e-9	9.887755950344079e-5	7	18	281
Orphanet:97962	Rare surgical thoracic disease	GO:0051338	regulation of transferase activity	3.502309553482519e-12	7.724343720205695e-8	46	928	283
Orphanet:97962	Rare surgical thoracic disease	GO:0042327	positive regulation of phosphorylation	2.58792987040124e-12	5.7076793291699346e-8	45	910	283
Orphanet:97962	Rare surgical thoracic disease	GO:0030323	respiratory tube development	1.4999113062685865e-12	3.3080543859753675e-8	23	179	283
Orphanet:97962	Rare surgical thoracic disease	GO:0060541	respiratory system development	1.397548743398147e-12	3.082293753564613e-8	25	202	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048705	skeletal system morphogenesis	1.2922996006636822e-12	2.850166769263751e-8	23	204	283
Orphanet:97962	Rare surgical thoracic disease	GO:1901701	cellular response to oxygen-containing compound	1.2578826869003024e-12	2.774260265958617e-8	44	873	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001763	morphogenesis of a branching structure	1.1322054405127346e-12	2.4970790990508362e-8	22	193	283
Orphanet:97962	Rare surgical thoracic disease	GO:0035265	organ growth	6.024070131616099e-13	1.3286086675279307e-8	20	132	283
Orphanet:97962	Rare surgical thoracic disease	GO:0055001	muscle cell development	5.606626274357041e-13	1.2365414248094453e-8	21	140	283
Orphanet:97962	Rare surgical thoracic disease	GO:0055002	striated muscle cell development	5.577760475716786e-13	1.2301750729193373e-8	20	127	283
Orphanet:97962	Rare surgical thoracic disease	GO:0003205	cardiac chamber development	3.2795988147427124e-13	7.233155185915052e-9	21	142	283
Orphanet:97962	Rare surgical thoracic disease	GO:0090130	tissue migration	2.544631172440859e-13	5.612184050818314e-9	24	227	283
Orphanet:97962	Rare surgical thoracic disease	GO:0035051	cardiocyte differentiation	1.4410694859634532e-13	3.178278751292396e-9	20	107	283
Orphanet:97962	Rare surgical thoracic disease	GO:0055123	digestive system development	3.1541436129600697e-13	6.956463738383434e-9	19	150	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010631	epithelial cell migration	1.3203882431866987e-12	2.912116270348264e-8	22	218	283
Orphanet:97962	Rare surgical thoracic disease	GO:0043500	muscle adaptation	2.244093799674829e-12	4.949348875182835e-8	15	84	283
Orphanet:97962	Rare surgical thoracic disease	GO:0085029	extracellular matrix assembly	2.3242519020527652e-12	5.126137569977374e-8	10	26	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001934	positive regulation of protein phosphorylation	3.0169200471164004e-12	6.653817163915221e-8	44	870	283
Orphanet:97962	Rare surgical thoracic disease	GO:0003206	cardiac chamber morphogenesis	4.282130205979229e-12	9.444238169287189e-8	16	104	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001503	ossification	4.410583009928359e-12	9.727540828396997e-8	32	363	283
Orphanet:97962	Rare surgical thoracic disease	GO:0003231	cardiac ventricle development	5.1312287752125485e-12	1.1316925063731276e-7	16	105	283
Orphanet:97962	Rare surgical thoracic disease	GO:2000147	positive regulation of cell motility	6.151301690238142e-12	1.3566695877820223e-7	29	399	283
Orphanet:97962	Rare surgical thoracic disease	GO:0045926	negative regulation of growth	6.3018479323773136e-12	1.3898725614858165e-7	22	230	283
Orphanet:97962	Rare surgical thoracic disease	GO:0007548	sex differentiation	6.7399419378944e-12	1.48649419440261e-7	24	274	283
Orphanet:97962	Rare surgical thoracic disease	GO:0031012	extracellular matrix	7.164602244813523e-12	1.5801530250936224e-7	30	423	283
Orphanet:97962	Rare surgical thoracic disease	GO:0045596	negative regulation of cell differentiation	8.087419622881953e-12	1.7836803978266147e-7	36	597	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001654	eye development	8.742007118200945e-12	1.9280496699192184e-7	26	327	283
Orphanet:97962	Rare surgical thoracic disease	GO:2000377	regulation of reactive oxygen species metabolic process	9.015010959956271e-12	1.9882606672183556e-7	18	147	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048598	embryonic morphogenesis	1.1514789122202274e-11	2.5395867409017114e-7	35	560	283
Orphanet:97962	Rare surgical thoracic disease	GO:0060284	regulation of cell development	1.2518541758765878e-11	2.7609643848958143e-7	44	828	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010942	positive regulation of cell death	1.3554157796136224e-11	2.989369501937844e-7	35	596	283
Orphanet:97962	Rare surgical thoracic disease	GO:0031966	mitochondrial membrane	1.3980483437592284e-11	3.083395622160978e-7	38	656	283
Orphanet:97962	Rare surgical thoracic disease	GO:0008284	positive regulation of cell proliferation	1.4265810754920949e-11	3.1463245619978153e-7	45	815	283
Orphanet:97962	Rare surgical thoracic disease	GO:0000302	response to reactive oxygen species	1.4281242854963239e-11	3.1497281116621423e-7	21	216	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048608	reproductive structure development	1.438416052934599e-11	3.172426604747258e-7	29	418	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001822	kidney development	1.6277645897844195e-11	3.590034802769537e-7	23	262	283
Orphanet:97962	Rare surgical thoracic disease	GO:0071900	regulation of protein serine/threonine kinase activity	2.448519165199059e-11	5.400209018846525e-7	29	431	283
Orphanet:97962	Rare surgical thoracic disease	GO:0090287	regulation of cellular response to growth factor stimulus	3.769684564502995e-11	8.314039307011356e-7	21	226	283
Orphanet:97962	Rare surgical thoracic disease	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	4.076206039371755e-11	8.990072419834405e-7	20	204	283
Orphanet:97962	Rare surgical thoracic disease	GO:0071560	cellular response to transforming growth factor beta stimulus	5.891331866791916e-11	1.299333243220957e-6	20	208	283
Orphanet:97962	Rare surgical thoracic disease	GO:0006875	cellular metal ion homeostasis	6.0643490229495e-11	1.3374921770115122e-6	29	450	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010632	regulation of epithelial cell migration	6.170497446333911e-11	1.3609032117889441e-6	18	164	283
Orphanet:97962	Rare surgical thoracic disease	GO:0031667	response to nutrient levels	7.238731836167744e-11	1.596502306466796e-6	32	546	283
Orphanet:97962	Rare surgical thoracic disease	GO:0002520	immune system development	7.446809835442991e-11	1.6423939092069517e-6	39	782	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001701	in utero embryonic development	8.208489443717326e-11	1.8103823468118563e-6	24	312	283
Orphanet:97962	Rare surgical thoracic disease	GO:0007492	endoderm development	9.300626935271339e-11	2.051253270574094e-6	13	75	283
Orphanet:97962	Rare surgical thoracic disease	GO:0060323	head morphogenesis	9.792633370864223e-11	2.1597652899441044e-6	10	36	283
Orphanet:97962	Rare surgical thoracic disease	GO:0006809	nitric oxide biosynthetic process	1.2858514253366593e-10	2.835945318580002e-6	12	62	283
Orphanet:97962	Rare surgical thoracic disease	GO:0043502	regulation of muscle adaptation	1.565624296873125e-10	3.452984386753677e-6	12	63	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048534	hematopoietic or lymphoid organ development	1.814586259030193e-10	4.002069994291091e-6	37	739	283
Orphanet:97962	Rare surgical thoracic disease	GO:0071260	cellular response to mechanical stimulus	2.1571655572927284e-10	4.7576286366091125e-6	13	80	283
Orphanet:97962	Rare surgical thoracic disease	GO:0050679	positive regulation of epithelial cell proliferation	2.16566098387716e-10	4.776365299941077e-6	17	155	283
Orphanet:97962	Rare surgical thoracic disease	GO:0033674	positive regulation of kinase activity	2.660521802866356e-10	5.867780836221748e-6	29	480	283
Orphanet:97962	Rare surgical thoracic disease	GO:1901342	regulation of vasculature development	3.1211699891287026e-10	6.8837404110233535e-6	20	228	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048562	embryonic organ morphogenesis	3.322095931679314e-10	7.326882577318727e-6	22	280	283
Orphanet:97962	Rare surgical thoracic disease	GO:0051341	regulation of oxidoreductase activity	4.724213242823794e-10	1.0419252307047877e-5	13	85	283
Orphanet:97962	Rare surgical thoracic disease	GO:0060325	face morphogenesis	5.59892576745824e-10	1.234843078012915e-5	9	31	283
Orphanet:97962	Rare surgical thoracic disease	GO:0007179	transforming growth factor beta receptor signaling pathway	6.382081529920924e-10	1.4075680814240599e-5	17	166	283
Orphanet:97962	Rare surgical thoracic disease	GO:1900182	positive regulation of protein localization to nucleus	7.201030882697523e-10	1.5881873611789388e-5	15	125	283
Orphanet:97962	Rare surgical thoracic disease	GO:0003300	cardiac muscle hypertrophy	7.947470459512829e-10	1.7528146098455544e-5	11	57	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010959	regulation of metal ion transport	7.995976103458702e-10	1.7635125296178167e-5	23	321	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001558	regulation of cell growth	8.023360864584106e-10	1.7695522386840246e-5	25	379	283
Orphanet:97962	Rare surgical thoracic disease	GO:0034599	cellular response to oxidative stress	1.0567720032383932e-9	2.330710653142276e-5	19	219	283
Orphanet:97962	Rare surgical thoracic disease	GO:0051353	positive regulation of oxidoreductase activity	1.0913040471294266e-9	2.4068710759439504e-5	10	45	283
Orphanet:97962	Rare surgical thoracic disease	GO:0097191	extrinsic apoptotic signaling pathway	1.1417478074093879e-9	2.518124789241405e-5	19	220	283
Orphanet:97962	Rare surgical thoracic disease	GO:0000904	cell morphogenesis involved in differentiation	1.2246368363832971e-9	2.7009365426433618e-5	35	720	283
Orphanet:97962	Rare surgical thoracic disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.244721214987976e-9	2.7452326396559812e-5	16	151	283
Orphanet:97962	Rare surgical thoracic disease	GO:2001234	negative regulation of apoptotic signaling pathway	1.5039907097502692e-9	3.3170515103542186e-5	18	199	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010594	regulation of endothelial cell migration	1.5609153969364797e-9	3.442598907943406e-5	14	112	283
Orphanet:97962	Rare surgical thoracic disease	GO:0014065	phosphatidylinositol 3-kinase signaling	1.6652784706749912e-9	3.672771667073693e-5	16	154	283
Orphanet:97962	Rare surgical thoracic disease	GO:0086004	regulation of cardiac muscle cell contraction	1.7245179728675453e-9	3.803424389159371e-5	10	47	283
Orphanet:97962	Rare surgical thoracic disease	GO:0031960	response to corticosteroid	2.055809522616414e-9	4.5340879021305014e-5	17	179	283
Orphanet:97962	Rare surgical thoracic disease	GO:0048638	regulation of developmental growth	2.3791908443371312e-9	5.247305407185543e-5	21	283	283
Orphanet:97962	Rare surgical thoracic disease	GO:0001657	ureteric bud development	2.5341564402481254e-9	5.5890820289672405e-5	13	97	283
Orphanet:97962	Rare surgical thoracic disease	GO:0045471	response to ethanol	2.6218244242315336e-9	5.7824337676426474e-5	15	137	283
Orphanet:97962	Rare surgical thoracic disease	GO:0045765	regulation of angiogenesis	3.0592489652647714e-9	6.747173592891453e-5	18	208	283
Orphanet:97962	Rare surgical thoracic disease	GO:0043086	negative regulation of catalytic activity	3.1771022479532007e-9	7.007099007860784e-5	37	822	283
Orphanet:97962	Rare surgical thoracic disease	GO:2000738	positive regulation of stem cell differentiation	3.2868000543473386e-9	7.249037519863055e-5	10	50	283
Orphanet:97962	Rare surgical thoracic disease	GO:0010634	positive regulation of epithelial cell migration	4.2035964709086215e-9	9.271032016588965e-5	13	101	283
Orphanet:97962	Rare surgical thoracic disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	4.332434744291902e-9	9.55518482853579e-5	12	83	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0002263	cell activation involved in immune response	1.0746958878371515e-12	2.3702417806248377e-8	30	210	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0002821	positive regulation of adaptive immune response	1.021405182655144e-13	2.25270913034592e-9	15	71	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0060284	regulation of cell development	1.2518541758765878e-11	2.7609643848958143e-7	44	828	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0002695	negative regulation of leukocyte activation	2.3231550017044356e-10	5.123718356259133e-6	16	135	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0051250	negative regulation of lymphocyte activation	2.4733193271231357e-10	5.454905775970076e-6	15	116	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	5.050537765782792e-10	1.1138961042433948e-5	14	103	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:2000107	negative regulation of leukocyte apoptotic process	5.239757516761756e-10	1.1556285203218053e-5	10	42	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0070231	T cell apoptotic process	8.602137890889594e-10	1.8972015118357e-5	10	44	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0050798	activated T cell proliferation	8.602137890889594e-10	1.8972015118357e-5	10	44	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0031341	regulation of cell killing	9.678153833903025e-10	2.134516828067312e-5	11	58	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0007162	negative regulation of cell adhesion	9.777009202238673e-10	2.1563193795537394e-5	19	218	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.244721214987976e-9	2.7452326396559812e-5	16	151	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0032649	regulation of interferon-gamma production	1.4895386035718161e-9	3.2851773901776404e-5	13	93	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0045637	regulation of myeloid cell differentiation	2.055809522616414e-9	4.5340879021305014e-5	17	179	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0002507	tolerance induction	2.183040859193852e-9	4.814696614952041e-5	8	25	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0045121	membrane raft	2.233443985311112e-9	4.925860709603658e-5	21	282	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0070229	negative regulation of lymphocyte apoptotic process	3.112025526164075e-9	6.863572297954867e-5	8	26	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0031343	positive regulation of cell killing	3.1905403874432636e-9	7.036736824506118e-5	9	37	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0032845	negative regulation of homeostatic process	3.501345324785632e-9	7.722217113814711e-5	16	162	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0032680	regulation of tumor necrosis factor production	3.7124465723792355e-9	8.187800915382404e-5	13	100	283
Orphanet:169361	Immune dysregulation disease with immunodeficiency	GO:0009615	response to virus	4.40681890978567e-9	9.719239105532296e-5	25	412	283
DOID:3753	Hermansky-Pudlak syndrome	GO:0002263	cell activation involved in immune response	1.0746958878371515e-12	2.3702417806248377e-8	29	210	283
DOID:3753	Hermansky-Pudlak syndrome	GO:0060284	regulation of cell development	1.3569811940783438e-11	2.9928220235397873e-7	43	828	283
DOID:9351	diabetes mellitus	GO:0048878	chemical homeostasis	2.1482593481891854e-11	4.7379859924312484e-7	84	988	285
DOID:9351	diabetes mellitus	GO:0019752	carboxylic acid metabolic process	1.4293899397443965e-11	3.1525195121062666e-7	52	967	285
DOID:9351	diabetes mellitus	GO:0022603	regulation of anatomical structure morphogenesis	1.0486722601399379e-11	2.312846669738633e-7	46	986	285
DOID:9351	diabetes mellitus	GO:0032940	secretion by cell	1.0007994433181011e-11	2.207263172238072e-7	68	956	285
DOID:9351	diabetes mellitus	GO:0023014	signal transduction by protein phosphorylation	4.295230837669806e-12	9.473131612480756e-8	50	879	285
DOID:9351	diabetes mellitus	GO:0001775	cell activation	1.894484569220367e-12	4.17828571741552e-8	50	854	285
DOID:9351	diabetes mellitus	GO:0050714	positive regulation of protein secretion	1.1148859613285822e-12	2.458880987710188e-8	24	205	285
DOID:9351	diabetes mellitus	GO:0006140	regulation of nucleotide metabolic process	1.0906830993917538e-12	2.405501575708513e-8	23	209	285
DOID:9351	diabetes mellitus	GO:1903531	negative regulation of secretion by cell	1.0371703496048212e-12	2.2874792060534332e-8	21	174	285
DOID:9351	diabetes mellitus	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	9.388045896230324e-13	2.070533522413598e-8	23	212	285
DOID:9351	diabetes mellitus	GO:0071219	cellular response to molecule of bacterial origin	6.237232952344129e-13	1.3756217276394977e-8	24	158	285
DOID:9351	diabetes mellitus	GO:1990267	response to transition metal nanoparticle	5.961897642237091e-13	1.3148965249953903e-8	20	150	285
DOID:9351	diabetes mellitus	GO:0032355	response to estradiol	5.855316231873076e-13	1.2913899949396068e-8	20	145	285
DOID:9351	diabetes mellitus	GO:0033002	muscle cell proliferation	5.482281295599023e-13	1.2091171397443645e-8	21	151	285
DOID:9351	diabetes mellitus	GO:0035150	regulation of tube size	3.2729374765949615e-13	7.2184636046301875e-9	24	140	285
DOID:9351	diabetes mellitus	GO:0070371	ERK1 and ERK2 cascade	2.466915560717098e-13	5.440782269161559e-9	25	247	285
DOID:9351	diabetes mellitus	GO:2000021	regulation of ion homeostasis	6.195044477408373e-14	1.3663170594924168e-9	21	189	285
DOID:9351	diabetes mellitus	GO:1902105	regulation of leukocyte differentiation	4.9960036108132044e-14	1.1018685963648522e-9	23	225	285
DOID:9351	diabetes mellitus	GO:1904019	epithelial cell apoptotic process	7.560618797697316e-14	1.667494475832143e-9	16	77	285
DOID:9351	diabetes mellitus	GO:0097050	type B pancreatic cell apoptotic process	1.0769163338864018e-13	2.3751389743864593e-9	8	10	285
DOID:9351	diabetes mellitus	GO:0071331	cellular response to hexose stimulus	1.929567616798522e-13	4.2556613788491404e-9	19	114	285
DOID:9351	diabetes mellitus	GO:0042311	vasodilation	2.3370194668359545e-13	5.154296434106698e-9	15	68	285
DOID:9351	diabetes mellitus	GO:0070372	regulation of ERK1 and ERK2 cascade	5.935252289646087e-13	1.3090198924814445e-8	23	233	285
DOID:9351	diabetes mellitus	GO:0006953	acute-phase response	8.345546476107302e-13	1.8406102753054654e-8	13	53	285
DOID:9351	diabetes mellitus	GO:0071260	cellular response to mechanical stimulus	1.183941833460267e-12	2.6111837136966187e-8	15	80	285
DOID:9351	diabetes mellitus	GO:0034110	regulation of homotypic cell-cell adhesion	2.0232704400768853e-12	4.4623229555895705e-8	27	304	285
DOID:9351	diabetes mellitus	GO:0072507	divalent inorganic cation homeostasis	2.582378755278114e-12	5.695436344765881e-8	31	393	285
DOID:9351	diabetes mellitus	GO:0051251	positive regulation of lymphocyte activation	3.1388225352202426e-12	6.922673101428245e-8	24	257	285
DOID:9351	diabetes mellitus	GO:0072503	cellular divalent inorganic cation homeostasis	3.2046587605805144e-12	7.067874896460324e-8	30	375	285
DOID:9351	diabetes mellitus	GO:0070838	divalent metal ion transport	3.816835736358826e-12	8.41803121653939e-8	33	410	285
DOID:9351	diabetes mellitus	GO:1900076	regulation of cellular response to insulin stimulus	4.141798015666609e-12	9.134735523552706e-8	13	59	285
DOID:9351	diabetes mellitus	GO:0006816	calcium ion transport	4.190647828750116e-12	9.24247378630838e-8	30	366	285
DOID:9351	diabetes mellitus	GO:0055074	calcium ion homeostasis	4.338196468722799e-12	9.567892311768134e-8	29	364	285
DOID:9351	diabetes mellitus	GO:0001818	negative regulation of cytokine production	4.410138920718509e-12	9.726561389644672e-8	21	203	285
DOID:9351	diabetes mellitus	GO:0006874	cellular calcium ion homeostasis	4.4256820430632615e-12	9.760841745976023e-8	28	352	285
DOID:9351	diabetes mellitus	GO:0010959	regulation of metal ion transport	4.477862525220644e-12	9.87592579937413e-8	30	321	285
DOID:9351	diabetes mellitus	GO:0048514	blood vessel morphogenesis	4.724443058989891e-12	1.0419759166602205e-7	34	484	285
DOID:9351	diabetes mellitus	GO:0006606	protein import into nucleus	5.814682069171795e-12	1.2824281303558394e-7	24	268	285
DOID:9351	diabetes mellitus	GO:0019900	kinase binding	6.032840893510638e-12	1.3305430590637712e-7	37	598	285
DOID:9351	diabetes mellitus	GO:0019915	lipid storage	6.586731160496129e-12	1.4527035574474212e-7	13	61	285
DOID:9351	diabetes mellitus	GO:0032386	regulation of intracellular transport	7.356226738863825e-12	1.6224158072564165e-7	36	575	285
DOID:9351	diabetes mellitus	GO:0045765	regulation of angiogenesis	7.664424650499768e-12	1.690388856667724e-7	21	208	285
DOID:9351	diabetes mellitus	GO:0032943	mononuclear cell proliferation	7.765232901135732e-12	1.7126221163454858e-7	23	252	285
DOID:9351	diabetes mellitus	GO:0048010	vascular endothelial growth factor receptor signaling pathway	7.790990075307036e-12	1.7183028611089668e-7	15	91	285
DOID:9351	diabetes mellitus	GO:0019221	cytokine-mediated signaling pathway	7.886691300029725e-12	1.7394097662215557e-7	36	534	285
DOID:9351	diabetes mellitus	GO:0006869	lipid transport	8.17423906340764e-12	1.802828425434555e-7	25	300	285
DOID:9351	diabetes mellitus	GO:0042060	wound healing	8.192113654104105e-12	1.8067706664126604e-7	35	534	285
DOID:9351	diabetes mellitus	GO:0044236	multicellular organismal metabolic process	9.291789559995323e-12	2.0493041874569684e-7	17	127	285
DOID:9351	diabetes mellitus	GO:1903827	regulation of cellular protein localization	9.308220860759775e-12	2.0529281108405684e-7	35	543	285
DOID:9351	diabetes mellitus	GO:0051480	cytosolic calcium ion homeostasis	9.874767670225992e-12	2.1778800096683426e-7	23	255	285
DOID:9351	diabetes mellitus	GO:0071887	leukocyte apoptotic process	1.2530199100524442e-11	2.7635354116206656e-7	15	94	285
DOID:9351	diabetes mellitus	GO:0050878	regulation of body fluid levels	1.470623622878975e-11	3.243460400259579e-7	32	504	285
DOID:9351	diabetes mellitus	GO:0019901	protein kinase binding	1.47111212100981e-11	3.244537782887136e-7	33	532	285
DOID:9351	diabetes mellitus	GO:0032103	positive regulation of response to external stimulus	1.5624390670154753e-11	3.445959362302631e-7	24	285	285
DOID:9351	diabetes mellitus	GO:0031668	cellular response to extracellular stimulus	1.600997112660707e-11	3.530999131973189e-7	20	193	285
DOID:9351	diabetes mellitus	GO:0042310	vasoconstriction	1.6707635275281518e-11	3.684868959963339e-7	14	80	285
DOID:9351	diabetes mellitus	GO:0009986	cell surface	1.8414159086432846e-11	4.0612427865127643e-7	39	715	285
DOID:9351	diabetes mellitus	GO:0045785	positive regulation of cell adhesion	2.08296713211098e-11	4.5939840098707663e-7	27	368	285
DOID:9351	diabetes mellitus	GO:0019932	second-messenger-mediated signaling	2.286026923314921e-11	5.041832379371058e-7	21	219	285
DOID:9351	diabetes mellitus	GO:0050764	regulation of phagocytosis	2.769939833058288e-11	6.109102301810054e-7	13	68	285
DOID:9351	diabetes mellitus	GO:0046683	response to organophosphorus	2.959588130124757e-11	6.527371620990152e-7	17	136	285
DOID:9351	diabetes mellitus	GO:0019903	protein phosphatase binding	3.297728756734841e-11	7.273140772978692e-7	16	118	285
DOID:9351	diabetes mellitus	GO:0070848	response to growth factor	3.6383562829200855e-11	8.024394781980249e-7	35	621	285
DOID:9351	diabetes mellitus	GO:0070555	response to interleukin-1	3.7350900150556754e-11	8.237741028205292e-7	16	119	285
DOID:9351	diabetes mellitus	GO:0051341	regulation of oxidoreductase activity	3.915090474038152e-11	8.634732040491144e-7	14	85	285
DOID:9351	diabetes mellitus	GO:0050778	positive regulation of immune response	5.711942030472983e-11	1.2597688148208164e-6	34	603	285
DOID:9351	diabetes mellitus	GO:0048471	perinuclear region of cytoplasm	6.254596840449267e-11	1.3794513331610858e-6	35	636	285
DOID:9351	diabetes mellitus	GO:0035295	tube development	6.63956667423804e-11	1.4643564300031997e-6	33	573	285
DOID:9351	diabetes mellitus	GO:0045860	positive regulation of protein kinase activity	7.167122451079422e-11	1.5807088565855665e-6	29	450	285
DOID:9351	diabetes mellitus	GO:0043270	positive regulation of ion transport	7.533795809422372e-11	1.6615786657681042e-6	21	233	285
DOID:9351	diabetes mellitus	GO:0048661	positive regulation of smooth muscle cell proliferation	9.266276634889437e-11	2.0436773118248652e-6	12	60	285
DOID:9351	diabetes mellitus	GO:0045913	positive regulation of carbohydrate metabolic process	1.0132461536471737e-10	2.2347143918688417e-6	13	75	285
DOID:9351	diabetes mellitus	GO:0032368	regulation of lipid transport	1.0133849315252519e-10	2.235020466478943e-6	14	91	285
DOID:9351	diabetes mellitus	GO:1900180	regulation of protein localization to nucleus	1.0328660149383495e-10	2.27798599594653e-6	20	213	285
DOID:9351	diabetes mellitus	GO:0032944	regulation of mononuclear cell proliferation	1.1320311354978685e-10	2.496694669340549e-6	19	191	285
DOID:9351	diabetes mellitus	GO:0002252	immune effector process	1.1929091048301643e-10	2.6309610307029274e-6	38	757	285
DOID:9351	diabetes mellitus	GO:0022409	positive regulation of cell-cell adhesion	1.2155687567627638e-10	2.6809368930402755e-6	21	239	285
DOID:9351	diabetes mellitus	GO:0001763	morphogenesis of a branching structure	1.361497581342519e-10	3.0027829156509256e-6	19	193	285
DOID:9351	diabetes mellitus	GO:0045730	respiratory burst	1.4614320864581032e-10	3.2231884666833466e-6	9	27	285
DOID:9351	diabetes mellitus	GO:0050795	regulation of behavior	1.666897730956407e-10	3.6763429456243557e-6	21	243	285
DOID:9351	diabetes mellitus	GO:0035994	response to muscle stretch	1.7460599632812546e-10	3.850935249016807e-6	8	19	285
DOID:9351	diabetes mellitus	GO:0001659	temperature homeostasis	1.901326873721132e-10	4.1933764199919565e-6	10	38	285
DOID:9351	diabetes mellitus	GO:0044433	cytoplasmic vesicle part	1.9593626721103874e-10	4.321374373339459e-6	33	599	285
DOID:9351	diabetes mellitus	GO:0050994	regulation of lipid catabolic process	2.3966506557115963e-10	5.285813021171926e-6	11	51	285
DOID:9351	diabetes mellitus	GO:0001990	regulation of systemic arterial blood pressure by hormone	2.523544706534153e-10	5.565677850261075e-6	10	39	285
DOID:9351	diabetes mellitus	GO:0046651	lymphocyte proliferation	2.621926009638287e-10	5.7826578142572416e-6	21	249	285
DOID:9351	diabetes mellitus	GO:0061138	morphogenesis of a branching epithelium	2.9880242724544814e-10	6.590087532898359e-6	18	179	285
DOID:9351	diabetes mellitus	GO:0050870	positive regulation of T cell activation	3.0007152318489716e-10	6.618077443842907e-6	19	202	285
DOID:9351	diabetes mellitus	GO:0002026	regulation of the force of heart contraction	3.039836160567688e-10	6.704358652132036e-6	9	29	285
DOID:9351	diabetes mellitus	GO:1903708	positive regulation of hemopoiesis	3.2745872680095545e-10	7.222102219595072e-6	17	158	285
DOID:9351	diabetes mellitus	GO:0080135	regulation of cellular response to stress	3.4918967717345595e-10	7.701378330060571e-6	35	681	285
DOID:9351	diabetes mellitus	GO:0005768	endosome	3.6500324984700683e-10	8.050146675375736e-6	38	789	285
DOID:9351	diabetes mellitus	GO:0045766	positive regulation of angiogenesis	3.9334346890740335e-10	8.675190206752781e-6	15	119	285
DOID:9351	diabetes mellitus	GO:0060402	calcium ion transport into cytosol	3.9334346890740335e-10	8.675190206752781e-6	15	119	285
DOID:9351	diabetes mellitus	GO:0030808	regulation of nucleotide biosynthetic process	4.0089698227774306e-10	8.841782944135623e-6	16	139	285
DOID:9351	diabetes mellitus	GO:1900371	regulation of purine nucleotide biosynthetic process	4.0089698227774306e-10	8.841782944135623e-6	16	139	285
DOID:9351	diabetes mellitus	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	4.402622710841797e-10	9.709984388761583e-6	17	161	285
DOID:9351	diabetes mellitus	GO:0019319	hexose biosynthetic process	4.422455734953701e-10	9.753726123440387e-6	13	84	285
DOID:9351	diabetes mellitus	GO:0033619	membrane protein proteolysis	4.626142802166555e-10	1.0202957950178337e-5	11	54	285
DOID:9351	diabetes mellitus	GO:0071383	cellular response to steroid hormone stimulus	4.855142954340863e-10	1.0708017785798774e-5	17	162	285
DOID:9351	diabetes mellitus	GO:0050663	cytokine secretion	4.855142954340863e-10	1.0708017785798774e-5	17	162	285
DOID:9351	diabetes mellitus	GO:0035690	cellular response to drug	5.159593863268697e-10	1.137948426543911e-5	12	69	285
DOID:9351	diabetes mellitus	GO:0031349	positive regulation of defense response	5.198800279160309e-10	1.1465954015688062e-5	26	398	285
DOID:9351	diabetes mellitus	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	5.323412821667262e-10	1.1740786978187145e-5	33	623	285
DOID:9351	diabetes mellitus	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	6.310514333307538e-10	1.3917839362109774e-5	14	104	285
DOID:9351	diabetes mellitus	GO:0030810	positive regulation of nucleotide biosynthetic process	6.310514333307538e-10	1.3917839362109774e-5	14	104	285
DOID:9351	diabetes mellitus	GO:1900373	positive regulation of purine nucleotide biosynthetic process	6.310514333307538e-10	1.3917839362109774e-5	14	104	285
DOID:9351	diabetes mellitus	GO:0051402	neuron apoptotic process	6.333287227988649e-10	1.3968064981328965e-5	19	211	285
DOID:9351	diabetes mellitus	GO:0043491	protein kinase B signaling	6.806296637407172e-10	1.5011287233801518e-5	16	144	285
DOID:9351	diabetes mellitus	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	7.193299289554034e-10	1.586482158311142e-5	23	317	285
DOID:9351	diabetes mellitus	GO:0046626	regulation of insulin receptor signaling pathway	7.213269981320991e-10	1.5908866943803446e-5	10	43	285
DOID:9351	diabetes mellitus	GO:0045776	negative regulation of blood pressure	7.213269981320991e-10	1.5908866943803446e-5	10	43	285
DOID:9351	diabetes mellitus	GO:0050670	regulation of lymphocyte proliferation	7.295601900381143e-10	1.6090449991290612e-5	18	189	285
DOID:9351	diabetes mellitus	GO:0043523	regulation of neuron apoptotic process	7.950721192528931e-10	1.7535315590122558e-5	18	190	285
DOID:9351	diabetes mellitus	GO:0008285	negative regulation of cell proliferation	8.229280590299481e-10	1.8149678341905506e-5	33	634	285
DOID:9351	diabetes mellitus	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	8.559462028046028e-10	1.8877893502855514e-5	11	57	285
DOID:9351	diabetes mellitus	GO:0032768	regulation of monooxygenase activity	8.559462028046028e-10	1.8877893502855514e-5	11	57	285
DOID:9351	diabetes mellitus	GO:0070374	positive regulation of ERK1 and ERK2 cascade	8.576238608171138e-10	1.8914894250321446e-5	17	168	285
DOID:9351	diabetes mellitus	GO:0046822	regulation of nucleocytoplasmic transport	8.701537268507309e-10	1.919124044569287e-5	19	215	285
DOID:9351	diabetes mellitus	GO:0018105	peptidyl-serine phosphorylation	9.407984391529567e-10	2.074930957551846e-5	20	241	285
DOID:9351	diabetes mellitus	GO:1902107	positive regulation of leukocyte differentiation	9.94006543741932e-10	2.1922814322228312e-5	15	127	285
DOID:9351	diabetes mellitus	GO:1901655	cellular response to ketone	1.0194456390166806e-9	2.248387356851289e-5	12	73	285
DOID:9351	diabetes mellitus	GO:0007259	JAK-STAT cascade	1.0308766063005237e-9	2.273598355195805e-5	17	170	285
DOID:9351	diabetes mellitus	GO:0045087	innate immune response	1.0483118817461445e-9	2.3120518551911218e-5	37	783	285
DOID:9351	diabetes mellitus	GO:0007263	nitric oxide mediated signal transduction	1.0741502132205483e-9	2.3690382952579192e-5	8	23	285
DOID:9351	diabetes mellitus	GO:0034762	regulation of transmembrane transport	1.1507754749118249e-9	2.5380353099180297e-5	25	383	285
DOID:9351	diabetes mellitus	GO:0030099	myeloid cell differentiation	1.3087534389555344e-9	2.886455709616431e-5	23	327	285
DOID:9351	diabetes mellitus	GO:0042312	regulation of vasodilation	1.4727637998035448e-9	3.248180560466718e-5	10	46	285
DOID:9351	diabetes mellitus	GO:0002764	immune response-regulating signaling pathway	1.6090854204620086e-9	3.54883789482896e-5	27	451	285
DOID:9351	diabetes mellitus	GO:0008202	steroid metabolic process	1.6124884760770897e-9	3.556343333988021e-5	21	275	285
DOID:9351	diabetes mellitus	GO:0042306	regulation of protein import into nucleus	1.6149972470458351e-9	3.5618764283595894e-5	17	175	285
DOID:9351	diabetes mellitus	GO:0046427	positive regulation of JAK-STAT cascade	1.6516272793865028e-9	3.642663964686932e-5	12	76	285
DOID:9351	diabetes mellitus	GO:2000106	regulation of leukocyte apoptotic process	1.6516272793865028e-9	3.642663964686932e-5	12	76	285
DOID:9351	diabetes mellitus	GO:0034349	glial cell apoptotic process	1.8245779331849121e-9	4.024106631639324e-5	7	16	285
DOID:9351	diabetes mellitus	GO:0030799	regulation of cyclic nucleotide metabolic process	1.8437932292059145e-9	4.0664859670136444e-5	16	154	285
DOID:9351	diabetes mellitus	GO:0050766	positive regulation of phagocytosis	1.845764319163834e-9	4.070833205915836e-5	10	47	285
DOID:9351	diabetes mellitus	GO:0002443	leukocyte mediated immunity	2.0916072207555203e-9	4.6130397253763e-5	21	279	285
DOID:9351	diabetes mellitus	GO:0048589	developmental growth	2.4038921964120163e-9	5.301784239186702e-5	30	558	285
DOID:9351	diabetes mellitus	GO:0009267	cellular response to starvation	2.4315714997058535e-9	5.36283094260126e-5	14	115	285
DOID:9351	diabetes mellitus	GO:0001959	regulation of cytokine-mediated signaling pathway	2.605601401306501e-9	5.746653890581488e-5	15	136	285
DOID:9351	diabetes mellitus	GO:0045471	response to ethanol	2.8861585343875618e-9	6.365422647591767e-5	15	137	285
DOID:9351	diabetes mellitus	GO:1903035	negative regulation of response to wounding	2.947687871568405e-9	6.501125600744118e-5	16	159	285
DOID:9351	diabetes mellitus	GO:0098552	side of membrane	3.094192901897941e-9	6.824242445135908e-5	25	402	285
DOID:9351	diabetes mellitus	GO:0002573	myeloid leukocyte differentiation	3.2101893365776846e-9	7.080072581822083e-5	17	183	285
DOID:9351	diabetes mellitus	GO:0036296	response to increased oxygen levels	3.2890034029620097e-9	7.253897005232712e-5	8	26	285
DOID:9351	diabetes mellitus	GO:0055093	response to hyperoxia	3.2890034029620097e-9	7.253897005232712e-5	8	26	285
DOID:9351	diabetes mellitus	GO:0009895	negative regulation of catabolic process	3.41919692559145e-9	7.541038819391943e-5	18	208	285
DOID:9351	diabetes mellitus	GO:0048872	homeostasis of number of cells	3.41919692559145e-9	7.541038819391943e-5	18	208	285
DOID:9351	diabetes mellitus	GO:0046824	positive regulation of nucleocytoplasmic transport	3.4207539023611844e-9	7.544472731657592e-5	14	118	285
DOID:9351	diabetes mellitus	GO:0000060	protein import into nucleus, translocation	3.5168389311834858e-9	7.756388262725178e-5	10	50	285
DOID:9351	diabetes mellitus	GO:0006094	gluconeogenesis	3.5181878521584053e-9	7.759363307935363e-5	12	81	285
DOID:9351	diabetes mellitus	GO:0032845	negative regulation of homeostatic process	3.873240395080302e-9	8.542431691349606e-5	16	162	285
DOID:9351	diabetes mellitus	GO:1990748	cellular detoxification	4.065738523628681e-9	8.966986313863057e-5	12	82	285
Orphanet:98456	Dense granule disease	GO:0050817	coagulation	1.4206025245044884e-9	3.133138867794649e-5	24	356	286
Orphanet:98456	Dense granule disease	GO:0007599	hemostasis	1.5018750687545435e-9	3.3123854641381456e-5	24	357	286
Orphanet:98456	Dense granule disease	GO:0042060	wound healing	3.8973770877248626e-9	8.595665166977184e-5	29	534	286
DOID:3146	lipid metabolism disorder	GO:0019752	carboxylic acid metabolic process	1.2962741990918403e-11	2.8589327460970537e-7	76	967	287
DOID:3146	lipid metabolism disorder	GO:0032101	regulation of response to external stimulus	1.979527652906654e-12	4.3658482384856256e-8	47	920	287
DOID:3146	lipid metabolism disorder	GO:0009611	response to wounding	1.872502153332789e-12	4.129803499175466e-8	45	875	287
DOID:3146	lipid metabolism disorder	GO:0097164	ammonium ion metabolic process	1.3413714583521141e-12	2.9583947513955877e-8	22	178	287
DOID:3146	lipid metabolism disorder	GO:0071216	cellular response to biotic stimulus	1.0675904604795505e-12	2.3545707605876487e-8	22	175	287
DOID:3146	lipid metabolism disorder	GO:0046395	carboxylic acid catabolic process	7.553957459549565e-13	1.6660253177036566e-8	27	219	287
DOID:3146	lipid metabolism disorder	GO:0030258	lipid modification	4.89386309254769e-13	1.079341505061393e-8	34	237	287
DOID:3146	lipid metabolism disorder	GO:0072329	monocarboxylic acid catabolic process	5.995204332975845e-14	1.3222423156378227e-9	23	109	287
DOID:3146	lipid metabolism disorder	GO:0050996	positive regulation of lipid catabolic process	2.731148640577885e-14	6.023548326794526e-10	13	24	287
DOID:3146	lipid metabolism disorder	GO:0009062	fatty acid catabolic process	5.995204332975845e-15	1.3222423156378227e-10	22	86	287
DOID:3146	lipid metabolism disorder	GO:0003018	vascular process in circulatory system	1.5543122344752192e-15	3.428035633135096e-11	20	159	287
DOID:3146	lipid metabolism disorder	GO:0034440	lipid oxidation	2.842170943040401e-14	6.268408014875604e-10	24	93	287
DOID:3146	lipid metabolism disorder	GO:0008206	bile acid metabolic process	7.494005416219807e-14	1.6528028945472784e-9	14	41	287
DOID:3146	lipid metabolism disorder	GO:0072593	reactive oxygen species metabolic process	1.2811973704174306e-13	2.8256808004556433e-9	23	223	287
DOID:3146	lipid metabolism disorder	GO:0035150	regulation of tube size	1.454392162258955e-13	3.2076619138621254e-9	19	140	287
DOID:3146	lipid metabolism disorder	GO:0019395	fatty acid oxidation	1.6986412276764895e-13	3.746353227640498e-9	24	91	287
DOID:3146	lipid metabolism disorder	GO:0006635	fatty acid beta-oxidation	2.395861287141088e-13	5.284072068789669e-9	19	65	287
DOID:3146	lipid metabolism disorder	GO:0019217	regulation of fatty acid metabolic process	2.530198273120732e-13	5.580352291367774e-9	18	79	287
DOID:3146	lipid metabolism disorder	GO:0050892	intestinal absorption	3.2385205628315816e-13	7.142557101325053e-9	11	30	287
DOID:3146	lipid metabolism disorder	GO:0090181	regulation of cholesterol metabolic process	3.8624659026709196e-13	8.518668548340713e-9	10	22	287
DOID:3146	lipid metabolism disorder	GO:0046889	positive regulation of lipid biosynthetic process	8.819611707622244e-13	1.9451653621160858e-8	14	64	287
DOID:3146	lipid metabolism disorder	GO:0045923	positive regulation of fatty acid metabolic process	9.124923039394162e-13	2.0125017763383823e-8	11	32	287
DOID:3146	lipid metabolism disorder	GO:0090207	regulation of triglyceride metabolic process	1.917466185830108e-12	4.228971672848303e-8	11	34	287
DOID:3146	lipid metabolism disorder	GO:0043434	response to peptide hormone	2.2474244687487044e-12	4.9566946658252675e-8	34	389	287
DOID:3146	lipid metabolism disorder	GO:0031100	organ regeneration	2.6969537714194303e-12	5.9481315428655535e-8	15	84	287
DOID:3146	lipid metabolism disorder	GO:0006644	phospholipid metabolic process	2.76578759894619e-12	6.099944549475822e-8	35	402	287
DOID:3146	lipid metabolism disorder	GO:0098857	membrane microdomain	3.206102050512527e-12	7.071058072405378e-8	25	283	287
DOID:3146	lipid metabolism disorder	GO:0045121	membrane raft	3.6805003489348564e-12	8.117343519575826e-8	25	282	287
DOID:3146	lipid metabolism disorder	GO:0042493	response to drug	3.88278298402156e-12	8.56347787125955e-8	39	433	287
DOID:3146	lipid metabolism disorder	GO:0005506	iron ion binding	5.486611165395061e-12	1.2100720925278807e-7	19	161	287
DOID:3146	lipid metabolism disorder	GO:0090208	positive regulation of triglyceride metabolic process	6.119105222524013e-12	1.349568656827671e-7	9	20	287
DOID:3146	lipid metabolism disorder	GO:0097305	response to alcohol	7.160161352715022e-12	1.579173586341298e-7	28	369	287
DOID:3146	lipid metabolism disorder	GO:0045940	positive regulation of steroid metabolic process	1.0563327990098514e-11	2.3297419882162274e-7	9	21	287
DOID:3146	lipid metabolism disorder	GO:0051384	response to glucocorticoid	1.1603495941869824e-11	2.5591510299793896e-7	19	167	287
DOID:3146	lipid metabolism disorder	GO:0071417	cellular response to organonitrogen compound	1.2045253683368173e-11	2.6565806998668506e-7	31	462	287
DOID:3146	lipid metabolism disorder	GO:0048608	reproductive structure development	1.7468027024847288e-11	3.8525733603300694e-7	29	418	287
DOID:3146	lipid metabolism disorder	GO:0061365	positive regulation of triglyceride lipase activity	2.1752599721480692e-11	4.797535868572567e-7	7	10	287
DOID:3146	lipid metabolism disorder	GO:0015908	fatty acid transport	2.6059931990118912e-11	5.747518000420726e-7	14	82	287
DOID:3146	lipid metabolism disorder	GO:0006633	fatty acid biosynthetic process	4.216638149756591e-11	9.299795439288161e-7	17	138	287
DOID:3146	lipid metabolism disorder	GO:0002526	acute inflammatory response	5.947520254068195e-11	1.3117255920347404e-6	17	141	287
DOID:3146	lipid metabolism disorder	GO:0020037	heme binding	8.847977905901416e-11	1.9514215271465574e-6	16	125	287
DOID:3146	lipid metabolism disorder	GO:0071375	cellular response to peptide hormone stimulus	1.0228673463785753e-10	2.255933932437948e-6	23	285	287
DOID:3146	lipid metabolism disorder	GO:0006720	isoprenoid metabolic process	1.1271561461967394e-10	2.485942880436909e-6	16	127	287
DOID:3146	lipid metabolism disorder	GO:0008217	regulation of blood pressure	1.1708245484243207e-10	2.5822535415498393e-6	18	168	287
DOID:3146	lipid metabolism disorder	GO:0045017	glycerolipid biosynthetic process	1.1877965278017655e-10	2.6196852420667938e-6	21	237	287
DOID:3146	lipid metabolism disorder	GO:0050810	regulation of steroid biosynthetic process	1.2767886747866442e-10	2.8159574222419437e-6	11	48	287
DOID:3146	lipid metabolism disorder	GO:0090407	organophosphate biosynthetic process	1.414686146006261e-10	3.1200902950168086e-6	33	587	287
DOID:3146	lipid metabolism disorder	GO:0010743	regulation of macrophage derived foam cell differentiation	2.2603074967264547e-10	4.985108184030196e-6	9	28	287
DOID:3146	lipid metabolism disorder	GO:0051050	positive regulation of transport	2.3910973201424213e-10	5.27356513957411e-6	42	920	287
DOID:3146	lipid metabolism disorder	GO:0010885	regulation of cholesterol storage	2.98936098097613e-10	6.593035643542855e-6	7	13	287
DOID:3146	lipid metabolism disorder	GO:0042311	vasodilation	4.682813026235522e-10	1.0327944129362443e-5	12	68	287
DOID:3146	lipid metabolism disorder	GO:0051341	regulation of oxidoreductase activity	5.609734898825991e-10	1.2372270319360723e-5	13	85	287
DOID:3146	lipid metabolism disorder	GO:0044853	plasma membrane raft	5.609734898825991e-10	1.2372270319360723e-5	13	85	287
DOID:3146	lipid metabolism disorder	GO:0042327	positive regulation of phosphorylation	5.98372684734727e-10	1.3197109561824405e-5	41	910	287
DOID:3146	lipid metabolism disorder	GO:0031907	microbody lumen	6.005475006176653e-10	1.3245075126122607e-5	10	42	287
DOID:3146	lipid metabolism disorder	GO:0005782	peroxisomal matrix	6.005475006176653e-10	1.3245075126122607e-5	10	42	287
DOID:3146	lipid metabolism disorder	GO:0097285	cell-type specific apoptotic process	6.331802859804725e-10	1.396479120729932e-5	27	429	287
DOID:3146	lipid metabolism disorder	GO:0033500	carbohydrate homeostasis	7.713699679001706e-10	1.7012564642038264e-5	19	212	287
DOID:3146	lipid metabolism disorder	GO:0042593	glucose homeostasis	7.713699679001706e-10	1.7012564642038264e-5	19	212	287
DOID:3146	lipid metabolism disorder	GO:0019725	cellular homeostasis	8.386022987139086e-10	1.8495373698135253e-5	37	771	287
DOID:3146	lipid metabolism disorder	GO:0007568	aging	8.42605540896102e-10	1.858366520446353e-5	22	290	287
DOID:3146	lipid metabolism disorder	GO:0061041	regulation of wound healing	8.740269619167407e-10	1.9276664645073716e-5	15	125	287
DOID:3146	lipid metabolism disorder	GO:0016627	oxidoreductase activity, acting on the CH-CH group of donors	9.21542731013858e-10	2.0324624932510638e-5	11	57	287
DOID:3146	lipid metabolism disorder	GO:0032768	regulation of monooxygenase activity	9.21542731013858e-10	2.0324624932510638e-5	11	57	287
DOID:3146	lipid metabolism disorder	GO:0051006	positive regulation of lipoprotein lipase activity	1.0119263205154994e-9	2.2318034998969338e-5	6	9	287
DOID:3146	lipid metabolism disorder	GO:2000377	regulation of reactive oxygen species metabolic process	1.0248950577107507e-9	2.2604060497810607e-5	16	147	287
DOID:3146	lipid metabolism disorder	GO:1900407	regulation of cellular response to oxidative stress	1.1219465356759883e-9	2.4744530844333923e-5	11	58	287
DOID:3146	lipid metabolism disorder	GO:0051048	negative regulation of secretion	1.3559317002531657e-9	2.990507364908357e-5	18	195	287
DOID:3146	lipid metabolism disorder	GO:0043086	negative regulation of catalytic activity	1.364213408905357e-9	3.008772673340765e-5	38	822	287
DOID:3146	lipid metabolism disorder	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	1.3827836653490522e-9	3.0497293739273346e-5	16	150	287
DOID:3146	lipid metabolism disorder	GO:0005901	caveola	1.5262339170263317e-9	3.3661089040015746e-5	12	75	287
DOID:3146	lipid metabolism disorder	GO:0005768	endosome	1.5600153391304161e-9	3.440613830452133e-5	37	789	287
DOID:3146	lipid metabolism disorder	GO:1903531	negative regulation of secretion by cell	1.6437157190907214e-9	3.625215018454586e-5	17	174	287
DOID:3146	lipid metabolism disorder	GO:0001934	positive regulation of protein phosphorylation	1.911998337433829e-9	4.21691233321031e-5	39	870	287
DOID:3146	lipid metabolism disorder	GO:0009749	response to glucose	1.9608773493828835e-9	4.3247149940639495e-5	17	176	287
DOID:3146	lipid metabolism disorder	GO:0072358	cardiovascular system development	2.029131418446184e-9	4.475249343383059e-5	40	910	287
DOID:3146	lipid metabolism disorder	GO:0006091	generation of precursor metabolites and energy	2.1209274336797534e-9	4.677705454980696e-5	24	362	287
DOID:3146	lipid metabolism disorder	GO:0031331	positive regulation of cellular catabolic process	2.1259363158776523e-9	4.688752544668162e-5	23	333	287
DOID:3146	lipid metabolism disorder	GO:0055082	cellular chemical homeostasis	2.779908414574095e-9	6.131088008343166e-5	33	661	287
DOID:3146	lipid metabolism disorder	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	3.049917318698192e-9	6.726592646388863e-5	10	49	287
DOID:3146	lipid metabolism disorder	GO:0032373	positive regulation of sterol transport	3.21362414457127e-9	7.087648050851936e-5	7	17	287
DOID:3146	lipid metabolism disorder	GO:0032376	positive regulation of cholesterol transport	3.21362414457127e-9	7.087648050851936e-5	7	17	287
DOID:3146	lipid metabolism disorder	GO:0042803	protein homodimerization activity	3.5090356176326054e-9	7.739178054688711e-5	34	703	287
DOID:3146	lipid metabolism disorder	GO:0048037	cofactor binding	4.240413020717426e-9	9.352230917192283e-5	20	261	287
DOID:3146	lipid metabolism disorder	GO:0001568	blood vessel development	4.441733647553292e-9	9.796243559678786e-5	30	569	287
DOID:1205	hypersensitivity reaction type I disease	GO:0048878	chemical homeostasis	2.0714319148851246e-11	4.568543088279142e-7	59	988	287
DOID:1205	hypersensitivity reaction type I disease	GO:0023014	signal transduction by protein phosphorylation	3.1381564014054675e-12	6.921203943299759e-8	53	879	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030217	T cell differentiation	1.425970452828551e-12	3.1449778337133694e-8	23	199	287
DOID:1205	hypersensitivity reaction type I disease	GO:0050920	regulation of chemotaxis	1.3413714583521141e-12	2.9583947513955877e-8	26	179	287
DOID:1205	hypersensitivity reaction type I disease	GO:0009897	external side of plasma membrane	1.1364242880063102e-12	2.5063837671979172e-8	27	212	287
DOID:1205	hypersensitivity reaction type I disease	GO:0071216	cellular response to biotic stimulus	1.1024514634527804e-12	2.4314567026451073e-8	32	175	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006959	humoral immune response	8.477663016037695e-13	1.8697485781871137e-8	21	173	287
DOID:1205	hypersensitivity reaction type I disease	GO:1903708	positive regulation of hemopoiesis	5.830891325331322e-13	1.2860030818018231e-8	22	158	287
DOID:1205	hypersensitivity reaction type I disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	5.297984273511247e-13	1.1684704315229055e-8	23	168	287
DOID:1205	hypersensitivity reaction type I disease	GO:0071356	cellular response to tumor necrosis factor	3.4017233474514796e-13	7.502500842804238e-9	29	243	287
DOID:1205	hypersensitivity reaction type I disease	GO:0046425	regulation of JAK-STAT cascade	3.1175062531474396e-13	6.875660041316678e-9	21	143	287
DOID:1205	hypersensitivity reaction type I disease	GO:0050707	regulation of cytokine secretion	2.6423307986078726e-13	5.827660576329663e-9	25	142	287
DOID:1205	hypersensitivity reaction type I disease	GO:0097191	extrinsic apoptotic signaling pathway	2.460254222569347e-13	5.4260906878766946e-9	25	220	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002526	acute inflammatory response	1.4144241333724494e-13	3.1195124261529372e-9	25	141	287
DOID:1205	hypersensitivity reaction type I disease	GO:0097530	granulocyte migration	1.2145839889399213e-13	2.6787649876069963e-9	24	108	287
DOID:1205	hypersensitivity reaction type I disease	GO:0048020	CCR chemokine receptor binding	1.0458300891968975e-13	2.3065782617237574e-9	13	35	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002274	myeloid leukocyte activation	8.482103908136196e-14	1.870728016939438e-9	20	153	287
DOID:1205	hypersensitivity reaction type I disease	GO:0007260	tyrosine phosphorylation of STAT protein	6.195044477408373e-14	1.3663170594924168e-9	17	71	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002821	positive regulation of adaptive immune response	6.195044477408373e-14	1.3663170594924168e-9	17	71	287
DOID:1205	hypersensitivity reaction type I disease	GO:0048247	lymphocyte chemotaxis	4.718447854656915e-14	1.0406536743445827e-9	15	52	287
DOID:1205	hypersensitivity reaction type I disease	GO:0050715	positive regulation of cytokine secretion	7.316369732279782e-14	1.6136253444543058e-9	18	95	287
DOID:1205	hypersensitivity reaction type I disease	GO:0008009	chemokine activity	1.2301271112846734e-13	2.7130453439383473e-9	19	49	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002688	regulation of leukocyte chemotaxis	1.3877787807814457e-13	3.0607461010134784e-9	22	96	287
DOID:1205	hypersensitivity reaction type I disease	GO:0070098	chemokine-mediated signaling pathway	1.417754802446325e-13	3.1268582167953696e-9	25	80	287
DOID:1205	hypersensitivity reaction type I disease	GO:0031348	negative regulation of defense response	1.454392162258955e-13	3.2076619138621254e-9	19	140	287
DOID:1205	hypersensitivity reaction type I disease	GO:0035150	regulation of tube size	1.454392162258955e-13	3.2076619138621254e-9	19	140	287
DOID:1205	hypersensitivity reaction type I disease	GO:1990266	neutrophil migration	1.6986412276764895e-13	3.746353227640498e-9	22	91	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002548	monocyte chemotaxis	1.7463808177353712e-13	3.851642893515361e-9	18	60	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030593	neutrophil chemotaxis	1.865174681370263e-13	4.113642759762115e-9	21	84	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	3.5371705564557487e-13	7.801229662263154e-9	14	58	287
DOID:1205	hypersensitivity reaction type I disease	GO:0004896	cytokine receptor activity	5.544453784978032e-13	1.2228292822769049e-8	16	89	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002444	myeloid leukocyte mediated immunity	5.695444116327053e-13	1.2561301998559316e-8	15	74	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042102	positive regulation of T cell proliferation	1.255884285455977e-12	2.7698527915731574e-8	16	95	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032612	interleukin-1 production	1.2709833185908792e-12	2.803153709152184e-8	14	66	287
DOID:1205	hypersensitivity reaction type I disease	GO:0036293	response to decreased oxygen levels	1.3021805855828461e-12	2.871959281502967e-8	27	302	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002718	regulation of cytokine production involved in immune response	2.2872814753327475e-12	5.0445992938463746e-8	13	56	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002253	activation of immune response	2.7641222644092522e-12	6.096271654154606e-8	37	475	287
DOID:1205	hypersensitivity reaction type I disease	GO:0050728	negative regulation of inflammatory response	2.974398505273257e-12	6.560035903380168e-8	16	100	287
DOID:1205	hypersensitivity reaction type I disease	GO:1900046	regulation of hemostasis	3.088751476809648e-12	6.812241382103679e-8	15	85	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030193	regulation of blood coagulation	3.088751476809648e-12	6.812241382103679e-8	15	85	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002764	immune response-regulating signaling pathway	3.089861699834273e-12	6.81468997898449e-8	34	451	287
DOID:1205	hypersensitivity reaction type I disease	GO:0060548	negative regulation of cell death	3.52751161614151e-12	7.7799268694001e-8	50	867	287
DOID:1205	hypersensitivity reaction type I disease	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	4.532152431124814e-12	9.995662186845777e-8	16	103	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043900	regulation of multi-organism process	4.860889468716323e-12	1.072069172325385e-7	32	467	287
DOID:1205	hypersensitivity reaction type I disease	GO:0098542	defense response to other organism	6.058265000774554e-12	1.336150345920828e-7	38	550	287
DOID:1205	hypersensitivity reaction type I disease	GO:0010942	positive regulation of cell death	6.285638676217786e-12	1.3862976100398328e-7	37	596	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002761	regulation of myeloid leukocyte differentiation	6.662781437682952e-12	1.469476446080975e-7	16	106	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002757	immune response-activating signal transduction	7.76378961120372e-12	1.7123037987509804e-7	30	419	287
DOID:1205	hypersensitivity reaction type I disease	GO:1903522	regulation of blood circulation	7.985834216128751e-12	1.761275736367196e-7	25	297	287
DOID:1205	hypersensitivity reaction type I disease	GO:0097285	cell-type specific apoptotic process	8.861467115650612e-12	1.9543965723567425e-7	30	429	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043069	negative regulation of programmed cell death	1.23244747740614e-11	2.718162911419242e-7	49	806	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042113	B cell activation	1.334832244737072e-11	2.943972515767612e-7	21	212	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002437	inflammatory response to antigenic stimulus	1.463484888830635e-11	3.2277159223159657e-7	11	40	287
DOID:1205	hypersensitivity reaction type I disease	GO:0098869	cellular oxidant detoxification	1.549671502232286e-11	3.417800498173307e-7	14	79	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043066	negative regulation of apoptotic process	1.5553114351973818e-11	3.4302393703278256e-7	46	795	287
DOID:1205	hypersensitivity reaction type I disease	GO:0061082	myeloid leukocyte cytokine production	1.7692514120426495e-11	3.9020839892600634e-7	9	22	287
DOID:1205	hypersensitivity reaction type I disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.9021340058600344e-11	4.195156549924306e-7	18	151	287
DOID:1205	hypersensitivity reaction type I disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	2.2180368652868765e-11	4.891880306390206e-7	15	97	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032680	regulation of tumor necrosis factor production	3.472977461171922e-11	7.659651790614674e-7	15	100	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002455	humoral immune response mediated by circulating immunoglobulin	3.489308841864158e-11	7.695670650731401e-7	11	43	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006887	exocytosis	3.708688911530089e-11	8.179513394379612e-7	28	405	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043065	positive regulation of apoptotic process	4.1901482283890346e-11	9.241371917712016e-7	33	556	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032760	positive regulation of tumor necrosis factor production	4.24430490753025e-11	9.360814473557966e-7	12	56	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032652	regulation of interleukin-1 production	4.24430490753025e-11	9.360814473557966e-7	12	56	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032611	interleukin-1 beta production	5.290834437232661e-11	1.1668935351316634e-6	12	57	287
DOID:1205	hypersensitivity reaction type I disease	GO:0048245	eosinophil chemotaxis	5.902678346103585e-11	1.3018357092331456e-6	7	11	287
DOID:1205	hypersensitivity reaction type I disease	GO:0008285	negative regulation of cell proliferation	6.738098967673523e-11	1.4860877273203954e-6	35	634	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042089	cytokine biosynthetic process	7.108047483939117e-11	1.5676798725827723e-6	15	105	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002576	platelet degranulation	8.104650284224135e-11	1.787480620185633e-6	15	106	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042108	positive regulation of cytokine biosynthetic process	8.155320863068027e-11	1.7986560163496534e-6	12	59	287
DOID:1205	hypersensitivity reaction type I disease	GO:2000021	regulation of ion homeostasis	1.0642209335998132e-10	2.347139269054388e-6	19	189	287
DOID:1205	hypersensitivity reaction type I disease	GO:0007249	I-kappaB kinase/NF-kappaB signaling	1.0668199657004607e-10	2.352871434352366e-6	22	260	287
DOID:1205	hypersensitivity reaction type I disease	GO:0050702	interleukin-1 beta secretion	1.1243816988582012e-10	2.4798238368317627e-6	10	36	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032635	interleukin-6 production	1.219806478047758e-10	2.6902831873343303e-6	15	109	287
DOID:1205	hypersensitivity reaction type I disease	GO:0051345	positive regulation of hydrolase activity	1.2285483741436565e-10	2.7095634391738344e-6	42	900	287
DOID:1205	hypersensitivity reaction type I disease	GO:0001660	fever generation	1.3979850610468247e-10	3.083256052138772e-6	7	12	287
DOID:1205	hypersensitivity reaction type I disease	GO:0031294	lymphocyte costimulation	1.844027153197203e-10	4.067001886376431e-6	13	78	287
DOID:1205	hypersensitivity reaction type I disease	GO:0009266	response to temperature stimulus	1.9437051967940988e-10	4.286841811529385e-6	20	219	287
DOID:1205	hypersensitivity reaction type I disease	GO:0019932	second-messenger-mediated signaling	1.9437051967940988e-10	4.286841811529385e-6	20	219	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002768	immune response-regulating cell surface receptor signaling pathway	2.166437029771373e-10	4.778076869160763e-6	24	323	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030141	secretory granule	2.1952040185624355e-10	4.8415224629394515e-6	25	351	287
DOID:1205	hypersensitivity reaction type I disease	GO:0045807	positive regulation of endocytosis	2.341122851134969e-10	5.163346448178174e-6	15	114	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030162	regulation of proteolysis	2.4189295011467493e-10	5.334949014779156e-6	36	701	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042742	defense response to bacterium	2.4864499348353775e-10	5.483865331279425e-6	20	222	287
DOID:1205	hypersensitivity reaction type I disease	GO:0060333	interferon-gamma-mediated signaling pathway	2.563615986161949e-10	5.6540550574801784e-6	13	80	287
DOID:1205	hypersensitivity reaction type I disease	GO:0009615	response to virus	2.6205471126417024e-10	5.7796166569312746e-6	27	412	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006939	smooth muscle contraction	2.678227639663078e-10	5.906831059276918e-6	14	97	287
DOID:1205	hypersensitivity reaction type I disease	GO:0051235	maintenance of location	2.8697255682885725e-10	6.329179740860447e-6	22	274	287
DOID:1205	hypersensitivity reaction type I disease	GO:0001959	regulation of cytokine-mediated signaling pathway	3.199188691738186e-10	7.05581065962857e-6	16	136	287
DOID:1205	hypersensitivity reaction type I disease	GO:0051051	negative regulation of transport	4.3061776366926097e-10	9.49727477772555e-6	28	452	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006898	receptor-mediated endocytosis	4.3069003918816406e-10	9.498868814294958e-6	21	254	287
DOID:1205	hypersensitivity reaction type I disease	GO:0048771	tissue remodeling	4.442068934906729e-10	9.79698303593679e-6	16	139	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032755	positive regulation of interleukin-6 production	4.682813026235522e-10	1.0327944129362443e-5	12	68	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032845	negative regulation of homeostatic process	5.406280978448308e-10	1.1923552697967743e-5	17	162	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	5.864055907522925e-10	1.293317530404181e-5	20	233	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042516	regulation of tyrosine phosphorylation of Stat3 protein	6.005475006176653e-10	1.3245075126122607e-5	10	42	287
DOID:1205	hypersensitivity reaction type I disease	GO:0010574	regulation of vascular endothelial growth factor production	6.33658570059481e-10	1.3975339762661854e-5	9	31	287
DOID:1205	hypersensitivity reaction type I disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	6.912871386433039e-10	1.5246337842778068e-5	14	104	287
DOID:1205	hypersensitivity reaction type I disease	GO:0090257	regulation of muscle system process	8.352484259788184e-10	1.842140403496284e-5	19	213	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032846	positive regulation of homeostatic process	1.054491827190418e-9	2.325681724868467e-5	18	192	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006606	protein import into nucleus	1.1486553930240007e-9	2.5333594693144335e-5	21	268	287
DOID:1205	hypersensitivity reaction type I disease	GO:0045088	regulation of innate immune response	1.148675377038444e-9	2.533403544058288e-5	24	351	287
DOID:1205	hypersensitivity reaction type I disease	GO:0045859	regulation of protein kinase activity	1.1888001694160266e-9	2.6218987736470467e-5	35	709	287
DOID:1205	hypersensitivity reaction type I disease	GO:0043901	negative regulation of multi-organism process	1.3827836653490522e-9	3.0497293739273346e-5	16	150	287
DOID:1205	hypersensitivity reaction type I disease	GO:0006940	regulation of smooth muscle contraction	1.643173375143192e-9	3.62401887887831e-5	11	60	287
DOID:1205	hypersensitivity reaction type I disease	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	1.7989669753859516e-9	3.967621664213716e-5	24	359	287
DOID:1205	hypersensitivity reaction type I disease	GO:0030799	regulation of cyclic nucleotide metabolic process	2.039506674655911e-9	4.4981319709536116e-5	16	154	287
DOID:1205	hypersensitivity reaction type I disease	GO:0031295	T cell costimulation	2.0888618612602272e-9	4.606984835009431e-5	12	77	287
DOID:1205	hypersensitivity reaction type I disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	2.1011373751989026e-9	4.63405848100118e-5	19	225	287
DOID:1205	hypersensitivity reaction type I disease	GO:0045670	regulation of osteoclast differentiation	2.3716670849438515e-9	5.2307117558436644e-5	11	62	287
DOID:1205	hypersensitivity reaction type I disease	GO:2000501	regulation of natural killer cell chemotaxis	2.4972095502562297e-9	5.5075956630901146e-5	6	10	287
DOID:1205	hypersensitivity reaction type I disease	GO:0031622	positive regulation of fever generation	2.4972095502562297e-9	5.5075956630901146e-5	6	10	287
DOID:1205	hypersensitivity reaction type I disease	GO:1900542	regulation of purine nucleotide metabolic process	2.5890051214005894e-9	5.710050795249e-5	18	203	287
DOID:1205	hypersensitivity reaction type I disease	GO:0002763	positive regulation of myeloid leukocyte differentiation	3.049917318698192e-9	6.726592646388863e-5	10	49	287
DOID:1205	hypersensitivity reaction type I disease	GO:0009408	response to heat	3.2589592136034184e-9	7.18763454560234e-5	16	159	287
DOID:1205	hypersensitivity reaction type I disease	GO:0071260	cellular response to mechanical stimulus	3.286923733192282e-9	7.249310293555578e-5	12	80	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042307	positive regulation of protein import into nucleus	3.4143606830738804e-9	7.530372486519443e-5	13	98	287
DOID:1205	hypersensitivity reaction type I disease	GO:0042346	positive regulation of NF-kappaB import into nucleus	3.4746641119909327e-9	7.663371698996002e-5	8	26	287
DOID:1205	hypersensitivity reaction type I disease	GO:0044764	multi-organism cellular process	3.5964100586483028e-9	7.931882384348832e-5	35	740	287
DOID:1205	hypersensitivity reaction type I disease	GO:0032570	response to progesterone	3.761024602866314e-9	8.294939761621656e-5	10	50	287
DOID:1205	hypersensitivity reaction type I disease	GO:0019229	regulation of vasoconstriction	4.009046317143827e-9	8.841951652460711e-5	11	65	287
DOID:1205	hypersensitivity reaction type I disease	GO:0060402	calcium ion transport into cytosol	4.182693857934794e-9	9.224931303675188e-5	14	119	287
DOID:1205	hypersensitivity reaction type I disease	GO:0070542	response to fatty acid	4.398217567924689e-9	9.700268846057902e-5	12	82	287
OMIM:185050	Platelet storage pool disease	GO:0007596	blood coagulation	1.39703626444998e-9	3.081163481244431e-5	24	352	289
OMIM:185050	Platelet storage pool disease	GO:0071456	cellular response to hypoxia	2.561037715231862e-9	5.6483686809438716e-5	15	134	289
OMIM:185050	Platelet storage pool disease	GO:0001889	liver development	2.8416901054484356e-9	6.267347527566525e-5	15	135	289
OMIM:185050	Platelet storage pool disease	GO:0006935	chemotaxis	4.176233692199105e-9	9.210683408145126e-5	29	530	289
Orphanet:101944	Rare pulmonary disease	GO:0032101	regulation of response to external stimulus	3.0193625377705757e-12	6.659204077053005e-8	62	920	289
Orphanet:101944	Rare pulmonary disease	GO:0023014	signal transduction by protein phosphorylation	2.8395064077813004e-12	6.262531382361658e-8	52	879	289
Orphanet:101944	Rare pulmonary disease	GO:0042327	positive regulation of phosphorylation	1.8558488079634117e-12	4.0930745459633044e-8	57	910	289
Orphanet:101944	Rare pulmonary disease	GO:0032944	regulation of mononuclear cell proliferation	1.6278089987054045e-12	3.5901327466447697e-8	29	191	289
Orphanet:101944	Rare pulmonary disease	GO:0060541	respiratory system development	1.5287771049088406e-12	3.371717904876448e-8	26	202	289
Orphanet:101944	Rare pulmonary disease	GO:0030323	respiratory tube development	1.504130153762162e-12	3.3173590541224485e-8	23	179	289
Orphanet:101944	Rare pulmonary disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.1595169269185135e-12	2.5573145823187815e-8	29	212	289
Orphanet:101944	Rare pulmonary disease	GO:0070372	regulation of ERK1 and ERK2 cascade	9.21707155043805e-13	2.032825130449112e-8	26	233	289
Orphanet:101944	Rare pulmonary disease	GO:0090130	tissue migration	7.616129948928574e-14	1.679737460236197e-9	23	227	289
Orphanet:101944	Rare pulmonary disease	GO:0097014	ciliary cytoplasm	3.2307490016592055e-14	7.125416923159378e-10	19	90	289
Orphanet:101944	Rare pulmonary disease	GO:0005930	axoneme	3.2307490016592055e-14	7.125416923159378e-10	19	90	289
Orphanet:101944	Rare pulmonary disease	GO:0048659	smooth muscle cell proliferation	5.56776846849516e-13	1.2279713357266075e-8	17	104	289
Orphanet:101944	Rare pulmonary disease	GO:0003013	circulatory system process	5.367706279457707e-12	1.1838476199343972e-7	34	493	289
Orphanet:101944	Rare pulmonary disease	GO:0007507	heart development	6.023070930893937e-12	1.3283882938086577e-7	35	487	289
Orphanet:101944	Rare pulmonary disease	GO:0002687	positive regulation of leukocyte migration	1.1601275495820573e-11	2.5586613106032274e-7	16	109	289
Orphanet:101944	Rare pulmonary disease	GO:0003002	regionalization	1.1886602813149239e-11	2.6215902504400646e-7	26	327	289
Orphanet:101944	Rare pulmonary disease	GO:0045428	regulation of nitric oxide biosynthetic process	1.4062084829902233e-11	3.1013928092349374e-7	12	51	289
Orphanet:101944	Rare pulmonary disease	GO:0008217	regulation of blood pressure	1.4537815395954112e-11	3.2063151855776795e-7	19	168	289
Orphanet:101944	Rare pulmonary disease	GO:0044433	cytoplasmic vesicle part	2.022548795110879e-11	4.4607313676170435e-7	35	599	289
Orphanet:101944	Rare pulmonary disease	GO:0010243	response to organonitrogen compound	2.3256285786033004e-11	5.129173830109579e-7	41	780	289
Orphanet:101944	Rare pulmonary disease	GO:0071346	cellular response to interferon-gamma	2.5612512111194974e-11	5.648839546124051e-7	17	133	289
Orphanet:101944	Rare pulmonary disease	GO:0003073	regulation of systemic arterial blood pressure	3.379752033794148e-11	7.454043110532993e-7	14	83	289
Orphanet:101944	Rare pulmonary disease	GO:0048660	regulation of smooth muscle cell proliferation	3.8245073774589855e-11	8.434951020985793e-7	15	100	289
Orphanet:101944	Rare pulmonary disease	GO:0010634	positive regulation of epithelial cell migration	4.414624221737995e-11	9.736453721043148e-7	15	101	289
Orphanet:101944	Rare pulmonary disease	GO:0072001	renal system development	6.220124415534656e-11	1.3718484398461683e-6	23	276	289
Orphanet:101944	Rare pulmonary disease	GO:0030097	hemopoiesis	7.073752694708446e-11	1.5601161568179478e-6	37	695	289
Orphanet:101944	Rare pulmonary disease	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	8.356360048367151e-11	1.842995208667375e-6	11	46	289
Orphanet:101944	Rare pulmonary disease	GO:0048732	gland development	1.035402874549618e-10	2.2835810398191825e-6	28	421	289
Orphanet:101944	Rare pulmonary disease	GO:0001822	kidney development	1.4035694828606893e-10	3.09557249444925e-6	22	262	289
Orphanet:101944	Rare pulmonary disease	GO:0032846	positive regulation of homeostatic process	1.577983299583252e-10	3.4802421672308625e-6	19	192	289
Orphanet:101944	Rare pulmonary disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.980697827974609e-10	4.368429059598e-6	17	151	289
Orphanet:101944	Rare pulmonary disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	3.803456438689068e-10	8.38852317552874e-6	10	40	289
Orphanet:101944	Rare pulmonary disease	GO:0051480	cytosolic calcium ion homeostasis	5.26210852669351e-10	1.1605580355622536e-5	21	255	289
Orphanet:101944	Rare pulmonary disease	GO:0061061	muscle structure development	6.051860124145492e-10	1.3347377503802882e-5	31	551	289
Orphanet:101944	Rare pulmonary disease	GO:0051341	regulation of oxidoreductase activity	6.107009342670722e-10	1.3469009105260277e-5	13	85	289
Orphanet:101944	Rare pulmonary disease	GO:0007204	positive regulation of cytosolic calcium ion concentration	7.146410130332015e-10	1.576140754244726e-5	20	234	289
Orphanet:101944	Rare pulmonary disease	GO:0048598	embryonic morphogenesis	8.974413434614803e-10	1.9793068830042948e-5	31	560	289
Orphanet:101944	Rare pulmonary disease	GO:0048871	multicellular organismal homeostasis	1.2005988425656255e-9	2.647920747278487e-5	23	321	289
Orphanet:101944	Rare pulmonary disease	GO:0071496	cellular response to external stimulus	1.488829282081383e-9	3.2836129816304904e-5	21	270	289
Orphanet:101944	Rare pulmonary disease	GO:0031667	response to nutrient levels	2.0177368664775486e-9	4.4501186590162334e-5	30	546	289
Orphanet:101944	Rare pulmonary disease	GO:0071260	cellular response to mechanical stimulus	3.5541967147167952e-9	7.838780854307892e-5	12	80	289
Orphanet:101944	Rare pulmonary disease	GO:0009306	protein secretion	3.6637047839960246e-9	8.080300901103232e-5	27	462	289
DOID:0050632	oculocutaneous albinism	GO:0048066	developmental pigmentation	1.7252865802674933e-13	3.805119552779956e-9	14	46	294
DOID:0050632	oculocutaneous albinism	GO:0030318	melanocyte differentiation	3.3519853559482726e-12	7.392803702543915e-8	10	26	294
DOID:0050632	oculocutaneous albinism	GO:0009314	response to radiation	1.1913140474106854e-9	2.6274431315642666e-5	27	431	294
DOID:0050632	oculocutaneous albinism	GO:0002695	negative regulation of leukocyte activation	3.588128238973809e-9	7.913616831056736e-5	15	135	294
DOID:0050632	oculocutaneous albinism	GO:0045637	regulation of myeloid cell differentiation	3.6577418871530654e-9	8.067149732116086e-5	17	179	294
DOID:0050632	oculocutaneous albinism	GO:0051250	negative regulation of lymphocyte activation	4.064850123164376e-9	8.965026946639032e-5	14	116	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0009887	organ morphogenesis	4.459321800709404e-12	9.83503423146459e-8	52	950	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0090596	sensory organ morphogenesis	1.5145662501936386e-12	3.34037586480207e-8	31	239	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0071482	cellular response to light stimulus	3.086420008457935e-14	6.807099328653976e-10	18	109	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0060042	retina morphogenesis in camera-type eye	5.93607385468431e-11	1.3092010886506245e-6	11	44	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0042622	photoreceptor outer segment membrane	2.264641252303079e-9	4.994666281954441e-5	7	16	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0016101	diterpenoid metabolic process	3.0907375547784e-9	6.816621677063761e-5	13	95	294
Orphanet:98657	Genetic vitreous-retinal disease	GO:0048562	embryonic organ morphogenesis	3.88744880730485e-9	8.573768344510846e-5	21	280	294
Orphanet:68362	Rare vascular disease	GO:1901701	cellular response to oxygen-containing compound	1.765254609153999e-12	3.8932690404891446e-8	47	873	294
Orphanet:68362	Rare vascular disease	GO:0009790	embryo development	1.0975664821444298e-12	2.4206828763695398e-8	46	932	294
Orphanet:68362	Rare vascular disease	GO:0001944	vasculature development	5.063727215315339e-12	1.116805037337798e-7	39	588	294
Orphanet:68362	Rare vascular disease	GO:1901699	cellular response to nitrogen compound	9.804823619674607e-12	2.1624538493192347e-7	35	518	294
Orphanet:68362	Rare vascular disease	GO:1901652	response to peptide	1.0713874232237686e-11	2.3629449619200216e-7	30	423	294
Orphanet:68362	Rare vascular disease	GO:0022603	regulation of anatomical structure morphogenesis	1.3907097695664561e-11	3.067210396778819e-7	46	986	294
Orphanet:68362	Rare vascular disease	GO:0043068	positive regulation of programmed cell death	1.5146661702658548e-11	3.340596238521343e-7	35	561	294
Orphanet:68362	Rare vascular disease	GO:0051270	regulation of cellular component movement	1.6577406114492987e-11	3.6561469185514284e-7	51	787	294
Orphanet:68362	Rare vascular disease	GO:0071417	cellular response to organonitrogen compound	1.722721965080609e-11	3.7994632939852835e-7	31	462	294
Orphanet:68362	Rare vascular disease	GO:0002520	immune system development	1.7813084340900787e-11	3.9286757513856685e-7	43	782	294
Orphanet:68362	Rare vascular disease	GO:0043434	response to peptide hormone	2.4853341606956292e-11	5.48140449141421e-7	28	389	294
Orphanet:68362	Rare vascular disease	GO:0048514	blood vessel morphogenesis	4.242917128749468e-11	9.357753727456952e-7	31	484	294
Orphanet:68362	Rare vascular disease	GO:1903409	reactive oxygen species biosynthetic process	4.24661417142147e-11	9.365907555070052e-7	14	83	294
Orphanet:68362	Rare vascular disease	GO:0048534	hematopoietic or lymphoid organ development	4.719769020056219e-11	1.0409450573733992e-6	39	739	294
Orphanet:68362	Rare vascular disease	GO:0001775	cell activation	5.253930623894121e-11	1.1587543990998483e-6	42	854	294
Orphanet:68362	Rare vascular disease	GO:0045471	response to ethanol	5.4116489067723705e-11	1.1935391663886463e-6	17	137	294
Orphanet:68362	Rare vascular disease	GO:0071900	regulation of protein serine/threonine kinase activity	5.505496059043935e-11	1.2142371558221399e-6	29	431	294
Orphanet:68362	Rare vascular disease	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	7.743383712011109e-11	1.7078032776840502e-6	11	45	294
Orphanet:68362	Rare vascular disease	GO:0001654	eye development	8.238054682863094e-11	1.8169029603054554e-6	25	327	294
Orphanet:68362	Rare vascular disease	GO:0031983	vesicle lumen	1.136342131502488e-10	2.5062025710287372e-6	15	106	294
Orphanet:68362	Rare vascular disease	GO:0050801	ion homeostasis	1.325149989739316e-10	2.9226183023700614e-6	36	668	294
Orphanet:68362	Rare vascular disease	GO:0031032	actomyosin structure organization	1.3547440946837241e-10	2.9878881008249536e-6	17	145	294
Orphanet:68362	Rare vascular disease	GO:0042803	protein homodimerization activity	1.4015488769558715e-10	3.0911160481261746e-6	37	703	294
Orphanet:68362	Rare vascular disease	GO:0035295	tube development	1.4326539954367945e-10	3.1597183869358503e-6	33	573	294
Orphanet:68362	Rare vascular disease	GO:0008284	positive regulation of cell proliferation	1.8263668355444906e-10	4.028052055793374e-6	40	815	294
Orphanet:68362	Rare vascular disease	GO:1901215	negative regulation of neuron death	2.109042940290351e-10	4.651494204810369e-6	18	170	294
Orphanet:68362	Rare vascular disease	GO:2000147	positive regulation of cell motility	2.1928825422179443e-10	4.836402446861676e-6	27	399	294
Orphanet:68362	Rare vascular disease	GO:0043086	negative regulation of catalytic activity	2.3233859280935576e-10	5.124227664410341e-6	40	822	294
Orphanet:68362	Rare vascular disease	GO:2001234	negative regulation of apoptotic signaling pathway	3.927174141438172e-10	8.661382568941889e-6	19	199	294
Orphanet:68362	Rare vascular disease	GO:0001933	negative regulation of protein phosphorylation	4.987530388689265e-10	1.0999998272254174e-5	26	385	294
Orphanet:68362	Rare vascular disease	GO:0030335	positive regulation of cell migration	5.565057303869025e-10	1.2273733883683136e-5	26	387	294
Orphanet:68362	Rare vascular disease	GO:0035690	cellular response to drug	7.356348863396533e-10	1.6224427418221055e-5	12	69	294
Orphanet:68362	Rare vascular disease	GO:0031667	response to nutrient levels	7.425760006896098e-10	1.6377513695209345e-5	31	546	294
Orphanet:68362	Rare vascular disease	GO:0051051	negative regulation of transport	7.456082418144661e-10	1.644438977321805e-5	28	452	294
Orphanet:68362	Rare vascular disease	GO:0009986	cell surface	7.769324072981476e-10	1.7135244242960646e-5	36	715	294
Orphanet:68362	Rare vascular disease	GO:0045765	regulation of angiogenesis	8.367599946268456e-10	1.845474168149508e-5	19	208	294
Orphanet:68362	Rare vascular disease	GO:0000904	cell morphogenesis involved in differentiation	9.36353439229265e-10	2.065127510220144e-5	36	720	294
Orphanet:68362	Rare vascular disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	9.453877680698497e-10	2.0850527224780535e-5	14	104	294
Orphanet:68362	Rare vascular disease	GO:0006469	negative regulation of protein kinase activity	9.636055287032264e-10	2.1252319935549657e-5	20	234	294
Orphanet:68362	Rare vascular disease	GO:0046982	protein heterodimerization activity	1.0520060378382823e-9	2.3201993164523316e-5	28	459	294
Orphanet:68362	Rare vascular disease	GO:0007159	leukocyte cell-cell adhesion	1.1589084136787164e-9	2.555972506368409e-5	28	461	294
Orphanet:68362	Rare vascular disease	GO:0009314	response to radiation	1.1913140474106854e-9	2.6274431315642666e-5	27	431	294
Orphanet:68362	Rare vascular disease	GO:1900182	positive regulation of protein localization to nucleus	1.2172933772092165e-9	2.684740543434927e-5	15	125	294
Orphanet:68362	Rare vascular disease	GO:0002576	platelet degranulation	1.2216582190305303e-9	2.6943672020718346e-5	14	106	294
Orphanet:68362	Rare vascular disease	GO:2000377	regulation of reactive oxygen species metabolic process	1.453281717189725e-9	3.2052128272619385e-5	16	147	294
Orphanet:68362	Rare vascular disease	GO:0071901	negative regulation of protein serine/threonine kinase activity	1.7015514552909394e-9	3.752771734644167e-5	15	128	294
Orphanet:68362	Rare vascular disease	GO:0051050	positive regulation of transport	1.7223888981732216e-9	3.79872871492104e-5	41	920	294
Orphanet:68362	Rare vascular disease	GO:0031589	cell-substrate adhesion	2.4869089010337575e-9	5.484877581229952e-5	22	300	294
Orphanet:68362	Rare vascular disease	GO:0033674	positive regulation of kinase activity	2.8350443104230294e-9	6.252690226637991e-5	28	480	294
Orphanet:68362	Rare vascular disease	GO:0048608	reproductive structure development	2.842640012268305e-9	6.269442547057746e-5	26	418	294
Orphanet:68362	Rare vascular disease	GO:0006809	nitric oxide biosynthetic process	3.0512318227593482e-9	6.729491785095743e-5	11	62	294
Orphanet:68362	Rare vascular disease	GO:0090130	tissue migration	3.6257116198257222e-9	7.99650697752563e-5	19	227	294
Orphanet:68362	Rare vascular disease	GO:0031960	response to corticosteroid	3.6577418871530654e-9	8.067149732116086e-5	17	179	294
Orphanet:68362	Rare vascular disease	GO:0070489	T cell aggregation	3.827246630727643e-9	8.440992444069817e-5	26	424	294
Orphanet:68362	Rare vascular disease	GO:0042110	T cell activation	3.827246630727643e-9	8.440992444069817e-5	26	424	294
Orphanet:352728	Disorder of melanin metabolism	GO:0033162	melanosome membrane	1.1938056099225491e-9	2.632938272684182e-5	6	9	295
Orphanet:352728	Disorder of melanin metabolism	GO:0048753	pigment granule organization	3.0258601180221945e-9	6.67353449029795e-5	8	25	295
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0006582	melanin metabolic process	2.4228263839631836e-10	5.3435435898308015e-6	8	19	297
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0048770	pigment granule	8.298269849049689e-10	1.830183415207909e-5	14	102	297
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0042470	melanosome	8.298269849049689e-10	1.830183415207909e-5	14	102	297
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0033162	melanosome membrane	1.2432750384760993e-9	2.742043097359037e-5	6	9	297
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0048753	pigment granule organization	3.1907486652826833e-9	7.037196181280958e-5	8	25	297
Orphanet:98706	Oculocutaneous or ocular albinism	GO:0044550	secondary metabolite biosynthetic process	3.1907486652826833e-9	7.037196181280958e-5	8	25	297
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.227685034332353e-12	1.3735159343220005e-7	49	996	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0046661	male sex differentiation	1.0433875985427221e-12	2.3011913485859736e-8	22	151	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0060249	anatomical structure homeostasis	3.546274385257675e-12	7.821308156685802e-8	30	351	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0001944	vasculature development	6.744382829992901e-12	1.4874736331549343e-7	37	588	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0001568	blood vessel development	7.621347997144312e-12	1.680888300770178e-7	37	569	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0032870	cellular response to hormone stimulus	1.1908141139826967e-11	2.6263405283888375e-7	34	519	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0014070	response to organic cyclic compound	1.195510357376861e-11	2.636698093194667e-7	44	873	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0001067	regulatory region nucleic acid binding	1.3598233650213842e-11	2.999090431554663e-7	44	811	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0060548	negative regulation of cell death	1.3842704760236302e-11	3.0530085348701164e-7	44	867	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:1901698	response to nitrogen compound	1.3998802117498599e-11	3.087435807014316e-7	44	870	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0044212	transcription regulatory region DNA binding	1.6451062734290645e-11	3.6282818860478017e-7	43	807	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0048514	blood vessel morphogenesis	1.793332149446769e-11	3.9551940556048493e-7	32	484	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.8098633702834377e-11	3.991653663160122e-7	37	623	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0046660	female sex differentiation	2.032041201971424e-11	4.4816668709479757e-7	17	127	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0003690	double-stranded DNA binding	2.3237745061521764e-11	5.125084673318625e-7	41	756	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0043066	negative regulation of apoptotic process	2.6895152771544417e-11	5.931725943764121e-7	42	795	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0010243	response to organonitrogen compound	3.764111244919377e-11	8.301747350669686e-7	41	780	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0046620	regulation of organ growth	1.0685730078563438e-10	2.3567377688271662e-6	13	72	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0001085	RNA polymerase II transcription factor binding	1.0922396320722783e-10	2.4089345085354097e-6	15	104	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0019953	sexual reproduction	1.2136447402610884e-10	2.6766934746458304e-6	39	754	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.8115819955255574e-10	3.995444091131617e-6	38	732	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0045664	regulation of neuron differentiation	3.01366265276215e-10	6.646632980666922e-6	32	548	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	3.407228943430596e-10	7.514643434736179e-6	24	317	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0045165	cell fate commitment	4.041725842895971e-10	8.914026346507065e-6	21	243	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0050769	positive regulation of neurogenesis	4.3273107319663495e-10	9.543883819351784e-6	26	376	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0048806	genitalia development	6.903151383852446e-10	1.522490037708657e-5	10	41	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0048545	response to steroid hormone	8.087847058746434e-10	1.783774668806526e-5	28	446	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0007276	gamete generation	8.675670182256567e-10	1.913419058696686e-5	33	605	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0002520	immune system development	1.1076415340482981e-9	2.4429034033435215e-5	38	782	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0035107	appendage morphogenesis	1.6762793375590945e-9	3.697034078986583e-5	16	146	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0035108	limb morphogenesis	1.6762793375590945e-9	3.697034078986583e-5	16	146	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0002065	columnar/cuboidal epithelial cell differentiation	2.1426576068961367e-9	4.7256313520094295e-5	15	128	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:1901615	organic hydroxy compound metabolic process	2.6894703131219444e-9	5.9316267755904484e-5	30	534	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0048639	positive regulation of developmental growth	3.339028609161687e-9	7.364227597506101e-5	16	153	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0008284	positive regulation of cell proliferation	3.4254025171875924e-9	7.554725251657235e-5	38	815	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0072001	renal system development	4.0614180907283526e-9	8.957457599101382e-5	21	276	299
Orphanet:183731	Rare genetic gynecological and obstetrical diseases	GO:0006704	glucocorticoid biosynthetic process	4.269194331385506e-9	9.415708097870734e-5	7	17	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0019752	carboxylic acid metabolic process	1.0093259561472223e-11	2.2260683962826988e-7	53	967	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0055114	oxidation-reduction process	4.983125023727553e-12	1.0990282239831117e-7	72	949	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0043209	myelin sheath	1.0444978215673473e-12	2.3036399454667844e-8	22	168	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0022900	electron transport chain	2.1516122217235534e-13	4.745380755011297e-9	33	107	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0016651	oxidoreductase activity, acting on NAD(P)H	3.519406988061746e-14	7.762052112170181e-10	23	98	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0010035	response to inorganic substance	5.541012093601694e-12	1.2220702172438536e-7	36	502	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0044283	small molecule biosynthetic process	7.813749647311852e-12	1.723322484714629e-7	35	530	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0006665	sphingolipid metabolic process	1.3662458941965383e-9	3.0132553196504652e-5	16	144	299
Orphanet:98497	Genetic peripheral neuropathy	GO:0030424	axon	3.3192339987664354e-9	7.320570584279373e-5	26	414	299
MESH:D000417	Albinism	GO:0002065	columnar/cuboidal epithelial cell differentiation	4.363176486776865e-13	9.622985741586376e-9	19	128	300
MESH:D000417	Albinism	GO:0051170	nuclear import	2.1557200469146665e-12	4.754440563470297e-8	27	287	300
MESH:D000417	Albinism	GO:0034504	protein localization to nucleus	2.307154467473538e-12	5.0884291780128876e-8	29	344	300
MESH:D000417	Albinism	GO:0006582	melanin metabolic process	2.6242841233425906e-10	5.787858634032084e-6	8	19	300
MESH:D000417	Albinism	GO:0048770	pigment granule	9.455818350545542e-10	2.0854807372128192e-5	14	102	300
MESH:D000417	Albinism	GO:0042470	melanosome	9.455818350545542e-10	2.0854807372128192e-5	14	102	300
MESH:D000417	Albinism	GO:0033273	response to vitamin	1.22853771600262e-9	2.7095399326437786e-5	14	104	300
MESH:D000417	Albinism	GO:0033162	melanosome membrane	1.3206594706716146e-9	2.912714462566246e-5	6	9	300
MESH:D000417	Albinism	GO:0010212	response to ionizing radiation	1.588616349579297e-9	3.50369335899714e-5	16	145	300
MESH:D000417	Albinism	GO:0048015	phosphatidylinositol-mediated signaling	2.3222375133968853e-9	5.1216948357968306e-5	18	193	300
MESH:D000417	Albinism	GO:0006935	chemotaxis	2.442642310640508e-9	5.387247616117641e-5	30	530	300
MESH:D000417	Albinism	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.8879518776392388e-9	6.369377866133341e-5	16	151	300
MESH:D000417	Albinism	GO:0048753	pigment granule organization	3.452799934855477e-9	7.615150256323755e-5	8	25	300
MESH:D000417	Albinism	GO:0044550	secondary metabolite biosynthetic process	3.452799934855477e-9	7.615150256323755e-5	8	25	300
Orphanet:79376	Hypopigmentation of the skin	GO:0002065	columnar/cuboidal epithelial cell differentiation	6.061817714453355e-13	1.3369338969226874e-8	22	128	302
Orphanet:79376	Hypopigmentation of the skin	GO:0051170	nuclear import	2.18103313187612e-12	4.810268572352783e-8	27	287	302
Orphanet:79376	Hypopigmentation of the skin	GO:0034504	protein localization to nucleus	2.2785107134382088e-12	5.0252553784879694e-8	29	344	302
Orphanet:79376	Hypopigmentation of the skin	GO:0006935	chemotaxis	1.6854695417123366e-10	3.7173030742465585e-6	32	530	302
Orphanet:79376	Hypopigmentation of the skin	GO:0006582	melanin metabolic process	2.765918605263096e-10	6.100233483907758e-6	8	19	302
Orphanet:79376	Hypopigmentation of the skin	GO:0001667	ameboidal-type cell migration	3.6678382553390065e-10	8.089417272150179e-6	24	315	302
Orphanet:79376	Hypopigmentation of the skin	GO:0033273	response to vitamin	1.3388401498559688e-9	2.952811950507339e-5	14	104	302
Orphanet:79376	Hypopigmentation of the skin	GO:0010212	response to ionizing radiation	1.7486064818328373e-9	3.8565515956823226e-5	16	145	302
Orphanet:79376	Hypopigmentation of the skin	GO:0048469	cell maturation	2.36559227762001e-9	5.217313768290932e-5	16	148	302
Orphanet:79376	Hypopigmentation of the skin	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3.176835905449593e-9	7.006511589469078e-5	16	151	302
Orphanet:79376	Hypopigmentation of the skin	GO:0044550	secondary metabolite biosynthetic process	3.63763241750803e-9	8.02279829681396e-5	8	25	302
Orphanet:79376	Hypopigmentation of the skin	GO:0032940	secretion by cell	3.692836592072979e-9	8.144551103816955e-5	42	956	302
MESH:D017496	Hypopigmentation	GO:0032940	secretion by cell	4.081747717599171e-9	9.002294591164972e-5	42	956	303
Orphanet:89043	Rare dementia	GO:0006066	alcohol metabolic process	2.7819968551057173e-12	6.13569406393566e-8	30	382	304
Orphanet:89043	Rare dementia	GO:0000323	lytic vacuole	1.1141976230533146e-11	2.4573628576440854e-7	38	515	304
Orphanet:89043	Rare dementia	GO:0005764	lysosome	1.1141976230533146e-11	2.4573628576440854e-7	38	515	304
Orphanet:89043	Rare dementia	GO:0008202	steroid metabolic process	2.763711481890141e-11	6.095365673308706e-7	24	275	304
Orphanet:89043	Rare dementia	GO:0044456	synapse part	1.264630622443974e-10	2.789142837800185e-6	35	613	304
Orphanet:89043	Rare dementia	GO:0031329	regulation of cellular catabolic process	2.0091772690022935e-10	4.431240466784558e-6	35	624	304
Orphanet:89043	Rare dementia	GO:0006816	calcium ion transport	3.482251154096616e-10	7.680104920360087e-6	26	366	304
Orphanet:89043	Rare dementia	GO:0097305	response to alcohol	4.1431702513250457e-10	9.137761989297388e-6	26	369	304
Orphanet:89043	Rare dementia	GO:0072503	cellular divalent inorganic cation homeostasis	5.844619233030812e-10	1.2890307718449456e-5	26	375	304
Orphanet:89043	Rare dementia	GO:0046916	cellular transition metal ion homeostasis	6.096627647167452e-10	1.3446112275827815e-5	13	81	304
Orphanet:89043	Rare dementia	GO:0007626	locomotory behavior	1.2140526362003357e-9	2.6775930891398403e-5	18	183	304
Orphanet:89043	Rare dementia	GO:0080135	regulation of cellular response to stress	1.936783178280166e-9	4.271575299696906e-5	35	681	304
Orphanet:89043	Rare dementia	GO:1901215	negative regulation of neuron death	2.7460367313381084e-9	6.056384010966198e-5	17	170	304
Orphanet:89043	Rare dementia	GO:0000302	response to reactive oxygen species	2.7532340851621484e-9	6.072257774825118e-5	19	216	304
Orphanet:89043	Rare dementia	GO:0043025	neuronal cell body	2.8755486880527314e-9	6.342022631500299e-5	27	434	304
Orphanet:89043	Rare dementia	GO:0043627	response to estrogen	2.9737489137815487e-9	6.558603229345206e-5	19	217	304
Orphanet:89043	Rare dementia	GO:0019216	regulation of lipid metabolic process	4.20383128307833e-9	9.271549894829256e-5	21	272	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0002065	columnar/cuboidal epithelial cell differentiation	6.696865284538944e-13	1.4769936385050642e-8	22	128	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0051170	nuclear import	2.258526698994956e-12	4.9811806346333753e-8	27	287	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0034504	protein localization to nucleus	2.262190434976219e-12	4.989261004340051e-8	29	344	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0006935	chemotaxis	1.982862762872628e-10	4.373203823515581e-6	32	530	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0001667	ameboidal-type cell migration	4.187765689778189e-10	9.236117228805796e-6	24	315	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0033273	response to vitamin	1.458013376698375e-9	3.215648502308266e-5	14	104	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0010212	response to ionizing radiation	1.923095904743377e-9	4.241388017911518e-5	16	145	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0048469	cell maturation	2.6009576714614013e-9	5.7364121444081206e-5	16	148	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0048015	phosphatidylinositol-mediated signaling	2.863788317597482e-9	6.316085134461247e-5	18	193	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3.3373260821534245e-9	7.360472674189378e-5	15	130	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3.49189543946693e-9	7.701375391744314e-5	16	151	304
Orphanet:98700	Pigmentation disorder with eye involvement	GO:0032940	secretion by cell	4.5089229017136745e-9	9.944429459729509e-5	42	956	304
DOID:1240	leukemia	GO:0022603	regulation of anatomical structure morphogenesis	1.2708722962884167e-11	2.802908849464103e-7	49	986	306
DOID:1240	leukemia	GO:0006259	DNA metabolic process	9.708012171927294e-12	2.1411020845185647e-7	54	937	306
DOID:1240	leukemia	GO:0009607	response to biotic stimulus	7.114087097193078e-12	1.5690119092859334e-7	50	934	306
DOID:1240	leukemia	GO:0042327	positive regulation of phosphorylation	5.1598725292478775e-12	1.1380098863256194e-7	53	910	306
DOID:1240	leukemia	GO:0007167	enzyme linked receptor protein signaling pathway	4.056754931980322e-12	8.9471730024826e-8	47	935	306
DOID:1240	leukemia	GO:1902105	regulation of leukocyte differentiation	1.3506973317589654e-12	2.9789629651943983e-8	32	225	306
DOID:1240	leukemia	GO:0042113	B cell activation	1.142197447734361e-12	2.5191164709781333e-8	26	212	306
DOID:1240	leukemia	GO:0072593	reactive oxygen species metabolic process	8.948397578478762e-13	1.973569085933491e-8	24	223	306
DOID:1240	leukemia	GO:0097191	extrinsic apoptotic signaling pathway	7.880363028789361e-13	1.7380140659994936e-8	24	220	306
DOID:1240	leukemia	GO:1902107	positive regulation of leukocyte differentiation	2.566835632933362e-13	5.66115598843453e-9	19	127	306
DOID:1240	leukemia	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.5512925105886097e-13	5.626875632103179e-9	22	195	306
DOID:1240	leukemia	GO:0000278	mitotic cell cycle	3.6060043839825084e-13	7.953042668873422e-9	48	927	306
DOID:1240	leukemia	GO:0023014	signal transduction by protein phosphorylation	8.957279362675763e-13	1.9755279634381395e-8	48	879	306
DOID:1240	leukemia	GO:0030218	erythrocyte differentiation	1.1399770016851107e-12	2.5142192772165117e-8	16	90	306
DOID:1240	leukemia	GO:0036293	response to decreased oxygen levels	1.5836221223253233e-12	3.4926785907885005e-8	28	302	306
DOID:1240	leukemia	GO:0001934	positive regulation of protein phosphorylation	1.6285861548226421e-12	3.591846764461337e-8	50	870	306
DOID:1240	leukemia	GO:0005694	chromosome	1.8902657217267915e-12	4.168981049268439e-8	48	876	306
DOID:1240	leukemia	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	2.4098500972513648e-12	5.314924389487885e-8	23	227	306
DOID:1240	leukemia	GO:0048545	response to steroid hormone	2.5355273436389325e-12	5.5921055563956656e-8	35	446	306
DOID:1240	leukemia	GO:0050673	epithelial cell proliferation	3.1764590957550354e-12	7.00568053568773e-8	28	335	306
DOID:1240	leukemia	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	3.665068248892567e-12	8.083308022932556e-8	33	359	306
DOID:1240	leukemia	GO:2001233	regulation of apoptotic signaling pathway	3.9285241726361164e-12	8.664360062748955e-8	30	359	306
DOID:1240	leukemia	GO:0001666	response to hypoxia	4.182654222972815e-12	9.224843888766543e-8	27	292	306
DOID:1240	leukemia	GO:0048608	reproductive structure development	4.419131727217973e-12	9.74639502437924e-8	32	418	306
DOID:1240	leukemia	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	5.388800516925585e-12	1.1884999540079377e-7	22	212	306
DOID:1240	leukemia	GO:0000165	MAPK cascade	6.1840532694645844e-12	1.363892948580414e-7	48	843	306
DOID:1240	leukemia	GO:0003682	chromatin binding	6.5670802129602635e-12	1.448369540968386e-7	32	433	306
DOID:1240	leukemia	GO:0051707	response to other organism	6.921241357815688e-12	1.52647978146625e-7	47	898	306
DOID:1240	leukemia	GO:0050678	regulation of epithelial cell proliferation	7.372547017325815e-12	1.6260152446712084e-7	25	277	306
DOID:1240	leukemia	GO:0019901	protein kinase binding	7.503775378836508e-12	1.6549576598023918e-7	36	532	306
DOID:1240	leukemia	GO:0043068	positive regulation of programmed cell death	1.0740630607131152e-11	2.3688460804027756e-7	42	561	306
DOID:1240	leukemia	GO:0045859	regulation of protein kinase activity	1.2775780433571526e-11	2.8176983746242e-7	41	709	306
DOID:1240	leukemia	GO:0043408	regulation of MAPK cascade	1.280020534011328e-11	2.823085287761984e-7	42	651	306
DOID:1240	leukemia	GO:0000785	chromatin	1.3374745755356798e-11	2.949800176343942e-7	31	438	306
DOID:1240	leukemia	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.3741008331180637e-11	3.0305793874418896e-7	41	647	306
DOID:1240	leukemia	GO:0050767	regulation of neurogenesis	1.637623370243091e-11	3.611778343071137e-7	39	658	306
DOID:1240	leukemia	GO:0070661	leukocyte proliferation	1.686928374766694e-11	3.720520530547944e-7	24	266	306
DOID:1240	leukemia	GO:0080135	regulation of cellular response to stress	1.7784884676075308e-11	3.922456315308409e-7	40	681	306
DOID:1240	leukemia	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.789890458070431e-11	3.947603405274336e-7	19	161	306
DOID:1240	leukemia	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	2.7169599903231756e-11	5.992255258657764e-7	35	573	306
DOID:1240	leukemia	GO:0002366	leukocyte activation involved in immune response	3.243971757882491e-11	7.154579712009834e-7	21	208	306
DOID:1240	leukemia	GO:0007507	heart development	3.3837044277618133e-11	7.462760115428679e-7	32	487	306
DOID:1240	leukemia	GO:2000377	regulation of reactive oxygen species metabolic process	3.488731525891353e-11	7.694397380353379e-7	18	147	306
DOID:1240	leukemia	GO:0035270	endocrine system development	3.8196112939203886e-11	8.424152708741417e-7	17	129	306
DOID:1240	leukemia	GO:0000228	nuclear chromosome	4.00661726018825e-11	8.836594367345185e-7	33	520	306
DOID:1240	leukemia	GO:0044843	cell cycle G1/S phase transition	4.628142313833905e-11	1.0207367873160678e-6	22	234	306
DOID:1240	leukemia	GO:0070997	neuron death	4.659550523200551e-11	1.0276638678918815e-6	24	281	306
DOID:1240	leukemia	GO:0045787	positive regulation of cell cycle	5.4653503944734894e-11	1.205383029501128e-6	25	308	306
DOID:1240	leukemia	GO:1903047	mitotic cell cycle process	5.893230348164025e-11	1.2997519532875756e-6	43	857	306
DOID:1240	leukemia	GO:0048015	phosphatidylinositol-mediated signaling	6.081257719614541e-11	1.341221390060987e-6	20	193	306
DOID:1240	leukemia	GO:0001047	core promoter binding	6.190947754447507e-11	1.3654135272433976e-6	18	152	306
DOID:1240	leukemia	GO:0031400	negative regulation of protein modification process	7.79071251955088e-11	1.7182416461869465e-6	36	628	306
DOID:1240	leukemia	GO:0000989	transcription factor activity, transcription factor binding	1.037079311316802e-10	2.2872784211092068e-6	34	574	306
DOID:1240	leukemia	GO:0002244	hematopoietic progenitor cell differentiation	1.1473000327555383e-10	2.5303702222423397e-6	17	138	306
DOID:1240	leukemia	GO:0007260	tyrosine phosphorylation of STAT protein	1.181951203577114e-10	2.606793379489325e-6	13	71	306
DOID:1240	leukemia	GO:0032259	methylation	1.232101087822457e-10	2.717398949192429e-6	25	320	306
DOID:1240	leukemia	GO:0098552	side of membrane	1.306929009459168e-10	2.882431930362195e-6	28	402	306
DOID:1240	leukemia	GO:0070371	ERK1 and ERK2 cascade	1.3380418995012633e-10	2.951051409350036e-6	22	247	306
DOID:1240	leukemia	GO:0000082	G1/S transition of mitotic cell cycle	1.347867373269196e-10	2.9727214917452116e-6	21	224	306
DOID:1240	leukemia	GO:0043414	macromolecule methylation	1.4463341635462257e-10	3.1898899977012007e-6	22	248	306
DOID:1240	leukemia	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.4677226101156293e-10	3.2370622166100205e-6	21	225	306
DOID:1240	leukemia	GO:0071345	cellular response to cytokine stimulus	1.5403678332859272e-10	3.3972812563121124e-6	37	677	306
DOID:1240	leukemia	GO:1901214	regulation of neuron death	1.6910184363894132e-10	3.7295411614568508e-6	22	250	306
DOID:1240	leukemia	GO:0001776	leukocyte homeostasis	1.7060985957328967e-10	3.7628004528889036e-6	13	73	306
DOID:1240	leukemia	GO:0016571	histone methylation	1.7897738846528455e-10	3.947346302601851e-6	16	123	306
DOID:1240	leukemia	GO:1903707	negative regulation of hemopoiesis	1.7897738846528455e-10	3.947346302601851e-6	16	123	306
DOID:1240	leukemia	GO:0051054	positive regulation of DNA metabolic process	1.8222268138856634e-10	4.018921238024831e-6	19	183	306
DOID:1240	leukemia	GO:0007417	central nervous system development	1.9119661409661148e-10	4.216841323900766e-6	43	889	306
DOID:1240	leukemia	GO:0050900	leukocyte migration	1.9602708345445308e-10	4.323377325587963e-6	26	354	306
DOID:1240	leukemia	GO:0070848	response to growth factor	2.095780216038179e-10	4.6222432664722035e-6	35	621	306
DOID:1240	leukemia	GO:0043086	negative regulation of catalytic activity	2.2285162604163133e-10	4.914992612348179e-6	41	822	306
DOID:1240	leukemia	GO:0018022	peptidyl-lysine methylation	2.2788204656620792e-10	5.025938537017716e-6	15	107	306
DOID:1240	leukemia	GO:0009790	embryo development	2.3704993523665507e-10	5.228136321644428e-6	44	932	306
DOID:1240	leukemia	GO:0042330	taxis	2.4452451174994394e-10	5.392988106645014e-6	32	531	306
DOID:1240	leukemia	GO:0032355	response to estradiol	2.5207391729509254e-10	5.559490245943266e-6	17	145	306
DOID:1240	leukemia	GO:0019221	cytokine-mediated signaling pathway	2.8326319068128214e-10	6.247369670475678e-6	32	534	306
DOID:1240	leukemia	GO:0048708	astrocyte differentiation	3.1487890073123026e-10	6.944654155627283e-6	12	62	306
DOID:1240	leukemia	GO:0042326	negative regulation of phosphorylation	3.5526526165341465e-10	7.83537534576606e-6	28	420	306
DOID:1240	leukemia	GO:0035239	tube morphogenesis	3.803630743703934e-10	8.388907605239027e-6	25	338	306
DOID:1240	leukemia	GO:0002764	immune response-regulating signaling pathway	3.9293479581203883e-10	8.666176921634516e-6	29	451	306
DOID:1240	leukemia	GO:0071453	cellular response to oxygen levels	4.312254997529408e-10	9.510678397051109e-6	17	150	306
DOID:1240	leukemia	GO:0007346	regulation of mitotic cell cycle	4.3584047482170263e-10	9.612461672192651e-6	29	453	306
DOID:1240	leukemia	GO:0001763	morphogenesis of a branching structure	4.573090794934842e-10	1.0085951748228794e-5	19	193	306
DOID:1240	leukemia	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.790196017623316e-10	1.0564777316868224e-5	17	151	306
DOID:1240	leukemia	GO:0044454	nuclear chromosome part	5.152864801516444e-10	1.1364643319744516e-5	30	486	306
DOID:1240	leukemia	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	6.186666734464552e-10	1.364469348286157e-5	14	97	306
DOID:1240	leukemia	GO:0034968	histone lysine methylation	6.186666734464552e-10	1.364469348286157e-5	14	97	306
DOID:1240	leukemia	GO:0090398	cellular senescence	6.365050708723174e-10	1.4038119338088961e-5	11	52	306
DOID:1240	leukemia	GO:0014065	phosphatidylinositol 3-kinase signaling	6.530386231773377e-10	1.4402766834176184e-5	17	154	306
DOID:1240	leukemia	GO:0043410	positive regulation of MAPK cascade	7.62093943507125e-10	1.6807981924049642e-5	29	464	306
DOID:1240	leukemia	GO:0001944	vasculature development	7.662708245703698e-10	1.6900103035899505e-5	33	588	306
DOID:1240	leukemia	GO:0014706	striated muscle tissue development	7.890271769284141e-10	1.7401994387156172e-5	24	323	306
DOID:1240	leukemia	GO:0048873	homeostasis of number of cells within a tissue	8.023681719038223e-10	1.76962300313388e-5	9	30	306
DOID:1240	leukemia	GO:1903034	regulation of response to wounding	8.236076265433212e-10	1.816466620341295e-5	27	407	306
DOID:1240	leukemia	GO:0040007	growth	9.100552533780615e-10	2.0071268613253146e-5	43	936	306
DOID:1240	leukemia	GO:0061138	morphogenesis of a branching epithelium	9.413021473392291e-10	2.0760418859566698e-5	18	179	306
DOID:1240	leukemia	GO:0031960	response to corticosteroid	9.413021473392291e-10	2.0760418859566698e-5	18	179	306
DOID:1240	leukemia	GO:0006935	chemotaxis	9.622778129880771e-10	2.122303716545204e-5	31	530	306
DOID:1240	leukemia	GO:0060562	epithelial tube morphogenesis	1.0439588082888918e-9	2.3024511516811508e-5	23	301	306
DOID:1240	leukemia	GO:0048511	rhythmic process	1.1387756293501639e-9	2.5115696505317864e-5	24	329	306
DOID:1240	leukemia	GO:0001933	negative regulation of protein phosphorylation	1.1765736163127372e-9	2.5949331107777418e-5	26	385	306
DOID:1240	leukemia	GO:0035162	embryonic hemopoiesis	1.2445696695451147e-9	2.7448984061817505e-5	8	22	306
DOID:1240	leukemia	GO:0001568	blood vessel development	1.337180588478759e-9	2.9491517878899032e-5	32	569	306
DOID:1240	leukemia	GO:0002443	leukocyte mediated immunity	1.3550885968882653e-9	2.9886479004370692e-5	22	279	306
DOID:1240	leukemia	GO:1902806	regulation of cell cycle G1/S phase transition	1.3975078871908408e-9	3.0822036451993995e-5	16	141	306
DOID:1240	leukemia	GO:0002757	immune response-activating signal transduction	1.5530648989070528e-9	3.425284634539505e-5	27	419	306
DOID:1240	leukemia	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	1.6353496334886586e-9	3.6067636166592365e-5	12	71	306
DOID:1240	leukemia	GO:0060322	head development	1.771924384996737e-9	3.9079792311103034e-5	36	708	306
DOID:1240	leukemia	GO:0070372	regulation of ERK1 and ERK2 cascade	1.7924302042615636e-9	3.9532048154988786e-5	20	233	306
DOID:1240	leukemia	GO:0042542	response to hydrogen peroxide	1.8802215340230077e-9	4.1468285932877436e-5	15	124	306
DOID:1240	leukemia	GO:0002761	regulation of myeloid leukocyte differentiation	2.0482728846360487e-9	4.5174658470648055e-5	14	106	306
DOID:1240	leukemia	GO:0045664	regulation of neuron differentiation	2.1421191487291935e-9	4.724443782522236e-5	31	548	306
DOID:1240	leukemia	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	2.198725312929639e-9	4.849288677666319e-5	11	58	306
DOID:1240	leukemia	GO:0001655	urogenital system development	2.224826545216274e-9	4.9068549454744925e-5	23	313	306
DOID:1240	leukemia	GO:0044728	DNA methylation or demethylation	2.281009603422035e-9	5.0307666803472983e-5	12	73	306
DOID:1240	leukemia	GO:0009986	cell surface	2.2992184822712147e-9	5.070926362649164e-5	36	715	306
DOID:1240	leukemia	GO:0048008	platelet-derived growth factor receptor signaling pathway	2.319467617972748e-9	5.115585831438896e-5	10	45	306
DOID:1240	leukemia	GO:0044706	multi-multicellular organism process	2.410776023253902e-9	5.316966519286481e-5	20	237	306
DOID:1240	leukemia	GO:0061061	muscle structure development	2.4366307860290704e-9	5.3739891985871147e-5	31	551	306
DOID:1240	leukemia	GO:0007565	female pregnancy	2.470486926142712e-9	5.4486589156077514e-5	18	190	306
DOID:1240	leukemia	GO:0001667	ameboidal-type cell migration	2.5144221149631107e-9	5.545557974551141e-5	23	315	306
DOID:1240	leukemia	GO:0001101	response to acid chemical	2.5144221149631107e-9	5.545557974551141e-5	23	315	306
DOID:1240	leukemia	GO:0048754	branching morphogenesis of an epithelial tube	2.586743819144033e-9	5.7050634931221644e-5	16	147	306
DOID:1240	leukemia	GO:0042506	tyrosine phosphorylation of Stat5 protein	2.7819125891781482e-9	6.135508215432406e-5	8	24	306
DOID:1240	leukemia	GO:0050769	positive regulation of neurogenesis	3.4096563350516362e-9	7.519997046956384e-5	25	376	306
DOID:1240	leukemia	GO:0010631	epithelial cell migration	3.576743123900883e-9	7.888506959763397e-5	19	218	306
DOID:1240	leukemia	GO:0045165	cell fate commitment	3.7159407773046382e-9	8.19550738434538e-5	20	243	306
DOID:1240	leukemia	GO:0030334	regulation of cell migration	3.7346392645076776e-9	8.236746897871683e-5	34	660	306
DOID:1240	leukemia	GO:0071363	cellular response to growth factor stimulus	3.802371861816312e-9	8.386131141235875e-5	32	594	306
DOID:1240	leukemia	GO:0002703	regulation of leukocyte mediated immunity	3.8355372211640315e-9	8.459277341277271e-5	16	151	306
DOID:1240	leukemia	GO:0051272	positive regulation of cellular component movement	3.980770713063464e-9	8.77958980766147e-5	26	408	306
DOID:1240	leukemia	GO:2000045	regulation of G1/S transition of mitotic cell cycle	4.0602056161631594e-9	8.954783486447848e-5	15	131	306
Orphanet:98059	Rare digestive tumor	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	5.399014568752136e-12	1.1907526631382837e-7	53	996	307
Orphanet:98059	Rare digestive tumor	GO:0009790	embryo development	5.233369293478063e-12	1.1542195976765868e-7	53	932	307
Orphanet:98059	Rare digestive tumor	GO:0055114	oxidation-reduction process	3.928635194938579e-12	8.664604922437036e-8	52	949	307
Orphanet:98059	Rare digestive tumor	GO:0072593	reactive oxygen species metabolic process	1.2667644710973036e-12	2.793849041005103e-8	27	223	307
Orphanet:98059	Rare digestive tumor	GO:0001763	morphogenesis of a branching structure	7.027711745877241e-13	1.5499618255532255e-8	22	193	307
Orphanet:98059	Rare digestive tumor	GO:0010631	epithelial cell migration	3.3173463975799677e-13	7.316407479862619e-9	23	218	307
Orphanet:98059	Rare digestive tumor	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3.170796958329447e-13	6.9931926915955955e-9	22	195	307
Orphanet:98059	Rare digestive tumor	GO:0061138	morphogenesis of a branching epithelium	4.555245070037017e-13	1.0046593001966642e-8	21	179	307
Orphanet:98059	Rare digestive tumor	GO:0000082	G1/S transition of mitotic cell cycle	1.3016254740705335e-12	2.8707349830625617e-8	23	224	307
Orphanet:98059	Rare digestive tumor	GO:0031625	ubiquitin protein ligase binding	2.144617816668415e-12	4.729954594662189e-8	26	257	307
Orphanet:98059	Rare digestive tumor	GO:0032355	response to estradiol	2.18058904266627e-12	4.8092891336004584e-8	19	145	307
Orphanet:98059	Rare digestive tumor	GO:0001503	ossification	2.7413626924044365e-12	6.046075418097985e-8	34	363	307
Orphanet:98059	Rare digestive tumor	GO:0030111	regulation of Wnt signaling pathway	2.8589353107122406e-12	6.305381827775847e-8	27	306	307
Orphanet:98059	Rare digestive tumor	GO:0097193	intrinsic apoptotic signaling pathway	2.9911628729450968e-12	6.597009716280411e-8	26	272	307
Orphanet:98059	Rare digestive tumor	GO:0007050	cell cycle arrest	3.131161996350329e-12	6.90577778295065e-8	24	242	307
Orphanet:98059	Rare digestive tumor	GO:0007346	regulation of mitotic cell cycle	3.3151259515307174e-12	7.311510286100997e-8	34	453	307
Orphanet:98059	Rare digestive tumor	GO:0051098	regulation of binding	3.5491609651217004e-12	7.82767450857591e-8	26	279	307
Orphanet:98059	Rare digestive tumor	GO:0010638	positive regulation of organelle organization	5.2985393850235596e-12	1.1685928613669461e-7	38	573	307
Orphanet:98059	Rare digestive tumor	GO:0046822	regulation of nucleocytoplasmic transport	7.74791342195158e-12	1.708802305211421e-7	22	215	307
Orphanet:98059	Rare digestive tumor	GO:0043009	chordate embryonic development	8.848477506262498e-12	1.9515317140061939e-7	39	552	307
Orphanet:98059	Rare digestive tumor	GO:0042060	wound healing	9.16811071505208e-12	2.0220268182047363e-7	39	534	307
Orphanet:98059	Rare digestive tumor	GO:0046824	positive regulation of nucleocytoplasmic transport	9.33930710544928e-12	2.0597841821068386e-7	17	118	307
Orphanet:98059	Rare digestive tumor	GO:0045862	positive regulation of proteolysis	1.181343911582644e-11	2.6054539969955215e-7	28	357	307
Orphanet:98059	Rare digestive tumor	GO:0097191	extrinsic apoptotic signaling pathway	1.3316237001959053e-11	2.936896070782069e-7	22	220	307
Orphanet:98059	Rare digestive tumor	GO:0016491	oxidoreductase activity	1.3932521802928477e-11	3.0728176836358756e-7	41	710	307
Orphanet:98059	Rare digestive tumor	GO:0009894	regulation of catabolic process	1.4239165402329945e-11	3.1404479294838694e-7	44	727	307
Orphanet:98059	Rare digestive tumor	GO:0001775	cell activation	1.432765017739257e-11	3.1599632466239314e-7	44	854	307
Orphanet:98059	Rare digestive tumor	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.495392698558362e-11	3.2980885966704676e-7	42	732	307
Orphanet:98059	Rare digestive tumor	GO:0043086	negative regulation of catalytic activity	1.5026091482184256e-11	3.3140044763957377e-7	46	822	307
Orphanet:98059	Rare digestive tumor	GO:0005912	adherens junction	1.571032193226074e-11	3.464911502160106e-7	32	465	307
Orphanet:98059	Rare digestive tumor	GO:0016337	single organismal cell-cell adhesion	1.6648460388068997e-11	3.6718179385886174e-7	41	697	307
Orphanet:98059	Rare digestive tumor	GO:0001816	cytokine production	1.8309798122118082e-11	4.038225975833143e-7	37	613	307
Orphanet:98059	Rare digestive tumor	GO:0001101	response to acid chemical	2.0019985669250673e-11	4.415407839353236e-7	26	315	307
Orphanet:98059	Rare digestive tumor	GO:0030055	cell-substrate junction	2.0164758751661793e-11	4.4473375426790085e-7	29	395	307
Orphanet:98059	Rare digestive tumor	GO:0070201	regulation of establishment of protein localization	2.0887735985297695e-11	4.6067901715574067e-7	43	803	307
Orphanet:98059	Rare digestive tumor	GO:0019725	cellular homeostasis	2.5688007276869484e-11	5.665490004913565e-7	42	771	307
Orphanet:98059	Rare digestive tumor	GO:0031329	regulation of cellular catabolic process	2.6031288236083583e-11	5.741200620468234e-7	37	624	307
Orphanet:98059	Rare digestive tumor	GO:0048871	multicellular organismal homeostasis	2.804279031209944e-11	6.184837403333532e-7	26	321	307
Orphanet:98059	Rare digestive tumor	GO:0001649	osteoblast differentiation	2.8163360532573734e-11	6.211429165459137e-7	21	206	307
Orphanet:98059	Rare digestive tumor	GO:0051345	positive regulation of hydrolase activity	2.867917014981458e-11	6.325190976541606e-7	45	900	307
Orphanet:98059	Rare digestive tumor	GO:0031400	negative regulation of protein modification process	2.880840010988095e-11	6.353692644234243e-7	37	628	307
Orphanet:98059	Rare digestive tumor	GO:0046660	female sex differentiation	3.101818801809486e-11	6.841061367390822e-7	17	127	307
Orphanet:98059	Rare digestive tumor	GO:0051223	regulation of protein transport	3.5842884216208404e-11	7.905148113884763e-7	40	730	307
Orphanet:98059	Rare digestive tumor	GO:0007507	heart development	3.616529298255955e-11	7.976255367303509e-7	32	487	307
Orphanet:98059	Rare digestive tumor	GO:0034109	homotypic cell-cell adhesion	4.8550052866858096e-11	1.0707714159785553e-6	32	495	307
Orphanet:98059	Rare digestive tumor	GO:0046545	development of primary female sexual characteristics	5.1036064263598746e-11	1.1256003973336703e-6	16	113	307
Orphanet:98059	Rare digestive tumor	GO:1900180	regulation of protein localization to nucleus	5.4744431210451694e-11	1.2073884303465121e-6	21	213	307
Orphanet:98059	Rare digestive tumor	GO:0001817	regulation of cytokine production	5.732037067218698e-11	1.2642007751750839e-6	34	556	307
Orphanet:98059	Rare digestive tumor	GO:0007610	behavior	5.846301220913119e-11	1.2894017342723885e-6	39	714	307
Orphanet:98059	Rare digestive tumor	GO:0005925	focal adhesion	6.390721285498557e-11	1.4094735795167068e-6	28	388	307
Orphanet:98059	Rare digestive tumor	GO:0050776	regulation of immune response	6.582556721923538e-11	1.4517828850202363e-6	42	816	307
Orphanet:98059	Rare digestive tumor	GO:0009266	response to temperature stimulus	9.317036031575299e-11	2.054872296763932e-6	21	219	307
Orphanet:98059	Rare digestive tumor	GO:0006606	protein import into nucleus	1.1563405788450609e-10	2.550309146642782e-6	23	268	307
Orphanet:98059	Rare digestive tumor	GO:0048471	perinuclear region of cytoplasm	1.1639911257077529e-10	2.567182427748449e-6	36	636	307
Orphanet:98059	Rare digestive tumor	GO:0050801	ion homeostasis	1.1760181717335172e-10	2.593708077758272e-6	37	668	307
Orphanet:98059	Rare digestive tumor	GO:0010959	regulation of metal ion transport	1.4040635321066475e-10	3.096662120061211e-6	25	321	307
Orphanet:98059	Rare digestive tumor	GO:0033157	regulation of intracellular protein transport	1.455864317989608e-10	3.2109087533260805e-6	27	375	307
Orphanet:98059	Rare digestive tumor	GO:1903829	positive regulation of cellular protein localization	1.7570833676927577e-10	3.875247367446377e-6	26	351	307
Orphanet:98059	Rare digestive tumor	GO:0060249	anatomical structure homeostasis	1.7570833676927577e-10	3.875247367446377e-6	26	351	307
Orphanet:98059	Rare digestive tumor	GO:0022604	regulation of cell morphogenesis	1.930089421620096e-10	4.2568122193831215e-6	32	524	307
Orphanet:98059	Rare digestive tumor	GO:0001819	positive regulation of cytokine production	2.0696666602759706e-10	4.564649819238653e-6	27	381	307
Orphanet:98059	Rare digestive tumor	GO:0048589	developmental growth	2.271277610432776e-10	5.009302769809487e-6	33	558	307
Orphanet:98059	Rare digestive tumor	GO:0045926	negative regulation of growth	2.360369677489871e-10	5.20579532370391e-6	21	230	307
Orphanet:98059	Rare digestive tumor	GO:0051348	negative regulation of transferase activity	2.525947229159442e-10	5.570976613911149e-6	26	357	307
Orphanet:98059	Rare digestive tumor	GO:1903706	regulation of hemopoiesis	2.6349833426309033e-10	5.811455762172457e-6	24	305	307
Orphanet:98059	Rare digestive tumor	GO:0008585	female gonad development	2.729033665715974e-10	6.018883749736581e-6	15	108	307
Orphanet:98059	Rare digestive tumor	GO:0034614	cellular response to reactive oxygen species	3.048985508513624e-10	6.724537539026798e-6	16	127	307
Orphanet:98059	Rare digestive tumor	GO:0071396	cellular response to lipid	3.095018685783657e-10	6.8260637114958556e-6	28	416	307
Orphanet:98059	Rare digestive tumor	GO:0055082	cellular chemical homeostasis	3.141561455421993e-10	6.928713789933205e-6	36	661	307
Orphanet:98059	Rare digestive tumor	GO:0043393	regulation of protein binding	3.1743019324181887e-10	7.000922911948315e-6	18	167	307
Orphanet:98059	Rare digestive tumor	GO:0002253	activation of immune response	3.2378510983477327e-10	7.141080597405924e-6	30	475	307
Orphanet:98059	Rare digestive tumor	GO:0071902	positive regulation of protein serine/threonine kinase activity	3.329900799542429e-10	7.344096213390827e-6	23	283	307
Orphanet:98059	Rare digestive tumor	GO:0006091	generation of precursor metabolites and energy	3.401237069766694e-10	7.501428357370443e-6	26	362	307
Orphanet:98059	Rare digestive tumor	GO:0001701	in utero embryonic development	4.1987413545996333e-10	9.260324057569491e-6	24	312	307
Orphanet:98059	Rare digestive tumor	GO:0044087	regulation of cellular component biogenesis	4.238673856349351e-10	9.348395190178493e-6	38	735	307
Orphanet:98059	Rare digestive tumor	GO:0002764	immune response-regulating signaling pathway	4.240666706678553e-10	9.352790421579549e-6	29	451	307
Orphanet:98059	Rare digestive tumor	GO:0007420	brain development	4.335501957442034e-10	9.561949567138406e-6	36	669	307
Orphanet:98059	Rare digestive tumor	GO:0090068	positive regulation of cell cycle process	4.814573184575011e-10	1.0618541158580186e-5	21	239	307
Orphanet:98059	Rare digestive tumor	GO:1902532	negative regulation of intracellular signal transduction	5.266953539972974e-10	1.1616266032410394e-5	28	426	307
Orphanet:98059	Rare digestive tumor	GO:0071345	cellular response to cytokine stimulus	5.95046678597555e-10	1.3123754496469076e-5	36	677	307
Orphanet:98059	Rare digestive tumor	GO:0042306	regulation of protein import into nucleus	6.857917567160143e-10	1.5125137194371696e-5	18	175	307
Orphanet:98059	Rare digestive tumor	GO:0032403	protein complex binding	6.884186554145799e-10	1.518307344516856e-5	43	924	307
Orphanet:98059	Rare digestive tumor	GO:0050679	positive regulation of epithelial cell proliferation	7.595594153642082e-10	1.6752082905857613e-5	17	155	307
Orphanet:98059	Rare digestive tumor	GO:0033044	regulation of chromosome organization	8.339587909134138e-10	1.8392961133595342e-5	22	271	307
Orphanet:98059	Rare digestive tumor	GO:0000904	cell morphogenesis involved in differentiation	8.555497421625091e-10	1.886914956339414e-5	37	720	307
Orphanet:98059	Rare digestive tumor	GO:0048568	embryonic organ development	9.337866035963316e-10	2.0594663542317093e-5	27	408	307
Orphanet:98059	Rare digestive tumor	GO:0048660	regulation of smooth muscle cell proliferation	9.75828529092837e-10	2.152189820914252e-5	14	100	307
Orphanet:98059	Rare digestive tumor	GO:0006935	chemotaxis	1.04194253225387e-9	2.2980042548859103e-5	31	530	307
Orphanet:98059	Rare digestive tumor	GO:0046649	lymphocyte activation	1.0762368773953312e-9	2.373640433095403e-5	33	594	307
Orphanet:98059	Rare digestive tumor	GO:0010634	positive regulation of epithelial cell migration	1.1160936619347694e-9	2.461544571397134e-5	14	101	307
Orphanet:98059	Rare digestive tumor	GO:0042633	hair cycle	1.1160936619347694e-9	2.461544571397134e-5	14	101	307
Orphanet:98059	Rare digestive tumor	GO:0009408	response to heat	1.1314175152321582e-9	2.495341329844525e-5	17	159	307
Orphanet:98059	Rare digestive tumor	GO:0048771	tissue remodeling	1.1845163738755105e-9	2.6124508625824383e-5	16	139	307
Orphanet:98059	Rare digestive tumor	GO:0045931	positive regulation of mitotic cell cycle	1.2366092594362499e-9	2.727341721686649e-5	15	120	307
Orphanet:98059	Rare digestive tumor	GO:1901342	regulation of vasculature development	1.2979431973647593e-9	2.8626137217879766e-5	20	228	307
Orphanet:98059	Rare digestive tumor	GO:0060326	cell chemotaxis	1.2979431973647593e-9	2.8626137217879766e-5	20	228	307
Orphanet:98059	Rare digestive tumor	GO:0030234	enzyme regulator activity	1.3117620323299661e-9	2.8930911623037403e-5	43	944	307
Orphanet:98059	Rare digestive tumor	GO:0090316	positive regulation of intracellular protein transport	1.4636755141239632e-9	3.228136346400401e-5	21	254	307
Orphanet:98059	Rare digestive tumor	GO:0051146	striated muscle cell differentiation	1.5121505159143567e-9	3.3350479628491136e-5	20	230	307
Orphanet:98059	Rare digestive tumor	GO:0051924	regulation of calcium ion transport	1.5879171311183882e-9	3.502151232681605e-5	19	207	307
Orphanet:98059	Rare digestive tumor	GO:0030522	intracellular receptor signaling pathway	1.644552161117474e-9	3.627059791344589e-5	22	281	307
Orphanet:98059	Rare digestive tumor	GO:0002757	immune response-activating signal transduction	1.6675358871509616e-9	3.677750399111446e-5	27	419	307
Orphanet:98059	Rare digestive tumor	GO:0045765	regulation of angiogenesis	1.7221032377889856e-9	3.7980986909436076e-5	19	208	307
Orphanet:98059	Rare digestive tumor	GO:0007173	epidermal growth factor receptor signaling pathway	1.753852507668796e-9	3.86812170566353e-5	15	123	307
Orphanet:98059	Rare digestive tumor	GO:0046332	SMAD binding	2.0066694972342702e-9	4.425709576150183e-5	12	72	307
Orphanet:98059	Rare digestive tumor	GO:0098771	inorganic ion homeostasis	2.0068877670809115e-9	4.4261909702969504e-5	33	609	307
Orphanet:98059	Rare digestive tumor	GO:0060828	regulation of canonical Wnt signaling pathway	2.2006216848780014e-9	4.853471125998432e-5	20	235	307
Orphanet:98059	Rare digestive tumor	GO:1900182	positive regulation of protein localization to nucleus	2.2009279954104954e-9	4.854146693877848e-5	15	125	307
Orphanet:98059	Rare digestive tumor	GO:0030308	negative regulation of cell growth	2.2071152683267314e-9	4.867792724294606e-5	17	166	307
Orphanet:98059	Rare digestive tumor	GO:0055065	metal ion homeostasis	2.2642350216983687e-9	4.993770340355752e-5	30	516	307
Orphanet:98059	Rare digestive tumor	GO:0048666	neuron development	2.3853232722359508e-9	5.2608304769163894e-5	42	926	307
Orphanet:98059	Rare digestive tumor	GO:0051099	positive regulation of binding	2.461886805527058e-9	5.429691349589927e-5	15	126	307
Orphanet:98059	Rare digestive tumor	GO:0032844	regulation of homeostatic process	2.507933860584899e-9	5.5312481295199944e-5	27	427	307
Orphanet:98059	Rare digestive tumor	GO:0031349	positive regulation of defense response	2.538971588528227e-9	5.599701838499005e-5	26	398	307
Orphanet:98059	Rare digestive tumor	GO:0030879	mammary gland development	3.070303233876359e-9	6.77155378231431e-5	15	128	307
Orphanet:98059	Rare digestive tumor	GO:0001837	epithelial to mesenchymal transition	3.1000590983154552e-9	6.837180341334737e-5	14	109	307
Orphanet:98059	Rare digestive tumor	GO:0070486	leukocyte aggregation	3.2204545696856712e-9	7.102712553441748e-5	27	432	307
Orphanet:98059	Rare digestive tumor	GO:0003007	heart morphogenesis	3.2371533231767557e-9	7.139541654266335e-5	19	216	307
Orphanet:98059	Rare digestive tumor	GO:0060284	regulation of cell development	3.3508057439846084e-9	7.390202068358054e-5	39	828	307
Orphanet:98059	Rare digestive tumor	GO:1901988	negative regulation of cell cycle phase transition	3.646062896045521e-9	8.041391717228397e-5	16	150	307
Orphanet:98059	Rare digestive tumor	GO:0030178	negative regulation of Wnt signaling pathway	3.94289290106542e-9	8.696050293299784e-5	18	195	307
Orphanet:98059	Rare digestive tumor	GO:0050680	negative regulation of epithelial cell proliferation	4.445409818032431e-9	9.804351353670526e-5	14	112	307
MESH:D052439	Lipid Metabolism Disorders	GO:0005496	steroid binding	1.6586731987899839e-13	3.6582037399313094e-9	18	89	307
MESH:D052439	Lipid Metabolism Disorders	GO:0071825	protein-lipid complex subunit organization	8.215650382226158e-15	1.8119616917999792e-10	14	36	307
MESH:D052439	Lipid Metabolism Disorders	GO:0060191	regulation of lipase activity	4.5075054799781356e-14	9.941303336091778e-10	18	80	307
MESH:D052439	Lipid Metabolism Disorders	GO:0031099	regeneration	1.1071144001562061e-12	2.4417408095445126e-8	21	182	307
MESH:D052439	Lipid Metabolism Disorders	GO:0015711	organic anion transport	4.199973702156967e-12	9.263042000107191e-8	33	423	307
MESH:D052439	Lipid Metabolism Disorders	GO:0006650	glycerophospholipid metabolic process	4.427869182421773e-11	9.76566548183122e-7	25	304	307
MESH:D052439	Lipid Metabolism Disorders	GO:0051051	negative regulation of transport	9.930645195055376e-11	2.1902037977694633e-6	30	452	307
MESH:D052439	Lipid Metabolism Disorders	GO:0008654	phospholipid biosynthetic process	1.4226664291072666e-10	3.1376908093960765e-6	22	247	307
MESH:D052439	Lipid Metabolism Disorders	GO:0015909	long-chain fatty acid transport	6.588064538348704e-10	1.4529976339328066e-5	11	52	307
MESH:D052439	Lipid Metabolism Disorders	GO:0097191	extrinsic apoptotic signaling pathway	6.916560657543869e-10	1.5254474530213002e-5	20	220	307
MESH:D052439	Lipid Metabolism Disorders	GO:0046321	positive regulation of fatty acid oxidation	9.437557402236507e-10	2.0814532850632617e-5	7	14	307
MESH:D052439	Lipid Metabolism Disorders	GO:0010038	response to metal ion	1.7426158294142624e-9	3.843339211773156e-5	24	335	307
MESH:D052439	Lipid Metabolism Disorders	GO:0044706	multi-multicellular organism process	2.549969457810164e-9	5.6239576392003165e-5	20	237	307
MESH:D052439	Lipid Metabolism Disorders	GO:0032868	response to insulin	2.743023919116183e-9	6.049739253610742e-5	20	238	307
MESH:D052439	Lipid Metabolism Disorders	GO:0043627	response to estrogen	3.4957641226185387e-9	7.709907772435187e-5	19	217	307
MESH:D052439	Lipid Metabolism Disorders	GO:1990267	response to transition metal nanoparticle	3.646062896045521e-9	8.041391717228397e-5	16	150	307
MESH:D052439	Lipid Metabolism Disorders	GO:0005975	carbohydrate metabolic process	3.6578504669648737e-9	8.067389204891029e-5	37	760	307
MESH:D052439	Lipid Metabolism Disorders	GO:0070482	response to oxygen levels	3.838085294027849e-9	8.46489711597842e-5	23	321	307
MESH:D052439	Lipid Metabolism Disorders	GO:0045444	fat cell differentiation	4.27781698952856e-9	9.434725370405239e-5	18	196	307
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:0033365	protein localization to organelle	6.5503158452884236e-12	1.4446721596783618e-7	46	859	308
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:0001525	angiogenesis	1.309948483019241e-9	2.889091379298936e-5	27	413	308
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:0010212	response to ionizing radiation	2.321339676036871e-9	5.119714655499319e-5	16	145	308
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:0048871	multicellular organismal homeostasis	4.083930527087887e-9	9.007108777492334e-5	23	321	308
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:0043542	endothelial cell migration	4.209712467506677e-9	9.284520847085975e-5	16	151	308
Orphanet:275729	Rare hemorrhagic disorder due to a constitutional thrombocytopenia	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.209712467506677e-9	9.284520847085975e-5	16	151	308
DOID:345	uterine disease	GO:0022603	regulation of anatomical structure morphogenesis	1.209765621013048e-11	2.6681380771442775e-7	57	986	311
DOID:345	uterine disease	GO:0009607	response to biotic stimulus	6.020739462542224e-12	1.3278740884636875e-7	49	934	311
DOID:345	uterine disease	GO:0051216	cartilage development	1.5136780717739384e-12	3.338416987297421e-8	22	180	311
DOID:345	uterine disease	GO:0097191	extrinsic apoptotic signaling pathway	8.189005029635155e-13	1.8060850592860334e-8	24	220	311
DOID:345	uterine disease	GO:0051338	regulation of transferase activity	5.508926648190027e-13	1.2149937722583104e-8	49	928	311
DOID:345	uterine disease	GO:0046427	positive regulation of JAK-STAT cascade	2.3636648194269583e-13	5.2130627592461565e-9	16	76	311
DOID:345	uterine disease	GO:0023014	signal transduction by protein phosphorylation	3.094968725747549e-12	6.825953524636219e-8	49	879	311
DOID:345	uterine disease	GO:0051384	response to glucocorticoid	4.786393503763975e-12	1.0556390872551447e-7	20	167	311
DOID:345	uterine disease	GO:0010035	response to inorganic substance	7.295941628626679e-12	1.609119926193614e-7	38	502	311
DOID:345	uterine disease	GO:0002009	morphogenesis of an epithelium	9.115264099079923e-12	2.010371497052077e-7	36	506	311
DOID:345	uterine disease	GO:0001763	morphogenesis of a branching structure	9.461209593553122e-12	2.086669775858141e-7	21	193	311
DOID:345	uterine disease	GO:0043068	positive regulation of programmed cell death	9.749534513048275e-12	2.150259836852797e-7	41	561	311
DOID:345	uterine disease	GO:0016049	cell growth	1.0055845045542355e-11	2.2178166247943665e-7	33	479	311
DOID:345	uterine disease	GO:0048598	embryonic morphogenesis	1.0555556428926138e-11	2.3280279703996598e-7	38	560	311
DOID:345	uterine disease	GO:0030155	regulation of cell adhesion	1.0564771280030527e-11	2.3300603058107328e-7	39	621	311
DOID:345	uterine disease	GO:0071229	cellular response to acid chemical	1.0929701588224816e-11	2.410545685282983e-7	20	174	311
DOID:345	uterine disease	GO:0052547	regulation of peptidase activity	1.2881029576305991e-11	2.8409110730542864e-7	29	382	311
DOID:345	uterine disease	GO:0045321	leukocyte activation	1.5194956404229742e-11	3.3512476349528697e-7	42	694	311
DOID:345	uterine disease	GO:0010038	response to metal ion	1.601707655396467e-11	3.532566233976908e-7	27	335	311
DOID:345	uterine disease	GO:0002520	immune system development	1.7691181852796944e-11	3.901790157634366e-7	45	782	311
DOID:345	uterine disease	GO:0045597	positive regulation of cell differentiation	1.8667734025257232e-11	4.1171687392704825e-7	44	815	311
DOID:345	uterine disease	GO:1901699	cellular response to nitrogen compound	1.9256041206006103e-11	4.246919887984646e-7	34	518	311
DOID:345	uterine disease	GO:0050920	regulation of chemotaxis	1.9502732762077812e-11	4.3013277106762615e-7	20	179	311
DOID:345	uterine disease	GO:0051050	positive regulation of transport	2.1421198148630083e-11	4.724445251680365e-7	46	920	311
DOID:345	uterine disease	GO:0030097	hemopoiesis	2.2269186494838777e-11	4.911469081436692e-7	40	695	311
DOID:345	uterine disease	GO:0009792	embryo development ending in birth or egg hatching	2.5894619781752226e-11	5.711058392865453e-7	35	558	311
DOID:345	uterine disease	GO:0031099	regeneration	2.6758262272608135e-11	5.901534744223724e-7	20	182	311
DOID:345	uterine disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	2.9422020375591273e-11	6.489026593836655e-7	13	63	311
DOID:345	uterine disease	GO:0051726	regulation of cell cycle	3.026512374049162e-11	6.674973040965426e-7	46	930	311
DOID:345	uterine disease	GO:0042445	hormone metabolic process	4.517941576409612e-11	9.9643201467714e-7	20	187	311
DOID:345	uterine disease	GO:0098609	cell-cell adhesion	4.587985547033213e-11	1.0118802123981752e-6	44	867	311
DOID:345	uterine disease	GO:0060249	anatomical structure homeostasis	4.600164693613351e-11	1.0145663231764246e-6	27	351	311
DOID:345	uterine disease	GO:0043549	regulation of kinase activity	4.6023074240508777e-11	1.015038902374421e-6	41	761	311
DOID:345	uterine disease	GO:0008206	bile acid metabolic process	4.6530557185064936e-11	1.0262314387166072e-6	11	41	311
DOID:345	uterine disease	GO:0007507	heart development	4.6962989053156434e-11	1.0357687235673652e-6	32	487	311
DOID:345	uterine disease	GO:0016337	single organismal cell-cell adhesion	4.83287854180503e-11	1.0658913623950994e-6	39	697	311
DOID:345	uterine disease	GO:0060688	regulation of morphogenesis of a branching structure	5.334532815481907e-11	1.1765312124545346e-6	12	53	311
DOID:345	uterine disease	GO:0045859	regulation of protein kinase activity	6.624512050024123e-11	1.4610361326328203e-6	39	709	311
DOID:345	uterine disease	GO:0045787	positive regulation of cell cycle	7.645228894403999e-11	1.686155232660802e-6	25	308	311
DOID:345	uterine disease	GO:0042692	muscle cell differentiation	7.819189740132515e-11	1.7245222971862262e-6	26	334	311
DOID:345	uterine disease	GO:0052548	regulation of endopeptidase activity	9.007616874612268e-11	1.9866299016957356e-6	27	362	311
DOID:345	uterine disease	GO:0046649	lymphocyte activation	1.0076817158477525e-10	2.222442024302218e-6	35	594	311
DOID:345	uterine disease	GO:0008406	gonad development	1.3015777344804746e-10	2.870629693396687e-6	21	220	311
DOID:345	uterine disease	GO:1901652	response to peptide	1.309887753819794e-10	2.8889574410495555e-6	29	423	311
DOID:345	uterine disease	GO:0046677	response to antibiotic	1.4085232979965667e-10	3.106498133731428e-6	11	45	311
DOID:345	uterine disease	GO:0061138	morphogenesis of a branching epithelium	1.6356260790217902e-10	3.6073733172825584e-6	19	179	311
DOID:345	uterine disease	GO:0071417	cellular response to organonitrogen compound	2.3033130958083348e-10	5.079957032805282e-6	30	462	311
DOID:345	uterine disease	GO:0032102	negative regulation of response to external stimulus	2.4478075122402743e-10	5.398639468245925e-6	23	275	311
DOID:345	uterine disease	GO:0032504	multicellular organism reproduction	2.729463322026504e-10	6.019831356729455e-6	40	780	311
DOID:345	uterine disease	GO:1900182	positive regulation of protein localization to nucleus	2.90090618193517e-10	6.3979485842580175e-6	16	125	311
DOID:345	uterine disease	GO:0043086	negative regulation of catalytic activity	3.5740044257437376e-10	7.882466760977813e-6	41	822	311
DOID:345	uterine disease	GO:0051346	negative regulation of hydrolase activity	4.36101488254792e-10	9.618218323459438e-6	27	389	311
DOID:345	uterine disease	GO:0043434	response to peptide hormone	4.36101488254792e-10	9.618218323459438e-6	27	389	311
DOID:345	uterine disease	GO:0051052	regulation of DNA metabolic process	4.422694432903995e-10	9.754252571769761e-6	25	335	311
DOID:345	uterine disease	GO:2001252	positive regulation of chromosome organization	4.980236223417478e-10	1.0983910990747248e-5	17	149	311
DOID:345	uterine disease	GO:0051781	positive regulation of cell division	5.248146361935824e-10	1.157478680124946e-5	16	130	311
DOID:345	uterine disease	GO:0071453	cellular response to oxygen levels	5.532073688030437e-10	1.2200988518951128e-5	17	150	311
DOID:345	uterine disease	GO:0048609	multicellular organismal reproductive process	5.747154974145019e-10	1.267535029547684e-5	39	767	311
DOID:345	uterine disease	GO:1904018	positive regulation of vasculature development	5.89114090843168e-10	1.299291127354607e-5	16	131	311
DOID:345	uterine disease	GO:0007517	muscle organ development	6.023366250218487e-10	1.3284534264856873e-5	25	340	311
DOID:345	uterine disease	GO:0090068	positive regulation of cell cycle process	6.096640969843747e-10	1.3446141658990385e-5	21	239	311
DOID:345	uterine disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	7.753548914024577e-10	1.7100452129881205e-5	10	40	311
DOID:345	uterine disease	GO:0030324	lung development	8.44118996923271e-10	1.861704447714274e-5	18	175	311
DOID:345	uterine disease	GO:0051347	positive regulation of transferase activity	8.698465281398171e-10	1.9184465178123666e-5	34	613	311
DOID:345	uterine disease	GO:0042307	positive regulation of protein import into nucleus	8.778308080437114e-10	1.9360558471404055e-5	14	98	311
DOID:345	uterine disease	GO:0048871	multicellular organismal homeostasis	9.644963716581856e-10	2.1271967476921283e-5	24	321	311
DOID:345	uterine disease	GO:0045471	response to ethanol	1.1514059705675095e-9	2.539425868086642e-5	16	137	311
DOID:345	uterine disease	GO:0042311	vasodilation	1.1684354594976298e-9	2.5769844059220226e-5	12	68	311
DOID:345	uterine disease	GO:1903034	regulation of response to wounding	1.1762505414125712e-9	2.594220569085426e-5	27	407	311
DOID:345	uterine disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	1.2881726796365456e-9	2.8410648449384013e-5	20	225	311
DOID:345	uterine disease	GO:0045766	positive regulation of angiogenesis	1.311339037357584e-9	2.8921582468921514e-5	15	119	311
DOID:345	uterine disease	GO:0050921	positive regulation of chemotaxis	1.311339037357584e-9	2.8921582468921514e-5	15	119	311
DOID:345	uterine disease	GO:0090287	regulation of cellular response to growth factor stimulus	1.3927430320137546e-9	3.071694757106336e-5	20	226	311
DOID:345	uterine disease	GO:0006066	alcohol metabolic process	1.4079779564468708e-9	3.1052953829435737e-5	26	382	311
DOID:345	uterine disease	GO:0060562	epithelial tube morphogenesis	1.4287909744226113e-9	3.151198494089069e-5	23	301	311
DOID:345	uterine disease	GO:0022617	extracellular matrix disassembly	1.4923344782147296e-9	3.291343691702586e-5	13	85	311
DOID:345	uterine disease	GO:0051341	regulation of oxidoreductase activity	1.4923344782147296e-9	3.291343691702586e-5	13	85	311
DOID:345	uterine disease	GO:0051054	positive regulation of DNA metabolic process	1.7445279665295743e-9	3.847556430180976e-5	18	183	311
DOID:345	uterine disease	GO:0051146	striated muscle cell differentiation	1.8920657263166163e-9	4.172950959391297e-5	20	230	311
DOID:345	uterine disease	GO:0033273	response to vitamin	1.955779538320712e-9	4.313471771766331e-5	14	104	311
DOID:345	uterine disease	GO:0002521	leukocyte differentiation	2.168205615049601e-9	4.781977483991895e-5	28	448	311
DOID:345	uterine disease	GO:0043010	camera-type eye development	2.388019892940463e-9	5.266777873880191e-5	22	283	311
DOID:345	uterine disease	GO:0033674	positive regulation of kinase activity	2.3957145156572324e-9	5.283748364282026e-5	29	480	311
DOID:345	uterine disease	GO:0009612	response to mechanical stimulus	2.505751162118486e-9	5.5264341880523205e-5	19	210	311
DOID:345	uterine disease	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	2.605092030982803e-9	5.745530474332572e-5	11	58	311
DOID:345	uterine disease	GO:0051147	regulation of muscle cell differentiation	2.6682903664365654e-9	5.884914403175845e-5	16	145	311
DOID:345	uterine disease	GO:0016491	oxidoreductase activity	2.9560844883036452e-9	6.51964433895369e-5	36	710	311
DOID:345	uterine disease	GO:2000027	regulation of organ morphogenesis	2.9605713436353653e-9	6.529540098387798e-5	20	236	311
DOID:345	uterine disease	GO:0002694	regulation of leukocyte activation	3.0021691799220207e-9	6.621284126318017e-5	27	425	311
DOID:345	uterine disease	GO:2001235	positive regulation of apoptotic signaling pathway	3.2269396044171117e-9	7.11701529754194e-5	17	168	311
DOID:345	uterine disease	GO:0034754	cellular hormone metabolic process	3.237669465860904e-9	7.140680006956224e-5	14	108	311
DOID:345	uterine disease	GO:0048754	branching morphogenesis of an epithelial tube	3.263658343577447e-9	7.197998476760059e-5	16	147	311
DOID:345	uterine disease	GO:0009986	cell surface	3.5553304744695424e-9	7.841281361442576e-5	36	715	311
DOID:345	uterine disease	GO:0032846	positive regulation of homeostatic process	3.773668599826863e-9	8.322826096918146e-5	18	192	311
DOID:345	uterine disease	GO:0007492	endoderm development	3.7774717798200186e-9	8.331214010393051e-5	12	75	311
DOID:345	uterine disease	GO:0048661	positive regulation of smooth muscle cell proliferation	3.806482462564986e-9	8.395197071187077e-5	11	60	311
DOID:345	uterine disease	GO:0007159	leukocyte cell-cell adhesion	4.078642312776992e-9	8.995445620829656e-5	28	461	311
DOID:345	uterine disease	GO:0014031	mesenchymal cell development	4.2319665549683805e-9	9.333602236982763e-5	17	171	311
DOID:345	uterine disease	GO:0043588	skin development	4.2515917453300744e-9	9.376885594325479e-5	20	241	311
DOID:345	uterine disease	GO:0001817	regulation of cytokine production	4.4519786746022305e-9	9.81883896683522e-5	31	556	311
Orphanet:71202	Rare hemorrhagic disorder due to a constitutional platelet anomaly	GO:0032940	secretion by cell	1.2308725150234068e-9	2.7146893318841236e-5	44	956	314
Orphanet:71202	Rare hemorrhagic disorder due to a constitutional platelet anomaly	GO:0045862	positive regulation of proteolysis	2.01219418904941e-9	4.4378942839484736e-5	25	357	314
Orphanet:71202	Rare hemorrhagic disorder due to a constitutional platelet anomaly	GO:0045121	membrane raft	2.6725675006389338e-9	5.8943476226591685e-5	22	282	314
Orphanet:71202	Rare hemorrhagic disorder due to a constitutional platelet anomaly	GO:0001667	ameboidal-type cell migration	4.118509755457467e-9	9.083373265661443e-5	23	315	314
Orphanet:71202	Rare hemorrhagic disorder due to a constitutional platelet anomaly	GO:0032403	protein complex binding	4.4310121127821844e-9	9.772597214741108e-5	42	924	314
DOID:2214	inherited blood coagulation disease	GO:0032940	secretion by cell	2.205347016115411e-12	4.863892844042539e-8	49	956	314
DOID:2214	inherited blood coagulation disease	GO:1903035	negative regulation of response to wounding	1.2077006061872453e-12	2.6635836869459695e-8	25	159	314
DOID:2214	inherited blood coagulation disease	GO:0030168	platelet activation	1.1965983759409937e-12	2.6390977181378616e-8	25	162	314
DOID:2214	inherited blood coagulation disease	GO:0032102	negative regulation of response to external stimulus	2.301159263140562e-12	5.0752067548565094e-8	30	275	314
DOID:2214	inherited blood coagulation disease	GO:0033365	protein localization to organelle	7.92621523970638e-12	1.748126771117242e-7	46	859	314
DOID:2214	inherited blood coagulation disease	GO:0050818	regulation of coagulation	1.8217316544166806e-11	4.017829163815989e-7	15	88	314
DOID:2214	inherited blood coagulation disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	1.938393889844292e-11	4.275127724051586e-7	16	104	314
DOID:2214	inherited blood coagulation disease	GO:0031091	platelet alpha granule	2.0053958493804203e-11	4.422900545808517e-7	14	74	314
DOID:2214	inherited blood coagulation disease	GO:1900047	negative regulation of hemostasis	2.1924351223390204e-11	4.835415662318709e-7	12	49	314
DOID:2214	inherited blood coagulation disease	GO:0030195	negative regulation of blood coagulation	2.1924351223390204e-11	4.835415662318709e-7	12	49	314
DOID:2214	inherited blood coagulation disease	GO:0006887	exocytosis	5.948264103494694e-11	1.3118896480257547e-6	29	405	314
DOID:2214	inherited blood coagulation disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	8.431744191739199e-11	1.8596211814880803e-6	18	151	314
DOID:2214	inherited blood coagulation disease	GO:0031093	platelet alpha granule lumen	9.539624645782396e-11	2.1039642156273075e-6	12	55	314
DOID:2214	inherited blood coagulation disease	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.408321237406085e-10	3.1060524890991204e-6	14	85	314
DOID:2214	inherited blood coagulation disease	GO:0001889	liver development	1.0626499680199686e-9	2.3436745044680407e-5	16	135	314
DOID:2214	inherited blood coagulation disease	GO:0031589	cell-substrate adhesion	1.6136902925012464e-9	3.558993940111499e-5	23	300	314
DOID:2214	inherited blood coagulation disease	GO:1904035	regulation of epithelial cell apoptotic process	1.940595240057519e-9	4.279982801946858e-5	11	56	314
DOID:2214	inherited blood coagulation disease	GO:0050714	positive regulation of protein secretion	1.960891893304506e-9	4.324747070683088e-5	19	205	314
DOID:2214	inherited blood coagulation disease	GO:1904036	negative regulation of epithelial cell apoptotic process	2.5965453120946336e-9	5.7266806858247143e-5	9	33	314
DOID:2214	inherited blood coagulation disease	GO:0002576	platelet degranulation	2.854673275543007e-9	6.295981909210102e-5	14	106	314
Orphanet:98054	Rare genetic cardiac disease	GO:0048878	chemical homeostasis	1.1668888078020245e-11	2.573573265607365e-7	56	988	315
Orphanet:98054	Rare genetic cardiac disease	GO:0034220	ion transmembrane transport	6.470157742910487e-12	1.426993290198908e-7	57	962	315
Orphanet:98054	Rare genetic cardiac disease	GO:0009612	response to mechanical stimulus	1.0016432128168162e-12	2.2091241058674882e-8	24	210	315
Orphanet:98054	Rare genetic cardiac disease	GO:0035051	cardiocyte differentiation	3.561595462997502e-13	7.855098793640991e-9	21	107	315
Orphanet:98054	Rare genetic cardiac disease	GO:0043271	negative regulation of ion transport	1.9106938253798944e-12	4.214035231875357e-8	18	121	315
Orphanet:98054	Rare genetic cardiac disease	GO:0019900	kinase binding	7.651435041111654e-12	1.6875239983171753e-7	40	598	315
Orphanet:98054	Rare genetic cardiac disease	GO:0032410	negative regulation of transporter activity	2.243560892623009e-11	4.948173548680046e-7	13	61	315
Orphanet:98054	Rare genetic cardiac disease	GO:0023014	signal transduction by protein phosphorylation	3.040745433224856e-11	6.70636405297742e-7	45	879	315
Orphanet:98054	Rare genetic cardiac disease	GO:0070848	response to growth factor	3.726641217838278e-11	8.219107205942322e-7	37	621	315
Orphanet:98054	Rare genetic cardiac disease	GO:1901698	response to nitrogen compound	7.463318851819167e-11	1.6460349727687174e-6	44	870	315
Orphanet:98054	Rare genetic cardiac disease	GO:0022890	inorganic cation transmembrane transporter activity	1.0435108332984555e-10	2.3014631428397436e-6	33	527	315
Orphanet:98054	Rare genetic cardiac disease	GO:0001944	vasculature development	1.0704681585593789e-10	2.3609175237027102e-6	35	588	315
Orphanet:98054	Rare genetic cardiac disease	GO:0071363	cellular response to growth factor stimulus	1.4084577948381138e-10	3.10635366651546e-6	35	594	315
Orphanet:98054	Rare genetic cardiac disease	GO:0001568	blood vessel development	1.7790369177816956e-10	3.92366592216753e-6	34	569	315
Orphanet:98054	Rare genetic cardiac disease	GO:0060548	negative regulation of cell death	2.2330237658962915e-10	4.924933915684271e-6	43	867	315
Orphanet:98054	Rare genetic cardiac disease	GO:0010243	response to organonitrogen compound	3.9369418836088244e-10	8.682925324299262e-6	40	780	315
Orphanet:98054	Rare genetic cardiac disease	GO:0002028	regulation of sodium ion transport	4.129316888423773e-10	9.107208397418631e-6	13	76	315
Orphanet:98054	Rare genetic cardiac disease	GO:0031966	mitochondrial membrane	5.159247473685014e-10	1.1378720303212297e-5	36	656	315
Orphanet:98054	Rare genetic cardiac disease	GO:0002026	regulation of the force of heart contraction	7.35633109982814e-10	1.622438824067096e-5	9	29	315
Orphanet:98054	Rare genetic cardiac disease	GO:0035265	organ growth	7.951470593070553e-10	1.7536968393017105e-5	16	132	315
Orphanet:98054	Rare genetic cardiac disease	GO:0043500	muscle adaptation	1.4986071272815593e-9	3.305178019219479e-5	13	84	315
Orphanet:98054	Rare genetic cardiac disease	GO:0043066	negative regulation of apoptotic process	2.258778497576941e-9	4.981735976405943e-5	39	795	315
Orphanet:98054	Rare genetic cardiac disease	GO:0048545	response to steroid hormone	2.612444260918778e-9	5.761745817456365e-5	28	446	315
Orphanet:98054	Rare genetic cardiac disease	GO:0002576	platelet degranulation	2.973634227743105e-9	6.558350289287418e-5	14	106	315
Orphanet:98054	Rare genetic cardiac disease	GO:0048514	blood vessel morphogenesis	3.870657350191209e-9	8.536734785846711e-5	29	484	315
Orphanet:98054	Rare genetic cardiac disease	GO:0097305	response to alcohol	4.205428116854648e-9	9.275071711722926e-5	25	369	315
DOID:0080015	physical disorder	GO:0040007	growth	1.0123235583137102e-11	2.232679607860888e-7	56	936	316
DOID:0080015	physical disorder	GO:0030323	respiratory tube development	1.795008586213953e-12	3.9588914368948736e-8	26	179	316
DOID:0080015	physical disorder	GO:0003007	heart morphogenesis	1.7277290709216686e-12	3.81050646591774e-8	26	216	316
DOID:0080015	physical disorder	GO:0035148	tube formation	3.8058445284150366e-13	8.393790107419363e-9	23	131	316
DOID:0080015	physical disorder	GO:0001841	neural tube formation	1.758593271006248e-13	3.87857745920428e-9	21	95	316
DOID:0080015	physical disorder	GO:0014020	primary neural tube formation	1.7474910407599964e-13	3.854091490396172e-9	21	86	316
DOID:0080015	physical disorder	GO:0001578	microtubule bundle formation	8.215650382226158e-15	1.8119616917999792e-10	17	66	316
DOID:0080015	physical disorder	GO:0048546	digestive tract morphogenesis	3.697042672001771e-14	8.153827613099907e-10	14	49	316
DOID:0080015	physical disorder	GO:0048566	embryonic digestive tract development	7.51620987671231e-14	1.6577000883089e-9	12	33	316
DOID:0080015	physical disorder	GO:0061371	determination of heart left/right asymmetry	1.4428458428028534e-12	3.182196506301693e-8	14	61	316
DOID:0080015	physical disorder	GO:0043010	camera-type eye development	2.164490808809205e-12	4.773784478828702e-8	30	283	316
DOID:0080015	physical disorder	GO:0007548	sex differentiation	2.680300426050053e-12	5.911402589653392e-8	27	274	316
DOID:0080015	physical disorder	GO:0072001	renal system development	3.158251438151183e-12	6.965523546842434e-8	31	276	316
DOID:0080015	physical disorder	GO:0005875	microtubule associated complex	3.369748924342275e-12	7.431981252636888e-8	19	144	316
DOID:0080015	physical disorder	GO:0001822	kidney development	4.453104551771503e-12	9.82132208893205e-8	28	262	316
DOID:0080015	physical disorder	GO:0023014	signal transduction by protein phosphorylation	5.4367621515893916e-12	1.1990778925330403e-7	47	879	316
DOID:0080015	physical disorder	GO:0001568	blood vessel development	7.99149635355434e-12	1.7625245207764095e-7	37	569	316
DOID:0080015	physical disorder	GO:0061351	neural precursor cell proliferation	9.11293263072821e-12	2.0098572917071067e-7	18	132	316
DOID:0080015	physical disorder	GO:0000904	cell morphogenesis involved in differentiation	1.494104839849797e-11	3.295248224288727e-7	44	720	316
DOID:0080015	physical disorder	GO:0072089	stem cell proliferation	2.2645441077884243e-11	4.99445202972737e-7	18	139	316
DOID:0080015	physical disorder	GO:0042063	gliogenesis	5.265199387594066e-11	1.1612397249338713e-6	22	228	316
DOID:0080015	physical disorder	GO:0051093	negative regulation of developmental process	5.974765127092496e-11	1.31773444878025e-6	42	788	316
DOID:0080015	physical disorder	GO:0061061	muscle structure development	8.796929851229152e-11	1.9401628786885894e-6	34	551	316
DOID:0080015	physical disorder	GO:0016055	Wnt signaling pathway	9.268996681299768e-11	2.044277218060664e-6	31	465	316
DOID:0080015	physical disorder	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1.0009082451745144e-10	2.2075031347323915e-6	25	307	316
DOID:0080015	physical disorder	GO:0022603	regulation of anatomical structure morphogenesis	1.09349307386708e-10	2.411698974413845e-6	47	986	316
DOID:0080015	physical disorder	GO:0051960	regulation of nervous system development	1.1879197625574989e-10	2.6199570363205638e-6	40	744	316
DOID:0080015	physical disorder	GO:0021761	limbic system development	1.3327039471988655e-10	2.939278555547098e-6	15	100	316
DOID:0080015	physical disorder	GO:0007517	muscle organ development	1.6391554780170736e-10	3.615157406766656e-6	26	340	316
DOID:0080015	physical disorder	GO:0030855	epithelial cell differentiation	1.858779796748422e-10	4.099538841728645e-6	34	568	316
DOID:0080015	physical disorder	GO:0072091	regulation of stem cell proliferation	2.476324700850796e-10	5.461534127726431e-6	14	88	316
DOID:0080015	physical disorder	GO:0021846	cell proliferation in forebrain	3.6468505992814926e-10	8.043128996715332e-6	9	27	316
DOID:0080015	physical disorder	GO:0035137	hindlimb morphogenesis	3.8885183961667735e-10	8.576127322745819e-6	10	37	316
DOID:0080015	physical disorder	GO:0010171	body morphogenesis	4.509325135515496e-10	9.945316586379427e-6	11	49	316
DOID:0080015	physical disorder	GO:0098727	maintenance of cell number	5.141636005845385e-10	1.1339878210891996e-5	17	147	316
DOID:0080015	physical disorder	GO:0021532	neural tube patterning	6.888131176552292e-10	1.519177330988608e-5	10	39	316
DOID:0080015	physical disorder	GO:0035116	embryonic hindlimb morphogenesis	7.564676662852321e-10	1.6683894379920794e-5	9	29	316
DOID:0080015	physical disorder	GO:0098773	skin epidermis development	1.144270900255151e-9	2.5236894705127355e-5	13	82	316
DOID:0080015	physical disorder	GO:0008406	gonad development	1.1462591986699522e-9	2.5280746626665795e-5	20	220	316
DOID:0080015	physical disorder	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1.2382712633041137e-9	2.731007271217223e-5	14	99	316
DOID:0080015	physical disorder	GO:0003401	axis elongation	1.4781940116392889e-9	3.2601568926704516e-5	9	31	316
DOID:0080015	physical disorder	GO:0048666	neuron development	1.815270600502572e-9	4.0035793094084227e-5	43	926	316
DOID:0080015	physical disorder	GO:0021953	central nervous system neuron differentiation	2.1302547503765368e-9	4.698276851955452e-5	17	161	316
DOID:0080015	physical disorder	GO:0060571	morphogenesis of an epithelial fold	2.422802958257364e-9	5.3434919244366164e-5	8	23	316
DOID:0080015	physical disorder	GO:0060395	SMAD protein signal transduction	2.531437393038516e-9	5.583085170346447e-5	11	57	316
DOID:0080015	physical disorder	GO:0045596	negative regulation of cell differentiation	2.5439750306333053e-9	5.610736930061755e-5	33	597	316
DOID:0080015	physical disorder	GO:0031175	neuron projection development	2.5614994569878036e-9	5.649387052386601e-5	39	796	316
DOID:0080015	physical disorder	GO:0021766	hippocampus development	3.277319082783947e-9	7.228127237079995e-5	12	73	316
DOID:0080015	physical disorder	GO:0060537	muscle tissue development	3.28153060280556e-9	7.237415744487663e-5	24	336	316
DOID:0080015	physical disorder	GO:0019827	stem cell population maintenance	3.353607613831855e-9	7.396381592306156e-5	16	145	316
DOID:0080015	physical disorder	GO:0048701	embryonic cranial skeleton morphogenesis	3.976968754315635e-9	8.771204587643133e-5	10	46	316
DOID:0080015	physical disorder	GO:0048514	blood vessel morphogenesis	4.160499944561025e-9	9.17598262772934e-5	29	484	316
DOID:1307	dementia	GO:0030424	axon	9.356626584633432e-12	2.0636039932409034e-7	31	414	317
DOID:1307	dementia	GO:0043524	negative regulation of neuron apoptotic process	1.2596035325884714e-11	2.7780555911238736e-7	18	134	317
DOID:1307	dementia	GO:0048666	neuron development	1.3206546967126087e-11	2.9127039335996585e-7	47	926	317
DOID:1307	dementia	GO:0007268	synaptic transmission	2.2857826742495035e-11	5.04129368805728e-7	37	605	317
DOID:1307	dementia	GO:0043068	positive regulation of programmed cell death	1.498917656661547e-10	3.305862891767042e-6	34	561	317
DOID:1307	dementia	GO:0071248	cellular response to metal ion	1.5682732890098805e-10	3.4588267389112914e-6	17	136	317
DOID:1307	dementia	GO:0072507	divalent inorganic cation homeostasis	1.7522305828521212e-10	3.864544550480353e-6	28	393	317
DOID:1307	dementia	GO:0045471	response to ethanol	1.761821799561858e-10	3.885697978933678e-6	17	137	317
DOID:1307	dementia	GO:0001775	cell activation	5.690052873319473e-10	1.2549411612106098e-5	42	854	317
DOID:1307	dementia	GO:1902533	positive regulation of intracellular signal transduction	7.090104059415125e-10	1.563722450304006e-5	42	860	317
DOID:1307	dementia	GO:0031175	neuron projection development	8.398115536323303e-10	1.8522043815361044e-5	40	796	317
DOID:1307	dementia	GO:1901701	cellular response to oxygen-containing compound	1.1079447359563233e-9	2.443572115151671e-5	42	873	317
DOID:1307	dementia	GO:0034599	cellular response to oxidative stress	1.1173191261093507e-9	2.464247332634173e-5	20	219	317
DOID:1307	dementia	GO:0046777	protein autophosphorylation	2.4393571607106423e-9	5.380002217947322e-5	20	229	317
DOID:1307	dementia	GO:0030426	growth cone	2.580056057688296e-9	5.6903136352315364e-5	16	142	317
DOID:1307	dementia	GO:0043549	regulation of kinase activity	2.7136046742981534e-9	5.9848551091645774e-5	38	761	317
DOID:1307	dementia	GO:0044087	regulation of cellular component biogenesis	3.6014774495995994e-9	7.943058515091916e-5	37	735	317
DOID:1307	dementia	GO:0055074	calcium ion homeostasis	3.6288984039956063e-9	8.00353543001231e-5	25	364	317
DOID:1307	dementia	GO:0050804	modulation of synaptic transmission	3.87587417716162e-9	8.548240497729953e-5	22	285	317
Orphanet:290836	Systemic disease with skin involvement	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.1468603844377867e-12	2.5294005778775386e-8	22	151	321
Orphanet:290836	Systemic disease with skin involvement	GO:0042306	regulation of protein import into nucleus	1.0298428776422952e-12	2.271318466640082e-8	22	175	321
Orphanet:290836	Systemic disease with skin involvement	GO:0071219	cellular response to molecule of bacterial origin	1.0269562977782698e-12	2.264952114749974e-8	22	158	321
Orphanet:290836	Systemic disease with skin involvement	GO:0050663	cytokine secretion	9.99422766767566e-13	2.2042269121058666e-8	23	162	321
Orphanet:290836	Systemic disease with skin involvement	GO:0050707	regulation of cytokine secretion	7.025491299827991e-13	1.5494721061770633e-8	22	142	321
Orphanet:290836	Systemic disease with skin involvement	GO:0031348	negative regulation of defense response	4.75175454539567e-13	1.047999464987015e-8	20	140	321
Orphanet:290836	Systemic disease with skin involvement	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3.992361996552063e-13	8.805154383395575e-9	20	130	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002821	positive regulation of adaptive immune response	1.7341683644644945e-13	3.824708327826443e-9	17	71	321
Orphanet:290836	Systemic disease with skin involvement	GO:0050729	positive regulation of inflammatory response	4.2543746303636e-13	9.38302324726692e-9	19	114	321
Orphanet:290836	Systemic disease with skin involvement	GO:0045765	regulation of angiogenesis	4.29101199017623e-13	9.463826944333675e-9	23	208	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032675	regulation of interleukin-6 production	2.0089485630592208e-12	4.4307360558271114e-8	17	103	321
Orphanet:290836	Systemic disease with skin involvement	GO:0006809	nitric oxide biosynthetic process	2.167488410975693e-12	4.780395690406891e-8	14	62	321
Orphanet:290836	Systemic disease with skin involvement	GO:1903426	regulation of reactive oxygen species biosynthetic process	2.6296742561271458e-12	5.79974657188842e-8	14	63	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002218	activation of innate immune response	3.2509550607073834e-12	7.169981386390134e-8	25	247	321
Orphanet:290836	Systemic disease with skin involvement	GO:0034612	response to tumor necrosis factor	4.0921710464658645e-12	9.025283242980464e-8	26	265	321
Orphanet:290836	Systemic disease with skin involvement	GO:0045862	positive regulation of proteolysis	4.279576693022591e-12	9.438606396461324e-8	30	357	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	5.2302606690091125e-12	1.1535339905499598e-7	12	43	321
Orphanet:290836	Systemic disease with skin involvement	GO:0010212	response to ionizing radiation	5.736189301330796e-12	1.265116550408507e-7	19	145	321
Orphanet:290836	Systemic disease with skin involvement	GO:0050714	positive regulation of protein secretion	7.238321053648633e-12	1.596411708382206e-7	22	205	321
Orphanet:290836	Systemic disease with skin involvement	GO:0071356	cellular response to tumor necrosis factor	7.562617199141641e-12	1.667935223270689e-7	24	243	321
Orphanet:290836	Systemic disease with skin involvement	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	8.978151555538716e-12	1.9801313255740638e-7	16	97	321
Orphanet:290836	Systemic disease with skin involvement	GO:0060284	regulation of cell development	1.1626588580782027e-11	2.564244111491476e-7	48	828	321
Orphanet:290836	Systemic disease with skin involvement	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.485589429250922e-11	3.2764674862129084e-7	15	85	321
Orphanet:290836	Systemic disease with skin involvement	GO:0006935	chemotaxis	1.791655712679585e-11	3.951496674314825e-7	35	530	321
Orphanet:290836	Systemic disease with skin involvement	GO:0045428	regulation of nitric oxide biosynthetic process	4.730926761453702e-11	1.043405897238614e-6	12	51	321
Orphanet:290836	Systemic disease with skin involvement	GO:0042990	regulation of transcription factor import into nucleus	4.842837242335918e-11	1.0680877537971867e-6	15	92	321
Orphanet:290836	Systemic disease with skin involvement	GO:0070851	growth factor receptor binding	5.5694671097228365e-11	1.2283459710493716e-6	17	126	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032649	regulation of interferon-gamma production	5.679734460528607e-11	1.2526654352695843e-6	15	93	321
Orphanet:290836	Systemic disease with skin involvement	GO:0060326	cell chemotaxis	7.125611212188687e-11	1.571553552848215e-6	22	228	321
Orphanet:290836	Systemic disease with skin involvement	GO:0050715	positive regulation of cytokine secretion	7.793254930277271e-11	1.7188023748726522e-6	15	95	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032612	interleukin-1 production	8.128098194504219e-11	1.7926520567979054e-6	13	66	321
Orphanet:290836	Systemic disease with skin involvement	GO:0033619	membrane protein proteolysis	9.780243281909407e-11	2.1570326558251196e-6	12	54	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002718	regulation of cytokine production involved in immune response	1.5421419696792782e-10	3.401194114127648e-6	12	56	321
Orphanet:290836	Systemic disease with skin involvement	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.7505297211783954e-10	3.860793300058951e-6	20	195	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032611	interleukin-1 beta production	1.922044745583662e-10	4.2390696863847666e-6	12	57	321
Orphanet:290836	Systemic disease with skin involvement	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	1.9726009714560178e-10	4.350571442546247e-6	11	45	321
Orphanet:290836	Systemic disease with skin involvement	GO:0031329	regulation of cellular catabolic process	2.3021207162798873e-10	5.0773272397552915e-6	36	624	321
Orphanet:290836	Systemic disease with skin involvement	GO:0042346	positive regulation of NF-kappaB import into nucleus	2.8356939019147376e-10	6.254122900672954e-6	9	26	321
Orphanet:290836	Systemic disease with skin involvement	GO:0071496	cellular response to external stimulus	3.179578822454232e-10	7.012561092922809e-6	23	270	321
Orphanet:290836	Systemic disease with skin involvement	GO:0030856	regulation of epithelial cell differentiation	3.192031083898428e-10	7.0400245555379826e-6	16	122	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032651	regulation of interleukin-1 beta production	3.281513949460191e-10	7.237379015534451e-6	11	47	321
Orphanet:290836	Systemic disease with skin involvement	GO:2000147	positive regulation of cell motility	3.301413586953572e-10	7.281267666026103e-6	28	399	321
Orphanet:290836	Systemic disease with skin involvement	GO:0070371	ERK1 and ERK2 cascade	3.3303992896804857e-10	7.345195633390311e-6	22	247	321
Orphanet:290836	Systemic disease with skin involvement	GO:0009790	embryo development	3.4620795119622017e-10	7.635616363632636e-6	45	932	321
Orphanet:290836	Systemic disease with skin involvement	GO:0043409	negative regulation of MAPK cascade	5.272442482606721e-10	1.1628371895389122e-5	17	145	321
Orphanet:290836	Systemic disease with skin involvement	GO:0051348	negative regulation of transferase activity	6.581212241840717e-10	1.4514863599379701e-5	26	357	321
Orphanet:290836	Systemic disease with skin involvement	GO:0070372	regulation of ERK1 and ERK2 cascade	6.804057317566503e-10	1.5006348413892923e-5	21	233	321
Orphanet:290836	Systemic disease with skin involvement	GO:0009615	response to virus	6.827723941782438e-10	1.5058545153601166e-5	28	412	321
Orphanet:290836	Systemic disease with skin involvement	GO:0030335	positive regulation of cell migration	7.834544124563081e-10	1.7279087066723875e-5	27	387	321
Orphanet:290836	Systemic disease with skin involvement	GO:0006509	membrane protein ectodomain proteolysis	8.019704900164015e-10	1.7687459157311736e-5	10	39	321
Orphanet:290836	Systemic disease with skin involvement	GO:0010952	positive regulation of peptidase activity	8.093731240776947e-10	1.7850724251533556e-5	17	149	321
Orphanet:290836	Systemic disease with skin involvement	GO:0043200	response to amino acid	8.550006258545295e-10	1.885703880322165e-5	15	112	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032846	positive regulation of homeostatic process	9.350590302048545e-10	2.0622726911168066e-5	19	192	321
Orphanet:290836	Systemic disease with skin involvement	GO:0043542	endothelial cell migration	9.974250314570554e-10	2.1998209068785357e-5	17	151	321
Orphanet:290836	Systemic disease with skin involvement	GO:0071260	cellular response to mechanical stimulus	1.0088264668084435e-9	2.224966772546022e-5	13	80	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002712	regulation of B cell mediated immunity	1.0531302496730177e-9	2.3226787656538406e-5	10	40	321
Orphanet:290836	Systemic disease with skin involvement	GO:0090398	cellular senescence	1.0541446604506177e-9	2.3249160486238374e-5	11	52	321
Orphanet:290836	Systemic disease with skin involvement	GO:0000302	response to reactive oxygen species	1.089160317491178e-9	2.402143080226793e-5	20	216	321
Orphanet:290836	Systemic disease with skin involvement	GO:0071456	cellular response to hypoxia	1.3088030659247352e-9	2.8865651618970034e-5	16	134	321
Orphanet:290836	Systemic disease with skin involvement	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.6168062444421594e-9	3.5658661721171825e-5	13	83	321
Orphanet:290836	Systemic disease with skin involvement	GO:0030595	leukocyte chemotaxis	1.6824980297869274e-9	3.7107494046950684e-5	18	177	321
Orphanet:290836	Systemic disease with skin involvement	GO:0030100	regulation of endocytosis	1.7146922770550077e-9	3.7817538170448195e-5	19	199	321
Orphanet:290836	Systemic disease with skin involvement	GO:0048871	multicellular organismal homeostasis	1.814648653564177e-9	4.0022076054357925e-5	24	321	321
Orphanet:290836	Systemic disease with skin involvement	GO:0045637	regulation of myeloid cell differentiation	2.0175817683210084e-9	4.449776590031984e-5	18	179	321
Orphanet:290836	Systemic disease with skin involvement	GO:0045766	positive regulation of angiogenesis	2.022038203541854e-9	4.4596052579115586e-5	15	119	321
Orphanet:290836	Systemic disease with skin involvement	GO:0051341	regulation of oxidoreductase activity	2.1895767421398205e-9	4.829111504789374e-5	13	85	321
Orphanet:290836	Systemic disease with skin involvement	GO:0090342	regulation of cell aging	2.3248143410370403e-9	5.1273780291571924e-5	9	32	321
Orphanet:290836	Systemic disease with skin involvement	GO:0051235	maintenance of location	2.354312078622911e-9	5.19243528940283e-5	22	274	321
Orphanet:290836	Systemic disease with skin involvement	GO:0001818	negative regulation of cytokine production	2.395920573050603e-9	5.2842028238631045e-5	19	203	321
Orphanet:290836	Systemic disease with skin involvement	GO:0033673	negative regulation of kinase activity	2.447347768885777e-9	5.397625504277581e-5	21	250	321
Orphanet:290836	Systemic disease with skin involvement	GO:0006066	alcohol metabolic process	2.751294747582733e-9	6.067980565793718e-5	26	382	321
Orphanet:290836	Systemic disease with skin involvement	GO:0033273	response to vitamin	2.938437604349531e-9	6.48072413639289e-5	14	104	321
Orphanet:290836	Systemic disease with skin involvement	GO:0032768	regulation of monooxygenase activity	2.982750491042907e-9	6.578456207995131e-5	11	57	321
Orphanet:290836	Systemic disease with skin involvement	GO:0042092	type 2 immune response	3.148579064138346e-9	6.944191125957122e-5	9	33	321
Orphanet:290836	Systemic disease with skin involvement	GO:0031341	regulation of cell killing	3.6250565882411934e-9	7.995062305365952e-5	11	58	321
Orphanet:290836	Systemic disease with skin involvement	GO:0031331	positive regulation of cellular catabolic process	3.748558352612008e-9	8.267445446685784e-5	24	333	321
Orphanet:290836	Systemic disease with skin involvement	GO:0002761	regulation of myeloid leukocyte differentiation	3.7873407743305165e-9	8.352980077785954e-5	14	106	321
Orphanet:290836	Systemic disease with skin involvement	GO:0006469	negative regulation of protein kinase activity	4.393607477837236e-9	9.690101292370024e-5	20	234	321
MESH:D009385	Neoplastic Processes	GO:0032880	regulation of protein localization	7.613021324459623e-12	1.67905185310957e-7	54	933	322
MESH:D009385	Neoplastic Processes	GO:0051338	regulation of transferase activity	3.710365348297273e-12	8.183210775669636e-8	52	928	322
MESH:D009385	Neoplastic Processes	GO:0048666	neuron development	2.5714985696367876e-12	5.671440095333935e-8	50	926	322
MESH:D009385	Neoplastic Processes	GO:0001775	cell activation	1.1806111643863915e-12	2.6038379230541864e-8	49	854	322
MESH:D009385	Neoplastic Processes	GO:0000302	response to reactive oxygen species	8.961720254774264e-13	1.976507402190464e-8	24	216	322
MESH:D009385	Neoplastic Processes	GO:0045216	cell-cell junction organization	5.524469770534779e-13	1.2184218078914455e-8	24	212	322
MESH:D009385	Neoplastic Processes	GO:0048771	tissue remodeling	4.445332990599127e-13	9.804181910766374e-9	20	139	322
MESH:D009385	Neoplastic Processes	GO:0036293	response to decreased oxygen levels	1.3087309014281345e-12	2.8864060030997507e-8	30	302	322
MESH:D009385	Neoplastic Processes	GO:0071900	regulation of protein serine/threonine kinase activity	3.400058012914542e-12	7.498827947483022e-8	34	431	322
MESH:D009385	Neoplastic Processes	GO:0042493	response to drug	3.443578755479848e-12	7.594812945210805e-8	35	433	322
MESH:D009385	Neoplastic Processes	GO:0061138	morphogenesis of a branching epithelium	3.478439758453078e-12	7.671698887268263e-8	21	179	322
MESH:D009385	Neoplastic Processes	GO:0097285	cell-type specific apoptotic process	4.119149465964256e-12	9.084784147184166e-8	35	429	322
MESH:D009385	Neoplastic Processes	GO:0061564	axon development	4.717559676237215e-12	1.0404577865941178e-7	33	440	322
MESH:D009385	Neoplastic Processes	GO:0048608	reproductive structure development	5.424882765225902e-12	1.1964578938705728e-7	32	418	322
MESH:D009385	Neoplastic Processes	GO:0010942	positive regulation of cell death	9.00257646208047e-12	1.9855182387118475e-7	40	596	322
MESH:D009385	Neoplastic Processes	GO:0043065	positive regulation of apoptotic process	1.129574211944373e-11	2.4912759244433147e-7	37	556	322
MESH:D009385	Neoplastic Processes	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.1310841152578632e-11	2.4946060162012174e-7	20	168	322
MESH:D009385	Neoplastic Processes	GO:0001667	ameboidal-type cell migration	1.1615042261325925e-11	2.561697570735433e-7	27	315	322
MESH:D009385	Neoplastic Processes	GO:0007610	behavior	1.164479623838588e-11	2.5682598103760057e-7	44	714	322
MESH:D009385	Neoplastic Processes	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.305178187749334e-11	2.878570493081156e-7	15	84	322
MESH:D009385	Neoplastic Processes	GO:0061061	muscle structure development	1.4771406320335245e-11	3.2578336639499383e-7	36	551	322
MESH:D009385	Neoplastic Processes	GO:0034097	response to cytokine	1.6170398353665405e-11	3.566381356900905e-7	46	784	322
MESH:D009385	Neoplastic Processes	GO:0032403	protein complex binding	2.4270585541330547e-11	5.352877641140452e-7	47	924	322
MESH:D009385	Neoplastic Processes	GO:0007409	axonogenesis	2.484967787097503e-11	5.480596454443543e-7	30	406	322
MESH:D009385	Neoplastic Processes	GO:1903034	regulation of response to wounding	2.5979884910043438e-11	5.72986361691008e-7	30	407	322
MESH:D009385	Neoplastic Processes	GO:0072089	stem cell proliferation	3.1159519409129643e-11	6.872232005683543e-7	18	139	322
MESH:D009385	Neoplastic Processes	GO:0050776	regulation of immune response	3.1390334775949214e-11	6.923138334835599e-7	44	816	322
MESH:D009385	Neoplastic Processes	GO:0042692	muscle cell differentiation	3.148459271073989e-11	6.943926922353683e-7	27	334	322
MESH:D009385	Neoplastic Processes	GO:0010038	response to metal ion	3.401168235939167e-11	7.501276544363833e-7	27	335	322
MESH:D009385	Neoplastic Processes	GO:0006954	inflammatory response	3.742428589248448e-11	8.253926253587451e-7	38	637	322
MESH:D009385	Neoplastic Processes	GO:0016032	viral process	3.917088875482477e-11	8.639139514876604e-7	41	726	322
MESH:D009385	Neoplastic Processes	GO:0007420	brain development	4.258393637712743e-11	9.391887167975455e-7	39	669	322
MESH:D009385	Neoplastic Processes	GO:0048010	vascular endothelial growth factor receptor signaling pathway	4.297995293001122e-11	9.479228618713975e-7	15	91	322
MESH:D009385	Neoplastic Processes	GO:0031344	regulation of cell projection organization	4.346079052197638e-11	9.58527734962189e-7	34	524	322
MESH:D009385	Neoplastic Processes	GO:0071407	cellular response to organic cyclic compound	4.577949130890602e-11	1.0096666808179222e-6	30	416	322
MESH:D009385	Neoplastic Processes	GO:0007568	aging	4.5785597535541456e-11	1.0098013536463668e-6	25	290	322
MESH:D009385	Neoplastic Processes	GO:0040008	regulation of growth	5.6214144450450476e-11	1.2398029558546853e-6	37	617	322
MESH:D009385	Neoplastic Processes	GO:0071496	cellular response to external stimulus	5.914191358868948e-11	1.3043749041985464e-6	24	270	322
MESH:D009385	Neoplastic Processes	GO:0002764	immune response-regulating signaling pathway	6.686051712279095e-11	1.4746087051431545e-6	31	451	322
MESH:D009385	Neoplastic Processes	GO:0051051	negative regulation of transport	7.137612723084885e-11	1.5742004860763714e-6	31	452	322
MESH:D009385	Neoplastic Processes	GO:0048871	multicellular organismal homeostasis	7.313938343855853e-11	1.6130891017374083e-6	26	321	322
MESH:D009385	Neoplastic Processes	GO:0032388	positive regulation of intracellular transport	7.464295848080837e-11	1.6462504492942287e-6	27	347	322
MESH:D009385	Neoplastic Processes	GO:1902532	negative regulation of intracellular signal transduction	7.71269714761047e-11	1.7010353559054892e-6	30	426	322
MESH:D009385	Neoplastic Processes	GO:2000811	negative regulation of anoikis	8.188494327043827e-11	1.805972423829516e-6	8	16	322
MESH:D009385	Neoplastic Processes	GO:0045765	regulation of angiogenesis	8.613931790080187e-11	1.8998026563021853e-6	21	208	322
MESH:D009385	Neoplastic Processes	GO:0035295	tube development	9.704981263070067e-11	2.1404336175701033e-6	35	573	322
MESH:D009385	Neoplastic Processes	GO:0060249	anatomical structure homeostasis	9.798584166276214e-11	2.161077737872219e-6	27	351	322
MESH:D009385	Neoplastic Processes	GO:0008285	negative regulation of cell proliferation	1.051689846320869e-10	2.3195019560606767e-6	37	634	322
MESH:D009385	Neoplastic Processes	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	1.6156054272187248e-10	3.5632177697308975e-6	27	359	322
MESH:D009385	Neoplastic Processes	GO:0010769	regulation of cell morphogenesis involved in differentiation	1.6654189138876063e-10	3.6730814145791157e-6	26	334	322
MESH:D009385	Neoplastic Processes	GO:0050768	negative regulation of neurogenesis	1.728800436140432e-10	3.8128693619077225e-6	22	238	322
MESH:D009385	Neoplastic Processes	GO:0032103	positive regulation of response to external stimulus	1.7572876487292888e-10	3.875697909272446e-6	24	285	322
MESH:D009385	Neoplastic Processes	GO:0050878	regulation of body fluid levels	2.4306068269197567e-10	5.3607033567715234e-6	32	504	322
MESH:D009385	Neoplastic Processes	GO:0016049	cell growth	2.9073554674852176e-10	6.412172483538647e-6	31	479	322
MESH:D009385	Neoplastic Processes	GO:0045321	leukocyte activation	3.360896005943914e-10	7.412456141109303e-6	38	694	322
MESH:D009385	Neoplastic Processes	GO:1903827	regulation of cellular protein localization	3.8551029035716056e-10	8.502429453827176e-6	33	543	322
MESH:D009385	Neoplastic Processes	GO:0051223	regulation of protein transport	3.9077818758670446e-10	8.618612927224767e-6	39	730	322
MESH:D009385	Neoplastic Processes	GO:0009314	response to radiation	4.535780639969289e-10	1.0003664201452267e-5	29	431	322
MESH:D009385	Neoplastic Processes	GO:0031346	positive regulation of cell projection organization	4.959469501741864e-10	1.0938109986091682e-5	24	300	322
MESH:D009385	Neoplastic Processes	GO:0051129	negative regulation of cellular component organization	4.964738620216735e-10	1.094973102688801e-5	34	579	322
MESH:D009385	Neoplastic Processes	GO:0045666	positive regulation of neuron differentiation	6.481460923524196e-10	1.4294862066832614e-5	24	304	322
MESH:D009385	Neoplastic Processes	GO:0030900	forebrain development	7.030787063655453e-10	1.55064008688921e-5	26	357	322
MESH:D009385	Neoplastic Processes	GO:2000027	regulation of organ morphogenesis	9.099025977121755e-10	2.006790179254203e-5	21	236	322
MESH:D009385	Neoplastic Processes	GO:0071453	cellular response to oxygen levels	9.424523383927408e-10	2.0785786323251898e-5	17	150	322
MESH:D009385	Neoplastic Processes	GO:0071214	cellular response to abiotic stimulus	9.71496771917657e-10	2.1426361304643926e-5	23	285	322
MESH:D009385	Neoplastic Processes	GO:0019900	kinase binding	1.1410705713643665e-9	2.5166311451441103e-5	34	598	322
MESH:D009385	Neoplastic Processes	GO:0044259	multicellular organismal macromolecule metabolic process	1.1483654027699686e-9	2.5327198958091657e-5	15	114	322
MESH:D009385	Neoplastic Processes	GO:0071456	cellular response to hypoxia	1.3689400724103962e-9	3.0191973297011288e-5	16	134	322
MESH:D009385	Neoplastic Processes	GO:0048145	regulation of fibroblast proliferation	1.437952978911028e-9	3.171405294988272e-5	13	82	322
MESH:D009385	Neoplastic Processes	GO:0048660	regulation of smooth muscle cell proliferation	1.8080046348956103e-9	3.9875542222622684e-5	14	100	322
MESH:D009385	Neoplastic Processes	GO:0010975	regulation of neuron projection development	1.8214887376188926e-9	4.017293410818468e-5	27	401	322
MESH:D009385	Neoplastic Processes	GO:0098552	side of membrane	1.92299864920642e-9	4.241173520824759e-5	27	402	322
MESH:D009385	Neoplastic Processes	GO:0033044	regulation of chromosome organization	2.0311933246475178e-9	4.4797968775101005e-5	22	271	322
MESH:D009385	Neoplastic Processes	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	2.0665722466617353e-9	4.557825090012457e-5	14	101	322
MESH:D009385	Neoplastic Processes	GO:0022407	regulation of cell-cell adhesion	2.107234275960934e-9	4.64750519563184e-5	26	376	322
MESH:D009385	Neoplastic Processes	GO:0031960	response to corticosteroid	2.119540876144299e-9	4.6746474023362516e-5	18	179	322
MESH:D009385	Neoplastic Processes	GO:0048770	pigment granule	2.358711004291081e-9	5.202137119963979e-5	14	102	322
MESH:D009385	Neoplastic Processes	GO:0042470	melanosome	2.358711004291081e-9	5.202137119963979e-5	14	102	322
MESH:D009385	Neoplastic Processes	GO:0021537	telencephalon development	2.538758869796709e-9	5.5992326873366416e-5	20	226	322
MESH:D009385	Neoplastic Processes	GO:0031099	regeneration	2.7701773097632554e-9	6.10962605668286e-5	18	182	322
MESH:D009385	Neoplastic Processes	GO:0001819	positive regulation of cytokine production	2.780906283028628e-9	6.133288807219639e-5	26	381	322
MESH:D009385	Neoplastic Processes	GO:0060326	cell chemotaxis	2.957903699751796e-9	6.523656609802586e-5	20	228	322
MESH:D009385	Neoplastic Processes	GO:0033273	response to vitamin	3.0580864507356864e-9	6.744609667097556e-5	14	104	322
MESH:D009385	Neoplastic Processes	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3.113498125983938e-9	6.866820116857575e-5	17	162	322
MESH:D009385	Neoplastic Processes	GO:0050663	cytokine secretion	3.113498125983938e-9	6.866820116857575e-5	17	162	322
MESH:D009385	Neoplastic Processes	GO:0050770	regulation of axonogenesis	3.422394256880068e-9	7.54809053354899e-5	17	163	322
MESH:D009385	Neoplastic Processes	GO:0072091	regulation of stem cell proliferation	3.527019343252391e-9	7.778841161543149e-5	13	88	322
MESH:D009385	Neoplastic Processes	GO:1903706	regulation of hemopoiesis	3.592289798959314e-9	7.922795151604767e-5	23	305	322
MESH:D009385	Neoplastic Processes	GO:0046649	lymphocyte activation	3.604982423688341e-9	7.950788735444636e-5	33	594	322
MESH:D009385	Neoplastic Processes	GO:0010632	regulation of epithelial cell migration	3.759487054999511e-9	8.291548699801421e-5	17	164	322
MESH:D009385	Neoplastic Processes	GO:0042542	response to hydrogen peroxide	3.762240186055976e-9	8.297620730346456e-5	15	124	322
MESH:D009385	Neoplastic Processes	GO:0006879	cellular iron ion homeostasis	3.78419895419313e-9	8.346050793472948e-5	10	45	322
MESH:D009385	Neoplastic Processes	GO:0048872	homeostasis of number of cells	3.786181479448203e-9	8.350423252923012e-5	19	208	322
MESH:D009385	Neoplastic Processes	GO:0070997	neuron death	3.980950680215756e-9	8.779986725215849e-5	22	281	322
MESH:D009385	Neoplastic Processes	GO:0051222	positive regulation of protein transport	4.476092052563274e-9	9.872021021928301e-5	28	447	322
MESH:D019966	Substance-Related Disorders	GO:0048878	chemical homeostasis	1.4510614931850796e-12	3.200316123219693e-8	50	988	324
MESH:D019966	Substance-Related Disorders	GO:0006836	neurotransmitter transport	1.2800871473928055e-12	2.8232322035748325e-8	23	183	324
MESH:D019966	Substance-Related Disorders	GO:0009190	cyclic nucleotide biosynthetic process	9.690026558928366e-13	2.1371353575716512e-8	24	149	324
MESH:D019966	Substance-Related Disorders	GO:0030808	regulation of nucleotide biosynthetic process	7.598366380534571e-13	1.6758197052268997e-8	23	139	324
MESH:D019966	Substance-Related Disorders	GO:0030814	regulation of cAMP metabolic process	4.3454129183828627e-13	9.583808191493404e-9	22	128	324
MESH:D019966	Substance-Related Disorders	GO:0001963	synaptic transmission, dopaminergic	5.3512749786932545e-14	1.1802236965507973e-9	12	28	324
MESH:D019966	Substance-Related Disorders	GO:0014072	response to isoquinoline alkaloid	1.6653345369377348e-15	3.672895321216174e-11	12	30	324
MESH:D019966	Substance-Related Disorders	GO:0043278	response to morphine	1.6653345369377348e-15	3.672895321216174e-11	12	30	324
MESH:D019966	Substance-Related Disorders	GO:0050806	positive regulation of synaptic transmission	1.936228954946273e-13	4.270352960134005e-9	20	118	324
MESH:D019966	Substance-Related Disorders	GO:0009152	purine ribonucleotide biosynthetic process	5.224709553885987e-13	1.1523096921095544e-8	27	240	324
MESH:D019966	Substance-Related Disorders	GO:0006171	cAMP biosynthetic process	5.837552663479073e-13	1.2874722399303096e-8	21	116	324
MESH:D019966	Substance-Related Disorders	GO:0009914	hormone transport	1.846633956859023e-12	4.072751191852575e-8	31	307	324
MESH:D019966	Substance-Related Disorders	GO:0060079	excitatory postsynaptic potential	6.080913550476907e-12	1.341145483557682e-7	13	54	324
MESH:D019966	Substance-Related Disorders	GO:0006874	cellular calcium ion homeostasis	6.510569861006843e-12	1.4359061828450592e-7	29	352	324
MESH:D019966	Substance-Related Disorders	GO:0010876	lipid localization	7.087219699997149e-12	1.5630863048343713e-7	28	333	324
MESH:D019966	Substance-Related Disorders	GO:0006939	smooth muscle contraction	1.0503264924466293e-11	2.316495079091041e-7	16	97	324
MESH:D019966	Substance-Related Disorders	GO:0051047	positive regulation of secretion	1.1079248629641825e-11	2.4435282852675044e-7	29	363	324
MESH:D019966	Substance-Related Disorders	GO:0036293	response to decreased oxygen levels	2.1725843346587226e-11	4.791634750089813e-7	26	302	324
MESH:D019966	Substance-Related Disorders	GO:1903531	negative regulation of secretion by cell	2.4568902468047327e-11	5.418671439327838e-7	20	174	324
MESH:D019966	Substance-Related Disorders	GO:0043627	response to estrogen	3.0632163472432694e-11	6.755923653845031e-7	22	217	324
MESH:D019966	Substance-Related Disorders	GO:0098810	neurotransmitter reuptake	4.369959949457325e-11	9.63794666852813e-7	8	15	324
MESH:D019966	Substance-Related Disorders	GO:0002209	behavioral defense response	4.759270755272382e-11	1.049657165075324e-6	10	30	324
MESH:D019966	Substance-Related Disorders	GO:0001662	behavioral fear response	4.759270755272382e-11	1.049657165075324e-6	10	30	324
MESH:D019966	Substance-Related Disorders	GO:0001934	positive regulation of protein phosphorylation	5.874134512140472e-11	1.295540366652581e-6	45	870	324
MESH:D019966	Substance-Related Disorders	GO:0001666	response to hypoxia	6.092260029788577e-11	1.3436479495698705e-6	25	292	324
MESH:D019966	Substance-Related Disorders	GO:1903792	negative regulation of anion transport	6.920242157093526e-11	1.526259407746977e-6	10	31	324
MESH:D019966	Substance-Related Disorders	GO:0042310	vasoconstriction	9.138911849504439e-11	2.015587008408204e-6	14	80	324
MESH:D019966	Substance-Related Disorders	GO:0032844	regulation of homeostatic process	9.504530495973995e-11	2.0962242008870646e-6	30	427	324
MESH:D019966	Substance-Related Disorders	GO:0014069	postsynaptic density	9.589840033186192e-11	2.1150392193192147e-6	20	187	324
MESH:D019966	Substance-Related Disorders	GO:0006869	lipid transport	1.0333423006159137e-10	2.2790364440083977e-6	25	300	324
MESH:D019966	Substance-Related Disorders	GO:0071417	cellular response to organonitrogen compound	1.4326906327966071e-10	3.159799190632917e-6	31	462	324
MESH:D019966	Substance-Related Disorders	GO:0042069	regulation of catecholamine metabolic process	1.6007140057894276e-10	3.5303747397685825e-6	8	17	324
MESH:D019966	Substance-Related Disorders	GO:0042053	regulation of dopamine metabolic process	1.6007140057894276e-10	3.5303747397685825e-6	8	17	324
MESH:D019966	Substance-Related Disorders	GO:0051953	negative regulation of amine transport	2.0444301807032161e-10	4.508990763540943e-6	9	25	324
MESH:D019966	Substance-Related Disorders	GO:0042165	neurotransmitter binding	2.0444301807032161e-10	4.508990763540943e-6	9	25	324
MESH:D019966	Substance-Related Disorders	GO:0018105	peptidyl-serine phosphorylation	2.4749347016239653e-10	5.4584684844316556e-6	22	241	324
MESH:D019966	Substance-Related Disorders	GO:0043197	dendritic spine	2.504902951727672e-10	5.524563460035381e-6	16	119	324
MESH:D019966	Substance-Related Disorders	GO:0022898	regulation of transmembrane transporter activity	2.985336422511864e-10	6.584159479849916e-6	19	178	324
MESH:D019966	Substance-Related Disorders	GO:1903524	positive regulation of blood circulation	4.0135461620849355e-10	8.851876060478325e-6	14	89	324
MESH:D019966	Substance-Related Disorders	GO:0046888	negative regulation of hormone secretion	4.119281582504186e-10	9.085075530212983e-6	13	74	324
MESH:D019966	Substance-Related Disorders	GO:0008066	glutamate receptor activity	4.5483228294784794e-10	1.0031326000414786e-5	9	27	324
MESH:D019966	Substance-Related Disorders	GO:0098793	presynapse	5.077442910561558e-10	1.1198300339243517e-5	20	205	324
MESH:D019966	Substance-Related Disorders	GO:0007616	long-term memory	6.600873181383804e-10	1.455822580154198e-5	9	28	324
MESH:D019966	Substance-Related Disorders	GO:0009611	response to wounding	7.177437533201214e-10	1.5829838479475278e-5	43	875	324
MESH:D019966	Substance-Related Disorders	GO:0051480	cytosolic calcium ion homeostasis	7.274161273329582e-10	1.6043162688328394e-5	22	255	324
MESH:D019966	Substance-Related Disorders	GO:0051926	negative regulation of calcium ion transport	7.414953095974397e-10	1.6353679053171533e-5	11	50	324
MESH:D019966	Substance-Related Disorders	GO:0000165	MAPK cascade	7.643179422700541e-10	1.6857032216766044e-5	42	843	324
MESH:D019966	Substance-Related Disorders	GO:2000021	regulation of ion homeostasis	8.358045366918532e-10	1.8433669056738822e-5	19	189	324
MESH:D019966	Substance-Related Disorders	GO:0007204	positive regulation of cytosolic calcium ion concentration	8.709563070752324e-10	1.920894135254425e-5	21	234	324
MESH:D019966	Substance-Related Disorders	GO:1903532	positive regulation of secretion by cell	1.0365551750268764e-9	2.286122438521776e-5	25	335	324
MESH:D019966	Substance-Related Disorders	GO:0071407	cellular response to organic cyclic compound	1.0469134448243267e-9	2.3089676025600525e-5	28	416	324
MESH:D019966	Substance-Related Disorders	GO:0019229	regulation of vasoconstriction	1.0766590952115962e-9	2.3745716344891754e-5	12	65	324
MESH:D019966	Substance-Related Disorders	GO:0032412	regulation of ion transmembrane transporter activity	1.4782479684782857e-9	3.260275894478859e-5	18	174	324
MESH:D019966	Substance-Related Disorders	GO:0043235	receptor complex	1.811067962265156e-9	3.9943103907758015e-5	24	318	324
MESH:D019966	Substance-Related Disorders	GO:1901701	cellular response to oxygen-containing compound	2.1623782764379484e-9	4.769125288683895e-5	42	873	324
MESH:D019966	Substance-Related Disorders	GO:0009636	response to toxic substance	2.687704281356673e-9	5.927731792532143e-5	21	249	324
MESH:D019966	Substance-Related Disorders	GO:0007416	synapse assembly	2.8635419591083178e-9	6.315541790813395e-5	16	140	324
MESH:D019966	Substance-Related Disorders	GO:0032845	negative regulation of homeostatic process	3.417475080702559e-9	7.537241290489494e-5	17	162	324
MESH:D019966	Substance-Related Disorders	GO:1903793	positive regulation of anion transport	3.994142239172049e-9	8.809080708493955e-5	11	58	324
MESH:D019966	Substance-Related Disorders	GO:0048169	regulation of long-term neuronal synaptic plasticity	4.356617400169682e-9	9.608519676074234e-5	8	24	324
Orphanet:139009	Developmental anomaly of metabolic origin	GO:0006643	membrane lipid metabolic process	1.4557244298885053e-12	3.2106002301190983e-8	23	191	325
Orphanet:139009	Developmental anomaly of metabolic origin	GO:1903509	liposaccharide metabolic process	1.673106098110111e-13	3.6900354993818496e-9	21	118	325
Orphanet:139009	Developmental anomaly of metabolic origin	GO:0006664	glycolipid metabolic process	5.276890036043369e-13	1.163818097449365e-8	21	116	325
Orphanet:139009	Developmental anomaly of metabolic origin	GO:0044242	cellular lipid catabolic process	2.855750080854591e-10	6.2983568033248005e-6	19	177	325
MESH:D015179	Colorectal Neoplasms	GO:0006259	DNA metabolic process	6.711520228463996e-12	1.4802257863877344e-7	52	937	326
MESH:D015179	Colorectal Neoplasms	GO:0048878	chemical homeostasis	6.479483616317339e-12	1.429050111578789e-7	51	988	326
MESH:D015179	Colorectal Neoplasms	GO:0040007	growth	6.150857601028292e-12	1.3565716439067899e-7	50	936	326
MESH:D015179	Colorectal Neoplasms	GO:0009790	embryo development	4.907407813448117e-12	1.0823287932559822e-7	55	932	326
MESH:D015179	Colorectal Neoplasms	GO:0022857	transmembrane transporter activity	4.548361687284341e-12	1.0031411701305615e-7	51	990	326
MESH:D015179	Colorectal Neoplasms	GO:1901654	response to ketone	1.638023050531956e-12	3.612659837948229e-8	24	181	326
MESH:D015179	Colorectal Neoplasms	GO:0043627	response to estrogen	1.2136958105202211e-12	2.6768061101023477e-8	25	217	326
MESH:D015179	Colorectal Neoplasms	GO:0055123	digestive system development	1.2032597140887447e-12	2.6537892994227263e-8	23	150	326
MESH:D015179	Colorectal Neoplasms	GO:0048565	digestive tract development	5.211386877590485e-13	1.1493713758525814e-8	23	138	326
MESH:D015179	Colorectal Neoplasms	GO:0016820	hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances	1.3633538742396922e-13	3.0068769696356412e-9	31	106	326
MESH:D015179	Colorectal Neoplasms	GO:0043492	ATPase activity, coupled to movement of substances	9.57012247226885e-14	2.1106905112588947e-9	31	119	326
MESH:D015179	Colorectal Neoplasms	GO:0032355	response to estradiol	7.283063041541027e-14	1.6062795538118735e-9	20	145	326
MESH:D015179	Colorectal Neoplasms	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	2.4635848916432224e-13	5.433436478519127e-9	31	104	326
MESH:D015179	Colorectal Neoplasms	GO:0035690	cellular response to drug	6.038503030936226e-13	1.3317918434729847e-8	15	69	326
MESH:D015179	Colorectal Neoplasms	GO:0036293	response to decreased oxygen levels	1.0864642518981782e-12	2.396196907561432e-8	30	302	326
MESH:D015179	Colorectal Neoplasms	GO:0043225	anion transmembrane-transporting ATPase activity	1.2622125566963405e-12	2.783809793793779e-8	8	11	326
MESH:D015179	Colorectal Neoplasms	GO:0010876	lipid localization	1.978417429882029e-12	4.363399641604815e-8	29	333	326
MESH:D015179	Colorectal Neoplasms	GO:0001763	morphogenesis of a branching structure	2.0308199566443363e-12	4.478973414379084e-8	22	193	326
MESH:D015179	Colorectal Neoplasms	GO:0050679	positive regulation of epithelial cell proliferation	2.2691848400313575e-12	5.004687164689159e-8	20	155	326
MESH:D015179	Colorectal Neoplasms	GO:0046824	positive regulation of nucleocytoplasmic transport	2.449485059230483e-12	5.40233929813283e-8	18	118	326
MESH:D015179	Colorectal Neoplasms	GO:0048863	stem cell differentiation	2.5264235148370062e-12	5.572027061973017e-8	28	266	326
MESH:D015179	Colorectal Neoplasms	GO:0043062	extracellular structure organization	3.748890087251766e-12	8.26817708743377e-8	29	321	326
MESH:D015179	Colorectal Neoplasms	GO:0030198	extracellular matrix organization	3.814726312612038e-12	8.41337888246585e-8	29	320	326
MESH:D015179	Colorectal Neoplasms	GO:0001503	ossification	4.166000877603437e-12	9.188114935554381e-8	30	363	326
MESH:D015179	Colorectal Neoplasms	GO:0071396	cellular response to lipid	4.668709863153708e-12	1.0296839603185504e-7	33	416	326
MESH:D015179	Colorectal Neoplasms	GO:0006869	lipid transport	4.8739901004069e-12	1.0749585166447417e-7	27	300	326
MESH:D015179	Colorectal Neoplasms	GO:0061138	morphogenesis of a branching epithelium	4.884870286048226e-12	1.0773581415879363e-7	21	179	326
MESH:D015179	Colorectal Neoplasms	GO:0010717	regulation of epithelial to mesenchymal transition	8.018141706145343e-12	1.7684011532903554e-7	14	67	326
MESH:D015179	Colorectal Neoplasms	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.0592415833343694e-11	2.3361573120439516e-7	50	996	326
MESH:D015179	Colorectal Neoplasms	GO:0006606	protein import into nucleus	1.301647678531026e-11	2.870783955000178e-7	25	268	326
MESH:D015179	Colorectal Neoplasms	GO:0042307	positive regulation of protein import into nucleus	1.3683165711597667e-11	3.0178221976928654e-7	16	98	326
MESH:D015179	Colorectal Neoplasms	GO:0009986	cell surface	1.4444223594978212e-11	3.1856735138724446e-7	43	715	326
MESH:D015179	Colorectal Neoplasms	GO:0030155	regulation of cell adhesion	1.5866419289523037e-11	3.499338774304306e-7	39	621	326
MESH:D015179	Colorectal Neoplasms	GO:0042910	xenobiotic transporter activity	2.7077784459095255e-11	5.972005362453459e-7	6	6	326
MESH:D015179	Colorectal Neoplasms	GO:0071229	cellular response to acid chemical	2.7627233833982245e-11	6.093186422084784e-7	20	174	326
MESH:D015179	Colorectal Neoplasms	GO:0002520	immune system development	4.2201575567446525e-11	9.307557491400331e-7	43	782	326
MESH:D015179	Colorectal Neoplasms	GO:0001933	negative regulation of protein phosphorylation	4.271372144870611e-11	9.420511265512133e-7	29	385	326
MESH:D015179	Colorectal Neoplasms	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	4.3496872770276696e-11	9.593235289484525e-7	28	359	326
MESH:D015179	Colorectal Neoplasms	GO:0042803	protein homodimerization activity	6.159595056232092e-11	1.358498689651988e-6	40	703	326
MESH:D015179	Colorectal Neoplasms	GO:0001667	ameboidal-type cell migration	6.373668259840315e-11	1.4057125347077815e-6	26	315	326
MESH:D015179	Colorectal Neoplasms	GO:0090287	regulation of cellular response to growth factor stimulus	8.027833953150321e-11	1.7705387783673032e-6	22	226	326
MESH:D015179	Colorectal Neoplasms	GO:0097193	intrinsic apoptotic signaling pathway	8.701095399743508e-11	1.9190265904134307e-6	24	272	326
MESH:D015179	Colorectal Neoplasms	GO:0006766	vitamin metabolic process	9.122580468812203e-11	2.0119851223965313e-6	17	128	326
MESH:D015179	Colorectal Neoplasms	GO:1901342	regulation of vasculature development	9.516820664856596e-11	2.098934797634122e-6	22	228	326
MESH:D015179	Colorectal Neoplasms	GO:0045596	negative regulation of cell differentiation	1.0798584249016585e-10	2.381627756120608e-6	36	597	326
MESH:D015179	Colorectal Neoplasms	GO:0045926	negative regulation of growth	1.1244771780383189e-10	2.4800344161635124e-6	22	230	326
MESH:D015179	Colorectal Neoplasms	GO:0001657	ureteric bud development	1.3208034665979085e-10	2.913032045581687e-6	15	97	326
MESH:D015179	Colorectal Neoplasms	GO:0010638	positive regulation of organelle organization	1.347340017332499e-10	2.9715584082268265e-6	35	573	326
MESH:D015179	Colorectal Neoplasms	GO:0051241	negative regulation of multicellular organismal process	1.7235701754714228e-10	3.801334022002223e-6	47	966	326
MESH:D015179	Colorectal Neoplasms	GO:0030111	regulation of Wnt signaling pathway	1.775626312650047e-10	3.916143832549679e-6	25	306	326
MESH:D015179	Colorectal Neoplasms	GO:0042908	xenobiotic transport	1.86727189266378e-10	4.118268159269967e-6	6	7	326
MESH:D015179	Colorectal Neoplasms	GO:0051052	regulation of DNA metabolic process	2.3210966482167805e-10	5.1191786576421094e-6	26	335	326
MESH:D015179	Colorectal Neoplasms	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	2.3833490736535623e-10	5.256476381942932e-6	15	101	326
MESH:D015179	Colorectal Neoplasms	GO:0010631	epithelial cell migration	2.628248729763527e-10	5.796602573493459e-6	21	218	326
MESH:D015179	Colorectal Neoplasms	GO:0097191	extrinsic apoptotic signaling pathway	3.127261782864821e-10	6.897175862108362e-6	21	220	326
MESH:D015179	Colorectal Neoplasms	GO:0022412	cellular process involved in reproduction in multicellular organism	3.2024993767976184e-10	7.0631123755271474e-6	23	266	326
MESH:D015179	Colorectal Neoplasms	GO:0048645	organ formation	3.5242631035714567e-10	7.772762274926848e-6	12	59	326
MESH:D015179	Colorectal Neoplasms	GO:0001775	cell activation	4.099660610989986e-10	9.041801477538414e-6	43	854	326
MESH:D015179	Colorectal Neoplasms	GO:0043086	negative regulation of catalytic activity	4.4314607539064355e-10	9.773586692740643e-6	42	822	326
MESH:D015179	Colorectal Neoplasms	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	4.736003811345313e-10	1.0445256405922088e-5	21	225	326
MESH:D015179	Colorectal Neoplasms	GO:0030336	negative regulation of cell migration	5.182275719661789e-10	1.1429509099714075e-5	20	204	326
MESH:D015179	Colorectal Neoplasms	GO:0097285	cell-type specific apoptotic process	5.433949956668016e-10	1.198457662943131e-5	29	429	326
MESH:D015179	Colorectal Neoplasms	GO:0048546	digestive tract morphogenesis	6.268620067473307e-10	1.3825441558812379e-5	11	49	326
MESH:D015179	Colorectal Neoplasms	GO:0045765	regulation of angiogenesis	7.324145734344256e-10	1.6153403417096257e-5	20	208	326
MESH:D015179	Colorectal Neoplasms	GO:0061061	muscle structure development	7.566499649058755e-10	1.6687914975999085e-5	33	551	326
MESH:D015179	Colorectal Neoplasms	GO:0030308	negative regulation of cell growth	7.567447779521785e-10	1.6690006077735298e-5	18	166	326
MESH:D015179	Colorectal Neoplasms	GO:0021700	developmental maturation	7.681372204970671e-10	1.6941266398062815e-5	21	231	326
MESH:D015179	Colorectal Neoplasms	GO:0061326	renal tubule development	7.940041957255062e-10	1.751176253672604e-5	14	93	326
MESH:D015179	Colorectal Neoplasms	GO:0030879	mammary gland development	8.251923588886712e-10	1.8199617475289642e-5	16	128	326
MESH:D015179	Colorectal Neoplasms	GO:0070374	positive regulation of ERK1 and ERK2 cascade	9.209986107094892e-10	2.0312624359197784e-5	18	168	326
MESH:D015179	Colorectal Neoplasms	GO:0010720	positive regulation of cell development	1.0038089248709525e-9	2.2139005838028858e-5	30	469	326
MESH:D015179	Colorectal Neoplasms	GO:0098602	single organism cell adhesion	1.0236177461209195e-9	2.257588939069688e-5	39	746	326
MESH:D015179	Colorectal Neoplasms	GO:0033002	muscle cell proliferation	1.262202342644514e-9	2.7837872667024754e-5	17	151	326
MESH:D015179	Colorectal Neoplasms	GO:0044703	multi-organism reproductive process	1.5216979898369232e-9	3.356104916585334e-5	44	926	326
MESH:D015179	Colorectal Neoplasms	GO:0030178	negative regulation of Wnt signaling pathway	1.5740242442774388e-9	3.471510470753891e-5	19	195	326
MESH:D015179	Colorectal Neoplasms	GO:0008559	xenobiotic-transporting ATPase activity	1.5743413239732718e-9	3.472209790023051e-5	5	5	326
MESH:D015179	Colorectal Neoplasms	GO:0045321	leukocyte activation	1.6635924859897955e-9	3.669053227850494e-5	37	694	326
MESH:D015179	Colorectal Neoplasms	GO:0018105	peptidyl-serine phosphorylation	1.6637574651312548e-9	3.6694170893469824e-5	21	241	326
MESH:D015179	Colorectal Neoplasms	GO:0019752	carboxylic acid metabolic process	1.8583187211262953e-9	4.098521939444044e-5	45	967	326
MESH:D015179	Colorectal Neoplasms	GO:0016337	single organismal cell-cell adhesion	1.868124988035902e-9	4.1201496611131816e-5	37	697	326
MESH:D015179	Colorectal Neoplasms	GO:0010574	regulation of vascular endothelial growth factor production	1.942541016930477e-9	4.284274212840167e-5	9	31	326
MESH:D015179	Colorectal Neoplasms	GO:1903409	reactive oxygen species biosynthetic process	1.9495748349029896e-9	4.2997872983785435e-5	13	83	326
MESH:D015179	Colorectal Neoplasms	GO:0048660	regulation of smooth muscle cell proliferation	2.119904474184864e-9	4.675449317814717e-5	14	100	326
MESH:D015179	Colorectal Neoplasms	GO:0008013	beta-catenin binding	2.2706159175100993e-9	5.007843406068524e-5	13	84	326
MESH:D015179	Colorectal Neoplasms	GO:0090183	regulation of kidney development	2.344712424218187e-9	5.171263251613212e-5	11	55	326
MESH:D015179	Colorectal Neoplasms	GO:0007507	heart development	2.426025713653246e-9	5.350599711462234e-5	30	487	326
MESH:D015179	Colorectal Neoplasms	GO:0072089	stem cell proliferation	2.81396173029691e-9	6.206192596169835e-5	16	139	326
MESH:D015179	Colorectal Neoplasms	GO:0060322	head development	2.842110768952466e-9	6.268275300924664e-5	37	708	326
MESH:D015179	Colorectal Neoplasms	GO:0060914	heart formation	3.0947009399540093e-9	6.825362923068568e-5	8	23	326
MESH:D015179	Colorectal Neoplasms	GO:0055114	oxidation-reduction process	3.221187094837319e-9	7.104328137663707e-5	44	949	326
MESH:D015179	Colorectal Neoplasms	GO:0048568	embryonic organ development	3.4584066721521367e-9	7.627515915431538e-5	27	408	326
MESH:D015179	Colorectal Neoplasms	GO:0030856	regulation of epithelial cell differentiation	3.541540838369883e-9	7.810868319024777e-5	15	122	326
MESH:D015179	Colorectal Neoplasms	GO:0002573	myeloid leukocyte differentiation	3.674272441855919e-9	8.10360787051323e-5	18	183	326
MESH:D015179	Colorectal Neoplasms	GO:0009792	embryo development ending in birth or egg hatching	3.978112284030999e-9	8.773726642430368e-5	32	558	326
MESH:D015179	Colorectal Neoplasms	GO:0042886	amide transport	4.006610709872405e-9	8.836579920623588e-5	24	329	326
MESH:D015179	Colorectal Neoplasms	GO:0048598	embryonic morphogenesis	4.337799786036101e-9	9.56701742810262e-5	32	560	326
MESH:D015179	Colorectal Neoplasms	GO:0010632	regulation of epithelial cell migration	4.524246532966458e-9	9.978225728457524e-5	17	164	326
Orphanet:68385	Neurometabolic disease	GO:0019752	carboxylic acid metabolic process	4.011679877180541e-12	8.847759969121682e-8	79	967	326
Orphanet:68385	Neurometabolic disease	GO:0006643	membrane lipid metabolic process	1.7617018954751984e-12	3.88543353047055e-8	32	191	326
Orphanet:68385	Neurometabolic disease	GO:0050662	coenzyme binding	1.6904255772942633e-12	3.728233610722498e-8	28	185	326
Orphanet:68385	Neurometabolic disease	GO:0051188	cofactor biosynthetic process	1.063815702195825e-12	2.346245531192892e-8	32	157	326
Orphanet:68385	Neurometabolic disease	GO:0006665	sphingolipid metabolic process	1.014521799902468e-12	2.2375278296848933e-8	25	144	326
Orphanet:68385	Neurometabolic disease	GO:0009108	coenzyme biosynthetic process	6.139533326177116e-13	1.3540740750883629e-8	27	132	326
Orphanet:68385	Neurometabolic disease	GO:0046395	carboxylic acid catabolic process	3.568256801145253e-13	7.869790374925856e-9	30	219	326
Orphanet:68385	Neurometabolic disease	GO:0043202	lysosomal lumen	1.680877659282487e-13	3.707175677547525e-9	23	87	326
Orphanet:68385	Neurometabolic disease	GO:0008652	cellular amino acid biosynthetic process	1.1857181902996672e-13	2.615101468705916e-9	19	89	326
Orphanet:68385	Neurometabolic disease	GO:0006687	glycosphingolipid metabolic process	7.016609515630989e-14	1.5475132286724147e-9	18	72	326
Orphanet:68385	Neurometabolic disease	GO:1901606	alpha-amino acid catabolic process	7.904787935331115e-14	1.7434009791372773e-9	19	96	326
Orphanet:68385	Neurometabolic disease	GO:1901607	alpha-amino acid biosynthetic process	1.503241975342462e-13	3.3154001766178e-9	16	73	326
Orphanet:68385	Neurometabolic disease	GO:0043648	dicarboxylic acid metabolic process	2.6278978992877455e-13	5.795828816879123e-9	19	103	326
Orphanet:68385	Neurometabolic disease	GO:0006790	sulfur compound metabolic process	2.5413005033669833e-12	5.604838260175882e-8	35	360	326
Orphanet:68385	Neurometabolic disease	GO:0032787	monocarboxylic acid metabolic process	5.6279425564298435e-12	1.241242730820602e-7	39	572	326
Orphanet:68385	Neurometabolic disease	GO:0010035	response to inorganic substance	8.152478692124987e-12	1.798029175548166e-7	36	502	326
Orphanet:68385	Neurometabolic disease	GO:1901615	organic hydroxy compound metabolic process	1.0025869023877476e-11	2.2112054132161774e-7	38	534	326
Orphanet:68385	Neurometabolic disease	GO:1990267	response to transition metal nanoparticle	1.5292100918884444e-11	3.372672857659964e-7	19	150	326
Orphanet:68385	Neurometabolic disease	GO:0044242	cellular lipid catabolic process	3.875233467454109e-11	8.546827412470037e-7	20	177	326
Orphanet:68385	Neurometabolic disease	GO:1901136	carbohydrate derivative catabolic process	3.875233467454109e-11	8.546827412470037e-7	20	177	326
Orphanet:68385	Neurometabolic disease	GO:0006979	response to oxidative stress	4.5296100203984224e-11	9.99005489998872e-7	29	386	326
Orphanet:68385	Neurometabolic disease	GO:0009311	oligosaccharide metabolic process	6.531841734158661e-11	1.4405976944686927e-6	13	64	326
Orphanet:68385	Neurometabolic disease	GO:0006720	isoprenoid metabolic process	8.031197928914935e-11	1.7712807032221889e-6	17	127	326
Orphanet:68385	Neurometabolic disease	GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	8.307754484349061e-11	1.8322752515231855e-6	15	94	326
Orphanet:68385	Neurometabolic disease	GO:0006672	ceramide metabolic process	1.1805367794437416e-10	2.603673867063172e-6	14	81	326
Orphanet:68385	Neurometabolic disease	GO:0016620	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	2.8604074664428936e-10	6.308628667239802e-6	10	35	326
Orphanet:68385	Neurometabolic disease	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	5.031335348348875e-10	1.1096610110783445e-5	47	997	326
Orphanet:68385	Neurometabolic disease	GO:0009066	aspartate family amino acid metabolic process	6.268620067473307e-10	1.3825441558812379e-5	11	49	326
Orphanet:68385	Neurometabolic disease	GO:0006022	aminoglycan metabolic process	9.209986107094892e-10	2.0312624359197784e-5	18	168	326
Orphanet:68385	Neurometabolic disease	GO:0006099	tricarboxylic acid cycle	9.950783530499052e-10	2.194645307651566e-5	9	29	326
Orphanet:68385	Neurometabolic disease	GO:0042417	dopamine metabolic process	2.66150124161868e-9	5.869940988389999e-5	9	32	326
Orphanet:68385	Neurometabolic disease	GO:0030203	glycosaminoglycan metabolic process	3.408059057186108e-9	7.516474250623961e-5	17	161	326
Orphanet:68385	Neurometabolic disease	GO:0007626	locomotory behavior	3.674272441855919e-9	8.10360787051323e-5	18	183	326
Orphanet:68385	Neurometabolic disease	GO:0006066	alcohol metabolic process	3.805805559586872e-9	8.393704161668847e-5	26	382	326
DOID:0050117	disease by infectious agent	GO:1903036	positive regulation of response to wounding	1.3071765891936593e-12	2.8829779674666156e-8	23	162	329
DOID:0050117	disease by infectious agent	GO:0051338	regulation of transferase activity	1.1863843241144423e-12	2.6165706268344024e-8	50	928	329
DOID:0050117	disease by infectious agent	GO:0032946	positive regulation of mononuclear cell proliferation	9.310330284506563e-13	2.0533933442479224e-8	22	129	329
DOID:0050117	disease by infectious agent	GO:0034340	response to type I interferon	7.149836278586008e-14	1.576896391242144e-9	22	80	329
DOID:0050117	disease by infectious agent	GO:0045069	regulation of viral genome replication	3.0175861809311755e-13	6.6552863220437075e-9	17	75	329
DOID:0050117	disease by infectious agent	GO:0019724	B cell mediated immunity	3.22519788653608e-13	7.113173938755324e-9	21	100	329
DOID:0050117	disease by infectious agent	GO:0032606	type I interferon production	1.5948353748740374e-12	3.5174094192846894e-8	18	113	329
DOID:0050117	disease by infectious agent	GO:0048878	chemical homeostasis	5.248024237403115e-12	1.157451745559257e-7	50	988	329
DOID:0050117	disease by infectious agent	GO:0006909	phagocytosis	1.1072476269191611e-11	2.44203464117021e-7	22	204	329
DOID:0050117	disease by infectious agent	GO:1903409	reactive oxygen species biosynthetic process	1.4758194666342206e-11	3.2549198336617735e-7	15	83	329
DOID:0050117	disease by infectious agent	GO:0002009	morphogenesis of an epithelium	1.4778400725390384e-11	3.259376279984849e-7	35	506	329
DOID:0050117	disease by infectious agent	GO:0043086	negative regulation of catalytic activity	1.7491674775271804e-11	3.8577888716861963e-7	46	822	329
DOID:0050117	disease by infectious agent	GO:0031400	negative regulation of protein modification process	2.0754953311552526e-11	4.5775049528629097e-7	39	628	329
DOID:0050117	disease by infectious agent	GO:0002274	myeloid leukocyte activation	2.6470936553835145e-11	5.838165056948341e-7	19	153	329
DOID:0050117	disease by infectious agent	GO:0019725	cellular homeostasis	9.715828142020655e-11	2.1428258967226554e-6	42	771	329
DOID:0050117	disease by infectious agent	GO:0001618	virus receptor activity	1.345598077406862e-10	2.9677165597208344e-6	13	67	329
DOID:0050117	disease by infectious agent	GO:0010952	positive regulation of peptidase activity	1.4572210105257e-10	3.2139009387144313e-6	18	149	329
DOID:0050117	disease by infectious agent	GO:0055082	cellular chemical homeostasis	1.6237244881978086e-10	3.581124358720267e-6	38	661	329
DOID:0050117	disease by infectious agent	GO:0009991	response to extracellular stimulus	1.7281143183112135e-10	3.8113561290353815e-6	35	573	329
DOID:0050117	disease by infectious agent	GO:0051444	negative regulation of ubiquitin-protein transferase activity	1.7449142131198414e-10	3.84840829703581e-6	15	98	329
DOID:0050117	disease by infectious agent	GO:0031667	response to nutrient levels	1.966596885338845e-10	4.3373294306148225e-6	34	546	329
DOID:0050117	disease by infectious agent	GO:0051272	positive regulation of cellular component movement	2.0863477612209635e-10	4.601439987372835e-6	29	408	329
DOID:0050117	disease by infectious agent	GO:0050801	ion homeostasis	2.1565171870463473e-10	4.756198656030719e-6	38	668	329
DOID:0050117	disease by infectious agent	GO:0030335	positive regulation of cell migration	2.8767088711134647e-10	6.3445814152407465e-6	28	387	329
DOID:0050117	disease by infectious agent	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	2.8911784077934044e-10	6.376493978388353e-6	13	71	329
DOID:0050117	disease by infectious agent	GO:1901698	response to nitrogen compound	3.0112934368276e-10	6.641407674923272e-6	44	870	329
DOID:0050117	disease by infectious agent	GO:0010950	positive regulation of endopeptidase activity	3.5181946245188556e-10	7.759378244376336e-6	17	138	329
DOID:0050117	disease by infectious agent	GO:0048545	response to steroid hormone	3.7911784822597383e-10	8.361444142623853e-6	30	446	329
DOID:0050117	disease by infectious agent	GO:0043408	regulation of MAPK cascade	3.8011505054669215e-10	8.383437439807295e-6	37	651	329
DOID:0050117	disease by infectious agent	GO:0002673	regulation of acute inflammatory response	4.969659128661874e-10	1.0960583208263763e-5	13	74	329
DOID:0050117	disease by infectious agent	GO:0055065	metal ion homeostasis	7.447816807726326e-10	1.6426159969440413e-5	32	516	329
DOID:0050117	disease by infectious agent	GO:0009612	response to mechanical stimulus	1.0175023046343767e-9	2.244101332871118e-5	20	210	329
DOID:0050117	disease by infectious agent	GO:0002920	regulation of humoral immune response	1.0936744843093038e-9	2.4120990751441695e-5	11	51	329
DOID:0050117	disease by infectious agent	GO:0046718	viral entry into host cell	1.1987068004870594e-9	2.6437478484742094e-5	15	112	329
DOID:0050117	disease by infectious agent	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	1.2514002056818185e-9	2.7599631536312508e-5	26	359	329
DOID:0050117	disease by infectious agent	GO:0030888	regulation of B cell proliferation	1.6961834159445743e-9	3.740932523865759e-5	11	53	329
DOID:0050117	disease by infectious agent	GO:0006875	cellular metal ion homeostasis	2.0119214072522595e-9	4.4372926636948584e-5	29	450	329
DOID:0050117	disease by infectious agent	GO:0042306	regulation of protein import into nucleus	2.0686394819335874e-9	4.562384377404527e-5	18	175	329
DOID:0050117	disease by infectious agent	GO:0046824	positive regulation of nucleocytoplasmic transport	2.5102825373934934e-9	5.5364281362213497e-5	15	118	329
DOID:0050117	disease by infectious agent	GO:0032844	regulation of homeostatic process	2.6350446269418626e-9	5.811590924720278e-5	28	427	329
DOID:0050117	disease by infectious agent	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	2.946936472625339e-9	6.499468390375185e-5	13	85	329
DOID:0050117	disease by infectious agent	GO:0070371	ERK1 and ERK2 cascade	3.05467684480476e-9	6.737089781216898e-5	21	247	329
DOID:0050117	disease by infectious agent	GO:0045058	T cell selection	3.6736025332828603e-9	8.102130387155349e-5	10	44	329
DOID:0050117	disease by infectious agent	GO:0006958	complement activation, classical pathway	3.903637857405329e-9	8.609473294507453e-5	9	33	329
DOID:0050117	disease by infectious agent	GO:0002573	myeloid leukocyte differentiation	4.2428365265578805e-9	9.357575959323405e-5	18	183	329
Orphanet:98028	Rare circulatory system disease	GO:0045766	positive regulation of angiogenesis	1.1501910535116622e-13	2.536746368519971e-9	19	119	331
Orphanet:98028	Rare circulatory system disease	GO:0001701	in utero embryonic development	4.623079696841614e-12	1.019620227138418e-7	28	312	331
Orphanet:98028	Rare circulatory system disease	GO:0042692	muscle cell differentiation	1.0213718759644053e-11	2.2526356724394958e-7	28	334	331
Orphanet:98028	Rare circulatory system disease	GO:0097190	apoptotic signaling pathway	1.5878298675886526e-11	3.5019587729667734e-7	37	564	331
Orphanet:98028	Rare circulatory system disease	GO:0045597	positive regulation of cell differentiation	5.7565840982931604e-11	1.2696146228785565e-6	44	815	331
Orphanet:98028	Rare circulatory system disease	GO:0035051	cardiocyte differentiation	6.689371279122724e-11	1.4753408356105169e-6	16	107	331
Orphanet:98028	Rare circulatory system disease	GO:0030097	hemopoiesis	6.890621406796527e-11	1.519726551268974e-6	40	695	331
Orphanet:98028	Rare circulatory system disease	GO:0018108	peptidyl-tyrosine phosphorylation	2.1598700605807153e-10	4.7635934186107676e-6	27	354	331
Orphanet:98028	Rare circulatory system disease	GO:0043524	negative regulation of neuron apoptotic process	2.4146129540270067e-10	5.325428870106563e-6	17	134	331
Orphanet:98028	Rare circulatory system disease	GO:0060284	regulation of cell development	2.6714275236372487e-10	5.891833403381952e-6	43	828	331
Orphanet:98028	Rare circulatory system disease	GO:0034774	secretory granule lumen	2.8142621566473736e-10	6.206855186485782e-6	14	85	331
Orphanet:98028	Rare circulatory system disease	GO:0032868	response to insulin	2.917887043096812e-10	6.435399873550018e-6	22	238	331
Orphanet:98028	Rare circulatory system disease	GO:0001822	kidney development	3.205270493467083e-10	7.069224073341651e-6	23	262	331
Orphanet:98028	Rare circulatory system disease	GO:0001816	cytokine production	3.2591151999383783e-10	7.187978573464093e-6	36	613	331
Orphanet:98028	Rare circulatory system disease	GO:0002521	leukocyte differentiation	4.890571281279676e-10	1.0786154960862326e-5	30	448	331
Orphanet:98028	Rare circulatory system disease	GO:0034504	protein localization to nucleus	5.715364848057902e-10	1.2605237172391703e-5	26	344	331
Orphanet:98028	Rare circulatory system disease	GO:0060840	artery development	6.372555816369641e-10	1.4054671853003242e-5	13	75	331
Orphanet:98028	Rare circulatory system disease	GO:1902532	negative regulation of intracellular signal transduction	6.585286760341091e-10	1.4523849949932277e-5	29	426	331
Orphanet:98028	Rare circulatory system disease	GO:0001501	skeletal system development	6.688252174313902e-10	1.4750940170449311e-5	31	482	331
Orphanet:98028	Rare circulatory system disease	GO:0090287	regulation of cellular response to growth factor stimulus	6.779994343730777e-10	1.495327752509823e-5	21	226	331
Orphanet:98028	Rare circulatory system disease	GO:0009060	aerobic respiration	7.717175787291808e-10	1.7020231198872082e-5	12	62	331
Orphanet:98028	Rare circulatory system disease	GO:0046890	regulation of lipid biosynthetic process	8.123829386974535e-10	1.7917105712972337e-5	16	126	331
Orphanet:98028	Rare circulatory system disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	8.14438516627547e-10	1.7962441484220548e-5	47	996	331
Orphanet:98028	Rare circulatory system disease	GO:0007179	transforming growth factor beta receptor signaling pathway	9.65389657103799e-10	2.1291668887424287e-5	18	166	331
Orphanet:98028	Rare circulatory system disease	GO:0032870	cellular response to hormone stimulus	9.96060567359791e-10	2.1968115813120193e-5	32	519	331
Orphanet:98028	Rare circulatory system disease	GO:0001819	positive regulation of cytokine production	1.0932155181109238e-9	2.4110868251936424e-5	27	381	331
Orphanet:98028	Rare circulatory system disease	GO:0051098	regulation of binding	1.0951151097060574e-9	2.4152763744567096e-5	23	279	331
Orphanet:98028	Rare circulatory system disease	GO:0072132	mesenchyme morphogenesis	1.4163807904310488e-9	3.123827833295678e-5	10	40	331
Orphanet:98028	Rare circulatory system disease	GO:0055123	digestive system development	1.4338301657090824e-9	3.162312430471381e-5	17	150	331
Orphanet:98028	Rare circulatory system disease	GO:0010720	positive regulation of cell development	1.4406076331852091e-9	3.177260134989979e-5	30	469	331
Orphanet:98028	Rare circulatory system disease	GO:0007160	cell-matrix adhesion	1.559287254870867e-9	3.439008040617697e-5	19	192	331
Orphanet:98028	Rare circulatory system disease	GO:0048037	cofactor binding	1.6789365453462324e-9	3.7028945507611155e-5	22	261	331
Orphanet:98028	Rare circulatory system disease	GO:0010810	regulation of cell-substrate adhesion	1.7212509195729808e-9	3.796218903118209e-5	18	172	331
Orphanet:98028	Rare circulatory system disease	GO:0032147	activation of protein kinase activity	2.0246221366093664e-9	4.4653041222919576e-5	23	288	331
Orphanet:98028	Rare circulatory system disease	GO:0007050	cell cycle arrest	2.3555879469228103e-9	5.195249216938258e-5	21	242	331
Orphanet:98028	Rare circulatory system disease	GO:0072073	kidney epithelium development	2.8261440965238194e-9	6.233060804883284e-5	16	137	331
Orphanet:98028	Rare circulatory system disease	GO:0016773	phosphotransferase activity, alcohol group as acceptor	2.8510164229444968e-9	6.287916720804088e-5	39	762	331
Orphanet:98028	Rare circulatory system disease	GO:0004672	protein kinase activity	2.873402626946131e-9	6.337289493729692e-5	35	634	331
Orphanet:98028	Rare circulatory system disease	GO:0048565	digestive tract development	3.1464627570088055e-9	6.93952361058292e-5	16	138	331
Orphanet:98028	Rare circulatory system disease	GO:0001823	mesonephros development	3.3599844018183944e-9	7.410445598210469e-5	14	102	331
Orphanet:98028	Rare circulatory system disease	GO:0019725	cellular homeostasis	3.951686755598871e-9	8.71544513947331e-5	39	771	331
Orphanet:98028	Rare circulatory system disease	GO:0032768	regulation of monooxygenase activity	4.107299944600129e-9	9.058650027815585e-5	11	57	331
Orphanet:98028	Rare circulatory system disease	GO:0030856	regulation of epithelial cell differentiation	4.352059934653596e-9	9.598468185878506e-5	15	122	331
MESH:D007414	Intestinal Neoplasms	GO:0000165	MAPK cascade	8.996803302352419e-12	1.984244968333826e-7	47	843	332
MESH:D007414	Intestinal Neoplasms	GO:0032870	cellular response to hormone stimulus	2.7171997984964946e-10	5.992784155584019e-6	33	519	332
MESH:D007414	Intestinal Neoplasms	GO:0001816	cytokine production	3.533677794820278e-10	7.793526376476123e-6	36	613	332
MESH:D007414	Intestinal Neoplasms	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.0145728701616008e-9	2.2376404651414106e-5	39	732	332
MESH:D007414	Intestinal Neoplasms	GO:0006820	anion transport	1.6413602699216767e-9	3.620020075312258e-5	34	588	332
MESH:D007414	Intestinal Neoplasms	GO:0044089	positive regulation of cellular component biogenesis	2.0113903875795813e-9	4.4361214998067666e-5	28	418	332
MESH:D007414	Intestinal Neoplasms	GO:0046649	lymphocyte activation	2.1259961568986796e-9	4.688884524040038e-5	34	594	332
MESH:D007414	Intestinal Neoplasms	GO:0010634	positive regulation of epithelial cell migration	3.0614578649945656e-9	6.752045321245514e-5	14	101	332
MESH:D007414	Intestinal Neoplasms	GO:0009746	response to hexose	4.103954176493119e-9	9.051270936255573e-5	18	181	332
MESH:D007414	Intestinal Neoplasms	GO:0009117	nucleotide metabolic process	4.124866781474168e-9	9.097393686541277e-5	35	641	332
MESH:D007414	Intestinal Neoplasms	GO:0019725	cellular homeostasis	4.303556511153772e-9	9.491493885349644e-5	39	771	332
MESH:D007414	Intestinal Neoplasms	GO:0090087	regulation of peptide transport	4.454946411769356e-9	9.825384311157315e-5	21	250	332
MESH:D007414	Intestinal Neoplasms	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	4.526160113371702e-9	9.982446130041289e-5	19	204	332
Orphanet:97955	Rare respiratory disease	GO:0035150	regulation of tube size	8.715250743307479e-13	1.9221485514364645e-8	24	140	332
Orphanet:97955	Rare respiratory disease	GO:0060562	epithelial tube morphogenesis	9.969802761133906e-14	2.198839998968083e-9	30	301	332
Orphanet:97955	Rare respiratory disease	GO:2000377	regulation of reactive oxygen species metabolic process	7.324141293452158e-13	1.6153393622708734e-8	20	147	332
Orphanet:97955	Rare respiratory disease	GO:0051353	positive regulation of oxidoreductase activity	1.4055423491754482e-11	3.099923651106451e-7	12	45	332
Orphanet:97955	Rare respiratory disease	GO:0060322	head development	1.909439273362068e-11	4.211268317400041e-7	42	708	332
Orphanet:97955	Rare respiratory disease	GO:0055123	digestive system development	2.1314505715963605e-11	4.700914235655773e-7	19	150	332
Orphanet:97955	Rare respiratory disease	GO:0001936	regulation of endothelial cell proliferation	9.163791947486288e-11	2.021074314018101e-6	15	93	332
Orphanet:97955	Rare respiratory disease	GO:0050878	regulation of body fluid levels	1.3004675114558495e-10	2.868181096515876e-6	33	504	332
Orphanet:97955	Rare respiratory disease	GO:0001938	positive regulation of endothelial cell proliferation	1.8330192919080446e-10	4.042724048303192e-6	13	68	332
Orphanet:97955	Rare respiratory disease	GO:0008285	negative regulation of cell proliferation	2.384843433844708e-10	5.259772193344503e-6	37	634	332
Orphanet:97955	Rare respiratory disease	GO:0000302	response to reactive oxygen species	3.091512601471891e-10	6.818331042546255e-6	21	216	332
Orphanet:97955	Rare respiratory disease	GO:0010035	response to inorganic substance	4.722925384115229e-10	1.0416411934666137e-5	32	502	332
Orphanet:97955	Rare respiratory disease	GO:0032722	positive regulation of chemokine production	9.587769467245266e-10	2.1145825560009435e-5	11	50	332
Orphanet:97955	Rare respiratory disease	GO:0007420	brain development	1.0213471179909561e-9	2.2525810687290537e-5	37	669	332
Orphanet:97955	Rare respiratory disease	GO:0050708	regulation of protein secretion	1.1031333624345052e-9	2.4329606308493013e-5	27	380	332
Orphanet:97955	Rare respiratory disease	GO:2000021	regulation of ion homeostasis	1.256179493758225e-9	2.770503873483765e-5	19	189	332
Orphanet:97955	Rare respiratory disease	GO:0042113	B cell activation	1.4074349463655267e-9	3.104097774209169e-5	20	212	332
Orphanet:97955	Rare respiratory disease	GO:0043627	response to estrogen	2.1157461338461303e-9	4.6662780981976404e-5	20	217	332
Orphanet:97955	Rare respiratory disease	GO:0045596	negative regulation of cell differentiation	2.4166892931276607e-9	5.3300082359930556e-5	34	597	332
Orphanet:97955	Rare respiratory disease	GO:0042311	vasodilation	2.4466167980463638e-9	5.396013348091255e-5	12	68	332
Orphanet:97955	Rare respiratory disease	GO:0090287	regulation of cellular response to growth factor stimulus	4.284971821810757e-9	9.450505353003624e-5	20	226	332
Orphanet:97955	Rare respiratory disease	GO:0071417	cellular response to organonitrogen compound	4.493010297146327e-9	9.909334210356224e-5	29	462	332
Orphanet:90692	Rare endocrine growth disease	GO:0044703	multi-organism reproductive process	3.785194380157009e-12	8.348246205436283e-8	51	926	333
Orphanet:90692	Rare endocrine growth disease	GO:0042445	hormone metabolic process	1.5734080704987718e-12	3.470151499485041e-8	33	187	333
Orphanet:90692	Rare endocrine growth disease	GO:0035264	multicellular organism growth	3.6060043839825084e-13	7.953042668873422e-9	20	137	333
Orphanet:90692	Rare endocrine growth disease	GO:0044706	multi-multicellular organism process	1.8446355554146976e-12	4.0683437174671155e-8	25	237	333
Orphanet:90692	Rare endocrine growth disease	GO:0014070	response to organic cyclic compound	2.5260904479296187e-12	5.571292482908774e-8	50	873	333
Orphanet:90692	Rare endocrine growth disease	GO:0048545	response to steroid hormone	3.1874503036988244e-12	7.029921644807757e-8	35	446	333
Orphanet:90692	Rare endocrine growth disease	GO:1901698	response to nitrogen compound	5.858424856342026e-12	1.2920756020662338e-7	51	870	333
Orphanet:90692	Rare endocrine growth disease	GO:0008202	steroid metabolic process	6.206923863771863e-12	1.3689370581548843e-7	26	275	333
Orphanet:90692	Rare endocrine growth disease	GO:0060284	regulation of cell development	1.16112675030422e-11	2.560865047795957e-7	51	828	333
Orphanet:90692	Rare endocrine growth disease	GO:1901615	organic hydroxy compound metabolic process	1.186151177279271e-11	2.616056421489432e-7	37	534	333
Orphanet:90692	Rare endocrine growth disease	GO:0001657	ureteric bud development	1.6032841720914348e-11	3.5360432415476595e-7	16	97	333
Orphanet:90692	Rare endocrine growth disease	GO:0048609	multicellular organismal reproductive process	1.6905254973664796e-11	3.728453984441771e-7	46	767	333
Orphanet:90692	Rare endocrine growth disease	GO:0045597	positive regulation of cell differentiation	1.7469248270174376e-11	3.8528427059869585e-7	46	815	333
Orphanet:90692	Rare endocrine growth disease	GO:0010243	response to organonitrogen compound	1.794964177292968e-11	3.958793493019641e-7	49	780	333
Orphanet:90692	Rare endocrine growth disease	GO:0043069	negative regulation of programmed cell death	2.215150285422851e-11	4.885513954500098e-7	45	806	333
Orphanet:90692	Rare endocrine growth disease	GO:0046661	male sex differentiation	2.555977651752528e-11	5.6372087109402e-7	19	151	333
Orphanet:90692	Rare endocrine growth disease	GO:0021984	adenohypophysis development	2.577082991450652e-11	5.683756537644413e-7	8	14	333
Orphanet:90692	Rare endocrine growth disease	GO:0046620	regulation of organ growth	2.951461297584501e-11	6.509447891822617e-7	14	72	333
Orphanet:90692	Rare endocrine growth disease	GO:0048511	rhythmic process	4.7410519954382835e-11	1.0456390175939134e-6	27	329	333
Orphanet:90692	Rare endocrine growth disease	GO:0071371	cellular response to gonadotropin stimulus	5.434941385829006e-11	1.1986763226445873e-6	8	15	333
Orphanet:90692	Rare endocrine growth disease	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	5.882383469213437e-11	1.2973596741350235e-6	15	90	333
Orphanet:90692	Rare endocrine growth disease	GO:0044344	cellular response to fibroblast growth factor stimulus	1.2677903171720573e-10	2.7961115445229723e-6	17	128	333
Orphanet:90692	Rare endocrine growth disease	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	1.3045131641575836e-10	2.8771037835495505e-6	22	227	333
Orphanet:90692	Rare endocrine growth disease	GO:0002521	leukocyte differentiation	1.3052303682314914e-10	2.8786855771345543e-6	31	448	333
Orphanet:90692	Rare endocrine growth disease	GO:0098727	maintenance of cell number	1.416217143557219e-10	3.1234669101154466e-6	18	147	333
Orphanet:90692	Rare endocrine growth disease	GO:0018958	phenol-containing compound metabolic process	1.5259349339658002e-10	3.3654494968615722e-6	15	96	333
Orphanet:90692	Rare endocrine growth disease	GO:0008015	blood circulation	2.686940669960336e-10	5.926047647597521e-6	32	489	333
Orphanet:90692	Rare endocrine growth disease	GO:0048863	stem cell differentiation	4.843255796416202e-10	1.0681800658995932e-5	23	266	333
Orphanet:90692	Rare endocrine growth disease	GO:1901701	cellular response to oxygen-containing compound	4.852821477996372e-10	1.0702897769720998e-5	44	873	333
Orphanet:90692	Rare endocrine growth disease	GO:0048762	mesenchymal cell differentiation	8.369243076344901e-10	1.845836560487868e-5	19	184	333
Orphanet:90692	Rare endocrine growth disease	GO:0097285	cell-type specific apoptotic process	8.910798765526806e-10	1.965276667736937e-5	29	429	333
Orphanet:90692	Rare endocrine growth disease	GO:0046660	female sex differentiation	9.980852810898e-10	2.201277087443554e-5	16	127	333
Orphanet:90692	Rare endocrine growth disease	GO:1901699	cellular response to nitrogen compound	1.104595859224844e-9	2.4361861675203933e-5	32	518	333
Orphanet:90692	Rare endocrine growth disease	GO:0071417	cellular response to organonitrogen compound	1.171239882857833e-9	2.5831695616429506e-5	30	462	333
Orphanet:90692	Rare endocrine growth disease	GO:0014855	striated muscle cell proliferation	1.2418472916664314e-9	2.7388942017703144e-5	11	51	333
Orphanet:90692	Rare endocrine growth disease	GO:0007565	female pregnancy	1.4439373030583624e-9	3.1846037218952183e-5	19	190	333
Orphanet:90692	Rare endocrine growth disease	GO:0014031	mesenchymal cell development	1.7233169335995058e-9	3.80077549705371e-5	18	171	333
Orphanet:90692	Rare endocrine growth disease	GO:0060126	somatotropin secreting cell differentiation	1.7519142803124055e-9	3.86384694522901e-5	5	5	333
Orphanet:90692	Rare endocrine growth disease	GO:0001838	embryonic epithelial tube formation	2.057417014533769e-9	4.537633225554227e-5	15	115	333
Orphanet:90692	Rare endocrine growth disease	GO:0043627	response to estrogen	2.227944162491724e-9	4.913730850375497e-5	20	217	333
Orphanet:90692	Rare endocrine growth disease	GO:0097305	response to alcohol	2.8821067754591922e-9	6.356486493275249e-5	26	369	333
Orphanet:90692	Rare endocrine growth disease	GO:0001764	neuron migration	3.0810219930899052e-9	6.795194005759786e-5	16	137	333
Orphanet:90692	Rare endocrine growth disease	GO:0030325	adrenal gland development	3.656112634864428e-9	8.063556416193496e-5	8	23	333
Orphanet:90692	Rare endocrine growth disease	GO:0008544	epidermis development	3.844587093126961e-9	8.479236833891513e-5	23	296	333
Orphanet:90692	Rare endocrine growth disease	GO:0044708	single-organism behavior	4.425384170225755e-9	9.760184787432902e-5	27	404	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0007417	central nervous system development	4.797828800917614e-12	1.0581611420423798e-7	48	889	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0007568	aging	1.6928902724089312e-11	3.733669495797898e-7	26	290	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0048666	neuron development	2.2518431563867125e-11	4.966440081410894e-7	48	926	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0010035	response to inorganic substance	5.091618238139972e-10	1.1229564024217709e-5	32	502	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0070482	response to oxygen levels	7.5643691310745e-10	1.668321611858481e-5	25	321	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0031175	neuron projection development	1.0810214945422558e-9	2.3841929062129452e-5	41	796	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0019725	cellular homeostasis	1.4262778735840698e-9	3.145655850189666e-5	40	771	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0009792	embryo development ending in birth or egg hatching	1.7842015642699494e-9	3.935056549997373e-5	33	558	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0007584	response to nutrient	2.655296427178655e-9	5.8562562701425236e-5	19	197	333
Orphanet:140653	Neuro-ophthalmological disease	GO:0060284	regulation of cell development	3.3653096975783114e-9	7.422190538008966e-5	41	828	333
DOID:75	lymphatic system disease	GO:0009790	embryo development	4.022560062821867e-12	8.871756218553628e-8	50	932	334
DOID:75	lymphatic system disease	GO:0016772	transferase activity, transferring phosphorus-containing groups	3.105293799876563e-12	6.84872547562776e-8	51	973	334
DOID:75	lymphatic system disease	GO:0010632	regulation of epithelial cell migration	4.39648317751562e-13	9.6964436480107e-9	21	164	334
DOID:75	lymphatic system disease	GO:0034504	protein localization to nucleus	6.729061752253074e-13	1.4840945694594154e-8	30	344	334
DOID:75	lymphatic system disease	GO:0010594	regulation of endothelial cell migration	1.8741674878697268e-12	4.1334763944966824e-8	18	112	334
DOID:75	lymphatic system disease	GO:0001525	angiogenesis	3.4232616741292077e-12	7.550003622291968e-8	34	413	334
DOID:75	lymphatic system disease	GO:0050679	positive regulation of epithelial cell proliferation	3.90265597616235e-12	8.607307755426064e-8	20	155	334
DOID:75	lymphatic system disease	GO:0060284	regulation of cell development	1.138711347437038e-11	2.5114278767723874e-7	50	828	334
DOID:75	lymphatic system disease	GO:0032386	regulation of intracellular transport	1.1757261830780408e-11	2.593064096778619e-7	38	575	334
DOID:75	lymphatic system disease	GO:0007423	sensory organ development	1.2657430659146485e-11	2.791596331874757e-7	35	494	334
DOID:75	lymphatic system disease	GO:0045765	regulation of angiogenesis	2.407740673504577e-11	5.310272055414345e-7	22	208	334
DOID:75	lymphatic system disease	GO:1903827	regulation of cellular protein localization	2.4191870728884624e-11	5.335517089255504e-7	36	543	334
DOID:75	lymphatic system disease	GO:0043534	blood vessel endothelial cell migration	2.5029200934056917e-11	5.520190266006253e-7	14	71	334
DOID:75	lymphatic system disease	GO:0048608	reproductive structure development	2.6473601089094245e-11	5.838752720199736e-7	31	418	334
DOID:75	lymphatic system disease	GO:0043405	regulation of MAP kinase activity	3.971367679156401e-11	8.758851416379443e-7	25	278	334
DOID:75	lymphatic system disease	GO:0043535	regulation of blood vessel endothelial cell migration	4.507882955806508e-11	9.942135859031254e-7	12	49	334
DOID:75	lymphatic system disease	GO:0048771	tissue remodeling	5.750377951585506e-11	1.2682458572221833e-6	18	139	334
DOID:75	lymphatic system disease	GO:1903649	regulation of cytoplasmic transport	7.701728144127173e-11	1.698616142187248e-6	31	437	334
DOID:75	lymphatic system disease	GO:0006935	chemotaxis	1.35437105974745e-10	2.987065372273001e-6	34	530	334
DOID:75	lymphatic system disease	GO:2000147	positive regulation of cell motility	1.7537959973168427e-10	3.8679970720822965e-6	29	399	334
DOID:75	lymphatic system disease	GO:0048015	phosphatidylinositol-mediated signaling	2.938805865326799e-10	6.481536335978255e-6	20	193	334
DOID:75	lymphatic system disease	GO:0046822	regulation of nucleocytoplasmic transport	3.1691316237925093e-10	6.989519796274379e-6	21	215	334
DOID:75	lymphatic system disease	GO:0014065	phosphatidylinositol 3-kinase signaling	3.2393676629993706e-10	7.144425380745112e-6	18	154	334
DOID:75	lymphatic system disease	GO:0048871	multicellular organismal homeostasis	8.048410826688723e-10	1.775077007826198e-5	25	321	334
DOID:75	lymphatic system disease	GO:0048010	vascular endothelial growth factor receptor signaling pathway	8.088766323410823e-10	1.783977412628257e-5	14	91	334
DOID:75	lymphatic system disease	GO:0038095	Fc-epsilon receptor signaling pathway	8.214621205482331e-10	1.811734706869128e-5	16	125	334
DOID:75	lymphatic system disease	GO:0004672	protein kinase activity	1.0169343145349785e-9	2.242848630706895e-5	36	634	334
DOID:75	lymphatic system disease	GO:0046982	protein heterodimerization activity	1.07821784833817e-9	2.3780094645098337e-5	30	459	334
DOID:75	lymphatic system disease	GO:0048568	embryonic organ development	1.3401169063342877e-9	2.9556278369202715e-5	28	408	334
DOID:75	lymphatic system disease	GO:0051092	positive regulation of NF-kappaB transcription factor activity	1.477789557391418e-9	3.259264868826772e-5	16	130	334
DOID:75	lymphatic system disease	GO:0010595	positive regulation of endothelial cell migration	1.5193639679722537e-9	3.3509572313628055e-5	12	65	334
DOID:75	lymphatic system disease	GO:0090398	cellular senescence	1.5997163593794994e-9	3.528174430611486e-5	11	52	334
DOID:75	lymphatic system disease	GO:0071260	cellular response to mechanical stimulus	1.6333894237163804e-9	3.602440374006477e-5	13	80	334
DOID:75	lymphatic system disease	GO:0048873	homeostasis of number of cells within a tissue	1.7316327260985531e-9	3.819115977410359e-5	9	30	334
DOID:75	lymphatic system disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.8232031440135188e-9	4.021074534121816e-5	17	151	334
DOID:75	lymphatic system disease	GO:0004713	protein tyrosine kinase activity	2.393790721200162e-9	5.279505435606957e-5	18	174	334
DOID:75	lymphatic system disease	GO:0001655	urogenital system development	2.4147156496567845e-9	5.325655365318038e-5	24	313	334
DOID:75	lymphatic system disease	GO:0001889	liver development	2.588559033789295e-9	5.70906694902229e-5	16	135	334
DOID:75	lymphatic system disease	GO:0034612	response to tumor necrosis factor	2.635720197652347e-9	5.813080895922251e-5	22	265	334
DOID:75	lymphatic system disease	GO:0032940	secretion by cell	2.8296791576565283e-9	6.240857382211473e-5	45	956	334
DOID:75	lymphatic system disease	GO:0010001	glial cell differentiation	2.87797374820542e-9	6.347371101667054e-5	18	176	334
DOID:75	lymphatic system disease	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	3.5338613146862485e-9	7.793931129540521e-5	13	85	334
DOID:75	lymphatic system disease	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	3.580066021413586e-9	7.895835610227664e-5	16	138	334
DOID:75	lymphatic system disease	GO:0045637	regulation of myeloid cell differentiation	3.775181611764822e-9	8.326163044747315e-5	18	179	334
DOID:1682	congenital heart disease	GO:0022603	regulation of anatomical structure morphogenesis	1.0722089882619912e-11	2.3647569236118215e-7	58	986	336
DOID:1682	congenital heart disease	GO:0040007	growth	8.565592679588008e-12	1.889141465483135e-7	59	936	336
DOID:1682	congenital heart disease	GO:0009887	organ morphogenesis	2.255307052223543e-12	4.974079703679024e-8	94	950	336
DOID:1682	congenital heart disease	GO:0001763	morphogenesis of a branching structure	1.4077627952246985e-12	3.1048208448680725e-8	24	193	336
DOID:1682	congenital heart disease	GO:0030323	respiratory tube development	1.3891110484109959e-12	3.0636844172704514e-8	23	179	336
DOID:1682	congenital heart disease	GO:0055123	digestive system development	1.2798651027878805e-12	2.8227424841986704e-8	22	150	336
DOID:1682	congenital heart disease	GO:0042692	muscle cell differentiation	1.0644818360106e-12	2.3477146893213785e-8	36	334	336
DOID:1682	congenital heart disease	GO:1904062	regulation of cation transmembrane transport	1.0249578963339445e-12	2.2605446403645146e-8	23	165	336
DOID:1682	congenital heart disease	GO:0060541	respiratory system development	1.0196288258157438e-12	2.248791375336623e-8	24	202	336
DOID:1682	congenital heart disease	GO:0051241	negative regulation of multicellular organismal process	8.808509477375992e-13	1.942716765235275e-8	51	966	336
DOID:1682	congenital heart disease	GO:0055002	striated muscle cell development	8.251177519014163e-13	1.8197972018185737e-8	22	127	336
DOID:1682	congenital heart disease	GO:0035265	organ growth	7.700506898800086e-13	1.698346796530359e-8	23	132	336
DOID:1682	congenital heart disease	GO:0061337	cardiac conduction	7.016609515630989e-13	1.5475132286724147e-8	27	131	336
DOID:1682	congenital heart disease	GO:0023014	signal transduction by protein phosphorylation	6.870060076380469e-13	1.5151917498457124e-8	56	879	336
DOID:1682	congenital heart disease	GO:0060562	epithelial tube morphogenesis	6.146194664324867e-13	1.3555432332168493e-8	34	301	336
DOID:1682	congenital heart disease	GO:0048864	stem cell development	5.275779813018744e-13	1.163573237761284e-8	22	175	336
DOID:1682	congenital heart disease	GO:0030324	lung development	5.275779813018744e-13	1.163573237761284e-8	22	175	336
DOID:1682	congenital heart disease	GO:0014031	mesenchymal cell development	5.186961971048731e-13	1.1439844627147977e-8	22	171	336
DOID:1682	congenital heart disease	GO:0001508	action potential	3.963496197911809e-13	8.741490864494494e-9	25	119	336
DOID:1682	congenital heart disease	GO:0061138	morphogenesis of a branching epithelium	1.8984813721090177e-13	4.1871006661864385e-9	22	179	336
DOID:1682	congenital heart disease	GO:0086009	membrane repolarization	7.194245199571014e-14	1.5866907787653872e-9	15	36	336
DOID:1682	congenital heart disease	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	1.84297022087776e-14	4.0646708221458994e-10	10	13	336
DOID:1682	congenital heart disease	GO:0060840	artery development	7.882583474838611e-14	1.7385037853756558e-9	21	75	336
DOID:1682	congenital heart disease	GO:0001654	eye development	2.1471713296250527e-13	4.735586367488054e-9	30	327	336
DOID:1682	congenital heart disease	GO:0048562	embryonic organ morphogenesis	1.5261125696497402e-12	3.365841272362502e-8	32	280	336
DOID:1682	congenital heart disease	GO:0001503	ossification	1.6519008383397704e-12	3.6432672989583637e-8	36	363	336
DOID:1682	congenital heart disease	GO:0033993	response to lipid	2.1266322036694874e-12	4.6902873251930544e-8	49	850	336
DOID:1682	congenital heart disease	GO:0046620	regulation of organ growth	2.1436186159462522e-12	4.7277508574694593e-8	15	72	336
DOID:1682	congenital heart disease	GO:0010959	regulation of metal ion transport	2.2892798767770728e-12	5.049006768231834e-8	32	321	336
DOID:1682	congenital heart disease	GO:0050678	regulation of epithelial cell proliferation	2.3090418466154006e-12	5.092591792710266e-8	27	277	336
DOID:1682	congenital heart disease	GO:0001667	ameboidal-type cell migration	2.8287372444424363e-12	6.238779992617793e-8	30	315	336
DOID:1682	congenital heart disease	GO:0090130	tissue migration	3.0287994334798896e-12	6.680017150539896e-8	24	227	336
DOID:1682	congenital heart disease	GO:0003230	cardiac atrium development	3.3063551896361787e-12	7.292166370742592e-8	11	31	336
DOID:1682	congenital heart disease	GO:0086069	bundle of His cell to Purkinje myocyte communication	4.705902334478651e-12	1.0378867598692665e-7	8	12	336
DOID:1682	congenital heart disease	GO:0003143	embryonic heart tube morphogenesis	4.936273612088371e-12	1.0886951451460902e-7	14	63	336
DOID:1682	congenital heart disease	GO:0010631	epithelial cell migration	9.135692202733026e-12	2.0148769153127688e-7	23	218	336
DOID:1682	congenital heart disease	GO:0001501	skeletal system development	9.259815136886118e-12	2.0422522284402334e-7	45	482	336
DOID:1682	congenital heart disease	GO:0003170	heart valve development	1.075906030933993e-11	2.3729107512249215e-7	11	34	336
DOID:1682	congenital heart disease	GO:0043010	camera-type eye development	1.1589618154062009e-11	2.556090283878376e-7	26	283	336
DOID:1682	congenital heart disease	GO:0030334	regulation of cell migration	1.163424911965194e-11	2.5659336433392355e-7	45	660	336
DOID:1682	congenital heart disease	GO:0035994	response to muscle stretch	1.4004797321831575e-11	3.088758049329954e-7	9	19	336
DOID:1682	congenital heart disease	GO:0035107	appendage morphogenesis	1.6522450074774042e-11	3.644026363991415e-7	19	146	336
DOID:1682	congenital heart disease	GO:0035108	limb morphogenesis	1.6522450074774042e-11	3.644026363991415e-7	19	146	336
DOID:1682	congenital heart disease	GO:0048705	skeletal system morphogenesis	1.7851276012947892e-11	3.9370989246556576e-7	22	204	336
DOID:1682	congenital heart disease	GO:0048754	branching morphogenesis of an epithelial tube	1.8492096742761532e-11	4.078431936616056e-7	19	147	336
DOID:1682	congenital heart disease	GO:0002520	immune system development	1.912392466607571e-11	4.2177815851029976e-7	46	782	336
DOID:1682	congenital heart disease	GO:0050801	ion homeostasis	1.9534263095977167e-11	4.308281725817764e-7	41	668	336
DOID:1682	congenital heart disease	GO:0048534	hematopoietic or lymphoid organ development	1.9920287641639334e-11	4.393419439363555e-7	44	739	336
DOID:1682	congenital heart disease	GO:0060323	head morphogenesis	2.1828649998667515e-11	4.81430875720612e-7	11	36	336
DOID:1682	congenital heart disease	GO:0001947	heart looping	2.5080382215492136e-11	5.531478297626791e-7	13	58	336
DOID:1682	congenital heart disease	GO:0019725	cellular homeostasis	2.869415816064702e-11	6.3284965823307e-7	44	771	336
DOID:1682	congenital heart disease	GO:0055065	metal ion homeostasis	3.031386253127266e-11	6.685722381272186e-7	35	516	336
DOID:1682	congenital heart disease	GO:0048608	reproductive structure development	3.043121310497554e-11	6.711604050302356e-7	31	418	336
DOID:1682	congenital heart disease	GO:0048645	organ formation	3.1627367391706684e-11	6.975415878240909e-7	13	59	336
DOID:1682	congenital heart disease	GO:0060038	cardiac muscle cell proliferation	4.252975749352572e-11	9.379938015197098e-7	11	38	336
DOID:1682	congenital heart disease	GO:0006875	cellular metal ion homeostasis	4.3640313585058266e-11	9.6248711611846e-7	32	450	336
DOID:1682	congenital heart disease	GO:0044706	multi-multicellular organism process	5.842037964498559e-11	1.2884614730701571e-6	23	237	336
DOID:1682	congenital heart disease	GO:0042327	positive regulation of phosphorylation	6.155287390896547e-11	1.3575486340622334e-6	47	910	336
DOID:1682	congenital heart disease	GO:2000738	positive regulation of stem cell differentiation	6.24970075691067e-11	1.3783715019366483e-6	12	50	336
DOID:1682	congenital heart disease	GO:0048771	tissue remodeling	6.363010118803913e-11	1.4033618817022031e-6	18	139	336
DOID:1682	congenital heart disease	GO:0005740	mitochondrial envelope	9.790379618124234e-11	2.1592682247773e-6	40	694	336
DOID:1682	congenital heart disease	GO:0060325	face morphogenesis	9.883582841041516e-11	2.1798241955917064e-6	10	31	336
DOID:1682	congenital heart disease	GO:0072593	reactive oxygen species metabolic process	1.0988165932701577e-10	2.4234399964573328e-6	22	223	336
DOID:1682	congenital heart disease	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1.3184553449008263e-10	2.9078532631787724e-6	21	204	336
DOID:1682	congenital heart disease	GO:0060284	regulation of cell development	1.322605358566875e-10	2.917006118319243e-6	44	828	336
DOID:1682	congenital heart disease	GO:0010632	regulation of epithelial cell migration	1.3294965128807235e-10	2.9322045591584356e-6	19	164	336
DOID:1682	congenital heart disease	GO:0043388	positive regulation of DNA binding	1.41834655131845e-10	3.1281633189328417e-6	11	42	336
DOID:1682	congenital heart disease	GO:0001934	positive regulation of protein phosphorylation	1.8104506782634644e-10	3.992948970910071e-6	45	870	336
DOID:1682	congenital heart disease	GO:0007548	sex differentiation	1.8542045676639418e-10	4.089448173982824e-6	24	274	336
DOID:1682	congenital heart disease	GO:0071560	cellular response to transforming growth factor beta stimulus	1.9073553847448466e-10	4.206672301054759e-6	21	208	336
DOID:1682	congenital heart disease	GO:0045765	regulation of angiogenesis	1.9073553847448466e-10	4.206672301054759e-6	21	208	336
DOID:1682	congenital heart disease	GO:0031966	mitochondrial membrane	2.3734003651298963e-10	5.234534505293986e-6	38	656	336
DOID:1682	congenital heart disease	GO:0043500	muscle adaptation	2.9085700514741575e-10	6.414851248526254e-6	14	84	336
DOID:1682	congenital heart disease	GO:0051353	positive regulation of oxidoreductase activity	3.203155518605172e-10	7.064559496283707e-6	11	45	336
DOID:1682	congenital heart disease	GO:2000027	regulation of organ morphogenesis	3.2978497710445254e-10	7.273407670038701e-6	22	236	336
DOID:1682	congenital heart disease	GO:0008285	negative regulation of cell proliferation	3.311078078382934e-10	7.302582701873561e-6	37	634	336
DOID:1682	congenital heart disease	GO:0050679	positive regulation of epithelial cell proliferation	3.97009758401623e-10	8.756050221547795e-6	18	155	336
DOID:1682	congenital heart disease	GO:0050999	regulation of nitric-oxide synthase activity	4.142746146129639e-10	9.136826625288919e-6	11	46	336
DOID:1682	congenital heart disease	GO:0001822	kidney development	4.289555377567922e-10	9.460614385226052e-6	23	262	336
DOID:1682	congenital heart disease	GO:0050880	regulation of blood vessel size	5.453666407362334e-10	1.2028061261437628e-5	17	139	336
DOID:1682	congenital heart disease	GO:0031960	response to corticosteroid	6.073720415500361e-10	1.3395590376386046e-5	19	179	336
DOID:1682	congenital heart disease	GO:0032770	positive regulation of monooxygenase activity	6.268175978263457e-10	1.3824462120060055e-5	9	27	336
DOID:1682	congenital heart disease	GO:0055024	regulation of cardiac muscle tissue development	6.793532403293057e-10	1.4983135715462836e-5	11	48	336
DOID:1682	congenital heart disease	GO:0030855	epithelial cell differentiation	9.258810385048832e-10	2.04203063042252e-5	34	568	336
DOID:1682	congenital heart disease	GO:0051000	positive regulation of nitric-oxide synthase activity	1.0563945274100206e-9	2.3298781302028004e-5	8	20	336
DOID:1682	congenital heart disease	GO:0071900	regulation of protein serine/threonine kinase activity	1.2196035292788565e-9	2.689835583824518e-5	29	431	336
DOID:1682	congenital heart disease	GO:0032838	cell projection cytoplasm	1.236925895042873e-9	2.7280400615170564e-5	15	110	336
DOID:1682	congenital heart disease	GO:0003179	heart valve morphogenesis	1.2977166008454333e-9	2.862113963164603e-5	9	29	336
DOID:1682	congenital heart disease	GO:2000021	regulation of ion homeostasis	1.5327360491923514e-9	3.380449356493731e-5	19	189	336
DOID:1682	congenital heart disease	GO:0007565	female pregnancy	1.675580674209698e-9	3.695493176969489e-5	19	190	336
DOID:1682	congenital heart disease	GO:0071260	cellular response to mechanical stimulus	1.7558664522354661e-9	3.8725634604053205e-5	13	80	336
DOID:1682	congenital heart disease	GO:0001701	in utero embryonic development	2.550071487306127e-9	5.624182665253663e-5	24	312	336
DOID:1682	congenital heart disease	GO:0043627	response to estrogen	2.5993679431124406e-9	5.732905998534488e-5	20	217	336
DOID:1682	congenital heart disease	GO:0003184	pulmonary valve morphogenesis	2.60779609018158e-9	5.7514942768954747e-5	6	9	336
DOID:1682	congenital heart disease	GO:0031093	platelet alpha granule lumen	3.2148794737452135e-9	7.090416679345068e-5	11	55	336
DOID:1682	congenital heart disease	GO:0060841	venous blood vessel development	3.2655185222552063e-9	7.202101100833858e-5	7	15	336
DOID:1682	congenital heart disease	GO:0035690	cellular response to drug	3.3350605610493744e-9	7.355476067394395e-5	12	69	336
DOID:1682	congenital heart disease	GO:1901652	response to peptide	3.417129690319598e-9	7.536479531999873e-5	28	423	336
DOID:1682	congenital heart disease	GO:0030278	regulation of ossification	3.4632076095775233e-9	7.638104382923228e-5	18	177	336
DOID:1682	congenital heart disease	GO:0009952	anterior/posterior pattern specification	3.6437353134743944e-9	8.036258233867777e-5	19	199	336
DOID:4194	glucose metabolism disease	GO:0016051	carbohydrate biosynthetic process	1.3109513474773848e-12	2.8913031968613723e-8	24	197	337
DOID:4194	glucose metabolism disease	GO:0015749	monosaccharide transport	1.071365218763276e-12	2.3628959899824054e-8	31	148	337
DOID:4194	glucose metabolism disease	GO:0034112	positive regulation of homotypic cell-cell adhesion	3.0020430585864233e-13	6.6210059657123566e-9	24	207	337
DOID:4194	glucose metabolism disease	GO:1903039	positive regulation of leukocyte cell-cell adhesion	1.680877659282487e-13	3.707175677547525e-9	24	208	337
DOID:4194	glucose metabolism disease	GO:1903706	regulation of hemopoiesis	4.592992652874273e-13	1.0129845295914208e-8	29	305	337
DOID:4194	glucose metabolism disease	GO:0019395	fatty acid oxidation	7.399636459126668e-13	1.6319898210603867e-8	17	91	337
DOID:4194	glucose metabolism disease	GO:0034504	protein localization to nucleus	8.61866134016509e-13	1.9008457585734106e-8	30	344	337
DOID:4194	glucose metabolism disease	GO:0050886	endocrine process	2.3596680165383077e-12	5.2042478104752377e-8	16	85	337
DOID:4194	glucose metabolism disease	GO:0050873	brown fat cell differentiation	2.545297306255634e-12	5.6136532089468005e-8	12	39	337
DOID:4194	glucose metabolism disease	GO:0019693	ribose phosphate metabolic process	7.99238453197404e-12	1.7627204085268744e-7	39	531	337
DOID:4194	glucose metabolism disease	GO:0009152	purine ribonucleotide biosynthetic process	1.3408607557607866e-11	2.957268396830415e-7	24	240	337
DOID:4194	glucose metabolism disease	GO:0031331	positive regulation of cellular catabolic process	1.4781953439069184e-11	3.2601598309867086e-7	28	333	337
DOID:4194	glucose metabolism disease	GO:0048520	positive regulation of behavior	1.5013101872796142e-11	3.311139618045189e-7	19	145	337
DOID:4194	glucose metabolism disease	GO:1904035	regulation of epithelial cell apoptotic process	1.6185719431405232e-11	3.569760420596424e-7	13	56	337
DOID:4194	glucose metabolism disease	GO:0034774	secretory granule lumen	2.96932478605072e-11	6.548845815634863e-7	15	85	337
DOID:4194	glucose metabolism disease	GO:0007596	blood coagulation	5.726508156556065e-11	1.2629813739284401e-6	28	352	337
DOID:4194	glucose metabolism disease	GO:0090322	regulation of superoxide metabolic process	7.394007628391819e-11	1.6307483824418156e-6	9	22	337
DOID:4194	glucose metabolism disease	GO:0008134	transcription factor binding	1.0084943991017781e-10	2.2242343972189715e-6	34	518	337
DOID:4194	glucose metabolism disease	GO:1903036	positive regulation of response to wounding	1.1259038146249623e-10	2.4831808631553542e-6	19	162	337
DOID:4194	glucose metabolism disease	GO:1900078	positive regulation of cellular response to insulin stimulus	1.1955558765208707e-10	2.6367984856667803e-6	9	23	337
DOID:4194	glucose metabolism disease	GO:0006096	glycolytic process	1.21147758491702e-10	2.6719138135344878e-6	13	65	337
DOID:4194	glucose metabolism disease	GO:0098869	cellular oxidant detoxification	1.2866419041301924e-10	2.8376887195591394e-6	14	79	337
DOID:4194	glucose metabolism disease	GO:0052652	cyclic purine nucleotide metabolic process	1.721007780730588e-10	3.7956826604013116e-6	18	147	337
DOID:4194	glucose metabolism disease	GO:0032946	positive regulation of mononuclear cell proliferation	1.7305379351739703e-10	3.816701416026191e-6	17	129	337
DOID:4194	glucose metabolism disease	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	1.8108836652430682e-10	3.993903923693587e-6	13	67	337
DOID:4194	glucose metabolism disease	GO:0042098	T cell proliferation	1.9251955585275482e-10	4.2460188043325076e-6	19	167	337
DOID:4194	glucose metabolism disease	GO:0006694	steroid biosynthetic process	2.1580370823670592e-10	4.759550785160549e-6	18	149	337
DOID:4194	glucose metabolism disease	GO:0031644	regulation of neurological system process	2.2034418734051542e-10	4.8596910517950676e-6	13	68	337
DOID:4194	glucose metabolism disease	GO:0050678	regulation of epithelial cell proliferation	2.4615165461483457e-10	5.4288747425301764e-6	24	277	337
DOID:4194	glucose metabolism disease	GO:0009409	response to cold	2.538079746372546e-10	5.59773488062465e-6	11	44	337
DOID:4194	glucose metabolism disease	GO:0030804	positive regulation of cyclic nucleotide biosynthetic process	2.825593092836698e-10	6.231845566251337e-6	15	99	337
DOID:4194	glucose metabolism disease	GO:0061061	muscle structure development	4.582419999010767e-10	1.0106527307818247e-5	34	551	337
DOID:4194	glucose metabolism disease	GO:0002757	immune response-activating signal transduction	6.829160570376303e-10	1.5061713637964935e-5	29	419	337
DOID:4194	glucose metabolism disease	GO:0050810	regulation of steroid biosynthetic process	7.009827163173554e-10	1.5460173808379274e-5	11	48	337
DOID:4194	glucose metabolism disease	GO:0014896	muscle hypertrophy	7.757290365617564e-10	1.7108703901369537e-5	12	61	337
DOID:4194	glucose metabolism disease	GO:0042129	regulation of T cell proliferation	7.994126471899676e-10	1.7631045933774736e-5	17	142	337
DOID:4194	glucose metabolism disease	GO:0030168	platelet activation	8.631442227624575e-10	1.9036645833026e-5	18	162	337
DOID:4194	glucose metabolism disease	GO:0031663	lipopolysaccharide-mediated signaling pathway	8.894734948583505e-10	1.961733792910092e-5	11	49	337
DOID:4194	glucose metabolism disease	GO:0009887	organ morphogenesis	1.0067734423913066e-9	2.2204388271940267e-5	46	950	337
DOID:4194	glucose metabolism disease	GO:0070301	cellular response to hydrogen peroxide	1.1141397804337316e-9	2.457235285746595e-5	13	77	337
DOID:4194	glucose metabolism disease	GO:0032635	interleukin-6 production	1.130615046029959e-9	2.4935714840190748e-5	15	109	337
DOID:4194	glucose metabolism disease	GO:0050671	positive regulation of lymphocyte proliferation	1.1864867976996152e-9	2.6167966323265013e-5	16	127	337
DOID:4194	glucose metabolism disease	GO:0071900	regulation of protein serine/threonine kinase activity	1.306383889954077e-9	2.8812296692937167e-5	29	431	337
DOID:4194	glucose metabolism disease	GO:0044708	single-organism behavior	1.3140624144369895e-9	2.8981646550407802e-5	28	404	337
DOID:4194	glucose metabolism disease	GO:0033028	myeloid cell apoptotic process	1.3319971792213892e-9	2.9377197787727738e-5	9	29	337
DOID:4194	glucose metabolism disease	GO:0032637	interleukin-8 production	1.3929289943703793e-9	3.0721048970838716e-5	12	64	337
DOID:4194	glucose metabolism disease	GO:0034220	ion transmembrane transport	1.5031350608651906e-9	3.315164376738178e-5	46	962	337
DOID:4194	glucose metabolism disease	GO:0015909	long-chain fatty acid transport	1.7569253829563536e-9	3.874898932110238e-5	11	52	337
DOID:4194	glucose metabolism disease	GO:1902001	fatty acid transmembrane transport	1.8057576545160714e-9	3.9825985070351955e-5	7	14	337
DOID:4194	glucose metabolism disease	GO:0048638	regulation of developmental growth	2.0381567544802692e-9	4.495154722006234e-5	23	283	337
DOID:4194	glucose metabolism disease	GO:0050729	positive regulation of inflammatory response	2.139276422674641e-9	4.71817415020892e-5	15	114	337
DOID:4194	glucose metabolism disease	GO:0006984	ER-nucleus signaling pathway	2.1921748860620482e-9	4.8348417112098474e-5	10	41	337
DOID:4194	glucose metabolism disease	GO:0044212	transcription regulatory region DNA binding	2.283821465276503e-9	5.036968241667328e-5	41	807	337
DOID:4194	glucose metabolism disease	GO:0006110	regulation of glycolytic process	2.59745136510503e-9	5.728678985739144e-5	9	31	337
DOID:4194	glucose metabolism disease	GO:1900077	negative regulation of cellular response to insulin stimulus	2.59745136510503e-9	5.728678985739144e-5	9	31	337
DOID:4194	glucose metabolism disease	GO:0032147	activation of protein kinase activity	2.856273328966097e-9	6.299510827034727e-5	23	288	337
DOID:4194	glucose metabolism disease	GO:0001889	liver development	2.9427219550015593e-9	6.490173271755939e-5	16	135	337
DOID:4194	glucose metabolism disease	GO:1901615	organic hydroxy compound metabolic process	3.1018803081650503e-9	6.841197019658019e-5	32	534	337
DOID:4194	glucose metabolism disease	GO:0032680	regulation of tumor necrosis factor production	3.246050206406892e-9	7.1591637302304e-5	14	100	337
DOID:4194	glucose metabolism disease	GO:0050921	positive regulation of chemotaxis	3.915894608574888e-9	8.636505559211916e-5	15	119	337
DOID:4194	glucose metabolism disease	GO:0032403	protein complex binding	4.035670797541968e-9	8.90067194397881e-5	44	924	337
MESH:D010859	Pigmentation Disorders	GO:0009790	embryo development	5.439648731453417e-12	1.199714527722051e-7	54	932	339
MESH:D010859	Pigmentation Disorders	GO:0016445	somatic diversification of immunoglobulins	2.199351811782435e-13	4.850670420886161e-9	14	48	339
MESH:D010859	Pigmentation Disorders	GO:0070227	lymphocyte apoptotic process	2.866595849582154e-13	6.322277146253441e-9	16	65	339
MESH:D010859	Pigmentation Disorders	GO:1900180	regulation of protein localization to nucleus	6.7976735351749085e-12	1.499226898182826e-7	23	213	339
MESH:D010859	Pigmentation Disorders	GO:0001667	ameboidal-type cell migration	7.164713267115985e-12	1.5801775110624305e-7	28	315	339
MESH:D010859	Pigmentation Disorders	GO:0007219	Notch signaling pathway	1.4461543074162364e-11	3.1894933250065094e-7	20	162	339
MESH:D010859	Pigmentation Disorders	GO:0044087	regulation of cellular component biogenesis	2.997080361666349e-11	6.610060737655132e-7	43	735	339
MESH:D010859	Pigmentation Disorders	GO:0048871	multicellular organismal homeostasis	4.223299487904342e-11	9.314487020573026e-7	27	321	339
MESH:D010859	Pigmentation Disorders	GO:0043405	regulation of MAP kinase activity	5.412514880731578e-11	1.1937301569453496e-6	25	278	339
MESH:D010859	Pigmentation Disorders	GO:0045860	positive regulation of protein kinase activity	5.445033313122849e-11	1.2009020972092443e-6	32	450	339
MESH:D010859	Pigmentation Disorders	GO:0042306	regulation of protein import into nucleus	6.381084549644811e-11	1.407348197424163e-6	20	175	339
MESH:D010859	Pigmentation Disorders	GO:0001503	ossification	1.329127918836548e-10	2.9313916249940064e-6	28	363	339
MESH:D010859	Pigmentation Disorders	GO:0048608	reproductive structure development	1.6616685805104225e-10	3.664810054315737e-6	30	418	339
MESH:D010859	Pigmentation Disorders	GO:0043254	regulation of protein complex assembly	1.8119838962604717e-10	3.99633048320247e-6	28	368	339
MESH:D010859	Pigmentation Disorders	GO:0042060	wound healing	2.413065303130679e-10	5.322015526054713e-6	34	534	339
MESH:D010859	Pigmentation Disorders	GO:0002009	morphogenesis of an epithelium	2.4499458017857023e-10	5.4033554658383665e-6	33	506	339
MESH:D010859	Pigmentation Disorders	GO:1903047	mitotic cell cycle process	4.849394219519354e-10	1.0695338951149935e-5	44	857	339
MESH:D010859	Pigmentation Disorders	GO:0010001	glial cell differentiation	5.275967440709906e-10	1.1636146190485697e-5	19	176	339
MESH:D010859	Pigmentation Disorders	GO:0007162	negative regulation of cell adhesion	5.374625189347171e-10	1.1853735855105185e-5	21	218	339
MESH:D010859	Pigmentation Disorders	GO:0010631	epithelial cell migration	5.374625189347171e-10	1.1853735855105185e-5	21	218	339
MESH:D010859	Pigmentation Disorders	GO:0001894	tissue homeostasis	5.519998902414613e-10	1.217435757927543e-5	20	197	339
MESH:D010859	Pigmentation Disorders	GO:0001701	in utero embryonic development	6.060874024882423e-10	1.3367257661878185e-5	25	312	339
MESH:D010859	Pigmentation Disorders	GO:0044089	positive regulation of cellular component biogenesis	7.399441059874334e-10	1.6319467257552844e-5	29	418	339
MESH:D010859	Pigmentation Disorders	GO:0002761	regulation of myeloid leukocyte differentiation	8.221988645473743e-10	1.813359595759234e-5	15	106	339
MESH:D010859	Pigmentation Disorders	GO:0043535	regulation of blood vessel endothelial cell migration	9.466548656078544e-10	2.087847306098123e-5	11	49	339
MESH:D010859	Pigmentation Disorders	GO:0060326	cell chemotaxis	1.2259347981213864e-9	2.7037991972567177e-5	21	228	339
MESH:D010859	Pigmentation Disorders	GO:0048469	cell maturation	1.6712006223329468e-9	3.685832972555314e-5	17	148	339
MESH:D010859	Pigmentation Disorders	GO:0048568	embryonic organ development	1.8703377735462823e-9	4.1250299595563256e-5	28	408	339
MESH:D010859	Pigmentation Disorders	GO:0050817	coagulation	1.9759553993026202e-9	4.357969633161929e-5	26	356	339
MESH:D010859	Pigmentation Disorders	GO:0055123	digestive system development	2.0587366256208384e-9	4.540543627806759e-5	17	150	339
MESH:D010859	Pigmentation Disorders	GO:0045121	membrane raft	2.1330615052050916e-9	4.7044671497298296e-5	23	282	339
MESH:D010859	Pigmentation Disorders	GO:0007423	sensory organ development	2.1441837194657865e-9	4.728997193281792e-5	31	494	339
MESH:D010859	Pigmentation Disorders	GO:0071902	positive regulation of protein serine/threonine kinase activity	2.2829415025071853e-9	5.035027483779597e-5	23	283	339
MESH:D010859	Pigmentation Disorders	GO:0051046	regulation of secretion	2.3065850340842076e-9	5.08717329267272e-5	37	675	339
MESH:D010859	Pigmentation Disorders	GO:0001525	angiogenesis	2.4542126109139417e-9	5.4127659133706985e-5	28	413	339
MESH:D010859	Pigmentation Disorders	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3.00373359518602e-9	6.624734444182767e-5	19	195	339
MESH:D010859	Pigmentation Disorders	GO:0014065	phosphatidylinositol 3-kinase signaling	3.0939779627203734e-9	6.823768396779784e-5	17	154	339
MESH:D010859	Pigmentation Disorders	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	4.224985916678747e-9	9.318206439234977e-5	13	85	339
MESH:D010859	Pigmentation Disorders	GO:0030316	osteoclast differentiation	4.224985916678747e-9	9.318206439234977e-5	13	85	339
MESH:D010859	Pigmentation Disorders	GO:0035004	phosphatidylinositol 3-kinase activity	4.376059181687708e-9	9.65139852521224e-5	12	70	339
MESH:D010859	Pigmentation Disorders	GO:0048565	digestive tract development	4.426039090787981e-9	9.761629214732892e-5	16	138	339
Orphanet:248308	Rare hemorrhagic disorder	GO:1903036	positive regulation of response to wounding	1.0034195696562165e-12	2.2130418608767854e-8	22	162	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0031983	vesicle lumen	1.4344081478157023e-13	3.1635871700075313e-9	20	106	340
Orphanet:248308	Rare hemorrhagic disorder	GO:1900047	negative regulation of hemostasis	2.631228568361621e-13	5.803174607521555e-9	14	49	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0030195	negative regulation of blood coagulation	2.631228568361621e-13	5.803174607521555e-9	14	49	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0031589	cell-substrate adhesion	9.20608034249426e-12	2.0304010195371092e-7	27	300	340
Orphanet:248308	Rare hemorrhagic disorder	GO:1904035	regulation of epithelial cell apoptotic process	1.8045454019954832e-11	3.979924884101038e-7	13	56	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0072594	establishment of protein localization to organelle	2.2106538821731192e-11	4.875597137132814e-7	40	641	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	3.3702041157823714e-11	7.43298517735802e-7	15	85	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0007160	cell-matrix adhesion	5.0912385418655504e-11	1.1228726604084471e-6	21	192	340
Orphanet:248308	Rare hemorrhagic disorder	GO:2000351	regulation of endothelial cell apoptotic process	6.616041048346233e-11	1.4591678532127617e-6	11	39	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0016485	protein processing	9.252187904706943e-11	2.0405700423831163e-6	26	308	340
Orphanet:248308	Rare hemorrhagic disorder	GO:1904036	negative regulation of epithelial cell apoptotic process	2.2423984891162263e-10	4.945609867745837e-6	10	33	340
Orphanet:248308	Rare hemorrhagic disorder	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	2.3738000454187613e-10	5.235416000171078e-6	15	97	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0050729	positive regulation of inflammatory response	2.63915445053442e-10	5.820655140653663e-6	16	114	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0030162	regulation of proteolysis	5.95480442733276e-10	1.3133321164482403e-5	39	701	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0002526	acute inflammatory response	8.190380595962665e-10	1.8063884404395658e-5	17	141	340
Orphanet:248308	Rare hemorrhagic disorder	GO:2000147	positive regulation of cell motility	1.2138109406478748e-9	2.6770600295988878e-5	28	399	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0048514	blood vessel morphogenesis	1.4134594605863526e-9	3.117384840323201e-5	31	484	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0032965	regulation of collagen biosynthetic process	2.024070688833035e-9	4.464087904221259e-5	9	30	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0006953	acute-phase response	2.3933645065810083e-9	5.278565419264414e-5	11	53	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0031638	zymogen activation	2.4135696774507664e-9	5.3231279236176654e-5	15	114	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0010810	regulation of cell-substrate adhesion	2.6316043788554566e-9	5.8040034575657096e-5	18	172	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0030335	positive regulation of cell migration	2.752189365295976e-9	6.0699536451602754e-5	27	387	340
Orphanet:248308	Rare hemorrhagic disorder	GO:0070527	platelet aggregation	3.63702468142435e-9	8.021457934881404e-5	11	55	340
Orphanet:399980	Rare genetic male infertility	GO:0001763	morphogenesis of a branching structure	1.4694911953938572e-12	3.240962831441152e-8	27	193	340
Orphanet:399980	Rare genetic male infertility	GO:0046661	male sex differentiation	1.3515855101786656e-12	2.980921842699047e-8	22	151	340
Orphanet:399980	Rare genetic male infertility	GO:0008406	gonad development	9.681144774731365e-14	2.1351764800670026e-9	25	220	340
Orphanet:399980	Rare genetic male infertility	GO:0055123	digestive system development	2.467137605322023e-12	5.4412719885377214e-8	20	150	340
Orphanet:399980	Rare genetic male infertility	GO:0046546	development of primary male sexual characteristics	2.0877521933471144e-11	4.604537462427061e-7	18	129	340
Orphanet:399980	Rare genetic male infertility	GO:0008584	male gonad development	2.0877521933471144e-11	4.604537462427061e-7	18	129	340
Orphanet:399980	Rare genetic male infertility	GO:0072001	renal system development	4.972011691251055e-11	1.0965771785054201e-6	25	276	340
Orphanet:399980	Rare genetic male infertility	GO:0030324	lung development	6.740330515953019e-11	1.4865798952934384e-6	20	175	340
Orphanet:399980	Rare genetic male infertility	GO:0048565	digestive tract development	6.857248102676294e-11	1.5123660690452567e-6	18	138	340
Orphanet:399980	Rare genetic male infertility	GO:0001822	kidney development	9.569955938815156e-11	2.1106537823056826e-6	24	262	340
Orphanet:399980	Rare genetic male infertility	GO:0022412	cellular process involved in reproduction in multicellular organism	1.2940204463518512e-10	2.853962094429008e-6	24	266	340
Orphanet:399980	Rare genetic male infertility	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	2.0614920881456555e-10	4.546620800405243e-6	49	996	340
Orphanet:399980	Rare genetic male infertility	GO:0070848	response to growth factor	2.6293012211908717e-10	5.798923843336468e-6	37	621	340
Orphanet:399980	Rare genetic male infertility	GO:0071363	cellular response to growth factor stimulus	2.891843431385155e-10	6.377960687919959e-6	36	594	340
Orphanet:399980	Rare genetic male infertility	GO:0014070	response to organic cyclic compound	2.902078577449174e-10	6.400534302564154e-6	45	873	340
Orphanet:399980	Rare genetic male infertility	GO:0001085	RNA polymerase II transcription factor binding	6.514043748850895e-10	1.4366723488090649e-5	15	104	340
Orphanet:399980	Rare genetic male infertility	GO:0010817	regulation of hormone levels	8.143745677813286e-10	1.79610310924172e-5	31	473	340
Orphanet:399980	Rare genetic male infertility	GO:0070482	response to oxygen levels	1.1623925155745951e-9	2.5636566930997695e-5	25	321	340
Orphanet:399980	Rare genetic male infertility	GO:0030855	epithelial cell differentiation	1.259435666867148e-9	2.777685363275495e-5	34	568	340
Orphanet:399980	Rare genetic male infertility	GO:0090102	cochlea development	1.39825850897779e-9	3.0838591415505157e-5	10	39	340
Orphanet:399980	Rare genetic male infertility	GO:0036293	response to decreased oxygen levels	1.6846074535337152e-9	3.715401738768609e-5	24	302	340
Orphanet:399980	Rare genetic male infertility	GO:0001503	ossification	3.164465911531522e-9	6.979229567882772e-5	26	363	340
Orphanet:399980	Rare genetic male infertility	GO:0010243	response to organonitrogen compound	3.622565136751632e-9	7.989567409105724e-5	40	780	340
Orphanet:399980	Rare genetic male infertility	GO:0001666	response to hypoxia	4.405660836148684e-9	9.716684974125922e-5	23	292	340
Orphanet:183500	Genetic neurodegenerative disease	GO:0043005	neuron projection	8.250289340594463e-12	1.819601314068109e-7	58	941	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0048666	neuron development	2.523981024182831e-12	5.5666401488352335e-8	56	926	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0042982	amyloid precursor protein metabolic process	6.694644838489694e-14	1.476503919128902e-9	12	31	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0044708	single-organism behavior	1.5987211554602254e-13	3.525979508367527e-9	35	404	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0051402	neuron apoptotic process	7.37854222165879e-13	1.6273374869868462e-8	24	211	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0030424	axon	4.478528659035419e-12	9.877394957502617e-8	33	414	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0009991	response to extracellular stimulus	7.176259586572087e-12	1.5827240518184738e-7	43	573	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0008202	steroid metabolic process	9.405032308507089e-12	2.0742798756412384e-7	26	275	341
Orphanet:183500	Genetic neurodegenerative disease	GO:1901615	organic hydroxy compound metabolic process	9.975242853954569e-12	2.2000398114396802e-7	38	534	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0061564	axon development	1.2110978886425983e-11	2.6710763934012505e-7	33	440	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0036477	somatodendritic compartment	1.28531629783879e-11	2.8347650948834513e-7	44	649	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0005768	endosome	1.55161439252538e-11	3.4220855427147256e-7	58	789	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0009636	response to toxic substance	3.505395973490977e-11	7.731150819534349e-7	24	249	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0043523	regulation of neuron apoptotic process	4.386824237201381e-11	9.675140855147646e-7	21	190	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0006066	alcohol metabolic process	1.0240985837128846e-10	2.258649426378767e-6	29	382	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0005770	late endosome	1.1906564623132e-10	2.6259928276317623e-6	21	200	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0044297	cell body	1.5445411616354932e-10	3.40648553198708e-6	33	494	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0050905	neuromuscular process	2.4722945912714067e-10	5.4526457210490875e-6	15	97	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0043209	myelin sheath	2.6105351214056327e-10	5.757535210260123e-6	19	168	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0030425	dendrite	2.7477697894795483e-10	6.060206270697144e-6	31	451	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0016125	sterol metabolic process	3.009741345039174e-10	6.6379845364838985e-6	17	132	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0048812	neuron projection morphogenesis	3.5657832242463883e-10	7.86433490107541e-6	34	539	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0007409	axonogenesis	4.305945600080463e-10	9.496763020977461e-6	29	406	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0008203	cholesterol metabolic process	4.6531245523340203e-10	1.0262466200172682e-5	16	118	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0043025	neuronal cell body	4.714334478350679e-10	1.0397464692002423e-5	30	434	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	7.481562036559808e-10	1.6500585071632656e-5	48	997	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0009314	response to radiation	1.7141135177922706e-9	3.780477363490853e-5	29	431	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0046916	cellular transition metal ion homeostasis	2.4601338743934775e-9	5.425825259974815e-5	13	81	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0010876	lipid localization	2.621604155983448e-9	5.7819479660214945e-5	25	333	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0007568	aging	4.084667271087028e-9	9.00873366638244e-5	23	290	341
Orphanet:183500	Genetic neurodegenerative disease	GO:0031329	regulation of cellular catabolic process	4.162389100059727e-9	9.180149160181728e-5	35	624	341
Orphanet:98696	Genodermatosis with ocular features	GO:0009790	embryo development	2.999156478722398e-12	6.614639613822249e-8	51	932	341
Orphanet:98696	Genodermatosis with ocular features	GO:0070227	lymphocyte apoptotic process	2.724487302430134e-13	6.008856745509661e-9	16	65	341
Orphanet:98696	Genodermatosis with ocular features	GO:1903827	regulation of cellular protein localization	1.0301759445496828e-11	2.2720530457043253e-7	39	543	341
Orphanet:98696	Genodermatosis with ocular features	GO:1900180	regulation of protein localization to nucleus	5.873335151562742e-11	1.2953640676771627e-6	22	213	341
Orphanet:98696	Genodermatosis with ocular features	GO:0042306	regulation of protein import into nucleus	7.114131506114063e-11	1.5690217036734566e-6	20	175	341
Orphanet:98696	Genodermatosis with ocular features	GO:0046148	pigment biosynthetic process	7.406697477563284e-11	1.6335471286765824e-6	12	50	341
Orphanet:98696	Genodermatosis with ocular features	GO:0048871	multicellular organismal homeostasis	2.452706926447945e-10	5.409445126280943e-6	26	321	341
Orphanet:98696	Genodermatosis with ocular features	GO:0001889	liver development	4.3070425004287927e-10	9.499182234695702e-6	17	135	341
Orphanet:98696	Genodermatosis with ocular features	GO:0010039	response to iron ion	4.4311054825385554e-10	9.772803141738784e-6	10	35	341
Orphanet:98696	Genodermatosis with ocular features	GO:0043405	regulation of MAP kinase activity	1.8126221634773287e-9	3.9977381815492485e-5	23	278	341
Orphanet:98696	Genodermatosis with ocular features	GO:0007162	negative regulation of cell adhesion	3.6267198133543843e-9	7.998730548353095e-5	20	218	341
DOID:403	mouth disease	GO:0032880	regulation of protein localization	6.368461313854823e-12	1.4045641427706812e-7	52	933	342
DOID:403	mouth disease	GO:0009607	response to biotic stimulus	6.342260050473669e-12	1.3987854541319678e-7	57	934	342
DOID:403	mouth disease	GO:0032101	regulation of response to external stimulus	5.633493671552969e-12	1.2424670292610074e-7	57	920	342
DOID:403	mouth disease	GO:0051050	positive regulation of transport	5.6270543780101434e-12	1.241046843070137e-7	55	920	342
DOID:403	mouth disease	GO:0023014	signal transduction by protein phosphorylation	1.6375789613221059e-12	3.6116803991959046e-8	62	879	342
DOID:403	mouth disease	GO:0033002	muscle cell proliferation	1.4688250615790821e-12	3.2394936733126656e-8	22	151	342
DOID:403	mouth disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.4688250615790821e-12	3.2394936733126656e-8	22	151	342
DOID:403	mouth disease	GO:2001234	negative regulation of apoptotic signaling pathway	1.4153123117921496e-12	3.121471303657586e-8	25	199	342
DOID:403	mouth disease	GO:0002573	myeloid leukocyte differentiation	1.3253842467975119e-12	2.9231349563119124e-8	23	183	342
DOID:403	mouth disease	GO:0071216	cellular response to biotic stimulus	1.1834977442504169e-12	2.6102042749442944e-8	23	175	342
DOID:403	mouth disease	GO:0010631	epithelial cell migration	1.092237411626229e-12	2.408929611341648e-8	27	218	342
DOID:403	mouth disease	GO:0071222	cellular response to lipopolysaccharide	5.977440764581843e-13	1.3183245606285254e-8	21	152	342
DOID:403	mouth disease	GO:0030335	positive regulation of cell migration	5.055955654142963e-13	1.1150910195212305e-8	37	387	342
DOID:403	mouth disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	4.580780199603396e-13	1.010291073022529e-8	22	168	342
DOID:403	mouth disease	GO:0060537	muscle tissue development	3.6504133049675147e-13	8.050986544105854e-9	31	336	342
DOID:403	mouth disease	GO:1903706	regulation of hemopoiesis	1.9118040484045196e-13	4.216483828756168e-9	31	305	342
DOID:403	mouth disease	GO:0036293	response to decreased oxygen levels	1.3500311979441904e-13	2.977493807065912e-9	33	302	342
DOID:403	mouth disease	GO:0002684	positive regulation of immune system process	2.6645352591003757e-14	5.876632513945879e-10	58	872	342
DOID:403	mouth disease	GO:0009611	response to wounding	4.4297898682543746e-14	9.769901554435023e-10	61	875	342
DOID:403	mouth disease	GO:0045787	positive regulation of cell cycle	2.920996777788787e-13	6.4422583934131694e-9	30	308	342
DOID:403	mouth disease	GO:0048771	tissue remodeling	3.4638958368304884e-13	7.639622268129642e-9	20	139	342
DOID:403	mouth disease	GO:0003007	heart morphogenesis	3.9768188742073107e-13	8.770874027064224e-9	24	216	342
DOID:403	mouth disease	GO:0072593	reactive oxygen species metabolic process	5.229150445984487e-13	1.1532891308618787e-8	25	223	342
DOID:403	mouth disease	GO:1903034	regulation of response to wounding	1.0755840662568517e-12	2.3722006581294863e-8	34	407	342
DOID:403	mouth disease	GO:0001775	cell activation	1.3099521467552222e-12	2.8890994596686426e-8	58	854	342
DOID:403	mouth disease	GO:0007568	aging	1.3670176102209552e-12	3.014957339342317e-8	31	290	342
DOID:403	mouth disease	GO:0031349	positive regulation of defense response	1.4717116414431075e-12	3.2458600252027736e-8	33	398	342
DOID:403	mouth disease	GO:2000377	regulation of reactive oxygen species metabolic process	1.9340085088970227e-12	4.2654557663723836e-8	20	147	342
DOID:403	mouth disease	GO:0001655	urogenital system development	2.0028423364237824e-12	4.417268772982652e-8	32	313	342
DOID:403	mouth disease	GO:0043062	extracellular structure organization	2.14572803969304e-12	4.732403191543e-8	30	321	342
DOID:403	mouth disease	GO:0001701	in utero embryonic development	2.4207302828926913e-12	5.338920638919831e-8	29	312	342
DOID:403	mouth disease	GO:0072001	renal system development	2.4767965456362617e-12	5.462574781400775e-8	28	276	342
DOID:403	mouth disease	GO:0097193	intrinsic apoptotic signaling pathway	2.4823476607593875e-12	5.474817765804829e-8	27	272	342
DOID:403	mouth disease	GO:0001101	response to acid chemical	2.6256774532384952e-12	5.790931623117501e-8	31	315	342
DOID:403	mouth disease	GO:0001822	kidney development	3.38540306898949e-12	7.46650646865632e-8	27	262	342
DOID:403	mouth disease	GO:0048738	cardiac muscle tissue development	3.4929836800756675e-12	7.703775506406885e-8	21	168	342
DOID:403	mouth disease	GO:0001525	angiogenesis	3.5234037909503968e-12	7.7708670609411e-8	41	413	342
DOID:403	mouth disease	GO:1901698	response to nitrogen compound	3.671285497830468e-12	8.097020165465096e-8	51	870	342
DOID:403	mouth disease	GO:0051052	regulation of DNA metabolic process	3.9012126862303376e-12	8.60412457948101e-8	29	335	342
DOID:403	mouth disease	GO:0071900	regulation of protein serine/threonine kinase activity	3.9686032238250846e-12	8.752754410146224e-8	35	431	342
DOID:403	mouth disease	GO:2000738	positive regulation of stem cell differentiation	4.0596415118443474e-12	8.953539354372708e-8	13	50	342
DOID:403	mouth disease	GO:1902105	regulation of leukocyte differentiation	4.130251696210507e-12	9.109270115992274e-8	24	225	342
DOID:403	mouth disease	GO:0043588	skin development	4.132028053049908e-12	9.113187871001571e-8	25	241	342
DOID:403	mouth disease	GO:0042633	hair cycle	4.156008870381811e-12	9.166077563627084e-8	17	101	342
DOID:403	mouth disease	GO:0097285	cell-type specific apoptotic process	4.292233235503318e-12	9.466520400902567e-8	36	429	342
DOID:403	mouth disease	GO:0046824	positive regulation of nucleocytoplasmic transport	4.717670698539678e-12	1.0404822725629259e-7	18	118	342
DOID:403	mouth disease	GO:0007346	regulation of mitotic cell cycle	4.8158144139165415e-12	1.0621278689892932e-7	37	453	342
DOID:403	mouth disease	GO:0006979	response to oxidative stress	5.6710192097853e-12	1.2507432867181478e-7	31	386	342
DOID:403	mouth disease	GO:0098609	cell-cell adhesion	5.897393684506369e-12	1.3006701771178797e-7	52	867	342
DOID:403	mouth disease	GO:1901342	regulation of vasculature development	6.1524119132627675e-12	1.3569144474701034e-7	24	228	342
DOID:403	mouth disease	GO:0045926	negative regulation of growth	7.2558625774377106e-12	1.600280491453887e-7	24	230	342
DOID:403	mouth disease	GO:0006935	chemotaxis	7.48001660610953e-12	1.6497176624774568e-7	38	530	342
DOID:403	mouth disease	GO:0007159	leukocyte cell-cell adhesion	7.649103572759941e-12	1.687009792972205e-7	35	461	342
DOID:403	mouth disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	7.68218821889377e-12	1.694306611677021e-7	23	212	342
DOID:403	mouth disease	GO:0046649	lymphocyte activation	8.467337941908681e-12	1.8674713830879597e-7	43	594	342
DOID:403	mouth disease	GO:0042060	wound healing	8.635314685534468e-12	1.9045186538946268e-7	43	534	342
DOID:403	mouth disease	GO:0060425	lung morphogenesis	8.95494789432405e-12	1.9750137580931693e-7	13	53	342
DOID:403	mouth disease	GO:0072089	stem cell proliferation	8.981593246915054e-12	1.9808903906071151e-7	19	139	342
DOID:403	mouth disease	GO:0034109	homotypic cell-cell adhesion	9.491740726730313e-12	2.0934034172803706e-7	36	495	342
DOID:403	mouth disease	GO:0010942	positive regulation of cell death	9.753864382844313e-12	2.1512147896363132e-7	46	596	342
DOID:403	mouth disease	GO:0043065	positive regulation of apoptotic process	9.847678228425139e-12	2.1719054332791643e-7	43	556	342
DOID:403	mouth disease	GO:0045596	negative regulation of cell differentiation	1.0014877815933687e-11	2.2087813023041747e-7	44	597	342
DOID:403	mouth disease	GO:0030855	epithelial cell differentiation	1.0397571692521979e-11	2.2931844367857224e-7	39	568	342
DOID:403	mouth disease	GO:0030155	regulation of cell adhesion	1.1212697437201768e-11	2.47296041977485e-7	43	621	342
DOID:403	mouth disease	GO:0010564	regulation of cell cycle process	1.1513234809967798e-11	2.539243937338398e-7	39	561	342
DOID:403	mouth disease	GO:0050776	regulation of immune response	1.314048869716089e-11	2.8981347821588344e-7	51	816	342
DOID:403	mouth disease	GO:0061041	regulation of wound healing	1.3222867245588077e-11	2.9163033710144504e-7	18	125	342
DOID:403	mouth disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.3387402297837525e-11	2.952591576788066e-7	43	647	342
DOID:403	mouth disease	GO:0071345	cellular response to cytokine stimulus	1.3464118708839123e-11	2.9695113812344687e-7	44	677	342
DOID:403	mouth disease	GO:0001816	cytokine production	1.3708367774256658e-11	3.023380512612306e-7	40	613	342
DOID:403	mouth disease	GO:0031625	ubiquitin protein ligase binding	1.377464808882678e-11	3.0379986359907463e-7	25	257	342
DOID:403	mouth disease	GO:0070851	growth factor receptor binding	1.5360046567991503e-11	3.387658270570526e-7	18	126	342
DOID:403	mouth disease	GO:0061061	muscle structure development	1.7307377753184028e-11	3.8171421634647373e-7	37	551	342
DOID:403	mouth disease	GO:0009986	cell surface	1.747169076082855e-11	3.853381397300737e-7	44	715	342
DOID:403	mouth disease	GO:0080135	regulation of cellular response to stress	1.7703505328370284e-11	3.904508100172066e-7	42	681	342
DOID:403	mouth disease	GO:0010243	response to organonitrogen compound	1.9682366847462163e-11	4.34094600820778e-7	46	780	342
DOID:403	mouth disease	GO:0050680	negative regulation of epithelial cell proliferation	2.2309154523725283e-11	4.920284030207611e-7	17	112	342
DOID:403	mouth disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	2.3870128096348253e-11	5.264556751649607e-7	16	97	342
DOID:403	mouth disease	GO:0034612	response to tumor necrosis factor	2.469213722378072e-11	5.445850864704838e-7	25	265	342
DOID:403	mouth disease	GO:0030162	regulation of proteolysis	2.8222535419786254e-11	6.224480186833858e-7	42	701	342
DOID:403	mouth disease	GO:0070201	regulation of establishment of protein localization	3.399480696941737e-11	7.497554677105001e-7	45	803	342
DOID:403	mouth disease	GO:0017038	protein import	3.452171881690447e-11	7.61376508506828e-7	27	315	342
DOID:403	mouth disease	GO:0010638	positive regulation of organelle organization	3.707389950591278e-11	8.176648536029063e-7	37	573	342
DOID:403	mouth disease	GO:0035137	hindlimb morphogenesis	3.709110796279447e-11	8.18044386119432e-7	11	37	342
DOID:403	mouth disease	GO:0045765	regulation of angiogenesis	3.885258781366474e-11	8.568938242303759e-7	22	208	342
DOID:403	mouth disease	GO:0010634	positive regulation of epithelial cell migration	4.4465542359262145e-11	9.806875367335266e-7	16	101	342
DOID:403	mouth disease	GO:0034504	protein localization to nucleus	4.547340282101686e-11	1.0029158992175269e-6	28	344	342
DOID:403	mouth disease	GO:0072091	regulation of stem cell proliferation	6.130851382124547e-11	1.3521592723275688e-6	15	88	342
DOID:403	mouth disease	GO:0043405	regulation of MAP kinase activity	6.48318065898934e-11	1.429865494340099e-6	25	278	342
DOID:403	mouth disease	GO:0051223	regulation of protein transport	6.621614367929851e-11	1.4603970488469287e-6	42	730	342
DOID:403	mouth disease	GO:0070489	T cell aggregation	6.632638882564379e-11	1.4628285055495738e-6	31	424	342
DOID:403	mouth disease	GO:0042110	T cell activation	6.632638882564379e-11	1.4628285055495738e-6	31	424	342
DOID:403	mouth disease	GO:0006809	nitric oxide biosynthetic process	7.741896013158112e-11	1.7074751657020215e-6	13	62	342
DOID:403	mouth disease	GO:0044057	regulation of system process	8.974165854880312e-11	1.9792522792938527e-6	34	508	342
DOID:403	mouth disease	GO:0045732	positive regulation of protein catabolic process	9.239553566686709e-11	2.0377835391327537e-6	24	260	342
DOID:403	mouth disease	GO:0071902	positive regulation of protein serine/threonine kinase activity	9.30130417131636e-11	2.0514026349838232e-6	25	283	342
DOID:403	mouth disease	GO:1903708	positive regulation of hemopoiesis	9.312139948036702e-11	2.0537924655394946e-6	19	158	342
DOID:403	mouth disease	GO:0090068	positive regulation of cell cycle process	9.734524297755343e-11	2.146949333869941e-6	23	239	342
DOID:403	mouth disease	GO:0031329	regulation of cellular catabolic process	1.0158507368629444e-10	2.2404588001512238e-6	38	624	342
DOID:403	mouth disease	GO:0050865	regulation of cell activation	1.0410838857666249e-10	2.2961105100582913e-6	32	458	342
DOID:403	mouth disease	GO:0034599	cellular response to oxidative stress	1.078115374752997e-10	2.377783459017735e-6	22	219	342
DOID:403	mouth disease	GO:0032103	positive regulation of response to external stimulus	1.0877143630239061e-10	2.398954027649225e-6	25	285	342
DOID:403	mouth disease	GO:0045862	positive regulation of proteolysis	1.1155021351072492e-10	2.460239958979038e-6	28	357	342
DOID:403	mouth disease	GO:0061180	mammary gland epithelium development	1.181302833330733e-10	2.6053633989109315e-6	13	64	342
DOID:403	mouth disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.2987200204150895e-10	2.86432700502548e-6	19	161	342
DOID:403	mouth disease	GO:0001837	epithelial to mesenchymal transition	1.4431478234655515e-10	3.182862524653274e-6	16	109	342
DOID:403	mouth disease	GO:0051099	positive regulation of binding	1.491137213704974e-10	3.28870312482632e-6	17	126	342
DOID:403	mouth disease	GO:0006606	protein import into nucleus	1.6995593821178545e-10	3.748378217260928e-6	24	268	342
DOID:403	mouth disease	GO:0051054	positive regulation of DNA metabolic process	1.7052881329249203e-10	3.7610129771659118e-6	20	183	342
DOID:403	mouth disease	GO:0071407	cellular response to organic cyclic compound	1.8437185111963572e-10	4.066321176443566e-6	30	416	342
DOID:403	mouth disease	GO:0048878	chemical homeostasis	1.8565482484689255e-10	4.094617161998215e-6	49	988	342
DOID:403	mouth disease	GO:0001817	regulation of cytokine production	2.2417367961935497e-10	4.944150504004874e-6	35	556	342
DOID:403	mouth disease	GO:0072006	nephron development	2.789704023342665e-10	6.152692223482248e-6	17	131	342
DOID:403	mouth disease	GO:0051345	positive regulation of hydrolase activity	2.8658009298965226e-10	6.3205239508867805e-6	46	900	342
DOID:403	mouth disease	GO:0042307	positive regulation of protein import into nucleus	2.9898183928622757e-10	6.594044465457749e-6	15	98	342
DOID:403	mouth disease	GO:0010718	positive regulation of epithelial to mesenchymal transition	3.309887919300536e-10	7.299957806017332e-6	10	34	342
DOID:403	mouth disease	GO:0045088	regulation of innate immune response	3.702588236009774e-10	8.166058354519556e-6	27	351	342
DOID:403	mouth disease	GO:0048660	regulation of smooth muscle cell proliferation	4.008755549733678e-10	8.841310364937627e-6	15	100	342
DOID:403	mouth disease	GO:0002683	negative regulation of immune system process	6.095254301285991e-10	1.3443083361486252e-5	27	359	342
DOID:403	mouth disease	GO:0006954	inflammatory response	6.120731699255089e-10	1.3499273762707098e-5	37	637	342
DOID:403	mouth disease	GO:0045931	positive regulation of mitotic cell cycle	6.263458640631825e-10	1.381405803191349e-5	16	120	342
DOID:403	mouth disease	GO:0034505	tooth mineralization	7.405890345424382e-10	1.6333691156833474e-5	8	19	342
DOID:403	mouth disease	GO:0009952	anterior/posterior pattern specification	7.707301463710792e-10	1.699845337821415e-5	20	199	342
DOID:403	mouth disease	GO:0030856	regulation of epithelial cell differentiation	8.036571408354121e-10	1.7724658241125013e-5	16	122	342
DOID:403	mouth disease	GO:0071356	cellular response to tumor necrosis factor	8.040492716077097e-10	1.7733306685308037e-5	22	243	342
DOID:403	mouth disease	GO:0031960	response to corticosteroid	8.173344223649792e-10	1.8026310685259617e-5	19	179	342
DOID:403	mouth disease	GO:0070663	regulation of leukocyte proliferation	8.425836695025168e-10	1.858318283087801e-5	20	200	342
DOID:403	mouth disease	GO:0005125	cytokine activity	8.827232278463271e-10	1.9468460790150743e-5	21	222	342
DOID:403	mouth disease	GO:0060441	epithelial tube branching involved in lung morphogenesis	1.062346655089641e-9	2.3430055478002032e-5	9	28	342
DOID:403	mouth disease	GO:0005126	cytokine receptor binding	1.0881953116381737e-9	2.4000147598179922e-5	23	270	342
DOID:403	mouth disease	GO:0043406	positive regulation of MAP kinase activity	1.3037049217956564e-9	2.8753212050203203e-5	20	205	342
DOID:403	mouth disease	GO:0050918	positive chemotaxis	1.309792718728886e-9	2.888747841156558e-5	11	50	342
DOID:403	mouth disease	GO:0048871	multicellular organismal homeostasis	1.3116330244145047e-9	2.89280663534619e-5	25	321	342
DOID:403	mouth disease	GO:0051249	regulation of lymphocyte activation	1.327275289675356e-9	2.9273056513789975e-5	27	372	342
DOID:403	mouth disease	GO:0060326	cell chemotaxis	1.4368967127253995e-9	3.169075699915869e-5	21	228	342
DOID:403	mouth disease	GO:0032844	regulation of homeostatic process	1.4823332561419988e-9	3.2692859964211785e-5	29	427	342
DOID:403	mouth disease	GO:0035116	embryonic hindlimb morphogenesis	1.5157316513025876e-9	3.342946156947857e-5	9	29	342
DOID:403	mouth disease	GO:0030098	lymphocyte differentiation	1.5514440843134025e-9	3.421709927953209e-5	24	299	342
DOID:403	mouth disease	GO:0022407	regulation of cell-cell adhesion	1.674885785618585e-9	3.693960600181789e-5	27	376	342
DOID:403	mouth disease	GO:0009314	response to radiation	1.8329346929135681e-9	4.0425374652208745e-5	29	431	342
DOID:403	mouth disease	GO:0002252	immune effector process	1.8388188749440815e-9	4.055515028689172e-5	40	757	342
DOID:403	mouth disease	GO:0050778	positive regulation of immune response	1.8542180013625398e-9	4.0894778020050815e-5	35	603	342
DOID:403	mouth disease	GO:0050670	regulation of lymphocyte proliferation	2.055043024640213e-9	4.5323973908439896e-5	19	189	342
DOID:403	mouth disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.1300240460320197e-9	4.6977680335236194e-5	21	233	342
DOID:403	mouth disease	GO:1904018	positive regulation of vasculature development	2.3290603889947192e-9	5.136742687927853e-5	16	131	342
DOID:403	mouth disease	GO:0052547	regulation of peptidase activity	2.3604668220045255e-9	5.206009575930981e-5	27	382	342
DOID:403	mouth disease	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2.6254542984105456e-9	5.790439455144458e-5	24	307	342
DOID:403	mouth disease	GO:0043010	camera-type eye development	2.7028117521865624e-9	5.9610513194474635e-5	23	283	342
DOID:403	mouth disease	GO:0030279	negative regulation of ossification	3.416732674565992e-9	7.535603913755295e-5	12	68	342
DOID:403	mouth disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.474996623786808e-9	7.664105053761805e-5	13	83	342
DOID:403	mouth disease	GO:0007224	smoothened signaling pathway	3.768464873488142e-9	8.311349278478097e-5	15	117	342
DOID:403	mouth disease	GO:1901863	positive regulation of muscle tissue development	3.866257647366922e-9	8.527031241267746e-5	11	55	342
DOID:403	mouth disease	GO:0030282	bone mineralization	3.919174651478841e-9	8.643739693836583e-5	14	100	342
DOID:403	mouth disease	GO:0007584	response to nutrient	4.116230356565609e-9	9.07834605140545e-5	19	197	342
DOID:403	mouth disease	GO:0019221	cytokine-mediated signaling pathway	4.445687262766285e-9	9.804963258031041e-5	32	534	342
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0001763	morphogenesis of a branching structure	1.2390088954816747e-12	2.7326341189848335e-8	24	193	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0061138	morphogenesis of a branching epithelium	1.149524919696887e-12	2.5352772103914845e-8	23	179	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0009913	epidermal cell differentiation	1.1175504965876826e-12	2.464757620224134e-8	23	176	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0002065	columnar/cuboidal epithelial cell differentiation	7.640554855470327e-13	1.6851243733739807e-8	22	128	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048706	embryonic skeletal system development	6.24389429049188e-13	1.3770908857679842e-8	20	122	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0042733	embryonic digit morphogenesis	3.240963053485757e-12	7.147944014462837e-8	14	60	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048871	multicellular organismal homeostasis	3.6983749396313215e-12	8.15676592935688e-8	29	321	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048732	gland development	5.242251077675064e-12	1.1561784751812354e-7	34	421	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0060872	semicircular canal development	2.3661850256928574e-11	5.218621074165597e-7	7	9	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0050678	regulation of epithelial cell proliferation	6.723899215188567e-11	1.4829559719098384e-6	25	277	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0001944	vasculature development	8.258815853423584e-11	1.8214818364725716e-6	37	588	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0001654	eye development	8.532186068777037e-11	1.8817736374687755e-6	27	327	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048589	developmental growth	2.864185555395693e-10	6.316961242425201e-6	35	558	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0031012	extracellular matrix	3.1456492965986627e-10	6.9377295236483505e-6	30	423	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0060485	mesenchyme development	5.577796002853574e-10	1.2301829084293558e-5	22	237	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0001701	in utero embryonic development	8.210686575083059e-10	1.8108669241345687e-5	25	312	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048863	stem cell differentiation	9.107732346080866e-10	2.008710368928135e-5	23	266	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0060541	respiratory system development	1.1120185883228828e-9	2.452556996546118e-5	20	202	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0008589	regulation of smoothened signaling pathway	1.1950243017366802e-9	2.635626097480248e-5	12	62	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048762	mesenchymal cell differentiation	1.438666408226652e-9	3.172978763343881e-5	19	184	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0001568	blood vessel development	1.7812193942035037e-9	3.9284793739158275e-5	34	569	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0035270	endocrine system development	2.015062894322739e-9	4.4442212134288006e-5	16	129	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0042473	outer ear morphogenesis	3.0030239406286796e-9	6.623169301056553e-5	6	9	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0043010	camera-type eye development	3.0216628088552966e-9	6.664277324930357e-5	23	283	344
Orphanet:98036	Rare otorhinolaryngologic disease	GO:0048864	stem cell development	4.177340584554656e-9	9.213124659235294e-5	18	175	344
DOID:5353	colonic disease	GO:0014031	mesenchymal cell development	1.283195771861756e-12	2.8300882748411027e-8	30	171	344
DOID:5353	colonic disease	GO:2000736	regulation of stem cell differentiation	2.6666446828471635e-12	5.881284848019419e-8	18	113	344
DOID:5353	colonic disease	GO:0010769	regulation of cell morphogenesis involved in differentiation	3.874345289034409e-12	8.544868534965389e-8	29	334	344
DOID:5353	colonic disease	GO:0000165	MAPK cascade	5.494271704264975e-12	1.2117616243756402e-7	50	843	344
DOID:5353	colonic disease	GO:1900180	regulation of protein localization to nucleus	9.679701484799352e-12	2.1348581624724972e-7	23	213	344
DOID:5353	colonic disease	GO:0042306	regulation of protein import into nucleus	9.797052058502231e-12	2.160739831502667e-7	21	175	344
DOID:5353	colonic disease	GO:0051271	negative regulation of cellular component movement	2.8622548775558698e-11	6.312703132449471e-7	24	244	344
DOID:5353	colonic disease	GO:0048589	developmental growth	7.864886519826086e-11	1.7346007219476434e-6	36	558	344
DOID:5353	colonic disease	GO:0043009	chordate embryonic development	2.1416812767682814e-10	4.7234780559124445e-6	35	552	344
DOID:5353	colonic disease	GO:0007389	pattern specification process	5.192688501409748e-10	1.1452474489859199e-5	30	432	344
DOID:5353	colonic disease	GO:0042692	muscle cell differentiation	6.924857354206893e-10	1.52727728947033e-5	26	334	344
DOID:5353	colonic disease	GO:0007420	brain development	7.806223445427918e-10	1.7216625808891273e-5	38	669	344
DOID:5353	colonic disease	GO:0051046	regulation of secretion	9.99153204617187e-10	2.2036323927832058e-5	38	675	344
DOID:5353	colonic disease	GO:0072080	nephron tubule development	1.1853062975575313e-9	2.6141930392631352e-5	14	91	344
DOID:5353	colonic disease	GO:0007610	behavior	1.393108961522671e-9	3.072501814638251e-5	39	714	344
DOID:5353	colonic disease	GO:0061333	renal tubule morphogenesis	1.4300259865152043e-9	3.153922313259283e-5	13	77	344
DOID:5353	colonic disease	GO:0060675	ureteric bud morphogenesis	1.7575103594680286e-9	3.876189097806737e-5	12	64	344
DOID:5353	colonic disease	GO:0090184	positive regulation of kidney development	2.671254772934617e-9	5.891452401707298e-5	10	41	344
DOID:5353	colonic disease	GO:0060828	regulation of canonical Wnt signaling pathway	2.7578210826106897e-9	6.082374397697876e-5	21	235	344
DOID:5353	colonic disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	2.792199471635115e-9	6.158195934691246e-5	39	732	344
DOID:5353	colonic disease	GO:0031175	neuron projection development	2.8262896467623477e-9	6.233381815934358e-5	41	796	344
DOID:5353	colonic disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.8458332357317317e-9	6.276485201406334e-5	17	151	344
DOID:5353	colonic disease	GO:0009117	nucleotide metabolic process	3.0096579672900248e-9	6.63780064685815e-5	36	641	344
DOID:5353	colonic disease	GO:0003007	heart morphogenesis	3.5904306194822766e-9	7.918694731268161e-5	20	216	344
DOID:5353	colonic disease	GO:0019725	cellular homeostasis	3.6577171291796162e-9	8.067095128405644e-5	40	771	344
DOID:5353	colonic disease	GO:0006820	anion transport	4.09213884999815e-9	9.02521223367092e-5	34	588	344
DOID:8466	retinal degeneration	GO:0098590	plasma membrane region	1.4763745781465332e-12	3.256144132102179e-8	52	926	345
DOID:8466	retinal degeneration	GO:0071482	cellular response to light stimulus	2.495781359357352e-13	5.50444578806264e-9	20	109	345
DOID:8466	retinal degeneration	GO:0035845	photoreceptor cell outer segment organization	5.443534512039605e-12	1.200571536630335e-7	7	8	345
DOID:8466	retinal degeneration	GO:0060042	retina morphogenesis in camera-type eye	1.6397327939898787e-11	3.6164306771446775e-7	12	44	345
DOID:8466	retinal degeneration	GO:0050885	neuromuscular process controlling balance	1.088724665976315e-10	2.4011822508107628e-6	12	51	345
DOID:8466	retinal degeneration	GO:0016101	diterpenoid metabolic process	2.142117594416959e-10	4.724440354486603e-6	15	95	345
DOID:8466	retinal degeneration	GO:0003407	neural retina development	1.800295690301823e-9	3.9705521449606707e-5	11	51	345
DOID:8466	retinal degeneration	GO:0060219	camera-type eye photoreceptor cell differentiation	2.1255086579685667e-9	4.687809345149674e-5	7	14	345
DOID:8466	retinal degeneration	GO:0006979	response to oxidative stress	3.5686027466397263e-9	7.870553357713916e-5	27	386	345
Orphanet:98496	Rare peripheral neuropathy	GO:0043005	neuron projection	1.926679926711472e-10	4.2492925783621516e-6	48	941	347
Orphanet:98496	Rare peripheral neuropathy	GO:0007568	aging	2.123807796294841e-10	4.684058094728272e-6	25	290	347
Orphanet:98496	Rare peripheral neuropathy	GO:0072593	reactive oxygen species metabolic process	1.2456475850797233e-9	2.7472757488933297e-5	21	223	347
Orphanet:98496	Rare peripheral neuropathy	GO:0009636	response to toxic substance	1.6693042503845845e-9	3.681650524223201e-5	22	249	347
Orphanet:98496	Rare peripheral neuropathy	GO:0002439	chronic inflammatory response to antigenic stimulus	2.1551201934144615e-9	4.753117586575595e-5	5	5	347
Orphanet:98496	Rare peripheral neuropathy	GO:0000266	mitochondrial fission	2.419391242902691e-9	5.335967386221885e-5	9	30	347
Orphanet:98496	Rare peripheral neuropathy	GO:0031667	response to nutrient levels	2.933194465093436e-9	6.469160392763573e-5	33	546	347
Orphanet:98496	Rare peripheral neuropathy	GO:0043524	negative regulation of neuron apoptotic process	4.0058737438286585e-9	8.834954542014106e-5	16	134	347
Orphanet:98496	Rare peripheral neuropathy	GO:0000302	response to reactive oxygen species	4.164336986356432e-9	9.18444522340911e-5	20	216	347
MESH:D018376	Cardiovascular Abnormalities	GO:0048762	mesenchymal cell differentiation	1.5514256546111937e-12	3.421669281244988e-8	24	184	350
MESH:D018376	Cardiovascular Abnormalities	GO:0071773	cellular response to BMP stimulus	5.697664562376303e-13	1.2566199192320937e-8	21	147	350
MESH:D018376	Cardiovascular Abnormalities	GO:0010594	regulation of endothelial cell migration	3.222422328974517e-12	7.107052446553297e-8	18	112	350
MESH:D018376	Cardiovascular Abnormalities	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	4.188538405003328e-12	9.23782145223484e-8	17	99	350
MESH:D018376	Cardiovascular Abnormalities	GO:0019693	ribose phosphate metabolic process	6.217470982505802e-12	1.3712632251916546e-7	39	531	350
MESH:D018376	Cardiovascular Abnormalities	GO:0001569	patterning of blood vessels	7.808864666003501e-12	1.7222451020870722e-7	11	32	350
MESH:D018376	Cardiovascular Abnormalities	GO:0003197	endocardial cushion development	7.808864666003501e-12	1.7222451020870722e-7	11	32	350
MESH:D018376	Cardiovascular Abnormalities	GO:1901215	negative regulation of neuron death	7.937317469952632e-12	1.750575367998053e-7	21	170	350
MESH:D018376	Cardiovascular Abnormalities	GO:0072521	purine-containing compound metabolic process	9.020895141986784e-12	1.9895584235651853e-7	42	568	350
MESH:D018376	Cardiovascular Abnormalities	GO:0009205	purine ribonucleoside triphosphate metabolic process	9.047540494577788e-12	1.9954350560791312e-7	25	245	350
MESH:D018376	Cardiovascular Abnormalities	GO:0006163	purine nucleotide metabolic process	9.189538019427346e-12	2.026752610184701e-7	40	522	350
MESH:D018376	Cardiovascular Abnormalities	GO:0030509	BMP signaling pathway	9.331646566579366e-12	2.058094650259079e-7	19	136	350
MESH:D018376	Cardiovascular Abnormalities	GO:0001655	urogenital system development	1.019684336966975e-11	2.2489138051806634e-7	28	313	350
MESH:D018376	Cardiovascular Abnormalities	GO:0009150	purine ribonucleotide metabolic process	1.0652478898975914e-11	2.349404221169138e-7	39	501	350
MESH:D018376	Cardiovascular Abnormalities	GO:0007179	transforming growth factor beta receptor signaling pathway	4.271105691344701e-11	9.419923602260738e-7	20	166	350
MESH:D018376	Cardiovascular Abnormalities	GO:0090287	regulation of cellular response to growth factor stimulus	5.115807777400505e-11	1.1282914053056814e-6	23	226	350
MESH:D018376	Cardiovascular Abnormalities	GO:0043524	negative regulation of neuron apoptotic process	6.685463294076044e-11	1.4744789295084715e-6	18	134	350
MESH:D018376	Cardiovascular Abnormalities	GO:0045926	negative regulation of growth	7.17788051218804e-11	1.5830815469630721e-6	23	230	350
MESH:D018376	Cardiovascular Abnormalities	GO:0043535	regulation of blood vessel endothelial cell migration	7.728162554343498e-11	1.7044462513604586e-6	12	49	350
MESH:D018376	Cardiovascular Abnormalities	GO:0014033	neural crest cell differentiation	1.0225931212914929e-10	2.2553291290083877e-6	14	75	350
MESH:D018376	Cardiovascular Abnormalities	GO:0001974	blood vessel remodeling	1.2225098711127202e-10	2.6962455207391045e-6	11	40	350
MESH:D018376	Cardiovascular Abnormalities	GO:0072132	mesenchyme morphogenesis	1.2225098711127202e-10	2.6962455207391045e-6	11	40	350
MESH:D018376	Cardiovascular Abnormalities	GO:0043583	ear development	1.320307196905901e-10	2.9119375227759647e-6	21	196	350
MESH:D018376	Cardiovascular Abnormalities	GO:0003018	vascular process in circulatory system	1.5530854380330084e-10	3.4253299335818e-6	19	159	350
MESH:D018376	Cardiovascular Abnormalities	GO:0030336	negative regulation of cell migration	2.807635235413386e-10	6.192239511704223e-6	21	204	350
MESH:D018376	Cardiovascular Abnormalities	GO:0001570	vasculogenesis	2.881559435508052e-10	6.355279335013009e-6	13	67	350
MESH:D018376	Cardiovascular Abnormalities	GO:0033674	positive regulation of kinase activity	5.82440984331356e-10	1.2845735909428058e-5	32	480	350
MESH:D018376	Cardiovascular Abnormalities	GO:0014065	phosphatidylinositol 3-kinase signaling	6.88562207251664e-10	1.5186239480935448e-5	18	154	350
MESH:D018376	Cardiovascular Abnormalities	GO:0072073	kidney epithelium development	8.100616843975672e-10	1.7865910449388345e-5	17	137	350
MESH:D018376	Cardiovascular Abnormalities	GO:0090596	sensory organ morphogenesis	9.040438397889261e-10	1.9938686886544765e-5	22	239	350
MESH:D018376	Cardiovascular Abnormalities	GO:0034330	cell junction organization	9.786566002034647e-10	2.1584271317487413e-5	22	240	350
MESH:D018376	Cardiovascular Abnormalities	GO:0008406	gonad development	1.1358541884831652e-9	2.505126412699621e-5	21	220	350
MESH:D018376	Cardiovascular Abnormalities	GO:0007417	central nervous system development	1.3212128058270878e-9	2.913934843251642e-5	45	889	350
MESH:D018376	Cardiovascular Abnormalities	GO:0032403	protein complex binding	1.4401285719500834e-9	3.176203565435909e-5	46	924	350
MESH:D018376	Cardiovascular Abnormalities	GO:0035113	embryonic appendage morphogenesis	1.6168559824336626e-9	3.565975869257443e-5	16	125	350
MESH:D018376	Cardiovascular Abnormalities	GO:0030326	embryonic limb morphogenesis	1.6168559824336626e-9	3.565975869257443e-5	16	125	350
MESH:D018376	Cardiovascular Abnormalities	GO:0050680	negative regulation of epithelial cell proliferation	2.7873687802326685e-9	6.14754184480315e-5	15	112	350
MESH:D018376	Cardiovascular Abnormalities	GO:0000904	cell morphogenesis involved in differentiation	2.8822458864041778e-9	6.356793302464414e-5	39	720	350
MESH:D018376	Cardiovascular Abnormalities	GO:0035904	aorta development	3.1536809830257084e-9	6.9554434080632e-5	10	41	350
MESH:D018376	Cardiovascular Abnormalities	GO:0061448	connective tissue development	3.2161514562645266e-9	7.093222036791413e-5	21	233	350
MESH:D018376	Cardiovascular Abnormalities	GO:0048845	venous blood vessel morphogenesis	3.3310353364512935e-9	7.346598434543328e-5	6	9	350
MESH:D018376	Cardiovascular Abnormalities	GO:0001657	ureteric bud development	3.5051983537925935e-9	7.730714969289565e-5	14	97	350
MESH:D018376	Cardiovascular Abnormalities	GO:0042476	odontogenesis	3.5773242146319717e-9	7.889788555370814e-5	15	114	350
MESH:D018376	Cardiovascular Abnormalities	GO:0030097	hemopoiesis	3.6142018267071307e-9	7.971122128802577e-5	38	695	350
MESH:D018376	Cardiovascular Abnormalities	GO:0061323	cell proliferation involved in heart morphogenesis	4.333524095123664e-9	9.557587391795241e-5	7	15	350
Orphanet:101957	Pituitary deficiency	GO:0023014	signal transduction by protein phosphorylation	1.6184831252985532e-12	3.569564532845959e-8	53	879	353
Orphanet:101957	Pituitary deficiency	GO:0001657	ureteric bud development	3.212985433265203e-13	7.086239373066405e-9	18	97	353
Orphanet:101957	Pituitary deficiency	GO:0098609	cell-cell adhesion	1.2516654379624015e-12	2.7605481234260765e-8	51	867	353
Orphanet:101957	Pituitary deficiency	GO:0001775	cell activation	1.450950470882617e-12	3.200071263531612e-8	50	854	353
Orphanet:101957	Pituitary deficiency	GO:0022407	regulation of cell-cell adhesion	2.0713430970431546e-12	4.5683472005286774e-8	32	376	353
Orphanet:101957	Pituitary deficiency	GO:0021532	neural tube patterning	4.408362563879109e-12	9.722643634635375e-8	12	39	353
Orphanet:101957	Pituitary deficiency	GO:0044706	multi-multicellular organism process	5.254685575550866e-12	1.1589209036877435e-7	25	237	353
Orphanet:101957	Pituitary deficiency	GO:2000826	regulation of heart morphogenesis	7.939759960606807e-12	1.7511140593118313e-7	10	24	353
Orphanet:101957	Pituitary deficiency	GO:0072091	regulation of stem cell proliferation	8.032907672372858e-12	1.7716577871418338e-7	16	88	353
Orphanet:101957	Pituitary deficiency	GO:0060675	ureteric bud morphogenesis	1.1549317058268116e-11	2.547201877201033e-7	14	64	353
Orphanet:101957	Pituitary deficiency	GO:0035264	multicellular organism growth	1.2190137788081756e-11	2.6885348891614314e-7	19	137	353
Orphanet:101957	Pituitary deficiency	GO:0040014	regulation of multicellular organism growth	1.4679701898501207e-11	3.2376082537144413e-7	14	65	353
Orphanet:101957	Pituitary deficiency	GO:2000145	regulation of cell motility	1.772415547662831e-11	3.909062490370374e-7	44	709	353
Orphanet:101957	Pituitary deficiency	GO:0007498	mesoderm development	1.7888801551180222e-11	3.945375182112798e-7	18	123	353
Orphanet:101957	Pituitary deficiency	GO:0014070	response to organic cyclic compound	2.51794141092887e-11	5.553319781803623e-7	48	873	353
Orphanet:101957	Pituitary deficiency	GO:0048545	response to steroid hormone	2.7652435896641236e-11	6.098744737004225e-7	33	446	353
Orphanet:101957	Pituitary deficiency	GO:0022409	positive regulation of cell-cell adhesion	3.0320634891722875e-11	6.68721602536948e-7	24	239	353
Orphanet:101957	Pituitary deficiency	GO:1902692	regulation of neuroblast proliferation	4.979705536811707e-11	1.098274056143822e-6	10	28	353
Orphanet:101957	Pituitary deficiency	GO:0035137	hindlimb morphogenesis	5.2137960615539214e-11	1.1499027213757174e-6	11	37	353
Orphanet:101957	Pituitary deficiency	GO:0001658	branching involved in ureteric bud morphogenesis	5.821920723292351e-11	1.284024615522128e-6	13	59	353
Orphanet:101957	Pituitary deficiency	GO:0035116	embryonic hindlimb morphogenesis	7.477907182362742e-11	1.6492524290701027e-6	10	29	353
Orphanet:101957	Pituitary deficiency	GO:0008015	blood circulation	7.582401373440462e-11	1.6722986229122938e-6	34	489	353
Orphanet:101957	Pituitary deficiency	GO:0061323	cell proliferation involved in heart morphogenesis	8.649636562552132e-11	1.9076773438708727e-6	8	15	353
Orphanet:101957	Pituitary deficiency	GO:0032870	cellular response to hormone stimulus	8.849421195833429e-11	1.9517398447410628e-6	35	519	353
Orphanet:101957	Pituitary deficiency	GO:0001656	metanephros development	9.538247969231861e-11	2.103660589614087e-6	15	88	353
Orphanet:101957	Pituitary deficiency	GO:0001085	RNA polymerase II transcription factor binding	1.1148404421845726e-10	2.458780595238075e-6	16	104	353
Orphanet:101957	Pituitary deficiency	GO:0048771	tissue remodeling	1.4294643246870464e-10	3.152683568097281e-6	18	139	353
Orphanet:101957	Pituitary deficiency	GO:0003156	regulation of organ formation	1.6021095561313814e-10	3.5334526260477617e-6	10	31	353
Orphanet:101957	Pituitary deficiency	GO:0051961	negative regulation of nervous system development	1.6147705395042067e-10	3.561376424876528e-6	24	259	353
Orphanet:101957	Pituitary deficiency	GO:0021904	dorsal/ventral neural tube patterning	1.8044465921462916e-10	3.979706958978646e-6	9	23	353
Orphanet:101957	Pituitary deficiency	GO:0030879	mammary gland development	3.1391012011994235e-10	6.9232876992453285e-6	17	128	353
Orphanet:101957	Pituitary deficiency	GO:0030334	regulation of cell migration	3.182437646742642e-10	7.018866229890897e-6	39	660	353
Orphanet:101957	Pituitary deficiency	GO:0048762	mesenchymal cell differentiation	3.3035307822615323e-10	7.2859371402778095e-6	20	184	353
Orphanet:101957	Pituitary deficiency	GO:0044463	cell projection part	3.312005114608496e-10	7.304627280269038e-6	48	939	353
Orphanet:101957	Pituitary deficiency	GO:0098727	maintenance of cell number	3.6541303316539597e-10	8.059184446462808e-6	18	147	353
Orphanet:101957	Pituitary deficiency	GO:0090130	tissue migration	3.987545849071239e-10	8.794532370126618e-6	22	227	353
Orphanet:101957	Pituitary deficiency	GO:0021522	spinal cord motor neuron differentiation	4.503846184888971e-10	9.933232760772626e-6	10	34	353
Orphanet:101957	Pituitary deficiency	GO:0001838	embryonic epithelial tube formation	5.216972409627374e-10	1.1506032649433173e-5	16	115	353
Orphanet:101957	Pituitary deficiency	GO:0033002	muscle cell proliferation	5.704038352760676e-10	1.2580256587013672e-5	18	151	353
Orphanet:101957	Pituitary deficiency	GO:0060348	bone development	7.013959413271209e-10	1.546928748596965e-5	19	172	353
Orphanet:101957	Pituitary deficiency	GO:0014020	primary neural tube formation	7.653632172477387e-10	1.6880085756398877e-5	14	86	353
Orphanet:101957	Pituitary deficiency	GO:0050679	positive regulation of epithelial cell proliferation	8.777553128780369e-10	1.9358893425525103e-5	18	155	353
Orphanet:101957	Pituitary deficiency	GO:1901698	response to nitrogen compound	8.833351827775004e-10	1.9481957456157772e-5	45	870	353
Orphanet:101957	Pituitary deficiency	GO:0007369	gastrulation	1.0391137950094276e-9	2.2917654748932925e-5	19	176	353
Orphanet:101957	Pituitary deficiency	GO:0010243	response to organonitrogen compound	1.0511749248820479e-9	2.3183662968273566e-5	42	780	353
Orphanet:101957	Pituitary deficiency	GO:2000648	positive regulation of stem cell proliferation	1.312784547735646e-9	2.895346320030967e-5	12	61	353
Orphanet:101957	Pituitary deficiency	GO:0090132	epithelium migration	1.4394330172251557e-9	3.174669519490081e-5	21	221	353
Orphanet:101957	Pituitary deficiency	GO:0044703	multi-organism reproductive process	2.033442303428501e-9	4.484757000211559e-5	46	926	353
Orphanet:101957	Pituitary deficiency	GO:0034504	protein localization to nucleus	2.2493323870165227e-9	4.960902579564941e-5	26	344	353
Orphanet:101957	Pituitary deficiency	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	2.4923004771082446e-9	5.4967687022622336e-5	7	14	353
Orphanet:101957	Pituitary deficiency	GO:0021984	adenohypophysis development	2.4923004771082446e-9	5.4967687022622336e-5	7	14	353
Orphanet:101957	Pituitary deficiency	GO:0035282	segmentation	2.5640248813019184e-9	5.654956875711381e-5	14	94	353
Orphanet:101957	Pituitary deficiency	GO:0044344	cellular response to fibroblast growth factor stimulus	2.6013177167882873e-9	5.7372062243765676e-5	16	128	353
Orphanet:101957	Pituitary deficiency	GO:0048709	oligodendrocyte differentiation	2.714093061406686e-9	5.985932246932446e-5	13	79	353
Orphanet:101957	Pituitary deficiency	GO:0050680	negative regulation of epithelial cell proliferation	3.1296690794491155e-9	6.902485154725024e-5	15	112	353
Orphanet:101957	Pituitary deficiency	GO:0097285	cell-type specific apoptotic process	3.400341008763519e-9	7.499452094827941e-5	29	429	353
Orphanet:101957	Pituitary deficiency	GO:0060425	lung morphogenesis	3.540813198199544e-9	7.809263508629094e-5	11	53	353
Orphanet:101957	Pituitary deficiency	GO:0042475	odontogenesis of dentin-containing tooth	3.730949438285336e-9	8.228608986138308e-5	13	81	353
Orphanet:101957	Pituitary deficiency	GO:0007565	female pregnancy	3.781472468489255e-9	8.340037529253053e-5	19	190	353
Orphanet:101957	Pituitary deficiency	GO:0021513	spinal cord dorsal/ventral patterning	3.828468098099336e-9	8.443686390358085e-5	8	22	353
Orphanet:101957	Pituitary deficiency	GO:0035909	aorta morphogenesis	3.828468098099336e-9	8.443686390358085e-5	8	22	353
Orphanet:101957	Pituitary deficiency	GO:0002088	lens development in camera-type eye	4.082203242106175e-9	9.003299250465169e-5	12	67	353
Orphanet:101957	Pituitary deficiency	GO:0014031	mesenchymal cell development	4.323827074159681e-9	9.536200612059176e-5	18	171	353
Orphanet:101957	Pituitary deficiency	GO:0001843	neural tube closure	4.359084759819609e-9	9.613961437782148e-5	13	82	353
Orphanet:101957	Pituitary deficiency	GO:0010463	mesenchymal cell proliferation	4.41749814505954e-9	9.742792158928815e-5	10	42	353
Orphanet:101957	Pituitary deficiency	GO:2000179	positive regulation of neural precursor cell proliferation	4.41749814505954e-9	9.742792158928815e-5	10	42	353
Orphanet:183654	Rare genetic coagulation disorder	GO:1903036	positive regulation of response to wounding	1.0418332863082469e-12	2.2977633129528385e-8	26	162	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0031983	vesicle lumen	4.1366909897533333e-13	9.123471977900977e-9	25	106	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0016485	protein processing	3.097522238704187e-13	6.831585297462084e-9	31	308	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0030335	positive regulation of cell migration	7.249756350802272e-14	1.5989337631694411e-9	33	387	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0031589	cell-substrate adhesion	1.8807178037150152e-13	4.147923116093466e-9	30	300	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0002526	acute inflammatory response	2.050581926482664e-12	4.522558438857516e-8	20	141	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0052548	regulation of endopeptidase activity	4.8508974614946965e-12	1.0698654351326553e-7	31	362	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0031638	zymogen activation	5.187517082561044e-12	1.1441068925588382e-7	18	114	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0050729	positive regulation of inflammatory response	5.187517082561044e-12	1.1441068925588382e-7	18	114	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0010810	regulation of cell-substrate adhesion	1.3078316207781882e-11	2.884422639626294e-7	21	172	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0050820	positive regulation of coagulation	1.3783418850721318e-11	3.039933027526587e-7	10	25	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0007160	cell-matrix adhesion	1.5421108834345887e-11	3.4011255534149853e-7	22	192	355
Orphanet:183654	Rare genetic coagulation disorder	GO:1904035	regulation of epithelial cell apoptotic process	3.068878484668858e-11	6.768411497937166e-7	13	56	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	6.174805111669457e-11	1.3618532673786987e-6	15	85	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0070374	positive regulation of ERK1 and ERK2 cascade	6.977562971854923e-11	1.5389015134426032e-6	20	168	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0060326	cell chemotaxis	7.979061855678538e-11	1.7597820922699015e-6	23	228	355
Orphanet:183654	Rare genetic coagulation disorder	GO:2000351	regulation of endothelial cell apoptotic process	1.0484069168370524e-10	2.312261455084119e-6	11	39	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0014065	phosphatidylinositol 3-kinase signaling	1.1279444045442233e-10	2.4876813842222845e-6	19	154	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.3903000972703694e-10	3.0663068645297997e-6	18	138	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0070851	growth factor receptor binding	2.663639309119503e-10	5.874656496263064e-6	17	126	355
Orphanet:183654	Rare genetic coagulation disorder	GO:1904036	negative regulation of epithelial cell apoptotic process	3.415678850871018e-10	7.53327970559603e-6	10	33	355
Orphanet:183654	Rare genetic coagulation disorder	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	4.3116521464270363e-10	9.509348808944829e-6	15	97	355
Orphanet:183654	Rare genetic coagulation disorder	GO:1901342	regulation of vasculature development	4.821009147448763e-10	1.0632735674698246e-5	22	228	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0045765	regulation of angiogenesis	5.232936306498459e-10	1.1541241023982352e-5	21	208	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0048008	platelet-derived growth factor receptor signaling pathway	5.731071173187274e-10	1.2639877472464534e-5	11	45	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0035004	phosphatidylinositol 3-kinase activity	6.09447159405363e-10	1.344135710068528e-5	13	70	355
Orphanet:183654	Rare genetic coagulation disorder	GO:1903725	regulation of phospholipid metabolic process	9.304760295592018e-10	2.0521648831928196e-5	12	59	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0050921	positive regulation of chemotaxis	9.4913388259954e-10	2.0933147780732853e-5	16	119	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0050679	positive regulation of epithelial cell proliferation	9.605910511467641e-10	2.1185835633041883e-5	18	155	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.0299351371756416e-9	2.2715219450408775e-5	20	195	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0002020	protease binding	1.1782805842130983e-9	2.5986978284819884e-5	15	104	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0043535	regulation of blood vessel endothelial cell migration	1.536611615726713e-9	3.388996918485265e-5	11	49	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0060627	regulation of vesicle-mediated transport	1.687115558368646e-9	3.7209333639820485e-5	30	440	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0051347	positive regulation of transferase activity	2.1537663874582336e-9	4.750131767539134e-5	36	613	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0007598	blood coagulation, extrinsic pathway	2.4168489431986018e-9	5.330360344224516e-5	5	5	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0050714	positive regulation of protein secretion	2.480758487521939e-9	5.4713128442296366e-5	20	205	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0045860	positive regulation of protein kinase activity	2.8471296431575865e-9	6.279344427984057e-5	30	450	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0032965	regulation of collagen biosynthetic process	2.953039035524796e-9	6.512927592849937e-5	9	30	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0090398	cellular senescence	3.027090023088874e-9	6.676247045922512e-5	11	52	355
Orphanet:183654	Rare genetic coagulation disorder	GO:0006953	acute-phase response	3.7554523935057205e-9	8.282650253876866e-5	11	53	355
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0032200	telomere organization	5.850875339774575e-13	1.2904105561872825e-8	23	146	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002200	somatic diversification of immune receptors	1.8030021919912542e-13	3.976521334436711e-9	23	59	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002637	regulation of immunoglobulin production	1.9229062786507711e-13	4.240969797564276e-9	14	46	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0032846	positive regulation of homeostatic process	1.2438938767900254e-12	2.743407945260401e-8	23	192	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0010212	response to ionizing radiation	3.863576125695545e-12	8.521117145221524e-8	20	145	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0033365	protein localization to organelle	4.7484238763217945e-12	1.0472648859227718e-7	52	859	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0048536	spleen development	4.7839510131097995e-12	1.0551003959413663e-7	12	39	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0072594	establishment of protein localization to organelle	9.32920407592519e-12	2.0575559589453007e-7	45	641	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0016772	transferase activity, transferring phosphorus-containing groups	4.2097880736946536e-11	9.284687596533558e-7	51	973	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0051347	positive regulation of transferase activity	5.5017213007602095e-11	1.2134046328826642e-6	39	613	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0007260	tyrosine phosphorylation of STAT protein	5.848499462501877e-11	1.289886556454789e-6	14	71	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0044454	nuclear chromosome part	7.970535342849416e-11	1.7579015698654388e-6	34	486	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:1901991	negative regulation of mitotic cell cycle phase transition	1.6424162030403977e-10	3.622348935805597e-6	18	139	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0040012	regulation of locomotion	2.4588064917452357e-10	5.422897717544117e-6	43	766	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0006974	cellular response to DNA damage stimulus	2.558664391472121e-10	5.643134315391762e-6	43	767	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0051092	positive regulation of NF-kappaB transcription factor activity	4.5789039226917794e-10	1.009877260149672e-5	17	130	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	6.306994926319476e-10	1.3910077309997604e-5	13	70	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	6.306994926319476e-10	1.3910077309997604e-5	13	70	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0033674	positive regulation of kinase activity	8.883241919832585e-10	1.9591990054190767e-5	32	480	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002456	T cell mediated immunity	1.2986340891529835e-9	2.864137483626905e-5	13	74	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0003823	antigen binding	1.5442523926267882e-9	3.405848651938381e-5	13	75	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0034612	response to tumor necrosis factor	1.6404477776177373e-9	3.6180075735359196e-5	23	265	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002360	T cell lineage commitment	1.6662927704302888e-9	3.675008705184002e-5	8	20	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0007093	mitotic cell cycle checkpoint	2.2864321547189093e-9	5.0427261172325544e-5	17	144	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0001910	regulation of leukocyte mediated cytotoxicity	2.5000482795078938e-9	5.51385648045466e-5	11	51	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0032615	interleukin-12 production	2.5000482795078938e-9	5.51385648045466e-5	11	51	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0002639	positive regulation of immunoglobulin production	3.026534023398142e-9	6.675020788604602e-5	9	30	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0008156	negative regulation of DNA replication	3.867035691662579e-9	8.528747217961818e-5	11	53	356
Orphanet:179006	Primary immunodeficiency due to a defect in adaptive immunity	GO:0048514	blood vessel morphogenesis	4.258255192901572e-9	9.391581827944417e-5	31	484	356
DOID:2218	blood platelet disease	GO:0071219	cellular response to molecule of bacterial origin	8.417710972707937e-13	1.8565261550307355e-8	22	158	356
DOID:2218	blood platelet disease	GO:1903036	positive regulation of response to wounding	3.7769787297747826e-13	8.330126588518283e-9	22	162	356
DOID:2218	blood platelet disease	GO:0034504	protein localization to nucleus	3.388400671155978e-13	7.473117680234509e-9	31	344	356
DOID:2218	blood platelet disease	GO:2000147	positive regulation of cell motility	2.1678214778830807e-12	4.7811302694711344e-8	33	399	356
DOID:2218	blood platelet disease	GO:1903035	negative regulation of response to wounding	2.2494228701930297e-12	4.961102140210727e-8	21	159	356
DOID:2218	blood platelet disease	GO:0051170	nuclear import	2.5199842212941803e-12	5.557825200064315e-8	28	287	356
DOID:2218	blood platelet disease	GO:0032940	secretion by cell	2.522537734250818e-12	5.5634569728901795e-8	55	956	356
DOID:2218	blood platelet disease	GO:0030335	positive regulation of cell migration	2.680078381445128e-12	5.9109128702772296e-8	32	387	356
DOID:2218	blood platelet disease	GO:0070851	growth factor receptor binding	3.038347351491666e-12	6.701075083714869e-8	19	126	356
DOID:2218	blood platelet disease	GO:0032403	protein complex binding	5.9924287754142824e-12	1.32163016641762e-7	51	924	356
DOID:2218	blood platelet disease	GO:0045862	positive regulation of proteolysis	1.2709944208211255e-11	2.803178195120992e-7	30	357	356
DOID:2218	blood platelet disease	GO:0032102	negative regulation of response to external stimulus	2.1695867324922347e-11	4.785023538511624e-7	26	275	356
DOID:2218	blood platelet disease	GO:0001525	angiogenesis	2.30540031509463e-11	5.084560394941207e-7	32	413	356
DOID:2218	blood platelet disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.317401825990828e-11	5.111029727222771e-7	22	195	356
DOID:2218	blood platelet disease	GO:0031589	cell-substrate adhesion	2.5967006322957786e-11	5.72702324452834e-7	27	300	356
DOID:2218	blood platelet disease	GO:0050729	positive regulation of inflammatory response	5.5206506033300684e-11	1.2175794905644466e-6	17	114	356
DOID:2218	blood platelet disease	GO:0006887	exocytosis	5.5910831520122883e-11	1.2331133891763102e-6	31	405	356
DOID:2218	blood platelet disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	8.343381541209283e-11	1.8401327989137073e-6	19	151	356
DOID:2218	blood platelet disease	GO:1901342	regulation of vasculature development	8.41103853232994e-11	1.8550545483053682e-6	23	228	356
DOID:2218	blood platelet disease	GO:0031091	platelet alpha granule	1.057012255500922e-10	2.3312405295072836e-6	14	74	356
DOID:2218	blood platelet disease	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	1.0876066713905175e-10	2.3987165137517863e-6	16	103	356
DOID:2218	blood platelet disease	GO:0014065	phosphatidylinositol 3-kinase signaling	1.183995124165449e-10	2.6113012463468976e-6	19	154	356
DOID:2218	blood platelet disease	GO:0048871	multicellular organismal homeostasis	1.238356084343195e-10	2.731194344018917e-6	27	321	356
DOID:2218	blood platelet disease	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.456427201063093e-10	3.2121501919446516e-6	18	138	356
DOID:2218	blood platelet disease	GO:0002576	platelet degranulation	1.6928036750130104e-10	3.7334785052411945e-6	16	106	356
DOID:2218	blood platelet disease	GO:0045860	positive regulation of protein kinase activity	1.7884238534549013e-10	3.944368808794785e-6	32	450	356
DOID:2218	blood platelet disease	GO:0045121	membrane raft	2.0110335618994668e-10	4.435334520769274e-6	25	282	356
DOID:2218	blood platelet disease	GO:0002526	acute inflammatory response	2.0914547871342393e-10	4.612703533024565e-6	18	141	356
DOID:2218	blood platelet disease	GO:0045637	regulation of myeloid cell differentiation	2.3355417599901784e-10	5.1510373516583385e-6	20	179	356
DOID:2218	blood platelet disease	GO:0050764	regulation of phagocytosis	4.3159231744027693e-10	9.518768561145308e-6	13	68	356
DOID:2218	blood platelet disease	GO:0010952	positive regulation of peptidase activity	5.243445677649561e-10	1.1564419442056106e-5	18	149	356
DOID:2218	blood platelet disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	5.2439974584928e-10	1.156563639470587e-5	14	83	356
DOID:2218	blood platelet disease	GO:0048608	reproductive structure development	5.372492450916866e-10	1.1849032100497148e-5	30	418	356
DOID:2218	blood platelet disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	5.400390135079647e-10	1.1910560442918161e-5	19	168	356
DOID:2218	blood platelet disease	GO:0045765	regulation of angiogenesis	5.50831047441136e-10	1.2148578751314254e-5	21	208	356
DOID:2218	blood platelet disease	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	5.903502131587857e-10	1.3020173951217018e-5	11	45	356
DOID:2218	blood platelet disease	GO:0035004	phosphatidylinositol 3-kinase activity	6.306994926319476e-10	1.3910077309997604e-5	13	70	356
DOID:2218	blood platelet disease	GO:0043542	endothelial cell migration	6.535365582038821e-10	1.441374879118662e-5	18	151	356
DOID:2218	blood platelet disease	GO:0032680	regulation of tumor necrosis factor production	6.967333376906026e-10	1.536645376276624e-5	15	100	356
DOID:2218	blood platelet disease	GO:1903725	regulation of phospholipid metabolic process	9.606643258663894e-10	2.1187451706983218e-5	12	59	356
DOID:2218	blood platelet disease	GO:0050679	positive regulation of epithelial cell proliferation	1.0047181975281205e-9	2.2159059846482698e-5	18	155	356
DOID:2218	blood platelet disease	GO:0010950	positive regulation of endopeptidase activity	1.1765917129480385e-9	2.594973022906899e-5	17	138	356
DOID:2218	blood platelet disease	GO:0033273	response to vitamin	1.2245209290995263e-9	2.700680909129005e-5	15	104	356
DOID:2218	blood platelet disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	1.2245209290995263e-9	2.700680909129005e-5	15	104	356
DOID:2218	blood platelet disease	GO:0001894	tissue homeostasis	1.2948738747908806e-9	2.855844330851287e-5	20	197	356
DOID:2218	blood platelet disease	GO:0050663	cytokine secretion	2.0656781840600047e-9	4.5558532349443404e-5	18	162	356
DOID:2218	blood platelet disease	GO:0032635	interleukin-6 production	2.3907738011530455e-9	5.272851618443042e-5	15	109	356
DOID:2218	blood platelet disease	GO:0048520	positive regulation of behavior	2.545790134256265e-9	5.6147401411021924e-5	17	145	356
DOID:2218	blood platelet disease	GO:0002712	regulation of B cell mediated immunity	2.854560476883705e-9	6.295733131767012e-5	10	40	356
DOID:2218	blood platelet disease	GO:0060326	cell chemotaxis	2.9439692905697257e-9	6.49292427035153e-5	21	228	356
DOID:2218	blood platelet disease	GO:0090398	cellular senescence	3.1171807357566195e-9	6.874942112711224e-5	11	52	356
DOID:2218	blood platelet disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	4.3554969630932305e-9	9.60604855210212e-5	14	97	356
DOID:2218	blood platelet disease	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	4.502397454864138e-9	9.930037586702856e-5	15	114	356
Orphanet:98429	Rare coagulation disorder	GO:0052548	regulation of endopeptidase activity	4.91329199547863e-12	1.0836265496028119e-7	31	362	356
Orphanet:98429	Rare coagulation disorder	GO:0050820	positive regulation of coagulation	1.4168666240266248e-11	3.124899339290721e-7	10	25	356
Orphanet:98429	Rare coagulation disorder	GO:0070374	positive regulation of ERK1 and ERK2 cascade	7.340883456663505e-11	1.619031846367136e-6	20	168	356
Orphanet:98429	Rare coagulation disorder	GO:0060326	cell chemotaxis	8.41103853232994e-11	1.8550545483053682e-6	23	228	356
Orphanet:98429	Rare coagulation disorder	GO:0014065	phosphatidylinositol 3-kinase signaling	1.183995124165449e-10	2.6113012463468976e-6	19	154	356
Orphanet:98429	Rare coagulation disorder	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.456427201063093e-10	3.2121501919446516e-6	18	138	356
Orphanet:98429	Rare coagulation disorder	GO:0070851	growth factor receptor binding	2.782358787811745e-10	6.136492306518804e-6	17	126	356
Orphanet:98429	Rare coagulation disorder	GO:1901342	regulation of vasculature development	5.080973419779866e-10	1.1206086877324495e-5	22	228	356
Orphanet:98429	Rare coagulation disorder	GO:0045765	regulation of angiogenesis	5.50831047441136e-10	1.2148578751314254e-5	21	208	356
Orphanet:98429	Rare coagulation disorder	GO:0048008	platelet-derived growth factor receptor signaling pathway	5.903502131587857e-10	1.3020173951217018e-5	11	45	356
Orphanet:98429	Rare coagulation disorder	GO:0035004	phosphatidylinositol 3-kinase activity	6.306994926319476e-10	1.3910077309997604e-5	13	70	356
Orphanet:98429	Rare coagulation disorder	GO:1903725	regulation of phospholipid metabolic process	9.606643258663894e-10	2.1187451706983218e-5	12	59	356
Orphanet:98429	Rare coagulation disorder	GO:0050921	positive regulation of chemotaxis	9.88698012349687e-10	2.1805734662372345e-5	16	119	356
Orphanet:98429	Rare coagulation disorder	GO:0050679	positive regulation of epithelial cell proliferation	1.0047181975281205e-9	2.2159059846482698e-5	18	155	356
Orphanet:98429	Rare coagulation disorder	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.0814914519485797e-9	2.3852293972725924e-5	20	195	356
Orphanet:98429	Rare coagulation disorder	GO:0002020	protease binding	1.2245209290995263e-9	2.700680909129005e-5	15	104	356
Orphanet:98429	Rare coagulation disorder	GO:0043535	regulation of blood vessel endothelial cell migration	1.582546427236764e-9	3.490306145270683e-5	11	49	356
Orphanet:98429	Rare coagulation disorder	GO:0060627	regulation of vesicle-mediated transport	1.802268334571977e-9	3.974902811898495e-5	30	440	356
Orphanet:98429	Rare coagulation disorder	GO:0051347	positive regulation of transferase activity	2.3224077105865604e-9	5.122070205698659e-5	36	613	356
Orphanet:98429	Rare coagulation disorder	GO:0007598	blood coagulation, extrinsic pathway	2.4512749607907836e-9	5.406286926024073e-5	5	5	356
Orphanet:98429	Rare coagulation disorder	GO:0050714	positive regulation of protein secretion	2.603520066202236e-9	5.742063506009032e-5	20	205	356
Orphanet:98429	Rare coagulation disorder	GO:0045860	positive regulation of protein kinase activity	3.040573015589132e-9	6.70598378588183e-5	30	450	356
Orphanet:98429	Rare coagulation disorder	GO:0090398	cellular senescence	3.1171807357566195e-9	6.874942112711224e-5	11	52	356
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0070489	T cell aggregation	5.696110250141828e-12	1.2562771156687802e-7	34	424	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0042110	T cell activation	5.696110250141828e-12	1.2562771156687802e-7	34	424	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0010817	regulation of hormone levels	6.636806659798822e-10	1.4637477088186301e-5	32	473	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0001764	neuron migration	1.0949936513071634e-9	2.415008497957949e-5	17	137	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0051050	positive regulation of transport	2.386579711632919e-9	5.263601554006403e-5	46	920	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0002052	positive regulation of neuroblast proliferation	2.706161628118764e-9	5.968439470815934e-5	8	21	357
Orphanet:181384	Rare hypothalamic or pituitary disease	GO:0008217	regulation of blood pressure	3.883887322864155e-9	8.565913490576893e-5	18	168	357
Orphanet:275742	Genetic infertility	GO:0046660	female sex differentiation	1.0080825063596421e-13	2.2233259677761907e-9	20	127	358
Orphanet:275742	Genetic infertility	GO:0032838	cell projection cytoplasm	7.105427357601002e-15	1.567102003718901e-10	26	110	358
Orphanet:275742	Genetic infertility	GO:0007167	enzyme linked receptor protein signaling pathway	4.2897130292374186e-11	9.460962085983127e-7	50	935	358
Orphanet:275742	Genetic infertility	GO:1901698	response to nitrogen compound	1.396254223351434e-10	3.079438689601588e-6	47	870	358
Orphanet:275742	Genetic infertility	GO:0032870	cellular response to hormone stimulus	4.758587968112238e-10	1.049506576367154e-5	34	519	358
Orphanet:275742	Genetic infertility	GO:0022612	gland morphogenesis	1.0721082910336577e-9	2.364534835874732e-5	16	119	358
Orphanet:275742	Genetic infertility	GO:0043066	negative regulation of apoptotic process	2.8061094559106436e-9	6.188874405010925e-5	42	795	358
Orphanet:275742	Genetic infertility	GO:0048545	response to steroid hormone	2.81472412044792e-9	6.207874047647888e-5	30	446	358
Orphanet:275742	Genetic infertility	GO:0007292	female gamete generation	3.336811826848418e-9	7.359338484114186e-5	15	111	358
Orphanet:275742	Genetic infertility	GO:0035148	tube formation	4.478848070199604e-9	9.878099418825226e-5	16	131	358
MESH:D009421	Nervous System Malformations	GO:0007417	central nervous system development	1.2969625373671079e-12	2.8604508761631564e-8	71	889	358
MESH:D009421	Nervous System Malformations	GO:0060562	epithelial tube morphogenesis	9.530154443382344e-13	2.101875562487976e-8	31	301	358
MESH:D009421	Nervous System Malformations	GO:0048666	neuron development	5.111466805374221e-13	1.1273340039252844e-8	62	926	358
MESH:D009421	Nervous System Malformations	GO:0014020	primary neural tube formation	6.59472476627343e-14	1.454466547201605e-9	18	86	358
MESH:D009421	Nervous System Malformations	GO:0001654	eye development	5.095923683029469e-13	1.1239059682921493e-8	30	327	358
MESH:D009421	Nervous System Malformations	GO:0048839	inner ear development	7.902567489281864e-13	1.742911259761115e-8	22	170	358
MESH:D009421	Nervous System Malformations	GO:0042063	gliogenesis	8.245626403891038e-13	1.8185729033781683e-8	27	228	358
MESH:D009421	Nervous System Malformations	GO:0010001	glial cell differentiation	2.3528956560880943e-12	5.189311369502292e-8	22	176	358
MESH:D009421	Nervous System Malformations	GO:0061564	axon development	1.042765873648932e-11	2.2998201343327196e-7	34	440	358
MESH:D009421	Nervous System Malformations	GO:0045664	regulation of neuron differentiation	1.0592415833343694e-11	2.3361573120439516e-7	40	548	358
MESH:D009421	Nervous System Malformations	GO:0021782	glial cell development	1.3169354495801144e-11	2.9045011340489424e-7	15	76	358
MESH:D009421	Nervous System Malformations	GO:0048589	developmental growth	1.3338330440149093e-11	2.9417687785748825e-7	39	558	358
MESH:D009421	Nervous System Malformations	GO:0032990	cell part morphogenesis	1.9358625813481467e-11	4.2695449231633376e-7	47	787	358
MESH:D009421	Nervous System Malformations	GO:0048858	cell projection morphogenesis	3.816680305135378e-11	8.417688412976077e-7	45	767	358
MESH:D009421	Nervous System Malformations	GO:0000904	cell morphogenesis involved in differentiation	5.709244188523144e-11	1.2591738057787794e-6	43	720	358
MESH:D009421	Nervous System Malformations	GO:0007409	axonogenesis	6.83889611607924e-11	1.5083185384012765e-6	31	406	358
MESH:D009421	Nervous System Malformations	GO:0001568	blood vessel development	1.0191669730374997e-10	2.2477727590342056e-6	37	569	358
MESH:D009421	Nervous System Malformations	GO:0007018	microtubule-based movement	1.5184731250172945e-10	3.348992477225643e-6	22	213	358
MESH:D009421	Nervous System Malformations	GO:0090596	sensory organ morphogenesis	2.3940993632010077e-10	5.2801861455398225e-6	23	239	358
MESH:D009421	Nervous System Malformations	GO:0014037	Schwann cell differentiation	3.7061409496885744e-10	8.173893864538151e-6	10	33	358
MESH:D009421	Nervous System Malformations	GO:0030424	axon	4.889972871069403e-10	1.078483516714357e-5	30	414	358
MESH:D009421	Nervous System Malformations	GO:0021871	forebrain regionalization	4.93928342670813e-10	1.089358959760478e-5	9	25	358
MESH:D009421	Nervous System Malformations	GO:0044463	cell projection part	5.449509732358138e-10	1.2018893714715873e-5	48	939	358
MESH:D009421	Nervous System Malformations	GO:0014044	Schwann cell development	7.427060078057934e-10	1.6380381002156774e-5	9	26	358
MESH:D009421	Nervous System Malformations	GO:0008017	microtubule binding	1.3041614455033823e-9	2.8763280680577097e-5	20	196	358
MESH:D009421	Nervous System Malformations	GO:0009799	specification of symmetry	1.5576332446087804e-9	3.435360120984665e-5	16	122	358
MESH:D009421	Nervous System Malformations	GO:0060840	artery development	1.6527128554599813e-9	3.6450582027169887e-5	13	75	358
MESH:D009421	Nervous System Malformations	GO:0001655	urogenital system development	1.9933031891739006e-9	4.396230183723038e-5	25	313	358
MESH:D009421	Nervous System Malformations	GO:0070848	response to growth factor	3.796318148729938e-9	8.372779677023878e-5	36	621	358
MESH:D014565	Urogenital Neoplasms	GO:0006979	response to oxidative stress	6.228351168147128e-14	1.3736628501348491e-9	33	386	360
MESH:D014565	Urogenital Neoplasms	GO:0001763	morphogenesis of a branching structure	2.4616975125013596e-12	5.4292738638217486e-8	23	193	360
MESH:D014565	Urogenital Neoplasms	GO:1902806	regulation of cell cycle G1/S phase transition	3.097966327914037e-12	6.832564736214408e-8	20	141	360
MESH:D014565	Urogenital Neoplasms	GO:0051241	negative regulation of multicellular organismal process	3.4519054281645367e-12	7.613177421816886e-8	53	966	360
MESH:D014565	Urogenital Neoplasms	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	5.250688772662215e-12	1.1580394088106516e-7	16	84	360
MESH:D014565	Urogenital Neoplasms	GO:0023014	signal transduction by protein phosphorylation	7.337797036655047e-12	1.6183511364342706e-7	50	879	360
MESH:D014565	Urogenital Neoplasms	GO:0000165	MAPK cascade	8.814726726313893e-12	1.944087979488529e-7	50	843	360
MESH:D014565	Urogenital Neoplasms	GO:0043408	regulation of MAPK cascade	1.0039413744777903e-11	2.2141927014107665e-7	45	651	360
MESH:D014565	Urogenital Neoplasms	GO:0030855	epithelial cell differentiation	1.1027290192089367e-11	2.43206885186531e-7	40	568	360
MESH:D014565	Urogenital Neoplasms	GO:0030334	regulation of cell migration	1.2373546631749832e-11	2.7289857096324255e-7	43	660	360
MESH:D014565	Urogenital Neoplasms	GO:0001944	vasculature development	1.3523626662959032e-11	2.9826358605156145e-7	40	588	360
MESH:D014565	Urogenital Neoplasms	GO:0001568	blood vessel development	1.5287215937576093e-11	3.3715954750324073e-7	39	569	360
MESH:D014565	Urogenital Neoplasms	GO:0045859	regulation of protein kinase activity	1.6062817742579227e-11	3.5426544531258486e-7	45	709	360
MESH:D014565	Urogenital Neoplasms	GO:0045862	positive regulation of proteolysis	1.6072032593683616e-11	3.5446867885369215e-7	30	357	360
MESH:D014565	Urogenital Neoplasms	GO:0030097	hemopoiesis	2.0812129797320722e-11	4.590115226799085e-7	44	695	360
MESH:D014565	Urogenital Neoplasms	GO:0000904	cell morphogenesis involved in differentiation	2.1492252422206093e-11	4.740116271717554e-7	45	720	360
MESH:D014565	Urogenital Neoplasms	GO:0002009	morphogenesis of an epithelium	2.6598057090154725e-11	5.866201491233625e-7	36	506	360
MESH:D014565	Urogenital Neoplasms	GO:0001775	cell activation	2.6741053815726445e-11	5.897739419058468e-7	48	854	360
MESH:D014565	Urogenital Neoplasms	GO:0051053	negative regulation of DNA metabolic process	2.6759594540237686e-11	5.901828575849422e-7	17	108	360
MESH:D014565	Urogenital Neoplasms	GO:0034097	response to cytokine	3.1833979896589426e-11	7.020984266192798e-7	46	784	360
MESH:D014565	Urogenital Neoplasms	GO:0010948	negative regulation of cell cycle process	3.1856850490896704e-11	7.026028375767268e-7	23	215	360
MESH:D014565	Urogenital Neoplasms	GO:0070848	response to growth factor	3.558198180542149e-11	7.84760608718571e-7	40	621	360
MESH:D014565	Urogenital Neoplasms	GO:0061138	morphogenesis of a branching epithelium	3.918843027861385e-11	8.643008297948285e-7	21	179	360
MESH:D014565	Urogenital Neoplasms	GO:0034599	cellular response to oxidative stress	4.622147109500929e-11	1.01941454500043e-6	23	219	360
MESH:D014565	Urogenital Neoplasms	GO:0010212	response to ionizing radiation	4.916456131098812e-11	1.084324399713843e-6	19	145	360
MESH:D014565	Urogenital Neoplasms	GO:0001892	embryonic placenta development	5.2720605658862496e-11	1.1627529578062124e-6	15	83	360
MESH:D014565	Urogenital Neoplasms	GO:0072593	reactive oxygen species metabolic process	6.702760568799704e-11	1.4782938434487747e-6	23	223	360
MESH:D014565	Urogenital Neoplasms	GO:2001233	regulation of apoptotic signaling pathway	8.633049830564232e-11	1.9040191401309414e-6	29	359	360
MESH:D014565	Urogenital Neoplasms	GO:0006606	protein import into nucleus	8.758960223786971e-11	1.9317886773562165e-6	25	268	360
MESH:D014565	Urogenital Neoplasms	GO:0000723	telomere maintenance	9.362322028749759e-11	2.0648601234407593e-6	18	133	360
MESH:D014565	Urogenital Neoplasms	GO:0042063	gliogenesis	1.0415535101060414e-10	2.2971462665388742e-6	23	228	360
MESH:D014565	Urogenital Neoplasms	GO:0046649	lymphocyte activation	1.067133048593405e-10	2.3535619386727546e-6	38	594	360
MESH:D014565	Urogenital Neoplasms	GO:0022603	regulation of anatomical structure morphogenesis	1.1059064775054139e-10	2.4390767361381904e-6	51	986	360
MESH:D014565	Urogenital Neoplasms	GO:0006974	cellular response to DNA damage stimulus	1.152815620741876e-10	2.5425348515462076e-6	44	767	360
MESH:D014565	Urogenital Neoplasms	GO:0009612	response to mechanical stimulus	1.2842316099437312e-10	2.832372815730899e-6	22	210	360
MESH:D014565	Urogenital Neoplasms	GO:0043410	positive regulation of MAPK cascade	1.2920675640515356e-10	2.8496550125156617e-6	33	464	360
MESH:D014565	Urogenital Neoplasms	GO:0032496	response to lipopolysaccharide	1.37621469775695e-10	3.0352415159029533e-6	27	319	360
MESH:D014565	Urogenital Neoplasms	GO:0048667	cell morphogenesis involved in neuron differentiation	1.6527390567233624e-10	3.645115989603376e-6	34	495	360
MESH:D014565	Urogenital Neoplasms	GO:1901653	cellular response to peptide	1.9303236786782918e-10	4.2573288733249726e-6	26	301	360
MESH:D014565	Urogenital Neoplasms	GO:0060562	epithelial tube morphogenesis	1.9303236786782918e-10	4.2573288733249726e-6	26	301	360
MESH:D014565	Urogenital Neoplasms	GO:0009611	response to wounding	2.0246049281524847e-10	4.465266169040305e-6	47	875	360
MESH:D014565	Urogenital Neoplasms	GO:0030522	intracellular receptor signaling pathway	2.3522350733884423e-10	5.1878544543582095e-6	25	281	360
MESH:D014565	Urogenital Neoplasms	GO:0003002	regionalization	2.3697210860262885e-10	5.226419855230979e-6	27	327	360
MESH:D014565	Urogenital Neoplasms	GO:0009952	anterior/posterior pattern specification	2.9620905728222624e-10	6.5328907583595e-6	21	199	360
MESH:D014565	Urogenital Neoplasms	GO:0042692	muscle cell differentiation	3.806912562964726e-10	8.396145657618703e-6	27	334	360
MESH:D014565	Urogenital Neoplasms	GO:0048812	neuron projection morphogenesis	3.8665504131785156e-10	8.527676936265216e-6	35	539	360
MESH:D014565	Urogenital Neoplasms	GO:0080135	regulation of cellular response to stress	3.998817943440258e-10	8.81939297425749e-6	40	681	360
MESH:D014565	Urogenital Neoplasms	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	4.078335447132986e-10	8.9947688286518e-6	28	359	360
MESH:D014565	Urogenital Neoplasms	GO:0048863	stem cell differentiation	4.0986936067355373e-10	9.039668749655227e-6	24	266	360
MESH:D014565	Urogenital Neoplasms	GO:0051054	positive regulation of DNA metabolic process	4.237936668261e-10	9.346769321849635e-6	20	183	360
MESH:D014565	Urogenital Neoplasms	GO:0007517	muscle organ development	5.663207680584037e-10	1.2490204539528094e-5	27	340	360
MESH:D014565	Urogenital Neoplasms	GO:0051302	regulation of cell division	5.692665228096416e-10	1.2555173160566646e-5	25	293	360
MESH:D014565	Urogenital Neoplasms	GO:0071897	DNA biosynthetic process	5.875664399468405e-10	1.2958777833027568e-5	19	167	360
MESH:D014565	Urogenital Neoplasms	GO:2001252	positive regulation of chromosome organization	6.272844466082006e-10	1.3834758469943864e-5	18	149	360
MESH:D014565	Urogenital Neoplasms	GO:0060065	uterus development	6.537275165641176e-10	1.4417960377821615e-5	8	18	360
MESH:D014565	Urogenital Neoplasms	GO:0042326	negative regulation of phosphorylation	7.84661557950983e-10	1.730571066060893e-5	30	420	360
MESH:D014565	Urogenital Neoplasms	GO:0044419	interspecies interaction between organisms	9.150384894240915e-10	2.0181173884248338e-5	42	761	360
MESH:D014565	Urogenital Neoplasms	GO:0044403	symbiosis, encompassing mutualism through parasitism	9.150384894240915e-10	2.0181173884248338e-5	42	761	360
MESH:D014565	Urogenital Neoplasms	GO:0031647	regulation of protein stability	1.1374260422414295e-9	2.5085931361634728e-5	21	214	360
MESH:D014565	Urogenital Neoplasms	GO:2000027	regulation of organ morphogenesis	1.2054742759559645e-9	2.6586735156208796e-5	22	236	360
MESH:D014565	Urogenital Neoplasms	GO:0048864	stem cell development	1.3077988691989617e-9	2.88435040601831e-5	19	175	360
MESH:D014565	Urogenital Neoplasms	GO:0044764	multi-organism cellular process	1.315855424621759e-9	2.9021191390032897e-5	41	740	360
MESH:D014565	Urogenital Neoplasms	GO:0018108	peptidyl-tyrosine phosphorylation	1.3779731800056538e-9	3.0391198485024695e-5	27	354	360
MESH:D014565	Urogenital Neoplasms	GO:0001085	RNA polymerase II transcription factor binding	1.4268195513977844e-9	3.1468505206078135e-5	15	104	360
MESH:D014565	Urogenital Neoplasms	GO:0010001	glial cell differentiation	1.440645047701139e-9	3.177342652704862e-5	19	176	360
MESH:D014565	Urogenital Neoplasms	GO:0072089	stem cell proliferation	1.5606668180012662e-9	3.4420506671017925e-5	17	139	360
MESH:D014565	Urogenital Neoplasms	GO:0071375	cellular response to peptide hormone stimulus	1.6493293397701336e-9	3.63759585886303e-5	24	285	360
MESH:D014565	Urogenital Neoplasms	GO:0007507	heart development	1.6743686437337146e-9	3.6928200437547076e-5	32	487	360
MESH:D014565	Urogenital Neoplasms	GO:0031400	negative regulation of protein modification process	1.714155373200299e-9	3.7805696755932594e-5	37	628	360
MESH:D014565	Urogenital Neoplasms	GO:0030335	positive regulation of cell migration	2.2073111116682753e-9	4.868224656784381e-5	28	387	360
MESH:D014565	Urogenital Neoplasms	GO:0045664	regulation of neuron differentiation	2.211294480858328e-9	4.877009977533042e-5	34	548	360
MESH:D014565	Urogenital Neoplasms	GO:1901654	response to ketone	2.313357172489816e-9	5.1021092439262894e-5	19	181	360
MESH:D014565	Urogenital Neoplasms	GO:0016032	viral process	2.483982908252358e-9	5.4784243041505754e-5	40	726	360
MESH:D014565	Urogenital Neoplasms	GO:0051129	negative regulation of cellular component organization	2.494262685281967e-9	5.5010963523893786e-5	35	579	360
MESH:D014565	Urogenital Neoplasms	GO:0030879	mammary gland development	3.4453515596055695e-9	7.598722864710084e-5	16	128	360
MESH:D014565	Urogenital Neoplasms	GO:0048754	branching morphogenesis of an epithelial tube	3.7224778814959336e-9	8.209924967639282e-5	17	147	360
MESH:D014565	Urogenital Neoplasms	GO:2000377	regulation of reactive oxygen species metabolic process	3.7224778814959336e-9	8.209924967639282e-5	17	147	360
MESH:D014565	Urogenital Neoplasms	GO:0071345	cellular response to cytokine stimulus	3.86099929805539e-9	8.515433951861162e-5	38	677	360
MESH:D014565	Urogenital Neoplasms	GO:0035270	endocrine system development	3.864938147302155e-9	8.524121083874903e-5	16	129	360
MESH:D014565	Urogenital Neoplasms	GO:0071260	cellular response to mechanical stimulus	4.034170664191095e-9	8.897363399873459e-5	13	80	360
MESH:D014565	Urogenital Neoplasms	GO:0051249	regulation of lymphocyte activation	4.0342243989854865e-9	8.89748191196249e-5	27	372	360
MESH:D014565	Urogenital Neoplasms	GO:0032204	regulation of telomere maintenance	4.249040452819486e-9	9.371258718693376e-5	12	66	360
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0010817	regulation of hormone levels	2.1888302281780625e-10	4.827465068246717e-6	33	473	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0001764	neuron migration	1.2971635987568675e-9	2.8608943170582712e-5	17	137	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0045859	regulation of protein kinase activity	1.3699822387636118e-9	3.021495827593146e-5	40	709	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:1901701	cellular response to oxygen-containing compound	2.02179728514551e-9	4.4590739123884227e-5	45	873	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0002052	positive regulation of neuroblast proliferation	2.953600031219139e-9	6.514164868853811e-5	8	21	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0001816	cytokine production	3.3723938086538396e-9	7.437814544986043e-5	36	613	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0051050	positive regulation of transport	3.418378580199999e-9	7.539233958631097e-5	46	920	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0002521	leukocyte differentiation	3.79637232761354e-9	8.372899168551662e-5	30	448	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:0048609	multicellular organismal reproductive process	4.010217158345597e-9	8.844533942731214e-5	41	767	361
Orphanet:183628	Rare genetic hypothalamic or pituitary disease	GO:1901652	response to peptide	4.113114404624696e-9	9.071473819399767e-5	29	423	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0032846	positive regulation of homeostatic process	7.582823258189819e-13	1.6723916695937646e-8	24	192	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0050931	pigment cell differentiation	1.34781075189494e-13	2.9725966133042903e-9	17	35	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0070227	lymphocyte apoptotic process	2.887690087050032e-13	6.368800486988846e-9	16	65	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0009790	embryo development	5.972999872483342e-13	1.3173451218762011e-8	58	932	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:1900180	regulation of protein localization to nucleus	1.0732525979051388e-12	2.3670586046797837e-8	25	213	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0002761	regulation of myeloid leukocyte differentiation	1.6002754676947006e-12	3.529407544000662e-8	18	106	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0006275	regulation of DNA replication	2.382316566240661e-12	5.2541991868437776e-8	21	157	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:1903649	regulation of cytoplasmic transport	9.515943588667142e-12	2.098741358480538e-7	34	437	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0051347	positive regulation of transferase activity	1.0676237671702893e-11	2.354644218494073e-7	42	613	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0048608	reproductive structure development	1.0943357331427706e-11	2.4135574594463804e-7	33	418	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0042306	regulation of protein import into nucleus	2.6546764786417043e-11	5.854888973644279e-7	21	175	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0007162	negative regulation of cell adhesion	4.414901777494151e-11	9.73706587026335e-7	23	218	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0045860	positive regulation of protein kinase activity	6.346723147032662e-11	1.3997697900780537e-6	33	450	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0030316	osteoclast differentiation	7.795031287116672e-11	1.719194150373582e-6	15	85	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0001701	in utero embryonic development	8.83567663478857e-11	1.948708481802619e-6	27	312	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0044728	DNA methylation or demethylation	1.0471379319199059e-10	2.3094627088493525e-6	14	73	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0048871	multicellular organismal homeostasis	1.6820767001490822e-10	3.7098201621788007e-6	27	321	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0043405	regulation of MAP kinase activity	1.9916523985585854e-10	4.39258936502096e-6	25	278	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0045121	membrane raft	2.6948943077087506e-10	5.9435893956516495e-6	25	282	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0042060	wound healing	3.2429869900596486e-10	7.152407806576555e-6	35	534	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0050817	coagulation	3.5876168702486666e-10	7.912489007333434e-6	28	356	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0032845	negative regulation of homeostatic process	3.6418124071957436e-10	8.032017264070213e-6	19	162	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0051348	negative regulation of transferase activity	3.8229197585337715e-10	8.431449527446233e-6	28	357	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0000228	nuclear chromosome	6.207613312270155e-10	1.3690891160211827e-5	34	520	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	6.837526100866853e-10	1.5080163815461844e-5	11	45	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0035004	phosphatidylinositol 3-kinase activity	7.476690377927753e-10	1.648984062851966e-5	13	70	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	8.718054056444657e-10	1.9227668221488692e-5	14	85	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0014065	phosphatidylinositol 3-kinase signaling	1.1287742962551306e-9	2.4895117103906905e-5	18	154	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0044087	regulation of cellular component biogenesis	1.1741675409737695e-9	2.5896265116176487e-5	41	735	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0007596	blood coagulation	1.2936323123824423e-9	2.8531060649594764e-5	27	352	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0060322	head development	1.316261544204167e-9	2.9030148357422902e-5	40	708	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0044454	nuclear chromosome part	1.7037821153920163e-9	3.757691455497092e-5	32	486	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0048568	embryonic organ development	1.8096664167188692e-9	3.991219282073466e-5	29	408	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0090132	epithelium migration	2.148311084582133e-9	4.738100097045894e-5	21	221	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0007423	sensory organ development	2.5353449339959866e-9	5.5917032519281484e-5	32	494	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0007219	Notch signaling pathway	2.5747148857391267e-9	5.678533680497644e-5	18	162	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0002712	regulation of B cell mediated immunity	3.263342707171546e-9	7.197302340666845e-5	10	40	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0033673	negative regulation of kinase activity	3.737027354233646e-9	8.242013829762307e-5	22	250	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0060326	cell chemotaxis	3.770442402739604e-9	8.315710719242198e-5	21	228	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0050680	negative regulation of epithelial cell proliferation	4.239458339938551e-9	9.350125368734474e-5	15	112	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0010564	regulation of cell cycle process	4.295007904886461e-9	9.47263993422709e-5	34	561	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0008156	negative regulation of DNA replication	4.471158887575655e-9	9.861140926548106e-5	11	53	361
Orphanet:79374	Pigmentation anomaly of the skin	GO:0051092	positive regulation of NF-kappaB transcription factor activity	4.505648298902543e-9	9.937207323229558e-5	16	130	361
MESH:D002277	Carcinoma	GO:0042327	positive regulation of phosphorylation	2.51909604287448e-12	5.555866322559666e-8	58	910	372
MESH:D002277	Carcinoma	GO:0050673	epithelial cell proliferation	1.4572787421229805e-12	3.2140282657522334e-8	40	335	372
MESH:D002277	Carcinoma	GO:0010212	response to ionizing radiation	9.903189379656396e-13	2.1841484176832182e-8	23	145	372
MESH:D002277	Carcinoma	GO:0030879	mammary gland development	6.159517340620368e-13	1.3584815494738223e-8	21	128	372
MESH:D002277	Carcinoma	GO:0051241	negative regulation of multicellular organismal process	2.2426505097428162e-13	4.946165699237781e-9	58	966	372
MESH:D002277	Carcinoma	GO:0033273	response to vitamin	2.220446049250313e-15	4.8971937616215655e-11	20	104	372
MESH:D002277	Carcinoma	GO:0030522	intracellular receptor signaling pathway	2.3636648194269583e-13	5.2130627592461565e-9	31	281	372
MESH:D002277	Carcinoma	GO:0071383	cellular response to steroid hormone stimulus	3.3373304120232206e-13	7.360482223717213e-9	22	162	372
MESH:D002277	Carcinoma	GO:0001701	in utero embryonic development	7.602807272633072e-13	1.676799143979224e-8	31	312	372
MESH:D002277	Carcinoma	GO:0023014	signal transduction by protein phosphorylation	1.1154410728408948e-12	2.4601052861505934e-8	52	879	372
MESH:D002277	Carcinoma	GO:0072001	renal system development	1.5906165273804618e-12	3.5081047511376084e-8	29	276	372
MESH:D002277	Carcinoma	GO:0009636	response to toxic substance	1.7460477508279837e-12	3.850908314451118e-8	28	249	372
MESH:D002277	Carcinoma	GO:0045926	negative regulation of growth	2.0289325775024736e-12	4.4748107996817055e-8	26	230	372
MESH:D002277	Carcinoma	GO:0001558	regulation of cell growth	2.263300658000844e-12	4.991709601220862e-8	33	379	372
MESH:D002277	Carcinoma	GO:0044389	ubiquitin-like protein ligase binding	2.534750187521695e-12	5.590391538579098e-8	28	261	372
MESH:D002277	Carcinoma	GO:0031625	ubiquitin protein ligase binding	2.7798874313589295e-12	6.131041729862119e-8	28	257	372
MESH:D002277	Carcinoma	GO:0030856	regulation of epithelial cell differentiation	3.2527314175467836e-12	7.173899141399431e-8	19	122	372
MESH:D002277	Carcinoma	GO:0006259	DNA metabolic process	3.2933655802480644e-12	7.263517787237106e-8	56	937	372
MESH:D002277	Carcinoma	GO:0003002	regionalization	3.315903107647955e-12	7.313224303917565e-8	30	327	372
MESH:D002277	Carcinoma	GO:0097306	cellular response to alcohol	4.229727679216921e-12	9.32866439651292e-8	19	123	372
MESH:D002277	Carcinoma	GO:0010942	positive regulation of cell death	9.68003455170674e-12	2.1349316203789215e-7	49	596	372
MESH:D002277	Carcinoma	GO:0001568	blood vessel development	1.0418998996897244e-11	2.2979102287656872e-7	41	569	372
MESH:D002277	Carcinoma	GO:0048589	developmental growth	1.047528730424574e-11	2.3103246149513978e-7	44	558	372
MESH:D002277	Carcinoma	GO:0005912	adherens junction	1.065936228172859e-11	2.3509223512352406e-7	37	465	372
MESH:D002277	Carcinoma	GO:0043549	regulation of kinase activity	1.2115419778524483e-11	2.672055832153575e-7	54	761	372
MESH:D002277	Carcinoma	GO:0007507	heart development	1.2230105816968262e-11	2.69734983793235e-7	38	487	372
MESH:D002277	Carcinoma	GO:0031099	regeneration	1.323186005208754e-11	2.918286734487907e-7	22	182	372
MESH:D002277	Carcinoma	GO:0048598	embryonic morphogenesis	1.4432122164009797e-11	3.183004543272361e-7	40	560	372
MESH:D002277	Carcinoma	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.62195812336563e-11	3.577228641082897e-7	48	732	372
MESH:D002277	Carcinoma	GO:0048534	hematopoietic or lymphoid organ development	1.6290524484929847e-11	3.592875175151278e-7	48	739	372
MESH:D002277	Carcinoma	GO:0055123	digestive system development	1.8786083799682274e-11	4.1432707820199255e-7	20	150	372
MESH:D002277	Carcinoma	GO:2001236	regulation of extrinsic apoptotic signaling pathway	2.1476931344466266e-11	4.736737208022035e-7	20	151	372
MESH:D002277	Carcinoma	GO:0071363	cellular response to growth factor stimulus	2.5921154112040767e-11	5.716910539410591e-7	40	594	372
MESH:D002277	Carcinoma	GO:0051052	regulation of DNA metabolic process	3.3780200858757325e-11	7.450223299398928e-7	29	335	372
MESH:D002277	Carcinoma	GO:0048565	digestive tract development	3.582634189314149e-11	7.901499704532355e-7	19	138	372
MESH:D002277	Carcinoma	GO:0097193	intrinsic apoptotic signaling pathway	4.3402392790881095e-11	9.572397730028825e-7	26	272	372
MESH:D002277	Carcinoma	GO:0001503	ossification	5.156275406648092e-11	1.1372165409362367e-6	30	363	372
MESH:D002277	Carcinoma	GO:0008544	epidermis development	5.198319552590647e-11	1.1464893773238671e-6	27	296	372
MESH:D002277	Carcinoma	GO:0016331	morphogenesis of embryonic epithelium	5.259404023405523e-11	1.159961557362088e-6	19	141	372
MESH:D002277	Carcinoma	GO:0002684	positive regulation of immune system process	5.312672524127038e-11	1.1717099251962182e-6	49	872	372
MESH:D002277	Carcinoma	GO:0046822	regulation of nucleocytoplasmic transport	6.09734485124136e-11	1.3447694069412819e-6	23	215	372
MESH:D002277	Carcinoma	GO:0010948	negative regulation of cell cycle process	6.09734485124136e-11	1.3447694069412819e-6	23	215	372
MESH:D002277	Carcinoma	GO:0001525	angiogenesis	6.45545839006445e-11	1.4237513479287145e-6	32	413	372
MESH:D002277	Carcinoma	GO:0003007	heart morphogenesis	6.633971150193929e-11	1.463122337175271e-6	23	216	372
MESH:D002277	Carcinoma	GO:0043086	negative regulation of catalytic activity	9.009260004688713e-11	1.9869922940340956e-6	47	822	372
MESH:D002277	Carcinoma	GO:0033157	regulation of intracellular protein transport	1.1280054668105777e-10	2.487816057050729e-6	30	375	372
MESH:D002277	Carcinoma	GO:0030308	negative regulation of cell growth	1.2904721735651492e-10	2.8461363787979366e-6	20	166	372
MESH:D002277	Carcinoma	GO:0048471	perinuclear region of cytoplasm	1.4621415189708387e-10	3.2247531200901847e-6	40	636	372
MESH:D002277	Carcinoma	GO:0045137	development of primary sexual characteristics	1.530914284231244e-10	3.3764314538720086e-6	23	225	372
MESH:D002277	Carcinoma	GO:1990267	response to transition metal nanoparticle	1.5747070314375833e-10	3.47301635783559e-6	19	150	372
MESH:D002277	Carcinoma	GO:0010769	regulation of cell morphogenesis involved in differentiation	1.622849632454404e-10	3.579194864378188e-6	28	334	372
MESH:D002277	Carcinoma	GO:0071384	cellular response to corticosteroid stimulus	1.7535151108916125e-10	3.867377577071451e-6	13	61	372
MESH:D002277	Carcinoma	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	1.7535151108916125e-10	3.867377577071451e-6	13	61	372
MESH:D002277	Carcinoma	GO:0051347	positive regulation of transferase activity	1.7928936113520422e-10	3.954226859836929e-6	39	613	372
MESH:D002277	Carcinoma	GO:0060537	muscle tissue development	1.869596699677345e-10	4.123395521138384e-6	28	336	372
MESH:D002277	Carcinoma	GO:0003690	double-stranded DNA binding	2.0051160731782147e-10	4.4222834993945526e-6	44	756	372
MESH:D002277	Carcinoma	GO:0009612	response to mechanical stimulus	2.40294784070727e-10	5.299701462679884e-6	22	210	372
MESH:D002277	Carcinoma	GO:0005925	focal adhesion	2.5874979936446607e-10	5.706726824983299e-6	30	388	372
MESH:D002277	Carcinoma	GO:0032496	response to lipopolysaccharide	2.8577951116659506e-10	6.302867118779254e-6	27	319	372
MESH:D002277	Carcinoma	GO:1900180	regulation of protein localization to nucleus	3.153577399217511e-10	6.95521495397422e-6	22	213	372
MESH:D002277	Carcinoma	GO:0030518	intracellular steroid hormone receptor signaling pathway	3.720536101425864e-10	8.205642371694744e-6	17	123	372
MESH:D002277	Carcinoma	GO:0014706	striated muscle tissue development	3.7643321793012774e-10	8.302234621448967e-6	27	323	372
MESH:D002277	Carcinoma	GO:0010720	positive regulation of cell development	3.7701874955331505e-10	8.315148521398363e-6	33	469	372
MESH:D002277	Carcinoma	GO:0048878	chemical homeostasis	4.054337976455713e-10	8.941842407073075e-6	51	988	372
MESH:D002277	Carcinoma	GO:1903533	regulation of protein targeting	4.5506776125137094e-10	1.0036519474398986e-5	26	303	372
MESH:D002277	Carcinoma	GO:0019199	transmembrane receptor protein kinase activity	4.690262622730756e-10	1.0344374214432683e-5	14	79	372
MESH:D002277	Carcinoma	GO:0001837	epithelial to mesenchymal transition	4.951385967899569e-10	1.0920281752202499e-5	16	109	372
MESH:D002277	Carcinoma	GO:0045860	positive regulation of protein kinase activity	5.377872591694199e-10	1.1860898000981557e-5	32	450	372
MESH:D002277	Carcinoma	GO:0009952	anterior/posterior pattern specification	5.391751489725038e-10	1.1891507910588572e-5	21	199	372
MESH:D002277	Carcinoma	GO:0048511	rhythmic process	5.647090572935554e-10	1.2454658258609363e-5	27	329	372
MESH:D002277	Carcinoma	GO:0008406	gonad development	5.868945329723374e-10	1.2943958924704901e-5	22	220	372
MESH:D002277	Carcinoma	GO:0009611	response to wounding	6.061693369474597e-10	1.3369064726376223e-5	47	875	372
MESH:D002277	Carcinoma	GO:0071214	cellular response to abiotic stimulus	6.291932530544386e-10	1.3876857196115644e-5	25	285	372
MESH:D002277	Carcinoma	GO:0009894	regulation of catabolic process	6.416066566927725e-10	1.4150634813359098e-5	42	727	372
MESH:D002277	Carcinoma	GO:0007050	cell cycle arrest	6.507594463300848e-10	1.435249958881002e-5	23	242	372
MESH:D002277	Carcinoma	GO:0043200	response to amino acid	7.48857420518334e-10	1.6516050409531857e-5	16	112	372
MESH:D002277	Carcinoma	GO:0050680	negative regulation of epithelial cell proliferation	7.48857420518334e-10	1.6516050409531857e-5	16	112	372
MESH:D002277	Carcinoma	GO:0001501	skeletal system development	7.551622660528778e-10	1.665510377779622e-5	33	482	372
MESH:D002277	Carcinoma	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	8.211986646244895e-10	1.8111536548293117e-5	15	97	372
MESH:D002277	Carcinoma	GO:0046649	lymphocyte activation	9.316948323956353e-10	2.0548529528485737e-5	37	594	372
MESH:D002277	Carcinoma	GO:0072006	nephron development	1.0120485560705106e-9	2.232073090413511e-5	17	131	372
MESH:D002277	Carcinoma	GO:0031329	regulation of cellular catabolic process	1.027180784873849e-9	2.265447221039274e-5	38	624	372
MESH:D002277	Carcinoma	GO:0071385	cellular response to glucocorticoid stimulus	1.0351970392008525e-9	2.28312706995748e-5	12	57	372
MESH:D002277	Carcinoma	GO:0001667	ameboidal-type cell migration	1.0534684236063185e-9	2.3234246082637355e-5	26	315	372
MESH:D002277	Carcinoma	GO:0001838	embryonic epithelial tube formation	1.1162465396452603e-9	2.4618817431876217e-5	16	115	372
MESH:D002277	Carcinoma	GO:1901988	negative regulation of cell cycle phase transition	1.1819702994131376e-9	2.606835495355675e-5	18	150	372
MESH:D002277	Carcinoma	GO:0019748	secondary metabolic process	1.2822310990756591e-9	2.8279606890113662e-5	12	58	372
MESH:D002277	Carcinoma	GO:0051146	striated muscle cell differentiation	1.365296209421274e-9	3.0111607898786197e-5	22	230	372
MESH:D002277	Carcinoma	GO:0030857	negative regulation of epithelial cell differentiation	1.4004910564580086e-9	3.088783025018138e-5	10	36	372
MESH:D002277	Carcinoma	GO:0044212	transcription regulatory region DNA binding	1.439294128324775e-9	3.1743632000202915e-5	44	807	372
MESH:D002277	Carcinoma	GO:0021700	developmental maturation	1.481647249335083e-9	3.2677730084085255e-5	22	231	372
MESH:D002277	Carcinoma	GO:0030850	prostate gland development	1.5531272934410367e-9	3.4254222456842065e-5	11	47	372
MESH:D002277	Carcinoma	GO:0046824	positive regulation of nucleocytoplasmic transport	1.6428998161899244e-9	3.623415544606878e-5	16	118	372
MESH:D002277	Carcinoma	GO:0072073	kidney epithelium development	2.0428765346025557e-9	4.5055641970659366e-5	17	137	372
MESH:D002277	Carcinoma	GO:0042306	regulation of protein import into nucleus	2.2498642948676206e-9	4.962075702330537e-5	19	175	372
MESH:D002277	Carcinoma	GO:0010950	positive regulation of endopeptidase activity	2.2883261951989198e-9	5.0469034235112176e-5	17	138	372
MESH:D002277	Carcinoma	GO:0030234	enzyme regulator activity	2.36860575597575e-9	5.223959994804517e-5	48	944	372
MESH:D002277	Carcinoma	GO:0030521	androgen receptor signaling pathway	2.3737942722590333e-9	5.235403267467298e-5	12	61	372
MESH:D002277	Carcinoma	GO:0000302	response to reactive oxygen species	2.42256292803944e-9	5.342962537790985e-5	21	216	372
MESH:D002277	Carcinoma	GO:1901991	negative regulation of mitotic cell cycle phase transition	2.560118117500565e-9	5.646340508147496e-5	17	139	372
MESH:D002277	Carcinoma	GO:0032446	protein modification by small protein conjugation	2.6592958946025647e-9	5.8650770955459564e-5	46	885	372
MESH:D002277	Carcinoma	GO:0071345	cellular response to cytokine stimulus	2.9195101891588138e-9	6.438979722189764e-5	39	677	372
MESH:D002277	Carcinoma	GO:0009266	response to temperature stimulus	3.1095849228890415e-9	6.858189547431781e-5	21	219	372
MESH:D002277	Carcinoma	GO:0045787	positive regulation of cell cycle	3.1317238802230918e-9	6.907017017832029e-5	25	308	372
MESH:D002277	Carcinoma	GO:0072080	nephron tubule development	3.2431182184211593e-9	7.152697230727867e-5	14	91	372
MESH:D002277	Carcinoma	GO:0050681	androgen receptor binding	3.321492414443128e-9	7.325551520054319e-5	10	39	372
MESH:D002277	Carcinoma	GO:0051348	negative regulation of transferase activity	3.3702821644610026e-9	7.433157313718741e-5	27	357	372
MESH:D002277	Carcinoma	GO:0031400	negative regulation of protein modification process	4.187959978807498e-9	9.236545733259938e-5	37	628	372
MESH:D002277	Carcinoma	GO:0061180	mammary gland epithelium development	4.240857220949579e-9	9.353210600804296e-5	12	64	372
MESH:D002277	Carcinoma	GO:0045682	regulation of epidermis development	4.240857220949579e-9	9.353210600804296e-5	12	64	372
MESH:D002277	Carcinoma	GO:0072593	reactive oxygen species metabolic process	4.308051804180479e-9	9.501408254120047e-5	21	223	372
MESH:D002277	Carcinoma	GO:0007093	mitotic cell cycle checkpoint	4.4249429675957686e-9	9.759211715032468e-5	17	144	372
DOID:3393	coronary artery disease	GO:0048878	chemical homeostasis	1.1462386595439966e-11	2.5280293636242845e-7	67	988	372
DOID:3393	coronary artery disease	GO:0042327	positive regulation of phosphorylation	2.5222046673434306e-12	5.562722393825936e-8	70	910	372
DOID:3393	coronary artery disease	GO:1901654	response to ketone	1.2501111257279263e-12	2.7571200877929414e-8	26	181	372
DOID:3393	coronary artery disease	GO:0071219	cellular response to molecule of bacterial origin	1.1299849944634843e-12	2.4921819052892147e-8	29	158	372
DOID:3393	coronary artery disease	GO:0002685	regulation of leukocyte migration	1.0307310560619953e-12	2.2732773441447307e-8	25	149	372
DOID:3393	coronary artery disease	GO:1903036	positive regulation of response to wounding	9.949818746690653e-13	2.1944325245826235e-8	25	162	372
DOID:3393	coronary artery disease	GO:0032355	response to estradiol	9.903189379656396e-13	2.1841484176832182e-8	23	145	372
DOID:3393	coronary artery disease	GO:0035150	regulation of tube size	9.35918009759007e-13	2.06416717052349e-8	29	140	372
DOID:3393	coronary artery disease	GO:0031960	response to corticosteroid	9.123812816369536e-13	2.0122569166503013e-8	28	179	372
DOID:3393	coronary artery disease	GO:0033002	muscle cell proliferation	8.915090887740007e-13	1.9662232952910585e-8	22	151	372
DOID:3393	coronary artery disease	GO:0048520	positive regulation of behavior	8.72413252750448e-13	1.924107428941113e-8	22	145	372
DOID:3393	coronary artery disease	GO:0023014	signal transduction by protein phosphorylation	7.061018436615996e-13	1.5573076161956578e-8	65	879	372
DOID:3393	coronary artery disease	GO:0008217	regulation of blood pressure	5.193623309196482e-13	1.1454536208432842e-8	24	168	372
DOID:3393	coronary artery disease	GO:0070555	response to interleukin-1	3.5993430458347575e-13	7.938351087588558e-9	20	119	372
DOID:3393	coronary artery disease	GO:0050921	positive regulation of chemotaxis	3.5993430458347575e-13	7.938351087588558e-9	20	119	372
DOID:3393	coronary artery disease	GO:0007584	response to nutrient	3.1596947280831955e-13	6.968706722787488e-9	30	197	372
DOID:3393	coronary artery disease	GO:0051241	negative regulation of multicellular organismal process	2.6623148130511254e-13	5.871735320184257e-9	68	966	372
DOID:3393	coronary artery disease	GO:0002687	positive regulation of leukocyte migration	2.347011474057581e-13	5.176333806033995e-9	22	109	372
DOID:3393	coronary artery disease	GO:1903522	regulation of blood circulation	2.3425705819590803e-13	5.166539418510752e-9	35	297	372
DOID:3393	coronary artery disease	GO:1903524	positive regulation of blood circulation	1.949551631241775e-13	4.2997361227037345e-9	19	89	372
DOID:3393	coronary artery disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	7.549516567451064e-14	1.6650458789513323e-9	19	83	372
DOID:3393	coronary artery disease	GO:0048659	smooth muscle cell proliferation	2.220446049250313e-15	4.8971937616215655e-11	20	104	372
DOID:3393	coronary artery disease	GO:0072562	blood microparticle	1.8884893648873913e-13	4.1650632942591415e-9	20	114	372
DOID:3393	coronary artery disease	GO:0043434	response to peptide hormone	4.384270724244743e-13	9.669509082321781e-9	38	389	372
DOID:3393	coronary artery disease	GO:0009266	response to temperature stimulus	4.4919623576333834e-13	9.907022979760427e-9	32	219	372
DOID:3393	coronary artery disease	GO:0019932	second-messenger-mediated signaling	4.5430326167661406e-13	1.0019658436277723e-8	28	219	372
DOID:3393	coronary artery disease	GO:0001819	positive regulation of cytokine production	6.755707104844078e-13	1.4899712019733613e-8	38	381	372
DOID:3393	coronary artery disease	GO:0051924	regulation of calcium ion transport	8.473222123939195e-13	1.8687691394347894e-8	27	207	372
DOID:3393	coronary artery disease	GO:0045765	regulation of angiogenesis	9.380274335057948e-13	2.0688195045970303e-8	27	208	372
DOID:3393	coronary artery disease	GO:0051050	positive regulation of transport	9.491296637520463e-13	2.0933054734051382e-8	61	920	372
DOID:3393	coronary artery disease	GO:0009612	response to mechanical stimulus	1.0368372826974337e-12	2.28674462698919e-8	27	210	372
DOID:3393	coronary artery disease	GO:0006006	glucose metabolic process	1.305178187749334e-12	2.8785704930811562e-8	24	199	372
DOID:3393	coronary artery disease	GO:0003012	muscle system process	1.3610224058879794e-12	3.0017349161859386e-8	34	393	372
DOID:3393	coronary artery disease	GO:0070372	regulation of ERK1 and ERK2 cascade	1.4189760477734126e-12	3.1295516733642614e-8	27	233	372
DOID:3393	coronary artery disease	GO:0043542	endothelial cell migration	1.5203394099216894e-12	3.353108568582286e-8	21	151	372
DOID:3393	coronary artery disease	GO:0034612	response to tumor necrosis factor	1.5233370120881773e-12	3.359719780160475e-8	31	265	372
DOID:3393	coronary artery disease	GO:0031349	positive regulation of defense response	1.5401013797600172e-12	3.396693593060718e-8	37	398	372
DOID:3393	coronary artery disease	GO:0050727	regulation of inflammatory response	1.5911716388927744e-12	3.509329049578014e-8	29	289	372
DOID:3393	coronary artery disease	GO:0009636	response to toxic substance	1.6103784972187896e-12	3.5516897756160404e-8	32	249	372
DOID:3393	coronary artery disease	GO:0001101	response to acid chemical	1.6326939800137552e-12	3.600906572920337e-8	34	315	372
DOID:3393	coronary artery disease	GO:0090257	regulation of muscle system process	1.6817658377021871e-12	3.709134555052174e-8	25	213	372
DOID:3393	coronary artery disease	GO:0007596	blood coagulation	1.7067458557562531e-12	3.764227984870416e-8	32	352	372
DOID:3393	coronary artery disease	GO:0007167	enzyme linked receptor protein signaling pathway	1.7507106875314093e-12	3.861192421350523e-8	58	935	372
DOID:3393	coronary artery disease	GO:0009409	response to cold	1.9193535649719706e-12	4.233134287545681e-8	13	44	372
DOID:3393	coronary artery disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.2497559371004172e-12	4.96183671927497e-8	22	168	372
DOID:3393	coronary artery disease	GO:0050708	regulation of protein secretion	2.418065747633591e-12	5.333044006405885e-8	33	380	372
DOID:3393	coronary artery disease	GO:0071356	cellular response to tumor necrosis factor	2.6476598691260733e-12	5.839413841357555e-8	27	243	372
DOID:3393	coronary artery disease	GO:0007204	positive regulation of cytosolic calcium ion concentration	2.8457236567192012e-12	6.276243524894198e-8	26	234	372
DOID:3393	coronary artery disease	GO:0044706	multi-multicellular organism process	3.2632785362807226e-12	7.197160811767134e-8	26	237	372
DOID:3393	coronary artery disease	GO:0019752	carboxylic acid metabolic process	4.034994560697669e-12	8.899180503618709e-8	55	967	372
DOID:3393	coronary artery disease	GO:0050673	epithelial cell proliferation	5.332845276484477e-12	1.1761590257286514e-7	30	335	372
DOID:3393	coronary artery disease	GO:0061041	regulation of wound healing	5.463074437273008e-12	1.204881067140562e-7	19	125	372
DOID:3393	coronary artery disease	GO:0043500	muscle adaptation	8.210210289405495e-12	1.810761879328382e-7	16	84	372
DOID:3393	coronary artery disease	GO:0019216	regulation of lipid metabolic process	8.28326296442583e-12	1.826873646804117e-7	27	272	372
DOID:3393	coronary artery disease	GO:0031663	lipopolysaccharide-mediated signaling pathway	8.707479182135103e-12	1.920434533619897e-7	13	49	372
DOID:3393	coronary artery disease	GO:0071363	cellular response to growth factor stimulus	8.874678769643651e-12	1.9573104026449073e-7	43	594	372
DOID:3393	coronary artery disease	GO:0048661	positive regulation of smooth muscle cell proliferation	9.229506048313851e-12	2.03556755895562e-7	14	60	372
DOID:3393	coronary artery disease	GO:0019221	cytokine-mediated signaling pathway	9.273359857786545e-12	2.0452395166348225e-7	44	534	372
DOID:3393	coronary artery disease	GO:0006897	endocytosis	9.3102192622041e-12	2.0533688582791143e-7	45	593	372
DOID:3393	coronary artery disease	GO:0032870	cellular response to hormone stimulus	9.929945754549863e-12	2.1900495361659722e-7	39	519	372
DOID:3393	coronary artery disease	GO:0071417	cellular response to organonitrogen compound	1.0131229188914403e-11	2.2344425976150717e-7	37	462	372
DOID:3393	coronary artery disease	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1.026967400008516e-11	2.2649766007187822e-7	45	647	372
DOID:3393	coronary artery disease	GO:0009150	purine ribonucleotide metabolic process	1.0604295219707183e-11	2.3387773107064191e-7	38	501	372
DOID:3393	coronary artery disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	1.1061485061247822e-11	2.439610530258207e-7	12	40	372
DOID:3393	coronary artery disease	GO:0051047	positive regulation of secretion	1.1229683849478533e-11	2.4767067730024905e-7	31	363	372
DOID:3393	coronary artery disease	GO:0050776	regulation of immune response	1.2755241307615961e-11	2.8131684703947e-7	51	816	372
DOID:3393	coronary artery disease	GO:0043549	regulation of kinase activity	1.358180234944939e-11	2.995466508171063e-7	48	761	372
DOID:3393	coronary artery disease	GO:0051093	negative regulation of developmental process	1.4648393609206778e-11	3.230703210510555e-7	51	788	372
DOID:3393	coronary artery disease	GO:0030155	regulation of cell adhesion	1.48109302600119e-11	3.2665506688456247e-7	42	621	372
DOID:3393	coronary artery disease	GO:0080135	regulation of cellular response to stress	1.5023871036135006e-11	3.3135147570195755e-7	49	681	372
DOID:3393	coronary artery disease	GO:0045859	regulation of protein kinase activity	1.5157985977509725e-11	3.34309380733977e-7	46	709	372
DOID:3393	coronary artery disease	GO:0061061	muscle structure development	1.6354473331148256e-11	3.606979093184748e-7	39	551	372
DOID:3393	coronary artery disease	GO:0016337	single organismal cell-cell adhesion	1.762168189145541e-11	3.8864619411604906e-7	47	697	372
DOID:3393	coronary artery disease	GO:0009986	cell surface	1.7864709711545856e-11	3.9400617268814386e-7	46	715	372
DOID:3393	coronary artery disease	GO:0005125	cytokine activity	1.9748980228939672e-11	4.3556375894926447e-7	24	222	372
DOID:3393	coronary artery disease	GO:0098552	side of membrane	3.127365033606111e-11	6.897403581618278e-7	32	402	372
DOID:3393	coronary artery disease	GO:1903532	positive regulation of secretion by cell	3.3780200858757325e-11	7.450223299398928e-7	29	335	372
DOID:3393	coronary artery disease	GO:0071496	cellular response to external stimulus	3.7605585312405765e-11	8.293911840651091e-7	26	270	372
DOID:3393	coronary artery disease	GO:0002690	positive regulation of leukocyte chemotaxis	4.7810422287852816e-11	1.0544588635585939e-6	15	80	372
DOID:3393	coronary artery disease	GO:0050865	regulation of cell activation	5.5902060758228345e-11	1.2329199500227261e-6	34	458	372
DOID:3393	coronary artery disease	GO:0009408	response to heat	5.79947201373443e-11	1.2790735526291286e-6	20	159	372
DOID:3393	coronary artery disease	GO:0007159	leukocyte cell-cell adhesion	6.472367086729491e-11	1.4274805609781893e-6	34	461	372
DOID:3393	coronary artery disease	GO:0002443	leukocyte mediated immunity	7.607825480704378e-11	1.6779059097693505e-6	26	279	372
DOID:3393	coronary artery disease	GO:0044419	interspecies interaction between organisms	7.93770604801125e-11	1.7506610688888813e-6	45	761	372
DOID:3393	coronary artery disease	GO:0044403	symbiosis, encompassing mutualism through parasitism	7.93770604801125e-11	1.7506610688888813e-6	45	761	372
DOID:3393	coronary artery disease	GO:0050663	cytokine secretion	8.220957248283867e-11	1.8131321211090068e-6	20	162	372
DOID:3393	coronary artery disease	GO:0010594	regulation of endothelial cell migration	8.236766824154529e-11	1.8166189230672813e-6	17	112	372
DOID:3393	coronary artery disease	GO:0045121	membrane raft	9.553291491215532e-11	2.1069784383875856e-6	26	282	372
DOID:3393	coronary artery disease	GO:0034109	homotypic cell-cell adhesion	1.0055600796476938e-10	2.2177627556629886e-6	35	495	372
DOID:3393	coronary artery disease	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	1.0459977328736159e-10	2.3069479998527598e-6	14	71	372
DOID:3393	coronary artery disease	GO:0006090	pyruvate metabolic process	1.1248979525646519e-10	2.4809624343813397e-6	16	99	372
DOID:3393	coronary artery disease	GO:0002026	regulation of the force of heart contraction	1.2499867807491682e-10	2.7568458449422906e-6	10	29	372
DOID:3393	coronary artery disease	GO:0045860	positive regulation of protein kinase activity	1.3278234067826133e-10	2.9285145236590537e-6	33	450	372
DOID:3393	coronary artery disease	GO:0070661	leukocyte proliferation	1.4738943399095206e-10	3.2506739666704476e-6	25	266	372
DOID:3393	coronary artery disease	GO:0050714	positive regulation of protein secretion	1.5037682210561343e-10	3.316560811539304e-6	22	205	372
DOID:3393	coronary artery disease	GO:1990267	response to transition metal nanoparticle	1.5747070314375833e-10	3.47301635783559e-6	19	150	372
DOID:3393	coronary artery disease	GO:0043209	myelin sheath	1.6106993516729062e-10	3.5523974201145947e-6	20	168	372
DOID:3393	coronary artery disease	GO:0030097	hemopoiesis	1.752139544564102e-10	3.864343765536127e-6	42	695	372
DOID:3393	coronary artery disease	GO:0002703	regulation of leukocyte mediated immunity	1.771000013306434e-10	3.90594052934734e-6	19	151	372
DOID:3393	coronary artery disease	GO:0071456	cellular response to hypoxia	1.8141299573670722e-10	4.001063620973078e-6	18	134	372
DOID:3393	coronary artery disease	GO:0045087	innate immune response	1.8591583827998193e-10	4.100373813265001e-6	45	783	372
DOID:3393	coronary artery disease	GO:0046683	response to organophosphorus	2.3277491045803345e-10	5.133850650151928e-6	18	136	372
DOID:3393	coronary artery disease	GO:0014065	phosphatidylinositol 3-kinase signaling	2.503002249909514e-10	5.520371462175433e-6	19	154	372
DOID:3393	coronary artery disease	GO:0051402	neuron apoptotic process	2.6366231420382746e-10	5.815072339765415e-6	22	211	372
DOID:3393	coronary artery disease	GO:0009896	positive regulation of catabolic process	2.744021676548414e-10	6.051939807627527e-6	30	389	372
DOID:3393	coronary artery disease	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	2.972043722238027e-10	6.554842429395968e-6	18	138	372
DOID:3393	coronary artery disease	GO:0006801	superoxide metabolic process	3.3037939051183685e-10	7.286517457738562e-6	12	52	372
DOID:3393	coronary artery disease	GO:0048771	tissue remodeling	3.3499947260651197e-10	7.3884133683366215e-6	18	139	372
DOID:3393	coronary artery disease	GO:0001664	G-protein coupled receptor binding	3.3579239389069926e-10	7.405901247259372e-6	24	255	372
DOID:3393	coronary artery disease	GO:0050678	regulation of epithelial cell proliferation	3.458883179874306e-10	7.6285668532127815e-6	25	277	372
DOID:3393	coronary artery disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3.6987268803301276e-10	8.157542134568097e-6	21	195	372
DOID:3393	coronary artery disease	GO:0071347	cellular response to interleukin-1	3.804098147597301e-10	8.389938464525848e-6	15	92	372
DOID:3393	coronary artery disease	GO:0006953	acute-phase response	4.1939862693851637e-10	9.249836717128979e-6	12	53	372
DOID:3393	coronary artery disease	GO:0045834	positive regulation of lipid metabolic process	4.233593475788666e-10	9.337190410851903e-6	17	124	372
DOID:3393	coronary artery disease	GO:0034599	cellular response to oxidative stress	5.37403455069807e-10	1.1852433201564594e-5	22	219	372
DOID:3393	coronary artery disease	GO:0071383	cellular response to steroid hormone stimulus	6.029546861796575e-10	1.3298165603692347e-5	19	162	372
DOID:3393	coronary artery disease	GO:0031099	regeneration	6.817769682143648e-10	1.5036591033967817e-5	20	182	372
DOID:3393	coronary artery disease	GO:0070542	response to fatty acid	7.849801919590504e-10	1.7312738133656858e-5	14	82	372
DOID:3393	coronary artery disease	GO:0019722	calcium-mediated signaling	7.933274037696947e-10	1.7496835890140616e-5	17	129	372
DOID:3393	coronary artery disease	GO:0050729	positive regulation of inflammatory response	9.783303056565273e-10	2.157707489125471e-5	16	114	372
DOID:3393	coronary artery disease	GO:0006091	generation of precursor metabolites and energy	1.033374275039023e-9	2.279106963598565e-5	28	362	372
DOID:3393	coronary artery disease	GO:0042312	regulation of vasodilation	1.211089672992216e-9	2.6710582737843325e-5	11	46	372
DOID:3393	coronary artery disease	GO:0050778	positive regulation of immune response	1.4001632075988368e-9	3.0880599543592346e-5	37	603	372
DOID:3393	coronary artery disease	GO:0051345	positive regulation of hydrolase activity	1.509989022707714e-9	3.330280789581863e-5	47	900	372
DOID:3393	coronary artery disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.6108016032134742e-9	3.5526229358873174e-5	50	996	372
DOID:3393	coronary artery disease	GO:0006898	receptor-mediated endocytosis	1.6755442588944902e-9	3.695412862991798e-5	23	254	372
DOID:3393	coronary artery disease	GO:0009897	external side of plasma membrane	1.72608849435818e-9	3.806888174306966e-5	21	212	372
DOID:3393	coronary artery disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.72608849435818e-9	3.806888174306966e-5	21	212	372
DOID:3393	coronary artery disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1.7431617260754706e-9	3.8445431868594504e-5	22	233	372
DOID:3393	coronary artery disease	GO:0040007	growth	1.7961797604826302e-9	3.961474461744441e-5	48	936	372
DOID:3393	coronary artery disease	GO:0051098	regulation of binding	2.066650184318064e-9	4.55799698151349e-5	24	279	372
DOID:3393	coronary artery disease	GO:0046031	ADP metabolic process	2.2103447960830636e-9	4.874915447761197e-5	13	74	372
DOID:3393	coronary artery disease	GO:0033273	response to vitamin	2.2312911518440615e-9	4.9211126353920776e-5	15	104	372
DOID:3393	coronary artery disease	GO:0044724	single-organism carbohydrate catabolic process	2.2883261951989198e-9	5.0469034235112176e-5	17	138	372
DOID:3393	coronary artery disease	GO:1902532	negative regulation of intracellular signal transduction	2.3749447963794523e-9	5.237940748414882e-5	30	426	372
DOID:3393	coronary artery disease	GO:0022407	regulation of cell-cell adhesion	2.4137950527247654e-9	5.32362498878447e-5	28	376	372
DOID:3393	coronary artery disease	GO:0032868	response to insulin	2.5961183203193627e-9	5.7257389554643545e-5	22	238	372
DOID:3393	coronary artery disease	GO:0097306	cellular response to alcohol	3.0507414372493713e-9	6.728410239853488e-5	16	123	372
DOID:3393	coronary artery disease	GO:0071900	regulation of protein serine/threonine kinase activity	3.1157505464562973e-9	6.871787830209364e-5	30	431	372
DOID:3393	coronary artery disease	GO:0033574	response to testosterone	3.321492414443128e-9	7.325551520054319e-5	10	39	372
DOID:3393	coronary artery disease	GO:0010876	lipid localization	3.412089832899312e-9	7.525364126459433e-5	26	333	372
DOID:3393	coronary artery disease	GO:0031331	positive regulation of cellular catabolic process	3.412089832899312e-9	7.525364126459433e-5	26	333	372
DOID:3393	coronary artery disease	GO:0042542	response to hydrogen peroxide	3.4398597303919587e-9	7.586610635379465e-5	16	124	372
DOID:3393	coronary artery disease	GO:0043502	regulation of muscle adaptation	3.508049184475226e-9	7.737002476360111e-5	12	63	372
DOID:3393	coronary artery disease	GO:0050707	regulation of cytokine secretion	3.565492234791634e-9	7.863693123832949e-5	17	142	372
DOID:3393	coronary artery disease	GO:0070663	regulation of leukocyte proliferation	3.592398600815727e-9	7.923035114099086e-5	20	200	372
DOID:3393	coronary artery disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3.7351030046650635e-9	8.237769676788798e-5	18	161	372
DOID:3393	coronary artery disease	GO:0045596	negative regulation of cell differentiation	3.74461439633933e-9	8.258747051126392e-5	36	597	372
DOID:3393	coronary artery disease	GO:0060537	muscle tissue development	4.11753020568284e-9	9.081212868633504e-5	26	336	372
DOID:3393	coronary artery disease	GO:0030168	platelet activation	4.1269326844783905e-9	9.10195003561709e-5	18	162	372
DOID:3393	coronary artery disease	GO:0046889	positive regulation of lipid biosynthetic process	4.240857220949579e-9	9.353210600804296e-5	12	64	372
DOID:3393	coronary artery disease	GO:1903649	regulation of cytoplasmic transport	4.2922739806883214e-9	9.466610264408093e-5	30	437	372
DOID:3393	coronary artery disease	GO:0001935	endothelial cell proliferation	4.338869485920327e-9	9.569376651197281e-5	15	109	372
DOID:204	enthesopathy	GO:1901701	cellular response to oxygen-containing compound	1.1521894549559875e-12	2.5411538429054303e-8	58	873	374
DOID:204	enthesopathy	GO:0023014	signal transduction by protein phosphorylation	1.0231815394945443e-12	2.2566268853552174e-8	54	879	374
DOID:204	enthesopathy	GO:0014070	response to organic cyclic compound	1.0176304243714185e-12	2.2443839009511635e-8	54	873	374
DOID:204	enthesopathy	GO:0033002	muscle cell proliferation	9.92761428619815e-13	2.189535330821002e-8	22	151	374
DOID:204	enthesopathy	GO:0002684	positive regulation of immune system process	9.279244039817058e-13	2.0465372729816522e-8	70	872	374
DOID:204	enthesopathy	GO:0071216	cellular response to biotic stimulus	7.73159314348959e-13	1.705202867796629e-8	24	175	374
DOID:204	enthesopathy	GO:0042098	T cell proliferation	3.390621117205228e-13	7.47801487399613e-9	23	167	374
DOID:204	enthesopathy	GO:0048659	smooth muscle cell proliferation	4.551914400963142e-15	1.0039247211324209e-10	20	104	374
DOID:204	enthesopathy	GO:0032101	regulation of response to external stimulus	9.408029910673577e-13	2.0749409967990573e-8	59	920	374
DOID:204	enthesopathy	GO:2001233	regulation of apoptotic signaling pathway	1.7068568780587157e-12	3.7644728445584974e-8	33	359	374
DOID:204	enthesopathy	GO:1901698	response to nitrogen compound	2.2218893391823258e-12	4.9003769375666195e-8	57	870	374
DOID:204	enthesopathy	GO:0043069	negative regulation of programmed cell death	9.650835686159098e-12	2.128491810582389e-7	58	806	374
DOID:204	enthesopathy	GO:1902532	negative regulation of intracellular signal transduction	1.1242562436564185e-11	2.479547145384231e-7	34	426	374
DOID:204	enthesopathy	GO:2001234	negative regulation of apoptotic signaling pathway	1.3353096406376608e-11	2.945025412426361e-7	23	199	374
DOID:204	enthesopathy	GO:0010035	response to inorganic substance	1.6227019727921288e-11	3.57886920099304e-7	37	502	374
DOID:204	enthesopathy	GO:0032940	secretion by cell	1.9767520953450912e-11	4.3597267462835987e-7	53	956	374
DOID:204	enthesopathy	GO:0032870	cellular response to hormone stimulus	3.232125678209741e-11	7.128453183291583e-7	37	519	374
DOID:204	enthesopathy	GO:0002253	activation of immune response	4.287614707720877e-11	9.456334237878394e-7	35	475	374
DOID:204	enthesopathy	GO:0045597	positive regulation of cell differentiation	7.979938931867991e-11	1.7599755314234855e-6	47	815	374
DOID:204	enthesopathy	GO:0045859	regulation of protein kinase activity	1.1236778174605888e-10	2.4782714264093286e-6	43	709	374
DOID:204	enthesopathy	GO:0001568	blood vessel development	3.353627375801693e-10	7.3964251773306344e-6	37	569	374
DOID:204	enthesopathy	GO:0070848	response to growth factor	1.0432460451070824e-9	2.3008791524836703e-5	38	621	374
DOID:204	enthesopathy	GO:0001933	negative regulation of protein phosphorylation	1.0767711167147809e-9	2.3748186979144492e-5	29	385	374
DOID:204	enthesopathy	GO:0001101	response to acid chemical	1.1805053601321447e-9	2.603604571771445e-5	26	315	374
DOID:204	enthesopathy	GO:0048661	positive regulation of smooth muscle cell proliferation	2.0622799024039296e-9	4.5483583247518666e-5	12	60	374
DOID:204	enthesopathy	GO:0000302	response to reactive oxygen species	2.665277332170035e-9	5.8782691561010125e-5	21	216	374
DOID:204	enthesopathy	GO:0043627	response to estrogen	2.897468043272511e-9	6.390365769437523e-5	21	217	374
DOID:204	enthesopathy	GO:0042060	wound healing	3.048185148735172e-9	6.722772345535422e-5	34	534	374
DOID:204	enthesopathy	GO:0097285	cell-type specific apoptotic process	3.169247198009373e-9	6.989774695209672e-5	30	429	374
DOID:204	enthesopathy	GO:0032655	regulation of interleukin-12 production	3.3388858344807204e-9	7.363912707947229e-5	11	50	374
DOID:204	enthesopathy	GO:0031960	response to corticosteroid	3.5937109954531365e-9	7.925929600471893e-5	19	179	374
DOID:204	enthesopathy	GO:0006897	endocytosis	3.618752519862767e-9	7.981158682557332e-5	36	593	374
DOID:204	enthesopathy	GO:0042493	response to drug	3.9303127419287875e-9	8.668304752323941e-5	30	433	374
DOID:204	enthesopathy	GO:0022603	regulation of anatomical structure morphogenesis	4.000137887594235e-9	8.822304111089085e-5	49	986	374
DOID:204	enthesopathy	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	4.26489610294567e-9	9.406228355046675e-5	27	359	374
DOID:204	enthesopathy	GO:1903036	positive regulation of response to wounding	4.488488469789331e-9	9.89936132012037e-5	18	162	374
DOID:204	enthesopathy	GO:0019900	kinase binding	4.509964734999983e-9	9.946727223042462e-5	36	598	374
DOID:0050700	cardiomyopathy	GO:0042327	positive regulation of phosphorylation	3.0691005292737827e-12	6.768901217313328e-8	58	910	377
DOID:0050700	cardiomyopathy	GO:1901701	cellular response to oxygen-containing compound	2.645661467681748e-12	5.835006366972095e-8	55	873	377
DOID:0050700	cardiomyopathy	GO:1901654	response to ketone	1.2170264795940966e-12	2.68415190074478e-8	25	181	377
DOID:0050700	cardiomyopathy	GO:2000377	regulation of reactive oxygen species metabolic process	1.1624035067825389e-12	2.5636809342088895e-8	26	147	377
DOID:0050700	cardiomyopathy	GO:0003018	vascular process in circulatory system	1.0671463712697005e-12	2.3535913218353244e-8	26	159	377
DOID:0050700	cardiomyopathy	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.0333955913210957e-12	2.2791539766586766e-8	22	151	377
DOID:0050700	cardiomyopathy	GO:0035150	regulation of tube size	9.15267861500979e-13	2.0186232685404093e-8	25	140	377
DOID:0050700	cardiomyopathy	GO:0050880	regulation of blood vessel size	8.817391261572993e-13	1.9446756427399237e-8	25	139	377
DOID:0050700	cardiomyopathy	GO:0042391	regulation of membrane potential	8.562039965909207e-13	1.8883579144812757e-8	37	340	377
DOID:0050700	cardiomyopathy	GO:0031960	response to corticosteroid	7.704947790898586e-13	1.6993262352826832e-8	24	179	377
DOID:0050700	cardiomyopathy	GO:0032970	regulation of actin filament-based process	5.17808018685173e-13	1.142025585210149e-8	36	326	377
DOID:0050700	cardiomyopathy	GO:0001508	action potential	5.131450819817474e-13	1.1317414783107438e-8	20	119	377
DOID:0050700	cardiomyopathy	GO:0035051	cardiocyte differentiation	4.731770530952417e-13	1.0435919906015556e-8	22	107	377
DOID:0050700	cardiomyopathy	GO:0051384	response to glucocorticoid	2.7067237340361316e-13	5.969679195416688e-9	23	167	377
DOID:0050700	cardiomyopathy	GO:0055007	cardiac muscle cell differentiation	2.2160051571518125e-13	4.887399374098322e-9	22	87	377
DOID:0050700	cardiomyopathy	GO:1903524	positive regulation of blood circulation	1.3389289676979388e-13	2.953007838257804e-9	22	89	377
DOID:0050700	cardiomyopathy	GO:0071260	cellular response to mechanical stimulus	2.9753977059954195e-14	6.562239640572898e-10	19	80	377
DOID:0050700	cardiomyopathy	GO:2000379	positive regulation of reactive oxygen species metabolic process	7.549516567451064e-15	1.6650458789513323e-10	19	83	377
DOID:0050700	cardiomyopathy	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	2.786659791809143e-14	6.145978170835065e-10	10	13	377
DOID:0050700	cardiomyopathy	GO:1903409	reactive oxygen species biosynthetic process	5.140332604014475e-14	1.1337003558153924e-9	18	83	377
DOID:0050700	cardiomyopathy	GO:2000021	regulation of ion homeostasis	7.860379014346108e-14	1.7336065916140342e-9	24	189	377
DOID:0050700	cardiomyopathy	GO:1901698	response to nitrogen compound	2.750022431996513e-13	6.065174473768309e-9	63	870	377
DOID:0050700	cardiomyopathy	GO:0001934	positive regulation of protein phosphorylation	2.8677060726067793e-13	6.324725743134252e-9	56	870	377
DOID:0050700	cardiomyopathy	GO:0045428	regulation of nitric oxide biosynthetic process	1.0024203689340538e-12	2.2108381236840557e-8	14	51	377
DOID:0050700	cardiomyopathy	GO:0006874	cellular calcium ion homeostasis	1.5324408408901036e-12	3.3797982745831234e-8	32	352	377
DOID:0050700	cardiomyopathy	GO:2001234	negative regulation of apoptotic signaling pathway	2.0689006063889792e-12	4.5629602873908937e-8	24	199	377
DOID:0050700	cardiomyopathy	GO:0051241	negative regulation of multicellular organismal process	2.157163336846679e-12	4.757623739415351e-8	55	966	377
DOID:0050700	cardiomyopathy	GO:0051353	positive regulation of oxidoreductase activity	3.137601289893155e-12	6.919979644859353e-8	13	45	377
DOID:0050700	cardiomyopathy	GO:0034599	cellular response to oxidative stress	3.3022473644450656e-12	7.283106562283592e-8	25	219	377
DOID:0050700	cardiomyopathy	GO:1903034	regulation of response to wounding	4.533373676451902e-12	9.998355643414669e-8	34	407	377
DOID:0050700	cardiomyopathy	GO:0048871	multicellular organismal homeostasis	4.760858374197596e-12	1.0500073144292799e-7	30	321	377
DOID:0050700	cardiomyopathy	GO:0042311	vasodilation	4.9751314179502515e-12	1.097265234228928e-7	15	68	377
DOID:0050700	cardiomyopathy	GO:0009991	response to extracellular stimulus	8.735123735448269e-12	1.9265315398531158e-7	43	573	377
DOID:0050700	cardiomyopathy	GO:0007159	leukocyte cell-cell adhesion	9.037548487356162e-12	1.9932313188864015e-7	38	461	377
DOID:0050700	cardiomyopathy	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	9.113931831450373e-12	2.0100776654263797e-7	15	71	377
DOID:0050700	cardiomyopathy	GO:0010942	positive regulation of cell death	9.874878692528455e-12	2.1779044956371507e-7	49	596	377
DOID:0050700	cardiomyopathy	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.0348388812531084e-11	2.2823371526037306e-7	23	195	377
DOID:0050700	cardiomyopathy	GO:0031966	mitochondrial membrane	1.0725864640903637e-11	2.3655894465512972e-7	47	656	377
DOID:0050700	cardiomyopathy	GO:0001819	positive regulation of cytokine production	1.1186163106913227e-11	2.4671082732297123e-7	32	381	377
DOID:0050700	cardiomyopathy	GO:0031667	response to nutrient levels	1.2221779144283573e-11	2.695513390271742e-7	42	546	377
DOID:0050700	cardiomyopathy	GO:0007584	response to nutrient	1.2868706100732652e-11	2.8381931305165864e-7	23	197	377
DOID:0050700	cardiomyopathy	GO:0008284	positive regulation of cell proliferation	1.3058998327153404e-11	2.880162081053683e-7	51	815	377
DOID:0050700	cardiomyopathy	GO:0001944	vasculature development	2.7423840975870917e-11	6.048328127228331e-7	40	588	377
DOID:0050700	cardiomyopathy	GO:0008217	regulation of blood pressure	2.755995431868996e-11	6.078347924987071e-7	21	168	377
DOID:0050700	cardiomyopathy	GO:0019229	regulation of vasoconstriction	3.5537572884436486e-11	7.837811699662467e-7	14	65	377
DOID:0050700	cardiomyopathy	GO:2000147	positive regulation of cell motility	3.567535156179247e-11	7.868198786953329e-7	32	399	377
DOID:0050700	cardiomyopathy	GO:0051924	regulation of calcium ion transport	3.7033598410118884e-11	8.16776012935172e-7	23	207	377
DOID:0050700	cardiomyopathy	GO:0090130	tissue migration	4.0080494478900164e-11	8.839753057321431e-7	24	227	377
DOID:0050700	cardiomyopathy	GO:0002237	response to molecule of bacterial origin	4.0594638761604074e-11	8.953147578871778e-7	29	333	377
DOID:0050700	cardiomyopathy	GO:0032386	regulation of intracellular transport	4.712752410540588e-11	1.0393975441447267e-6	39	575	377
DOID:0050700	cardiomyopathy	GO:0048771	tissue remodeling	5.10445019585859e-11	1.125786490696612e-6	19	139	377
DOID:0050700	cardiomyopathy	GO:0019216	regulation of lipid metabolic process	5.760192323123192e-11	1.27041041686482e-6	26	272	377
DOID:0050700	cardiomyopathy	GO:0042542	response to hydrogen peroxide	6.017963904980661e-11	1.3272619392434848e-6	18	124	377
DOID:0050700	cardiomyopathy	GO:0030335	positive regulation of cell migration	7.369060917028492e-11	1.6252463852506338e-6	31	387	377
DOID:0050700	cardiomyopathy	GO:0043627	response to estrogen	9.517919785650975e-11	2.0991772087253224e-6	23	217	377
DOID:0050700	cardiomyopathy	GO:0003073	regulation of systemic arterial blood pressure	1.0022627172645571e-10	2.2104904229269806e-6	15	83	377
DOID:0050700	cardiomyopathy	GO:0040007	growth	1.0195411181967984e-10	2.248597936183039e-6	51	936	377
DOID:0050700	cardiomyopathy	GO:0010631	epithelial cell migration	1.0482059664695953e-10	2.3118182590486924e-6	23	218	377
DOID:0050700	cardiomyopathy	GO:0051093	negative regulation of developmental process	1.1187328841089084e-10	2.4673653759021974e-6	46	788	377
DOID:0050700	cardiomyopathy	GO:0001568	blood vessel development	1.1858503068395976e-10	2.6153928517347325e-6	38	569	377
DOID:0050700	cardiomyopathy	GO:0098857	membrane microdomain	1.3679379851083695e-10	3.016987226156509e-6	26	283	377
DOID:0050700	cardiomyopathy	GO:0080135	regulation of cellular response to stress	1.439204311282083e-10	3.174165108532634e-6	42	681	377
DOID:0050700	cardiomyopathy	GO:0071453	cellular response to oxygen levels	1.9743173762520883e-10	4.354356973323981e-6	19	150	377
DOID:0050700	cardiomyopathy	GO:0033135	regulation of peptidyl-serine phosphorylation	2.0441959236450202e-10	4.508474109599092e-6	17	117	377
DOID:0050700	cardiomyopathy	GO:0046688	response to copper ion	2.0968160541201541e-10	4.624527807362e-6	10	30	377
DOID:0050700	cardiomyopathy	GO:0071456	cellular response to hypoxia	2.247194652582607e-10	4.95618780627094e-6	18	134	377
DOID:0050700	cardiomyopathy	GO:0016049	cell growth	2.327815717961812e-10	5.133997565964776e-6	34	479	377
DOID:0050700	cardiomyopathy	GO:0045429	positive regulation of nitric oxide biosynthetic process	2.691329381576679e-10	5.935726951067366e-6	11	40	377
DOID:0050700	cardiomyopathy	GO:0009636	response to toxic substance	2.698639089970811e-10	5.951848512930624e-6	24	249	377
DOID:0050700	cardiomyopathy	GO:0048514	blood vessel morphogenesis	3.044984264732875e-10	6.715712795868356e-6	34	484	377
DOID:0050700	cardiomyopathy	GO:0045926	negative regulation of growth	3.0824209851232354e-10	6.798279482689296e-6	23	230	377
DOID:0050700	cardiomyopathy	GO:0032496	response to lipopolysaccharide	3.8389491585633095e-10	8.46680236921138e-6	27	319	377
DOID:0050700	cardiomyopathy	GO:0071407	cellular response to organic cyclic compound	4.487645810513641e-10	9.897502835087835e-6	31	416	377
DOID:0050700	cardiomyopathy	GO:0043279	response to alkaloid	4.680885679064772e-10	1.0323693365177355e-5	18	140	377
DOID:0050700	cardiomyopathy	GO:0015672	monovalent inorganic cation transport	4.819500354358297e-10	1.0629408031537224e-5	37	572	377
DOID:0050700	cardiomyopathy	GO:0044706	multi-multicellular organism process	5.584950280024259e-10	1.2317607842593503e-5	23	237	377
DOID:0050700	cardiomyopathy	GO:0045823	positive regulation of heart contraction	6.121375628609371e-10	1.3500693948897968e-5	10	33	377
DOID:0050700	cardiomyopathy	GO:0032940	secretion by cell	6.480083136750636e-10	1.4291823358103528e-5	50	956	377
DOID:0050700	cardiomyopathy	GO:0045121	membrane raft	6.650321404677584e-10	1.4667283858016411e-5	25	282	377
DOID:0050700	cardiomyopathy	GO:0098798	mitochondrial protein complex	7.467909624025992e-10	1.6470474675789326e-5	18	144	377
DOID:0050700	cardiomyopathy	GO:0032103	positive regulation of response to external stimulus	8.291809461269395e-10	1.828758576682965e-5	25	285	377
DOID:0050700	cardiomyopathy	GO:0031099	regeneration	8.601432899268957e-10	1.8970460259337685e-5	20	182	377
DOID:0050700	cardiomyopathy	GO:0010632	regulation of epithelial cell migration	9.305488601896172e-10	2.052325511148201e-5	19	164	377
DOID:0050700	cardiomyopathy	GO:0016264	gap junction assembly	9.399798717169006e-10	2.0731256070716242e-5	7	12	377
DOID:0050700	cardiomyopathy	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	1.0794860560991992e-9	2.380806496726784e-5	11	45	377
DOID:0050700	cardiomyopathy	GO:0050673	epithelial cell proliferation	1.1269570832084241e-9	2.4855038470161794e-5	27	335	377
DOID:0050700	cardiomyopathy	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.1860803450503e-9	2.6159002010084365e-5	16	114	377
DOID:0050700	cardiomyopathy	GO:0032768	regulation of monooxygenase activity	1.2044323316473537e-9	2.6563755074482387e-5	12	57	377
DOID:0050700	cardiomyopathy	GO:0042312	regulation of vasodilation	1.3933291187484542e-9	3.072987371399716e-5	11	46	377
DOID:0050700	cardiomyopathy	GO:0034284	response to monosaccharide	1.5281289567070644e-9	3.3702884140174305e-5	20	188	377
DOID:0050700	cardiomyopathy	GO:0007565	female pregnancy	1.8413676139417134e-9	4.061136272548449e-5	20	190	377
DOID:0050700	cardiomyopathy	GO:0051235	maintenance of location	1.874777777466363e-9	4.134822388202064e-5	24	274	377
DOID:0050700	cardiomyopathy	GO:0007204	positive regulation of cytosolic calcium ion concentration	2.4185750069349865e-9	5.334167177795113e-5	22	234	377
DOID:0050700	cardiomyopathy	GO:0045471	response to ethanol	2.4979484036791177e-9	5.509225204314294e-5	17	137	377
DOID:0050700	cardiomyopathy	GO:0030258	lipid modification	3.0692949293253946e-9	6.769329966627158e-5	22	237	377
DOID:0050700	cardiomyopathy	GO:0060306	regulation of membrane repolarization	3.5557204958180932e-9	7.842141553526805e-5	9	29	377
DOID:0050700	cardiomyopathy	GO:0071902	positive regulation of protein serine/threonine kinase activity	3.568072948212375e-9	7.869384887282393e-5	24	283	377
DOID:0050700	cardiomyopathy	GO:0051046	regulation of secretion	3.919069069269199e-9	8.643506832273218e-5	39	675	377
DOID:0050700	cardiomyopathy	GO:0045834	positive regulation of lipid metabolic process	4.1613817947094844e-9	9.177927548231768e-5	16	124	377
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0016772	transferase activity, transferring phosphorus-containing groups	3.341105170306946e-12	7.36880745311197e-8	56	973	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0002684	positive regulation of immune system process	2.4844570845061753e-12	5.4794700998783696e-8	71	872	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0036293	response to decreased oxygen levels	2.107425345343472e-12	4.647926599155028e-8	33	302	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0034504	protein localization to nucleus	1.3733458814613186e-12	3.028914341562938e-8	34	344	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051170	nuclear import	4.944933351680447e-13	1.0906050507131226e-8	30	287	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0090398	cellular senescence	1.716404796070492e-13	3.78553077773347e-9	15	52	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0035004	phosphatidylinositol 3-kinase activity	3.993472219576688e-13	8.807602980276386e-9	16	70	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:2000045	regulation of G1/S transition of mitotic cell cycle	1.570854557542134e-12	3.4645197266591765e-8	20	131	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045765	regulation of angiogenesis	1.5841772338376359e-12	3.493902889228906e-8	25	208	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.0514701049023643e-12	4.5245173163621644e-8	24	195	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0032101	regulation of response to external stimulus	2.9446445282133027e-12	6.494413506974439e-8	56	920	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001655	urogenital system development	3.0003777240494856e-12	6.61733307039114e-8	30	313	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001933	negative regulation of protein phosphorylation	3.790412428372747e-12	8.359754610776093e-8	33	385	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0009790	embryo development	4.353295501857701e-12	9.60119322934716e-8	56	932	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048608	reproductive structure development	4.7264414604342164e-12	1.0424166640987664e-7	35	418	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0016570	histone modification	4.7264414604342164e-12	1.0424166640987664e-7	35	418	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048511	rhythmic process	6.4426242118997834e-12	1.4209207699344972e-7	30	329	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:1903308	regulation of chromatin modification	6.6454619584987995e-12	1.4656566349469102e-7	20	139	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0009314	response to radiation	6.746381231437226e-12	1.4879143805934802e-7	36	431	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:1903707	negative regulation of hemopoiesis	6.778910766058743e-12	1.4950887694542558e-7	19	123	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001822	kidney development	7.188583062145426e-12	1.5854419943561737e-7	27	262	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045834	positive regulation of lipid metabolic process	7.765343923438195e-12	1.712646602314294e-7	19	124	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0000976	transcription regulatory region sequence-specific DNA binding	9.145795232257115e-12	2.0171051384743066e-7	46	653	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0071216	cellular response to biotic stimulus	9.54059053981382e-12	2.104177243555938e-7	22	175	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010001	glial cell differentiation	1.0776490810826544e-11	2.3767550483277944e-7	22	176	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:1903035	negative regulation of response to wounding	1.0854983578667543e-11	2.3940666282751266e-7	21	159	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0033674	positive regulation of kinase activity	1.3127610110075238e-11	2.895294409777094e-7	37	480	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001667	ameboidal-type cell migration	1.546840433519492e-11	3.4115565761272393e-7	29	315	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0030168	platelet activation	1.6128987034846887e-11	3.557248090535481e-7	21	162	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0060322	head development	1.751399025806677e-11	3.862710551416626e-7	46	708	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045860	positive regulation of protein kinase activity	1.8878898444540937e-11	4.1637410519435036e-7	35	450	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048568	embryonic organ development	1.9416357410761975e-11	4.2822776269435536e-7	33	408	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010631	epithelial cell migration	2.031375068156649e-11	4.480197712819489e-7	24	218	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0018205	peptidyl-lysine modification	2.2834734103582832e-11	5.036200606545194e-7	32	388	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0090068	positive regulation of cell cycle process	2.4115265340185488e-11	5.318621770777909e-7	25	239	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051223	regulation of protein transport	2.5541457837618964e-11	5.633168526086862e-7	46	730	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0014706	striated muscle tissue development	2.5926372160256506e-11	5.718061379944572e-7	29	323	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	3.3238301000437787e-11	7.330707285646554e-7	29	327	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0070301	cellular response to hydrogen peroxide	3.757494315692611e-11	8.287153713260054e-7	15	77	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045931	positive regulation of mitotic cell cycle	4.068878567409229e-11	8.973911680421054e-7	18	120	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0007420	brain development	4.1709968812142506e-11	9.19913362151803e-7	43	669	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0002819	regulation of adaptive immune response	4.695799304954562e-11	1.0356585367077287e-6	18	121	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0030900	forebrain development	6.114309059057632e-11	1.3485108629751608e-6	30	357	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0071241	cellular response to inorganic substance	6.249400996694021e-11	1.3783053898208664e-6	20	156	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045582	positive regulation of T cell differentiation	6.283340514556812e-11	1.385790750485505e-6	14	67	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0006275	regulation of DNA replication	7.053790884725686e-11	1.55571357962625e-6	20	157	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:1900182	positive regulation of protein localization to nucleus	8.223455250089273e-11	1.8136830554071892e-6	18	125	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0019902	phosphatase binding	8.939826656728656e-11	1.971678769141505e-6	20	159	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.1611633876640326e-10	2.560945851493024e-6	15	83	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0043405	regulation of MAP kinase activity	1.1672685040764463e-10	2.5744106857406024e-6	26	278	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0044454	nuclear chromosome part	1.1704814895097115e-10	2.581496925113669e-6	35	486	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010594	regulation of endothelial cell migration	1.1880907369032911e-10	2.6203341202402086e-6	17	112	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0035270	endocrine system development	1.400347615643227e-10	3.0884666663011373e-6	18	129	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048754	branching morphogenesis of an epithelial tube	1.6592516249858136e-10	3.659479458906212e-6	19	147	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0000989	transcription factor activity, transcription factor binding	1.9682755425520782e-10	4.341031709098608e-6	38	574	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0043535	regulation of blood vessel endothelial cell migration	2.0524715260705761e-10	4.526725950748656e-6	12	49	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0044764	multi-organism cellular process	2.1935875338385813e-10	4.837957305880991e-6	44	740	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0043009	chordate embryonic development	2.442548385772625e-10	5.387040464821524e-6	37	552	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001656	metanephros development	2.7591184892372667e-10	6.085235828012792e-6	15	88	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	2.913866925524644e-10	6.4265335042446026e-6	23	227	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0071222	cellular response to lipopolysaccharide	2.9864655193279077e-10	6.5866497028777005e-6	19	152	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0002695	negative regulation of leukocyte activation	3.024092087855479e-10	6.669635099765259e-6	18	135	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051427	hormone receptor binding	3.0455549193675324e-10	6.716971374665093e-6	20	170	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0046777	protein autophosphorylation	3.4702996032365263e-10	7.653745774938159e-6	23	229	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051146	striated muscle cell differentiation	3.7821357157241664e-10	8.341500321029649e-6	23	230	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0016032	viral process	3.935032300006469e-10	8.678713737664268e-6	43	726	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0046854	phosphatidylinositol phosphorylation	4.5138082160889326e-10	9.95520402058414e-6	15	91	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051046	regulation of secretion	4.873842440744625e-10	1.074925950306227e-5	41	675	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0032102	negative regulation of response to external stimulus	4.881695048197798e-10	1.0766578428800244e-5	25	275	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0042803	protein homodimerization activity	4.888467408648012e-10	1.078151486977319e-5	42	703	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:1903530	regulation of secretion by cell	5.841123140726268e-10	1.2882597086871783e-5	39	624	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0031346	positive regulation of cell projection organization	6.130700391793198e-10	1.3521259714099898e-5	26	300	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	6.751685877048885e-10	1.4890843201831316e-5	37	573	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0007610	behavior	7.695158954490466e-10	1.6971673074128724e-5	42	714	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051099	positive regulation of binding	7.871771012801787e-10	1.736119096873434e-5	17	126	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045121	membrane raft	8.26690160771193e-10	1.823265149580866e-5	25	282	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0060249	anatomical structure homeostasis	8.811574803146982e-10	1.943392822834067e-5	28	351	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0071902	positive regulation of protein serine/threonine kinase activity	8.892826475204174e-10	1.9613128791062806e-5	25	283	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0032403	protein complex binding	8.900210568540956e-10	1.962941440891708e-5	49	924	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051129	negative regulation of cellular component organization	8.971481335606768e-10	1.9786602085680727e-5	37	579	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048666	neuron development	9.552494351083851e-10	2.1068026291315434e-5	49	926	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010212	response to ionizing radiation	9.9069541459329e-10	2.184978736885501e-5	18	145	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0032103	positive regulation of response to external stimulus	1.0305966080537132e-9	2.2729808190624645e-5	25	285	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0042307	positive regulation of protein import into nucleus	1.3211748361996456e-9	2.9138511012383184e-5	15	98	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0000790	nuclear chromatin	1.3769351214776293e-9	3.0368304104189114e-5	25	289	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0031100	organ regeneration	1.488352552314609e-9	3.28256155412987e-5	14	84	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010952	positive regulation of peptidase activity	1.548623229652435e-9	3.415488532998445e-5	18	149	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001649	osteoblast differentiation	1.5684632481693939e-9	3.459245693837598e-5	21	206	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.6728564089518727e-9	3.689484809943355e-5	19	168	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	1.6804189151287119e-9	3.706163917316374e-5	12	58	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0071496	cellular response to external stimulus	1.7217250958267982e-9	3.7972646988460035e-5	24	270	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.7491630366350819e-9	3.857779077298673e-5	14	85	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0051250	negative regulation of lymphocyte activation	1.7936842011678777e-9	3.9559705056757544e-5	16	116	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045740	positive regulation of DNA replication	2.050960401511759e-9	4.523393165534184e-5	14	86	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0019903	protein phosphatase binding	2.316012936987022e-9	5.107966532524877e-5	16	118	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0001889	liver development	2.32885799533733e-9	5.1362963087164815e-5	17	135	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048871	multicellular organismal homeostasis	2.603176785243022e-9	5.741306399853485e-5	26	321	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0010950	positive regulation of endopeptidase activity	3.2782063730252275e-9	7.23008415570714e-5	17	138	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0045598	regulation of fat cell differentiation	3.5355788297053437e-9	7.797719108915135e-5	15	105	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0048708	astrocyte differentiation	3.781993052065502e-9	8.341185676330465e-5	12	62	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0006809	nitric oxide biosynthetic process	3.781993052065502e-9	8.341185676330465e-5	12	62	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0072503	cellular divalent inorganic cation homeostasis	3.864632169836568e-9	8.523446250574551e-5	28	375	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0002761	regulation of myeloid leukocyte differentiation	4.04229882899898e-9	8.915290067357251e-5	15	106	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0006874	cellular calcium ion homeostasis	4.156455735149223e-9	9.16706312387161e-5	27	352	381
Orphanet:68347	Tumor of hematopoietic and lymphoid tissues	GO:0043029	T cell homeostasis	4.176658241483722e-9	9.211619751592348e-5	10	39	381
Orphanet:182222	Rare systemic disease	GO:0034504	protein localization to nucleus	1.4155343563970746e-12	3.121961023033748e-8	37	344	383
Orphanet:182222	Rare systemic disease	GO:1903035	negative regulation of response to wounding	6.443734434924409e-13	1.4211656296225783e-8	24	159	383
Orphanet:182222	Rare systemic disease	GO:0051170	nuclear import	6.297184995673888e-13	1.388844150795876e-8	34	287	383
Orphanet:182222	Rare systemic disease	GO:0050663	cytokine secretion	5.986322548778844e-13	1.320283438133174e-8	24	162	383
Orphanet:182222	Rare systemic disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	5.095923683029469e-13	1.1239059682921493e-8	22	151	383
Orphanet:182222	Rare systemic disease	GO:0042306	regulation of protein import into nucleus	4.760636329592671e-13	1.0499583424916636e-8	25	175	383
Orphanet:182222	Rare systemic disease	GO:0050707	regulation of cytokine secretion	4.4231285301066237e-13	9.755209973150158e-9	22	142	383
Orphanet:182222	Rare systemic disease	GO:0002821	positive regulation of adaptive immune response	3.8347103270552907e-13	8.457453626320444e-9	17	71	383
Orphanet:182222	Rare systemic disease	GO:1904591	positive regulation of protein import	2.4713564528155985e-13	5.450576656684802e-9	21	101	383
Orphanet:182222	Rare systemic disease	GO:0032102	negative regulation of response to external stimulus	1.9984014443252818e-14	4.407474385459409e-10	31	275	383
Orphanet:182222	Rare systemic disease	GO:0032846	positive regulation of homeostatic process	8.004708007547379e-14	1.7654383510645744e-9	25	192	383
Orphanet:182222	Rare systemic disease	GO:0010631	epithelial cell migration	8.459899447643693e-14	1.8658308231778165e-9	27	218	383
Orphanet:182222	Rare systemic disease	GO:0043200	response to amino acid	1.6786572132332367e-13	3.7022784837859035e-9	21	112	383
Orphanet:182222	Rare systemic disease	GO:0048771	tissue remodeling	3.3006930522105904e-13	7.279678526650457e-9	21	139	383
Orphanet:182222	Rare systemic disease	GO:0002718	regulation of cytokine production involved in immune response	3.714806240395774e-13	8.193005163192879e-9	15	56	383
Orphanet:182222	Rare systemic disease	GO:0001503	ossification	1.1853851233922796e-12	2.6143668896416727e-8	33	363	383
Orphanet:182222	Rare systemic disease	GO:0090287	regulation of cellular response to growth factor stimulus	1.3217205108162489e-12	2.915054586605237e-8	27	226	383
Orphanet:182222	Rare systemic disease	GO:0050714	positive regulation of protein secretion	1.4116485758108865e-12	3.11339093395091e-8	25	205	383
Orphanet:182222	Rare systemic disease	GO:0071560	cellular response to transforming growth factor beta stimulus	1.7569279364693102e-12	3.874904563883064e-8	25	208	383
Orphanet:182222	Rare systemic disease	GO:0010632	regulation of epithelial cell migration	2.460698311779197e-12	5.427070126629019e-8	22	164	383
Orphanet:182222	Rare systemic disease	GO:0009790	embryo development	3.4093838863213932e-12	7.519396161281833e-8	62	932	383
Orphanet:182222	Rare systemic disease	GO:0043405	regulation of MAP kinase activity	4.312328272249033e-12	9.510840004445242e-8	28	278	383
Orphanet:182222	Rare systemic disease	GO:0001525	angiogenesis	4.349187676666588e-12	9.59213342088816e-8	36	413	383
Orphanet:182222	Rare systemic disease	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	7.229217224846707e-12	1.5944038589399412e-7	29	307	383
Orphanet:182222	Rare systemic disease	GO:0045765	regulation of angiogenesis	8.93329854534386e-12	1.9702389941755882e-7	24	208	383
Orphanet:182222	Rare systemic disease	GO:0061448	connective tissue development	1.625666268267878e-11	3.585406954664805e-7	25	233	383
Orphanet:182222	Rare systemic disease	GO:1903036	positive regulation of response to wounding	1.8086088182656113e-11	3.9888867486848056e-7	21	162	383
Orphanet:182222	Rare systemic disease	GO:0030168	platelet activation	1.8086088182656113e-11	3.9888867486848056e-7	21	162	383
Orphanet:182222	Rare systemic disease	GO:0000302	response to reactive oxygen species	1.857269893434932e-11	4.096208749970742e-7	24	216	383
Orphanet:182222	Rare systemic disease	GO:0051092	positive regulation of NF-kappaB transcription factor activity	1.973166074975552e-11	4.35181777835858e-7	19	130	383
Orphanet:182222	Rare systemic disease	GO:0006809	nitric oxide biosynthetic process	2.2084223338936226e-11	4.870675457402385e-7	14	62	383
Orphanet:182222	Rare systemic disease	GO:0007162	negative regulation of cell adhesion	2.295208467728571e-11	5.062082275575364e-7	24	218	383
Orphanet:182222	Rare systemic disease	GO:0048871	multicellular organismal homeostasis	2.611721949818957e-11	5.76015276032571e-7	29	321	383
Orphanet:182222	Rare systemic disease	GO:0007179	transforming growth factor beta receptor signaling pathway	2.9351965302737426e-11	6.473575947518739e-7	21	166	383
Orphanet:182222	Rare systemic disease	GO:0043542	endothelial cell migration	3.7204905822818546e-11	8.20554197922263e-7	20	151	383
Orphanet:182222	Rare systemic disease	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3.7438274702594754e-11	8.257011485657273e-7	23	204	383
Orphanet:182222	Rare systemic disease	GO:0033273	response to vitamin	3.810596282960432e-11	8.404270102069233e-7	17	104	383
Orphanet:182222	Rare systemic disease	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	4.065547898335353e-11	8.966565889778622e-7	12	43	383
Orphanet:182222	Rare systemic disease	GO:2000147	positive regulation of cell motility	5.332712049721522e-11	1.1761296425660817e-6	32	399	383
Orphanet:182222	Rare systemic disease	GO:0009894	regulation of catabolic process	5.583000728393017e-11	1.23133081064708e-6	45	727	383
Orphanet:182222	Rare systemic disease	GO:0010810	regulation of cell-substrate adhesion	5.868694419319809e-11	1.2943405541809838e-6	21	172	383
Orphanet:182222	Rare systemic disease	GO:0001701	in utero embryonic development	6.639822025533704e-11	1.4644127477314584e-6	28	312	383
Orphanet:182222	Rare systemic disease	GO:0045860	positive regulation of protein kinase activity	6.974654187530405e-11	1.5382599810598307e-6	34	450	383
Orphanet:182222	Rare systemic disease	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	7.328671003392628e-11	1.6163383897982442e-6	12	45	383
Orphanet:182222	Rare systemic disease	GO:0051235	maintenance of location	9.48843226211693e-11	2.092673735409889e-6	26	274	383
Orphanet:182222	Rare systemic disease	GO:0030335	positive regulation of cell migration	1.0906420211398427e-10	2.405410977623923e-6	31	387	383
Orphanet:182222	Rare systemic disease	GO:0050729	positive regulation of inflammatory response	1.7169510257986076e-10	3.786735487398829e-6	17	114	383
Orphanet:182222	Rare systemic disease	GO:0051341	regulation of oxidoreductase activity	1.7774615113097525e-10	3.920191363193659e-6	15	85	383
Orphanet:182222	Rare systemic disease	GO:0001654	eye development	1.951592221161036e-10	4.304236643770665e-6	28	327	383
Orphanet:182222	Rare systemic disease	GO:0048660	regulation of smooth muscle cell proliferation	2.0175394688237702e-10	4.449683298490825e-6	16	100	383
Orphanet:182222	Rare systemic disease	GO:0001818	negative regulation of cytokine production	2.163197398985517e-10	4.7709318634625575e-6	22	203	383
Orphanet:182222	Rare systemic disease	GO:0002719	negative regulation of cytokine production involved in immune response	2.301487889155851e-10	5.075931539533229e-6	9	22	383
Orphanet:182222	Rare systemic disease	GO:2000738	positive regulation of stem cell differentiation	2.8144109265326733e-10	6.207183298467811e-6	12	50	383
Orphanet:182222	Rare systemic disease	GO:0032675	regulation of interleukin-6 production	3.183127095240934e-10	7.02038680855388e-6	16	103	383
Orphanet:182222	Rare systemic disease	GO:0045862	positive regulation of proteolysis	3.229438938490148e-10	7.122527578840021e-6	29	357	383
Orphanet:182222	Rare systemic disease	GO:0006935	chemotaxis	3.4311198326975045e-10	7.567334791014346e-6	36	530	383
Orphanet:182222	Rare systemic disease	GO:0016049	cell growth	3.4755331945746093e-10	7.6652884606343e-6	34	479	383
Orphanet:182222	Rare systemic disease	GO:1903426	regulation of reactive oxygen species biosynthetic process	3.851186036740728e-10	8.493790804031676e-6	13	63	383
Orphanet:182222	Rare systemic disease	GO:0045926	negative regulation of growth	4.191814673148997e-10	9.245047261630113e-6	23	230	383
Orphanet:182222	Rare systemic disease	GO:0050679	positive regulation of epithelial cell proliferation	4.582527690644156e-10	1.0106764821715686e-5	19	155	383
Orphanet:182222	Rare systemic disease	GO:0048565	digestive tract development	4.754062699063866e-10	1.0485085282785356e-5	18	138	383
Orphanet:182222	Rare systemic disease	GO:0030856	regulation of epithelial cell differentiation	5.106498557339023e-10	1.1262382568211216e-5	17	122	383
Orphanet:182222	Rare systemic disease	GO:0009615	response to virus	5.196463259693473e-10	1.1460799719253956e-5	31	412	383
Orphanet:182222	Rare systemic disease	GO:0007507	heart development	5.343929743162334e-10	1.1786037048544529e-5	34	487	383
Orphanet:182222	Rare systemic disease	GO:0042990	regulation of transcription factor import into nucleus	5.690109494693729e-10	1.254953649054702e-5	15	92	383
Orphanet:182222	Rare systemic disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	6.289109233392765e-10	1.3870630414247742e-5	21	195	383
Orphanet:182222	Rare systemic disease	GO:0055065	metal ion homeostasis	6.341432934320324e-10	1.3986030336643474e-5	35	516	383
Orphanet:182222	Rare systemic disease	GO:0032649	regulation of interferon-gamma production	6.65823951528921e-10	1.4684747250970354e-5	15	93	383
Orphanet:182222	Rare systemic disease	GO:0060322	head development	7.004222757345246e-10	1.544781329132494e-5	42	708	383
Orphanet:182222	Rare systemic disease	GO:0032612	interleukin-1 production	7.115213973563073e-10	1.5692604418693357e-5	13	66	383
Orphanet:182222	Rare systemic disease	GO:2000146	negative regulation of cell motility	7.129006274197991e-10	1.572302333774367e-5	22	216	383
Orphanet:182222	Rare systemic disease	GO:0042092	type 2 immune response	7.134602908465126e-10	1.5735366714619836e-5	10	33	383
Orphanet:182222	Rare systemic disease	GO:0019725	cellular homeostasis	8.877789614558651e-10	1.9579964994909105e-5	44	771	383
Orphanet:182222	Rare systemic disease	GO:0050715	positive regulation of cytokine secretion	9.064150541249205e-10	1.9990984018725122e-5	15	95	383
Orphanet:182222	Rare systemic disease	GO:0051216	cartilage development	9.299588876743314e-10	2.051024326765738e-5	20	180	383
Orphanet:182222	Rare systemic disease	GO:0061061	muscle structure development	9.759507646478482e-10	2.1524594114308293e-5	36	551	383
Orphanet:182222	Rare systemic disease	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	9.813222456855897e-10	2.164306212859568e-5	19	162	383
Orphanet:182222	Rare systemic disease	GO:0030141	secretory granule	9.917681120796829e-10	2.1873445711917405e-5	28	351	383
Orphanet:182222	Rare systemic disease	GO:1901654	response to ketone	1.0261264060673625e-9	2.263121788581568e-5	20	181	383
Orphanet:182222	Rare systemic disease	GO:0043409	negative regulation of MAPK cascade	1.077077427247275e-9	2.375494265793865e-5	18	145	383
Orphanet:182222	Rare systemic disease	GO:0006875	cellular metal ion homeostasis	1.1075873551646964e-9	2.442783911815738e-5	32	450	383
Orphanet:182222	Rare systemic disease	GO:0032652	regulation of interleukin-1 production	1.1582550474287245e-9	2.554531507104052e-5	12	56	383
Orphanet:182222	Rare systemic disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1.2244772973346585e-9	2.7005846792715893e-5	15	97	383
Orphanet:182222	Rare systemic disease	GO:0051353	positive regulation of oxidoreductase activity	1.274333527589988e-9	2.8105425950997187e-5	11	45	383
Orphanet:182222	Rare systemic disease	GO:2000379	positive regulation of reactive oxygen species metabolic process	1.3517670316431918e-9	2.9813221882890595e-5	14	83	383
Orphanet:182222	Rare systemic disease	GO:0030336	negative regulation of cell migration	1.4414571758436523e-9	3.179133801323175e-5	21	204	383
Orphanet:182222	Rare systemic disease	GO:0031100	organ regeneration	1.59220658879633e-9	3.5116116315903056e-5	14	84	383
Orphanet:182222	Rare systemic disease	GO:0001655	urogenital system development	1.7038616073605795e-9	3.757866775033758e-5	26	313	383
Orphanet:182222	Rare systemic disease	GO:0046332	SMAD binding	2.2075075101213315e-9	4.8686578135725966e-5	13	72	383
Orphanet:182222	Rare systemic disease	GO:0000323	lytic vacuole	2.236067886407511e-9	4.931647723471766e-5	34	515	383
Orphanet:182222	Rare systemic disease	GO:0005764	lysosome	2.236067886407511e-9	4.931647723471766e-5	34	515	383
Orphanet:182222	Rare systemic disease	GO:0009612	response to mechanical stimulus	2.443860447343127e-9	5.3899342166152664e-5	21	210	383
Orphanet:182222	Rare systemic disease	GO:0002695	negative regulation of leukocyte activation	2.5200984632434142e-9	5.55807716068335e-5	17	135	383
Orphanet:182222	Rare systemic disease	GO:0002274	myeloid leukocyte activation	2.590732850471511e-9	5.7138613017149176e-5	18	153	383
Orphanet:182222	Rare systemic disease	GO:0045766	positive regulation of angiogenesis	2.8310461752667493e-9	6.243872339550816e-5	16	119	383
Orphanet:182222	Rare systemic disease	GO:0048015	phosphatidylinositol-mediated signaling	3.177122009923039e-9	7.007142592885263e-5	20	193	383
Orphanet:182222	Rare systemic disease	GO:0034341	response to interferon-gamma	3.1973339531532474e-9	7.051720033679487e-5	18	155	383
Orphanet:182222	Rare systemic disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	3.3138674027100024e-9	7.30873455667691e-5	15	104	383
Orphanet:182222	Rare systemic disease	GO:0042993	positive regulation of transcription factor import into nucleus	3.3981147895545405e-9	7.494542168362539e-5	11	49	383
Orphanet:182222	Rare systemic disease	GO:0032872	regulation of stress-activated MAPK cascade	3.476679832914442e-9	7.667817371492802e-5	20	194	383
Orphanet:182222	Rare systemic disease	GO:0010001	glial cell differentiation	3.996171948905669e-9	8.813557233311453e-5	19	176	383
Orphanet:182222	Rare systemic disease	GO:0035821	modification of morphology or physiology of other organism	4.338650438917568e-9	9.568893543032697e-5	15	106	383
Orphanet:182222	Rare systemic disease	GO:0030278	regulation of ossification	4.394006936081496e-9	9.690982297527739e-5	19	177	383
DOID:5679	retinal disease	GO:0071214	cellular response to abiotic stimulus	6.710187960834446e-13	1.4799319547620371e-8	32	285	387
DOID:5679	retinal disease	GO:0048593	camera-type eye morphogenesis	7.460698725481052e-14	1.645457103904846e-9	20	100	387
DOID:5679	retinal disease	GO:0046549	retinal cone cell development	5.24956411673827e-10	1.1577913659466255e-5	6	7	387
DOID:1285	rectal disease	GO:0042623	ATPase activity, coupled	1.8751666885918894e-12	4.135680131689412e-8	35	309	393
DOID:1285	rectal disease	GO:0022804	active transmembrane transporter activity	1.3700152123874432e-12	3.021568550920506e-8	37	346	393
DOID:1285	rectal disease	GO:0007548	sex differentiation	7.278622149442526e-13	1.6053001150595492e-8	30	274	393
DOID:1285	rectal disease	GO:0051170	nuclear import	4.960476474025199e-13	1.0940330863462577e-8	30	287	393
DOID:1285	rectal disease	GO:0048864	stem cell development	4.218847493575595e-15	9.304668147080974e-11	28	175	393
DOID:1285	rectal disease	GO:0034504	protein localization to nucleus	1.822986206434507e-13	4.020596078291305e-9	32	344	393
DOID:1285	rectal disease	GO:0070371	ERK1 and ERK2 cascade	3.318678665209518e-12	7.319345796119592e-8	27	247	393
DOID:1285	rectal disease	GO:0035107	appendage morphogenesis	3.5014213750628187e-12	7.722384842701047e-8	21	146	393
DOID:1285	rectal disease	GO:0035108	limb morphogenesis	3.5014213750628187e-12	7.722384842701047e-8	21	146	393
DOID:1285	rectal disease	GO:0003007	heart morphogenesis	4.54081217071689e-12	1.0014761242516101e-7	25	216	393
DOID:1285	rectal disease	GO:0009314	response to radiation	4.916289597645118e-12	1.0842876707606308e-7	37	431	393
DOID:1285	rectal disease	GO:0048589	developmental growth	1.3611334281904419e-11	3.0019797758740197e-7	41	558	393
DOID:1285	rectal disease	GO:0035113	embryonic appendage morphogenesis	1.541855532138925e-11	3.400562376132399e-7	19	125	393
DOID:1285	rectal disease	GO:0030326	embryonic limb morphogenesis	1.541855532138925e-11	3.400562376132399e-7	19	125	393
DOID:1285	rectal disease	GO:0007420	brain development	1.855116060767159e-11	4.0914584720219693e-7	45	669	393
DOID:1285	rectal disease	GO:0006809	nitric oxide biosynthetic process	3.097100353954829e-11	6.830654830647376e-7	14	62	393
DOID:1285	rectal disease	GO:0010634	positive regulation of epithelial cell migration	3.521594127420258e-11	7.766875848025379e-7	17	101	393
DOID:1285	rectal disease	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	6.203859648223897e-11	1.3682612454157805e-6	23	204	393
DOID:1285	rectal disease	GO:0061008	hepaticobiliary system development	9.26253518329645e-11	2.042852134676032e-6	19	138	393
DOID:1285	rectal disease	GO:0002062	chondrocyte differentiation	1.3278356192358842e-10	2.9285414582247427e-6	16	95	393
DOID:1285	rectal disease	GO:0045667	regulation of osteoblast differentiation	1.6630197219313914e-10	3.6677899967196836e-6	17	111	393
DOID:1285	rectal disease	GO:0048534	hematopoietic or lymphoid organ development	1.738085231295372e-10	3.833346977621943e-6	45	739	393
DOID:1285	rectal disease	GO:0003151	outflow tract morphogenesis	2.200898352455738e-10	4.85408131634113e-6	13	59	393
DOID:1285	rectal disease	GO:0045995	regulation of embryonic development	2.2215296269223472e-10	4.899583592177237e-6	17	113	393
DOID:1285	rectal disease	GO:0010721	negative regulation of cell development	2.2486179585001764e-10	4.959326907472139e-6	27	299	393
DOID:1285	rectal disease	GO:0051098	regulation of binding	2.4734025938499826e-10	5.455089420736137e-6	26	279	393
DOID:1285	rectal disease	GO:0014706	striated muscle tissue development	2.674184207407393e-10	5.897913269437005e-6	28	323	393
DOID:1285	rectal disease	GO:0072006	nephron development	3.013328475631738e-10	6.645895953005798e-6	18	131	393
DOID:1285	rectal disease	GO:0098590	plasma membrane region	3.1921121301792255e-10	7.040203303110282e-6	51	926	393
DOID:1285	rectal disease	GO:0003690	double-stranded DNA binding	3.4613489852119983e-10	7.634005186885062e-6	45	756	393
DOID:1285	rectal disease	GO:0051046	regulation of secretion	3.714957230727123e-10	8.19333817236867e-6	42	675	393
DOID:1285	rectal disease	GO:1903530	regulation of secretion by cell	4.146341048283375e-10	9.144755181988984e-6	40	624	393
DOID:1285	rectal disease	GO:0046661	male sex differentiation	4.4913051056028053e-10	9.905573410406987e-6	19	151	393
DOID:1285	rectal disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.4913051056028053e-10	9.905573410406987e-6	19	151	393
DOID:1285	rectal disease	GO:0007492	endoderm development	4.653978313839957e-10	1.0264349171174025e-5	14	75	393
DOID:1285	rectal disease	GO:0045766	positive regulation of angiogenesis	5.086713272817178e-10	1.1218746123198287e-5	17	119	393
DOID:1285	rectal disease	GO:0090184	positive regulation of kidney development	5.605258479590702e-10	1.2362397576737294e-5	11	41	393
DOID:1285	rectal disease	GO:0007565	female pregnancy	6.195595148028588e-10	1.366438509897705e-5	21	190	393
DOID:1285	rectal disease	GO:0060675	ureteric bud morphogenesis	6.497063997912278e-10	1.4329274647395529e-5	13	64	393
DOID:1285	rectal disease	GO:0001569	patterning of blood vessels	6.502876015446191e-10	1.4342093052066573e-5	10	32	393
DOID:1285	rectal disease	GO:0015850	organic hydroxy compound transport	6.917828532237991e-10	1.5257270827850888e-5	23	230	393
DOID:1285	rectal disease	GO:0035051	cardiocyte differentiation	8.292436737278308e-10	1.828896922406731e-5	16	107	393
DOID:1285	rectal disease	GO:0030097	hemopoiesis	8.81591910584234e-10	1.944350958793528e-5	42	695	393
DOID:1285	rectal disease	GO:0050801	ion homeostasis	8.963378927973054e-10	1.976873222564457e-5	41	668	393
DOID:1285	rectal disease	GO:0009117	nucleotide metabolic process	8.977880661120707e-10	1.980071579810172e-5	40	641	393
DOID:1285	rectal disease	GO:0007369	gastrulation	9.754764773717284e-10	2.151413370843347e-5	20	176	393
DOID:1285	rectal disease	GO:0009306	protein secretion	1.0420317941850499e-9	2.2982011220751275e-5	33	462	393
DOID:1285	rectal disease	GO:0045444	fat cell differentiation	1.0994251065099547e-9	2.424782072407705e-5	21	196	393
DOID:1285	rectal disease	GO:0022405	hair cycle process	1.1378148423446532e-9	2.5094506347911327e-5	14	80	393
DOID:1285	rectal disease	GO:0001942	hair follicle development	1.1378148423446532e-9	2.5094506347911327e-5	14	80	393
DOID:1285	rectal disease	GO:0072521	purine-containing compound metabolic process	1.2502482382714675e-9	2.7574224895077215e-5	37	568	393
DOID:1285	rectal disease	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.3514392938063224e-9	2.980599362489844e-5	39	623	393
DOID:1285	rectal disease	GO:0071383	cellular response to steroid hormone stimulus	1.5053502888662251e-9	3.3200500620944595e-5	19	162	393
DOID:1285	rectal disease	GO:0046546	development of primary male sexual characteristics	1.8258246026192637e-9	4.026856161076786e-5	17	129	393
DOID:1285	rectal disease	GO:0008584	male gonad development	1.8258246026192637e-9	4.026856161076786e-5	17	129	393
DOID:1285	rectal disease	GO:0048511	rhythmic process	1.877716759857151e-9	4.1413043138649464e-5	27	329	393
DOID:1285	rectal disease	GO:0015833	peptide transport	1.9430095310468687e-9	4.285307520723869e-5	26	307	393
DOID:1285	rectal disease	GO:0009914	hormone transport	1.9430095310468687e-9	4.285307520723869e-5	26	307	393
DOID:1285	rectal disease	GO:0048144	fibroblast proliferation	2.2182535808212833e-9	4.8923582725013404e-5	14	84	393
DOID:1285	rectal disease	GO:0048469	cell maturation	2.2662640652981736e-9	4.998245396015122e-5	18	148	393
DOID:1285	rectal disease	GO:0001658	branching involved in ureteric bud morphogenesis	2.936319298818546e-9	6.476052213544303e-5	12	59	393
DOID:1285	rectal disease	GO:0071560	cellular response to transforming growth factor beta stimulus	3.248681323952951e-9	7.164966659978234e-5	21	208	393
DOID:1285	rectal disease	GO:0045669	positive regulation of osteoblast differentiation	3.6014373705484104e-9	7.942970120744519e-5	12	60	393
DOID:1285	rectal disease	GO:0001889	liver development	3.710696527825519e-9	8.183941192119182e-5	17	135	393
DOID:1285	rectal disease	GO:0022612	gland morphogenesis	4.0900073328131725e-9	9.020511172519452e-5	16	119	393
DOID:1285	rectal disease	GO:0046649	lymphocyte activation	4.179963930539543e-9	9.218910448804962e-5	37	594	393
Orphanet:98048	Rare male infertility	GO:0046661	male sex differentiation	9.205969320191798e-13	2.030376533568301e-8	24	151	397
Orphanet:98048	Rare male infertility	GO:0010927	cellular component assembly involved in morphogenesis	5.289102489314246e-13	1.1665115540182569e-8	52	270	397
Orphanet:98048	Rare male infertility	GO:0045137	development of primary sexual characteristics	3.9113157157544265e-13	8.626406811096388e-9	27	225	397
Orphanet:98048	Rare male infertility	GO:0008406	gonad development	7.100986465502501e-13	1.5661225649665766e-8	27	220	397
Orphanet:98048	Rare male infertility	GO:0022412	cellular process involved in reproduction in multicellular organism	3.2569502650403592e-12	7.183203809546512e-8	28	266	397
Orphanet:98048	Rare male infertility	GO:0046546	development of primary male sexual characteristics	3.220324007457975e-11	7.102424598448565e-7	19	129	397
Orphanet:98048	Rare male infertility	GO:0008584	male gonad development	3.220324007457975e-11	7.102424598448565e-7	19	129	397
Orphanet:98048	Rare male infertility	GO:0035107	appendage morphogenesis	3.8465675089582874e-11	8.483604641007503e-7	20	146	397
Orphanet:98048	Rare male infertility	GO:0035108	limb morphogenesis	3.8465675089582874e-11	8.483604641007503e-7	20	146	397
Orphanet:98048	Rare male infertility	GO:0048667	cell morphogenesis involved in neuron differentiation	4.0393910438751846e-11	8.90887694726672e-7	37	495	397
Orphanet:98048	Rare male infertility	GO:0072001	renal system development	4.521349961095211e-11	9.971837339195488e-7	27	276	397
Orphanet:98048	Rare male infertility	GO:0070482	response to oxygen levels	6.027567334143669e-11	1.3293799755453861e-6	29	321	397
Orphanet:98048	Rare male infertility	GO:0036293	response to decreased oxygen levels	6.828060339358899e-11	1.5059287078456052e-6	28	302	397
Orphanet:98048	Rare male infertility	GO:0006935	chemotaxis	6.884992576061677e-11	1.5184851126504029e-6	38	530	397
Orphanet:98048	Rare male infertility	GO:0001822	kidney development	7.802769541598309e-11	1.720900822399507e-6	26	262	397
Orphanet:98048	Rare male infertility	GO:0042493	response to drug	2.5962987315608643e-10	5.726136852457486e-6	33	433	397
Orphanet:98048	Rare male infertility	GO:0090132	epithelium migration	3.82212483884814e-10	8.429696332079573e-6	23	221	397
Orphanet:98048	Rare male infertility	GO:0043010	camera-type eye development	4.1830749974991477e-10	9.22577190698437e-6	26	283	397
Orphanet:98048	Rare male infertility	GO:0001568	blood vessel development	4.911556716891141e-10	1.0832438339103412e-5	38	569	397
Orphanet:98048	Rare male infertility	GO:0051093	negative regulation of developmental process	5.62293211991971e-10	1.2401376790482921e-5	46	788	397
Orphanet:98048	Rare male infertility	GO:0044087	regulation of cellular component biogenesis	6.303483290892586e-10	1.39023323980636e-5	44	735	397
Orphanet:98048	Rare male infertility	GO:0001666	response to hypoxia	8.265138573548825e-10	1.8228763123961933e-5	26	292	397
Orphanet:98048	Rare male infertility	GO:0030286	dynein complex	8.29052160256083e-10	1.828474539444791e-5	11	42	397
Orphanet:98048	Rare male infertility	GO:0001667	ameboidal-type cell migration	9.031606573728368e-10	1.9919208298357916e-5	27	315	397
Orphanet:98048	Rare male infertility	GO:0030855	epithelial cell differentiation	1.650188541368891e-9	3.639490827989089e-5	37	568	397
Orphanet:98048	Rare male infertility	GO:0010631	epithelial cell migration	1.6594695617655475e-9	3.659960118473915e-5	22	218	397
Orphanet:98048	Rare male infertility	GO:0001838	embryonic epithelial tube formation	2.842281410231351e-9	6.268651650265245e-5	16	115	397
Orphanet:98048	Rare male infertility	GO:0007224	smoothened signaling pathway	3.674242909923464e-9	8.1035427378362e-5	16	117	397
DOID:848	arthritis	GO:0033002	muscle cell proliferation	9.50794998288984e-13	2.0969783687263543e-8	24	151	400
DOID:848	arthritis	GO:1903532	positive regulation of secretion by cell	8.992806499463768e-13	1.983363473456734e-8	32	335	400
DOID:848	arthritis	GO:1903036	positive regulation of response to wounding	2.815525590449397e-13	6.209641689736145e-9	26	162	400
DOID:848	arthritis	GO:0048659	smooth muscle cell proliferation	7.949196856316121e-14	1.7531953666605204e-9	22	104	400
DOID:848	arthritis	GO:0032640	tumor necrosis factor production	4.495293026707259e-13	9.91436877040286e-9	19	101	400
DOID:848	arthritis	GO:0014070	response to organic cyclic compound	6.769029781139579e-13	1.4929095182303342e-8	62	873	400
DOID:848	arthritis	GO:2001233	regulation of apoptotic signaling pathway	1.176614361497741e-12	2.5950229742832676e-8	35	359	400
DOID:848	arthritis	GO:0023014	signal transduction by protein phosphorylation	1.2484457911909885e-12	2.7534471924717252e-8	60	879	400
DOID:848	arthritis	GO:0010035	response to inorganic substance	6.23989748760323e-12	1.3762093908908923e-7	43	502	400
DOID:848	arthritis	GO:1902532	negative regulation of intracellular signal transduction	6.759037773917953e-12	1.4907057810376045e-7	36	426	400
DOID:848	arthritis	GO:0000302	response to reactive oxygen species	7.025380277525528e-12	1.5494476202082552e-7	25	216	400
DOID:848	arthritis	GO:2001234	negative regulation of apoptotic signaling pathway	7.508105248632546e-12	1.655912612585908e-7	24	199	400
DOID:848	arthritis	GO:0032870	cellular response to hormone stimulus	9.647949106295073e-12	2.1278551753933783e-7	41	519	400
DOID:848	arthritis	GO:0043068	positive regulation of programmed cell death	1.054634157782175e-11	2.3259956349885869e-7	50	561	400
DOID:848	arthritis	GO:0043549	regulation of kinase activity	1.0823009155558339e-11	2.3870146692583916e-7	50	761	400
DOID:848	arthritis	GO:0045859	regulation of protein kinase activity	1.1855072479249884e-11	2.614636235298562e-7	49	709	400
DOID:848	arthritis	GO:0045597	positive regulation of cell differentiation	1.1866285731798598e-11	2.617109318148181e-7	54	815	400
DOID:848	arthritis	GO:0097285	cell-type specific apoptotic process	1.8386292488514755e-11	4.055096808341929e-7	35	429	400
DOID:848	arthritis	GO:0048661	positive regulation of smooth muscle cell proliferation	2.4247048813208494e-11	5.347686615753133e-7	14	60	400
DOID:848	arthritis	GO:0032602	chemokine production	2.6932567287474285e-11	5.939977715252454e-7	15	72	400
DOID:848	arthritis	GO:0006897	endocytosis	4.8577808442473724e-11	1.071383565198758e-6	41	593	400
DOID:848	arthritis	GO:0043627	response to estrogen	5.091982391292049e-11	1.1230367163994615e-6	24	217	400
DOID:848	arthritis	GO:0002253	activation of immune response	5.99373883858334e-11	1.3219191008495557e-6	36	475	400
DOID:848	arthritis	GO:0071417	cellular response to organonitrogen compound	1.1238199260077408e-10	2.4785848468100724e-6	35	462	400
DOID:848	arthritis	GO:0070371	ERK1 and ERK2 cascade	1.3893197703396254e-10	3.064144753484044e-6	25	247	400
DOID:848	arthritis	GO:0001568	blood vessel development	1.7228574122896134e-10	3.7997620228047424e-6	39	569	400
DOID:848	arthritis	GO:0070848	response to growth factor	1.763628132422923e-10	3.889681846058757e-6	41	621	400
DOID:848	arthritis	GO:0045860	positive regulation of protein kinase activity	2.1336366007318475e-10	4.70573552291409e-6	34	450	400
DOID:848	arthritis	GO:0032677	regulation of interleukin-8 production	2.1745760747649e-10	4.796027532893987e-6	13	58	400
DOID:848	arthritis	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2.2817892020299269e-10	5.032486085077004e-6	30	359	400
DOID:848	arthritis	GO:0031960	response to corticosteroid	2.8104685245722294e-10	6.198488330944052e-6	21	179	400
DOID:848	arthritis	GO:0097191	extrinsic apoptotic signaling pathway	4.0449144034226947e-10	8.921058716748753e-6	23	220	400
DOID:848	arthritis	GO:0043410	positive regulation of MAPK cascade	4.740460246566158e-10	1.0455085073801662e-5	34	464	400
DOID:848	arthritis	GO:0046824	positive regulation of nucleocytoplasmic transport	5.825275817272768e-10	1.284764581499509e-5	17	118	400
DOID:848	arthritis	GO:0022603	regulation of anatomical structure morphogenesis	6.034376331953695e-10	1.3308817000123874e-5	53	986	400
DOID:848	arthritis	GO:0019900	kinase binding	7.01730340502138e-10	1.5476662659774654e-5	39	598	400
DOID:848	arthritis	GO:0098542	defense response to other organism	8.460233624774105e-10	1.865904525943929e-5	37	550	400
DOID:848	arthritis	GO:0051897	positive regulation of protein kinase B signaling	1.2021691420116554e-9	2.651384042706706e-5	14	79	400
DOID:848	arthritis	GO:0032642	regulation of chemokine production	1.206530320096988e-9	2.6610026209739068e-5	13	66	400
DOID:848	arthritis	GO:0001933	negative regulation of protein phosphorylation	1.212659528349036e-9	2.674520589773799e-5	30	385	400
DOID:848	arthritis	GO:0042542	response to hydrogen peroxide	1.280432204708859e-9	2.8239932274853885e-5	17	124	400
DOID:848	arthritis	GO:0002526	acute inflammatory response	1.3565754075628433e-9	2.991927061379851e-5	18	141	400
DOID:848	arthritis	GO:0032963	collagen metabolic process	1.4165314476954904e-9	3.124160107892404e-5	16	109	400
DOID:848	arthritis	GO:0097305	response to alcohol	1.901288237959875e-9	4.193291208820504e-5	29	369	400
DOID:848	arthritis	GO:0071363	cellular response to growth factor stimulus	1.9995805011774337e-9	4.41007479534683e-5	38	594	400
DOID:848	arthritis	GO:0030855	epithelial cell differentiation	2.0272208356431065e-9	4.4710355530108714e-5	37	568	400
DOID:848	arthritis	GO:0002697	regulation of immune effector process	2.1089358037684747e-9	4.651257915211371e-5	31	418	400
DOID:848	arthritis	GO:0048520	positive regulation of behavior	2.1442183584241548e-9	4.729073589504473e-5	18	145	400
DOID:848	arthritis	GO:0006909	phagocytosis	3.1264090205596062e-9	6.895295094844212e-5	21	204	400
DOID:848	arthritis	GO:0051384	response to glucocorticoid	3.3695145562617768e-9	7.431464353835349e-5	19	167	400
DOID:848	arthritis	GO:0007417	central nervous system development	3.749623722626438e-9	8.26979512025261e-5	48	889	400
MESH:D009069	Movement Disorders	GO:0009914	hormone transport	2.23487894857044e-12	4.929025521072106e-8	34	307	401
MESH:D009069	Movement Disorders	GO:1901293	nucleoside phosphate biosynthetic process	2.0812240819623185e-12	4.5901397127678933e-8	32	307	401
MESH:D009069	Movement Disorders	GO:0009165	nucleotide biosynthetic process	2.0410340084708878e-12	4.501500505682543e-8	32	304	401
MESH:D009069	Movement Disorders	GO:0046879	hormone secretion	1.1148859613285822e-12	2.458880987710188e-8	34	297	401
MESH:D009069	Movement Disorders	GO:0045981	positive regulation of nucleotide metabolic process	6.17284001691587e-13	1.3614198657307952e-8	24	132	401
MESH:D009069	Movement Disorders	GO:1900544	positive regulation of purine nucleotide metabolic process	6.17284001691587e-13	1.3614198657307952e-8	24	132	401
MESH:D009069	Movement Disorders	GO:0030808	regulation of nucleotide biosynthetic process	5.206945985491984e-13	1.1483919371002571e-8	26	139	401
MESH:D009069	Movement Disorders	GO:1900371	regulation of purine nucleotide biosynthetic process	5.206945985491984e-13	1.1483919371002571e-8	26	139	401
MESH:D009069	Movement Disorders	GO:0009152	purine ribonucleotide biosynthetic process	4.2943426592501055e-13	9.471172734976108e-9	32	240	401
MESH:D009069	Movement Disorders	GO:0030802	regulation of cyclic nucleotide biosynthetic process	3.19300141882195e-13	7.042164629211811e-9	24	133	401
MESH:D009069	Movement Disorders	GO:0030814	regulation of cAMP metabolic process	3.1885605267234496e-13	7.032370241688568e-9	21	128	401
MESH:D009069	Movement Disorders	GO:0090276	regulation of peptide hormone secretion	2.728928194528635e-13	6.018651133032904e-9	26	199	401
MESH:D009069	Movement Disorders	GO:0048167	regulation of synaptic plasticity	2.560174294785611e-13	5.646464407149665e-9	22	140	401
MESH:D009069	Movement Disorders	GO:0051339	regulation of lyase activity	7.616129948928574e-14	1.679737460236197e-9	19	85	401
MESH:D009069	Movement Disorders	GO:0051048	negative regulation of secretion	6.261657858885883e-14	1.3810086407772815e-9	26	195	401
MESH:D009069	Movement Disorders	GO:0034762	regulation of transmembrane transport	5.81756864903582e-14	1.2830647655448502e-9	36	383	401
MESH:D009069	Movement Disorders	GO:0015850	organic hydroxy compound transport	5.10702591327572e-14	1.12635456517296e-9	29	230	401
MESH:D009069	Movement Disorders	GO:0030817	regulation of cAMP biosynthetic process	2.4424906541753444e-15	5.386913137783722e-11	21	113	401
MESH:D009069	Movement Disorders	GO:0031279	regulation of cyclase activity	1.1457501614131615e-13	2.526951980996728e-9	18	84	401
MESH:D009069	Movement Disorders	GO:0050806	positive regulation of synaptic transmission	5.407896352949138e-13	1.1927115406429323e-8	20	118	401
MESH:D009069	Movement Disorders	GO:0030810	positive regulation of nucleotide biosynthetic process	8.349987368205802e-13	1.8415897140577897e-8	19	104	401
MESH:D009069	Movement Disorders	GO:1900373	positive regulation of purine nucleotide biosynthetic process	8.349987368205802e-13	1.8415897140577897e-8	19	104	401
MESH:D009069	Movement Disorders	GO:0051402	neuron apoptotic process	1.4440670881299411e-12	3.184889962870585e-8	26	211	401
MESH:D009069	Movement Disorders	GO:0051952	regulation of amine transport	2.098321516541546e-12	4.6278481047323794e-8	16	72	401
MESH:D009069	Movement Disorders	GO:0060548	negative regulation of cell death	3.170574913724522e-12	6.992702972219433e-8	58	867	401
MESH:D009069	Movement Disorders	GO:0070482	response to oxygen levels	3.5088598693278072e-12	7.738790441802479e-8	31	321	401
MESH:D009069	Movement Disorders	GO:0043270	positive regulation of ion transport	6.32860430727078e-12	1.3957736799685705e-7	26	233	401
MESH:D009069	Movement Disorders	GO:0003013	circulatory system process	6.795453089125658e-12	1.498737178806664e-7	43	493	401
MESH:D009069	Movement Disorders	GO:0034702	ion channel complex	7.87725440432041e-12	1.7373284588728666e-7	28	274	401
MESH:D009069	Movement Disorders	GO:0098590	plasma membrane region	1.0137557460154767e-11	2.2358382978371338e-7	56	926	401
MESH:D009069	Movement Disorders	GO:0050708	regulation of protein secretion	1.1532441668293814e-11	2.5434800099422006e-7	33	380	401
MESH:D009069	Movement Disorders	GO:0050880	regulation of blood vessel size	1.8095080989155576e-11	3.9908701121582624e-7	20	139	401
MESH:D009069	Movement Disorders	GO:0060284	regulation of cell development	2.2329582627378386e-11	4.924789448468303e-7	51	828	401
MESH:D009069	Movement Disorders	GO:0009894	regulation of catabolic process	3.064970499622177e-11	6.759792436916712e-7	47	727	401
MESH:D009069	Movement Disorders	GO:0051349	positive regulation of lyase activity	3.201428011578855e-11	7.060749479537165e-7	14	61	401
MESH:D009069	Movement Disorders	GO:0032990	cell part morphogenesis	3.4369396217925896e-11	7.580170335863556e-7	49	787	401
MESH:D009069	Movement Disorders	GO:0061564	axon development	3.4597991138696216e-11	7.63058694563945e-7	35	440	401
MESH:D009069	Movement Disorders	GO:0030804	positive regulation of cyclic nucleotide biosynthetic process	3.4819480632108935e-11	7.679436453411626e-7	17	99	401
MESH:D009069	Movement Disorders	GO:0042327	positive regulation of phosphorylation	4.1820658047697634e-11	9.223546132419713e-7	53	910	401
MESH:D009069	Movement Disorders	GO:0010975	regulation of neuron projection development	4.454225877026374e-11	9.823795171781669e-7	33	401	401
MESH:D009069	Movement Disorders	GO:0048667	cell morphogenesis involved in neuron differentiation	5.2083226620425194e-11	1.1486955631134776e-6	37	495	401
MESH:D009069	Movement Disorders	GO:0043627	response to estrogen	5.372913225443199e-11	1.1849960118714975e-6	24	217	401
MESH:D009069	Movement Disorders	GO:0097060	synaptic membrane	5.730782515200872e-11	1.2639240837275523e-6	26	256	401
MESH:D009069	Movement Disorders	GO:0051259	protein oligomerization	6.722888912236158e-11	1.4827331495936846e-6	35	452	401
MESH:D009069	Movement Disorders	GO:0050805	negative regulation of synaptic transmission	8.009592988855729e-11	1.7665157336921311e-6	14	65	401
MESH:D009069	Movement Disorders	GO:0008217	regulation of blood pressure	8.888745295365652e-11	1.9604127748928946e-6	21	168	401
MESH:D009069	Movement Disorders	GO:0048858	cell projection morphogenesis	1.0739742428711452e-10	2.3686501926523107e-6	47	767	401
MESH:D009069	Movement Disorders	GO:0048812	neuron projection morphogenesis	1.4809020676409546e-10	3.2661295101821253e-6	38	539	401
MESH:D009069	Movement Disorders	GO:0031644	regulation of neurological system process	1.5247403339913035e-10	3.36281480661782e-6	14	68	401
MESH:D009069	Movement Disorders	GO:0050432	catecholamine secretion	1.6469758890025332e-10	3.632405323195087e-6	12	46	401
MESH:D009069	Movement Disorders	GO:0006897	endocytosis	1.715410036240428e-10	3.7833368349282637e-6	40	593	401
MESH:D009069	Movement Disorders	GO:0032409	regulation of transporter activity	1.930391402282794e-10	4.257478237734702e-6	22	193	401
MESH:D009069	Movement Disorders	GO:0098797	plasma membrane protein complex	2.358755413212066e-10	5.202235063839211e-6	36	499	401
MESH:D009069	Movement Disorders	GO:0051241	negative regulation of multicellular organismal process	3.189161157379772e-10	7.033694932601087e-6	53	966	401
MESH:D009069	Movement Disorders	GO:0015075	ion transmembrane transporter activity	3.362804479323245e-10	7.416665279147416e-6	49	852	401
MESH:D009069	Movement Disorders	GO:0060078	regulation of postsynaptic membrane potential	3.3645730646014727e-10	7.420565893978548e-6	15	85	401
MESH:D009069	Movement Disorders	GO:0014046	dopamine secretion	3.455147279396442e-10	7.620327324708853e-6	9	22	401
MESH:D009069	Movement Disorders	GO:0014059	regulation of dopamine secretion	3.455147279396442e-10	7.620327324708853e-6	9	22	401
MESH:D009069	Movement Disorders	GO:0030073	insulin secretion	3.498612510810517e-10	7.716189892592595e-6	22	199	401
MESH:D009069	Movement Disorders	GO:0001975	response to amphetamine	3.8246283917686696e-10	8.435217918045801e-6	10	30	401
MESH:D009069	Movement Disorders	GO:0019932	second-messenger-mediated signaling	3.874699450179264e-10	8.545649637370367e-6	23	219	401
MESH:D009069	Movement Disorders	GO:0036293	response to decreased oxygen levels	4.3967751661710963e-10	9.697087628990353e-6	27	302	401
MESH:D009069	Movement Disorders	GO:0031281	positive regulation of cyclase activity	4.4017212097458014e-10	9.707996128094365e-6	13	61	401
MESH:D009069	Movement Disorders	GO:1901338	catecholamine binding	4.676327103325661e-10	1.0313639426384746e-5	8	16	401
MESH:D009069	Movement Disorders	GO:0071407	cellular response to organic cyclic compound	4.954241461518905e-10	1.0926579543379944e-5	32	416	401
MESH:D009069	Movement Disorders	GO:0005216	ion channel activity	5.26200305550617e-10	1.1605347738918859e-5	32	417	401
MESH:D009069	Movement Disorders	GO:0050808	synapse organization	6.629740090247083e-10	1.462189176903994e-5	23	225	401
MESH:D009069	Movement Disorders	GO:0009205	purine ribonucleoside triphosphate metabolic process	6.712568278999242e-10	1.480456933933283e-5	24	245	401
MESH:D009069	Movement Disorders	GO:0050796	regulation of insulin secretion	6.713155586979269e-10	1.4805864647082778e-5	20	169	401
MESH:D009069	Movement Disorders	GO:0051338	regulation of transferase activity	6.943742247855766e-10	1.5314423527645893e-5	51	928	401
MESH:D009069	Movement Disorders	GO:0009167	purine ribonucleoside monophosphate metabolic process	7.024257842047632e-10	1.5492000670636052e-5	25	266	401
MESH:D009069	Movement Disorders	GO:0032225	regulation of synaptic transmission, dopaminergic	8.667908613091413e-10	1.911707244617311e-5	8	17	401
MESH:D009069	Movement Disorders	GO:0007269	neurotransmitter secretion	8.781367855092981e-10	1.936730680440757e-5	18	137	401
MESH:D009069	Movement Disorders	GO:0044309	neuron spine	9.025703517906436e-10	1.9906189108742645e-5	17	121	401
MESH:D009069	Movement Disorders	GO:0032844	regulation of homeostatic process	9.464881101095557e-10	2.087479526846625e-5	32	427	401
MESH:D009069	Movement Disorders	GO:0046034	ATP metabolic process	1.0216856249911643e-9	2.253327645918013e-5	23	230	401
MESH:D009069	Movement Disorders	GO:0001666	response to hypoxia	1.0236225200799254e-9	2.2575994680362754e-5	26	292	401
MESH:D009069	Movement Disorders	GO:0007409	axonogenesis	1.1091896290338354e-9	2.446317726834124e-5	31	406	401
MESH:D009069	Movement Disorders	GO:0045776	negative regulation of blood pressure	1.2142892247268833e-9	2.678114885135141e-5	11	43	401
MESH:D009069	Movement Disorders	GO:1903522	regulation of blood circulation	1.4698470218732496e-9	3.241747606741452e-5	26	297	401
MESH:D009069	Movement Disorders	GO:0051705	multi-organism behavior	1.475641941972583e-9	3.254528303020532e-5	14	80	401
MESH:D009069	Movement Disorders	GO:0022898	regulation of transmembrane transporter activity	1.6879673214731383e-9	3.7228119275090066e-5	20	178	401
MESH:D009069	Movement Disorders	GO:0030819	positive regulation of cAMP biosynthetic process	1.7495354054375412e-9	3.858600336692497e-5	14	81	401
MESH:D009069	Movement Disorders	GO:0097190	apoptotic signaling pathway	1.7929256967974538e-9	3.9542976242867844e-5	37	564	401
MESH:D009069	Movement Disorders	GO:0007622	rhythmic behavior	2.061707249367828e-9	4.5470953384807444e-5	11	45	401
MESH:D009069	Movement Disorders	GO:0032355	response to estradiol	2.230464146713018e-9	4.9192886755755616e-5	18	145	401
MESH:D009069	Movement Disorders	GO:0005768	endosome	2.4603032944270353e-9	5.4261989158588264e-5	45	789	401
MESH:D009069	Movement Disorders	GO:0010720	positive regulation of cell development	2.5138848780414946e-9	5.5443730985205164e-5	33	469	401
MESH:D009069	Movement Disorders	GO:0050769	positive regulation of neurogenesis	3.0913533954901595e-9	6.817979913753547e-5	29	376	401
MESH:D009069	Movement Disorders	GO:0048471	perinuclear region of cytoplasm	4.259826602570627e-9	9.395047571969517e-5	39	636	401
MESH:D009069	Movement Disorders	GO:0032101	regulation of response to external stimulus	4.30826552211272e-9	9.501879609019603e-5	49	920	401
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	6.938671859302303e-12	1.530324078569123e-7	69	996	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0007568	aging	3.141931159689193e-13	6.929529172694515e-9	31	290	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0072001	renal system development	2.1271873151818e-13	4.69151162363346e-9	30	276	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001701	in utero embryonic development	1.0835776720341528e-13	2.389830555671324e-9	32	312	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0008206	bile acid metabolic process	2.4646951146678475e-14	5.435885075399938e-10	15	41	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001085	RNA polymerase II transcription factor binding	1.4876988529977098e-14	3.281119820286449e-10	20	104	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0023014	signal transduction by protein phosphorylation	5.896394483784206e-13	1.3004498033986067e-8	56	879	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0030850	prostate gland development	6.972200594645983e-13	1.5377188411491716e-8	14	47	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0042471	ear morphogenesis	7.006617508409363e-13	1.545309491479685e-8	20	112	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.1468603844377867e-12	2.5294005778775386e-8	35	317	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:1901698	response to nitrogen compound	1.6150414339222152e-12	3.5619738825154457e-8	60	870	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048806	genitalia development	1.947442207494987e-12	4.295083788630194e-8	13	41	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001822	kidney development	4.447886503555765e-12	9.809813683592239e-8	28	262	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001944	vasculature development	5.722200491220519e-12	1.2620313183386855e-7	52	588	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048514	blood vessel morphogenesis	6.4827032630887516e-12	1.4297602046742242e-7	42	484	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0035107	appendage morphogenesis	6.711520228463996e-12	1.4802257863877344e-7	21	146	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0035108	limb morphogenesis	6.711520228463996e-12	1.4802257863877344e-7	21	146	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0009991	response to extracellular stimulus	7.222999975908806e-12	1.5930326446866871e-7	43	573	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0022612	gland morphogenesis	1.0335732270050357e-11	2.2795457521596063e-7	19	119	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0008284	positive regulation of cell proliferation	1.1181056080999952e-11	2.4659819186645393e-7	56	815	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060284	regulation of cell development	1.118938275368464e-11	2.4678183663251474e-7	54	828	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.2717049635568856e-11	2.804745297124711e-7	58	732	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0010243	response to organonitrogen compound	1.3128609310797401e-11	2.895514783496367e-7	55	780	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045597	positive regulation of cell differentiation	1.40014666527577e-11	3.0880234702657106e-7	52	815	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0051093	negative regulation of developmental process	1.4124479363886167e-11	3.115153923705094e-7	52	788	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0019748	secondary metabolic process	1.7392309814567852e-11	3.83587392960294e-7	14	58	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048871	multicellular organismal homeostasis	1.9837687048607222e-11	4.375201878570323e-7	30	321	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0002520	immune system development	2.0359380847878583e-11	4.4902614459996215e-7	50	782	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:2000145	regulation of cell motility	2.078293093177308e-11	4.583675417002553e-7	47	709	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0071417	cellular response to organonitrogen compound	4.411082610289441e-11	9.728642696993361e-7	36	462	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0021953	central nervous system neuron differentiation	4.68890481997164e-11	1.0341379580447452e-6	21	161	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0050769	positive regulation of neurogenesis	4.811562259732227e-11	1.0611900563839427e-6	32	376	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001666	response to hypoxia	5.1347148755098715e-11	1.1324613657937022e-6	28	292	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045664	regulation of neuron differentiation	8.941514195726086e-11	1.972050955867388e-6	39	548	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0055123	digestive system development	9.083089835826286e-11	2.0032754632914873e-6	20	150	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0043549	regulation of kinase activity	1.1392176091362671e-10	2.512544436950037e-6	47	761	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060560	developmental growth involved in morphogenesis	1.2485290579178354e-10	2.753630837237786e-6	23	205	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045165	cell fate commitment	1.27237331781771e-10	2.806219352446959e-6	25	243	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0051241	negative regulation of multicellular organismal process	1.5166401468036383e-10	3.3449498437754244e-6	54	966	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0035282	segmentation	1.7536405660933951e-10	3.867654268518983e-6	16	94	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:1901342	regulation of vasculature development	1.8635770704378274e-10	4.110119228850628e-6	24	228	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001657	ureteric bud development	2.856925807037669e-10	6.300949867421579e-6	16	97	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0019218	regulation of steroid metabolic process	3.194402520279027e-10	7.045254758475394e-6	14	71	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045859	regulation of protein kinase activity	3.884044197377534e-10	8.566259477316152e-6	44	709	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0016049	cell growth	3.88704846088217e-10	8.572885380475626e-6	35	479	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0046620	regulation of organ growth	3.889144561952662e-10	8.577508331386596e-6	14	72	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0033674	positive regulation of kinase activity	4.114111273878507e-10	9.073672414539047e-6	35	480	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060485	mesenchyme development	4.148349441734922e-10	9.14918469374637e-6	24	237	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0030334	regulation of cell migration	4.682378929032893e-10	1.0326986727982046e-5	42	660	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0071599	otic vesicle development	5.058731211704526e-10	1.1157031687414332e-5	8	16	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001525	angiogenesis	5.291824756170627e-10	1.1671119499734317e-5	32	413	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048588	developmental cell growth	5.88246340527121e-10	1.2973773040325653e-5	21	184	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0071600	otic vesicle morphogenesis	6.571562183310675e-10	1.4493580395291694e-5	7	11	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0008015	blood circulation	6.741842639712559e-10	1.4869133941886048e-5	35	489	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048639	positive regulation of developmental growth	9.32477539627996e-10	2.0565792136495453e-5	19	153	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0021543	pallium development	9.32477539627996e-10	2.0565792136495453e-5	19	153	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	9.538776435391583e-10	2.1037771428256136e-5	9	24	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	9.558874802806372e-10	2.1082098377589453e-5	23	227	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0035264	multicellular organism growth	1.0287680707321556e-9	2.268947979999769e-5	18	137	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0014065	phosphatidylinositol 3-kinase signaling	1.042973263309932e-9	2.300277532230055e-5	19	154	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0007565	female pregnancy	1.0650723636373982e-9	2.3490170980022818e-5	21	190	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060348	bone development	1.0914371628700792e-9	2.4071646627099597e-5	20	172	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048565	digestive tract development	1.1601952731865595e-9	2.558810675012957e-5	18	138	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045926	negative regulation of growth	1.2368286395059158e-9	2.7278255644302973e-5	23	230	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060537	muscle tissue development	1.2961391959720459e-9	2.858634996716347e-5	28	336	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0001667	ameboidal-type cell migration	1.3965385514680406e-9	3.0800657752627636e-5	27	315	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0060740	prostate gland epithelium morphogenesis	1.4621026611649768e-9	3.224667419199356e-5	9	25	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0035113	embryonic appendage morphogenesis	1.753620137989742e-9	3.867609214336376e-5	17	125	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0030326	embryonic limb morphogenesis	1.753620137989742e-9	3.867609214336376e-5	17	125	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0044057	regulation of system process	1.8332538820331479e-9	4.0432414368241076e-5	35	508	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0071396	cellular response to lipid	2.5326817310045158e-9	5.5858295577304595e-5	31	416	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0002065	columnar/cuboidal epithelial cell differentiation	2.5433309902567203e-9	5.6093164990111966e-5	17	128	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0030879	mammary gland development	2.5433309902567203e-9	5.6093164990111966e-5	17	128	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0019953	sexual reproduction	2.548086630582702e-9	5.6198050637501495e-5	44	754	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0043010	camera-type eye development	3.1096861752288874e-9	6.858412859467311e-5	25	283	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0005694	chromosome	3.5114878782493975e-9	7.744586515479046e-5	48	876	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0048511	rhythmic process	3.5937282039100182e-9	7.925967553723545e-5	27	329	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0010638	positive regulation of organelle organization	3.595802766653833e-9	7.930543001855028e-5	37	573	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0061053	somite development	3.828431349717221e-9	8.44360534180133e-5	14	85	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0045787	positive regulation of cell cycle	3.9089655956559e-9	8.621223621219087e-5	26	308	405
Orphanet:96344	Rare gynecologic or obstetric disease	GO:0002521	leukocyte differentiation	3.912843049569403e-9	8.629775345825319e-5	32	448	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060537	muscle tissue development	2.3006041516282494e-12	5.073982456416104e-8	35	336	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0003002	regionalization	2.1533885785629536e-12	4.749298510020594e-8	41	327	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048638	regulation of developmental growth	1.8678392166293634e-12	4.119519392276061e-8	32	283	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035270	endocrine system development	6.388223283693151e-13	1.4089226452185244e-8	22	129	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0072001	renal system development	6.163958232718869e-13	1.3594609882261466e-8	38	276	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048754	branching morphogenesis of an epithelial tube	5.195843755245733e-13	1.1459433402194463e-8	26	147	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0009799	specification of symmetry	5.149214388211476e-13	1.135659233320041e-8	28	122	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048706	embryonic skeletal system development	5.146993942162226e-13	1.1351695139438789e-8	24	122	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001701	in utero embryonic development	4.2299497238218464e-13	9.329154115889082e-9	34	312	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035148	tube formation	3.4994229736184934e-13	7.717977368315587e-9	26	131	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0014706	striated muscle tissue development	3.4283687000424834e-13	7.561267167943697e-9	33	323	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0010927	cellular component assembly involved in morphogenesis	3.4150460237469815e-13	7.531884005373968e-9	34	270	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0072089	stem cell proliferation	2.795541576006144e-13	6.165566945881551e-9	25	139	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048592	eye morphogenesis	1.5698553568199713e-13	3.462315989466447e-9	25	136	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0002065	columnar/cuboidal epithelial cell differentiation	8.393286066166183e-14	1.8511392418929518e-9	21	128	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0072073	kidney epithelium development	7.72715225139109e-14	1.7042234290443048e-9	22	137	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048546	digestive tract morphogenesis	3.2529534621517087e-14	7.174388860775593e-10	15	49	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048704	embryonic skeletal system morphogenesis	3.752553823233029e-14	8.276257457140446e-10	19	93	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0003151	outflow tract morphogenesis	6.461498003318411e-14	1.4250833846318756e-9	16	59	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001841	neural tube formation	1.2079226507921703e-13	2.6640734063221316e-9	19	95	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0014020	primary neural tube formation	1.6120438317557273e-13	3.5553626709372566e-9	18	86	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048593	camera-type eye morphogenesis	1.8918200339612667e-13	4.172409084901574e-9	20	100	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060606	tube closure	2.462474668618597e-13	5.430987881638316e-9	18	83	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:2000027	regulation of organ morphogenesis	3.214095656289828e-13	7.088687969947216e-9	28	236	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060563	neuroepithelial cell differentiation	4.121147867408581e-13	9.089191621569626e-9	17	74	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0030323	respiratory tube development	4.340972026284362e-13	9.57401380397016e-9	30	179	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001823	mesonephros development	7.496225862269057e-13	1.6532926139234405e-8	19	102	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001503	ossification	7.738254481637341e-13	1.7066720259251156e-8	38	363	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048645	organ formation	1.4122036873231991e-12	3.1146152323913157e-8	15	59	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001843	neural tube closure	1.716626840675417e-12	3.786020497109632e-8	17	82	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001657	ureteric bud development	2.8207436386651352e-12	6.221150095075956e-8	18	97	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060348	bone development	3.888778188354536e-12	8.576700294415929e-8	23	172	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060425	lung morphogenesis	4.398481578959945e-12	9.700851122396159e-8	14	53	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0016568	chromatin modification	4.589217894590547e-12	1.0121520066519452e-7	45	608	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060840	artery development	4.9719117711788385e-12	1.0965551411334928e-7	16	75	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048864	stem cell development	5.413891557282113e-12	1.19403378295857e-7	23	175	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0051726	regulation of cell cycle	6.45661302201006e-12	1.4240060020043188e-7	57	930	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060249	anatomical structure homeostasis	7.791878253726736e-12	1.7184987488594317e-7	32	351	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0005815	microtubule organizing center	7.933653733971369e-12	1.7497673310273854e-7	46	617	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001085	RNA polymerase II transcription factor binding	9.263922962077231e-12	2.0431582092861333e-7	18	104	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048667	cell morphogenesis involved in neuron differentiation	9.623857266660707e-12	2.122541720162019e-7	39	495	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048701	embryonic cranial skeleton morphogenesis	1.0365042157900461e-11	2.2860100479249468e-7	13	46	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0008544	epidermis development	1.2122969295091934e-11	2.673720878032526e-7	29	296	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	1.2884249223077404e-11	2.8416211661497215e-7	44	623	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0044427	chromosomal part	1.3537504450766846e-11	2.985696606616628e-7	52	776	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0051093	negative regulation of developmental process	1.4124479363886167e-11	3.115153923705094e-7	52	788	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048812	neuron projection morphogenesis	1.4371392964562801e-11	3.169610718334326e-7	41	539	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0007517	muscle organ development	1.4556023053557965e-11	3.210330884462209e-7	31	340	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0008285	negative regulation of cell proliferation	1.6389223311819023e-11	3.6146432014216856e-7	44	634	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0021543	pallium development	1.721522924214014e-11	3.796818809354008e-7	21	153	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0007498	mesoderm development	1.9682810936672013e-11	4.3410439520830124e-7	19	123	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0010564	regulation of cell cycle process	2.101940843601824e-11	4.6358305305638225e-7	41	561	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0090102	cochlea development	2.1256330029473247e-11	4.6880835880003247e-7	12	39	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0016569	covalent chromatin modification	2.5822233240546666e-11	5.695093541202567e-7	35	431	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0045596	negative regulation of cell differentiation	2.680744515259903e-11	5.912382028405716e-7	42	597	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0042063	gliogenesis	3.172073714807766e-11	6.996008578008528e-7	25	228	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035272	exocrine system development	3.325517639041209e-11	7.334429152905386e-7	13	50	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048806	genitalia development	4.128242192535936e-11	9.104838155638006e-7	12	41	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048844	artery morphogenesis	4.3800962856721526e-11	9.660302358049933e-7	13	51	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0021761	limbic system development	4.805034148347431e-11	1.059750281418026e-6	17	100	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0061448	connective tissue development	5.05433472852701e-11	1.114733524376632e-6	25	233	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0050673	epithelial cell proliferation	5.401179503650155e-11	1.1912301395300418e-6	30	335	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0043566	structure-specific DNA binding	6.257971918444127e-11	1.3801957066128523e-6	18	116	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035265	organ growth	7.001699220410273e-11	1.5442247630614858e-6	19	132	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	7.260847478818278e-11	1.6013799114533711e-6	29	317	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0070848	response to growth factor	7.564116000224885e-11	1.6682657838495984e-6	42	621	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	8.535550044541651e-11	1.8825155623236611e-6	40	573	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0045664	regulation of neuron differentiation	8.941514195726086e-11	1.972050955867388e-6	39	548	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0002053	positive regulation of mesenchymal cell proliferation	1.2533263316072407e-10	2.7642112243597694e-6	10	27	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060993	kidney morphogenesis	1.25352062063655e-10	2.7646397288139113e-6	16	92	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035264	multicellular organism growth	1.3590550906883436e-10	2.997396002513142e-6	19	137	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035137	hindlimb morphogenesis	2.25078400362122e-10	4.964104119986601e-6	11	37	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0090103	cochlea morphogenesis	2.2717849823550296e-10	5.010421778584018e-6	9	21	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0042692	muscle cell differentiation	2.4589374980621415e-10	5.423186651976053e-6	29	334	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0010001	glial cell differentiation	2.570075263719218e-10	5.668300994132736e-6	21	176	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0007369	gastrulation	2.570075263719218e-10	5.668300994132736e-6	21	176	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0030278	regulation of ossification	2.858936420935265e-10	6.3053842763727275e-6	21	177	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0051216	cartilage development	3.9080672031843733e-10	8.619242216623135e-6	21	180	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0061351	neural precursor cell proliferation	5.551040738183133e-10	1.22428203480629e-5	18	132	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0014033	neural crest cell differentiation	6.88105905588543e-10	1.5176175747755316e-5	14	75	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0022612	gland morphogenesis	8.053330224910837e-10	1.7761619811040852e-5	17	119	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0003206	cardiac chamber morphogenesis	8.320206745793257e-10	1.835021597784703e-5	16	104	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0045787	positive regulation of cell cycle	8.489314806681136e-10	1.8723183806135246e-5	27	308	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0050769	positive regulation of neurogenesis	9.289939928436297e-10	2.0488962512166253e-5	30	376	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0007405	neuroblast proliferation	1.3908333373890969e-9	3.067482925611653e-5	12	54	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048854	brain morphogenesis	1.701029983536273e-9	3.75162162868925e-5	10	34	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0002088	lens development in camera-type eye	1.706431107528772e-9	3.7635338076547065e-5	13	67	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0018205	peptidyl-lysine modification	1.9516170901567875e-9	4.304291492340795e-5	30	388	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0050678	regulation of epithelial cell proliferation	2.0006629686264432e-9	4.4124621773056205e-5	25	277	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0048871	multicellular organismal homeostasis	2.1085344581450727e-9	4.650372747438958e-5	27	321	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0021953	central nervous system neuron differentiation	2.226345996447776e-9	4.91020609516557e-5	19	161	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0061525	hindgut development	2.7102834421199873e-9	5.977530131595632e-5	6	8	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0045995	regulation of embryonic development	2.90959900617338e-9	6.41712060811539e-5	16	113	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0035019	somatic stem cell population maintenance	3.0094547964765184e-9	6.637352553628961e-5	13	70	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0043588	skin development	3.0731179823106913e-9	6.77776170998623e-5	23	241	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0021846	cell proliferation in forebrain	3.2276337158521073e-9	7.118546160311823e-5	9	27	405
Orphanet:68341	Multiple congenital anomalies/dysmorphic syndrome	GO:0060560	developmental growth involved in morphogenesis	4.255410024356365e-9	9.385306808717964e-5	21	205	405
DOID:1561	cognitive disorder	GO:0006869	lipid transport	2.097877427331696e-12	4.626868665980055e-8	38	300	405
DOID:1561	cognitive disorder	GO:0002237	response to molecule of bacterial origin	1.9317880628477724e-12	4.260558572610762e-8	33	333	405
DOID:1561	cognitive disorder	GO:0048638	regulation of developmental growth	1.1122214260694818e-12	2.453004355196242e-8	30	283	405
DOID:1561	cognitive disorder	GO:0044306	neuron projection terminus	6.388223283693151e-13	1.4089226452185244e-8	22	129	405
DOID:1561	cognitive disorder	GO:0033267	axon part	5.944134073843088e-13	1.3109787699860931e-8	29	217	405
DOID:1561	cognitive disorder	GO:0007612	learning	4.9649173661237e-13	1.095012525098582e-8	22	130	405
DOID:1561	cognitive disorder	GO:0046717	acid secretion	4.0234482412415673e-13	8.873715096058277e-9	20	106	405
DOID:1561	cognitive disorder	GO:0048167	regulation of synaptic plasticity	3.097522238704187e-13	6.831585297462084e-9	23	140	405
DOID:1561	cognitive disorder	GO:0044070	regulation of anion transport	2.7466917629226373e-13	6.0578286831258765e-9	25	135	405
DOID:1561	cognitive disorder	GO:0006874	cellular calcium ion homeostasis	2.2648549702353193e-13	4.995137636853997e-9	41	352	405
DOID:1561	cognitive disorder	GO:0050806	positive regulation of synaptic transmission	1.5876189252139739e-13	3.5014935395594193e-9	21	118	405
DOID:1561	cognitive disorder	GO:0030534	adult behavior	1.1324274851176597e-13	2.4975688184269984e-9	22	135	405
DOID:1561	cognitive disorder	GO:0042220	response to cocaine	3.064215547965432e-14	6.75812739103776e-10	18	47	405
DOID:1561	cognitive disorder	GO:0043195	terminal bouton	1.1657341758564144e-14	2.571026724851322e-10	17	64	405
DOID:1561	cognitive disorder	GO:0051048	negative regulation of secretion	8.004708007547379e-14	1.7654383510645744e-9	26	195	405
DOID:1561	cognitive disorder	GO:0007584	response to nutrient	8.104628079763643e-14	1.7874757229918714e-9	26	197	405
DOID:1561	cognitive disorder	GO:0035249	synaptic transmission, glutamatergic	1.0480505352461478e-13	2.311475455485379e-9	17	70	405
DOID:1561	cognitive disorder	GO:0001505	regulation of neurotransmitter levels	4.5075054799781356e-13	9.941303336091778e-9	26	179	405
DOID:1561	cognitive disorder	GO:0007631	feeding behavior	7.607248164731573e-13	1.6777785827315483e-8	19	106	405
DOID:1561	cognitive disorder	GO:0009612	response to mechanical stimulus	1.4127587988355117e-12	3.115839530831721e-8	26	210	405
DOID:1561	cognitive disorder	GO:0015844	monoamine transport	1.5257795027423526e-12	3.365106693298259e-8	16	70	405
DOID:1561	cognitive disorder	GO:0051966	regulation of synaptic transmission, glutamatergic	1.8095525078365426e-12	3.990968056033495e-8	14	50	405
DOID:1561	cognitive disorder	GO:0051480	cytosolic calcium ion homeostasis	1.8169910021015312e-12	4.007373655134927e-8	28	255	405
DOID:1561	cognitive disorder	GO:0000165	MAPK cascade	3.892108857428411e-12	8.584046085058361e-8	54	843	405
DOID:1561	cognitive disorder	GO:1903531	negative regulation of secretion by cell	4.633293748668166e-12	1.021872936268764e-7	23	174	405
DOID:1561	cognitive disorder	GO:0023061	signal release	5.130007529885461e-12	1.1314231607162384e-7	38	416	405
DOID:1561	cognitive disorder	GO:0032409	regulation of transporter activity	5.1992854466220706e-12	1.1467024052524977e-7	24	193	405
DOID:1561	cognitive disorder	GO:0032101	regulation of response to external stimulus	5.268230296451293e-12	1.1619081918823326e-7	59	920	405
DOID:1561	cognitive disorder	GO:0051338	regulation of transferase activity	5.9438010069357006e-12	1.3109053120796688e-7	58	928	405
DOID:1561	cognitive disorder	GO:0044297	cell body	6.086686710204958e-12	1.3424187539357035e-7	54	494	405
DOID:1561	cognitive disorder	GO:0032844	regulation of homeostatic process	6.3403726713318065e-12	1.39836919266223e-7	37	427	405
DOID:1561	cognitive disorder	GO:0015711	organic anion transport	7.221556685976793e-12	1.5927143270921817e-7	36	423	405
DOID:1561	cognitive disorder	GO:0071496	cellular response to external stimulus	7.520983835718198e-12	1.6587529849676486e-7	28	270	405
DOID:1561	cognitive disorder	GO:0048858	cell projection morphogenesis	9.550138457825597e-12	2.1062830368734353e-7	59	767	405
DOID:1561	cognitive disorder	GO:0032368	regulation of lipid transport	9.878320383904793e-12	2.178663560670202e-7	17	91	405
DOID:1561	cognitive disorder	GO:0045860	positive regulation of protein kinase activity	1.0223377699958291e-11	2.2547659517258012e-7	37	450	405
DOID:1561	cognitive disorder	GO:0015696	ammonium transport	1.190214593549399e-11	2.6250182860731996e-7	17	92	405
DOID:1561	cognitive disorder	GO:0072521	purine-containing compound metabolic process	1.2413736705241263e-11	2.7378496303409605e-7	42	568	405
DOID:1561	cognitive disorder	GO:0009611	response to wounding	1.3006373755786171e-11	2.86855573183864e-7	53	875	405
DOID:1561	cognitive disorder	GO:0009416	response to light stimulus	1.3243628416148567e-11	2.9208822471815665e-7	29	297	405
DOID:1561	cognitive disorder	GO:0051705	multi-organism behavior	1.3580359059517377e-11	2.9951481905765576e-7	16	80	405
DOID:1561	cognitive disorder	GO:0046942	carboxylic acid transport	1.557576290167617e-11	3.4352345079646796e-7	29	299	405
DOID:1561	cognitive disorder	GO:1900542	regulation of purine nucleotide metabolic process	1.6111334488755347e-11	3.5533548214949917e-7	24	203	405
DOID:1561	cognitive disorder	GO:0098590	plasma membrane region	1.634448132392663e-11	3.604775355992018e-7	55	926	405
DOID:1561	cognitive disorder	GO:0001975	response to amphetamine	1.638378321899836e-11	3.6134433889500883e-7	11	30	405
DOID:1561	cognitive disorder	GO:1903793	positive regulation of anion transport	1.7392309814567852e-11	3.83587392960294e-7	14	58	405
DOID:1561	cognitive disorder	GO:0072358	cardiovascular system development	2.1139312522677756e-11	4.662275376876579e-7	54	910	405
DOID:1561	cognitive disorder	GO:0007565	female pregnancy	2.59853250028641e-11	5.731063429381678e-7	23	190	405
DOID:1561	cognitive disorder	GO:0007420	brain development	2.93535196149719e-11	6.473918751082053e-7	45	669	405
DOID:1561	cognitive disorder	GO:0032846	positive regulation of homeostatic process	3.221445332712847e-11	7.104897681298183e-7	23	192	405
DOID:1561	cognitive disorder	GO:0048511	rhythmic process	3.4156122374895403e-11	7.533132789783181e-7	30	329	405
DOID:1561	cognitive disorder	GO:0042417	dopamine metabolic process	3.7429948029910065e-11	8.255175037996665e-7	11	32	405
DOID:1561	cognitive disorder	GO:0006809	nitric oxide biosynthetic process	4.627331851025929e-11	1.0205580397437686e-6	14	62	405
DOID:1561	cognitive disorder	GO:0032880	regulation of protein localization	4.6757819838205705e-11	1.0312437165316268e-6	54	933	405
DOID:1561	cognitive disorder	GO:0032355	response to estradiol	4.834865841019109e-11	1.0663296612367645e-6	20	145	405
DOID:1561	cognitive disorder	GO:0043410	positive regulation of MAPK cascade	4.900035932564606e-11	1.0807029249271238e-6	36	464	405
DOID:1561	cognitive disorder	GO:0001504	neurotransmitter uptake	5.049372031606936e-11	1.1136390015709097e-6	10	25	405
DOID:1561	cognitive disorder	GO:1903532	positive regulation of secretion by cell	5.401179503650155e-11	1.1912301395300418e-6	30	335	405
DOID:1561	cognitive disorder	GO:0007204	positive regulation of cytosolic calcium ion concentration	5.58497692537685e-11	1.2317666608918643e-6	25	234	405
DOID:1561	cognitive disorder	GO:0097190	apoptotic signaling pathway	5.791156443279988e-11	1.2772395535654013e-6	40	564	405
DOID:1561	cognitive disorder	GO:0010975	regulation of neuron projection development	5.8147486825532724e-11	1.2824428219371242e-6	33	401	405
DOID:1561	cognitive disorder	GO:0051235	maintenance of location	6.000822061480449e-11	1.323481305659513e-6	27	274	405
DOID:1561	cognitive disorder	GO:0001101	response to acid chemical	6.208999980827912e-11	1.369394945771596e-6	29	315	405
DOID:1561	cognitive disorder	GO:0098794	postsynapse	6.804623531309062e-11	1.5007597198302136e-6	32	381	405
DOID:1561	cognitive disorder	GO:0043405	regulation of MAP kinase activity	8.423484132435988e-11	1.857799425408757e-6	27	278	405
DOID:1561	cognitive disorder	GO:0070405	ammonium ion binding	9.131184697253047e-11	2.0138827849791596e-6	14	65	405
DOID:1561	cognitive disorder	GO:0050805	negative regulation of synaptic transmission	9.131184697253047e-11	2.0138827849791596e-6	14	65	405
DOID:1561	cognitive disorder	GO:0010959	regulation of metal ion transport	9.69475610901327e-11	2.1381784598428766e-6	29	321	405
DOID:1561	cognitive disorder	GO:0007618	mating	1.0401657313252599e-10	2.2940855204378607e-6	12	44	405
DOID:1561	cognitive disorder	GO:0051962	positive regulation of nervous system development	1.2162826301675977e-10	2.682511340834637e-6	34	435	405
DOID:1561	cognitive disorder	GO:0014065	phosphatidylinositol 3-kinase signaling	1.48266288135801e-10	3.270012984835091e-6	20	154	405
DOID:1561	cognitive disorder	GO:0032103	positive regulation of response to external stimulus	1.488059675480713e-10	3.2819156142727124e-6	27	285	405
DOID:1561	cognitive disorder	GO:0051924	regulation of calcium ion transport	1.521489600975201e-10	3.355645314950806e-6	23	207	405
DOID:1561	cognitive disorder	GO:0031644	regulation of neurological system process	1.738325039468691e-10	3.833875874548198e-6	14	68	405
DOID:1561	cognitive disorder	GO:0050880	regulation of blood vessel size	1.7556012199548832e-10	3.871978490610495e-6	19	139	405
DOID:1561	cognitive disorder	GO:0051703	intraspecies interaction between organisms	1.8454227035391568e-10	4.07007977265561e-6	12	46	405
DOID:1561	cognitive disorder	GO:0035176	social behavior	1.8454227035391568e-10	4.07007977265561e-6	12	46	405
DOID:1561	cognitive disorder	GO:0001963	synaptic transmission, dopaminergic	1.9120416361317893e-10	4.217007828488661e-6	10	28	405
DOID:1561	cognitive disorder	GO:0051937	catecholamine transport	2.532478671213312e-10	5.585381709360959e-6	13	58	405
DOID:1561	cognitive disorder	GO:0009150	purine ribonucleotide metabolic process	3.4496316914101044e-10	7.608162695404985e-6	36	501	405
DOID:1561	cognitive disorder	GO:0051341	regulation of oxidoreductase activity	3.8601910556934627e-10	8.513651373331932e-6	15	85	405
DOID:1561	cognitive disorder	GO:0050865	regulation of cell activation	4.662744634842397e-10	1.0283683292144907e-5	34	458	405
DOID:1561	cognitive disorder	GO:0008306	associative learning	4.71875871710381e-10	1.0407222350572454e-5	14	73	405
DOID:1561	cognitive disorder	GO:0016125	sterol metabolic process	5.551040738183133e-10	1.22428203480629e-5	18	132	405
DOID:1561	cognitive disorder	GO:0045429	positive regulation of nitric oxide biosynthetic process	5.741666031511272e-10	1.266324443249811e-5	11	40	405
DOID:1561	cognitive disorder	GO:0071902	positive regulation of protein serine/threonine kinase activity	6.424668574922521e-10	1.416960654199162e-5	26	283	405
DOID:1561	cognitive disorder	GO:0061564	axon development	6.495495252778483e-10	1.4325814780002943e-5	33	440	405
DOID:1561	cognitive disorder	GO:0032370	positive regulation of lipid transport	6.825514597963434e-10	1.5053672445808353e-5	12	51	405
DOID:1561	cognitive disorder	GO:0048812	neuron projection morphogenesis	6.884514069938064e-10	1.51837957812484e-5	37	539	405
DOID:1561	cognitive disorder	GO:0008203	cholesterol metabolic process	7.0430117293796e-10	1.5533362369146708e-5	17	118	405
DOID:1561	cognitive disorder	GO:0098793	presynapse	7.47819473012612e-10	1.6493158477293157e-5	22	205	405
DOID:1561	cognitive disorder	GO:0030141	secretory granule	7.970578641547377e-10	1.757911119393274e-5	29	351	405
DOID:1561	cognitive disorder	GO:0050808	synapse organization	8.032112752687226e-10	1.7714824676051677e-5	23	225	405
DOID:1561	cognitive disorder	GO:0048667	cell morphogenesis involved in neuron differentiation	9.278130486123359e-10	2.046291678714507e-5	35	495	405
DOID:1561	cognitive disorder	GO:0010506	regulation of autophagy	9.646483611902568e-10	2.1275319606051113e-5	24	247	405
DOID:1561	cognitive disorder	GO:2000021	regulation of ion homeostasis	9.663764233280858e-10	2.1313432016500933e-5	21	189	405
DOID:1561	cognitive disorder	GO:0018108	peptidyl-tyrosine phosphorylation	9.71151603579301e-10	2.1418748616941485e-5	29	354	405
DOID:1561	cognitive disorder	GO:0035264	multicellular organism growth	1.0287680707321556e-9	2.268947979999769e-5	18	137	405
DOID:1561	cognitive disorder	GO:0043271	negative regulation of ion transport	1.0495063706983387e-9	2.314686300575186e-5	17	121	405
DOID:1561	cognitive disorder	GO:0010817	regulation of hormone levels	1.0657847937523002e-9	2.350588362620698e-5	34	473	405
DOID:1561	cognitive disorder	GO:0040014	regulation of multicellular organism growth	1.1487341078364466e-9	2.533533074833283e-5	13	65	405
DOID:1561	cognitive disorder	GO:0015872	dopamine transport	1.2241818669878057e-9	2.6999331076416055e-5	10	33	405
DOID:1561	cognitive disorder	GO:0050433	regulation of catecholamine secretion	1.3475554005992763e-9	2.9720334360217038e-5	11	43	405
DOID:1561	cognitive disorder	GO:0048609	multicellular organismal reproductive process	1.4004580828341773e-9	3.088710301690778e-5	45	767	405
DOID:1561	cognitive disorder	GO:0007409	axonogenesis	1.4104543089032973e-9	3.110756978286222e-5	31	406	405
DOID:1561	cognitive disorder	GO:0042391	regulation of membrane potential	1.6917880429900833e-9	3.731238528814629e-5	28	340	405
DOID:1561	cognitive disorder	GO:0032102	negative regulation of response to external stimulus	1.7224598414244952e-9	3.798885180261724e-5	25	275	405
DOID:1561	cognitive disorder	GO:0045927	positive regulation of growth	1.8835800696948013e-9	4.154235843711884e-5	23	235	405
DOID:1561	cognitive disorder	GO:0022898	regulation of transmembrane transporter activity	2.0018788848830127e-9	4.4151438806094845e-5	20	178	405
DOID:1561	cognitive disorder	GO:0090407	organophosphate biosynthetic process	2.0393809974095234e-9	4.497854789786704e-5	38	587	405
DOID:1561	cognitive disorder	GO:0006879	cellular iron ion homeostasis	2.2871247118416704e-9	5.044253551966804e-5	11	45	405
DOID:1561	cognitive disorder	GO:0010039	response to iron ion	2.335727944391408e-9	5.1514479813552505e-5	10	35	405
DOID:1561	cognitive disorder	GO:0015908	fatty acid transport	2.3502653156981523e-9	5.183510153772275e-5	14	82	405
DOID:1561	cognitive disorder	GO:0014823	response to activity	2.4991937408458398e-9	5.5119717954354996e-5	13	69	405
DOID:1561	cognitive disorder	GO:0071407	cellular response to organic cyclic compound	2.5326817310045158e-9	5.5858295577304595e-5	31	416	405
DOID:1561	cognitive disorder	GO:0009266	response to temperature stimulus	2.6167352729089544e-9	5.771209644400699e-5	22	219	405
DOID:1561	cognitive disorder	GO:0050905	neuromuscular process	2.621277195302696e-9	5.781226854240096e-5	15	97	405
DOID:1561	cognitive disorder	GO:0071363	cellular response to growth factor stimulus	2.8236385452018453e-9	6.22753481144267e-5	38	594	405
DOID:1561	cognitive disorder	GO:0009152	purine ribonucleotide biosynthetic process	2.835088830366317e-9	6.252788415372912e-5	23	240	405
DOID:1561	cognitive disorder	GO:0044089	positive regulation of cellular component biogenesis	2.838655421832925e-9	6.260654532852516e-5	31	418	405
DOID:1561	cognitive disorder	GO:0045121	membrane raft	2.892491579586931e-9	6.379390178778976e-5	25	282	405
DOID:1561	cognitive disorder	GO:0018105	peptidyl-serine phosphorylation	3.0731179823106913e-9	6.77776170998623e-5	23	241	405
DOID:1561	cognitive disorder	GO:0051931	regulation of sensory perception	3.1720791549005867e-9	6.996020576133244e-5	10	36	405
DOID:1561	cognitive disorder	GO:0051930	regulation of sensory perception of pain	3.1720791549005867e-9	6.996020576133244e-5	10	36	405
DOID:1561	cognitive disorder	GO:0051054	positive regulation of DNA metabolic process	3.2548689299360944e-9	7.178613424974056e-5	20	183	405
DOID:1561	cognitive disorder	GO:0050886	endocrine process	3.828431349717221e-9	8.44360534180133e-5	14	85	405
DOID:1561	cognitive disorder	GO:0030431	sleep	4.263665420722873e-9	9.403514085404296e-5	10	37	405
DOID:1561	cognitive disorder	GO:0071453	cellular response to oxygen levels	4.5180187369098235e-9	9.964490324254616e-5	18	150	405
Orphanet:404584	Rare genetic bone development disorder	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1.9737544931786033e-12	4.3531155347054096e-8	37	307	408
Orphanet:404584	Rare genetic bone development disorder	GO:0008544	epidermis development	1.007194327939942e-12	2.221367090271542e-8	31	296	408
Orphanet:404584	Rare genetic bone development disorder	GO:0072089	stem cell proliferation	2.1027624086400465e-13	4.6376424922556225e-9	24	139	408
Orphanet:404584	Rare genetic bone development disorder	GO:0072091	regulation of stem cell proliferation	9.547918011776346e-15	2.1057933174972732e-10	19	88	408
Orphanet:404584	Rare genetic bone development disorder	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3.3306690738754696e-15	7.345790642432348e-11	27	204	408
Orphanet:404584	Rare genetic bone development disorder	GO:0043062	extracellular structure organization	1.4943601911454607e-13	3.2958114015713136e-9	36	321	408
Orphanet:404584	Rare genetic bone development disorder	GO:0045778	positive regulation of ossification	3.1186164761720647e-13	6.878108638197489e-9	18	84	408
Orphanet:404584	Rare genetic bone development disorder	GO:0007517	muscle organ development	1.9447776722358867e-12	4.289207156116248e-8	32	340	408
Orphanet:404584	Rare genetic bone development disorder	GO:0014031	mesenchymal cell development	4.3046677333791195e-12	9.493944685967648e-8	23	171	408
Orphanet:404584	Rare genetic bone development disorder	GO:0098743	cell aggregation	6.2841953862857736e-12	1.3859792924453274e-7	10	21	408
Orphanet:404584	Rare genetic bone development disorder	GO:0001502	cartilage condensation	6.2841953862857736e-12	1.3859792924453274e-7	10	21	408
Orphanet:404584	Rare genetic bone development disorder	GO:0048534	hematopoietic or lymphoid organ development	1.6569967620228e-11	3.654506358641285e-7	49	739	408
Orphanet:404584	Rare genetic bone development disorder	GO:0048738	cardiac muscle tissue development	1.8203438756358992e-11	4.0147684177149756e-7	22	168	408
Orphanet:404584	Rare genetic bone development disorder	GO:0048332	mesoderm morphogenesis	2.3042789898397587e-11	5.082087312091588e-7	15	70	408
Orphanet:404584	Rare genetic bone development disorder	GO:0001837	epithelial to mesenchymal transition	2.378575114647674e-11	5.245947415355445e-7	18	109	408
Orphanet:404584	Rare genetic bone development disorder	GO:0007017	microtubule-based process	2.5173307882653262e-11	5.551973053519177e-7	42	591	408
Orphanet:404584	Rare genetic bone development disorder	GO:0010171	body morphogenesis	2.758726580509574e-11	6.084371473313865e-7	13	49	408
Orphanet:404584	Rare genetic bone development disorder	GO:0030097	hemopoiesis	9.055700633808783e-11	1.997234774786527e-6	45	695	408
Orphanet:404584	Rare genetic bone development disorder	GO:0001707	mesoderm formation	1.9143475693539358e-10	4.222093564210105e-6	14	68	408
Orphanet:404584	Rare genetic bone development disorder	GO:0055024	regulation of cardiac muscle tissue development	3.4564140438675395e-10	7.623121173749858e-6	12	48	408
Orphanet:404584	Rare genetic bone development disorder	GO:0032403	protein complex binding	3.7791592077951464e-10	8.334935632792195e-6	52	924	408
Orphanet:404584	Rare genetic bone development disorder	GO:0061311	cell surface receptor signaling pathway involved in heart development	4.025504374283173e-10	8.878249897481538e-6	9	22	408
Orphanet:404584	Rare genetic bone development disorder	GO:0021532	neural tube patterning	4.5893000510943693e-10	1.0121701262688632e-5	11	39	408
Orphanet:404584	Rare genetic bone development disorder	GO:2000738	positive regulation of stem cell differentiation	5.789733137362418e-10	1.2769256434452814e-5	12	50	408
Orphanet:404584	Rare genetic bone development disorder	GO:0060324	face development	5.789733137362418e-10	1.2769256434452814e-5	12	50	408
Orphanet:404584	Rare genetic bone development disorder	GO:0072132	mesenchyme morphogenesis	6.206655189799903e-10	1.3688778021103687e-5	11	40	408
Orphanet:404584	Rare genetic bone development disorder	GO:0060325	face morphogenesis	6.549802922251047e-10	1.4445590345024684e-5	10	31	408
Orphanet:404584	Rare genetic bone development disorder	GO:0003156	regulation of organ formation	6.549802922251047e-10	1.4445590345024684e-5	10	31	408
Orphanet:404584	Rare genetic bone development disorder	GO:0000578	embryonic axis specification	9.343282814100462e-10	2.060661024649857e-5	10	32	408
Orphanet:404584	Rare genetic bone development disorder	GO:0030177	positive regulation of Wnt signaling pathway	9.421859958891332e-10	2.0779912139334833e-5	19	152	408
Orphanet:404584	Rare genetic bone development disorder	GO:2000826	regulation of heart morphogenesis	1.0178086151668708e-9	2.2447769007505336e-5	9	24	408
Orphanet:404584	Rare genetic bone development disorder	GO:0030514	negative regulation of BMP signaling pathway	1.1050586001815077e-9	2.4372067427003152e-5	11	42	408
Orphanet:404584	Rare genetic bone development disorder	GO:0042692	muscle cell differentiation	1.3361715067716773e-9	2.9469262581849343e-5	28	334	408
Orphanet:404584	Rare genetic bone development disorder	GO:0021700	developmental maturation	1.5521738339074886e-9	3.423319390682966e-5	23	231	408
Orphanet:404584	Rare genetic bone development disorder	GO:0002076	osteoblast development	1.7546603059415133e-9	3.869903304754008e-5	8	18	408
Orphanet:404584	Rare genetic bone development disorder	GO:0001708	cell fate specification	2.185508218843779e-9	4.820138376659955e-5	14	81	408
Orphanet:404584	Rare genetic bone development disorder	GO:0002065	columnar/cuboidal epithelial cell differentiation	2.841814339404891e-9	6.267621525557487e-5	17	128	408
Orphanet:404584	Rare genetic bone development disorder	GO:0030879	mammary gland development	2.841814339404891e-9	6.267621525557487e-5	17	128	408
Orphanet:404584	Rare genetic bone development disorder	GO:0048701	embryonic cranial skeleton morphogenesis	3.183766028591606e-9	7.021795976058787e-5	11	46	408
Orphanet:404584	Rare genetic bone development disorder	GO:0002053	positive regulation of mesenchymal cell proliferation	3.4424140205047138e-9	7.592244122223146e-5	9	27	408
Orphanet:404584	Rare genetic bone development disorder	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3.874536580461552e-9	8.545290428207952e-5	15	99	408
Orphanet:404584	Rare genetic bone development disorder	GO:0005694	chromosome	4.471242265324804e-9	9.861324816173855e-5	48	876	408
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0050804	modulation of synaptic transmission	9.945377854592152e-13	2.1934530858302992e-8	32	285	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:1901698	response to nitrogen compound	4.659606034351782e-13	1.0276761108762855e-8	60	870	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0030534	adult behavior	1.868172283536751e-12	4.120253971340304e-8	21	135	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0098771	inorganic ion homeostasis	3.861910791158607e-12	8.517444249900308e-8	52	609	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0030426	growth cone	5.257905222322279e-12	1.1596309967831786e-7	21	142	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048666	neuron development	5.795253166240855e-12	1.2781430858144205e-7	63	926	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048667	cell morphogenesis involved in neuron differentiation	7.459033390944114e-12	1.6450898143727244e-7	41	495	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048858	cell projection morphogenesis	1.0673351091838867e-11	2.3540075833050622e-7	64	767	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0060322	head development	1.2110756841821058e-11	2.671027421463634e-7	54	708	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048812	neuron projection morphogenesis	1.2820633443766383e-11	2.8275907060226757e-7	42	539	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0051052	regulation of DNA metabolic process	1.3949064125995392e-11	3.0764660929882837e-7	31	335	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0032940	secretion by cell	1.84323667440367e-11	4.065258485397294e-7	56	956	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0061564	axon development	2.114919350759692e-11	4.6644546281005006e-7	36	440	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0098794	postsynapse	2.247979580261017e-11	4.957918964265673e-7	33	381	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0007409	axonogenesis	2.927225128956934e-11	6.455995021914518e-7	34	406	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0040007	growth	3.06588088250237e-11	6.761800286358977e-7	55	936	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:2000379	positive regulation of reactive oxygen species metabolic process	3.067690546032509e-11	6.765791499274698e-7	16	83	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048167	regulation of synaptic plasticity	3.284883476339928e-11	7.244810507067712e-7	20	140	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0030424	axon	4.9977355587316197e-11	1.1022505774782587e-6	34	414	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:1901701	cellular response to oxygen-containing compound	6.196343438347185e-11	1.3666035453274716e-6	52	873	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0042391	regulation of membrane potential	1.1430589808014702e-10	2.5210165821576425e-6	30	340	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0044057	regulation of system process	2.0576751413869943e-10	4.538202524329016e-6	37	508	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0050767	regulation of neurogenesis	6.672592478551564e-10	1.4716402711445475e-5	42	658	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0051054	positive regulation of DNA metabolic process	6.936106133892395e-10	1.5297582078299676e-5	21	183	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0051241	negative regulation of multicellular organismal process	7.906693078041371e-10	1.7438211583620244e-5	53	966	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0016358	dendrite development	9.371305953465026e-10	2.0668415280367114e-5	21	186	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0072521	purine-containing compound metabolic process	1.2395455772917785e-9	2.7338177707170175e-5	38	568	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0045664	regulation of neuron differentiation	1.613833955360633e-9	3.559310788547876e-5	37	548	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0060079	excitatory postsynaptic potential	1.6424265281145267e-9	3.622371707756589e-5	12	54	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0045073	regulation of chemokine biosynthetic process	1.714463571111935e-9	3.7812494060873725e-5	7	12	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0006898	receptor-mediated endocytosis	2.2677244526647655e-9	5.0014662803521404e-5	24	254	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0048589	developmental growth	2.629139017606974e-9	5.798566103332181e-5	37	558	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0046128	purine ribonucleoside metabolic process	2.676285304481496e-9	5.9025472390339395e-5	28	342	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0034976	response to endoplasmic reticulum stress	3.099935863559722e-9	6.836908547080967e-5	24	258	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0050905	neuromuscular process	3.1995898153169833e-9	7.056695337681607e-5	15	97	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0030100	regulation of endocytosis	3.226449551974042e-9	7.11593448687875e-5	21	199	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0007612	learning	4.037691403446786e-9	8.905128390301886e-5	17	130	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0018105	peptidyl-serine phosphorylation	4.0632399667117625e-9	8.961475746582792e-5	23	241	411
Orphanet:98033	Rare neurologic disease with psychiatric involvement	GO:0007613	memory	4.277368348404309e-9	9.433735892405704e-5	15	99	411
Orphanet:97935	Rare gastroenterologic disease	GO:0001775	cell activation	3.0615510127063317e-12	6.752250758523815e-8	57	854	413
Orphanet:97935	Rare gastroenterologic disease	GO:0036293	response to decreased oxygen levels	2.773337115513641e-12	6.116595008265335e-8	33	302	413
Orphanet:97935	Rare gastroenterologic disease	GO:0097193	intrinsic apoptotic signaling pathway	1.3005152510459084e-12	2.868286386181751e-8	30	272	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010631	epithelial cell migration	1.035393992765421e-12	2.283561451044136e-8	29	218	413
Orphanet:97935	Rare gastroenterologic disease	GO:0097191	extrinsic apoptotic signaling pathway	4.780620344035924e-13	1.054365816877123e-8	29	220	413
Orphanet:97935	Rare gastroenterologic disease	GO:0002237	response to molecule of bacterial origin	3.622657729351886e-13	7.989771622085584e-9	32	333	413
Orphanet:97935	Rare gastroenterologic disease	GO:0055123	digestive system development	1.9210188995089084e-12	4.2368071828668974e-8	22	150	413
Orphanet:97935	Rare gastroenterologic disease	GO:0098771	inorganic ion homeostasis	3.0121460881105122e-12	6.643288197327735e-8	47	609	413
Orphanet:97935	Rare gastroenterologic disease	GO:0046649	lymphocyte activation	5.4996007747831754e-12	1.2129369508784293e-7	45	594	413
Orphanet:97935	Rare gastroenterologic disease	GO:0055080	cation homeostasis	7.041256466777668e-12	1.5529491137478146e-7	46	595	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001503	ossification	7.390976719534592e-12	1.6300799154933543e-7	33	363	413
Orphanet:97935	Rare gastroenterologic disease	GO:0043009	chordate embryonic development	8.102629678319317e-12	1.7870349755533255e-7	43	552	413
Orphanet:97935	Rare gastroenterologic disease	GO:0032355	response to estradiol	8.573031173852996e-12	1.8907820253932783e-7	21	145	413
Orphanet:97935	Rare gastroenterologic disease	GO:0048589	developmental growth	9.013900736931646e-12	1.9880158075302745e-7	45	558	413
Orphanet:97935	Rare gastroenterologic disease	GO:0045926	negative regulation of growth	9.465650485651622e-12	2.0876492146104653e-7	26	230	413
Orphanet:97935	Rare gastroenterologic disease	GO:0055065	metal ion homeostasis	1.0946799022804043e-11	2.414316524479432e-7	42	516	413
Orphanet:97935	Rare gastroenterologic disease	GO:0007610	behavior	1.3450129898728846e-11	2.966426149164647e-7	49	714	413
Orphanet:97935	Rare gastroenterologic disease	GO:0006873	cellular ion homeostasis	2.229361140138053e-11	4.916855994574476e-7	40	532	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001819	positive regulation of cytokine production	2.536870713498729e-11	5.595068358621447e-7	33	381	413
Orphanet:97935	Rare gastroenterologic disease	GO:0030098	lymphocyte differentiation	2.562827727814465e-11	5.652316553694803e-7	29	299	413
Orphanet:97935	Rare gastroenterologic disease	GO:0042060	wound healing	2.5899726807665502e-11	5.712184747430626e-7	40	534	413
Orphanet:97935	Rare gastroenterologic disease	GO:0052547	regulation of peptidase activity	2.6467050773248957e-11	5.837308048040057e-7	33	382	413
Orphanet:97935	Rare gastroenterologic disease	GO:0051098	regulation of binding	2.6717739132209317e-11	5.892597365608765e-7	28	279	413
Orphanet:97935	Rare gastroenterologic disease	GO:0052548	regulation of endopeptidase activity	3.0677682616442326e-11	6.765962901056355e-7	32	362	413
Orphanet:97935	Rare gastroenterologic disease	GO:0007050	cell cycle arrest	3.083677757587111e-11	6.801051294358373e-7	26	242	413
Orphanet:97935	Rare gastroenterologic disease	GO:0016491	oxidoreductase activity	3.1487035201394065e-11	6.944465613667461e-7	47	710	413
Orphanet:97935	Rare gastroenterologic disease	GO:1901699	cellular response to nitrogen compound	3.640898693646477e-11	8.030002068837305e-7	39	518	413
Orphanet:97935	Rare gastroenterologic disease	GO:0030003	cellular cation homeostasis	3.6569747230430494e-11	8.065457751671445e-7	39	519	413
Orphanet:97935	Rare gastroenterologic disease	GO:0007346	regulation of mitotic cell cycle	4.055378255429787e-11	8.944136742350395e-7	36	453	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010638	positive regulation of organelle organization	4.482680893147517e-11	9.886552709836849e-7	41	573	413
Orphanet:97935	Rare gastroenterologic disease	GO:0042063	gliogenesis	4.8206660885341535e-11	1.0631979058262075e-6	25	228	413
Orphanet:97935	Rare gastroenterologic disease	GO:0042113	B cell activation	6.108991090769678e-11	1.3473379850692524e-6	24	212	413
Orphanet:97935	Rare gastroenterologic disease	GO:1900180	regulation of protein localization to nucleus	6.718747780354306e-11	1.4818198229571422e-6	24	213	413
Orphanet:97935	Rare gastroenterologic disease	GO:0043269	regulation of ion transport	7.171663263250139e-11	1.581710332709818e-6	41	583	413
Orphanet:97935	Rare gastroenterologic disease	GO:0033044	regulation of chromosome organization	7.23225923593418e-11	1.5950747744852833e-6	27	271	413
Orphanet:97935	Rare gastroenterologic disease	GO:0006801	superoxide metabolic process	7.306832916498252e-11	1.6115219997336894e-6	13	52	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001701	in utero embryonic development	7.683975677963417e-11	1.6947008357748317e-6	29	312	413
Orphanet:97935	Rare gastroenterologic disease	GO:0050776	regulation of immune response	7.870071261351086e-11	1.735744216690982e-6	50	816	413
Orphanet:97935	Rare gastroenterologic disease	GO:0051345	positive regulation of hydrolase activity	8.053591127321624e-11	1.7762195231307842e-6	53	900	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010769	regulation of cell morphogenesis involved in differentiation	8.133060891424293e-11	1.7937465796036278e-6	30	334	413
Orphanet:97935	Rare gastroenterologic disease	GO:0016055	Wnt signaling pathway	8.14500689116926e-11	1.7963812698473802e-6	36	465	413
Orphanet:97935	Rare gastroenterologic disease	GO:0043086	negative regulation of catalytic activity	1.0012124462832617e-10	2.2081740502777336e-6	50	822	413
Orphanet:97935	Rare gastroenterologic disease	GO:0007162	negative regulation of cell adhesion	1.0806855410550043e-10	2.383451960796812e-6	24	218	413
Orphanet:97935	Rare gastroenterologic disease	GO:0006875	cellular metal ion homeostasis	1.2595435805451416e-10	2.7779233668923098e-6	35	450	413
Orphanet:97935	Rare gastroenterologic disease	GO:2001236	regulation of extrinsic apoptotic signaling pathway	1.462531207252482e-10	3.2256125775953493e-6	20	151	413
Orphanet:97935	Rare gastroenterologic disease	GO:0045931	positive regulation of mitotic cell cycle	1.5304779665825663e-10	3.37546915529785e-6	18	120	413
Orphanet:97935	Rare gastroenterologic disease	GO:0048871	multicellular organismal homeostasis	1.5339807202252587e-10	3.383194478456808e-6	29	321	413
Orphanet:97935	Rare gastroenterologic disease	GO:0031400	negative regulation of protein modification process	1.9082313507112758e-10	4.208604243993719e-6	42	628	413
Orphanet:97935	Rare gastroenterologic disease	GO:0032403	protein complex binding	2.0141466272605157e-10	4.4422003864230675e-6	53	924	413
Orphanet:97935	Rare gastroenterologic disease	GO:0032103	positive regulation of response to external stimulus	2.3074431254599403e-10	5.0890658132018984e-6	27	285	413
Orphanet:97935	Rare gastroenterologic disease	GO:0030111	regulation of Wnt signaling pathway	2.365709850238318e-10	5.21757307470061e-6	28	306	413
Orphanet:97935	Rare gastroenterologic disease	GO:0048771	tissue remodeling	2.4453361557874587e-10	5.39318889158924e-6	19	139	413
Orphanet:97935	Rare gastroenterologic disease	GO:0060326	cell chemotaxis	2.773610230377699e-10	6.117197363098015e-6	24	228	413
Orphanet:97935	Rare gastroenterologic disease	GO:0005912	adherens junction	3.0124291949817916e-10	6.6439125895323414e-6	35	465	413
Orphanet:97935	Rare gastroenterologic disease	GO:0051146	striated muscle cell differentiation	3.319688968161927e-10	7.32157401928113e-6	24	230	413
Orphanet:97935	Rare gastroenterologic disease	GO:0003013	circulatory system process	3.7922209816798613e-10	8.363743375094934e-6	36	493	413
Orphanet:97935	Rare gastroenterologic disease	GO:0070201	regulation of establishment of protein localization	3.993841923843888e-10	8.808418363037696e-6	48	803	413
Orphanet:97935	Rare gastroenterologic disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	4.126995412079282e-10	9.102088381340856e-6	22	195	413
Orphanet:97935	Rare gastroenterologic disease	GO:0046822	regulation of nucleocytoplasmic transport	4.768478945038623e-10	1.0516880313282684e-5	23	215	413
Orphanet:97935	Rare gastroenterologic disease	GO:0045596	negative regulation of cell differentiation	4.909143092035606e-10	1.082711508948453e-5	40	597	413
Orphanet:97935	Rare gastroenterologic disease	GO:0032844	regulation of homeostatic process	4.983728985052949e-10	1.0991614276534278e-5	33	427	413
Orphanet:97935	Rare gastroenterologic disease	GO:0046332	SMAD binding	5.016419502013036e-10	1.1063713211689752e-5	14	72	413
Orphanet:97935	Rare gastroenterologic disease	GO:0003007	heart morphogenesis	5.221943988331645e-10	1.1516997466265444e-5	23	216	413
Orphanet:97935	Rare gastroenterologic disease	GO:0051223	regulation of protein transport	5.594107399531367e-10	1.233780386966643e-5	45	730	413
Orphanet:97935	Rare gastroenterologic disease	GO:0050778	positive regulation of immune response	6.526112983351595e-10	1.4393342184781943e-5	40	603	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010632	regulation of epithelial cell migration	6.549549791401432e-10	1.4445032064935859e-5	20	164	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010634	positive regulation of epithelial cell migration	7.067267882021611e-10	1.5586859313798662e-5	16	101	413
Orphanet:97935	Rare gastroenterologic disease	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	7.067267882021611e-10	1.5586859313798662e-5	16	101	413
Orphanet:97935	Rare gastroenterologic disease	GO:0010959	regulation of metal ion transport	7.168190485629111e-10	1.5809444116055005e-5	28	321	413
Orphanet:97935	Rare gastroenterologic disease	GO:0030308	negative regulation of cell growth	8.135684348431482e-10	1.7943251830465634e-5	20	166	413
Orphanet:97935	Rare gastroenterologic disease	GO:0045785	positive regulation of cell adhesion	8.860921996145521e-10	1.9542763462498947e-5	30	368	413
Orphanet:97935	Rare gastroenterologic disease	GO:0043393	regulation of protein binding	9.058712668874591e-10	1.997899079120291e-5	20	167	413
Orphanet:97935	Rare gastroenterologic disease	GO:0031175	neuron projection development	9.161889025222081e-10	2.02065462451273e-5	47	796	413
Orphanet:97935	Rare gastroenterologic disease	GO:0046824	positive regulation of nucleocytoplasmic transport	9.486708085759687e-10	2.092293468314299e-5	17	118	413
Orphanet:97935	Rare gastroenterologic disease	GO:0003012	muscle system process	1.0278845552491589e-9	2.26699938660202e-5	31	393	413
Orphanet:97935	Rare gastroenterologic disease	GO:0071396	cellular response to lipid	1.0289135099483815e-9	2.2692687461911554e-5	32	416	413
Orphanet:97935	Rare gastroenterologic disease	GO:0008015	blood circulation	1.1302339064656053e-9	2.4927308807098925e-5	35	489	413
Orphanet:97935	Rare gastroenterologic disease	GO:0030055	cell-substrate junction	1.1634275765004531e-9	2.5659395199717494e-5	31	395	413
Orphanet:97935	Rare gastroenterologic disease	GO:0006606	protein import into nucleus	1.5073036152557506e-9	3.324358123446558e-5	25	268	413
Orphanet:97935	Rare gastroenterologic disease	GO:0019199	transmembrane receptor protein kinase activity	1.8152903624724104e-9	4.003622894432901e-5	14	79	413
Orphanet:97935	Rare gastroenterologic disease	GO:0002253	activation of immune response	1.964262530407268e-9	4.33218101081323e-5	34	475	413
Orphanet:97935	Rare gastroenterologic disease	GO:0042306	regulation of protein import into nucleus	2.0754734597616675e-9	4.577456715504358e-5	20	175	413
Orphanet:97935	Rare gastroenterologic disease	GO:0051051	negative regulation of transport	2.093008766301807e-9	4.6161308340786356e-5	33	452	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001101	response to acid chemical	2.1336534761218218e-9	4.705772741586678e-5	27	315	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001837	epithelial to mesenchymal transition	2.2433925828124757e-9	4.947802341392915e-5	16	109	413
Orphanet:97935	Rare gastroenterologic disease	GO:1900182	positive regulation of protein localization to nucleus	2.3552518824132562e-9	5.1945080266624366e-5	17	125	413
Orphanet:97935	Rare gastroenterologic disease	GO:0003018	vascular process in circulatory system	2.485362915471967e-9	5.481467910073423e-5	19	159	413
Orphanet:97935	Rare gastroenterologic disease	GO:2000027	regulation of organ morphogenesis	2.9724871453140622e-9	6.555820398990164e-5	23	236	413
Orphanet:97935	Rare gastroenterologic disease	GO:0044057	regulation of system process	3.0554623275946824e-9	6.738822163510072e-5	35	508	413
Orphanet:97935	Rare gastroenterologic disease	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3.0705867848368484e-9	6.772179153957669e-5	19	161	413
Orphanet:97935	Rare gastroenterologic disease	GO:0005925	focal adhesion	3.0814193419104186e-9	6.796070358583428e-5	30	388	413
Orphanet:97935	Rare gastroenterologic disease	GO:0050920	regulation of chemotaxis	3.086832345289281e-9	6.808008737535509e-5	20	179	413
Orphanet:97935	Rare gastroenterologic disease	GO:0038127	ERBB signaling pathway	3.16992154747453e-9	6.991261972955076e-5	18	144	413
Orphanet:97935	Rare gastroenterologic disease	GO:0050680	negative regulation of epithelial cell proliferation	3.3691589518269893e-9	7.430680068254425e-5	16	112	413
Orphanet:97935	Rare gastroenterologic disease	GO:0001657	ureteric bud development	3.416852911719559e-9	7.535869096797487e-5	15	97	413
Orphanet:97935	Rare gastroenterologic disease	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	3.416852911719559e-9	7.535869096797487e-5	15	97	413
Orphanet:97935	Rare gastroenterologic disease	GO:0007420	brain development	4.024006239333744e-9	8.874945760850572e-5	41	669	413
Orphanet:97935	Rare gastroenterologic disease	GO:0032835	glomerulus development	4.1643302139959815e-9	9.184430286968137e-5	12	58	413
DOID:2213	hemorrhagic disease	GO:0043062	extracellular structure organization	1.8895995879120164e-13	4.167511891139952e-9	36	321	414
DOID:2213	hemorrhagic disease	GO:0030198	extracellular matrix organization	1.5476508963274682e-13	3.413344051850231e-9	36	320	414
DOID:2213	hemorrhagic disease	GO:0050819	negative regulation of coagulation	9.2148511043888e-15	2.0323354110729497e-10	18	51	414
DOID:2213	hemorrhagic disease	GO:0009790	embryo development	6.210476577450663e-12	1.3697206091567438e-7	58	932	414
DOID:2213	hemorrhagic disease	GO:0050820	positive regulation of coagulation	6.260314489026086e-11	1.3807123605547034e-6	10	25	414
DOID:2213	hemorrhagic disease	GO:2000146	negative regulation of cell motility	9.34357036186384e-11	2.06072444330907e-6	24	216	414
DOID:2213	hemorrhagic disease	GO:0052548	regulation of endopeptidase activity	1.4494982991664074e-10	3.1968684988115115e-6	31	362	414
DOID:2213	hemorrhagic disease	GO:0032964	collagen biosynthetic process	2.036996127330326e-10	4.492594958827034e-6	11	36	414
DOID:2213	hemorrhagic disease	GO:0010594	regulation of endothelial cell migration	4.278346565911306e-10	9.435893351117386e-6	17	112	414
DOID:2213	hemorrhagic disease	GO:0043200	response to amino acid	4.278346565911306e-10	9.435893351117386e-6	17	112	414
DOID:2213	hemorrhagic disease	GO:0043535	regulation of blood vessel endothelial cell migration	5.300994088131006e-10	1.1691342461372933e-5	12	49	414
DOID:2213	hemorrhagic disease	GO:0007162	negative regulation of cell adhesion	6.570993749122067e-10	1.4492326713688719e-5	23	218	414
DOID:2213	hemorrhagic disease	GO:0002673	regulation of acute inflammatory response	7.591289818975611e-10	1.674258969575071e-5	14	74	414
DOID:2213	hemorrhagic disease	GO:0001501	skeletal system development	8.243014049114095e-10	1.8179967485321136e-5	35	482	414
DOID:2213	hemorrhagic disease	GO:0030336	negative regulation of cell migration	1.0271203887413094e-9	2.265314017368958e-5	22	204	414
DOID:2213	hemorrhagic disease	GO:0050921	positive regulation of chemotaxis	1.1249838838267578e-9	2.4811519557799144e-5	17	119	414
DOID:2213	hemorrhagic disease	GO:0002020	protease binding	1.1432419455559284e-9	2.5214201109236e-5	16	104	414
DOID:2213	hemorrhagic disease	GO:0051046	regulation of secretion	1.7682943997954226e-9	3.8999732987488045e-5	42	675	414
DOID:2213	hemorrhagic disease	GO:0001701	in utero embryonic development	1.8235738474814411e-9	4.0218921206203184e-5	27	312	414
DOID:2213	hemorrhagic disease	GO:0032846	positive regulation of homeostatic process	1.9135670825676243e-9	4.2203722006028954e-5	21	192	414
DOID:2213	hemorrhagic disease	GO:0001936	regulation of endothelial cell proliferation	1.9321291233609372e-9	4.261310781572547e-5	15	93	414
DOID:2213	hemorrhagic disease	GO:0071260	cellular response to mechanical stimulus	2.2244147634964406e-9	4.9059467608914e-5	14	80	414
DOID:2213	hemorrhagic disease	GO:0051047	positive regulation of secretion	2.863382420059679e-9	6.315189927441622e-5	29	363	414
DOID:2213	hemorrhagic disease	GO:0048008	platelet-derived growth factor receptor signaling pathway	2.877207250229219e-9	6.345680590380542e-5	11	45	414
DOID:2213	hemorrhagic disease	GO:0000302	response to reactive oxygen species	3.0263831440890954e-9	6.6746880242885e-5	22	216	414
DOID:2213	hemorrhagic disease	GO:0019725	cellular homeostasis	3.2829085006014225e-9	7.240454698076437e-5	45	771	414
DOID:2213	hemorrhagic disease	GO:0043491	protein kinase B signaling	3.292603856230869e-9	7.261837804917182e-5	18	144	414
DOID:2213	hemorrhagic disease	GO:0005788	endoplasmic reticulum lumen	3.670089898655249e-9	8.094383271484151e-5	21	199	414
DOID:2213	hemorrhagic disease	GO:0050839	cell adhesion molecule binding	4.30036350973495e-9	9.484451720720433e-5	20	182	414
Orphanet:139012	Rare bone development disorder	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2.184918912462308e-12	4.8188386614356205e-8	37	307	417
Orphanet:139012	Rare bone development disorder	GO:0010927	cellular component assembly involved in morphogenesis	8.550937735662956e-13	1.885909317600465e-8	35	270	417
Orphanet:139012	Rare bone development disorder	GO:0008544	epidermis development	7.556177905598815e-13	1.6665150370798187e-8	31	296	417
Orphanet:139012	Rare bone development disorder	GO:0007517	muscle organ development	4.440892098500626e-13	9.794387523243131e-9	33	340	417
Orphanet:139012	Rare bone development disorder	GO:0072091	regulation of stem cell proliferation	3.1086244689504383e-15	6.856071266270192e-11	20	88	417
Orphanet:139012	Rare bone development disorder	GO:0045778	positive regulation of ossification	1.0114131754335176e-13	2.230671758418623e-9	19	84	417
Orphanet:139012	Rare bone development disorder	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1.3988810110276972e-13	3.0852320698215863e-9	27	204	417
Orphanet:139012	Rare bone development disorder	GO:0043062	extracellular structure organization	2.1793677973391823e-13	4.8065956770315665e-9	36	321	417
Orphanet:139012	Rare bone development disorder	GO:0048864	stem cell development	1.2865264409356314e-12	2.837434065483535e-8	24	175	417
Orphanet:139012	Rare bone development disorder	GO:0048332	mesoderm morphogenesis	2.281397293302234e-12	5.0316217303780775e-8	16	70	417
Orphanet:139012	Rare bone development disorder	GO:0014031	mesenchymal cell development	5.8759663801311035e-12	1.295944385137915e-7	23	171	417
Orphanet:139012	Rare bone development disorder	GO:0098743	cell aggregation	7.806977286861638e-12	1.7218288406173343e-7	10	21	417
Orphanet:139012	Rare bone development disorder	GO:0001502	cartilage condensation	7.806977286861638e-12	1.7218288406173343e-7	10	21	417
Orphanet:139012	Rare bone development disorder	GO:0048534	hematopoietic or lymphoid organ development	1.3837153645113176e-11	3.051784236429711e-7	50	739	417
Orphanet:139012	Rare bone development disorder	GO:0007017	microtubule-based process	1.5234702388511323e-11	3.3600136117861723e-7	43	591	417
Orphanet:139012	Rare bone development disorder	GO:0048738	cardiac muscle tissue development	2.737898796567606e-11	6.038435795829855e-7	22	168	417
Orphanet:139012	Rare bone development disorder	GO:0001837	epithelial to mesenchymal transition	3.399525105862722e-11	7.497652620980233e-7	18	109	417
Orphanet:139012	Rare bone development disorder	GO:0010171	body morphogenesis	3.625855171662806e-11	7.996823581102319e-7	13	49	417
Orphanet:139012	Rare bone development disorder	GO:0030097	hemopoiesis	1.6883139331014263e-10	3.7235763794551957e-6	45	695	417
Orphanet:139012	Rare bone development disorder	GO:0044212	transcription regulatory region DNA binding	2.1369517266833782e-10	4.713047033200191e-6	49	807	417
Orphanet:139012	Rare bone development disorder	GO:0048701	embryonic cranial skeleton morphogenesis	2.579686464443398e-10	5.6894984973299145e-6	12	46	417
Orphanet:139012	Rare bone development disorder	GO:0032403	protein complex binding	2.8379032457337416e-10	6.258995608465767e-6	53	924	417
Orphanet:139012	Rare bone development disorder	GO:0031128	developmental induction	3.8024661197511023e-10	8.386339027111056e-6	10	29	417
Orphanet:139012	Rare bone development disorder	GO:0055024	regulation of cardiac muscle tissue development	4.434871359038084e-10	9.781108782358494e-6	12	48	417
Orphanet:139012	Rare bone development disorder	GO:0061311	cell surface receptor signaling pathway involved in heart development	4.88009188615024e-10	1.0763042654904353e-5	9	22	417
Orphanet:139012	Rare bone development disorder	GO:0021532	neural tube patterning	5.778950651347259e-10	1.274547566154638e-5	11	39	417
Orphanet:139012	Rare bone development disorder	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	6.707043809228708e-10	1.4792385121253915e-5	28	317	417
Orphanet:139012	Rare bone development disorder	GO:2000738	positive regulation of stem cell differentiation	7.421462333567774e-10	1.6368035176683726e-5	12	50	417
Orphanet:139012	Rare bone development disorder	GO:0060324	face development	7.421462333567774e-10	1.6368035176683726e-5	12	50	417
Orphanet:139012	Rare bone development disorder	GO:0072132	mesenchyme morphogenesis	7.812269720020026e-10	1.7229960867504168e-5	11	40	417
Orphanet:139012	Rare bone development disorder	GO:0060325	face morphogenesis	8.090740299948607e-10	1.7844127731536652e-5	10	31	417
Orphanet:139012	Rare bone development disorder	GO:0000578	embryonic axis specification	1.1536287480851115e-9	2.5443282039017134e-5	10	32	417
Orphanet:139012	Rare bone development disorder	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	1.3519639852077603e-9	2.9817565693757153e-5	28	327	417
Orphanet:139012	Rare bone development disorder	GO:0030177	positive regulation of Wnt signaling pathway	1.3534209308829759e-9	2.9849698630624033e-5	19	152	417
Orphanet:139012	Rare bone development disorder	GO:0030514	negative regulation of BMP signaling pathway	1.3895595785129444e-9	3.064673650410299e-5	11	42	417
Orphanet:139012	Rare bone development disorder	GO:0008134	transcription factor binding	1.8514935140601096e-9	4.083468945259572e-5	36	518	417
Orphanet:139012	Rare bone development disorder	GO:0002076	osteoblast development	2.0833247349472117e-9	4.5947727029260754e-5	8	18	417
Orphanet:139012	Rare bone development disorder	GO:0021700	developmental maturation	2.3577871877122902e-9	5.200099642499456e-5	23	231	417
Orphanet:139012	Rare bone development disorder	GO:0001843	neural tube closure	3.416102845044122e-9	7.534214824744812e-5	14	82	417
Orphanet:139012	Rare bone development disorder	GO:0002065	columnar/cuboidal epithelial cell differentiation	3.941250326100487e-9	8.692427594214625e-5	17	128	417
Orphanet:139012	Rare bone development disorder	GO:0030879	mammary gland development	3.941250326100487e-9	8.692427594214625e-5	17	128	417
Orphanet:139012	Rare bone development disorder	GO:0051960	regulation of nervous system development	4.172737932961468e-9	9.202973511146517e-5	44	744	417
MESH:D019465	Craniofacial Abnormalities	GO:0022603	regulation of anatomical structure morphogenesis	1.0859091403858656e-11	2.3949726091210266e-7	75	986	418
MESH:D019465	Craniofacial Abnormalities	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2.0410340084708878e-12	4.501500505682543e-8	39	307	418
MESH:D019465	Craniofacial Abnormalities	GO:0007517	muscle organ development	1.6229240173970538e-12	3.579358920369202e-8	45	340	418
MESH:D019465	Craniofacial Abnormalities	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	1.4912515666765103e-12	3.2889553303050434e-8	33	327	418
MESH:D019465	Craniofacial Abnormalities	GO:0008544	epidermis development	1.4634959910608814e-12	3.227740408284774e-8	35	296	418
MESH:D019465	Craniofacial Abnormalities	GO:0007548	sex differentiation	9.472422846101836e-13	2.08914285870776e-8	32	274	418
MESH:D019465	Craniofacial Abnormalities	GO:0001701	in utero embryonic development	8.828493491819245e-13	1.9471242396207344e-8	43	312	418
MESH:D019465	Craniofacial Abnormalities	GO:0040007	growth	5.966338534335591e-13	1.3158759637477146e-8	84	936	418
MESH:D019465	Craniofacial Abnormalities	GO:0035270	endocrine system development	4.474198789239381e-13	9.867845429667454e-9	30	129	418
MESH:D019465	Craniofacial Abnormalities	GO:0072009	nephron epithelium development	4.445332990599127e-13	9.804181910766374e-9	23	106	418
MESH:D019465	Craniofacial Abnormalities	GO:0001837	epithelial to mesenchymal transition	4.289901767151605e-13	9.461378347452865e-9	22	109	418
MESH:D019465	Craniofacial Abnormalities	GO:0014706	striated muscle tissue development	3.7481129311345285e-13	8.266463069617203e-9	43	323	418
MESH:D019465	Craniofacial Abnormalities	GO:0061326	renal tubule development	2.524647157997606e-13	5.56810930696372e-9	23	93	418
MESH:D019465	Craniofacial Abnormalities	GO:0009799	specification of symmetry	2.5068835896036035e-13	5.5289317568707474e-9	24	122	418
MESH:D019465	Craniofacial Abnormalities	GO:0002062	chondrocyte differentiation	2.291500322826323e-13	5.053903961993456e-9	23	95	418
MESH:D019465	Craniofacial Abnormalities	GO:0001763	morphogenesis of a branching structure	2.0250467969162855e-13	4.466240710598868e-9	41	193	418
MESH:D019465	Craniofacial Abnormalities	GO:0009855	determination of bilateral symmetry	1.787459069646502e-13	3.94224097810536e-9	23	121	418
MESH:D019465	Craniofacial Abnormalities	GO:0010721	negative regulation of cell development	1.729727472365994e-13	3.8149139403031995e-9	31	299	418
MESH:D019465	Craniofacial Abnormalities	GO:0035148	tube formation	1.580957587066223e-13	3.4868019582745546e-9	27	131	418
MESH:D019465	Craniofacial Abnormalities	GO:0031214	biomineral tissue development	1.5631940186722204e-13	3.447624408181582e-9	24	131	418
MESH:D019465	Craniofacial Abnormalities	GO:0021915	neural tube development	1.0724754417879012e-13	2.365344586863216e-9	33	151	418
MESH:D019465	Craniofacial Abnormalities	GO:0072080	nephron tubule development	1.0591527654923993e-13	2.3359614242934867e-9	22	91	418
MESH:D019465	Craniofacial Abnormalities	GO:0060675	ureteric bud morphogenesis	1.0502709812953981e-13	2.3163726492470005e-9	19	64	418
MESH:D019465	Craniofacial Abnormalities	GO:0046332	SMAD binding	9.769962616701378e-14	2.154765255113489e-9	18	72	418
MESH:D019465	Craniofacial Abnormalities	GO:0072091	regulation of stem cell proliferation	6.372680161348399e-14	1.4054946095853893e-9	29	88	418
MESH:D019465	Craniofacial Abnormalities	GO:0001656	metanephros development	5.906386491005833e-14	1.3026535405913364e-9	20	88	418
MESH:D019465	Craniofacial Abnormalities	GO:0060323	head morphogenesis	4.951594689828198e-14	1.0920742088416091e-9	15	36	418
MESH:D019465	Craniofacial Abnormalities	GO:0007369	gastrulation	4.884981308350689e-14	1.0773826275567444e-9	29	176	418
MESH:D019465	Craniofacial Abnormalities	GO:0010001	glial cell differentiation	4.618527782440651e-14	1.0186163024172856e-9	27	176	418
MESH:D019465	Craniofacial Abnormalities	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3.9968028886505635e-14	8.814948770918818e-10	31	204	418
MESH:D019465	Craniofacial Abnormalities	GO:0002088	lens development in camera-type eye	3.885780586188048e-14	8.57008908283774e-10	20	67	418
MESH:D019465	Craniofacial Abnormalities	GO:0048663	neuron fate commitment	3.419486915845482e-14	7.541678392897211e-10	18	67	418
MESH:D019465	Craniofacial Abnormalities	GO:2000826	regulation of heart morphogenesis	3.397282455352979e-14	7.492706455280995e-10	12	24	418
MESH:D019465	Craniofacial Abnormalities	GO:0019827	stem cell population maintenance	3.108624468950438e-14	6.856071266270192e-10	27	145	418
MESH:D019465	Craniofacial Abnormalities	GO:0035116	embryonic hindlimb morphogenesis	2.7755575615628914e-14	6.121492202026957e-10	13	29	418
MESH:D019465	Craniofacial Abnormalities	GO:0042633	hair cycle	1.9317880628477724e-14	4.260558572610762e-10	20	101	418
MESH:D019465	Craniofacial Abnormalities	GO:0048593	camera-type eye morphogenesis	8.881784197001252e-15	1.9588775046486262e-10	27	100	418
MESH:D019465	Craniofacial Abnormalities	GO:0016202	regulation of striated muscle tissue development	8.43769498715119e-15	1.860933629416195e-10	22	100	418
MESH:D019465	Craniofacial Abnormalities	GO:0042733	embryonic digit morphogenesis	4.884981308350689e-15	1.0773826275567444e-10	23	60	418
MESH:D019465	Craniofacial Abnormalities	GO:0061053	somite development	1.709743457922741e-14	3.7708391964486054e-10	19	85	418
MESH:D019465	Craniofacial Abnormalities	GO:0061035	regulation of cartilage development	3.097522238704187e-14	6.831585297462084e-10	17	63	418
MESH:D019465	Craniofacial Abnormalities	GO:0045778	positive regulation of ossification	3.319566843629218e-14	7.32130467362424e-10	22	84	418
MESH:D019465	Craniofacial Abnormalities	GO:0060325	face morphogenesis	4.8405723873656825e-14	1.0675882400335013e-9	13	31	418
MESH:D019465	Craniofacial Abnormalities	GO:0001841	neural tube formation	5.2735593669694936e-14	1.1630835183851218e-9	19	95	418
MESH:D019465	Craniofacial Abnormalities	GO:2000738	positive regulation of stem cell differentiation	5.3179682879545e-14	1.172877905908365e-9	16	50	418
MESH:D019465	Craniofacial Abnormalities	GO:0030509	BMP signaling pathway	5.540012892879531e-14	1.2218498435245806e-9	24	136	418
MESH:D019465	Craniofacial Abnormalities	GO:0042474	middle ear morphogenesis	5.850875339774575e-14	1.2904105561872825e-9	11	20	418
MESH:D019465	Craniofacial Abnormalities	GO:0098773	skin epidermis development	6.061817714453355e-14	1.3369338969226874e-9	19	82	418
MESH:D019465	Craniofacial Abnormalities	GO:0048844	artery morphogenesis	6.494804694057166e-14	1.432429175274308e-9	16	51	418
MESH:D019465	Craniofacial Abnormalities	GO:0048546	digestive tract morphogenesis	8.448797217397441e-14	1.8633822262970057e-9	20	49	418
MESH:D019465	Craniofacial Abnormalities	GO:0072132	mesenchyme morphogenesis	8.559819519859957e-14	1.8878681951051135e-9	18	40	418
MESH:D019465	Craniofacial Abnormalities	GO:0035050	embryonic heart tube development	8.981704269217516e-14	1.9809148765759232e-9	20	74	418
MESH:D019465	Craniofacial Abnormalities	GO:0003151	outflow tract morphogenesis	1.630917623174355e-13	3.59698881791104e-9	16	59	418
MESH:D019465	Craniofacial Abnormalities	GO:0007498	mesoderm development	1.630917623174355e-13	3.59698881791104e-9	25	123	418
MESH:D019465	Craniofacial Abnormalities	GO:0035136	forelimb morphogenesis	1.730837695390619e-13	3.81736253718401e-9	14	40	418
MESH:D019465	Craniofacial Abnormalities	GO:0010718	positive regulation of epithelial to mesenchymal transition	1.815214645262131e-13	4.00345590012563e-9	13	34	418
MESH:D019465	Craniofacial Abnormalities	GO:0022405	hair cycle process	1.999511667349907e-13	4.40992298234022e-9	18	80	418
MESH:D019465	Craniofacial Abnormalities	GO:0001942	hair follicle development	1.999511667349907e-13	4.40992298234022e-9	18	80	418
MESH:D019465	Craniofacial Abnormalities	GO:0003205	cardiac chamber development	2.0539125955565396e-13	4.529904229499948e-9	25	142	418
MESH:D019465	Craniofacial Abnormalities	GO:0014855	striated muscle cell proliferation	2.6634250360757505e-13	5.874183917065068e-9	15	51	418
MESH:D019465	Craniofacial Abnormalities	GO:0001667	ameboidal-type cell migration	2.9820590441431705e-13	6.5769312218577625e-9	39	315	418
MESH:D019465	Craniofacial Abnormalities	GO:0003203	endocardial cushion morphogenesis	3.426148253993233e-13	7.556369974182076e-9	11	22	418
MESH:D019465	Craniofacial Abnormalities	GO:0060606	tube closure	3.714806240395774e-13	8.193005163192879e-9	18	83	418
MESH:D019465	Craniofacial Abnormalities	GO:0014020	primary neural tube formation	4.3653969328261155e-13	9.627882935347998e-9	18	86	418
MESH:D019465	Craniofacial Abnormalities	GO:0006259	DNA metabolic process	4.4209080840573733e-13	9.750312779388537e-9	59	937	418
MESH:D019465	Craniofacial Abnormalities	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	5.635492072997295e-13	1.2429077766995533e-8	19	99	418
MESH:D019465	Craniofacial Abnormalities	GO:0021537	telencephalon development	5.909717160079708e-13	1.3033881196555797e-8	32	226	418
MESH:D019465	Craniofacial Abnormalities	GO:0021543	pallium development	6.826761378420088e-13	1.5056422220105503e-8	23	153	418
MESH:D019465	Craniofacial Abnormalities	GO:0030282	bone mineralization	7.381872890732666e-13	1.6280720660510895e-8	19	100	418
MESH:D019465	Craniofacial Abnormalities	GO:0014033	neural crest cell differentiation	7.792655409843974e-13	1.7186701506410884e-8	17	75	418
MESH:D019465	Craniofacial Abnormalities	GO:0034504	protein localization to nucleus	8.504308368628699e-13	1.8756252107010596e-8	33	344	418
MESH:D019465	Craniofacial Abnormalities	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	8.728573419602981e-13	1.9250868676934374e-8	37	317	418
MESH:D019465	Craniofacial Abnormalities	GO:0048738	cardiac muscle tissue development	9.149347945935915e-13	2.017888689476166e-8	27	168	418
MESH:D019465	Craniofacial Abnormalities	GO:0021536	diencephalon development	9.633405184672483e-13	2.1246475134795162e-8	17	77	418
MESH:D019465	Craniofacial Abnormalities	GO:0090132	epithelium migration	1.0094147739891923e-12	2.2262642840331637e-8	27	221	418
MESH:D019465	Craniofacial Abnormalities	GO:0030850	prostate gland development	1.1858292126021297e-12	2.615346328393997e-8	14	47	418
MESH:D019465	Craniofacial Abnormalities	GO:0061351	neural precursor cell proliferation	1.5013545962005992e-12	3.3112375619204215e-8	21	132	418
MESH:D019465	Craniofacial Abnormalities	GO:0023014	signal transduction by protein phosphorylation	1.5053513990892498e-12	3.32005251069134e-8	71	879	418
MESH:D019465	Craniofacial Abnormalities	GO:0090102	cochlea development	1.5094592242803628e-12	3.32911231915034e-8	13	39	418
MESH:D019465	Craniofacial Abnormalities	GO:0001704	formation of primary germ layer	1.6010526238119382e-12	3.53112156181723e-8	20	117	418
MESH:D019465	Craniofacial Abnormalities	GO:0005694	chromosome	2.0741186546047174e-12	4.5744686927307043e-8	59	876	418
MESH:D019465	Craniofacial Abnormalities	GO:0035282	segmentation	2.439159985101469e-12	5.37956734714129e-8	18	94	418
MESH:D019465	Craniofacial Abnormalities	GO:0007219	Notch signaling pathway	2.5839330675125893e-12	5.698864380399016e-8	23	162	418
MESH:D019465	Craniofacial Abnormalities	GO:0010631	epithelial cell migration	2.669087173501339e-12	5.886671761157203e-8	26	218	418
MESH:D019465	Craniofacial Abnormalities	GO:0001843	neural tube closure	2.8053115386228455e-12	6.187114598432686e-8	17	82	418
MESH:D019465	Craniofacial Abnormalities	GO:0045669	positive regulation of osteoblast differentiation	2.9362068332261515e-12	6.475804170680277e-8	15	60	418
MESH:D019465	Craniofacial Abnormalities	GO:0051347	positive regulation of transferase activity	2.950306665638891e-12	6.506901351066574e-8	48	613	418
MESH:D019465	Craniofacial Abnormalities	GO:0060428	lung epithelium development	3.018363337048413e-12	6.657000339860275e-8	13	41	418
MESH:D019465	Craniofacial Abnormalities	GO:0061371	determination of heart left/right asymmetry	3.95516952522712e-12	8.723126387888414e-8	15	61	418
MESH:D019465	Craniofacial Abnormalities	GO:0003279	cardiac septum development	4.211297977008144e-12	9.288017688291461e-8	17	84	418
MESH:D019465	Craniofacial Abnormalities	GO:0006260	DNA replication	4.3303138852479606e-12	9.550507273914377e-8	32	337	418
MESH:D019465	Craniofacial Abnormalities	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	4.708011758225439e-12	1.0383519932766205e-7	49	573	418
MESH:D019465	Craniofacial Abnormalities	GO:0001525	angiogenesis	4.721223412218478e-12	1.0412658235647854e-7	42	413	418
MESH:D019465	Craniofacial Abnormalities	GO:0097285	cell-type specific apoptotic process	5.571876293686273e-12	1.2288773165725075e-7	40	429	418
MESH:D019465	Craniofacial Abnormalities	GO:0003682	chromatin binding	5.712874617813668e-12	1.2599744969588045e-7	51	433	418
MESH:D019465	Craniofacial Abnormalities	GO:0050769	positive regulation of neurogenesis	5.912381695338809e-12	1.3039757829069742e-7	34	376	418
MESH:D019465	Craniofacial Abnormalities	GO:0003143	embryonic heart tube morphogenesis	6.356803972096259e-12	1.40199311604583e-7	15	63	418
MESH:D019465	Craniofacial Abnormalities	GO:0051098	regulation of binding	6.446398970183509e-12	1.421753292873973e-7	29	279	418
MESH:D019465	Craniofacial Abnormalities	GO:0051961	negative regulation of nervous system development	6.901923477187211e-12	1.5222192228936393e-7	28	259	418
MESH:D019465	Craniofacial Abnormalities	GO:0043069	negative regulation of programmed cell death	7.771561172376096e-12	1.714017816567548e-7	63	806	418
MESH:D019465	Craniofacial Abnormalities	GO:0048638	regulation of developmental growth	8.025247133502944e-12	1.7699682552940743e-7	29	283	418
MESH:D019465	Craniofacial Abnormalities	GO:0071902	positive regulation of protein serine/threonine kinase activity	8.025247133502944e-12	1.7699682552940743e-7	29	283	418
MESH:D019465	Craniofacial Abnormalities	GO:0010638	positive regulation of organelle organization	8.635980819349243e-12	1.9046655697074755e-7	43	573	418
MESH:D019465	Craniofacial Abnormalities	GO:0070482	response to oxygen levels	8.964828879243214e-12	1.9771930093170909e-7	31	321	418
MESH:D019465	Craniofacial Abnormalities	GO:0008134	transcription factor binding	1.1592615756228497e-11	2.556751405036195e-7	41	518	418
MESH:D019465	Craniofacial Abnormalities	GO:0045664	regulation of neuron differentiation	1.2370660051885807e-11	2.7283490744434147e-7	42	548	418
MESH:D019465	Craniofacial Abnormalities	GO:0060041	retina development in camera-type eye	1.2718937014710718e-11	2.805161558594449e-7	20	131	418
MESH:D019465	Craniofacial Abnormalities	GO:0021872	forebrain generation of neurons	1.3082424032972995e-11	2.885328620472194e-7	15	66	418
MESH:D019465	Craniofacial Abnormalities	GO:0043066	negative regulation of apoptotic process	1.3187340108800072e-11	2.908467860995856e-7	63	795	418
MESH:D019465	Craniofacial Abnormalities	GO:0051270	regulation of cellular component movement	1.4731771358356127e-11	3.249092173085444e-7	53	787	418
MESH:D019465	Craniofacial Abnormalities	GO:0032330	regulation of chondrocyte differentiation	1.5462520153164405e-11	3.4102588197804096e-7	13	46	418
MESH:D019465	Craniofacial Abnormalities	GO:0014032	neural crest cell development	1.653255310429813e-11	3.646254587152953e-7	15	67	418
MESH:D019465	Craniofacial Abnormalities	GO:0007411	axon guidance	1.671740523789822e-11	3.6870237252184523e-7	25	215	418
MESH:D019465	Craniofacial Abnormalities	GO:0033044	regulation of chromosome organization	1.7093326754036298e-11	3.7699332156027054e-7	28	271	418
MESH:D019465	Craniofacial Abnormalities	GO:0048709	oligodendrocyte differentiation	1.793942772110313e-11	3.956540783889295e-7	16	79	418
MESH:D019465	Craniofacial Abnormalities	GO:0040012	regulation of locomotion	1.975153374189631e-11	4.356200766775231e-7	50	766	418
MESH:D019465	Craniofacial Abnormalities	GO:0001666	response to hypoxia	2.061562032196207e-11	4.5467750620087344e-7	29	292	418
MESH:D019465	Craniofacial Abnormalities	GO:0048538	thymus development	2.0862533922638704e-11	4.601231856637966e-7	13	47	418
MESH:D019465	Craniofacial Abnormalities	GO:0001707	mesoderm formation	2.090427830836461e-11	4.6104385809098147e-7	15	68	418
MESH:D019465	Craniofacial Abnormalities	GO:0042692	muscle cell differentiation	2.116207209468257e-11	4.667295000482241e-7	31	334	418
MESH:D019465	Craniofacial Abnormalities	GO:0060038	cardiac muscle cell proliferation	2.1716184406272987e-11	4.789504470803507e-7	12	38	418
MESH:D019465	Craniofacial Abnormalities	GO:0051052	regulation of DNA metabolic process	2.3519297620566704e-11	5.187181090215987e-7	31	335	418
MESH:D019465	Craniofacial Abnormalities	GO:0060571	morphogenesis of an epithelial fold	2.504663143554353e-11	5.524034563109126e-7	10	23	418
MESH:D019465	Craniofacial Abnormalities	GO:0048557	embryonic digestive tract morphogenesis	2.688116396143414e-11	5.9286407116943e-7	9	17	418
MESH:D019465	Craniofacial Abnormalities	GO:0050768	negative regulation of neurogenesis	2.75607314748072e-11	6.078519326768728e-7	26	238	418
MESH:D019465	Craniofacial Abnormalities	GO:0035019	somatic stem cell population maintenance	3.2394864568630055e-11	7.144687380611359e-7	15	70	418
MESH:D019465	Craniofacial Abnormalities	GO:0003156	regulation of organ formation	3.51806361820195e-11	7.7590893099444e-7	11	31	418
MESH:D019465	Craniofacial Abnormalities	GO:2000145	regulation of cell motility	3.8252623291157306e-11	8.436616066864744e-7	47	709	418
MESH:D019465	Craniofacial Abnormalities	GO:0000987	core promoter proximal region sequence-specific DNA binding	4.2031267355469026e-11	9.269996015248694e-7	32	362	418
MESH:D019465	Craniofacial Abnormalities	GO:0042481	regulation of odontogenesis	4.206668346995457e-11	9.27780703929848e-7	10	24	418
MESH:D019465	Craniofacial Abnormalities	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	4.6226023009410255e-11	1.0195149374725432e-6	31	343	418
MESH:D019465	Craniofacial Abnormalities	GO:0046620	regulation of organ growth	4.988354174173537e-11	1.1001815131139736e-6	15	72	418
MESH:D019465	Craniofacial Abnormalities	GO:0035115	embryonic forelimb morphogenesis	5.25796073347351e-11	1.1596432397675827e-6	11	32	418
MESH:D019465	Craniofacial Abnormalities	GO:0019904	protein domain specific binding	5.388112178650317e-11	1.1883481410013275e-6	43	619	418
MESH:D019465	Craniofacial Abnormalities	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	5.694611449058584e-11	1.2559465550898707e-6	25	227	418
MESH:D019465	Craniofacial Abnormalities	GO:0030111	regulation of Wnt signaling pathway	6.24597040754793e-11	1.3775487733846958e-6	29	306	418
MESH:D019465	Craniofacial Abnormalities	GO:0051170	nuclear import	6.949185671345504e-11	1.5326428998152508e-6	28	287	418
MESH:D019465	Craniofacial Abnormalities	GO:0006606	protein import into nucleus	7.50907114266397e-11	1.6561256405145386e-6	27	268	418
MESH:D019465	Craniofacial Abnormalities	GO:0000988	transcription factor activity, protein binding	7.883260710883633e-11	1.7386531497853852e-6	41	578	418
MESH:D019465	Craniofacial Abnormalities	GO:0000790	nuclear chromatin	8.238631998835899e-11	1.8170302873432576e-6	28	289	418
MESH:D019465	Craniofacial Abnormalities	GO:0021700	developmental maturation	8.277034613257683e-11	1.825499983953982e-6	25	231	418
MESH:D019465	Craniofacial Abnormalities	GO:0021953	central nervous system neuron differentiation	8.518208360897006e-11	1.8786908539958347e-6	21	161	418
MESH:D019465	Craniofacial Abnormalities	GO:0048745	smooth muscle tissue development	9.824485669440719e-11	2.1667903143951506e-6	9	19	418
MESH:D019465	Craniofacial Abnormalities	GO:0043566	structure-specific DNA binding	1.0470735389844776e-10	2.3093206902302654e-6	18	116	418
MESH:D019465	Craniofacial Abnormalities	GO:0048636	positive regulation of muscle organ development	1.4230994160868704e-10	3.1386457621795927e-6	13	54	418
MESH:D019465	Craniofacial Abnormalities	GO:0045844	positive regulation of striated muscle tissue development	1.4230994160868704e-10	3.1386457621795927e-6	13	54	418
MESH:D019465	Craniofacial Abnormalities	GO:0007405	neuroblast proliferation	1.4230994160868704e-10	3.1386457621795927e-6	13	54	418
MESH:D019465	Craniofacial Abnormalities	GO:0060443	mammary gland morphogenesis	1.4969159245481478e-10	3.30144807159094e-6	12	44	418
MESH:D019465	Craniofacial Abnormalities	GO:0051054	positive regulation of DNA metabolic process	1.503265290025979e-10	3.315451597152297e-6	22	183	418
MESH:D019465	Craniofacial Abnormalities	GO:0031076	embryonic camera-type eye development	1.5985635037907286e-10	3.525631807610452e-6	11	35	418
MESH:D019465	Craniofacial Abnormalities	GO:0001756	somitogenesis	1.7171675192884095e-10	3.787212963790587e-6	14	66	418
MESH:D019465	Craniofacial Abnormalities	GO:0000989	transcription factor activity, transcription factor binding	2.214883831896941e-10	4.8849262912487035e-6	40	574	418
MESH:D019465	Craniofacial Abnormalities	GO:1901862	negative regulation of muscle tissue development	2.2561197354775686e-10	4.9758720765957776e-6	11	36	418
MESH:D019465	Craniofacial Abnormalities	GO:0035326	enhancer binding	2.35723218722228e-10	5.198875588918739e-6	16	93	418
MESH:D019465	Craniofacial Abnormalities	GO:1902692	regulation of neuroblast proliferation	2.601492354870061e-10	5.737591388665919e-6	10	28	418
MESH:D019465	Craniofacial Abnormalities	GO:0046982	protein heterodimerization activity	2.9149860303334663e-10	6.42900168990046e-6	35	459	418
MESH:D019465	Craniofacial Abnormalities	GO:0060395	SMAD protein signal transduction	2.953431943453211e-10	6.5137941512860564e-6	13	57	418
MESH:D019465	Craniofacial Abnormalities	GO:0090103	cochlea morphogenesis	3.0040037124479113e-10	6.625330187803868e-6	9	21	418
MESH:D019465	Craniofacial Abnormalities	GO:0071560	cellular response to transforming growth factor beta stimulus	3.117706093291872e-10	6.876100788755224e-6	23	208	418
MESH:D019465	Craniofacial Abnormalities	GO:0030500	regulation of bone mineralization	3.225851807897584e-10	7.1146161623181214e-6	14	69	418
MESH:D019465	Craniofacial Abnormalities	GO:0040017	positive regulation of locomotion	3.267548454033431e-10	7.206578115370732e-6	33	415	418
MESH:D019465	Craniofacial Abnormalities	GO:0061323	cell proliferation involved in heart morphogenesis	3.3119595954644865e-10	7.304526887796925e-6	8	15	418
MESH:D019465	Craniofacial Abnormalities	GO:0042060	wound healing	3.570052031776072e-10	7.873749756082127e-6	38	534	418
MESH:D019465	Craniofacial Abnormalities	GO:0045787	positive regulation of cell cycle	3.637948831070048e-10	8.023496146924991e-6	28	308	418
MESH:D019465	Craniofacial Abnormalities	GO:0030334	regulation of cell migration	3.732908426812287e-10	8.232929535334499e-6	43	660	418
MESH:D019465	Craniofacial Abnormalities	GO:0032147	activation of protein kinase activity	3.819556892992182e-10	8.424032727494257e-6	27	288	418
MESH:D019465	Craniofacial Abnormalities	GO:0051146	striated muscle cell differentiation	4.2383674347945544e-10	9.34771937743939e-6	24	230	418
MESH:D019465	Craniofacial Abnormalities	GO:0009948	anterior/posterior axis specification	4.557805244331803e-10	1.0052239466373791e-5	12	48	418
MESH:D019465	Craniofacial Abnormalities	GO:0021879	forebrain neuron differentiation	4.688524013474193e-10	1.0340539711717334e-5	13	59	418
MESH:D019465	Craniofacial Abnormalities	GO:1900180	regulation of protein localization to nucleus	5.003663039460093e-10	1.1035578833529236e-5	23	213	418
MESH:D019465	Craniofacial Abnormalities	GO:0007017	microtubule-based process	5.202334119047691e-10	1.1473747899559683e-5	40	591	418
MESH:D019465	Craniofacial Abnormalities	GO:0045995	regulation of embryonic development	5.713856054967437e-10	1.2601909529230682e-5	17	113	418
MESH:D019465	Craniofacial Abnormalities	GO:0021532	neural tube patterning	5.927049961940156e-10	1.3072108691059015e-5	11	39	418
MESH:D019465	Craniofacial Abnormalities	GO:0048339	paraxial mesoderm development	6.494742521567787e-10	1.4324154631317754e-5	8	16	418
MESH:D019465	Craniofacial Abnormalities	GO:0060572	morphogenesis of an epithelial bud	6.494742521567787e-10	1.4324154631317754e-5	8	16	418
MESH:D019465	Craniofacial Abnormalities	GO:0021761	limbic system development	7.22771065220229e-10	1.594071584343215e-5	16	100	418
MESH:D019465	Craniofacial Abnormalities	GO:0060914	heart formation	8.027193354465112e-10	1.7703974943272804e-5	9	23	418
MESH:D019465	Craniofacial Abnormalities	GO:0010632	regulation of epithelial cell migration	8.070030199647249e-10	1.7798451605322008e-5	20	164	418
MESH:D019465	Craniofacial Abnormalities	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	8.191182176986445e-10	1.8065652291343604e-5	7	11	418
MESH:D019465	Craniofacial Abnormalities	GO:0060391	positive regulation of SMAD protein import into nucleus	8.191182176986445e-10	1.8065652291343604e-5	7	11	418
MESH:D019465	Craniofacial Abnormalities	GO:0051272	positive regulation of cellular component movement	8.545210095078914e-10	1.8846460864696546e-5	32	408	418
MESH:D019465	Craniofacial Abnormalities	GO:0060563	neuroepithelial cell differentiation	8.597560441359064e-10	1.8961919553417417e-5	14	74	418
MESH:D019465	Craniofacial Abnormalities	GO:0002064	epithelial cell development	1.0181401277620239e-9	2.2455080517791437e-5	22	202	418
MESH:D019465	Craniofacial Abnormalities	GO:0007492	endoderm development	1.0358637281271399e-9	2.284597452384407e-5	14	75	418
MESH:D019465	Craniofacial Abnormalities	GO:0048806	genitalia development	1.0730768496003407e-9	2.3666709917935513e-5	11	41	418
MESH:D019465	Craniofacial Abnormalities	GO:0060389	pathway-restricted SMAD protein phosphorylation	1.1180336656479994e-9	2.4658232495866628e-5	13	63	418
MESH:D019465	Craniofacial Abnormalities	GO:0001569	patterning of blood vessels	1.1806308153339273e-9	2.6038812632189767e-5	10	32	418
MESH:D019465	Craniofacial Abnormalities	GO:0009954	proximal/distal pattern formation	1.1806308153339273e-9	2.6038812632189767e-5	10	32	418
MESH:D019465	Craniofacial Abnormalities	GO:0021782	glial cell development	1.2441265795359868e-9	2.743921171166619e-5	14	76	418
MESH:D019465	Craniofacial Abnormalities	GO:0043542	endothelial cell migration	1.2573179164476755e-9	2.7730146647253484e-5	19	151	418
MESH:D019465	Craniofacial Abnormalities	GO:0003206	cardiac chamber morphogenesis	1.3132719356434563e-9	2.896421254061643e-5	16	104	418
MESH:D019465	Craniofacial Abnormalities	GO:0010564	regulation of cell cycle process	1.4094159173083654e-9	3.1084668056236e-5	38	561	418
MESH:D019465	Craniofacial Abnormalities	GO:0021983	pituitary gland development	1.424919293668836e-9	3.142659502186618e-5	11	42	418
MESH:D019465	Craniofacial Abnormalities	GO:0090288	negative regulation of cellular response to growth factor stimulus	1.48588374937475e-9	3.277116609246011e-5	17	120	418
MESH:D019465	Craniofacial Abnormalities	GO:0030510	regulation of BMP signaling pathway	1.4897845179717706e-9	3.28571975438674e-5	14	77	418
MESH:D019465	Craniofacial Abnormalities	GO:0051101	regulation of DNA binding	1.8848420602068927e-9	4.157019163786302e-5	15	92	418
MESH:D019465	Craniofacial Abnormalities	GO:0060601	lateral sprouting from an epithelium	1.928038506626706e-9	4.2522889263652e-5	7	12	418
MESH:D019465	Craniofacial Abnormalities	GO:0060317	cardiac epithelial to mesenchymal transition	1.9286258146067325e-9	4.2535842341151486e-5	9	25	418
MESH:D019465	Craniofacial Abnormalities	GO:2000147	positive regulation of cell motility	1.9838977127761837e-9	4.375486405527873e-5	31	399	418
MESH:D019465	Craniofacial Abnormalities	GO:0031490	chromatin DNA binding	2.11881279188475e-9	4.673041612501816e-5	14	79	418
MESH:D019465	Craniofacial Abnormalities	GO:0002076	osteoblast development	2.1229432656255653e-9	4.6821513723371844e-5	8	18	418
MESH:D019465	Craniofacial Abnormalities	GO:0060037	pharyngeal system development	2.1229432656255653e-9	4.6821513723371844e-5	8	18	418
MESH:D019465	Craniofacial Abnormalities	GO:0045843	negative regulation of striated muscle tissue development	2.3054818054646375e-9	5.084740121952258e-5	10	34	418
MESH:D019465	Craniofacial Abnormalities	GO:0006275	regulation of DNA replication	2.4439947843291066e-9	5.3902304968378445e-5	19	157	418
MESH:D019465	Craniofacial Abnormalities	GO:0032403	protein complex binding	2.531087450741154e-9	5.582313372609615e-5	51	924	418
MESH:D019465	Craniofacial Abnormalities	GO:0009913	epidermal cell differentiation	2.8185602740649074e-9	6.216334684450153e-5	20	176	418
MESH:D019465	Craniofacial Abnormalities	GO:0007346	regulation of mitotic cell cycle	2.9867962547669435e-9	6.587379139888494e-5	33	453	418
MESH:D019465	Craniofacial Abnormalities	GO:0021954	central nervous system neuron development	3.0269770023849674e-9	6.675997778760046e-5	13	68	418
MESH:D019465	Craniofacial Abnormalities	GO:0030279	negative regulation of ossification	3.0269770023849674e-9	6.675997778760046e-5	13	68	418
MESH:D019465	Craniofacial Abnormalities	GO:0030501	positive regulation of bone mineralization	3.163668216288329e-9	6.97747025102391e-5	10	35	418
MESH:D019465	Craniofacial Abnormalities	GO:0003712	transcription cofactor activity	3.2710207875652486e-9	7.214236346975156e-5	36	528	418
MESH:D019465	Craniofacial Abnormalities	GO:0032808	lacrimal gland development	3.2757908607905506e-9	7.22475674347356e-5	6	8	418
MESH:D019465	Craniofacial Abnormalities	GO:0002089	lens morphogenesis in camera-type eye	3.5954760280176856e-9	7.929822379793006e-5	8	19	418
MESH:D019465	Craniofacial Abnormalities	GO:0046660	female sex differentiation	3.6156223570671386e-9	7.974255108511574e-5	17	127	418
MESH:D019465	Craniofacial Abnormalities	GO:0016568	chromatin modification	3.910825441266752e-9	8.625325510713822e-5	39	608	418
MESH:D019465	Craniofacial Abnormalities	GO:0043627	response to estrogen	3.936767578593958e-9	8.682540894588975e-5	22	217	418
MESH:D019465	Craniofacial Abnormalities	GO:0048368	lateral mesoderm development	4.097033934336025e-9	9.036008342178103e-5	7	13	418
MESH:D019465	Craniofacial Abnormalities	GO:0061029	eyelid development in camera-type eye	4.097033934336025e-9	9.036008342178103e-5	7	13	418
MESH:D019465	Craniofacial Abnormalities	GO:0000226	microtubule cytoskeleton organization	4.267222131204562e-9	9.411358410371662e-5	31	412	418
MESH:D019465	Craniofacial Abnormalities	GO:0030857	negative regulation of epithelial cell differentiation	4.293679856104404e-9	9.469710922638264e-5	10	36	418
Orphanet:182070	Rare neurodegenerative disease	GO:0008202	steroid metabolic process	8.595346656647962e-13	1.895703705123708e-8	32	275	418
Orphanet:182070	Rare neurodegenerative disease	GO:0006066	alcohol metabolic process	5.452305273934144e-13	1.2025059281661754e-8	36	382	418
Orphanet:182070	Rare neurodegenerative disease	GO:0005773	vacuole	1.5762946503627973e-12	3.4765178513751493e-8	46	603	418
Orphanet:182070	Rare neurodegenerative disease	GO:0098771	inorganic ion homeostasis	3.696820627396846e-12	8.153337893723744e-8	45	609	418
Orphanet:182070	Rare neurodegenerative disease	GO:0030424	axon	4.548472709586804e-12	1.0031656560993696e-7	41	414	418
Orphanet:182070	Rare neurodegenerative disease	GO:0048666	neuron development	5.470290886933071e-12	1.206472655113089e-7	62	926	418
Orphanet:182070	Rare neurodegenerative disease	GO:0055080	cation homeostasis	6.2124749788949885e-12	1.3701613565952897e-7	45	595	418
Orphanet:182070	Rare neurodegenerative disease	GO:0006873	cellular ion homeostasis	6.587841383520754e-12	1.4529484171355023e-7	43	532	418
Orphanet:182070	Rare neurodegenerative disease	GO:0061564	axon development	7.291278691923253e-12	1.6080915155036735e-7	38	440	418
Orphanet:182070	Rare neurodegenerative disease	GO:0044297	cell body	8.295475417696707e-12	1.8295671033730088e-7	40	494	418
Orphanet:182070	Rare neurodegenerative disease	GO:0048858	cell projection morphogenesis	8.996137168537643e-12	1.9840980525209773e-7	59	767	418
Orphanet:182070	Rare neurodegenerative disease	GO:0043025	neuronal cell body	1.0268896843967923e-11	2.2648051989371254e-7	37	434	418
Orphanet:182070	Rare neurodegenerative disease	GO:0016125	sterol metabolic process	1.4642398404873802e-11	3.229380968194917e-7	20	132	418
Orphanet:182070	Rare neurodegenerative disease	GO:0008203	cholesterol metabolic process	1.600508614529872e-11	3.5299217493456325e-7	19	118	418
Orphanet:182070	Rare neurodegenerative disease	GO:0045202	synapse	1.707667340866692e-11	3.7662603202814893e-7	50	755	418
Orphanet:182070	Rare neurodegenerative disease	GO:0043209	myelin sheath	2.8522961770249822e-11	6.290739218428598e-7	22	168	418
Orphanet:182070	Rare neurodegenerative disease	GO:0044456	synapse part	1.2946277383463212e-10	2.8553014769228113e-6	42	613	418
Orphanet:182070	Rare neurodegenerative disease	GO:0051054	positive regulation of DNA metabolic process	1.503265290025979e-10	3.315451597152297e-6	22	183	418
Orphanet:182070	Rare neurodegenerative disease	GO:0034976	response to endoplasmic reticulum stress	1.6926859913724002e-10	3.7332189539718286e-6	26	258	418
Orphanet:182070	Rare neurodegenerative disease	GO:0019216	regulation of lipid metabolic process	5.357579935250101e-10	1.1816142547194097e-5	26	272	418
Orphanet:182070	Rare neurodegenerative disease	GO:0007409	axonogenesis	7.564068260634826e-10	1.668255254883011e-5	32	406	418
Orphanet:182070	Rare neurodegenerative disease	GO:0005770	late endosome	8.418401531429254e-10	1.856678457756722e-5	22	200	418
Orphanet:182070	Rare neurodegenerative disease	GO:0080135	regulation of cellular response to stress	9.663986277885783e-10	2.1313921735877095e-5	43	681	418
Orphanet:182070	Rare neurodegenerative disease	GO:0097305	response to alcohol	1.256450277153931e-9	2.7711010862629948e-5	30	369	418
Orphanet:182070	Rare neurodegenerative disease	GO:0040007	growth	1.3828409528571228e-9	3.0498557215263844e-5	52	936	418
Orphanet:182070	Rare neurodegenerative disease	GO:0010876	lipid localization	2.1461266097588805e-9	4.733282237823211e-5	28	333	418
Orphanet:182070	Rare neurodegenerative disease	GO:0031329	regulation of cellular catabolic process	2.4917279350944455e-9	5.4955059608507995e-5	40	624	418
Orphanet:182070	Rare neurodegenerative disease	GO:0030426	growth cone	3.0509669235456727e-9	6.728907549879981e-5	18	142	418
Orphanet:182070	Rare neurodegenerative disease	GO:0009416	response to light stimulus	3.5158155275993863e-9	7.754131146120447e-5	26	297	418
Orphanet:182070	Rare neurodegenerative disease	GO:0000302	response to reactive oxygen species	3.6110531231869913e-9	7.96417766318891e-5	22	216	418
Orphanet:182070	Rare neurodegenerative disease	GO:0030705	cytoskeleton-dependent intracellular transport	3.999514497365908e-9	8.82092922394051e-5	16	112	418
Orphanet:182070	Rare neurodegenerative disease	GO:0050905	neuromuscular process	4.02050071013349e-9	8.867214316199412e-5	15	97	418
Orphanet:182070	Rare neurodegenerative disease	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	4.352913030025718e-9	9.600349687721721e-5	53	997	418
DOID:3459	breast carcinoma	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.1800782573345714e-11	2.602662596551397e-7	85	996	422
DOID:3459	breast carcinoma	GO:0022603	regulation of anatomical structure morphogenesis	1.0941469952285843e-11	2.4131411979766426e-7	80	986	422
DOID:3459	breast carcinoma	GO:0051241	negative regulation of multicellular organismal process	6.735723090400825e-12	1.485563727587902e-7	76	966	422
DOID:3459	breast carcinoma	GO:0001775	cell activation	4.1529002459128606e-12	9.159221492360814e-8	57	854	422
DOID:3459	breast carcinoma	GO:0033993	response to lipid	2.3221424783059774e-12	5.121485235903833e-8	103	850	422
DOID:3459	breast carcinoma	GO:0042692	muscle cell differentiation	2.1871393585115584e-12	4.823735855197242e-8	40	334	422
DOID:3459	breast carcinoma	GO:0045787	positive regulation of cell cycle	2.127853448996575e-12	4.692980781761946e-8	33	308	422
DOID:3459	breast carcinoma	GO:0036293	response to decreased oxygen levels	2.0976553827267708e-12	4.626378946603893e-8	41	302	422
DOID:3459	breast carcinoma	GO:0060562	epithelial tube morphogenesis	2.0867751970854442e-12	4.602382697171947e-8	39	301	422
DOID:3459	breast carcinoma	GO:0007167	enzyme linked receptor protein signaling pathway	1.9098056469601943e-12	4.2120763543707085e-8	79	935	422
DOID:3459	breast carcinoma	GO:0002237	response to molecule of bacterial origin	1.7275070263167436e-12	3.810016746541578e-8	39	333	422
DOID:3459	breast carcinoma	GO:0050673	epithelial cell proliferation	1.7195134205394424e-12	3.79238684899974e-8	50	335	422
DOID:3459	breast carcinoma	GO:0009887	organ morphogenesis	1.6893153542696382e-12	3.725785013841687e-8	82	950	422
DOID:3459	breast carcinoma	GO:0040007	growth	1.5760726057578722e-12	3.476028131998987e-8	79	936	422
DOID:3459	breast carcinoma	GO:0048638	regulation of developmental growth	1.567856955375646e-12	3.4579085150809874e-8	34	283	422
DOID:3459	breast carcinoma	GO:0030522	intracellular receptor signaling pathway	1.1861622795095172e-12	2.6160809074582403e-8	43	281	422
DOID:3459	breast carcinoma	GO:0070997	neuron death	1.1315393066979595e-12	2.4956099409223498e-8	32	281	422
DOID:3459	breast carcinoma	GO:0048511	rhythmic process	1.085354028873553e-12	2.3937483106806212e-8	34	329	422
DOID:3459	breast carcinoma	GO:0032103	positive regulation of response to external stimulus	9.99644811372491e-13	2.2047166314820288e-8	32	285	422
DOID:3459	breast carcinoma	GO:0050678	regulation of epithelial cell proliferation	8.950618024528012e-13	1.974058805309653e-8	42	277	422
DOID:3459	breast carcinoma	GO:0008544	epidermis development	8.308909116294672e-13	1.8325299055987898e-8	32	296	422
DOID:3459	breast carcinoma	GO:0000302	response to reactive oxygen species	7.66275931596283e-13	1.6900215671356023e-8	35	216	422
DOID:3459	breast carcinoma	GO:0003007	heart morphogenesis	7.66053886991358e-13	1.68953184775944e-8	31	216	422
DOID:3459	breast carcinoma	GO:0043627	response to estrogen	7.147615832536758e-13	1.576406671865982e-8	45	217	422
DOID:3459	breast carcinoma	GO:0002684	positive regulation of immune system process	6.967759702547482e-13	1.5367394023968473e-8	62	872	422
DOID:3459	breast carcinoma	GO:0007568	aging	6.079581282847357e-13	1.3408516519319846e-8	42	290	422
DOID:3459	breast carcinoma	GO:0001701	in utero embryonic development	4.662936703425657e-13	1.0284106899405288e-8	34	312	422
DOID:3459	breast carcinoma	GO:0048762	mesenchymal cell differentiation	4.545253062815391e-13	1.0024555630039345e-8	26	184	422
DOID:3459	breast carcinoma	GO:2001234	negative regulation of apoptotic signaling pathway	3.8835601401387976e-13	8.565191889076118e-9	34	199	422
DOID:3459	breast carcinoma	GO:0034504	protein localization to nucleus	3.717026686445024e-13	8.1979023569545e-9	34	344	422
DOID:3459	breast carcinoma	GO:0030879	mammary gland development	3.708144902248023e-13	8.178313581908014e-9	29	128	422
DOID:3459	breast carcinoma	GO:0010631	epithelial cell migration	3.5127456499139953e-13	7.747360530885317e-9	30	218	422
DOID:3459	breast carcinoma	GO:0022612	gland morphogenesis	3.2152058793144533e-13	7.091136566828027e-9	28	119	422
DOID:3459	breast carcinoma	GO:0050921	positive regulation of chemotaxis	2.9687363678476686e-13	6.547548059288033e-9	22	119	422
DOID:3459	breast carcinoma	GO:0001649	osteoblast differentiation	2.680078381445128e-13	5.9109128702772296e-9	33	206	422
DOID:3459	breast carcinoma	GO:0007565	female pregnancy	2.6290081223123707e-13	5.7982774137599336e-9	26	190	422
DOID:3459	breast carcinoma	GO:1901701	cellular response to oxygen-containing compound	2.1094237467877974e-13	4.652334073540487e-9	79	873	422
DOID:3459	breast carcinoma	GO:0009636	response to toxic substance	2.0450308113595383e-13	4.510315454453462e-9	35	249	422
DOID:3459	breast carcinoma	GO:0051054	positive regulation of DNA metabolic process	2.0272672429655358e-13	4.471137904360489e-9	26	183	422
DOID:3459	breast carcinoma	GO:0033273	response to vitamin	1.787459069646502e-13	3.94224097810536e-9	27	104	422
DOID:3459	breast carcinoma	GO:0030856	regulation of epithelial cell differentiation	1.532107773982716e-13	3.37906369551888e-9	22	122	422
DOID:3459	breast carcinoma	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1.354472090042691e-13	2.987288194589155e-9	28	212	422
DOID:3459	breast carcinoma	GO:0061138	morphogenesis of a branching epithelium	1.2612133559741778e-13	2.781606056601049e-9	36	179	422
DOID:3459	breast carcinoma	GO:0031960	response to corticosteroid	1.254552017826427e-13	2.7669144753161845e-9	28	179	422
DOID:3459	breast carcinoma	GO:0043405	regulation of MAP kinase activity	8.815170815523743e-14	1.9441859233637615e-9	31	278	422
DOID:3459	breast carcinoma	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	6.350475700855895e-14	1.4005974158237677e-9	21	101	422
DOID:3459	breast carcinoma	GO:0032355	response to estradiol	3.885780586188048e-14	8.57008908283774e-10	38	145	422
DOID:3459	breast carcinoma	GO:0070372	regulation of ERK1 and ERK2 cascade	3.5083047578154947e-14	7.737566143362073e-10	31	233	422
DOID:3459	breast carcinoma	GO:0051341	regulation of oxidoreductase activity	1.4210854715202004e-14	3.134204007437802e-10	20	85	422
DOID:3459	breast carcinoma	GO:0043491	protein kinase B signaling	5.329070518200751e-15	1.1753265027891757e-10	26	144	422
DOID:3459	breast carcinoma	GO:2001236	regulation of extrinsic apoptotic signaling pathway	6.217248937900877e-15	1.3712142532540383e-10	29	151	422
DOID:3459	breast carcinoma	GO:1902533	positive regulation of intracellular signal transduction	9.43689570931383e-15	2.0813073486891653e-10	78	860	422
DOID:3459	breast carcinoma	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	3.141931159689193e-14	6.929529172694515e-10	22	97	422
DOID:3459	breast carcinoma	GO:0048754	branching morphogenesis of an epithelial tube	5.240252676230739e-14	1.1557377277426895e-9	28	147	422
DOID:3459	breast carcinoma	GO:2000377	regulation of reactive oxygen species metabolic process	5.2735593669694936e-14	1.1630835183851218e-9	26	147	422
DOID:3459	breast carcinoma	GO:0010001	glial cell differentiation	7.460698725481052e-14	1.645457103904846e-9	25	176	422
DOID:3459	breast carcinoma	GO:0034599	cellular response to oxidative stress	7.971401316808624e-14	1.758092560422142e-9	33	219	422
DOID:3459	breast carcinoma	GO:0071496	cellular response to external stimulus	1.1257661469699087e-13	2.4828772371421337e-9	35	270	422
DOID:3459	breast carcinoma	GO:0045765	regulation of angiogenesis	1.1579626146840383e-13	2.5538865466856464e-9	27	208	422
DOID:3459	breast carcinoma	GO:0030850	prostate gland development	1.3589129821411916e-13	2.997082582112398e-9	15	47	422
DOID:3459	breast carcinoma	GO:2001242	regulation of intrinsic apoptotic signaling pathway	1.5443202272535927e-13	3.405998261207799e-9	23	145	422
DOID:3459	breast carcinoma	GO:0030518	intracellular steroid hormone receptor signaling pathway	1.6686652060116103e-13	3.6802411118586065e-9	23	123	422
DOID:3459	breast carcinoma	GO:0048771	tissue remodeling	2.0605739337042905e-13	4.544595810784813e-9	23	139	422
DOID:3459	breast carcinoma	GO:0007548	sex differentiation	3.2163161023390785e-13	7.093585163708838e-9	30	274	422
DOID:3459	breast carcinoma	GO:0061311	cell surface receptor signaling pathway involved in heart development	3.7492231541591536e-13	8.268911666498013e-9	11	22	422
DOID:3459	breast carcinoma	GO:0098773	skin epidermis development	3.9401815143946806e-13	8.690070329997468e-9	18	82	422
DOID:3459	breast carcinoma	GO:1901214	regulation of neuron death	4.1011638529653283e-13	9.045116877715031e-9	31	250	422
DOID:3459	breast carcinoma	GO:0001890	placenta development	4.147793219999585e-13	9.147957946709084e-9	23	138	422
DOID:3459	breast carcinoma	GO:0001666	response to hypoxia	4.3010039973978564e-13	9.485864316260972e-9	41	292	422
DOID:3459	breast carcinoma	GO:0032880	regulation of protein localization	4.557465516086268e-13	1.0051490195728263e-8	65	933	422
DOID:3459	breast carcinoma	GO:0033002	muscle cell proliferation	4.747313653297169e-13	1.0470200262346907e-8	23	151	422
DOID:3459	breast carcinoma	GO:0050679	positive regulation of epithelial cell proliferation	4.767297667740422e-13	1.0514275006201501e-8	25	155	422
DOID:3459	breast carcinoma	GO:0061448	connective tissue development	5.319078510979125e-13	1.173122765596446e-8	28	233	422
DOID:3459	breast carcinoma	GO:0046660	female sex differentiation	5.840883332552949e-13	1.2882068189945528e-8	21	127	422
DOID:3459	breast carcinoma	GO:0070374	positive regulation of ERK1 and ERK2 cascade	5.936362512670712e-13	1.3092647521695255e-8	26	168	422
DOID:3459	breast carcinoma	GO:0045667	regulation of osteoblast differentiation	6.041833700010102e-13	1.332526422537228e-8	20	111	422
DOID:3459	breast carcinoma	GO:0051384	response to glucocorticoid	6.31494856406789e-13	1.3927619058051732e-8	25	167	422
DOID:3459	breast carcinoma	GO:0097306	cellular response to alcohol	6.591394097199554e-13	1.4537319681373617e-8	21	123	422
DOID:3459	breast carcinoma	GO:0032496	response to lipopolysaccharide	7.147615832536758e-13	1.576406671865982e-8	39	319	422
DOID:3459	breast carcinoma	GO:0030335	positive regulation of cell migration	7.795986078917849e-13	1.7194047297053316e-8	50	387	422
DOID:3459	breast carcinoma	GO:0043523	regulation of neuron apoptotic process	8.788525462932739e-13	1.9383092908498156e-8	25	190	422
DOID:3459	breast carcinoma	GO:0071383	cellular response to steroid hormone stimulus	8.844036614163997e-13	1.9505522752538695e-8	24	162	422
DOID:3459	breast carcinoma	GO:0001101	response to acid chemical	8.872902412804251e-13	1.9569186271439776e-8	40	315	422
DOID:3459	breast carcinoma	GO:0048660	regulation of smooth muscle cell proliferation	9.492406860545088e-13	2.0935503330932193e-8	19	100	422
DOID:3459	breast carcinoma	GO:0042633	hair cycle	9.945377854592152e-13	2.1934530858302992e-8	19	101	422
DOID:3459	breast carcinoma	GO:1901698	response to nitrogen compound	1.042721464727947e-12	2.299722190457487e-8	79	870	422
DOID:3459	breast carcinoma	GO:0050769	positive regulation of neurogenesis	1.0504930259003231e-12	2.3168623686231626e-8	39	376	422
DOID:3459	breast carcinoma	GO:0090287	regulation of cellular response to growth factor stimulus	1.1528555887707626e-12	2.5426230010339168e-8	28	226	422
DOID:3459	breast carcinoma	GO:0014065	phosphatidylinositol 3-kinase signaling	1.2754242106893798e-12	2.8129480966754272e-8	23	154	422
DOID:3459	breast carcinoma	GO:0032768	regulation of monooxygenase activity	1.4019896354966477e-12	3.0920881410878565e-8	15	57	422
DOID:3459	breast carcinoma	GO:0051098	regulation of binding	1.4097611966690238e-12	3.109228319253532e-8	30	279	422
DOID:3459	breast carcinoma	GO:0048864	stem cell development	1.422306716847288e-12	3.136897464006694e-8	24	175	422
DOID:3459	breast carcinoma	GO:0051302	regulation of cell division	1.4621637234313312e-12	3.224802092027801e-8	31	293	422
DOID:3459	breast carcinoma	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	1.5544232567776817e-12	3.428280492823177e-8	18	91	422
DOID:3459	breast carcinoma	GO:0007569	cell aging	1.5544232567776817e-12	3.428280492823177e-8	18	91	422
DOID:3459	breast carcinoma	GO:0003002	regionalization	2.020161815607935e-12	4.4554668843233e-8	32	327	422
DOID:3459	breast carcinoma	GO:0001558	regulation of cell growth	2.0481394358284888e-12	4.517171525719732e-8	36	379	422
DOID:3459	breast carcinoma	GO:0009611	response to wounding	2.098543561146471e-12	4.6283378241085416e-8	63	875	422
DOID:3459	breast carcinoma	GO:0042826	histone deacetylase binding	2.1139756611887606e-12	4.6623733207518114e-8	19	106	422
DOID:3459	breast carcinoma	GO:0008083	growth factor activity	2.125299936039937e-12	4.6873490089360814e-8	23	159	422
DOID:3459	breast carcinoma	GO:0022405	hair cycle process	2.1910251390977464e-12	4.83230594428008e-8	17	80	422
DOID:3459	breast carcinoma	GO:0001942	hair follicle development	2.1910251390977464e-12	4.83230594428008e-8	17	80	422
DOID:3459	breast carcinoma	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2.1962431873134847e-12	4.8438143496198904e-8	36	359	422
DOID:3459	breast carcinoma	GO:0014706	striated muscle tissue development	2.344235916496018e-12	5.170212313831968e-8	32	323	422
DOID:3459	breast carcinoma	GO:1900180	regulation of protein localization to nucleus	2.3807622540061857e-12	5.2507711512106425e-8	26	213	422
DOID:3459	breast carcinoma	GO:0019900	kinase binding	2.560174294785611e-12	5.646464407149665e-8	48	598	422
DOID:3459	breast carcinoma	GO:0002521	leukocyte differentiation	2.573719015686038e-12	5.6763372890955566e-8	40	448	422
DOID:3459	breast carcinoma	GO:1901654	response to ketone	2.741029625497049e-12	6.045340839033742e-8	24	181	422
DOID:3459	breast carcinoma	GO:0048568	embryonic organ development	2.8580471322925405e-12	6.303422950271198e-8	38	408	422
DOID:3459	breast carcinoma	GO:0045860	positive regulation of protein kinase activity	3.1482594309295564e-12	6.943486174915137e-8	40	450	422
DOID:3459	breast carcinoma	GO:0071453	cellular response to oxygen levels	3.1611380180152082e-12	6.971889898732542e-8	22	150	422
DOID:3459	breast carcinoma	GO:0008585	female gonad development	3.223310507394217e-12	7.109011324057946e-8	19	108	422
DOID:3459	breast carcinoma	GO:0003158	endothelium development	3.223310507394217e-12	7.109011324057946e-8	19	108	422
DOID:3459	breast carcinoma	GO:0010638	positive regulation of organelle organization	3.3354430328813578e-12	7.356319609019835e-8	47	573	422
DOID:3459	breast carcinoma	GO:0010942	positive regulation of cell death	3.3952840539086537e-12	7.488298980895536e-8	61	596	422
DOID:3459	breast carcinoma	GO:0045786	negative regulation of cell cycle	3.6090019861489964e-12	7.959653880451611e-8	42	449	422
DOID:3459	breast carcinoma	GO:0006606	protein import into nucleus	3.680167282027469e-12	8.116608940511583e-8	29	268	422
DOID:3459	breast carcinoma	GO:0007417	central nervous system development	3.965494599356134e-12	8.745898338879954e-8	64	889	422
DOID:3459	breast carcinoma	GO:1903409	reactive oxygen species biosynthetic process	4.114597551563293e-12	9.074744899972842e-8	17	83	422
DOID:3459	breast carcinoma	GO:0045927	positive regulation of growth	4.189648628027953e-12	9.240270049115651e-8	27	235	422
DOID:3459	breast carcinoma	GO:2000027	regulation of organ morphogenesis	4.913180973176168e-12	1.0836020636340038e-7	27	236	422
DOID:3459	breast carcinoma	GO:0030155	regulation of cell adhesion	4.979683332351215e-12	1.0982691589500604e-7	51	621	422
DOID:3459	breast carcinoma	GO:0042493	response to drug	5.2871040878699205e-12	1.166070806579711e-7	54	433	422
DOID:3459	breast carcinoma	GO:0042542	response to hydrogen peroxide	5.370148770111882e-12	1.1843863112481756e-7	20	124	422
DOID:3459	breast carcinoma	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	5.37403455069807e-12	1.1852433201564594e-7	21	138	422
DOID:3459	breast carcinoma	GO:1903829	positive regulation of cellular protein localization	5.71165337248658e-12	1.2597051513019153e-7	33	351	422
DOID:3459	breast carcinoma	GO:0006809	nitric oxide biosynthetic process	5.739964059614522e-12	1.2659490733479828e-7	15	62	422
DOID:3459	breast carcinoma	GO:0071417	cellular response to organonitrogen compound	5.946465542194801e-12	1.3114929753310633e-7	40	462	422
DOID:3459	breast carcinoma	GO:0051427	hormone receptor binding	6.267319996311471e-12	1.382257425186495e-7	23	170	422
DOID:3459	breast carcinoma	GO:1901215	negative regulation of neuron death	6.267319996311471e-12	1.382257425186495e-7	23	170	422
DOID:3459	breast carcinoma	GO:0007346	regulation of mitotic cell cycle	6.622591364191521e-12	1.46061252537244e-7	38	453	422
DOID:3459	breast carcinoma	GO:0051145	smooth muscle cell differentiation	6.7548189264243774e-12	1.4897753142228964e-7	13	43	422
DOID:3459	breast carcinoma	GO:0014031	mesenchymal cell development	6.889155912404021e-12	1.519403336480707e-7	23	171	422
DOID:3459	breast carcinoma	GO:0008285	negative regulation of cell proliferation	6.931566431944702e-12	1.528756976565404e-7	70	634	422
DOID:3459	breast carcinoma	GO:0001501	skeletal system development	7.124190126717167e-12	1.5712401324474712e-7	40	482	422
DOID:3459	breast carcinoma	GO:0070201	regulation of establishment of protein localization	7.364220344641126e-12	1.6241787970106003e-7	60	803	422
DOID:3459	breast carcinoma	GO:0060688	regulation of morphogenesis of a branching structure	7.900013976325226e-12	1.7423480824785287e-7	14	53	422
DOID:3459	breast carcinoma	GO:0034614	cellular response to reactive oxygen species	8.124279027299508e-12	1.7918097394709065e-7	20	127	422
DOID:3459	breast carcinoma	GO:0043065	positive regulation of apoptotic process	8.189116051937617e-12	1.8061095452548415e-7	57	556	422
DOID:3459	breast carcinoma	GO:0045664	regulation of neuron differentiation	8.206768598029157e-12	1.8100028142953306e-7	51	548	422
DOID:3459	breast carcinoma	GO:0061180	mammary gland epithelium development	9.270695322527445e-12	2.044651853383428e-7	15	64	422
DOID:3459	breast carcinoma	GO:0032386	regulation of intracellular transport	9.328537942110415e-12	2.057409043132452e-7	43	575	422
DOID:3459	breast carcinoma	GO:0060322	head development	9.342082663010842e-12	2.0603963313270413e-7	52	708	422
DOID:3459	breast carcinoma	GO:0008134	transcription factor binding	9.354628183189106e-12	2.0631632458023574e-7	54	518	422
DOID:3459	breast carcinoma	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	9.542255874350758e-12	2.1045445330880597e-7	59	647	422
DOID:3459	breast carcinoma	GO:0048609	multicellular organismal reproductive process	9.74931246844335e-12	2.1502108649151808e-7	52	767	422
DOID:3459	breast carcinoma	GO:0006954	inflammatory response	1.0149436846518256e-11	2.2384582964996014e-7	46	637	422
DOID:3459	breast carcinoma	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.050182163453428e-11	2.3161767614965356e-7	73	732	422
DOID:3459	breast carcinoma	GO:0071902	positive regulation of protein serine/threonine kinase activity	1.0552447804457188e-11	2.3273423632730328e-7	29	283	422
DOID:3459	breast carcinoma	GO:0051223	regulation of protein transport	1.0662692950802466e-11	2.3516569302994839e-7	51	730	422
DOID:3459	breast carcinoma	GO:0071216	cellular response to biotic stimulus	1.0823564267070651e-11	2.387137099102432e-7	23	175	422
DOID:3459	breast carcinoma	GO:0007420	brain development	1.0936251904070105e-11	2.4119903574426615e-7	51	669	422
DOID:3459	breast carcinoma	GO:0000904	cell morphogenesis involved in differentiation	1.1939560451423858e-11	2.633270057561532e-7	51	720	422
DOID:3459	breast carcinoma	GO:0080135	regulation of cellular response to stress	1.1963319224150837e-11	2.638510054886467e-7	59	681	422
DOID:3459	breast carcinoma	GO:1903706	regulation of hemopoiesis	1.2651213410208584e-11	2.790225117621503e-7	30	305	422
DOID:3459	breast carcinoma	GO:0019901	protein kinase binding	1.3031797863050087e-11	2.874163018695697e-7	41	532	422
DOID:3459	breast carcinoma	GO:0034097	response to cytokine	1.3053447212030278e-11	2.878937782613278e-7	61	784	422
DOID:3459	breast carcinoma	GO:0051147	regulation of muscle cell differentiation	1.3284928712664623e-11	2.9299910275781826e-7	21	145	422
DOID:3459	breast carcinoma	GO:0045321	leukocyte activation	1.368372082310998e-11	3.017944627536906e-7	50	694	422
DOID:3459	breast carcinoma	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1.448918762747553e-11	3.195590331239728e-7	22	161	422
DOID:3459	breast carcinoma	GO:0051146	striated muscle cell differentiation	1.6067702723887578e-11	3.5437318357534053e-7	26	230	422
DOID:3459	breast carcinoma	GO:0044212	transcription regulatory region DNA binding	1.6294854354725885e-11	3.593830127934794e-7	52	807	422
DOID:3459	breast carcinoma	GO:0045444	fat cell differentiation	1.7700174659296408e-11	3.903773521107823e-7	24	196	422
DOID:3459	breast carcinoma	GO:0003206	cardiac chamber morphogenesis	1.8299695092593993e-11	4.035997752671605e-7	18	104	422
DOID:3459	breast carcinoma	GO:0030330	DNA damage response, signal transduction by p53 class mediator	1.8299695092593993e-11	4.035997752671605e-7	18	104	422
DOID:3459	breast carcinoma	GO:0048598	embryonic morphogenesis	1.882960454224758e-11	4.152869281792704e-7	42	560	422
DOID:3459	breast carcinoma	GO:0009894	regulation of catabolic process	1.9812262941343306e-11	4.369594591713266e-7	49	727	422
DOID:3459	breast carcinoma	GO:0071345	cellular response to cytokine stimulus	2.077049643389728e-11	4.580932988496045e-7	47	677	422
DOID:3459	breast carcinoma	GO:0046822	regulation of nucleocytoplasmic transport	2.0919599386104437e-11	4.6138176446053336e-7	25	215	422
DOID:3459	breast carcinoma	GO:0045598	regulation of fat cell differentiation	2.1867840871436783e-11	4.822952304195383e-7	18	105	422
DOID:3459	breast carcinoma	GO:0035257	nuclear hormone receptor binding	2.2676083233363897e-11	5.001210157118408e-7	21	149	422
DOID:3459	breast carcinoma	GO:0035258	steroid hormone receptor binding	2.5211943643910217e-11	5.560494170664398e-7	16	80	422
DOID:3459	breast carcinoma	GO:0002573	myeloid leukocyte differentiation	2.7415070213976378e-11	6.04639373569249e-7	23	183	422
DOID:3459	breast carcinoma	GO:0043542	endothelial cell migration	2.937816656611858e-11	6.479354636157453e-7	21	151	422
DOID:3459	breast carcinoma	GO:1900407	regulation of cellular response to oxidative stress	3.007860627235459e-11	6.633836613367805e-7	14	58	422
DOID:3459	breast carcinoma	GO:0071222	cellular response to lipopolysaccharide	3.379485580268238e-11	7.453455447281598e-7	21	152	422
DOID:3459	breast carcinoma	GO:0072073	kidney epithelium development	3.549671667713028e-11	7.828800863141083e-7	20	137	422
DOID:3459	breast carcinoma	GO:0030900	forebrain development	3.769062839609205e-11	8.312668092758102e-7	32	357	422
DOID:3459	breast carcinoma	GO:0048639	positive regulation of developmental growth	3.8291814163926574e-11	8.445259613854006e-7	21	153	422
DOID:3459	breast carcinoma	GO:0001935	endothelial cell proliferation	4.139977249906224e-11	9.130719824668176e-7	18	109	422
DOID:3459	breast carcinoma	GO:0042803	protein homodimerization activity	4.258626784547914e-11	9.392401373320425e-7	47	703	422
DOID:3459	breast carcinoma	GO:0043406	positive regulation of MAP kinase activity	4.638511796883904e-11	1.023023776802745e-6	24	205	422
DOID:3459	breast carcinoma	GO:0072089	stem cell proliferation	4.6629367034256575e-11	1.0284106899405288e-6	20	139	422
DOID:3459	breast carcinoma	GO:0007517	muscle organ development	4.689748589470355e-11	1.0343240514076868e-6	31	340	422
DOID:3459	breast carcinoma	GO:0001816	cytokine production	5.062283925383326e-11	1.1164867197432926e-6	43	613	422
DOID:3459	breast carcinoma	GO:1900182	positive regulation of protein localization to nucleus	5.3458015791818525e-11	1.1790165382885576e-6	19	125	422
DOID:3459	breast carcinoma	GO:0007292	female gamete generation	5.728395535697928e-11	1.263397635398178e-6	18	111	422
DOID:3459	breast carcinoma	GO:0048666	neuron development	5.791211954431219e-11	1.2772517965498054e-6	55	926	422
DOID:3459	breast carcinoma	GO:0003197	endocardial cushion development	5.8185123386067517e-11	1.283272896279719e-6	11	32	422
DOID:3459	breast carcinoma	GO:0030521	androgen receptor signaling pathway	6.276579256336845e-11	1.3842995549850912e-6	14	61	422
DOID:3459	breast carcinoma	GO:0046649	lymphocyte activation	6.648603889658489e-11	1.4663495878641797e-6	42	594	422
DOID:3459	breast carcinoma	GO:0004713	protein tyrosine kinase activity	6.650890949089217e-11	1.4668539988216267e-6	22	174	422
DOID:3459	breast carcinoma	GO:0043086	negative regulation of catalytic activity	7.078859720621722e-11	1.5612425113831208e-6	51	822	422
DOID:3459	breast carcinoma	GO:0031175	neuron projection development	7.418021752414461e-11	1.6360446974950094e-6	50	796	422
DOID:3459	breast carcinoma	GO:0042306	regulation of protein import into nucleus	7.476286256746789e-11	1.6488949339255043e-6	22	175	422
DOID:3459	breast carcinoma	GO:0060326	cell chemotaxis	7.715050820422675e-11	1.701554458444221e-6	25	228	422
DOID:3459	breast carcinoma	GO:2001020	regulation of response to DNA damage stimulus	7.904199517128063e-11	1.7432712035025943e-6	20	143	422
DOID:3459	breast carcinoma	GO:0003682	chromatin binding	8.106848525812893e-11	1.7879654423680336e-6	35	433	422
DOID:3459	breast carcinoma	GO:0031668	cellular response to extracellular stimulus	8.25939316939639e-11	1.8216091635103737e-6	23	193	422
DOID:3459	breast carcinoma	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	8.744860391374232e-11	1.928678959317587e-6	43	623	422
DOID:3459	breast carcinoma	GO:0043409	negative regulation of MAPK cascade	1.0171674613701498e-10	2.2433628360518654e-6	20	145	422
DOID:3459	breast carcinoma	GO:0000988	transcription factor activity, protein binding	1.0325851285131193e-10	2.2773665009356847e-6	41	578	422
DOID:3459	breast carcinoma	GO:0030162	regulation of proteolysis	1.0368195191290397e-10	2.286705449439097e-6	46	701	422
DOID:3459	breast carcinoma	GO:0051129	negative regulation of cellular component organization	1.0792500226841639e-10	2.3802859250299235e-6	41	579	422
DOID:3459	breast carcinoma	GO:0001817	regulation of cytokine production	1.2018297468330275e-10	2.650635506640242e-6	40	556	422
DOID:3459	breast carcinoma	GO:1904018	positive regulation of vasculature development	1.2370870994260486e-10	2.72839559778415e-6	19	131	422
DOID:3459	breast carcinoma	GO:0045682	regulation of epidermis development	1.253186443506138e-10	2.7639027011527872e-6	14	64	422
DOID:3459	breast carcinoma	GO:0001823	mesonephros development	1.2580891883828826e-10	2.7747157049784477e-6	17	102	422
DOID:3459	breast carcinoma	GO:0050900	leukocyte migration	1.3309653379423025e-10	2.9354440528317483e-6	31	354	422
DOID:3459	breast carcinoma	GO:0010632	regulation of epithelial cell migration	1.4395551417578645e-10	3.17493886514697e-6	21	164	422
DOID:3459	breast carcinoma	GO:0010038	response to metal ion	1.523414727699901e-10	3.3598911819421318e-6	30	335	422
DOID:3459	breast carcinoma	GO:0032403	protein complex binding	1.5235612771391516e-10	3.360214396730399e-6	54	924	422
DOID:3459	breast carcinoma	GO:0009952	anterior/posterior pattern specification	1.537326932421479e-10	3.3905745494555717e-6	23	199	422
DOID:3459	breast carcinoma	GO:0010564	regulation of cell cycle process	1.5497292338295665e-10	3.417927825211109e-6	40	561	422
DOID:3459	breast carcinoma	GO:1904019	epithelial cell apoptotic process	1.5748391479775137e-10	3.4733077408644064e-6	15	77	422
DOID:3459	breast carcinoma	GO:0060443	mammary gland morphogenesis	1.6698720184393778e-10	3.682902736668048e-6	12	44	422
DOID:3459	breast carcinoma	GO:0071456	cellular response to hypoxia	1.8478618635242583e-10	4.075459340002752e-6	19	134	422
DOID:3459	breast carcinoma	GO:0051896	regulation of protein kinase B signaling	1.8811907587235055e-10	4.148966218364691e-6	18	119	422
DOID:3459	breast carcinoma	GO:0045766	positive regulation of angiogenesis	1.8811907587235055e-10	4.148966218364691e-6	18	119	422
DOID:3459	breast carcinoma	GO:0005694	chromosome	1.937683347108532e-10	4.273560622047867e-6	52	876	422
DOID:3459	breast carcinoma	GO:0045931	positive regulation of mitotic cell cycle	2.1707868835818545e-10	4.78767047173978e-6	18	120	422
DOID:3459	breast carcinoma	GO:0030857	negative regulation of epithelial cell differentiation	2.496280959718433e-10	5.5055476566590045e-6	11	36	422
DOID:3459	breast carcinoma	GO:0035051	cardiocyte differentiation	2.738568261051455e-10	6.039912299748984e-6	17	107	422
DOID:3459	breast carcinoma	GO:0022604	regulation of cell morphogenesis	2.7522450984918123e-10	6.070076564723692e-6	38	524	422
DOID:3459	breast carcinoma	GO:0060560	developmental growth involved in morphogenesis	2.803717258359484e-10	6.1835984133118416e-6	23	205	422
DOID:3459	breast carcinoma	GO:0050999	regulation of nitric-oxide synthase activity	2.95648505677093e-10	6.520527792708286e-6	12	46	422
DOID:3459	breast carcinoma	GO:0048565	digestive tract development	3.1032032499211937e-10	6.844114767701193e-6	19	138	422
DOID:3459	breast carcinoma	GO:0022602	ovulation cycle process	3.2012315021034965e-10	7.0603160778892615e-6	16	94	422
DOID:3459	breast carcinoma	GO:0050927	positive regulation of positive chemotaxis	3.2678049155521194e-10	7.207143741250199e-6	9	21	422
DOID:3459	breast carcinoma	GO:0045666	positive regulation of neuron differentiation	3.3480174188582623e-10	7.3840524172918975e-6	28	304	422
DOID:3459	breast carcinoma	GO:0014074	response to purine-containing compound	3.448460406119125e-10	7.60557942569573e-6	20	155	422
DOID:3459	breast carcinoma	GO:0050865	regulation of cell activation	3.539334381130743e-10	7.806001977583854e-6	35	458	422
DOID:3459	breast carcinoma	GO:0032388	positive regulation of intracellular transport	3.6141789561128235e-10	7.971071687706832e-6	30	347	422
DOID:3459	breast carcinoma	GO:0001837	epithelial to mesenchymal transition	3.697209205455465e-10	8.154194902632028e-6	17	109	422
DOID:3459	breast carcinoma	GO:0003179	heart valve morphogenesis	4.2693182322750545e-10	9.415981361282633e-6	10	29	422
DOID:3459	breast carcinoma	GO:0009612	response to mechanical stimulus	4.543054821226633e-10	1.001970740821534e-5	23	210	422
DOID:3459	breast carcinoma	GO:0042060	wound healing	4.656728336271954e-10	1.0270414345647794e-5	38	534	422
DOID:3459	breast carcinoma	GO:0046777	protein autophosphorylation	4.699562961008041e-10	1.0364886110503235e-5	24	229	422
DOID:3459	breast carcinoma	GO:0045926	negative regulation of growth	5.136316927334406e-10	1.1328146983236032e-5	24	230	422
DOID:3459	breast carcinoma	GO:0001657	ureteric bud development	5.201766795082108e-10	1.1472496666553589e-5	16	97	422
DOID:3459	breast carcinoma	GO:0048471	perinuclear region of cytoplasm	5.335637487391409e-10	1.1767748478441753e-5	42	636	422
DOID:3459	breast carcinoma	GO:0030728	ovulation	5.420963677948976e-10	1.1955935391716466e-5	9	22	422
DOID:3459	breast carcinoma	GO:0042307	positive regulation of protein import into nucleus	6.089756476868047e-10	1.3430957909732477e-5	16	98	422
DOID:3459	breast carcinoma	GO:0002065	columnar/cuboidal epithelial cell differentiation	6.41751762842091e-10	1.4153835129482317e-5	18	128	422
DOID:3459	breast carcinoma	GO:0038127	ERBB signaling pathway	6.503150240533273e-10	1.4342697855496134e-5	19	144	422
DOID:3459	breast carcinoma	GO:0019216	regulation of lipid metabolic process	6.575227029514963e-10	1.450166321359525e-5	26	272	422
DOID:3459	breast carcinoma	GO:0048546	digestive tract morphogenesis	6.59201471187032e-10	1.453868844702999e-5	12	49	422
DOID:3459	breast carcinoma	GO:0003181	atrioventricular valve morphogenesis	7.002327606642211e-10	1.5443633536449397e-5	8	16	422
DOID:3459	breast carcinoma	GO:0000228	nuclear chromosome	7.971051596555867e-10	1.7580154296203965e-5	37	520	422
DOID:3459	breast carcinoma	GO:0001819	positive regulation of cytokine production	8.169800391755189e-10	1.801849476401607e-5	31	381	422
DOID:3459	breast carcinoma	GO:0032844	regulation of homeostatic process	8.612258683982077e-10	1.899433652752247e-5	33	427	422
DOID:3459	breast carcinoma	GO:0042368	vitamin D biosynthetic process	8.753348046397491e-10	1.9305509116329667e-5	7	11	422
DOID:3459	breast carcinoma	GO:0061383	trabecula morphogenesis	8.856119171340993e-10	1.953217083239256e-5	11	40	422
DOID:3459	breast carcinoma	GO:0051051	negative regulation of transport	9.545015888789976e-10	2.1051532542726292e-5	34	452	422
DOID:3459	breast carcinoma	GO:0045930	negative regulation of mitotic cell cycle	1.0054088672717398e-9	2.2174292567678222e-5	22	200	422
DOID:3459	breast carcinoma	GO:0000989	transcription factor activity, transcription factor binding	1.0149741047627003e-9	2.2385253880541356e-5	39	574	422
DOID:3459	breast carcinoma	GO:1903034	regulation of response to wounding	1.0185950971575153e-9	2.2465114867809e-5	32	407	422
DOID:3459	breast carcinoma	GO:0010721	negative regulation of cell development	1.085876832895849e-9	2.394901354951795e-5	27	299	422
DOID:3459	breast carcinoma	GO:0048634	regulation of muscle organ development	1.1220104845222068e-9	2.474594123613727e-5	16	102	422
DOID:3459	breast carcinoma	GO:1901861	regulation of muscle tissue development	1.1220104845222068e-9	2.474594123613727e-5	16	102	422
DOID:3459	breast carcinoma	GO:0051961	negative regulation of nervous system development	1.1536781530097073e-9	2.5444371664629095e-5	25	259	422
DOID:3459	breast carcinoma	GO:1990267	response to transition metal nanoparticle	1.313637421063163e-9	2.897227332154806e-5	19	150	422
DOID:3459	breast carcinoma	GO:0031669	cellular response to nutrient levels	1.3138446997018605e-9	2.8976844851924533e-5	20	167	422
DOID:3459	breast carcinoma	GO:0046906	tetrapyrrole binding	1.3718530755824077e-9	3.025621958197e-5	18	134	422
DOID:3459	breast carcinoma	GO:0046982	protein heterodimerization activity	1.4202683473740763e-9	3.132401840133525e-5	34	459	422
DOID:3459	breast carcinoma	GO:0051345	positive regulation of hydrolase activity	1.444297015318341e-9	3.185397067284601e-5	51	900	422
DOID:3459	breast carcinoma	GO:0009798	axis specification	1.562752482975327e-9	3.446650601202084e-5	15	90	422
DOID:3459	breast carcinoma	GO:0042176	regulation of protein catabolic process	1.7319964351614203e-9	3.8199181377485125e-5	31	393	422
DOID:3459	breast carcinoma	GO:0090399	replicative senescence	2.059983073010585e-9	4.543292667524845e-5	7	12	422
DOID:3459	breast carcinoma	GO:0007595	lactation	2.07310391076021e-9	4.572230675181643e-5	11	43	422
DOID:3459	breast carcinoma	GO:0060317	cardiac epithelial to mesenchymal transition	2.0963910607463276e-9	4.6235904844760256e-5	9	25	422
DOID:3459	breast carcinoma	GO:0009895	negative regulation of catabolic process	2.117651276556387e-9	4.670479890445112e-5	22	208	422
DOID:3459	breast carcinoma	GO:0044772	mitotic cell cycle phase transition	2.215298833263546e-9	4.8858415767627505e-5	35	491	422
DOID:3459	breast carcinoma	GO:0044427	chromosomal part	2.4542965437746034e-9	5.412951027294888e-5	46	776	422
DOID:3459	breast carcinoma	GO:0001936	regulation of endothelial cell proliferation	2.5060492570005977e-9	5.527091636314818e-5	15	93	422
DOID:3459	breast carcinoma	GO:0007423	sensory organ development	2.5927713309670253e-9	5.718357170447774e-5	35	494	422
DOID:3459	breast carcinoma	GO:1901652	response to peptide	2.6347860559994274e-9	5.811020646506737e-5	32	423	422
DOID:3459	breast carcinoma	GO:0071229	cellular response to acid chemical	2.7132412983021936e-9	5.984053683405488e-5	20	174	422
DOID:3459	breast carcinoma	GO:0006275	regulation of DNA replication	2.857864833671897e-9	6.303020890663369e-5	19	157	422
DOID:3459	breast carcinoma	GO:0002694	regulation of leukocyte activation	2.9573949955619128e-9	6.522534662711799e-5	32	425	422
DOID:3459	breast carcinoma	GO:0042113	B cell activation	3.030969475403822e-9	6.684803178003129e-5	22	212	422
DOID:3459	breast carcinoma	GO:0020037	heme binding	3.255700042892329e-9	7.180446444599031e-5	17	125	422
DOID:3459	breast carcinoma	GO:0007369	gastrulation	3.3159588408437912e-9	7.313347223480982e-5	20	176	422
DOID:3459	breast carcinoma	GO:0001938	positive regulation of endothelial cell proliferation	3.3942498811612154e-9	7.48601811290106e-5	13	68	422
DOID:3459	breast carcinoma	GO:1902883	negative regulation of response to oxidative stress	3.4662016590303324e-9	7.644707758991398e-5	10	35	422
DOID:3459	breast carcinoma	GO:1900408	negative regulation of cellular response to oxidative stress	3.4662016590303324e-9	7.644707758991398e-5	10	35	422
DOID:3459	breast carcinoma	GO:0051353	positive regulation of oxidoreductase activity	3.512540591721347e-9	7.746908275041431e-5	11	45	422
DOID:3459	breast carcinoma	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	3.512540591721347e-9	7.746908275041431e-5	11	45	422
DOID:3459	breast carcinoma	GO:0052547	regulation of peptidase activity	3.537736659176005e-9	7.802478201812679e-5	30	382	422
DOID:3459	breast carcinoma	GO:0031647	regulation of protein stability	3.6143246173736543e-9	7.971392943617595e-5	22	214	422
DOID:3459	breast carcinoma	GO:0046890	regulation of lipid biosynthetic process	3.6865723807011364e-9	8.130735385636356e-5	17	126	422
DOID:3459	breast carcinoma	GO:0044843	cell cycle G1/S phase transition	3.798842351798726e-9	8.37834680689209e-5	23	234	422
DOID:3459	breast carcinoma	GO:0007623	circadian rhythm	3.911455825900134e-9	8.626715824022746e-5	21	196	422
DOID:3459	breast carcinoma	GO:0010948	negative regulation of cell cycle process	3.943587012500416e-9	8.697581156069667e-5	22	215	422
DOID:3459	breast carcinoma	GO:0048145	regulation of fibroblast proliferation	3.977839280189244e-9	8.773124532457377e-5	14	82	422
DOID:3459	breast carcinoma	GO:0044419	interspecies interaction between organisms	3.991873831488135e-9	8.804077735347082e-5	45	761	422
DOID:3459	breast carcinoma	GO:0044403	symbiosis, encompassing mutualism through parasitism	3.991873831488135e-9	8.804077735347082e-5	45	761	422
DOID:3459	breast carcinoma	GO:0043525	positive regulation of neuron apoptotic process	4.523547425527852e-9	9.976683847001677e-5	11	46	422
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006732	coenzyme metabolic process	7.902567489281864e-13	1.742911259761115e-8	33	295	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0044282	small molecule catabolic process	6.008527009271347e-13	1.3251806318947956e-8	64	345	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006766	vitamin metabolic process	4.82280881897168e-13	1.063670485024204e-8	28	128	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0008652	cellular amino acid biosynthetic process	2.569056078982612e-13	5.666053182196151e-9	28	89	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0043177	organic acid binding	2.3803181647963356e-13	5.249791712458318e-9	27	196	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0043648	dicarboxylic acid metabolic process	1.765254609153999e-13	3.8932690404891446e-9	30	103	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0031406	carboxylic acid binding	2.90878432451791e-14	6.415323827724251e-10	27	195	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006575	cellular modified amino acid metabolic process	5.906386491005833e-14	1.3026535405913364e-9	33	219	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0009084	glutamine family amino acid biosynthetic process	7.338574192772285e-14	1.6185225382159274e-9	11	20	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0009069	serine family amino acid metabolic process	2.1271873151818e-13	4.69151162363346e-9	14	41	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0042558	pteridine-containing compound metabolic process	2.4347190930029683e-13	5.3697729596180466e-9	13	34	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0001889	liver development	3.232969447708456e-13	7.130314116920999e-9	22	135	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0070227	lymphocyte apoptotic process	1.0494938251781605e-12	2.314658631430433e-8	16	65	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0043603	cellular amide metabolic process	4.4472203697409896e-12	9.808344525463752e-8	58	955	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:1990267	response to transition metal nanoparticle	2.676592281147805e-11	5.903224276071484e-7	21	150	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0009066	aspartate family amino acid metabolic process	4.333611247631097e-11	9.557779606650385e-7	13	49	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0016491	oxidoreductase activity	5.473188569027343e-11	1.2071117388989805e-6	47	710	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0072594	establishment of protein localization to organelle	6.874689706393156e-11	1.5162128147450105e-6	44	641	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0043200	response to amino acid	6.974687494221143e-11	1.5382673268504732e-6	18	112	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006525	arginine metabolic process	1.0919576354240235e-10	2.4083125649276838e-6	9	19	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0033273	response to vitamin	1.7901791160568337e-10	3.948240040463347e-6	17	104	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0071941	nitrogen cycle metabolic process	7.134647317386111e-10	1.573546465849507e-5	8	16	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:2001057	reactive nitrogen species metabolic process	3.4921459057812854e-9	7.701927795200625e-5	13	68	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006730	one-carbon metabolic process	3.5457493607893298e-9	7.820150215220867e-5	10	35	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0051259	protein oligomerization	3.80088760465469e-9	8.382857612065919e-5	33	452	423
Orphanet:79062	Disorder of amino acid and other organic acid metabolism	GO:0006865	amino acid transport	4.1194969657709635e-9	9.08555055800786e-5	18	143	423
Orphanet:97929	Rare cardiac disease	GO:0033993	response to lipid	2.531530540750282e-12	5.583290607624747e-8	66	850	424
Orphanet:97929	Rare cardiac disease	GO:0034220	ion transmembrane transport	1.0955680807001045e-12	2.4162754019840804e-8	71	962	424
Orphanet:97929	Rare cardiac disease	GO:0071214	cellular response to abiotic stimulus	1.0331735467161707e-12	2.2786642572825144e-8	32	285	424
Orphanet:97929	Rare cardiac disease	GO:0009141	nucleoside triphosphate metabolic process	6.974421040695233e-13	1.5382085605253337e-8	32	274	424
Orphanet:97929	Rare cardiac disease	GO:0034764	positive regulation of transmembrane transport	1.4810375148499588e-13	3.266428239001584e-9	21	103	424
Orphanet:97929	Rare cardiac disease	GO:0043271	negative regulation of ion transport	7.438494264988549e-14	1.6405599101432244e-9	23	121	424
Orphanet:97929	Rare cardiac disease	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	2.5091040356528538e-14	5.533828950632369e-10	12	22	424
Orphanet:97929	Rare cardiac disease	GO:0051480	cytosolic calcium ion homeostasis	3.985700658404312e-14	8.79046280211071e-10	32	255	424
Orphanet:97929	Rare cardiac disease	GO:0044291	cell-cell contact zone	1.45328193923433e-13	3.2052133169813146e-9	20	62	424
Orphanet:97929	Rare cardiac disease	GO:0010522	regulation of calcium ion transport into cytosol	1.8840484727888906e-13	4.155268906735898e-9	18	78	424
Orphanet:97929	Rare cardiac disease	GO:0002028	regulation of sodium ion transport	2.9620750296999176e-13	6.532856478003168e-9	18	76	424
Orphanet:97929	Rare cardiac disease	GO:0097191	extrinsic apoptotic signaling pathway	8.307798893270046e-13	1.8322850459107087e-8	28	220	424
Orphanet:97929	Rare cardiac disease	GO:0019900	kinase binding	1.9416690477669363e-12	4.282351084849978e-8	52	598	424
Orphanet:97929	Rare cardiac disease	GO:2001233	regulation of apoptotic signaling pathway	2.637445817299522e-12	5.8168867500540955e-8	35	359	424
Orphanet:97929	Rare cardiac disease	GO:0022890	inorganic cation transmembrane transporter activity	1.2632450641092419e-11	2.786086988892933e-7	41	527	424
Orphanet:97929	Rare cardiac disease	GO:0035265	organ growth	1.9059198663740062e-11	4.203506265287871e-7	20	132	424
Orphanet:97929	Rare cardiac disease	GO:0051928	positive regulation of calcium ion transport	1.979660879669609e-11	4.366142070111323e-7	18	104	424
Orphanet:97929	Rare cardiac disease	GO:0032410	negative regulation of transporter activity	6.683120723494085e-11	1.4739622755666204e-6	14	61	424
Orphanet:97929	Rare cardiac disease	GO:0032770	positive regulation of monooxygenase activity	1.9607515611141935e-10	4.324437568037354e-6	10	27	424
Orphanet:97929	Rare cardiac disease	GO:1901699	cellular response to nitrogen compound	2.2988178027816275e-10	5.0700426640348795e-6	38	518	424
Orphanet:97929	Rare cardiac disease	GO:0040008	regulation of growth	2.472444471379731e-10	5.452976281627997e-6	42	617	424
Orphanet:97929	Rare cardiac disease	GO:0002576	platelet degranulation	2.5289015326279696e-10	5.577492330210987e-6	17	106	424
Orphanet:97929	Rare cardiac disease	GO:0050999	regulation of nitric-oxide synthase activity	3.1211055961932743e-10	6.8835983924042665e-6	12	46	424
Orphanet:97929	Rare cardiac disease	GO:0014074	response to purine-containing compound	3.7465963664828905e-10	8.263118286278015e-6	20	155	424
Orphanet:97929	Rare cardiac disease	GO:0071417	cellular response to organonitrogen compound	5.056208784992577e-10	1.115146847530113e-5	35	462	424
Orphanet:97929	Rare cardiac disease	GO:0051345	positive regulation of hydrolase activity	1.7013416231392853e-9	3.752308949833694e-5	51	900	424
Orphanet:97929	Rare cardiac disease	GO:0070201	regulation of establishment of protein localization	2.8300966015137874e-9	6.241778054638658e-5	47	803	424
Orphanet:97929	Rare cardiac disease	GO:0003014	renal system process	3.267019876851407e-9	7.205412338395778e-5	16	109	424
Orphanet:97929	Rare cardiac disease	GO:0035690	cellular response to drug	4.336096037782511e-9	9.563259811329328e-5	13	69	424
Orphanet:97929	Rare cardiac disease	GO:0003300	cardiac muscle hypertrophy	4.524139729511489e-9	9.97799017343759e-5	12	57	424
DOID:1612	breast cancer	GO:0006259	DNA metabolic process	1.6535661728767082e-12	3.64694019427958e-8	68	937	424
DOID:1612	breast cancer	GO:0007584	response to nutrient	2.353672812205332e-13	5.1910253873188594e-9	39	197	424
DOID:1612	breast cancer	GO:0001763	morphogenesis of a branching structure	1.0680345496894006e-13	2.355550199339973e-9	39	193	424
DOID:1612	breast cancer	GO:0010035	response to inorganic substance	5.236477917947013e-12	1.1549052048032138e-7	55	502	424
DOID:1612	breast cancer	GO:0098602	single organism cell adhesion	2.5111568380253857e-9	5.538356406264988e-5	45	746	424
Orphanet:98047	Rare infertility	GO:0048545	response to steroid hormone	1.3605006010664056e-11	3.0005840756519575e-7	37	446	425
Orphanet:98047	Rare infertility	GO:0043069	negative regulation of programmed cell death	1.8910650823045216e-11	4.1707440390226225e-7	52	806	425
Orphanet:98047	Rare infertility	GO:0000904	cell morphogenesis involved in differentiation	3.6760927635270946e-11	8.107622589959007e-7	48	720	425
Orphanet:98047	Rare infertility	GO:0001657	ureteric bud development	6.141942510140552e-11	1.3546054206114988e-6	17	97	425
Orphanet:98047	Rare infertility	GO:0022612	gland morphogenesis	2.110829289136973e-10	4.655433997191594e-6	18	119	425
Orphanet:98047	Rare infertility	GO:1901701	cellular response to oxygen-containing compound	2.1916812809053e-10	4.833753065036639e-6	52	873	425
Orphanet:98047	Rare infertility	GO:0060348	bone development	4.0083447672145667e-10	8.840404384091727e-6	21	172	425
Orphanet:98047	Rare infertility	GO:0007292	female gamete generation	5.528882907057664e-10	1.2193951251515678e-5	17	111	425
Orphanet:98047	Rare infertility	GO:0001658	branching involved in ureteric bud morphogenesis	5.741366271294623e-10	1.2662583311340292e-5	13	59	425
Orphanet:98047	Rare infertility	GO:0030334	regulation of cell migration	1.990449693956009e-9	4.389936800019978e-5	42	660	425
Orphanet:98047	Rare infertility	GO:1901652	response to peptide	3.131584214166594e-9	6.906708984344423e-5	32	423	425
Orphanet:98047	Rare infertility	GO:0034109	homotypic cell-cell adhesion	3.286237726385366e-9	7.247797305542925e-5	35	495	425
DOID:9252	amino acid metabolic disorder	GO:0043603	cellular amide metabolic process	1.780353642288901e-12	3.926569958068171e-8	60	955	426
DOID:9252	amino acid metabolic disorder	GO:0006732	coenzyme metabolic process	8.51096970677645e-13	1.877094368829546e-8	32	295	426
DOID:9252	amino acid metabolic disorder	GO:0044282	small molecule catabolic process	8.444356325298941e-13	1.8624027875446814e-8	67	345	426
DOID:9252	amino acid metabolic disorder	GO:0046395	carboxylic acid catabolic process	2.2071233729548112e-13	4.867810599051836e-9	60	219	426
DOID:9252	amino acid metabolic disorder	GO:0006575	cellular modified amino acid metabolic process	2.2071233729548112e-13	4.867810599051836e-9	36	219	426
DOID:9252	amino acid metabolic disorder	GO:0008652	cellular amino acid biosynthetic process	1.816324868286756e-13	4.0059044970064406e-9	24	89	426
DOID:9252	amino acid metabolic disorder	GO:0043648	dicarboxylic acid metabolic process	1.4810375148499588e-13	3.266428239001584e-9	28	103	426
DOID:9252	amino acid metabolic disorder	GO:1901605	alpha-amino acid metabolic process	1.0524914273446484e-13	2.321269843008622e-9	64	258	426
DOID:9252	amino acid metabolic disorder	GO:0009064	glutamine family amino acid metabolic process	8.08242361927114e-14	1.7825785292302498e-9	19	70	426
DOID:9252	amino acid metabolic disorder	GO:1901607	alpha-amino acid biosynthetic process	1.9984014443252818e-15	4.407474385459409e-11	21	73	426
DOID:9252	amino acid metabolic disorder	GO:0009069	serine family amino acid metabolic process	2.3880897259687117e-13	5.266931890623994e-9	14	41	426
DOID:9252	amino acid metabolic disorder	GO:0042558	pteridine-containing compound metabolic process	2.5934809855243657e-13	5.7199223135739885e-9	13	34	426
DOID:9252	amino acid metabolic disorder	GO:0070227	lymphocyte apoptotic process	1.148414696672262e-12	2.5328286135106737e-8	16	65	426
DOID:9252	amino acid metabolic disorder	GO:0006790	sulfur compound metabolic process	1.748268196877234e-12	3.8558055082127396e-8	42	360	426
DOID:9252	amino acid metabolic disorder	GO:0000096	sulfur amino acid metabolic process	1.875277710894352e-12	4.135924991377493e-8	13	39	426
DOID:9252	amino acid metabolic disorder	GO:0031406	carboxylic acid binding	2.8591573553171656e-12	6.305871547152009e-8	25	195	426
DOID:9252	amino acid metabolic disorder	GO:0001889	liver development	4.1877612488860905e-12	9.236107434418273e-8	21	135	426
DOID:9252	amino acid metabolic disorder	GO:0072329	monocarboxylic acid catabolic process	4.8965276278067904e-12	1.0799291683127876e-7	19	109	426
DOID:9252	amino acid metabolic disorder	GO:1990267	response to transition metal nanoparticle	3.102262891019336e-11	6.842040806143146e-7	21	150	426
DOID:9252	amino acid metabolic disorder	GO:0006536	glutamate metabolic process	4.3126169302354356e-11	9.511476639634253e-7	11	31	426
DOID:9252	amino acid metabolic disorder	GO:0009066	aspartate family amino acid metabolic process	4.7290504845420855e-11	1.042992084365757e-6	13	49	426
DOID:9252	amino acid metabolic disorder	GO:0002821	positive regulation of adaptive immune response	5.255629265121797e-11	1.1591290344226124e-6	15	71	426
DOID:9252	amino acid metabolic disorder	GO:0072594	establishment of protein localization to organelle	8.50866044288523e-11	1.8765850606783374e-6	44	641	426
DOID:9252	amino acid metabolic disorder	GO:0016491	oxidoreductase activity	2.0033075198711003e-10	4.418294735075712e-6	46	710	426
DOID:9252	amino acid metabolic disorder	GO:0043200	response to amino acid	6.619634840276944e-10	1.4599604640230801e-5	17	112	426
DOID:9252	amino acid metabolic disorder	GO:0044242	cellular lipid catabolic process	7.140236180092074e-10	1.574779089519307e-5	21	177	426
DOID:9252	amino acid metabolic disorder	GO:0009062	fatty acid catabolic process	9.185858740323738e-10	2.0259411451784004e-5	15	86	426
DOID:9252	amino acid metabolic disorder	GO:0032259	methylation	1.3407424059863615e-9	2.9570073764029203e-5	28	320	426
DOID:9252	amino acid metabolic disorder	GO:0016597	amino acid binding	1.4903706047064702e-9	3.28701236868012e-5	16	103	426
DOID:9252	amino acid metabolic disorder	GO:0042398	cellular modified amino acid biosynthetic process	1.5427177313398488e-9	3.4024639564700365e-5	12	52	426
DOID:9252	amino acid metabolic disorder	GO:0006730	one-carbon metabolic process	3.794183855987399e-9	8.368072494380208e-5	10	35	426
Orphanet:101998	Rare epilepsy	GO:0043005	neuron projection	5.363709476569056e-12	1.1829661250573054e-7	68	941	428
Orphanet:101998	Rare epilepsy	GO:0006732	coenzyme metabolic process	1.1719514247943152e-12	2.5847388673838623e-8	33	295	428
Orphanet:101998	Rare epilepsy	GO:0032940	secretion by cell	7.389644451905042e-13	1.629786083867657e-8	60	956	428
Orphanet:101998	Rare epilepsy	GO:0044282	small molecule catabolic process	6.645795025406187e-13	1.4657300928533346e-8	35	345	428
Orphanet:101998	Rare epilepsy	GO:0007626	locomotory behavior	4.5075054799781356e-13	9.941303336091778e-9	28	183	428
Orphanet:101998	Rare epilepsy	GO:1903509	liposaccharide metabolic process	2.708944180085382e-14	5.97457638917831e-10	24	118	428
Orphanet:101998	Rare epilepsy	GO:0006664	glycolipid metabolic process	3.135269821541442e-13	6.9148375914096505e-9	23	116	428
Orphanet:101998	Rare epilepsy	GO:1901698	response to nitrogen compound	3.2619462686511724e-12	7.194222495510161e-8	65	870	428
Orphanet:101998	Rare epilepsy	GO:0015980	energy derivation by oxidation of organic compounds	3.817501870173601e-12	8.419500374667876e-8	29	266	428
Orphanet:101998	Rare epilepsy	GO:0048666	neuron development	5.550671033915933e-12	1.224200496530159e-7	59	926	428
Orphanet:101998	Rare epilepsy	GO:0097285	cell-type specific apoptotic process	9.756528918103413e-12	2.1518024528877078e-7	37	429	428
Orphanet:101998	Rare epilepsy	GO:0042493	response to drug	1.0762279956111342e-11	2.3736208443203566e-7	37	433	428
Orphanet:101998	Rare epilepsy	GO:0015075	ion transmembrane transporter activity	1.0880851775141309e-11	2.399771859007416e-7	54	852	428
Orphanet:101998	Rare epilepsy	GO:0036477	somatodendritic compartment	1.940025917690491e-11	4.278727161466378e-7	46	649	428
Orphanet:101998	Rare epilepsy	GO:0008324	cation transmembrane transporter activity	4.356426330787144e-11	9.608098272551047e-7	44	623	428
Orphanet:101998	Rare epilepsy	GO:0061564	axon development	4.654088225919395e-11	1.0264591582265226e-6	36	440	428
Orphanet:101998	Rare epilepsy	GO:0048167	regulation of synaptic plasticity	6.856426537638072e-11	1.5121848728760767e-6	20	140	428
Orphanet:101998	Rare epilepsy	GO:0007409	axonogenesis	8.35307378821426e-11	1.842270423990655e-6	34	406	428
Orphanet:101998	Rare epilepsy	GO:0006865	amino acid transport	1.0158884844457816e-10	2.2405420524451714e-6	20	143	428
Orphanet:101998	Rare epilepsy	GO:0006606	protein import into nucleus	1.281897921145969e-10	2.827225865087435e-6	27	268	428
Orphanet:101998	Rare epilepsy	GO:0007568	aging	1.5524159735491594e-10	3.423853429662671e-6	28	290	428
Orphanet:101998	Rare epilepsy	GO:0080135	regulation of cellular response to stress	1.998780030376679e-10	4.4083093569957654e-6	45	681	428
Orphanet:101998	Rare epilepsy	GO:0033267	axon part	2.0455970251020972e-10	4.511564238862675e-6	24	217	428
Orphanet:101998	Rare epilepsy	GO:0021954	central nervous system neuron development	3.577237395191446e-10	7.889597075094734e-6	14	68	428
Orphanet:101998	Rare epilepsy	GO:2001057	reactive nitrogen species metabolic process	3.577237395191446e-10	7.889597075094734e-6	14	68	428
Orphanet:101998	Rare epilepsy	GO:0043408	regulation of MAPK cascade	5.070194264433781e-10	1.1182313450208703e-5	43	651	428
Orphanet:101998	Rare epilepsy	GO:1903531	negative regulation of secretion by cell	5.650022671943589e-10	1.2461125002971585e-5	21	174	428
Orphanet:101998	Rare epilepsy	GO:1903409	reactive oxygen species biosynthetic process	5.826423787880231e-10	1.2850177664169848e-5	15	83	428
Orphanet:101998	Rare epilepsy	GO:0046034	ATP metabolic process	6.813013486706154e-10	1.5026101244930423e-5	24	230	428
Orphanet:101998	Rare epilepsy	GO:1901615	organic hydroxy compound metabolic process	6.91657286999714e-10	1.5254501464778691e-5	38	534	428
Orphanet:101998	Rare epilepsy	GO:0010001	glial cell differentiation	6.992071366340724e-10	1.5421013398464467e-5	21	176	428
Orphanet:101998	Rare epilepsy	GO:0051341	regulation of oxidoreductase activity	8.258762562718402e-10	1.8214700832075437e-5	15	85	428
Orphanet:101998	Rare epilepsy	GO:0014070	response to organic cyclic compound	8.33217828066779e-10	1.837661919801281e-5	51	873	428
Orphanet:101998	Rare epilepsy	GO:1901701	cellular response to oxygen-containing compound	8.33217828066779e-10	1.837661919801281e-5	51	873	428
Orphanet:101998	Rare epilepsy	GO:0001775	cell activation	1.1439639235888421e-9	2.5230124334751913e-5	50	854	428
Orphanet:101998	Rare epilepsy	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	1.1455306703211932e-9	2.5264678933933915e-5	30	359	428
Orphanet:101998	Rare epilepsy	GO:0006809	nitric oxide biosynthetic process	1.2068608334914188e-9	2.6617315682653242e-5	13	62	428
Orphanet:101998	Rare epilepsy	GO:0045428	regulation of nitric oxide biosynthetic process	1.2774568070028636e-9	2.8174309878448156e-5	12	51	428
Orphanet:101998	Rare epilepsy	GO:0051050	positive regulation of transport	1.7599768309395358e-9	3.881628900637146e-5	52	920	428
Orphanet:101998	Rare epilepsy	GO:0070997	neuron death	1.783728831306064e-9	3.934013937445524e-5	26	281	428
Orphanet:101998	Rare epilepsy	GO:0021549	cerebellum development	2.5993830421455755e-9	5.732939299452067e-5	15	92	428
Orphanet:101998	Rare epilepsy	GO:1901214	regulation of neuron death	3.667940173812667e-9	8.089642053343837e-5	24	250	428
Orphanet:101998	Rare epilepsy	GO:0044297	cell body	3.744005216965718e-9	8.257403506017891e-5	35	494	428
Orphanet:101998	Rare epilepsy	GO:0071216	cellular response to biotic stimulus	3.817180127541064e-9	8.418790771291818e-5	20	175	428
Orphanet:101998	Rare epilepsy	GO:0071219	cellular response to molecule of bacterial origin	4.0079808361070945e-9	8.839601734034197e-5	19	158	428
Orphanet:101998	Rare epilepsy	GO:0051353	positive regulation of oxidoreductase activity	4.068713810312374e-9	8.973548308643942e-5	11	45	428
Orphanet:101998	Rare epilepsy	GO:0006119	oxidative phosphorylation	4.280729659633664e-9	9.441149264322046e-5	16	110	428
DOID:1247	blood coagulation disease	GO:0052547	regulation of peptidase activity	1.2787548797632553e-12	2.8202938873178596e-8	37	382	428
DOID:1247	blood coagulation disease	GO:0002718	regulation of cytokine production involved in immune response	3.1100777508896726e-10	6.859276479587173e-6	13	56	428
DOID:1247	blood coagulation disease	GO:0030856	regulation of epithelial cell differentiation	3.60111274133601e-10	7.94225415101657e-6	18	122	428
DOID:1247	blood coagulation disease	GO:0050795	regulation of behavior	4.032885136950881e-10	8.894528169545168e-6	25	243	428
DOID:1247	blood coagulation disease	GO:0050766	positive regulation of phagocytosis	4.5694203976154313e-10	1.0077856686940834e-5	12	47	428
DOID:1247	blood coagulation disease	GO:0055065	metal ion homeostasis	9.531123668082842e-10	2.1020893249956707e-5	37	516	428
DOID:1247	blood coagulation disease	GO:0050920	regulation of chemotaxis	9.564278258267223e-10	2.109401569860836e-5	21	179	428
DOID:1247	blood coagulation disease	GO:0048660	regulation of smooth muscle cell proliferation	1.0175760234432119e-9	2.2442639197040037e-5	16	100	428
DOID:1247	blood coagulation disease	GO:1904018	positive regulation of vasculature development	1.1811123190597073e-9	2.6049432196861844e-5	18	131	428
DOID:1247	blood coagulation disease	GO:0006875	cellular metal ion homeostasis	1.225430867890509e-9	2.7026877791325177e-5	34	450	428
DOID:1247	blood coagulation disease	GO:0002685	regulation of leukocyte migration	1.4803065440105456e-9	3.2648160828152584e-5	19	149	428
DOID:1247	blood coagulation disease	GO:1903530	regulation of secretion by cell	1.5216847781829301e-9	3.3560757782824524e-5	41	624	428
DOID:1247	blood coagulation disease	GO:0043537	negative regulation of blood vessel endothelial cell migration	1.5493243354924857e-9	3.417034821928677e-5	9	24	428
DOID:1247	blood coagulation disease	GO:0045766	positive regulation of angiogenesis	1.8606191032333186e-9	4.103595432181084e-5	17	119	428
DOID:1247	blood coagulation disease	GO:0045861	negative regulation of proteolysis	2.256642872566772e-9	4.9770258554460156e-5	28	326	428
DOID:1247	blood coagulation disease	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	2.893233097545078e-9	6.38102559663567e-5	10	34	428
DOID:1247	blood coagulation disease	GO:0048771	tissue remodeling	3.1240463549409014e-9	6.890084235822158e-5	18	139	428
DOID:1247	blood coagulation disease	GO:0003158	endothelium development	3.2542510908228905e-9	7.177250780809885e-5	16	108	428
DOID:1247	blood coagulation disease	GO:0070613	regulation of protein processing	3.405848492121777e-9	7.511598849374579e-5	14	80	428
DOID:1247	blood coagulation disease	GO:0045601	regulation of endothelial cell differentiation	3.5547647048161934e-9	7.840033556472115e-5	9	26	428
DOID:1247	blood coagulation disease	GO:0006275	regulation of DNA replication	3.601026588029299e-9	7.942064139898619e-5	19	157	428
DOID:2986	IgA glomerulonephritis	GO:0007059	chromosome segregation	2.411182364880915e-12	5.317862705744858e-8	35	308	430
DOID:2986	IgA glomerulonephritis	GO:1903047	mitotic cell cycle process	2.339684002095055e-12	5.1601730666206436e-8	69	857	430
DOID:2986	IgA glomerulonephritis	GO:0000819	sister chromatid segregation	5.551115123125783e-14	1.2242984404053914e-9	28	208	430
DOID:2986	IgA glomerulonephritis	GO:0050778	positive regulation of immune response	3.219646771412954e-14	7.10093095435127e-10	55	603	430
DOID:2986	IgA glomerulonephritis	GO:0002764	immune response-regulating signaling pathway	2.5486279753295094e-12	5.620998999589233e-8	39	451	430
DOID:2986	IgA glomerulonephritis	GO:0048285	organelle fission	2.8516078387497146e-12	6.289221088362495e-8	51	577	430
DOID:2986	IgA glomerulonephritis	GO:0000070	mitotic sister chromatid segregation	4.00857125271159e-12	8.840903897855412e-8	20	120	430
DOID:2986	IgA glomerulonephritis	GO:0002253	activation of immune response	4.141353926456759e-12	9.133756084800382e-8	46	475	430
DOID:2986	IgA glomerulonephritis	GO:0002757	immune response-activating signal transduction	5.807465619511731e-12	1.2808365423833123e-7	39	419	430
DOID:2986	IgA glomerulonephritis	GO:0051301	cell division	8.285150343567693e-12	1.8272899082738547e-7	51	648	430
DOID:2986	IgA glomerulonephritis	GO:0002252	immune effector process	1.4789391933334173e-11	3.261800390896852e-7	51	757	430
DOID:2986	IgA glomerulonephritis	GO:0007052	mitotic spindle organization	2.7303714844606475e-11	6.021834308977958e-7	16	79	430
DOID:2986	IgA glomerulonephritis	GO:0051302	regulation of cell division	4.4699022261340815e-11	9.858369359738717e-7	29	293	430
DOID:2986	IgA glomerulonephritis	GO:0006909	phagocytosis	6.116407380574174e-11	1.348973647785634e-6	24	204	430
DOID:2986	IgA glomerulonephritis	GO:0005819	spindle	6.927391993372112e-11	1.5278363041382192e-6	28	279	430
DOID:2986	IgA glomerulonephritis	GO:0010564	regulation of cell cycle process	7.913003585713341e-11	1.7452129408290773e-6	41	561	430
DOID:2986	IgA glomerulonephritis	GO:0045087	innate immune response	8.098577364279436e-11	1.7861412376918295e-6	50	783	430
DOID:2986	IgA glomerulonephritis	GO:0045321	leukocyte activation	4.1616732282534485e-10	9.17857030491298e-6	45	694	430
DOID:2986	IgA glomerulonephritis	GO:0051783	regulation of nuclear division	5.373005373954243e-10	1.1850163352256082e-5	20	156	430
DOID:2986	IgA glomerulonephritis	GO:0002429	immune response-activating cell surface receptor signaling pathway	9.710717785438305e-10	2.1416988075784182e-5	27	292	430
DOID:2986	IgA glomerulonephritis	GO:0007088	regulation of mitotic nuclear division	1.633146173851685e-9	3.6019038864298913e-5	18	133	430
DOID:2986	IgA glomerulonephritis	GO:0007062	sister chromatid cohesion	3.353653243998167e-9	7.396482229637957e-5	17	123	430
DOID:2986	IgA glomerulonephritis	GO:0031349	positive regulation of defense response	3.6722307417136335e-9	8.099104900849419e-5	31	398	430
DOID:2986	IgA glomerulonephritis	GO:0044770	cell cycle phase transition	3.980370033573877e-9	8.778706109047185e-5	36	517	430
DOID:2986	IgA glomerulonephritis	GO:0051983	regulation of chromosome segregation	4.279481657931683e-9	9.438396796568327e-5	14	81	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0032940	secretion by cell	2.8628210912984287e-12	6.313951916858684e-8	68	956	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:1903533	regulation of protein targeting	2.8170799026838722e-12	6.21306972536928e-8	33	303	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:1903532	positive regulation of secretion by cell	1.574740338128322e-12	3.473089815742014e-8	35	335	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0090316	positive regulation of intracellular protein transport	1.056710274838224e-12	2.330574511155703e-8	31	254	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:1904589	regulation of protein import	2.604583215770617e-13	5.744408282382096e-9	29	179	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0046822	regulation of nucleocytoplasmic transport	9.592326932761353e-14	2.1155877050205163e-9	30	215	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0071219	cellular response to molecule of bacterial origin	2.710054403110007e-13	5.977024986059121e-9	28	158	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0007260	tyrosine phosphorylation of STAT protein	2.76445533131664e-13	6.097006233218849e-9	17	71	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0043062	extracellular structure organization	4.1366909897533333e-13	9.123471977900977e-9	43	321	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0007596	blood coagulation	5.796474411567942e-13	1.2784124314713097e-8	36	352	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0034612	response to tumor necrosis factor	1.0001999228848035e-12	2.2059409299224342e-8	30	265	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0005125	cytokine activity	2.0339285811132868e-12	4.485829485645354e-8	27	222	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0052547	regulation of peptidase activity	2.2499779817053422e-12	4.962326438651132e-8	36	382	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:2000116	regulation of cysteine-type endopeptidase activity	2.2847279623761096e-12	5.03896752102051e-8	26	208	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002507	tolerance induction	2.811417765258284e-12	6.200581881277145e-8	11	25	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002437	inflammatory response to antigenic stimulus	3.0306868126217523e-12	6.684179765237275e-8	13	40	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0042346	positive regulation of NF-kappaB import into nucleus	4.766853578530572e-12	1.0513295567449177e-7	11	26	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0010952	positive regulation of peptidase activity	4.825140287323393e-12	1.0641846903691743e-7	22	149	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0001501	skeletal system development	6.122546913900351e-12	1.3503277218607224e-7	45	482	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0000975	regulatory region DNA binding	8.759326597385098e-12	1.9318694810532833e-7	55	810	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0031589	cell-substrate adhesion	1.3392287279145876e-11	2.953668959415623e-7	30	300	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050777	negative regulation of immune response	1.6856516182883752e-11	3.7177046441350114e-7	19	115	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0070371	ERK1 and ERK2 cascade	2.1484369838731254e-11	4.738377767932178e-7	27	247	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050764	regulation of phagocytosis	3.133815429379183e-11	6.911629929495788e-7	15	68	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0070372	regulation of ERK1 and ERK2 cascade	3.1510460907213655e-11	6.949632153085972e-7	26	233	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0003158	endothelium development	4.8153259157857065e-11	1.0620201307265376e-6	18	108	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0010950	positive regulation of endopeptidase activity	5.747524678412219e-11	1.267616567823815e-6	20	138	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002712	regulation of B cell mediated immunity	5.969869043553899e-11	1.3166546175558125e-6	12	40	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050701	interleukin-1 secretion	5.969869043553899e-11	1.3166546175558125e-6	12	40	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0042742	defense response to bacterium	6.417322229168576e-11	1.4153404176431295e-6	25	222	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0043900	regulation of multi-organism process	6.915479300317884e-11	1.5252089596851093e-6	37	467	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050704	regulation of interleukin-1 secretion	7.111244926250038e-11	1.5683850684844458e-6	11	32	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	8.721101618647253e-11	1.9234389619926517e-6	16	85	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0045428	regulation of nitric oxide biosynthetic process	9.211942320064281e-11	2.0316938786901773e-6	13	51	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002456	T cell mediated immunity	1.1282696998904385e-10	2.488398823108362e-6	15	74	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0060326	cell chemotaxis	1.1373302299944044e-10	2.508381822252659e-6	25	228	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0045601	regulation of endothelial cell differentiation	1.4448719998227944e-10	3.186665195609173e-6	10	26	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0019955	cytokine binding	3.0185631771928456e-10	6.657441087298821e-6	16	92	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0070374	positive regulation of ERK1 and ERK2 cascade	3.19199555676164e-10	7.039946200437797e-6	21	168	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:1904035	regulation of epithelial cell apoptotic process	3.2936675609107624e-10	7.2641838055886865e-6	13	56	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0071260	cellular response to mechanical stimulus	3.609248455660463e-10	7.960197468959151e-6	15	80	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:2001056	positive regulation of cysteine-type endopeptidase activity	5.102520628241791e-10	1.125360924558727e-5	18	124	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050706	regulation of interleukin-1 beta secretion	5.123067525758529e-10	1.1298925428060436e-5	10	29	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0031341	regulation of cell killing	5.273801395588862e-10	1.1631368977971235e-5	13	58	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0061041	regulation of wound healing	5.834257521541986e-10	1.286745496376085e-5	18	125	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0051099	positive regulation of binding	6.665517027215628e-10	1.4700797803524068e-5	18	126	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0070851	growth factor receptor binding	6.665517027215628e-10	1.4700797803524068e-5	18	126	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002889	regulation of immunoglobulin mediated immune response	7.98656363265593e-10	1.7614366091822653e-5	11	39	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0044087	regulation of cellular component biogenesis	8.073086643634042e-10	1.780519259253488e-5	46	735	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0030595	leukocyte chemotaxis	8.448796107174417e-10	1.8633819814373176e-5	21	177	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0010212	response to ionizing radiation	1.0022193075442942e-9	2.210394682788941e-5	19	145	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.0119152182852531e-9	2.2317790139281257e-5	17	114	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0045637	regulation of myeloid cell differentiation	1.0400167393953552e-9	2.293756918736456e-5	21	179	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0051250	negative regulation of lymphocyte activation	1.333893440147449e-9	2.9419019822451986e-5	17	116	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0032615	interleukin-12 production	1.3465962789283026e-9	2.9699180931763713e-5	12	51	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0006066	alcohol metabolic process	1.3715744096032267e-9	3.0250073603799166e-5	31	382	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0022408	negative regulation of cell-cell adhesion	1.4419847538249542e-9	3.1802973745609364e-5	18	132	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0071346	cellular response to interferon-gamma	1.633146173851685e-9	3.6019038864298913e-5	18	133	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:1990267	response to transition metal nanoparticle	1.792272108502857e-9	3.952856135303051e-5	19	150	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0071456	cellular response to hypoxia	1.8469138440835309e-9	4.0733684831262273e-5	18	134	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0006953	acute-phase response	2.1704880115436254e-9	4.787011309459466e-5	12	53	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0043406	positive regulation of MAP kinase activity	2.276534960543586e-9	5.0208978554788786e-5	22	205	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0097529	myeloid leukocyte migration	2.511127195070628e-9	5.5382910287282705e-5	19	153	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0002761	regulation of myeloid leukocyte differentiation	2.628045892016928e-9	5.796155214843335e-5	16	106	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0033619	membrane protein proteolysis	2.7334048358085283e-9	6.028524365375709e-5	12	54	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0048511	rhythmic process	3.070042775554782e-9	6.770979341486072e-5	28	329	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0016485	protein processing	3.1201243810841106e-9	6.881434322481006e-5	27	308	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0050798	activated T cell proliferation	3.2944702521575664e-9	7.265954141133513e-5	11	44	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0031093	platelet alpha granule lumen	3.424052708034253e-9	7.551748247569545e-5	12	55	430
Orphanet:98023	Rare systemic or rheumatologic disease	GO:0032732	positive regulation of interleukin-1 production	4.149395937957934e-9	9.151492741166223e-5	10	35	430
DOID:3463	breast disease	GO:0009607	response to biotic stimulus	2.7273738822941596e-12	6.015223097399769e-8	61	934	430
DOID:3463	breast disease	GO:0009790	embryo development	1.5123458041443882e-12	3.335478671040448e-8	79	932	430
DOID:3463	breast disease	GO:0044706	multi-multicellular organism process	7.920331057675867e-13	1.7468290147704124e-8	32	237	430
DOID:3463	breast disease	GO:0050795	regulation of behavior	2.546851618490109e-13	5.617081244579936e-9	30	243	430
DOID:3463	breast disease	GO:1901342	regulation of vasculature development	1.3145040611561853e-13	2.8991387068799668e-9	32	228	430
DOID:3463	breast disease	GO:0042063	gliogenesis	1.3011813848606835e-13	2.8697555443102374e-9	31	228	430
DOID:3463	breast disease	GO:0072593	reactive oxygen species metabolic process	1.305622276959184e-13	2.8795499318334805e-9	34	223	430
DOID:3463	breast disease	GO:0060537	muscle tissue development	8.76076988731711e-13	1.9321877986477887e-8	33	336	430
DOID:3463	breast disease	GO:0008406	gonad development	1.5599743719008075e-12	3.440523477227231e-8	27	220	430
DOID:3463	breast disease	GO:0043068	positive regulation of programmed cell death	7.8944628612021e-12	1.7411237840381233e-7	58	561	430
DOID:3463	breast disease	GO:0072001	renal system development	9.255818333997468e-12	2.0413707335631415e-7	29	276	430
DOID:3463	breast disease	GO:0008202	steroid metabolic process	4.846290035942502e-11	1.0688492674271188e-6	28	275	430
DOID:3463	breast disease	GO:0060512	prostate gland morphogenesis	2.248645714075792e-10	4.959388122394159e-6	10	27	430
DOID:3463	breast disease	GO:0060525	prostate glandular acinus development	9.97710580818989e-10	2.2004506859962802e-5	7	11	430
DOID:3463	breast disease	GO:0002064	epithelial cell development	1.7221469805761558e-9	3.7981951656607116e-5	22	202	430
DOID:3463	breast disease	GO:0046661	male sex differentiation	2.007427446493182e-9	4.4273812332407125e-5	19	151	430
DOID:3463	breast disease	GO:0043434	response to peptide hormone	2.12449935421688e-9	4.685583325725329e-5	31	389	430
DOID:3463	breast disease	GO:0000082	G1/S transition of mitotic cell cycle	2.328610304580536e-9	5.1357500267523726e-5	23	224	430
DOID:3463	breast disease	GO:0060740	prostate gland epithelium morphogenesis	2.4708447510235487e-9	5.449448098382437e-5	9	25	430
DOID:3463	breast disease	GO:0000785	chromatin	2.6148384568713823e-9	5.7670262166298336e-5	33	438	430
DOID:3463	breast disease	GO:0019221	cytokine-mediated signaling pathway	2.738021698256432e-9	6.038706855504561e-5	37	534	430
DOID:3463	breast disease	GO:0045747	positive regulation of Notch signaling pathway	3.025583006355248e-9	6.6729233205165e-5	10	34	430
DOID:3463	breast disease	GO:0009986	cell surface	3.215627542019206e-9	7.092066543923359e-5	44	715	430
DOID:3463	breast disease	GO:0019752	carboxylic acid metabolic process	4.129779185291227e-9	9.108227993159801e-5	53	967	430
DOID:3463	breast disease	GO:1902806	regulation of cell cycle G1/S phase transition	4.238893569485924e-9	9.348879767501206e-5	18	141	430
DOID:3463	breast disease	GO:0009411	response to UV	4.312159185282383e-9	9.510467083140295e-5	17	125	430
DOID:3463	breast disease	GO:0019904	protein domain specific binding	4.4626160544680715e-9	9.842299708129332e-5	40	619	430
Orphanet:68336	Rare genetic tumor	GO:0022603	regulation of anatomical structure morphogenesis	1.403810401257033e-11	3.096103839972386e-7	66	986	431
Orphanet:68336	Rare genetic tumor	GO:0040007	growth	6.430633803233832e-12	1.4182762853032216e-7	66	936	431
Orphanet:68336	Rare genetic tumor	GO:0032880	regulation of protein localization	3.915756607852927e-12	8.636201198619631e-8	60	933	431
Orphanet:68336	Rare genetic tumor	GO:0060562	epithelial tube morphogenesis	3.1294966618133913e-12	6.902104887629434e-8	34	301	431
Orphanet:68336	Rare genetic tumor	GO:0045787	positive regulation of cell cycle	2.560618383995461e-12	5.6474438459019893e-8	36	308	431
Orphanet:68336	Rare genetic tumor	GO:1903047	mitotic cell cycle process	2.2251089859537387e-12	4.907477868520971e-8	58	857	431
Orphanet:68336	Rare genetic tumor	GO:0098857	membrane microdomain	1.8467449791614854e-12	4.072996051540656e-8	32	283	431
Orphanet:68336	Rare genetic tumor	GO:0010038	response to metal ion	1.7568169141668477e-12	3.8746597041949826e-8	35	335	431
Orphanet:68336	Rare genetic tumor	GO:0009416	response to light stimulus	1.4859224961583095e-12	3.2772020652771516e-8	32	297	431
Orphanet:68336	Rare genetic tumor	GO:0034504	protein localization to nucleus	1.3149481503660354e-12	2.900118145632291e-8	36	344	431
Orphanet:68336	Rare genetic tumor	GO:0071214	cellular response to abiotic stimulus	1.1497469643018121e-12	2.5357669297676466e-8	32	285	431
Orphanet:68336	Rare genetic tumor	GO:0045121	membrane raft	1.1113332476497817e-12	2.4510454776915935e-8	32	282	431
Orphanet:68336	Rare genetic tumor	GO:0007568	aging	9.983125437429408e-13	2.201778315225056e-8	40	290	431
Orphanet:68336	Rare genetic tumor	GO:1901987	regulation of cell cycle phase transition	9.936496070395151e-13	2.1914942083256506e-8	34	312	431
Orphanet:68336	Rare genetic tumor	GO:0060485	mesenchyme development	9.818812429784884e-13	2.1655390813890563e-8	33	237	431
Orphanet:68336	Rare genetic tumor	GO:2001234	negative regulation of apoptotic signaling pathway	6.268319197033634e-13	1.382477798905768e-8	27	199	431
Orphanet:68336	Rare genetic tumor	GO:0048762	mesenchymal cell differentiation	3.5060843117662444e-13	7.732668949600452e-9	28	184	431
Orphanet:68336	Rare genetic tumor	GO:0042063	gliogenesis	3.326228181776969e-13	7.335996254909105e-9	31	228	431
Orphanet:68336	Rare genetic tumor	GO:0001763	morphogenesis of a branching structure	2.2182256032010628e-13	4.892296567859944e-9	30	193	431
Orphanet:68336	Rare genetic tumor	GO:0010948	negative regulation of cell cycle process	2.2182256032010628e-13	4.892296567859944e-9	31	215	431
Orphanet:68336	Rare genetic tumor	GO:0010001	glial cell differentiation	6.816769371198461e-14	1.5034384848178206e-9	27	176	431
Orphanet:68336	Rare genetic tumor	GO:1901990	regulation of mitotic cell cycle phase transition	4.6851411639181606e-14	1.0333078837021503e-9	33	292	431
Orphanet:68336	Rare genetic tumor	GO:0097191	extrinsic apoptotic signaling pathway	3.730349362740526e-14	8.22728551952423e-10	31	220	431
Orphanet:68336	Rare genetic tumor	GO:0072091	regulation of stem cell proliferation	1.5210055437364645e-14	3.3545777267107724e-10	19	88	431
Orphanet:68336	Rare genetic tumor	GO:0090068	positive regulation of cell cycle process	4.085620730620576e-14	9.010836521383681e-10	28	239	431
Orphanet:68336	Rare genetic tumor	GO:0048864	stem cell development	5.2513549064769904e-14	1.1581863246235002e-9	28	175	431
Orphanet:68336	Rare genetic tumor	GO:0019199	transmembrane receptor protein kinase activity	7.87148124459236e-14	1.736055188494845e-9	20	79	431
Orphanet:68336	Rare genetic tumor	GO:0009636	response to toxic substance	1.4377388168895777e-13	3.1709329606499637e-9	29	249	431
Orphanet:68336	Rare genetic tumor	GO:0035270	endocrine system development	1.6509016376176078e-13	3.641063561765634e-9	22	129	431
Orphanet:68336	Rare genetic tumor	GO:0009612	response to mechanical stimulus	2.403632848313464e-13	5.301212246955345e-9	29	210	431
Orphanet:68336	Rare genetic tumor	GO:0044843	cell cycle G1/S phase transition	2.7766677845875165e-13	6.123940798907768e-9	28	234	431
Orphanet:68336	Rare genetic tumor	GO:1902807	negative regulation of cell cycle G1/S phase transition	3.115285807098189e-13	6.870762847555056e-9	19	94	431
Orphanet:68336	Rare genetic tumor	GO:0014031	mesenchymal cell development	3.6259883984257613e-13	7.997117412728016e-9	27	171	431
Orphanet:68336	Rare genetic tumor	GO:1901215	negative regulation of neuron death	4.3665071558507407e-13	9.630331532228809e-9	27	170	431
Orphanet:68336	Rare genetic tumor	GO:2001236	regulation of extrinsic apoptotic signaling pathway	5.435651928564766e-13	1.1988330328449592e-8	25	151	431
Orphanet:68336	Rare genetic tumor	GO:0007093	mitotic cell cycle checkpoint	5.622169396701793e-13	1.2399694604425804e-8	24	144	431
Orphanet:68336	Rare genetic tumor	GO:0001775	cell activation	6.725731083179198e-13	1.4833599903951722e-8	55	854	431
Orphanet:68336	Rare genetic tumor	GO:0001701	in utero embryonic development	6.905587213168474e-13	1.523027259864307e-8	32	312	431
Orphanet:68336	Rare genetic tumor	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	6.905587213168474e-13	1.523027259864307e-8	19	97	431
Orphanet:68336	Rare genetic tumor	GO:0043434	response to peptide hormone	1.141309269314661e-12	2.5171575934734847e-8	38	389	431
Orphanet:68336	Rare genetic tumor	GO:0042327	positive regulation of phosphorylation	1.1428635815491361e-12	2.5205856291066198e-8	71	910	431
Orphanet:68336	Rare genetic tumor	GO:0048754	branching morphogenesis of an epithelial tube	1.197930643570544e-12	2.6420360343948346e-8	23	147	431
Orphanet:68336	Rare genetic tumor	GO:0048660	regulation of smooth muscle cell proliferation	1.2845280394913061e-12	2.8330265910980756e-8	19	100	431
Orphanet:68336	Rare genetic tumor	GO:0000165	MAPK cascade	1.4241940959891508e-12	3.141060078704072e-8	64	843	431
Orphanet:68336	Rare genetic tumor	GO:0002521	leukocyte differentiation	1.5235590566931023e-12	3.360209499536637e-8	42	448	431
Orphanet:68336	Rare genetic tumor	GO:0050769	positive regulation of neurogenesis	1.610489519521252e-12	3.5519346353041215e-8	36	376	431
Orphanet:68336	Rare genetic tumor	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1.6355805598777806e-12	3.607272924810445e-8	22	138	431
Orphanet:68336	Rare genetic tumor	GO:0043010	camera-type eye development	1.8286483438600953e-12	4.03308392238344e-8	30	283	431
Orphanet:68336	Rare genetic tumor	GO:0000082	G1/S transition of mitotic cell cycle	1.8497425813279733e-12	4.079607263118845e-8	27	224	431
Orphanet:68336	Rare genetic tumor	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	1.9936274853193936e-12	4.3969454188719226e-8	36	359	431
Orphanet:68336	Rare genetic tumor	GO:0048568	embryonic organ development	2.4726887204451486e-12	5.4535149729417753e-8	45	408	431
Orphanet:68336	Rare genetic tumor	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	2.48334686148155e-12	5.477021502997559e-8	18	91	431
Orphanet:68336	Rare genetic tumor	GO:0033273	response to vitamin	2.6403323971635473e-12	5.8232531019442035e-8	19	104	431
Orphanet:68336	Rare genetic tumor	GO:0018108	peptidyl-tyrosine phosphorylation	2.647548846823611e-12	5.8391689816694736e-8	34	354	431
Orphanet:68336	Rare genetic tumor	GO:0031668	cellular response to extracellular stimulus	2.7858826356919053e-12	6.144264153018497e-8	25	193	431
Orphanet:68336	Rare genetic tumor	GO:0051347	positive regulation of transferase activity	3.820721516945014e-12	8.426601305622228e-8	47	613	431
Orphanet:68336	Rare genetic tumor	GO:0048608	reproductive structure development	4.1634473646467995e-12	9.182483162728516e-8	46	418	431
Orphanet:68336	Rare genetic tumor	GO:0045931	positive regulation of mitotic cell cycle	4.268585485078802e-12	9.414365287341298e-8	20	120	431
Orphanet:68336	Rare genetic tumor	GO:0030900	forebrain development	4.289013588731905e-12	9.459419469948216e-8	34	357	431
Orphanet:68336	Rare genetic tumor	GO:0071900	regulation of protein serine/threonine kinase activity	4.3658410220359656e-12	9.628862374100322e-8	41	431	431
Orphanet:68336	Rare genetic tumor	GO:0003682	chromatin binding	4.5040637886017976e-12	9.933712685761265e-8	43	433	431
Orphanet:68336	Rare genetic tumor	GO:0019901	protein kinase binding	4.874323167314287e-12	1.075031974551166e-7	46	532	431
Orphanet:68336	Rare genetic tumor	GO:0019838	growth factor binding	4.963696120796612e-12	1.0947431794416929e-7	20	121	431
Orphanet:68336	Rare genetic tumor	GO:0071407	cellular response to organic cyclic compound	5.119127344244134e-12	1.1290235357730438e-7	49	416	431
Orphanet:68336	Rare genetic tumor	GO:0030855	epithelial cell differentiation	5.214606524361898e-12	1.1500814689480165e-7	50	568	431
Orphanet:68336	Rare genetic tumor	GO:0071453	cellular response to oxygen levels	5.5034865553693635e-12	1.213793959786713e-7	22	150	431
Orphanet:68336	Rare genetic tumor	GO:0033674	positive regulation of kinase activity	5.62339064202888e-12	1.2402388060994696e-7	41	480	431
Orphanet:68336	Rare genetic tumor	GO:0071417	cellular response to organonitrogen compound	5.8124616231225446e-12	1.2819384109796772e-7	46	462	431
Orphanet:68336	Rare genetic tumor	GO:0048514	blood vessel morphogenesis	6.0960125836118095e-12	1.3444755753155846e-7	45	484	431
Orphanet:68336	Rare genetic tumor	GO:0032386	regulation of intracellular transport	6.097011784333972e-12	1.3446959490348576e-7	44	575	431
Orphanet:68336	Rare genetic tumor	GO:2000648	positive regulation of stem cell proliferation	6.160738585947456e-12	1.3587508951307115e-7	15	61	431
Orphanet:68336	Rare genetic tumor	GO:0044708	single-organism behavior	6.447842260115522e-12	1.4220716104684783e-7	36	404	431
Orphanet:68336	Rare genetic tumor	GO:0018209	peptidyl-serine modification	6.6202598958398085e-12	1.4600983200274698e-7	28	254	431
Orphanet:68336	Rare genetic tumor	GO:0007611	learning or memory	6.7167382766797346e-12	1.4813766269217155e-7	26	218	431
Orphanet:68336	Rare genetic tumor	GO:0044454	nuclear chromosome part	7.1206374130383665e-12	1.5704565814456117e-7	41	486	431
Orphanet:68336	Rare genetic tumor	GO:0001067	regulatory region nucleic acid binding	7.170264382239111e-12	1.581401809502836e-7	58	811	431
Orphanet:68336	Rare genetic tumor	GO:0030155	regulation of cell adhesion	7.194134177268552e-12	1.586666292796579e-7	47	621	431
Orphanet:68336	Rare genetic tumor	GO:0044212	transcription regulatory region DNA binding	7.467804152838653e-12	1.647024205908565e-7	58	807	431
Orphanet:68336	Rare genetic tumor	GO:0007507	heart development	7.491673947868094e-12	1.652288689202308e-7	49	487	431
Orphanet:68336	Rare genetic tumor	GO:0045860	positive regulation of protein kinase activity	7.772560373098258e-12	1.714238190286821e-7	38	450	431
Orphanet:68336	Rare genetic tumor	GO:0001890	placenta development	8.228862036219198e-12	1.814875522088144e-7	21	138	431
Orphanet:68336	Rare genetic tumor	GO:1903827	regulation of cellular protein localization	8.635314685534468e-12	1.9045186538946268e-7	46	543	431
Orphanet:68336	Rare genetic tumor	GO:0032870	cellular response to hormone stimulus	8.676392937445598e-12	1.9135784623536267e-7	45	519	431
Orphanet:68336	Rare genetic tumor	GO:0048598	embryonic morphogenesis	8.679612584217011e-12	1.9142885554490618e-7	52	560	431
Orphanet:68336	Rare genetic tumor	GO:0040008	regulation of growth	9.709344439556844e-12	2.141395916144262e-7	46	617	431
Orphanet:68336	Rare genetic tumor	GO:0018105	peptidyl-serine phosphorylation	1.1895817664253627e-11	2.6236225858511375e-7	27	241	431
Orphanet:68336	Rare genetic tumor	GO:0016331	morphogenesis of embryonic epithelium	1.2187362230520193e-11	2.6879227399412287e-7	21	141	431
Orphanet:68336	Rare genetic tumor	GO:1903649	regulation of cytoplasmic transport	1.2959633366449452e-11	2.8582471389704267e-7	37	437	431
Orphanet:68336	Rare genetic tumor	GO:0080135	regulation of cellular response to stress	1.3086420835861645e-11	2.886210115349286e-7	49	681	431
Orphanet:68336	Rare genetic tumor	GO:0048562	embryonic organ morphogenesis	1.3931522602206314e-11	3.0725973099166026e-7	29	280	431
Orphanet:68336	Rare genetic tumor	GO:1990837	sequence-specific double-stranded DNA binding	1.4316881014053706e-11	3.157588107649545e-7	49	683	431
Orphanet:68336	Rare genetic tumor	GO:0001656	metanephros development	1.488109635516821e-11	3.282025801132349e-7	17	88	431
Orphanet:68336	Rare genetic tumor	GO:0071396	cellular response to lipid	1.5555667864930456e-11	3.430802547610412e-7	36	416	431
Orphanet:68336	Rare genetic tumor	GO:0071902	positive regulation of protein serine/threonine kinase activity	1.826250262126905e-11	4.027794953120889e-7	29	283	431
Orphanet:68336	Rare genetic tumor	GO:0033500	carbohydrate homeostasis	2.4604429604835332e-11	5.426506949346432e-7	25	212	431
Orphanet:68336	Rare genetic tumor	GO:0042593	glucose homeostasis	2.4604429604835332e-11	5.426506949346432e-7	25	212	431
Orphanet:68336	Rare genetic tumor	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	2.4619528637970234e-11	5.429837041104335e-7	24	195	431
Orphanet:68336	Rare genetic tumor	GO:2000377	regulation of reactive oxygen species metabolic process	2.6642910100349582e-11	5.8760938226321e-7	21	147	431
Orphanet:68336	Rare genetic tumor	GO:1900180	regulation of protein localization to nucleus	2.708144819507652e-11	5.972813399424126e-7	25	213	431
Orphanet:68336	Rare genetic tumor	GO:0046822	regulation of nucleocytoplasmic transport	3.310196561301382e-11	7.300638515950197e-7	25	215	431
Orphanet:68336	Rare genetic tumor	GO:0072215	regulation of metanephros development	3.384847957477177e-11	7.465282170215914e-7	10	23	431
Orphanet:68336	Rare genetic tumor	GO:0007389	pattern specification process	3.569966544603176e-11	7.873561214122304e-7	36	432	431
Orphanet:68336	Rare genetic tumor	GO:0051054	positive regulation of DNA metabolic process	4.208433601604611e-11	9.281700308338969e-7	23	183	431
Orphanet:68336	Rare genetic tumor	GO:0031669	cellular response to nutrient levels	4.465827707633707e-11	9.849383009186141e-7	22	167	431
Orphanet:68336	Rare genetic tumor	GO:0001501	skeletal system development	5.029876515294518e-11	1.109339265448206e-6	38	482	431
Orphanet:68336	Rare genetic tumor	GO:0048645	organ formation	5.117384294095473e-11	1.1286391060627565e-6	14	59	431
Orphanet:68336	Rare genetic tumor	GO:0060541	respiratory system development	5.203504294115646e-11	1.1476328720672058e-6	24	202	431
Orphanet:68336	Rare genetic tumor	GO:0031625	ubiquitin protein ligase binding	5.718558959699749e-11	1.2612281785617796e-6	27	257	431
Orphanet:68336	Rare genetic tumor	GO:0018958	phenol-containing compound metabolic process	6.414879738514401e-11	1.414801726329351e-6	17	96	431
Orphanet:68336	Rare genetic tumor	GO:0048589	developmental growth	7.252642930666298e-11	1.599570398358452e-6	41	558	431
Orphanet:68336	Rare genetic tumor	GO:0010165	response to X-ray	7.293698978116936e-11	1.6086253096236902e-6	11	32	431
Orphanet:68336	Rare genetic tumor	GO:1901653	cellular response to peptide	8.737754964016631e-11	1.927111857313868e-6	29	301	431
Orphanet:68336	Rare genetic tumor	GO:0044853	plasma membrane raft	9.023748415160071e-11	1.9901877129635537e-6	16	85	431
Orphanet:68336	Rare genetic tumor	GO:0006275	regulation of DNA replication	9.242462351011227e-11	2.038425071515526e-6	21	157	431
Orphanet:68336	Rare genetic tumor	GO:0048667	cell morphogenesis involved in neuron differentiation	1.0117218174343634e-10	2.2313524683514885e-6	38	495	431
Orphanet:68336	Rare genetic tumor	GO:2000736	regulation of stem cell differentiation	1.1036105362904891e-10	2.4340130377886737e-6	18	113	431
Orphanet:68336	Rare genetic tumor	GO:0030879	mammary gland development	1.1752288031630087e-10	2.5919671253760157e-6	19	128	431
Orphanet:68336	Rare genetic tumor	GO:0071375	cellular response to peptide hormone stimulus	1.2091327938890117e-10	2.6667423769222154e-6	28	285	431
Orphanet:68336	Rare genetic tumor	GO:0030278	regulation of ossification	1.4026746431028414e-10	3.0935989253633167e-6	22	177	431
Orphanet:68336	Rare genetic tumor	GO:0003002	regionalization	1.4071754872446718e-10	3.1035255371181236e-6	30	327	431
Orphanet:68336	Rare genetic tumor	GO:0005901	caveola	1.4262302450163133e-10	3.145550805383479e-6	15	75	431
Orphanet:68336	Rare genetic tumor	GO:0006606	protein import into nucleus	1.4964729455613224e-10	3.3004710814354965e-6	27	268	431
Orphanet:68336	Rare genetic tumor	GO:0048285	organelle fission	1.8368750964725677e-10	4.051228025270248e-6	41	577	431
Orphanet:68336	Rare genetic tumor	GO:0009894	regulation of catabolic process	2.0172474801682938e-10	4.449039317511172e-6	47	727	431
Orphanet:68336	Rare genetic tumor	GO:0031400	negative regulation of protein modification process	2.115194686069799e-10	4.665061880126942e-6	43	628	431
Orphanet:68336	Rare genetic tumor	GO:0016568	chromatin modification	2.5714541607158026e-10	5.6713421514587026e-6	42	608	431
Orphanet:68336	Rare genetic tumor	GO:0043524	negative regulation of neuron apoptotic process	2.644254815109548e-10	5.831903994724108e-6	19	134	431
Orphanet:68336	Rare genetic tumor	GO:0010623	developmental programmed cell death	3.1220137586274177e-10	6.88560134465277e-6	11	36	431
Orphanet:68336	Rare genetic tumor	GO:0071260	cellular response to mechanical stimulus	3.726463582154338e-10	8.218715430441392e-6	15	80	431
Orphanet:68336	Rare genetic tumor	GO:0045471	response to ethanol	3.895143096954712e-10	8.590738100333617e-6	19	137	431
Orphanet:68336	Rare genetic tumor	GO:0030856	regulation of epithelial cell differentiation	4.0303482773396127e-10	8.888933125672516e-6	18	122	431
Orphanet:68336	Rare genetic tumor	GO:0001933	negative regulation of protein phosphorylation	4.2964609647810903e-10	9.475844657824695e-6	32	385	431
Orphanet:68336	Rare genetic tumor	GO:0045321	leukocyte activation	4.478576398625478e-10	9.877500247168491e-6	45	694	431
Orphanet:68336	Rare genetic tumor	GO:1902105	regulation of leukocyte differentiation	4.996055791295362e-10	1.101880104770192e-5	24	225	431
Orphanet:68336	Rare genetic tumor	GO:0045664	regulation of neuron differentiation	5.012524839642651e-10	1.1055123533831868e-5	39	548	431
Orphanet:68336	Rare genetic tumor	GO:0010638	positive regulation of organelle organization	5.177153150626168e-10	1.1418211273706014e-5	40	573	431
Orphanet:68336	Rare genetic tumor	GO:0070201	regulation of establishment of protein localization	5.530174096435303e-10	1.219679896968806e-5	49	803	431
Orphanet:68336	Rare genetic tumor	GO:0043279	response to alkaloid	5.678907344375261e-10	1.2524830148019639e-5	19	140	431
Orphanet:68336	Rare genetic tumor	GO:0090130	tissue migration	5.990218321372254e-10	1.3211426507786506e-5	24	227	431
Orphanet:68336	Rare genetic tumor	GO:0070371	ERK1 and ERK2 cascade	6.586673428898848e-10	1.452690824743641e-5	25	247	431
Orphanet:68336	Rare genetic tumor	GO:0042803	protein homodimerization activity	6.672116192874e-10	1.4715352263383608e-5	45	703	431
Orphanet:68336	Rare genetic tumor	GO:0045667	regulation of osteoblast differentiation	6.849202316416836e-10	1.5105915708857331e-5	17	111	431
Orphanet:68336	Rare genetic tumor	GO:0036294	cellular response to decreased oxygen levels	7.264343571122822e-10	1.6021509746111384e-5	19	142	431
Orphanet:68336	Rare genetic tumor	GO:0032147	activation of protein kinase activity	7.513156763394591e-10	1.657026724166677e-5	27	288	431
Orphanet:68336	Rare genetic tumor	GO:0044774	mitotic DNA integrity checkpoint	8.267887485757797e-10	1.823482584983882e-5	16	98	431
Orphanet:68336	Rare genetic tumor	GO:0042060	wound healing	8.416212171624693e-10	1.856195594451826e-5	38	534	431
Orphanet:68336	Rare genetic tumor	GO:0033157	regulation of intracellular protein transport	9.259746303058591e-10	2.0422370471395723e-5	31	375	431
Orphanet:68336	Rare genetic tumor	GO:0033044	regulation of chromosome organization	9.511690324259803e-10	2.0978033010154995e-5	26	271	431
Orphanet:68336	Rare genetic tumor	GO:0061448	connective tissue development	1.0200734701371061e-9	2.2497720383873876e-5	24	233	431
Orphanet:68336	Rare genetic tumor	GO:0070372	regulation of ERK1 and ERK2 cascade	1.0200734701371061e-9	2.2497720383873876e-5	24	233	431
Orphanet:68336	Rare genetic tumor	GO:0007612	learning	1.1625783669089174e-9	2.5640665882176172e-5	18	130	431
Orphanet:68336	Rare genetic tumor	GO:0035148	tube formation	1.3197977155599006e-9	2.9108138616673607e-5	18	131	431
Orphanet:68336	Rare genetic tumor	GO:1902532	negative regulation of intracellular signal transduction	1.3808175713947435e-9	3.0453931537111067e-5	33	426	431
Orphanet:68336	Rare genetic tumor	GO:0010631	epithelial cell migration	1.4313973339952213e-9	3.1569468201264606e-5	23	218	431
Orphanet:68336	Rare genetic tumor	GO:0034599	cellular response to oxidative stress	1.5661506536090997e-9	3.454145266534869e-5	23	219	431
Orphanet:68336	Rare genetic tumor	GO:0032868	response to insulin	1.5686804077930105e-9	3.459724639387485e-5	24	238	431
Orphanet:68336	Rare genetic tumor	GO:0055123	digestive system development	1.8622881015062376e-9	4.107276407872007e-5	19	150	431
Orphanet:68336	Rare genetic tumor	GO:0048871	multicellular organismal homeostasis	1.865725351990477e-9	4.114857263814997e-5	28	321	431
Orphanet:68336	Rare genetic tumor	GO:0071456	cellular response to hypoxia	1.915978709021715e-9	4.2256910427473926e-5	18	134	431
Orphanet:68336	Rare genetic tumor	GO:0016049	cell growth	2.0152759461211645e-9	4.444691099170228e-5	35	479	431
Orphanet:68336	Rare genetic tumor	GO:0030330	DNA damage response, signal transduction by p53 class mediator	2.0397098454694174e-9	4.4985800641828e-5	16	104	431
Orphanet:68336	Rare genetic tumor	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2.098837659225694e-9	4.628986457422268e-5	20	168	431
Orphanet:68336	Rare genetic tumor	GO:0044773	mitotic DNA damage checkpoint	2.857602265926573e-9	6.302441797501057e-5	15	92	431
Orphanet:68336	Rare genetic tumor	GO:0048565	digestive tract development	3.0996573086028434e-9	6.836294194123571e-5	18	138	431
Orphanet:68336	Rare genetic tumor	GO:0007498	mesoderm development	3.4724663144913848e-9	7.658524456610749e-5	17	123	431
Orphanet:68336	Rare genetic tumor	GO:0071241	cellular response to inorganic substance	3.623797262264361e-9	7.992284861924048e-5	19	156	431
Orphanet:68336	Rare genetic tumor	GO:0001837	epithelial to mesenchymal transition	4.1259523575476464e-9	9.099787924571334e-5	16	109	431
Orphanet:68336	Rare genetic tumor	GO:0030324	lung development	4.298496891763648e-9	9.480334894784725e-5	20	175	431
Orphanet:68336	Rare genetic tumor	GO:0021700	developmental maturation	4.416561893982873e-9	9.740727257179227e-5	23	231	431
Orphanet:68336	Rare genetic tumor	GO:0042692	muscle cell differentiation	4.514700502333824e-9	9.957171957897248e-5	28	334	431
DOID:0060118	thoracic disease	GO:0045137	development of primary sexual characteristics	2.2137847111025621e-13	4.882502180336701e-9	28	225	432
DOID:0060118	thoracic disease	GO:0030278	regulation of ossification	3.8191672047105385e-13	8.423173269989093e-9	25	177	432
DOID:0060118	thoracic disease	GO:0050680	negative regulation of epithelial cell proliferation	8.192245770644035e-10	1.806799804715542e-5	17	112	432
DOID:0060118	thoracic disease	GO:0051216	cartilage development	1.2526589765471385e-9	2.762739372774714e-5	21	180	432
DOID:0060118	thoracic disease	GO:0030111	regulation of Wnt signaling pathway	2.9925533162611373e-9	6.600076339013938e-5	27	306	432
DOID:0060118	thoracic disease	GO:0044454	nuclear chromosome part	3.1249066667626835e-9	6.891981653545098e-5	35	486	432
DOID:0060118	thoracic disease	GO:0000790	nuclear chromatin	3.9309658861341745e-9	8.669745261868922e-5	26	289	432
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0016772	transferase activity, transferring phosphorus-containing groups	3.027800232757727e-12	6.677813413347167e-8	60	973	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0009790	embryo development	2.8819169273219813e-12	6.35606778320863e-8	76	932	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1903047	mitotic cell cycle process	1.6902035326893383e-12	3.7277438913463357e-8	65	857	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0051170	nuclear import	1.2758682998992299e-12	2.8139275354277515e-8	35	287	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0034504	protein localization to nucleus	1.198152688175469e-12	2.6425257537709967e-8	43	344	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0098687	chromosomal region	1.0402789740737717e-12	2.2943352773197034e-8	35	332	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1901987	regulation of cell cycle phase transition	9.752199048307375e-13	2.1508475001041916e-8	38	312	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001701	in utero embryonic development	9.732215033864122e-13	2.146440025718732e-8	36	312	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0032846	positive regulation of homeostatic process	6.974421040695233e-13	1.5382085605253337e-8	29	192	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0010948	negative regulation of cell cycle process	1.7075230118734908e-13	3.765942002686984e-9	29	215	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1900180	regulation of protein localization to nucleus	1.1080025785759062e-13	2.443699687049161e-9	31	213	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0046822	regulation of nucleocytoplasmic transport	4.951594689828198e-14	1.0920742088416091e-9	28	215	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0008156	negative regulation of DNA replication	1.4432899320127035e-14	3.1831759450540176e-10	16	53	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0016445	somatic diversification of immunoglobulins	5.706546346573305e-14	1.2585787967367423e-9	18	48	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0002821	positive regulation of adaptive immune response	2.453592884421596e-13	5.41139910659183e-9	17	71	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1901988	negative regulation of cell cycle phase transition	3.086420008457935e-13	6.807099328653976e-9	25	150	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0071897	DNA biosynthetic process	3.1863400806741993e-13	7.0274730479269465e-9	32	167	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0045637	regulation of myeloid cell differentiation	4.2099657093785936e-13	9.285079372034488e-9	25	179	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1901991	negative regulation of mitotic cell cycle phase transition	5.198064201294983e-13	1.1464330595956085e-8	24	139	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0043566	structure-specific DNA binding	5.581091144790662e-13	1.2309096519835805e-8	21	116	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0007093	mitotic cell cycle checkpoint	6.570299859731676e-13	1.4490796340638212e-8	25	144	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0050680	negative regulation of epithelial cell proliferation	6.712408406883696e-13	1.4804216741381993e-8	21	112	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0070227	lymphocyte apoptotic process	1.4103163081813364e-12	3.110452617693937e-8	16	65	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:2001251	negative regulation of chromosome organization	1.5023537969227618e-12	3.313441299113151e-8	19	101	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001655	urogenital system development	1.6148193893172902e-12	3.5614841631392835e-8	32	313	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0035270	endocrine system development	2.1505019986989282e-12	4.742932158130486e-8	21	129	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1902806	regulation of cell cycle G1/S phase transition	2.362554596402333e-12	5.210614162365346e-8	22	141	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0042306	regulation of protein import into nucleus	2.4722446312352986e-12	5.452535534189451e-8	24	175	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048568	embryonic organ development	2.596145520783466e-12	5.7257989460879344e-8	41	408	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0051347	positive regulation of transferase activity	3.453015651189162e-12	7.615626018697697e-8	48	613	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0009612	response to mechanical stimulus	3.640088230838501e-12	8.028214593114313e-8	26	210	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0032403	protein complex binding	3.820388450037626e-12	8.425866726557985e-8	61	924	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0016569	covalent chromatin modification	4.312772361458883e-12	9.511819443197567e-8	39	431	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048608	reproductive structure development	4.355849014814339e-12	9.606825002173025e-8	41	418	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1902807	negative regulation of cell cycle G1/S phase transition	4.519051799434237e-12	9.96676874365221e-8	18	94	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0010035	response to inorganic substance	4.9432680171435095e-12	1.090237761181001e-7	47	502	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0060284	regulation of cell development	7.396749879262643e-12	1.631353185871376e-7	60	828	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0033674	positive regulation of kinase activity	7.421951941921634e-12	1.6369115007908164e-7	40	480	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0044089	positive regulation of cellular component biogenesis	7.462919171530302e-12	1.6459468232810082e-7	37	418	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0018205	peptidyl-lysine modification	9.407141732253876e-12	2.0747451090485924e-7	35	388	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0007423	sensory organ development	1.2065348720113889e-11	2.661012660221118e-7	40	494	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001649	osteoblast differentiation	1.3965384404457382e-11	3.0800655304030755e-7	25	206	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0060322	head development	1.597333376679444e-11	3.5229187622665137e-7	49	708	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0044451	nucleoplasm part	1.8656298728103593e-11	4.1146466844832474e-7	49	712	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001822	kidney development	1.9384938099165083e-11	4.275348097770859e-7	28	262	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048871	multicellular organismal homeostasis	2.1629920077259612e-11	4.770478873039607e-7	31	321	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0030278	regulation of ossification	2.3168467144785154e-11	5.109805428782366e-7	23	177	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0002637	regulation of immunoglobulin production	2.3958057759898566e-11	5.283949638945629e-7	13	46	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:2000045	regulation of G1/S transition of mitotic cell cycle	2.4660273822973977e-11	5.438823391656911e-7	20	131	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0032845	negative regulation of homeostatic process	2.6398216945722197e-11	5.822126747379031e-7	22	162	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048598	embryonic morphogenesis	3.0647706594777446e-11	6.759351689478166e-7	42	560	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0044773	mitotic DNA damage checkpoint	3.3842040281228947e-11	7.463861984025044e-7	17	92	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0043254	regulation of protein complex assembly	3.570976847555585e-11	7.875789437283842e-7	33	368	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0002761	regulation of myeloid leukocyte differentiation	3.897515643558336e-11	8.59597075186791e-7	18	106	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:2001236	regulation of extrinsic apoptotic signaling pathway	4.7782555689934725e-11	1.0538442657415104e-6	21	151	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001501	skeletal system development	5.637623701204575e-11	1.243377907300669e-6	38	482	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0032205	negative regulation of telomere maintenance	5.949596371124244e-11	1.312183479651452e-6	10	24	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0006935	chemotaxis	6.190126189409284e-11	1.3652323310742176e-6	40	530	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0031400	negative regulation of protein modification process	7.648393030024181e-11	1.686853082771833e-6	44	628	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0010165	response to X-ray	7.663625289922038e-11	1.6902125576923055e-6	11	32	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0045667	regulation of osteoblast differentiation	8.745315582814328e-11	1.9287793517897e-6	18	111	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0030316	osteoclast differentiation	9.65462154667307e-11	2.1293267821187456e-6	16	85	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048015	phosphatidylinositol-mediated signaling	1.3722800673576785e-10	3.02656368855736e-6	23	193	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001894	tissue homeostasis	2.0790669186254718e-10	4.585382089028478e-6	23	197	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0006312	mitotic recombination	2.2429835766502038e-10	4.946900278302024e-6	12	44	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0010631	epithelial cell migration	2.8524704820398483e-10	6.2911236481388855e-6	24	218	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0071456	cellular response to hypoxia	2.8576441213346016e-10	6.302534109603464e-6	19	134	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	2.994487990903849e-10	6.604343263938439e-6	12	45	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0051348	negative regulation of transferase activity	3.1089553154117766e-10	6.856800948140673e-6	31	357	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0006304	DNA modification	3.338437304378772e-10	7.362923474807381e-6	16	92	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0014065	phosphatidylinositol 3-kinase signaling	4.806709474891591e-10	1.0601197746873403e-5	20	154	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0045121	membrane raft	5.206088893316974e-10	1.1482029054210585e-5	27	282	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0007420	brain development	5.222727805787031e-10	1.1518726175663296e-5	44	669	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0043414	macromolecule methylation	7.891989284303236e-10	1.7405782366530786e-5	25	248	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0045926	negative regulation of growth	8.594677192164113e-10	1.895556054731795e-5	24	230	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0031334	positive regulation of protein complex assembly	9.91643323011715e-10	2.1870693489023374e-5	23	213	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0004672	protein kinase activity	1.0560332608378076e-9	2.3290813567777846e-5	42	634	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:1901796	regulation of signal transduction by p53 class mediator	1.0668815830783274e-9	2.353007331479251e-5	20	161	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0044728	DNA methylation or demethylation	1.1226998219981965e-9	2.4761144574170224e-5	14	73	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0030855	epithelial cell differentiation	1.5748381487767915e-9	3.473305537127214e-5	39	568	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0090342	regulation of cell aging	1.6587208273577403e-9	3.658308784737496e-5	10	32	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0000217	DNA secondary structure binding	1.7154402343066977e-9	3.783403436763422e-5	9	24	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0090398	cellular senescence	1.854476572304975e-9	4.090048080218622e-5	12	52	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0018105	peptidyl-serine phosphorylation	2.213255911875933e-9	4.8813359136423706e-5	24	241	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0043542	endothelial cell migration	2.2506083663387244e-9	4.963716751960057e-5	19	151	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0019058	viral life cycle	2.474937699226132e-9	5.458475095643234e-5	33	434	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0002320	lymphoid progenitor cell differentiation	2.800857989981864e-9	6.177292296905001e-5	8	18	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0044270	cellular nitrogen compound catabolic process	2.936452969670711e-9	6.476347024608753e-5	33	437	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0001654	eye development	3.1251582433000635e-9	6.89253650559829e-5	28	327	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	3.3331131188418794e-9	7.351180983605765e-5	18	138	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0050679	positive regulation of epithelial cell proliferation	3.5063090209064285e-9	7.733164545609128e-5	19	155	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0048771	tissue remodeling	3.748085286581215e-9	8.26640209955487e-5	18	139	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0072089	stem cell proliferation	3.748085286581215e-9	8.26640209955487e-5	18	139	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0046777	protein autophosphorylation	4.077185700168684e-9	8.992233061722033e-5	23	229	433
Orphanet:140162	Inherited cancer-predisposing syndrome	GO:0090150	establishment of protein localization to membrane	4.188818514272441e-9	9.238439233227869e-5	29	353	433
DOID:12336	male infertility	GO:0022612	gland morphogenesis	3.8652414602324825e-12	8.52479004054274e-8	20	119	435
DOID:12336	male infertility	GO:0060548	negative regulation of cell death	4.521161223181025e-12	9.97142107772575e-8	57	867	435
DOID:12336	male infertility	GO:0043069	negative regulation of programmed cell death	1.070477040343576e-11	2.3609371124777567e-7	54	806	435
DOID:12336	male infertility	GO:0033993	response to lipid	1.843547536850565e-11	4.065944092523921e-7	54	850	435
DOID:12336	male infertility	GO:0048545	response to steroid hormone	2.4997448555552637e-11	5.513187278927134e-7	37	446	435
DOID:12336	male infertility	GO:0048771	tissue remodeling	8.026701525665203e-11	1.7702890214854605e-6	20	139	435
DOID:12336	male infertility	GO:0046660	female sex differentiation	1.195300525225207e-10	2.636235308384194e-6	19	127	435
DOID:12336	male infertility	GO:2000241	regulation of reproductive process	1.195300525225207e-10	2.636235308384194e-6	19	127	435
DOID:12336	male infertility	GO:0048514	blood vessel morphogenesis	2.5651192281372914e-10	5.657370457656796e-6	37	484	435
DOID:12336	male infertility	GO:1901699	cellular response to nitrogen compound	4.701854461330868e-10	1.0369940014465229e-5	38	518	435
DOID:12336	male infertility	GO:0001658	branching involved in ureteric bud morphogenesis	7.623184306027042e-10	1.681293298694264e-5	13	59	435
DOID:12336	male infertility	GO:0048515	spermatid differentiation	8.01638866398946e-10	1.7680145198428754e-5	18	126	435
DOID:12336	male infertility	GO:0048546	digestive tract morphogenesis	9.30386545583417e-10	2.0519675262842263e-5	12	49	435
DOID:12336	male infertility	GO:0060485	mesenchyme development	1.7306486244095254e-9	3.816945541135208e-5	24	237	435
DOID:12336	male infertility	GO:0008585	female gonad development	4.100747075241884e-9	9.044197674445975e-5	16	108	435
DOID:12336	male infertility	GO:1901701	cellular response to oxygen-containing compound	4.1547425499999235e-9	9.163284694024831e-5	50	873	435
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0043005	neuron projection	7.325251516476783e-12	1.6155842219589545e-7	85	941	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0044429	mitochondrial part	3.759881295195555e-12	8.292418196553797e-8	67	956	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0048666	neuron development	1.4910295220715852e-12	3.288465610928881e-8	65	926	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0055114	oxidation-reduction process	9.743317264110374e-13	2.148888622599543e-8	60	949	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0045333	cellular respiration	2.8110846983508964e-13	6.199847302212902e-9	26	173	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0006119	oxidative phosphorylation	7.4495964952348e-14	1.6430085070240352e-9	21	110	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0051402	neuron apoptotic process	1.1290968160437842e-12	2.490223027784566e-8	27	211	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0006979	response to oxidative stress	1.2526646386845641e-12	2.7627518606188062e-8	37	386	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007417	central nervous system development	1.847744179883648e-12	4.075199788733386e-8	61	889	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0043523	regulation of neuron apoptotic process	1.9845236565174673e-12	4.376866924449274e-8	25	190	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0030425	dendrite	2.262856568790994e-12	4.9907301624685374e-8	41	451	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007268	synaptic transmission	2.4735768988648488e-12	5.455473850446424e-8	52	605	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0030424	axon	4.1840975129048275e-12	9.228027064711597e-8	46	414	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0010035	response to inorganic substance	6.4118710341176666e-12	1.4141381565746514e-7	44	502	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007568	aging	8.061773471013112e-12	1.7780241390319418e-7	30	290	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0019752	carboxylic acid metabolic process	9.083511720575643e-12	2.003368509972958e-7	59	967	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0016491	oxidoreductase activity	1.2557621609232683e-11	2.769583445916268e-7	50	710	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0031175	neuron projection development	1.2771672608380413e-11	2.8167923937783e-7	56	796	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0060322	head development	4.3836156926602143e-11	9.668064410162103e-7	48	708	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0043209	myelin sheath	6.265710172925765e-11	1.3819023786387774e-6	22	168	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0050905	neuromuscular process	9.124667688098498e-11	2.0124454586101237e-6	17	97	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0050812	regulation of acyl-CoA biosynthetic process	9.63892299310487e-11	2.125864466129279e-6	8	13	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0044463	cell projection part	9.894485231143335e-11	2.1822287177286626e-6	56	939	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0044708	single-organism behavior	1.1809186961642126e-10	2.604516184390171e-6	34	404	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0044297	cell body	1.3240886165277743e-10	2.9202774437520063e-6	38	494	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0050804	modulation of synaptic transmission	1.5786494333980272e-10	3.481711325359349e-6	28	285	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007420	brain development	2.0573898140696656e-10	4.5375732349306475e-6	45	669	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0019725	cellular homeostasis	2.154388889508141e-10	4.751504695810205e-6	49	771	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0033267	axon part	2.975979462860323e-10	6.563522705338443e-6	24	217	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0045202	synapse	3.2502700531011897e-10	7.168470602114674e-6	48	755	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007626	locomotory behavior	3.3460556547737497e-10	7.379725746603505e-6	22	183	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0044456	synapse part	4.730315028567134e-10	1.0432709795504813e-5	42	613	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0043025	neuronal cell body	7.788077960313444e-10	1.71766059414713e-5	34	434	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0061564	axon development	1.1091695339970897e-9	2.4462734072305814e-5	34	440	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:1901615	organic hydroxy compound metabolic process	1.1633949359435292e-9	2.5658675312234536e-5	38	534	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0097164	ammonium ion metabolic process	1.2025960227646237e-9	2.6523255282073777e-5	21	178	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0032990	cell part morphogenesis	1.2551839567720435e-9	2.768308216660742e-5	48	787	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0055082	cellular chemical homeostasis	1.4208049181618776e-9	3.133585247006021e-5	43	661	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0048812	neuron projection morphogenesis	1.5086483173831766e-9	3.327323863988596e-5	38	539	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0009060	aerobic respiration	1.5102138428702006e-9	3.330776630450227e-5	13	62	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0042417	dopamine metabolic process	1.772768598584662e-9	3.909841144178472e-5	10	32	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0048667	cell morphogenesis involved in neuron differentiation	1.8165643433931677e-9	4.0064326593536315e-5	36	495	436
MESH:D020271	Heredodegenerative Disorders, Nervous System	GO:0007409	axonogenesis	2.1418132822859093e-9	4.723769194081573e-5	32	406	436
DOID:2531	hematologic cancer	GO:0048878	chemical homeostasis	1.5480505766163333e-11	3.414225546727323e-7	65	988	436
DOID:2531	hematologic cancer	GO:0016772	transferase activity, transferring phosphorus-containing groups	3.9181990985071025e-12	8.641588111757414e-8	60	973	436
DOID:2531	hematologic cancer	GO:0042692	muscle cell differentiation	1.9322321520576224e-12	4.261538011363086e-8	34	334	436
DOID:2531	hematologic cancer	GO:0048017	inositol lipid-mediated signaling	9.072742557236779e-13	2.0009933709985717e-8	32	196	436
DOID:2531	hematologic cancer	GO:0032101	regulation of response to external stimulus	8.497647030480948e-13	1.874156052572573e-8	61	920	436
DOID:2531	hematologic cancer	GO:1901342	regulation of vasculature development	6.437073096776658e-13	1.4196964714940918e-8	29	228	436
DOID:2531	hematologic cancer	GO:0019216	regulation of lipid metabolic process	2.1271873151818e-13	4.69151162363346e-9	30	272	436
DOID:2531	hematologic cancer	GO:0050866	negative regulation of cell activation	1.2023715356690445e-13	2.6518304219180777e-9	25	153	436
DOID:2531	hematologic cancer	GO:0035004	phosphatidylinositol 3-kinase activity	3.098632461728812e-13	6.834033894342895e-9	17	70	436
DOID:2531	hematologic cancer	GO:0045765	regulation of angiogenesis	4.233280392895722e-13	9.336499906531515e-9	27	208	436
DOID:2531	hematologic cancer	GO:0001822	kidney development	1.0882406087375784e-12	2.4001146625707293e-8	30	262	436
DOID:2531	hematologic cancer	GO:0070374	positive regulation of ERK1 and ERK2 cascade	1.5805134978563729e-12	3.48582251952223e-8	24	168	436
DOID:2531	hematologic cancer	GO:0006275	regulation of DNA replication	1.9246826354901714e-12	4.244887552573573e-8	23	157	436
DOID:2531	hematologic cancer	GO:0033365	protein localization to organelle	2.080891015054931e-12	4.58940513370365e-8	58	859	436
DOID:2531	hematologic cancer	GO:0001503	ossification	2.429279000182305e-12	5.357774834902074e-8	35	363	436
DOID:2531	hematologic cancer	GO:0071216	cellular response to biotic stimulus	2.7262636592695344e-12	6.012774500518958e-8	24	175	436
DOID:2531	hematologic cancer	GO:0060326	cell chemotaxis	3.77819997510187e-12	8.332820045087175e-8	27	228	436
DOID:2531	hematologic cancer	GO:0048568	embryonic organ development	4.011124765668228e-12	8.846535670681277e-8	37	408	436
DOID:2531	hematologic cancer	GO:0050817	coagulation	5.079381359962554e-12	1.1202575589397412e-7	34	356	436
DOID:2531	hematologic cancer	GO:0034504	protein localization to nucleus	5.248024237403115e-12	1.157451745559257e-7	33	344	436
DOID:2531	hematologic cancer	GO:0071396	cellular response to lipid	5.704214878221592e-12	1.258064591391772e-7	38	416	436
DOID:2531	hematologic cancer	GO:0006913	nucleocytoplasmic transport	6.310285627364465e-12	1.3917334951152327e-7	43	530	436
DOID:2531	hematologic cancer	GO:0033674	positive regulation of kinase activity	6.532774321499346e-12	1.4408033766066808e-7	41	480	436
DOID:2531	hematologic cancer	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	6.861067269881005e-12	1.5132083863722556e-7	32	327	436
DOID:2531	hematologic cancer	GO:0043542	endothelial cell migration	7.263301071702699e-12	1.6019210513640303e-7	22	151	436
DOID:2531	hematologic cancer	GO:0045860	positive regulation of protein kinase activity	1.0747847056791215e-11	2.3704376683753026e-7	38	450	436
DOID:2531	hematologic cancer	GO:0044764	multi-organism cellular process	1.1019962720126841e-11	2.430452777923975e-7	52	740	436
DOID:2531	hematologic cancer	GO:0090068	positive regulation of cell cycle process	1.2011502903419569e-11	2.649136965349186e-7	27	239	436
DOID:2531	hematologic cancer	GO:0050679	positive regulation of epithelial cell proliferation	1.2165823903842465e-11	2.683172461992456e-7	22	155	436
DOID:2531	hematologic cancer	GO:0007596	blood coagulation	1.2855827513647e-11	2.835352758134846e-7	33	352	436
DOID:2531	hematologic cancer	GO:0044419	interspecies interaction between organisms	1.2886358646824192e-11	2.8420863995570755e-7	52	761	436
DOID:2531	hematologic cancer	GO:0044403	symbiosis, encompassing mutualism through parasitism	1.2886358646824192e-11	2.8420863995570755e-7	52	761	436
DOID:2531	hematologic cancer	GO:0010594	regulation of endothelial cell migration	1.3240519791679617e-11	2.9201966400549395e-7	19	112	436
DOID:2531	hematologic cancer	GO:0009314	response to radiation	1.3919643215842825e-11	3.069977311254135e-7	37	431	436
DOID:2531	hematologic cancer	GO:0016032	viral process	1.889399747767584e-11	4.1670711437014063e-7	50	726	436
DOID:2531	hematologic cancer	GO:0042803	protein homodimerization activity	2.026168122171157e-11	4.4687137934484866e-7	49	703	436
DOID:2531	hematologic cancer	GO:0030522	intracellular receptor signaling pathway	2.053801573254077e-11	4.529659369811867e-7	29	281	436
DOID:2531	hematologic cancer	GO:0070301	cellular response to hydrogen peroxide	2.2019386314298117e-11	4.85637565161845e-7	16	77	436
DOID:2531	hematologic cancer	GO:0009792	embryo development ending in birth or egg hatching	3.274336357605989e-11	7.221548836700009e-7	42	558	436
DOID:2531	hematologic cancer	GO:0045444	fat cell differentiation	3.4301783635726224e-11	7.565258380859419e-7	24	196	436
DOID:2531	hematologic cancer	GO:0000790	nuclear chromatin	4.332856295974352e-11	9.556114560771434e-7	29	289	436
DOID:2531	hematologic cancer	GO:0045931	positive regulation of mitotic cell cycle	4.5007886306791534e-11	9.926489324962873e-7	19	120	436
DOID:2531	hematologic cancer	GO:0002695	negative regulation of leukocyte activation	4.872280356948977e-11	1.0745814327250969e-6	20	135	436
DOID:2531	hematologic cancer	GO:0097193	intrinsic apoptotic signaling pathway	5.122025026338406e-11	1.1296626195589354e-6	28	272	436
DOID:2531	hematologic cancer	GO:0002819	regulation of adaptive immune response	5.226352683962432e-11	1.1526720844479144e-6	19	121	436
DOID:2531	hematologic cancer	GO:0060249	anatomical structure homeostasis	5.436551209214713e-11	1.199031369192305e-6	32	351	436
DOID:2531	hematologic cancer	GO:0071222	cellular response to lipopolysaccharide	6.149936115917853e-11	1.3563684103656826e-6	21	152	436
DOID:2531	hematologic cancer	GO:2001235	positive regulation of apoptotic signaling pathway	6.265710172925765e-11	1.3819023786387774e-6	22	168	436
DOID:2531	hematologic cancer	GO:0043535	regulation of blood vessel endothelial cell migration	6.296652088622068e-11	1.388726618145597e-6	13	49	436
DOID:2531	hematologic cancer	GO:0003712	transcription cofactor activity	6.946820896303052e-11	1.5321213486796381e-6	40	528	436
DOID:2531	hematologic cancer	GO:0043009	chordate embryonic development	7.334388651969448e-11	1.6175994171918617e-6	41	552	436
DOID:2531	hematologic cancer	GO:0051427	hormone receptor binding	7.89645016041618e-11	1.7415620828797884e-6	22	170	436
DOID:2531	hematologic cancer	GO:0045834	positive regulation of lipid metabolic process	8.14035505669608e-11	1.7953553077543205e-6	19	124	436
DOID:2531	hematologic cancer	GO:0045862	positive regulation of proteolysis	8.494493997091013e-11	1.8734606510584229e-6	32	357	436
DOID:2531	hematologic cancer	GO:0030900	forebrain development	8.494493997091013e-11	1.8734606510584229e-6	32	357	436
DOID:2531	hematologic cancer	GO:0071241	cellular response to inorganic substance	1.0051393051213608e-10	2.2168347374451614e-6	21	156	436
DOID:2531	hematologic cancer	GO:0051223	regulation of protein transport	1.0950207407489643e-10	2.4150682437218407e-6	48	730	436
DOID:2531	hematologic cancer	GO:0048871	multicellular organismal homeostasis	1.1993317450276209e-10	2.645126163658418e-6	30	321	436
DOID:2531	hematologic cancer	GO:1903035	negative regulation of response to wounding	1.447808539722928e-10	3.1931417343589175e-6	21	159	436
DOID:2531	hematologic cancer	GO:0019902	phosphatase binding	1.447808539722928e-10	3.1931417343589175e-6	21	159	436
DOID:2531	hematologic cancer	GO:0007610	behavior	1.6343493225434713e-10	3.604557430869626e-6	47	714	436
DOID:2531	hematologic cancer	GO:0046777	protein autophosphorylation	1.6664747359840248e-10	3.675410030212767e-6	25	229	436
DOID:2531	hematologic cancer	GO:0032403	protein complex binding	1.6949208703209706e-10	3.7381479794929007e-6	55	924	436
DOID:2531	hematologic cancer	GO:0051146	striated muscle cell differentiation	1.828622808730529e-10	4.033027604655182e-6	25	230	436
DOID:2531	hematologic cancer	GO:0051250	negative regulation of lymphocyte activation	2.0722046301102637e-10	4.5702473117081865e-6	18	116	436
DOID:2531	hematologic cancer	GO:0098727	maintenance of cell number	2.332187776232786e-10	5.143640140481409e-6	20	147	436
DOID:2531	hematologic cancer	GO:0003713	transcription coactivator activity	2.7923774403859625e-10	6.15858844477124e-6	28	292	436
DOID:2531	hematologic cancer	GO:0046854	phosphatidylinositol phosphorylation	3.1159774760425307e-10	6.8722883234118015e-6	16	91	436
DOID:2531	hematologic cancer	GO:0071456	cellular response to hypoxia	3.207947241179454e-10	7.075127640421286e-6	19	134	436
DOID:2531	hematologic cancer	GO:0030225	macrophage differentiation	3.5279990040493203e-10	7.781001803430776e-6	11	36	436
DOID:2531	hematologic cancer	GO:0001889	liver development	3.6548775117495325e-10	8.060832352163594e-6	19	135	436
DOID:2531	hematologic cancer	GO:0060541	respiratory system development	3.945153093098952e-10	8.701035146829739e-6	23	202	436
DOID:2531	hematologic cancer	GO:0044087	regulation of cellular component biogenesis	4.1265690864378257e-10	9.101148120138625e-6	47	735	436
DOID:2531	hematologic cancer	GO:0043405	regulation of MAP kinase activity	4.400324549180823e-10	9.704915793218305e-6	27	278	436
DOID:2531	hematologic cancer	GO:0032940	secretion by cell	5.876296116369417e-10	1.296017108465275e-5	55	956	436
DOID:2531	hematologic cancer	GO:0045121	membrane raft	6.05870575931533e-10	1.3362475552169961e-5	27	282	436
DOID:2531	hematologic cancer	GO:0014074	response to purine-containing compound	6.084714954113224e-10	1.3419838831296715e-5	20	155	436
DOID:2531	hematologic cancer	GO:0071902	positive regulation of protein serine/threonine kinase activity	6.548502851089211e-10	1.4442723038077254e-5	27	283	436
DOID:2531	hematologic cancer	GO:1903409	reactive oxygen species biosynthetic process	7.516167688237374e-10	1.657690783640753e-5	15	83	436
DOID:2531	hematologic cancer	GO:0031329	regulation of cellular catabolic process	8.114656724345082e-10	1.7896875405543078e-5	42	624	436
DOID:2531	hematologic cancer	GO:0070851	growth factor receptor binding	8.316151101084301e-10	1.8341271253441427e-5	18	126	436
DOID:2531	hematologic cancer	GO:0030324	lung development	8.780131066643548e-10	1.9364579067482346e-5	21	175	436
DOID:2531	hematologic cancer	GO:0046982	protein heterodimerization activity	8.915315152790981e-10	1.966272756948051e-5	35	459	436
DOID:2531	hematologic cancer	GO:0090344	negative regulation of cell aging	9.061705830148981e-10	1.9985592208393577e-5	8	16	436
DOID:2531	hematologic cancer	GO:0097028	dendritic cell differentiation	9.240862519632742e-10	2.0380722287050013e-5	11	39	436
DOID:2531	hematologic cancer	GO:0043029	T cell homeostasis	9.240862519632742e-10	2.0380722287050013e-5	11	39	436
DOID:2531	hematologic cancer	GO:0043200	response to amino acid	9.42066868958591e-10	2.0777284794881723e-5	17	112	436
DOID:2531	hematologic cancer	GO:0051129	negative regulation of cellular component organization	9.829090874546864e-10	2.167805992381311e-5	40	579	436
DOID:2531	hematologic cancer	GO:0019827	stem cell population maintenance	1.2610832378356918e-9	2.7813190810466182e-5	19	145	436
DOID:2531	hematologic cancer	GO:0030168	platelet activation	1.3423043787597067e-9	2.960452307354533e-5	20	162	436
DOID:2531	hematologic cancer	GO:0048666	neuron development	1.5040144685229961e-9	3.317103910327468e-5	53	926	436
DOID:2531	hematologic cancer	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	1.5102138428702006e-9	3.330776630450227e-5	13	62	436
DOID:2531	hematologic cancer	GO:0006809	nitric oxide biosynthetic process	1.5102138428702006e-9	3.330776630450227e-5	13	62	436
DOID:2531	hematologic cancer	GO:1904018	positive regulation of vasculature development	1.58402457817175e-9	3.4935662071577944e-5	18	131	436
DOID:2531	hematologic cancer	GO:2000027	regulation of organ morphogenesis	1.6628939336627013e-9	3.667512570693088e-5	24	236	436
DOID:2531	hematologic cancer	GO:0001656	metanephros development	1.7618051462164885e-9	3.8856612499804655e-5	15	88	436
DOID:2531	hematologic cancer	GO:1902532	negative regulation of intracellular signal transduction	1.8454034966808308e-9	4.0700374119295724e-5	33	426	436
DOID:2531	hematologic cancer	GO:1903827	regulation of cellular protein localization	1.8510745158906161e-9	4.082544844796754e-5	38	543	436
DOID:2531	hematologic cancer	GO:0040029	regulation of gene expression, epigenetic	1.90401294730691e-9	4.19930055528539e-5	27	297	436
DOID:2531	hematologic cancer	GO:0030855	epithelial cell differentiation	1.9170383058764173e-9	4.2280279836104384e-5	39	568	436
DOID:2531	hematologic cancer	GO:0000987	core promoter proximal region sequence-specific DNA binding	2.152248490538966e-9	4.7467840458836896e-5	30	362	436
DOID:2531	hematologic cancer	GO:0019903	protein phosphatase binding	2.153445310959512e-9	4.7494236333212037e-5	17	118	436
DOID:2531	hematologic cancer	GO:1990267	response to transition metal nanoparticle	2.2511984498763127e-9	4.9650181812022076e-5	19	150	436
DOID:2531	hematologic cancer	GO:0061180	mammary gland epithelium development	2.2884582007165477e-9	5.047194561680346e-5	13	64	436
DOID:2531	hematologic cancer	GO:0031346	positive regulation of cell projection organization	2.371642437992705e-9	5.2306573969929104e-5	27	300	436
DOID:2531	hematologic cancer	GO:0022612	gland morphogenesis	2.4590004477076377e-9	5.423325487419195e-5	17	119	436
DOID:2531	hematologic cancer	GO:0045766	positive regulation of angiogenesis	2.4590004477076377e-9	5.423325487419195e-5	17	119	436
DOID:2531	hematologic cancer	GO:0048738	cardiac muscle tissue development	2.5568512862506054e-9	5.63913551182571e-5	20	168	436
DOID:2531	hematologic cancer	GO:1903530	regulation of secretion by cell	2.622610906222178e-9	5.784168353673014e-5	41	624	436
DOID:2531	hematologic cancer	GO:0010595	positive regulation of endothelial cell migration	2.800692566751195e-9	6.17692745596976e-5	13	65	436
DOID:2531	hematologic cancer	GO:0043406	positive regulation of MAP kinase activity	2.93861068811907e-9	6.481105872646609e-5	22	205	436
DOID:2531	hematologic cancer	GO:0050795	regulation of behavior	2.992816106051066e-9	6.600655921895626e-5	24	243	436
DOID:2531	hematologic cancer	GO:1902106	negative regulation of leukocyte differentiation	3.0554883068134586e-9	6.738879460677083e-5	14	78	436
DOID:2531	hematologic cancer	GO:0001501	skeletal system development	3.2062302812718713e-9	7.071340885345112e-5	35	482	436
DOID:2531	hematologic cancer	GO:0001649	osteoblast differentiation	3.220086752797613e-9	7.101901333295135e-5	22	206	436
DOID:2531	hematologic cancer	GO:0051101	regulation of DNA binding	3.3405742616565703e-9	7.367636534083566e-5	15	92	436
DOID:2531	hematologic cancer	GO:1903649	regulation of cytoplasmic transport	3.488563438125425e-9	7.694026662785625e-5	33	437	436
DOID:2531	hematologic cancer	GO:0032103	positive regulation of response to external stimulus	3.5498235462227967e-9	7.829135831194378e-5	26	285	436
DOID:2531	hematologic cancer	GO:0031490	chromatin DNA binding	3.6355886079419975e-9	8.018290674816075e-5	14	79	436
DOID:2531	hematologic cancer	GO:0048589	developmental growth	3.910420875996579e-9	8.624433242010454e-5	38	558	436
DOID:2531	hematologic cancer	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	4.217887150659294e-9	9.302550110779073e-5	6	8	436
DOID:2531	hematologic cancer	GO:0035258	steroid hormone receptor binding	4.314012480577389e-9	9.514554525913432e-5	14	80	436
DOID:850	lung disease	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.1393996857123057e-11	2.51294600683849e-7	65	996	439
DOID:850	lung disease	GO:0040007	growth	7.412737090817245e-12	1.6348791653797434e-7	63	936	439
DOID:850	lung disease	GO:0032880	regulation of protein localization	7.02105040772949e-12	1.548492667424739e-7	70	933	439
DOID:850	lung disease	GO:0051338	regulation of transferase activity	3.5342839765917233e-12	7.794863310373046e-8	76	928	439
DOID:850	lung disease	GO:0002250	adaptive immune response	2.3105961588498758e-12	5.096019828343401e-8	36	334	439
DOID:850	lung disease	GO:0030098	lymphocyte differentiation	2.077449323678593e-12	4.581814483373137e-8	35	299	439
DOID:850	lung disease	GO:0071902	positive regulation of protein serine/threonine kinase activity	2.0667911826421914e-12	4.558307953317353e-8	36	283	439
DOID:850	lung disease	GO:0050673	epithelial cell proliferation	1.886935052652916e-12	4.1616352586260064e-8	44	335	439
DOID:850	lung disease	GO:0010038	response to metal ion	1.886713008047991e-12	4.161145539249844e-8	39	335	439
DOID:850	lung disease	GO:0051052	regulation of DNA metabolic process	1.8818280267396403e-12	4.150371712974277e-8	37	335	439
DOID:850	lung disease	GO:0050678	regulation of epithelial cell proliferation	1.84341431008761e-12	4.065650260898224e-8	38	277	439
DOID:850	lung disease	GO:0051170	nuclear import	1.4386269953092778e-12	3.172891838154612e-8	32	287	439
DOID:850	lung disease	GO:0070372	regulation of ERK1 and ERK2 cascade	1.24145138613585e-12	2.7380210321226173e-8	48	233	439
DOID:850	lung disease	GO:0071496	cellular response to external stimulus	1.2398970739013748e-12	2.7345929964894822e-8	35	270	439
DOID:850	lung disease	GO:0046651	lymphocyte proliferation	1.0260681193585697e-12	2.2629932372453254e-8	40	249	439
DOID:850	lung disease	GO:0034599	cellular response to oxidative stress	9.818812429784884e-13	2.1655390813890563e-8	30	219	439
DOID:850	lung disease	GO:0048017	inositol lipid-mediated signaling	8.577583088253959e-13	1.8917859501144108e-8	28	196	439
DOID:850	lung disease	GO:1901342	regulation of vasculature development	8.080203173221889e-13	1.7820888098540877e-8	38	228	439
DOID:850	lung disease	GO:0048015	phosphatidylinositol-mediated signaling	7.860379014346108e-13	1.7336065916140342e-8	28	193	439
DOID:850	lung disease	GO:0050795	regulation of behavior	7.536193891155563e-13	1.6621075626943593e-8	40	243	439
DOID:850	lung disease	GO:0001664	G-protein coupled receptor binding	4.505285033928885e-13	9.936406142330156e-9	36	255	439
DOID:850	lung disease	GO:0007260	tyrosine phosphorylation of STAT protein	3.6570746431152656e-13	8.065678125390718e-9	19	71	439
DOID:850	lung disease	GO:0060541	respiratory system development	2.9976021664879227e-13	6.6112115781891134e-9	27	202	439
DOID:850	lung disease	GO:0097530	granulocyte migration	2.9665159217984183e-13	6.5426508655264115e-9	23	108	439
DOID:850	lung disease	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	2.948752353404416e-13	6.503473315433439e-9	41	212	439
DOID:850	lung disease	GO:0032602	chemokine production	2.7422508708241367e-13	6.048034295602633e-9	19	72	439
DOID:850	lung disease	GO:0042113	B cell activation	1.56097357262297e-13	3.4427272144199605e-9	28	212	439
DOID:850	lung disease	GO:0030323	respiratory tube development	1.0302869668521453e-13	2.2722979053924064e-9	27	179	439
DOID:850	lung disease	GO:0033002	muscle cell proliferation	9.703349235223868e-14	2.140073673828624e-9	27	151	439
DOID:850	lung disease	GO:0050715	positive regulation of cytokine secretion	9.614531393253856e-14	2.120484898782138e-9	20	95	439
DOID:850	lung disease	GO:0032872	regulation of stress-activated MAPK cascade	9.43689570931383e-14	2.0813073486891653e-9	26	194	439
DOID:850	lung disease	GO:0030324	lung development	4.107825191113079e-14	9.059808458999896e-10	27	175	439
DOID:850	lung disease	GO:1903035	negative regulation of response to wounding	3.2862601528904634e-14	7.247846767199917e-10	25	159	439
DOID:850	lung disease	GO:0071453	cellular response to oxygen levels	1.2878587085651816e-14	2.840372381740508e-10	24	150	439
DOID:850	lung disease	GO:0048659	smooth muscle cell proliferation	1.8540724511240114e-14	4.089156790954007e-10	22	104	439
DOID:850	lung disease	GO:0032722	positive regulation of chemokine production	7.205347429817266e-14	1.589139375646198e-9	16	50	439
DOID:850	lung disease	GO:0050866	negative regulation of cell activation	1.3933298959045715e-13	3.0729890854175324e-9	24	153	439
DOID:850	lung disease	GO:0032640	tumor necrosis factor production	1.6275869541004795e-13	3.5896430272686075e-9	20	101	439
DOID:850	lung disease	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.403632848313464e-13	5.301212246955345e-9	28	233	439
DOID:850	lung disease	GO:0032680	regulation of tumor necrosis factor production	2.604583215770617e-13	5.744408282382096e-9	20	100	439
DOID:850	lung disease	GO:0032355	response to estradiol	4.645173135031655e-13	1.0244929349312315e-8	26	145	439
DOID:850	lung disease	GO:0043062	extracellular structure organization	6.933342788784103e-13	1.5291487520663338e-8	35	321	439
DOID:850	lung disease	GO:0009612	response to mechanical stimulus	7.209788321915767e-13	1.5901188143985223e-8	27	210	439
DOID:850	lung disease	GO:0051341	regulation of oxidoreductase activity	8.099076964640517e-13	1.786251424551466e-8	18	85	439
DOID:850	lung disease	GO:0048871	multicellular organismal homeostasis	8.802958362252866e-13	1.9414924667948696e-8	34	321	439
DOID:850	lung disease	GO:0035150	regulation of tube size	8.818501484597618e-13	1.9449205024280047e-8	31	140	439
DOID:850	lung disease	GO:0071456	cellular response to hypoxia	1.2785328351583303e-12	2.8198041679416974e-8	22	134	439
DOID:850	lung disease	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	1.6759926779741363e-12	3.6964018512719576e-8	14	46	439
DOID:850	lung disease	GO:2000021	regulation of ion homeostasis	2.0317081350640365e-12	4.4809322918837324e-8	25	189	439
DOID:850	lung disease	GO:1903649	regulation of cytoplasmic transport	2.783662189642655e-12	6.139366959256876e-8	43	437	439
DOID:850	lung disease	GO:0001938	positive regulation of endothelial cell proliferation	3.3633096307994492e-12	7.417779390728185e-8	16	68	439
DOID:850	lung disease	GO:0043434	response to peptide hormone	3.4682257066265265e-12	7.649171795964804e-8	36	389	439
DOID:850	lung disease	GO:0010942	positive regulation of cell death	3.784750290947159e-12	8.347266766683958e-8	52	596	439
DOID:850	lung disease	GO:0045429	positive regulation of nitric oxide biosynthetic process	3.8727909767999336e-12	8.541440499332253e-8	13	40	439
DOID:850	lung disease	GO:0019955	cytokine binding	3.892441924335799e-12	8.584780664122604e-8	18	92	439
DOID:850	lung disease	GO:0045580	regulation of T cell differentiation	4.687583654572336e-12	1.0338465750159287e-7	19	105	439
DOID:850	lung disease	GO:0032845	negative regulation of homeostatic process	4.829470157119431e-12	1.0651396431526905e-7	23	162	439
DOID:850	lung disease	GO:0048732	gland development	5.402789327035862e-12	1.1915851860777593e-7	42	421	439
DOID:850	lung disease	GO:1990748	cellular detoxification	6.0499383280898655e-12	1.3343138982602198e-7	17	82	439
DOID:850	lung disease	GO:0060401	cytosolic calcium ion transport	6.066813718064168e-12	1.3380357655190522e-7	20	120	439
DOID:850	lung disease	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	7.279732372467151e-12	1.6055449747476302e-7	34	359	439
DOID:850	lung disease	GO:0003073	regulation of systemic arterial blood pressure	7.433831328285123e-12	1.639531499453284e-7	17	83	439
DOID:850	lung disease	GO:0050878	regulation of body fluid levels	7.540634783254063e-12	1.6630870014466836e-7	49	504	439
DOID:850	lung disease	GO:0043068	positive regulation of programmed cell death	7.56605889051798e-12	1.6686942883037403e-7	48	561	439
DOID:850	lung disease	GO:0043065	positive regulation of apoptotic process	8.171241461241152e-12	1.802167304276736e-7	48	556	439
DOID:850	lung disease	GO:0032870	cellular response to hormone stimulus	9.368839037904308e-12	2.0662974498097952e-7	44	519	439
DOID:850	lung disease	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.095457058397642e-11	2.4160305422959993e-7	17	85	439
DOID:850	lung disease	GO:0060322	head development	1.275302086156671e-11	2.812678751018538e-7	50	708	439
DOID:850	lung disease	GO:0060249	anatomical structure homeostasis	1.4588774632784407e-11	3.217554245260601e-7	33	351	439
DOID:850	lung disease	GO:0005578	proteinaceous extracellular matrix	1.8031354187542092e-11	3.9768151660624085e-7	33	354	439
DOID:850	lung disease	GO:0007417	central nervous system development	1.8067991547354723e-11	3.984895535769084e-7	56	889	439
DOID:850	lung disease	GO:0060284	regulation of cell development	1.9362844660975043e-11	4.2704753899780457e-7	54	828	439
DOID:850	lung disease	GO:0010634	positive regulation of epithelial cell migration	2.117928055156426e-11	4.671090325647498e-7	18	101	439
DOID:850	lung disease	GO:1903827	regulation of cellular protein localization	2.2810975330855854e-11	5.030960609220259e-7	42	543	439
DOID:850	lung disease	GO:0061082	myeloid leukocyte cytokine production	2.3469337584458572e-11	5.176162404252338e-7	10	22	439
DOID:850	lung disease	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	2.3469337584458572e-11	5.176162404252338e-7	10	22	439
DOID:850	lung disease	GO:1903651	positive regulation of cytoplasmic transport	2.6007640485659067e-11	5.735985109112107e-7	28	262	439
DOID:850	lung disease	GO:0044433	cytoplasmic vesicle part	2.6179614032173504e-11	5.773913874795866e-7	44	599	439
DOID:850	lung disease	GO:0010212	response to ionizing radiation	2.8373414728832813e-11	6.257756618444077e-7	21	145	439
DOID:850	lung disease	GO:0009790	embryo development	2.8941182783626118e-11	6.38297786292874e-7	57	932	439
DOID:850	lung disease	GO:0032760	positive regulation of tumor necrosis factor production	3.0379698756632934e-11	6.700242560775393e-7	14	56	439
DOID:850	lung disease	GO:0042063	gliogenesis	3.0490610036792987e-11	6.724704043614693e-7	26	228	439
DOID:850	lung disease	GO:1903533	regulation of protein targeting	3.075784071882026e-11	6.783641770535809e-7	30	303	439
DOID:850	lung disease	GO:0002285	lymphocyte activation involved in immune response	3.259548186917982e-11	7.18893352624761e-7	21	146	439
DOID:850	lung disease	GO:0051402	neuron apoptotic process	3.2977398589650875e-11	7.2731652589475e-7	25	211	439
DOID:850	lung disease	GO:0032755	positive regulation of interleukin-6 production	4.1732506339542397e-11	9.204104273186076e-7	15	68	439
DOID:850	lung disease	GO:0060402	calcium ion transport into cytosol	4.353717386607059e-11	9.602123696161868e-7	19	119	439
DOID:850	lung disease	GO:0031983	vesicle lumen	4.9006354529979035e-11	1.0808351491586876e-6	18	106	439
DOID:850	lung disease	GO:0002253	activation of immune response	5.483646869919312e-11	1.2094183171607042e-6	38	475	439
DOID:850	lung disease	GO:0071887	leukocyte apoptotic process	6.0188853900911e-11	1.327465172784592e-6	17	94	439
DOID:850	lung disease	GO:0030855	epithelial cell differentiation	6.079159398098e-11	1.3407586052505138e-6	42	568	439
DOID:850	lung disease	GO:0003012	muscle system process	6.765543680842256e-11	1.4921406588097597e-6	34	393	439
DOID:850	lung disease	GO:0007596	blood coagulation	6.963107868074303e-11	1.5357134403037875e-6	32	352	439
DOID:850	lung disease	GO:0009266	response to temperature stimulus	7.28020976836774e-11	1.6056502644135051e-6	25	219	439
DOID:850	lung disease	GO:0006925	inflammatory cell apoptotic process	8.157419184584569e-11	1.7991188011601267e-6	9	18	439
DOID:850	lung disease	GO:1900542	regulation of purine nucleotide metabolic process	8.503964199491065e-11	1.8755493041977545e-6	24	203	439
DOID:850	lung disease	GO:0072001	renal system development	8.702405462912566e-11	1.9193155248453664e-6	28	276	439
DOID:850	lung disease	GO:0001657	ureteric bud development	1.015674211402029e-10	2.240069473247175e-6	17	97	439
DOID:850	lung disease	GO:0042116	macrophage activation	1.190297860276246e-10	2.6252019308392605e-6	13	51	439
DOID:850	lung disease	GO:0009894	regulation of catabolic process	1.2157475026697284e-10	2.681331117138086e-6	48	727	439
DOID:850	lung disease	GO:0043523	regulation of neuron apoptotic process	1.3057033232399817e-10	2.8797286794057797e-6	23	190	439
DOID:850	lung disease	GO:0010563	negative regulation of phosphorus metabolic process	1.3867640369369383e-10	3.0585080834644174e-6	40	537	439
DOID:850	lung disease	GO:0045936	negative regulation of phosphate metabolic process	1.3867640369369383e-10	3.0585080834644174e-6	40	537	439
DOID:850	lung disease	GO:0034614	cellular response to reactive oxygen species	1.3982348612273654e-10	3.0838069864369544e-6	19	127	439
DOID:850	lung disease	GO:0045121	membrane raft	1.4453627183996787e-10	3.1877474754304913e-6	28	282	439
DOID:850	lung disease	GO:0042306	regulation of protein import into nucleus	1.5920587070894499e-10	3.5112854784857817e-6	22	175	439
DOID:850	lung disease	GO:0001933	negative regulation of protein phosphorylation	1.6471146668806114e-10	3.6327113978051884e-6	33	385	439
DOID:850	lung disease	GO:0002764	immune response-regulating signaling pathway	1.750548594969814e-10	3.860834926205925e-6	36	451	439
DOID:850	lung disease	GO:0000303	response to superoxide	1.7689794074016163e-10	3.901484083024265e-6	10	26	439
DOID:850	lung disease	GO:0040008	regulation of growth	2.1825252716212162e-10	4.813559486560592e-6	43	617	439
DOID:850	lung disease	GO:0015833	peptide transport	2.214164407376984e-10	4.883339600469938e-6	29	307	439
DOID:850	lung disease	GO:0045637	regulation of myeloid cell differentiation	2.4785240526625785e-10	5.466384798147317e-6	22	179	439
DOID:850	lung disease	GO:0043086	negative regulation of catalytic activity	2.621819428227923e-10	5.782422748956684e-6	51	822	439
DOID:850	lung disease	GO:0048754	branching morphogenesis of an epithelial tube	2.629289008737601e-10	5.798896908770779e-6	20	147	439
DOID:850	lung disease	GO:1903829	positive regulation of cellular protein localization	2.8571822685563575e-10	6.3015154933010464e-6	31	351	439
DOID:850	lung disease	GO:0097193	intrinsic apoptotic signaling pathway	3.12994519191534e-10	6.903094120769282e-6	27	272	439
DOID:850	lung disease	GO:0002020	protease binding	3.174102092273756e-10	7.000482164509769e-6	17	104	439
DOID:850	lung disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	3.174102092273756e-10	7.000482164509769e-6	17	104	439
DOID:850	lung disease	GO:0048608	reproductive structure development	3.494179390273189e-10	7.706412645247518e-6	34	418	439
DOID:850	lung disease	GO:0051353	positive regulation of oxidoreductase activity	3.504139201027101e-10	7.728379007865271e-6	12	45	439
DOID:850	lung disease	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	3.504139201027101e-10	7.728379007865271e-6	12	45	439
DOID:850	lung disease	GO:0022612	gland morphogenesis	3.561178019140243e-10	7.854178121213806e-6	18	119	439
DOID:850	lung disease	GO:0007162	negative regulation of cell adhesion	3.765061595828456e-10	8.30384334959966e-6	24	218	439
DOID:850	lung disease	GO:1990267	response to transition metal nanoparticle	3.7903102878544814e-10	8.359529339863059e-6	20	150	439
DOID:850	lung disease	GO:0098869	cellular oxidant detoxification	3.9884118230304466e-10	8.79644227569365e-6	15	79	439
DOID:850	lung disease	GO:0019932	second-messenger-mediated signaling	4.142046705624125e-10	9.135284009254008e-6	24	219	439
DOID:850	lung disease	GO:0031669	cellular response to nutrient levels	4.1559833352522446e-10	9.166021245898825e-6	21	167	439
DOID:850	lung disease	GO:0002675	positive regulation of acute inflammatory response	4.190452429497782e-10	9.242042833257358e-6	10	28	439
DOID:850	lung disease	GO:0043005	neuron projection	4.2207770611923934e-10	9.308923808459824e-6	55	941	439
DOID:850	lung disease	GO:0043542	endothelial cell migration	4.276005105552372e-10	9.430729260295756e-6	20	151	439
DOID:850	lung disease	GO:0002761	regulation of myeloid leukocyte differentiation	4.3175396591266235e-10	9.522333718203768e-6	17	106	439
DOID:850	lung disease	GO:0019430	removal of superoxide radicals	4.632152439398851e-10	1.0216212205094166e-5	9	21	439
DOID:850	lung disease	GO:0007566	embryo implantation	4.640753337170622e-10	1.0235181485129807e-5	12	46	439
DOID:850	lung disease	GO:0001818	negative regulation of cytokine production	4.983332635433158e-10	1.0990740127447829e-5	23	203	439
DOID:850	lung disease	GO:0042742	defense response to bacterium	5.489043664042015e-10	1.2106085801044664e-5	24	222	439
DOID:850	lung disease	GO:0052547	regulation of peptidase activity	5.589796403526748e-10	1.2328295967978242e-5	32	382	439
DOID:850	lung disease	GO:0044708	single-organism behavior	5.711285888665429e-10	1.2596241027451605e-5	33	404	439
DOID:850	lung disease	GO:0000187	activation of MAPK activity	6.019753584496357e-10	1.3276566530606715e-5	19	138	439
DOID:850	lung disease	GO:0052548	regulation of endopeptidase activity	6.122737872260586e-10	1.3503698377270723e-5	31	362	439
DOID:850	lung disease	GO:0033028	myeloid cell apoptotic process	6.262673712953415e-10	1.3812326873918757e-5	10	29	439
DOID:850	lung disease	GO:0042035	regulation of cytokine biosynthetic process	6.697354892892804e-10	1.4771016216275079e-5	16	95	439
DOID:850	lung disease	GO:0048145	regulation of fibroblast proliferation	6.912123096114442e-10	1.5244687488480402e-5	15	82	439
DOID:850	lung disease	GO:0051051	negative regulation of transport	7.101830235001216e-10	1.5663086583295183e-5	35	452	439
DOID:850	lung disease	GO:0042542	response to hydrogen peroxide	7.10879466403469e-10	1.567844663152851e-5	18	124	439
DOID:850	lung disease	GO:0030728	ovulation	7.67744978702467e-10	1.693261550528291e-5	9	22	439
DOID:850	lung disease	GO:0070265	necrotic cell death	7.96129717706151e-10	1.755864092400916e-5	12	48	439
DOID:850	lung disease	GO:0048872	homeostasis of number of cells	8.088800740324587e-10	1.7839850032785876e-5	23	208	439
DOID:850	lung disease	GO:0071229	cellular response to acid chemical	8.931804185152714e-10	1.969909413035431e-5	21	174	439
DOID:850	lung disease	GO:0034111	negative regulation of homotypic cell-cell adhesion	9.221563512795683e-10	2.033815832747088e-5	16	97	439
DOID:850	lung disease	GO:0061061	muscle structure development	9.884864038411934e-10	2.180106763671752e-5	39	551	439
DOID:850	lung disease	GO:0031329	regulation of cellular catabolic process	9.975597015099424e-10	2.200117921680178e-5	42	624	439
DOID:850	lung disease	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	1.0321237198240851e-9	2.2763488640720198e-5	12	49	439
DOID:850	lung disease	GO:0046660	female sex differentiation	1.0575907927190542e-9	2.332516493341874e-5	18	127	439
DOID:850	lung disease	GO:0046982	protein heterodimerization activity	1.068478971966158e-9	2.3565303726713616e-5	35	459	439
DOID:850	lung disease	GO:0009408	response to heat	1.0826080032444452e-9	2.3876919511556238e-5	20	159	439
DOID:850	lung disease	GO:0010001	glial cell differentiation	1.1040248715232792e-9	2.4349268541445923e-5	21	176	439
DOID:850	lung disease	GO:0031620	regulation of fever generation	1.1525858045757786e-9	2.5420279919918798e-5	7	11	439
DOID:850	lung disease	GO:0046545	development of primary female sexual characteristics	1.204212285443873e-9	2.655890195546462e-5	17	113	439
DOID:850	lung disease	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1.2933311088758614e-9	2.8524417606257124e-5	22	195	439
DOID:850	lung disease	GO:0060627	regulation of vesicle-mediated transport	1.3234797702210699e-9	2.9189346332225696e-5	34	440	439
DOID:850	lung disease	GO:0044089	positive regulation of cellular component biogenesis	1.3602711179672156e-9	3.000077950676694e-5	33	418	439
DOID:850	lung disease	GO:0043409	negative regulation of MAPK cascade	1.4125201008852173e-9	3.115313082502347e-5	19	145	439
DOID:850	lung disease	GO:0002757	immune response-activating signal transduction	1.4461248865060838e-9	3.189428437189168e-5	33	419	439
DOID:850	lung disease	GO:0019724	B cell mediated immunity	1.4671456272097316e-9	3.235789680811063e-5	16	100	439
DOID:850	lung disease	GO:0002702	positive regulation of production of molecular mediator of immune response	1.640790725510044e-9	3.618763945112402e-5	13	62	439
DOID:850	lung disease	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	1.640790725510044e-9	3.618763945112402e-5	13	62	439
DOID:850	lung disease	GO:0007611	learning or memory	2.0361220487430387e-9	4.490667178502772e-5	23	218	439
DOID:850	lung disease	GO:0019882	antigen processing and presentation	2.2267671040410164e-9	4.911134847962462e-5	23	219	439
DOID:850	lung disease	GO:0046824	positive regulation of nucleocytoplasmic transport	2.387704034489957e-9	5.2660812480676e-5	17	118	439
DOID:850	lung disease	GO:0042698	ovulation cycle	2.387704034489957e-9	5.2660812480676e-5	17	118	439
DOID:850	lung disease	GO:0007420	brain development	2.5126414282539145e-9	5.541630670014008e-5	43	669	439
DOID:850	lung disease	GO:1904019	epithelial cell apoptotic process	2.79612433207177e-9	6.166852214384289e-5	14	77	439
DOID:850	lung disease	GO:0002695	negative regulation of leukocyte activation	2.890844674752202e-9	6.375757930165982e-5	18	135	439
DOID:850	lung disease	GO:1901653	cellular response to peptide	2.955563016548979e-9	6.518494232998773e-5	27	301	439
DOID:850	lung disease	GO:0036477	somatodendritic compartment	3.1862782412517276e-9	7.027336661080685e-5	42	649	439
DOID:850	lung disease	GO:0001959	regulation of cytokine-mediated signaling pathway	3.260854253284151e-9	7.191814055618195e-5	18	136	439
DOID:850	lung disease	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	3.690438177272881e-9	8.13926139997534e-5	10	34	439
DOID:850	lung disease	GO:0051962	positive regulation of nervous system development	3.6917691126348018e-9	8.142196777916055e-5	33	435	439
DOID:850	lung disease	GO:0009187	cyclic nucleotide metabolic process	3.694663797126907e-9	8.148581004563393e-5	21	188	439
DOID:850	lung disease	GO:0032612	interleukin-1 production	3.7074439074302745e-9	8.17676753783747e-5	13	66	439
DOID:850	lung disease	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	3.764733413902377e-9	8.303119544361692e-5	23	225	439
DOID:850	lung disease	GO:0045639	positive regulation of myeloid cell differentiation	3.968222306305336e-9	8.751914296556418e-5	14	79	439
DOID:850	lung disease	GO:0009895	negative regulation of catabolic process	4.3763367374438644e-9	9.652010674432443e-5	22	208	439
Orphanet:101997	Primary immunodeficiency	GO:0032102	negative regulation of response to external stimulus	1.1006751066133802e-12	2.42753894763581e-8	31	275	440
Orphanet:101997	Primary immunodeficiency	GO:0071219	cellular response to molecule of bacterial origin	1.9806378759312793e-13	4.3682968353664364e-9	24	158	440
Orphanet:101997	Primary immunodeficiency	GO:0050729	positive regulation of inflammatory response	4.686251386942786e-13	1.0335527433902314e-8	21	114	440
Orphanet:101997	Primary immunodeficiency	GO:0032635	interleukin-6 production	6.925571227611726e-13	1.5274347342497663e-8	20	109	440
Orphanet:101997	Primary immunodeficiency	GO:0034341	response to interferon-gamma	1.745048550105821e-12	3.848704577258388e-8	23	155	440
Orphanet:101997	Primary immunodeficiency	GO:0032675	regulation of interleukin-6 production	3.2472913247261204e-12	7.161901016683458e-8	19	103	440
Orphanet:101997	Primary immunodeficiency	GO:0050663	cytokine secretion	5.104472400319082e-12	1.1257913878903736e-7	23	162	440
Orphanet:101997	Primary immunodeficiency	GO:0032655	regulation of interleukin-12 production	5.777045508637002e-12	1.2741273869298908e-7	14	50	440
Orphanet:101997	Primary immunodeficiency	GO:0043900	regulation of multi-organism process	7.132849866309243e-12	1.5731500380145036e-7	41	467	440
Orphanet:101997	Primary immunodeficiency	GO:0000975	regulatory region DNA binding	1.3197998249836473e-11	2.910818514001434e-7	54	810	440
Orphanet:101997	Primary immunodeficiency	GO:0001818	negative regulation of cytokine production	1.432143292845467e-11	3.1585920323706773e-7	25	203	440
Orphanet:101997	Primary immunodeficiency	GO:0050707	regulation of cytokine secretion	2.034472590395353e-11	4.4870292981169513e-7	21	142	440
Orphanet:101997	Primary immunodeficiency	GO:0032386	regulation of intracellular transport	2.707001289792288e-11	5.970291344636891e-7	43	575	440
Orphanet:101997	Primary immunodeficiency	GO:0046638	positive regulation of alpha-beta T cell differentiation	2.7485236309132688e-11	6.061868867979214e-7	12	37	440
Orphanet:101997	Primary immunodeficiency	GO:0001783	B cell apoptotic process	4.153277721741233e-11	9.16005401530029e-7	10	23	440
Orphanet:101997	Primary immunodeficiency	GO:0002761	regulation of myeloid leukocyte differentiation	5.085099008539373e-11	1.1215185863333588e-6	18	106	440
Orphanet:101997	Primary immunodeficiency	GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production	5.2320703325392515e-11	1.153933111841532e-6	14	58	440
Orphanet:101997	Primary immunodeficiency	GO:0050714	positive regulation of protein secretion	1.0968426167323742e-10	2.419086391203251e-6	24	205	440
Orphanet:101997	Primary immunodeficiency	GO:0045860	positive regulation of protein kinase activity	1.7638746019343898e-10	3.890225434566297e-6	36	450	440
Orphanet:101997	Primary immunodeficiency	GO:0032729	positive regulation of interferon-gamma production	2.706974644439697e-10	5.970232578311752e-6	14	65	440
Orphanet:101997	Primary immunodeficiency	GO:0032760	positive regulation of tumor necrosis factor production	4.3623316070551255e-10	9.62112235936008e-6	13	56	440
Orphanet:101997	Primary immunodeficiency	GO:0071260	cellular response to mechanical stimulus	4.956687282842154e-10	1.093197380230837e-5	15	80	440
Orphanet:101997	Primary immunodeficiency	GO:0050764	regulation of phagocytosis	5.124615176654856e-10	1.1302338772112286e-5	14	68	440
Orphanet:101997	Primary immunodeficiency	GO:0042348	NF-kappaB import into nucleus	6.259116558382516e-10	1.3804481569512639e-5	12	47	440
Orphanet:101997	Primary immunodeficiency	GO:0042345	regulation of NF-kappaB import into nucleus	6.259116558382516e-10	1.3804481569512639e-5	12	47	440
Orphanet:101997	Primary immunodeficiency	GO:0042104	positive regulation of activated T cell proliferation	6.402315344544718e-10	1.4120306492393375e-5	10	29	440
Orphanet:101997	Primary immunodeficiency	GO:0050715	positive regulation of cytokine secretion	6.922128426012364e-10	1.526675424357027e-5	16	95	440
Orphanet:101997	Primary immunodeficiency	GO:0071356	cellular response to tumor necrosis factor	7.157202608354396e-10	1.578521035272562e-5	25	243	440
Orphanet:101997	Primary immunodeficiency	GO:0045765	regulation of angiogenesis	8.452195610075819e-10	1.864131741802222e-5	23	208	440
Orphanet:101997	Primary immunodeficiency	GO:0032481	positive regulation of type I interferon production	9.379945709042659e-10	2.0687470261293583e-5	14	71	440
Orphanet:101997	Primary immunodeficiency	GO:0032602	chemokine production	1.13986786676179e-9	2.513978580143128e-5	14	72	440
Orphanet:101997	Primary immunodeficiency	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1.20605792020001e-9	2.659960743001122e-5	15	85	440
Orphanet:101997	Primary immunodeficiency	GO:0048660	regulation of smooth muscle cell proliferation	1.5159473676362722e-9	3.3434219193217984e-5	16	100	440
Orphanet:101997	Primary immunodeficiency	GO:0002709	regulation of T cell mediated immunity	1.7461089241166405e-9	3.851043232139251e-5	12	51	440
Orphanet:101997	Primary immunodeficiency	GO:0072538	T-helper 17 type immune response	1.8018875280745306e-9	3.974062943168377e-5	8	17	440
Orphanet:101997	Primary immunodeficiency	GO:0045862	positive regulation of proteolysis	1.9212071933338848e-9	4.237222464897883e-5	30	357	440
Orphanet:101997	Primary immunodeficiency	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	1.9356923841584717e-9	4.269169553261509e-5	10	32	440
Orphanet:101997	Primary immunodeficiency	GO:1903426	regulation of reactive oxygen species biosynthetic process	2.079868499649251e-9	4.5871499759764234e-5	13	63	440
Orphanet:101997	Primary immunodeficiency	GO:0019725	cellular homeostasis	2.5761478505970103e-9	5.681694084491706e-5	47	771	440
Orphanet:101997	Primary immunodeficiency	GO:0052548	regulation of endopeptidase activity	2.663163245486544e-9	5.8736065379205726e-5	30	362	440
Orphanet:101997	Primary immunodeficiency	GO:0001959	regulation of cytokine-mediated signaling pathway	3.37935357475061e-9	7.45316430911247e-5	18	136	440
Orphanet:101997	Primary immunodeficiency	GO:0002274	myeloid leukocyte activation	3.659012537404749e-9	8.069952151246174e-5	19	153	440
Orphanet:101997	Primary immunodeficiency	GO:0033209	tumor necrosis factor-mediated signaling pathway	4.084683924432397e-9	9.008770395335652e-5	19	154	440
Orphanet:101997	Primary immunodeficiency	GO:0042346	positive regulation of NF-kappaB import into nucleus	4.5243879753797955e-9	9.978537679700139e-5	9	26	440
Orphanet:183770	Rare genetic immune disease	GO:0060326	cell chemotaxis	1.0367544600597967e-9	2.2865619616618815e-5	24	228	441
Orphanet:98004	Rare immune disease	GO:0060326	cell chemotaxis	1.0846643583306559e-9	2.3922272422982616e-5	24	228	442
Orphanet:98056	Rare genetic renal disease	GO:0048878	chemical homeostasis	1.496847090720621e-11	3.3012962585843297e-7	74	988	443
Orphanet:98056	Rare genetic renal disease	GO:0009790	embryo development	6.6917582586256685e-12	1.4758672839398912e-7	79	932	443
Orphanet:98056	Rare genetic renal disease	GO:0044463	cell projection part	6.339595515214569e-12	1.3981977908805732e-7	77	939	443
Orphanet:98056	Rare genetic renal disease	GO:0009887	organ morphogenesis	2.7071678232459817e-12	5.970658634169013e-8	84	950	443
Orphanet:98056	Rare genetic renal disease	GO:0033993	response to lipid	1.1262102361797588e-12	2.483856675894458e-8	58	850	443
Orphanet:98056	Rare genetic renal disease	GO:0010927	cellular component assembly involved in morphogenesis	9.063860773039778e-13	1.999034493493923e-8	44	270	443
Orphanet:98056	Rare genetic renal disease	GO:0072009	nephron epithelium development	2.5979218776228663e-13	5.729716701097232e-9	22	106	443
Orphanet:98056	Rare genetic renal disease	GO:0003014	renal system process	4.973799150320701e-14	1.0969714026032307e-9	21	109	443
Orphanet:98056	Rare genetic renal disease	GO:0046501	protoporphyrinogen IX metabolic process	2.8976820942716586e-14	6.390837858916143e-10	9	10	443
Orphanet:98056	Rare genetic renal disease	GO:0042440	pigment metabolic process	6.661338147750939e-14	1.4691581284864696e-9	19	65	443
Orphanet:98056	Rare genetic renal disease	GO:0014070	response to organic cyclic compound	9.543477119677846e-13	2.104813878744949e-8	58	873	443
Orphanet:98056	Rare genetic renal disease	GO:0009799	specification of symmetry	1.4768186673563832e-12	3.257123570854503e-8	21	122	443
Orphanet:98056	Rare genetic renal disease	GO:0009611	response to wounding	1.8994805728311803e-12	4.189304403379168e-8	60	875	443
Orphanet:98056	Rare genetic renal disease	GO:1901698	response to nitrogen compound	4.97946128774629e-12	1.0982201870124442e-7	57	870	443
Orphanet:98056	Rare genetic renal disease	GO:0061326	renal tubule development	5.538014491435206e-12	1.2214090960860347e-7	18	93	443
Orphanet:98056	Rare genetic renal disease	GO:0043009	chordate embryonic development	6.549760733776111e-12	1.4445497298343213e-7	46	552	443
Orphanet:98056	Rare genetic renal disease	GO:0050878	regulation of body fluid levels	8.464895451254506e-12	1.8669326917741813e-7	48	504	443
Orphanet:98056	Rare genetic renal disease	GO:0009991	response to extracellular stimulus	1.0197953592694375e-11	2.2491586648687445e-7	44	573	443
Orphanet:98056	Rare genetic renal disease	GO:0048736	appendage development	1.2721268483062431e-11	2.805675763939419e-7	23	168	443
Orphanet:98056	Rare genetic renal disease	GO:0060173	limb development	1.2721268483062431e-11	2.805675763939419e-7	23	168	443
Orphanet:98056	Rare genetic renal disease	GO:0051241	negative regulation of multicellular organismal process	1.5933032671000547e-11	3.5140303555891705e-7	59	966	443
Orphanet:98056	Rare genetic renal disease	GO:0031667	response to nutrient levels	1.608724264912098e-11	3.5480413662636323e-7	43	546	443
Orphanet:98056	Rare genetic renal disease	GO:0061333	renal tubule morphogenesis	2.7976732042134245e-11	6.170268251892708e-7	16	77	443
Orphanet:98056	Rare genetic renal disease	GO:0070848	response to growth factor	3.7330250002298726e-11	8.233186638006984e-7	45	621	443
Orphanet:98056	Rare genetic renal disease	GO:0072080	nephron tubule development	4.030631384210892e-11	8.889557517877122e-7	17	91	443
Orphanet:98056	Rare genetic renal disease	GO:0031960	response to corticosteroid	4.620992477555319e-11	1.0191598909248256e-6	23	179	443
Orphanet:98056	Rare genetic renal disease	GO:0031983	vesicle lumen	5.688294280048467e-11	1.2545533034646894e-6	18	106	443
Orphanet:98056	Rare genetic renal disease	GO:0051384	response to glucocorticoid	7.532874324311933e-11	1.661375432226997e-6	22	167	443
Orphanet:98056	Rare genetic renal disease	GO:0071363	cellular response to growth factor stimulus	8.777134574700085e-11	1.9357970304501038e-6	43	594	443
Orphanet:98056	Rare genetic renal disease	GO:0044057	regulation of system process	1.312434605438284e-10	2.8945745222941355e-6	39	508	443
Orphanet:98056	Rare genetic renal disease	GO:0071241	cellular response to inorganic substance	1.3493584027912675e-10	2.9760099573561405e-6	21	156	443
Orphanet:98056	Rare genetic renal disease	GO:0072078	nephron tubule morphogenesis	1.3864787096196096e-10	3.057878794066049e-6	15	73	443
Orphanet:98056	Rare genetic renal disease	GO:0042060	wound healing	1.5233092565125617e-10	3.3596585652384547e-6	40	534	443
Orphanet:98056	Rare genetic renal disease	GO:0042803	protein homodimerization activity	1.7001844376807185e-10	3.7497567773048246e-6	47	703	443
Orphanet:98056	Rare genetic renal disease	GO:0060322	head development	2.088144102074807e-10	4.605401817125987e-6	47	708	443
Orphanet:98056	Rare genetic renal disease	GO:0010817	regulation of hormone levels	2.2577872904605556e-10	4.979549869110755e-6	37	473	443
Orphanet:98056	Rare genetic renal disease	GO:0032870	cellular response to hormone stimulus	2.363017559403602e-10	5.211635227264644e-6	39	519	443
Orphanet:98056	Rare genetic renal disease	GO:0048534	hematopoietic or lymphoid organ development	2.7434565730288796e-10	6.050693471815194e-6	48	739	443
Orphanet:98056	Rare genetic renal disease	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	3.6481606624505503e-10	8.046018341034689e-6	17	104	443
Orphanet:98056	Rare genetic renal disease	GO:0048514	blood vessel morphogenesis	4.247521223632589e-10	9.367908058721675e-6	37	484	443
Orphanet:98056	Rare genetic renal disease	GO:0001667	ameboidal-type cell migration	5.09763564693344e-10	1.1242835419311703e-5	29	315	443
Orphanet:98056	Rare genetic renal disease	GO:0071248	cellular response to metal ion	5.434951377836228e-10	1.19867852638178e-5	19	136	443
Orphanet:98056	Rare genetic renal disease	GO:0031253	cell projection membrane	5.918412426808572e-10	1.3053058607326307e-5	28	297	443
Orphanet:98056	Rare genetic renal disease	GO:0061005	cell differentiation involved in kidney development	6.762482795963365e-10	1.4914655806497201e-5	12	47	443
Orphanet:98056	Rare genetic renal disease	GO:0061008	hepaticobiliary system development	7.00227209549098e-10	1.5443511106605357e-5	19	138	443
Orphanet:98056	Rare genetic renal disease	GO:0002526	acute inflammatory response	1.015087791600422e-9	2.2387761243747306e-5	19	141	443
Orphanet:98056	Rare genetic renal disease	GO:0055080	cation homeostasis	1.0439937803141675e-9	2.3025282824828963e-5	41	595	443
Orphanet:98056	Rare genetic renal disease	GO:0097305	response to alcohol	1.2167921115135982e-9	2.683635001943241e-5	31	369	443
Orphanet:98056	Rare genetic renal disease	GO:0008285	negative regulation of cell proliferation	2.0958073054799797e-9	4.622303012236095e-5	42	634	443
Orphanet:98056	Rare genetic renal disease	GO:0001823	mesonephros development	2.2555546319580344e-9	4.974625740783445e-5	16	102	443
Orphanet:98056	Rare genetic renal disease	GO:0055082	cellular chemical homeostasis	2.305527990742462e-9	5.0848419835825e-5	43	661	443
Orphanet:98056	Rare genetic renal disease	GO:0055065	metal ion homeostasis	2.43951980838375e-9	5.3803609373903605e-5	37	516	443
Orphanet:98056	Rare genetic renal disease	GO:0002064	epithelial cell development	2.9839921644736478e-9	6.58119471874663e-5	22	202	443
Orphanet:98056	Rare genetic renal disease	GO:0097285	cell-type specific apoptotic process	3.275761439880398e-9	7.224691855656218e-5	33	429	443
Orphanet:98056	Rare genetic renal disease	GO:0001889	liver development	3.3333731330742467e-9	7.351754444995251e-5	18	135	443
Orphanet:98056	Rare genetic renal disease	GO:0050954	sensory perception of mechanical stimulus	4.088604010910046e-9	9.017416146062107e-5	19	153	443
Orphanet:98056	Rare genetic renal disease	GO:0051046	regulation of secretion	4.309675505353994e-9	9.504989327058233e-5	43	675	443
MESH:D001848	Bone Diseases, Developmental	GO:0022603	regulation of anatomical structure morphogenesis	1.5674794795472735e-11	3.4570759921415117e-7	64	986	447
MESH:D001848	Bone Diseases, Developmental	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1.9961809982760315e-12	4.4025771916977874e-8	39	307	447
MESH:D001848	Bone Diseases, Developmental	GO:0008544	epidermis development	1.807887173299605e-12	3.9872951607122786e-8	34	296	447
MESH:D001848	Bone Diseases, Developmental	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	8.408829188510936e-13	1.854567277526087e-8	29	204	447
MESH:D001848	Bone Diseases, Developmental	GO:0021700	developmental maturation	7.811529201262601e-13	1.7228327653384667e-8	30	231	447
MESH:D001848	Bone Diseases, Developmental	GO:0009725	response to hormone	5.269118474870993e-13	1.1621040796327975e-8	62	865	447
MESH:D001848	Bone Diseases, Developmental	GO:0060675	ureteric bud morphogenesis	2.1471713296250527e-13	4.735586367488054e-9	19	64	447
MESH:D001848	Bone Diseases, Developmental	GO:0048864	stem cell development	1.7430501486614958e-13	3.844297102872929e-9	27	175	447
MESH:D001848	Bone Diseases, Developmental	GO:0045778	positive regulation of ossification	1.7208456881689926e-13	3.795325165256713e-9	23	84	447
MESH:D001848	Bone Diseases, Developmental	GO:0090287	regulation of cellular response to growth factor stimulus	1.6475709685437323e-13	3.6337177711232016e-9	31	226	447
MESH:D001848	Bone Diseases, Developmental	GO:0021536	diencephalon development	8.704148513061227e-14	1.9196999545556537e-9	19	77	447
MESH:D001848	Bone Diseases, Developmental	GO:0042472	inner ear morphogenesis	5.728750807065808e-14	1.263475990498364e-9	22	92	447
MESH:D001848	Bone Diseases, Developmental	GO:0072091	regulation of stem cell proliferation	3.3306690738754696e-14	7.345790642432348e-10	19	88	447
MESH:D001848	Bone Diseases, Developmental	GO:2000738	positive regulation of stem cell differentiation	6.661338147750939e-15	1.4691581284864696e-10	16	50	447
MESH:D001848	Bone Diseases, Developmental	GO:0098743	cell aggregation	5.551115123125783e-15	1.2242984404053914e-10	12	21	447
MESH:D001848	Bone Diseases, Developmental	GO:0001502	cartilage condensation	5.551115123125783e-15	1.2242984404053914e-10	12	21	447
MESH:D001848	Bone Diseases, Developmental	GO:0001837	epithelial to mesenchymal transition	6.994405055138486e-15	1.5426160349107931e-10	21	109	447
MESH:D001848	Bone Diseases, Developmental	GO:0040014	regulation of multicellular organism growth	6.961098364399732e-14	1.5352702442683608e-9	17	65	447
MESH:D001848	Bone Diseases, Developmental	GO:0021510	spinal cord development	5.634381849972669e-13	1.2426629170114722e-8	20	106	447
MESH:D001848	Bone Diseases, Developmental	GO:0098727	maintenance of cell number	7.838174553853605e-13	1.7287093978524126e-8	23	147	447
MESH:D001848	Bone Diseases, Developmental	GO:0072175	epithelial tube formation	8.427702979929563e-13	1.8587298922234652e-8	22	116	447
MESH:D001848	Bone Diseases, Developmental	GO:0010171	body morphogenesis	5.2268189776327745e-12	1.1527749255169084e-7	14	49	447
MESH:D001848	Bone Diseases, Developmental	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	6.2202465400673645e-12	1.3718753744118573e-7	45	573	447
MESH:D001848	Bone Diseases, Developmental	GO:0060324	face development	7.065348306412034e-12	1.558262568979174e-7	14	50	447
MESH:D001848	Bone Diseases, Developmental	GO:0001843	neural tube closure	7.818190539410352e-12	1.7243019234669532e-7	17	82	447
MESH:D001848	Bone Diseases, Developmental	GO:0010463	mesenchymal cell proliferation	9.770184661306303e-12	2.154814227051105e-7	13	42	447
MESH:D001848	Bone Diseases, Developmental	GO:0048534	hematopoietic or lymphoid organ development	1.1930234578017007e-11	2.631213236181651e-7	61	739	447
MESH:D001848	Bone Diseases, Developmental	GO:0030097	hemopoiesis	1.3494649842016315e-11	2.9762450226566983e-7	56	695	447
MESH:D001848	Bone Diseases, Developmental	GO:0033993	response to lipid	1.7630008564140098e-11	3.8882983888210987e-7	55	850	447
MESH:D001848	Bone Diseases, Developmental	GO:0050680	negative regulation of epithelial cell proliferation	2.055877690310126e-11	4.534238245978983e-7	19	112	447
MESH:D001848	Bone Diseases, Developmental	GO:0071599	otic vesicle development	2.3532509274559743e-11	5.190094920504151e-7	9	16	447
MESH:D001848	Bone Diseases, Developmental	GO:0001656	metanephros development	2.6308177858425097e-11	5.802268626675655e-7	17	88	447
MESH:D001848	Bone Diseases, Developmental	GO:0030879	mammary gland development	2.841171742318238e-11	6.266204277682874e-7	20	128	447
MESH:D001848	Bone Diseases, Developmental	GO:0008134	transcription factor binding	3.1614155737713645e-11	6.972502047952744e-7	41	518	447
MESH:D001848	Bone Diseases, Developmental	GO:0048701	embryonic cranial skeleton morphogenesis	3.5470848480656514e-11	7.823095632408794e-7	13	46	447
MESH:D001848	Bone Diseases, Developmental	GO:0007369	gastrulation	3.886968524824397e-11	8.572709081500207e-7	23	176	447
MESH:D001848	Bone Diseases, Developmental	GO:0001934	positive regulation of protein phosphorylation	4.563305289195796e-11	1.0064369815321328e-6	55	870	447
MESH:D001848	Bone Diseases, Developmental	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	5.439337869006522e-11	1.1996459670093884e-6	45	623	447
MESH:D001848	Bone Diseases, Developmental	GO:0002521	leukocyte differentiation	6.396916329975966e-11	1.4108398965761992e-6	37	448	447
MESH:D001848	Bone Diseases, Developmental	GO:0060325	face morphogenesis	7.203093677077277e-11	1.5886423104793934e-6	11	31	447
MESH:D001848	Bone Diseases, Developmental	GO:0010817	regulation of hormone levels	8.18608514308039e-11	1.8054410783063801e-6	38	473	447
MESH:D001848	Bone Diseases, Developmental	GO:0000578	embryonic axis specification	1.0749245937802243e-10	2.3707461915822847e-6	11	32	447
MESH:D001848	Bone Diseases, Developmental	GO:0060548	negative regulation of cell death	1.219335743485317e-10	2.6892449822568665e-6	54	867	447
MESH:D001848	Bone Diseases, Developmental	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	1.6293422167024119e-10	3.5935142589371694e-6	30	317	447
MESH:D001848	Bone Diseases, Developmental	GO:0046660	female sex differentiation	1.900423152179087e-10	4.1913832621309766e-6	19	127	447
MESH:D001848	Bone Diseases, Developmental	GO:0010718	positive regulation of epithelial to mesenchymal transition	2.2820090261888026e-10	5.032970907259404e-6	11	34	447
MESH:D001848	Bone Diseases, Developmental	GO:0061180	mammary gland epithelium development	2.663363973809396e-10	5.874049244236623e-6	14	64	447
MESH:D001848	Bone Diseases, Developmental	GO:0003416	endochondral bone growth	3.171048978956037e-10	6.99374852308754e-6	9	20	447
MESH:D001848	Bone Diseases, Developmental	GO:0060443	mammary gland morphogenesis	3.226710010295619e-10	7.116508927706988e-6	12	44	447
MESH:D001848	Bone Diseases, Developmental	GO:0021515	cell differentiation in spinal cord	3.2408753458668116e-10	7.147750575309253e-6	13	54	447
MESH:D001848	Bone Diseases, Developmental	GO:0003281	ventricular septum development	3.2408753458668116e-10	7.147750575309253e-6	13	54	447
MESH:D001848	Bone Diseases, Developmental	GO:0051960	regulation of nervous system development	4.602490610849941e-10	1.0150793042229544e-5	48	744	447
MESH:D001848	Bone Diseases, Developmental	GO:0043066	negative regulation of apoptotic process	4.668057052015229e-10	1.0295399828219587e-5	50	795	447
MESH:D001848	Bone Diseases, Developmental	GO:0048514	blood vessel morphogenesis	5.44277956038286e-10	1.2004050320424398e-5	37	484	447
MESH:D001848	Bone Diseases, Developmental	GO:0008406	gonad development	6.550918696390795e-10	1.4448051184889898e-5	24	220	447
MESH:D001848	Bone Diseases, Developmental	GO:0030177	positive regulation of Wnt signaling pathway	6.599532031970057e-10	1.455526789650996e-5	20	152	447
MESH:D001848	Bone Diseases, Developmental	GO:0048639	positive regulation of developmental growth	7.425686732176473e-10	1.637735208781521e-5	20	153	447
MESH:D001848	Bone Diseases, Developmental	GO:0031128	developmental induction	7.459564077549885e-10	1.645206857303627e-5	10	29	447
MESH:D001848	Bone Diseases, Developmental	GO:0048545	response to steroid hormone	8.040877963466642e-10	1.7734156348425678e-5	35	446	447
MESH:D001848	Bone Diseases, Developmental	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	8.127774009381028e-10	1.7925805577689857e-5	19	138	447
MESH:D001848	Bone Diseases, Developmental	GO:0010564	regulation of cell cycle process	8.205706114594591e-10	1.809768483573837e-5	40	561	447
MESH:D001848	Bone Diseases, Developmental	GO:0035019	somatic stem cell population maintenance	9.439581338810399e-10	2.0818996642746335e-5	14	70	447
MESH:D001848	Bone Diseases, Developmental	GO:0071695	anatomical structure maturation	9.771324860352593e-10	2.1550656979507643e-5	12	48	447
MESH:D001848	Bone Diseases, Developmental	GO:0060603	mammary gland duct morphogenesis	1.0951873852249605e-9	2.4154357781136504e-5	10	30	447
MESH:D001848	Bone Diseases, Developmental	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	1.4963119632227517e-9	3.300116034887779e-5	29	327	447
MESH:D001848	Bone Diseases, Developmental	GO:0051146	striated muscle cell differentiation	1.619776424099939e-9	3.5724169033524156e-5	24	230	447
MESH:D001848	Bone Diseases, Developmental	GO:0072132	mesenchyme morphogenesis	1.6204567687694293e-9	3.5739174035209764e-5	11	40	447
MESH:D001848	Bone Diseases, Developmental	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1.6329028129646872e-9	3.6013671539936176e-5	16	99	447
MESH:D001848	Bone Diseases, Developmental	GO:0045787	positive regulation of cell cycle	1.6559760229739595e-9	3.652255118669068e-5	28	308	447
MESH:D001848	Bone Diseases, Developmental	GO:0021953	central nervous system neuron differentiation	1.8455087458235653e-9	4.070269538913873e-5	20	161	447
MESH:D001848	Bone Diseases, Developmental	GO:0043410	positive regulation of MAPK cascade	2.2843656966031745e-9	5.038168543858301e-5	35	464	447
MESH:D001848	Bone Diseases, Developmental	GO:0051302	regulation of cell division	2.427604672838868e-9	5.354082105946123e-5	27	293	447
MESH:D001848	Bone Diseases, Developmental	GO:0043627	response to estrogen	2.627764783547093e-9	5.7955352301131136e-5	23	217	447
MESH:D001848	Bone Diseases, Developmental	GO:0051270	regulation of cellular component movement	2.8455104938984732e-9	6.275773394293083e-5	48	787	447
MESH:D001848	Bone Diseases, Developmental	GO:0045682	regulation of epidermis development	3.0887952195968182e-9	6.812337856820783e-5	13	64	447
MESH:D001848	Bone Diseases, Developmental	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	3.16499060293296e-9	6.980386774768643e-5	30	359	447
MESH:D001848	Bone Diseases, Developmental	GO:0002076	osteoblast development	3.5957883337545127e-9	7.930511170095578e-5	8	18	447
MESH:D001848	Bone Diseases, Developmental	GO:0070482	response to oxygen levels	4.177086232459715e-9	9.212563685689901e-5	28	321	447
MESH:D001848	Bone Diseases, Developmental	GO:0021522	spinal cord motor neuron differentiation	4.386973340153588e-9	9.675469701708739e-5	10	34	447
MESH:D005770	Gastrointestinal Neoplasms	GO:0042623	ATPase activity, coupled	1.823874384854207e-12	4.022554955795954e-8	38	309	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0000302	response to reactive oxygen species	1.2312373343092986e-12	2.715493940819158e-8	28	216	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048762	mesenchymal cell differentiation	7.622791287076325e-13	1.6812066183646834e-8	26	184	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0022804	active transmembrane transporter activity	4.369837824924616e-13	9.637677322871241e-9	38	346	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042692	muscle cell differentiation	1.7763568394002505e-14	3.9177550092972524e-10	34	334	453
MESH:D005770	Gastrointestinal Neoplasms	GO:1990748	cellular detoxification	5.051514762044462e-14	1.1141115807689062e-9	19	82	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001649	osteoblast differentiation	7.30526750203353e-14	1.611176747573495e-9	27	206	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048864	stem cell development	4.1378012127779584e-13	9.125920574781787e-9	25	175	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0014031	mesenchymal cell development	5.302425165609748e-13	1.1694498702752298e-8	25	171	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0098609	cell-cell adhesion	1.1294298829511717e-12	2.4909576068488093e-8	61	867	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001837	epithelial to mesenchymal transition	1.8597345885495997e-12	4.101644635046142e-8	20	109	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0050680	negative regulation of epithelial cell proliferation	3.790079361465359e-12	8.35902003171185e-8	20	112	453
MESH:D005770	Gastrointestinal Neoplasms	GO:2000736	regulation of stem cell differentiation	4.189315561120566e-12	9.239535470051408e-8	20	113	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0098869	cellular oxidant detoxification	5.213718345942198e-12	1.1498855811975517e-7	17	79	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042306	regulation of protein import into nucleus	6.237788063856442e-12	1.3757441574835383e-7	24	175	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051098	regulation of binding	7.863820705722446e-12	1.7343656566470855e-7	30	279	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042060	wound healing	9.056533301077252e-12	1.997418419552588e-7	47	534	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0016491	oxidoreductase activity	1.0570877506665965e-11	2.3314070340951787e-7	53	710	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0060284	regulation of cell development	1.1697087742845724e-11	2.5797927016846245e-7	57	828	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001501	skeletal system development	1.1912137942715617e-11	2.6272220232659294e-7	41	482	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0050801	ion homeostasis	1.342026489936643e-11	2.959839423555266e-7	50	668	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0055082	cellular chemical homeostasis	1.3784418051443481e-11	3.04015340124586e-7	49	661	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0003007	heart morphogenesis	1.6670553826259038e-11	3.676690646381431e-7	26	216	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0060828	regulation of canonical Wnt signaling pathway	2.097355622510122e-11	4.625717825446074e-7	27	235	453
MESH:D005770	Gastrointestinal Neoplasms	GO:2000027	regulation of organ morphogenesis	2.3697710460623966e-11	5.226530042090616e-7	27	236	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0045785	positive regulation of cell adhesion	2.8588797995610093e-11	6.305259397931806e-7	34	368	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0034614	cellular response to reactive oxygen species	3.132927250959483e-11	6.90967105199114e-7	20	127	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051348	negative regulation of transferase activity	5.3449689119133836e-11	1.1788328935224968e-6	33	357	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0044087	regulation of cellular component biogenesis	5.911160450011721e-11	1.303706437250085e-6	50	735	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042063	gliogenesis	6.180178591108643e-11	1.3630383882690111e-6	26	228	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0007610	behavior	6.459099921585221e-11	1.4245544877056204e-6	49	714	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0050776	regulation of immune response	7.626410614136603e-11	1.6820048609478278e-6	53	816	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001817	regulation of cytokine production	8.463618694776187e-11	1.866651103132888e-6	42	556	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0003684	damaged DNA binding	9.834488778892592e-11	2.168996500184761e-6	14	59	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0009894	regulation of catabolic process	1.1611911432396482e-10	2.561007066415044e-6	49	727	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0098771	inorganic ion homeostasis	1.1717959935708677e-10	2.5843960638205488e-6	44	609	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048471	perinuclear region of cytoplasm	1.424533824234686e-10	3.1418093493496e-6	45	636	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0045667	regulation of osteoblast differentiation	1.821339745688988e-10	4.016964809117063e-6	18	111	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0034330	cell junction organization	1.944540084508617e-10	4.288683156383755e-6	26	240	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0043009	chordate embryonic development	2.2250079556584978e-10	4.907255046204817e-6	41	552	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0006801	superoxide metabolic process	2.2844082181450176e-10	5.038262325118836e-6	13	52	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051345	positive regulation of hydrolase activity	2.690139222494281e-10	5.933102055211137e-6	55	900	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0050778	positive regulation of immune response	2.8031854615306884e-10	6.182425535405933e-6	43	603	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001819	positive regulation of cytokine production	2.8365287896292557e-10	6.2559642455273234e-6	33	381	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048589	developmental growth	3.068898468683301e-10	6.76845557268102e-6	41	558	453
MESH:D005770	Gastrointestinal Neoplasms	GO:1902532	negative regulation of intracellular signal transduction	3.3954927758372833e-10	7.488759317109128e-6	35	426	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0055065	metal ion homeostasis	3.8003056257451817e-10	8.381574057580998e-6	39	516	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0072006	nephron development	4.1030268072006493e-10	9.049225623281032e-6	19	131	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0007219	Notch signaling pathway	4.1502823400207944e-10	9.153447700915862e-6	21	162	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051051	negative regulation of transport	4.422772148515719e-10	9.754423973551418e-6	36	452	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0015833	peptide transport	4.653608609572757e-10	1.0263533788412715e-5	29	307	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0061448	connective tissue development	5.378152367896405e-10	1.1861515047395521e-5	25	233	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0030234	enzyme regulator activity	5.481246567740072e-10	1.208888930515073e-5	56	944	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0045766	positive regulation of angiogenesis	5.894659205196717e-10	1.300067087706136e-5	18	119	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0019199	transmembrane receptor protein kinase activity	6.146171349641349e-10	1.3555380911633996e-5	15	79	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0032403	protein complex binding	7.047044059405039e-10	1.5542255673017813e-5	55	924	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0043542	endothelial cell migration	7.383660349802312e-10	1.6284662901489e-5	20	151	453
MESH:D005770	Gastrointestinal Neoplasms	GO:2001236	regulation of extrinsic apoptotic signaling pathway	7.383660349802312e-10	1.6284662901489e-5	20	151	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051235	maintenance of location	7.389253653400374e-10	1.6296998932574525e-5	27	274	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0006873	cellular ion homeostasis	8.945868490428666e-10	1.9730112955640422e-5	39	532	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0045862	positive regulation of proteolysis	9.347872476084262e-10	2.061673274600384e-5	31	357	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0005912	adherens junction	9.549664392594082e-10	2.1061784817866247e-5	36	465	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0034329	cell junction assembly	1.0411577155977625e-9	2.2962733417508652e-5	22	187	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0001935	endothelial cell proliferation	1.0912089010162163e-9	2.406661231191265e-5	17	109	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0007249	I-kappaB kinase/NF-kappaB signaling	1.121762571720808e-9	2.474047351930242e-5	26	260	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048771	tissue remodeling	1.1478198391756678e-9	2.5315166553019353e-5	19	139	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0007050	cell cycle arrest	1.196526655533603e-9	2.6389395387793613e-5	25	242	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0048871	multicellular organismal homeostasis	1.3252399178043106e-9	2.922816638717407e-5	29	321	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0006875	cellular metal ion homeostasis	1.449515507623289e-9	3.196906452063164e-5	35	450	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051099	positive regulation of binding	1.5269147057850319e-9	3.367610383608888e-5	18	126	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0046660	female sex differentiation	1.7395179741086508e-9	3.8365068918966294e-5	18	127	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0032103	positive regulation of response to external stimulus	1.7655581441289314e-9	3.893938486876358e-5	27	285	453
MESH:D005770	Gastrointestinal Neoplasms	GO:1903706	regulation of hemopoiesis	1.7873158508763254e-9	3.9419251091077356e-5	28	305	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0071559	response to transforming growth factor beta	1.9615712387732742e-9	4.326245367114456e-5	23	211	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051146	striated muscle cell differentiation	2.1081256740274057e-9	4.649471174067443e-5	24	230	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0030029	actin filament-based process	2.109398433702836e-9	4.652278245531605e-5	42	620	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0007420	brain development	2.120496667146199e-9	4.6767553993909416e-5	44	669	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0045216	cell-cell junction organization	2.151094857794078e-9	4.744239708864839e-5	23	212	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042113	B cell activation	2.151094857794078e-9	4.744239708864839e-5	23	212	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0090090	negative regulation of canonical Wnt signaling pathway	2.3195898535277593e-9	5.115855421955473e-5	20	161	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0060249	anatomical structure homeostasis	2.5450334062426805e-9	5.613071177468232e-5	30	351	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0042633	hair cycle	2.675641042060306e-9	5.901126318264005e-5	16	101	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	2.7355995246836073e-9	6.033364751689696e-5	24	233	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0071345	cellular response to cytokine stimulus	3.0434176290228265e-9	6.712257580809844e-5	44	677	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0018108	peptidyl-tyrosine phosphorylation	3.1064826266913315e-9	6.851347433167732e-5	30	354	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0031349	positive regulation of defense response	3.3473026572750086e-9	7.382476010620032e-5	32	398	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0043269	regulation of ion transport	3.6195078045864193e-9	7.982824463015348e-5	40	583	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0010952	positive regulation of peptidase activity	3.761656652834233e-9	8.296333747825901e-5	19	149	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0015893	drug transport	3.895241129647786e-9	8.590954311438193e-5	9	25	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0051054	positive regulation of DNA metabolic process	3.9444868482618745e-9	8.699565743841564e-5	21	183	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0046906	tetrapyrrole binding	4.1878601697575846e-9	9.236325604400353e-5	18	134	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0022612	gland morphogenesis	4.3622024881173616e-9	9.620837587542841e-5	17	119	453
MESH:D005770	Gastrointestinal Neoplasms	GO:0043393	regulation of protein binding	4.416928378603302e-9	9.741535539009583e-5	20	167	453
DOID:0050161	lower respiratory tract disease	GO:0051707	response to other organism	1.3560264022771662e-12	2.99071623022229e-8	107	898	462
DOID:0050161	lower respiratory tract disease	GO:0050663	cytokine secretion	5.762057497804562e-14	1.2708217811407962e-9	25	162	462
DOID:0050161	lower respiratory tract disease	GO:0036294	cellular response to decreased oxygen levels	1.195377130613906e-12	2.6364042615689698e-8	23	142	462
DOID:0050161	lower respiratory tract disease	GO:0070838	divalent metal ion transport	2.9247715360725124e-12	6.450583622807926e-8	40	410	462
DOID:0050161	lower respiratory tract disease	GO:1901652	response to peptide	6.468603430676012e-12	1.4266504866355945e-7	39	423	462
DOID:0050161	lower respiratory tract disease	GO:0001822	kidney development	8.490330660748668e-11	1.8725424272281188e-6	28	262	462
DOID:0050161	lower respiratory tract disease	GO:0050886	endocrine process	2.5062463215874686e-10	5.527526262261162e-6	16	85	462
DOID:0050161	lower respiratory tract disease	GO:0090257	regulation of muscle system process	6.536540197998875e-10	1.4416339406686518e-5	24	213	462
DOID:0050161	lower respiratory tract disease	GO:0032504	multicellular organism reproduction	7.561752335405458e-10	1.667744477573674e-5	50	780	462
DOID:0050161	lower respiratory tract disease	GO:0044087	regulation of cellular component biogenesis	9.195837424869069e-10	2.028141944054873e-5	48	735	462
DOID:0050161	lower respiratory tract disease	GO:0003006	developmental process involved in reproduction	1.144757955096054e-9	2.5247636699643472e-5	43	619	462
DOID:0050161	lower respiratory tract disease	GO:0007507	heart development	1.5928320884484037e-9	3.5129911710729544e-5	37	487	462
DOID:0050161	lower respiratory tract disease	GO:0001990	regulation of systemic arterial blood pressure by hormone	1.6970106431202225e-9	3.742756973401651e-5	11	39	462
DOID:0050161	lower respiratory tract disease	GO:0061041	regulation of wound healing	1.826004680793858e-9	4.0272533234908536e-5	18	125	462
DOID:0050161	lower respiratory tract disease	GO:0006939	smooth muscle contraction	1.9241211957066184e-9	4.243649297130947e-5	16	97	462
DOID:0050161	lower respiratory tract disease	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	3.0369033954258384e-9	6.697890438611687e-5	13	62	462
DOID:423	myopathy	GO:0055114	oxidation-reduction process	1.8527401834944612e-12	4.086218474697034e-8	83	949	464
DOID:423	myopathy	GO:0009141	nucleoside triphosphate metabolic process	1.4646062140855065e-12	3.2301890051655846e-8	49	274	464
DOID:423	myopathy	GO:0009161	ribonucleoside monophosphate metabolic process	1.0200729150255938e-12	2.2497708140889472e-8	50	279	464
DOID:423	myopathy	GO:0050879	multicellular organismal movement	4.3298697960381105e-14	9.549527835162053e-10	19	50	464
DOID:423	myopathy	GO:0050881	musculoskeletal movement	4.3298697960381105e-14	9.549527835162053e-10	19	50	464
DOID:423	myopathy	GO:0060538	skeletal muscle organ development	2.398081733190338e-14	5.288969262551291e-10	25	167	464
DOID:423	myopathy	GO:0007519	skeletal muscle tissue development	8.195333300875518e-12	1.8074807595080955e-7	23	158	464
DOID:423	myopathy	GO:0008015	blood circulation	2.1044832543282155e-11	4.641437817420879e-7	41	489	464
DOID:423	myopathy	GO:0014070	response to organic cyclic compound	6.229939897295367e-10	1.3740132443484931e-5	54	873	464
DOID:423	myopathy	GO:0016528	sarcoplasm	1.0199485700468358e-9	2.2494965712382964e-5	14	68	464
DOID:423	myopathy	GO:0060047	heart contraction	1.0340455158797113e-9	2.2805873852727032e-5	26	253	464
DOID:423	myopathy	GO:0045214	sarcomere organization	4.523973085035493e-9	9.97762263904578e-5	10	33	464
MESH:D015785	Eye Diseases, Hereditary	GO:0007600	sensory perception	6.683320563638517e-12	1.474006350310475e-7	90	902	467
MESH:D015785	Eye Diseases, Hereditary	GO:0048666	neuron development	1.98463467881993e-12	4.377111784137355e-8	66	926	467
MESH:D015785	Eye Diseases, Hereditary	GO:0090596	sensory organ morphogenesis	1.7013057629355899e-12	3.7522298601544435e-8	33	239	467
MESH:D015785	Eye Diseases, Hereditary	GO:0043010	camera-type eye development	1.6997514507011147e-12	3.7488018245213084e-8	45	283	467
MESH:D015785	Eye Diseases, Hereditary	GO:0001895	retina homeostasis	8.482103908136196e-14	1.870728016939438e-9	20	66	467
MESH:D015785	Eye Diseases, Hereditary	GO:0048592	eye morphogenesis	2.345901251032956e-13	5.173885209153184e-9	28	136	467
MESH:D015785	Eye Diseases, Hereditary	GO:0001754	eye photoreceptor cell differentiation	4.4519943287468777e-13	9.818873492051239e-9	14	40	467
MESH:D015785	Eye Diseases, Hereditary	GO:0042462	eye photoreceptor cell development	2.954858580039854e-12	6.516940598277898e-8	12	30	467
MESH:D015785	Eye Diseases, Hereditary	GO:0070227	lymphocyte apoptotic process	3.800959547106686e-12	8.383016281143796e-8	16	65	467
MESH:D015785	Eye Diseases, Hereditary	GO:0071478	cellular response to radiation	8.023026687453694e-12	1.7694785359179122e-7	23	157	467
MESH:D015785	Eye Diseases, Hereditary	GO:0010035	response to inorganic substance	8.23907608804575e-12	1.81712823121849e-7	47	502	467
MESH:D015785	Eye Diseases, Hereditary	GO:0071482	cellular response to light stimulus	2.6171731448698665e-11	5.772175371010491e-7	19	109	467
MESH:D015785	Eye Diseases, Hereditary	GO:0009790	embryo development	4.576228285202433e-11	1.0092871483013965e-6	59	932	467
MESH:D015785	Eye Diseases, Hereditary	GO:0048568	embryonic organ development	6.166211985458858e-11	1.3599580533929512e-6	36	408	467
MESH:D015785	Eye Diseases, Hereditary	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	7.086772280118225e-10	1.5629876263800746e-5	12	45	467
MESH:D015785	Eye Diseases, Hereditary	GO:0001655	urogenital system development	1.482994838042373e-9	3.2707451153024536e-5	29	313	467
MESH:D015785	Eye Diseases, Hereditary	GO:0072001	renal system development	1.6867446328561186e-9	3.72011528776417e-5	27	276	467
MESH:D015785	Eye Diseases, Hereditary	GO:0033059	cellular pigmentation	2.076090743763359e-9	4.5788181353700885e-5	12	49	467
MESH:D015785	Eye Diseases, Hereditary	GO:0006766	vitamin metabolic process	3.193014297409036e-9	7.042193032935629e-5	18	128	467
DOID:381	arthropathy	GO:0032101	regulation of response to external stimulus	4.32631708235931e-12	9.541692325143458e-8	74	920	469
DOID:381	arthropathy	GO:0051707	response to other organism	3.4585667663122877e-12	7.62786900310175e-8	75	898	469
DOID:381	arthropathy	GO:0032940	secretion by cell	3.391065206415078e-12	7.478994312748455e-8	66	956	469
DOID:381	arthropathy	GO:0071216	cellular response to biotic stimulus	9.159339953157541e-13	2.0200924266688958e-8	27	175	469
DOID:381	arthropathy	GO:0001503	ossification	4.002242981471227e-12	8.826946895634791e-8	37	363	469
DOID:381	arthropathy	GO:0042098	T cell proliferation	4.2730263771773025e-12	9.42415967486454e-8	24	167	469
DOID:381	arthropathy	GO:0051338	regulation of transferase activity	5.0218718072869706e-12	1.1075738270971414e-7	61	928	469
DOID:381	arthropathy	GO:0072358	cardiovascular system development	1.5947132503413286e-11	3.5171400736278e-7	59	910	469
DOID:381	arthropathy	GO:0040007	growth	2.041655733364678e-11	4.502871719935797e-7	60	936	469
DOID:381	arthropathy	GO:1903708	positive regulation of hemopoiesis	7.34584615358358e-11	1.6201263691728585e-6	22	158	469
DOID:381	arthropathy	GO:0009790	embryo development	1.6210499609314866e-10	3.5752256888343936e-6	58	932	469
DOID:381	arthropathy	GO:0045667	regulation of osteoblast differentiation	3.1848113035692904e-10	7.02410133002207e-6	18	111	469
DOID:381	arthropathy	GO:0001501	skeletal system development	5.169171757302138e-10	1.1400608310729865e-5	38	482	469
DOID:381	arthropathy	GO:0040008	regulation of growth	5.186752138897077e-10	1.1439381842337504e-5	44	617	469
DOID:381	arthropathy	GO:1903035	negative regulation of response to wounding	5.468923092166733e-10	1.206170987977373e-5	21	159	469
DOID:381	arthropathy	GO:0009612	response to mechanical stimulus	6.601450497356609e-10	1.4559499071920001e-5	24	210	469
DOID:381	arthropathy	GO:0036293	response to decreased oxygen levels	7.091004450288096e-10	1.5639210315110397e-5	29	302	469
DOID:381	arthropathy	GO:0042060	wound healing	7.94416310512247e-10	1.752085172834761e-5	40	534	469
DOID:381	arthropathy	GO:0019838	growth factor binding	1.3514129815206388e-9	2.980541330743769e-5	18	121	469
DOID:381	arthropathy	GO:0001525	angiogenesis	1.4183357821551112e-9	3.128139567543098e-5	34	413	469
DOID:381	arthropathy	GO:0001666	response to hypoxia	1.452471587448656e-9	3.203426086118011e-5	28	292	469
DOID:381	arthropathy	GO:0050673	epithelial cell proliferation	1.9068018275447685e-9	4.205451430649987e-5	30	335	469
DOID:381	arthropathy	GO:0009887	organ morphogenesis	2.5327435704269874e-9	5.585965944576721e-5	56	950	469
DOID:381	arthropathy	GO:1901653	cellular response to peptide	2.8706040877679584e-9	6.331117315572232e-5	28	301	469
DOID:381	arthropathy	GO:0008083	growth factor activity	3.3636531338032682e-9	7.418536986603108e-5	20	159	469
DOID:3342	bone inflammation disease	GO:0044236	multicellular organismal metabolic process	5.148104165186851e-13	1.13541437363196e-8	22	127	471
DOID:2921	glomerulonephritis	GO:0042327	positive regulation of phosphorylation	3.141931159689193e-12	6.929529172694515e-8	64	910	476
DOID:2921	glomerulonephritis	GO:0051707	response to other organism	1.9377832671807482e-12	4.27378099576714e-8	64	898	476
DOID:2921	glomerulonephritis	GO:0071216	cellular response to biotic stimulus	1.1168843627729075e-12	2.4632884620956474e-8	27	175	476
DOID:2921	glomerulonephritis	GO:0071219	cellular response to molecule of bacterial origin	1.0615952561465747e-12	2.3413483374312705e-8	26	158	476
DOID:2921	glomerulonephritis	GO:0001775	cell activation	8.484324354185446e-13	1.8712177363156002e-8	64	854	476
DOID:2921	glomerulonephritis	GO:0071222	cellular response to lipopolysaccharide	6.59250432022418e-13	1.4539768278254428e-8	25	152	476
DOID:2921	glomerulonephritis	GO:1903036	positive regulation of response to wounding	3.3950620093037287e-13	7.487809261519374e-9	25	162	476
DOID:2921	glomerulonephritis	GO:0050729	positive regulation of inflammatory response	1.6622259124687844e-12	3.666039249949904e-8	21	114	476
DOID:2921	glomerulonephritis	GO:0050900	leukocyte migration	2.3477886301748185e-12	5.178047823850562e-8	39	354	476
DOID:2921	glomerulonephritis	GO:0050663	cytokine secretion	2.7214897002636462e-12	6.002245533931472e-8	24	162	476
DOID:2921	glomerulonephritis	GO:0002684	positive regulation of immune system process	2.8458346790216638e-12	6.27648838458228e-8	85	872	476
DOID:2921	glomerulonephritis	GO:0051249	regulation of lymphocyte activation	3.435141060492697e-12	7.576203608916643e-8	38	372	476
DOID:2921	glomerulonephritis	GO:0001934	positive regulation of protein phosphorylation	5.404787728480187e-12	1.1920259335163053e-7	62	870	476
DOID:2921	glomerulonephritis	GO:0007067	mitotic nuclear division	5.8972826622039065e-12	1.3006456911490716e-7	47	421	476
DOID:2921	glomerulonephritis	GO:0001817	regulation of cytokine production	6.7871264164409695e-12	1.4969007311460558e-7	48	556	476
DOID:2921	glomerulonephritis	GO:0030155	regulation of cell adhesion	9.246492460590616e-12	2.0393139121832604e-7	50	621	476
DOID:2921	glomerulonephritis	GO:0050867	positive regulation of cell activation	1.3756329408920465e-11	3.0339584511374085e-7	31	288	476
DOID:2921	glomerulonephritis	GO:0051251	positive regulation of lymphocyte activation	2.0650814391842687e-11	4.5545371141209046e-7	29	257	476
DOID:2921	glomerulonephritis	GO:1903037	regulation of leukocyte cell-cell adhesion	2.4301005652205276e-11	5.359586796593874e-7	31	294	476
DOID:2921	glomerulonephritis	GO:0002250	adaptive immune response	3.1468938566092675e-11	6.940474400751739e-7	33	334	476
DOID:2921	glomerulonephritis	GO:0002697	regulation of immune effector process	5.419042992116374e-11	1.1951699319112663e-6	37	418	476
DOID:2921	glomerulonephritis	GO:0001819	positive regulation of cytokine production	6.37140340487008e-11	1.405213020944096e-6	35	381	476
DOID:2921	glomerulonephritis	GO:0098552	side of membrane	6.890477077803325e-11	1.5196947195095234e-6	36	402	476
DOID:2921	glomerulonephritis	GO:0007568	aging	8.266010098623155e-11	1.823068527251337e-6	30	290	476
DOID:2921	glomerulonephritis	GO:0050707	regulation of cytokine secretion	8.355571790019667e-11	1.8428213582888375e-6	21	142	476
DOID:2921	glomerulonephritis	GO:0051726	regulation of cell cycle	9.732881167678897e-11	2.146586941531581e-6	59	930	476
DOID:2921	glomerulonephritis	GO:1903039	positive regulation of leukocyte cell-cell adhesion	1.329983900788534e-10	2.9332794931891115e-6	25	208	476
DOID:2921	glomerulonephritis	GO:0032403	protein complex binding	2.1318447007701025e-10	4.701783487548461e-6	58	924	476
DOID:2921	glomerulonephritis	GO:0050863	regulation of T cell activation	2.34483654715234e-10	5.171537004744486e-6	29	284	476
DOID:2921	glomerulonephritis	GO:0002687	positive regulation of leukocyte migration	2.962027290109859e-10	6.5327511883372935e-6	18	109	476
DOID:2921	glomerulonephritis	GO:0008284	positive regulation of cell proliferation	3.97899824200465e-10	8.775680622741255e-6	53	815	476
DOID:2921	glomerulonephritis	GO:0050670	regulation of lymphocyte proliferation	5.747677889189617e-10	1.2676503584607701e-5	23	189	476
DOID:2921	glomerulonephritis	GO:0050864	regulation of B cell activation	5.807850866901276e-10	1.2809215086950765e-5	17	100	476
DOID:2921	glomerulonephritis	GO:0034112	positive regulation of homotypic cell-cell adhesion	6.607498992394767e-10	1.4572839027726658e-5	24	207	476
DOID:2921	glomerulonephritis	GO:0002443	leukocyte mediated immunity	7.176432781363928e-10	1.5827622499298144e-5	28	279	476
DOID:2921	glomerulonephritis	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	8.051661559704826e-10	1.7757939569928993e-5	24	209	476
DOID:2921	glomerulonephritis	GO:0034097	response to cytokine	8.601563905585863e-10	1.897074919376962e-5	51	784	476
DOID:2921	glomerulonephritis	GO:0030595	leukocyte chemotaxis	9.112703924785137e-10	2.009806850611362e-5	22	177	476
DOID:2921	glomerulonephritis	GO:0009986	cell surface	9.994447491834535e-10	2.2042753943241067e-5	48	715	476
DOID:2921	glomerulonephritis	GO:0050921	positive regulation of chemotaxis	1.2952166006385823e-9	2.8566002127083934e-5	18	119	476
DOID:2921	glomerulonephritis	GO:0051050	positive regulation of transport	1.3708439938753259e-9	3.023396428492031e-5	56	920	476
DOID:2921	glomerulonephritis	GO:0050764	regulation of phagocytosis	1.418318906765137e-9	3.1281023488705095e-5	14	68	476
DOID:2921	glomerulonephritis	GO:0002690	positive regulation of leukocyte chemotaxis	1.4576388984721689e-9	3.2148225905803685e-5	15	80	476
DOID:2921	glomerulonephritis	GO:0050766	positive regulation of phagocytosis	1.5268210029617535e-9	3.367403722032147e-5	12	47	476
DOID:2921	glomerulonephritis	GO:0019882	antigen processing and presentation	2.08506945043041e-9	4.5986206729242696e-5	24	219	476
DOID:2921	glomerulonephritis	GO:0051347	positive regulation of transferase activity	2.110427721468966e-9	4.6545483396998044e-5	43	613	476
DOID:2921	glomerulonephritis	GO:0050870	positive regulation of T cell activation	2.1504137359684705e-9	4.742737494678462e-5	23	202	476
DOID:2921	glomerulonephritis	GO:0002520	immune system development	2.2569672797345675e-9	4.9777413354545885e-5	50	782	476
DOID:2921	glomerulonephritis	GO:0061640	cytoskeleton-dependent cytokinesis	2.319050174115489e-9	5.114665159011711e-5	11	39	476
DOID:2921	glomerulonephritis	GO:0050851	antigen receptor-mediated signaling pathway	2.369131668622515e-9	5.225119895146957e-5	23	203	476
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0007548	sex differentiation	1.2090328738167955e-12	2.6665220032029424e-8	35	274	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:2001234	negative regulation of apoptotic signaling pathway	1.106004177131581e-12	2.4392922126637018e-8	28	199	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0033002	muscle cell proliferation	9.234835118832052e-13	2.036742885458409e-8	25	151	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1903706	regulation of hemopoiesis	7.822631431508853e-13	1.7252813622192775e-8	34	305	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0030278	regulation of ossification	7.02327085377874e-13	1.5489823868009012e-8	26	177	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0044843	cell cycle G1/S phase transition	6.021849685566849e-13	1.3281189481517686e-8	34	234	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0000082	G1/S transition of mitotic cell cycle	3.5771385853422544e-13	7.889379149972342e-9	32	224	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0046661	male sex differentiation	2.466915560717098e-13	5.440782269161559e-9	24	151	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:2000027	regulation of organ morphogenesis	4.39648317751562e-14	9.6964436480107e-10	30	236	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0072089	stem cell proliferation	1.2778667013435552e-13	2.818335009813211e-9	25	139	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001657	ureteric bud development	8.469891454865319e-13	1.868034560370546e-8	21	97	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0007498	mesoderm development	1.0405010186786967e-12	2.2948249966958656e-8	22	123	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0046546	development of primary male sexual characteristics	1.323274823050724e-12	2.918482622238372e-8	22	129	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0008584	male gonad development	1.323274823050724e-12	2.918482622238372e-8	22	129	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0022612	gland morphogenesis	2.6072477510297176e-12	5.750284914896042e-8	21	119	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1902807	negative regulation of cell cycle G1/S phase transition	3.0130342665302123e-12	6.645247074832383e-8	19	94	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0060675	ureteric bud morphogenesis	4.124922625692307e-12	9.097516850964382e-8	16	64	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0007423	sensory organ development	7.40807415411382e-12	1.633850754689803e-7	47	494	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048638	regulation of developmental growth	8.529732475892615e-12	1.8812324975581163e-7	31	283	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010631	epithelial cell migration	1.1702860902573775e-11	2.581065972062646e-7	27	218	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001658	branching involved in ureteric bud morphogenesis	1.4749756971355055e-11	3.2530589000323573e-7	15	59	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0030099	myeloid cell differentiation	1.901812041182893e-11	4.194446456828871e-7	33	327	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0045669	positive regulation of osteoblast differentiation	1.9205859125293046e-11	4.235852230083381e-7	15	60	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010463	mesenchymal cell proliferation	2.1833090890766016e-11	4.815288195958445e-7	13	42	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010464	regulation of mesenchymal cell proliferation	2.2071788841060425e-11	4.867933028895877e-7	12	34	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:2000377	regulation of reactive oxygen species metabolic process	2.3655299941083285e-11	5.217176402005919e-7	22	147	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0043588	skin development	2.3722801500980495e-11	5.232063871041248e-7	28	241	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051302	regulation of cell division	2.442424040793867e-11	5.386766221970873e-7	31	293	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0005694	chromosome	3.342559562469205e-11	7.372015115025832e-7	58	876	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010721	negative regulation of cell development	3.905120671277018e-11	8.612743640501463e-7	31	299	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0035264	multicellular organism growth	4.344280490897745e-11	9.581310622674977e-7	21	137	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0031647	regulation of protein stability	4.644740148052051e-11	1.0243974396528799e-6	26	214	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042326	negative regulation of phosphorylation	6.540623598283446e-11	1.442534534601414e-6	37	420	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0060541	respiratory system development	7.284173264565652e-11	1.6065244134999546e-6	25	202	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0045604	regulation of epidermal cell differentiation	7.924749745313875e-11	1.747803556328975e-6	13	46	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001933	negative regulation of protein phosphorylation	8.840306264801256e-11	1.949729546701917e-6	35	385	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0002065	columnar/cuboidal epithelial cell differentiation	8.842149235022134e-11	1.9501360137841317e-6	20	128	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0006275	regulation of DNA replication	8.969824882854027e-11	1.9782948779134557e-6	22	157	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0035270	endocrine system development	1.0198120126148069e-10	2.2491953938219567e-6	20	129	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051961	negative regulation of nervous system development	1.350662914845202e-10	2.978887058691093e-6	28	259	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0035107	appendage morphogenesis	1.4780598966979142e-10	3.2598611021672497e-6	21	146	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0035108	limb morphogenesis	1.4780598966979142e-10	3.2598611021672497e-6	21	146	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0006974	cellular response to DNA damage stimulus	1.5220325000342427e-10	3.3568426788255223e-6	52	767	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051098	regulation of binding	1.6100609734337468e-10	3.5509894769081285e-6	29	279	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0098727	maintenance of cell number	1.68172809011935e-10	3.709051302758226e-6	21	147	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0016568	chromatin modification	1.7199364155118246e-10	3.7933197644113292e-6	45	608	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048645	organ formation	1.9401069639712887e-10	4.278905909038677e-6	14	59	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048332	mesoderm morphogenesis	2.060622783517374e-10	4.5447035490475685e-6	15	70	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0007517	muscle organ development	2.3652513281291476e-10	5.216561804188835e-6	32	340	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010332	response to gamma radiation	2.516291619514277e-10	5.549681166838738e-6	13	50	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010638	positive regulation of organelle organization	2.874626092719268e-10	6.3399878474923455e-6	43	573	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0070489	T cell aggregation	3.1547064960335547e-10	6.957705177002005e-6	36	424	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042110	T cell activation	3.1547064960335547e-10	6.957705177002005e-6	36	424	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0002064	epithelial cell development	4.1547687512633047e-10	9.163342480911219e-6	24	202	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0090316	positive regulation of intracellular protein transport	4.217304283571366e-10	9.301264597416647e-6	27	254	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0035113	embryonic appendage morphogenesis	4.272325826448764e-10	9.422614610232749e-6	19	125	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1900182	positive regulation of protein localization to nucleus	4.272325826448764e-10	9.422614610232749e-6	19	125	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0030326	embryonic limb morphogenesis	4.272325826448764e-10	9.422614610232749e-6	19	125	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042307	positive regulation of protein import into nucleus	4.3224446244494175e-10	9.53315161922319e-6	17	98	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048839	inner ear development	4.3409642547231897e-10	9.573996663791995e-6	22	170	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0050768	negative regulation of neurogenesis	4.936783204456674e-10	1.0888075357429194e-5	26	238	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048812	neuron projection morphogenesis	5.086590038061445e-10	1.1218474328944517e-5	41	539	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0060249	anatomical structure homeostasis	5.307827510847574e-10	1.1706413575174324e-5	32	351	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:2000736	regulation of stem cell differentiation	5.640563571773782e-10	1.2440262957547077e-5	18	113	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0000228	nuclear chromosome	6.026407151082935e-10	1.3291240971713414e-5	40	520	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0002053	positive regulation of mesenchymal cell proliferation	6.162298449297055e-10	1.3590949229924654e-5	10	27	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0007565	female pregnancy	6.65490773599231e-10	1.467739901173104e-5	23	190	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001656	metanephros development	6.854905532094335e-10	1.5118494151034056e-5	16	88	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042633	hair cycle	7.039343552506239e-10	1.552527220505251e-5	17	101	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0030324	lung development	7.610854169115555e-10	1.6785738869984357e-5	22	175	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0019904	protein domain specific binding	9.663927436065478e-10	2.1313791960242412e-5	44	619	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001704	formation of primary germ layer	1.0100578151650552e-9	2.2276825113465293e-5	18	117	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0046777	protein autophosphorylation	1.0849864340300996e-9	2.3929375802533848e-5	25	229	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0044708	single-organism behavior	1.2379989255961732e-9	2.73040663040236e-5	34	404	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048469	cell maturation	1.2567883400649293e-9	2.7718466840132017e-5	20	148	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048609	multicellular organismal reproductive process	1.269045646346001e-9	2.798880173016105e-5	50	767	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051129	negative regulation of cellular component organization	1.2919014746870516e-9	2.8492887024222924e-5	42	579	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042060	wound healing	1.2955121420077376e-9	2.8572520291980652e-5	40	534	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0010952	positive regulation of peptidase activity	1.4177837792672676e-9	3.126922125173959e-5	20	149	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1901654	response to ketone	1.4549335070057623e-9	3.208855849701209e-5	22	181	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001707	mesoderm formation	1.4571754913816903e-9	3.213800546242318e-5	14	68	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0001654	eye development	1.6001474589799614e-9	3.529125220780305e-5	30	327	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051054	positive regulation of DNA metabolic process	1.7950182451542673e-9	3.9589127396877366e-5	22	183	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0043542	endothelial cell migration	1.7987694667098708e-9	3.96718605882862e-5	20	151	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0021915	neural tube development	1.7987694667098708e-9	3.96718605882862e-5	20	151	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042803	protein homodimerization activity	1.8417629643607825e-9	4.062008217897706e-5	47	703	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0044427	chromosomal part	1.8734713780332868e-9	4.131941124252414e-5	50	776	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:2001235	positive regulation of apoptotic signaling pathway	2.0640146258799064e-9	4.5521842573781335e-5	21	168	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051249	regulation of lymphocyte activation	2.2512324227008662e-9	4.9650931082667604e-5	32	372	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1903707	negative regulation of hemopoiesis	2.3152506578583143e-9	5.106285325906512e-5	18	123	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0003684	damaged DNA binding	2.32799235444503e-9	5.134387137728513e-5	13	59	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0042542	response to hydrogen peroxide	2.6452761092699006e-9	5.834156458994766e-5	18	124	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0005057	receptor signaling protein activity	2.861745840299079e-9	6.311580450779619e-5	20	155	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048661	positive regulation of smooth muscle cell proliferation	2.903524309871841e-9	6.403722865422345e-5	13	60	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0046332	SMAD binding	3.217837107882815e-9	7.096939741435548e-5	14	72	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0043005	neuron projection	3.337922938051463e-9	7.361789039872502e-5	56	941	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0051099	positive regulation of binding	3.4393841108482093e-9	7.585561656475726e-5	18	126	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0043235	receptor complex	3.45675310597926e-9	7.623868975237258e-5	29	318	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0044057	regulation of system process	3.5426899192003702e-9	7.813402616796417e-5	38	508	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0044853	plasma membrane raft	3.615486798835832e-9	7.973956134832427e-5	15	85	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:1902105	regulation of leukocyte differentiation	3.741659648781592e-9	8.252230355387802e-5	24	225	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0046660	female sex differentiation	3.913944723876739e-9	8.632205088510148e-5	18	127	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0034614	cellular response to reactive oxygen species	3.913944723876739e-9	8.632205088510148e-5	18	127	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0000988	transcription factor activity, protein binding	3.922354552265972e-9	8.650752965022601e-5	41	578	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0014020	primary neural tube formation	4.277892373671932e-9	9.434891630133446e-5	15	86	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0048871	multicellular organismal homeostasis	4.2815252454531105e-9	9.442903928846835e-5	29	321	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0071901	negative regulation of protein serine/threonine kinase activity	4.448434398618417e-9	9.811022066152919e-5	18	128	477
MESH:D009375	Neoplasms, Glandular and Epithelial	GO:0036473	cell death in response to oxidative stress	4.4567278756346695e-9	9.829313329712264e-5	13	62	477
DOID:5223	infertility	GO:0042327	positive regulation of phosphorylation	3.2747138334343617e-12	7.222381359639485e-8	63	910	481
DOID:5223	infertility	GO:0023014	signal transduction by protein phosphorylation	9.81770220676026e-13	2.1652942217009752e-8	64	879	481
DOID:5223	infertility	GO:0001944	vasculature development	6.238010108461367e-12	1.3757931294211545e-7	50	588	481
DOID:5223	infertility	GO:0071407	cellular response to organic cyclic compound	6.3541394368371584e-12	1.4014054527944353e-7	40	416	481
DOID:5223	infertility	GO:0001934	positive regulation of protein phosphorylation	6.750933145838189e-12	1.4889183053146127e-7	60	870	481
DOID:5223	infertility	GO:0008134	transcription factor binding	1.3204659587984224e-11	2.9122876721299207e-7	44	518	481
DOID:5223	infertility	GO:0007568	aging	2.2469803795388543e-11	4.955715227072943e-7	31	290	481
DOID:5223	infertility	GO:0042471	ear morphogenesis	7.028566617606202e-11	1.550150367513048e-6	19	112	481
DOID:5223	infertility	GO:0001541	ovarian follicle development	7.506262278411668e-11	1.6555061455036935e-6	15	65	481
DOID:5223	infertility	GO:0042562	hormone binding	7.506262278411668e-11	1.6555061455036935e-6	15	65	481
DOID:5223	infertility	GO:0031667	response to nutrient levels	8.766110060065557e-11	1.9333655737474587e-6	43	546	481
DOID:5223	infertility	GO:0097305	response to alcohol	1.4408840787183408e-10	3.1778698356133006e-6	34	369	481
DOID:5223	infertility	GO:1901615	organic hydroxy compound metabolic process	1.4583889651476056e-10	3.2164768626330442e-6	42	534	481
DOID:5223	infertility	GO:0032355	response to estradiol	1.5051537793908665e-10	3.319616660446556e-6	21	145	481
DOID:5223	infertility	GO:0002237	response to molecule of bacterial origin	1.7156809306584364e-10	3.7839342925671815e-6	32	333	481
DOID:5223	infertility	GO:0031960	response to corticosteroid	2.350840633269513e-10	5.184779016675911e-6	23	179	481
DOID:5223	infertility	GO:0045926	negative regulation of growth	2.78579492807296e-10	6.144070713864913e-6	26	230	481
DOID:5223	infertility	GO:0044057	regulation of system process	3.9209302471476803e-10	8.647611660084209e-6	40	508	481
DOID:5223	infertility	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	4.880646997662552e-10	1.0764266953344759e-5	45	623	481
DOID:5223	infertility	GO:0002064	epithelial cell development	4.916369533702891e-10	1.0843053006581727e-5	24	202	481
DOID:5223	infertility	GO:0097285	cell-type specific apoptotic process	5.441741501854835e-10	1.200176088234084e-5	36	429	481
DOID:5223	infertility	GO:0050680	negative regulation of epithelial cell proliferation	5.548420611845017e-10	1.2237041659424186e-5	18	112	481
DOID:5223	infertility	GO:0001701	in utero embryonic development	6.361935422916076e-10	1.4031248575241406e-5	30	312	481
DOID:5223	infertility	GO:0030879	mammary gland development	7.43364814148606e-10	1.6394910976047505e-5	19	128	481
DOID:5223	infertility	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	1.0380466486381579e-9	2.2894118835714572e-5	49	732	481
DOID:5223	infertility	GO:0032496	response to lipopolysaccharide	1.082947842512283e-9	2.38844146666084e-5	30	319	481
DOID:5223	infertility	GO:0042063	gliogenesis	1.175098796046825e-9	2.5916803946812728e-5	25	228	481
DOID:5223	infertility	GO:1901653	cellular response to peptide	1.175962660582286e-9	2.5935856479142316e-5	29	301	481
DOID:5223	infertility	GO:0071383	cellular response to steroid hormone stimulus	1.2229377510664108e-9	2.697189209976969e-5	21	162	481
DOID:5223	infertility	GO:0009636	response to toxic substance	1.5694696653412166e-9	3.461465346910053e-5	26	249	481
DOID:5223	infertility	GO:0051241	negative regulation of multicellular organismal process	1.6748552544854078e-9	3.693893263767567e-5	58	966	481
DOID:5223	infertility	GO:0060440	trachea formation	1.941502181246335e-9	4.281983060738792e-5	6	7	481
DOID:5223	infertility	GO:0035264	multicellular organism growth	2.405875609845509e-9	5.3061586575142705e-5	19	137	481
DOID:5223	infertility	GO:0042803	protein homodimerization activity	2.410110111483732e-9	5.315497850877371e-5	47	703	481
DOID:5223	infertility	GO:0061008	hepaticobiliary system development	2.7247243350458916e-9	6.009379520943714e-5	19	138	481
DOID:5223	infertility	GO:0051726	regulation of cell cycle	2.9741368257063527e-9	6.559458769095361e-5	56	930	481
DOID:5223	infertility	GO:0044212	transcription regulatory region DNA binding	3.256949487884242e-9	7.183202095528696e-5	51	807	481
DOID:5223	infertility	GO:0001974	blood vessel remodeling	3.485536748115692e-9	7.687351297969158e-5	11	40	481
DOID:5223	infertility	GO:0060537	muscle tissue development	3.6828013971756945e-9	8.122418481470994e-5	30	336	481
DOID:5223	infertility	GO:0001649	osteoblast differentiation	3.8464753604472435e-9	8.483401407466395e-5	23	206	481
DOID:5223	infertility	GO:0045165	cell fate commitment	4.4122844267135974e-9	9.731293303116839e-5	25	243	481
DOID:10952	nephritis	GO:0009607	response to biotic stimulus	2.8987923172962837e-12	6.393286455796954e-8	68	934	490
DOID:10952	nephritis	GO:0009611	response to wounding	2.5976998330179413e-12	5.7292269817210695e-8	67	875	490
DOID:10952	nephritis	GO:0000278	mitotic cell cycle	1.7474910407599964e-13	3.854091490396172e-9	73	927	490
DOID:10952	nephritis	GO:0000280	nuclear division	6.409539565765954e-12	1.413623951229681e-7	54	541	490
DOID:10952	nephritis	GO:0002696	positive regulation of leukocyte activation	1.4291234862184865e-11	3.151931848854872e-7	31	280	490
DOID:10952	nephritis	GO:0030198	extracellular matrix organization	2.5473179121604517e-11	5.618109655269876e-7	33	320	490
DOID:10952	nephritis	GO:0098602	single organism cell adhesion	2.87205814686331e-11	6.33432424290703e-7	54	746	490
DOID:10952	nephritis	GO:0007159	leukocyte cell-cell adhesion	4.537925590852865e-11	1.0008394890625993e-6	40	461	490
DOID:10952	nephritis	GO:0051338	regulation of transferase activity	7.573516258574386e-10	1.670339010828581e-5	58	928	490
DOID:10952	nephritis	GO:0032680	regulation of tumor necrosis factor production	9.019769375839815e-10	1.989310135841471e-5	17	100	490
DOID:10952	nephritis	GO:0030162	regulation of proteolysis	1.363594570591431e-9	3.007407825439401e-5	48	701	490
DOID:10952	nephritis	GO:0032760	positive regulation of tumor necrosis factor production	1.6142727154999648e-9	3.560278474035172e-5	13	56	490
DOID:10952	nephritis	GO:1902533	positive regulation of intracellular signal transduction	2.628539830240584e-9	5.7972445955956076e-5	54	860	490
DOID:10952	nephritis	GO:0002521	leukocyte differentiation	2.858687730977749e-9	6.304835790671426e-5	36	448	490
